0001237831-15-000009.txt : 20150226 0001237831-15-000009.hdr.sgml : 20150226 20150226161245 ACCESSION NUMBER: 0001237831-15-000009 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150226 DATE AS OF CHANGE: 20150226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 15652687 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 10-K 1 gmed12311410k.htm 10-K GMED 12.31.14 10K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 10-K

(Mark One)
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2014
or
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______________ to _______________

Commission File No. 001-35621

GLOBUS MEDICAL, INC.
(Exact name of registrant as specified in its charter)


DELAWARE
 
04-3744954
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
2560 General Armistead Avenue, Audubon, PA
 
19403
(Address of principal executive offices)
 
(Zip Code)
 
 
 
Registrant’s telephone number, including Area Code:
(610) 930-1800

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Name of each exchange on which registered
Class A Common Stock, par value $.001 per share
New York Stock Exchange
 
 

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act:
Yes   o
No   x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act:
Yes   o
No   x


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:
Yes   x
No   o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files):
Yes   x
No   o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405) is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K:
o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

Large accelerated filer x
Accelerated filer o
Non-accelerated filer o
(Do not check if a smaller reporting company)
Smaller reporting company o


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act):

 Yes ¨  No x

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, computed by reference to the closing sales price for the registrant’s common stock on the last business day of the registrant’s most recently completed second quarter, June 30, 2014, as reported on the New York Stock Exchange, was approximately $1.6 billion.

The number of shares outstanding of the registrant’s common stock (par value $0.001 per share) as of January 31, 2015 was 94,761,428 shares.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of our Proxy Statement for our 2015 Annual Meeting of Stockholders, to be filed within 120 days of December 31, 2014, are incorporated by reference in Part III, Items 10, 11, 12, 13 and 14 herein of this Annual Report. Such Proxy Statement, except for the parts therein which have been specifically incorporated by reference, shall not be deemed “filed” for the purposes of this Annual Report on Form 10-K.


GLOBUS MEDICAL, INC. AND SUBSIDIARIES
TABLE OF CONTENTS
 
 
Page
 
 
 
 
PART I
 
Item 1.
Business
Item 1A.
Risk Factors
Item 1B.
Unresolved Staff Comments
Item 2.
Properties
Item 3.
Legal Proceedings
Item 4.
Mine Safety Disclosures
 
 
 
 
PART II
 
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 6.
Selected Financial Data
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
Item 8.
Financial Statements and Supplementary Data
Item 9.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
Item 9A.
Controls and Procedures
Item 9B.
Other Information
 
 
 
 
PART III
 
Item 10.
Directors, Executive Officers and Corporate Governance
Item 11.
Executive Compensation
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13.
Certain Relationships and Related Transactions, and Director Independence
Item 14.
Principal Accountant Fees and Services
 
 
 
 
PART IV
 
Item 15
Exhibits and Financial Statement Schedules
 
 
 
 
SIGNATURES
 
 
 



3

PART I
CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact are forward-looking statements. We have tried to identify forward-looking statements by using words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and similar words. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changes and applicable laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, and general economic conditions, and other risks set forth throughout this Annual Report, including under “Item 1, Business,” “Item 1A, Risk Factors,” and “Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and those discussed in other documents we file with the Securities and Exchange Commission (the “SEC”). Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this Annual Report speak only as of the date of this Annual Report. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Item 1. Business
Overview
Globus Medical, Inc. (“Globus,” “we,” “us” or “our”) is a medical device company focused on developing products that promote healing in patients with musculoskeletal disorders. We are currently focused on products to treat patients with spine disorders. We are an engineering-driven company with a history of rapidly developing and commercializing advanced and innovative products and procedures that assist surgeons in effectively treating their patients. Since our inception in 2003, we have launched over 130 products and offer a comprehensive portfolio of innovative and differentiated products addressing a broad array of spinal pathologies, anatomies and surgical approaches. We continue to devote significant efforts to the development of new and innovative technologies for the treatment of patients with spine disorders. In 2014, those efforts resulted in the launch of sixteen new products.
All of our products fall into one of two categories: Innovative Fusion or Disruptive Technologies. Our Innovative Fusion products comprise fusion products to treat a wide variety of spinal disorders for the

4

entire spine and can be used in a variety of surgical approaches. We believe our Innovative Fusion products have features and characteristics that may provide advantages for surgeons and potentially contribute to better outcomes for patients as compared to competing traditional fusion products.
We define Disruptive Technologies as those that represent a significant shift in the treatment of spinal disorders by allowing for novel surgical procedures, improvements to existing surgical procedures and the treatment of spinal disorders earlier in the continuum of care. We believe the use of Disruptive Technologies may improve patient outcomes and reduce costs given the expected lower morbidity rates, shorter patient recovery times and shorter hospital stays associated with these procedures. Additionally, Disruptive Technologies may help a patient avoid progression of spinal disc disease sometimes caused by traditional surgical options such as spinal fusion. Our current portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (“MIS”) techniques, as well as new treatment alternatives, including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies, as well as interventional pain management solutions, including treatments for vertebral compression fractures.
While we group our products into two categories, we do not limit our products to a particular technology, platform or surgical approach. Our goal, instead, is to offer spine surgeons a complete suite of products they can use to most effectively treat their patients, based on the patient’s particular anatomy and condition and the surgeon’s particular training and surgical preference.
Recent Developments
In October 2014, we completed the acquisition of Transplant Technologies of Texas, Ltd., (“TTOT”), an allograft tissue processor based in San Antonio, Texas. TTOT is a provider of human tissue products such as bone allografts, biomaterials and soft tissue products for spine, orthopedics, sports medicine, dental and wound care markets. This acquisition represents a key step in fulfilling our strategy of building a broad business in regenerative biologics. While we currently partner with third party suppliers for our existing allograft products, the acquisition of TTOT will expand our suite of regenerative biologics products. We believe this acquisition will also greatly improve our capabilities for the development of new and innovative human allograft tissue products in the future.
On February 25, 2015, we entered into an agreement to acquire medical device manufacturer Branch Medical Group, Inc. (“BMG”). Under the terms of the agreement we have agreed to pay approximately $52.9 million in cash subject to certain closing adjustments for BMG on a cash-free, debt-free basis. We expect the closing of the acquisition to occur in March 2015 following satisfaction of the applicable closing conditions.
Strategy
Our goal is to become the leader in providing innovative solutions across the continuum of care in the spine market. To achieve this goal, we are employing the following business strategies:
•
Leverage our product development engine. We plan to continue developing both Innovative Fusion products and Disruptive Technology products using our product development engine. We believe our team-oriented approach, active surgeon input and demonstrated product development capabilities position us to maintain a rapid rate of new product launches. We launched sixteen new products in 2014, have over 30 potential new products in various stages of development, and expect to launch approximately five to ten new products in each of the next three years.

5

•
Increase the size, scope and productivity of our exclusive U.S. sales force. We believe there is significant opportunity for us to further penetrate existing markets and to enter new markets by increasing the size and geographic scope of our exclusive U.S. sales force. We expect to continue to increase the number of our direct and distributor sales representatives in the United States to expand into new geographic territories and to deepen our penetration in existing territories. We will also continue to provide our sales representatives with specialized development programs designed to improve their productivity.
•
Continue to expand into international markets. As of December 31, 2014, we had an existing direct or distributor sales presence in 33 countries outside the United States. We expect to continue to increase our international presence through the commercialization of additional products and through the expansion of our international sales force.
•
Pursue strategic acquisitions and alliances. We intend to selectively pursue acquisitions and alliances in the future that will provide us with new or complementary technologies, personnel with significant relevant experience, or increased market penetration. We are currently evaluating a number of possible acquisitions or strategic relationships and believe that our resources and experience make us an attractive acquirer or partner.
The Spine Market
Spine disorders are a leading driver of healthcare costs worldwide. Spine disorders range in severity from mild pain and loss of feeling to extreme pain and paralysis. These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma.
Treatment alternatives for spine disorders range from non-operative conservative therapies to surgical interventions. Conservative therapies include bed rest, medication and physical therapy. When conservative therapies fail to provide adequate quality of life improvements, surgical interventions may be used to address pain. Surgical treatments for spine disorders can be instrumented, which include the use of implants, or non-instrumented, which forego the use of any such implants.
We believe the spine market will continue to experience growth as a result of the following market influences:
•
Favorable patient demographics. The number of people over the age of 65 is large and growing. Improvements in healthcare have led to increasing life expectancies worldwide and the opportunity to lead more active lifestyles at advanced ages. These trends are expected to generate increased demand for spine surgeries.
•
Improving technologies leading to increased use in fusion procedures. Due to the longevity of its practice and acceptable clinical outcomes, fusion has become a standard treatment option for patients presenting more advanced stages of spine disease. We expect that the development of improved fusion products will continue to contribute to spinal fusion as a leading treatment for advanced stages of spine disease.
•
Disruptive Technologies driving earlier interventions and creating an expanded patient base. Newer technology products and procedures are gaining increasing acceptance among patients and surgeons because they allow for novel surgical procedures, improvements to existing surgical procedures, the treatment of spine disorders by new physician specialties, and surgical intervention earlier in the continuum of care, all of which can result in better outcomes for patients. As a

6

result, we expect Disruptive Technologies to drive accelerated growth and increase the size of the addressable patient population for spine surgery.
•
Increased demand in international markets. While the United States comprises approximately 4% of the worldwide population, we believe that approximately half of all spine surgeries occur in the United States. We believe that improvements to the standard of care outside of the United States will increase the international demand for spine products.
The Globus Solution
We currently offer over 130 products for the treatment of spine disorders.
Innovative Fusion Products
The depth of our Innovative Fusion portfolio encompasses treatment modalities from the occiput to the sacrum, with novel designs and features that provide key improvements to the standards of care. We also build on proven technologies to continuously upgrade our offerings, including a range of interbody implant and surgical approach options.
Our Innovative Fusion products address the entire spine to treat degenerative, deformity, tumor, and trauma conditions. We believe that our products offer features and characteristics that provide advantages over traditional fusion products that may help improve surgical techniques and may contribute to better outcomes for patients. For example, in 2013, we introduced a new pedicle screw platform, CREO®. This new system is optionally modular and offers lower profile constructs along with a variety of options to meet surgical and patient needs. CREO® includes our convenient non-threaded locking cap design that eases building of thoracolumbar fixation constructs to readily adapt to the patient’s anatomy and condition, for a range of clinical applications. In 2014, among several other new products, we launched several additions to the CREO® platform including streamlined and intuitive instruments that offer surgeons options for almost any situation or preference.
The depth of our Innovative Fusion portolio encompasses treatment modalities from the occiput to the sacrum, with novel designs and features that provide improvements to the standard of care. We also build on proven technologies to continuously upgrade out offerings.
Disruptive Technologies Products
We believe we are well positioned to capitalize on this higher-growth segment of the spine market given our multiple existing commercialized products and several products in various stages of development. We have a broad, comprehensive product portfolio and pipeline of Disruptive Technologies, including MIS, motion preservation, and advanced biomaterials technologies, as well as interventional pain management solutions.
Our MIS products enable a surgeon to perform a procedure less invasively to minimize tissue disruption and maximize native anatomy, which may lead to better patient recovery and fewer approach-related complications. For example, our MARS™ 3V retractor system facilitates smaller incisions with the use of positionable radiolucent retractor blades to access the surgical site and to allow both direct and radiographic visualization. We believe we have the most comprehensive offering of expandable interbody cages in the industry, and added ALTERA®, an articulating expandable spacer, to our lineup in 2014. Key products in this family, including CALIBER®, RISE® and LATIS® interbody spacers, are designed to enable reliable, minimally disruptive delivery through small MIS incisions with streamlined implants and

7

instruments. We offer a variety of innovative fixation options including plates and pedicle screw systems designed for minimally invasive insertion.
Similarly, other Disruptive Technology products include our motion preservation offerings, such as SECURE®-C and SECURE®-CR, which are next-generation cervical arthroplasty devices that allow segmental motion, are semi-constrained, and provide alternatives to fusion in the treatment of degenerative conditions. In 2014, we launched MONUMENT®, our interbody implant intended to aid in the reduction of a grade 1 spondylolisthesis using its built-in, self-locking mechanical reduction feature.
Our advanced biomaterials products, including bioactive glass-based KINEX® and SIGNIFY™ bone void fillers and CONDUCT® ceramic-collagen, are well suited for pelvic/extremity and posterolateral spinal fusion procedures. Our SHIELD® and AFFIRM® products allow for the treatment of painful vertebral compression fractures.
Product Development and Research
Globus was founded with a goal of leveraging our team’s extensive experience in the spine industry to use a distinctive product development process that significantly reduces the length of time between a product’s concept stage and commercialization. Our product development engine is the name we give to our particular approach to product development, which we believe is unique and highly efficient. We employ an integrated team approach to product development that involves collaboration among surgeons, our engineers, our dedicated researchers, our highly-skilled machinists, and our clinical and regulatory personnel. We believe that utilizing these integrated teams, as well as our extensive in-house facilities, allows us to design, test, and obtain timely regulatory clearance and approvals of our products. We also believe that our product development engine enables us to develop products that provide advantages for surgeons and contribute to better outcome for patients.
Our product development efforts are supported by our in-house research capabilities. We believe that centralizing and consolidating the critical elements of the product development and commercialization process in one facility allows us to bring products from the concept stage to the market rapidly in order to respond to surgeon and patient needs. Our research resources include a clinical research group, a mechanical testing laboratory, a spinal kinematics laboratory, a tribology laboratory, a cadaveric laboratory, a materials characterization laboratory, and a computational laboratory.
The markets in which we operate are subject to rapid technological advancements. We must constantly improve our existing products and introduce new products in order to continue to succeed. Accordingly, we have made significant investments in our product development and research capabilities. For the years ended December 31, 2014, 2013 and 2012, we spent $31.7 million, $26.9 million and $27.9 million, respectively, on research and development.
Clinical Development Programs
In addition to the products we currently market, we continue to develop and test new spine products. As we focus our attention on developing more Disruptive Technologies, we are required to conduct clinical trials in order to obtain U.S. Food and Drug Administration (“FDA”) approval or clearance to market some of those products. We received our first FDA pre-market approval (“PMA”) for our SECURE®-C Cervical Artificial Disc in September 2012 and are currently conducting other clinical trials under FDA-approved investigational device exemptions (“IDEs”), including ACADIA® and TRIUMPH®. The ACADIA® Facet Replacement System is a motion preserving anatomic reconstruction of the facet joint intended for the treatment of spinal stenosis, and was acquired in 2011 from Facet Solutions. A prospective randomized

8

pivotal study of ACADIA® is currently underway in the United States to enroll and treat up to 750 qualified patients randomly selected for the treatment or control of posterolateral fusion arm in a 2:1 ratio. The TRIUMPH® Lumbar Disc is a motion preserving disc replacement inserted obliquely into the disc space from a posterolateral approach to address posterior spinal pathology and maintain important anterior anatomical structures. A 20-patient IDE pilot study for treatment of patients suffering from back and leg pain has been completed. Both ACADIA® and TRIUMPH® are European Conformity marked (“CE marked”) and available for sale in certain jurisdictions outside the United States.
Sales and Marketing
We market and sell our products through our exclusive global sales force. As of December 31, 2014, we had a direct or distributor sales presence in the United States and in 33 countries outside the United States. We expect to continue to increase the number of our direct and distributor sales representatives, both in the U.S. and internationally, to expand into new geographic territories and to deepen our penetration in existing territories. We believe the expansion of our U.S. and international sales forces provides us with significant opportunities for future growth as we continue to penetrate existing geographic markets and enter new ones.
Our sales representatives are present in the operating room during most surgeries in the United States and in many, but not all, of the other countries in which our products are sold. Our representatives have the responsibility to confirm that all of the items needed in the surgery are sterile when provided or are capable of being sterilized at the hospital and are available to the surgeon and surgical staff. Various sizes and quantities of implants are made available to be able to satisfy varying surgical requirements and patient anatomy, along with numerous surgical instruments and cases needed to safely perform the surgery and implantation. As our products are used in surgeries, we ship replacement items to our sales representatives and hospitals to replenish their supply.
All of our independent distributors are compensated solely on commission. Most of our new direct sales representatives start with a compensation arrangement that is largely based on salary. Our goal is to have members of our direct sales force move toward a compensation model based solely on commission as they become familiar with our products and drive higher sales.
Advancement of Spine Care
We are committed to the advancement of spine care through our support of numerous educational and research programs geared towards spine surgeons, such as:
•
national and regional educational courses;
•
intensive hands-on cadaveric training on new products and new techniques;
•
research collaboration and support;
•
educational support; and
•
fellowship support.
We devote significant resources to training and educating surgeons in the safe and effective use of our products and techniques. To that end, we have made significant investments in the creation, staffing and program offerings of our Musculoskeletal Education and Research Center (“MERC”). Through MERC, we offer educational and training programs both internally in our modern bioskills laboratory and 100 person lecture facility and externally through regionally-based didactic education and cadaveric bioskills training programs.
We are highly focused on training through programs such as our Skin-to-Skin® Series programs that feature intensive two day MIS training programs on thoracolumbar interbody fusion procedures and our lateral lumbar interbody fusion labs. To complement these intensive cadaveric bioskills training programs,

9

we also conduct product-based programs providing surgeons with informative didactic sessions coupled with hands-on-lab segments to allow surgeons to learn and experience new instrumentation and techniques. For more complex procedures and techniques, surgeon preceptorships are offered which provide surgeons with one-on-one intraoperative training followed in some instances by focused bioskills labs.
We have a strong commitment to research performed in conjunction with surgeons from around the world. Many surgeons, particularly in non-academic settings, lack the resources to pursue academic investigation of areas of interest, and we actively support these research opportunities as well as opportunities in collaboration with leading academic institutions. Supported by a large, focused research team, these efforts range from basic biomechanical testing conducted internally with our six degrees of freedom machine to support of major clinical outcomes studies. We are committed to providing the spine surgeon community with high quality research to support the new surgical techniques and novel product designs that we develop.
Competition
We believe that our significant competitors are Medtronic, the DePuy Synthes Companies (a division of Johnson & Johnson), Stryker and NuVasive. Alphatec Spine, Orthofix International, Zimmer, LDR Holding, Biomet, K2M and other smaller public and private companies are also competitors of ours. At any time, these or other market participants may develop alternative treatments, products or procedures for the treatment of spine disorders that compete directly or indirectly with our products. They may also develop and patent processes or products earlier than we can or obtain regulatory clearance or approvals for competing products more rapidly than we can.
We compete in the marketplace to recruit and retain qualified scientific, management and sales personnel, as well as in acquiring technologies and technology licenses complementary to our products or advantageous to our business.
Our currently marketed products are, and any future products we commercialize will be, subject to intense competition. Many of our current and potential competitors are major medical device companies that have substantially greater financial, technical and marketing resources than we do, and they may succeed in developing products that would render our products obsolete or noncompetitive. In addition, many of these competitors have significantly longer operating history and more established reputations than we do. The spine market is intensely competitive, subject to rapid change and highly sensitive to the introduction of new products or other market activities of industry participants. Our ability to compete successfully will depend on our ability to develop proprietary products that reach the market in a timely manner, receive adequate coverage and reimbursement, and are safer, less invasive and more effective than alternatives available for similar purposes. Because of the size of the potential market, we anticipate that companies will dedicate significant resources to developing competing products.
Manufacturing and Supply
Most of our products are generally manufactured through a network of over 100 international and domestic third-party suppliers.  Our suppliers utilize state-of-the-art, high precision, computer-aided manufacturing equipment to manufacture our products. We have focused on developing a strong supplier base as part of our manufacturing strategy. Our relationship with our suppliers enables significant interaction between our design engineers and project managers and the suppliers' engineers and schedulers to work through issues arising during the entire product development cycle.  Many of our suppliers, including our largest suppliers, are located within a 100-mile radius of the Philadelphia area, which affords our engineers and other members of our product development team the opportunity to work closely with them to commercialize our products.

10

We select our suppliers carefully and generally use a small number of suppliers for each of our key products for added reliability.  Our internal quality assurance group evaluates the potential vendor through a formal vendor approval process before we enter into a relationship with the vendor.  Suppliers that meet our internal quality assurance standards are added to our approved supplier list. All of our suppliers that provide us with implants or human tissue are ISO-13485 certified, meaning they meet the International Organization for Standardization (“ISO”) requirements for the manufacture of medical devices, and/or are accredited by the American Association of Tissue Banks.  Our quality assurance group conducts periodic audits to ensure continued compliance with our standards.  With every shipment of inventory that we receive, our suppliers provide a certificate of compliance with our quality control standards.  Our receiving group also performs inspections, packaging and labeling onsite at our headquarters facility.
We work closely with our suppliers to ensure that our inventory needs are met while maintaining high quality and reliability. To date, we have not experienced significant difficulty in locating and obtaining the materials necessary to fulfill our production requirements, and we have not experienced a meaningful backlog of sales orders. We believe our supplier relationships and facilities will support our potential capacity needs for the foreseeable future.
A small percentage of our products, chiefly some of our advanced biomaterials, are manufactured in-house at our headquarters. We also use our facilities for inspection, packaging and labeling a large percentage of our inventory. Additionally, our recent acquisition of TTOT has significantly expanded our dedicated manufacturing capabilities. TTOT provides us with biomaterial products processed from human allograft tissue in its facility in San Antonio, Texas.
A majority of our product inventory is held primarily with our sales representatives and at hospitals throughout the United States. We stock inventory in our warehouse facilities and retain title to consigned inventory which is maintained with our field representatives and hospitals in sufficient quantities so that products are available when needed for surgical procedures. Safety stock levels are determined based on a number of factors, including demand, manufacturing lead times and quantities required to maintain service levels.
Intellectual Property
We protect our proprietary rights through a variety of methods. In particular, we rely on patent, trademark, copyright, trade secret and other intellectual property laws and also utilize nondisclosure agreements and other measures to protect our rights.
As of December 31, 2014, we owned 264 issued U.S. patents (249 utility patents; 15 design patents) and had applications pending for 383 U.S. patents (379 utility patent applications; four design patent applications), and we owned 78 issued foreign patents and had applications pending for 140 foreign patents. One of our issued patents expires in March 2015, and the rest of our issued patents expire between November 2019 and May 2032.
Our trademark portfolio contains 117 registered trademarks and 56 pending trademarks. Our portfolio includes domestic and foreign trademarks with associated logos and tag lines.
Third-Party Coverage and Reimbursement
We expect that, in the future, sales volumes and prices of our products may grow to be more dependent on the availability of coverage and reimbursement from third-party payors, such as government programs including Medicare and Medicaid, private insurance plans and managed care programs. Reimbursement is

11

dynamic and is contingent on coding for given services or procedures, coverage by third-party payors, and adequate payment for the services or procedures.
Physicians use Current Procedural Terminology (“CPT”) codes to bill for services and procedures, which are established by the American Medical Association (“AMA”). Specialty societies such as the North American Spine Society, the American Association of Neurological Surgeons, and the American Academy of Orthopaedic Surgeons provide advice to the AMA CPT Editorial Panel for developing codes. The Centers for Medicare and Medicaid Services (“CMS”), the agency responsible for administering Medicare, and the National Center for Health Statistics, are jointly responsible for overseeing changes and modifications to International Classification of Diseases and Clinical Modification procedure codes used by hospitals for reporting inpatient procedures. Physician and hospital coding is subject to change, which could impact coverage and reimbursement and thus potentially impact physician practice behavior.
Independent of coding status, third-party payors may deny coverage based on their own criteria. Payor medical policies continue to become more restrictive. Payors may deem the clinical efficacy of a device or procedure to be experimental or investigational, not the most cost-effective treatment available, or used for an unapproved indication. For example, Aetna changed its medical policy from coverage for all indications to coverage for only limited indications for biomechanical devices (e.g., spine cages) for cervical fusion procedures, citing they have not been proven more effective than bone graft for cervical fusions. Additionally, many private payors use coverage decisions and payment amounts established by CMS for the Medicare program as guidelines in setting their coverage and reimbursement policies. As the portion of the U.S. population over the age of 65 and eligible for Medicare continues to grow, we may be more vulnerable to coverage and reimbursement limitations imposed by CMS. National and regional coverage policy decisions are subject to unforeseeable change and have the potential to impact physician behavior. We will continue to provide the appropriate resources to patients, physicians, hospitals, and insurers in order to promote the best patient care, provide clarity regarding coverage and reimbursement policies, and work to reverse any non-coverage policies.
For some government programs, such as Medicaid, coverage and reimbursement differ from state to state. Some state Medicaid programs may not reimburse an adequate amount for the procedures performed with our products, if any payment is made at all. In addition, payment by Medicare and other third-party payors may not be adequate to cover the cost of medical devices used in spine procedures. Additionally, the percentage of individuals covered by managed care programs is expected to grow in the United States over the next decade. Many managed care programs reimburse providers on a capitated basis, which puts the providers at financial risk for the services provided to their patients by paying them a predetermined amount per member per month.
In international markets, reimbursement and healthcare payment systems vary significantly by country and some countries have instituted price ceilings on specific product lines. There can be no assurance that our products will be accepted by third-party payors, that coverage and reimbursement will be available or, if available, that the third-party payors’ coverage and reimbursement policies will not adversely affect our ability to sell our products profitably.
We believe that the overall escalating cost of medical products and services has led to, and will continue to lead to, increased pressures on the healthcare industry to reduce the costs of products and services. There can be no assurance that third-party coverage and reimbursement will be available or adequate, or that future legislation, regulation, or coverage and reimbursement policies of third-party payors will not adversely affect the demand for our products or our ability to sell these products on a profitable basis.

12

Government Regulation
Our business is subject to extensive federal, state, local and foreign regulations. Some of the pertinent laws have not been definitively interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of subjective interpretations. In addition, these laws and their interpretations are subject to change.
Both federal and state governmental agencies continue to subject the healthcare industry to intense regulatory scrutiny, including heightened civil and criminal enforcement efforts. We believe that we have structured our business operations and relationships with our customers to comply with all applicable legal requirements. However, it is possible that governmental entities or other third parties could interpret these laws differently and assert otherwise. We discuss below the statutes and regulations that are most relevant to our business.
U.S. Food and Drug Administration Regulation
Our products are medical devices and human tissue products subject to extensive regulation by the FDA and other federal, state, local and foreign regulatory bodies. FDA regulations govern, among other things, the following activities that we or our partners perform and will continue to perform:
•
product design and development;
•
product testing, manufacturing and safety;
•
post-market surveillance and reporting;
•
product labeling;
•
complaint handling;
•
post-market approval studies; and
•
product advertising, marketing and promotion.
FDA’s Pre-market Clearance and Approval Requirements
Unless an exemption applies, each medical device we wish to commercially distribute in the United States requires either 510(k) clearance or a PMA from the FDA. The FDA classifies medical devices into one of three classes. Devices deemed to pose lower risk are placed in either Class I or II, which requires the manufacturer to submit to the FDA a pre-market notification requesting permission for commercial distribution. This process is known as 510(k) clearance. Some low risk devices are exempt from this requirement. Devices deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices, or devices deemed not substantially equivalent to a previously cleared 510(k) device are placed in Class III, typically requiring approval of a PMA application. Both pre-market clearance and PMA applications are subject to the payment of user fees, paid at the time of submission for FDA review. The FDA can also impose restrictions on the sale, distribution or use of devices at the time of their clearance or approval, or subsequent to marketing.

13

Human Cell, Tissue and Cellular and Tissue Based Products
We currently distribute a number of products processed from human tissue, some of which are manufactured by third-party suppliers. FDA regulates human tissue products as Human Cells and Cellular and Tissue Based Products (“HCT/Ps”). Certain HCT/Ps are regulated solely under Section 361 of the Public Health Service Act and are referred to as “Section 361 HCT/Ps,” while other HCT/Ps are subject to FDA's regulatory requirements for medical devices or biologics. Section 361 HCT/Ps do not require 510(k) clearance, PMA approval, or other premarket approvals from FDA before marketing. Tissue banks that handle HCT/Ps must register their establishments with FDA, list their HCT/P products with FDA, and comply with FDA's requirements for donor eligibility and screening, current Good Tissue Practices (“CGTPs”), product labeling, and postmarket reporting for HCT/Ps.
The FDA periodically inspects tissue processors to determine compliance with these requirements. Entities that provide us with allograft bone tissue are responsible for performing donor recovery, donor screening and donor testing and our compliance with those aspects of the CGTPs regulations that regulate those functions are dependent upon the actions of these independent entities.
The procurement and transplantation of allograft bone tissue is subject to U.S. federal law pursuant to the National Organ Transplant Act (“NOTA”), a criminal statute which prohibits the purchase and sale of human organs used in human transplantation, including bone and related tissue, for “valuable consideration.” NOTA permits reasonable payments associated with the removal, transportation, processing, preservation, quality control, implantation and storage of human bone tissue. With the exception of removal and implantation, we provide services in all of these areas.
The procurement of human tissue is also subject to state anatomical gift acts and some states have statutes similar to NOTA. In addition, some states require that tissue processors be licensed by that state.
FDA Enforcement
The FDA enforces these requirements by inspection and market surveillance. Failure to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include any of the following sanctions:
•
untitled letters or warning letters;
•
fines, injunctions and civil penalties;
•
recall or seizure of our products;
•
operating restrictions, partial suspension or total shutdown of production;
•
refusing our request for 510(k) clearance or PMA of new products;
•
withdrawing 510(k) clearance or PMAs that are already granted; and
•
criminal prosecution.
We are subject to unannounced device inspections by the FDA, the Office of Compliance, the Center for Devices and Radiological Health, and the Center for Biologics Evaluation and Research, as well as other regulatory agencies overseeing the implementation and adherence of applicable state and federal tissue licensing regulations. These inspections may include our suppliers’ facilities.

14

International
International sales of medical devices are subject to foreign government regulations, which vary substantially from country to country. In order to market our products in other countries, we must obtain regulatory approvals and comply with extensive safety and quality regulations in other countries. The time required to obtain approval by a foreign country may be longer or shorter than that required for FDA clearance or approval, and the requirements may differ. The European Union/European Economic Area (“EEA”) requires CE conformity mark in order to market medical devices. Many other countries, such as Australia, India, New Zealand, Pakistan and Sri Lanka, accept CE or FDA clearance or approval although others, such as Brazil, Canada and Japan, require separate regulatory filings.
In the EEA, our devices are required to comply with the essential requirements of the EU Medical Device Directive (Council Directive 93/42/EEC). Compliance with these requirements entitles us to affix the CE conformity mark to our medical devices, without which they cannot be commercialized in the EEA. To demonstrate compliance with the essential requirements and obtain the right to affix the CE conformity mark we must undergo a conformity assessment procedure, which varies according to the type of medical device and its classification.
Additionally in the EEA, the procurement, testing, processing, preservation, storage and distribution of human tissues and cells is subject to the requirements of the laws of individual EEA Member States implementing Directive 2004/23/EC, Directive 2006/17/EC and Directive 2006/86/EC.
Further, the advertising and promotion of our products in the EEA is subject to the laws of individual EEA Member States implementing the EU Medical Device Directive, Directive 2006/114/EC concerning misleading and comparative advertising, and Directive 2005/29/EC on unfair commercial practices, as well as other EEA Member State laws governing the advertising and promotion of medical devices. These laws may limit or restrict the advertising and promotion of our products to the general public and may impose limitations on our promotional activities with healthcare professionals.
We are subject to unannounced device inspections by the Notified Body (an organization accredited by a Member State of the EEA to conduct conformity assessments), as well as other regulatory agencies overseeing the implementation and adherence of applicable regulations. These inspections may include our suppliers’ facilities.
Sales and Marketing Commercial Compliance
Federal anti-kickback laws and regulations prohibit, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in exchange for, or to induce either the referral of an individual, or the purchase, order or recommendation of, any good or service paid for under federal healthcare programs such as the Medicare and Medicaid programs.
In addition, federal false claims laws prohibit any person from knowingly presenting, or causing to be presented, a false claim for payment to the federal government, or knowingly making, or causing to be made, a false statement to get a false claim paid. Off-label promotion has been pursued as a violation of the federal false claims laws. Pursuant to FDA regulations, we can only market our products for cleared or approved uses. Although surgeons are permitted to use medical devices for indications other than those cleared or approved by the FDA based on their medical judgment, we are prohibited from promoting products for such off-label uses. Additionally, the majority of states in which we market our products have similar anti-kickback, false claims, anti-fee splitting and self-referral laws, which may apply to items or services

15

reimbursed by any third-party payor, including commercial insurers, and violations may result in substantial civil and criminal penalties.
The United States and foreign government regulators have increased regulation, enforcement, inspections and governmental investigations of the medical device industry, including under the United Kingdom’s Bribery Act and increased U.S. government oversight and enforcement of the U.S. Foreign Corrupt Practices Act (“FCPA”).
Additionally, the commercial compliance environment is continually evolving in the healthcare industry as some states, including California, Massachusetts and Vermont, mandate implementation of corporate compliance programs, along with the tracking and reporting of gifts, compensation and other remuneration to physicians. The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively “PPACA”) also imposes new reporting and disclosure requirements on device manufacturers for any “transfer of value” made or distributed to prescribers and other healthcare providers. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply in multiple jurisdictions with different compliance and/or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements.
Environmental Matters
The manufacture of certain of our products, including our allograft implants and products, and the handling of materials used in the product testing process, including in our cadaveric laboratory, involve the controlled use of biological, hazardous and/or radioactive materials and wastes. Our business and facilities and those of our suppliers are subject to foreign, federal, state and local laws and regulations relating to the protection of human health and the environment, including those governing the use, manufacture, storage, handling and disposal of, and exposure to, such materials and wastes. In addition, under some environmental laws and regulations, we could be held responsible for costs relating to any contamination at our past or present facilities and at third-party waste disposal sites even if such contamination was not caused by us.
We are not currently aware of any material costs or liabilities relating to environmental matters, including any claims or actions under environmental laws or obligations to perform any cleanups at any of our facilities or any third-party waste disposal sites, that we expect to have a material adverse effect on our business, financial condition or operating results. However, it is possible that material environmental costs or liabilities may arise in the future.
Seasonality and Backlog
Our sales may be influenced by summer vacation and winter holiday periods during which we have experienced fewer spine surgeries taking place. In addition, we have recently experienced increased sales of our products in the last quarter of each year. Our sales generally consist of products that are in stock in our warehouse facilities or maintained at hospitals or with our sales representatives. Accordingly, we do not have a backlog of sales orders.
Employees
As of December 31, 2014, we had over 900 employees, including sales and marketing, product development, general administrative and accounting, both domestically and internationally. None of our employees is subject to a collective bargaining agreement and we consider our relationship with our employees to be good.

16

Facilities
As of December 31, 2014, our owned corporate headquarters in Audubon, Pennsylvania, comprised approximately 245,000 square feet. Our headquarters houses our research, product development, education, administration, warehouse and shipping functions, as well as our in-house manufacturing facility. In October 2014, we acquired a 13,000 square foot distribution center in Heerlen, Netherlands to support our international operations. Additionally, pursuant to our October 23, 2014 acquisition of Transplant Technologies of Texas, Ltd., we now lease approximately 20,000 square feet in San Antonio, Texas. We believe our facilities are adequate and suitable for our current needs.
Financial Information
For financial information about our business segment and the geographic areas in which we derive revenues, see “Item 8. Financial Statements and Supplementary Data; Notes to Consolidated Financial Statements; Note 17. Segment and Geographic Information” below.
Corporate and Available Information
We were incorporated in Delaware in March 2003. Our principal executive offices are located at 2560 General Armistead Avenue, Audubon, Pennsylvania 19403, and our telephone number at that location is (610) 930-1800. Our corporate website address is http://www.globusmedical.com. The information contained in or accessible through our website or contained on other websites is not deemed to be part of this Annual Report on Form 10-K.
We are subject to the filing requirements of the Exchange Act. Therefore, we file annual reports, periodic reports, proxy statements and other information with the SEC. Such reports, proxy statements and other information may be obtained by visiting the Public Reference Room of the Securities and Exchange Commission at 100 F Street, NE, Washington, D.C. 20549. You may obtain information regarding the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically.
We make our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to such reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act available free of charge through a link on the Investors section of our website located at http://www.globusmedical.com (under “SEC Filings”) as soon as reasonably practicable after they are filed with or furnished to the SEC.
Item 1A. Risk Factors
Risk factors that could cause our actual results to differ from our expectations and that could negatively impact our business, results of operations and financial condition are discussed below and elsewhere in this Annual Report on Form 10-K. If any of these risks actually occurs, our business, results of operations, financial condition and future growth prospects could be materially and adversely affected. You should carefully read and consider each of these risks, together with all of the other information set forth in this Annual Report on Form 10-K. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe are immaterial may also materially adversely affect our business, results of operations, financial condition and future growth prospects, and our stock price.

17

Risks Related to Our Business and Our Industry
To be commercially successful, we must convince spine surgeons and hospitals that our products are an attractive alternative to our competitors’ products and that our Disruptive Technologies are an attractive alternative to existing surgical treatments of spine disorders.
Spine surgeons play a significant role in determining the course of treatment and, ultimately, the type of product that will be used to treat a patient, so we rely on effectively marketing to them. Hospitals, however, are also often actively involved in the evaluation of products and the decision of which product to purchase. In order for us to sell our products, we must convince spine surgeons and hospitals that our products are attractive alternatives to competing products for use in spine procedures. Acceptance of our products depends on educating spine surgeons and hospitals as to the distinctive characteristics, perceived benefits, safety and cost-effectiveness of our products as compared to our competitors’ products and on training spine surgeons in the proper application of our products. If we are not successful in convincing spine surgeons and hospitals of the merit of our products or educating them on the use of our products, they may not use our products and we will be unable to increase our sales and sustain growth or profitability.
Furthermore, we believe spine surgeons will not widely adopt our Disruptive Technology products unless they determine, based on experience, clinical data and published peer-reviewed journal articles, that MIS techniques and our motion preservation and advanced biomaterials technologies provide benefits or are an attractive alternative to conventional treatments of spine disorders and incorporate improved technologies that permit novel surgical procedures.
Surgeons, and in certain instances, hospitals, may be hesitant to change their medical treatment practices or the products available for use to treat patients for the following reasons, among others:
•
lack of experience with MIS or our motion preservation or advanced biomaterials technologies;
•
lack or perceived lack of evidence supporting additional patient benefits;
•
perceived liability risks generally associated with the use of new products and procedures;
•
limited or lack of availability of coverage and reimbursement within healthcare payment systems;
•
costs associated with the purchase of new products and equipment; and
•
the time commitment that may be required for training.
If we are unable to convince surgeons and hospitals to use our products, we will not achieve expected sales or sustain our growth, and our financial condition and results of operation may be adversely affected.
In addition, we believe recommendations and support of our products by influential spine surgeons are essential for market acceptance and adoption. If we do not receive support from such surgeons or long-term data does not show the benefits of using our products, surgeons may not use our products. In such circumstances, we may not achieve expected sales or sustain our growth and may be unable to maintain profitability.
Pricing pressure from our competitors and our customers may impact our ability to sell our products at prices necessary to support our current business strategies.
The spine industry is characterized by intense competition, and the spine market continues to attract numerous new companies and technologies, which has encouraged more established companies to intensify competitive pricing pressure. As a result of this increased competition, as well as the challenges of third-party coverage and reimbursement practices, we believe there will be continued pricing pressure in the future. If competitive forces drive down the prices we are able to charge for our products, our profit margins will

18

shrink, which will adversely affect our ability to maintain our profitability and to invest in and grow our business.
If our hospital and other healthcare provider customers are unable to obtain adequate coverage and reimbursement for their purchases of our products, we may not be able to sell our products at prices necessary to maintain our profitability or at all.
Maintaining and growing sales of our products depends on the availability of adequate coverage and reimbursement from third party payors, including government programs such as Medicare and Medicaid, private insurance plans and managed care programs. Hospitals and other healthcare providers that purchase our products generally rely on third party payors to cover all or part of the costs associated with the procedures performed with these products, including the cost to purchase the product. Our customers’ access to adequate coverage and reimbursement for the procedures performed with our products by government and private insurance plans is central to the acceptance of our current and future products. We may be unable to sell our products on a profitable basis, or at all, if third party payors deny coverage or reduce their current levels of payment. If our cost of production increases faster than increases in reimbursement levels for the products, our profitability may be negatively impacted.
Future action by CMS (which administers the Medicare program), other government agencies or private payors, may diminish payments to physicians, outpatient surgery centers and/or hospitals, which could harm our ability to market and sell our products. Private payors may adopt coverage decisions and payment amounts determined by CMS as guidelines in setting their coverage and reimbursement policies. Private payors that do not follow the Medicare guidelines may adopt different coverage and reimbursement policies for procedures performed with our products. In addition, for some governmental programs, such as Medicaid, coverage and reimbursement differs from state to state. Medicaid payments to physicians and facilities are often lower than payments by other third party payors and some state Medicaid programs may not pay an adequate amount for the procedures performed with our products, if any payment is made at all. Furthermore, the healthcare industry in the United States has experienced a trend toward cost containment as government and private insurers seek to control rising healthcare costs by imposing lower payment rates and negotiating reduced contract rates with service providers.
Third party payors, including public and private payors, may develop negative coverage policies impacting our products. For example, Aetna recently changed its medical policy from coverage in all or most cases to coverage only for limited indications for biomechanical devices (e.g., spine cages) for cervical fusion procedures, stating that they have not been proven more effective than bone graft for cervical fusions, which may limit demand for our products. In addition, some payors have changed their coverage policies to be more restrictive as to the criteria under which they will cover and reimburse for vertebral fusions in the lumbar spine to treat multilevel degenerative disc disease (“DDD”), initial primary laminectomy/discectomy for nerve root decompression, or spinal stenosis. Although these coverage policy changes have not had a material impact on our business, other insurers may adopt similar coverage decisions in the future. Patients covered by these insurers may be unwilling or unable to afford lumbar fusion surgeries to treat these conditions, which could materially harm or limit our ability to sell our products designed for lumbar fusion procedures. Our business would be negatively impacted if the trend by governmental agencies or third party payors continues to reduce coverage of and/or reimbursement for procedures using our products.
We cannot be certain that under current and future payment systems, such as those utilized by Medicare and in many private managed care systems, the cost of our products will be adequately incorporated into the overall cost of the procedure. Therefore, we cannot be certain that the procedures performed with our products will be reimbursed at a cost-effective level, or at all.

19

To the extent we sell our products internationally, market acceptance may depend, in part, upon the availability of coverage and reimbursement within prevailing healthcare payment systems. Reimbursement and healthcare payment systems in international markets vary significantly by country, and include both government-sponsored healthcare and private insurance. Our products may not obtain international coverage and reimbursement approvals in a timely manner, if at all. Our failure to receive such approvals would negatively impact market acceptance of our products in the international markets in which those approvals are sought.
The implementation of healthcare reform in the United States could have a material adverse effect on our business.
In March 2010, the PPACA was enacted into law in the United States. The PPACA includes provisions that, among other things, reduce and/or limit Medicare reimbursement, require all individuals to have health insurance (with limited exceptions) and impose new and/or increased taxes. Specifically, beginning in January 2013, the law imposed a 2.3% excise tax on the sale in the United States of certain medical devices by a manufacturer, producer or importer of such devices. During fiscal 2014, our medical device tax expense was $7.1 million. Although there are ongoing discussions in the U.S. Congress regarding the repeal or deferral of the medical device tax, there can be no assurances as to the outcome of any of these discussions. The PPACA also reduces Medicare and Medicaid payments to hospitals and clinical laboratories, which could reduce medical procedure volumes and impact the demand for our products or the prices at which we sell them. While this legislation is intended to expand health insurance coverage to uninsured persons in the United States, the impact of any overall increase in access to healthcare on sales of our products remains uncertain. Various healthcare reform proposals have also emerged at the state level. The impact of the PPACA and these proposals could have a material adverse effect on our business, results of operations, financial condition and cash flows.
If we are unable to maintain and expand our network of direct sales representatives and independent distributors, we may not be able to generate anticipated sales.
Our operating results are directly dependent upon the sales and marketing efforts of not only our employees, but also our independent distributors. We expect our direct sales representatives and independent distributors to develop long-lasting relationships with the surgeons they serve. If our direct sales representatives or independent distributors fail to adequately promote, market and sell our products, our sales could significantly decrease.
We face significant challenges and risks in managing our geographically dispersed distribution network and retaining the individuals who make up that network. If any of our direct sales representatives were to leave us, or if any of our independent distributors were to cease to do business with us, our sales could be adversely affected. Some of our independent distributors account for a significant portion of our sales volume, and if any such independent distributor were to cease to distribute our products, our sales could be adversely affected. In such a situation, we may need to seek alternative independent distributors or increase our reliance on our direct sales representatives, which may not prevent our sales from being adversely affected. If a direct sales representative or independent distributor were to depart and be retained by one of our competitors, we may be unable to prevent them from helping competitors solicit business from our existing customers, which could further adversely affect our sales. Because of the intense competition for their services, we may be unable to recruit or retain additional qualified independent distributors or to hire additional direct sales representatives to work with us. We may not be able to enter into agreements with them on favorable or commercially reasonable terms, if at all. Failure to hire or retain qualified direct sales representatives or independent distributors would prevent us from maintaining or expanding our business and generating sales.

20

As we launch new products and increase our marketing efforts with respect to existing products, we will need to expand the reach of our marketing and sales networks. Our future success will depend largely on our ability to continue to hire, train, retain and motivate skilled direct sales representatives and independent distributors with significant technical knowledge in various areas, such as spinal care practices, spine injuries and disease and spinal health. New hires require training and take time to achieve full productivity. If we fail to train new hires adequately, or if we experience high turnover in our sales force in the future, we cannot be certain that new hires will become as productive as may be necessary to maintain or increase our sales.
If we are unable to expand our sales and marketing capabilities domestically and internationally, we may not be able to effectively commercialize our products, which would adversely affect our business, results of operations and financial condition.
We operate in a very competitive business environment and if we are unable to compete successfully against our existing or potential competitors, our sales and operating results may be negatively affected and we may not grow.
The spine industry is intensely competitive, subject to rapid change and highly sensitive to the introduction of new products or other market activities of industry participants. We believe that our significant competitors are Medtronic, the DePuy Synthes Companies (a division of Johnson & Johnson), Stryker and NuVasive. Alphatec Spine, Orthofix International, Zimmer, LDR Holding, Biomet, K2M and other smaller public and private companies are also competitors of ours. At any time, these or other industry participants may develop alternative treatments, products or procedures for the treatment of spine disorders that compete directly or indirectly with our products. They may also develop and patent processes or products earlier than we can or obtain regulatory clearance or approvals for competing products more rapidly than we can, which could impair our ability to develop and commercialize similar processes or products. If alternative treatments are, or are perceived to be, superior to our spine surgery products, sales of our products could be negatively affected and our results of operations could suffer.
Many of our current and potential competitors are major medical device companies that have substantially greater financial, technical and marketing resources than we do, and they may succeed in developing products that would render our products obsolete or noncompetitive.
Many of our larger competitors enjoy several competitive advantages over us, including:
•
greater financial, human and other resources for product research and development, sales and marketing and litigation;
•
significantly greater name recognition;
•
established relationships with spine surgeons, hospitals and other healthcare providers;
•
large and established sales and marketing and distribution networks;
•
products supported by long-term clinical data;
•
greater experience in obtaining and maintaining regulatory clearances or approvals for products and product enhancements;
•
more expansive portfolios of intellectual property rights; and
•
greater ability to cross-sell their products or to incentivize hospitals or surgeons to use their products.
The frequent introduction by competitors of products that compete with our existing or planned products may also make it difficult to market or sell our products. In addition, the entry of multiple new products and competitors, including physician-owned distributorships (“PODs”), may lead some of our

21

competitors to employ pricing strategies that could adversely affect the pricing of our products and pricing in the spine market generally.
As a result, our ability to compete successfully will depend on our ability to develop proprietary products that reach the market in a timely manner, receive adequate coverage and reimbursement from third-party payors, and are safer, less invasive and more effective than alternatives available for similar purposes. If we are unable to do so, our sales or margins could decrease, thereby harming our business.
We are dependent on a limited number of third-party suppliers for most of our products and components, and the loss of any of these suppliers, or their inability to provide us with an adequate supply of materials, could harm our business.
We rely on third-party suppliers to supply substantially all of our products. For us to be successful, our suppliers must be able to provide us with products and components in substantial quantities, in compliance with regulatory requirements, in accordance with agreed upon specifications, at acceptable costs and on a timely basis. Our anticipated growth could strain the ability of our suppliers to deliver an increasingly large supply of products, materials and components. Other issues, including shortages of raw materials or components, problems with production yields and quality control and assurance, especially with products such as allograft, which is processed human tissue, could impair a supplier’s ability to supply us with product quantities necessary to support our sales. Furthermore, under our supplier agreements, our suppliers generally have no obligation to manufacture for us or sell to us any specific quantity of products. If we are unable to obtain sufficient quantities of high quality components to meet demand on a timely basis, we could lose customers, our reputation may be harmed and our business could suffer.
We generally use a small number of suppliers for each of our products. Our dependence on such a limited number of suppliers exposes us to risks, including limited control over pricing, availability, quality and delivery schedules. If any one or more of our suppliers cease to provide us with sufficient quantities of manufactured products in a timely manner or on terms acceptable to us, or cease to manufacture components of acceptable quality, we would have to seek alternative sources of supply. Because of the nature of our internal quality control requirements, regulatory requirements and the custom and proprietary nature of the parts, we cannot quickly engage additional or replacement suppliers for many of our critical components. Failure of any of our third-party suppliers to deliver products at the level our business requires would limit our ability to meet our sales commitments to our customers and could have a material adverse effect on our business. We may also have difficulty obtaining similar components from other suppliers that are acceptable to the FDA or other foreign regulatory authorities. We could incur delays while we locate and engage qualified alternative suppliers, and we may be unable to engage alternative suppliers on favorable terms or at all. Any such disruption or increased expenses could harm our commercialization efforts and adversely affect our ability to generate sales.
If we do not successfully implement our business strategy, our business and results of operations will be adversely affected.
Our business strategy was formed based on assumptions about the spine market that might prove wrong. We believe that various demographics and industry-specific trends, including the aging of the general population, increasingly active lifestyles, improving fusion technologies and increasing acceptance of Disruptive Technologies leading to earlier interventions, will help drive growth in the spine market and our business, but these demographics and trends are uncertain. Actual demand for our products could differ materially from projected demand if our assumptions regarding these factors prove to be incorrect or do not materialize, or if alternative treatments to those offered by our products gain widespread acceptance.

22

We may not be able to successfully implement our business strategy. To implement our business strategy we need to, among other things, strengthen our brand, develop and introduce new spine surgery products, find new applications for and improve our existing products, obtain regulatory clearance or approval for new products and applications and educate spine surgeons about the clinical and cost benefits of our products, all of which we believe could increase acceptance of our products by spine surgeons. Our strategy of focusing exclusively on the spine market may limit our ability to grow. In addition, we are seeking to increase our sales and, in order to do so, will need to commercialize additional products and expand our direct and distributor sales forces in existing and new territories, all of which could result in our becoming subject to additional or different foreign and domestic regulatory requirements, with which we may not be able to comply. Moreover, even if we successfully implement our business strategy, our operating results may not improve or may decline. We may decide to alter or discontinue aspects of our business strategy and may adopt different strategies due to business or competitive factors not currently foreseen, such as new medical technologies that would make our products obsolete. Any failure to implement our business strategy may adversely affect our business, results of operations and financial condition.
The proliferation of PODs could result in increased pricing pressure on our products or harm our ability to sell our products to physicians who own or are affiliated with those distributorships.
PODs are medical device distributors that are owned, directly or indirectly, by physicians. These physicians derive a proportion of their revenue from selling or arranging for the sale of medical devices for use in procedures they perform on their own patients at hospitals that agree to purchase from or through the POD, or that otherwise furnish ordering physicians with income that is based directly or indirectly on those orders of medical devices.
We do not sell or distribute any of our products through PODs. The number of PODs in the spine industry may continue to grow as economic pressures increase throughout the industry, as hospitals, insurers and physicians search for ways to reduce costs, and, in the case of the physicians, search for ways to increase their incomes. These companies and the physicians who own, or partially own, them have significant market knowledge and access to the surgeons who use our products and the hospitals that purchase our products, and growth in this area may reduce our ability to compete effectively for business from surgeons who own such distributorships.
Our business could suffer if we lose the services of key members of our senior management, key advisors or personnel.
We are dependent upon the continued services of key members of our senior management and a limited number of key advisors and personnel. In particular, we are highly dependent on the skills and leadership of our Chief Executive Officer (“CEO”), David C. Paul. The loss of any one of these individuals could disrupt our operations or our strategic plans. Additionally, our future success will depend on, among other things, our ability to continue to hire and retain the necessary qualified scientific, technical and managerial personnel, for whom we compete with numerous other companies, academic institutions and organizations. The loss of members of our management team, key advisors or personnel, or our inability to attract or retain other qualified personnel or advisors, could have a material adverse effect on our business, results of operations and financial condition. Though members of our sales force generally enter into noncompetition agreements that restrict their ability to compete with us, most of the members of our executive management team are not subject to such agreements. Accordingly, the adverse effect resulting from the loss of certain executives could be compounded by our inability to prevent them from competing with us.

23

The safety and efficacy of our products is not yet supported by long-term clinical data, which could limit sales, and our products might therefore prove to be less safe and effective than initially thought.
All of the products we currently market in the United States, other than our SECURE®-C cervical disc, have either received pre-market clearance under Section 510(k) of the FDCA or are exempt from pre-market review. The FDA's 510(k) clearance process requires us to show that our proposed product is “substantially equivalent” to another 510(k)-cleared product. This process is shorter and typically requires the submission of less supporting documentation than other FDA approval processes and does not always require long-term clinical studies. We also continue to gather long term follow-up data in our SECURE®-C clinical trial. Additionally, to date, we have not been required to complete long-term clinical studies in connection with the sale of our products outside the United States. As a result, we currently lack the breadth of published long-term clinical data supporting the safety and efficacy of virtually all of our products and the benefits they offer that might have been generated in connection with other approval processes. For these reasons, spine surgeons may be slow to adopt our products, we may not have comparative data that our competitors have or are generating, and we may be subject to greater regulatory and product liability risks. Further, future patient studies or clinical experience may indicate that treatment with our products does not improve patient outcomes. Such results would slow the adoption of our products by spine surgeons, significantly reduce our ability to achieve expected sales, and could prevent us from sustaining our profitability.
Moreover, if future results and experience indicate that our products cause unexpected or serious complications or other unforeseen negative effects, we could be subject to mandatory product recalls, suspension or withdrawal of FDA clearance or approval, significant legal liability or harm to our business reputation.
If we do not enhance our product offerings through our research and development efforts, we may be unable to effectively compete.
In order to increase our market share in the spine market, we must enhance and broaden our product offerings in response to changing customer demands and competitive pressures and technologies. The success of any new product offering or enhancement to an existing product will depend on numerous factors, including our ability to:
•
properly identify and anticipate surgeon and patient needs;
•
develop and introduce new products or product enhancements in a timely manner;
•
adequately protect our intellectual property and avoid infringing upon the intellectual property rights of third parties;
•
demonstrate the safety and efficacy of new products; and
•
obtain the necessary regulatory clearances or approvals for new products or product enhancements.
If we do not develop and obtain regulatory clearance or approval for new products or product enhancements in time to meet market demand, or if there is insufficient demand for these products or enhancements, our results of operations will suffer. Our research and development efforts may require a substantial investment of time and resources before we are adequately able to determine the commercial viability of a new product, technology, material or other innovation. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of products may not produce sales in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.

24

If we fail to properly manage our anticipated growth, our business could suffer.
Our rapid growth has placed, and will continue to place, a significant strain on our management and on our operational and financial resources and systems. Failure to manage our growth effectively could cause us to over-invest or under-invest in infrastructure, and result in losses or weaknesses in our infrastructure, which could materially adversely affect us. Additionally, our anticipated growth will increase the demands placed on our suppliers, resulting in an increased need for us to carefully monitor for quality assurance. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our development and commercialization goals.
Our results of operations could suffer if we are unable to manage our planned international expansion effectively.
Expansion into international markets is an element of our business strategy and involves risk. The sale and shipment of our products across international borders, as well as the purchase of components and products from international sources, subject us to extensive U.S. and foreign governmental trade, import and export and customs regulations and laws. Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Other laws and regulations that can significantly affect us include various anti-bribery laws, including the FCPA and anti-boycott laws. Any failure to comply with applicable legal and regulatory obligations in the United States or abroad could adversely affect us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments and restrictions on certain business activities. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our distribution and sales activities.
Our international operations expose us and our independent distributors to risks inherent in operating in foreign jurisdictions, including:
•
exposure to different legal and regulatory standards;
•
lack of stringent protection of intellectual property;
•
obstacles to obtaining domestic and foreign export, import and other governmental approvals, permits and licenses and compliance with foreign laws;
•
potentially adverse tax consequences and the complexities of foreign value-added tax systems;
•
adverse changes in tariffs and trade restrictions;
•
limitations on the repatriation of earnings;
•
difficulties in staffing and managing foreign operations;
•
transportation delays and difficulties of managing international distribution channels;
•
longer collection periods and difficulties in collecting receivables from foreign entities;
•
increased financing costs; and
•
political, social and economic instability and increased security concerns.
These risks may limit or disrupt our expansion, restrict the movement of funds or result in the deprivation of contractual rights or the taking of property by nationalization or expropriation without fair compensation.
Our goal of succeeding as an international company depends, in part, on our ability to develop and implement policies and strategies that are effective in anticipating and managing these and other risks in the countries in which we do business. Failure to manage these and other risks may have a material adverse effect on our operations in any particular country and on our business as a whole.

25

We may seek to grow our business through acquisitions of or investments in new or complementary businesses, products or technologies, and the failure to manage acquisitions or investments, or the failure to integrate them with our existing business, could have a material adverse effect on us.
From time to time we expect to consider opportunities to acquire or make investments in other technologies, products and businesses that may enhance our capabilities, complement our current products or expand the breadth of our markets or customer base. Potential and completed acquisitions and strategic investments involve numerous risks, including:
•
problems assimilating the purchased technologies, products or business operations;
•
issues maintaining uniform standards, procedures, controls and policies;
•
unanticipated costs associated with acquisitions;
•
diversion of management’s attention from our core business;
•
adverse effects on existing business relationships with suppliers and customers;
•
risks associated with entering new markets in which we have limited or no experience;
•
potential loss of key employees of acquired businesses; and
•
increased legal and accounting compliance costs.
We do not know if we will be able to identify acquisitions we deem suitable, whether we will be able to successfully complete any such acquisitions on favorable terms or at all, or whether we will be able to successfully integrate any acquired business, product or technology into our business or retain any key personnel, suppliers or distributors. Our ability to successfully grow through acquisitions depends upon our ability to identify, negotiate, complete and integrate suitable target businesses and to obtain any necessary financing. These efforts could be expensive and time-consuming, and may disrupt our ongoing business and prevent management from focusing on our operations. If we are unable to integrate any acquired businesses, products or technologies effectively, our business, results of operations and financial condition will be materially adversely affected.
We are required to maintain high levels of inventory, which could consume a significant amount of our resources and reduce our cash flows.
As a result of the need to maintain substantial levels of inventory, we are subject to the risk of inventory obsolescence. Many of our products come in sets, which feature components in a variety of sizes to satisfy the particular patient’s anatomical needs. In order to market our products effectively, we often must maintain implant sets consisting of the full range of product sizes. For each surgery, fewer than all of the components of the set are used, and therefore certain portions of the set, like uncommon sizes, may become obsolete before they can be used. In the event that a substantial portion of our inventory becomes obsolete, it could have a material adverse effect on our earnings and cash flows due to the resulting costs associated with the inventory impairment charges and costs required to replace such inventory.
If we experience significant disruptions in our information technology systems, our business, results of operations and financial condition could be adversely affected.
The efficient operation of our business depends on our information technology systems. We rely on our information technology systems to effectively manage:
•
sales and marketing, accounting and financial functions;
•
inventory management;
•
engineering and product development tasks; and
•
our research and development data.

26

Our information technology systems are vulnerable to damage or interruption from:
•
earthquakes, fires, floods and other natural disasters;
•
terrorist attacks and attacks by computer viruses or hackers;
•
power losses; and
•
computer systems, or Internet, telecommunications or data network failures.
The failure of our information technology systems to perform as we anticipate or our failure to effectively implement new systems could disrupt our entire operation and could result in decreased sales, increased overhead costs, excess inventory and product shortages, all of which could have a material adverse effect on our reputation, business, results of operations and financial condition.
Consolidation in the healthcare industry could lead to demands for price concessions or to the exclusion of some suppliers from certain of our markets, which could have an adverse effect on our business, results of operations or financial condition.
Because healthcare costs have risen significantly over the past decade, numerous initiatives and reforms initiated by legislators, regulators and third-party payors to curb these costs have resulted in a consolidation trend in the healthcare industry to aggregate purchasing power. As the healthcare industry consolidates, competition to provide products and services to industry participants has become and will continue to become more intense. This in turn has resulted and will likely continue to result in greater pricing pressures and the exclusion of certain suppliers from important market segments as group purchasing organizations, independent delivery networks and large single accounts continue to use their market power to consolidate purchasing decisions for hospitals. We expect that market demand, government regulation, third-party coverage and reimbursement policies and societal pressures will continue to change the worldwide healthcare industry, resulting in further business consolidations and alliances among our customers, which may reduce competition, exert further downward pressure on the prices of our products and may adversely impact our business, results of operations or financial condition.
Fluctuations in insurance cost and availability could adversely affect our profitability or our risk management profile.
We hold a number of insurance policies, including product liability insurance, directors’ and officers’ liability insurance, property insurance, health insurance and workers’ compensation insurance. If the costs of maintaining adequate insurance coverage increase significantly in the future, our operating results could be materially adversely affected. Likewise, if any of our current insurance coverage should become unavailable to us or become economically impractical, we would be required to operate our business without indemnity from commercial insurance providers. If we operate our business without insurance, we could be responsible for paying claims or judgments against us that would have otherwise been covered by insurance, which could adversely affect our results of operations or financial condition.
Risks Related to our Legal and Regulatory Environment
Our medical device products and operations are subject to extensive governmental regulation both in the United States and abroad, and our failure to comply with applicable requirements could cause our business to suffer.
The medical device industry is regulated extensively by governmental authorities, principally the FDA and corresponding state and foreign regulatory agencies. The FDA and other U.S. and foreign governmental agencies regulate, among other things, with respect to medical devices:

27

•
design, development and manufacturing;
•
testing, labeling, content and language of instructions for use and storage;
•
clinical trials;
•
product safety;
•
marketing, sales and distribution;
•
pre-market clearance and approval;
•
record keeping procedures;
•
advertising and promotion;
•
recalls and field safety corrective actions;
•
post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury;
•
post-market approval studies; and
•
product import and export.
The regulations to which we are subject are complex and have tended to become more stringent over time; see “Item 1. Business; Government Regulation” for a summary of certain regulations to which we are subject. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales.
The processes by which 510(k) clearance or PMA approval is obtained can be expensive and lengthy and require the payment of significant fees. The FDA’s 510(k) clearance process usually takes from three to 12 months, but may last longer. The process of obtaining a PMA is much more costly and uncertain than the 510(k) clearance process and generally takes one to three years, or even longer, from the time the application is submitted to the FDA until an approval is obtained. The process of obtaining regulatory clearances or approvals through the 510(k) process or approvals through the PMA process to market a medical device in the United States or internationally can be costly and time-consuming, and we may not be able to obtain these clearances or approvals on a timely basis, if at all.
In the United States, all of our currently commercialized medical device products, other than SECURE®-C have either received pre-market clearance under Section 510(k) of the FDCA or are exempt from pre-market review. If the FDA requires us to go through a lengthier, more rigorous examination for future products or modifications to existing products than we had expected, our product introductions or modifications could be delayed or canceled, which could cause our sales to decline and potentially harm our ability to compete. In addition, if the FDA disagrees with our determination that a product we currently market is subject to an exemption from pre-market review, the FDA may require us to submit a 510(k) or PMA and may require us to cease distribution of the product and/or recall the product unless and until we obtain 510(k) clearance or PMA. Further, even with respect to those future products where a PMA is not required, we cannot assure you that we will be able to obtain the 510(k) clearances with respect to those products. The FDA may also reclassify devices currently on the market from Class II to Class III, which could result in additional regulatory burden requiring PMA prior to marketing, or could result in FDA rescinding a 510(k) for a previously cleared device.
The FDA can delay, limit or deny clearance or approval of a device for many reasons, including:
•
we may not be able to demonstrate to the FDA’s satisfaction that our products are safe and effective for their intended uses;
•
the data from our pre-clinical studies and clinical trials may be insufficient to support clearance or approval, where required; and
•
the manufacturing process or facilities we use may not meet applicable requirements.

28

In addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay approval or clearance of our products under development or impact our ability to modify our currently approved or cleared products on a timely basis. It is also possible that, if we obtain new FDA regulatory clearances or approvals, the clearances or approvals may contain limitations on the indicated uses or may prohibit certain uses which may impact the marketability of the product.
Any delay in, or failure to receive or maintain, clearance or approval for our medical device products under development could prevent us from generating revenue from these products or achieving profitability. Additionally, the FDA and other regulatory authorities have broad enforcement powers. Regulatory enforcement or inquiries, or other increased scrutiny on us, could dissuade some surgeons from using our products and adversely affect our reputation and the perceived safety and efficacy of our products.
In addition, even after we have obtained the proper regulatory approval to market a product, the FDA has the power to require us to conduct postmarketing studies. For example, the FDA issued a 522 Order in October 2009 requiring companies that market dynamic stabilization systems, such as our TRANSITION® system, to conduct postmarketing studies on those systems. These studies can be very expensive and time-consuming to conduct. Failure to comply with those studies in a timely manner could result in the revocation of the 510(k) clearance for the product that is subject to such a 522 Order and the recall or withdrawal of the product, which could prevent us from generating sales from that product in the United States.
Similarly, we must comply with numerous international laws and regulations in order to market our products outside of the United States; see “Item 1. Business; Government Regulation; International” for a summary of certain international laws and regulations to which we are subject. As is the case in the United States, the applicable regulatory body may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay approval or clearance of our products under development or impact our ability to modify our currently approved or cleared products on a timely basis. Any delay in, or failure to receive or maintain, clearance or approval for our products under development could prevent us from generating revenue from these products or achieving profitability. Conducting clinical studies to obtain clinical data that might be required as part of the clinical evaluation process can be expensive and time-consuming. Additionally, the regulatory authorities have broad enforcement powers. Regulatory enforcement or inquiries, or other increased scrutiny on us, could dissuade some surgeons from using our products and adversely affect the perceived safety and efficacy of our products and our reputation.
Failure to comply with applicable regulations could jeopardize our ability to sell our products and result in enforcement actions such as:
•
warning letters;
•
fines;
•
injunctions;
•
civil penalties;
•
termination of distribution;
•
recalls or seizures of products;
•
delays in the introduction of products into the market;
•
total or partial suspension of production;
•
refusal of the FDA or other regulator to grant future clearances or approvals;
•
withdrawals or suspensions of current clearances or approvals, resulting in prohibitions on sales of our products; and/or
•
in the most serious cases, criminal penalties.

29

Any of these sanctions could result in higher than anticipated costs or lower than anticipated sales and have a material adverse effect on our reputation, business, results of operations and financial condition. For example, in February 2012 we executed a settlement agreement with the FDA in which we and our CEO, David C. Paul, agreed to pay a total of $1.0 million in exchange for the FDA’s release of claims related solely to the FDA’s determination that we failed to obtain the 510(k) clearance required for the sale of our NUBONE® product, which we ceased selling in the United States in December 2010.
Modifications to our products may require new 510(k) clearances or PMAs, or may require us to cease marketing or recall the modified products until clearances are obtained.
Any modification to a 510(k)-cleared device that could significantly affect its safety or effectiveness or that would constitute a major change in its intended use, design, or manufacture, requires a new 510(k) clearance or, possibly, approval of a PMA. The FDA requires every manufacturer to make this determination in the first instance, but the FDA may review any manufacturer’s decision. The FDA may not agree with our decisions regarding whether new clearances or approvals are necessary. We have modified some of our 510(k) cleared products, and have determined based on our review of the applicable FDA guidance that in certain instances new 510(k) clearances or PMAs are not required. If the FDA disagrees with our determination and requires us to submit new 510(k) notifications or PMAs for modifications to our previously cleared products for which we have concluded that new clearances or approvals are unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval, and we may be subject to significant regulatory fines or penalties.
Recent changes to FDA’s 510(k) program may make it more difficult for us to gain FDA clearance for our products, by imposing more onerous acceptance and review requirements for new 510(k) submissions , and future changes may further increase this burden.
Our HCT/P products are subject to extensive government regulation and our failure to comply with these requirements could cause our business to suffer.
In the United States, we are marketing our human tissue products as Section 361 HCT/Ps, which are not subject to FDA premarket clearance or approval requirements. The FDA could disagree with our determination that our human tissue products are Section 361 HCT/Ps and could determine that these products are biologics requiring a biological license application (“BLA”) approval or medical devices requiring 510(k) clearance or PMA approval. FDA may then require that we cease marketing our human tissue products and/or recall the products unless and until we receive the appropriate clearance or approval from FDA.
HCT/Ps also are subject to donor eligibility and screening, CGTPs, product labeling, and postmarket reporting requirements. If we or our suppliers fail to comply with these requirements, we could be subject to FDA enforcement action, including, for example, warning letters, fines, injunctions, product recalls or seizures, and, in the most serious cases, criminal penalties.
We may fail to obtain or maintain foreign regulatory approvals to market our products in other countries.
We currently market our products internationally and intend to expand our international marketing. International jurisdictions require separate regulatory approvals and compliance with numerous and varying regulatory requirements. For example, we intend to continue to seek regulatory clearance to market our primary products in the EEA, Brazil, Canada and other key markets. The approval procedures vary among countries and may involve requirements for additional testing, and the time required to obtain approval may differ from country to country and from that required to obtain FDA clearance or approval.

30

Clearance or approval by the FDA does not ensure approval or certification by regulatory authorities in other countries or jurisdictions, and approval or certification by one foreign regulatory authority does not ensure approval or certification by regulatory authorities in other foreign countries or by the FDA. The foreign regulatory approval or certification process may include all of the risks associated with obtaining FDA clearance or approval. We may not obtain foreign regulatory approvals on a timely basis, if at all. We may not be able to file for regulatory approvals or certifications and may not receive necessary approvals to commercialize our products in any market. If we fail to receive necessary approvals or certifications to commercialize our products in foreign jurisdictions on a timely basis, or at all, our business, results of operations and financial condition could be adversely affected.
Additionally, in the EEA, we must inform the Notified Body that carried out the conformity assessment of the medical devices we market or sell in the EEA of any planned substantial changes to our quality system or changes to our devices which could affect compliance with the essential requirements or the devices’ intended use. The Notified Body will then assess the changes and verify whether they affect the products’ conformity. If the assessment is not favorable, it could prevent us from selling that product in the EEA, which could adversely impact our business and results of operations.
We are subject to risks associated with our non-U.S. operations.
The FCPA and similar worldwide anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments for the purpose of obtaining or retaining business. The FCPA also imposes accounting standards and requirements on publicly traded U.S. corporations and their foreign affiliates, which are intended to prevent the diversion of corporate funds to the payment of bribes and other improper payments, and to prevent the establishment of “off books” slush funds from which such improper payments can be made. Because of the predominance of government-sponsored healthcare systems around the world, many of our customer relationships outside of the United States are with governmental entities and are therefore subject to such anti-bribery laws. Our internal control policies and procedures may not always protect us from reckless or criminal acts committed by our employees or agents. Violations of these laws, or allegations of such violations, could disrupt our operations, involve significant management distraction and result in a material adverse effect on our business, results of operations and financial condition. We also could suffer severe penalties, including criminal and civil penalties, disgorgement and other remedial measures, including further changes or enhancements to our procedures, policies and controls, as well as potential personnel changes and disciplinary actions.
Furthermore, we are subject to the export controls and economic embargo rules and regulations of the United States, including, but not limited to, the Export Administration Regulations and trade sanctions against embargoed countries, which are administered by the Office of Foreign Assets Control within the Department of the Treasury, as well as the laws and regulations administered by the Department of Commerce. These regulations limit our ability to market, sell, distribute or otherwise transfer our products or technology to prohibited countries or persons. A determination that we have failed to comply, whether knowingly or inadvertently, may result in substantial penalties, including fines and enforcement actions and civil and/or criminal sanctions, the disgorgement of profits and the imposition of a court-appointed monitor, as well as the denial of export privileges, and may have an adverse effect on our reputation.
These and other factors may have a material adverse effect on our international operations or on our business, results of operations and financial condition generally.

31

If we or our suppliers fail to comply with the FDA’s good manufacturing practice regulations and similar international regulations, this could impair our ability to market our products in a cost-effective and timely manner.
We and our third-party suppliers are required to comply with Quality System Regulations (“QSRs”), which cover the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage and shipping of our products. In addition, suppliers and processors of allograft must comply with the CGTPs, which govern the methods used in and the facilities and controls used for the manufacture of human cell tissue and cellular and tissue-based products, record-keeping and the establishment of a quality program.
The FDA audits compliance with the QSRs and CGTPs through periodic announced and unannounced inspections of manufacturing and other facilities. The FDA may conduct inspections or audits at any time. If we or our suppliers have significant non-compliance issues or if any corrective action plan that we or our suppliers propose in response to observed deficiencies is not sufficient, the FDA could take enforcement action, including any of the following sanctions:
•
untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties;
•
customer notifications or repair, replacement, refunds, recall, detention or seizure of our products;
•
operating restrictions or partial suspension or total shutdown of production;
•
refusing or delaying our requests for 510(k) clearance or PMA of new products or modified products;
•
withdrawing 510(k) clearances or PMAs that have already been granted;
•
refusal to grant export approval for our products; or
•
criminal prosecution.
Any of these sanctions could have a material adverse effect on our reputation, business, results of operations and financial condition.
Outside the United States, our products and operations are also often required to comply with standards set by industrial standards bodies, such as the ISO. Foreign regulatory bodies may evaluate our products or the testing that our products undergo against these standards. The specific standards, types of evaluation and scope of review differ among foreign regulatory bodies. We intend to comply with the standards enforced by such foreign regulatory bodies as needed to commercialize our products. If we fail to adequately comply with any of these standards, a foreign regulatory body may take adverse actions similar to those within the power of the FDA. Any such action may harm our reputation and business, and could have an adverse effect on our business, results of operations and financial condition.
A recall of our products, either voluntarily or at the direction of the FDA or another governmental authority, or the discovery of serious safety issues with our products, could have a significant adverse impact on us.
The FDA and similar foreign governmental authorities have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture or in the event that a product poses an unacceptable risk to health. Manufacturers may, under their own initiative, recall a product if any material deficiency in a device is found. A government-mandated or voluntary recall by us or one of our distributors could occur as a result of an unacceptable risk to health, component failures, manufacturing errors, design or labeling defects or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our reputation, results of operations and financial condition, which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our customers’ demands. We may also be required to bear other

32

costs or take other actions that may have a negative impact on our future sales and our ability to generate profits.
In the EEA, we must comply with the EU Medical Device Vigilance System. Under this system, manufacturers are required to take Field Safety Corrective Actions (“FSCAs”) to reduce a risk of death or serious deterioration in the state of health associated with the use of a medical device that is already placed on the market. A FSCA may include the recall, modification, exchange, destruction or retrofitting of the device.
Any adverse event involving our products, whether in the United States or abroad, could result in future voluntary corrective actions, such as recalls or customer notifications, or agency action, such as inspection, mandatory recall or other enforcement action. Any corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, will require the dedication of our time and capital, distract management from operating our business and may harm our reputation and financial results.
We may be subject to enforcement action if we engage in the off-label promotion of our products.
Our promotional materials and training methods must comply with FDA and other applicable laws and regulations, including the prohibition of the promotion of off-label use. Physicians may use our products off-label, as the FDA does not restrict or regulate a physician’s choice of treatment within the practice of medicine. However, if the FDA determines that our promotional efforts constitutes promotion of an off-label use, it could request that we modify our training or promotional efforts or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine and criminal penalties. It is also possible that other federal, state or foreign enforcement authorities, such as the Department of Justice (“DOJ”), might take action if they consider our promotional or training materials to constitute promotion of an unapproved/off-label use, which could result in significant criminal and/or civil fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement (e.g., the False Claims Act). In that event, our reputation could be damaged and adoption of the products would be impaired. Although our policy is to refrain from statements that could be considered off-label promotion of our products, the FDA or another regulatory agency could disagree and conclude that we have engaged in off-label promotion. In addition, the off-label use of our products may increase the risk of injury to patients, and, in turn, the risk of product liability claims. Product liability claims are expensive to defend and could divert our management’s attention, result in substantial damage awards against us and harm our reputation.
Governmental regulation and limited sources and suppliers could restrict our procurement and use of tissue.
In the United States, the procurement and transplantation of allograft bone tissue is subject to federal law pursuant to the NOTA, a criminal statute which prohibits the purchase and sale of human organs used in human transplantation, including bone and related tissue, for “valuable consideration.” NOTA permits reasonable payments associated with the removal, transportation, processing, preservation, quality control, implantation and storage of human bone tissue. We provide services in all of these areas in the United States, with the exception of removal and implantation, and receive payments for all such services. We make payments to tissue banks for their services related to recovering allograft bone tissue on our behalf. If NOTA is interpreted or enforced in a manner that prevents us from receiving payment for services we render or that prevents us from paying tissue banks or certain of our clients for the services they render for us, our business could be materially adversely affected.

33

We depend on a limited number of sources of human tissue for use in some of our advanced biomaterials products and a limited number of entities to process the human tissue for use in those advanced biomaterials products, and any failure to obtain tissue from these sources or to have the tissue processed by these entities for us in a timely manner will interfere with our ability to effectively meet demand for our advanced biomaterials products incorporating human tissue. Less than five third-party suppliers currently supply all of our needs for allograft implants and products, other than those implants and products that we process ourselves. The processing of human tissue into our advanced biomaterials products is very labor-intensive and it is therefore difficult to maintain a steady supply stream. In addition, due to seasonal changes in mortality rates, some scarce tissues used in our advanced biomaterials products are at times in particularly short supply. We cannot be certain that our current supply of human tissue and allograft implants, plus any additional source that we identify in the future, will be sufficient to meet our needs. Our dependence on a small number of third-party suppliers and the challenges we may face in obtaining adequate supplies of human tissue involve several risks, including limited control over pricing, availability, quality and delivery schedules. In addition, any interruption in the supply of any human tissue component could materially harm our and our third-party suppliers’ ability to manufacture our advanced biomaterials products until a new source of supply, if any, could be found. We may be unable to find a sufficient alternative supply channel in a reasonable time period or on commercially reasonable terms, if at all, which would have a material adverse effect on our business, results of operations and financial condition.
Negative publicity concerning methods of tissue recovery and screening of donor tissue in our industry could reduce demand for our advanced biomaterials products and impact the supply of available donor tissue.
Media reports or other negative publicity concerning both alleged improper methods of tissue recovery from donors and disease transmission from donated tissue could limit widespread acceptance of some of our advanced biomaterials products. Unfavorable reports of improper or illegal tissue recovery practices, both in the United States and internationally, as well as incidents of improperly processed tissue leading to the transmission of disease, may broadly affect the rate of future tissue donation and market acceptance of technologies incorporating human tissue. In addition, such negative publicity could cause the families of potential donors to become reluctant to agree to donate tissue to for-profit tissue processors. For example, the media has reported examples of alleged illegal harvesting of body parts from cadavers and resulting recalls conducted by certain companies selling human tissue based products affected by the alleged illegal harvesting. These reports and others could have a negative effect on our tissue regeneration business.
We are subject to environmental laws and regulations that can impose significant costs and expose us to potential financial liabilities.
The manufacture of certain of our products, including our allograft implants and products, and the handling of materials used in the product testing process, including in our cadaveric laboratory, involve the controlled use of biological, hazardous and/or radioactive materials and wastes. Our business and facilities and those of our suppliers are subject to foreign, federal, state and local laws and regulations relating to the protection of human health and the environment, including those governing the use, manufacture, storage, handling and disposal of, and exposure to, such materials and wastes. In addition, under some environmental laws and regulations, we could be held responsible for costs relating to any contamination at our past or present facilities and at third-party waste disposal sites even if such contamination was not caused by us. A failure to comply with current or future environmental laws and regulations could result in severe fines or penalties. Any such expenses or liability could have a significant negative impact on our business, results of operations and financial condition.

34

We or our suppliers may be the subject of claims for non-compliance with FDA regulations in connection with the processing, manufacturing or distribution of our proposed allograft or other advanced biomaterials implants and products.
Allegations may be made against us or against donor recovery groups or tissue banks, including those with which we have a contractual supplier relationship, claiming that the acquisition or processing of tissue for allograft implants and products or other advanced biomaterials products does not comply with applicable FDA regulations or other relevant statutes and regulations. Allegations like these could cause regulators or other authorities to take investigative or other action against us or our suppliers, or could cause negative publicity for us or our industry generally. These actions or any negative publicity could cause us to incur substantial costs, divert the attention of our management from our business and harm our reputation.
We and our distributor sales representatives might be subject to claims for failing to comply with U.S. federal, state and foreign fraud and abuse laws, including anti-kickback laws and other anti-referral laws.
There are numerous U.S. federal and state laws pertaining to healthcare fraud and abuse, including anti-kickback laws and physician self-referral laws. Our relationships with surgeons, hospitals and our independent distributors are subject to scrutiny under these laws. Violations of these laws are punishable by criminal and civil sanctions, including, in some instances, imprisonment and exclusion from participation in federal and state healthcare programs, including the Medicare, Medicaid and Veterans Administration health programs. Because of the broad and far-reaching nature of these laws, we may be required to alter or discontinue one or more of our business practices to be in compliance with these laws.
Healthcare fraud and abuse regulations are complex, and even minor irregularities can potentially give rise to claims that a statute or prohibition has been violated. Examples of laws that may affect our ability to operate include:
•
the Federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made under federal healthcare programs such as the Medicare and Medicaid programs;
•
federal false claims laws which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third-party payors that are false or fraudulent;
•
the federal Health Insurance Portability and Accountability Act of 1996, which created federal criminal laws that prohibit executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters;
•
the Federal Trade Commission Act and similar laws regulating advertisement and consumer protections;
•
the FCPA, which prohibits corrupt payments, gifts or transfers of value to foreign officials;
•
foreign and U.S. state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers; and
•
the Physician Payment Sunshine Act, which requires medical device companies to report all compensation, gifts and benefits they have provided to certain healthcare professionals.
Possible sanctions for violation of these laws include monetary fines, civil and criminal penalties, exclusion from Medicare and Medicaid programs and forfeiture of amounts collected in violation of such prohibitions. Any violations of these laws, or any action against us for violation of these laws, even if we

35

successfully defend against it, could result in a material adverse effect on our reputation, business, results of operations and financial condition.
We have entered into consulting, royalty and other agreements with surgeons, including some who make referrals to us. In addition, some of our referring surgeons own our stock, which they either purchased in an arm’s length transaction on terms identical to those offered to non-referral sources or received from us as fair market value consideration for consulting services performed. While these transactions were structured with the intention of complying with all applicable laws, including the federal ban on physician self-referrals, commonly known as the “Stark Law,” state anti-referral laws and other applicable anti-kickback laws, it is possible that regulatory agencies may view these transactions as prohibited arrangements that must be restructured, or discontinued, or for which we could be subject to other significant penalties. Regulators also could prohibit us from accepting payment for referrals from these surgeons. We would be materially and adversely affected if regulatory agencies interpret our financial relationships with spine surgeons who order our products to be in violation of applicable laws and we were unable to comply with applicable laws. This could subject us to monetary penalties for non-compliance, the cost of which could be substantial, or we may be unable to accept referrals from such surgeons.
To enforce compliance with the federal laws, the DOJ has increased its scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Dealing with investigations can be time- and resource-consuming and can divert management’s attention from the business. Additionally, if an investigation were initiated involving us and we decided to settle that investigation with the DOJ or other law enforcement agencies, we may be forced to agree to additional onerous compliance and reporting requirements as part of a consent decree or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business, financial condition and results of operations.
In addition, there has been a recent trend of increased federal and state regulation of payments made to physicians for marketing. Some states, such as California, Massachusetts and Vermont, mandate implementation of commercial compliance programs, along with the tracking and reporting of gifts, compensation and other remuneration to physicians. The shifting commercial compliance environment and the need to build and maintain robust and expandable systems to comply with different compliance and/or reporting requirements in multiple jurisdictions increase the possibility that a healthcare company may run afoul of one or more of the requirements.
The scope and enforcement of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal or state regulatory authorities might challenge our current or future activities under these laws. Any such challenge could have a material adverse effect on our reputation, business, results of operations and financial condition. In addition to the penalties described above, any state or federal regulatory review of us, regardless of the outcome, would be costly and time-consuming and could have a material adverse effect on our business, financial condition and results of operations.
Risks Related to our Financial Results and Need for Financing
We will need to generate significant sales to remain profitable.
We intend to increase our operating expenses substantially as we add sales representatives and distributors to increase our geographic sales coverage, submit additional IDE applications to the FDA, increase our marketing capabilities, conduct clinical trials and increase our general and administrative functions to support our growing operations. We will need to generate significant sales to maintain

36

profitability and we might not be able to do so. Even if we do generate significant sales, we might not be able to sustain or increase profitability on a quarterly or annual basis in the future. If our sales grow more slowly than we anticipate or if our operating expenses exceed our expectations, our business, financial condition and results of operations will likely be adversely affected.
We may be unable to grow our revenue or earnings as anticipated, which may have a material adverse effect on our results of operations.
We have experienced rapid growth since our inception and have increased our revenues to $474.4 million in 2014. Our ability to achieve future growth will depend upon, among other things, the success of our growth strategies, which we cannot assure will be successful. In addition, we may have more difficulty maintaining our historical or prior rate of growth of revenues, profitability or cash flows. Our future success will depend upon numerous factors, including the strength of our brand, the market success of our current and future products, competitive conditions, our ability to attract and retain our employees and our ability to manage our business and implement our growth strategy. If we are unable to achieve future growth, our business, financial condition and results of operations could be adversely affected. In addition, we anticipate significantly expanding our infrastructure and adding personnel in connection with our anticipated growth, which we expect will cause our selling, general and administrative expenses to increase, which could adversely impact our results of operations.
Our quarterly and annual operating results may fluctuate significantly.
Our operating results are difficult to predict and may be subject to periodic fluctuations. Our sales and results of operations will be affected by numerous factors, including:
•
our ability to drive increased sales of our products;
•
our ability to establish and maintain an effective and dedicated sales force;
•
pricing pressure applicable to our products, including adverse third-party coverage and reimbursement outcomes;
•
results of clinical research and trials on our existing products and products in development;
•
the mix of our products sold because profit margins differ amongst our products;
•
timing of new product offerings, acquisitions, licenses or other significant events by us or our competitors;
•
the ability of our suppliers to timely provide us with an adequate supply of materials and components;
•
the evolving product offerings of our competitors;
•
regulatory approvals and legislative changes affecting the products we may offer or those of our competitors;
•
interruption in the manufacturing or distribution of our products;
•
the effect of competing technological, industry and market developments;
•
changes in our ability to obtain regulatory clearance or approval for our products; and
•
our ability to expand the geographic reach of our sales and marketing efforts.
Many of the products we may seek to develop and introduce in the future will require FDA approval or clearance before commercialization in the United States, and commercialization of such products outside of the United States would likely require additional regulatory approvals and import licenses. As a result, it will be difficult for us to forecast demand for these products with any degree of certainty. In addition, we will be increasing our operating expenses as we expand our commercial capabilities. Accordingly, we may experience significant, unanticipated quarterly or annual losses. If our quarterly or annual operating results fall below the expectations of investors or securities analysts, the price of our Class A common stock could

37

decline substantially. Furthermore, any quarterly or annual fluctuations in our operating results may, in turn, cause the price of our Class A common stock to fluctuate substantially. We believe that quarterly comparisons of our financial results are not necessarily meaningful and should not be relied upon as an indication of our future performance.
The availability of funding under existing credit arrangements might be limited, and our cash and cash equivalents are subject to volatility.
Any lender that is obligated to provide funding to us under any now existing or future credit agreement with us may not be able to provide funding in a timely manner, or at all, when we require it. The cost of, or lack of, available credit or equity financing could impact our ability to develop sufficient liquidity to maintain or grow our company, which in turn may adversely affect our business, results of operations or financial condition. We also manage cash and cash equivalents and short-term investments through various institutions. There may be a risk of loss on investments based on the volatility of the underlying instruments that will prevent us from recovering the full principal of our investments. Negative changes in domestic and global economic conditions or disruptions of either or both of the financial and credit markets may also affect third-party payors and may have a material adverse effect on our stock price, business, results of operations, financial condition and liquidity.
Our future capital needs are uncertain and we may need to raise funds in the future, and such funds may not be available on acceptable terms or at all.
Continued expansion of our business will be expensive and we may seek funds from public and private stock offerings, borrowings under our existing or future credit facilities or other sources. Our capital requirements will depend on many factors, including:
•
the revenues generated by sales of our products;
•
the costs associated with expanding our sales and marketing efforts;
•
the expenses we incur in manufacturing and selling our products;
•
the costs of developing and commercializing new products or technologies;
•
the cost of obtaining and maintaining regulatory approval or clearance of our products and products in development;
•
the number and timing of acquisitions and other strategic transactions;
•
the costs associated with our planned international expansion;
•
the costs associated with increased capital expenditures, including fixed asset purchases of instrument sets which we loan to hospitals to support surgeries; and
•
unanticipated general and administrative expenses.
As a result of these factors, we may seek to raise capital, and such capital may not be available on favorable terms, or at all. Furthermore, if we issue equity or debt securities to raise capital, our existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of our existing stockholders. In addition, if we raise capital through collaboration, licensing or other similar arrangements, it may be necessary to relinquish valuable rights to our products, potential products or proprietary technologies, or grant licenses on terms that are not favorable to us. If we cannot raise capital on acceptable terms, we may not be able to develop or enhance our products, execute our business plan, take advantage of future opportunities, or respond to competitive pressures, changes in our supplier relationships, or unanticipated customer requirements. Any of these events could adversely affect our ability to achieve our development and commercialization goals, which could have a material adverse effect on our business, results of operations and financial condition.

38

Our existing revolving credit facility contains restrictive covenants that may limit our operating flexibility.
Our existing revolving credit facility contains certain restrictive covenants that limit our ability to transfer or dispose of assets, merge with other companies or consummate certain changes of control, acquire other companies, pay dividends, incur additional indebtedness and liens, experience changes in management and enter into new businesses. We therefore may not be able to engage in any of the foregoing transactions unless we obtain the consent of the lender or terminate the revolving credit facility. There is no guarantee that we will be able to generate sufficient cash flow or sales to meet the financial covenants or pay the principal and interest on any such debt. Furthermore, there is no guarantee that future working capital, borrowings or equity financing will be available to repay or refinance any such debt.
Risks Related to our Intellectual Property and Potential Litigation
Our ability to protect our intellectual property and proprietary technology is uncertain.
We rely primarily on patent, copyright, trademark and trade secret laws, as well as confidentiality and non-disclosure agreements and other methods, to protect our proprietary technologies and know-how. We have applied for patent protection relating to certain existing and proposed products and processes. While we generally apply for patents in those countries where we intend to make, have made, use or sell patented products, we may not accurately predict all of the countries where patent protection will ultimately be desirable. If we fail to timely file a patent application in any such country, we may be precluded from doing so at a later date. Furthermore, we cannot assure you that any of our patent applications will be approved. The rights granted to us under our patents, including prospective rights sought in our pending patent applications, may not be meaningful or provide us with any commercial advantage and they could be opposed, contested or circumvented by our competitors or be declared invalid or unenforceable in judicial or administrative proceedings. The failure of our patents to adequately protect our technology might make it easier for our competitors to offer the same or similar products or technologies. Competitors may be able to design around our patents or develop products that provide outcomes which are comparable to ours without infringing on our intellectual property rights. We have entered into confidentiality agreements and intellectual property assignment agreements with our officers, employees, consultants and advisors regarding our intellectual property and proprietary technology. In the event of unauthorized use or disclosure or other breaches of such agreements, we may not be provided with meaningful protection for our trade secrets or other proprietary information. Due to differences between foreign and U.S. patent laws, our patented intellectual property rights may not receive the same degree of protection in foreign countries as they would in the United States. Even if patents are granted outside the United States, effective enforcement in those countries may not be available. Since most of our issued patents and pending patent applications are for the United States only, we lack a corresponding scope of patent protection in other countries. In countries where we do not have significant patent protection, we may not be able to stop a competitor from marketing products in such countries that are the same as or similar to our products.
We rely on our trademarks, trade names and brand names to distinguish our products from the products of our competitors, and have registered or applied to register many of these trademarks. We cannot assure you that our trademark applications will be approved. Third parties may also oppose our trademark applications, or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our products, which could result in loss of brand recognition, and could require us to devote resources to advertising and marketing new brands. Further, we cannot assure you that competitors will not infringe upon our trademarks, or that we will have adequate resources to enforce our trademarks.

39

If a competitor infringes upon one of our patents, trademarks or other intellectual property rights, enforcing those patents, trademarks and other rights may be difficult and time consuming. Even if successful, litigation to defend our patents and trademarks against challenges or to enforce our intellectual property rights could be expensive and time consuming and could divert management’s attention from managing our business. Moreover, we may not have sufficient resources or desire to defend our patents or trademarks against challenges or to enforce our intellectual property rights.
The medical device industry is characterized by patent litigation and we could become subject to litigation that could be costly, result in the diversion of management’s time and efforts, require us to pay damages, and/or prevent us from marketing our existing or future products.
Our commercial success will depend in part on not infringing the patents or violating the other proprietary rights of third parties. Significant litigation regarding patent rights exists in our industry. Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit or otherwise interfere with our ability to make and sell our products. We have not conducted an independent review of patents issued to third parties. The large number of patents, the rapid rate of new patent issuances, the complexities of the technology involved and uncertainty of litigation increase the risk of business assets and management’s attention being diverted to patent litigation. We have received in the past, and expect to receive in the future, communications from various industry participants alleging our infringement of their patents, trade secrets or other intellectual property rights and/or offering licenses to such intellectual property. We are currently subject to lawsuits, and have received other written allegations, claiming that we have infringed certain patents of our competitors and others in the spine industry, including N-Spine (subsequently acquired by Depuy Synthes), Depuy Synthes, and Bonutti Skeletal Innovations LLC. A summary of the N-Spine, Depuy Synthes, and Bonutti Skeletal Innovations LLC cases is provided under “Item 3. Legal Proceedings” below. Any lawsuits resulting from such allegations could subject us to significant liability for damages, such as the jury verdict returned against us in June 2013 in the patent infringement case brought by DePuy Synthes, and invalidate our proprietary rights. Any potential intellectual property litigation also could force us to do one or more of the following:
•
stop selling products or using technology that contains the allegedly infringing intellectual property;
•
lose the opportunity to license our technology to others or to collect royalty payments based upon successful protection and assertion of our intellectual property rights against others;
•
incur significant legal expenses;
•
pay substantial damages to the party whose intellectual property rights we may be found to be infringing;
•
redesign those products that contain the allegedly infringing intellectual property, which could be costly and disruptive; or
•
attempt to obtain a license to the relevant intellectual property from third parties, which may not be available on reasonable terms or at all.
Any litigation or claim against us, even those without merit, may cause us to incur substantial costs, and could place a significant strain on our financial resources, divert the attention of management from our core business, and harm our reputation. Further, as the number of participants in the spine industry grows, the possibility of intellectual property infringement claims against us increases. If we are found to infringe the intellectual property rights of third parties, we could be required to pay substantial damages (including treble, or triple, damages if an infringement is found to be willful) and/or royalties and could be prevented from selling our products unless we obtain a license or are able to redesign our products to avoid infringement.

40

Any such license may not be available on reasonable terms, if at all, and there can be no assurance that we would be able to redesign our products in a way that would not infringe the intellectual property rights of others. If we fail to obtain any required licenses or make any necessary changes to our products or technologies, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our products, all of which could have a material adverse effect on our business, results of operations and financial condition.
Further, in the course of our regular review of pending legal matters, we determine whether it is reasonably possible that a potential loss relating to a legal proceeding may have a material impact on our business, financial performance or cash position.  However, estimates of possible losses are inherently uncertain, and even if we determine that a loss is reasonably possible, in accordance with authoritative accounting guidance, if we are unable to estimate the possible loss or range of loss, we do not record an accrual related to such litigation.  As a result of this accounting policy, we may experience variability in our results of operations if damages for which we are found liable exceed the amounts we have accrued. For example, on June 14, 2013, the jury in the patent infringement case in the U.S. District Court in Delaware brought by DePuy Synthes returned a verdict in favor of DePuy Synthes and on January 17, 2014, the jury in a misappropriation of trade secret suit filed against us in the Federal District Court for the Eastern District of Texas by Sabatino Bianco returned a verdict in favor of Bianco. In prior periods, we were unable to determine the probable outcomes in these cases or estimate the potential loss. As a result of these verdicts, we have a combined $26.0 million accrued in damages and other related costs as of December 31, 2014, which reduced our 2014 and 2013 U.S. GAAP diluted earnings per share by approximately $0.04 and $0.17, respectively (see further discussion under “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; Non-GAAP Financial Measures” below).
In addition, we generally indemnify our customers and distributors with respect to infringement by our products of the proprietary rights of third parties. Third parties may assert infringement claims against our customers or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers or distributors or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products.
We may be subject to damages resulting from claims that we, our employees or our independent distributors have wrongfully used or disclosed alleged trade secrets, proprietary or confidential information of our competitors or are in breach of non-competition or non-solicitation agreements with our competitors.
Many of our employees were previously employed at other medical device companies, including our competitors or potential competitors, in some cases until recently. Many of our independent distributors sell, or in the past have sold, products of our competitors. We may be subject to claims that we, our employees, or our independent distributors have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of these former employers or competitors. In addition, we have been and may in the future be subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and could be a distraction to management. If our defense to those claims fails, in addition to paying monetary damages, we may lose valuable personnel. There can be no assurance that this type of litigation will not continue, and any future litigation or the threat thereof may adversely affect our ability to hire additional direct sales representatives. A loss of key personnel or their work product could hamper or prevent our ability to commercialize product candidates, which could have an adverse effect on our business, results of operations and financial condition.

41

We may incur product liability losses and insurance coverage may be inadequate or unavailable to cover these losses.
Our business exposes us to potential product liability claims that are inherent in the testing, design, manufacture and sale of medical devices for spine surgery procedures. The development of allograft implants and technologies for human tissue repair and treatment may entail particular risk of transmitting diseases to human recipients, which could result in the assertion of substantial product liability claims against us. Spine surgery involves significant risk of serious complications, including bleeding, nerve injury, paralysis and even death. In addition, if longer-term patient results and experience indicates that our products or any component of a product cause tissue damage, motor impairment or other adverse effects, we could be subject to significant liability. Furthermore, if spine surgeons are not sufficiently trained in the use of our products, they may misuse or ineffectively use our products, which may result in unsatisfactory patient outcomes or patient injury. We could become the subject of product liability lawsuits alleging that component failures, manufacturing flaws, design defects or inadequate disclosure of product-related risks or product-related information resulted in an unsafe condition or injury to patients. The spine industry has been particularly prone to potential product liability claims that are inherent in the testing, manufacture and sale of medical devices and products for spine surgery procedures.
A product liability or other damages claim, product recall or product misuse, regardless of the outcome, could require us to spend significant time and money in litigation or to pay significant damages or costs, and could seriously harm our business. If our product liability insurance is inadequate to pay a damages award, we may have to pay the excess out of our cash reserves, which may harm our financial condition. Any product liability claim brought against us, with or without merit, could result in the increase of the costs we incur to obtain product liability insurance or our inability to secure product liability coverage in the future. If any of our products are found to cause tissue damage, motor impairment or other adverse effects, we could be subject to significant liability. Even a meritless or unsuccessful product liability claim could harm our reputation in the industry, impair our ability to sell one or more of our products in the future, result in significant legal fees and cause significant diversion of management’s attention from managing our business. A product liability or other claim, product recall, or product misuse involving any of our products, whether or not meritorious, could also materially and adversely harm our reputation and our ability to attract and retain customers.
In addition, any product liability claim brought against us, with or without merit, could result in an increase of our product liability insurance rates. Insurance coverage varies in cost and can be difficult to obtain, and we cannot guarantee that we will be able to obtain insurance coverage in the future on terms acceptable to us or at all.
Risks Related to the Ownership of our Class A Common Stock
Because of their significant stock ownership, our chief executive officer, our other executive officers, and our directors and principal stockholders will be able to exert control over us and our significant corporate decisions.
Because of their significant stock ownership, our chief executive officer, our other executive officers, and our directors will be able to exert substantial control over us and our significant corporate decisions. Based on an aggregate of 94,705,743 shares of our Class A and Class B common stock outstanding as of December 31, 2014, our executive officers and directors and their affiliates beneficially owned, in the aggregate, approximately 78.5% of the voting power of our outstanding capital stock. In particular, as of December 31, 2014, David C. Paul, our CEO and his family members, controlled approximately 28.4% of

42

our Class A and Class B common stock, representing approximately 78.1% of the voting power of our outstanding capital stock as of that date.
As a result, David C. Paul has, and these persons acting together have, the ability to significantly influence or determine the outcome of all matters submitted to our stockholders for approval, including the election and removal of directors and any merger, consolidation, or sale of all or substantially all of our assets. Furthermore, as of December 31, 2014, we had 192,562,323 shares of Class B common stock available for issuance. This amount exceeds 5% of our outstanding common stock, meaning our Board of Directors (“Board”) could issue Class B common stock without necessarily triggering the automatic conversion of that Class B common stock to Class A common stock that, pursuant to our charter, will occur when any holder’s shares of Class B common stock represents less than 5% of the aggregate number of all outstanding shares of our common stock, thereby further concentrating the voting power of our capital stock in a limited number of stockholders.
The interests of our executive officers, directors and principal stockholders might not coincide with the interests of the other holders of our capital stock. This concentration of ownership may harm the value of our Class A common stock by, among other things:
•
delaying, deferring or preventing a change in control of our company;
•
impeding a merger, consolidation, takeover or other business combination involving our company; or
•
causing us to enter into transactions or agreements that are not in the best interests of all stockholders.
We are a “controlled company” within the meaning of the New York Stock Exchange Rules, and we take, and intend to continue to take, advantage of exemptions from certain corporate governance requirements.
David C. Paul, alone, and our management, directors and significant stockholders, collectively, beneficially own a majority of the voting power of our outstanding common stock. Under the New York Stock Exchange Rules, a company of which more than 50% of the voting power is held by an individual, group or another company is a “controlled company” and may elect not to comply with certain corporate governance requirements, including the requirement that a majority of our directors be independent, as defined in the New York Stock Exchange Rules, and the requirement that our compensation and nominating and corporate governance committees consist entirely of independent directors. We rely, and intend to continue to rely, on the “controlled company” exemption under the New York Stock Exchange Rules. As a result, a majority of the members of our Board may not be independent directors and our nominating and corporate governance and compensation committees will not consist entirely of independent directors. Accordingly, while we remain a controlled company and during any transition period following a time when we are no longer a controlled company, you will not have the same protections afforded to stockholders of companies that are subject to all of the New York Stock Exchange’s corporate governance requirements.
Our Board is authorized to issue and designate shares of our preferred stock in additional series without stockholder approval.
Our amended and restated certificate of incorporation authorizes our Board, without the approval of our stockholders, to issue 35 million shares of our preferred stock, subject to limitations prescribed by applicable law, rules and regulations and the provisions of our amended and restated certificate of incorporation, as shares of preferred stock in series, and to establish from time to time the number of shares to be included in each such series, and to fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof. The powers, preferences and rights

43

of these additional series of preferred stock may be senior to or on parity with our Class A common stock, which may reduce its value.
Anti-takeover provisions in our organizational documents and Delaware law may discourage or prevent a change of control, even if an acquisition would be beneficial to our stockholders, which could depress the price of our Class A common stock and prevent attempts by our stockholders to replace or remove our current management.
Our amended and restated certificate of incorporation and amended and restated bylaws contain other provisions that could delay or prevent a change of control of our company or changes in our Board that our stockholders might consider favorable.
In addition, we are subject to the provisions of Section 203 of the Delaware General Corporation Law regulating corporate takeovers, which may restrict or prohibit certain business combination transactions with stockholders owning 15% or more of our outstanding voting stock, including discouraging takeover attempts that might result in a premium over the market price for shares of our Class A common stock.
Section 203 and other provisions in our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could make it more difficult for stockholders or potential acquirers to obtain control of our Board or initiate actions that are opposed by our then-current Board, including delay or impede a merger, tender offer, or proxy contest involving our company. The existence of these provisions could negatively affect the price of our Class A common stock and limit opportunities for you to realize value in a corporate transaction.
We do not intend to pay cash dividends.
We have never declared or paid cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future. In addition, we have a revolving credit facility that, if we borrow under it, may preclude us from paying any dividends. Accordingly, you may have to sell some or all of your shares of our Class A common stock in order to generate cash flow from your investment. You may not receive a gain on your investment when you sell shares and you may lose the entire amount of the investment.
The price of our Class A common stock might fluctuate significantly, and you could lose all or part of your investment.
The trading price of our Class A common stock may be volatile and subject to wide price fluctuations in response to various factors, including:
•
actual or anticipated fluctuations in our quarterly financial and operating results;
•
the overall performance of the equity markets;
•
introduction of new services or announcements of significant contracts, acquisitions or capital commitments by us or our competitors;
•
legislative, political or regulatory developments;
•
issuance of new or changed securities analysts’ reports or recommendations;
•
additions or departures of key personnel;
•
threatened or actual litigation and government investigations;
•
investor perceptions of us and the medical device industry, changes in accounting standards, policies, guidance, interpretations or principles;

44

•
sale of shares of our Class A common stock by us or members of our management;
•
general economic conditions;
•
changes in interest rates; and
•
availability of capital.
These and other factors might cause the market price of our Class A common stock to fluctuate substantially, which might limit or prevent investors from readily selling their shares of our Class A common stock and may otherwise negatively affect the liquidity of our Class A common stock. In addition, in recent years, the stock market has experienced significant price and volume fluctuations. This volatility has had a significant impact on the market price of securities issued by many companies across many industries. The changes frequently appear to occur without regard to the operating performance of the affected companies. Accordingly, the price of our Class A common stock could fluctuate based upon factors that have little or nothing to do with our company, and these fluctuations could materially reduce our share price. Securities class action litigation has often been instituted against companies following periods of volatility in the overall market and in the market price of a company’s securities. This litigation, if instituted against us, could result in substantial costs, divert our management’s attention and resources, and harm our business, operating results and financial condition.
Item 1B. Unresolved Staff Comments
None.
Item 2. Properties
As of December 31, 2014, our owned corporate headquarters in Audubon, Pennsylvania, comprised approximately 245,000 square feet. Our headquarters houses our research, product development, education, administration, warehouse and shipping functions, as well as our in-house manufacturing facility. In October

45

2014, we acquired a 13,000 square foot distribution center in Heerlen, Netherlands to support our international operations. Additionally, pursuant to our October 23, 2014 acquisition of Transplant Technologies of Texas, Ltd., we now lease approximately 20,000 square feet in San Antonio, Texas.
Item 3. Legal Proceedings
We are involved in a number of proceedings, legal actions and claims. Such matters are subject to many uncertainties, and the outcomes of these matters are not within our control and may not be known for prolonged periods of time. In some actions, the claimants seek damages, as well as other relief, including injunctions prohibiting us from engaging in certain activities, which, if granted, could require significant expenditures and/or result in lost revenues. The material legal proceedings to which we are currently a party are described below.
N-Spine, Synthes and Depuy Synthes Litigation
In April 2010, N-Spine, Inc. and Synthes USA Sales, LLC filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. N-Spine, the patent owner, and Synthes USA, a licensee of the subject patent, allege that we infringe one or more claims of the patent by making, using, offering for sale or selling our TRANSITION® stabilization system product. N-Spine and Synthes USA seek injunctive relief and an unspecified amount in damages. We intend to defend our rights vigorously. This matter was stayed on July 14, 2011 pending the resolution of an inter partes reexamination on the asserted patent granted by the U.S. Patent and Trademark Office (“USPTO”) in February 2011. In December 2011, the examiner withdrew the original grounds of rejection of the asserted patent and we appealed the examiner’s decision. In January 2014, the USPTO ruled on the appeal, rejecting certain claims in view of the prior art and affirming certain other claims. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
In a related matter, on January 8, 2014, Depuy Synthes Products, LLC (“Depuy Synthes”) filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. Depuy Synthes alleges that we infringe one or more claims of the asserted patent by making, using, offering for sale or selling our TRANSITION® stabilization system product. Depuy Synthes seeks injunctive relief and an unspecified amount in damages. We intend to defend our rights vigorously. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
Synthes USA, LLC, Synthes USA Products, LLC and Synthes USA Sales, LLC Litigation
In July 2011, Synthes USA, LLC, Synthes USA Products, LLC and Synthes USA Sales, LLC filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. Synthes USA LLC, the patent owner, Synthes USA Products, LLC, a licensee to manufacture products of the subject patents, and Synthes USA Sales LLC, a licensee to sell products of the subject patents, allege that we infringe one or more claims of three patents by making, using, offering for sale or selling our COALITION®, INDEPENDENCE® and INTERCONTINENTAL® products. As a result of the acquisition of Synthes, Inc. by Johnson & Johnson, a motion was filed to change the plaintiff in this matter to DePuy Synthes in February 2013. On June 14, 2013, the jury in this case returned a verdict, finding that prior versions of the three products we previously sold did infringe on DePuy Synthes’ patents and awarding monetary damages in the amount of $16.0 million. The jury also upheld the validity of DePuy Synthes’ patents. There was no finding of willful infringement by Globus.

46

We do not expect the verdict to impact our ability to conduct our business or to have any material impact on our future revenues. As this lawsuit involved only three products that are no longer part of our product portfolio, this verdict is not expected to impair our ability to sell any of our future products.
We believe the facts and the law do not support the jury’s findings of infringement and patent validity and are seeking to overturn the verdict through the appeals process.
For the year ended December 31, 2013, we accrued $19.5 million in damages and other litigation-related costs related to this case, of which $1.3 million was included in provision for litigation loss (cost of goods sold, due to a write off of certain inventory which will not be sold due to the verdict) and $18.2 million was included in provision for litigation loss (operating expense). During the year ended December 31, 2014, we accrued an additional $0.6 million in interest included in provision for litigation related to this litigation.
L5 Litigation
In December 2009, we filed suit in the Court of Common Pleas of Montgomery County, Pennsylvania against our former exclusive independent distributor L5 Surgical, LLC and its principals, seeking an injunction and declaratory judgment concerning certain restrictive covenants made to L5 by its sales representatives. L5 brought counterclaims against us alleging tortious interference, unfair competition and conspiracy. The injunction phase was resolved in September 2010, and this matter is now in the discovery phase of litigation on the underlying damages claims. We intend to defend our rights vigorously. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
NuVasive Litigation
In October 2010, NuVasive, Inc. filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. NuVasive, the patent owner, alleges that we infringe one or more claims of three patents by making, using, offering for sale or selling our MARS™ 3V retractor for use in certain lateral fusion procedures. NuVasive sought injunctive relief and an unspecified amount in damages. This matter was settled on February 12, 2015 for an undisclosed amount.
NuVasive Employee Litigation
We have hired several employees who were formerly employed by NuVasive, Inc. In July 2011, NuVasive filed suit against us in the District Court of Travis County, Texas alleging that our hiring of one named former employee and other unnamed former employees constitutes tortious interference with its contracts with those employees, and with prospective business relationships, as well as aiding and abetting the breach of fiduciary duty. NuVasive sought compensatory damages, permanent injunction, punitive damages and attorneys’ fees. This matter was settled on February 12, 2015 for an undisclosed amount.
Bianco Litigation
On March 21, 2012, Sabatino Bianco filed suit against us in the Federal District Court for the Eastern District of Texas claiming that we misappropriated his trade secret and confidential information and improperly utilized it in developing our CALIBER® product. Bianco alleges that we engaged in misappropriation of trade secrets, breach of contract, unfair competition, fraud and theft and seeks correction of inventorship, injunctive relief and exemplary damages. On April 20, 2012, Bianco filed a motion for a preliminary injunction, seeking to enjoin us from making, using, selling, importing or offering for sale our CALIBER® product. On November 15, 2012, the court denied Bianco’s motion for preliminary injunction.

47

On October 1, 2013, Bianco amended his complaint to include that his trade secrets and confidential information were also used improperly in developing our RISE® and CALIBER®-L products.
On January 17, 2014, the jury in this case returned a verdict in favor of Bianco on a claim of misappropriation of trade secret. We accrued the verdict amount of $4.3 million as of December 31, 2013. The jury found against Bianco on the claims of breach of contract and disgorgement of profits. The court granted our motion for judgment as a matter of law and dismissed Bianco’s claims for unfair competition, fraud, and exemplary damages, and Bianco abandoned the claim of misappropriation of confidential information. Bianco’s claims of correction of inventorship, unjust enrichment, and permanent injunctive relief were not submitted to the jury. On March 7, 2014, the court denied Bianco’s claim for correction of inventorship and ruled he is not entitled to be named as a co-inventor on any of the patents at issue, and also denied his claim for unjust enrichment. On March 17, 2014, the court denied Bianco’s claim for permanent injunctive relief. On July 2, 2014, the court awarded Bianco an ongoing royalty of 5% of the net sales of the CALIBER®, CALIBER®-L, and RISE® products, or products that are not colorably different from those products, for a fifteen year period on sales starting on January 18, 2014. The court entered final judgment on the jury verdict on July 17, 2014. Post-trial motions were denied on October 27, 2014 and the matter is currently on appeal.
We do not expect the verdict to impact our ability to conduct our business or to have any material impact on our future revenues. We believe the facts and the law do not support the jury’s findings of misappropriation of trade secret and are seeking to overturn the verdict through the appeals process.
Altus Partners, LLC Litigation
On February 20, 2013, Altus Partners, LLC filed suit against us in the U.S. District Court for the Eastern District of Pennsylvania for patent infringement.  On April 7, 2014, we settled the litigation with Altus Partners and recognized a provision for litigation of $2.0 million.
Bonutti Skeletal Innovations, LLC Litigation
On November 19, 2014, Bonutti Skeletal Innovations, LLC filed suit against us in the U.S. District Court for the Eastern District of Pennsylvania for patent infringement. Bonutti Skeletal, a non-practicing entity, alleges that Globus willfully infringes one or more claims of six patents by making, using, offering for sale or selling the CALIBER®, CALIBER®-L, COALITION®, CONTINENTAL®, FORGE®, FORTIFY®, INDEPENDENCE®, INTERCONTINENTAL®, MONUMENT®, NIKO®, RISE®, SIGNATURE®, SUSTAIN®, and TRANSCONTINENTAL® products. Bonutti Skeletal seeks an unspecified amount in damages and injunctive relief. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
In addition, we are subject to legal proceedings arising in the ordinary course of business.
Item 4. Mine Safety Disclosures
Not applicable.

48

PART II
Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Class A Common Stock Market Price
Our Class A common stock trades on The New York Stock Exchange, under the symbol “GMED.” Prior to that time, there was no public trading market for our Class A common stock. The following table sets forth the high and low sales prices per share for our Class A common stock for the periods indicated, as reported by New York Stock Exchange:
Year Ended December 31, 2014:
 
High
 
Low
1st Quarter
 
$
27.14

 
$
19.52

2nd Quarter
 
27.00

 
22.33

3rd Quarter
 
24.41

 
17.45

4th Quarter
 
24.65

 
19.00

 
 
 
 
 
Year Ended December 31, 2013:
 
High
 
Low
1st Quarter
 
$
15.15

 
$
10.55

2nd Quarter
 
17.37

 
13.79

3rd Quarter
 
18.20

 
16.22

4th Quarter
 
20.25

 
16.93

We had approximately 83 stockholders of record as of 1/31/15. We believe that the number of beneficial owners is substantially greater than the number of record holders because a large portion of our Class A common stock is held of record through brokerage firms in “street name.”
Recent Sales of Unregistered Securities
None.
Issuer Purchases of Equity Securities
None.
Use of Proceeds
On August 2, 2012, our registration statement on Form S-1 (File No. 333-180426) was declared effective for our IPO, pursuant to which we registered the sale of 9,583,333 shares of Class A common stock at $12.00 per share, of which 2,083,333 shares were sold by us and 6,250,000 shares were sold by selling stockholders, plus 1,250,000 additional shares to cover the underwriters’ overallotment option, all of which were sold by selling stockholders. On August 8, 2012, we closed the IPO and the exercise of the underwriters’ overallotment. These sales were at the IPO price of $12.00 per share, for an aggregate gross offering price of $25.0 million for the shares sold by our company, and $90.0 million for the shares sold by selling stockholders. We did not receive any proceeds from the sale of securities by selling stockholders.
From the IPO effective date through December 31, 2013, we used $16.8 million for an acquisition that occurred in December 2013. The remainder of the net proceeds were invested in marketable securities.
The remaining proceeds from our initial public offering were used for the October 23, 2014, acquisition of Transplant Technologies of Texas, Ltd. for $36.1 million in cash. No further proceeds from the initial public offering remain.

49

Dividend Policy
We have never declared or paid any cash dividends on our capital stock. We currently intend to retain future earnings, if any, for development of our business and do not anticipate that we will declare or pay cash dividends on our capital stock in the foreseeable future.
Comparative Stock Performance Graph
The following graph illustrates a comparison of the total cumulative stockholder return on our Class A common stock from August 3, 2012 (which is the date our Class A common stock first began trading on The New York Stock Exchange) through December 31, 2014 to two indices: the S&P 500 Index and the S&P 500 Health Care Equipment Index. The graph assumes an initial investment of $100 on August 3, 2012, in each of our Class A common stock, the stocks comprising the S&P 500 Index, and the stocks comprising the S&P 500 Health Care Equipment Index, including reinvestment of dividends, if any. Historical stockholder return is not necessarily indicative of the performance to be expected for any future periods.
The following graph and related information shall not be deemed “soliciting material” or to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filing, except to the extent that we specifically incorporate it by reference into such filing.
Company/Index
 
August 3,
2012
 
December 31,
2012
 
June 30,
2013
 
December 31,
2013
 
June 30,
2014
 
December 31,
2014
Globus Medical, Inc.
 
$
100

 
$
78

 
$
125

 
$
149

 
$
177

 
$
176

S&P 500 Index
 
$
100

 
$
104

 
$
118

 
$
137

 
$
147

 
$
156

S&P 500 Health Care Equipment
 
$
100

 
$
106

 
$
121

 
$
135

 
$
151

 
$
170

Item 6. Selected Financial Data
The selected consolidated financial data set forth in the table below has been derived from our audited financial statements. The data set forth below should be read in conjunction with “Item 7. Management’s

50

Discussion and Analysis of Financial Condition and Results of Operations” and “Item 8. Financial Statements and Supplementary Data” below.
Statement of Operations Data:
Year Ended December 31,
(In thousands, except per share amounts)
2014
 
2013
 
2012
 
2011
 
2010
Sales
$
474,371

 
$
434,459

 
$
385,994

 
$
331,478

 
$
288,195

Cost of goods sold
110,857

 
100,343

 
75,199

 
68,796

 
53,825

Gross profit
363,514

 
334,116

 
310,795

 
262,682

 
234,370

Operating expenses:
 
 
 
 
 
 
 
 
 
Research and development
31,687

 
26,870

 
27,926

 
23,464

 
21,309

Selling, general and administrative
187,798

 
182,518

 
168,862

 
140,386

 
122,589

Provision for litigation loss/(income)
5,667

 
23,055

 
(786
)
 
1,470

 
2,787

Total operating expenses
225,152

 
232,443

 
196,002

 
165,320

 
146,685

Operating income
138,362

 
101,673

 
114,793

 
97,362

 
87,685

Other income/(expense), net
280

 
328

 
(140
)
 
(413
)
 
54

Income before income taxes
138,642

 
102,001

 
114,653

 
96,949

 
87,739

Income tax provision
46,157

 
33,389

 
40,822

 
36,165

 
33,281

Net income
$
92,485

 
$
68,612

 
$
73,831

 
$
60,784

 
$
54,458

Net income per common share:
 
 
 
 
 
 
 
 
 
Basic
$
0.98

 
$
0.74

 
$
0.82

 
$
0.69

 
$
0.61

Diluted
$
0.97

 
$
0.73

 
$
0.80

 
$
0.67

 
$
0.60

Weighted average number of common shares:
 
 
 
 
 
 
 
 
 
Basic
94,227

 
92,647

 
89,608

 
88,112

 
88,925

Diluted
95,457

 
94,192

 
92,208

 
90,420

 
91,352

Balance Sheet Data:
As of December 31,
(In thousands)
2014
 
2013
 
2012
 
2011
 
2010
Cash, cash equivalents and marketable securities
$
304,051

 
$
275,452

 
$
212,400

 
$
142,668

 
$
111,701

Working capital
380,613

 
348,866

 
320,602

 
229,504

 
187,245

Total assets
703,547

 
566,304

 
447,133

 
329,390

 
266,575

Business acquisition liabilities, including current portion (1)
26,276

 
17,258

 
11,344

 
10,289

 
—

Stockholders’ equity
$
585,454

 
$
472,360

 
$
386,502

 
$
282,476

 
$
228,195

(1) 
In connection with acquisitions completed in 2014 through 2011, we have certain contingent consideration obligations payable to the sellers in these transactions upon the achievement of certain regulatory and sales milestones. The maximum aggregate undiscounted amounts potentially payable were $38.9 million, $23.9 million, $9.9 million and $7.2 million as of December 31, 2014, 2013, 2012 and 2011, respectively.

51

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and related notes included elsewhere in this Annual Report. This discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. You should review the “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements” sections of this Annual Report for a discussion of certain of the important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements described in the following discussion and analysis. Certain amounts and percentages in this discussion and analysis have been rounded for convenience of presentation.
Overview
We are a medical device company focused exclusively on the design, development and commercialization of musculoskeletal implants. We are currently focused on implants that promote healing in patients with spine disorders. We are an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures that assist surgeons in effectively treating their patients, respond to evolving surgeon needs and address new treatment options. Since our inception in 2003, we have launched over 130 products and offer a comprehensive product portfolio of innovative and differentiated products addressing a broad array of spinal pathologies, anatomies and surgical approaches.
We sell implants and related disposables to our customers, primarily hospitals, for use by surgeons to treat spine disorders. All of our products fall into one of two categories: Innovative Fusion or Disruptive Technologies. Spinal fusion is a surgical procedure to correct problems with the individual vertebrae, the interlocking bones making up the spine, by preventing movement of the affected bones. Our Innovative Fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions.
We define Disruptive Technologies as those that represent a significant shift in the treatment of spine disorders by allowing for novel surgical procedures, improvements to existing surgical procedures, the treatment of spine disorders by new physician specialties, and surgical intervention earlier in the continuum of care. Our current portfolio of approved and pipeline products includes a variety of Disruptive Technology products, which we believe offer material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies, as well as interventional pain management solutions, including treatments for vertebral compression fractures.
To date, the primary market for our products has been the United States, where we sell our products through a combination of direct sales representatives employed by us and distributor sales representatives employed by our exclusive independent distributors, who distribute our products on our behalf for a commission that is generally based on a percentage of sales. We believe there is significant opportunity to strengthen our position in the U.S. market by increasing the size of our U.S. sales force and we intend to add additional direct and distributor sales representatives by the end of 2015.
During the year ended December 31, 2014, our international sales accounted for approximately 10% of our total sales. We sell our products through a combination of direct sales representatives employed by us and international distributors. We believe there are significant opportunities for us to increase our presence in both existing and new international markets through the expansion of our direct and distributor sales forces and the commercialization of additional products.

52

Recent Developments
In October 2014, we completed the acquisition of Transplant Technologies of Texas, Ltd. (“TTOT”), an allograft tissue processor based in San Antonio, Texas. TTOT is a provider of human tissue products such as bone allografts, biomaterials and soft tissue products for spine, orthopedics, sports medicine, dental and wound care markets. This acquisition represents a key step in fulfilling our strategy of building a broad business in regenerative biologics. While we currently partner with third party suppliers for our existing allograft products, the acquisition of TTOT will expand our suite of regenerative biologics products. We believe this acquisition will also greatly improve our capabilities for the development of new and innovative human allograft tissue products in the future.
On February 25, 2015, we entered into an agreement to acquire medical device manufacturer Branch Medical Group, Inc. (“BMG”). Under the terms of the agreement we have agreed to pay approximately $52.9 million in cash subject to certain closing adjustments for BMG on a cash-free, debt-free basis. We expect the closing of the acquisition to occur in March 2015 following satisfaction of the applicable closing conditions.
Components of our Results of Operations
We manage our business globally within one reportable segment, which is consistent with how our management reviews our business, makes investment and resource allocation decisions and assesses operating performance.
Sales
We sell implants and related disposables, primarily to hospitals, for use by spine surgeons to treat spine disorders. We generally consign our surgical sets, which contain our implants, disposables, surgical instruments and cases to our sales representatives, and the sets are maintained with the sales representatives or at our hospital customers that purchase the implants and related disposables used in the surgeries. We recognize revenue when we are notified that consigned implants and related disposables have been implanted or used, or for sets that are sold directly and not consigned, when title to the goods and risk of loss are transferred to customers with no remaining performance obligations which affect the customer’s final acceptance of the sale. We expect to expand our U.S. and international sales forces, which will provide us with significant opportunity to continue to increase our penetration in existing markets and to enter new international markets. We also expect to increase sales by commercializing new products, but expect the increase of sales from new products to be partially offset by decreased sales of earlier-generation products.
We classify our products into two categories: Innovative Fusion and Disruptive Technologies. Disruptive Technologies are those that represent a significant shift in the treatment of spine disorders, by allowing for novel surgical procedures, improvements to existing surgical procedures, the treatment of spine disorders by new physician specialties, and surgical intervention earlier in the continuum of care. As a result, we anticipate Disruptive Technology products to continue to drive our sales growth in the future.
Cost of Goods Sold
Our products are generally manufactured by third-party suppliers. Substantially all of our suppliers manufacture our products in the United States. Our cost of goods sold consists primarily of costs of products purchased from our third-party suppliers, excess and obsolete inventory charges, depreciation of surgical instruments and cases, royalties, shipping, inspection and related costs incurred in making our products

53

available for sale or use. Beginning in January 2013, our cost of goods sold increased as a result of a medical device excise tax (“MDET”) of up to 2.3% on the sale of certain medical devices in the United States.
Research and Development Expenses
Our research and development expenses primarily consist of engineering, product development, clinical and regulatory expenses, consulting services, outside prototyping services, internal and external research activities, materials, depreciation, and other costs associated with development of our products. Research and development expenses also include related personnel and consultants’ compensation and stock-based compensation expense. We expense research and development costs as they are incurred.
We expect to incur additional research and development costs as we continue to develop new products. These costs will increase in absolute terms as we continue to expand our product pipeline and add personnel.
Selling, General and Administrative Expenses
Selling, general and administrative expenses primarily consist of salaries, benefits and other related costs, including stock-based compensation for personnel employed in sales, marketing, finance, legal, compliance, administrative, information technology, medical education and training, quality and human resource departments. Our selling, general and administrative expenses also include commissions, generally based on a percentage of sales, to direct sales representatives and distributors. We expect our selling, general and administrative expenses will increase in absolute terms with the continued expansion of our sales force and commercialization of our current and pipeline products. We plan to hire more personnel to support the growth of our business.
Provision for Litigation Loss/(Income)
We record a provision for litigation settlements when a loss is known or considered probable and the amount can be reasonably estimated.
Income Tax Provision
We are taxed at the rates applicable within each jurisdiction. The composite income tax rate, tax provisions, deferred tax assets and deferred tax liabilities will vary according to the jurisdiction in which profits arise. Tax laws are complex and subject to different interpretations by management and the respective governmental taxing authorities, and require us to exercise judgment in determining our income tax provision, our deferred tax assets and liabilities, and the valuation allowance recorded against our net deferred tax assets.
Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not that the future realization of all or some of the deferred tax assets will not be achieved.
Critical Accounting Policies and Estimates
The preparation of the consolidated financial statements requires us to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities as of the date of the consolidated financial statements, and the reported amounts of sales and expenses during the reporting periods. Certain of our more critical accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. On an ongoing basis, we evaluate our judgments, including but not limited to those related to inventories, recoverability of long-lived assets and the fair value of our common stock. We use historical experience and other assumptions as the basis for our judgments and making these estimates. Because future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Any changes in

54

those estimates will be reflected in our consolidated financial statements as they occur. While our significant accounting policies are more fully described in “Item 8. Financial Statements and Supplementary Data; Notes to Consolidated Financial Statements; Note 1. Background and Summary of Significant Accounting Policies” below in this Annual Report, we believe that the following accounting policies and estimates are most critical to a full understanding and evaluation of our reported financial results. The critical accounting policies addressed below reflect our most significant judgments and estimates used in the preparation of our consolidated financial statements. We have reviewed these critical accounting policies with the audit committee of our Board.
Revenue Recognition. We recognize revenue when persuasive evidence of an arrangement exists, product delivery has occurred, pricing is fixed or determinable, and collection is reasonably assured. We generate a significant portion of our revenue from consigned inventory maintained at hospitals or with sales representatives. For these products, we recognize revenue at the time we are notified the product has been used or implanted. For all other transactions, we recognize revenue when title to the goods and risk of loss transfer to customers, provided there are no remaining performance obligations that will affect the customer’s final acceptance of the sale. Our policy is to classify shipping and handling costs billed to customers as sales and the related expenses as cost of goods sold. In general, our customers do not have any rights of return or exchange.
Accounts Receivable and Allowance for Doubtful Accounts. The majority of our accounts receivable is composed of amounts due from hospitals. Accounts receivable is carried at cost less an allowance for doubtful accounts. On a regular basis, we evaluate accounts receivable and estimate an allowance for doubtful accounts, as needed, based on various factors such as customers’ current credit conditions, length of time past due, and the general economy as a whole. Receivables are written off against the allowance when they are deemed uncollectible.
Excess and Obsolete Inventory. We state inventories at the lower of cost or market. We determine cost on a first-in, first-out basis. The majority of our inventory is finished goods, because we primarily utilize third-party suppliers to source our products. We periodically evaluate the carrying value of our inventories in relation to the estimated forecast of product demand, which takes into consideration the estimated life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we record a reserve for excess inventories, which results in a corresponding charge to cost of goods sold. Charges incurred for excess and obsolete inventory were $7.0 million, $8.2 million and $6.1 million for the years ended December 31, 2014, 2013 and 2012, respectively.
The need to maintain substantial levels of inventory impacts the risk of carrying excess inventory. Many of our products come in sets which feature components in a variety of sizes so that the implant or device may be customized to the patient’s needs. In order to market our products effectively, we must often maintain and provide surgeons and hospitals with consignment implant sets, back-up products and products of different sizes. For each surgery, fewer than all of the components of the set are used, and therefore certain portions of the set may be considered excess inventory since they are not likely to be used. One of our primary business goals is to focus on continual product innovation. Though we believe this provides us with a competitive advantage, it also increases the risk that our products will become excess or obsolete inventory prior to sale or prior to the end of their anticipated useful lives. When we introduce new products or next-generation products, we may be required to take charges for excess and obsolete inventory that have a significant impact on the value of our inventory or on our operating results.
Goodwill and Intangible Assets. Goodwill represents the excess purchase price over the fair values of the identifiable assets acquired less the liabilities assumed. We acquired goodwill in connection with the various acquisitions completed. Goodwill is tested for impairment at a minimum on an annual basis. The

55

fair value is estimated using an income and discounted cash flow approach. We completed our annual goodwill and intangible assets impairment test in the fourth quarter of 2014 and determined that there was no impairment.
Intangible assets consist of purchased in-process research and development (“IPR&D”), patents, customer relationships, supplier networks and non-compete agreements. Intangible assets with finite useful lives are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to seventeen years. Intangible assets are tested for impairment annually or whenever events or circumstances indicate that a carrying amount of an asset (asset group) may not be recoverable. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset. Fair value is generally determined using a discounted future cash flow analysis.
IPR&D has an indefinite life and is not amortized until completion and development of the project at which time the IPR&D becomes an amortizable asset. If the related project is not completed in a timely manner, we may have an impairment related to the IPR&D, calculated as the excess of the asset’s carrying value over its fair value.
Long-Lived Assets. We periodically evaluate the recoverability of the carrying amount of long-lived assets, which include property and equipment, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. We assess impairment when the undiscounted future cash flows from the use and eventual disposition of an asset are less than its carrying value. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset. We base our fair value methodology on quoted market prices, if available. If quoted market prices are not available, we estimate fair value based on prices of similar assets or other valuation techniques including present value techniques.
Income Taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the year in which such items are expected to be received or settled. We recognize the effect on deferred tax assets and liabilities of a change in tax rates in the period that includes the enactment date. We establish a valuation allowance to offset any deferred tax assets if, based upon available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.
While we believe that our tax positions are fully supportable, there is a risk that certain positions could be challenged successfully. In these instances, we look to establish reserves. If we determine that a tax position is more likely than not of being sustained upon audit, based solely on the technical merits of the position, we recognize the benefit. We measure the benefit by determining the amount that has likelihood greater than 50% of being realized upon settlement. We presume that all tax positions will be examined by a taxing authority with full knowledge of all relevant information. We regularly monitor our tax positions, tax assets and tax liabilities. We reevaluate the technical merits of our tax positions and recognize an uncertain tax benefit or reverse a previously recorded tax benefit when (i) a tax audit is completed, (ii) applicable tax law, including a tax case or legislative guidance, changes or (iii) the statute of limitations expires. Significant judgment is required in accounting for tax reserves.
Legal Proceedings. We are involved in a number of legal actions involving both product liability and intellectual property disputes. The outcomes of these legal actions are not within our complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could

56

require significant expenditures or result in lost sales. In accordance with authoritative guidance, we record a liability in our consolidated financial statements for these actions when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is possible, but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded. While it is not possible to predict the outcome for these matters, we believe it is possible that costs associated with them could have a material adverse impact on our consolidated earnings, financial position or cash flows.
Stock-Based Compensation Expense. We measure the cost for employee and non-employee awards at the grant date based on the fair value of the award. For employee awards, we amortize the expense, which is the fair value of the portion of the award that is ultimately expected to vest, over the requisite service periods (generally the vesting period of the equity award). We record the awards issued to non-employees at their fair value as determined in accordance with authoritative guidance, and we periodically revalue the awards as they vest, recognizing the expense over the requisite service period. We estimate the fair value of stock options using a Black-Scholes option-pricing model. Our determination of the fair value is affected by our stock price and a number of assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends.
As we have only recently become a public entity, historic volatility is not available for our common stock. As a result, we estimate volatility based on a peer group of public companies that we believe collectively provides a reasonable basis for estimating volatility. We intend to continue to consistently use the same group of publicly traded peer companies to determine volatility in the future until sufficient information regarding volatility of the price of our shares of Class A common stock becomes available or the selected companies are no longer suitable for this purpose.
We do not have sufficient history of stock option exercises as a public company available that is indicative of future exercise and post-vesting behavior to estimate the expected term after our initial public offering (“IPO”). As a result, we use the simplified method of estimating the expected term, under which the expected term is presumed to be the mid-point between the vesting date and the contractual end of the term. We base the risk-free interest rate on observed interest rates of U.S. Treasury securities equivalent to the expected terms of the stock options. We estimate our pre-vesting forfeiture rate based on our historical experience. Our dividend yield assumption is based on the history and expectation of no dividend payouts.
We estimate the weighted-average fair value of the options granted using a Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected stock price volatility, the calculation of expected term and fair value of the underlying common stock on the date of grant, among other inputs.
To the extent that further evidence regarding these variables is available and provides estimates that we believe are more indicative of actual trends, we may refine or change our approach to deriving these input estimates. Any such changes could materially affect the stock-based compensation expense we record in the future.
We expect to continue to grant stock options in the future, and to the extent that we do, our actual stock-based compensation expense recognized may increase.
Significant Factors Used in Determining Fair Value of Our Common Stock. Prior to our IPO, our Board, with the assistance of management, used the market approach and the income approach in order to

57

estimate the fair value of common stock underlying our option grants during those periods. Prior to our IPO, there had been no public market for our common stock. Our Board had determined the fair value of our common stock by utilizing, among other things, independent third-party valuation studies conducted following our equity financing in 2007 and biannually as of April 30 and October 31 until October of 2011. The findings of these valuations were based on our business and general economic, market and other conditions that could be reasonably evaluated at that time. The analyses of the valuation studies included a review of our company, including our financial results and capital structure, as well as an independent third-party review of the conditions of the industry in which we operate and the markets that we serve. The methodologies and assumptions used were consistent with those set forth in the American Institute of Certified Public Accountants (the “AICPA”), in the AICPA Technical Practice Guide, Valuations of Privately-Held Company Equity Securities Issued as Compensation.
Results of Operations
Year Ended December 31, 2014 Compared to the Year Ended December 31, 2013
Sales
The following table sets forth, for the periods indicated, our sales by product category and geography expressed as dollar amounts and the changes in sales between the specified periods expressed in dollar amounts and as percentages:
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2014
 
December 31,
2013
 
$
 
%
Innovative Fusion
$
270,852

 
$
254,033

 
$
16,819

 
6.6
%
Disruptive Technology
203,519

 
180,426

 
23,093

 
12.8
%
Total sales
$
474,371

 
$
434,459

 
$
39,912

 
9.2
%
Product launches continue to be a driving force in our sales growth, particularly from products launched during the last three years. The growth in Disruptive Technology of $23.1 million was due primarily to sales of minimally invasive, biologic, artificial disc and interventional pain management products launched during the past three years in addition to the sales from TTOT since the acquistion in late 2014. Innovative Fusion sales increased by $16.8 million due to strong sales of legacy and new pedicle screw systems.
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2014
 
December 31,
2013
 
$
 
%
United States
$
427,091

 
$
396,615

 
$
30,476

 
7.7
%
International
47,280

 
37,844

 
9,436

 
24.9
%
Total sales
$
474,371

 
$
434,459

 
$
39,912

 
9.2
%
In the United States, the increase in sales of $30.5 million was due primarily to expansion into new territories and increased penetration in existing territories. We saw strong sales in both Disruptive Technology and Innovative Fusion products, led by sales of legacy and new pedicle screw systems.
Internationally, the increase in sales of $9.4 million was due primarily to increased market penetration in existing international territories, as well as sales from expansion into five new countries and new territories in existing countries, with sales increases primarily driven by pedicle screw, minimally invasive and interbody systems.

58

Cost of Goods Sold
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2014
 
December 31,
2013
 
$
 
%
Cost of goods sold
$
110,857

 
$
100,343

 
$
10,514

 
10.5
%
Percentage of sales
23.4
%
 
23.1
%
 
 
 
 
The increase in cost of goods sold was due primarily to $7.8 million of increased sales volume and mix, an increase of $2.8 million in freight, and an increase of $2.1 million in depreciation, offset partially by a decrease of $2.2 million for inventory reserves and write-offs and a decrease of $0.7 million due to changes in material and other costs.
Research and Development Expenses
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2014
 
December 31,
2013
 
$
 
%
Research and development
$
31,687

 
$
26,870

 
$
4,817

 
17.9
%
Percentage of sales
6.7
%
 
6.2
%
 
 
 
 
The increase in research and development expenses was due primarily to an increase of $3.4 million in employee compensation, due primarily to increased headcount, including employees for the recently acquired surgical robotic positioning system and TTOT, and an increase of $1.4 million in project and clinical trial costs.
Selling, General and Administrative Expenses
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2014
 
December 31,
2013
 
$
 
%
Selling, general and administrative
$
187,798

 
$
182,518

 
$
5,280

 
2.9
%
Percentage of sales
39.6
%
 
42.0
%
 
 
 
 
The increase in selling, general and administrative expenses was due primarily to an increase of $2.7 million for expansion and growth of our international sales efforts, $3.1 million related to increased compensation costs in the United States to support increased sales volume and company growth, and an increase of $1.4 million in legal expenses and other selling, general and administrative costs, offset by a decrease of $1.9 million related to the reduction of an acquisition related contingent liability.
Provision for Litigation Loss/(Income)
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2014
 
December 31,
2013
 
$
 
%
Provision for litigation loss/(income)
$
5,667

 
$
23,055

 
$
(17,388
)
 
(75.4
)%
Percentage of sales
1.2
%
 
5.3
%
 
 
 
 
The provision for litigation in the current year was due primarily to the Bianco, Altus and other litigation matters. In the prior year we recognized the DePuy Synthes charge of $18.2 million.

59

For additional information regarding litigation, please refer to “Item 8. Financial Statements and Supplementary Data; Notes to Consolidated Financial Statements; Note 14. Commitments and Contingencies” below for more information.
Other Income, Net
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2014
 
December 31,
2013
 
$
 
%
Other income, net
$
280

 
$
328

 
$
(48
)
 
(14.6
)%
Percentage of sales
0.1
%
 
0.1
%
 
 
 
 
The decrease in other income, net is due primarily to increases in foreign exchange losses and decreases in miscellaneous income, partially offset by increases in interest income.
Income Tax Provision
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2014
 
December 31,
2013
 
$
 
%
Income tax provision
$
46,157

 
$
33,389

 
$
12,768

 
38.2
%
Effective income tax rate
33.3
%
 
32.7
%
 
 
 
 
The increase in the effective tax rate was due primarily to the timing of the previous American Taxpayer Relief Act of 2012 (the “ATRA”). Under prior law, a taxpayer was entitled to a research and experimentation tax credit for qualifying amounts incurred through December 31, 2011. The ATRA, which was signed into law on January 2, 2013, extended the research and experimentation tax credit from January 1, 2012 through December 31, 2013. However, as of December 31, 2012, no benefit could be recognized for this tax credit, and therefore, we recognized the credit during 2013 in accordance with accounting guidance.
Year Ended December 31, 2013 Compared to the Year Ended December 31, 2012
Sales
The following table sets forth, for the periods indicated, our sales by product category and geography expressed as dollar amounts and the changes in sales between the specified periods expressed in dollar amounts and as percentages:
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2013
 
December 31, 2012
 
$
 
%
Innovative Fusion
$
254,033

 
$
238,723

 
$
15,310

 
6.4
%
Disruptive Technology
180,426

 
147,271

 
33,155

 
22.5
%
Total sales
$
434,459

 
$
385,994

 
$
48,465

 
12.6
%
Product launches continue to be a driving force in our sales growth, particularly from products launched during the last three years. The growth in Disruptive Technology of $33.2 million was due primarily to sales of minimally invasive, biologic, artificial disc and interventional pain management products launched during the past three years. Innovative Fusion sales increased by $15.3 million due to strong sales of legacy and new pedicle screw systems.

60

 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2013
 
December 31, 2012
 
$
 
%
United States
$
396,615

 
$
355,609

 
$
41,006

 
11.5
%
International
37,844

 
30,385

 
7,459

 
24.5
%
Total sales
$
434,459

 
$
385,994

 
$
48,465

 
12.6
%
In the United States, the increase in sales of $41.0 million was due primarily to increased sales of Disruptive Technology products and increased productivity from sales representatives.
Internationally, the increase in sales of $7.5 million was due primarily to increased sales of Innovative Fusion products including pedicle screw and interbody systems, increased market penetration in existing country territories, as well as sales from expansion into new countries and territories.
Cost of Goods Sold
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2013
 
December 31, 2012
 
$
 
%
Cost of goods sold
$
100,343

 
$
75,199

 
$
25,144

 
33.4
%
Percentage of sales
23.1
%
 
19.5
%
 
 
 
 
The increase in cost of goods sold was due to increased sales volume (an increase in cost of sales of $8.6 million), the Medical Device Excise Tax ($7.2 million), increases in inventory reserves and write-offs due to new product launches of $4.1 million and an increase in depreciation of surgical instruments and cases, distribution and other costs of approximately$3.9 million . Additionally, a $1.3 million provision for litigation loss was recorded as a component of cost of sales related to the unfavorable jury verdict in one of our pending lawsuits (see Provision for Litigation Loss/(Income) below).
Research and Development Expenses
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2013
 
December 31,
2012
 
$
 
%
Research and development
$
26,870

 
$
27,926

 
$
(1,056
)
 
(3.8
)%
Percentage of sales
6.2
%
 
7.2
%
 
 
 
 
The decrease in research and development expenses was due to a decrease of $1.7 million in supplies, outside services and other costs, offset by an increase of $0.4 million in employee compensation due primarily to increased headcount and an increase of $0.2 million in clinical trial and other costs.
Selling, General and Administrative Expenses
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2013
 
December 31, 2012
 
$
 
%
Selling, general and administrative
$
182,518

 
$
168,862

 
$
13,656

 
8.1
%
Percentage of sales
42.0
%
 
43.7
%
 
 
 
 

61

The increase in selling, general and administrative expenses was due primarily to an increase of $9.5 million in compensation costs in the United States.  This was to support increased sales volume and company growth, including hiring additional sales representatives, and general administrative personnel.  Additionally, the costs to support international sales growth and expansion into new international territories increased by $2.2 million; and there was an increase of $2.0 million of other selling, general and administrative costs.
Provision for Litigation Loss/(Income)
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2013
 
December 31, 2012
 
$
 
%
Provision for litigation loss/(income)
$
23,055

 
$
(786
)
 
$
23,841

 
(3,033.2
)%
Percentage of sales
5.3
%
 
(0.2
)%
 
 
 
 
The increase in provision for litigation loss was due primarily to unfavorable jury verdicts in two lawsuits. On June 14, 2013, the jury returned a verdict in a patent infringement case in the U.S. District Court in Delaware brought by DePuy Synthes against us. The jury found that prior versions of three products we previously sold did infringe on DePuty Synthes’ patents and awarded monetary damages. The jury also upheld the validity of DePuy Synthes’ patents. There was no finding of willful infringement. As a result of the verdict, we recorded $18.2 million in damages and other litigation-related costs in addition to the $1.3 million recorded as a component of cost of goods sold noted above.
Additionally, on January 17, 2014, the jury returned a verdict in a misappropriation of trade secret suit filed against us in the Federal District Court for the Eastern District of Texas by Sabatino Bianco. The jury found in favor of Bianco on a claim of misappropriation of trade secret. The jury found against Bianco on the claims of breach of contract and disgorgement of profits. As a result of the verdict, we recorded $4.3 million in damages.
The provision for litigation income in the prior year was due to the favorable settlement of a lawsuit .
Other Income/(Expense), Net
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2013
 
December 31, 2012
 
$
 
%
Other income/(expense), net
$
328

 
$
(140
)
 
$
468

 
(334.3
)%
Percentage of sales
0.1
%
 
—
%
 
 
 
 
The change in other income/(expense), net is attributable to gains recorded as a result of insurance claims, interest and other income, net of the effect of changes in foreign exchange rates on payables and receivables held in currencies other than their functional (local) currency.
Income Tax Provision
 
Year Ended
 
Change
(In thousands, except percentages)
December 31,
2013
 
December 31, 2012
 
$
 
%
Income tax provision
$
33,389

 
$
40,822

 
$
(7,433
)
 
(18.2
)%
Effective income tax rate
32.7
%
 
35.6
%
 
 
 
 

62

The decrease in the effective tax rate was due primarily to the increase in the domestic production activities deduction and the timing of the American Taxpayer Relief Act of 2012 (the “ATRA”). Under prior law, a taxpayer was entitled to a research and experimentation tax credit for qualifying amounts incurred through December 31, 2011. The ATRA, which was signed into law on January 2, 2013, extended the research and experimentation tax credit from January 1, 2012 through December 31, 2013. However, as of December 31, 2012, no benefit could be recognized for this tax credit, and therefore, we recognized the credit during 2013 in accordance with accounting guidance.
Non-GAAP Financial Measures
To supplement our financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”), management uses certain non-GAAP financial measures. For example, Adjusted EBITDA, which represents net income before interest (income)/expense, net and other non-operating expenses, provision for income taxes, depreciation and amortization, stock-based compensation, changes in the fair value of contingent consideration in connection with business acquisitions and other acquisition related costs, provision for litigation loss/(income), and provision for litigation loss -cost of goods sold, is useful as an additional measure of operating performance, and particularly as a measure of comparative operating performance from period to period, as it is reflective of changes in pricing decisions, cost controls and other factors that affect operating performance, and it removes the effect of our capital structure, asset base, income taxes and interest income and expense. Our management also uses Adjusted EBITDA for planning purposes, including the preparation of our annual operating budget and financial projections.
The following is a reconciliation of Adjusted EBITDA to net income for the periods presented:
 
 
Year Ended
(In thousands, except percentages)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Net income
 
$
92,485

 
$
68,612

 
$
73,831

Interest income, net
 
(805
)
 
(467
)
 
(80
)
Provision for income taxes
 
46,157

 
33,389

 
40,822

Depreciation and amortization
 
21,754

 
19,397

 
18,108

EBITDA
 
159,591

 
120,931

 
132,681

Stock-based compensation
 
7,111

 
5,177

 
4,635

Provision for litigation loss/(income)
 
5,667

 
23,055

 
(786
)
Provision for litigation loss - cost of good sold
 
—

 
1,260

 
—

Change in fair value of contingent consideration and other acquisition related costs
 
(937
)
 
120

 
119

Adjusted EBITDA
 
$
171,432

 
$
150,543

 
$
136,649

Adjusted EBITDA as a percentage of sales
 
36.1
%
 
34.7
%
 
35.4
%
Adjusted EBITDA for the years ended December 31, 2014 and 2013 was unfavorably affected by 1.5% and 1.6%, respectively, due to the impact of the MDET that went into effect on January 1, 2013. The impact of MDET was partially offset by operating efficiencies with respect to selling, general & administrative expenses.
In addition, for the year ended December 31, 2014 and for other comparative periods, we are presenting a non-GAAP measure of Diluted Earnings Per Share, which represents diluted earnings per share before provision for litigation loss/(income) and provision for litigation loss - cost of goods sold, net of the tax effects of such provisions. We believe this non-GAAP measure is also a useful indicator of our operating

63

performance, and particularly as an additional measure of comparative operative performance from period to period as it removes the effects of litigations which we believe are not reflective of underlying business trends.
The following is a reconciliation of non-GAAP Diluted Earnings Per Share to Diluted Earnings Per Share as computed in accordance with U.S. GAAP for the periods presented.
 
 
Year Ended
(Per share amounts)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Diluted earnings per share, as reported
 
$
0.97

 
$
0.73

 
$
0.80

Provision for litigation loss/(income), net of taxes
 
0.04

 
0.16

 
(0.01
)
Provision for litigation loss - cost of goods sold, net of taxes
 
—

 
0.01

 
—

Non-GAAP diluted earnings per share
 
$
1.01

 
$
0.90

 
$
0.79

We also define Free Cash Flow as the net cash flows provided by operating activities, adjusted for the impact of restricted cash, less the cash impact of purchases of property and equipment. We believe that this financial measure provides meaningful information for evaluating our overall financial performance for the comparative periods as it facilitates an assessment of funds available to satisfy current and future obligations and fund acquisitions. Below is a reconciliation of Free Cash Flow to net cash provided by operating activities as computed in accordance with U.S. GAAP.
 
 
Year Ended
(Per share amounts)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Net cash provided by operating activities
 
$
79,172

 
$
93,471

 
$
76,519

Adjustment for impact of restricted cash
 
23,370

 
—

 
—

Purchases of property and equipment
 
(24,754
)
 
(23,680
)
 
(24,684
)
Free cash flow
 
$
77,788

 
$
69,791

 
$
51,835

In December 2014, we set aside $23.4 million in cash for the payment of a portion of the Synthes and Bianco litigations. We classified this cash as restricted, as the amount was placed in escrow to be used for payment of the litigation obligations, should we not be successful with our appeals. Restricted cash unfavorably affected our net cash provided by operating activities for the year ended December 31, 2014. (For additional information regarding litigation, please refer to “Item 8. Financial Statements and Supplementary Data; Notes to Consolidated Financial Statements; Note 14. Commitments and Contingencies” below for more information.)
Adjusted EBITDA, non-GAAP Diluted Earnings Per Share and Free Cash Flow are not calculated in conformity with U.S. GAAP within the meaning of Item 10 of Regulation S-K. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for financial measures prepared in accordance with U.S. GAAP. These measures do not include certain expenses that may be necessary to evaluate our liquidity or operating results. Our definitions of Adjusted EBITDA, non-GAAP Diluted Earnings Per Share and Free Cash Flow may differ from that of other companies and therefore may not be comparable.

64

Cash Flows
The following table summarizes, for the periods indicated, cash flows from operating, investing and financing activities:
 
 
Year Ended
 
2014 - 2013 Change
 
2013 - 2012 Change
(In thousands)
December 31, 2014
 
December 31, 2013
 
December 31, 2012
 
$
 
$
Net cash provided by operating activities
$
79,172

 
$
93,471

 
$
76,519

 
$
(14,299
)
 
$
16,952

Net cash used in investing activities
(100,000
)
 
(227,150
)
 
(30,715
)
 
127,150

 
(196,435
)
Net cash provided by financing activities
12,946

 
11,011

 
24,025

 
1,935

 
(13,014
)
Effect of foreign exchange rate changes on cash
185

 
230

 
(97
)
 
(45
)
 
327

Increase/(decrease) in cash and cash equivalents
$
(7,697
)
 
$
(122,438
)
 
$
69,732

 
$
114,741

 
$
(192,170
)
The decrease in cash and cash equivalents for the year ended December 31, 2014 was due primarily to our continued cash management program to invest in more marketable securities in an effort to increase the returns on our cash and cash equivalents. During the year ended December 31, 2014, we purchased $39.1 million of marketable securities, net of maturities and sales. Our investment in marketable securities includes municipal bonds, corporate debt securities, commercial paper, securities of U.S. government-sponsored agencies and asset-backed securities, and are classified as available-for-sale as of December 31, 2014. In addition to our purchases of property and equipment in the normal course of business, we also used $36.1 million for the purchase of TTOT. Furthermore, during December 2014, we set aside $23.4 million as restricted cash during the appeals of two litigation cases, which unfavorably affected net cash provided by operations. During the year ended December 31, 2014, our total cash, cash equivalents, and marketable securities increased $28.6 million See “Liquidity and Capital Resources” below.
Cash Provided by Operating Activities
The decrease in net cash provided by operating activities for the year ended December 31, 2014 was due primarily to an increase in restricted cash of $23.4 million, offset partially by the $11.8 million increase in net income excluding provision for litigation (net of taxes).
The increase in net cash provided by operating activities for the year ended December 31, 2013 was due primarily to an increase in net income excluding accrued expenses from the DePuy Synthes and Bianco litigation verdicts of $10.5 million, a decrease in income tax payments over the prior year period of $6.2 million, a decrease in the change in inventories of $3.9 million and by a decrease in prepaid expense and other expenses of $1.0 million, offset by a decrease in the change in accounts payable and accounts payable to related party of $2.5 million, and an increase in the change in accounts receivable of $2.7 million.
Cash Used in Investing Activities
The decrease in net cash used in investing activities was due primarily to the $147.6 million decrease in the amount of cash invested in marketable securities in comparative periods. During the year ended December 31, 2014 we had a net outflow of $39.1 million of cash invested in marketable securities, net of maturities and sales, whereas in the prior year, we had a net cash outflow of $186.7 million. This increase was partilly offset by an increase in cash used for acquisitions of $19.4 million.
The increase in net cash used in investing activities for the year ended December 31, 2013 was attributable to $186.7 million of cash invested in marketable securities, net of maturities and sales, the increase

65

in cash used for acquisitions of $10.7 million, partially offset by a $1.0 million decrease in the purchases of property and equipment over the prior year.
Cash Provided by Financing Activities
The cash provided by financing activities for the year ended December 31, 2014 was due primarily to the net proceeds of $9.7 million received from the issuance of common stock from the exercise of stock options along with the $4.4 million increase in our excess tax benefit related to our nonqualified stock option exercises.
The cash provided by financing activities for the year ended December 31, 2013 was due primarily to the net proceeds of $7.6 million received from the issuance of common stock from the exercise of stock options along with the $4.8 million increase in our excess tax benefit related to our nonqualified stock option exercises.
Liquidity and Capital Resources
The following table highlights certain information related to our liquidity and capital resources:
(In thousands)
December 31, 2014
 
December 31,
2013
Cash and cash equivalents
$
82,265

 
$
89,962

Short-term marketable securities
146,439

 
148,962

Long-term marketable securities
75,347

 
36,528

Total cash, cash equivalents and marketable securities
$
304,051

 
$
275,452

 
 
 
 
Available borrowing capacity under revolving credit facility
50,000

 
50,000

Working capital
$
380,613

 
$
348,866

During the year ended December 31, 2014, our total cash, cash equivalents and marketable securities increased $28.6 million, primarily as a result of our cash provided by operating activities. Our investment in marketable securities includes municipal bonds, corporate debt securities, commercial paper, securities of U.S. government-sponsored agencies and asset-backed securities, and are classified as available-for-sale as of December 31, 2014.
On February 25, 2015, we entered into an agreement to acquire medical device manufacturer Branch Medical Group, Inc. (“BMG”). Under the terms of the agreement we have agreed to pay approximately $52.9 million in cash subject to certain closing adjustments for BMG on a cash-free, debt-free basis. We expect the closing of the acquisition to occur in March 2015 following satisfaction of the applicable closing conditions.
In May 2011, we entered into a credit agreement with Wells Fargo Bank related to a revolving credit facility that provides for borrowings up to $50.0 million. At our request, and with the approval of the bank, the amount of borrowings available under the revolving credit facility can be increased to $75.0 million. The revolving credit facility includes up to a $25.0 million sub-limit for letters of credit. As amended to date, the revolving credit facility extends to May 2015. Cash advances bear interest at our option either at a fluctuating rate per annum equal to the daily LIBOR in effect for a one-month period plus 0.75% or a fixed rate for a one- or three-month period equal to LIBOR plus 0.75%. The credit agreement governing the revolving credit facility also subjects us to various restrictive covenants, including the requirement to maintain maximum consolidated leverage. The covenants also include limitations on our ability to repurchase shares,

66

to pay cash dividends or to enter into a sale transaction. As of December 31, 2014, we were in compliance with all covenants under the credit agreement, there were no outstanding borrowings under the revolving credit facility and available borrowings were $50.0 million. We may terminate the credit agreement at any time on ten days’ notice without premium or penalty.
In addition to our existing cash and marketable securities balances, our principal sources of liquidity are cash flow from operating activities and our revolving credit facility, which was fully available as of December 31, 2014. We believe these sources will provide sufficient liquidity for us to meet our liquidity requirements for the foreseeable future. Our principal liquidity requirements are to meet our working capital, research and development, including clinical trials, and capital expenditure needs, principally for our surgical sets required to maintain and expand our business and potential future business or intellectual property acquisitions. We expect to continue to make investments in surgical sets as we launch new products, increase the sizes of our U.S. sales force, and expand into international markets. We may, however, require additional liquidity as we continue to execute our business strategy. Our liquidity may be negatively impacted as a result of a decline in sales of our products, including declines due to changes in our customers’ ability to obtain third-party coverage and reimbursement for procedures that use our products, increased pricing pressures resulting from intensifying competition, cost increases and slower product development cycles resulting from a changing regulatory environment; and unfavorable results from litigation which will affect our cash flow. We anticipate that to the extent that we require additional liquidity, it will be funded through the incurrence of other indebtedness, additional equity financings or a combination of these potential sources of liquidity. The sale of additional equity may result in dilution to our stockholders. There is no assurance that we will be able to secure such additional funding on terms acceptable to us, or at all.
Contractual Obligations and Commitments
The following table summarizes our outstanding contractual obligations as of December 31, 2014. There have been no material changes in our remaining contractual obligations since that time.
 
 
Payments Due by Period
(In thousands)
 
Total
 
Less than 1 Year
 
1-3 Years
 
3-5 Years
 
More than 5 Years
Operating leases
 
$
1,630

 
$
700

 
$
825

 
$
105

 
$
—

Purchase obligations(1)
 
699

 
649

 
50

 
—

 
—

Deferred purchase price liabilities(2)
 
2,000

 
1,200

 
800

 
—

 
—

Total
 
$
4,329

 
$
2,549

 
$
1,675

 
$
105

 
$
—

______________

(1) 
Reflects minimum annual volume commitments to purchase inventory under certain of our supplier contracts.
(2) 
In connection with acquisitions completed in 2014 though 2011, we have certain contingent consideration obligations payable to the sellers in these transactions upon the achievement of certain regulatory and sales milestones. The maximum aggregate undiscounted amounts potentially payable not included in the table above total $38.9 million.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
Related-Party Transactions
For a description of our related-party transactions, see “Item 8. Financial Statements and Supplementary Data; Notes to Consolidated Financial Statements; Note 16. Related-Party Transactions” and “Item 13. Certain Relationships and Related Transactions, and Director Independence; Related Person Transactions.”
Recently Issued Accounting Pronouncements
In May 2014, the FASB and the International Accounting Standards Board released a standard on the recognition of revenue from contracts with customers that is designed to create greater comparability for financial statement users across industries and jurisdictions. Under the new standard, an entity will recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the payment to which the entity expects to be entitled in exchange for those goods or services. The standard also will require enhanced disclosures and provide more comprehensive guidance for transactions such as service revenue and contract modifications. The standard will take effect for public companies for annual reporting periods beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. We are currently evaluating the impact of the new standard on our financial position, results of operations and disclosures.
Item 7A. Quantitative and Qualitative Disclosure About Market Risk
Market risk is the potential loss arising from adverse changes in the financial markets. We are exposed to various market risks, which may result in potential losses arising from adverse changes in market rates, such as interest rates and foreign exchange rates. We do not enter into derivatives or other financial instruments for trading or speculative purposes and do not believe we are exposed to material market risk with respect to our cash, cash equivalents and marketable debt securities. We also believe that there has been no material quantitative changes in our market risk exposure between December 31, 2014 and December 31, 2013.
Interest Rate Risk
Our exposure to interest rate risk relates primarily to our revolving credit facility and our investments in cash equivalents and marketable debt securities portfolio. At December 31, 2014, we had no debt outstanding under our revolving credit facility and therefore were not exposed to interest rate risk with respect to interest payable under that facility.
In general, our investments in cash equivalents and marketable debt securities are governed by our investment policy, which has been approved by our Board of Directors. Our investment policy seeks to preserve the value of capital, consistent with maximizing return on our investments while maintaining adequate liquidity. In 2013, we changed our cash management program to invest in more marketable securities in an effort to increase returns on our cash and cash equivalents. To achieve our investment objectives, we maintain a portfolio of various holdings, types and maturities and invest in securities that meet or exceed our investment policy standards, such as high credit quality debt securities.
We continue to be exposed to interest rate risk related to our cash equivalents and marketable securities. Generally, our interest rate risk with respect to these investments is limited due to yields earned. Changes in the overall level of interest rates affect the interest income generated by our cash, cash equivalents and marketable securities. Our investment policy limits the amount of credit exposure to any one issue, issuer or type of security. Our securities all have maturity dates within three years of the date of purchase and are designated as available for sale. As of December 31, 2014, we believe that a hypothetical 10% change in interest rates would not materially affect the underlying valuation of our marketable securities.
Foreign Exchange Risk
We operate in countries other than the United States and, therefore, we are exposed to foreign currency

67

risks. We bill most direct sales outside of the United States in local currencies. We expect that the percentage of our sales denominated in foreign currencies will increase in the foreseeable future as we continue to expand into international markets. When sales or expenses are not denominated in U.S. dollars, a fluctuation in exchange rates could affect our net income. We believe that the risk of a significant impact on our operating income from foreign currency fluctuations is minimal. We believe that a 10% change in foreign currency exchange rates would not have a material impact on our financial condition, results of operations or cash flows. We do not currently hedge our exposure to foreign currency exchange rate fluctuations; however, we may choose to hedge our exposure in the future.

68

Item 8. Financial Statements and Supplementary Data
GLOBUS MEDICAL, INC.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Comprehensive Income
Consolidated Statements of Equity
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements


69

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders
Globus Medical, Inc.:
We have audited the accompanying consolidated balance sheets of Globus Medical, Inc. and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, equity and cash flows for each of the years in the three‑year period ended December 31, 2014. In connection with our audits of the consolidated financial statements, we also have audited financial statement schedule II in Item 15 (a) (2). We also have audited Globus Medical, Inc.’s internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control - Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Globus Medical, Inc.’s management is responsible for these consolidated financial statements and financial statement schedule, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Report of Management on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule and an opinion on the Company’s internal control over financial reporting based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the consolidated financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

70

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Globus Medical, Inc. and subsidiaries as of December 31, 2014 and 2013, and the results of their operations and their cash flows for each of the years in the three‑year period ended December 31, 2014, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the related financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein. Also in our opinion, Globus Medical, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control - Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission.


/s/ KPMG LLP
Philadelphia, Pennsylvania
February 26, 2015



71

GLOBUS MEDICAL, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except par value)
December 31,
2014
 
December 31,
2013
 
 
 
 
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
82,265

 
$
89,962

Restricted cash
23,370

 
—

Short-term marketable securities
146,439

 
148,962

Accounts receivable, net of allowances of $1,647 and $1,581, respectively
75,430

 
62,414

Inventories
90,945

 
70,350

Prepaid expenses and other current assets
5,742

 
5,080

Income taxes receivable
5,772

 
2,723

Deferred income taxes
40,062

 
37,317

Total current assets
470,025

 
416,808

Property and equipment, net of accumulated depreciation of $118,544 and $99,910
69,475

 
64,150

Long-term marketable securities
75,347

 
36,528

Intangible assets, net
34,529

 
29,537

Goodwill
53,196

 
18,372

Other assets
975

 
909

Total assets
$
703,547

 
$
566,304

 
 
 
 
LIABILITIES AND EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
15,904

 
$
10,073

Accounts payable to related-party
5,359

 
2,656

Accrued expenses
61,499

 
51,125

Income taxes payable
569

 
2,358

Business acquisition liabilities, current
6,081

 
1,730

Total current liabilities
89,412

 
67,942

Business acquisition liabilities, net of current portion
20,195

 
15,528

Deferred income taxes
5,166

 
6,385

Other liabilities
3,320

 
4,089

Total liabilities
118,093

 
93,944

Commitments and contingencies (Note 14)


 


Equity:
 
 
 
Class A common stock; $0.001 par value. Authorized 500,000 shares; issued and outstanding 70,828 and 66,065 shares at December 31, 2014 and 2013, respectively
71

 
66

Class B common stock; $0.001 par value. Authorized 275,000 shares; issued and outstanding 23,878 and 27,378 shares at December 31, 2014 and 2013, respectively
24

 
27

Additional paid-in capital
175,242

 
153,987

Accumulated other comprehensive loss
(1,657
)
 
(1,009
)
Retained earnings
411,774

 
319,289

Total equity
585,454

 
472,360

Total liabilities and equity
$
703,547

 
$
566,304

See accompanying notes to consolidated financial statements.

72

GLOBUS MEDICAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
 
 
Year Ended
(In thousands, except per share amounts)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Sales
 
$
474,371

 
$
434,459

 
$
385,994

Cost of goods sold
 
110,857

 
100,343

 
75,199

Gross profit
 
363,514

 
334,116

 
310,795

 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
Research and development
 
31,687

 
26,870

 
27,926

Selling, general and administrative
 
187,798

 
182,518

 
168,862

Provision for litigation loss/(income)
 
5,667

 
23,055

 
(786
)
Total operating expenses
 
225,152

 
232,443

 
196,002

 
 
 
 
 
 
 
Operating income
 
138,362

 
101,673

 
114,793

 
 
 
 
 
 
 
Other income/(expense), net:
 
 
 
 
 
 
Interest income, net
 
805

 
467

 
80

Foreign currency transaction loss
 
(899
)
 
(804
)
 
(220
)
Other income
 
374

 
665

 
—

Total other income/(expense), net
 
280

 
328

 
(140
)
 
 
 
 
 
 
 
Income before income taxes
 
138,642

 
102,001

 
114,653

Income tax provision
 
46,157

 
33,389

 
40,822

 
 
 
 
 
 
 
Net income
 
$
92,485

 
$
68,612

 
$
73,831

 
 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
 
Basic
 
$
0.98

 
$
0.74

 
$
0.82

Diluted
 
$
0.97

 
$
0.73

 
$
0.80

Weighted average shares outstanding:
 
 
 
 
 
 
Basic
 
94,227

 
92,647

 
89,608

Dilutive stock options
 
1,230

 
1,545

 
2,600

Diluted
 
95,457

 
94,192

 
92,208

 
 
 
 
 
 
 
Anti-dilutive stock equivalents excluded from weighted average calculation
 
1,666

 
1,975

 
2,383

See accompanying notes to consolidated financial statements.

73

GLOBUS MEDICAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Net income
 
$
92,485

 
$
68,612

 
$
73,831

Other comprehensive income/(loss):
 
 
 
 
 
 
Unrealized gain/(loss) on marketable securities, net of tax
 
(96
)
 
32

 
—

Change in accumulated foreign currency translation gain/(loss)
 
(552
)
 
(274
)
 
435

Total other comprehensive income/(loss)
 
(648
)
 
(242
)
 
435

Comprehensive income
 
$
91,837

 
$
68,370

 
$
74,266

See accompanying notes to consolidated financial statements.

74

GLOBUS MEDICAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY
 
Convertible preferred stock
 
Class A Common stock
 
Class B Common Stock
 
Class C Common Stock
 
Additional paid-in capital
 
Accumulated other comprehensive income
 
Retained earnings
 
 
(In thousands)
Shares
 
$
 
Shares
 
$
 
Shares
 
$
 
Shares
 
$
 
 
 
 
Total
Balance at December 31, 2011
50,691

 
$
51

 
7,453

 
$
8

 
65,018

 
$
65

 
58

 
$
—

 
$
106,708

 
$
(1,202
)
 
$
176,846

 
$
282,476

Stock-based compensation
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
4,635

 
—

 
—

 
4,635

Exercise of stock options
—

 
—

 
898

 
1

 
147

 
—

 
16

 
—

 
1,503

 
—

 
—

 
1,504

Tax benefit related to nonqualified stock options exercised
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
2,661

 
—

 
—

 
2,661

Pre IPO conversion to Class A
—

 
—

 
690

 
1

 
(690
)
 
(1
)
 
—

 
—

 
—

 
—

 
—

 
—

Conversion in conjunction with IPO
(50,691
)
 
(51
)
 
52,768

 
52

 
(37,097
)
 
(37
)
 
(74
)
 
—

 
36

 
—

 
—

 
—

Issuance of common stock from IPO, net of expenses
—

 
—

 
2,083

 
2

 
—

 
—

 
—

 
—

 
20,958

 
—

 
—

 
20,960

Comprehensive income
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
435

 
73,831

 
74,266

Balance at December 31, 2012
—

 
—

 
63,892

 
64

 
27,378

 
27

 
—

 
—

 
136,501

 
(767
)
 
250,677

 
386,502

Stock-based compensation
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
5,177

 
—

 
—

 
5,177

Exercise of stock options
—

 
—

 
2,173

 
2

 
—

 
—

 
—

 
—

 
7,553

 
—

 
—

 
7,555

Tax benefit related to nonqualified stock options exercised
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
4,756

 
—

 
—

 
4,756

Comprehensive income
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(242
)
 
68,612

 
68,370

Balance at December 31, 2013
—

 
—

 
66,065

 
66

 
27,378

 
27

 
—

 
—

 
153,987

 
(1,009
)
 
319,289

 
472,360

Conversion to Class A
—

 
—

 
3,500

 
3

 
(3,500
)
 
(3
)
 
—

 
—

 
—

 
—

 
—

 
—

Stock-based compensation
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
7,111

 
—

 
—

 
7,111

Exercise of stock options
—

 
—

 
1,263

 
2

 
—

 
—

 
—

 
—

 
9,736

 
—

 
—

 
9,738

Tax benefit related to nonqualified stock options exercised
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
4,408

 
—

 
—

 
4,408

Comprehensive income
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(648
)
 
92,485

 
91,837

Balance at December 31, 2014
—

 
$
—

 
70,828

 
$
71

 
23,878

 
$
24

 
$
—

 
$
—

 
$
175,242

 
$
(1,657
)
 
$
411,774

 
$
585,454

See accompanying notes to consolidated financial statements.

75

GLOBUS MEDICAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Year Ended
(In thousands)
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Cash flows from operating activities:
 
 
 
 
 
Net income
$
92,485

 
$
68,612

 
$
73,831

Adjustments to reconcile net income to net cash provided by operating activities
 
 
 
 
 
Depreciation and amortization
21,754

 
19,397

 
18,108

Amortization of premium on marketable securities
2,680

 
2,358

 
—

Provision for excess and obsolete inventories
6,962

 
8,212

 
6,119

Stock-based compensation
7,111

 
5,177

 
4,635

Allowance for doubtful accounts
318

 
693

 
363

Change in deferred income taxes
(4,379
)
 
(14,858
)
 
(6,079
)
(Increase) decrease in:
 
 
 
 
 
Restricted cash
(23,370
)
 
—

 
—

Accounts receivable
(12,667
)
 
(9,612
)
 
(6,886
)
Inventories
(18,001
)
 
(16,678
)
 
(20,541
)
Prepaid expenses and other assets
(249
)
 
(2,955
)
 
(117
)
Increase (decrease) in:
 
 
 
 
 
Accounts payable
4,628

 
1,840

 
3,048

Accounts payable to related party
2,703

 
100

 
1,378

Accrued expenses and other liabilities
4,018

 
26,963

 
4,208

Income taxes payable/receivable
(4,821
)
 
4,222

 
(1,548
)
Net cash provided by operating activities
79,172

 
93,471

 
76,519

 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
Purchases of marketable securities
(251,422
)
 
(240,892
)
 
—

Maturities of marketable securities
184,567

 
40,560

 
—

Sales of marketable securities
27,737

 
13,637

 
—

Purchases of property and equipment
(24,754
)
 
(23,680
)
 
(24,684
)
Acquisition of businesses
(36,128
)
 
(16,775
)
 
(6,031
)
Net cash used in investing activities
(100,000
)
 
(227,150
)
 
(30,715
)
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
Payment of business acquisition liabilities
(1,200
)
 
(1,300
)
 
(1,100
)
Net proceeds from initial public offering
—

 
—

 
20,960

Net proceeds from issuance of common stock
9,738

 
7,555

 
1,504

Excess tax benefit related to nonqualified stock options
4,408

 
4,756

 
2,661

Net cash provided by financing activities
12,946

 
11,011

 
24,025

 
 
 
 
 
 
Effect of foreign exchange rate on cash
185

 
230

 
(97
)
 
 
 
 
 
 
Net increase/(decrease) in cash and cash equivalents
(7,697
)
 
(122,438
)
 
69,732

Cash and cash equivalents, beginning of period
89,962

 
212,400

 
142,668

Cash and cash equivalents, end of period
$
82,265

 
$
89,962

 
$
212,400

 
 
 
 
 
 
Supplemental disclosures of cash flow information:
 
 
 
 
 
Interest paid
32

 
96

 
63

Income taxes paid
$
51,096

 
$
38,719

 
$
44,875

See accompanying notes to consolidated financial statements.

76
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



NOTE 1. BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(a) The Company
Globus Medical, Inc. and its subsidiaries is a medical device company focused exclusively on the design, development and commercialization of musculoskeletal implants. We are currently focused on implants that promote healing in patients with spine disorders. We are an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures that assist surgeons in effectively treating their patients, respond to evolving surgeon needs and address new treatment options. Since our inception in 2003, we have launched over 130 products and offer a product portfolio addressing a broad array of spinal pathologies.
We are headquartered in Audubon, Pennsylvania and market and sell our products through our exclusive sales force in the United States, Europe, India, South Africa, Australia, South America and the Middle East. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.
The terms the “Company,” “Globus,” “we,” “us” and “our” refer to Globus Medical, Inc. and, where applicable, our consolidated subsidiaries.
(b) Basis of Presentation
The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) for financial statements and with the instructions to Form 10-K and Article 10 of Regulation S-X.
Certain reclassifications have been made to prior period statements to conform to the current period presentation.
(c) Principles of Consolidation
The accompanying consolidated financial statements include the accounts of Globus and its wholly owned subsidiaries. Our consolidation policy requires the consolidation of entities where a controlling financial interest is held. All intercompany balances and transactions are eliminated in consolidation.
(d) Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates, in part, on historical experience that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary.
Significant areas that require management’s estimates include intangible assets, contingent payment liabilities, allowance for doubtful accounts, stock-based compensation, provision for excess and obsolete

77
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

inventory, useful lives of assets, the outcome of litigation, and income taxes. We are subject to risks and uncertainties due to changes in the healthcare environment, regulatory oversight, competition, and legislation that may cause actual results to differ from estimated results.
(e) Foreign Currency Translation
The functional currency of our foreign subsidiaries is their local currency. Assets and liabilities of the foreign subsidiaries are translated at the period end currency exchange rate and revenues and expenses are translated at an average currency exchange rate for the period. The resulting foreign currency translation gains and losses are included as a component of accumulated other comprehensive income. Gains and losses arising from intercompany foreign transactions are included in other income/(expense) on the consolidated statement of operations. We recognized foreign exchange transaction losses in other income/(expense) of $0.9 million, $0.8 million, and $0.2 million for the years ended December 31, 2014, 2013, and 2012, respectively.
(f) Cash and Cash Equivalents
Cash and cash equivalents include cash on hand and all highly liquid investments with a maturity of three months or less when purchased.
(g) Restricted Cash
In December 2014, we set aside $23.4 million in cash for the payment of a portion of the Synthes and Bianco litigations. We classified this cash as restricted, as the amount was placed in escrow to be used for payment of the litigation obligations, should we not be successful with our appeals. See “Note 14. Commitments and Contingencies” below for more details regarding these litigations.
(h) Accounts Receivable and Allowance for Doubtful Accounts
The majority of our accounts receivable is composed of amounts due from hospitals. We carry our accounts receivable at cost less an allowance for doubtful accounts. On a regular basis, we evaluate our accounts receivable and estimate an allowance for doubtful accounts, as needed, based on various factors such as our customers’ current credit conditions, length of time past due, and the general economy as a whole. Receivables are written off against the allowance when they are deemed uncollectible.
(i) Concentrations of Credit Risk
Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents and accounts receivable. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of entities comprising our customer base. We perform ongoing credit evaluations of our customers and generally do not require collateral.
There was no customer that accounted for 10% or more of sales for the years ended December 31, 2014, 2013, and 2012, respectively.
(j) Marketable Securities
Our marketable securities include municipal bonds, corporate debt securities, commercial paper, securities of U.S. government-sponsored agencies and asset-backed securities, and are classified as available-

78
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

for-sale as of December 31, 2014. Available-for-sale securities are recorded at fair value in both short-term and long-term marketable securities on our consolidated balance sheets. The change in fair value for available-for-sale securities is recorded, net of taxes, as a component of accumulated other comprehensive income on our consolidated balance sheets. Premiums and discounts are recognized over the life of the related security as an adjustment to yield using the straight-line method. Realized gains or losses from the sale of our marketable securities are determined on a specific identification basis. Realized gains and losses, along with interest income and the amortization/accretion of premiums/discounts are included as a component of other income, net, on our consolidated statements of income. Interest receivable is recorded as a component of prepaid expenses and other current assets on our consolidated balance sheets.
We maintain a portfolio of various holdings, types and maturities, though most of the securities in our portfolio could be liquidated at minimal cost at any time. We invest in securities that meet or exceed standards as defined in our investment policy. Our policy also limits the amount of credit exposure to any one issue, issuer or type of security. We review our securities for other-than-temporary impairment at each reporting period. If an unrealized loss for any security is considered to be other-than-temporary, the loss will be recognized in our consolidated statement of income in the period the determination is made.
(k) Inventories
Inventories are stated at the lower of cost or market. Cost is determined on a first-in, first-out basis. The majority of our inventories are finished goods as we mainly utilize third-party suppliers to source our products. We periodically evaluate the carrying value of our inventories in relation to our estimated forecast of product demand, which takes into consideration the estimated life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we record a reserve for such excess inventories.
(l) Property and Equipment
Property and equipment are recorded at cost less accumulated depreciation. Additions or improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation and amortization are provided using the straight-line method over the related useful lives of the assets.
When assets are sold or otherwise disposed of, the related property, equipment, and accumulated depreciation amounts are relieved from the accounts, and any gain or loss is recorded in the consolidated statements of operations.
(m) Goodwill and Intangible Assets
Goodwill represents the excess purchase price over the fair values of the identifiable assets acquired less the liabilities assumed. Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by comparing the reporting unit’s carrying amount, to the fair value of the reporting unit. The fair values are estimated using an income and discounted cash flow approach. For the year ended December 31, 2014, we performed a qualitative test for impairment as permitted under Financial Accounting Standards Board (“FASB”) authoritative guidance. During the years ended December 31, 2014, 2013 and 2012, we did not record any impairment charges related to goodwill.
Intangible assets consist of purchased in-process research and development (“IPR&D”), supplier network, patents, customer relationships and non-compete agreements. Intangible assets with finite useful lives are amortized over the period of estimated benefit using the straight-line method and estimated useful

79
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

lives ranging from one to seventeen years. Intangible assets are tested for impairment annually or whenever events or circumstances indicate that a carrying amount of an asset (asset group) may not be recoverable. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset. Fair value is generally determined using a discounted future cash flow analysis.
IPR&D has an indefinite life and is not amortized until completion of the project at which time the IPR&D becomes an amortizable asset. If the related project is not completed in a timely manner, we may have an impairment related to the IPR&D, calculated as the excess of the asset’s carrying value over its fair value.
We completed our annual qualitative indefinite lived intangible asset impairment review in the fourth quarter of 2014 and determined that our intangible assets were not impaired.
(n) Impairment of Long-Lived Assets
We periodically evaluate the recoverability of the carrying amount of long-lived assets, which include property and equipment, as well as whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be fully recoverable. An impairment is assessed when the undiscounted future cash flows from the use and eventual disposition of an asset group are less than its carrying value. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset group. Our fair value methodology is based on quoted market prices, if available. If quoted market prices are not available, an estimate of fair value is made based on prices of similar assets or other valuation techniques including present value techniques. We reviewed our long-lived assets over the course of 2014 and 2013 and recorded an immaterial impairment charge as a component of cost of goods sold during 2013; there was no impairment of our long-lived assets during 2014.
(o) Revenue Recognition
Revenue is recognized when persuasive evidence of an arrangement exists, product delivery has occurred, pricing is fixed or determinable, and collection is reasonably assured. A significant portion of our revenue is generated from consigned inventory maintained at hospitals or with sales representatives. For these products, revenue is recognized at the time the product is used or implanted. For all other transactions, we recognize revenue when title to the goods and risk of loss transfer to customers, provided there are no remaining performance obligations that will affect the customer’s final acceptance of the sale. Our policy is to classify shipping and handling costs billed to customers as sales and the related expenses as cost of goods sold.
(p) Research and Development
Research and development costs are expensed as incurred. Research and development costs include salaries, employee benefits, supplies, consulting services, clinical services and clinical trial costs, and facilities costs. Costs incurred in obtaining technology licenses and patents are charged immediately to research and development expense if the technology licensed has not reached technological feasibility and has no alternative future use.

80
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(q) Stock-Based Compensation
The cost for employee and non-employee director awards is measured at the grant date based on the fair value of the award. The fair value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service period (generally the vesting period of the equity award). Awards issued to non-employees are recorded at their fair value as determined in accordance with authoritative guidance, and are periodically revalued as the awards vest and are recognized as expense over the requisite service period.
The determination of the fair value of stock options is made utilizing the Black-Scholes option-pricing model which is affected by our stock price and a number of assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends. The expected volatility is based upon the historical volatility of a public company peer group over the most recent period commensurate with the estimated expected term of the stock options. The expected term of the stock options is determined utilizing the simplified method given the limited extent of our historical data. The risk-free interest rate assumption is based on observed interest rates of U.S. Treasury securities appropriate for the expected terms of the stock options. The dividend yield assumption is based on the history and expectation of no dividend payouts.
(r) Income Taxes
Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which such items are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established to offset any deferred tax assets if, based upon available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.
Significant judgment is required in determining income tax provisions and in evaluating tax positions. We will establish additional provisions for income taxes when, despite the belief that tax positions are fully supportable, there remain certain positions that do not meet the minimum probability threshold that a tax position is more likely than not to be sustained upon examination by the taxing authority. In the normal course of business, we and our subsidiaries are examined by various federal, state, and foreign tax authorities. We regularly assess the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the provision for income taxes. We periodically assess the likelihood and amount of potential adjustments and adjust the income tax provision, the current tax liability, and deferred taxes in the period in which the facts that give rise to a revision become known.
(r) Fair Value of Financial Instruments
As of December 31, 2014, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued expenses approximate their respective fair values based on their short-term nature. We classify our financial assets and liabilities that are measured at fair value into one of the three categories based upon inputs used to determine fair value. See “Note 5. Fair Value Measurements” below for more details regarding inputs and classifications.

81
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(s) Advertising Expense
We expense advertising costs as they are incurred. Advertising expense was $0.5 million, $0.5 million and $0.4 million, for the years ended December 31, 2014, 2013, and 2012, respectively.
(t) Legal Costs
We expense legal costs related to loss contingencies as incurred.
(u) Medical Device Excise Tax
Effective as of January 1, 2013, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively “PPACA”) imposed a medical device excise tax (“MDET”) of 2.3% on any entity that manufactures or imports certain medical devices offered for sale in the United States. We account for the MDET as a component of our cost of goods sold. For the years ended December 31, 2014 and 2013, we recognized expenses of $7.1 million and $7.2 million, respectively.
(v) Recently Issued Accounting Pronouncements
In May 2014, the FASB and the International Accounting Standards Board released a standard on the recognition of revenue from contracts with customers that is designed to create greater comparability for financial statement users across industries and jurisdictions. Under the new standard, an entity will recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the payment to which the entity expects to be entitled in exchange for those goods or services. The standard also will require enhanced disclosures and provide more comprehensive guidance for transactions such as service revenue and contract modifications. The standard will take effect for public companies for annual reporting periods beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. We are currently evaluating the impact of the new standard on our financial position, results of operations and disclosures.
NOTE 2. ACQUISITIONS
On October 23, 2014, we entered into an equity interest purchase agreement with Transplant Technologies of Texas, Ltd. (“TTOT”), an allograft tissue processor located in San Antonio, Texas, pursuant to which we acquired 100% of the equity interests for $36.1 million. In addition to the initial purchase price, we may be obligated to make milestone payments of up to $15.0 million over the next three years based primarily on sales thresholds from the product lines we acquired.
TTOT was privately held and provides human tissue products including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets and represents a key step in fulfilling our strategy of building a broad business in regenerative biologics. While we currently partner with third party suppliers for our existing allograft products, the acquisition of TTOT will expand our suite of regenerative biologics products. We believe this acquisition will also improve our capabilities for the development of new and innovative human allograft tissue products in the future.
We accounted for the acquisition under the purchase method of accounting, and as a result, recorded goodwill of $34.8 million. The results of operations of TTOT have been included in our results of operations from the date of acquisition. Prior-period results have not been restated and pro forma supplemental financial

82
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

information is not provided as the impact of the TTOT acquisition is immaterial to the operating results for the years ended December 31, 2014 and December 31, 2013. Amounts recognized for assets acquired and liabilities assumed are based on preliminary purchase price allocations and on certain management judgments. These preliminary allocations are based on an analysis of the estimated fair values of assets acquired and liabilities assumed, including identifiable tangible and intangible assets, and estimates of the useful lives of tangible and amortizable intangible assets. The final purchase price allocations will be completed after we finalize our third-party appraisal, review all available data, and complete our own internal assessments. We expect to complete our final purchase price allocations by the end of March 2015. Any additional adjustments resulting from finalization of the purchase price allocations for TTOT will affect the amount assigned to goodwill.
As of December 31, 2014, we recorded the following preliminary purchase price allocation for the identifiable tangible and intangible assets and liabilities of TTOT:
(In thousands)
 
 
Consideration:
 
 
Cash paid at closing
$
36,128

 
Contingent consideration
11,300

(1) 
Fair value of consideration
$
47,428

 
 
 
 
Identifiable assets acquired and liabilities assumed:
 
 
Inventory
$
9,599

 
Supplier network
3,800

 
Customer relationships
1,600

 
Accounts receivable
1,529

 
Equipment
518

 
Trade names
300

 
Other assets
292

 
Accounts payable and accrued expenses
(5,034
)
 
Total identifiable net assets
12,604

 
 
 
 
Goodwill
34,824

 
Total allocated purchase price
$
47,428

 
(1)
The contingent consideration relates to the achievement of certain sales milestones. As of December 31, 2014, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranges from zero to $15.0 million (see “Note 5. Fair Value Measurements” below).
On December 23, 2013, we entered into an asset purchase agreement with a small robotics development company, pursuant to which we acquired substantially all of its assets for $16.8 million. In addition to the initial purchase price, we may be obligated to make a milestone payment and revenue sharing payments based upon a percentage of net sales of certain products based on the intellectual property we acquired in the transaction. The acquired company was privately held and is focused on developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets. The technology is intended to enable surgeons to perform minimally invasive and percutaneous surgical procedures with greater accuracy, safety and reproducibility than is currently available. We accounted for this acquisition under the purchase method

83
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

of accounting, and as a result, recorded goodwill of $3.0 million. The table below represents the valuation of the assets acquired and liabilities assumed as part of this 2013 purchase:
(In thousands)
 
 
Identifiable intangible assets:
 
 
In-process research & development
$
20,460

 
Non-compete agreements
20

 
Contingent consideration
(6,704
)
(2) 
Total identifiable net assets
13,776

 
Goodwill
2,999

 
Net assets acquired
$
16,775

 
(2)
The contingent consideration relates to the achievement of certain regulatory milestones and royalties. As of December 31, 2013, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranged from zero to $14.3 million (see “Note 5. Fair Value Measurements” below).
On July 18, 2012, we entered into an asset purchase agreement with a global medical device company, pursuant to which we acquired substantially all of its assets for $6.0 million. In addition to the initial purchase price, we may be obligated to make revenue sharing payments based upon a percentage of net sales of products we acquired from it. We accounted for this acquisition under the purchase method of accounting and as a result, recorded goodwill of $5.6 million. The table below represents the assets acquired and liabilities assumed as part of this 2012 purchase:
(In thousands)
 
 
Inventory
$
158

 
Identifiable intangible assets:
 
 
Customer relationships
120

 
Non-compete agreements
80

 
Patents
2,420

 
Contingent consideration
(2,311
)
 
Total identifiable net assets
467

 
Goodwill
5,564

 
Net assets acquired
$
6,031

 
These acquisitions, which expand our product pipeline, did not have a material effect on our consolidated net sales or operating income for the years ended December 31, 2014, 2013 or 2012. The assets acquired and liabilities assumed as a result of the acquisitions were included in our consolidated balance sheet as of the acquisition dates. The purchase price for each of the acquisitions was primarily allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates. The fair value assigned to identifiable intangible assets acquired was determined primarily by using the income approach, which discounts expected future cash flows to present value using estimates and assumptions determined by management. Purchased identifiable intangible assets are amortized on a straight-line basis over their respective estimated useful lives. The excess purchase price over the value of the net tangible and identifiable intangible assets was recorded as goodwill. The goodwill from these acquisitions is deductible for tax purposes.

84
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The fair value of the IPR&D was determined using a relief from royalty approach, including a pre-tax royalty rate ranging between 4% and 9% and a discount rate ranging between 13.5% and 19%. IPR&D will become an amortizable asset upon completion of the projects, which are currently expected to be completed between 2016 and 2020. The estimated costs to complete the IPR&D projects are approximately $14.1 million as of December 31, 2014.
The following table provides a reconciliation of the beginning and ending balances of contingent payments associated with acquisitions during the years ended December 31, 2014 and December 31, 2013:
(In thousands)
 
Balance at December 31, 2012
$
7,358

Purchase price contingent consideration
6,704

Contingent payments
(5
)
Changes in fair value of contingent consideration classified in operating expenses
120

Balance at December 31, 2013
14,177

Purchase price contingent consideration
11,300

Contingent payments
(11
)
Changes in fair value of contingent consideration classified in operating expenses (1)
(1,131
)
Balance at December 31, 2014
$
24,335

(1) 
Reduction in fair value during 2014 due primarily to reductions to a contingent royalty accrual, offset partially by increases in other royalty and milestone accruals.
NOTE 3. INTANGIBLE ASSETS
A summary of intangible assets is presented below:
 
 
 
December 31, 2014
(In thousands)
Weighted-
Average Amortization
Period
(in years)
 
Gross
Carrying
Amount  
 
Accumulated Amortization  
 
Intangible
Assets, net
 
 
In-process research & development
—
 
$
24,560

 
$
—

 
$
24,560

Supplier network
10.0
 
3,800

 
(88
)
 
3,712

Customer relationships & other intangibles
7.3
 
5,525

 
(1,344
)
 
4,181

Patents
17.0
 
2,420

 
(344
)
 
2,076

Total intangible assets
 
 
$
36,305

 
$
(1,776
)
 
$
34,529


85
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

 
 
 
December 31, 2013
(In thousands)
Weighted-
Average Amortization
Period
(in years)
 
Gross
Carrying
Amount  
 
Accumulated Amortization  
 
Intangible
Assets, net
 
 
In-process research & development
—
 
$
24,560

 
$
—

 
$
24,560

Customer relationships & other intangibles
9.5
 
3,623

 
(864
)
 
2,759

Patents
17.0
 
2,420

 
(202
)
 
2,218

Total intangible assets
 
 
$
30,603

 
$
(1,066
)
 
$
29,537

Amortization expense was as follows:
(in thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Intangible asset amortization expense
 
$
710

 
$
528

 
$
468

Expected future intangible asset amortization as of December 31, 2014 is as follows:
(In thousands)
 
Annual Amortization
Year ending December 31:
 
 
2015
 
$
1,545

2016
 
1,541

2017
 
1,423

2018
 
856

2019
 
852

Thereafter
 
3,752

Total
 
$
9,969


86
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 4. MARKETABLE SECURITIES
The composition of our short-term and long-term marketable securities is as follows:
 
 
 
December 31, 2014
(In thousands)
Contractual Maturity
(in years)
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Short-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
Less than 1
 
$
28,684

 
$
2

 
$
(3
)
 
$
28,683

Corporate debt securities
Less than 1
 
73,066

 
7

 
(42
)
 
73,031

Commercial paper
Less than 1
 
44,663

 
8

 
—

 
44,671

Asset backed securities
Less than 1
 
54

 
—

 
—

 
54

Total short-term marketable securities
 
 
$
146,467

 
$
17

 
$
(45
)
 
$
146,439

 
 
 
 
 
 
 
 
 
 
Long-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
1-2
 
$
26,005

 
$
3

 
$
(36
)
 
$
25,972

Corporate debt securities
1-2
 
19,617

 
3

 
(22
)
 
19,598

Asset backed securities
1-2
 
21,236

 
1

 
(8
)
 
21,229

Securities of U.S. government-sponsored agencies
1-2
 
8,564

 
—

 
(16
)
 
8,548

Total long-term marketable securities
 
 
$
75,422

 
$
7

 
$
(82
)
 
$
75,347

 
 
 
December 31, 2013
(In thousands)
Contractual Maturity
(in years)
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Short-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
Less than 1
 
$
77,342

 
$
17

 
$
(15
)
 
$
77,344

Corporate debt securities
Less than 1
 
35,525

 
15

 
(11
)
 
35,529

Commercial paper
Less than 1
 
36,083

 
6

 
—

 
36,089

Total short-term marketable securities
 
 
$
148,950

 
$
38

 
$
(26
)
 
$
148,962

 
 
 
 
 
 
 
 
 
 
Long-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
1-2
 
$
12,304

 
$
13

 
$
(1
)
 
$
12,316

Corporate debt securities
1-2
 
17,533

 
27

 
—

 
17,560

Asset backed securities
1-2
 
6,651

 
2

 
(1
)
 
6,652

Total long-term marketable securities
 
 
$
36,488

 
$
42

 
$
(2
)
 
$
36,528

NOTE 5. FAIR VALUE MEASUREMENTS
Under the accounting for fair value measurements and disclosures, fair value is defined as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or the liability in an orderly transaction between market participants on the measurement date. Additionally, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable inputs. The

87
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
Our assets and liabilities measured at fair value on a recurring basis are classified and disclosed in one of the following three categories:
Level 1—quoted prices (unadjusted) in active markets for identical assets and liabilities;
Level 2—observable inputs other than quoted prices in active markets for identical assets and liabilities; and
Level 3—unobservable inputs in which there is little or no market data available, which require the reporting entity to use significant unobservable inputs or valuation techniques.
The fair value of our assets and liabilities measured at fair value on a recurring basis was as follows:
 
Balance at
 
 
 
 
 
 
(In thousands)
December 31,
2014
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Cash equivalents
$
9,802

 
$
1,302

 
$
8,500

 
$
—

Municipal bonds
54,655

 
—

 
54,655

 
—

Corporate debt securities
92,629

 
—

 
92,629

 
—

Commercial paper
44,671

 
—

 
44,671

 
—

Asset-backed securities
21,283

 
—

 
21,283

 
—

Securities of U.S. government-sponsored agencies
8,548

 
—

 
8,548

 
—

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration
24,335

 
—

 
—

 
24,335

 
Balance at
 
 
 
 
 
 
(In thousands)
December 31,
2013
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Cash equivalents
$
20,363

 
$
800

 
$
19,563

 
$
—

Municipal bonds
89,660

 
—

 
89,660

 
—

Corporate debt securities
53,089

 
—

 
53,089

 
—

Commercial paper
36,089

 
—

 
36,089

 
—

Asset-backed securities
6,652

 
—

 
6,652

 
—

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration
14,177

 
—

 
—

 
14,177

Contingent consideration represents our contingent milestone, performance and revenue-sharing payment obligations related to our acquisitions and is measured at fair value and is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The valuation of contingent consideration uses assumptions we believe would be made by a market participant,

88
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

such as the probabilities associated with successfully completing clinical trials and obtaining regulatory approval, of achieving sales milestones and the period in which these milestones are expected to be achieved, as well as discount rates, which range from 3.1% to 13.5%. We assess these estimates on an ongoing basis as additional data impacting the assumptions is obtained. Changes in the fair value of contingent consideration related to updated assumptions and estimates are recognized within research and development and selling, general and administrative expenses in the consolidated statements of income.
Assets and Liabilities That Are Measured at Fair Value on a Nonrecurring Basis
The purchase price of business acquisitions is primarily allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the excess recorded as goodwill. We utilize Level 3 inputs in the determination of the initial fair value. Non-financial assets such as goodwill, intangible assets, and property, plant, and equipment are subsequently measured at fair value when there is an indicator of impairment and recorded at fair value only when an impairment is recognized. We assess the impairment of intangible assets annually or whenever events or changes in circumstances indicate that the carrying amount of an intangible asset may not be recoverable. The fair value of our goodwill and intangible assets is not estimated if there is no change in events or circumstances that indicate the carrying amount of an intangible asset may not be recoverable. We have not recorded impairment charges related to our business acquisitions.
NOTE 6. INVENTORIES
(In thousands)
December 31, 2014
 
December 31, 2013
Raw materials
$
8,847

 
$
1,369

Work in process
2,490

 
2,820

Finished goods
79,608

 
66,161

Total
$
90,945

 
$
70,350

NOTE 7. PROPERTY AND EQUIPMENT
(In thousands)
 
Useful Life
 
December 31, 2014
 
December 31, 2013
Land
 
—
 
$
4,116

 
$
3,769

Buildings and improvements
 
30
 
10,369

 
9,541

Equipment
 
5-7
 
17,783

 
14,588

Instruments
 
3
 
123,864

 
107,867

Modules and cases
 
3
 
25,155

 
22,325

Other property and equipment
 
3-5
 
6,732

 
5,970

 
 
 
 
188,019

 
164,060

Less: accumulated depreciation
 
 
 
(118,544
)
 
(99,910
)
Total
 
 
 
$
69,475

 
$
64,150

Instruments are hand-held devices used by surgeons to install implants during surgery. Modules and cases are used to store and transport the instruments and implants.

89
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Depreciation expense related to property and equipment was as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Depreciation
 
$
21,044

 
$
18,869

 
$
17,640

NOTE 8. ACCRUED EXPENSES
(In thousands)
December 31,
2014
 
December 31,
2013
Compensation and other employee-related costs
$
19,933

 
$
17,428

Legal and other settlements and expenses
27,686

 
23,765

Accrued non-income taxes
4,720

 
2,938

Other
9,160

 
6,994

Total accrued expenses
$
61,499

 
$
51,125

NOTE 9. DEBT
Line of Credit
In May 2011, we entered into a credit agreement with Wells Fargo Bank related to a revolving credit facility that provides for borrowings up to $50.0 million. At our request, and with the approval of the bank, the amount of borrowings available under the revolving credit facility can be increased to $75.0 million. The revolving credit facility includes up to a $25.0 million sub-limit for letters of credit. As amended to date, the revolving credit facility extends to May 2015. Cash advances bear interest at our option either at a fluctuating rate per annum equal to the daily LIBOR in effect for a one-month period plus 0.75%, or a fixed rate for a one- or three-month period equal to LIBOR plus 0.75%. The credit agreement governing the revolving credit facility also subjects us to various restrictive covenants, including the requirement to maintain maximum consolidated leverage. The covenants also include limitations on our ability to repurchase shares, to pay cash dividends or to enter into a sale transaction. As of December 31, 2014, we were in compliance with all covenants under the credit agreement, there were no outstanding borrowings under the revolving credit facility and available borrowings were $50.0 million. We may terminate the credit agreement at any time on ten days’ notice without premium or penalty.
NOTE 10. EQUITY
Our amended and restated Certificate of Incorporation provides for a total of 785,000,000 authorized shares of common stock. Of the authorized number of shares of common stock, 500,000,000 shares are designated as Class A common stock (“Class A Common”), 275,000,000 shares are designated as Class B common stock (“Class B Common”) and 10,000,000 shares are designated as Class C common stock (“Class C Common”).
The holders of Class A Common are entitled to one vote for each share of Class A Common held. The holders of Class B Common are entitled to 10 votes for each share of Class B Common held. The holders of Class A Common and Class B Common vote together as one class of common stock. The Class C Common is nonvoting. Except for voting rights, the Class A Common, Class B Common and Class C Common have the same rights and privileges.

90
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

In August 2012, we completed our IPO. We sold 2,083,333 shares of our Class A Common at an offering price of $12.00 per share. We recognized gross proceeds of $25.0 million and our net proceeds received after underwriting fees and offering expenses were $21.0 million.
Immediately prior to the closing of our IPO, we effectuated the following conversion:
•
the automatic conversion of all shares of our Series E preferred stock to 15,597,300 shares of our Class B Common;
•
the subsequent automatic conversion of 49,655,411 shares of our Class B Common (which reflects all such shares of Class B Common held by those who beneficially owned less than 10% of the aggregate number of all outstanding shares of our common stock) to 49,655,411 shares of our Class A Common;
•
the automatic conversion of all shares of our Class C Common to 73,554 shares of our Class A Common; and
•
the automatic conversion of 3,039,385 shares of Class B Common to 3,039,385 shares of Class A Common upon their sale by the selling stockholders.
Our issued and outstanding common shares by Class were as follows:
(Shares)
Class A Common
 
Class B
 Common
 
Total
December 31, 2014
70,828,187

 
23,877,556

 
94,705,743

December 31, 2013
66,065,197

 
27,377,556

 
93,442,753

NOTE 11. STOCK-BASED COMPENSATION
We have three stock plans: our Amended and Restated 2003 Stock Plan, our 2008 Stock Plan, and our 2012 Equity Incentive Plan (the "2012 Plan"). The 2012 Plan is the only remaining active stock plan.  The purpose of these stock plans was, and the 2012 Plan is, to provide incentive to employees, directors, and consultants of Globus.  The Plans are administered by the Board or its delegates. The number, type of option, exercise price, and vesting terms are determined by the Board or its delegates in accordance with the terms of the Plans. The options granted expire on a date specified by the Board, but generally not more than ten years from the grant date. Option grants to employees generally vest monthly over a four-year period.
The 2012 Plan was approved by our Board in March 2012, and by our stockholders in June 2012. Under the 2012 Plan, the aggregate number of shares of Class A Common that may be issued subject to options and other awards is equal to the sum of (i) 3,076,923 shares, (ii) any shares available for issuance under the 2008 Plan as of March 13, 2012, (iii) any shares underlying awards outstanding under the 2008 Plan as of March 13, 2012 that, on or after that date, are forfeited, terminated, expired or lapse for any reason, or are settled for cash without delivery of shares and (iv) starting January 1, 2013, an annual increase in the number of shares available under the 2012 Plan equal to up to 3% of the number of shares of our common and preferred stock outstanding at the end of the previous year, as determined by our Board. The number of shares that may be issued or transferred pursuant to incentive stock options under the 2012 Plan is limited to 10,769,230 shares. The shares of Class A Common covered by the 2012 Plan are authorized but unissued shares, treasury shares or shares of common stock purchased on the open market.

91
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of December 31, 2014, pursuant to the 2012 Plan, there were 9,085,832 shares of Class A Common stock reserved and 6,019,966 shares of Class A Common stock available for future grants.
The weighted average grant date per share fair values of the options awarded to employees were as follows:
 
 
Year Ended
 
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Weighted average grant date per share fair value
 
$
9.63

 
$
6.34

 
$
5.90

The fair value of the options was estimated on the date of the grant using a Black-Scholes option pricing model with the following assumptions:
 
Year Ended
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Risk-free interest rate
1.51
%
-
1.95
%
 
0.98
%
-
1.74
%
 
0.90
%
-
1.10
%
Expected term (years)
5.3
-
6.4
 
6.1
-
6.4
 
6
Expected volatility
35.0
%
-
41.0
%
 
41.0
%
-
44.0
%
 
44.0
%
-
47.0
%
Expected dividend yield
—%
 
—%
 
—%
Stock option activity during the years ended December 31, 2014, 2013 and 2012 is summarized as follows:  
 
Option Shares (thousands)
 
Weighted average exercise price
 
Weighted average remaining contractual life (years)
 
Aggregate intrinsic value (thousands)
Outstanding at December 31, 2011
6,454

 
$
5.14

 
 
 
 
Granted
1,228

 
13.10

 
 
 
 
Exercised
(1,061
)
 
1.42

 
 
 
 
Forfeited
(368
)
 
9.55

 
 
 
 
Outstanding at December 31, 2012
6,253

 
6.99

 
 
 
 
Granted
1,222

 
14.78

 
 
 
 
Exercised
(2,173
)
 
3.48

 
 
 
 
Forfeited
(416
)
 
12.23

 
 
 
 
Outstanding at December 31, 2013
4,886

 
10.04

 
 
 
 
Granted
1,495

 
23.45

 
 
 
 
Exercised
(1,263
)
 
7.71

 
 
 
 
Forfeited
(264
)
 
15.33

 
 
 
 
Outstanding at December 31, 2014
4,854

 
14.50

 
7.1
 
$
45,731

Exercisable at December 31, 2014
2,390

 
9.08

 
5.4
 
35,093

Expected to vest at December 31, 2014
2,464

 
$
19.76

 
8.8
 
$
10,638

We use the Black Scholes pricing model to determine the fair value of our stock options (see “Note 1. Background and Summary of Significant Accounting Policies, (q) Stock-Based Compensation” above). Subsequent to the February 2012 and March 2012 stock option grants, we reassessed the fair value

92
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

of our stock options on those dates of grant by updating the assumptions and facts considered in an October 2011 valuation report upon which we relied to take into account our actual results, market conditions, comparable company results, and the timing of our IPO.
Compensation expense related to stock options granted to employees and non-employees under the Plans and the intrinsic value of stock options exercised was as follows:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Compensation expense related to stock options
 
$
7,111

 
$
5,177

 
$
4,635

Intrinsic value of stock options exercised
 
20,216

 
25,034

 
12,507

As of December 31, 2014, there was $16.1 million of unrecognized compensation expense related to unvested employee stock options that vest over a weighted average period of three years.
NOTE 12. INCOME TAXES
The components of income before income taxes are as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Domestic
 
$
137,643

 
$
101,424

 
$
114,176

Foreign
 
999

 
577

 
477

Total
 
$
138,642

 
$
102,001

 
$
114,653

The components of the provision/(benefit) for income taxes are as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Current:
 
 
 
 
 
 
Federal
 
$
43,561

 
$
41,741

 
$
40,338

State
 
6,097

 
6,118

 
6,419

Foreign
 
519

 
912

 
345

 
 
50,177

 
48,771

 
47,102

Deferred:
 
 
 
 
 
 
Federal
 
(3,630
)
 
(14,088
)
 
(5,510
)
State
 
(357
)
 
(1,210
)
 
(352
)
Foreign
 
(33
)
 
(84
)
 
(418
)
 
 
(4,020
)
 
(15,382
)
 
(6,280
)
Total
 
$
46,157

 
$
33,389

 
$
40,822


93
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

A reconciliation of the statutory U.S. federal tax rate to our effective rate is as follows:
 
 
Year ended
 
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Statutory U.S. federal tax rate
 
35.0
 %
 
35.0
 %
 
35.0
 %
State income taxes, net of federal benefit
 
2.6

 
2.8

 
2.9

Domestic production activities deduction
 
(2.7
)
 
(3.5
)
 
(2.3
)
Tax credits
 
(1.2
)
 
(1.7
)
 
(0.1
)
Nondeductible expenses
 
0.7

 
1.7

 
1.4

Other
 
(1.1
)
 
(1.6
)
 
(1.3
)
Effective tax rate
 
33.3
 %
 
32.7
 %
 
35.6
 %
Deferred income taxes reflect the tax effects of temporary differences between the basis of assets and liabilities recognized for financial reporting purposes and tax purposes. Significant components of our deferred income taxes are as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
Deferred tax assets:
 
 
 
 
Inventory reserve
 
$
22,808

 
$
19,635

Accruals, reserves, and other currently not deductible
 
19,043

 
17,133

Stock-based compensation
 
5,548

 
5,152

Foreign net operating loss carryforwards
 
418

 
724

Total deferred tax assets
 
47,817

 
42,644

Valuation allowance
 
(45
)
 
(327
)
Total deferred tax assets, net of valuation allowance
 
47,772

 
42,317

Deferred tax liabilities:
 
 
 
 
Depreciation and amortization
 
(9,865
)
 
(9,759
)
Other
 
(2,643
)
 
(1,229
)
Total deferred tax liabilities
 
(12,508
)
 
(10,988
)
Net deferred tax assets
 
$
35,264

 
$
31,329

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that we will realize the benefits of these deductible differences at December 31, 2014. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced. Of the amounts presented above, $0.4 million of long-term deferred tax assets is included as a component of other assets on our consolidated balance sheet as of December 31, 2014 and 2013.

94
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Unrecognized tax benefits at the beginning of the year
 
$
3,978

 
$
3,500

 
$
2,799

Additions related to current year tax positions
 
—

 
661

 
673

Additions related to prior year tax positions
 
614

 
64

 
46

Reductions related to prior year tax positions
 
(209
)
 
(109
)
 
(18
)
Lapse of statute of limitations
 
(202
)
 
(138
)
 
—

Settlements
 
(953
)
 
—

 
—

Unrecognized tax benefits at the end of the year
 
$
3,228

 
$
3,978

 
$
3,500

The impact of our unrecognized tax benefits to the effective income tax rate is as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Portion of total unrecognized tax benefits that, if recognized, would affect the effective income tax rate
 
$
838

 
$
1,184

 
$
747

Interest and penalties are recorded in the statement of operations as provision for income taxes. The total interest and penalties recorded in the statement of operations was nominal for the years ended December 31, 2014, 2013 and 2012. Our uncertain tax benefits could increase in the next twelve months as we continue our current transfer pricing policies and deduct additional tax credits. We are unable to estimate a range of reasonably possible changes in our uncertain tax benefits in the next twelve months. In 2014, we settled the IRS audits of 2011 and 2012 tax years, resulting in no adjustments. The tax years that remained subject to examination by a major tax jurisdiction as of December 31, 2014 were 2009 and beyond for Switzerland; 2010 and beyond for India, Belgium, Germany, and Poland; 2011 and beyond for Denmark, Sweden and Australia; 2012 and beyond for South Africa and Israel; 2013 and beyond for the United States, the United Kingdom, Netherlands, and France.
On December 19, 2014, the Tax Increase Prevention Act of 2014 (the “TIPA”) was signed into law. One of the provisions of the TIPA was the reinstatement of the research and experimentation tax credit from January 1, 2014 through December 31, 2014. As of December 31, 2014 a benefit was recognized for this tax credit and is included in the 2014 tax provision.
On January 2, 2013, the American Taxpayer Relief Act of 2012 (the “ATRA”) was signed into law. One of the provisions of the ATRA was a reinstatement and extension of the research and experimentation tax credit from January 1, 2012 through December 31, 2013. However, as of December 31, 2012 no benefit could be recognized for this tax credit due to the passage of the ATRA in 2013. As the passage of the ATRA occurred in 2013, the entire reinstated credit for the year ended December 31, 2012 of $0.9 million was recognized in 2013 in accordance with accounting guidance.

95
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 13. LEASES
The Company leases certain equipment and office facilities under operating leases. As of December 31, 2014, minimum future rental payments under operating leases for each of the next five years are as follows:
(In thousands)
 
 
Year ending December 31:
 
 
2015
 
$
700

2016
 
546

2017
 
279

2018
 
105

2019
 
—

Thereafter
 
—

Total
 
$
1,630

Rent expense related to all operating leases recognized as a component of selling, general and administrative expenses was as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Rent expense
 
$
676

 
$
424

 
$
419

NOTE 14. COMMITMENTS AND CONTINGENCIES
We are involved in a number of proceedings, legal actions, and claims. Such matters are subject to many uncertainties, and the outcomes of these matters are not within our control and may not be known for prolonged periods of time. In some actions, the claimants seek damages, as well as other relief, including injunctions prohibiting us from engaging in certain activities, which, if granted, could require significant expenditures and/or result in lost revenues. We record a liability in the consolidated financial statements for these actions when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded. While it is not possible to predict the outcome for most of the matters discussed, we believe it is possible that costs associated with them could have a material adverse impact on our consolidated earnings, financial position or cash flows.
N-Spine, Synthes and Depuy Synthes Litigation
In April 2010, N-Spine, Inc. and Synthes USA Sales, LLC filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. N-Spine, the patent owner, and Synthes USA, a licensee of the subject patent, allege that we infringe one or more claims of the patent by making, using, offering for sale or selling our TRANSITION® stabilization system product. N-Spine and Synthes USA seek injunctive relief and an unspecified amount in damages. We intend to defend our rights vigorously. This

96
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

matter was stayed on July 14, 2011 pending the resolution of an inter partes reexamination on the asserted patent granted by the U.S. Patent and Trademark Office (“USPTO”) in February 2011. In December 2011, the examiner withdrew the original grounds of rejection of the asserted patent and we appealed the examiner’s decision. In January 2014, the USPTO ruled on the appeal, rejecting certain claims in view of the prior art and affirming certain other claims. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
In a related matter, on January 8, 2014, Depuy Synthes Products, LLC (“Depuy Synthes”) filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. Depuy Synthes alleges that we infringe one or more claims of the asserted patent by making, using, offering for sale or selling our TRANSITION® stabilization system product. Depuy Synthes seeks injunctive relief and an unspecified amount in damages. We intend to defend our rights vigorously. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
Synthes USA, LLC, Synthes USA Products, LLC and Synthes USA Sales, LLC Litigation
In July 2011, Synthes USA, LLC, Synthes USA Products, LLC and Synthes USA Sales, LLC filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. Synthes USA LLC, the patent owner, Synthes USA Products, LLC, a licensee to manufacture products of the subject patents, and Synthes USA Sales LLC, a licensee to sell products of the subject patents, allege that we infringe one or more claims of three patents by making, using, offering for sale or selling our COALITION®, INDEPENDENCE® and INTERCONTINENTAL® products. As a result of the acquisition of Synthes, Inc. by Johnson & Johnson, a motion was filed to change the plaintiff in this matter to DePuy Synthes in February 2013. On June 14, 2013, the jury in this case returned a verdict, finding that prior versions of the three products we previously sold did infringe on DePuy Synthes’ patents and awarding monetary damages in the amount of $16.0 million. The jury also upheld the validity of DePuy Synthes’ patents. There was no finding of willful infringement by Globus.
We do not expect the verdict to impact our ability to conduct our business or to have any material impact on our future revenues. As this lawsuit involved only three products that are no longer part of our product portfolio, this verdict is not expected to impair our ability to sell any of our future products.
We believe the facts and the law do not support the jury’s findings of infringement and patent validity and are seeking to overturn the verdict through the appeals process.
For the year ended December 31, 2013, we accrued $19.5 million in damages and other litigation-related costs related to this case, of which $1.3 million was included in provision for litigation loss (cost of goods sold, due to a write off of certain inventory which will not be sold due to the verdict) and $18.2 million was included in provision for litigation loss (operating expense). During the year ended December 31, 2014, we accrued an additional $0.6 million in interest included in provision for litigation related to this litigation.
L5 Litigation
In December 2009, we filed suit in the Court of Common Pleas of Montgomery County, Pennsylvania against our former exclusive independent distributor L5 Surgical, LLC and its principals, seeking an injunction

97
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

and declaratory judgment concerning certain restrictive covenants made to L5 by its sales representatives. L5 brought counterclaims against us alleging tortious interference, unfair competition and conspiracy. The injunction phase was resolved in September 2010, and this matter is now in the discovery phase of litigation on the underlying damages claims. We intend to defend our rights vigorously. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
NuVasive Litigation
In October 2010, NuVasive, Inc. filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. NuVasive, the patent owner, alleges that we infringe one or more claims of three patents by making, using, offering for sale or selling our MARS™ 3V retractor for use in certain lateral fusion procedures. NuVasive sought injunctive relief and an unspecified amount in damages. This matter was settled on Feburary 12, 2015 for an undisclosed amount.
NuVasive Employee Litigation
We have hired several employees who were formerly employed by NuVasive, Inc. In July 2011, NuVasive filed suit against us in the District Court of Travis County, Texas alleging that our hiring of one named former employee and other unnamed former employees constitutes tortious interference with its contracts with those employees, and with prospective business relationships, as well as aiding and abetting the breach of fiduciary duty. NuVasive sought compensatory damages, permanent injunction, punitive damages and attorneys’ fees. This matter was settled on Feburary 12, 2015 for an undisclosed amount.
Bianco Litigation
On March 21, 2012, Sabatino Bianco filed suit against us in the Federal District Court for the Eastern District of Texas claiming that we misappropriated his trade secret and confidential information and improperly utilized it in developing our CALIBER® product. Bianco alleges that we engaged in misappropriation of trade secrets, breach of contract, unfair competition, fraud and theft and seeks correction of inventorship, injunctive relief and exemplary damages. On April 20, 2012, Bianco filed a motion for a preliminary injunction, seeking to enjoin us from making, using, selling, importing or offering for sale our CALIBER® product. On November 15, 2012, the court denied Bianco’s motion for preliminary injunction. On October 1, 2013, Bianco amended his complaint to include that his trade secrets and confidential information were also used improperly in developing our RISE® and CALIBER®-L products.
On January 17, 2014, the jury in this case returned a verdict in favor of Bianco on a claim of misappropriation of trade secret. We have accrued the verdict amount of $4.3 million as of December 31, 2013. The jury found against Bianco on the claims of breach of contract and disgorgement of profits. The court granted our motion for judgment as a matter of law and dismissed Bianco’s claims for unfair competition, fraud, and exemplary damages, and Bianco abandoned the claim of misappropriation of confidential information. Bianco’s claims of correction of inventorship, unjust enrichment, and permanent injunctive relief were not submitted to the jury. On March 7, 2014, the court denied Bianco’s claim for correction of inventorship and ruled he is not entitled to be named as a co-inventor on any of the patents at issue, and also denied his claim for unjust enrichment. On March 17, 2014, the court denied Bianco’s claim for permanent injunctive relief. On July 2, 2014, the court awarded Bianco an ongoing royalty of 5% of the net sales of the CALIBER®, CALIBER®-L, and RISE® products, or products that are not colorably different from those

98
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

products, for a fifteen year period on sales starting on January 18, 2014. The court entered final judgment on the jury verdict on July 17, 2014. Post-trial motions were denied on October 27, 2014 and the matter is currently on appeal.
We do not expect the verdict to impact our ability to conduct our business or to have any material impact on our future revenues. We believe the facts and the law do not support the jury’s findings of misappropriation of trade secret and are seeking to overturn the verdict through the appeals process.
Altus Partners, LLC Litigation
On February 20, 2013, Altus Partners, LLC filed suit against us in the U.S. District Court for the Eastern District of Pennsylvania for patent infringement.  On April 7, 2014, we settled the litigation with Altus Partners and recognized a provision for litigation of $2.0 million.
Bonutti Skeletal Innovations, LLC Litigation
On November 19, 2014, Bonutti Skeletal Innovations, LLC filed suit against us in the U.S. District Court for the Eastern District of Pennsylvania for patent infringement. Bonutti Skeletal, a non-practicing entity, alleges that Globus willfully infringes one or more claims of six patents by making, using, offering for sale or selling the CALIBER®, CALIBER®-L, COALITION®, CONTINENTAL®, FORGE®, FORTIFY®, INDEPENDENCE®, INTERCONTINENTAL®, MONUMENT®, NIKO®, RISE®, SIGNATURE®, SUSTAIN®, and TRANSCONTINENTAL® products. Bonutti Skeletal seeks an unspecified amount in damages and injunctive relief. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
In addition, we are subject to legal proceedings arising in the ordinary course of business.
NOTE 15. RETIREMENT BENEFIT PLANS
We sponsor a 401(k) Plan covering all eligible U.S. employees. Under the 401(k) Plan, we make nondiscretionary matching contributions at the rate of 100% of employee’s contributions up to a maximum annual contribution of $6,000 per eligible employee, limited to 3% of the employee’s compensation for the period.
Additionally, we contribute to various foreign retirement benefit plans required by local law or coordinated with government sponsored plans which cover many of our international employees. The benefits offered under these plans are reflective of local customs and practices in the countries concerned.
Company contributions to these retirement plans were as follows:
 
 
Year ended
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
401(k) and other retirement plan contributions
 
$
2,185

 
$
2,106

 
$
1,055


99
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 16. RELATED-PARTY TRANSACTIONS
We have contracted with a third-party manufacturer in which certain of our senior management and significant stockholders have or had ownership interests and leadership positions.
We have purchased the following amounts of products and services from the supplier:
 
Year Ended
(In thousands)
December 31, 2014
 
December 31,
2013
 
December 31,
2012
Purchases from related-party supplier
$
21,948

 
$
20,039

 
$
20,159

As of December 31, 2014 and December 31, 2013, we had $5.4 million and $2.7 million of accounts payable due to the supplier.
NOTE 17. SEGMENT AND GEOGRAPHIC INFORMATION
Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. We globally manage the business within one reportable segment. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. Products are sold principally in the United States.
The following table represents total sales by geographic area, based on the location of the customer:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
United States
 
$
427,091

 
$
396,615

 
$
355,609

International
 
47,280

 
37,844

 
30,385

Total sales
 
$
474,371

 
$
434,459

 
$
385,994

 
We classify our products into two categories: Innovative Fusion products and Disruptive Technology products. The following table represents total sales by product category:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Innovative Fusion
 
$
270,852

 
$
254,033

 
$
238,723

Disruptive Technology
 
203,519

 
180,426

 
147,271

Total sales
 
$
474,371

 
$
434,459

 
$
385,994


100
GLOBUS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 18. QUARTERLY FINANCIAL DATA (unaudited)
 
 
(unaudited)
(In thousands, except per share amounts)
 
March 31,
2014
 
June 30,
2014
 
September 30,
2014
 
December 31,
2014
Sales
 
$
114,210

 
$
113,573

 
$
117,787

 
$
128,801

Gross profit
 
88,898

 
86,990

 
90,101

 
97,525

Net income
 
21,139

 
20,647

 
23,061

 
27,638

Net earnings per common share - basic
 
0.23

 
0.22

 
0.24

 
0.29

Net earnings per common share - diluted
 
0.22

 
0.22

 
0.24

 
0.29

 
 
(unaudited)
(In thousands, except per share amounts)
 
March 31,
2013
 
June 30,
2013
 
September 30,
2013
 
December 31,
2013
Sales
 
$
105,018

 
$
107,009

 
$
107,187

 
$
115,245

Gross profit
 
81,525

 
82,248

 
81,872

 
88,471

Net income
 
19,891

 
7,426

 
20,310

 
20,985

Net earnings per common share - basic
 
0.22

 
0.08

 
0.22

 
0.22

Net earnings per common share - diluted
 
0.21

 
0.08

 
0.22

 
0.22

NOTE 19. SUBSEQUENT EVENT
On February 25, 2015, we entered into an agreement to acquire medical device manufacturer Branch Medical Group, Inc. (“BMG”), a third party manufacturer of high precision medical devices located in
Audubon, PA. Under the terms of the agreement, we expect to pay approximately $52.9 million in cash subject to certain closing adjustments for BMG.
We expect the closing of the acquisition to occur in March 2015 following satisfaction of the applicable closing conditions.

101


Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our CEO and our Chief Operating Officer (“COO”), evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2014. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as amended, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures as of December 31, 2014, our CEO and COO concluded that, as of such date, our disclosure controls and procedures were effective.
Management’s Report on Internal Control over Financial Reporting
Management of Globus Medical, Inc. (“Globus”) is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable, but not absolute, assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. A company’s internal control over financial reporting includes those policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Management evaluated the internal control over financial reporting of Globus as of December 31, 2014. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (1992) (“COSO”). As a result of this assessment and based on the criteria in the COSO framework, management has concluded that, as of December 31, 2014, the internal control over financial reporting of Globus was effective.

102

Report of Independent Registered Public Accounting Firm
KPMG LLP, our independent registered public accounting firm, has audited the effectiveness of our internal control over financial reporting as of December 31, 2014 as stated in its report that is included in Item 8 of this Form 10-K.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information
None.

103

PART III
Certain information required by Part III is omitted from this Annual Report and will be included in the definitive proxy statement for our 2015 annual meeting of stockholders, which will be filed within 120 days after the end of our fiscal year.
Item 10. Directors, Executive Officers and Corporate Governance
Code of Ethics
We have adopted a Code of Ethics for all employees, officers, directors, as well as a Code of Ethics specifically for our principal executive officer and senior financial officers, both of which are available on our website, www.globusmedical.com. We intend to disclose future amendments to, or waivers from, provisions of our Code of Ethics that apply to our Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, or Controller, or persons performing similar functions, within four business days of such amendment or waiver.
The other information required by this Item 10 will be set forth in the Company's proxy statement for its 2015 annual meeting of stockholders, which information is incorporated herein by reference.
Item 11. Executive Compensation
The information required by this Item 11 will be set forth in the Company's proxy statement for its 2015 annual meeting of stockholders, which information is incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required by this Item 12 will be set forth in the Company's proxy statement for its 2015 annual meeting of stockholders, which information is incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required by this Item 13 will be set forth in the Company's proxy statement for its 2015 annual meeting of stockholders, which information is incorporated herein by reference.
Item 14. Principal Accountant Fees and Services
The information required by this Item 14 will be set forth in the Company's proxy statement for its 2015 annual meeting of stockholders, which information is incorporated herein by reference.

104

PART IV
Item 15. Exhibits and Financial Statement Schedules
(a) (1) Financial Statements
 
Page
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Comprehensive Income
Consolidated Statements of Equity
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements
(a) (2) Financial Statement Schedules
SCHEDULE II. VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS
Allowance for doubtful accounts:
(In thousands)
Beginning of period
 
Additions
 
Write-offs
 
End of period
Year ended December 31, 2012
$
602

 
$
363

 
$
(4
)
 
$
961

Year ended December 31, 2013
961

 
693

 
(73
)
 
1,581

Year ended December 31, 2014
$
1,581

 
$
318

 
$
(252
)
 
$
1,647

Deferred tax valuation allowance:
(In thousands)
Beginning of period
 
Additions
 
Write-offs
 
End of period
Year ended December 31, 2012
$
1,149

 
$
—

 
$
(616
)
 
$
533

Year ended December 31, 2013
533

 
—

 
(206
)
 
327

Year ended December 31, 2014
$
327

 
$
—

 
$
(282
)
 
$
45


105

(b) Exhibits, including those incorporated by reference
Exhibit No.
 
Item
 
 
 
3.1
 
Amended and Restated Certificate of Incorporation of Globus Medical, Inc. (incorporated by reference to Exhibit 3.1 of the Registrant’s Amendment No. 5 to the Registration Statement on Form S-1 filed on August 2, 2012).
3.2
 
Certificate of Amendment of the Amended and Restated Certificate of Incorporation, dated July 31, 2012 (incorporated by reference to Exhibit 3.2 of the Registrant’s Amendment No. 5 to the Registration Statement on Form S-1 filed on August 2, 2012).
3.3
 
Certificate of Amendment of the Amended and Restated Certificate of Incorporation, dated August 20, 2012 (incorporated by reference to Exhibit 3.1 of the Registrant’s Form 10-Q/A filed on September 19, 2012).
3.4
 
Amended and Restated Bylaws of Globus Medical, Inc. (incorporated by reference to Exhibit 3.6 of the Registrant’s Registration Statement on Form S-1 filed on March 29, 2012).
4.1
 
Specimen Certificate for Class A Common Stock (incorporated by reference to Exhibit 4.1 of the Registrant’s Amendment No. 3 to the Registration Statement on Form S-1 filed on July 16, 2012).
10.1
 
Globus Medical, Inc. Amended and Restated 2003 Stock Plan (incorporated by reference to Exhibit 10.4 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.2
 
First Amendment to the Globus Medical, Inc. Amended and Restated 2003 Stock Plan (incorporated by reference to Exhibit 10.5 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.3
 
Globus Medical, Inc. 2008 Stock Plan (incorporated by reference to Exhibit 10.6 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.4
 
Globus Medical, Inc. 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.7 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.5
 
Form of Grant Notice and Stock Option Agreement under 2003 Stock Plan (incorporated by reference to Exhibit 10.8 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.6
 
Form of Grant Notice and Stock Option Agreement under 2008 Stock Plan (incorporated by reference to Exhibit 10.9 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.7
 
Form of Incentive Stock Option Grant Notice and Incentive Stock Option Agreement under 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.10 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.8
 
Form of Nonqualified Stock Option Grant Notice and Nonqualified Stock Option Agreement under 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.11 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.9
 
Vice President Employment Agreement, dated June 1, 2005, by and between Globus Medical, Inc. and Brett Murphy (incorporated by reference to Exhibit 10.13 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.10
 
First Amendment to Vice President Employment Agreement, dated November 1, 2006, by and between Globus Medical, Inc. and Brett Murphy (incorporated by reference to Exhibit 10.14 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).

106

10.11
 
Second Amendment to Vice President Employment Agreement, dated February 8, 2011, by and between Globus Medical, Inc. and Brett Murphy (incorporated by reference to Exhibit 10.15 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.12
 
Credit Agreement, dated May 3, 2011, by and between Globus Medical, Inc. and Wells Fargo Bank, National Association (incorporated by reference to Exhibit 10.16 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.13
 
First Amendment to Credit Agreement, dated March 16, 2012, by and between Globus Medical, Inc. and Wells Fargo Bank, National Association (incorporated by reference to Exhibit 10.17 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.14
 
Form of Indemnification Agreement (incorporated by reference to Exhibit 10.18 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.15
 
Form of No Competition and Non-Disclosure Agreement (incorporated by reference to Exhibit 10.19 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.16
 
Second Amendment to Credit Agreement, dated May 1, 2013, by and between Globus Medical, Inc. and Wells Fargo Bank, National Association (incorporated herein by reference to Exhibit 10.1 to our Form 10-Q filed with the Securities and Exchange Commission on May 3, 2013).
10.17
 
Third Amendment to Credit Agreement, dated May 5, 2014, by and between Globus Medical, Inc. and Wells Fargo Bank, National Association (incorporated by reference herein to Exhibit 10.1 to our Form 10-Q filed with the Securities and Exchange Commission on August 6, 2014).
21.1*
 
Subsidiaries of Globus Medical, Inc.
23.1*
 
Consent of independent registered public accounting firm.
31.1*
 
Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
 
Certification by Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**
 
Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*
 
XBRL Instance Document
101.SCH*
 
XBRL Taxonomy Extension Schema Document
101.CAL*
 
XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB*
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
 
XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF*
 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
*
 
Filed herewith.
**
 
Furnished herewith.


107

SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 
 
GLOBUS MEDICAL, INC.
 
 
 
 
 
 
Dated:
February 26, 2015
/s/ DAVID C. PAUL
 
 
 
 
 
David C. Paul
 
 
Chairman
 
 
Chief Executive Officer
 
 
(Principal Executive Officer)
 
 
 
Dated:
February 26, 2015
/s/ DAVID M. DEMSKI
 
 
 
 
 
David M. Demski
 
 
President
 
 
Chief Operating Officer
 
 
(Principal Financial Officer)
 
 
 
Dated:
February 26, 2015
/s/ STEVEN M. PAYNE
 
 
 
 
 
Steven M. Payne
 
 
Chief Accounting Officer
 
 
(Principal Accounting Officer)


108

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 
SIGNATURE
TITLE
DATE
 
 
 
 
 
/s/ David C. Paul
Chief Executive Officer and Director
February 26, 2015
 
David C. Paul
(Principal Executive Officer)
 
 
 
 
 
 
/s/ David M. Demski
President and Chief Operating Officer
February 26, 2015
 
David M. Demski
 and Director
 
 
 
(Principal Financial Officer)
 
 
 
 
 
 
/s/ Steven M. Payne
Chief Accounting Officer
February 26, 2015
 
Steven M. Payne
(Principal Accounting Officer)
 
 
 
 
 
 
/s/ David D. Davidar
Senior Vice President, Operations
February 26, 2015
 
David D. Davidar
and Director
 
 
 
 
 
 
/s/ Kurt C. Wheeler
Director
February 26, 2015
 
Kurt C. Wheeler
 
 
 
 
 
 
 
/s/ Robert W. Liptak
Director
February 26, 2015
 
Robert W. Liptak
 
 
 
 
 
 
 
/s/ Daniel T. Lemaitre
Director
February 26, 2015
 
Daniel T. Lemaitre
 
 
 
 
 
 
 
/s/ Ann D. Rhoads
Director
February 26, 2015
 
Ann D. Rhoads
 
 




109

EXHIBIT INDEX
Exhibit No.
 
Item
 
 
 
3.1
 
Amended and Restated Certificate of Incorporation of Globus Medical, Inc. (incorporated by reference to Exhibit 3.1 of the Registrant’s Amendment No. 5 to the Registration Statement on Form S-1 filed on August 2, 2012).
3.2
 
Certificate of Amendment of the Amended and Restated Certificate of Incorporation, dated July 31, 2012 (incorporated by reference to Exhibit 3.2 of the Registrant’s Amendment No. 5 to the Registration Statement on Form S-1 filed on August 2, 2012).
3.3
 
Certificate of Amendment of the Amended and Restated Certificate of Incorporation, dated August 20, 2012 (incorporated by reference to Exhibit 3.1 of the Registrant’s Form 10-Q/A filed on September 19, 2012).
3.4
 
Amended and Restated Bylaws of Globus Medical, Inc. (incorporated by reference to Exhibit 3.6 of the Registrant’s Registration Statement on Form S-1 filed on March 29, 2012).
4.1
 
Specimen Certificate for Class A Common Stock (incorporated by reference to Exhibit 4.1 of the Registrant’s Amendment No. 3 to the Registration Statement on Form S-1 filed on July 16, 2012).
10.1
 
Globus Medical, Inc. Amended and Restated 2003 Stock Plan (incorporated by reference to Exhibit 10.4 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.2
 
First Amendment to the Globus Medical, Inc. Amended and Restated 2003 Stock Plan (incorporated by reference to Exhibit 10.5 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.3
 
Globus Medical, Inc. 2008 Stock Plan (incorporated by reference to Exhibit 10.6 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.4
 
Globus Medical, Inc. 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.7 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.5
 
Form of Grant Notice and Stock Option Agreement under 2003 Stock Plan (incorporated by reference to Exhibit 10.8 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.6
 
Form of Grant Notice and Stock Option Agreement under 2008 Stock Plan (incorporated by reference to Exhibit 10.9 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.7
 
Form of Incentive Stock Option Grant Notice and Incentive Stock Option Agreement under 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.10 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.8
 
Form of Nonqualified Stock Option Grant Notice and Nonqualified Stock Option Agreement under 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.11 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.9
 
Vice President Employment Agreement, dated June 1, 2005, by and between Globus Medical, Inc. and Brett Murphy (incorporated by reference to Exhibit 10.13 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.10
 
First Amendment to Vice President Employment Agreement, dated November 1, 2006, by and between Globus Medical, Inc. and Brett Murphy (incorporated by reference to Exhibit 10.14 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).

110

10.11
 
Second Amendment to Vice President Employment Agreement, dated February 8, 2011, by and between Globus Medical, Inc. and Brett Murphy (incorporated by reference to Exhibit 10.15 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.12
 
Credit Agreement, dated May 3, 2011, by and between Globus Medical, Inc. and Wells Fargo Bank, National Association (incorporated by reference to Exhibit 10.16 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.13
 
First Amendment to Credit Agreement, dated March 16, 2012, by and between Globus Medical, Inc. and Wells Fargo Bank, National Association (incorporated by reference to Exhibit 10.17 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.14
 
Form of Indemnification Agreement (incorporated by reference to Exhibit 10.18 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.15
 
Form of No Competition and Non-Disclosure Agreement (incorporated by reference to Exhibit 10.19 of the Registrant’s Amendment No. 1 to the Registration Statement on Form S-1 filed on May 8, 2012).
10.16
 
Second Amendment to Credit Agreement, dated May 1, 2013, by and between Globus Medical, Inc. and Wells Fargo Bank, National Association (incorporated herein by reference to Exhibit 10.1 to our Form 10-Q filed with the Securities and Exchange Commission on May 3, 2013).
10.17
 
Third Amendment to Credit Agreement, dated May 5, 2014, by and between Globus Medical, Inc. and Wells Fargo Bank, National Association (incorporated by reference herein to Exhibit 10.1 to our Form 10-Q filed with the Securities and Exchange Commission on August 6, 2014).
21.1*
 
Subsidiaries of Globus Medical, Inc.
23.1*
 
Consent of independent registered public accounting firm.
31.1*
 
Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
 
Certification by Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**
 
Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*
 
XBRL Instance Document
101.SCH*
 
XBRL Taxonomy Extension Schema Document
101.CAL*
 
XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB*
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
 
XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF*
 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
*
 
Filed herewith.
**
 
Furnished herewith.


111
 EX-21.1 2 gmed123114ex211.htm EXHIBIT 21.1 GMED 12.31.14 Ex 21.1


EXHIBIT 21.1
Subsidiaries of Globus Medical, Inc.

The following is a list of our subsidiaries as of December 31, 2014. Certain subsidiaries are not named because they were not significant in the aggregate.
Subsidiary
 
Jurisdiction
GMEDelaware 1 LLC
 
Delaware
 
 
 
GMEDelaware 2 LLC
 
Delaware
 
 
 
Transplant Technologies of Texas, Ltd.
 
Texas
 
 
 
Human Biologics of Texas, Ltd.
 
Texas
 
 
 
Tissue Transplant Technology, Ltd.
 
Texas
 
 
 
Globus Medical India Private Limited
 
India
 
 
 
Globus Medical SARL
 
Switzerland
 
 
 
Globus Medical South Africa Pty Limited
 
South Africa
 
 
 
Globus Medical Poland Sp. z o.o.
 
Poland
 
 
 
Globus Medical Australia Pty Limited
 
Australia
 
 
 
Globus Medical UK Limited
 
United Kingdom
 
 
 
Globus Medical Belgium BVBA
 
Belgium
 
 
 
Globus Medical Germany GmbH
 
Germany
 
 
 
Globus Medical Denmark ApS
 
Denmark
 
 
 
Globus Medical Sweden AB
 
Sweden
 
 
 
Globus Medical Israel Limited
 
Israel
 
 
 
Globus Medical France SARL
 
France
 
 
 
Globus Medical Netherlands B.V.
 
Netherlands
 
 
 
Globus Medical Austria GmbH
 
Austria



 EX-23.1 3 gmed123114ex231.htm EXHIBIT 23.1 GMED 12.31.14 Ex 23.1


EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm
The Board of Directors
Globus Medical, Inc.:

We consent to the incorporation by reference in the Registration Statement (No. 333‑180426) on Form S‑1 and in the Registration Statement (Nos. 333‑184196 and 333-198698) on Form S‑8 of Globus Medical, Inc. of our report dated February 26, 2015, with respect to the consolidated balance sheets of Globus Medical, Inc. as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, equity and cash flows for each of the years in the three year period ended December 31, 2014, and the related financial statement schedule, and the effectiveness of internal control over financial reporting as of December 31, 2014, which report appears in the December 31, 2014 Annual Report on Form 10‑K of Globus Medical, Inc.


/s/ KPMG, LLP
KPMG, LLP
Philadelphia, Pennsylvania
February 26, 2015



EX-31.1 4 gmed123114ex311.htm EXHIBIT 31.1 GMED 12.31.14 Ex 31.1


EXHIBIT 31.1

Certification By Principal Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David C. Paul, certify that:

1.
I have reviewed this Annual Report on Form 10-K of Globus Medical, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 

Date:
February 26, 2015
/s/ DAVID C. PAUL
 
 
David C. Paul
 
 
Chairman
 
 
Chief Executive Officer


 EX-31.2 5 gmed123114ex312.htm EXHIBIT 31.2 GMED 12.31.14 Ex 31.2


EXHIBIT 31.2

Certification By Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David M. Demski, certify that:

1.
I have reviewed this Annual Report on Form 10-K of Globus Medical, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
Date:
February 26, 2015
/s/ DAVID M. DEMSKI
 
 
David M. Demski
 
 
President
 
 
Chief Operating Officer

 




 EX-32 6 gmed123114ex32.htm EXHIBIT 32 GMED 12.31.14 Ex 32


EXHIBIT 32

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

 
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code), David C. Paul, Chairman and Chief Executive Officer, and David M. Demski, President and Chief Operating Officer of Globus Medical, Inc. (the “Company”), each certifies with respect to the Annual Report of the Company on Form 10-K for the period ended December 31, 2014 (the “Report”) that, to the best of his knowledge:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
Dated:
February 26, 2015
/s/ DAVID C. PAUL
 
 
David C. Paul
 
 
Chairman
 
 
Chief Executive Officer
 
 
 
Dated:
February 26, 2015
/s/ DAVID M. DEMSKI
 
 
David M. Demski
 
 
President
 
 
Chief Operating Officer

 
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code) and is not being filed as part of the Report or as a separate disclosure document.



 EX-101.INS 7 gmed-20141231.xml XBRL INSTANCE DOCUMENT 0001237831 2014-01-01 2014-12-31 0001237831 2013-01-01 2013-12-31 0001237831 2014-06-30 0001237831 2015-01-31 0001237831 us-gaap:CommonClassBMember 2013-12-31 0001237831 2014-12-31 0001237831 2013-12-31 0001237831 us-gaap:CommonClassBMember 2014-12-31 0001237831 us-gaap:CommonClassAMember 2014-12-31 0001237831 us-gaap:CommonClassAMember 2013-12-31 0001237831 2012-01-01 2012-12-31 0001237831 us-gaap:PreferredStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2013-01-01 2013-12-31 0001237831 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0001237831 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2014-12-31 0001237831 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2012-12-31 0001237831 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001237831 us-gaap:PreferredStockMember 2014-12-31 0001237831 us-gaap:PreferredStockMember 2011-12-31 0001237831 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2011-12-31 0001237831 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2014-12-31 0001237831 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2011-12-31 0001237831 gmed:PreIPOMember us-gaap:CommonClassCMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0001237831 us-gaap:PreferredStockMember 2013-12-31 0001237831 gmed:PreIPOMember us-gaap:PreferredStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:RetainedEarningsMember 2011-12-31 0001237831 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2011-12-31 0001237831 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2012-12-31 0001237831 gmed:InConjunctionwithIPOMember us-gaap:CommonClassBMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 gmed:InConjunctionwithIPOMember us-gaap:CommonClassCMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001237831 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0001237831 2011-12-31 0001237831 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0001237831 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:PreferredStockMember 2012-12-31 0001237831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0001237831 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2013-12-31 0001237831 gmed:InConjunctionwithIPOMember 2012-01-01 2012-12-31 0001237831 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0001237831 gmed:InConjunctionwithIPOMember us-gaap:PreferredStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2014-12-31 0001237831 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2012-12-31 0001237831 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2014-01-01 2014-12-31 0001237831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0001237831 gmed:InConjunctionwithIPOMember us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0001237831 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0001237831 gmed:PreIPOMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:RetainedEarningsMember 2014-12-31 0001237831 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2013-12-31 0001237831 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0001237831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-01-01 2012-12-31 0001237831 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001237831 gmed:PostIPOMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2014-01-01 2014-12-31 0001237831 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2013-12-31 0001237831 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001237831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0001237831 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2014-01-01 2014-12-31 0001237831 gmed:PreIPOMember us-gaap:CommonClassBMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 gmed:InConjunctionwithIPOMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001237831 us-gaap:RetainedEarningsMember 2012-12-31 0001237831 2012-12-31 0001237831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0001237831 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-12-31 0001237831 us-gaap:RetainedEarningsMember 2013-12-31 0001237831 us-gaap:CostOfGoodsTotalMember 2013-01-01 2013-12-31 0001237831 us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:CostOfGoodsTotalMember 2014-01-01 2014-12-31 0001237831 us-gaap:MinimumMember 2014-12-31 0001237831 us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 gmed:Acquisition2014Member 2014-01-01 2014-12-31 0001237831 gmed:Acquisition2014Member us-gaap:CustomerRelationshipsMember 2014-10-23 0001237831 gmed:Acquisition2014Member 2014-10-23 0001237831 gmed:Acquisition2014Member gmed:SupplierNetworkMember 2014-10-23 0001237831 gmed:Acquisitions2012Member 2012-07-18 0001237831 gmed:Acquisitions2012Member us-gaap:PatentsMember 2012-07-18 0001237831 gmed:Acquisitions2012Member us-gaap:CustomerRelationshipsMember 2012-07-18 0001237831 gmed:Acquisitions2012Member us-gaap:NoncompeteAgreementsMember 2012-07-18 0001237831 us-gaap:InProcessResearchAndDevelopmentMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:InProcessResearchAndDevelopmentMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 gmed:Acquisitions2013Member 2013-12-23 0001237831 gmed:Acquisition2014Member 2014-12-31 0001237831 gmed:Acquisitions2013Member us-gaap:InProcessResearchAndDevelopmentMember 2013-12-23 0001237831 gmed:Acquisitions2013Member us-gaap:NoncompeteAgreementsMember 2013-12-23 0001237831 us-gaap:OtherIntangibleAssetsMember 2013-12-31 0001237831 us-gaap:PatentsMember 2013-01-01 2013-12-31 0001237831 us-gaap:InProcessResearchAndDevelopmentMember 2013-12-31 0001237831 us-gaap:PatentsMember 2013-12-31 0001237831 us-gaap:OtherIntangibleAssetsMember 2013-01-01 2013-12-31 0001237831 us-gaap:OtherIntangibleAssetsMember 2014-12-31 0001237831 gmed:SupplierNetworkMember 2014-12-31 0001237831 us-gaap:PatentsMember 2014-12-31 0001237831 us-gaap:OtherIntangibleAssetsMember 2014-01-01 2014-12-31 0001237831 us-gaap:InProcessResearchAndDevelopmentMember 2014-12-31 0001237831 us-gaap:PatentsMember 2014-01-01 2014-12-31 0001237831 gmed:SupplierNetworkMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:MunicipalBondsMember 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CommercialPaperMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2014-01-01 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember 2014-01-01 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CommercialPaperMember 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:MunicipalBondsMember 2014-01-01 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember 2014-01-01 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:MunicipalBondsMember 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2014-01-01 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:MunicipalBondsMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:MunicipalBondsMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:MunicipalBondsMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:MunicipalBondsMember 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CommercialPaperMember 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:MunicipalBondsMember 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CommercialPaperMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2013-01-01 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:MunicipalBondsMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:MunicipalBondsMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:MunicipalBondsMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:MunicipalBondsMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CommercialPaperMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:MunicipalBondsMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:MunicipalBondsMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CommercialPaperMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:OtherLongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 us-gaap:ShortTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2014-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2013-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2013-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2013-12-31 0001237831 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0001237831 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2013-12-31 0001237831 us-gaap:LandMember 2013-12-31 0001237831 us-gaap:LandMember 2014-12-31 0001237831 us-gaap:EquipmentMember 2013-12-31 0001237831 gmed:ModulesAndCasesMember 2014-12-31 0001237831 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2014-12-31 0001237831 gmed:ModulesAndCasesMember 2013-12-31 0001237831 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2013-12-31 0001237831 gmed:InstrumentsMember 2013-12-31 0001237831 us-gaap:EquipmentMember 2014-12-31 0001237831 us-gaap:BuildingAndBuildingImprovementsMember 2014-12-31 0001237831 us-gaap:BuildingAndBuildingImprovementsMember 2013-12-31 0001237831 gmed:InstrumentsMember 2014-12-31 0001237831 us-gaap:PropertyPlantAndEquipmentOtherTypesMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 us-gaap:PropertyPlantAndEquipmentOtherTypesMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:EquipmentMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:BuildingAndBuildingImprovementsMember 2014-01-01 2014-12-31 0001237831 gmed:InstrumentsMember 2014-01-01 2014-12-31 0001237831 us-gaap:EquipmentMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 gmed:ModulesAndCasesMember 2014-01-01 2014-12-31 0001237831 gmed:LineOfCreditFixedRateMember us-gaap:RevolvingCreditFacilityMember 2014-01-01 2014-12-31 0001237831 us-gaap:RevolvingCreditFacilityMember 2014-12-31 0001237831 gmed:LineOfCreditVariableRatePerAnnumMember us-gaap:RevolvingCreditFacilityMember 2014-01-01 2014-12-31 0001237831 gmed:LineOfCreditFixedRateMember us-gaap:RevolvingCreditFacilityMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0001237831 us-gaap:LetterOfCreditMember us-gaap:RevolvingCreditFacilityMember 2014-12-31 0001237831 gmed:LineOfCreditFixedRateMember us-gaap:RevolvingCreditFacilityMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0001237831 us-gaap:RevolvingCreditFacilityMember 2014-01-01 2014-12-31 0001237831 gmed:ConversionOfClassCCommonStockToClassCommonStockMember 2012-08-01 2012-08-31 0001237831 us-gaap:CommonClassAMember 2012-08-03 0001237831 gmed:ConversionOfSeriesEPreferredStockToClassBCommonStockMember 2012-08-01 2012-08-31 0001237831 us-gaap:CommonClassAMember 2014-01-01 2014-12-31 0001237831 us-gaap:CommonClassBMember 2014-01-01 2014-12-31 0001237831 gmed:EquityOwnershipOfLessThanTenPercentMember gmed:ConversionOfClassBCommonStockToClassCommonStockMember 2012-08-01 2012-08-31 0001237831 us-gaap:CommonClassCMember 2014-12-31 0001237831 gmed:ConversionOfClassBCommonStockToClassCommonStockMember 2012-08-01 2012-08-31 0001237831 gmed:ConversionOfClassBCommonStockToClassCommonStockSellingStockholdersMember 2012-08-01 2012-08-31 0001237831 gmed:NewSharesIssuedByCompanyMember us-gaap:CommonClassAMember 2012-08-01 2012-08-31 0001237831 us-gaap:MinimumMember 2013-01-01 2013-12-31 0001237831 us-gaap:MaximumMember 2013-01-01 2013-12-31 0001237831 gmed:A2012EquityIncentivePlanMember us-gaap:MaximumMember 2014-12-31 0001237831 gmed:A2012EquityIncentivePlanMember 2014-12-31 0001237831 gmed:A2012EquityIncentivePlanMember us-gaap:CommonClassAMember 2014-12-31 0001237831 us-gaap:EmployeeStockOptionMember 2014-12-31 0001237831 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-12-31 0001237831 gmed:OriginalFairValueOfCommonStockMember gmed:February22012GrantMember 2012-12-31 0001237831 us-gaap:OtherAssetsMember 2014-12-31 0001237831 us-gaap:OtherAssetsMember 2013-12-31 0001237831 gmed:SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember 2013-01-01 2013-12-31 0001237831 gmed:SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember 2011-07-31 0001237831 gmed:NuvasiveIncMember us-gaap:MinimumMember 2010-10-31 0001237831 gmed:BiancoMember 2014-01-01 2014-12-31 0001237831 gmed:AltusPartnersLlcMember 2014-01-01 2014-03-31 0001237831 gmed:SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember 2014-01-01 2014-12-31 0001237831 gmed:BiancoMember 2013-01-01 2013-12-31 0001237831 gmed:NuvasiveIncMember 2010-10-31 0001237831 gmed:SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember us-gaap:MinimumMember 2014-12-31 0001237831 gmed:InternationalMember 2014-01-01 2014-12-31 0001237831 country:US 2012-01-01 2012-12-31 0001237831 gmed:InternationalMember 2012-01-01 2012-12-31 0001237831 country:US 2013-01-01 2013-12-31 0001237831 gmed:InternationalMember 2013-01-01 2013-12-31 0001237831 country:US 2014-01-01 2014-12-31 0001237831 gmed:InnovativeFusionMember 2014-01-01 2014-12-31 0001237831 gmed:DisruptiveTechnologyMember 2013-01-01 2013-12-31 0001237831 gmed:DisruptiveTechnologyMember 2014-01-01 2014-12-31 0001237831 gmed:InnovativeFusionMember 2013-01-01 2013-12-31 0001237831 gmed:DisruptiveTechnologyMember 2012-01-01 2012-12-31 0001237831 gmed:InnovativeFusionMember 2012-01-01 2012-12-31 0001237831 2013-01-01 2013-03-31 0001237831 2013-07-01 2013-09-30 0001237831 2013-04-01 2013-06-30 0001237831 2013-10-01 2013-12-31 0001237831 2014-04-01 2014-06-30 0001237831 2014-07-01 2014-09-30 0001237831 2014-01-01 2014-03-31 0001237831 2014-10-01 2014-12-31 0001237831 us-gaap:SubsequentEventMember 2015-02-25 2015-02-25 0001237831 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2011-12-31 0001237831 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2013-12-31 0001237831 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2013-01-01 2013-12-31 0001237831 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2014-01-01 2014-12-31 0001237831 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2012-12-31 0001237831 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2014-12-31 0001237831 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2012-01-01 2012-12-31 0001237831 us-gaap:AllowanceForDoubtfulAccountsMember 2014-01-01 2014-12-31 0001237831 us-gaap:AllowanceForDoubtfulAccountsMember 2013-12-31 0001237831 us-gaap:AllowanceForDoubtfulAccountsMember 2012-12-31 0001237831 us-gaap:AllowanceForDoubtfulAccountsMember 2013-01-01 2013-12-31 0001237831 us-gaap:AllowanceForDoubtfulAccountsMember 2014-12-31 0001237831 us-gaap:AllowanceForDoubtfulAccountsMember 2011-12-31 0001237831 us-gaap:AllowanceForDoubtfulAccountsMember 2012-01-01 2012-12-31 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares gmed:categories gmed:Stock_Plans gmed:claim gmed:segments false --12-31 FY 2014 2014-12-31 10-K 0001237831 94761428 Yes Large Accelerated Filer 1600000000 GLOBUS MEDICAL INC No No 23765000 27686000 P2Y P1Y P2Y P1Y P2Y P1Y P1Y P1Y P1Y P2Y P1Y P2Y P1Y P2Y P1Y P1Y P1Y P1Y P1Y 5000 11000 1730000 6081000 15528000 20195000 6704000 11300000 120000 -1131000 800000 19563000 0 20363000 1302000 8500000 0 9802000 4300000 19500000 0.10 9759000 9865000 0.09 0.04 14100000 900000 30603000 36305000 P3M P1M P1M P10D 7200000 7100000 0.023 2 130 1100000 1300000 1200000 20960000 0 0 1300000 0.05 0.03 3076923 10.34 P10Y 3 10073000 15904000 2656000 5359000 62414000 75430000 2358000 569000 51125000 61499000 99910000 118544000 -1009000 -1657000 153987000 175242000 4635000 4635000 5177000 5177000 7111000 7111000 2661000 2661000 4756000 4756000 4408000 4408000 400000 500000 500000 4635000 5177000 7111000 1581000 1647000 468000 528000 710000 2383000 1975000 1666000 566304000 703547000 416808000 470025000 36528000 6652000 17560000 12316000 148962000 36089000 35529000 77344000 0 0 0 0 6652000 36089000 53089000 89660000 0 0 0 0 6652000 36089000 53089000 89660000 75347000 21229000 19598000 25972000 8548000 146439000 54000 44671000 73031000 28683000 0 0 0 0 0 21283000 44671000 92629000 54655000 8548000 0 0 0 0 0 21283000 44671000 92629000 54655000 8548000 36488000 6651000 17533000 12304000 148950000 36083000 35525000 77342000 75422000 21236000 19617000 26005000 8564000 146467000 54000 44663000 73066000 28684000 148962000 146439000 42000 2000 27000 13000 38000 6000 15000 17000 7000 1000 3000 3000 0 17000 0 8000 7000 2000 2000 1000 0 1000 26000 0 11000 15000 82000 8000 22000 36000 16000 45000 0 0 42000 3000 36528000 75347000 47428000 15000000 14300000 15000000 7358000 14177000 24335000 2311000 6704000 11300000 292000 1529000 5034000 518000 120000 80000 2420000 20460000 20000 3800000 1600000 158000 9599000 467000 13776000 12604000 6031000 16775000 47428000 142668000 212400000 89962000 82265000 69732000 -122438000 -7697000 0.001 0.001 0.001 0.001 500000000 275000000 500000000 275000000 10000000 93442753 66065197 27377556 94705743 70828187 23877556 93442753 66065197 27377556 94705743 70828187 23877556 66000 27000 71000 24000 1 10 74266000 435000 73831000 68370000 -242000 68612000 91837000 -648000 92485000 37000 0 51000 1000 0 0 3000 0 52000 36000 1000 3000 49655411 3039385 73554 15597300 37097000 74000 50691000 690000 0 0 3500000 52768000 690000 3500000 75199000 100343000 110857000 40338000 41741000 43561000 345000 912000 519000 47102000 48771000 50177000 6419000 6118000 6097000 0.0075 0.0075 LIBOR LIBOR -5510000 -14088000 -3630000 -418000 -84000 -33000 -6280000 -15382000 -4020000 10988000 12508000 -6079000 -14858000 -4379000 -352000 -1210000 -357000 42644000 47817000 19635000 22808000 31329000 35264000 400000 400000 42317000 47772000 37317000 40062000 724000 418000 5152000 5548000 17133000 19043000 327000 45000 6385000 5166000 1229000 2643000 1055000 2106000 2185000 1.00 6000 0.03 17640000 18869000 21044000 18108000 19397000 21754000 0.82 0.22 0.08 0.22 0.22 0.74 0.23 0.22 0.24 0.29 0.98 0.80 0.21 0.08 0.22 0.22 0.73 0.22 0.22 0.24 0.29 0.97 -97000 230000 185000 0.356 0.327 0.333 0.350 0.350 0.350 0.023 0.035 0.027 0.014 0.017 0.007 -0.013 -0.016 -0.011 0.029 0.028 0.026 0.001 0.017 0.012 17428000 19933000 16100000 P3Y 2661000 4756000 4408000 0.135 0.031 0.19 0.135 P9Y6M P17Y P10Y P7Y3M P17Y P17Y P1Y 1066000 864000 202000 1776000 88000 1344000 344000 3752000 1545000 852000 856000 1423000 1541000 3623000 2420000 3800000 5525000 2420000 2759000 2218000 9969000 3712000 4181000 2076000 300000 -220000 -804000 -899000 18372000 53196000 5564000 2999000 34824000 310795000 81525000 82248000 81872000 88471000 334116000 88898000 86990000 90101000 97525000 363514000 114176000 101424000 137643000 477000 577000 999000 114653000 102001000 138642000 40822000 33389000 46157000 44875000 38719000 51096000 2723000 5772000 3048000 1840000 4628000 1378000 100000 2703000 6886000 9612000 12667000 -1548000 4222000 -4821000 4208000 26963000 4018000 20541000 16678000 18001000 117000 2955000 249000 0 0 23370000 2600000 1545000 1230000 24560000 24560000 29537000 34529000 80000 467000 805000 63000 96000 32000 66161000 79608000 70350000 90945000 1369000 8847000 2820000 2490000 6119000 8212000 6962000 0 2358000 2680000 93944000 118093000 566304000 703547000 67942000 89412000 0 0 14177000 14177000 0 0 24335000 24335000 50000000 25000000 75000000 -786000 23055000 18200000 2000000 5667000 600000 16000000 1 3 1 3 24025000 11011000 12946000 -30715000 -227150000 -100000000 76519000 93471000 79172000 73831000 19891000 7426000 20310000 20985000 68612000 21139000 20647000 23061000 27638000 92485000 1 196002000 232443000 225152000 114793000 101673000 138362000 1630000 700000 0 105000 279000 546000 0 419000 424000 676000 6994000 9160000 909000 975000 435000 -274000 -552000 435000 -242000 -648000 0 32000 -96000 4089000 3320000 0 665000 374000 -140000 328000 280000 52900000 36128000 6031000 16775000 36128000 0 240892000 251422000 24684000 23680000 24754000 5080000 5742000 25000000 1504000 7555000 9738000 0 40560000 184567000 0 13637000 27737000 164060000 107867000 22325000 9541000 14588000 3769000 5970000 188019000 123864000 25155000 10369000 17783000 4116000 6732000 64150000 69475000 P3Y P3Y P30Y P7Y P5Y P5Y P3Y 363000 693000 318000 20159000 20039000 21948000 27926000 26870000 31687000 0 23370000 319289000 411774000 2938000 4720000 385994000 147271000 238723000 355609000 30385000 105018000 107009000 107187000 115245000 434459000 180426000 254033000 396615000 37844000 114210000 113573000 117787000 128801000 474371000 203519000 270852000 427091000 47280000 168862000 182518000 187798000 4635000 5177000 7111000 P4Y 0 0 0 0.470 0.440 0.410 0.440 0.410 0.350 0.0110 0.0174 0.0195 0.0090 0.0098 0.0151 9085832 10769230 6019966 2390000 9.08 12507000 25034000 20216000 368000 416000 264000 1228000 1222000 1495000 5.90 6.34 9.63 45731000 6454000 6253000 4886000 4854000 5.14 6.99 10.04 14.50 19.76 10638000 2464000 1.42 3.48 7.71 9.55 12.23 15.33 13.10 14.78 23.45 12.00 P6Y P6Y4M16D P6Y0M28D P6Y4M16D P5Y3M22D 35093000 P5Y4M24D P7Y1M6D P8Y9M18D 7453000 65018000 58000 50691000 63892000 27378000 0 0 66065000 27378000 0 0 70828000 23878000 0 0 2083333 2083000 1061000 898000 147000 16000 0 2173000 2173000 1263000 1263000 20960000 2000 20958000 1504000 1000 0 0 1503000 0 7555000 2000 7553000 9738000 2000 9736000 282476000 8000 65000 0 -1202000 106708000 51000 176846000 386502000 64000 27000 0 -767000 136501000 0 250677000 472360000 66000 27000 0 -1009000 153987000 0 319289000 585454000 71000 24000 0 -1657000 175242000 0 411774000 2799000 3500000 3978000 3228000 18000 109000 209000 0 0 953000 673000 661000 0 46000 64000 614000 0 138000 202000 747000 1184000 838000 602000 1149000 961000 533000 1581000 327000 1647000 45000 363000 0 693000 0 318000 0 4000 616000 73000 206000 252000 282000 92208000 94192000 95457000 89608000 92647000 94227000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ACCRUED EXPENSES </font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and other employee-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,933</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal and other settlements and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,686</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,765</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued non-income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,720</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,938</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,160</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,994</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accrued expenses</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,499</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,125</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The impact of our unrecognized tax benefits to the effective income tax rate is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Portion of total unrecognized tax benefits that, if recognized, would affect the effective income tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A summary of intangible assets is presented below:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted- <br clear="none"/>Average Amortization <br clear="none"/>Period <br clear="none"/>(in&#160;years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross <br clear="none"/>Carrying <br clear="none"/>Amount &#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization &#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible <br clear="none"/>Assets,&#160;net</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research&#160;&amp; development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplier network</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,712</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships &amp; other intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,525</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,181</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(344</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,076</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,776</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,529</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted- <br clear="none"/>Average Amortization <br clear="none"/>Period <br clear="none"/>(in&#160;years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross <br clear="none"/>Carrying <br clear="none"/>Amount &#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization &#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible <br clear="none"/>Assets,&#160;net</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research&#160;&amp; development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships &amp; other intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,623</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(864</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,420</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(202</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,218</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,603</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,066</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Medical Device Excise Tax</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Effective as of January 1, 2013, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively &#8220;PPACA&#8221;) imposed a medical device excise tax (&#8220;MDET&#8221;) of </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2.3%</font><font style="font-family:inherit;font-size:12pt;"> on any entity that manufactures or imports certain medical devices offered for sale in the United States. We account for the MDET as a component of our cost of goods sold.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Depreciation expense related to property and equipment was as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,869</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,640</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Amortization expense was as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible asset amortization expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">710</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">528</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The following table represents total sales by geographic area, based on the location of the customer: </font></div><div style="line-height:120%;padding-bottom:16px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">427,091</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">396,615</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">355,609</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,280</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,844</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,385</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,371</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434,459</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Compensation expense related to stock options granted to employees and non-employees under the Plans and the intrinsic value of stock options exercised was as follows:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation expense related to stock options</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ccecff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,111</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ccecff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,177</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ccecff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,635</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intrinsic value of stock options exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,216</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,034</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,507</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Advertising Expense</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We expense advertising costs as they are incurred.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The composition of our short-term and long-term marketable securities is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contractual Maturity</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,684</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,066</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,031</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,663</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total short-term marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146,439</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,005</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,617</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,598</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:36px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities of U.S. government-sponsored agencies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,564</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,548</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,422</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(82</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,347</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contractual Maturity</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,344</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,525</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,529</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,083</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,089</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total short-term marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148,950</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148,962</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,304</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,316</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,651</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,652</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,488</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,528</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ACQUISITIONS </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On October 23, 2014, we entered into an equity interest purchase agreement with Transplant Technologies of Texas, Ltd. (&#8220;TTOT&#8221;), an allograft tissue processor located in San Antonio, Texas, pursuant to which we acquired 100% of the equity interests for </font><font style="font-family:inherit;font-size:12pt;">$36.1 million</font><font style="font-family:inherit;font-size:12pt;">. In addition to the initial purchase price, we may be obligated to make milestone payments of up to </font><font style="font-family:inherit;font-size:12pt;">$15.0 million</font><font style="font-family:inherit;font-size:12pt;"> over the next three years based primarily on sales thresholds from the product lines we acquired. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">TTOT was privately held and provides human tissue products including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets and represents a key step in fulfilling our strategy of building a broad business in regenerative biologics. </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">While we currently partner with third party suppliers for our existing allograft products, the acquisition of TTOT will expand our suite of regenerative biologics products. We believe this acquisition will also improve our capabilities for the development of new and innovative human allograft tissue products in the future.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We accounted for the acquisition under the purchase method of accounting, and as a result, recorded goodwill of </font><font style="font-family:inherit;font-size:12pt;">$34.8 million</font><font style="font-family:inherit;font-size:12pt;">. The results of operations of TTOT have been included in our results of operations from the date of acquisition. Prior-period results have not been restated and pro forma supplemental financial information is not provided as the impact of the TTOT acquisition is immaterial to the operating results for the years ended December&#160;31, 2014 and December&#160;31, 2013. Amounts recognized for assets acquired and liabilities assumed are based on preliminary purchase price allocations and on certain management judgments. These preliminary allocations are based on an analysis of the estimated fair values of assets acquired and liabilities assumed, including identifiable tangible and intangible assets, and estimates of the useful lives of tangible and amortizable intangible assets. The final purchase price allocations will be completed after we finalize our third-party appraisal, review all available data, and complete our own internal assessments. We expect to complete our final purchase price allocations by the end of March 2015. Any additional adjustments resulting from finalization of the purchase price allocations for TTOT will affect the amount assigned to goodwill. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As of </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, we recorded the following preliminary purchase price allocation for the identifiable tangible and intangible assets and liabilities of TTOT:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consideration:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid at closing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,128</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,300</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,428</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets acquired and liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,599</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplier network </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,529</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,034</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,824</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total allocated purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,428</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The contingent consideration relates to the achievement of certain sales milestones. As of December 31, 2014, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranges from zero to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> (see </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#8220;Note 5. Fair Value Measurements&#8221;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> below).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On December 23, 2013, we entered into an asset purchase agreement with a small robotics development company, pursuant to which we acquired substantially all of its assets for </font><font style="font-family:inherit;font-size:12pt;">$16.8 million</font><font style="font-family:inherit;font-size:12pt;">. In addition to the initial purchase price, we may be obligated to make a milestone payment and revenue sharing payments based upon a percentage of net sales of certain products based on the intellectual property we acquired in the transaction. The acquired company was privately held and is focused on developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets. The technology is intended to enable surgeons to perform minimally invasive and percutaneous surgical procedures with greater accuracy, safety and reproducibility than is currently available. We accounted for this acquisition under the purchase method of accounting, and as a result, recorded goodwill of </font><font style="font-family:inherit;font-size:12pt;">$3.0 million</font><font style="font-family:inherit;font-size:12pt;">. The table below represents the valuation of the assets acquired and liabilities assumed as part of this 2013 purchase:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research &amp; development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,460</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,704</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,775</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The contingent consideration relates to the achievement of certain regulatory milestones and royalties. As of December 31, 2013, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranged from zero to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">$14.3 million</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> (see </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#8220;Note 5. Fair Value Measurements&#8221;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> below).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On July 18, 2012, we entered into an asset purchase agreement with a global medical device company, pursuant to which we acquired substantially all of its assets for </font><font style="font-family:inherit;font-size:12pt;">$6.0 million</font><font style="font-family:inherit;font-size:12pt;">. In addition to the initial purchase price, we may be obligated to make revenue sharing payments based upon a percentage of net sales of products we acquired from it. We accounted for this acquisition under the purchase method of accounting and as a result, recorded goodwill of </font><font style="font-family:inherit;font-size:12pt;">$5.6 million</font><font style="font-family:inherit;font-size:12pt;">. The table below represents the assets acquired and liabilities assumed as part of this 2012 purchase:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,420</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">467</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,564</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,031</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">These acquisitions, which expand our product pipeline, did not have a material effect on our consolidated net sales or operating income for the years ended </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;">2013</font><font style="font-family:inherit;font-size:12pt;"> or </font><font style="font-family:inherit;font-size:12pt;">2012</font><font style="font-family:inherit;font-size:12pt;">. The assets acquired and liabilities assumed as a result of the acquisitions were included in our consolidated balance sheet as of the acquisition dates. The purchase price for each of the acquisitions was primarily allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates. The fair value assigned to identifiable intangible assets acquired was determined primarily by using the income approach, which discounts expected future cash flows to present value using estimates and assumptions determined by management. Purchased identifiable intangible assets are amortized on a straight-line basis over their respective estimated useful lives. The excess purchase price over the value of the net tangible and identifiable intangible assets was recorded as goodwill. The goodwill from these acquisitions is deductible for tax purposes.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The fair value of the IPR&amp;D was determined using a relief from royalty approach, including a pre-tax royalty rate ranging between </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">4%</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">9%</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and a discount rate ranging between </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">13.5%</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">19%</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">. IPR&amp;D will become an amortizable asset upon completion of the projects, which are currently expected to be completed between </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">2016</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">2020</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">. The estimated costs to complete the IPR&amp;D projects are approximately </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">$14.1 million</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> as of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The following table provides a reconciliation of the beginning and ending balances of contingent payments associated with acquisitions during the years ended </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase price contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in fair value of contingent consideration classified in operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase price contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in fair value of contingent consideration classified in operating expenses </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,131</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,335</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reduction in fair value during 2014 due primarily to reductions to a contingent royalty accrual, offset partially by increases in other royalty and milestone accruals.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(a) The Company </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Globus Medical, Inc. and its subsidiaries is a </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">medical device company focused exclusively on the design, development and commercialization of musculoskeletal implants. We are currently focused on implants that promote healing in patients with spine disorders.</font><font style="font-family:inherit;font-size:12pt;"> </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">We are an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures that assist surgeons in effectively treating their patients, respond to evolving surgeon needs and address new treatment options.</font><font style="font-family:inherit;font-size:12pt;"> Since our inception in 2003, we have launched over </font><font style="font-family:inherit;font-size:12pt;">130</font><font style="font-family:inherit;font-size:12pt;">&#160;products and offer a product portfolio addressing a broad array of spinal pathologies. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">We are headquartered in Audubon, Pennsylvania and market and sell our products through our exclusive sales force in the United States, Europe, India, South Africa, Australia, South America and the Middle East. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The terms the &#8220;Company,&#8221; &#8220;Globus,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Globus Medical, Inc. and, where applicable, our consolidated subsidiaries. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(b) Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for financial statements and with the instructions to Form 10-K and Article 10 of Regulation S-X. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Certain reclassifications have been made to prior period statements to conform to the current period presentation.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(c) Principles of Consolidation </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The accompanying consolidated financial statements include the accounts of Globus and its wholly owned subsidiaries. Our consolidation policy requires the consolidation of entities where a controlling financial interest is held. All intercompany balances and transactions are eliminated in consolidation. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(d) Use of Estimates </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates, in part, on historical experience that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Significant areas that require management&#8217;s estimates include intangible assets, contingent payment liabilities, allowance for doubtful accounts, stock-based compensation, provision for excess and obsolete inventory, useful lives of assets, the outcome of litigation, and income taxes. We are subject to risks and uncertainties due to changes in the healthcare environment, regulatory oversight, competition, and legislation that may cause actual results to differ from estimated results. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(e) Foreign Currency Translation</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The functional currency of our foreign subsidiaries is their local currency. Assets and liabilities of the foreign subsidiaries are translated at the period end currency exchange rate and revenues and expenses are translated at an average currency exchange rate for the period. The resulting foreign currency translation gains and losses are included as a component of accumulated other comprehensive income. Gains and losses arising from intercompany foreign transactions are included in other income/(expense) on the consolidated statement of operations. We recognized foreign exchange transaction losses in other income/(expense) of </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">$0.9 million</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">$0.8 million</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, and </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">$0.2 million</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> for the years ended </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, and </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, respectively.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(f) Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Cash and cash equivalents include cash on hand and all highly liquid investments with a maturity of three months or less when purchased.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(g) Restricted Cash</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">In December 2014, we set aside </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">$23.4 million</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> in cash for the payment of a portion of the Synthes and Bianco litigations. We classified this cash as restricted, as the amount was placed in escrow to be used for payment of the litigation obligations, should we not be successful with our appeals. </font><font style="font-family:inherit;font-size:12pt;">See </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;Note 14. Commitments and Contingencies&#8221;</font><font style="font-family:inherit;font-size:12pt;"> below for more details regarding these litigations.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(h) Accounts Receivable and Allowance for Doubtful Accounts</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The majority of our accounts receivable is composed of amounts due from hospitals. We carry our accounts receivable at cost less an allowance for doubtful accounts. On a regular basis, we evaluate our accounts receivable and estimate an allowance for doubtful accounts, as needed, based on various factors such as our customers&#8217; current credit conditions, length of time past due, and the general economy as a whole. Receivables are written off against the allowance when they are deemed uncollectible.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(i) Concentrations of Credit Risk</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents and accounts receivable. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of entities comprising our customer base. We perform ongoing credit evaluations of our customers and generally do not require collateral.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">There was no customer that accounted for 10% or more of sales for the years ended </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, and </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, respectively.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(j) Marketable Securities</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Our marketable securities include municipal bonds, corporate debt securities, commercial paper, </font><font style="font-family:inherit;font-size:12pt;">securities of U.S. government-sponsored agencies</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and asset-backed securities, and are classified as available-for-sale as of </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">. Available-for-sale securities are recorded at fair value in both short-term and long-term marketable securities on our consolidated balance sheets. The change in fair value for available-for-sale securities is recorded, net of taxes, as a component of accumulated other comprehensive income on our consolidated balance sheets. Premiums and discounts are recognized over the life of the related security as an adjustment to yield using the straight-line method. Realized gains or losses from the sale of our marketable securities are determined on a specific identification basis. Realized gains and losses, along with interest income and the amortization/accretion of premiums/discounts are included as a component of other income, net, on our consolidated statements of income. Interest receivable is recorded as a component of prepaid expenses and other current assets on our consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">We maintain a portfolio of various holdings, types and maturities, though most of the securities in our portfolio could be liquidated at minimal cost at any time. We invest in securities that meet or exceed standards as defined in our investment policy. Our policy also limits the amount of credit exposure to any one issue, issuer or type of security. We review our securities for other-than-temporary impairment at each reporting period. If an unrealized loss for any security is considered to be other-than-temporary, the loss will be recognized in our consolidated statement of income in the period the determination is made. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(k) Inventories</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">I</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">nventories are stated at the lower of cost or market. Cost is determined on a first-in, first-out basis. The majority of our inventories are finished goods as we mainly utilize third-party suppliers to source our products. We periodically evaluate the carrying value of our inventories in relation to our estimated forecast of product demand, which takes into consideration the estimated life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we record a reserve for such excess inventories.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(l) Property and Equipment</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Property and equipment are recorded at cost less accumulated depreciation. Additions or improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation and amortization are provided using the straight-line method over the related useful lives of the assets.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">When assets are sold or otherwise disposed of, the related property, equipment, and accumulated depreciation amounts are relieved from the accounts, and any gain or loss is recorded in the consolidated statements of operations.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(m) Goodwill and Intangible Assets</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Goodwill represents the excess purchase price over the fair values of the identifiable assets acquired less the liabilities assumed. Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by comparing the reporting unit&#8217;s carrying amount, to the fair value of the reporting unit. The fair values are estimated using an income and discounted cash flow approach. For the year ended </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, we performed a qualitative test for impairment as permitted under Financial Accounting Standards Board (&#8220;FASB&#8221;) authoritative guidance. During the years ended </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, we did not record any impairment charges related to goodwill. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Intangible assets consist of purchased in-process research and development (&#8220;IPR&amp;D&#8221;), supplier network, patents, customer relationships and non-compete agreements. Intangible assets with finite useful lives are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">one</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> to </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">seventeen</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> years. Intangible assets are tested for impairment annually or whenever events or circumstances indicate that a carrying amount of an asset (asset group) may not be recoverable. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset. Fair value is generally determined using a discounted future cash flow analysis. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">IPR&amp;D has an indefinite life and is not amortized until completion of the project at which time the IPR&amp;D becomes an amortizable asset. If the related project is not completed in a timely manner, we may have an impairment related to the IPR&amp;D, calculated as the excess of the asset&#8217;s carrying value over its fair value. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">We completed our annual qualitative indefinite lived intangible asset impairment review in the fourth quarter of </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and determined that our intangible assets were not impaired.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(n) Impairment of Long-Lived Assets</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">We periodically evaluate the recoverability of the carrying amount of long-lived assets, which include property and equipment, as well as whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be fully recoverable. An impairment is assessed when the undiscounted future cash flows from the use and eventual disposition of an asset group are less than its carrying value. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset group. Our fair value methodology is based on quoted market prices, if available. If quoted market prices are not available, an estimate of fair value is made based on prices of similar assets or other valuation techniques including present value techniques. We reviewed our long-lived assets over the course of </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and 2013 and recorded an immaterial impairment charge as a component of cost of goods sold during 2013; there was no impairment of our long-lived assets during </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(o) Revenue Recognition</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Revenue is recognized when persuasive evidence of an arrangement exists, product delivery has occurred, pricing is fixed or determinable, and collection is reasonably assured. A significant portion of our revenue is generated from consigned inventory maintained at hospitals or with sales representatives. For these products, revenue is recognized at the time the product is used or implanted. For all other transactions, we recognize revenue when title to the goods and risk of loss transfer to customers, provided there are no remaining performance obligations that will affect the customer&#8217;s final acceptance of the sale. Our policy is to classify shipping and handling costs billed to customers as sales and the related expenses as cost of goods sold.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(p) Research and Development</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Research and development costs are expensed as incurred. Research and development costs include salaries, employee benefits, supplies, consulting services, clinical services and clinical trial costs, and facilities costs. Costs incurred in obtaining technology licenses and patents are charged immediately to research and development expense if the technology licensed has not reached technological feasibility and has no alternative future use.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(q) Stock-Based Compensation</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The cost for employee and non-employee director awards is measured at the grant date based on the fair value of the award. The fair value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service period (generally the vesting period of the equity award). Awards issued to non-employees are recorded at their fair value as determined in accordance with authoritative guidance, and are periodically revalued as the awards vest and are recognized as expense over the requisite service period.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The determination of the fair value of stock options is made utilizing the Black-Scholes option-pricing model which is affected by our stock price and a number of assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends. The expected volatility is based upon the historical volatility of a public company peer group over the most recent period commensurate with the estimated expected term of the stock options. The expected term of the stock options is determined utilizing the simplified method given the limited extent of our historical data. The risk-free interest rate assumption is based on observed interest rates of U.S. Treasury securities appropriate for the expected terms of the stock options. The dividend yield assumption is based on the history and expectation of no dividend payouts.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(r) Income Taxes</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which such items are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established to offset any deferred tax assets if, based upon available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Significant judgment is required in determining income tax provisions and in evaluating tax positions. We will establish additional provisions for income taxes when, despite the belief that tax positions are fully supportable, there remain certain positions that do not meet the minimum probability threshold that a tax position is more likely than not to be sustained upon examination by the taxing authority. In the normal course of business, we and our subsidiaries are examined by various federal, state, and foreign tax authorities. We regularly assess the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the provision for income taxes. We periodically assess the likelihood and amount of potential adjustments and adjust the income tax provision, the current tax liability, and deferred taxes in the period in which the facts that give rise to a revision become known.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(r) Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As of </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued expenses approximate their respective fair values based on their short-term nature. We classify our financial assets and liabilities that are measured at fair value into one of the three categories based upon inputs used to determine fair value. See </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;Note 5. Fair Value Measurements&#8221;</font><font style="font-family:inherit;font-size:12pt;"> below for more details regarding inputs and classifications.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(s) Advertising Expense</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We expense advertising costs as they are incurred. Advertising expense was </font><font style="font-family:inherit;font-size:12pt;">$0.5 million</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;">$0.5 million</font><font style="font-family:inherit;font-size:12pt;"> and </font><font style="font-family:inherit;font-size:12pt;">$0.4 million</font><font style="font-family:inherit;font-size:12pt;">, for the years ended </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;">2013</font><font style="font-family:inherit;font-size:12pt;">, and </font><font style="font-family:inherit;font-size:12pt;">2012</font><font style="font-family:inherit;font-size:12pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(t) Legal Costs</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We expense legal costs related to loss contingencies as incurred.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(u) Medical Device Excise Tax</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Effective as of January 1, 2013, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively &#8220;PPACA&#8221;) imposed a medical device excise tax (&#8220;MDET&#8221;) of </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2.3%</font><font style="font-family:inherit;font-size:12pt;"> on any entity that manufactures or imports certain medical devices offered for sale in the United States. We account for the MDET as a component of our cost of goods sold. For the years ended </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;"> and </font><font style="font-family:inherit;font-size:12pt;">2013</font><font style="font-family:inherit;font-size:12pt;">, we recognized expenses of </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$7.1 million</font><font style="font-family:inherit;font-size:12pt;"> and </font><font style="font-family:inherit;font-size:12pt;">$7.2 million</font><font style="font-family:inherit;font-size:12pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(v) Recently Issued Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In May 2014, the FASB and the International Accounting Standards Board released a standard on the recognition of revenue from contracts with customers that is designed to create greater comparability for financial statement users across industries and jurisdictions. Under the new standard, an entity will recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the payment to which the entity expects to be entitled in exchange for those goods or services. The standard also will require enhanced disclosures and provide more comprehensive guidance for transactions such as service revenue and contract modifications. The standard will take effect for public companies for annual reporting periods beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. We are currently evaluating the impact of the new standard on our financial position, results of operations and disclosures.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Cash and cash equivalents include cash on hand and all highly liquid investments with a maturity of three months or less when purchased.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We are involved in a number of proceedings, legal actions, and claims. Such matters are subject to many uncertainties, and the outcomes of these matters are not within our control and may not be known for prolonged periods of time. In some actions, the claimants seek damages, as well as other relief, including injunctions prohibiting us from engaging in certain activities, which, if granted, could require significant expenditures and/or result in lost revenues. We record a liability in the consolidated financial statements for these actions when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded. While it is not possible to predict the outcome for most of the matters discussed, we believe it is possible that costs associated with them could have a material adverse impact on our consolidated earnings, financial position or cash flows.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">N-Spine, Synthes and Depuy Synthes Litigation </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In April 2010, N-Spine, Inc. and Synthes USA Sales, LLC filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. N-Spine, the patent owner, and Synthes USA, a licensee of the subject patent, allege that we infringe </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:12pt;"> or more claims of the patent by making, using, offering for sale or selling our TRANSITION</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> stabilization system product. N-Spine and Synthes USA seek injunctive relief and an unspecified amount in damages. We intend to defend our rights vigorously. This matter was stayed on July 14, 2011 pending the resolution of an </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">inter partes</font><font style="font-family:inherit;font-size:12pt;"> reexamination on the asserted patent granted by the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) in February 2011. In December 2011, the examiner withdrew the original grounds of rejection of the asserted patent and we appealed the examiner&#8217;s decision. In January 2014, the USPTO ruled on the appeal, rejecting certain claims in view of the prior art and affirming certain other claims. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In a related matter, on January 8, 2014, Depuy Synthes Products, LLC (&#8220;Depuy Synthes&#8221;) filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. Depuy Synthes alleges that we infringe one or more claims of the asserted patent by making, using, offering for sale or selling our TRANSITION</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> stabilization system product. Depuy Synthes seeks injunctive relief and an unspecified amount in damages. We intend to defend our rights vigorously. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Synthes USA, LLC, Synthes USA Products, LLC and Synthes USA Sales, LLC Litigation </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In July 2011, Synthes USA, LLC, Synthes USA Products, LLC and Synthes USA Sales, LLC filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. Synthes USA LLC, the patent owner, Synthes USA Products, LLC, a licensee to manufacture products of the subject patents, and Synthes USA Sales LLC, a licensee to sell products of the subject patents, allege that we infringe one or more claims of </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:12pt;"> patents by making, using, offering for sale or selling our COALITION</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, INDEPENDENCE</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> and INTERCONTINENTAL</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> products. As a result of the acquisition of Synthes, Inc. by Johnson &amp; Johnson, a motion was filed to change the plaintiff in this matter to DePuy Synthes in February 2013. On June 14, 2013, the jury in this case returned a verdict, finding that prior versions of the three products we previously sold did infringe on DePuy Synthes&#8217; patents and awarding monetary damages in the amount of </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">$16.0 million</font><font style="font-family:inherit;font-size:12pt;">. The jury also upheld the validity of DePuy Synthes&#8217; patents. There was no finding of willful infringement by Globus.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We do not expect the verdict to impact our ability to conduct our business or to have any material impact on our future revenues. As this lawsuit involved only three products that are no longer part of our product portfolio, this verdict is not expected to impair our ability to sell any of our future products.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We believe the facts and the law do not support the jury&#8217;s findings of infringement and patent validity and are seeking to overturn the verdict through the appeals process.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For the year ended December&#160;31, 2013, we accrued </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$19.5 million</font><font style="font-family:inherit;font-size:12pt;"> in damages and other litigation-related costs related to this case, of which </font><font style="font-family:inherit;font-size:12pt;">$1.3 million</font><font style="font-family:inherit;font-size:12pt;"> was included in provision for litigation loss (cost of goods sold, due to a write off of certain inventory which will not be sold due to the verdict) and </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$18.2 million</font><font style="font-family:inherit;font-size:12pt;"> was included in provision for litigation loss (operating expense). During the year ended </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, we accrued an additional </font><font style="font-family:inherit;font-size:12pt;">$0.6 million</font><font style="font-family:inherit;font-size:12pt;"> in interest included in provision for litigation related to this litigation.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">L5 Litigation </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In December 2009, we filed suit in the Court of Common Pleas of Montgomery County, Pennsylvania against our former exclusive independent distributor L5 Surgical, LLC and its principals, seeking an injunction and declaratory judgment concerning certain restrictive covenants made to L5 by its sales representatives. L5 brought counterclaims against us alleging tortious interference, unfair competition and conspiracy. The injunction phase was resolved in September 2010, and this matter is now in the discovery phase of litigation on the underlying damages claims. We intend to defend our rights vigorously. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">NuVasive Litigation </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In October 2010, NuVasive, Inc. filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. NuVasive, the patent owner, alleges that we infringe </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:12pt;"> or more claims of </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:12pt;"> patents by making, using, offering for sale or selling our MARS</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#8482;</sup></font><font style="font-family:inherit;font-size:12pt;"> 3V retractor for use in certain lateral fusion procedures. NuVasive sought injunctive relief and an unspecified amount in damages. This matter was settled on Feburary 12, 2015 for an undisclosed amount.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">NuVasive Employee Litigation </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We have hired several employees who were formerly employed by NuVasive, Inc. In July 2011, NuVasive filed suit against us in the District Court of Travis County, Texas alleging that our hiring of one named former employee and other unnamed former employees constitutes tortious interference with its contracts with those employees, and with prospective business relationships, as well as aiding and abetting the breach of fiduciary duty. NuVasive sought compensatory damages, permanent injunction, punitive damages and attorneys&#8217; fees. This matter was settled on Feburary 12, 2015 for an undisclosed amount.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Bianco Litigation </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On March 21, 2012, Sabatino Bianco filed suit against us in the Federal District Court for the Eastern District of Texas claiming that we misappropriated his trade secret and confidential information and improperly utilized it in developing our CALIBER</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> product. Bianco alleges that we engaged in misappropriation of trade secrets, breach of contract, unfair competition, fraud and theft and seeks correction of inventorship, injunctive relief and exemplary damages. On April 20, 2012, Bianco filed a motion for a preliminary injunction, seeking to enjoin us from making, using, selling, importing or offering for sale our CALIBER</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> product. On November 15, 2012, the court denied Bianco&#8217;s motion for preliminary injunction. On October 1, 2013, Bianco amended his complaint to include that his trade secrets and confidential information were also used improperly in developing our RISE</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> and CALIBER</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">-L products. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On January 17, 2014, the jury in this case returned a verdict in favor of Bianco on a claim of misappropriation of trade secret. We have accrued the verdict amount of </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;">$4.3 million</font><font style="font-family:inherit;font-size:12pt;"> as of December&#160;31, 2013. The jury found against Bianco on the claims of breach of contract and disgorgement of profits. The court granted our motion for judgment as a matter of law and dismissed Bianco&#8217;s claims for unfair competition, fraud, and exemplary damages, and Bianco abandoned the claim of misappropriation of confidential information. Bianco&#8217;s claims of correction of inventorship, unjust enrichment, and permanent injunctive relief were not submitted to the jury. On March 7, 2014, the court denied Bianco&#8217;s claim for correction of inventorship and ruled he is not entitled to be named as a co-inventor on any of the patents at issue, and also denied his claim for unjust enrichment. On March 17, 2014, the court denied Bianco&#8217;s claim for permanent injunctive relief. On July 2, 2014, the court awarded Bianco an ongoing royalty of </font><font style="font-family:inherit;font-size:12pt;">5%</font><font style="font-family:inherit;font-size:12pt;"> of the net sales of the CALIBER</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, CALIBER</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">-L, and RISE</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> products, or products that are not colorably different from those products, for a fifteen year period on sales starting on January 18, 2014. The court entered final judgment on the jury verdict on July 17, 2014. Post-trial motions were denied on October 27, 2014 and the matter is currently on appeal.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We do not expect the verdict to impact our ability to conduct our business or to have any material impact on our future revenues. We believe the facts and the law do not support the jury&#8217;s findings of misappropriation of trade secret and are seeking to overturn the verdict through the appeals process.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Altus Partners, LLC Litigation</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On February 20, 2013, Altus Partners, LLC filed suit against us in the U.S. District Court for the Eastern District of Pennsylvania for patent infringement.&#160; On April 7, 2014, we settled the litigation with Altus Partners and recognized a provision for litigation of </font><font style="font-family:inherit;font-size:12pt;">$2.0 million</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Bonutti Skeletal Innovations, LLC Litigation</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On November 19, 2014, Bonutti Skeletal Innovations, LLC filed suit against us in the U.S. District Court for the Eastern District of Pennsylvania for patent infringement. Bonutti Skeletal, a non-practicing entity, alleges that Globus willfully infringes one or more claims of six patents by making, using, offering for sale or selling the CALIBER</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, CALIBER</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">-L, COALITION</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, CONTINENTAL</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, FORGE</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, FORTIFY</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, INDEPENDENCE</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, INTERCONTINENTAL</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, MONUMENT</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, NIKO</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, RISE</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, SIGNATURE</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, SUSTAIN</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">, and TRANSCONTINENTAL</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;"> products. Bonutti Skeletal seeks an unspecified amount in damages and injunctive relief. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In addition, we are subject to legal proceedings arising in the ordinary course of business.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Concentrations of Credit Risk</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents and accounts receivable. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of entities comprising our customer base. We perform ongoing credit evaluations of our customers and generally do not require collateral.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">There was no customer that accounted for 10% or more of sales for the years ended </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, and </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Principles of Consolidation </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The accompanying consolidated financial statements include the accounts of Globus and its wholly owned subsidiaries. Our consolidation policy requires the consolidation of entities where a controlling financial interest is held. All intercompany balances and transactions are eliminated in consolidation. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DEBT </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Line of Credit </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">May 2011</font><font style="font-family:inherit;font-size:12pt;">, we entered into a credit agreement with Wells Fargo Bank related to a revolving credit facility that provides for borrowings up to </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">$50.0 million</font><font style="font-family:inherit;font-size:12pt;">. At our request, and with the approval of the bank, the amount of borrowings available under the revolving credit facility can be increased to </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">$75.0 million</font><font style="font-family:inherit;font-size:12pt;">. The revolving credit facility includes up to a </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">$25.0 million</font><font style="font-family:inherit;font-size:12pt;"> sub-limit for letters of credit. As amended to date, the revolving credit facility extends to </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">May 2015</font><font style="font-family:inherit;font-size:12pt;">. Cash advances bear interest at our option either at a fluctuating rate per annum equal to the daily </font><font style="font-family:inherit;font-size:12pt;">LIBOR</font><font style="font-family:inherit;font-size:12pt;"> in effect for a </font><font style="font-family:inherit;font-size:12pt;">one</font><font style="font-family:inherit;font-size:12pt;">-month period plus </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">0.75%</font><font style="font-family:inherit;font-size:12pt;">, or a fixed rate for a </font><font style="font-family:inherit;font-size:12pt;">one</font><font style="font-family:inherit;font-size:12pt;">- or </font><font style="font-family:inherit;font-size:12pt;">three</font><font style="font-family:inherit;font-size:12pt;">-month period equal to </font><font style="font-family:inherit;font-size:12pt;">LIBOR</font><font style="font-family:inherit;font-size:12pt;"> plus </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">0.75%</font><font style="font-family:inherit;font-size:12pt;">. The credit agreement governing the revolving credit facility also subjects us to various restrictive covenants, including the requirement to maintain maximum consolidated leverage. The covenants also include limitations on our ability to repurchase shares, to pay cash dividends or to enter into a sale transaction. As of </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, we were in compliance with all covenants under the credit agreement, there were no outstanding borrowings under the revolving credit facility and available borrowings were </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">$50.0 million</font><font style="font-family:inherit;font-size:12pt;">. We may terminate the credit agreement at any time on </font><font style="font-family:inherit;font-size:12pt;">ten</font><font style="font-family:inherit;font-size:12pt;"> days&#8217; notice without premium or penalty.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;"></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">STOCK-BASED COMPENSATION </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We have </font><font style="font-family:inherit;font-size:12pt;">three</font><font style="font-family:inherit;font-size:12pt;"> stock plans: our Amended and Restated 2003 Stock Plan, our 2008 Stock Plan, and our 2012 Equity Incentive Plan (the "2012 Plan"). The 2012 Plan is the only remaining active stock plan.&#160; The purpose of these stock plans was, and the 2012 Plan is, to provide incentive to employees, directors, and consultants of Globus.&#160; The Plans are administered by the Board or its delegates. The number, type of option, exercise price, and vesting terms are determined by the Board or its delegates in accordance with the terms of the Plans. The options granted expire on a date specified by the Board, but generally not more than </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">ten</font><font style="font-family:inherit;font-size:12pt;">&#160;years from the grant date. Option grants to employees generally vest monthly over a </font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">four</font><font style="font-family:inherit;font-size:12pt;">-year period. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The 2012 Plan was approved by our Board in March 2012, and by our stockholders in June 2012. Under the 2012 Plan, the aggregate number of shares of Class A Common that may be issued subject to options and other awards is equal to the sum of (i)&#160;</font><font style="font-family:Times New Roman;font-size:12pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">3,076,923</font><font style="font-family:inherit;font-size:12pt;"> shares, (ii)&#160;any shares available for issuance under the 2008 Plan as of March 13, 2012, (iii) any shares underlying awards outstanding under the 2008 Plan as of March&#160;13, 2012 that, on or after that date, are forfeited, terminated, expired or lapse for any reason, or are settled for cash without delivery of shares and (iv)&#160;starting January&#160;1, 2013, an annual increase in the number of shares available under the 2012 Plan equal to up to </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">3%</font><font style="font-family:inherit;font-size:12pt;"> of the number of shares of our common and preferred stock outstanding at the end of the previous year, as determined by our Board. The number of shares that may be issued or transferred pursuant to incentive stock options under the 2012 Plan is limited to </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">10,769,230</font><font style="font-family:inherit;font-size:12pt;"> shares. The shares of Class A Common covered by the 2012 Plan are authorized but unissued shares, treasury shares or shares of common stock purchased on the open market.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As of </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, pursuant to the 2012 Plan, there were </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">9,085,832</font><font style="font-family:inherit;font-size:12pt;"> shares of Class A Common stock reserved and </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">6,019,966</font><font style="font-family:inherit;font-size:12pt;"> shares of Class A Common stock available for future grants. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The weighted average grant date per share fair values of the options awarded to employees were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average grant date per share fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The fair value of the options was estimated on the date of the grant using a Black-Scholes option pricing model with the following assumptions:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term (years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Stock option activity during the years ended </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;">2013</font><font style="font-family:inherit;font-size:12pt;"> and </font><font style="font-family:inherit;font-size:12pt;">2012</font><font style="font-family:inherit;font-size:12pt;"> is summarized as follows: &#160;</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Shares (thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate intrinsic value (thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,061</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(368</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.55</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,253</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,222</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(416</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,886</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,495</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.45</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,263</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,854</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,731</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at December 31, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,390</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.08</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,093</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected to vest at December 31, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,464</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.76</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We use the Black Scholes pricing model to determine the fair value of our stock options (see </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;Note 1. Background and Summary of Significant Accounting Policies, (q) Stock-Based Compensation&#8221;</font><font style="font-family:inherit;font-size:12pt;"> above). Subsequent to the February 2012 and March 2012 stock option grants, we reassessed the fair value of our stock options on those dates of grant by updating the assumptions and facts considered in an October 2011 valuation report upon which we relied to take into account our actual results, market conditions, comparable company results, and the timing of our IPO. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Compensation expense related to stock options granted to employees and non-employees under the Plans and the intrinsic value of stock options exercised was as follows:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation expense related to stock options</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ccecff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,111</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ccecff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,177</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ccecff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,635</font></div></td><td style="vertical-align:bottom;background-color:#ccecff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intrinsic value of stock options exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,216</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,034</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,507</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As of </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, there was </font><font style="font-family:inherit;font-size:12pt;">$16.1 million</font><font style="font-family:inherit;font-size:12pt;"> of unrecognized compensation expense related to unvested employee stock options that vest over a weighted average period of </font><font style="font-family:inherit;font-size:12pt;">three</font><font style="font-family:inherit;font-size:12pt;">&#160;years.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FAIR VALUE MEASUREMENTS </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Under the accounting for fair value measurements and disclosures, fair value is defined as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or the liability in an orderly transaction between market participants on the measurement date. Additionally, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable inputs. The level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Our assets and liabilities measured at fair value on a recurring basis are classified and disclosed in one of the following three categories: </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Level&#160;1&#8212;quoted prices (unadjusted) in active markets for identical assets and liabilities; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Level&#160;2&#8212;observable inputs other than quoted prices in active markets for identical assets and liabilities; and </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Level&#160;3&#8212;unobservable inputs in which there is little or no market data available, which require the reporting entity to use significant unobservable inputs or valuation techniques. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The fair value of our assets and liabilities measured at fair value on a recurring basis was as follows: </font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,655</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,655</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities of U.S. government-sponsored agencies</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,660</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,660</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,089</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,089</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,089</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,089</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Contingent consideration represents our contingent milestone, performance and revenue-sharing payment obligations related to our acquisitions and is measured at fair value and is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The valuation of contingent consideration uses assumptions we believe would be made by a market participant, such as the probabilities associated with successfully completing clinical trials and obtaining regulatory approval, of achieving sales milestones and the period in which these milestones are expected to be achieved, as well as discount rates, which range from </font><font style="font-family:inherit;font-size:12pt;">3.1%</font><font style="font-family:inherit;font-size:12pt;"> to </font><font style="font-family:inherit;font-size:12pt;">13.5%</font><font style="font-family:inherit;font-size:12pt;">. We assess these estimates on an ongoing basis as additional data impacting the assumptions is obtained. Changes in the fair value of contingent consideration related to updated assumptions and estimates are recognized within research and development and selling, general and administrative expenses in the consolidated statements of income. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;font-style:italic;font-weight:bold;">Assets and Liabilities That Are Measured at Fair Value on a Nonrecurring Basis</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The purchase price of business acquisitions is primarily allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the excess recorded as goodwill. We utilize Level 3 inputs in the determination of the initial fair value. Non-financial assets such as goodwill, intangible assets, and property, plant, and equipment are subsequently measured at fair value when there is an indicator of impairment and recorded at fair value only when an impairment is recognized. We assess the impairment of intangible assets annually or whenever events or changes in circumstances indicate that the carrying amount of an intangible asset may not be recoverable. The fair value of our goodwill and intangible assets is not estimated if there is no change in events or circumstances that indicate the carrying amount of an intangible asset may not be recoverable. We have not recorded impairment charges related to our business acquisitions.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As of </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued expenses approximate their respective fair values based on their short-term nature. We classify our financial assets and liabilities that are measured at fair value into one of the three categories based upon inputs used to determine fair value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Foreign Currency Translation</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The functional currency of our foreign subsidiaries is their local currency. Assets and liabilities of the foreign subsidiaries are translated at the period end currency exchange rate and revenues and expenses are translated at an average currency exchange rate for the period. The resulting foreign currency translation gains and losses are included as a component of accumulated other comprehensive income. Gains and losses arising from intercompany foreign transactions are included in other income/(expense) on the consolidated statement of operations. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Goodwill and Intangible Assets</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Goodwill represents the excess purchase price over the fair values of the identifiable assets acquired less the liabilities assumed. Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by comparing the reporting unit&#8217;s carrying amount, to the fair value of the reporting unit. The fair values are estimated using an income and discounted cash flow approach. For the year ended </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, we performed a qualitative test for impairment as permitted under Financial Accounting Standards Board (&#8220;FASB&#8221;) authoritative guidance. During the years ended </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, we did not record any impairment charges related to goodwill. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Intangible assets consist of purchased in-process research and development (&#8220;IPR&amp;D&#8221;), supplier network, patents, customer relationships and non-compete agreements. Intangible assets with finite useful lives are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">one</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> to </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">seventeen</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> years. Intangible assets are tested for impairment annually or whenever events or circumstances indicate that a carrying amount of an asset (asset group) may not be recoverable. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset. Fair value is generally determined using a discounted future cash flow analysis. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">IPR&amp;D has an indefinite life and is not amortized until completion of the project at which time the IPR&amp;D becomes an amortizable asset. If the related project is not completed in a timely manner, we may have an impairment related to the IPR&amp;D, calculated as the excess of the asset&#8217;s carrying value over its fair value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">We periodically evaluate the recoverability of the carrying amount of long-lived assets, which include property and equipment, as well as whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be fully recoverable. An impairment is assessed when the undiscounted future cash flows from the use and eventual disposition of an asset group are less than its carrying value. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset group. Our fair value methodology is based on quoted market prices, if available. If quoted market prices are not available, an estimate of fair value is made based on prices of similar assets or other valuation techniques including present value techniques. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The components of income before income taxes are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137,643</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,424</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">999</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">577</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">477</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,642</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102,001</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114,653</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The components of the provision/(benefit) for income taxes are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,561</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,741</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,097</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,118</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,419</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">519</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">912</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,177</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,771</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,102</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,630</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,088</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,510</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(357</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(84</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,157</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,389</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,822</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">A reconciliation of the statutory U.S. federal tax rate to our effective rate is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statutory U.S. federal tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income taxes, net of federal benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic production activities deduction</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax credits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Deferred income taxes reflect the tax effects of temporary differences between the basis of assets and liabilities recognized for financial reporting purposes and tax purposes. Significant components of our deferred income taxes are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory reserve</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,808</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,635</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accruals, reserves, and other currently not deductible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,043</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,133</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign net operating loss carryforwards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">724</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,817</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,644</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(327</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,772</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,865</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,643</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,229</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,988</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,264</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,329</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that we will realize the benefits of these deductible differences at </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced. Of the amounts presented above</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">$0.4 million</font><font style="font-family:inherit;font-size:12pt;"> </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">of long-term deferred tax assets is included as a component of other assets on our consolidated balance sheet as of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;"> and </font><font style="font-family:inherit;font-size:12pt;">2013</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits at the beginning of the year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,799</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions related to current year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">661</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">673</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions related to prior year tax positions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">614</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reductions related to prior year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(209</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(109</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lapse of statute of limitations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(953</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits at the end of the year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,228</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,978</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The impact of our unrecognized tax benefits to the effective income tax rate is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Portion of total unrecognized tax benefits that, if recognized, would affect the effective income tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Interest and penalties are recorded in the statement of operations as provision for income taxes. The total interest and penalties recorded in the statement of operations was nominal for the years ended </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">2013</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">2012</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">. Our uncertain tax benefits could increase in the next twelve months as we continue our current transfer pricing policies and deduct additional tax credits. We are unable to estimate a range of reasonably possible changes in our uncertain tax benefits in the next twelve months. In 2014, we settled the IRS audits of 2011 and 2012 tax years, resulting in no adjustments. The tax years that remained subject to examination by a major tax jurisdiction as of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> were 2009 and beyond for Switzerland; 2010 and beyond for India, Belgium, Germany, and Poland; 2011 and beyond for Denmark, Sweden and Australia; 2012 and beyond for South Africa and Israel; 2013 and beyond for the United States, the United Kingdom, Netherlands, and France.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">On December 19, 2014, the Tax Increase Prevention Act of 2014 (the &#8220;TIPA&#8221;) was signed into law. One of the provisions of the TIPA was the reinstatement of the research and experimentation tax credit from January 1, 2014 through December 31, 2014. As of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> a benefit was recognized for this tax credit and is included in the 2014 tax provision.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">On January 2, 2013, the American Taxpayer Relief Act of 2012 (the &#8220;ATRA&#8221;) was signed into law. One of the provisions of the ATRA was a reinstatement and extension of the research and experimentation tax credit from January 1, 2012 through December 31, 2013. However, as of December 31, 2012 no benefit could be recognized for this tax credit due to the passage of the ATRA in 2013. A</font><font style="font-family:inherit;font-size:12pt;">s the passage of the ATRA occurred in 2013, the entire reinstated credit for the year ended December 31, 2012 of</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">$0.9 million</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> </font><font style="font-family:inherit;font-size:12pt;">was recognized in 2013 in accordance with accounting guidance.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;"> Income Taxes</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which such items are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established to offset any deferred tax assets if, based upon available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Significant judgment is required in determining income tax provisions and in evaluating tax positions. We will establish additional provisions for income taxes when, despite the belief that tax positions are fully supportable, there remain certain positions that do not meet the minimum probability threshold that a tax position is more likely than not to be sustained upon examination by the taxing authority. In the normal course of business, we and our subsidiaries are examined by various federal, state, and foreign tax authorities. We regularly assess the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the provision for income taxes. We periodically assess the likelihood and amount of potential adjustments and adjust the income tax provision, the current tax liability, and deferred taxes in the period in which the facts that give rise to a revision become known.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">INTANGIBLE ASSETS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A summary of intangible assets is presented below:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted- <br clear="none"/>Average Amortization <br clear="none"/>Period <br clear="none"/>(in&#160;years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross <br clear="none"/>Carrying <br clear="none"/>Amount &#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization &#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible <br clear="none"/>Assets,&#160;net</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research&#160;&amp; development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplier network</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,712</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships &amp; other intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,525</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,181</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(344</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,076</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,776</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,529</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted- <br clear="none"/>Average Amortization <br clear="none"/>Period <br clear="none"/>(in&#160;years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross <br clear="none"/>Carrying <br clear="none"/>Amount &#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization &#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible <br clear="none"/>Assets,&#160;net</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research&#160;&amp; development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships &amp; other intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,623</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(864</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,420</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(202</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,218</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,603</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,066</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Amortization expense was as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible asset amortization expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">710</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">528</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Expected future intangible asset amortization as of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Annual Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ending December 31:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,541</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,423</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,752</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,969</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;font-weight:bold;">INVENTORIES</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;color:#231f20;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,490</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,820</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,608</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,945</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Inventories</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">I</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">nventories are stated at the lower of cost or market. Cost is determined on a first-in, first-out basis. The majority of our inventories are finished goods as we mainly utilize third-party suppliers to source our products. We periodically evaluate the carrying value of our inventories in relation to our estimated forecast of product demand, which takes into consideration the estimated life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we record a reserve for such excess inventories.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">MARKETABLE SECURITIES</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The composition of our short-term and long-term marketable securities is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contractual Maturity</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,684</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,066</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,031</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,663</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total short-term marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146,439</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,005</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,617</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,598</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:36px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities of U.S. government-sponsored agencies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,564</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,548</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,422</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(82</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,347</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contractual Maturity</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,344</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,525</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,529</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,083</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,089</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total short-term marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148,950</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148,962</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,304</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,316</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,651</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,652</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,488</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,528</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Legal Costs</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We expense legal costs related to loss contingencies as incurred.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Marketable Securities</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Our marketable securities include municipal bonds, corporate debt securities, commercial paper, </font><font style="font-family:inherit;font-size:12pt;">securities of U.S. government-sponsored agencies</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and asset-backed securities, and are classified as available-for-sale as of </font><font style="font-family:Times New Roman;font-size:12pt;color:#231f20;font-style:normal;font-weight:normal;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">. Available-for-sale securities are recorded at fair value in both short-term and long-term marketable securities on our consolidated balance sheets. The change in fair value for available-for-sale securities is recorded, net of taxes, as a component of accumulated other comprehensive income on our consolidated balance sheets. Premiums and discounts are recognized over the life of the related security as an adjustment to yield using the straight-line method. Realized gains or losses from the sale of our marketable securities are determined on a specific identification basis. Realized gains and losses, along with interest income and the amortization/accretion of premiums/discounts are included as a component of other income, net, on our consolidated statements of income. Interest receivable is recorded as a component of prepaid expenses and other current assets on our consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">We maintain a portfolio of various holdings, types and maturities, though most of the securities in our portfolio could be liquidated at minimal cost at any time. We invest in securities that meet or exceed standards as defined in our investment policy. Our policy also limits the amount of credit exposure to any one issue, issuer or type of security. We review our securities for other-than-temporary impairment at each reporting period. If an unrealized loss for any security is considered to be other-than-temporary, the loss will be recognized in our consolidated statement of income in the period the determination is made. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Recently Issued Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In May 2014, the FASB and the International Accounting Standards Board released a standard on the recognition of revenue from contracts with customers that is designed to create greater comparability for financial statement users across industries and jurisdictions. Under the new standard, an entity will recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the payment to which the entity expects to be entitled in exchange for those goods or services. The standard also will require enhanced disclosures and provide more comprehensive guidance for transactions such as service revenue and contract modifications. The standard will take effect for public companies for annual reporting periods beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. We are currently evaluating the impact of the new standard on our financial position, results of operations and disclosures.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;font-weight:bold;"> LEASES</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The Company leases certain equipment and office facilities under operating leases. As of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, minimum future rental payments under operating leases for each of the next five years are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ending December 31:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,630</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Rent expense related to all operating leases recognized as a component of selling, general and administrative expenses was as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rent expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">676</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;font-weight:bold;">RETIREMENT BENEFIT PLANS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">We sponsor a 401(k) Plan covering all eligible U.S. employees. Under the 401(k) Plan, we make nondiscretionary matching contributions at the rate of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">100%</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> of employee&#8217;s contributions up to a maximum annual contribution of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">$6,000</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> per eligible employee, limited to </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">3%</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> of the employee&#8217;s compensation for the period. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Additionally, we contribute to various foreign retirement benefit plans required by local law or coordinated with government sponsored plans which cover many of our international employees. </font><font style="font-family:inherit;font-size:12pt;">The benefits offered under these plans are reflective of local customs and practices in the countries concerned. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Company contributions to these retirement plans were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401(k) and other retirement plan contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;font-weight:bold;">PROPERTY AND EQUIPMENT </font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings and improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,369</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,541</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5-7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,864</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,867</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Modules and cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,155</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,325</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,970</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188,019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164,060</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(118,544</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(99,910</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,475</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64,150</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Instruments are hand-held devices used by surgeons to install implants during surgery. Modules and cases are used to store and transport the instruments and implants.</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Depreciation expense related to property and equipment was as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,869</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,640</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Property and Equipment</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Property and equipment are recorded at cost less accumulated depreciation. Additions or improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation and amortization are provided using the straight-line method over the related useful lives of the assets.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">When assets are sold or otherwise disposed of, the related property, equipment, and accumulated depreciation amounts are relieved from the accounts, and any gain or loss is recorded in the consolidated statements of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings and improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,369</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,541</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5-7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,864</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,867</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Modules and cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,155</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,325</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,970</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188,019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164,060</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(118,544</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(99,910</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,475</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64,150</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">QUARTERLY FINANCIAL DATA (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="47%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands, except per share amounts)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113,573</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117,787</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,801</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,898</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,061</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.29</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share - diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="47%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands, except per share amounts)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,187</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,245</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,248</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,872</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,471</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,891</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,426</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,985</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share - diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RELATED-PARTY TRANSACTIONS </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We have contracted with a third-party manufacturer in which certain of our senior management and significant stockholders have or had ownership interests and leadership positions. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We have purchased the following amounts of products and services from the supplier:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases from related-party supplier</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,948</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,039</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As of </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;"> and </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:12pt;">, we had </font><font style="font-family:inherit;font-size:12pt;">$5.4 million</font><font style="font-family:inherit;font-size:12pt;"> and </font><font style="font-family:inherit;font-size:12pt;">$2.7 million</font><font style="font-family:inherit;font-size:12pt;"> of accounts payable due to the supplier.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Research and development costs are expensed as incurred. Research and development costs include salaries, employee benefits, supplies, consulting services, clinical services and clinical trial costs, and facilities costs. Costs incurred in obtaining technology licenses and patents are charged immediately to research and development expense if the technology licensed has not reached technological feasibility and has no alternative future use.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Revenue is recognized when persuasive evidence of an arrangement exists, product delivery has occurred, pricing is fixed or determinable, and collection is reasonably assured. A significant portion of our revenue is generated from consigned inventory maintained at hospitals or with sales representatives. For these products, revenue is recognized at the time the product is used or implanted. For all other transactions, we recognize revenue when title to the goods and risk of loss transfer to customers, provided there are no remaining performance obligations that will affect the customer&#8217;s final acceptance of the sale. Our policy is to classify shipping and handling costs billed to customers as sales and the related expenses as cost of goods sold.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and other employee-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,933</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal and other settlements and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,686</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,765</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued non-income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,720</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,938</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,160</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,994</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:20px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accrued expenses</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,499</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,125</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The following table provides a reconciliation of the beginning and ending balances of contingent payments associated with acquisitions during the years ended </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> and </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase price contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in fair value of contingent consideration classified in operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase price contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in fair value of contingent consideration classified in operating expenses </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,131</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,335</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reduction in fair value during 2014 due primarily to reductions to a contingent royalty accrual, offset partially by increases in other royalty and milestone accruals.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The components of the provision/(benefit) for income taxes are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,561</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,741</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,097</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,118</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,419</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">519</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">912</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,177</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,771</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,102</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,630</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,088</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,510</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(357</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(84</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,157</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,389</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,822</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Company contributions to these retirement plans were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401(k) and other retirement plan contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Significant components of our deferred income taxes are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory reserve</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,808</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,635</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accruals, reserves, and other currently not deductible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,043</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,133</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign net operating loss carryforwards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">724</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,817</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,644</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(327</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,772</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,865</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,643</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,229</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,988</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,264</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,329</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">A reconciliation of the statutory U.S. federal tax rate to our effective rate is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statutory U.S. federal tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income taxes, net of federal benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic production activities deduction</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax credits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The following table represents total sales by product category: </font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Innovative Fusion</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270,852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">254,033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238,723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disruptive Technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203,519</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,426</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,271</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,371</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434,459</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The fair value of our assets and liabilities measured at fair value on a recurring basis was as follows: </font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,655</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,655</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities of U.S. government-sponsored agencies</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,660</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,660</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,089</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,089</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,089</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,089</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">As of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;">, minimum future rental payments under operating leases for each of the next five years are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ending December 31:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,630</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The components of income before income taxes are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137,643</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,424</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">999</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">577</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">477</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,642</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102,001</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114,653</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;color:#231f20;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,490</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,820</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,608</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,945</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="47%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands, except per share amounts)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113,573</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117,787</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,801</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,898</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,061</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.29</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share - diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="47%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands, except per share amounts)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,187</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,245</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,248</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,872</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,471</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,891</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,426</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,985</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share - diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As of </font><font style="font-family:inherit;font-size:12pt;color:#000000;text-decoration:none;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, we recorded the following preliminary purchase price allocation for the identifiable tangible and intangible assets and liabilities of TTOT:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consideration:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid at closing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,128</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,300</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,428</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets acquired and liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,599</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplier network </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,529</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,034</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,824</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total allocated purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,428</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The contingent consideration relates to the achievement of certain sales milestones. As of December 31, 2014, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranges from zero to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> (see </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#8220;Note 5. Fair Value Measurements&#8221;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> below).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On December 23, 2013, we entered into an asset purchase agreement with a small robotics development company, pursuant to which we acquired substantially all of its assets for </font><font style="font-family:inherit;font-size:12pt;">$16.8 million</font><font style="font-family:inherit;font-size:12pt;">. In addition to the initial purchase price, we may be obligated to make a milestone payment and revenue sharing payments based upon a percentage of net sales of certain products based on the intellectual property we acquired in the transaction. The acquired company was privately held and is focused on developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets. The technology is intended to enable surgeons to perform minimally invasive and percutaneous surgical procedures with greater accuracy, safety and reproducibility than is currently available. We accounted for this acquisition under the purchase method of accounting, and as a result, recorded goodwill of </font><font style="font-family:inherit;font-size:12pt;">$3.0 million</font><font style="font-family:inherit;font-size:12pt;">. The table below represents the valuation of the assets acquired and liabilities assumed as part of this 2013 purchase:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research &amp; development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,460</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,704</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,775</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The contingent consideration relates to the achievement of certain regulatory milestones and royalties. As of December 31, 2013, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranged from zero to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">$14.3 million</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> (see </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#8220;Note 5. Fair Value Measurements&#8221;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> below).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On July 18, 2012, we entered into an asset purchase agreement with a global medical device company, pursuant to which we acquired substantially all of its assets for </font><font style="font-family:inherit;font-size:12pt;">$6.0 million</font><font style="font-family:inherit;font-size:12pt;">. In addition to the initial purchase price, we may be obligated to make revenue sharing payments based upon a percentage of net sales of products we acquired from it. We accounted for this acquisition under the purchase method of accounting and as a result, recorded goodwill of </font><font style="font-family:inherit;font-size:12pt;">$5.6 million</font><font style="font-family:inherit;font-size:12pt;">. The table below represents the assets acquired and liabilities assumed as part of this 2012 purchase:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,420</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">467</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,564</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,031</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We have purchased the following amounts of products and services from the supplier:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases from related-party supplier</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,948</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,039</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Rent expense related to all operating leases recognized as a component of selling, general and administrative expenses was as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rent expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">676</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Stock option activity during the years ended </font><font style="font-family:inherit;font-size:12pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;">2013</font><font style="font-family:inherit;font-size:12pt;"> and </font><font style="font-family:inherit;font-size:12pt;">2012</font><font style="font-family:inherit;font-size:12pt;"> is summarized as follows: &#160;</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Shares (thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate intrinsic value (thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,061</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(368</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.55</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,253</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,222</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(416</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,886</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,495</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.45</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,263</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:1px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,854</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,731</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at December 31, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,390</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.08</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,093</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected to vest at December 31, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,464</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.76</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The fair value of the options was estimated on the date of the grant using a Black-Scholes option pricing model with the following assumptions:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term (years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Our issued and outstanding common shares by Class were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(Shares)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:9px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Class A Common</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:9px;" rowspan="1"><div style="font-size:8pt;text-align:center;padding-left:9px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">Class B</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">&#160;Common</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:13px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,828,187</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,877,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,705,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,065,197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,377,556</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,442,753</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year ended</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits at the beginning of the year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,799</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions related to current year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">661</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">673</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions related to prior year tax positions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">614</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reductions related to prior year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(209</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(109</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lapse of statute of limitations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(953</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits at the end of the year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,228</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,978</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Allowance for doubtful accounts:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Additions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Write-offs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">End of period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">961</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">693</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(73</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">1,581</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">1,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">318</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">1,647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Deferred tax valuation allowance:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Additions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Write-offs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">End of period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">1,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(616</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">533</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(206</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">327</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Expected future intangible asset amortization as of </font><font style="font-family:inherit;font-size:12pt;color:#231f20;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:12pt;color:#231f20;"> is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Annual Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ending December 31:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,541</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,423</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,752</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,969</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SEGMENT AND GEOGRAPHIC INFORMATION </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. We globally manage the business within </font><font style="font-family:inherit;font-size:12pt;">one</font><font style="font-family:inherit;font-size:12pt;"> reportable segment. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. Products are sold principally in the United States.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The following table represents total sales by geographic area, based on the location of the customer: </font></div><div style="line-height:120%;padding-bottom:16px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">427,091</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">396,615</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">355,609</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,280</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,844</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,385</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,371</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434,459</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We classify our products into </font><font style="font-family:inherit;font-size:12pt;">two</font><font style="font-family:inherit;font-size:12pt;"> categories: Innovative Fusion products and Disruptive Technology products. The following table represents total sales by product category: </font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Innovative Fusion</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270,852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">254,033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238,723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disruptive Technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203,519</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,426</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,271</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,371</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434,459</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The weighted average grant date per share fair values of the options awarded to employees were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:33px;text-indent:-32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average grant date per share fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Stock-Based Compensation</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The cost for employee and non-employee director awards is measured at the grant date based on the fair value of the award. The fair value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service period (generally the vesting period of the equity award). Awards issued to non-employees are recorded at their fair value as determined in accordance with authoritative guidance, and are periodically revalued as the awards vest and are recognized as expense over the requisite service period.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The determination of the fair value of stock options is made utilizing the Black-Scholes option-pricing model which is affected by our stock price and a number of assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends. The expected volatility is based upon the historical volatility of a public company peer group over the most recent period commensurate with the estimated expected term of the stock options. The expected term of the stock options is determined utilizing the simplified method given the limited extent of our historical data. The risk-free interest rate assumption is based on observed interest rates of U.S. Treasury securities appropriate for the expected terms of the stock options. The dividend yield assumption is based on the history and expectation of no dividend payouts.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">EQUITY</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Our amended and restated Certificate of Incorporation provides for a total of 785,000,000 authorized shares of common stock. Of the authorized number of shares of common stock, </font><font style="font-family:inherit;font-size:12pt;">500,000,000</font><font style="font-family:inherit;font-size:12pt;"> shares are designated as Class A common stock (&#8220;Class A Common&#8221;), </font><font style="font-family:inherit;font-size:12pt;">275,000,000</font><font style="font-family:inherit;font-size:12pt;"> shares are designated as Class B common stock (&#8220;Class B Common&#8221;) and </font><font style="font-family:inherit;font-size:12pt;">10,000,000</font><font style="font-family:inherit;font-size:12pt;"> shares are designated as Class C common stock (&#8220;Class C Common&#8221;).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The holders of Class A Common are entitled to </font><font style="font-family:inherit;font-size:12pt;">one</font><font style="font-family:inherit;font-size:12pt;"> vote for each share of Class A Common held. The holders of Class B Common are entitled to </font><font style="font-family:inherit;font-size:12pt;">10</font><font style="font-family:inherit;font-size:12pt;"> votes for each share of Class B Common held. The holders of Class A Common and Class B Common vote together as one class of common stock. The Class C Common is nonvoting. Except for voting rights, the Class A Common, Class B Common and Class C Common have the same rights and privileges. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In August&#160;2012, we completed our IPO. We sold </font><font style="font-family:inherit;font-size:12pt;">2,083,333</font><font style="font-family:inherit;font-size:12pt;"> shares of our Class A Common at an offering price of </font><font style="font-family:inherit;font-size:12pt;">$12.00</font><font style="font-family:inherit;font-size:12pt;"> per share. We recognized gross proceeds of </font><font style="font-family:inherit;font-size:12pt;">$25.0 million</font><font style="font-family:inherit;font-size:12pt;"> and our net proceeds received after underwriting fees and offering expenses were </font><font style="font-family:inherit;font-size:12pt;">$21.0 million</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Immediately prior to the closing of our IPO, we effectuated the following conversion:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the automatic conversion of all shares of our Series E preferred stock to </font><font style="font-family:inherit;font-size:12pt;">15,597,300</font><font style="font-family:inherit;font-size:12pt;"> shares of our Class B Common; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the subsequent automatic conversion of </font><font style="font-family:inherit;font-size:12pt;">49,655,411</font><font style="font-family:inherit;font-size:12pt;"> shares of our Class B Common (which reflects all such shares of Class B Common held by those who beneficially owned less than </font><font style="font-family:inherit;font-size:12pt;">10%</font><font style="font-family:inherit;font-size:12pt;"> of the aggregate number of all outstanding shares of our common stock) to </font><font style="font-family:inherit;font-size:12pt;">49,655,411</font><font style="font-family:inherit;font-size:12pt;"> shares of our Class A Common;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the automatic conversion of all shares of our Class C Common to </font><font style="font-family:inherit;font-size:12pt;">73,554</font><font style="font-family:inherit;font-size:12pt;"> shares of our Class A Common; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the automatic conversion of </font><font style="font-family:inherit;font-size:12pt;">3,039,385</font><font style="font-family:inherit;font-size:12pt;"> shares of Class B Common to </font><font style="font-family:inherit;font-size:12pt;">3,039,385</font><font style="font-family:inherit;font-size:12pt;"> shares of Class A Common upon their sale by the selling stockholders.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Our issued and outstanding common shares by Class were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(Shares)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:9px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Class A Common</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:9px;" rowspan="1"><div style="font-size:8pt;text-align:center;padding-left:9px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">Class B</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-align:center;">&#160;Common</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:13px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,828,187</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,877,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,705,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,065,197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,377,556</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,442,753</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SUBSEQUENT EVENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On February 25, 2015, we entered into an agreement to acquire medical device manufacturer Branch Medical Group, Inc. (&#8220;BMG&#8221;), a third party manufacturer of high precision medical devices located in Audubon, PA. Under the terms of the agreement, we expect to pay approximately </font><font style="font-family:inherit;font-size:12pt;">$52.9 million</font><font style="font-family:inherit;font-size:12pt;"> in cash subject to certain closing adjustments for BMG.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We expect the closing of the acquisition to occur in March 2015 following satisfaction of the applicable closing conditions.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Allowance for doubtful accounts:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Additions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Write-offs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">End of period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">961</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">693</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(73</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">1,581</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">1,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">318</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">1,647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Deferred tax valuation allowance:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">(In thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Additions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Write-offs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">End of period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">1,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(616</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">533</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(206</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">327</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">(282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Accounts Receivable and Allowance for Doubtful Accounts</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The majority of our accounts receivable is composed of amounts due from hospitals. We carry our accounts receivable at cost less an allowance for doubtful accounts. On a regular basis, we evaluate our accounts receivable and estimate an allowance for doubtful accounts, as needed, based on various factors such as our customers&#8217; current credit conditions, length of time past due, and the general economy as a whole. Receivables are written off against the allowance when they are deemed uncollectible.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates, in part, on historical experience that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#231f20;">Significant areas that require management&#8217;s estimates include intangible assets, contingent payment liabilities, allowance for doubtful accounts, stock-based compensation, provision for excess and obsolete inventory, useful lives of assets, the outcome of litigation, and income taxes. We are subject to risks and uncertainties due to changes in the healthcare environment, regulatory oversight, competition, and legislation that may cause actual results to differ from estimated results. </font></div></div> The contingent consideration relates to the achievement of certain sales milestones. As of December 31, 2014, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranges from zero to $15.0 million (see “Note 5. Fair Value Measurements” below). The contingent consideration relates to the achievement of certain regulatory milestones and royalties. As of December 31, 2013, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranged from zero to $14.3 million (see “Note 5. Fair Value Measurements” below). EX-101.SCH 8 gmed-20141231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2128100 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 2428402 - Disclosure - ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 2328301 - Disclosure - ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - ACQUISTIONS link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - ACQUISTIONS (Assets Acquired and Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - ACQUISTIONS (Contingent Consideration Payment Rollforward) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - ACQUISTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - ACQUISTIONS (Textuals) (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2144100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2444401 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 1006000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Equity link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 2134100 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 2434401 - Disclosure - DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 2137100 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 2437402 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2337301 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2140100 - Disclosure - EQUITY link:presentationLink link:calculationLink link:definitionLink 2440403 - Disclosure - EQUITY (Schedule of Issued and Outstanding Shares) (Details) link:presentationLink link:calculationLink link:definitionLink 2440404 - Disclosure - EQUITY (Schedule of Options Indexed to Issuer's Equity) (Details) link:presentationLink link:calculationLink link:definitionLink 2340301 - Disclosure - EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 2440402 - Disclosure - EQUITY (Textuals) (Details) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2142100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2442405 - Disclosure - INCOME TAXES (Components of Deferred Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2442402 - Disclosure - INCOME TAXES (Components of Income (Loss) Before Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2442403 - Disclosure - INCOME TAXES (Components of Provision for Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2342301 - Disclosure - INCOME TAXES Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2442407 - Disclosure - INCOME TAXES (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2442406 - Disclosure - INCOME TAXES (Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits) (Details) link:presentationLink link:calculationLink link:definitionLink 2442404 - Disclosure - INCOME TAXES (Reconciliation of Statutory U.S. Federal Tax Rate to Effective Rate) (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - INTANGIBLE ASSETS Expected Future Amortization of Acquired Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2143100 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 2443402 - Disclosure - LEASES (Minimum Future Rental Payments Under Operating Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 2443403 - Disclosure - LEASES (Rent Expense Related to Operating Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 2343301 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - MARKETABLE SECURITIES link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - MARKETABLE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - MARKETABLE SECURITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - PROPERTY & EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - PROPERTY & EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - PROPERTY & EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 2148100 - Disclosure - QUARTERLY FINANCIAL DATA (unaudited) link:presentationLink link:calculationLink link:definitionLink 2448402 - Disclosure - QUARTERLY FINANCIAL DATA (unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 2348301 - Disclosure - QUARTERLY FINANCIAL DATA (unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 2146100 - Disclosure - RELATED-PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 2446402 - Disclosure - RELATED-PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2346301 - Disclosure - RELATED-PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 2145100 - Disclosure - RETIREMENT BENEFIT PLANS link:presentationLink link:calculationLink link:definitionLink 2445402 - Disclosure - RETIREMENT BENEFIT PLANS (Details) link:presentationLink link:calculationLink link:definitionLink 2345301 - Disclosure - RETIREMENT BENEFIT PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 2147100 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION link:presentationLink link:calculationLink link:definitionLink 2447402 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Geographic Location) (Details) link:presentationLink link:calculationLink link:definitionLink 2447403 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Products) (Details) link:presentationLink link:calculationLink link:definitionLink 2347301 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2141100 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2441406 - Disclosure - STOCK-BASED COMPENSATION (Compensation Expense Related to Stock Options and Their Intrinsic Values) (Details) link:presentationLink link:calculationLink link:definitionLink 2441404 - Disclosure - STOCK-BASED COMPENSATION (Fair Value of Options, Assumptions) (Details) link:presentationLink link:calculationLink link:definitionLink 2441403 - Disclosure - STOCK-BASED COMPENSATION (Grant Date Fair Values of Options Awarded to Employees) (Details) link:presentationLink link:calculationLink link:definitionLink 2441405 - Disclosure - STOCK-BASED COMPENSATION (Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2341301 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2441402 - Disclosure - STOCK-BASED COMPENSATION (Textuals) (Details) link:presentationLink link:calculationLink link:definitionLink 2149100 - Disclosure - SUBSEQUENT EVENT link:presentationLink link:calculationLink link:definitionLink 2449402 - Disclosure - SUBSEQUENT EVENT (Details) link:presentationLink link:calculationLink link:definitionLink 2349301 - Disclosure - SUBSEQUENT EVENT (Tables) link:presentationLink link:calculationLink link:definitionLink 2150100 - Disclosure - VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS link:presentationLink link:calculationLink link:definitionLink 2450402 - Disclosure - VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS (Details) link:presentationLink link:calculationLink link:definitionLink 2350301 - Disclosure - VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 gmed-20141231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 gmed-20141231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 gmed-20141231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Valuation and Qualifying Accounts [Abstract] Valuation and Qualifying Accounts Disclosure [Table] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves [Domain] Valuation Allowances and Reserves [Domain] Allowance for doubtful accounts Allowance for Doubtful Accounts [Member] Deferred tax valuation allowance Valuation Allowance of Deferred Tax Assets [Member] Valuation and Qualifying Accounts Disclosure Valuation and Qualifying Accounts Disclosure [Line Items] Movement in Valuation Allowances and Reserves [Roll Forward] Movement in Valuation Allowances and Reserves [Roll Forward] Beginning of period Valuation Allowances and Reserves, Balance Additions Valuation Allowances and Reserves, Charged to Cost and Expense Write-offs Valuation Allowances and Reserves, Deductions End of period Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process Research and Development In Process Research and Development [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Acquisition 2014 Acquisition 2014 [Member] Acquisition 2014 Acquisition 2013 Acquisitions 2013 [Member] Acquisitions 2013 Acquisition 2012 Acquisitions 2012 [Member] Acquisitions 2012 [Member] Business Acquisition Business Acquisition [Line Items] Payments to Acquire Businesses, Gross Payments to Acquire Businesses, Gross Range of aggregate undiscounted contingent consideration from acquisitions, maximum Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Goodwill Goodwill Pre tax royalty rate Fair Value Inputs, Pre Tax Royalty Rate Fair Value Inputs, Pre-Tax Royalty Rate Discount rate Fair Value Inputs, Discount Rate In process research and development, cost to complete In Process Research and Development, Cost to Complete In Process Research and Development, Cost to Complete Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Class A Common Common Class A [Member] Class B Common Common Class B [Member] Statement [Line Items] Statement [Line Items] Current Assets: Assets, Current [Abstract] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Equity: Stockholders' Equity Attributable to Parent [Abstract] Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Related Party Transactions [Abstract] Related-Party Transactions Related Party Transactions Disclosure [Text Block] Property, Plant and Equipment [Abstract] Property And Equipment Property, Plant and Equipment Disclosure [Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Derivative [Table] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Derivative Contract Type [Domain] Derivative Contract [Domain] Derivative [Line Items] Derivative [Line Items] DEI [Abstract] DEI [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Public Float Entity Public Float Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Common Stock Valuation [Axis] Common Stock Valuation [Axis] Information by type of valuation an entity uses for stock based compensation. Common Stock Valuation [Domain] Common Stock Valuation [Domain] Activities the entity engages in to value its stock based compensation. Original Fair Value of Common Stock Original Fair Value of Common Stock [Member] Fair value of common stock at grant date. Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2012 Equity Incentive Plan 2012 Equity Incentive Plan [Member] 2012 Equity Incentive Plan. February 2, 2012 Grant February 2, 2012 Grant [Member] February 2, 2012 Grant. Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Stock Options Employee Stock Option [Member] Share-based Compensation Arrangement by Share-based Payment Award Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation, Number of Stock Plans Share-based Compensation, Number of Stock Plans Share-based Compensation, Number of Stock Plans Shares reserved under the 2012 Equity Incentive Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of shares available for grant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Maximum contractual term Share Based Compensation By Share Based Payment Maximum Contractual Term Maximum term of stock options under the plan (years). Award vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Base number of shares that may be issuable under stock plan Share Based Compensation Arrangement By Share Based Payment Award Base Number Of Shares Issuable Base number of aggregate shares that may be issued subject to options and other awards. Annual percentage limit for incremental shares that may be issued Share Based Compensation Arrangement By Share Based Payment Award Annual Percentage Increase In Shares Available For Issuance Annual percentage limit, based on the previous year end outstanding shares, of the annual increase in shares that may be issued subject to options and other awards. Exercise price per share granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants, Exercise Price Exercise price per share for stock grant. Unrecognized compensation expense, unvested stock options Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted average period of recognition, unvested stock options Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Leases, Operating [Abstract] Year ending December 31, 2015 Operating Leases, Future Minimum Payments Due, Next Twelve Months Year ending December 31, 2016 Operating Leases, Future Minimum Payments, Due in Two Years Year ending December 31, 2017 Operating Leases, Future Minimum Payments, Due in Three Years Year ending December 31, 2018 Operating Leases, Future Minimum Payments, Due in Four Years Year ending December 31, 2019 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total Operating Leases, Future Minimum Payments Due Defined Contribution Pension and Other Postretirement Plans Disclosure [Abstract] Company Contributions To Retirement Benefit Plans Schedule of Costs of Retirement Plans [Table Text Block] Intangible Assets Disclosure [Abstract] Intangible Assets Disclosure Schedule of Intangible Assets [Table] Schedule of Intangible Assets [Table] Schedule of Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Supplier Network Supplier Network [Member] Supplier Network Customer relationships & other intangibles Other Intangible Assets [Member] Patents Patents [Member] Acquired Intangible Assets Acquired Intangible Assets [Line Items] Acquired Intangible Assets [Line Items] Weighted average amortization period Finite-Lived Intangible Asset, Useful Life Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Gross carrying amount Finite-Lived Intangible Assets, Gross Intangible Assets, Gross Carrying Amount Intangible Assets, Gross Sum of the gross carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date. Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Intangible asset amortization expense Amortization of Intangible Assets Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Finite-lived intangible assets, net Finite-Lived Intangible Assets, Net Marketable Securities [Abstract] Schedule of Marketable Securities [Table] Schedule of Available-for-sale Securities [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Short-term Marketable Securities Short-term Investments [Member] Long-term Marketable Securities Other Long-term Investments [Member] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Municipal Bonds Municipal Bonds [Member] Corporate Debt Securities Corporate Debt Securities [Member] Commercial Paper Commercial Paper [Member] Asset-backed Securities Asset-backed Securities [Member] US Government-sponsored Enterprises Debt Securities [Member] US Government-sponsored Enterprises Debt Securities [Member] Schedule of Marketable Securities Schedule of Available-for-sale Securities [Line Items] Available For Sale Securities Contractual Maturity Available For Sale Securities Contractual Maturity Contractual maturity (in years) of available for sale securities. Amortized Cost Available-for-sale Securities, Amortized Cost Basis Gross Unrealized Gains Available-for-sale Securities, Gross Unrealized Gain Gross Unrealized Losses Available-for-sale Securities, Gross Unrealized Loss Fair Value Available-for-sale Securities Intangible Assets Disclosure Intangible Assets Disclosure [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of shares outstanding beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of shares granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Number of shares exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of shares forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Number of shares outstanding ending balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted average exercise price per share outstanding beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average exercise price per share granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price per share exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average exercise price per share forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average exercise price per share outstanding ending balance Number of shares exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average exercise price per share exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted average remaining contractual life outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual life exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate intrinsic value outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Segment Reporting [Abstract] Segment And Geographic Information Segment Reporting Disclosure [Text Block] Schedule of Revenues from External Customers [Table] Schedule of Sales By Geographic Area [Table] Tabular disclosure of information concerning the amount of revenue from external customers attributed to that geographic region from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. Geographical [Axis] Geographical [Axis] Segment, Geographical [Domain] Geographical [Domain] United States UNITED STATES International International [Member] Group of countries excluding the United States and its territories/protectorates. Revenues from External Customers Schedule of Sales By Geographic Area [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Number of reportable segments Number of Reportable Segments Total sales Revenue, Net Debt Disclosure [Abstract] Debt Debt Disclosure [Text Block] Expected Future Amortization of Acquired Intangible Assets [Abstract] Expected Future Amortization of Acquired Intangible Assets [Abstract] Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] Year ending December 31, 2015 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Year ending December 31, 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Two Year ending December 31, 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Three Year ending December 30, 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Four Year ending December 31, 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Finite-lived intangible assets, net Retirement Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] ASSETS Assets [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Restricted cash Restricted Cash and Cash Equivalents, Current Short-term marketable securities Available-for-sale Securities, Current Accounts receivable, net of allowances of $1,647 and $1,581, respectively Accounts Receivable, Net, Current Inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Income taxes receivable Income Taxes Receivable, Current Deferred income taxes Deferred Tax Assets, Net of Valuation Allowance, Current Total current assets Assets, Current Property and equipment, net of accumulated depreciation of $118,544 and $99,910 Property, Plant and Equipment, Net Long-term marketable securities Available-for-sale Securities, Noncurrent Other assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Accounts payable Accounts Payable, Current Accounts payable to related-party Accounts Payable, Related Parties, Current Accrued expenses Accrued Liabilities, Current Income taxes payable Accrued Income Taxes, Current Business acquisition liabilities, current Business Acquisition Liabilities, Current Current portion, as of the balance sheet date, of carrying value of the obligations incurred and payable pertaining to business acquisitions, including but not limited to contractual milestone payments and contingent performance payments. Total current liabilities Liabilities, Current Business acquisition liabilities, net of current portion Business Acquisition Liabilities, Noncurrent Noncurrent portion, as of the balance sheet date, of carrying value of the obligations incurred and payable pertaining to business acquisitions, including but not limited to contractual milestone payments and contingent performance payments. Deferred income taxes Deferred Tax Liabilities, Net, Noncurrent Other liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 14) Commitments and Contingencies Common stock Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Total equity Stockholders' Equity Attributable to Parent Total liabilities and equity Liabilities and Equity Leases Operating Leases of Lessee Disclosure [Table Text Block] Business Acquisitions Business Combination Disclosure [Text Block] Equity [Abstract] Equity Stockholders' Equity Note Disclosure [Text Block] Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Net Income (Loss) Attributable to Parent Adjustments to reconcile net income to net cash provided by operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Amortization of premium on marketable securities Investment Income, Amortization of Premium Provision for excess and obsolete inventories Inventory Write-down Stock-based compensation Share-based Compensation Allowance for doubtful accounts Provision for Doubtful Accounts Change in deferred income taxes Deferred Income Taxes and Tax Credits (Increase) decrease in: Increase (Decrease) in Operating Assets [Abstract] Restricted cash Increase (Decrease) in Restricted Cash Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Increase (decrease) in: Increase (Decrease) in Operating Liabilities [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Accounts payable to related party Increase (Decrease) in Accounts Payable, Related Parties Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Income taxes payable/receivable Increase (Decrease) in Income Taxes Payable Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of marketable securities Payments to Acquire Investments Maturities of marketable securities Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities Sales of marketable securities Proceeds from Sale of Available-for-sale Securities Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Acquisition of businesses Payments to Acquire Businesses, Net of Cash Acquired Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Payment of business acquisition liabilities Payment of Business Acquisition Liabilities The cash outflow during the reporting period for obligations arising from the acquisition of a business, including but not limited to contractual milestone payments and contingent performance payments. Net proceeds from initial public offering Proceeds From Issuance Initial Public Offering, Net of Underwriting Fees and Offering Expenses Proceeds from initial public offering, after deducting underwriting and other offering fees and expenses. Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Excess tax benefit related to nonqualified stock options Excess Tax Benefit from Share-based Compensation, Financing Activities Net cash provided by/(used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of foreign exchange rate on cash Effect of Exchange Rate on Cash and Cash Equivalents Net increase/(decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid Income taxes paid Income Taxes Paid Weighted average grant date per share fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Inventory Disclosure [Abstract] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Subsequent Event Subsequent Event [Line Items] Subsequent Event Subsequent Events [Text Block] Valuation Accounts and Qualifying Accounts Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Schedule of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Contingent Consideration Rollforward Activity Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Statement of Stockholders' Equity [Abstract] Stock Conversion Description [Axis] Stock Conversion Description [Axis] Conversion of Stock, Name [Domain] Conversion of Stock, Name [Domain] Pre IPO Pre IPO [Member] Conversion prior to initial public offering In Conjunction with IPO In Conjunction with IPO [Member] Conversions made in conjunction with the initial public offering. Post IPO Post IPO [Member] Conversions after the initial public offering. Class C Common Common Class C [Member] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Convertible Preferred Stock Preferred Stock [Member] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Loss) [Member] Retained Earnings Retained Earnings [Member] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance, Shares Shares, Outstanding Total stockholders' equity, beginning of period Stock-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Exercise of stock options (shares) Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Tax benefit related to nonqualified stock options excercised Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Conversion of stock, converted (shares) Conversion of Stock, Shares Converted Conversion of stock, amount converted Conversion of Stock, Amount Converted Conversion of stock, issued (shares) Conversion of Stock, Shares Issued Conversion of stock, amount issued Conversion of Stock, Amount Issued Issuance of common stock from IPO, net of expenses (shares) Stock Issued During Period, Shares, New Issues Issuance of common stock from IPO, net of expenses Stock Issued During Period, Value, New Issues Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Balance, Shares Total stockholders' equity, end of period Income Statement [Abstract] Sales Cost of goods sold Cost of Goods Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Provision for litigation litigation loss/(income) Loss Contingency Accrual, Provision Total operating expenses Operating Expenses Operating income Operating Income (Loss) Other income/(expense), net Other Nonoperating Income (Expense) Interest income, net Interest Income (Expense), Net Foreign currency transaction loss Foreign Currency Transaction Gain (Loss), before Tax Other income Other Nonoperating Income Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax provision Income Tax Expense (Benefit) Net income Earnings per share: Earnings Per Share [Abstract] Basic Earnings Per Share, Basic Diluted Earnings Per Share, Diluted Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Weighted Average Number of Shares Outstanding, Basic Dilutive stock options Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Diluted Weighted Average Number of Shares Outstanding, Diluted Anti-dilutive stock equivalents excluded from weighted average calculation Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Class of Stock Class of Stock [Line Items] Common stock, shares outstanding Schedule of Property and Equipment [Table] Property, Plant and Equipment [Table] Property and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Land Land [Member] Building and improvements Building and Building Improvements [Member] Equipment Equipment [Member] Instruments Instruments [Member] Instruments Modules and cases Modules and Cases [Member] Modules and Cases Other property and equipment Property, Plant and Equipment, Other Types [Member] Property and Equipment Property, Plant and Equipment [Line Items] Depreciation Depreciation Useful Life Property, Plant and Equipment, Useful Life Property and equipment, gross Property, Plant and Equipment, Gross Less: accumulated depreciation Total Schedule of Issued and Outstanding Shares by Class Schedule of Stock by Class [Table Text Block] BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] Summary of Significant Accounting Policies [Table] Summary of Significant Accounting Policies [Table] Summary of Significant Accounting Policies [Table] Nature of Expense [Axis] Nature of Expense [Axis] Interim Period, Costs Not Allocable [Domain] Interim Period, Costs Not Allocable [Domain] Cost of Goods, Total Cost of Goods, Total [Member] Summary of Significant Accounting Policies Summary of Significant Accounting Policies [Line Items] Summary of Significant Accounting Policies [Line Items] Number of Products Launched Since Inception Number of Products Launched Since Inception Number of products launched since inception. Estimated useful life of finite-lived intangible assets Advertising expense Advertising Expense Medical Device Excise Tax Percentage Medical Device Excise Tax Percentage The percentage of Medical Device Excise Tax applied to domestic sales of certain medical devices. Medical Device Excise Tax Medical Device Excise Tax The dollar amount of the Medical Device Excise Tax recognized in the statement of income. Options Indexed to Issuer's Equity [Table] Option Indexed to Issuer's Equity [Table] Option Indexed to Issuer's Equity [Axis] Option Indexed to Issuer's Equity [Axis] Option Indexed to Issuer's Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Option Indexed to Issuer's Equity [Line Items] Option Indexed to Issuer's Equity [Line Items] Statement of Comprehensive Income [Abstract] Other comprehensive income/(loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Unrealized gain on marketable securities, net of tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Change in accumulated foreign currency translation gain/(loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Total other comprehensive income/(loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Comprehensive income Intangible Assets Acquired as Part of Business Combination Intangible Assets Acquired as Part of Business Combination [Table Text Block] Tabular disclosure of the major classes of acquired intangible assets showing the amount, any significant residual value, weighted average amortization period (if any), and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company. Schedule of intangible asset amortization expense Schedule of intangible asset amortization expense [Table Text Block] Schedule of intangible asset amortization expense. Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Examination [Table] Income Tax Examination [Table] Other Assets Other Assets [Member] Income Tax Examination Income Tax Examination [Line Items] Long term deferred tax asset Deferred Tax Assets, Net, Noncurrent Benefit recorded in 2013 for reinstated 2012 tax credit Income Tax Benefit, Enacted Legislation, Estimated Benefit Expected to be Recorded in Next Fiscal Year Income Tax Benefit, Enacted Legislation, Expected to be Recorded in Next Fiscal Year Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring Basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash equivalents Cash Equivalents, Fair Value Disclosure Fair value of cash equivalents as of the balance sheet date. Marketable Securities, Fair Value Contingent consideration Financial and Nonfinancial Liabilities, Fair Value Disclosure Background and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Purchases from related-party supplier Related Party Transaction, Purchases from Related Party Customer Relationships Customer Relationships [Member] Non-compete Agreements Noncompete Agreements [Member] Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Identifiable intangible assets: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment Trade Names Finite-Lived Trade Names, Gross Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Accounts payable and accrued expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Contingent consideration Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Business Combination, Consideration Transferred Business Combination, Consideration Transferred Total identifiable net assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Net assets acquired Statutory U.S. federal tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent State income taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Domestic production activities deduction Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent Tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Nondeductible expenses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent Income Taxes Income Tax Disclosure [Text Block] Quarterly Financial Information Disclosure [Abstract] Schedule of Quarterly Financial Information Schedule of Quarterly Financial Information [Table Text Block] Payables and Accruals [Abstract] Accrued Expenses Accrued Liabilities Disclosure [Text Block] The entire disclosure for accrued liabilities at the end of the reporting period. Inventories Inventory Disclosure [Text Block] Risk-free interest rate, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Expected volatility, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Summary of Valuation Allowance [Table Text Block] Summary of Valuation Allowance [Table Text Block] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Unrecognized tax benefits at the beginning of the year Unrecognized Tax Benefits Additions related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Additions related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Reductions related to prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Lapse of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Unrecognized tax benefit at the end of the year Portion of total unrecognized tax benefits that, if recognized, that would affect the effective income tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block] Fair Value of Options, Assumptions Schedule Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Stock Option Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Stock Option Compensation Expense and Intrinsic Value Schedule Stock Option Compensation Expense and Intrinsic Value Schedule [Table Text Block] Tabluar disclosure of the compensation expense related to stock options and the intrinsic value of stock options exercised. Principles of Consolidation Consolidation, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Accounts Receivable and Allowance for Doubtful Accounts Trade and Other Accounts Receivable, Policy [Policy Text Block] Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Marketable Securities Marketable Securities, Policy [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Goodwill and Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Research and Development Research and Development Expense, Policy [Policy Text Block] Stock-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Derivatives Derivatives, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Advertising Expense Advertising Costs, Policy [Policy Text Block] Legal costs Legal Costs, Policy [Policy Text Block] Medical Device Excise Tax Medical Device Excise Tax [Policy Text Block] Accounting policy regarding the recognition of the Medical Device Excise Tax. Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Nondiscretionary employee contribution match rate Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Maximum annual contribution match, per employee Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount Maximum annual contribution match, percent per employee Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 401(k) and other retirement plan contributions Defined Contribution Plan, Cost Recognized Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies [Table] Commitments and Contingencies [Table] Commitments and Contingencies [Table] Litigation Case [Axis] Litigation Case [Axis] Litigation Case Type [Domain] Litigation Case [Domain] Synthes USA, LLC, Synthes USA Products, LLC, and Synthes USA Sales, LLC Litigation Synthes USA, LLC, Synthes USA Products, LLC, and Synthes USA Sales, LLC Litigation [Member] Synthes USA, LLC, Synthes USA Products, LLC, and Synthes USA Sales, LLC Litigation [Member] NuVasive, Inc NuVasive, Inc [Member] NuVasive, Inc [Member] Bianco Bianco [Member] Bianco Altus Partners, LLC Altus Partners LLC [Member] Altus Partners, LLC [Member] Loss Contingencies Commitments and Contingencies [Line Items] Commitments and Contingencies [Line Items] Damages awarded Loss Contingency, Damages Awarded, Value Patent claims (number of claims) Loss Contingency, Pending Claims, Number Combined litigation loss Combined litigation loss Combined litigation loss. Royalty Rate Royalty Rate Royalty rate for the use of technology or intellectual property incurred and directly related to certain goods sold during the reporting period. Provision for litigation loss - cost of goods sold Provision for litigation loss - cost of goods sold Total costs of inventory written off related to a litigation loss during the period. Quarterly Financial Data (unaudited) Quarterly Financial Information [Text Block] Deferred Tax Assets, Net, Noncurrent Components of Deferred Tax Assets [Abstract] Components of Deferred Tax Assets [Abstract] Inventory reserve Deferred Tax Assets, Inventory Accruals, reserves, and other currently not deductible Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Foreign net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Foreign Total deferred tax assets Deferred Tax Assets, Gross Valuation allowance Deferred Tax Assets, Valuation Allowance Total deferred tax assets, net of valuation allowance Deferred Tax Assets, Net of Valuation Allowance Components of Deferred Tax Liabilities [Abstract] Components of Deferred Tax Liabilities [Abstract] Depreciation and amortization Deferred Tax Liabilities, Depreciation and Amortization Deferred Tax Liabilities, Depreciation and Amortization Other Deferred Tax Liabilities, Other Total deferred tax liabilities Deferred Tax Liabilities, Gross Net deferred tax assets Deferred Tax Assets, Net Rent expense Operating Leases, Rent Expense, Net Contingent Consideration Payment [Roll Forward] Contingent Consideration Payment [Roll Forward] Contingent Consideration Payment [Roll Forward] Business Combination, Contingent Consideration, Liability Business Combination, Contingent Consideration, Liability Purchase price contingent consideration Business Combination, Contingent Consideration Arrangements, Fair Value, Additions for Current Period Acquisitions Business Combination, Contingent Consideration Arrangements, Fair Value, Additions for Current Period Acquisitions Contingent payments Business Acquisition, Contingent Consideration, Milestone Payment Contingent payments resulting from business acquisition transactions. Changes in fair value of contingent consideration classified in operating expenses Business Combination, Contingent Consideration Arrangements, Fair Value, Change in Fair Value, Liability Business Combination, Contingent Consideration Arrangements, Fair Value, Change in Fair Value, Liability Business Combination, Contingent Consideration, Liability Fair Value Measurements Fair Value Disclosures [Text Block] Property And Equipment Property, Plant and Equipment [Table Text Block] Schedule Of Depreciation Of Property And Equipment Schedule Of Depreciation And Amortization Of Property And Equipment [Table Text Block] Schedule of depreciation and amortization of property equipment and leasehold improvements. Raw materials Inventory, Raw Materials, Gross Work in process Inventory, Work in Process, Gross Finished goods Inventory, Finished Goods, Net of Reserves Total Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Schedule of Minimum Future Rental Payments Under Operating Leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Rent Expense for Operating Leases Schedule of Rent Expense [Table Text Block] Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Innovative Fusion Innovative Fusion [Member] Innovative Fusion [Member] Disruptive Technology Disruptive Technology [Member] Disruptive Technology [Member] Revenue from External Customer Revenue from External Customer [Line Items] Textuals [Abstract] Textuals [Abstract] Number of product categories Number of product categories Number of product categories. Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Compensation expense related to stock options Allocated Share-based Compensation Expense Intrinsic value of stock options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Income before taxes, domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Income/(loss) before taxes, foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Equity Ownership by Amount [Axis] Equity Ownership by Amount [Axis] Equity Ownership by Amount [Axis] Equity Ownership Amount [Domain] Equity Ownership Amount [Domain] Equity Ownership Amount [Domain] Equity Ownership of Less Than Ten Percent Equity Ownership of Less Than Ten Percent [Member] Equity Ownership of Less Than Ten Percent [Member] Stock Conversion Description [Axis] Conversion of Class E to Class B Conversion of Series E Preferred Stock to Class B Common Stock [Member] Conversion of Series E Preferred Stock to Class B Common Stock [Member] Conversion of Class B to Class A Conversion of Class B Common Stock to Class A Common Stock [Member] Conversion of Class B Common Stock to Class A Common Stock [Member] Conversion of Class C to Class A Conversion of Class C Common Stock to Class A Common Stock [Member] Conversion of Class C Common Stock to Class A Common Stock [Member] Conversion of Class B to Class A, Selling Stockholders Conversion of Class B Common Stock to Class A Common Stock, Selling Stockholders [Member] Conversion of Class B Common Stock to Class A Common Stock, Selling Stockholders [Member] Stock Offering, Initial Public Offering, Transaction [Axis] Stock Offering, Initial Public Offering, Transaction [Axis] Stock Offering, Initial Public Offering, Transaction Type [Axis] Stock Offering, Initial Public Offering, Transaction [Domain] Stock Offering, Initial Public Offering, Transaction [Domain] Stock Offering, Initial Public Offering, Transaction Type [Domain] Issued by Company New Shares Issued by Company [Member] New Shares Issued by Company [Member] Offering price per share (in usd per share) Share Price Common stock, votes per share Common Stock, Voting Rights Shares sold for initial public offering (in shares) Development Stage Entities, Stock Issued, Shares, Issued for Cash Gross proceeds from issuance initial public offering Proceeds from Issuance Initial Public Offering Proceeds From Issuance Initial Public Offering, Net of Underwriting Fees and Offering Expenses Conversion of stock, shares converted Conversion of stock, requirements, maximum ownership percentage Conversion of Stock, Requirements, Maximum Ownership Percentage Individual stockholder limit, as a percentage of the aggregate number of all outstanding shares of common stock, to qualify for conversion from Class B to Class A. Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Letter of Credit Letter of Credit [Member] Line of Credit Facility, Interest Rate Options [Axis] Line of Credit Facility, Interest Rate Options [Axis] Information by type of interest rate option. Line of Credit, Interest Rate Options [Domain] Line of Credit, Interest Rate Options [Domain] Type of interest rate option, as determined by the Company based on the terms of the credit agreement. Fluctuating Rate Per Annum Line of Credit, Variable Rate Per Annum [Member] Fluctuating interest rate, as determined by the terms of the credit agreement. Fixed Rate Line of Credit, Fixed Rate [Member] Fixed interest rate, as determined by the terms of the credit agreement. Debt Instruments Debt Instrument [Line Items] Credit facility, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Credit facility, current borrowing capacity Line of Credit Facility, Current Borrowing Capacity Credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Credit facility, variable rate Debt Instrument, Description of Variable Rate Basis Credit facility, period of variable rate Line of Credit, Period of Variable Rate The period over which the applicable interest rate option is applied for the debt instrument. Revolving credit facility, minimum termination notice period Line of Credit, Termination Period Without Penalty Minimum notice period of intent to terminate line of credt agreement without premium or penalty. Gross Profit Net earnings per common share - basic Net earnings per common share - dilutive Current Income Tax Expense Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Current income tax provision, federal Current Federal Tax Expense (Benefit) Current income tax provision, state Current State and Local Tax Expense (Benefit) Current income tax provision, foreign Current Foreign Tax Expense (Benefit) Current income tax provision Current Income Tax Expense (Benefit) Deferred Income Tax Expense/(Benefit) Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Deferred income tax provision/(benefit), federal Deferred Federal Income Tax Expense (Benefit) Deferred income tax (benefit), state Deferred State and Local Income Tax Expense (Benefit) Deferred income tax provision/(benefit), foreign Deferred Foreign Income Tax Expense (Benefit) Deferred income tax provision/(benefit) Deferred Income Tax Expense (Benefit) Income tax provision, total Compensation and other employee-related costs Employee-related Liabilities, Current Legal and other settlements and expenses Accrued Liabilities, Legal and Other Settlements and Expenses Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal and other settlements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued non-income taxes Sales and Excise Tax Payable, Current Other Other Accrued Liabilities, Current Total accrued expenses Schedule of Income (loss) before Income Tax, Domestic and Foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of Components Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] U.S. Federal Tax Rate To Effective Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Components of Deferred Income Taxes Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Impact of Unrecognized Tax Benefits to Effective Income Tax Rate Impact of Unrecognized Tax Benefits to Effective Income Tax Rate [Table Text Block] Impact of Unrecognized Tax Benefits to Effective Income Tax Rate [Table Text Block] Schedule of Revenue from External Customers By Geographical Area International and Domestic Schedule of Revenue from External Customers By Geographical Area International and Domestic [Table Text Block] Tabular disclosure of information concerning the amount of revenue from external customers attributed to that geographic region from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. Revenue from External Customers by Products and Services Revenue from External Customers by Products and Services [Table Text Block] Marketable Securities Available-for-sale Securities [Table Text Block] Fair Value, Assets Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] EX-101.PRE 12 gmed-20141231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 gmed28mos2014a03.jpg begin 644 gmed28mos2014a03.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,# M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_ MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`(D`_P#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]$/\`@FE_ MP32_9Q^)/_!./]G_`,1>(OV?_@EK_B#7_AOX=U+4]3U+P-I=U>:C=3:7;233 MS320%Y)9'9F9V)9F8DDDU[;_`,.G?V6/^C:?V?\`_P`-YI'_`,CT?\$G?^46 M7[-/_9*O"_\`Z:+6O?Z`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^ MS_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__ M`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X M;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\T MC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^ M1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O M?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B M@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\ M`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^ M'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[ M^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL M?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1 MM/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^ MS_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__ M`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X M;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\T MC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^ M1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C M_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X= M._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[ M+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_ MT;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T M_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/ M_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\` M^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO M-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/ M_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y' MKW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_ MHH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*` M/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P# M_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X= M._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[ M+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_ MT;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T M_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/ M_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\` M^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO M-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/ M_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y' MH_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^ M'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[ M^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL M?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1 MM/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^ MS_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__ M`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X M;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\T MC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^ M1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O M?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B M@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\ M`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^ M'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[ M^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL M?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1 MM/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^ MS_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__ M`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X M;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\T MC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`^$_\`@I;_`,$TOV'?V?_@EH'B#0/AOXBU+3-3TWP-I=K>:==0Z7?VG/'7[77P+^)GA3X,?#OXGZ9<77@#5FB\2 M^(M(U#P3=6FL20%+*PL8=1@@GGN'S*S7*;8;2@FI7 MUM>5UJG?ELES2BS10YIPA>RE;7SYK-6\HV=[K>^T97^O:*_+'6OV<],\9?## MXN6/P9^#_CCP#\*==TKP-82>'AX.U'PK)J&M0:Z9-0NH+"2&"X\V.Q:V$]\D M>V7RTQ*QMV*[WQ1_X)WZ!X#\0?&O4_!/P?32;OPIX^\&ZM\._P"QM`>*+1?F MTAM1N-(BC0)`)"DOVI[95$OEL)BP3BY6C4Y9;?CNE>U[;/F6NJMM?3&+]C],**_*CX4?#71?%O[1^L:CX,^&7B^?XV:/\?]7U*;QH MFAW<5G#X>AO;G[9:_P!LL!;+;2PF:W_LX3*S7$XF-N03.?%++]GWQGXAT7QS MK'A'X)ZUX*N/%7P0\::=J^GZ+\*_$&B:J-9NA93V^G:EJM]<23>(K]6$VR^6 M!$D?S#&[F38D8>7M:<*BTYH\VOG351>J;?)S;*2:>KBI;^R_?NA?:7+?_M]P M=^S27/;K%I[7:_;"UURZN/%=[ISZ/J4%G:VT,\6J.]N;2\>1I`T,:K*9@\81 M68O$B$3)L9R'":5?G3\9?V.-.\#7OQT\-:'X!\4Z)\/KOX;^"K6VB\)>$TOH M+N:#6-:NKV-K!?+748B95DOK.$FXN8+F5%!DG3=R/A'X2SW/[-GA.U\3_!1W M^!^A_%V>]U_PYX;^&VLZ7I_B?1VT>9(+X>#;EKF\M[6/5I(=]DL3AY+;[:(P MKL]:N*YY13T5M7I>\HQ^6]UWL^BDXY7O%377IU_A<^G=W]VW?UC%_J)17YA_ M!;]AF+XR>/?AI8>/OA3J>H?"^P\-_$>;0-`\3:$\MEH^GW.OZ;+HEEW(7[6_X)SZ-KWAW]@'X)Z?XHMM8LO$EAX&T:WU2WU9 M)4OX+E+*%9$G67]X)0P(8/\`,"#GFG&%Z;F]'IH]]745GV:Y-5K\6_5DURRY M5JKM7Z:6LUW3OH]/373V:O,?@-^U%IW[0'_"97>G^'O$>D>'?"&LWNB)KVJ- M9)8:W-97$UM=O:B*XDF$<,T$B%KB*'=C*!UR1\5?M(?`V[\0_M<^.I;KX:>+ M=:^,NK?$;PMJ'P[\;0>&KJZL]%\,0KI8OH%UA8S;V%NHBUD7%E)/$US]H<". M3[2F[WK_`()=_`;1?V2?V5O%PM/AY#X(ED\;>+=3N;'3?#GV*[O[9-;O_L;K M!%&KS`V:P+``IS%Y03*[162_@.M)VT];.T'KL_=NXM?S*2W6FE2%FHQU?-%> M=FI^NC<59[V>J5RSX3_X*P>`M6TV?5_$'ACXA^!?"=SX5U#QOH/B+7=-M_L/ MBG1K%4>XN[1+:XFN(R(I895ANX;>=TE4K&2'"]_^S7^V+9?M#^+M?\,WO@CQ MW\./%OAVQLM6GT3Q5!9+>:+:\BDLKFY@:-GMYXROFB6-X6#QIE=WR'X M7\<^*OVV/"OQ1\;7?A3Q]IOQMU7P%KFD?#SPAXH^%NMZ;HG@JUGBYMYKS4[! M+"\O[MX[4S[V:+$:PQJ\22RS^D_\$OO"LFE_&CQ_J/AO0OBWIGPYNO#'AZTB MNOB7I=_::Y/K,7VTWD,3ZDBWS6D44EKA`391RR3"U"@RBM:<=6I=$GWW<^JL MGHHIM:*[CPRGBB/4S;1'1VB>6:-;7S1+YHN2+>>0*8MA2)COR-M2?!/]M?PI\> M_P!I3XI_"_0['Q`FL?"3[`-4U"YMXDTZ_-V)P!:.LC/)Y4EO-%)OC0+)&R@M M@D?-7[9/@7QIX._:Z^)OQ>\,^!?%/BG4/AUX<\$:[HMOIFGRRRZ_]FO_`!!% MJMC9D+B>Y.G7TP$2G.Z:'.-RFO)]7_9,^(/@_P`'^/X-1\'^)]836_!_P\U3 MQS!IMA-(?$Q;Q-J^I^*;*`*,W+M%=W'F6L>]Y(IQ$$8RJK332>LN_+KI\3TF MW_+%*2EII:[Z7UK02*7?WE:[2U:Z-K]3:Y7Q'\:?#GA7XCV' MA"\OV3Q+JNCWVO6=BMO(QN+.SDMX[B02;?+4J]U;C:S!F\S(!"L1^=GA7]D+ M3/B[\2O!^FZ9\)-=TK]GB]^-DVJ:1X5U/PE)1-HT7F+"S6-K]@-X+:1C'"(YV2-@)L-G64HPOM>+?G?V;DEZ\]HV MW>VC8*"5FW?;\937W*,&V^EUNM3]$O@!\:-+_:.^!G@[X@:';ZA:Z-XVT6TU MRQAOD1+J*"YA69%E5&=0X5P"%9@#G!/6L3]H#]IO3/@+>Z!I$>A^(?&GC/Q: M\ZZ%X6\/K;'4]56!5>YE5KJ:"VAAA1E+RSSQ)EXXPS2RQ1O\<_\`!,7]D"?] MFSQQ^S7J-AX#UGPM>:Q\#+JW\?7TNFS6\]WJTY_M4C5?@C^VA\-?C(_A?Q%XH\%Z;X7UKP?KK>'=%N-:U71'O;G M3KFVNEL[59+J>!FLGBD%O%(Z&2)ROEAW3JQ-.$:RBG:+@WJ(DGDS"&26%P\4L4J20RR1.DJE7/./1:^)?CI\=/$_Q M0\1?"'XJW/PG^)&D_#_X>?$^:6$IX?O[[Q'J.E2^']2L?[4DT2*W-];1?;;I M8Q$T;3^4!,\<:M@>9?`S]D5?CWXB^#EM\2OA3JNI^$1XA^*FJZAI'BGP_(UG M$M[KYN+`WMO*IB(EC82Q),"&*JZCN*^//QVTC]GCP;I^N:U;:E=6FI:]I/AZ) M+*-'D6XU&_@L8&8.ZCRUEN$+D$D*&(5CA3^8%[_P3_\`$>D?L>^#HO"7PUU^ MR^(7C/X&^-/#?BNZDL+A-2U6X-K:#3;+49Y1O9U,?EVR7#?NT3RX]J`J/1OB M:OB']IKXT>*/%_AOX>_%*UT2]F^$$,#:WX,U+1[B5M/\6WEQ?X@NH8Y=MM%( MKRL4"JGSY,95SK1C"=6$$_M14O1SY;_2541.':-MBO^7^M?`#4_C!_P`%`M%U ML?`M-&>]^(OB*S\7O/\`"_69M2NM*GTW5;%'U#Q3=W!M-2TZ]S;NEE;V[V]M M')!$7C$(\S4^`_[%6I?$GX`_L\^%-`\`>(/A]J'A'X*ZU9S2W?A.XT6/1?%] MKJ7AR[ADE$L,:F62^LI)A+R+@1RR*SC49QYYNRLGW^Q.4O\25HI-6]Y MI-:V+J4^6HZ:?7T^URKT>C;W7+JFUJ?J[17Y0?M%?`#QS\9-&\%?$WQUX#BM M_#GQ0GU[7?$_ACQ-\*-4^(\FBWLT=C;Z%'U&TO]3TN6ROO"8M=5L;*>W@FNXVF MUN-D3==6Y"3+'*1*/W8VN%^BWU!;?2S=W"/;(D7FRJ^&:(`9(.TD$CV)Z<9K MPSQ]X.U>\_X*:?##7X=*U*70M/\`AUXIL;K44MG:TMKB;4-!>*%Y0-BR.L,S M*I(+")R`0IQ\@>&/V9CXK_:$L-,OOA-XCF^+MU\1?%EQ\0O%NH^%;@:9XC\' MW<&K):6<^K2Q?9=0LY()](BBT]9Y6@:%-T*?9GVXRE)8>+BKR<9OYQFXK332 MR4I6UM=I-:+=PCS.3=DFM/6+E]]URQZ-M)N[/T;^%7Q0T+XV_#+P_P",?#%] M_:?AOQ5IT&K:7>>3)#]JMIXUDBDV2*KKN1@=K*&&<$`\5DZ!\=M(\1_M`^)_ MAO!;:DFN>%-$TS7KN=XT%I)!?S7L4*QL'+EU:PF+`H``R8+9(7\O_P#A3-@W M[!?[+GP^G_9XQ!H'A2]AU5/$WP8UWQ1I^F>((X;6WN+>30;62SC%W=S27$D> MKW3K`BQ3E9?])9Q]!_\`!'CX6^./`.LZ?-XS\.^*M'N8O@AX"T2>;6;&X@;[ M=9S:XMQ;%Y<[I8A)%N7IR/W8NT>O,O>UOY'+C0+:ULH+R:[BMU9M2U.S9G9K*?(16``&3SBN\_9Q^/^B_M/?![ M2_&>@V^JV%IJ#SVT]AJEN+>_TN[MYY+>ZM+A`S*)H9XI8GV,Z%HR5=U(8_-' MQB_9D^*GQ5_;W^+VL^`OB;X\^#NMLN!J% ME/YHMS)"S1VTL+[;@;C\T9'S=\9_@QX@\=_`KX-V.L_#*\T7P7X:3Q/IGCCP MWXL^%FN?$^`^+)KB&3^TTL;*:VN+M9V.IRV^JQEX4%V0!$THVUOXK:UX(M=0\ MWQ1X>TVSU?4++R)5^SVMW)]I<#:K%E\OY@`RYZ.ORGU_]B[Q! M;:7\9M-OO`7B7Q)\5?B!^S%I>A:=XNU#PD$O]:U6WM]3AO;6[OX6N8(+Z13I MJ-%)>.9?*BP\JQ!AM_'GPMJO[:'C[QYJFF_#CXHKX1\30_";2I8]<\&:EI$U M[%:^*KV35(S;W4*2F."WFS,638(VWY,;!CT2I+VBIP=WS)7Z:S<+^BMK_P`, M9R247-]D^^O+2;5^NM25O*'JU^GM%?F?XQ_8%T[P[\0OB5XJT#X3O9:_X>^. MW@8>"[S3_#S12:-H,$/AF"[;3#'&#!9"%+N*`?\`!6+_`)19?M+?]DJ\4?\`IHNJ]_KP#_@K%_RBR_:6 M_P"R5>*/_31=5[_0!X!_P2=_Y19?LT_]DJ\+_P#IHM:]_KP#_@D[_P`HLOV: M?^R5>%__`$T6M>_T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`'._#CX4:!\)++5;;P]8?V?#K>K7>N7 MJ^?)+YUY=2F6>7+LQ7<[$[5PHS@`#BNBHH)P"<$^WK2T44NB22\DE9)>BT2# M=M]6V_F]6_F]6>">/?V[].\"_MM>'?A!)X?N[BRU6V@34/$@N0MKI&HW:7DN MGV3IL(8SQZ?=_,77:YM5"N9P4]%UK]I?X<>&OC+IWPYU'X@>"-/^(6L0BYL/ M#%SKMK%K-]$0Y$D5HSB9UQ'(_\`")VB>'[K1M)U:SEB;1;>2Y^P/>,+>&RT^*4PWJJYCEVL M%+?VE]$\2:1\+O$OA(^,]<\,>)O%]KJ.K^&=<\%S/:PVJW;D MBM[O/*.J46UYN.FG7WE9I/6[E9V5E]@Z1^T[\-?$'Q>U7X?6'Q#\#7OCW08# M=:GX:M]>M9=7TZ(!&,DUJKF:-`)(SN90,2*?XA5U?CYX%?1[#41XT\)'3]4T M67Q)97(U>W\F[TN)8VEOXWWX>U030EIE)11*A+#<,_(G@#]F_P"*.B?MJ)'I MG@O7_#OPX3Q-X@U[4O[=U#P]K?AF(W]O<_Z?H:*XVVL:37 MT4;,GD%O-OA[^R9\;=>^#WA3PCJOPIU/P[-\./V>O$_PL^V76O:3-!K^K3QZ M3%:O:"&Z=UMYQ92,KW"PLO(D1/E+82G)4>=+WN3FMW:A4DUY>]&$4MWS;7T7 M13IP=?V73_`!N^$26NGZI' MH=U,WC'3A';:A(',=F[>=A;AA'(1$<.1&V!\IQUVM_M!^`?#/Q>TGX?:EXW\ M(:?X]U^V:\TSPU4_/RG'R7\1OV#M?UE M/'2V'@31W74/V<(?AOI(4V2#[>IO2VG)EALCR\')Q#]WYOEXX*__`&!/BO<_ MM$R0:J/BEJ7ACQ5XF\)>+GET?6/"UIH&D2:5::=%(E_-=VL^M"XCET^1D6PS M!,LZ(9(/,GD'5&,76]FW97M?NN><+_=#VG:THQNKJ;Y%*7LN>VO+>W9\L)6\ M]9N%M'>$GWC'[JT+]I?X<>*/C'J?PZTSX@>"-1^(.BPFXU#PQ:Z[:S:S81X0 M[Y;17,T:XDC.64#$B_WAGGOB?^U;I7PB_:)T+P7KJ:?I>BZGX/UKQ??>(K_4 MTM+728=-N-.B=90ZA0C+?ES(TBA!"<@[LK\\?"?]G[XH>#_VZ[&;3?!.OZ#\ M-[/Q9KOB/4UUS4?#VM>&4-]!<'[=H$-`_MF&^^"?C?PA$?MMM;[]3U&3239V_[V1<>8+:?Y MS\B[/F94;=7I=:\IU4Z<)5Y4I.RNDGYOK[P-X_^%GBO^QM>LM`U5E\86R6^FW$]U'`;>26 M$3;;L[R(K=U4S2[(]R;]Z\W^SW_P4'^'_P"UGH>C:O\`#SQ'X.U73+WQ;J?A M*Z6[\26T=YY]DMV3]DB@\];F25;9;B.,O$3:2&?/R^6WA_[07[$OC;7_`([: M]J/A?PI!_8$T7PI@LFBO+6%?+T+Q-=WE^H5I`P%O:21L,CYP=L>]@5$7PH_9 MC^*FBZO\-K"Z\#3V"_#OXV^,O%,NH7.J6+V6H:7J=OXBDM+R(1SM-L,FI6T+ MQO&LJL6.PH-]6U",).][-VZ724->N[E*RWT>KL[8K6E?:5D_OISE;U4E&+?? MHF['MOQE_P""D?PM\$?![XM:[X.\:^`?B3XG^$.@:CKFK^%]&\56DM_`;-6W MPSK$99+;]XOEEGC.UC@@GBNS_:2_:*_X9Z^%VB>)?['_`+7_`+9\2:#X>^S? M:_L_D_VIJ=K8>=NV-GROM/F;<#?LV[ESN'YKZM^PG^T?\6O!VHC5OAYK^E7, M7P7\7>"[?0IKCP=IVAZ1JVHQV3166B0Z9MF33"]NZ1OJ%P\HVH72+YGD_0+] MMOX/>(_B]\!O"VB^'=._M#4]-\;>$=7N(?M$4/EVMCKEA=74FZ1E4[((97V@ MEFVX4,Q`-0A&]'F>\HJ7DO:-/T3BKOM??J.=K^[_`-//PC!Q_%RMM?MH=%-^ MV]\%[?Q1J.AR?%[X7IK6D6EU?W^GMXJL1=65M:O)'=32Q>;N2.%XI5D=@`C1 MN&(*G&_\1_VA_A_\'=/U&[\7>.?!WA6TT>RAU*_FUC6K:QCL;6:;R(KB5I74 M)$\W[M7;"L_R@D\5\>^$/^"?'B*]\-?#'2->\%VGV&'XR>._$WBI#=6K'^R= M6@\1V]O<,1(=_G17UDA1-SJ)`&5=C;>1UK]@7XW1?"_PWXIN[GQ,/'?@/QM9 MQPP^$[_1KC7M3\.:5IE[H]A-;OJZ-IIN97NI=2:.Z`""ZD4.LR)6'17_`+OG MN[2_\!NM_B2DWRV+J04:CC%W7O6^3ERKK\2@W?:/-#1WU^W?'W[7GPG^%/PW MT+QEXI^*'P[\->$/%`C.C:YJOB.SL]-U<21F6/[/<22+'-OC!==C'*C(R.:P M-._;W^%=_P#M*>,OA4_B[0K3Q3X$\-VGBO51<:K9QPQ6%QYS%_\`6^8/)CBC MEE+HJ)'=6S;B)!CY/U/]CCXA_"O]GSX M`=&GO/'_`.SOI/@X7?A:YL;+0=.U^P@U=);"*WEEBEBAD;4(A`R1&)50AVCP M`57DX4JLXJ[C>R[OEDTD^MG%*]E=R22V;*4(R<8R=KVU[?O(1;\KPE*5M;)- MWT9]-2_\%`_@+!87ET_QN^$26NGZI'H=U,WC'3A';:A(',=F[>=A;AA'(1$< M.1&V!\IQUVM_M!^`?#/Q>TGX?:EXW\(:?X]U^V:\TSPU4_/RG'R7\1OV#M?UE/'2V'@31W74/V<(?AOI(4V2#[>IO2V MG)EALCR\')Q#]WYOEXX*_P#V!/BO<_M$R0:J/BEJ7ACQ5XF\)>+GET?6/"UI MH&D2:5::=%(E_-=VL^M"XCET^1D6PS!,LZ(9(/,GD&\8Q=;V;=E>U^ZYYPO] MT/:=K2C&ZNIOG4I>RY[:\M[=GRPE;SUFX6T=X2?>,?LZ^_;A^#-CK^K:.?BS M\-9-;T*PO=3O]+3Q/8F]M+:S:1;N9X?-WHD+0RK(S`*C1.&(*G&A^RI^T[X1 M_;*_9[\*_$SP/?QW_AOQ;81WUM^_AEFM68#?;S>2\B)/$V8Y$#ML=&4G(KY6 M^''[#?C;PW8?"?=X5M;*\T7XU>.?&.MR_;+4F"PU*+Q'%9W;%9"7,B7E@NQ- MTBAQN5=C;?>_^";'@SQ3\+_V%/A;X/\`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``+@P_37Q(^"VO>*_P!O;P'XOBL6;PII7P_\2Z#J%\L\0-O=7E[H MTD$8C+;VW1VMP=RJ5'EX8@LH.=-R=*G*UW:=[Z7DJ;<;[67,E9?S/EYY6L5) M1YY+9:6].:SMW=O/;7EBVK>9?#S_`(*OP7NAWGBCQOX&D\'^`=7\!ZE\2_!V MJP:P-1O->T73WC^T&YM3!$+2Z,-Q9S1PK+.K)<8,B.C+7IG[*7[5WB;XS>._ M$W@[Q]X#M/AWXST'3-,\0Q:?::]_;4%WI>H"<02&8V]N4N$FM;F&:$(RHT:E M995<$?)OA+]@#XL?&OX*Z;\+?%7A7_A`[3X6?!7Q!\)],\076IV=W:>+;V_% MI:V]_;1V\LLT5JL&FQ2N+F.&4-=A%1O+9J^B?V-?!_Q$\;?M#>,/BM\0O`%] M\+[C4/"6@>#K/0K[5+'4;F9[)[ZZNKOS+.::(0--?^5$&<2,MNS/''N5:Z%& ME]EW5GOH[R]YI0YET3O97(K)*-X_%?;I_R[TOVLZCO?XE:_V7]-T445 MB(****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/ M`/\`@K%_RBR_:6_[)5XH_P#31=5[_7@'_!6+_E%E^TM_V2KQ1_Z:+JO?Z`/` M/^"3O_*++]FG_LE7A?\`]-%K7O\`7@'_``2=_P"467[-/_9*O"__`*:+6O?Z M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^';7]KK]H5?V>/'_P`;XKWX M2ZWX,\`:]XD2?P5;^$=0M=:OM+T;5;NSF\O56U62$736]H\JYL=CR8CP@;S% M^XJ^'[#]D3]H)_V>_B!\$!:?"C0O!7C_`%WQ+)/XUM?%FH7FM6.F:QJEY>2> M7I3:7'#]J$%VT*DWVQ'Q+^\"^4TOFO[GQ=+[7NM_+OUM>QM#V?*O:;:V_ M+:5[==^7;6]CZ"U/]N[X6Z-\5-%\&7/B*Z36M=-I'!*FCWTVEV\UW&9+6VN= M12%K*VN9UP8H)YDED\R+8C>;'N=X;_;J^&'BWXWO\/=/U[4)_$*W]SI$WBG:5/)F#*#%(%^=/&G_!*S5+G]J[5-:T MZVTS5O`/BCQ)H?B>[_M#XA^)=-319--AL8A`GA^Q>/3M18_V;;O'YT+4;2" M]TVW9UGOK"66!4U*V1D(,UD9X\O'\W[Q-W)7G_!7WX`Z?IU]=S>*_$<<.G64 M6KS9\#Z]O_LN3?MU9$^Q;I-+_=L#J"`VBG:&F!=<^#_`S_@D/XM^&7PR\1>% MKL:!-+I'PUUCX>>%M>OOB-XH\03:@+R&*%+AM/O&^PZ)$4MX3+;V<=T"2HCD MC2$)+[-X_P#V'/%GBK_A./L^H^'4_P"$E^",7PVM?,GF'EZBOVW,KXB.+?\` MTA/F&7X;Y.!G*I-P3<5S65^UW:J_.U^2FK/5.IK>UC?DBY)7LKV[V5Z:^=N: M@:KHMCHFHV>AZC;&8M8U*YU*^_M?1H=-LK*WNQ!:"U,-RT_V9EC+7$'D_+(3 M(3Y:6?A7_P`$M]?^'O[2\FJ7$>EZKX2TWQ7KOC+2M6OOB)XFN9X[G4Q>OY$? MAT.FD6ZIJGANY<+:W]WHE]ID M5^IC202V_P!JAB,\)5QB6(-&6#*&W(P'B/[4G[2OQM^`GC&Z\4II7@"R^&=A MXLT/PM8:%?6EQ=^(O&:W\]K;RWEI=077E6ICENF"6TEI,\@LI&9XEE4IZW^Q M+\$=1_9I_8\^%WP]UB739]7\$^%M.T2^ET]F:UEN+>VCBD>(LJ,4+JQ!95)! MR0#Q7B^M?`KX[:Q^WA<_$76O"'PF\:^%M!N4M/`JWOQ!U'3I?"-E)$(KR\73 MTT6:&;4I@TH,K7/RQ;88VB5YWEZ*D81Q2C!WBG\FDU\O>5TKZ)-O5Q1-W[&3 M>]OGK?\`+=VU=K=;$7P[_;I\?^)_C[X9OKZQ\'I\(?'?C[7OAKH]K!:7(U^S MOM+2]VW\]R9S#)!/+I5\GD+;HT8>W8S/\ZCKOV>/VRO%WQ4_:Q^+WA'Q=X(7 MX=>$O`>@:+K>C2ZM=P-J=_!=RZG'-=W/DS20V\)-B#'$6\Q4!>78S^5%QWPV M_88^(?AG]H#P[8:C=^##\'_`7Q`U[XE:'=V]]_88U'XX_&GXP7^H>*M0\,^&?B;X-\.^&8[K0) MH?[8MWT^]U.XN59+JVFMC#-'>11%760.C3JRJ""<5I2BUOR]?1:O9\RES7UM M9Z*W+;>HH.=11VNK>GM>GE[+E\[WOK]U#0H-`TGPGX MP71_#T>UA=7NER:5I]];W5P"[`23"\,@0!2B/&C*'5R?H.OG/]AW]C;QE^RY M\3_C)K7BCXG^(?B!:?$+Q)!JVG+J4.F1R)''IEC:F><6>GV@6Y+6S1[8R8?) MB@(42-*S?1E7+EY8`?\%8O^467[2W_`&2KQ1_Z:+JO?Z\`_P""L7_*++]I;_LE7BC_`--% MU7O]`'@'_!)W_E%E^S3_`-DJ\+_^FBUKW^O`/^"3O_*++]FG_LE7A?\`]-%K M7O\`0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`'@'_``5B_P"467[2W_9*O%'_ M`*:+JO?Z\`_X*Q?\HLOVEO\`LE7BC_TT75>_T`>`?\$G?^467[-/_9*O"_\` MZ:+6O?Z\`_X)._\`*++]FG_LE7A?_P!-%K7O]`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`>`?\%8O^467[2W_`&2KQ1_Z:+JO?Z\`_P""L7_*++]I;_LE7BC_ M`--%U7O]`'@'_!)W_E%E^S3_`-DJ\+_^FBUKW^O`/^"3O_*++]FG_LE7A?\` M]-%K7@8_9T\&WG[>.FW?PDTVXU;X@?#_`,2ZEXG^)WQ,NHUDO)DNK6X\KPM) M>1*ANF_TFS9+([HK2VLX&8+(UOYF';'X;^.OV<_%OAVVB3Q3\;_`(*:OXG^ M(-Y&-]QXJU2*71[F*]O2/FEG2?4;V-7?)5)S$"%"J+7_``31\*:9X$^*?[-' MB?1((H?$?QT^#6J>)/B+?1G=<>*-2CGT:YCOKUAS+/'-J-ZBR/DHDYC!"A5' M4J$N?V@Z MM.4';[O7DC/7LK32OKK?3:_Z;445\R:[_P`%%/$N@?%[2_`LO[,7Q\D\2:YI MFH:SIUO'J'@TI>65C-9P7,X(O^B3_`!`_\#-# M_P#EC0!W]%(O^B3_$#_P,T/\`^6-` M'?T5P'_"Y/$7_1)_B!_X&:'_`/+&C_A(O^B3_$#_`,#-#_\`EC0!W]%(O\`HD_Q`_\` M`S0__EC0!W]%(O^B3_`!`_\#-#_P#EC0!W M]%(O^B3_$#_P,T/\`^6-`'?T5P'_" MY/$7_1)_B!_X&:'_`/+&C_A(O^B3_$#_`,#-#_\`EC0!W]%(O\`HD_Q`_\``S0__EC0 M!W]%(O^B3_`!`_\#-#_P#EC0!W]%(O^B3_$#_P,T/\`^6-`'?T5P'_"Y/$7_1)_ MB!_X&:'_`/+&C_A(O^B3_$#_`,#-#_\`EC0!W]%(O\`HD_Q`_\``S0__EC0!W]%(O^B3_`!`_\#-#_P#EC0!W]%(O^B3_$#_P,T/\`^6-`'?T5P'_"Y/$7_1)_B!_X&:'_ M`/+&C_A(O^B3_$#_`,#-#_\`EC0!W]%(O\`HD_Q`_\``S0__EC0!W]%(O^B3_`!`_\#-#_P#EC0!W]%(O^B3_$#_P,T/\`^6-`'?T5P'_"Y/$7_1)_B!_X&:'_`/+&C_A< MGB+_`*)/\0/_``,T/_Y8T`=_17`?\+D\1?\`1)_B!_X&:'_\L:/^%R>(O^B3 M_$#_`,#-#_\`EC0!W]%\*/\`$K2[C^T[K6'LC\3?$MQI,UW_T+27,M^_]>B^X'K'E>W_``_^;^]GE/P+ M_8C^&7[-GCW6_$O@WP]<:7J^O))#*\VKWM]!8PR7,EU);V4%Q-)%8V[SRO(T M-JD4;-M)4[5Q6^$?[!WPM^!/B;Q-K'A/0-1TC4?%5M-97,JZ_J,HT^WFGEN) M8-/62=ETV)IYGE,=D(%W[6QE$*^OT4N562[)KY/=>CZH;=VV^K3?FU:S]596 M?2R/(?C-^PA\+OV@]<\-ZEXPT#4-8O?"UJEC;2'7M1@^WVJS0SBVOQ%.HU&# MSH(I#%>B:,L&)4EV+6/%_P"Q'\,O'?[06G?%#5/#UQ<>,=->VF25-7O8;"XF MM5F6UN+BP286ES<0">41330O)%E=C+M7'JU%4F]'V;:\F]6_5O=DV5FNC5GY MKMZ>05X!\1O^4IOP;_[)5X\_]._@RO?Z\`^(W_*4WX-_]DJ\>?\`IW\&4AGO M]%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!7`?!O_`)*+\6/^QJ@_],>E5W]RT^2XLKJR@>RLQ+$#>D"\5GFA)B M0A4#.YD6)77-R];-_**$[OQMX1U&U\2#5;A]/MI[>*2/5+?[-"+"ZVW=NPCC MDN8]WG(90T>&N_LH?\%`]1_:,^(^@:=J_@-/"7A[XD>&KCQC\/M4&M_;I]>T MRWN(8I#=V_D1BRG,=W93I$DMP&CN#ET>-DJU"3:26]_PYKW[/W):/5\KMLQ2 M]V]^EE]]K6[K5:K17U/I>BOFK]KW]O[4_P!F_P`:Z[IV@>`D\:6'P\\,1>-_ M'EV^M_V=)HFC27$T0>TB$$OVR[\NTO9O(=H$V6V/.#.BFM\0O^"B]SX2^-MY MIVF^"8-8^&GAGQ)HGA#Q1XM.N>1<:;J6KI;M:"WL?(87,"&^T\32M<0E/M>5 M27RWPH)S:4>KLOOY?DF]$WHW9)CFG&_,ME?\$].[LT[+6S6FJ/IZO`/B-_RE M-^#?_9*O'G_IW\&5[_7@'Q&_Y2F_!O\`[)5X\_\`3OX,I"/?Z***`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N` M^#?_`"47XL?]C5!_Z8]*KOZX#X-_\E%^+'_8U0?^F/2J`//_`/@K%_RBR_:6 M_P"R5>*/_31=5[_7@'_!6+_E%E^TM_V2KQ1_Z:+JO?Z`/`/^"3O_`"BR_9I_ M[)5X7_\`31:UH?$/X/\`B77OV^_`/C6QM-OAS1?`'B31+O4?.B_T6]N[W1I; M9/*+!VW):7#952H\O#$%E!S_`/@D[_RBR_9I_P"R5>%__31:U[_2<4VF_P"\ MO_`HRB_PD[>=BE)I-+R_!I_H?`?_``3V_8X^('PK^,V@S:U\/-0^'_\`8W@K M4-!^(?BB;7K.];XP:Y+,?A;#XP^'U_HFF_LV_#;4O`]E>1ZKIUS_P`)]*FW;&[U]RT5HIR5FGT:Z=>?6VRM[222225UIHK#E=M]W?\` M*ZON[V5V[OLUH?$'[<7P$^*GC7QM\2Y/!7P^OO$-G^T1\+;3X?WEQ)JNG6O_ M``@EW'-?J;F^62X4RVX@U>9S]C^T2;[(J$(D5JH?$K]DGXE0?%?QC\/-&\'7 M6J^`OB9\0/"7CJ7QO_:=C':Z!!I4>EB\M)[9YENGN'.B0B$PP21'[<-[Q^4V M?NZBBG-PDIQW3^]*2FD_)22MULK-O6Y.4I;O6VGD^6,;KSM&.]UIMJPKX4^) M/[`7@5_^"EWPLTTZ]\;/L^J?#?QMJ$SCXQ^+Q<))%JOA-56*;^T_-AB(N)-T M,3+'(5B+JQAB*?==>`?$;_E*;\&_^R5>//\`T[^#*@D/^':?PZ_Z&/\`:`_\ M/MXX_P#EM1_P[3^'7_0Q_M`?^'V\./\` MY;4?\.T_AU_T,?[0'_A]O''_`,MJ]_HH`\`_X=I_#K_H8_V@/_#[>./_`);4 M?\.T_AU_T,?[0'_A]O''_P`MJ]_HH`\`_P"':?PZ_P"AC_:`_P##[>./_EM1 M_P`.T_AU_P!#'^T!_P"'V\./_EM1_P[3^'7 M_0Q_M`?^'V\./\`Y;4?\.T_AU_T,?[0'_A] MO''_`,MJ]_HH`\`_X=I_#K_H8_V@/_#[>./_`);4?\.T_AU_T,?[0'_A]O'' M_P`MJ]_HH`\`_P"':?PZ_P"AC_:`_P##[>./_EM1_P`.T_AU_P!#'^T!_P"' MV\./_EM1_P[3^'7_0Q_M`?^'V\./\`Y;4?\.T_AU_T,?[0'_A]O''_`,MJ]_HH`\`_X=I_ M#K_H8_V@/_#[>./_`);4?\.T_AU_T,?[0'_A]O''_P`MJ]_HH`\`_P"':?PZ M_P"AC_:`_P##[>./_EM1_P`.T_AU_P!#'^T!_P"'V\./_EM1_P[3^'7_0Q_M`?^'V\./\` MY;4?\.T_AU_T,?[0'_A]O''_`,MJ]_HH`\`_X=I_#K_H8_V@/_#[>./_`);4 M?\.T_AU_T,?[0'_A]O''_P`MJ]_I'<1H68A549))P`*`/`?^':?PZ_Z&/]H# M_P`/MXX_^6U'_#M/X=?]#'^T!_X?;QQ_\MJX[]J#_@M_^R_^R9J;Z3XA^*^A M:UXH#>5'X>\+[]?U66;M"8;02>7(>PE*=N>17D7_``\L_:T_:V)B_9]_9+U' MP=HERN;?Q?\`&K41H-NF?NO_`&5`6NY$/W@R.1CL,B@#Z._X=I_#K_H8_P!H M#_P^WCC_`.6U?"7QG\<_LH0ZSJ%]\0?VB?BI\*_`^C7$UA8Z-J/QP\7R^*M5 MU."4J+Z73+C4)KFRCL[F,/"DENLK30K)(%C54F]?;_@DC^T%^U:/._:4_:Y\ M?!O@?PCXVMMMA>ZCXIL9?$8O+2:5/M%SON6>9+R(%YHC&Z)*Z^5*!&ZO M"`?)/P1_X*:?L)"UO=!\=?M'_%QM9T5Q'%KEE\7?B2NG^(X,#;7M) M`_W7#;&DCPU=Y_P\7_X)P?\`1S_Q@_\`#P?$K_Y-K]&/A+^RAX"^#?@Z/1]- M\.Z;>,TC7-[J%_:Q7%]JMR^#)%?\`H6?# M_P#X+H?_`(F@#\P?^'B__!.#_HY_XP?^'@^)7_R;1_P\7_X)P?\`1S_Q@_\` M#P?$K_Y-K]/O^%3>%?\`H6?#_P#X+H?_`(FC_A4WA7_H6?#_`/X+H?\`XF@# M\Q]._P""@_\`P3CU2]CMXOVH?BRLDIP#-\9OB/"@^KO?A1^)%;/_``V9_P`$ M\?\`HZ?X@?\`A_O'G_RSK]&-2^"?@S6;&2UO/"/AB[MI1AXIM+@D1QG/*E<' MD5C?\,F_"O\`Z)I\/_\`PG;/_P"-T`?`'_#9G_!/'_HZ?X@?^'^\>?\`RSH_ MX;,_X)X_]'3_`!`_\/\`>//_`)9U]_\`_#)OPK_Z)I\/_P#PG;/_`.-T?\,F M_"O_`*)I\/\`_P`)VS_^-T`?`'_#9G_!/'_HZ?X@?^'^\>?_`"SJUI'[6W_! M/;6[U;>']JKQNDC`D&X_:&\<6Z(/\`Q)OQ=_\`+BC_`(:!_8"_Z.P\0?\`B3?B[_Y<5]@?\.]O@%_T0_X/ M_P#A&Z=_\9H_X=[?`+_HA_P?_P#"-T[_`.,T`?'_`/PT#^P%_P!'8>(/_$F_ M%W_RXH_X:!_8"_Z.P\0?^)-^+O\`Y<5]@?\`#O;X!?\`1#_@_P#^$;IW_P`9 MH_X=[?`+_HA_P?\`_"-T[_XS0!\F:)\9/V"?$%RT4'[6FJ1NB[R;G]J?Q3;+ MC('#2:VH)YZ`Y_*M/_A-OV$_^CN?_-N?$/\`\OJ^D];_`.":7[./B:W2+4OV M?_@EJ$4;;U2Y\#:7*JMC&0&@.#@UF?\`#IW]EC_HVG]G_P#\-YI'_P`CT`?/ M_P#PFW["?_1W/_FW/B'_`.7U'_";?L)_]'<_^;<^(?\`Y?5]`?\`#IW]EC_H MVG]G_P#\-YI'_P`CT?\`#IW]EC_HVG]G_P#\-YI'_P`CT`?/.H_$3]A#2]/G MN9?VMYFCMXVE<0_M9^(YI"%&2%1-=+,W'"J"2>`":\S^!OB#X0?&CQAJ7C31 M/BYXU\7?#)K.-[KP]X;_`&D_%FJ^)/!5DCL%US4(K?6W<03&55FAQNM$BA5K_Q5\%^%K'1 MSKVG@VTUS9V*Q0#R]0$5SI.9&&596&KX*D$$$<$&IO\`AVG\.O\`H8_V@/\`P^WC MC_Y;5Z[\)OA+X:^!7PYTGPCX0T:Q\/\`AO0H/L]C86B;8H5R6)]69F+,SL2S MLS,Q+,2>BH`\`_X=I_#K_H8_V@/_``^WCC_Y;4?\.T_AU_T,?[0'_A]O''_R MVKW^B@#P#_AVG\.O^AC_`&@/_#[>./\`Y;4?\.T_AU_T,?[0'_A]O''_`,MJ M]_HH`\`_X=I_#K_H8_V@/_#[>./_`);4?\.T_AU_T,?[0'_A]O''_P`MJ]_H MH`\`_P"':?PZ_P"AC_:`_P##[>./_EM70?LE?#33O@_=?$KPYI-SX@N]/T[Q M4GE2ZWKM]KE^^_1],D/F7E[--*/_ M`$T75>_T`>`?\$G?^467[-/_`&2KPO\`^FBUKW^O`/\`@D[_`,HLOV:?^R5> M%_\`TT6M>VW/C'2+/Q9::!-JNFQ:[J%K-?6NG/WJ=917) M_$?X]>!O@[K?A[3/%WC3PGX5U+Q=>#3M"M-8U>WL9]:NB5406R2NK3RDN@V1 MAFRZC'(HUWX]>!O"WQ6T;P'J?C3PGIWCCQ'`]SI/AVZU>WAU;5(D#EY(+5G$ MLJ*(Y"612`$;/0T+7;T^Y7?W+7T!Z:OU^6USK*\`^(W_`"E-^#?_`&2KQY_Z M=_!E>_UX!\1O^4IOP;_[)5X\_P#3OX,H`]_HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MN9^*_P`:?!WP'\)RZ_XX\5^&_!VAP?ZS4-;U*'3[5.,\R2LJY_&@#IJ*^!_& MG_!P_P#!WQ#XDN_#?P,\+_%#]ICQ7;'RWM?A]X;GN;"V<]#/>RA(DCYYD3S% M&?KC*;6O^"C'[9)Q8Z7\(/V0_"UV!B:_E'C;Q9`IZ,J*%L>G)5PK`D#UH`_0 M'Q#XCT_PCHEUJ>K7]GIFFV49EN+N[G6""W0=6=V(50/4FOC#XW?\'!W[-'PN M\5/X8\*>)M:^-WC8@F'PY\,-(E\37ER1QA)8?]&)S@8\[(]*YGP[_P`&\WPY M^(^N6VN_M$_$CXN?M-:_`XE6/Q?XAFM]$MI!WM]/MF1(E[[&=U.3QS7V?\$O MV=?`'[-?A1="^'G@KPKX'T=<9L]"TJ"PA:`/B,_M3? MM\_MAYC^&7P%\"?LZ^&;E<)X@^*>L-J.KNA_CCTVS&8)1V2XW*?7GAP_X(2: MS^TDYN?VI_VE/C!\O444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%8WCSXC^'OA9X?EU;Q/KVC>'-*@_U ME[JE[%9V\??F21@H_$T`;-%?&'Q@_P"#@_\`9#^$&JC3!\8M&\9:W*QCMM-\ M&VMQXCGNW&3L1K..2+.`>K@<=:XP?\%D?C%\<%V?`[]B7X[>*$FX@U+QY+:> M!M.D7_GJKW+2-(@Z@``MC`P:`/T"HK\_3X3_`."DG[1!/V[Q;^SG^SKI,WW/ M['TRZ\6Z[;9Z[_M!6S;`Z;>ISFC_`(<5:U\9!O\`CM^UC^T?\5@_,VE:?K:> M%M!N#W+V5HI_#$@P"1SF@#ZN^/7["I(AG[/K&O6UK< MO[)"SB1S[*I-?+>M_P#!QU^S[X@U2;3?A/I7Q>_:!U>!O*>T^'7@:^U'RY.R MF2988R.0@I<)=KIOB+2+?5+-9E#!91%.CIO`9@&QD!CSR:\L_X=._LL?]&T_L__ M`/AO-(_^1Z`/9?AQ\0M'^+?P^T/Q5X>OHM3T'Q)80:GIUW']RYMYHUDC<9YP M58'GGFMJL/X;_#+PW\&_!%AX9\(>'M#\*>&]*1H[+2M'L(K&QLU9B[+'#$JH M@+,S$*!DL3U-;E`!1110`4444`%%%%`!7`?!O_DHOQ8_[&J#_P!,>E5W]*/_`$T75>_T`>`?\$G?^467[-/_`&2KPO\`^FBUKS'QM\$=+^&/ M_!770?%V@QZM>^+_`!=\*?%TES=7^IW-\S>1J.A&VMH$E=DMX(VED*PPJB;I M'8@N[,?3O^"3O_*++]FG_LE7A?\`]-%K7MMSX.TB\\66FOS:5ILNNZ?:S6-K MJ+VR-=VUO,T;RPI*1O6-VAA9E!`8Q(2"5&(E"\KWMI-:;^]"4?P;3^1I"IR[ MJ^J=GMHT]?N/SQ_X)=^*/$O@7PU^SOX8UC2/A1J\GBSX3ZCJNAW>C:3+#XE\ M*7$)L#J*7EU-(_VG[7=W"M.RPVNRYB".LS8<6/\`@FY_9O\`PF?['?\`87V7 M^U/^%#ZW_P`)5]GQYWF_;=$W_:N_F?VC]OSN^;S?M/??7W/X%_9X^'_PO\>^ M(?%7AGP-X.\.^*/%T@EUW6-,T6VM+_6G#%@US/&@DF.YF.9&;DD]Z@\*?LR? M#;P)JOB^_P!#^'O@?1K[X@NTGBFXL="M;>7Q*S&0LUZR(#.=_;/G]K97]YV[-JJDD^BM5U=KOE6FMUE&-HN+=]M7U7NW;\[QNELF[WTL? M$W_!2;^R?^%@_M;?\))]D^T?\,ZV7_",_:L>9YGVS6O,^S=]_P!M_LO.WYO, M^R]]E<]\4_\`D(?&S^U_)_X69_PO/X9?V5YNW^T/+\KP[Y/E=]F/[7QCY$KKQ#\/O!&NW/@&59_#$VHZ%:W4GAR13&5>R9T) MMF!BBP8MI'E)_=&+&M_L^>`?$WQ>TGX@ZEX(\(:AX]T"V:STSQ+/N7VUNX^9U]?"GQ)_:I\=+_`,%+OA9>#]FKXV-<6/PW\;6L-B-4 M\(?:-0CDU7PF6N8C_;GE"*,Q1JPE=)";F+9&X$IB^ZZ\`^(W_*4WX-_]DJ\> M?^G?P94$A_PV1\1?^C3OV@/_``;^!_\`YH:/^&R/B+_T:=^T!_X-_`__`,T- M>_T4`>`?\-D?$7_HT[]H#_P;^!__`)H:/^&R/B+_`-&G?M`?^#?P/_\`-#7O M]%`'@'_#9'Q%_P"C3OV@/_!OX'_^:&C_`(;(^(O_`$:=^T!_X-_`_P#\T->_ MT4`>`?\`#9'Q%_Z-._:`_P#!OX'_`/FAH_X;(^(O_1IW[0'_`(-_`_\`\T-> M_P!%`'@'_#9'Q%_Z-._:`_\`!OX'_P#FAH_X;(^(O_1IW[0'_@W\#_\`S0U[ M_10!X!_PV1\1?^C3OV@/_!OX'_\`FAH_X;(^(O\`T:=^T!_X-_`__P`T->_T M4`>`?\-D?$7_`*-._:`_\&_@?_YH:/\`ALCXB_\`1IW[0'_@W\#_`/S0U[_1 M0!X!_P`-D?$7_HT[]H#_`,&_@?\`^:&C_ALCXB_]&G?M`?\`@W\#_P#S0U[_ M`$4`>`?\-D?$7_HT[]H#_P`&_@?_`.:&C_ALCXB_]&G?M`?^#?P/_P#-#7O] M%`'@'_#9'Q%_Z-._:`_\&_@?_P":&C_ALCXB_P#1IW[0'_@W\#__`#0U[_10 M!X!_PV1\1?\`HT[]H#_P;^!__FAH_P"&R/B+_P!&G?M`?^#?P/\`_-#7O]%` M'@'_``V1\1?^C3OV@/\`P;^!_P#YH:/^&R/B+_T:=^T!_P"#?P/_`/-#7O\` M10!X!_PV1\1?^C3OV@/_``;^!_\`YH:/^&R/B+_T:=^T!_X-_`__`,T->_T4 M`>`?\-D?$7_HT[]H#_P;^!__`)H:/^&R/B+_`-&G?M`?^#?P/_\`-#7O]%`' M@'_#9'Q%_P"C3OV@/_!OX'_^:&C_`(;(^(O_`$:=^T!_X-_`_P#\T->_T4`> M`?\`#9'Q%_Z-._:`_P#!OX'_`/FAH_X;(^(O_1IW[0'_`(-_`_\`\T->_P!% M`'@'_#9'Q%_Z-._:`_\`!OX'_P#FAH_X;(^(O_1IW[0'_@W\#_\`S0U[_10! MX!_PV1\1?^C3OV@/_!OX'_\`FAH_X;(^(O\`T:=^T!_X-_`__P`T->_T4`>` M?\-D?$7_`*-._:`_\&_@?_YH:/\`ALCXB_\`1IW[0'_@W\#_`/S0U[_10!X! M_P`-D?$7_HT[]H#_`,&_@?\`^:&C_ALCXB_]&G?M`?\`@W\#_P#S0U[_`$4` M>`?\-D?$7_HT[]H#_P`&_@?_`.:&C_ALCXB_]&G?M`?^#?P/_P#-#7O]%`'@ M'_#9'Q%_Z-._:`_\&_@?_P":&C_ALCXB_P#1IW[0'_@W\#__`#0U[_10!X!_ MPV1\1?\`HT[]H#_P;^!__FAH_P"&R/B+_P!&G?M`?^#?P/\`_-#7O]%`'@'_ M``V1\1?^C3OV@/\`P;^!_P#YH:/^&R/B+_T:=^T!_P"#?P/_`/-#7O\`10!X M!_PV1\1?^C3OV@/_``;^!_\`YH:/^&R/B+_T:=^T!_X-_`__`,T->_T4`>`? M\-D?$7_HT[]H#_P;^!__`)H:/^&R/B+_`-&G?M`?^#?P/_\`-#7O]%`'@'_# M9'Q%_P"C3OV@/_!OX'_^:&C_`(;(^(O_`$:=^T!_X-_`_P#\T->_T4`>`?\` M#9'Q%_Z-._:`_P#!OX'_`/FAH_X;(^(O_1IW[0'_`(-_`_\`\T->_P!%`'@' M_#9'Q%_Z-._:`_\`!OX'_P#FAH_X;(^(O_1IW[0'_@W\#_\`S0U[_10!X!_P MV1\1?^C3OV@/_!OX'_\`FAH_X;(^(O\`T:=^T!_X-_`__P`T->_T4`>`?\-D M?$7_`*-._:`_\&_@?_YH:/\`ALCXB_\`1IW[0'_@W\#_`/S0U[_10!X!_P`- MD?$7_HT[]H#_`,&_@?\`^:&C_ALCXB_]&G?M`?\`@W\#_P#S0U[_`$4`>`?\ M-D?$7_HT[]H#_P`&_@?_`.:&C_ALCXB_]&G?M`?^#?P/_P#-#7O]%`'@'_#9 M'Q%_Z-._:`_\&_@?_P":&C_ALCXB_P#1IW[0'_@W\#__`#0U[_10!X!_PV1\ M1?\`HT[]H#_P;^!__FAH_P"&R/B+_P!&G?M`?^#?P/\`_-#7O]%`'@'_``V1 M\1?^C3OV@/\`P;^!_P#YH:/^&R/B+_T:=^T!_P"#?P/_`/-#7O\`7@'[67_! M5#]GC]AV*Y7XG_%SP;X:U"U&7TD7GVS5OPLH`]P1[^7CWH`/^&R/B+_T:=^T M!_X-_`__`,T-'_#9'Q%_Z-._:`_\&_@?_P":&OG!_P#@LS\7/VH]UO\`LP?L MF_$[QI93`"#Q?X^:/P=X>93_`,MX?/)ENHQ_=38_7CCE6_8$_;1_:^W2?'#] MJ6S^$_A^['[[PK\$]*-C*JGJ!K%V#=(P'!`5E))(Z<@'H/[1_P#P66TO]D'0 M#J7Q/^"GQ.\"VQC,D:ZQXL\!6T]R.>(H3XC\R4\'Y8U8\'CBO&OAC_P<<7'[ M8&@R']G7]DW]HOXGZIYABCGU2ST_0M`5N@$FJ"YN(4Y]1R`3GBO.O%\KB6X\1^.;B3Q)J5S*.DI:Z+QI)_M11H:^OK6UBL;: M.&&..&&%0D<:*%5%`P``.``.U`'Y%>-/&W_!4/\`:>\1W5GXG\`Z[\`/!K-M M6'X9#PCK^L7<7='O-2UV'R7])(44C`^7KG0^%'_!*OX>>&_%D7BGXD_LB?M8 M?M"^-E`+Z[\4?&O@[7W8Y!8?9V\1+;%"1PKQ-@<9ZY_6BB@#YK\%_M(>*OAO MX;MM&\._L;?&O0='LEV6]CIU[X$M;:!?1(T\0!5'L!6K_P`-D?$7_HT[]H#_ M`,&_@?\`^:&O?Z*`/`/^&R/B+_T:=^T!_P"#?P/_`/-#1_PV1\1?^C3OV@/_ M``;^!_\`YH:]_HH`\`_X;(^(O_1IW[0'_@W\#_\`S0T?\-D?$7_HT[]H#_P; M^!__`)H:]_HH`\`_X;(^(O\`T:=^T!_X-_`__P`T-'_#9'Q%_P"C3OV@/_!O MX'_^:&O?Z*`/`/\`ALCXB_\`1IW[0'_@W\#_`/S0T?\`#9'Q%_Z-._:`_P#! MOX'_`/FAKW^JNKZY9>'[1)[^\M;&"2>&V62XE6)&EED6**,%B`6>1T15ZLSJ M!DD"@#PK_ALCXB_]&G?M`?\`@W\#_P#S0T?\-D?$7_HT[]H#_P`&_@?_`.:& MO?Z*`/`/^&R/B+_T:=^T!_X-_`__`,T-'_#9'Q%_Z-._:`_\&_@?_P":&O1O MC1^T[\-OV;],%Y\0OB!X*\#6K+O677];MM.5Q_L^FV01I`V2#C$IZ4`>V?\-D?$7_HT[]H# M_P`&_@?_`.:&C_ALCXB_]&G?M`?^#?P/_P#-#7S\?^"F'[67QY8+\(?V)?%6 MB:;/]S6OBKXGM/#1M_0R:,O`5Y?ICUMH/$3S?^.5 M(O\`P;Q_#KXI2^?\*O'-S!I/NL5K9^3Y2=]H<\YKZ$^` M7_!++]G#]EX6[>!/@E\-M!O+7'EWZZ'!<:@,=,W4JO.?Q>@#Y.^%/_!RSX?_ M`&FM$\_X1_LL?M;>/YY@/L\T/A"TBTQL]#)>)>2QQK[D$5F_&/\`;J_X*:>- M"H^''[%/A'P=87&,77B'Q[I&M7<:'^,0I?V85\<[')`/!)K]/Z*`/Q^'P$_; ML^.V&^,'C#]KO3K"7UWQOXE$#9/K%7ZT44`?)GP>\=O^SS MI9L?`/["?Q.\$6;*$:#05^'^FQLH[$0Z\H/0=:[3_ALCXB_]&G?M`?\`@W\# M_P#S0U[_`%7U75K70["2ZO;FWL[6+&^:>01QID@#+'`&20/J:`/"/^&R/B+_ M`-&G?M`?^#?P/_\`-#1_PV1\1?\`HT[]H#_P;^!__FAKHO'/_!0+X#?#!V7Q M+\;?A'X>9>"NI>,-.M2.2!Q),.X(_`UXKX[_`.#@G]C+X=)(VH?M!>![@1C) M_LLW&J$_+NX%K%)GCT[\=>*`/2/^&R/B+_T:=^T!_P"#?P/_`/-#1_PV1\1? M^C3OV@/_``;^!_\`YH:\$/\`P)%!\#VGQC^)P<$Q?\(M\.=5N//&W< M-OG119R,D>RD],95_P#@MWXN\7!AX*_8F_;`UF.N`#UWXE_P#!1G7_`(+^![_Q/XQ_9P^,?A/PWI2J][JVL^)_`5A8 MV:LZHIDFE\1JB`NRJ-Q&2P'4BO'[?_@XB^$-Y<1Q1:"\LLK!$1/BS\,69V)P M``/%/))KR/\`;@_;F_:]^*GP=T2UD_8J?P+H@^(/@JXM]8\0?%'2Y&DO8O%> ME/9VK6D$;2JL]TMO$9ZCJ_V[^S)P%E,B"#R?+$I)4[@QC`S\Q`!],?\-D?$7_HT M[]H#_P`&_@?_`.:&C_ALCXB_]&G?M`?^#?P/_P#-#7O]%`'@'_#9'Q%_Z-._ M:`_\&_@?_P":&C_ALCXB_P#1IW[0'_@W\#__`#0U[_10!X!_PV1\1?\`HT[] MH#_P;^!__FAH_P"&R/B+_P!&G?M`?^#?P/\`_-#7O]%`'@'_``V1\1?^C3OV M@/\`P;^!_P#YH:/^&R/B+_T:=^T!_P"#?P/_`/-#7O\`10!X!_PV1\1?^C3O MV@/_``;^!_\`YH:Z#]DKQEJ/Q`NOB5J^K>$_$'@;4+OQ4GFZ)K8UE<7-L=ZJ''ES/\`*Z[MK;E7U^N`^#?_`"47XL?]C5!_Z8]*H`\__P"" ML7_*++]I;_LE7BC_`--%U7O]>`?\%8O^467[2W_9*O%'_IHNJ]_H`\`_X)._ M\HLOV:?^R5>%_P#TT6M>_P!>`?\`!)W_`)19?LT_]DJ\+_\`IHM:]_H`**** M`"BBB@`KP#XC?\I3?@W_`-DJ\>?^G?P97O\`7@'Q&_Y2F_!O_LE7CS_T[^#* M`/?Z***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HKSG]H M/]K_`.%7[)^B?VA\3/B+X,\"VS(9(_[;U>"SDN!_TSC=@\AX/"`DXZ5\@ZK_ M`,'#_P`._BEJ0RS:?/:VK,L=NSNQM?1?V&?^"8OA+X/: ME8Z[J/PA^&WPQ;PS#_AA;Q^$=&5>\,LZ!I[N M,GG]X%;WX&/H']E'_@D;^S=^Q/+%=?#KX0^$=)UB$AQK-Y;G4]6W=2PO+HR3 MJ23DA7`SCC@8^C:*`"BBB@`HHHH`****`"BBDDD6&-G=E5%&68G``]30`M%> M$_&S_@J!^SG^SF)E\:_&_P"%^@W4#%7LIO$5K)>@CJ!;H[2G'?"<5\]WG_!Q M]^S]XLNY;7X5Z)\:OCU>PL4:W^'WP^U"_;<#C`:=($//<,1[T`??5%?GSJ?_ M``4Y_:T^)=A+(=2C7&>4U.X1'D`'1`0:`/UE MKC_BS^T+X!^`FG?;/'7CCP?X+M`AE\_7M9MM.CV#.6W3.HQP>?8U^+'COXT_ MLI:I=2E<3O>_P#"N-6\4O>MA3N8:G,(R",G&T*0 MC<>H!]X_$W_@XC_8_P#AQJO]F6WQ=L?&>MR';;Z;X0TR\U^:[;^[&]K$\1/U M<"OS[_X*'?\`!Q/X`_;9UZV^%G@SP3XVL;#PY=3WNJKXK\4Z/\/9WUB%"-,* MS7US^[2TNC]L.]0PN+*U!0INS]>?#+]O[XJ>#M'.G_!#_@FW\1M"LG&([;4K MO1/`T#'D`,IW!1D=<<`Y],_/'_!-B^_X*1:?X.\=7_@#X4_LI>%=,\9_$KQ7 MK6N7?BF\U*:Z?63K=U;Z@CFSO'#)!<0RP1E4P8K53ERP=P#UC]D7]KW]N[_@ MI_\`!U/$/P_U[]E#X:^'+&]N-!U36+2^N/%^JIJ%JWES>6D#FQ",<2KEV#1R MPNC,CACZA_PYC^*?QL/F?'/]M/X^^,XY>9M,\&-:^!M+G'>.2&U5R\?MN!.` M,K*&L[FR5_-8EY8&X"*H;W;_AVI^U_XW'_%8?M^>*%BD!+6OA?X M9:/HOD9`RJS!GD8!@,,W.,],F@#LO@O_`,&__P"R)\$]2_M&W^"_A[Q3K+L) M)]2\7RS^([BYD'\;"]>5`W3[J*..E?6/A'P3H'PO\-KIN@Z1I'AW2+4%EM;" MUCM+:$8Y(1`%'`';M7P]_P`.(Y_%1+^,_P!K[]L[Q.SY\RVB^(8TRP?Y@P/D M00#D'./FX!`QP*(?^#:7]DS5Y(I/%OA7QM\0IH6$B2>)?'>LW7S*25)5+E%. M`2N"",$Y!R:`/JWQ[^V?\'?A7YG_``E'Q8^&GAOR06D_M3Q/96>P!0Q)\R5< M#:0?H_#5G/]EZH-5S@@ISGKQGH,>S^!/V./ MA#\+50>&/A7\-_#@B&U!I?AFRLP@V[<#RXQ@;>/IQ0!\GM_P`M9NOF#;2`7MD!QE3D$CYA@G--7_@NS>^+HT7P7^QY^V;X MD:4@17-S\/UTJPDR2O$\]P.C@`_+@#))XK[Y1!&@50%51@`#``I:`/@4_P#! M2;]L/QOQX0_8$\11P2`;;OQ1\4-'T?R`+C5=GS9X^VRC/!(Y/\`"OJ334_X)7_M/^-(U7QO^W]\ M4=0#$>;_`,(OX(T?PR6'(.TQ!RIVG&>?F&[T`^^J*`/@4_\`!`70O%*Y\;?M M._MC^/!(/WMMJ?Q.EBLB2N&"0P0H$4\$C)Z#GKFQIW_!M'^QRU\+W7?AIK'C M+4@6)O/$'C'6;V5MP&[(-T$.3EL[5%`'S+X%_X(O_`+)GPZ_P##-KJ#H<@Y!N$<@@@8(Y':O9_`7[.'P\^%7E_\(OX#\&>&_*(* M?V7HEM9[""6!'EHN,$D_4FNSHH`****`,#XG_"GPO\;O`M_X7\:>&]`\7^&= M4""]TC6M/AU"QNPDBR)YD,JLC[9$1QN!PRJ1R`:\@3_@E!^RU&X9?V:O@`K* M<@CX>Z0"#_X#U[]10`4444`%%%%`!1110`4444`%E5W]O+*\TZ`FUAAF?RK14 MO3\UPJR2O]U$1`\UG_@D[_RBR_9I_P"R5>%__31:U?\`C=^RYK7Q<_:>T+Q; M;:_+X>T6S^'WB3P?<7FFW)AUJRN=3N-+>&YM"T3Q!HELICO?.US%\CC=A)M5 M$[75IZ;*_)+EU_Q6MZEQ47%INVVOS5_PN8/[.G[<-[\?/VN?C#X2BTJSM?`? MP^T;2;[1=74E[C77FN=4M[R<8);OXL^+?&'@:_\#Z+X1T[2]4MM%@F MVV4E^=DRV.EVH6*&.YC$)BD#,99_-#A8=N;^R'^Q1\4O@IXO\&2>*I?`5_H_ MP+\#:AX&\`_V;JEW]H\1Q7$]MLNM2#VJK9.MMIUE$8X3=`O)/)NP$0Z1Y(U+ MMWBD^G]VI>ZUU84_><[:)N-MNT-GVOS\S?3SL:'[;7[:OQ$^#O MCSQU;?#^P\&S:3\%O`UO\1/&":Y:W$]SKEG+/=@:?8O%/$MK-]GTZ]?[1*LZ M!V@7RB"S#.^(_P"WYXYTSXO:[K.@6?A!OA#X`\9^'/`_B""\L[E]>U2?6([$ M_;+6=9UA@CMFU:PS$\$S3!+C#Q83,O[8O[&'Q3^-'B_Q==^#9O`5C8_&SX?V MWP]\=?VKJ=T)O#L,4]R?MNG!+5A>N(-2OT\J;[*I9+=]X&]*K_$7]@3Q]JGQ MF\0:+H5UX-3X-^/O&/AKQQKUS>7]TOB#3;G1TL@UE;6ZV[0SQ7!TG3OWSW$3 M1![G$;VG/OY7]RQ M]D5X!\1O^4IOP;_[)5X\_P#3OX,KW^OA3XD_\$U?VL?#?QMJ5_9GP/IGV>^NH=5\)I#<2Q^1M>6-;FY578%E%Q*`0';.9)]UT5X! M_P`.G?V6/^C:?V?_`/PWFD?_`"/1_P`.G?V6/^C:?V?_`/PWFD?_`"/0![_1 M7@'_``Z=_98_Z-I_9_\`_#>:1_\`(]'_``Z=_98_Z-I_9_\`_#>:1_\`(]`' MO]%>`?\`#IW]EC_HVG]G_P#\-YI'_P`CT?\`#IW]EC_HVG]G_P#\-YI'_P`C MT`>_T5X!_P`.G?V6/^C:?V?_`/PWFD?_`"/1_P`.G?V6/^C:?V?_`/PWFD?_ M`"/0![_17@'_``Z=_98_Z-I_9_\`_#>:1_\`(]'_``Z=_98_Z-I_9_\`_#>: M1_\`(]`'O]%>`?\`#IW]EC_HVG]G_P#\-YI'_P`CT?\`#IW]EC_HVG]G_P#\ M-YI'_P`CT`>_T5X!_P`.G?V6/^C:?V?_`/PWFD?_`"/1_P`.G?V6/^C:?V?_ M`/PWFD?_`"/0![_17@'_``Z=_98_Z-I_9_\`_#>:1_\`(]'_``Z=_98_Z-I_ M9_\`_#>:1_\`(]`'O]%>`?\`#IW]EC_HVG]G_P#\-YI'_P`CT?\`#IW]EC_H MVG]G_P#\-YI'_P`CT`>_T5X!_P`.G?V6/^C:?V?_`/PWFD?_`"/1_P`.G?V6 M/^C:?V?_`/PWFD?_`"/0![_17@'_``Z=_98_Z-I_9_\`_#>:1_\`(]'_``Z= M_98_Z-I_9_\`_#>:1_\`(]`'O]%>`?\`#IW]EC_HVG]G_P#\-YI'_P`CT?\` M#IW]EC_HVG]G_P#\-YI'_P`CT`>_T5X!_P`.G?V6/^C:?V?_`/PWFD?_`"/1 M_P`.G?V6/^C:?V?_`/PWFD?_`"/0![_17@'_``Z=_98_Z-I_9_\`_#>:1_\` M(]'_``Z=_98_Z-I_9_\`_#>:1_\`(]`'O]%>`?\`#IW]EC_HVG]G_P#\-YI' M_P`CT?\`#IW]EC_HVG]G_P#\-YI'_P`CT`>_T5X!_P`.G?V6/^C:?V?_`/PW MFD?_`"/1_P`.G?V6/^C:?V?_`/PWFD?_`"/0![_17@'_``Z=_98_Z-I_9_\` M_#>:1_\`(]'_``Z=_98_Z-I_9_\`_#>:1_\`(]`'O]%>`?\`#IW]EC_HVG]G M_P#\-YI'_P`CT?\`#IW]EC_HVG]G_P#\-YI'_P`CT`>_T5X!_P`.G?V6/^C: M?V?_`/PWFD?_`"/1_P`.G?V6/^C:?V?_`/PWFD?_`"/0![_17@'_``Z=_98_ MZ-I_9_\`_#>:1_\`(]'_``Z=_98_Z-I_9_\`_#>:1_\`(]`'O]%>`?\`#IW] MEC_HVG]G_P#\-YI'_P`CT?\`#IW]EC_HVG]G_P#\-YI'_P`CT`>_T5X!_P`. MG?V6/^C:?V?_`/PWFD?_`"/1_P`.G?V6/^C:?V?_`/PWFD?_`"/0![_17@'_ M``Z=_98_Z-I_9_\`_#>:1_\`(]'_``Z=_98_Z-I_9_\`_#>:1_\`(]`'O]%> M`?\`#IW]EC_HVG]G_P#\-YI'_P`CT?\`#IW]EC_HVG]G_P#\-YI'_P`CT`>_ MT5X!_P`.G?V6/^C:?V?_`/PWFD?_`"/1_P`.G?V6/^C:?V?_`/PWFD?_`"/0 M![_17@'_``Z=_98_Z-I_9_\`_#>:1_\`(]'_``Z=_98_Z-I_9_\`_#>:1_\` M(]`'O]%>`?\`#IW]EC_HVG]G_P#\-YI'_P`CT?\`#IW]EC_HVG]G_P#\-YI' M_P`CT`>_T5X!_P`.G?V6/^C:?V?_`/PWFD?_`"/1_P`.G?V6/^C:?V?_`/PW MFD?_`"/0![_17@'_``Z=_98_Z-I_9_\`_#>:1_\`(]>-?M,?"O\`X)S?L;V\ MC?$_P!^R/X-N(UW_`&&_\(Z&+^08SE+58#.__`4/6@#[DHK\=A^TS^R?\?'> M#]F?_@G%8_M!;B1;ZW#\)=)\-^&)CV!U&]MALS_M1#BDC_X(S_';]K.,G6/@ MS^PG^RKH%R<"#0?A7I7C'Q+"I^\LDD\(LLXX#1$$')XX-`'[`:YKMCX8TBXU M#4KRTT^PM$,D]S/^"_W[*OP,\0#08/B9:_$/Q7* MYBM]"\!6DOB6]N9!UC5K4/"''0J\BG/':O"?V>/^#2;]E;X5ZL-8\<6GB7XK M:W(_G3#4[I-*TM9/^F5GIZP*BOVQ?$/AO2[K_6^&/@ MWI4?AR"`'[R+JF'3H.IS7T9_PZ=_98_Z-I_9__P##>:1_\CT?\.G? MV6/^C:?V?_\`PWFD?_(]`'G/[/?_``0/_93_`&=]9.LV_P`*=*\:>)Y9!/<: M[XUFD\27US-_SU)NR\:O[QHO(SUKZ^TO2K70].@L[*VM[.TMD$<,$$8CCB4< M!548``]!7@__``Z=_98_Z-I_9_\`_#>:1_\`(]'_``Z=_98_Z-I_9_\`_#>: M1_\`(]`'O]%?-_BG_@F7^R'X&T2;4];_`&?/V;]'TVV&9;N^\"Z+;P1#U9W@ M"C\37Y\?M3?'W_@F/^S_`/MS>`+B\T']F/5?!]EX'\4VFL6/A;P3IVOVTFK2 M7_AUM/26*QMI4,XABU,(SC]V#.NY=Y#`'[+T5_/Q=?M>?`/X]_$+X10>$_\` M@G!?3ZSIWQ`U"\ETVP^$FDZ=I_B[19]%\1+I5OYDJCS)7B6WO7CD3R@VFW$D M;-Y*5VOQJ_:7\"_#$S+J/_!-3]C[X;0HQ5;GXB^-/!&CW*L/X38"W-P6VD$A M%?@QJWB[58S_ M``A'BL8K-]Q4C/F$8;CD9,<7[$?[9_[4'DGP3^RC\._#%E<'_24UG]G_`,$^ M#C'&01\KZBL\P..?E7<#0!_3C17\WF@_\&B'[2?Q]U)+SQ[XO^!WP\LI6#/; MZ/I$$MXAR6;Y+&QM(0,MP%D[8X`%?2'P4_X,D?A!X<:.3X@_&3XA>+'0AF30 M["TT.*3V(D^U-CZ,#[B@#]:/B1^VE\'/@WG_`(2_XL_#/PIM.#_;'BBQL<<9 M_P"6LJ]J^=/B[_P<5?L6_!6^N+75/CUX6U*YMP?ET"VO-*+^V<.+GQ%K-[J`DQC`:!I1;L,CH8 MN?>*O^"UW_!0WXU/)%\*_ MV"M<\')*WEQ3>-(+Z1T&<;B)18*#P2,G`XSN')_1/_AT[^RQ_P!&T_L__P#A MO-(_^1Z/^'3O[+'_`$;3^S__`.&\TC_Y'H`_+#5/!7_!9K]IJ\D36;O1_AAH MEWRMMI>KZ#I;Q@XPWG0K>7*<,?EWY&TYYQGFC_P;7?MC_M`M(_QG^+OP]\;6 M]P_FJGBGQIXJ\0SP'J`41K6#@C`"C:%/@#\^_@K_P:[^+_AH(F'Q]\!^'=B^6!X8^ M!^A07T*C(^74;EIKHDC:3EN",\D`U]!V7_!!%?$-M&GC;]K/]L'Q5"BA&TZ# MQ\-)THJ,'`MK>!0H^\``V`K!1T!KZ!_X=._LL?\`1M/[/_\`X;S2/_D>C_AT M[^RQ_P!&T_L__P#AO-(_^1Z`/"M-_P"#:7]D"6]CO/$G@#Q#X\U*,8%YXE\9 MZQ?2IZ]KW[/OP0UO7-:NI+[4-1U#P+I=S=WUQ(Q> M2:65X"\DCL2S,Q))))))K/\`^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\` M1M/[/_\`X;S2/_D>@#U#X+?L^^`OV;?"DV@_#KP1X0\`Z''-&M]* MM);AE1&F:*!$0R%8XU+$9(11G`%=?7@'_#IW]EC_`*-I_9__`/#>:1_\CT?\ M.G?V6/\`HVG]G_\`\-YI'_R/0![_`$5X!_PZ=_98_P"C:?V?_P#PWFD?_(]' M_#IW]EC_`*-I_9__`/#>:1_\CT`>_P!%>`?\.G?V6/\`HVG]G_\`\-YI'_R/ M1_PZ=_98_P"C:?V?_P#PWFD?_(]`'O\`17@'_#IW]EC_`*-I_9__`/#>:1_\ MCT?\.G?V6/\`HVG]G_\`\-YI'_R/0![_`$5X!_PZ=_98_P"C:?V?_P#PWFD? M_(]'_#IW]EC_`*-I_9__`/#>:1_\CT`>_P!%>`?\.G?V6/\`HVG]G_\`\-YI M'_R/1_PZ=_98_P"C:?V?_P#PWFD?_(]`'O\`17@'_#IW]EC_`*-I_9__`/#> M:1_\CT?\.G?V6/\`HVG]G_\`\-YI'_R/0![_`$5X!_PZ=_98_P"C:?V?_P#P MWFD?_(]'_#IW]EC_`*-I_9__`/#>:1_\CT`>_P!%>`?\.G?V6/\`HVG]G_\` M\-YI'_R/1_PZ=_98_P"C:?V?_P#PWFD?_(]`'O\`17@'_#IW]EC_`*-I_9__ M`/#>:1_\CT?\.G?V6/\`HVG]G_\`\-YI'_R/0![_`$5X!_PZ=_98_P"C:?V? M_P#PWFD?_(]'_#IW]EC_`*-I_9__`/#>:1_\CT`>_P!%>`?\.G?V6/\`HVG] MG_\`\-YI'_R/1_PZ=_98_P"C:?V?_P#PWFD?_(]`'O\`17@'_#IW]EC_`*-I M_9__`/#>:1_\CT?\.G?V6/\`HVG]G_\`\-YI'_R/0![_`$5X!_PZ=_98_P"C M:?V?_P#PWFD?_(]'_#IW]EC_`*-I_9__`/#>:1_\CT`>_P! M&?#_`(/\,:7XJ3[%I&B:=#I]A:>9H^F2R>7!"JQIND=W.T#+.Q/))H`Y_P#X M*Q?\HLOVEO\`LE7BC_TT75>_UX!_P5B_Y19?M+?]DJ\4?^FBZKW^@#P#_@D[ M_P`HLOV:?^R5>%__`$T6M>_UX!_P2=_Y19?LT_\`9*O"_P#Z:+6O?Z`"BBB@ M`HHHH`*\`^(W_*4WX-_]DJ\>?^G?P97O]>`?$;_E*;\&_P#LE7CS_P!._@R@ M#W^BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BO._$7[4O@WPM\>=)^'-YJ,B>(=6MVE5UB+6=K*<&"TGF^Y%< MW""=X8F^:1+6B4`%%?._[47_!6G]FS]C);J/XC?&;P-H6H6>?.TN&_ M&H:HF/6SMA)<>W^KKY\;_@M[X\_:*B$7[-/[)GQI^*,=SQ;>(?%$,7@WPY*# MTECNKHLTJ@@QG-`'Z%UD>.OB#H'PO\-7&M>)M$O@MHMU\L/B#XO^(F M>YV'JQTNR'GQ.!T$A92<9R,BON/X2_!'P9\`_"L>A>!?"7AGP9HL6-EAH>F0 M:?;+C_IG$JKG\*ZB@#\]/^'/OQT_:642_M%_MC_%'7+&<9F\,_#:V@\&:2%[ MP22Q!I;F/W<*Q]>`:]E_9E_X(H?LM?LDW,=YX0^#/A&36HV\W^V-;A;7-2,I M.6D%Q>-*Z,3DG85'/``XKZ:U[Q#I_A729K_5+ZSTVQMQNEN+J988HAZLS$`# MZFOGOXO_`/!8/]EGX$F5/$WQ_P#A5:7-ON$MI:^(;>_NXRO4-!;M)(#Z`KSS MC.*`/H]$$:!5`55&``,`"EK\W?&?_!U9^R=8Z_%I'@B]^)?Q>UB=_+BL/!W@ MZZEN)FXX1;O[/NY.!MSD^V#4$7_!8O\`:L^/%QJ-K\&_V`OBAY2P[[35/B/K MMOX15K. M;(EBT6SGU?5(U)(P?/CNH"<=TD4],8YQQWB;_@VC^+/[3`<_'O\`;D^,OCRT MN<^=I.F6[:?8)GLL$`AO[=\42P^ M8#V/V!;7_/7-?4/PD_X(P?LH?`\QMX>_9]^%D<\/,=QJ&A0ZI<1G`&5ENA(X M.!U#=SZF@#\M?&/_``=S_$OXT>(+G1/A!\(O`VAZ@H`M_P"W+_4_%EQ=`YPZ MP:1;;$.`?D:8GYE_#6R)/.Z' M5[^66Y,97HSQCMQDU^^'ACPCI/@C2$T_1=,T[2+"/[EM96R6\*<`<(@`'``Z M=A6A0!^!_A;_`((7_M%_&C6X-9\4?`;X;W^N9#?VK\>OC+K7CJ_BSU+II9@M MI9`./FCV%B.,5A_M>?\`!+F^^&?QJ^%G@+XK_M5?L_?LY)XBTS5TU'3OA[H% MCX%M(M`F2);Q;BZ>Y@DO1<7$-I!'#<*XD'VF7G[/(K?T&44`?@_\4/V*OV-[ M3XB?#CQ!XY_;@UO]I."YUJV\/^(K/7?CC:7MU!;7"SV]I]NY,J%;=^F_P`$_P#@A_\`LD?L^&%O#7[/_P`.#-;J%BN-7TW^V[B/ M'<2WIF<-_M9S[U]4T4`4?#?A?3/!NCQ:?I&G6&E6%N,16UG;I!#&/144`#\! M5ZBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`*X#X-_P#)1?BQ_P!C5!_Z8]*KOZX#X-_\E%^+'_8U0?\`ICTJ@#S_`/X* MQ?\`*++]I;_LE7BC_P!-%U7O]>`?\%8O^467[2W_`&2KQ1_Z:+JO?Z`/`/\` M@D[_`,HLOV:?^R5>%_\`TT6M>VW/C'2+/Q9::!-JNFQ:[J%K-?6NG/`/\`@L=X5\3PMJ\NL^-?A?XK_M>_O]8NKED@BU+0?*@@\R0K:P1>=*5C M@$:!I'<@NS.4FW44.ZE]\82DOD^75].Q2BG%OM;\6E^I]'?#?]I?X(O"%@Z.N'`.Y6'4&K7@/X M]>!OBGXP\2>'O#'C3PGXCU_P;.MMK^F:7J]O>7FARL7"QW44;EX')C;]MT3?\`:N_F?VC]OSN^;S?M/??6E.'--0>FCWT>U22=M?LTUS1O>/.K MNZ::DK*371_+[*:;]9-)]6K6UT^[/B/\>O`WP=UOP]IGB[QIX3\*ZEXNO!IV MA6FL:O;V,^M71*J(+9)75IY270;(PS9=1CD4:[\>O`WA;XK:-X#U/QIX3T[Q MQXC@>YTGP[=:O;PZMJD2!R\D%JSB65%$^RN>^*?_`"$/ MC9_:_D_\+,_X7G\,O[*\W;_:'E^5X=\GRN^S']KXQ\N/MF?^6E*A'VDX1;W: M_P#)JBII+NTWS/T<=/B*K1Y&XI]/N?)"=WVC[]ODY>2_3*O`/B-_RE-^#?\` MV2KQY_Z=_!E>_P!?"GQ)\=_M&C_@I=\+)%^%7P3.J1?#?QM'86Y^*FIBWN;4 MZKX3,TLLO_"/;HI59;8+$L35__`)F*`/?Z*\`_X6-^U/\`]$;_`&?_ M`/P\FK__`#,4?\+&_:G_`.B-_L__`/AY-7_^9B@#W^BO`/\`A8W[4_\`T1O] MG_\`\/)J_P#\S%'_``L;]J?_`*(W^S__`.'DU?\`^9B@#W^BO`/^%C?M3_\` M1&_V?_\`P\FK_P#S,4?\+&_:G_Z(W^S_`/\`AY-7_P#F8H`]_HKP#_A8W[4_ M_1&_V?\`_P`/)J__`,S%'_"QOVI_^B-_L_\`_AY-7_\`F8H`]_HKP#_A8W[4 M_P#T1O\`9_\`_#R:O_\`,Q1_PL;]J?\`Z(W^S_\`^'DU?_YF*`/?Z*\`_P"% MC?M3_P#1&_V?_P#P\FK_`/S,4?\`"QOVI_\`HC?[/_\`X>35_P#YF*`/?Z*\ M`_X6-^U/_P!$;_9__P##R:O_`/,Q1_PL;]J?_HC?[/\`_P"'DU?_`.9B@#W^ MBO`/^%C?M3_]$;_9_P#_``\FK_\`S,4?\+&_:G_Z(W^S_P#^'DU?_P"9B@#W M^BO`/^%C?M3_`/1&_P!G_P#\/)J__P`S%'_"QOVI_P#HC?[/_P#X>35__F8H M`]_HKP#_`(6-^U/_`-$;_9__`/#R:O\`_,Q1_P`+&_:G_P"B-_L__P#AY-7_ M`/F8H`]_HKP#_A8W[4__`$1O]G__`,/)J_\`\S%'_"QOVI_^B-_L_P#_`(>3 M5_\`YF*`/?Z*\`_X6-^U/_T1O]G_`/\`#R:O_P#,Q1_PL;]J?_HC?[/_`/X> M35__`)F*`/?Z*\`_X6-^U/\`]$;_`&?_`/P\FK__`#,4?\+&_:G_`.B-_L__ M`/AY-7_^9B@#W^BO`/\`A8W[4_\`T1O]G_\`\/)J_P#\S%'_``L;]J?_`*(W M^S__`.'DU?\`^9B@#W^BO`/^%C?M3_\`1&_V?_\`P\FK_P#S,4?\+&_:G_Z( MW^S_`/\`AY-7_P#F8H`]_HKP#_A8W[4__1&_V?\`_P`/)J__`,S%'_"QOVI_ M^B-_L_\`_AY-7_\`F8H`]_HKP#_A8W[4_P#T1O\`9_\`_#R:O_\`,Q1_PL;] MJ?\`Z(W^S_\`^'DU?_YF*`/?Z*\`_P"%C?M3_P#1&_V?_P#P\FK_`/S,4?\` M"QOVI_\`HC?[/_\`X>35_P#YF*`/?Z*\`_X6-^U/_P!$;_9__P##R:O_`/,Q M1_PL;]J?_HC?[/\`_P"'DU?_`.9B@#W^BO`/^%C?M3_]$;_9_P#_``\FK_\` MS,4?\+&_:G_Z(W^S_P#^'DU?_P"9B@#W^BO`/^%C?M3_`/1&_P!G_P#\/)J_ M_P`S%'_"QOVI_P#HC?[/_P#X>35__F8H`]_HKY@^(7[3_P`??A'I/V_Q7X`_ M9@\,6."?M.K?'74;*'`Z_-)X:4%?\%%/VN?#W[&_[+WB/Q-K'Q*\#?#' M56M)$T34?$\4EU;S7*@'RTM8F$\[E<@")9&0D.8Y`IC;\L/&/_!R!^UG^V3X M"U+3?V8?V2=9NKB>=K6U\>6;:CXBT7:,J9(!/IUDBR9Y4W!P,'=$>:\U\%?L MS?M9?`;P)XP_:5^+'[,?AKQY\5/!7A^^\1WWC3XT?$6'Q%'80V<$EU(--T:Q M5([50(SY4;-O1S\LB*>`#LM9_P""N/CO]J#0?^%.?!CX4Z?\-_"'BB*&;6_& M'Q9L[S5=?\3:O>0FXM_(M+(!_P"T;HVTDEG)(5$HM1Y(@$**OU=\(_\`@A_\ M3OVC_A]IUS^UM^T[\:OB!=W,*_:?!V@:NGAW08HL`+!=I:9^U2A0-\BN!N9@ M&D`\Q_S\_:@^!W[6/C+7$^,7Q(_:,_8C^"?C7Q%-;^)?*U/7I;'Q!H4N+&:W MLUCGL[AXI+7[%`BI$S.FZZ7>WVJY,WD'@']LWQU^U'X,T2[U3Q7^T_\`M0>) MM2LH9M5\)^`?BCX@TVULKB2-2\$UI!X66W610=I$5W*@RV)&SNH`_>KX1?L# M?LA_\$T=+M;[0_`OPC^&KVP'DZUK4D']H#;S_P`?UZ[3GH3_`*SMFLCXL_\` M!?/]C?X+&0:S^T)\/KLQ_>&A7,FO>O3["DV>G:OS+^`O_!-7QA\2K&/4_"W_ M``3"\!^$=8O#F7Q!\:/BW>>(EF/`W2V+*LX(`'_+,#'3OGUN/_@E/_P4*TO7 M5'A3Q+^QQ\&_#K9$NF?"K2CX:F`/:.[DT*YGC/N&)H`^D[[_`(.(/`/BBSEF M^&OP._:?^*]NB[OM^A?#V>#38@!DM+<73Q"-0/XBO<>O'S%\?/\`@ZL\5^`& MGAL_@]\,O!JQ6[#JLNEZ5'/=H<8Z\Y/3BNFL/^""?C;QI>0W MOQB\"Z9^T+J43"4R_$#]J#Q+=Q+)U^2&W\-0H$!Z(0P`P.:^G/@)^R+XV_9; M6%OAW^Q_^QWX/N(,;;O3/B+?0WC$="TX\*^:Y]V8F@#\Z+3_`(+%_P#!1O\` M;`G>#X7>`4M[6X7_`$+5_!OPKOYM,8$Y7?>ZY-#&&[$^7MQR!6MI/_!-/_@K M%^V':VTOQ"_:`N_A1#/C^T(1XQ2UE=3RP2#0[=8NO\)G`V\9K]8/^%C?M3_] M$;_9_P#_``\FK_\`S,4?\+&_:G_Z(W^S_P#^'DU?_P"9B@#\V_`W_!G)X<\> M:W'JWQV_:+^*'Q*OV8RR+81K988D%E\Z[>\D8$CEAM8CT-?7GP!_X-N/V,OV M>W@GL_@QH_BC4(<;KKQ5=7&MB8CNT$[M;_E$!7M'_"QOVI_^B-_L_P#_`(>3 M5_\`YF*/^%C?M3_]$;_9_P#_``\FK_\`S,4`>O?#7X1^%/@SX?72?!_ACP]X M4TI,;;+1M.AL;=<<#$<2JO'TKH:\`_X6-^U/_P!$;_9__P##R:O_`/,Q1_PL M;]J?_HC?[/\`_P"'DU?_`.9B@#W^BO`/^%C?M3_]$;_9_P#_``\FK_\`S,4? M\+&_:G_Z(W^S_P#^'DU?_P"9B@#W^BO`/^%C?M3_`/1&_P!G_P#\/)J__P`S M%'_"QOVI_P#HC?[/_P#X>35__F8H`]_HKP#_`(6-^U/_`-$;_9__`/#R:O\` M_,Q1_P`+&_:G_P"B-_L__P#AY-7_`/F8H`]_HKP#_A8W[4__`$1O]G__`,/) MJ_\`\S%'_"QOVI_^B-_L_P#_`(>35_\`YF*`/?Z*\`_X6-^U/_T1O]G_`/\` M#R:O_P#,Q1_PL;]J?_HC?[/_`/X>35__`)F*`/?Z*\`_X6-^U/\`]$;_`&?_ M`/P\FK__`#,4?\+&_:G_`.B-_L__`/AY-7_^9B@#W^BO`/\`A8W[4_\`T1O] MG_\`\/)J_P#\S%'_``L;]J?_`*(W^S__`.'DU?\`^9B@#W^BO`/^%C?M3_\` M1&_V?_\`P\FK_P#S,4?\+&_:G_Z(W^S_`/\`AY-7_P#F8H`]_HKP#_A8W[4_ M_1&_V?\`_P`/)J__`,S%'_"QOVI_^B-_L_\`_AY-7_\`F8H`]_HKP#_A8W[4 M_P#T1O\`9_\`_#R:O_\`,Q1_PL;]J?\`Z(W^S_\`^'DU?_YF*`/?Z*\`_P"% MC?M3_P#1&_V?_P#P\FK_`/S,4?\`"QOVI_\`HC?[/_\`X>35_P#YF*`/?Z*\ M`_X6-^U/_P!$;_9__P##R:O_`/,Q1_PL;]J?_HC?[/\`_P"'DU?_`.9B@#W^ MBO`/^%C?M3_]$;_9_P#_``\FK_\`S,4?\+&_:G_Z(W^S_P#^'DU?_P"9B@#W M^BO`/^%C?M3_`/1&_P!G_P#\/)J__P`S%'_"QOVI_P#HC?[/_P#X>35__F8H M`]_HKP#_`(6-^U/_`-$;_9__`/#R:O\`_,Q1_P`+&_:G_P"B-_L__P#AY-7_ M`/F8H`]_HKP#_A8W[4__`$1O]G__`,/)J_\`\S%'_"QOVI_^B-_L_P#_`(>3 M5_\`YF*`/?Z*\`_X6-^U/_T1O]G_`/\`#R:O_P#,Q1_PL;]J?_HC?[/_`/X> M35__`)F*`/?Z*\`_X6-^U/\`]$;_`&?_`/P\FK__`#,4?\+&_:G_`.B-_L__ M`/AY-7_^9B@#W^BO`/\`A8W[4_\`T1O]G_\`\/)J_P#\S%'_``L;]J?_`*(W M^S__`.'DU?\`^9B@#W^BO`/^%C?M3_\`1&_V?_\`P\FK_P#S,4?\+&_:G_Z( MW^S_`/\`AY-7_P#F8H`]_HKP#_A8W[4__1&_V?\`_P`/)J__`,S%'_"QOVI_ M^B-_L_\`_AY-7_\`F8H`]_HKP#_A8W[4_P#T1O\`9_\`_#R:O_\`,Q1_PL;] MJ?\`Z(W^S_\`^'DU?_YF*`/?Z*\`_P"%C?M3_P#1&_V?_P#P\FK_`/S,4?\` M"QOVI_\`HC?[/_\`X>35_P#YF*`/?Z*\`_X6-^U/_P!$;_9__P##R:O_`/,Q M1_PL;]J?_HC?[/\`_P"'DU?_`.9B@#W^BO`/^%C?M3_]$;_9_P#_``\FK_\` MS,4?\+&_:G_Z(W^S_P#^'DU?_P"9B@#W^BO`/^%C?M3_`/1&_P!G_P#\/)J_ M_P`S%'_"QOVI_P#HC?[/_P#X>35__F8H`]_HKP#_`(6-^U/_`-$;_9__`/#R M:O\`_,Q1_P`+&_:G_P"B-_L__P#AY-7_`/F8H`]_HKP#_A8W[4__`$1O]G__ M`,/)J_\`\S%'_"QOVI_^B-_L_P#_`(>35_\`YF*`/?ZX#X-_\E%^+'_8U0?^ MF/2J\_\`^%C?M3_]$;_9_P#_``\FK_\`S,5T'[)6I>*M7NOB5<>-=&\/^'_$ M\GBI/MMAHFLS:Q86^-'TP1^7=36MK))NC",=T";69E&X*'8`Y_\`X*Q?\HLO MVEO^R5>*/_31=5[_`%X!_P`%8O\`E%E^TM_V2KQ1_P"FBZKW^@#P#_@D[_RB MR_9I_P"R5>%__31:U[+XA^&WASQ=JHO]6T#1=4OAI]SI(N+NQBGE%G<&,W%M MN92?)E,41>/.U_+3<#M&/&O^"3O_`"BR_9I_[)5X7_\`31:U[_2:3W_KI^0T MVM4>5?!W]A+X(?L[^,/^$A^'_P`&_A5X%U_R'M?[3\/>$K#3+SRGP7C\V")7 MV-M7*YP<#TK=\*?LR?#;P)JOB^_T/X>^!]&OOB"[2>*;BQT*UMY?$K,9"S7K M(@-R3YLN3*6SYK_WCGN**;U5GVM\NWH):;=[_-;/U1Q'C+]F;X;_`!%OO"5U MXA^'W@C7;GP#*L_AB;4="M;J3PY(IC*O9,Z$VS`Q18,6TCRD_NC%C6_V?/`/ MB;XO:3\0=2\$>$-0\>Z!;-9Z9XEN=&MY=7TZ!A(&BANV0S1H1+*"JL`?-?CY MCGKZ*?,]_5_-[OY]0Z?^G?P97O\`7@'Q M&_Y2F_!O_LE7CS_T[^#*0'O]%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`455US7++PSHMYJ6I7EKI^G M:?`]S=75S*L4%M$BEGD=V(555026)``!)JU0`4444`%%1WE[#IUI+<7$L4$$ M*EY))&"I&H&223P`!W->!_&3_@JU^S3^S^)E\7?'?X5Z3=0??L_^$CM;B]7_ M`+=XG:7_`,=H`^@**^![G_@X]_9[\5W$EO\`"_2/C3\=;N-F0P?#_P"'FI:@ MS.IQM5ITA1LG@$,0?7'-,_X>=?M5?%Q]OPQ_85\(_P!H'X8B:`9DM]+UA-7N8_8Q M6?FR`^Q7-?EIX8_9-^&_Q.UB/5?"O_!.;]K#XZ:V,F#6/C;XSD\.FXSU-V%4`9X MS0!Y5\7_`-I']JS2FD3XJ_MH_L2_LS\X^S^'[5-;U"`'D*8]5G0/*%ZA5P2# M@8KYC^)/[5_[-NJK>?\`"R?^"BG[67QMO+2(SWND?#>UN="TR>(9SYJ6MJ(- M@PS']^OW03T&?6+G7/V.?!7Q&NOAG^Q7^R'X#_:9^*&G'R+C54TR._\`"WAE MB<"6[UJ]\U3CJ!"Y#@,@D5N*]X^$/_!"O6_VBM3TWQ/^V%XXM/B&;*87NG?" M[PA`VA_#[P_+@8'V>/8]XZX`\R7!(^5O,7%`'YO>!?\`A1O[6%GJ#_L;_L`? M$+X[>+))&MI_'7Q;U6>?1[>X!&'E$UZ]K*QR6V/-`<$$@C(KL?V9?^#?[]KC M6/B/%XV\;_"K]EV+6TE-Q:Z9XSG:7PYH7S.]3T&]AT"X^(/Q!NKC2++5&@?[+*] MO;Q*!`EQY3E-CX"=&Z']+Z*`/S0^%?\`P1ST7X.V0@TC]A+]C"\0)LSKGQ-U M777Q_O7WAB9L^^?BUH_\`P4UTWPEK\7AG1_A3>^`_$&KZ M7IUA.;W4]5N+&]TJ,7MU(\*"W^2[=([>)G&"SR2,S+'#+G%2L]-)/Y1BY/\` M!.RW^5VJ46U=>2^]V_KI\VD_J&BOA_\`8G_:D^)>O>.OA5K7CCQ?+XIT/]H' MX;:A\0+?1?[,L[6'P9/:RV$J6EG)#$DTL#6VII&QNI)I#):AU=5D9!/^PI^T MM\3?&7Q,^$6H^-?&+^)]%_:)^'5]X[MM&.F6=K!X+N+>;3Y([2TDAB2:6!K; M5$1S=/-(9+4.KJLC(-E1GS,G\'Z?\`/AK:_$:XLDTRSNX_&%Q+/ MJ#_8+MYXI'BM/(TJ5,VS0S;[O<)0(PK9'Q,_:[^)-S\3_%WQ`T;Q9/I/@7X8 M_$+PGX'F\+.6W\0V^K1Z5]KNKBX>)KE)XSK41A$$T48^Q8D23S3MFE%U) M*,=VU\DY*";\G)I*UWK=I(=2$H-IKT\WRQE9>=I1WLM=]';[KKP#XC?\I3?@ MW_V2KQY_Z=_!E>_UX!\1O^4IOP;_`.R5>//_`$[^#*DD]_HHHH`****`"BBB M@`HHHH`**^Z7H]]JEK82M,_\`;#'3D_LXG6(Y;A+M72ZQYBQX M$0!^U5%?'_B3_@OS^QMX4N?*NOVA/`$K<\V<\MZO&/XH4<=_7G\*X;4_^#G_ M`/88TM?G^.<,K$$A8?">NRYQVRMD0#]2*`/OFBOS,\0_\';_`.Q?HN/LWBOQ MIJ^4+?Z)X5NEP1_#^]$?)_+W%<=/_P`'BO[->H+*/#_P^_:`\3M$F6;3_#=B M8XF.=JN6O05SCJ%/&>N,4`?K)17Y`7__``=O:-JMC]I\,?LK?'_7+=D;9++9 M)#&T@S\NZ,2C'3)ZCG@XYR-4_P"#HWXWZFD8\._\$_?C+>K=P[K>XN;K4%4N MP.S"1Z4^]3\IX89SCCK0!^RU%?BAJ7_!P1^WKXCO_LV@_P#!/;Q_ILDL1$9U M3P_KTD:R`$[FGRD@D\9R160?\`@L)_P55\:WDT&E?L M#]5::-CGYD,VH11MVXP<=3GI0!^XU%?A;>?MD?\`!7_X@6[RZ=\)$\/QLOE- MY7A+2X7B<<[D6[U!BW!')^7J,<5S]YJ?_!;CQCO_`!(MGND$R+`#N$^8^M4;G_`()%?\%'O',TD>J?$GXED7"#SUU;]H6^;3I-N,`0 M6=FA#9`(.2.#G)(-`'[[56U;6;/0+%KJ^N[:RMD(#2SRK&BDG`RS$#DU^"+_ M`/!O1^V1XY,C:U-\%M3#Q+'=+XM^+/CC4#?L-NV0FU>,978.&XY&`,#%C3/^ M#6SXQW5^VIZCX)_8M75)HA#-YFJ^.]523:%&\M([.W\LGH&WR#!.1U]:\^\4_P#!6?\`9;\& M&5=2_:,^"$$L#!)(5\;:=+,A/K&DQ&?\`@V7^+6B*NQOV-;,RQ")P MWPRN-3%L.,[#=2,7*]F?YFQ\QY->A>'/^#=_XT:*!;V7Q<_9@\,QN@CDOM+_ M`&8O#4MV%7D#$BX?)`!W'/)/6@#ZP\3_`/!P)^QGX2\S[5^T'X$E\I_+;[$\ M][D^WDQON'N,CWKC;O\`X.:_V+Y)+B+2?BIJOB2YM7"2PZ3X+URX*#GYMWV, M(5R.H8Y[9K@?#O\`P1$_:-TCY7_;0T>RB1`D8T'X`>&=&8`=F:(G>H'13P*[ M./\`X)'?M%:G&K:M^WS\9I)XQY&],TV%8QT!C0$%LD_-Z8':@#Y%_;S M_P"#AZ;]J_4?%'P<^&7P`\VL'B&4_P!LZ=JFN:0([:XN[62TBTJ9 M[2WN?.%L9&D:1H7<^7'YL;CO?V!O^"U?[4WCKP5<_"NU_8G\?^(?B#\,].T^ M*^G\2>,X?#TAL9Q<"SNKYM0M(761X;9LLJ-YSQ2MB/(0>-^/O^"+?[9/PI_: MS^*^O^%/CG^TSJ+>+-0LF_X2[PO9>&C)XJM8=/MUA:[-UXETZ9);=VGM@A@* M;(%D5L2[$Z#]B3_@W#\9_'']J36O$_[5NN?%7X@>"+'1+*R%C\0;\)JGBFY, MEZY/G:7XEOS#':'R&7S7*R_;)E$,90RN`>M_&/\`X*B_M1:.DP\5?%']@;]G M*VVN9+36_&EQXD\1VY':."!UBD9><_*=?_X*"V_Q@U>;3=;_`."A MWQ[^+%\KXFT'X#?"`Z-+`,?*D5X(6WDMT MUA6&*(>BJH``^@H`_!2U_9'TCX]WD5S;?L,_MN_M%WJGS(KWX]?$U_"YE?/S M2N'F"9/!P5P?2O?O@W_P3F_:9T1H7^'_`.RQ^P/^SY$K9^W:Q8W'BCQ#;<=8 MYX8]C$=,.V/O$=:_7FB@#\^[?_@F3^US\4+>*/X@_MS>(-&TW:J?V/\`#OP' MIV@+:)C!2*\):8C&`I9?EQFI?^(<;X*>//F^+/CS]H/XZM)S,OCGXCW]Q'*? M]VV,&`!\H`/"\<]:^_Z*`/F7X0_\$8OV4?@88V\._L_?"R.>$[H[G4-"AU2Y MB.,96:Z$DBG'HW<^IKZ+\->%=+\&:1%I^CZ;8:380#$=M9VZ00QC&.$4`#@# MH.U7Z*`"BODS]MW_`(++_"']C+Q?%X%MY=8^*7QBU%O)TWX>>"+4ZMKEQ,1E M5F6/*VR]"?-(;:2RH^#7A9_8U_:N_P""K)%Y^T7XRE_9W^#UZ-R_"SX?Z@)- M=U6$\A-5U;&`".&BA&UE."L;#-`'IO[5G_!<+X?_``L^)DOPN^#F@:Y^T?\` M&ULHGA/P3BXM]-8'&_4+\!H+2-6.')+M&?OJHYKS?3_^"6GQU_X*2WT6N?MH M_$?^S?!W^"_P\O);'0XUSE4U.^5O.O7'&Y4;8KKN20`[:^U?V4_V-/A= M^P_\,XO"'PI\$Z'X*T),-+%80_OKQP,"2XF8F6>3!QOE9FQQG%>FT`$?`'A;0O!WAG31BVTW2;-+6WC)ZMM0#<[8RSG+,>22>:ZRBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`K@/@W_`,E%^+'_`&-4'_ICTJN_K@/@W_R47XL?]C5!_P"F M/2J`//\`_@K%_P`HLOVEO^R5>*/_`$T75>_UX!_P5B_Y19?M+?\`9*O%'_IH MNJ]_H`\`_P""3O\`RBR_9I_[)5X7_P#31:UVWBK]GA/%7[5/A7XER:HJQ^&O M"VL>&6TIK3>+L:A=G[\_Q3B_O3:^8TVM%_6M_P`T?,7[)_\`P3SU+]GOQ[HEYX@\ M>6_C/PY\//#5WX,\`:4N@_8)=#TFYN8I9$O)S<2B]N!%:V5NLJ1VZB.W8F-F MD9A#^S#_`,$]?$'[/'BW2[Z\^(MAXFT_X=>%KWP;\-;*3PVUM_PC>GW%Q%+_ M`*?(+MCJ$R1VMA`'C%H#';-E=\IEJ]?>>NK!R;O MYM/[K6]%HKI:/JF?+_[5'_!/OQ%^T7XHU*_TWXC6/A.#X@>$8/`WQ&MX_#;7 M?_"0Z9'/)+_H+F[0V%QLNM0B$D@NE"78RA:)6*?$#_@G->^+/CK?ZEIWCBUT MCX7^)_$6A^+O$OA#^P/.NM1U32$A6V:"_P#M"K;V[FRTTS1-;2L_V,[9(_-: MOJ&BG&3BU*.Z=_QYOFE+5)Z)I62LA2;=[O=6_!+3L[)*ZUT6NB"OA3XD_P#! M-7]G)_\`@I=\+-);X`?!,Z7K'PW\;:E?V9\#Z9]GOKJ'5?":0W$L?D;7EC6Y MN55V!91<2@$!VS]UUX!\1O\`E*;\&_\`LE7CS_T[^#*D`_X=._LL?]&T_L__ M`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X M;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\T MC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^ M1Z/^'3O[+'_1M/[/_P#X;S2/_D>O?Z*`/R0_X+X_\$L_AJWP+^&6D?!?]G_P M!H/B74/&IEU74/#7PGNKN*'25TG48IUNI-%TN[N(E::>U\O]TQ\T1R*!Y)>/ MY%_:^_9WTO\`;$\/Z78Q_L#:5\)1X"UFTO\`4KSP?X"\<6=YX^L8)&-Q96"6 M_A:W2'[3&KJK7TD;(T\!+KL(O^#4GP%X2L[;Q3\"/'W_"-G5H8 M[]-'^*?PST;QE;A70,(&BO[6.YM>"`RMF1#G(##`>W[#GQH_9B<+XP_X)]?L M._M$:);_`'K_`.'V@Z9X=U7R^[R6VH6Q1Y.^R'@\`'O7["44`?D)HW[8W_!/ M7P1J\.D_&_\`8VT7]G+6)6$07Q[\"[*&QFD](KJWMI4=#V=M@X[5]:_`+]E[ M]@+]JG2_MGPU^&/[)/CJ$)O<:)X6T"]DA'_31(XBT9]F`(KZ]UC1K/Q#I<]C MJ%I;7UE=(8YK>XB66*53U5E8$$>QKY)^/?\`P07_`&3?VA-2.IW_`,'/#OAG M7E;S8=7\(M+XH-DT2L_?+JV3US0!Z!_PZ=_98_P"C:?V?_P#PWFD? M_(]'_#IW]EC_`*-I_9__`/#>:1_\CU\\C_@D;\?OV=4+_`/]M+XJ:?9P?-%H M'Q-L;;QI8NO_`#Q6>14F@C'8H&8`8YR32-^U/_P4"_9BPGQ`_9S^&'QXTB`8 MEUCX7>*WTJ[2,=':QU%2\LA&,I%@9)P<"@#Z'_X=._LL?]&T_L__`/AO-(_^ M1Z/^'3O[+'_1M/[/_P#X;S2/_D>O"/#/_!QA\!-%U^WT/XO:1\6/V=?$5PWE M)8_$CP;=Z:DK]]D\0EAV8R0[L@(P>,XKZ]^"'[3GPW_:8T,ZE\.O'W@WQU8* MH9YM!UFWU!8@>S^4[;3VPV"#P>:`/.?^'3O[+'_1M/[/_P#X;S2/_D>C_AT[ M^RQ_T;3^S_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL M?]&T_L__`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1 MM/[/_P#X;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^ MS_\`^&\TC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__ M`/AO-(_^1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X M;S2/_D>O?Z*`/`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\T MC_Y'KW^B@#P#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^ M1Z]_HH`\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>M MG]L[_@H)\'_^"?G@`>(OBQXWTGPO;SAOL-D[&;4=5 M))&W`,KQR'I0!N?MT6?_``3O_P"">MG;6WCSX'_`&[\7:IM72/!VA?#;2=2\ M1ZU(QQ&D%I'!N&\\*\A2,GC=GBOF>V_X(Z^+O^"K%S'<:]^SU\#_`-BSX)W# MAUTS2/`FCS_$?78_^)80BM@9!/-?3=`'R;\!O M^"%_[)'[/GPWLO#6G?`/X9>((;09?4/%'A^UU[4KIR!N>2XNHY'Y(SM4J@S\ MJJ.*[/\`X=._LL?]&T_L_P#_`(;S2/\`Y'KW^B@#P#_AT[^RQ_T;3^S_`/\` MAO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>O?Z*`/`/^'3O[+'_1M/[/\` M_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z]_HH`\`_X=._LL?]&T_L M_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'KW^B@#P#_AT[^RQ_T; M3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>O?Z*`/`/^'3O[+' M_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z]_HH`\`_X=._ MLL?]&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'KW^B@#P#_A MT[^RQ_T;3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>O?Z*`/` M/^'3O[+'_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z]_HH M`\`_X=._LL?]&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'KW M^B@#P#_AT[^RQ_T;3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D M>O?Z*`/`/^'3O[+'_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_ M`.1Z]_HH`\`_X=._LL?]&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S M2/\`Y'KW^B@#P#_AT[^RQ_T;3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\` MAO-(_P#D>O?Z*`/`/^'3O[+'_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\` M_P"&\TC_`.1Z]_HH`\`_X=._LL?]&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L M_P#_`(;S2/\`Y'KW^B@#P#_AT[^RQ_T;3^S_`/\`AO-(_P#D>C_AT[^RQ_T; M3^S_`/\`AO-(_P#D>O?Z*`/`/^'3O[+'_1M/[/\`_P"&\TC_`.1Z/^'3O[+' M_1M/[/\`_P"&\TC_`.1Z]_HH`\`_X=._LL?]&T_L_P#_`(;S2/\`Y'H_X=._ MLL?]&T_L_P#_`(;S2/\`Y'KW^B@#P#_AT[^RQ_T;3^S_`/\`AO-(_P#D>C_A MT[^RQ_T;3^S_`/\`AO-(_P#D>O?Z*`/`/^'3O[+'_1M/[/\`_P"&\TC_`.1Z M/^'3O[+'_1M/[/\`_P"&\TC_`.1Z]_HH`\`_X=._LL?]&T_L_P#_`(;S2/\` MY'H_X=._LL?]&T_L_P#_`(;S2/\`Y'KW^B@#P#_AT[^RQ_T;3^S_`/\`AO-( M_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>O?Z*`/`/^'3O[+'_1M/[/\`_P"& M\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z]_HH`\`_X=._LL?]&T_L_P#_ M`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'KW^B@#P#_AT[^RQ_T;3^S_ M`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>O?Z*`/`/^'3O[+'_1M/ M[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z]_HH`\`_X=._LL?] M&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'KW^B@#P#_AT[^R MQ_T;3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>O?Z*`/`/^'3 MO[+'_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z]_HH`\`_ MX=._LL?]&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'KW^B@# MP#_AT[^RQ_T;3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>O?Z M*`/`/^'3O[+'_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z M]_HH`\`_X=._LL?]&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\` MY'KW^B@#P#_AT[^RQ_T;3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-( M_P#D>O?Z*`/`/^'3O[+'_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"& M\TC_`.1Z]_HH`\`_X=._LL?]&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_ M`(;S2/\`Y'KW^B@#P#_AT[^RQ_T;3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_ M`/\`AO-(_P#D>O?Z*`/`/^'3O[+'_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/ M[/\`_P"&\TC_`.1Z]_HH`\`_X=._LL?]&T_L_P#_`(;S2/\`Y'KH/V2OA/X5 M^!UU\2O"W@KPSX?\'^&-+\5)]BTC1-.AT^PM/,T?3)9/+@A58TW2.[G:!EG8 MGDDUZ_7`?!O_`)*+\6/^QJ@_],>E4`>?_P#!6+_E%E^TM_V2KQ1_Z:+JO?Z\ M`_X*Q?\`*++]I;_LE7BC_P!-%U7O]`'@'_!)W_E%E^S3_P!DJ\+_`/IHM:]_ MKP#_`()._P#*++]FG_LE7A?_`--%K7OY(4$D@`=32;25V`45XQ\(_P#@H1\( M/CCXDU32_#WBXM-I>FS:WY^HZ5>Z59:CIT,GES7]E=74,4%]9H^T-]TFYC2>(36\ZPWD,4CV M\T;;HIT4Q2@-L=MK8I*^W:_RO:_I=->JL$O=?++1WM\[7MZV=_0]*HKRSX]_ MMJ?#3]F3Q3HVC>-?$4NE:AK:K-&D.EWE\EE`9X[<75Y);Q2)96OG2QQ_:;IH MH=S8W\'!XQ_;4^&G@'X]:9\--5\12P>+]6EM[>.%-+O)K*VGN%E:VM[F]2)K M6UGG$,GDPSRQR2X&Q6W+E1=[6ZNR\WV7GY";M>_17?DN[\O,]3KP#XC?\I3? M@W_V2KQY_P"G?P97O]>`?$;_`)2F_!O_`+)5X\_]._@R@9[_`$444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`%#Q-X5TOQKH=QIFLZ;8:MIMVNR>TO M;=+B"9?1D<%6'U%?(7QN_P"#?[]D_P"-6N'6HOA78>`O$R,9+?6O`UW/X;N[ M60]9$6T9(2WNT;5]F44`?GT/^"67[3G[."%_@9^VEXZO]/@YB\/_`!:TFW\6 M03#M&;_"7$2#H-BDXXH/[9_[=_[,J!?BA^RYX,^,6EP<3ZY\)/%1BE"C^)=- MOQY\C$=E8#/X5^@M%`'PAX*_X.+OV<7\2P>'_B7-\0O@#XIN.%TCXE^$KO19 M00<',H62!0#W:0"OL+X0_'SP+^T#X>&K^`_&?A3QKI1`/VS0M6@U&`9Z?/"[ M#]:U_&_@'0OB9X=GT?Q)HND^(-)N?]=9:E9QW=M+_O1R`J>IZBOCWXO?\&]/ M[*?Q,\2GQ!HOP]F^%?BM"3;ZW\/=5N?#5S:$]3'%;N+<=NL1Z?7(!]L45^?( M_P"":_[7/[-BE_@K^V9KGBS3(/\`5>'OC%H,/B`7&.GF:I$%NEP.#L3G.>PI M3^WQ^VS^S2@7XN_LC:7\2M-@_P"/CQ!\'/$ZW>*O@CXKEQNT/XE^&[KP]#F:OL/X9_%[PG\:O#::SX-\4>'?%ND28V7VC:E#?VS9Y&)(F93^=`'14444 M`%%%%`!17._%?XO>%?@3X"U#Q3XU\1Z+X4\-Z5'YMYJ>K7D=I:VZ_P"U(Y"@ MGH!G)/`R:^!-9_X*Y_%O_@H-K5SX9_8C^&3:YH2RM:WGQA\=V\VF>$K`@[6: MR@8">^=?0*-K8W1LAW4`?;O[2G[57PY_8\^&=UXQ^)_C+0?!/ARUR#=ZG^B/\`RUTC2FR9* M/_31=5[_`%X!_P`%8O\`E%E^TM_V2KQ1_P"FBZKW^@#P#_@D[_RBR_9I_P"R M5>%__31:U[QJJLVF7(6!;EC$P$+$`2G!^4YXP>GXUX/_`,$G?^467[-/_9*O M"_\`Z:+6O?ZBI#G@X=U8<79IGXP?#B#4/CI\!=2\$>$-=B^(GC"#]GGQ;H^I M>$;.V^?X+:D_V*&/PY!Y9\V+SWCEMQ%J+7%V_P#9JM',L6]&^U/V,/C]X'_: M%_:Z^)?Q5\"^(M&U7X9Z;\-?"^BWNNVUPBZ=!?03:M>SV\DF=BRVUM=VYF5B M&A\X*P4Y`^RZ*W=65K=4G;M=N;?6[7O]7>ZNY-MCJ2YER]+_`#M>F_1:TULK M6;5KZGYO?\%)/BAX;\%_$+]H&UUC5-/:?X]_`FP\-_#9!*LO_"7ZD)]8A-C8 MO)&%WW5H)VTZZ[6*^%/B3X$_:-/_!2[X61K\5? M@F-4E^&_C:2PN#\*]3-O;6HU7PF)HI8O^$AW2RLS6Q659(U012@QR&53%]UU MX!\1O^4IOP;_`.R5>//_`$[^#*S(#_A7/[4__19/V?\`_P`,WJ__`,T]'_"N M?VI_^BR?L_\`_AF]7_\`FGKW^B@#P#_A7/[4_P#T63]G_P#\,WJ__P`T]'_" MN?VI_P#HLG[/_P#X9O5__FGKW^B@#P#_`(5S^U/_`-%D_9__`/#-ZO\`_-/1 M_P`*Y_:G_P"BR?L__P#AF]7_`/FGKW^B@#P#_A7/[4__`$63]G__`,,WJ_\` M\T]'_"N?VI_^BR?L_P#_`(9O5_\`YIZ]_HH`\`_X5S^U/_T63]G_`/\`#-ZO M_P#-/1_PKG]J?_HLG[/_`/X9O5__`)IZ]_HH`\`_X5S^U/\`]%D_9_\`_#-Z MO_\`-/1_PKG]J?\`Z+)^S_\`^&;U?_YIZ]_HH`\`_P"%<_M3_P#19/V?_P#P MS>K_`/S3T?\`"N?VI_\`HLG[/_\`X9O5_P#YIZ]_HH`\`_X5S^U/_P!%D_9_ M_P##-ZO_`/-/1_PKG]J?_HLG[/\`_P"&;U?_`.:>O?Z*`/`/^%<_M3_]%D_9 M_P#_``S>K_\`S3T?\*Y_:G_Z+)^S_P#^&;U?_P":>O?Z*`/`/^%<_M3_`/19 M/V?_`/PS>K__`#3T?\*Y_:G_`.BR?L__`/AF]7_^:>O?Z*`/`/\`A7/[4_\` MT63]G_\`\,WJ_P#\T]'_``KG]J?_`*+)^S__`.&;U?\`^:>O?Z*`/`/^%<_M M3_\`19/V?_\`PS>K_P#S3T?\*Y_:G_Z+)^S_`/\`AF]7_P#FGKW^B@#Y@^)/ M[,'Q]^,OAN31O%_C_P#9@\5Z1+]^QUCX%:C?6S]N8Y?$K*?RKX[^)G_!LI-X MM\3OXB\'^//A#\%O%ASY>N?#;X>>(?#MS;_]>(:_6.B@#\WOAU M_P`$[?V]_P!ECP[$O@S]M/PU\7I+?[ND?$SP&T=M+CIOOH;F>]YZ'YO?K7G' MQ$_;G_X*@?L_^(IG\=_`/X8:OX4@ZZM\,_"5YXQN9,'G98'7[2X/&",J,YK] M:**`/Q=@_P""[6J?M0Z[<_"X_M3_``A^"&HZO8WEEKFK>*?@[JWA/5O"6R694B",V_>%1JVE?\%ROVG_`(S_`+0MK\'?V?M8^`_QX\5O MJEQIL7B/_A!K_0_#%_;6\*2R74>H2Z]^^N$1M\L%O;,J[6,;RIM)_2#]LK]C MK2_B,E_XTTGP!X0^(6N);'^U_!WB&RM9]+\T\(>) M?A[J&I>#_#UQW^RVEOK-C',`/EW3PG>,%U+#-?9FB_![]IKPWI%KI^G?%G]G M:PL+*)8+>VMO@MJL4-O&HPJ(B^)P%4````8`%?1-%`'@'_"N?VI_^BR?L_\` M_AF]7_\`FGH_X5S^U/\`]%D_9_\`_#-ZO_\`-/7O]%`'@'_"N?VI_P#HLG[/ M_P#X9O5__FGH_P"%<_M3_P#19/V?_P#PS>K_`/S3U[_10!X!_P`*Y_:G_P"B MR?L__P#AF]7_`/FGH_X5S^U/_P!%D_9__P##-ZO_`/-/7O\`10!X!_PKG]J? M_HLG[/\`_P"&;U?_`.:>C_A7/[4__19/V?\`_P`,WJ__`,T]>_T4`>`?\*Y_ M:G_Z+)^S_P#^&;U?_P":>C_A7/[4_P#T63]G_P#\,WJ__P`T]>_T4`>`?\*Y M_:G_`.BR?L__`/AF]7_^:>C_`(5S^U/_`-%D_9__`/#-ZO\`_-/7O]%`'@'_ M``KG]J?_`*+)^S__`.&;U?\`^:>C_A7/[4__`$63]G__`,,WJ_\`\T]>_P!% M`'@'_"N?VI_^BR?L_P#_`(9O5_\`YIZ/^%<_M3_]%D_9_P#_``S>K_\`S3U[ M_10!X!_PKG]J?_HLG[/_`/X9O5__`)IZ/^%<_M3_`/19/V?_`/PS>K__`#3U M[_10!X!_PKG]J?\`Z+)^S_\`^&;U?_YIZ/\`A7/[4_\`T63]G_\`\,WJ_P#\ MT]>_T4`>`?\`"N?VI_\`HLG[/_\`X9O5_P#YIZ/^%<_M3_\`19/V?_\`PS>K M_P#S3U[_`$4`>`?\*Y_:G_Z+)^S_`/\`AF]7_P#FGH_X5S^U/_T63]G_`/\` M#-ZO_P#-/7O]%`'@'_"N?VI_^BR?L_\`_AF]7_\`FGH_X5S^U/\`]%D_9_\` M_#-ZO_\`-/7O]%`'@'_"N?VI_P#HLG[/_P#X9O5__FGH_P"%<_M3_P#19/V? M_P#PS>K_`/S3U[_10!X!_P`*Y_:G_P"BR?L__P#AF]7_`/FGH_X5S^U/_P!% MD_9__P##-ZO_`/-/7O\`10!X!_PKG]J?_HLG[/\`_P"&;U?_`.:>C_A7/[4_ M_19/V?\`_P`,WJ__`,T]>_T4`>`?\*Y_:G_Z+)^S_P#^&;U?_P":>C_A7/[4 M_P#T63]G_P#\,WJ__P`T]>_T4`>`?\*Y_:G_`.BR?L__`/AF]7_^:>C_`(5S M^U/_`-%D_9__`/#-ZO\`_-/7O]%`'@'_``KG]J?_`*+)^S__`.&;U?\`^:>C M_A7/[4__`$63]G__`,,WJ_\`\T]>_P!%`'@'_"N?VI_^BR?L_P#_`(9O5_\` MYIZ/^%<_M3_]%D_9_P#_``S>K_\`S3U[_10!X!_PKG]J?_HLG[/_`/X9O5__ M`)IZ/^%<_M3_`/19/V?_`/PS>K__`#3U[_10!X!_PKG]J?\`Z+)^S_\`^&;U M?_YIZ/\`A7/[4_\`T63]G_\`\,WJ_P#\T]>_T4`>`?\`"N?VI_\`HLG[/_\` MX9O5_P#YIZ/^%<_M3_\`19/V?_\`PS>K_P#S3U[_`$4`>`?\*Y_:G_Z+)^S_ M`/\`AF]7_P#FGH_X5S^U/_T63]G_`/\`#-ZO_P#-/7O]%`'@'_"N?VI_^BR? ML_\`_AF]7_\`FGH_X5S^U/\`]%D_9_\`_#-ZO_\`-/7O]%`'@'_"N?VI_P#H MLG[/_P#X9O5__FGH_P"%<_M3_P#19/V?_P#PS>K_`/S3U[_10!X!_P`*Y_:G M_P"BR?L__P#AF]7_`/FGH_X5S^U/_P!%D_9__P##-ZO_`/-/7O\`10!X!_PK MG]J?_HLG[/\`_P"&;U?_`.:>C_A7/[4__19/V?\`_P`,WJ__`,T]>_T4`>`? M\*Y_:G_Z+)^S_P#^&;U?_P":>C_A7/[4_P#T63]G_P#\,WJ__P`T]>_T4`>` M?\*Y_:G_`.BR?L__`/AF]7_^:>C_`(5S^U/_`-%D_9__`/#-ZO\`_-/7O]%` M'@'_``KG]J?_`*+)^S__`.&;U?\`^:>C_A7/[4__`$63]G__`,,WJ_\`\T]> M_P!%`'@'_"N?VI_^BR?L_P#_`(9O5_\`YIZ/^%<_M3_]%D_9_P#_``S>K_\` MS3U[_10!X!_PKG]J?_HLG[/_`/X9O5__`)IZ/^%<_M3_`/19/V?_`/PS>K__ M`#3U[_10!X!_PKG]J?\`Z+)^S_\`^&;U?_YIZ/\`A7/[4_\`T63]G_\`\,WJ M_P#\T]>_T4`>`?\`"N?VI_\`HLG[/_\`X9O5_P#YIZ/^%<_M3_\`19/V?_\` MPS>K_P#S3U[_`$4`>`?\*Y_:G_Z+)^S_`/\`AF]7_P#FGH_X5S^U/_T63]G_ M`/\`#-ZO_P#-/7O]%`'@'_"N?VI_^BR?L_\`_AF]7_\`FGH_X5S^U/\`]%D_ M9_\`_#-ZO_\`-/7O]%`'@'_"N?VI_P#HLG[/_P#X9O5__FGH_P"%<_M3_P#1 M9/V?_P#PS>K_`/S3U[_10!X!_P`*Y_:G_P"BR?L__P#AF]7_`/FGH_X5S^U/ M_P!%D_9__P##-ZO_`/-/7O\`10!X!_PKG]J?_HLG[/\`_P"&;U?_`.:>C_A7 M/[4__19/V?\`_P`,WJ__`,T]>_T4`>`?\*Y_:G_Z+)^S_P#^&;U?_P":>C_A M7/[4_P#T63]G_P#\,WJ__P`T]>_T4`>`?\*Y_:G_`.BR?L__`/AF]7_^:>C_ M`(5S^U/_`-%D_9__`/#-ZO\`_-/7O]%`'@'_``KG]J?_`*+)^S__`.&;U?\` M^:>N@_9*TWQ5I%U\2K?QKK/A_P`0>)X_%2?;;_1-&FT>PN,Z/IAC\NUFNKJ2 M/;&44[IWW,K,-H8(OK]`?$; M_E*;\&_^R5>//_3OX,KW^O`/B-_RE-^#?_9*O'G_`*=_!E`'O]%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7 M`?!O_DHOQ8_[&J#_`-,>E5W]E4`>?_`/!6+_E% ME^TM_P!DJ\4?^FBZKW^O`/\`@K%_RBR_:6_[)5XH_P#31=5[_0!X!_P2=_Y1 M9?LT_P#9*O"__IHM:]Q\3ZTOAOPWJ&HLAD6PMI+DH."P1"V/TKP[_@D[_P`H MLOV:?^R5>%__`$T6M>^S0I<0O'(BR1N"K*PR&!Z@CTK.M&4J+"2:*.*+R+'SH'+%+D#S%^L?V,]&U3X%?M;^._A:?% M_C7QCX?'@CPYXPAG\4Z[VVH74VI6=X8YKAW=(9OL,$OD*1%$YD\M$5RH MW?!'_!,3P)X6U&XAU36O&/B_PK!X;U#P?H/A76KFU;1_"FD7VP75G9B"WBG9 M6CBBB#W,T\D<481'12P;H_V;/V)K']FRQ\2SP^/?B#XP\4>)K"STE_$_B2>P MN-4LK*SA>*SMH?)M8K?9"99I`9(7>22>1I6ESQT^TAJXQLK.R\KSM'LK7BW; MW6U_=B1)-QY6[ROJ]M7[/WK=O=J1UU2GI>[M\[?\%$_%_BK7_B3\=+K2_&OC M+PK_`,,^_".S\?>&H-#UFXT^VNM8DGU:NZOX1L[FU3P_K^IZ8NVPOKE&MVN1+#LMSMAN(XW-G;> M8C^7RJ'+"<'+9-?*U12C_``W\;:;?WA\<:9]GL;J; M5?";PV\LGG[4ED6VN65&(9A;RD`A&Q]UUX!\1O\`E*;\&_\`LE7CS_T[^#*S M)#_A[%^RQ_TQ?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_ M`(Q?LL?]'+?L_P#_`(Q?LL?] M'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L M_P#_`(Q?LL?]'+?L_P#_`(Q? MLL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L M_P#_`(Q?LL?]'+?L_P#_`(Q? MLL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_ M`(Q?LL?]'+?L_P#_`(Q?LL?] M'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_ M`(Q?LL?]'+?L_P#_`(Q?LL?] M'+?L_P#_`(Q?LL?]'+?L_P#_`(Q?LL?]'+?L_P#_`(%?CC=?$KQ3X*\3>'_&'AC5/%2?8M7T348=0L+OR]'TR*3RYX M6:-]LB.AVDX9&!Y!%>OUP'P;_P"2B_%C_L:H/_3'I5`'G_\`P5B_Y19?M+?] MDJ\4?^FBZKW^O`/^"L7_`"BR_:6_[)5XH_\`31=5[_0!X!_P2=_Y19?LT_\` M9*O"_P#Z:+6O?Z\`_P""3O\`RBR_9I_[)5X7_P#31:U[_0`4444`%%%%`!7@ M'Q&_Y2F_!O\`[)5X\_\`3OX,KW^O`/B-_P`I3?@W_P!DJ\>?^G?P90![_111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`5P'P;_`.2B_%C_`+&J#_TQZ57?UP'P;_Y*+\6/^QJ@_P#3'I5`'G__ M``5B_P"467[2W_9*O%'_`*:+JO?Z\`_X*Q?\HLOVEO\`LE7BC_TT75>_T`>` M?\$G?^467[-/_9*O"_\`Z:+6O?Z\`_X)._\`*++]FG_LE7A?_P!-%K7L_P`0 MFU]/`.MGPI'I$OB@6$YT=-5DDBL'O/+;R!.T:LZQ>9MWE%9@N<`G`J9RY8N5 MKVZ+:2CM<\TB_;N^')^*_P`7/""S%E63]ES]L?2_VG]1U[3!X3\:^`_$'A^"QU";1O%- MM;07L^GWT;O9WT8MYYT\F7RITVLZRH\$B21QL`#\-Z%^Q[\?==N?VE?`.L?# MWPAIC>-_@E::%%KUEXOOM5BUO6I)=?E:19KC2K2.2>>YO))+A=R"W$L!'F++ MB/Z-_9#\:WWQB_:8^(7QDF\&_$'PAX7@\`>'O#"6OB3PO?Z7JEU>VDFI7UXL M-G-$MQ*D0OH8A)'&R32"01-)MR=N6,;W::25WT7Q:][-Q27\J?O;JQ56K]GW MT7RI:>MIU'Y\GNZ)W]!_:@_;_P#"O[*WB[^R-4\/^,O$7]F:4GB+Q+=Z':6\ MUMX.T=[C[.-2OC-/$WD[UF.RW6>;9;3N(BL9-,\>_P#!0?PEX`^/L7@:70O% M^H6=OJNFZ!K'BJSMK9M!\.ZGJ2!K"RNG:=9S)/OMP&A@EC0W=OYCQ^8*^>/V M_M+\20^//C0FC>!_'OBB/]H_X.67@KPM-I7AR]N8;/54FU2$PZBRQ'^SDV:Q M!+YMWY486"X!8-'M.3\3_A3XL\/?$CX@_!Z'PAXRU.^^)_Q/\$^,M(\06>@W M4WA^+3+"/1?M\ES?JAMK:6'^P[@>3-(DDAN+;RU?S."A#FG",]FTO7]XHRC_ M`'>6%YW?;F?N:!545?D>EKW[+DC)2\_?_P!?"GQ)_96\=-_P4N^%EF/VE?C8MQ??#?QM=0WPTOPA]HT^ M./5?"8:VB']A^48I#+&S&5'D!MHMDB`RB7,D^ZZ*\`_X8W^(O_1V/[0'_@H\ M#_\`S/4?\,;_`!%_Z.Q_:`_\%'@?_P"9Z@#W^BO`/^&-_B+_`-'8_M`?^"CP M/_\`,]1_PQO\1?\`H[']H#_P4>!__F>H`]_HKP#_`(8W^(O_`$=C^T!_X*/` M_P#\SU'_``QO\1?^CL?V@/\`P4>!_P#YGJ`/?Z*\`_X8W^(O_1V/[0'_`(*/ M`_\`\SU'_#&_Q%_Z.Q_:`_\`!1X'_P#F>H`]_HKP#_AC?XB_]'8_M`?^"CP/ M_P#,]1_PQO\`$7_H[']H#_P4>!__`)GJ`/?Z*\`_X8W^(O\`T=C^T!_X*/`_ M_P`SU'_#&_Q%_P"CL?V@/_!1X'_^9Z@#W^BO`/\`AC?XB_\`1V/[0'_@H\#_ M`/S/4?\`#&_Q%_Z.Q_:`_P#!1X'_`/F>H`]_HKP#_AC?XB_]'8_M`?\`@H\# M_P#S/4?\,;_$7_H[']H#_P`%'@?_`.9Z@#W^BO`/^&-_B+_T=C^T!_X*/`__ M`,SU'_#&_P`1?^CL?V@/_!1X'_\`F>H`]_HKP#_AC?XB_P#1V/[0'_@H\#__ M`#/4?\,;_$7_`*.Q_:`_\%'@?_YGJ`/?Z*\`_P"&-_B+_P!'8_M`?^"CP/\` M_,]1_P`,;_$7_H[']H#_`,%'@?\`^9Z@#W^BO`/^&-_B+_T=C^T!_P""CP/_ M`/,]1_PQO\1?^CL?V@/_``4>!_\`YGJ`/?Z*\`_X8W^(O_1V/[0'_@H\#_\` MS/4?\,;_`!%_Z.Q_:`_\%'@?_P"9Z@#W^BO`/^&-_B+_`-'8_M`?^"CP/_\` M,]1_PQO\1?\`H[']H#_P4>!__F>H`]_HKP#_`(8W^(O_`$=C^T!_X*/`_P#\ MSU'_``QO\1?^CL?V@/\`P4>!_P#YGJ`/?Z*\`_X8W^(O_1V/[0'_`(*/`_\` M\SU'_#&_Q%_Z.Q_:`_\`!1X'_P#F>H`]_HKP#_AC?XB_]'8_M`?^"CP/_P#, M]1_PQO\`$7_H[']H#_P4>!__`)GJ`/?Z*\`_X8W^(O\`T=C^T!_X*/`__P`S MU'_#&_Q%_P"CL?V@/_!1X'_^9Z@#W^BO`/\`AC?XB_\`1V/[0'_@H\#_`/S/ M4?\`#&_Q%_Z.Q_:`_P#!1X'_`/F>H`]_HKP#_AC?XB_]'8_M`?\`@H\#_P#S M/4?\,;_$7_H[']H#_P`%'@?_`.9Z@#W^BO`/^&-_B+_T=C^T!_X*/`__`,SU M'_#&_P`1?^CL?V@/_!1X'_\`F>H`]_HKP#_AC?XB_P#1V/[0'_@H\#__`#/4 M?\,;_$7_`*.Q_:`_\%'@?_YGJ`/?Z*\`_P"&-_B+_P!'8_M`?^"CP/\`_,]1 M_P`,;_$7_H[']H#_`,%'@?\`^9Z@#W^BO`/^&-_B+_T=C^T!_P""CP/_`/,] M1_PQO\1?^CL?V@/_``4>!_\`YGJ`/?Z*\`_X8W^(O_1V/[0'_@H\#_\`S/4? M\,;_`!%_Z.Q_:`_\%'@?_P"9Z@#W^BO`/^&-_B+_`-'8_M`?^"CP/_\`,]1_ MPQO\1?\`H[']H#_P4>!__F>H`]_HKP#_`(8W^(O_`$=C^T!_X*/`_P#\SU'_ M``QO\1?^CL?V@/\`P4>!_P#YGJ`/?Z*\`_X8W^(O_1V/[0'_`(*/`_\`\SU' M_#&_Q%_Z.Q_:`_\`!1X'_P#F>H`]_HKP#_AC?XB_]'8_M`?^"CP/_P#,]1_P MQO\`$7_H[']H#_P4>!__`)GJ`/?Z*\`_X8W^(O\`T=C^T!_X*/`__P`SU'_# M&_Q%_P"CL?V@/_!1X'_^9Z@#W^BO`/\`AC?XB_\`1V/[0'_@H\#_`/S/4?\` M#&_Q%_Z.Q_:`_P#!1X'_`/F>H`]_HKP#_AC?XB_]'8_M`?\`@H\#_P#S/4?\ M,;_$7_H[']H#_P`%'@?_`.9Z@#W^BO`/^&-_B+_T=C^T!_X*/`__`,SU'_#& M_P`1?^CL?V@/_!1X'_\`F>H`]_HKP#_AC?XB_P#1V/[0'_@H\#__`#/4?\,; M_$7_`*.Q_:`_\%'@?_YGJ`/?Z*\`_P"&-_B+_P!'8_M`?^"CP/\`_,]1_P`, M;_$7_H[']H#_`,%'@?\`^9Z@#W^BO`/^&-_B+_T=C^T!_P""CP/_`/,]1_PQ MO\1?^CL?V@/_``4>!_\`YGJ`/?Z*\`_X8W^(O_1V/[0'_@H\#_\`S/4?\,;_ M`!%_Z.Q_:`_\%'@?_P"9Z@#W^BO`/^&-_B+_`-'8_M`?^"CP/_\`,]1_PQO\ M1?\`H[']H#_P4>!__F>H`]_HKP#_`(8W^(O_`$=C^T!_X*/`_P#\SU'_``QO M\1?^CL?V@/\`P4>!_P#YGJ`/?Z*\`_X8W^(O_1V/[0'_`(*/`_\`\SU'_#&_ MQ%_Z.Q_:`_\`!1X'_P#F>H`]_HKP#_AC?XB_]'8_M`?^"CP/_P#,]1_PQO\` M$7_H[']H#_P4>!__`)GJ`/?Z*\`_X8W^(O\`T=C^T!_X*/`__P`SU'_#&_Q% M_P"CL?V@/_!1X'_^9Z@#W^BO`/\`AC?XB_\`1V/[0'_@H\#_`/S/4?\`#&_Q M%_Z.Q_:`_P#!1X'_`/F>H`]_HKP#_AC?XB_]'8_M`?\`@H\#_P#S/4?\,;_$ M7_H[']H#_P`%'@?_`.9Z@#W^BO`/^&-_B+_T=C^T!_X*/`__`,SU'_#&_P`1 M?^CL?V@/_!1X'_\`F>H`]_HKP#_AC?XB_P#1V/[0'_@H\#__`#/4?\,;_$7_ M`*.Q_:`_\%'@?_YGJ`/?Z*\`_P"&-_B+_P!'8_M`?^"CP/\`_,]1_P`,;_$7 M_H[']H#_`,%'@?\`^9Z@#W^BO`/^&-_B+_T=C^T!_P""CP/_`/,]1_PQO\1? M^CL?V@/_``4>!_\`YGJ`/?Z*\`_X8W^(O_1V/[0'_@H\#_\`S/4?\,;_`!%_ MZ.Q_:`_\%'@?_P"9Z@#W^BO`/^&-_B+_`-'8_M`?^"CP/_\`,]1_PQO\1?\` MH[']H#_P4>!__F>H`]_HKP#_`(8W^(O_`$=C^T!_X*/`_P#\SU'_``QO\1?^ MCL?V@/\`P4>!_P#YGJ`/?Z*\`_X8W^(O_1V/[0'_`(*/`_\`\SU'_#&_Q%_Z M.Q_:`_\`!1X'_P#F>H`]_HKP#_AC?XB_]'8_M`?^"CP/_P#,]1_PQO\`$7_H M[']H#_P4>!__`)GJ`/?Z*\`_X8W^(O\`T=C^T!_X*/`__P`SU'_#&_Q%_P"C ML?V@/_!1X'_^9Z@#W^BO`/\`AC?XB_\`1V/[0'_@H\#_`/S/4?\`#&_Q%_Z. MQ_:`_P#!1X'_`/F>H`]_HKP#_AC?XB_]'8_M`?\`@H\#_P#S/4?\,;_$7_H[ M']H#_P`%'@?_`.9Z@#W^BO`/^&-_B+_T=C^T!_X*/`__`,SU'_#&_P`1?^CL M?V@/_!1X'_\`F>H`]_HKP#_AC?XB_P#1V/[0'_@H\#__`#/4?\,;_$7_`*.Q M_:`_\%'@?_YGJ`/?ZX#X-_\`)1?BQ_V-4'_ICTJO/_\`AC?XB_\`1V/[0'_@ MH\#_`/S/5T'[)7@W4?A_=?$K2-6\6>(/'.H6GBI/-UO6X;&&_O=VCZ8X\Q;* MWMK8;%8(/+A3Y47=N;E4`>?_P#!6+_E%E^TM_V2KQ1_Z:+JO?Z\ M`_X*Q?\`*++]I;_LE7BC_P!-%U7O]`'@'_!)W_E%E^S3_P!DJ\+_`/IHM:]_ MKP#_`()._P#*++]FG_LE7A?_`--%K7O=XDLEI*L$B13LA$;NF]4;'!*Y&0#V MR,^HI2;2;2N-*[L245^:'Q&\8^,/V2+OXIZO\.OBAXZ^)6K_``G^%FOWWQ/U MG7];NM0T,^*?L\-SI@M;*XDFMK*X4_:I7L['RXH8)($E4[X#7T)^QGHVJ?`K M]K?QW\+3XO\`&OC'P^/!'ASQA#/XIUVYUF]MM0NIM2L[PQS7#NZ0S?88)?(4 MB*)S)Y:(KE1I"%TGW6GGK+;;2T>9-I73C9:NQ43@G)[7^[X%KYWJ15E?:6NB MO]5T5\%_\%$_%_BK7_B3\=+K2_&OC+PK_P`,^_".S\?>&H-#UFXT^VNM8DGU M:+],O/A;\ M4/!7@_1_#]GK=S#H,VF:A%H@OX[JR5A!=23?VW<$331O)$8+?^G?P97O]?"GQ)_;]\"I_P4N^%FI'0?C9]GTOX;^-M/F0?!SQ>;AY M)=5\)LK10_V9YLT0%O)NFB5HXRT0=E,T0>2#[KHKP#_AY9\.O^A<_:`_\,3X MX_\`E31_P\L^'7_0N?M`?^&)\6?#K_`*%S]H#_`,,3 MXX_^5-'_``\L^'7_`$+G[0'_`(8GQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_``Q/ MCC_Y4T?\/+/AU_T+G[0'_AB?''_RIH`]_HKP#_AY9\.O^A<_:`_\,3XX_P#E M31_P\L^'7_0N?M`?^&)\6?#K_`*%S]H#_`,,3XX_^5-'_ M``\L^'7_`$+G[0'_`(8GQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y4T?\ M/+/AU_T+G[0'_AB?''_RIH`]_HKP#_AY9\.O^A<_:`_\,3XX_P#E31_P\L^' M7_0N?M`?^&)\6?#K_`*%S]H#_`,,3XX_^5-'_``\L^'7_ M`$+G[0'_`(8GQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y4T?\/+/AU_T+ MG[0'_AB?''_RIH`]_HKP#_AY9\.O^A<_:`_\,3XX_P#E31_P\L^'7_0N?M`? M^&)\6?#K_`*%S]H#_`,,3XX_^5-'_``\L^'7_`$+G[0'_ M`(8GQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y4T?\/+/AU_T+G[0'_AB? M''_RIH`]_HKP#_AY9\.O^A<_:`_\,3XX_P#E31_P\L^'7_0N?M`?^&)\6?#K_`*%S]H#_`,,3XX_^5-'_``\L^'7_`$+G[0'_`(8GQQ_\ MJ:`/?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y4T?\/+/AU_T+G[0'_AB?''_RIH`] M_HKP#_AY9\.O^A<_:`_\,3XX_P#E31_P\L^'7_0N?M`?^&)\6?#K_`*%S]H#_`,,3XX_^5-'_``\L^'7_`$+G[0'_`(8GQQ_\J:`/?Z*\ M`_X>6?#K_H7/V@/_``Q/CC_Y4T?\/+/AU_T+G[0'_AB?''_RIH`]_HKP#_AY M9\.O^A<_:`_\,3XX_P#E31_P\L^'7_0N?M`?^&)\6?#K_ M`*%S]H#_`,,3XX_^5-'_``\L^'7_`$+G[0'_`(8GQQ_\J:`/?Z*\`_X>6?#K M_H7/V@/_``Q/CC_Y4T?\/+/AU_T+G[0'_AB?''_RIH`]_HKP#_AY9\.O^A<_ M:`_\,3XX_P#E31_P\L^'7_0N?M`?^&)\6?#K_`*%S]H#_ M`,,3XX_^5-'_``\L^'7_`$+G[0'_`(8GQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_ M``Q/CC_Y4T?\/+/AU_T+G[0'_AB?''_RIH`]_HKP#_AY9\.O^A<_:`_\,3XX M_P#E31_P\L^'7_0N?M`?^&)\6?#K_`*%S]H#_`,,3XX_^ M5-'_``\L^'7_`$+G[0'_`(8GQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y M4T?\/+/AU_T+G[0'_AB?''_RIH`]_HKP#_AY9\.O^A<_:`_\,3XX_P#E31_P M\L^'7_0N?M`?^&)\6?#K_`*%S]H#_`,,3XX_^5-'_``\L M^'7_`$+G[0'_`(8GQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y4T?\/+/A MU_T+G[0'_AB?''_RIH`]_HKP#_AY9\.O^A<_:`_\,3XX_P#E31_P\L^'7_0N M?M`?^&)\6?#K_`*%S]H#_`,,3XX_^5-'_``\L^'7_`$+G M[0'_`(8GQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y4T?\/+/AU_T+G[0' M_AB?''_RIH`]_HKP#_AY9\.O^A<_:`_\,3XX_P#E31_P\L^'7_0N?M`?^&)\ M6?#K_`*%S]H#_`,,3XX_^5-'_``\L^'7_`$+G[0'_`(8G MQQ_\J:`/?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y4T?\/+/AU_T+G[0'_AB?''_R MIH`]_HKP#_AY9\.O^A<_:`_\,3XX_P#E31_P\L^'7_0N?M`?^&)\6?#K_`*%S]H#_`,,3XX_^5-'_``\L^'7_`$+G[0'_`(8GQQ_\J:`/ M?Z*\`_X>6?#K_H7/V@/_``Q/CC_Y4T?\/+/AU_T+G[0'_AB?''_RIH`]_HKP M#_AY9\.O^A<_:`_\,3XX_P#E31_P\L^'7_0N?M`?^&)\6 M?#K_`*%S]H#_`,,3XX_^5-'_``\L^'7_`$+G[0'_`(8GQQ_\J:`/?Z*\`_X> M6?#K_H7/V@/_``Q/CC_Y4T?\/+/AU_T+G[0'_AB?''_RIH`]_HKP#_AY9\.O M^A<_:`_\,3XX_P#E31_P\L^'7_0N?M`?^&)\6?#K_`*%S M]H#_`,,3XX_^5-'_``\L^'7_`$+G[0'_`(8GQQ_\J:`/?ZX#X-_\E%^+'_8U M0?\`ICTJO/\`_AY9\.O^A<_:`_\`#$^./_E370?LE?$O3OC!=?$KQ'I-MX@M M-/U'Q4GE1:WH5]H=^FS1],C/F6=[##_T`>`?\$G?^46 M7[-/_9*O"_\`Z:+6O=->TR36M"O;.*]N]-ENX'A2[M=GGVI92!)'O5DWKG(W M*PR!D$<5X7_P2=_Y19?LT_\`9*O"_P#Z:+6O?ZF45).+V8XMIW1\U?L[_P#! M-/3_`(`_"JZ^'MS\4_B9X]^&M]I-[H]WX5\1VOA];.\2\WFYFFGLM+MKR6>0 MR2L\CW#-(\SN^]CNKJOV;/V)K']FRQ\2SP^/?B#XP\4>)K"STE_$_B2>PN-4 MLK*SA>*SMH?)M8K?9"99I`9(7>22>1I6ESQ[715MM\U^JL_E>WS5W9[ZM;"[ M>3O]]K_?9-K9M)O5(^?_`-HS_@G=X;_:9\16FI:SXP\>Z7)=:%'X7\4PZ53>(?&5 MA8W6IZ7KNK^$;.YM4\/Z_J>F+ML+ZY1K=KD2P[+<[8;B.-S9VWF(_E\^]T4* M33371W7D[WT_[>]Y=I:JSU!ZII]59^EK;^B2OO9);*P5X!\1O^4IOP;_`.R5 M>//_`$[^#*]_KP#XC?\`*4WX-_\`9*O'G_IW\&4@/?Z***`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N`^#?_)1 M?BQ_V-4'_ICTJN_K@/@W_P`E%^+'_8U0?^F/2J`//_\`@K%_RBR_:6_[)5XH M_P#31=5[_7@'_!6+_E%E^TM_V2KQ1_Z:+JO?Z`/`/^"3O_*++]FG_LE7A?\` M]-%K7O\`7@'_``2=_P"467[-/_9*O"__`*:+6O?Z`"BF3SI:P/+(RI'&I9F8 MX"@,?A]J@UO[=/KVF6]Q# M%(;NW\B,64YCN[*=(DEN`T=PW4^EZ*^:OVO?V_M3_`&;_`!KKNG:!X"3QI8?#SPQ%XW\>7;ZW_9TFB:-) M<31![2(02_;+OR[2]F\AV@39;8\X,Z*8_P!K#_@H5??`#Q3K%MX9\#1>.=)\ M">%8/'?CB^.N?V>VC:)+/+&DEG&()?MET8[6]F$#M;H4MO\`7!G121U2:ZMK M[K[]EH]7H[:,IPDFU;56_'EM;N_>CHM?>7='TS7@'Q&_Y2F_!O\`[)5X\_\` M3OX,KWJRO8M2LX;B"198)T62-U.0ZD9!'L0:\%^(W_*4WX-_]DJ\>?\`IW\& M4VFG9D1DI*ZV/?Z***0PHHHH`****`"BBB@`HHJKI^N66K7=]!:WEK6J:C=P2W,%JTJB>:*)HUDD5,[F5&EB#,!A3 M*@.-PS:H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**J MZ1KEEX@M'GL+RUOH(YYK9I+>59466*1HI8R5)`9)$=&7JK(P.""*M4`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4455U?7++P_:)/?WEK8P23 MPVRR7$JQ(TLLBQ11@L0"SR.B*O5F=0,D@4`6J***`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`***JPZY97&M7&FQWEJ^HVD$5S/:K*IGABE:1 M8Y&3.Y5=HI0K$88Q.!G:<`%JBBB@`HHHH`****`"BBB@`K@/@W_R47XL?]C5 M!_Z8]*KOZ\[^"=]!=_$KXOQQ312R6OBZWBF5'#&)SH.D.%8#H=K*V#V8'H10 M!PG_``5B_P"467[2W_9*O%'_`*:+JO?Z\`_X*Q?\HLOVEO\`LE7BC_TT75>_ MT`>`?\$G?^467[-/_9*O"_\`Z:+6O?Z\`_X)._\`*++]FG_LE7A?_P!-%K7O M]`$&IV"ZIIMQ:N65+F)HF*]0&!''YU\0_L2_L^?%3P!XQ^%L/C#X?7^B:;^S M;\-M2\#V5Y'JNG7/_"?7,LUC'%<6")<%H83;:5&Y^VBV<27BIMVQN]?9S]C^T2;[(J$ M(D5JC_;8_9@^)K^+?B/IG@#P7<>--*^.?PKL_AG/JBZI96T&QL(W:1+&WCMU9NK!%"@GWXKYOUW_@G7XEU M_P"+VE^.I?VG?CY'XDT/3-0T;3KB/3_!H2SLKZ:SGN8`AT$JP>33[,[G#.OD MX#`,^[Z;HIRDY-R>[,80C"*A'9:'@'_#&_Q%_P"CL?V@/_!1X'_^9ZC_`(8W M^(O_`$=C^T!_X*/`_P#\SU>_T5)1X!_PQO\`$7_H[']H#_P4>!__`)GJ/^&- M_B+_`-'8_M`?^"CP/_\`,]7O]%`'@'_#&_Q%_P"CL?V@/_!1X'_^9ZC_`(8W M^(O_`$=C^T!_X*/`_P#\SU>_T4`>`?\`#&_Q%_Z.Q_:`_P#!1X'_`/F>H_X8 MW^(O_1V/[0'_`(*/`_\`\SU0W44G%P4BD$/S]KXZ_:4\>7OCKQ= MX;^&WPSL?&=_X5U'3])EO-4\3KHFFPW$]J;RX-Q(+>>9(X8'M`#!#4$?>@IK9_P#VK^ZTHN^UFAN+4G%[VO\`+7\='IO?2QG_`/#&_P`1?^CL M?V@/_!1X'_\`F>KG_!O_``3E\4?#_P`1^+-6TC]J/]H"TU#QSJL>MZW+_9W@ MR3[;>)8VE@LN&\/D)BUL;6/:@5?W6[&YF9MCPU^WJ=?_`&)[WXK?\(A-_;5C MJ5SX=_X1^UU#[7#?:O#JC:2(;:[2+]];2W:@1SB$%HW5C$K9C&?\#OVY_&/B M[XR>$_#/Q$^%FSEOMLF]]>G072_G;SO>STWT;U[=38_X8W^(O_1V M/[0'_@H\#_\`S/4?\,;_`!%_Z.Q_:`_\%'@?_P"9ZN=_9K_X*.7'QI\6Z8/$ M7@8>#O"?CGPG=^.?`NK)J[:E\*?"+QS=ZIX&\9P>#-%T/4;>;3K_77N+>PEAOKJ M&2'S=-M/]/$DC31M)%;Q&1HPY\@-1D]+:VO;K\7)MO?F]VV][Z:.S<6GKWMY M;!__`)GJ/^&-_B+_`-'8_M`?^"CP M/_\`,]6]^RE^TQK7QRUCQ]X:\7>%=-\(>-_AIK$.DZS9:7KAUO39?/LX;RWF MM[IH+:1E:&=-RRV\3JP889=KM[#1;1/ND_DU=?A]W4F_]?U_3W6AX!_PQO\` M$7_H[']H#_P4>!__`)GJ/^&-_B+_`-'8_M`?^"CP/_\`,]7O]%(9X!_PQO\` M$7_H[']H#_P4>!__`)GJ/^&-_B+_`-'8_M`?^"CP/_\`,]7O]%`'@'_#&_Q% M_P"CL?V@/_!1X'_^9ZC_`(8W^(O_`$=C^T!_X*/`_P#\SU>_T4`>`?\`#&_Q M%_Z.Q_:`_P#!1X'_`/F>H_X8W^(O_1V/[0'_`(*/`_\`\SU>_P!%`'@'_#&_ MQ%_Z.Q_:`_\`!1X'_P#F>H_X8W^(O_1V/[0'_@H\#_\`S/5[_10!X!_PQO\` M$7_H[']H#_P4>!__`)GJ/^&-_B+_`-'8_M`?^"CP/_\`,]7NNN:S;^'-%O-0 MO':.TL('N)W6-I"J(I9B%4%F.`>`"3V%?,WPT_X*0ZC\:_A=\4]>\*?"+QS= MZIX&\9P>#-%T/4;>;3K_`%U[BWL)8;ZZADA\W3;3_3Q)(TT;216\1D:,.?(! M'WFXQU:5_DVHK[VTDMW\G9\KLF]GI^%W\DMWLM+[HZ3_`(8W^(O_`$=C^T!_ MX*/`_P#\SU'_``QO\1?^CL?V@/\`P4>!_P#YGJ3X3?MN7>J>"/C#/\0O"MCX M0\2?`Z5QXDLM'ULZY82P_P!G1ZC%-;7+6]O*X:WE7*R6\3JX8;67:[8?CO\` M;:^)GPHO/"VK^*O@UINB^!M:U+0=!O;UO&LEJ5N;>"XN$C MD>6XMYRL-PZV[*B>:X1#(/M=GI:W<^)[ZRGL-->XL[JRMWLK3S8U^V$"\5I)HF,2$*@9W,B MQ8FO_MF?$;Q7X@O-)^&/P>A\6SP:QK-E'J>M^(IM$T0VVEO#;3O)=I8W)CN9 M;UYH8;<1L'2TFE:6-0%,.:Y%/HTY+S479O[T_5*ZTU*<&FT^C2^;5TOZZZ;Z M&G_PQO\`$7_H[']H#_P4>!__`)GJ/^&-_B+_`-'8_M`?^"CP/_\`,]7ENM_\ M%?&UCX5Z5XU\%?#:X\1Z!IW@.S^)7C9#&R6G$V9$!]5_:[_`&]M+_9:O?`=C;>%O$OC'4/'?B'1M(233[*=--TB MUU#4(;(7UU?>6T$05IALA+>;,V`JA!)+'K[.7.J?5RY5ZWY?NO?7:R;O9-D[ M)MJUE?732R?7K:4=-_>2M=J[/^&-_B+_`-'8_M`?^"CP/_\`,]1_PQO\1?\` MH[']H#_P4>!__F>K'^/?[=7C'X'>.M5O9OA.TGPH\,^(-)\-:MXFU#76T[4K MBXU"6VA6XT[3WM3'>6D4MY;QO*UW"Q=;A8XY#$-_TO41]Z/.MO\`@)[;[--/ M9]`>DN5_U_P=-5NNIX!_PQO\1?\`H[']H#_P4>!__F>H_P"&-_B+_P!'8_M` M?^"CP/\`_,]7O]%`'@'_``QO\1?^CL?V@/\`P4>!_P#YGJ/^&-_B+_T=C^T! M_P""CP/_`/,]7O\`10!X!_PQO\1?^CL?V@/_``4>!_\`YGJ/^&-_B+_T=C^T M!_X*/`__`,SU>_T4`>`?\,;_`!%_Z.Q_:`_\%'@?_P"9ZC_AC?XB_P#1V/[0 M'_@H\#__`#/5[_10!X!_PQO\1?\`H[']H#_P4>!__F>H_P"&-_B+_P!'8_M` M?^"CP/\`_,]7O]%`'@'_``QO\1?^CL?V@/\`P4>!_P#YGJ/^&-_B+_T=C^T! M_P""CP/_`/,]7OD\Z6L#RR,J1QJ69F.`H'))KP/]D7]K3QY^U`NE^)KKX56_ MAWX5^+M+EUCPQXB3Q1%>7T]L)$%L;ZP,$1M6N8'$\8AEN@J@K*8GPI2:NUVU M?9;O5[*]G:^]G:XVK+F_K^N_;J'_``QO\1?^CL?V@/\`P4>!_P#YGJ/^&-_B M+_T=C^T!_P""CP/_`/,]7$_$3_@HA\0/"G[/B_%S3?@WIMU\--/T*;Q3JFIZ MEXVCT^[FTT3R^0NGVPM9#YAB2>5B[)M_M7?\`!0K4?V?_ M`!/J]MX=\`-XQTWP'X4@\=^.KF?6?[,FT+199Y8U:VA\B4W=YY=K>R_9W:W7 M;:D&4,ZJ:L]$^[7I:^_9:/5V0W&5[6OZ:]4M+;N\HJRUN[;D6I?\$Y?%&K_% M/1O&MQ^U'^T!)XG\/Z5?Z)87O]G>#!]GL[Z:RFNHO+'A_P`MM\FGV;;F4LOD MX4J&<-T'_#&_Q%_Z.Q_:`_\`!1X'_P#F>J[\=?VP-6^'GB^ZT'P;X`U3XBZK M%H-EJD4=C7(6"UY]!_P4@\46_\` M:O@Z^^&FBQ_&JR\;6O@:V\.VGBXW&A7EQ<:;_:R77]IFR6:.V2P6623=8^:K MQ%%C<,CLEKM_5I*/YM?)\WPZD^:[7^7+S7].76^W2]]#M/\`AC?XB_\`1V/[ M0'_@H\#_`/S/4?\`#&_Q%_Z.Q_:`_P#!1X'_`/F>KA?BI_P5AL/A'^P5?_%^ M]^'GBO4_%.EKJUG>^#M(CEOC9:EI4\MOJ$4U^D/DP6D,L$A^US+&&C"%4,CI M"WL7[0OQ>^(_@31M+N/A]\._#WBX36D^H:I?>(O&"^'-*TF&)%8(TR6MW,\T MA8[0+<1!8Y#)-&0BNJC4(N!_P#YGJ/^&-_B+_T=C^T!_P""CP/_`/,]7IO[ M.OQILOVD/@'X,^(&FV.HZ7I_C71;36[:SOT5+FVCN(5E5)`I*[@&P2I*G&02 M"#795I4IRIS<)Z-.S^1G":E%2CLSP#_AC?XB_P#1V/[0'_@H\#__`#/4?\,; M_$7_`*.Q_:`_\%'@?_YGJ]_HJ"CP#_AC?XB_]'8_M`?^"CP/_P#,]1_PQO\` M$7_H[']H#_P4>!__`)GJ]_HH`\`_X8W^(O\`T=C^T!_X*/`__P`SU'_#&_Q% M_P"CL?V@/_!1X'_^9ZO?Z*`/`/\`AC?XB_\`1V/[0'_@H\#_`/S/4?\`#&_Q M%_Z.Q_:`_P#!1X'_`/F>KW^B@#P#_AC?XB_]'8_M`?\`@H\#_P#S/4?\,;_$ M7_H[']H#_P`%'@?_`.9ZO?Z*`/`/^&-_B+_T=C^T!_X*/`__`,SU'_#&_P`1 M?^CL?V@/_!1X'_\`F>J2Q_;ST[6OVY#\%['PCXL>*U\,:GK]WXENM.N+2PDG MLKFR@>RLUDB!O6`O%9Y828D(6,-(YD6+'^!/[<'C/QO\;?"'A3Q]\*5^'5O\ M3-"O_$7A)F\0F]U406CV_FV^JV+VL!L+KRKN!C'%)=(K>8C2*RKO(>^HN.TD MVO15U?^7K8U/^&-_B+_T=C^T!_P""CP/_`/,] M1_PQO\1?^CL?V@/_``4>!_\`YGJK>)_VM?B5K^FZW>_#KX4:!X@TO0];U;39 MM7\2>-AX?TP0:;MBFE9UL[F<2O="YB1!`8MEH\CSQ[DC;GO'W_!5+0O#'P=^ M"OBK2_`GCC69OC3<^'/(M#I\L-OXV%S?WH1[:(QM<`+"',D[X"#R] M\L;IIU.50^TXI=[SORZ>=GOM9WM8))QO?IS7_P"W79_BTEWZ7+7PT_X)R^*/ M@_X:A?3W]Y+F3P^Q'F75S/)M!VKO MVJ%4*HZ#_AC?XB_]'8_M`?\`@H\#_P#S/5I?M!?M9ZW\*O'FH>&/"GP\U;X@ M:Y9:)9Z@(+*X:%5N;[4!8V,4K"&3RKY.?L\-HS>7(6"UYS!_P4@\46 M_P#:O@Z^^&FBQ_&JR\;6O@:V\.VGBXW&A7EQ<:;_`&LEU_:9LEFCMDL%EDDW M6/FJ\118W#([3%\RNOZ]Y1_-KY/F^'4'%IM/IJ_)TN+"$PQCS$^T6TH6XD6*(1[99#"F[ M;G:/^V-\2/BI^RQ\+_B1\/\`X4>']3_X3SPK#XLU1?$?CA=$TOPW#):Q7'V= MKI+2XFFF)E(4BU2';%(SRQ'8KDFHQE)[1M=]%=-K7T3?I;NKN,&VHK=WTV>C ML]'MKIKU371VT?\`AC?XB_\`1V/[0'_@H\#_`/S/4?\`#&_Q%_Z.Q_:`_P#! M1X'_`/F>KTW]G7XTV7[2'P#\&?$#3;'4=+T_QKHMIK=M9WZ*ES;1W$*RJD@4 ME=P#8)4E3C()!!KLJTJ4Y4YN$]&G9_(SA-2BI1V9X!_PQO\`$7_H[']H#_P4 M>!__`)GJ/^&-_B+_`-'8_M`?^"CP/_\`,]7O]%04>`?\,;_$7_H[']H#_P`% M'@?_`.9ZC_AC?XB_]'8_M`?^"CP/_P#,]7O]%`'@'_#&_P`1?^CL?V@/_!1X M'_\`F>H_X8W^(O\`T=C^T!_X*/`__P`SU>_T4`>`?\,;_$7_`*.Q_:`_\%'@ M?_YGJ/\`AC?XB_\`1V/[0'_@H\#_`/S/5[_10!X!_P`,;_$7_H[']H#_`,%' M@?\`^9ZC_AC?XB_]'8_M`?\`@H\#_P#S/5[_`$4`>`?\,;_$7_H[']H#_P`% M'@?_`.9ZC_AC?XB_]'8_M`?^"CP/_P#,]3=4_:Y\<^(OVCO$7A+P#\++;QCX M6\`ZKINB^+-;F\4Q:;>VMU=Q0W,BV5F\#1W2VUK/+WQUXN\-_#;X9V/C._\*ZCI^DRWFJ>)UT338;B>U-Y<&XD%O/,D<,#V M@!@AN'DDNU4I&B/*$G>*DNOY::V_E=U:7PN^C&XM-Q?17_KS\M^EKF?_`,,; M_$7_`*.Q_:`_\%'@?_YGJY_XE_\`!.7Q1\8/#EMI/B/]J/\`:`U'3[35=-UN M*+^SO!D.R\T^^@O[.7,?A]2?+NK:"3:3M;9M8,I92NE_\%$K[Q5^SSX+U_1/ M`MO>_$'QYXNO/`FF>'9=?$>EOJEE->I>3?VFENY:P2/3KN9;A+9GD18QY*NY M1=OP)^W:?&WP/\#^(QX0N;?Q1XI\62^"]0\/+>F!__`)GJ/^&-_B+_`-'8_M`?^"CP/_\`,]7!VO\`P4\UOX<7 M4=_\7_A9+\-_#>M^"]9\>:$\>O?VAK0L=+2&6XM]2T^2VMS97ODW$+"**6Y0 M.7C:565=_7?!G]N_5-1?QOI_Q5\`S_#[Q%X,T?3/$QTW0[RY\627VEZCYR6[ M1I;VD<[W:W%M<026T4,N'1-DDH<$#T3D^BO]S:?S7*]-[*]K:@T]//2^Z?P[ M/:WO15]KM+?0O?\`#&_Q%_Z.Q_:`_P#!1X'_`/F>H_X8W^(O_1V/[0'_`(*/ M`_\`\SU:O[(_[9UE^TQ^RM-\5=9T"^^'.FV=]K=O?6&M3J;G2X=-O[JTDDN= MH"QOMMB[H"PC)*[GV[C?_8B_:JC_`&T/V?K;Q]%X:QJ^F)INH,?M< M2V.I7-D'E4HACD<6^]HB,QERA+%=QJ4))N+W6_E?;^O7L*7NJ[_F_T5('@'_#&_Q%_P"CL?V@/_!1X'_^9ZC_`(8W^(O_`$=C^T!_X*/`_P#\ MSU>_T4`>`?\`#&_Q%_Z.Q_:`_P#!1X'_`/F>H_X8W^(O_1V/[0'_`(*/`_\` M\SU>_P!%`'@'_#&_Q%_Z.Q_:`_\`!1X'_P#F>H_X8W^(O_1V/[0'_@H\#_\` MS/5[_10!X!_PQO\`$7_H[']H#_P4>!__`)GJ/^&-_B+_`-'8_M`?^"CP/_\` M,]7O]%`'@'_#&_Q%_P"CL?V@/_!1X'_^9ZC_`(8W^(O_`$=C^T!_X*/`_P#\ MSU>_UX1^V1^W38?LD:SX(TA?"?B?Q9JWC3Q)H^B-]ALITT[1;>_U"&Q^VW=[ MY;01!7E`2$MYLSX"J$$DL;BKSC!;R:2\VW9?UTW>@[:.71*[_K^KO1:E?_AC M?XB_]'8_M`?^"CP/_P#,]1_PQO\`$7_H[']H#_P4>!__`)GJQ_CW^W5XQ^!W MCK5;V;X3M)\*/#/B#2?#6K>)M0UUM.U*XN-0EMH5N-.T][4QWEI%+>6\;RM= MPL76X6..0Q#?W'Q@_:,\4>%_B5JG@_P-\/V\>>(--\.P:T\;ZU%I4$4MU>FU MM(Y99$8+$1%>32R('D1+4A(9W=4J8OF2:ZZ?='F^2L[IO1[+4&FFT^EOQ?+O MWOHUNNMCG_\`AC?XB_\`1V/[0'_@H\#_`/S/5S^F_P#!.7Q1I'Q3UGQK;_M1 M_M`1^)_$&E6&B7][_9W@P_:+.QFO9K6+RSX?\M=DFH7C;E4,WG88L%0+;\*? M\%"IK'X3?$;5?&?@/5H/%WPR\0-X8OM!\%/<>+8]7OC9P7D,=A.EM`[AHKB- M9'G@@6WD67S2L:>:=KP/^VZWCC]E[X)?$*#PG.NH_&E-(DMM$2],S:K@[7_@ MIYK?PXNH[_XO_"R7X;^&];\%ZSX\T)X]>_M#6A8Z6D,MQ;ZEI\EM;FRO?)N( M6$44MR@]%7VNTM]!G_``QO\1?^CL?V@/\`P4>!_P#YGJ/^&-_B+_T= MC^T!_P""CP/_`/,]4G[*W[>VD?M+>&_BSK]YX;U[P!X?^%OB&;1Y)_$L$FGW M=W:1Z=:7YOY;65$EM$:.ZRL4H\P(JLZQLQC3H/V(OVJH_P!M#]GZV\?1>'-2 M\*17FL:OIB:;J#'[7$MCJ5S9!Y5*(8Y'%OO:(C,9N_9BEHE)[-N/JU>]N^VZTV[J_-_\`#&_Q%_Z.Q_:`_P#!1X'_`/F>H_X8 MW^(O_1V/[0'_`(*/`_\`\SU>_P!%2!X!_P`,;_$7_H[']H#_`,%'@?\`^9ZC M_AC?XB_]'8_M`?\`@H\#_P#S/5[_`$4`>`?\,;_$7_H[']H#_P`%'@?_`.9Z MNP_9C_9BC_9K@\:33>-/&'C_`%OQ_P"(!XCUG6?$:Z='=37"Z=8Z&]<\+?%7^W;.WC\`:#:"S&IZ,J/<"^C6 M<6U\#!;0/;W1U3]\R[7(]:T3P3XP^%/[,MV-8^#K_%O4/B5X@U35/'GAA=1T MM;P6U^\VR%8[R5;"\6"`6=HT*=<\='PTE[9LVC6RRW<^A>''+GP[X6L0^Z/1M+CL]4N;I8SE7DG M>`-JY6^]VDDVVVTK7UE>7^-[W]).27:RDV MTDK)N_2-OB/]@S]F_P")_A/XD?"*P\;^"IO">C_LZ_#S4/`5MJ\FJ65W#XUG MGN+"*.\LXX)I)8K<6NEI*PND@E#W:H$81LU;7C#PU\%HTO-.8+8MHNCV4^HF.YN[>-_(>VN2MO)-$TKQ(,JC^8/L* MBKE4G)WD]6FF^_--5);=7)=+63=K.S5QG9Z+2Z:7165E\M;ZWUWTT/"_V`?! M+_#OX/7FF7'P_P#B5X+U-]1DO=4O_'>H:-?ZWXLO9@K3:C/-IEY=1,S$!`I, M8C6-(XXTBCC4>Z444IRYG?\`K3\O39=-#*$>56_K777N^[>KW>H4445)0444 M4`%%%%`!1110`4444`%?'OC#PU\)O%_Q`^(%G?>%H MTO-.8+8MHNCV4^HF.YN[>-_(>VN2MO)-$TKQ(,JC^8/L*BDE9MKJN5^G-&3^ M_E2OV;M9V:N,[=.M_G9K]?\`/30^-OA_^SWK7BC]E:V^'EO\-OB;X27Q'XRL MKGQOJ?CK4]"OM9\3VOG)=ZA?7,NGWUQ'(+E8%LR@VF..54CA2&)=FI^UU\+_ M`!E^T7\:/#>D1?!F33M8\'>*M*U;PM\6K?5-+F@T73H[FTN=1B;=-%J=O-BSF^?A%V?,RY7/B_P`+ M/`TVCO)\2_$'@K5M#L-J7?\`Q3E]S<]5UY8IW2=]7-WYEH[6NO2*OZI1T?2[:ULU\!_M*_LX M?$G6+3QG:?#KX-W]GH?QX^$=A\-#ILFI:/8CX8RVTM]"DE[''=F.2U6UU61@ MM@URP:RV!2)%8?0_[:7P-U[XC_L^^$O#7A:R;5KS1/&GA#4I$:>*$BST_7+" MYN92795)2""1]H.YMN%!8@'W6BM54DI1GNU)2]7&7,D_)-M=[;N^I'Z*WWQC M!_>HQ\M-$KN_QG\1!\4OBA^W.MSXW^"/Q0U_X6^`M6MCX)AT75?#/]BWMUM7 M?KVII<:M%=2M`[-]GMQ;D0^49]LD[1"#[,HHK..D%#MUZM]6_/3]%HDD2UFY M][+T2V2\M?ON]VVRBBB@`HHHH`****`"BBB@`HHHH`I>)=%7Q+XNTY:7L[^\FBN9V5MT[KRUB_3>*Z:6TL]3Y!_;T^!FM_$KX/-\&O#O MP)_X271(]!AM?`?C*RU72U3X>ZPD4MM;W\L=U+!=6ALP8)8[C3_M,Y`E`2-E M42\[^V_^S;\5M5\:?$JU\&>$)O'=M\>_A;:?#>^UA-3LK*+PE>037T9O[R.> M:.22U:#5II<6JSRA[,KY>)%8?<%%:.;D[SUNVW?K=-:_?NK-V5V[(*&945;R]6W:>-GDN_+;RP6*<7HGP$\6^%/A5\- M?$OA;X.?%4>*/A;\0V\5ZWIOB_6_#DOB?XAF\TZ\T^]OQ=6NHR61N%6^#JDT MUN@2T$,:QQK$H^[**2E).[>ONZ]?=M_Z4U>7=MOI'EA1BH^SBK1]Y6Z6DFOP MB[1ZI>LK_&=Y^RE\0=6_X)'_`!B\%3:`D/Q+^*ECXOUI/#RW]NWV"\UJZO;N M'3VN-X@+Q"YCB>02>675RKE,,?4_VPK34=<^'EAX1U3]GYOCYX&UZQ>'6=+M M[[1VFM+F,Q/;E[35)K>WEAR'8RI<&6*2.+;$X8O'[S14U4IQY&M--/)*R7?3 M[]-S15)(_@Q^RY\//"7B_6F\1>* M?#7AZQTW5=3:>2X-[90 MBHQ45T_KIH%%%%9E!1110`4444`%%%%`!1110!X5\4_AIXH;]NOP1\0M,T&? M5]`\,_#SQ-I=P8;JWBDDOKF\T::VME6213NE6SGPY_=J4^=ER,^/?L>-\7I? M$_B_XA?$WX'?$JV^,FN:'<_9[S4M6\,R^'=#AC)DM]!TM;;5IITCD?RS)<2Q M(;F5/,E:)$ABA^UJ*GE?)[._227=Z,;F75]T=P]S+: M:G-;VTDV)PQDC?XZ_99^(A_X)\?!WX>75TWC7QQX-UKP- M/KE\U\&-TNFZOIUQ>W'G7#*TNV*"5\L?,DV]"[;3]6T5NJMI^T22?/&?E>#< MHJW;6W>W4SBFHJ-[V37WI)OU=KZ:7Z;6^4OBIH_QG^$O@+XT^.OA_P"!KGQ3 M\4_'?B6WT_0K+[1IQ.DZ-;1Q6D-UBXO+>&94`O+U8&GC9Y+O8WEY8IP&B?`3 MQ;X4^%7PU\2^%O@Y\51XH^%OQ#;Q7K>F^+];\.2^)_B&;S3KS3[V_%U:ZC)9 M&X5;X.J336Z!+00QK'&L2C[LHK*%XK1Z^ZK];1M_Z4U>75MM](\M2?-=6T?- MIT]]-/[E)J/5+;>5_"/V)?@UXG^&7[+.HVOBG34TCQ9XQUK7_%=]I"W,=Q_9 M$NJZC=7RV32H3&[PK<)&[HS(71RK,N"?*/#/PK\5_#C_`()V?!GX2^-_V!-.T7Q7H-OJFB7$VF:E:VUL(T>WU&>"TGA$B2DSQ7+/')%$4B<,9(_L MZBE)*490:TERZ>4%))+K]KUT6N]ZC4DI<]];MWZWDTV].[7IJ_*WG?[(_P`- M/$?P8_9<^'GA+Q?K3>(O%/AKP]8Z;JNIM/)<&]N8H$223S)/GDRP/SO\S=3R M37HE%%:U:CJ3=26[=_O,H148J*Z?UTT"BBBLR@HHHH`****`"BBB@`HHHH`_ M/7X]_P#!/GQ!=?M2^*]6T+X7G7_$?C;X@Z'XRT#XHQZG9VY^'EK`FG0ZC:D2 MW"WB/)%83#99PO%=+=I'.R*C$>U:)X)\8?"G]F6[&L?!U_BWJ'Q*\0:IJGCS MPPNHZ6MX+:_>;9"L=Y*MA>+!`+.T:.2ZC4PQ%E:0J(W^H**F,>6FJ2V6G_;M MHKE[6M"-]+NR;;:33D[S=1[[_P#;WO>]WO[\GV5]%J[_``[H/[*?Q#^#O[.7 MP9U?1O!]]K.J?"KXC:CXNL_`%MJ5E%>Z;H.H#5+6'1[>::X6R$UA9ZG$%C%P MMN!:-%%(4\MCL?LE?LS_`!"\"^(="\4^,?"\UO+H\/BSQO'H,%_9SF+7=?U: M:Z2R$HEV&>TLB]N9/+;6][-*2;N^9)WZ! M)\R2ELK/MJI2ETM;XY*RLN635M(M?GMX&^`'Q4_:T^%?QALOBU\*OB'X0^+/ MQ=\%:GX>7Q'K.H^'KGPQX/MY8G6WTG3H['4[F[$.]T>:9H`]S)$7D,:K!#%[ M=^QKX/\`B)XV_:&\8?%;XA>`+[X7W&H>$M`\'6>A7VJ6.HW,SV3WUU=7?F6< MTT0@::_\J(,XD9;=F>./;4G>][[[W;4[R34GNVWYW< M';T3A&W:UE[NA\?>"_V,?B9KG[''6_#O@+5W^)VO^*+N'7=#_P"$DL-8 MTR;Q#J&H6MO+#;7ULP299;25@)P=JM%(F'=:[3_@F'\$?B?\`O@'KNB_%.\\ M-W&KW?C3Q'JUG'I&E-8JEO=ZQ>72ROF]NPPF\[SD7^NRO9!1112)"BBB@`HHHH`****` M"BBB@`KQ7]O+X2^(?C1\&]`TKPUI_P#:5_9>//"FLS1>?%#LM++7K&[N9,R, MH.R"&1]H.YMN%#,0#[513B^6<9K>,HR7K%J2^5UJ-/1KNFOO5CXS^(@^*7Q0 M_;G6Y\;_``1^*&O_``M\!:M;'P3#HNJ^&?[%O;K:N_7M32XU:*ZE:!V;[/;B MW(A\HS[9)VB$'I>D^&O'?PN?XO\`Q!@\"/XU\4^*O$D$=IX?.K6EE<3:!9I# M:QQV\KLT!D9?MEW'%/)"K279222#)9?H&BI2M!0>NC7K=Q;;Z7?+:_2+<596 M2).\^?KI\DDTDO+6]OYE?=RO\U?L)_L^ZE\(?AW\3A;^"9?A=X9\9:[+J?AC MP`[6*_\`"*0'3[:WEB$=C/-90_:+N&XNO+MY60?:=S$2/(J\O^R1^SCX\^&G MP^_9_A\4^&;I6^"7PDBLO[+BO;.0W7B.6UM[:2)'$Q02006\\0D)$1&H-B0@ M';]>T53D];.UU%=_AC*$=[W:4V];^\HOIJ7NK/75O[Y*3V[VL^MF];NY^>W@ M;X`?%3]K3X5_&&R^+7PJ^(?A#XL_%WP5J?AY?$>LZCX>N?#'@^WEB=;?2=.C ML=3N;L0[W1YIF@#W,D1>0QJL$,7MW[&O@_XB>-OVAO&'Q6^(7@"^^%]QJ'A+ M0/!UGH5]JECJ-S,]D]]=75WYEG--$(&FO_*B#.)&6W9GCCW*M?3=%4IVV[67 MEO=KS:D[WO??>[:G>2:D]VV_.[@[>B<(V[6LO=T/C[7/V,?B9X^U3XXVNFZW MX=\$6OC'XJ:=XJM)==T/_A(K#Q'I=MH>E0F"6V@OK65$:\M#N#2J66W961HY M>>T_X)A_!'XG_`+X!Z[HOQ3O/#=QJ]WXT\1ZM9QZ1I36*I;W>L7ETLKYO;L, M)O.\Y%W*T4FD5>UE>^FK*J2Y]^_-\_> M^_XWOKLKV04444B0HHHH`****`/`/^"L7_*++]I;_LE7BC_TT75>_P!>`?\` M!6+_`)19?M+?]DJ\4?\`IHNJ]_H`\`_X)._\HLOV:?\`LE7A?_TT6M>_UX!_ MP2=_Y19?LT_]DJ\+_P#IHM:]_H`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBO`[[_`(*6?"^WUS5K&TM/B[KIT34[S1KJ[T'X1^+-9T_[79W,EK=1 M1W=IILMO*8IX98F,A?`#]I;PE^TWH>M7WA.;72/#FIG1M5M-:\/:CH M.H:==_9H+H12VE_!!<(3!=6\JDQ@,DR$$@T`=[1110`4444`%%%%`!1110`4 M444`>`?\%8O^467[2W_9*O%'_IHNJ]_KP#_@K%_RBR_:6_[)5XH_]-%U7O\` M0!X!_P`$G?\`E%E^S3_V2KPO_P"FBUKW^O`/^"3O_*++]FG_`+)5X7_]-%K7 MO]`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5X!_P`$T_\`DW7Q'_V5 M7XC_`/J<:[7O]>`?\$T_^3=?$?\`V57XC_\`J<:[0![_`$444`%%%%`!1110 M`4444`%%?)?[6K?MV-\:KT?`E/V2U^'2P0BS/CQ_$+:T\VP><9!9@0JF_(4` MD[0"3DX'SE^U)#_P5,G^"6KK*O[($ECF(W\?@IO%JZU):>:OGK"5(FP8]V[[ M*1=;-WD'SME`'Z@T5^;'P4MO^"K-I\)?#L=^W[%#7BV$7F_\)(_B1]74E<[; MIK;]R90,!BA()&)(OC\W[,D.C2:/(-#G^'+ZW]MAU M''O MVA?A#/X:^$7]@_$W1U6+XEZOJWPMUBVUS4+DVTR7U])XQ2X@T_489)&1A;G[ M;YS-&X16B'D5/V&?$GQJ\&_#WX3^"]5;XP:5JFFZ'I&CS>";KX?>3X4AT5=# MA\V[FU9K'S([])O,_<-?*XE00_9,'S&'_".E^$ MTU^UU[X5S:;?Z"ZWMO!J&GZ5:)81W.H6ZV0F+,@O9$\M"ES(SG'46G[3WQL\ M4_M"?"^\L;+XHIX0\1^)]4@N="F\%W6DM_91U%X[2[O99]$GCBC6T`D$,U]I M=R`N6^TR.(%W]FG55*+WDXKY-)-]E*_NO5-)N_*KD.35.522VM^3;MZ6UV:; M4;6P-ZT4`RTDD*E02G'RAX_U;]IO]F;XU^,]3\)Z-XKT32_'6LQ^) MM9O['1-2OWU#5Y-)TH_97%IX;UR1K*+]_`3'%;$^1L%RC)L//&:<5*6E^;\) M-+Y22=NM[*WO)O24'=J.MK/\-;=W&\;]+-N_NM'ZVT5\(:KXK^*/Q%_;"\"V MWB>Z^):S:9XNM[S_`(1VQ\`S'P5;Z9_8DQ&HIJ[6(D6Y-U*T9BGO`RABAM%( M6:O+?A[\>?CS\,_@%X>6\;XY^'O&VE>%-,ATWP-X;^"4%YX9:U.BP-/=221V M,2VUW#TO=E)]+?E^:UNM6K.]N6222O\/9/[W)? M=:-T]GS*V\;_`*@T5^:OP0^,WQ9\0>'_``'XO^,MKXVGT+X:_%"[UU]QW%IH2^#M7$MS.#H6C/Y:7;R1@G3HSNDC4-+OC9OK3]L7P[K/B#XB?`._T3 M3=1U!=#\=76H7RCS2]=/1/ M[];6[E1CS.R?V92^<7-6_P#)5K_>6G?W:BOA;2=?_:(^'7P;GNM:\:_%3Q'- MKWA/PQK6IW__``A.FSZMX0GN+MTUB/3;2UT]!/-#;X=;:>&[F0H#LF)\I_H+ M]B;XE:EXZ^'%W;:KJ?Q+\0R:?=R-9:UXV\$/X5U/5;-I'6-Y(/(MTWJ\SL[-V9E*=K>=OQ7,OPW6Z;5TKH]GHH MHK,H****`"BBB@`HHHH`**\+_;A;]I@:%X?'[-B?`HZF9YCKC_$M]5$"P[5\ MH6RV`W%RV_<7(``7`.21\"%\6-XGR+2 M7_D%AOE-_P#\\`>/-\O-`'Z=T5^(O[',O_!0H?M.0IX`'P[V-X7U%M0/Q"7X MR?\`",9%WIWE;CXF^87_`#)Y`M.#%]M\[I#7V'I+?\%0TU6V-^G[!$EB)4-P MD#^+4E:/(W!&8$!L9P2"`>QZ4`?>]%?GY_P5!^#]CXF_:*AUUO!MQXLU\>'8 M;;1H_$'P9U/Q[I?GQS3NBZ3J6E3Q3^';XR.HFN[AU0C[))'S;2,."\6Z5X[\ M/_\`!4NV^,>K?#3Q7?ZIX;CL="7PY:^#]0O%TO3GMHXIM9C\41V5U]NC07ER MK:1;-"7>/SFB=U:0JB_:24=KM^FETM=FV[72^!/FGRQ38JS]FF]]%][MOV6K MU>DK6C>3L?J!17Y_?L9_\$R]3M_BZOQ-U?3?A5X1N[/XA^(]<%S8_"Y],\>7 MT3:OJ'E1W&NM?$RVL\;H67[&!+;LB`X(L[]DEK=Z=/,_1"BORN^'/P&TRU M^#^L+I/P4^(>C_"B.'P)'X_\*W/A&]@N/$FI6MU=MK<[::T`FU9MCZ>;F>&. M=;Y8"JM/L(/OUA\+=;/_``1;^+/AC2?"?B33FU;PWXUC\)>&9M/F34K;3+F7 M46TFR2S*"6$BTDMDCM2@>)=D14,FT=,J:7/9I\KMIU5D^9?W7?W7]KEEM:Q. M'7M*M.F].;E^7->]_.%K36G*VEK>Y]IT5\.?M"ZO^TCX1N?%?BKP1XD\>W4> MF^)3H6F>#X_"NG7.G'2SX?29K^,FT%Y-/'>L^PF[$+R(L+*T[7?'5HE[XJ\1>`KK0O%=S81Z)$JE+"+PO>L4%XODF5-$ M"[(P"RDFX;"4DH\_^'U]ZUK_`/@2_%)MIHBDW-1NK-J_YW^[E?GL]G<_4"BO MB'X3_'/X[^*/BA\-)-;G\:0>#]1M]+/C&6R\#7")8ZA(D_D6UN;W3[6\-G<# MR3?3O:`VLGEJIMEDF-K]=:=JGB^7XH:A:7>A^&X/!<5FCV.JPZY-+JESS>X779+W7C?W M-H_E*)=0,3V[.HU0&ZDW3?NXYUSYDEKOI?KN[>O MX*^RN]#6I'EJ2@M4EH^_N<_IUMN[.]]-3[_HK\O/A'\2_P!H3]HGP1XETOQS MI?Q&U_2(O%/@'5]*DUCPE>:;=6\L7BJTEU!%A?0M*,445LD4K)F_6-4PDDW*/5:6[O3]' M^FY^AE%?`4'QM_:)N_V_7\++<^*],^'&I3166DM+H.J26RZ6^GQL+YY1X7EA MCU$3>8V+O6HHUE^SS^T7\4_A+\`/`7@V33?CAK>MW_A3P?;Z5=:C M\.+SS+>[749H-<2]F%A'#;&*W1,?:_++Q(DD1E=][E.//%R7=))[ZW;TZ.-O M>3VZVLR.:SL^F[Z>6O5/HUHUKM8_0JBOA`Z?^TOXJ^'"7A^)WQ5T'6'\.^*O M$ABM?!VB$K?6UY;PZ5I6R;3'/DO")9-G_'Q,7=EE"A53T3]DKXO?%;Q9^VE\ M2-$\6KXPO_!L.GQ76FSW6A3Z5I&D3?N1]DA^T:1:M-(VZ4F6+4M1C;R2Q%KN M2-IHOVEDM&TWKY-I_P#I+M\NZNZCY(\SVO;\O_DE^/9V^JZ***!A1110`444 M4`%%%%`!17%?M%-\14^"OB`_"5/!4GQ%\A1H8\7/=)HHFWKDW)M@9M@3>0$& M2P49`)(^-?\`C:;_`-6`?^7=0!]_T5^)O@K]K'_@IAJ_[7[:G%I'PQ74_$%T MW@9_#NH_#CXB6_A'2TMKJ?R]:^T/9+;)'*58BX6Z9GBNXA)&!&H@^L_^-IO_ M`%8!_P"7=0!]_P!%?#/_``4;^%4GQ$T+X37_`,2O#6FZ]KVG:3/'J=M)\'=1 M^+G@6/4)4MC<8TNT:/4(K@/&_P!EO&"QK#]ICD^>9%KY^_:"\#?$KQ!\7O@; MXMU+X5>)7U7X0>&+#4-$\'VOA;4=97Q/(I8+W^P)+=K6!F@?9=7*. M+=IYAL43":;CSZ)RL^ME:6OX+3L^;97'--)\NKY;^KTT_'?:ZY=W8_6>BOSO MT/\`X)S:E^U)^U-\3OB/>Z/\,O"MKJGC'2]3T_6M9^$]P_CN*"+2-)?S-,UJ M>[MY+/$B21KNLG,4BS;EW;D7L_\`@K7^S?H7Q^\=_#N?Q9;^,-0TC0;#51I5 MAH_PIM_'=I>ZM.UH(5NQ<6=_%:1[(G7S'M8AB1R+R#:RNYMPA!S6LDFUO:\5 M+IN_LI)7B5WLC[=HK\G?A=\`_&,_PU\51V7PA M\:^%?BA+\/\`Q+:_%N33],N-.C\6ZI/JMI-:P6E^\:1ZLWV1-26VD@EE%M#, ML),9D5!]?_\`!/[P-IOACX8?%H>#/!.M>`/AMJ_B6:X\%^'[WP_<>'OLMI_9 M5C%<YXH9K.*2_CO7$;Q(79WE`Q*"2J^2G*:UY8.6FM[2<;7[27O1?5:I6 MU)I^\XIZ7:6NC6E]NZZKIWOH?4=%?FP?AQ^U)\+OA=\'=9M9O"GBC6_"WPKU M:'0M-T[P#J.CW'A^_.F6*PPW\TM]>K+*-C*$%M$7DB;$;9\L9B_M7?M+?\,H M2R27/Q/_`+;/BN.SM]7MO!>L2:T+7[))*Z7)E\#1>7$9=@2:#P_<)\IBDGB= MQ(KK6A4J4UKR6_&7*OQ[-JW5A3O*,96^*_X+F?\`5OD?IU17YC6ND?&'QU^T MO\&?'WC&R^*6@:A>^%O"5CXJ&B^%99[6]OQ:^,$GANQ]A%=<\7>*]5M[KX7:)=:6=&6 MRA,%M$[)$%MR8KIIYEV#=(=QRZJ<%4ZN';7F=I-I?*.G>ZVNKU)+GBD]&HN_ M;FY?R% M+S1WO;U40RK>ZA/Y,'B"XGND8QS1378W%Y1+&LF]O)?V(+OP/]EU#2(9KFX74EB@O_#EA#`J0FV;$B:BD1/%Y.%>J MY$ZRHQ=VVE?[.LN6Z?5=;VV_&)2Y:\3>'?B1%JD7AH3ZIFTNM'U-=.L88KAA9&QNAX:M+,L\1C+[]:O= M^6**I!5/*?%_P9T.V_X*7?$?7_%WPZ\&ZBUYX[TR^T_4=:_99\1>-]3N;5-, MTM!)9^)+1A:6JK+'*J%HW%O(CNV1\M11_>2@ME*/-?\`[>2M;J];V7;[G)\L M9M[Q=K?*^_3U/TZHK\Y/$_[7WQF^'?[0.EPW6N?&747.K7EUXK\)_P#"K3+I MVEZ=;:W81+_8MS#IWG:DATZ:=Y/(GO93E7'V=AY1;^T5^TI\7);GP3XVL+'Q M_P"%-+U'4=>TK^V3\-XY?$&E:5<>*?#]M:+!;W-FT\R>SM*VVNG([Z_UI)O3?11UZ^]'N?H[17P7J'B M[]HWQM\+GN_#?C3XIZ?;:!X:\4ZWHVHZAX`L;76O&-Q:7%I_9,&I6<]@OV=I M@]TIMX;>TGFCC1T\ELUD?M/?$?\`:C^#7AG6])T#7/'?B6PL_%-FTOBA?#J) MJT=C<:5YSP6D>G^'=462!+[$>_\`LR>1%RDDX)\U9G)1A&JU5FKIWTND[?H717PI^SEKW[27Q+CT'Q9XK\:^.=+3 M4_$RZ!=>'++PC!:Z9#II+'I MT#LD=U<2K^_1;:='=) M-O0OE=FU_P`/MM]^O5)-M6U/UOHKY/\`@1\5?B_XB_:UCM/$]QXR3X;7"7`L MI1X.-K!S,HS4K_`-=+_P#`?5--/5!1114EA1110`4444`%>`?L;_\`)Q7[6/\` MV56Q_P#4'\*5[_7@'[&__)Q7[6/_`&56Q_\`4'\*4`>_T444`%%%%`!1110` M4444`%%%%`'@'_!6+_E%E^TM_P!DJ\4?^FBZKW^O`/\`@K%_RBR_:6_[)5XH M_P#31=5[_0!X!_P2=_Y19?LT_P#9*O"__IHM:]_KP#_@D[_RBR_9I_[)5X7_ M`/31:U[_`$`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7@'_!-/_DW7 MQ'_V57XC_P#J<:[7O]>(>+_^"9G[-_Q!\5ZGKVO?L^_!#6]C_AT[^RQ_T;3^S_\`^&\TC_Y'H`]_HKP#_AT[^RQ_T;3^S_\`^&\TC_Y' MH_X=._LL?]&T_L__`/AO-(_^1Z`/?Z*\`_X=._LL?]&T_L__`/AO-(_^1Z/^ M'3O[+'_1M/[/_P#X;S2/_D>@#W^BO`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[ M^RQ_T;3^S_\`^&\TC_Y'H`]_HKP#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL M?]&T_L__`/AO-(_^1Z`/?Z*\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1 MM/[/_P#X;S2/_D>@#W^BO`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^ MS_\`^&\TC_Y'H`]_HKP#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__ M`/AO-(_^1Z`/?Z*\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X M;S2/_D>@#W^BO`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\T MC_Y'H`]_HKP#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^ M1Z`/?Z*\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>@ M#W^BO`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'H`]_ MHKP#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z`/?Z*\ M`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>@#W^BO`/^ M'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'H`]_HKP#_AT[ M^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z`/?Z*\`_X=._LL M?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>@#W^BO`/^'3O[+'_1 MM/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'H`]_HKP#_AT[^RQ_T;3^ MS_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z`/?Z*\`_X=._LL?]&T_L__ M`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>@#W^BO`/^'3O[+'_1M/[/_P#X M;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'H`]_HKP#_AT[^RQ_T;3^S_\`^&\T MC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z`/?Z*\`_X=._LL?]&T_L__`/AO-(_^ M1Z/^'3O[+'_1M/[/_P#X;S2/_D>@#W^BO`/^'3O[+'_1M/[/_P#X;S2/_D>C M_AT[^RQ_T;3^S_\`^&\TC_Y'H`]_HKP#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X= M._LL?]&T_L__`/AO-(_^1Z`/?Z*\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[ M+'_1M/[/_P#X;S2/_D>@#W^BO`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_ MT;3^S_\`^&\TC_Y'H`]_HKP#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T M_L__`/AO-(_^1Z`/?Z*\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/ M_P#X;S2/_D>@#W^BO`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\` M^&\TC_Y'H`]_HKP#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO M-(_^1Z`/?Z*\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/ M_D>@#W^BO`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y' MH`]_HKP#_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z`/ M?Z*\`_X=._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>@#W^B MO`/^'3O[+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'H`]_HKP# M_AT[^RQ_T;3^S_\`^&\TC_Y'H_X=._LL?]&T_L__`/AO-(_^1Z`/?Z*\`_X= M._LL?]&T_L__`/AO-(_^1Z/^'3O[+'_1M/[/_P#X;S2/_D>@#W^BO`/^'3O[ M+'_1M/[/_P#X;S2/_D>C_AT[^RQ_T;3^S_\`^&\TC_Y'H`]SNO#UA?:U::E/ M8VDD5K=/"K36R2;?,5'(W*'V)N`(SL7.<"C6O#VG^);>&'4;&SU"*WN M(KN)+F%95CFB<212J&!`='565ARK*"""*\,_X=._LL?]&T_L_P#_`(;S2/\` MY'H_X=._LL?]&T_L_P#_`(;S2/\`Y'H\P/?Z*\`_X=._LL?]&T_L_P#_`(;S M2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'H`]_HKP#_AT[^RQ_T;3^S_`/\` MAO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>@#W^BO`/^'3O[+'_1M/[/\` M_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z`/?Z*\`_X=._LL?]&T_L M_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'H`]_HKP#_AT[^RQ_T; M3^S_`/\`AO-(_P#D>C_AT[^RQ_T;3^S_`/\`AO-(_P#D>@#W^BO`/^'3O[+' M_1M/[/\`_P"&\TC_`.1Z/^'3O[+'_1M/[/\`_P"&\TC_`.1Z`/?Z*\`_X=._ MLL?]&T_L_P#_`(;S2/\`Y'H_X=._LL?]&T_L_P#_`(;S2/\`Y'H`]_KP#]C? M_DXK]K'_`+*K8_\`J#^%*/\`AT[^RQ_T;3^S_P#^&\TC_P"1Z]0^"W[/O@+] MFWPI-H/PZ\$>$/`.AW-TU]-IWAS1K?2K26X941IFB@1$,A6.-2Q&2$49P!0! MU]%%%`!1110`4444`%%%%`!1110!X!_P5B_Y19?M+?\`9*O%'_IHNJ]_KP#_ M`(*Q?\HLOVEO^R5>*/\`TT75>_T`>`O_`,$H/V6I'+-^S5\`&9CDD_#W2"2? M_`>D_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y M'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H M_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X M=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"' M3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._L ML?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+ M'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\` M1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[ M/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_ M`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\` MX;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X; MS2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2 M/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_ M`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D> MBB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'H MHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@` M_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/ M^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"' M3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O M[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+ M'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_ M`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3 M^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_ M`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__ M`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X; MS2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\ MTC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_ M`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y M'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H M_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X M=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"' M3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._L ML?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+ M'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\` M1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[ M/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_ M`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\` MX;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X; MS2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2 M/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_ M`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D> MBB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'H MHH`/^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@` M_P"'3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/ M^'3O[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"' M3O[+'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O M[+'_`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+ M'_1M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_ M`$;3^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M M/[/_`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3 M^S__`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_ M`/X;S2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__ M`.&\TC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X; MS2/_`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\ MTC_Y'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_ M`)'H_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`/^'3O[+'_`$;3^S__`.&\TC_Y M'H_X=._LL?\`1M/[/_\`X;S2/_D>BB@`_P"'3O[+'_1M/[/_`/X;S2/_`)'H M_P"'3O[+'_1M/[/_`/X;S2/_`)'HHH`5/^"4'[+4;AE_9J^`"LIR"/A[I`(/ *_@/7OU%%`'__V3\_ ` end XML 14 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
LEASES (Tables)
 12 Months Ended
Dec. 31, 2014
Leases, Operating [Abstract]  
Schedule of Minimum Future Rental Payments Under Operating Leases
As of December 31, 2014, minimum future rental payments under operating leases for each of the next five years are as follows:
(In thousands)
 
 
Year ending December 31:
 
 
2015
 
$
700

2016
 
546

2017
 
279

2018
 
105

2019
 
—

Thereafter
 
—

Total
 
$
1,630
Schedule of Rent Expense for Operating Leases
Rent expense related to all operating leases recognized as a component of selling, general and administrative expenses was as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Rent expense
 
$
676

 
$
424

 
$
419
XML 15 R54.htm IDEA: XBRL DOCUMENT v2.4.1.9
PROPERTY & EQUIPMENT (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Property and Equipment      
Depreciation $ 21,044us-gaap_Depreciation $ 18,869us-gaap_Depreciation $ 17,640us-gaap_Depreciation
Property and equipment, gross 188,019us-gaap_PropertyPlantAndEquipmentGross 164,060us-gaap_PropertyPlantAndEquipmentGross  
Less: accumulated depreciation (118,544)us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment (99,910)us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment  
Total 69,475us-gaap_PropertyPlantAndEquipmentNet 64,150us-gaap_PropertyPlantAndEquipmentNet  
Land      
Property and Equipment      
Property and equipment, gross 4,116us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_LandMember		 3,769us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_LandMember		  
Building and improvements      
Property and Equipment      
Useful Life 30 years    
Property and equipment, gross 10,369us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember		 9,541us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember		  
Equipment      
Property and Equipment      
Property and equipment, gross 17,783us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_EquipmentMember		 14,588us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_EquipmentMember		  
Equipment | Minimum      
Property and Equipment      
Useful Life 5 years    
Equipment | Maximum      
Property and Equipment      
Useful Life 7 years    
Instruments      
Property and Equipment      
Useful Life 3 years    
Property and equipment, gross 123,864us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= gmed_InstrumentsMember		 107,867us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= gmed_InstrumentsMember		  
Modules and cases      
Property and Equipment      
Useful Life 3 years    
Property and equipment, gross 25,155us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= gmed_ModulesAndCasesMember		 22,325us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= gmed_ModulesAndCasesMember		  
Other property and equipment      
Property and Equipment      
Property and equipment, gross $ 6,732us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_PropertyPlantAndEquipmentOtherTypesMember		 $ 5,970us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_PropertyPlantAndEquipmentOtherTypesMember		  
Other property and equipment | Minimum      
Property and Equipment      
Useful Life 3 years    
Other property and equipment | Maximum      
Property and Equipment      
Useful Life 5 years    
XML 16 R48.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACQUISTIONS (Contingent Consideration Payment Rollforward) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Contingent Consideration Payment [Roll Forward]    
Business Combination, Contingent Consideration, Liability $ 14,177us-gaap_BusinessCombinationContingentConsiderationLiability $ 7,358us-gaap_BusinessCombinationContingentConsiderationLiability
Purchase price contingent consideration 11,300gmed_BusinessCombinationContingentConsiderationArrangementsFairValueAdditionsForCurrentPeriodAcquisitions 6,704gmed_BusinessCombinationContingentConsiderationArrangementsFairValueAdditionsForCurrentPeriodAcquisitions
Contingent payments (11)gmed_BusinessAcquisitionContingentConsiderationMilestonePayment (5)gmed_BusinessAcquisitionContingentConsiderationMilestonePayment
Changes in fair value of contingent consideration classified in operating expenses (1,131)gmed_BusinessCombinationContingentConsiderationArrangementsFairValueChangeInFairValueLiability 120gmed_BusinessCombinationContingentConsiderationArrangementsFairValueChangeInFairValueLiability
Business Combination, Contingent Consideration, Liability $ 24,335us-gaap_BusinessCombinationContingentConsiderationLiability $ 14,177us-gaap_BusinessCombinationContingentConsiderationLiability
EXCEL 17 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"AB.H$=P(``,8N```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VD%OFS`8!N#[I/T'Q'4* M#@:;;@KIH=N.6Z5U/\"#+P$%;&2[7?+O9T@;5566*%JDO9>@!/Q];S@\IW=Q MN^V[Z(FL:XTNXS29QQ'IRM2M7I?QSX>OLYLXM)_Y M<4:\7'RFE7KL?/1E&W[>)['4N3BZVS\X[BIC-0Q=6RD?DK(G7;_9,GO>D(23 MTS.N:0?W(<2(V=$-XYV_+W@^]SV\&MO6%-TKZ[^I/L1@VX[]-G;SRYA-F2WKE(./_FP9? MF(.#Y,A`1E:/(RE%DY2BR1NW*U:S_TW.9&6:I_>!OZS%W+%[[I2-/8"J^I/K*;32WTY1\```#__P,`4$L#!!0`!@`(````(0"U M53`C]0```$P"```+``@"7W)E;',O+G)E;',@H@0"**```@`````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````C)+/3L,P#,;O2+Q#Y/OJ;D@(H:6[3$B[(50>P"3N'[6-HR1`]_:$ M`X)*8]O1]N?//UO>[N9I5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ. M'&%7W=YL7WBDE)MBU_NHLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&7< ME.4]AK\>4"T\U<%J"`=[!ZH^^CSYLK$SO+=N5#9@NI MS]NHFD++28,5\YS3$$X4UD^&'!Q0]47P```/__`P!02P,$%``&``@````A`%_M2;$( M`P``Q2X``!H`"`%X;"]?^W4B+GT%+(M4T?8)'7EHDM&:WZX;?O8F*I@79R$7,Q:(WE/]J9^0[-<]C' M4JW7KAS^OH?8O+IG\;BMQ?"X54X43Y=S_NJW;][O=HB<8PBCV,4',>SQ_%H'*?) MXS@-Q\E>HDK956@@L M;\A&]P89W=^QQ[E#XUCR-!8-X]BIXV#J5(NF3FK#$+??QB&WN92?^DOC>;6, M'HYD"T="X4BVK22TE5ITKZ8:.N_3M'1KII`0BDT(!0FA\TF"6G;T&DE9LU-' MP]@Q;'X:R$_#YJ>!_+3L9FIA,W7LW'$P=QP[E1U,9<_.'0]SAZUD+&1VN["P M77@VL3PD5K4H(L;\-Z(`DW2+*M+:&U%9OA"C)< MTZ4#M:/9R:=A]!DVPPUDN&5#TT)H.K:S'';6HDD\G5OF-)Z6;D<96-8-&YL& M(L*R^Y_%_8\-"0QLLQ_^1I_M_9]1IU+;JQT3!L0D%`2;9N)=2M9.M60MUJ]EYIN%F: MK6.-`<4F@H5$L&PB6$P$=C'VL!BSBRCLH7Y1'DSGIQD)T]++D.@9ECV)EC8.8X=N:X*7/*5S\^W_P!``#__P,`4$L# M!!0`!@`(````(0#?B+F]*08``-,6```/````>&PO=V]R:V)O;VLN>&ULE)A= MDYI*$(;O3]7Y#Y;W)PI^K:GLIA!'0T71`&ZR5U,$9K-4$`P?V""3Y;?^I*$YO!X,\>!)'/W^3 MGD0"WSRFV=$O8)A]&^2G3/AA_B1$<8P'^G`X'1S]*.F?%=YF?Z*1/CY&@5BF M07D427$6R43L%Q!^_A2=\O[=N\[W8C\O6!@5(KSM M3V"8/@OE@ZP\+J%X],NX\""]5W6HES[6]:G\I2S% M?22>\^LD.>R]?(Z2,'V6/X72_KJ,1A#`<_75YR@LGN#[X7!X^>R#B+X]%:\? M@OP`Z5<5A.=4?WM)E=YK13BL%&=)$16_N)6S,,R/:V=WL)?<@'_N8;LUG`>^6W'76MLXF!&2N:G+&.:G@^5ZULYV M\1Q?`EIQ]V3/;57*=X_VC$=J6;(&?,\?;1"-0R="\ M!Q37'#.H$7Q<;V=^7!@NA&;NMC(V0T*`!3`W&@''LF$>XY[Q14T*DZ,1=#:P M:NKO,2]@C74GVFVWEE M%BYP(V-BYC<@Q4P'``'$_+<*BT(;6.M,(;:$'.H$PZ[;0R" MJ)Y:G5AP%%]WJ4Z`1$[&/?]K#`T*GHRYU`F7Q-*:)#"J(X)JH[4UR6!41P35 M%HMK$L+$C@BQR.J:)F-61X15:GE-&IC3$>&T;GT-"G!`7)<46J':[C^;6M,\ M3.>(F&&+N34)83I'A$YLI+K7I@0@AO\EHI,L%?`H!8!\5NJH$%C@\(@U,J>LX'2":84!K4'O]IT.^83 MC"<,F@7EQ7D(<=K@/&<$#Q;?;^*#.M@1B>$T3:==>;#KD$Z M4WQ^P:"65YO.RH\R?H]U,!U3PFB;CENDP7$U#8X'GV93 M0JMR+,K)\$JH\5(^Q<3"H%:?#IU]AM]63+'9PJ!+QQ%!F@11'%4O@X`EG!<& M>4I`[HAG*;".!MW]=1]-"="*$`D('TA33#0,NC*S_2R#I'Z*ABT*;Z!P1`3I MWPW(-DJB8WF45EMF@CNP;'[,]ZA$&MP3KJG-"-._A>1,+IT[R:4,O'F#W5K@ M-9MAIF%0RPQNC^TW.\RT!K#A%L(#:Y#*#."=;<29',Y_C6X#B$E`G9WJX5CFBDA$;#K5\8&$F=**(3H M[EY-"06;]*PB>E!E#.\\`S\.X&6L_%/=#<>3Z?G6/WA]'WWW/P```/__`P!0 M2P,$%``&``@````A`-9ADG"G!0``X!,``!@```!X;"]W;W)K!W/=3TYX*$;]^YYFJ[WGC=6 MY[HMQUU_K3NP'/NA+2?X.IR\\3K4Y4%-:B\>]_W8:\NF<[6'^^%'?/3'8U/5 MHJ_>VKJ;M).AOI03\!_/S76\>6NK'W'7EL/KV_6NZMLKN'AI+LWT33EUG;:Z M_WKJ^J%\N<"^/UE85C??ZLO*?=M40S_VQVD'[CQ-=+WGS,L\\/3X<&A@!U)V M9ZB/>_>)W0N>N-[C@Q+HGZ;^&!?_.^.Y__AE:`Z_-5T-:D.<9`1>^OY50K\> MY!!,]E:SGU4$_AB<0WTLWR[3G_W'KW5S.D\0[DA.J?H+K`2?3MO('("MEY_J M[T=SF,Y[-XAW4>('C$>N\U*/TW,CY[I.]39.??NO!C'C2COAQDD(-(V=[W@: ML2C^?R^>9J1V(LJI?'P8^@\'T@/6'*^E3#9V#Y[-%@R/>5.@;2713Q*N)@'= M$4;?'Y/XP7L'D2H#R34D05,4P3,(@81A0($`0AA$A+9:`((VR+)P] M((J0XAL4Y2BA2!CD&A(KBHSY:43"6R"`[P)*F33N88855B@D\GW.[>\Q05NX-AKJ@(X8VDXU^&J,9!@DA4+"E.8Z) MO`*9OT=.UO0-XTMVZMAO$-(;,-0$?<8!97A-6( M6([@=;?;!E^WC8RV#8-)5&/R=ZLN3.STG`AB3ZUTF"%$:"-\7`[CWDL9Y`8S M,R0[*(A]U2R(W59J3'"[4W!=YN%SOL336I8;S#)TM^8P_[A:8O"ZVQV`;W0` MLO'<8'21R$+.":#``!Z'!"`0((5^_SUQMAN!_,5+HL=\6PQ-8FN0*65P-YJO MULI>&"?&'H7D<`IDYW`EF>=C';<[`=_H!':3AJ'&&!V!`9&I,$YN0K/,)KGR M(#``NI5=`I/$'4'=1,,(CIYR\P3/)&L];:DQ;%'ACV-22`KCQ.B9)2L]E_,Y MU#*BIWYHT<\3;3V]4CBS09X=KF6I_KW MA#EWZ"!Q?U[QE>TFKX\>WO`'SL^^GV M1;X!S6]SC_\!``#__P,`4$L#!!0`!@`(````(0`)P4*S@`,``"$,```9```` M>&PO=V]R:W-H965TOQ9NE[7.#R@'-6DJW_2KA_N_OX87-F]1//"!$> M,)1\ZV="5.L@X$E&"LPGK"(EK*2L+K"`G_4QX%5-\$$]5.1!.)W&08%IZ6N& M=7T-!TM3FI`'EIP*4@I-4I,<"]@_SVC%6[8BN8:NP/73J;I)6%$!Q9[F5+PJ M4M\KDO778\EJO,\A[Q>\"E8!,.TV!PH9 MR+)[-4FW_AU:WX=S/]AM5('^4'+F@^\>S]CY,7]?], M#R+;^K-X$BVF,Q1&OK?=,D*; MX!F*DC28^S$F[!`!J'120#^0:B5DU);H"=0V[L>8F5MBYI2044C+]P99]`1: M0F/4L!B;GAN,=GWDZM:'[0V8Y]W6-+/&+%7UHFFW:*C`%`Q*8ZO(55LEZHBT MBL;,E5@UIUQJ3&]NV:T"FSJ5\I$?'W4':NJ:. M[9`&-.X/0-RD$I#]CNUNX[DLM6!R&Y[`_J?OIM6[_KA\/BX[ZW) M!_:[V'?3[)V.P^5Q?UPT\]7:7+[\ABO5=CJPWA"6V-A"MTV5N'W*M*`'*1NSX;7>+8!F9Z]<$2';L^J ML%UY^Y!N0([-NST;ZA'7VG].`U(`?IVYZ%2][8L_94-R#](@[[53WA M^I*GKT85/I+ON#[2DGLY26'#TPF<\%ZMKWCZAV"5NK;LF8`;F_J:P56 M```9````>&PO=V]R:W-H965TZ_[PPS>+X#2K*YV&P>WAG>;TXO M-K>?OYV.BY>ZZYOVO`NB91@LZO.^/33GQUWPS]_J4QXL^J$Z'ZIC>ZYWP?>Z M#S[?_?S3[6O;?>V?ZGI8Z![._2YX&H;+S6K5[Y_J4]4OVTM]UE<>VNY4#?K/ M[G'57[JZ.HR-3L=5'(:;U:EJSH'MX:;[2!_MPT.SKT6[?S[5Y\%VTM7':M#^ M^Z?FTD^]G?8?Z>Y4=5^?+Y_V[>FBN[AOCLWP?>PT6)SV-[\]GMNNNC_JNK]% MZVH_]3W^P;H_-?NN[=N'8:F[6UFCO.;M:KO2/=W='AI=@1GV15<_[((OT8U* MML'J[G8O*=A*[3M;:IKL>+^,\C=+- M#_2B[S=:T;^G7M+E.DZS_$>\;%PO^O?42_SA7E9V=,91%=50W=UV[>M"+U5= M?W^IS,*/;G3/;CC=F%P'6,_SWJB_&/DNV`8+/72]IB]W^69[NWK1,[9WFH)K M8JPH)X69-=.MH$!:H/_U]\E"W(N:-&:YZ&JN)>E)`R5-S@TUSJ=[%A;`6R3X M!B57Q*16P259CGN17))G$=:H.8T?-%1=,EN=H7J%H_$BY116L[Z.0$F!H$!2 MH`!`KO0&F1ES0W>!+NXZBYFO:ISYPDHVXU+:KK,PS=;$=XDDR7H=9RF1""OQ MI4D*%`#(N-Z3P/BX_I/PNMS-55Q`GJWQW!56X^]=4B`LR,<:XS0H]2O^OTZM=N"7O-SE0<;C>F#-RUG)I/>TP! M@*K(>!5@U,U57$6TH558C1W3;9;DS$P)%5F:FG''=@541&FX9@II%7YN%0"H M(/-XX8_1ZRH:O'2OP=2@H$!9("!0`RI8_I&5.&OG=46`UP18&@0%*@ M`$"N(IWY,[9&C`>+'19.8]=@%N9Q'N49GM02:3:;<)-&6Z(13N/KDXPH2+!_ MDSM^KNF1$=E8@H=>GFVPR<*)O(&2$<&(9$0Y8K=!Y,]6;-BDRQN&;?A`PQG= M;9'5V(%W)QC=3N5'1,*)?.62$04)KL3$CZ]DVF:1325809Z1.2^LSC,2LX5^T#9GAY^\DA'!B&1$08+-F<"8,6=S!`X%,OJ`2#@1K,0V M\T1!#:[$A(JOY+K5;-;`"F:VVA1(YO-!1%*WC*:K?J]1(IE&08*-FIR9,6KC M!QJ-(G8F@(QRFXT2$5$B&5&0('/Q?-:-^+T,=B(_624C@A')B(($FWL[R&(> M9"P7G,8NUD@_/YD?G'6ET_@Z!".2$04)=JVG=&:^8X/QXT-./XH53N2ME(P( M1B0C"A)L;CZ@8AM0;Q^N3@3-V6:>"*:1C"A(L#F<2O1PBGDZY1GYO%LXD;=4 M,B(8D8ZX,RW,$_V#5XF"C;#K^;PR7[_0^<[)TBN<"+JE"2:81C*B(,'FYO,J MMCGSSGQ;$31'B7`=>8UD1$&"S9G3GI^,L0T!>#+F.7D@*IS(W[AD1#`B'7'' M09KJ#V;T.%"P%;9K4F#&K@T';-<_Z=IO$6*:("4C@A')B(($FS,I,&/.AL,[ M$TT3I(PI$8Q(1A0DR)S^Z`S-T8T]7B9'8T[V7^%$8,(9$8Q(1Z+,?`7QKY(>.CD.?W,[$30JVWFB6`:R8B"!)N;SYC$9LS;L^U$WDK) MB&!$,J(@P>9,*O"EF!A,9YE,1^%$T)QMYHE@&NF(W=99DJ9D0A1L@KV^'3G) M3.3D]('8B;S#DA'!B&1$08)-SB=,8J/BG=FF>5*Z9MZN8$0RHB#!YN83)K%1 M@4]%-MLT3TK7#)JC&NDT=K:3,-DF=$H4[`:[Q9$SGD3@Z\ED+GK(A[3"B;S' MDA'!B&1$08)-S@=-8C/DG?EF0>.:>;N"$KO1VSLB*\F\T3.W'_NQ=NT+.OLJZ51WCW59'X_]8M\^G_47"+&. M@RN]OAC\$IMW#X07T8U^_:/YZGI!O\:[5(_U'U7WV)S[Q;%^T%V&2QTRB\Z^ M\;-_#.UE?(%UWP[Z!=[XWR?]9K;6;Y3"I18_M.TP_6%N<'W7>_<_````__\# M`%!+`P04``8`"````"$`@?9SO?,"``"]"```&0```'AL+W=O%^2112M:FZ6VDKK59[>7;`!*N` MD>TT[=_O&),$`TK[DL#A^,R9&3-F??M65]8KX8*R)D7NPD$6:3*6TV:?HC^_ M'V\29`F)FQQ7K"$I>B<"W6Z^?ED?&7\1)2'2`H5&I*B4LEW9MLA*4F.Q8"UI MX$G!>(TEW/*]+5I.<-XMJBO;LC>K+L"_:7D M*`;7EBC9\1NG^0_:$*@V]$EU8,?8BZ(^Y0J"Q?9D]6/7@9_PDM"-XP^5K&UHRZ3!RSQ9LW9T8+M`3%%B]5F M@K%+P'2AEIA[>J:<=!V`!Z.LF2>*U_0I%R7K._93CFXSME.$MSQ0;C)S= M0(X#-R<7"@5;R+JXB$!%X<7BN$BF'6AT)$+=^1"4ZZZ,"A77<#FFZF%0DT7 M43!RH2F#:@\`(\]H-H)"/VJHY@Q"#``C1#P;0J%F$I.&:HHN9>PD7N*.]_9V M2(DB)PK=Y67[&R[43+^\1Z>=J]"1BW%#->6JBR'ENHOEK`N%FBZB:-1031E4 M>P`8>;HP)6<2[>"/6MJ3!E&&B!G&G$NG>KIZE%Q]3WN.KJCG)W$M[;G7'>B=7K.O!-]`.FQW>(]><9\3QMA5:2`<>4L M8GC[N#Y^](UD;3>U=TS":=)=EO"90&`N.@L@%XS)TXTZX,X?'IO_````__\# M`%!+`P04``8`"````"$`Z;6&K!\$``!4#@``&0```'AL+W=OS?I_J"W5TPX\T\C.WJ0YVN4]4'V'Y^:VKGE?5#Q=N=2SWB.JPM^;%J MSSOW[[^>/B6N,XQ%>RQJWK*=^YT-[N?]SS]MK[Q_'BZ,C0YD:(>=>QG';N/[ M0WEA33%XO&,MK)QXWQ0C_.S/_M#UK#C*BYK:#PB)_*:H6E=EV/0_DH.?3E7) MOO+RI6'MJ)+TK"Y&V/]PJ;IARM:4/Y*N*?KGE^Y3R9L.4ARJNAJ_RZ2NTY2; M;^>6]\6AAKK?Z+HHI]SRQRQ]4Y4]'_AI]""=KS8ZKSGU4Q\R[;?'"BH0LCL] M.^W<+W23!VO7WV^E0/]4[#H8WYWAPJ^_]-7QMZIEH#;T273@P/FS@'X[BA!< M[,^N?I(=^*-WCNQ4O-3CG_SZ*ZO.EQ':'8I+2EX#$_QWFDK,`)1>O,G/:W4< M+SMW%7EA3%8T"%WGP(;QJ1+7ND[Y,HR\^5>!J$ZED@0Z"7SJ)#3RUD$8)_\G MRTIG@<\I2^`%24C#Z/%>?%67U.-K,1;[;<^O#@P9['SH"C&R=`.9A1`K`@TI MQ>(7L2HQ$!X@^KI/DF3KOX*TI<9D#?K\*:$6`5I7.>N1$ILKDQAY-A*^7(C8%&MYU2&Z&)U MY\+J*J!1F+5N"2Y[6L-PPL$:!4XM%%+.A!F8*8Q1F!*S"(HM"3I.AH5A] MI*'"&%1&P***+:JI&A'%U2!],H4!E6[ZQC&J.)\P6$-Q`[@?EXE51#'K&G5, M84S6)`UM3#YA,&MJL>)#*E8Q>V1GSA0FEO,"YD.)^8>&*U=@V0-+<@H^:U2/ M]R&7\49BM!$-LG18(U!^`V$AJ&U7D_XRC)GOQUP>QDR#C-$R(W:APC7N;<9S M3)6I?&P&&F32J@,/Z#*1FQ#P$ZH09%R!!)':8#F/M>0!7[A&'?^ MFZHB;*N:$NQY5(',,HV(K:IM0#-5E:D\4-5P'N6Q<-L6NURHRC:C6U7*4$PU M4X).0$852*E)E9JH\EQC%HAM:YH=D[E'I03Y3T85B,;B#O2Z)QZ9=?,]BZ*V M1\WHYV:5XN29S*%%U3*_YTUTP9P,SY?+CTQ?@\PA>L^#@H\]2"[CF<56K$&J MNRE)PF2%],\U9-[<8-F!9!CSXJG2(,4;$9JF$?+I7$,6>(5YW,\H[FJ@O,6> M:G1[R33(D-F,6&ZCX`JDCU7J">@[OBS'XO^G/5#D[-3O!,0#PX=4ZOW@K4CY%W\E'TP$=X MR)=?+_#VQN`9F7@`/G$^3C_$/>OV/KC_#P``__\#`%!+`P04``8`"````"$` M:A7Z68X"``#'!0``&0```'AL+W=OKRYQLUIZ0_) MEJ1Q/">2B@X'AI7^"(>J*L'X3K&#Y)T-))JWU()^TXC>#&R2?81.4OU\Z&^8 MDCU0[$4K[)LGQ4BRU5/=*4WW+>3]FN24#=Q^<44O!=/*J,I&0$>"T.NO7-2-A6K/W!&F6K@)GD@*UP*0.7WU M_T=1VJ;`V3R:+>(L26<8[;FQC\*=Q8@=C%7R;P`E)ZI`DIY(P)A0#BG'.UN$B`@;%0'.4_4#2)(='D.V5U#%KY;/1HO<+I@X$9-G%W*V`>-;TQOP M/I[SSCHFH+G M49:?<\%PN?L"URQZ=S1(#H,3VDUR7?,'WK8&,77H0%\*"L;H.*_WJ2OK17P+ M<^R'@8P;,%X]K?EWJFO1&=3R"BCC:`'SI,,DAH55O6_RO;(P6/ZU@0\FAZZ+ M(P!72MEA`1>3\1.\^0<``/__`P!02P,$%``&``@````A``[VB%61`P``"PL` M`!D```!X;"]W;W)K&ULC%;;CILP$'VOU']`?E_` M$,(2):F6T&TKM5)5]?),B)-8"QC9SF;[]QWC<+&A[?*0P/&9\9FQ/9[UNY>J M=)X)%Y35&X1='SFD+MB!UJ<-^O']\>X>.4+F]2$O64TVZ#<1Z-WV[9OUE?$G M<29$.N"A%AMTEK)9>9XHSJ3*AH'O+[TJ MIS72'E;\-3[8\4@+DK'B4I%::B>),&]%YJXK7N*MR_G1I[@I6->!B M3TLJ?[=.D5,5JT^GFO%\7T+<+WB1%YWO]F/BOJ(%9X(=I0ON/"UT&G/B)1YX MVJX/%")0:7=MTFZ"OA,:P+9AG52*[!G M[$E1/QT4!,;>Q/JQ78&OW#F08WXIY3=V_4CHZ2QAN2-E4K`29H)?IZ)J#T#H M^4O[?Z4'>=Z@<.E&L1_B($+.G@CY2)4M#J<-@U9+O/MFK.K`WL+!(LF5SL5K\"SBC^$ M+.H@^HS`PA2*_:#H&Y0@!W@"T.=MXM^OO6=(<7'CI%-.8#)V'4.E6;G-1H`' MPGIUD+"1NDZ$0I6(SCS5`#CI5876C%-&D)B4;$J)A\@,5;!F,ZH4ND'@I1>1 M^-8;@.&I3A]T(^^,'O[^S4V5:)&Z<&$_\_LX*-3,M[EV#GR3AV,(("Y9_ M)BR%6F%AWTQ=JCE#6$DT#<3FQ*$I;&*1V1:^:9",+8Q`X$#.!*)0.Q!L!:(Y M72"^&T8F86<3%I:';$)8]!X,C-,G,RW`J]'Z!/D2MZS])JEG1I#XONO?0EVY%^(GL2%D* MIV"7&A8A@)N@1_N>YZ%M>2P\5;V0.E)>/P`=2I.?R)>H:FD\#=Z[M`/C(FNP\UP;5K8[=_````__\#`%!+ M`P04``8`"````"$`STPN*3$%```<$@``&0```'AL+W=OU#V\Q\'G^>^3RVL_[RUIRL%]D/===N;.%XMB7;JMO5[6%C M__/WP]W*MH:Q;'?EJ6OEQOXA!_O+]M=?UJ]=_S0G.L@7/ONN;

WW=26+ MKGIN9#MBD%Z>RA'X#\?Z/%RB-=5GPC5E__1\OJNZY@PA'NM3/?[006VKJ>Z_ M'=JN+Q]/L.XW$9;5);;^KSEU4Q[&E:@TF[U M$X0KDC-:3J3C`3_+::6FD`EEZ^Z;^O M]6X\;NP@=J+$"X0?V=:C',:'6HVUK>IY&+OF/P2)*10&\:<@\'<*X@>?'@Q( MS2"1B.*?4W!Q.3H-13F6VW7?O5J@+2`\G$NE5'$/D:?U3XN8,P*% MJ13ZJX+K0;#6`:POVU2LUNX+I+B:,!EB4MN:,3Y%Y!>$2K,*6Q@&%XC-["!1 MG%W@S624EY))$CI3=@T)*"*_1O@IA137D&19,^$+->)\XX6O\H)NC,2D@LV5 M(48K7JD&R;%$ M%L0=1N$\FK"$S6*PO,A*63D[,0?0B<@0@^Q$F$;4G1.W[S/)%=DF]9G6,L08FY0;"L-`YA9P0O')C11I-\\1JT4V@1)=2N$Y7I": M/VQ?$'3LI*SA%,0?.6*I""6N6O3[M178P6E_X<`$3H&&U6 MU[^@@,!Y9Y<(U;$_((L-G9)=)(WM1L?8V$@V<9)E*I0B\<-:V/B"^(43+@V# MYE6U\P^H8K>G5%D),X&@21"1$["]GU,`W!H8H""`U(DBS_Q9ZDBIJX[_`74\ M$`CU@!\Y`D$3]="Y4@3Q_T3K!8E&M$Z)J\-@(7XYA.#>=]6@`E;V;`)AA_*# ME"THG_Q+;RA,"Z6A>OY"0]^]S%Z`1P+-WZ*B2:4(PORECL=4F`OTFW0,"Z6C M>OP'=/`(H'28CC)Q.2>,:T:P=)1IYUQ`R_7/L%!.JJ-_P`D;/N7$))0)!(&0 MEJM/P'IJ/H,63I=A8*&<5&]?.,WJP99/N2P[9RH7@E9XQ8H2+J]<&`>''E*8 M%L+#IT?)A8CV)KD;W3[D'4@]&6$%1,_&Z8)[;`;->C8M-&&JQ2YZODH8=F"B MZY#))8,GNN*$NH;;*Q=+*?RX/\7O:'NAVLD]S#4,^!'%L]ON[QP]B=]HYX#X'W7C9&ULC%5; M;]HP%'Z?M/]@^;VYAP`BJ0JH6Z5-FJ9=GHWC$(LDCFQ3VG^_8QM2$J2N+X!] MOO.=[]S,ZOZE;=`SDXJ++L>A%V#$.BI*WNUS_/O7X]T<(Z5)5Y)&="S'KTSA M^^+SI]5)R(.J&=,(&#J5XUKK?NG[BM:L)

O`4@G9$@U'N?=5+QDIK5/; M^%$0S/R6\`X[AJ7\"(>H*D[95M!CRSKM2"1KB`;]JN:]NK"U]"-T+9&'8W]' M1=L#Q8XW7+]:4HQ:NGS:=T*270-YOX0)H1=N>[BA;SF50HE*>T#G.Z&W.2_\ MA0],Q:KDD($I.Y*LRO%#N-RFV"]6MCY_.#NIJ]](U>+T1?+R&^\8%!O:9!JP M$^)@H$^EN0)G_\;[T3;@AT0EJ\BQT3_%Z2OC^UI#MVT\*AJ(!)^HY68$('/R M8K]/O-1UCN.9EV9!'$8I1CNF]",WOAC1H]*B_>M`H8D^D$1GD@1DGNV1%\W3 M,)W]G\5WBFPF6Z))L9+BA&`Z(*;JB9FU<`G,YQ3..H:DH+34H!\,W#J!7`6W MS\4B25;^,U2)GC%KAUE@-&"B,6)S09CT#.WVZL('88,ZR'FJ+@X&,<8Z%A/- MQY'6MY!XC-C<(J+%&+*]A61O<49ZXUN]23KH-59H_55ADG@B9^TPB>V\*K&]NAC%ANZ]4RMCS3%D,C0ER29M63O,W+8U"\-P7(;-M3D-LVQLWEZ;DUF< M#N:12ICW=U0:ZU3EM$(.XU1&013.AD!VEC8C>QK$D_&$!\'$W)"V3>[9A3:,0%`: M>!G$ENZ=<`CO`.Z%A[>W/&IYS!HT//`!70NC+P;Q$PQ]$\0\``/__`P!0 M2P,$%``&``@````A`-&ULC%7+;MLP$+P7Z#\0O,=Z2Y9A.4@\+'"Q\C&A?\HKU^P+_^OEX ML\1(*M)7I.4]+?`[E?AV\_G3^LC%BVPH50@8>EG@1JEAY7FR;&A'Y((/M(=, MS45'%#R*O2<'04EE#G6M%_I^ZG6$]=@RK,1'.'A=LY(^\/+0T5Y9$D%;HL"_ M;-@@SVQ=^1&ZCHB7PW!3\FX`BAUKF7HWI!AUY>IIWW-!=BW4_1;$I#QSFXJP70>=;H="U@6^"U;;)?8V:].?WXP>Y>0W MD@T_?A&L^L9Z"LV&UZ1?P([S%PU]JG0(#GM7IQ_-"_@N4$5K\CJU13X"A=))D?!6&"T8Y*]*>C)@>N)$1?-\O$7WNOT(SRA+FWF!RC$1/-$=MK1)B/$`\,C"Z@MHD+ MI!L9^:,;G9V["9Q.E<[TZ"I*36F(_="0L)KY( M3`(SB7@FX1:CLP4&>V/;8C]QI"QF:1H?Y'GD-G:6S^))-V9&8+8FM;I&=-8U MDCI&+"8U1L(L73KY[2P?9>FED)F1=&;DW'0==0UDC@&+L0;B+'1F<#M-AWET MF8J9?/9/>1UUY2\$=JPLQLKG0>K*3]-IGL>C^9F\WO;75TQ'7?G+[;#R%F/G M(`WBW,G#;M,<-I\$L$P<`W9SV?O>4;&G6]JV$I7\T,/TA?!:QZA=F/?!"JX2 M+#`GOH5%:N+>F(#]-I`]?29BSWJ)6EH#I;_(8"2$787V0?'!W-T=5[#9S,\& M_K$H7%)_`>":&ULC%A-CYM($+VO MM/\!<<]``\8P&D\4:&5WI5UIM=J/,X.QC6*,!4PF^?=;3;6AJKL5SR49OWY4 MO:XJ7MO]]/%;=_:^-L/8]I>=+QY"WVLN=;]O+\>=_\_?GS]DOC=.U65?G?M+ ML_._-Z/_\?GGGY[>^N'+>&J:R8,(EW'GGZ;I^A@$8WUJNFI\Z*_-!58._=!5 M$WPA_?$Z`^'MFYD7[]VS67"($-SKB;0 M/Y[:ZWB+UM7O"==5PY?7ZX>Z[ZX0XJ4]M]/W.:CO=?7C;\=+/U0O9]CW-Y%4 M]2WV_,$*W[7UT(_]87J`<`$*M?>^.I?_ME:/>_MY<&J@U]4AUXZ?LOBOK;7D'P<&`]_7GNP)^# MMV\.U>MY^JM_^[5ICZ<)VKU1C]3]&3+!OU[7JAF`K5??YO_?VOUTVOEQ^K#9 MAK&(-K[WTHS3YU8]ZWOUZSCUW7]($CH4!HETD`1DZO7H(CQ*@HGDG MLIJJYZ>A?_-@/"#G>*W4L(E'B*RWH'4LFX+:UHK]2='GAT#N".C7YRS.GX*O M4*5:Y\(4A01;U-8I2J%;`W1)5M/Q,94A.NV(G52K>YPFRV% M,*8[/GI:"$?),8[9-ZW3$3RM`R2OOG$6%II$ M7@,+D13AB2&VH_J1@N\=3YI$$^-C*R(IAR=6/F6W/4+[HCMV5!])O/J&.Y0Z M$M5R>PSZP;4H]W)H05-C6G+#@8L(26N:TD(D17ABM_NIGS_WJV]Z7:D?6Z5( MBO#$;O>+T-C8CJV#29-X];?\O"X7TCK[Q#2Y%K40G@RE>3,<^FR)B M=VB)%B(IPA+#;U%7XAF^9XF:]..Q6$C+6%"$:W%;8NRR1//+NB;A6$1PHV!X M9LD)41P9!*D)]E#$RN+LWLRP4:+JJD'%X5MX/&Z')WVD&L$-]1_=@J15*$)W;;96S; MI7UP:M*==Q0C42T$X5JX0UI=L)TR2\S?.3&2UG2EA4B*<`%NIXS?XY2:1!.; MWBDIAR6&:UC72S'#A@U8!Z@F\2X87E$NI,4I*8):\"(7KS^[9C@V97,^CU[= MOU[@A!#P-BPH7B`7<($\7\(&RP)S M^_<=XX0`2=5]26#F^)PS,[;9W+^V#7JA0C+>I=BU'(QHE_."=56*?_U\NHLQ MDHIT!6EX1U/\1B6^WW[\L#ER\2QK2A4"ADZFN%:J7]NVS&O:$FGQGG:0*;EH MB8)74=FR%Y04PZ*VL3W'B>R6L`X;AK5X#PEUS8BC1SEY1K+F MQT^"%5]91Z'9,"8]@#WGSQKZI=`A6&Q?K7X:!O!=H(*6Y-"H'_SXF;*J5C#M M4"_)>0-*\(M:IK<`5$Y>A_\C*U2=8C^RPI7CNUZ(T9Y*]<3T6HSR@U2\_6-` M[HG*D'@G$A]LGO*>Y<6A&T;_9[&-HZ&21Z+(=B/X$<'N`$W9$[W7W+4/'//$=DUPDM&B`T&1A=0V\0%THWT MG=&-SL[=>$LS!I(,#=,59)/`3`FZ-U$ZUZNC(#FM)79'JT-/=@837"0F@9E$ M<%-"1U,,MB[MBKV%A,'$IN%QL)JGLVG:]:-_]!)VU(T*=70IOYC7SF"B0=X+ M$F-LFH\B-[H,:&9@==.`CLX- MN.ZE`C-A@S'M3YPD".<&X2K1'"8/AS>\K#<&S$5ACE=+144SVC02Y?S0P=`] MZ.L8-??3SEWO/+VA%O$,[JTA;H\)N$YZ4M%O1%2LDZBA)5`ZU@J&(LS-8UX4 M[X>CLN<*+I+AL88/!(4SX5@`+CE7YQ=]MXV?G.U?````__\#`%!+`P04``8` M"````"$`D1TA@^X#``"\#```&````'AL+W=OF^24/PN/M<)9__YK2J]5]KR@M4'G\Q#WZ-UQJY%?3OX?__U--OX'A=I M?4U+5M.#_XMR__/QMT_[!VN?^9U2X8&'FA_\NQ#-+@AX=J=5RN>LH37^5V6[K[>:M>FEA'V_D3C-E._N M8N2^*K*6<9:+.;@+).AXS]M@&X"GX_Y:P`XP[%Y+\X/_A>S.9.T'QWT7H'\* M^N#&;X_?V>/WMKA^*VH*T88\B?3R)RUI)N@5,N=[F)$+8\^X]"N80G06C+P] M=1GYT7I7FJQ?*Q5.!:WTO>^&"5?]*$>E=22=1[P2^'_)^1/ZWDT7O!+Y[)X3, M-\MEO-JL/XX2]U[@6WD!JO?W$\2;'\R0X<8A`7 M(20WPYM?\&ZG`3,'Z^LQW`>OD)2L5YS&BLA6)$J!B4&G9\,0`(5&@4V\@X)W M;11B/^@T5BQL13)6Q+;B/%8LM<*"A10:L"I>:(4`0FFK>*WT\F[S)ZF(N]K" M:"2NX6P8K"="=B:>B-:##]CZB6OGB5(!GUJQL16)4N@,&08+`6IT`@&M-L+6 M?L!)*N*N@$BT6&\63NX2I=`(AL%"6$TBH-5&(&ZA2@DRY,?9C$0S9,BQI&?$ MX4V45M,8!HMF/4F#5H?&V>])2LRD$+=OE$1#&`8+`E]P0PNK4D2K`^&TPTE* M+`BG'Q(ET1"&P8+83D*@U8$8^DDVA)0LN]J(X97J$LC[0\.<#8-%0."-,A&' MSNPPN$W9:V2!1B%Q&?1]'0;38E/@=!MG@\BA9_8I<1NUUUCY<%M5:P82Z;D+ MD$V"LVR"1(XXB\2I_Q.1&DERF9K[B98,(&H16&P0G&@#R.@=(P>>"12YS4N, MH=B53=);5AW<-EZO2!PYP3J;JVPBV)E!I%J&H-DNE:(U`XE:-:H7''03)'+^622C1C9F9%\GK@7/J!BW=5MK>BYEY)&ULE)M;;]LZ%H7?!YC_8/B]L76S MDB#)02W>#C`##`;GS#R[CI(8M:W`=IN>?S^D2(F;>ZE)YZ5N/BU27.(6%Q4K M=[_]..QGW]O3>=<=[^?9U7(^:X_;[G%W?+Z?__F'^G0]GYTOF^/C9M\=V_OY M7^UY_MO#W_]V]]:=OIY?VO8RLST7%^/;6;Q[[18;_(E\O5XK#9'>>^A]O3K_31/3WMMJWHMM\.[?'B M.SFU^\W%CO_\LGL]#[T=MK_2W6%S^OKM]=.V.[S:+K[L]KO+7WVG\]EA>_O[ M\[$[;;[LK>\?6;G9#GWW/T#WA]WVU)V[I\N5[6[A!XJ>;Q8W"]O3P]WCSCIP MEWUV:I_NYY^S6U-5\\7#77^!_K-KW\[D_[/S2_>F3[O'?^R.K;W:=I[<#'SI MNJ].^ONC0[;Q`EJK?@;^=9H]MD^;;_O+O[LWT^Z>7RYVNOOS;;N]/9/]=W;8 MN1JPUC<_^L^WW>/EY7Y>K*ZJ>EED>36??6G/%[5S;>>S[;?SI3O\UXLR=_:Q MDSQT4MAA8B?O-"Q#0_L9&N:KJZQTU%I\M_?Y0E]=WB^^V-+9!LT9- MGBJ:0>'FU'4K/+CI)]D!R8'B0'-@/.@+96&]C(9LL4P8"K,]UNKHT,E3ASDW MB)*"&41%?I-*A)?8,HI7LBA3C1PTPW52`Z"-JK21'C1#(^.!O3SD3*NQ47*M M[`U%KM4PZ8[:*D@ZJ,<.^AE<>TTYSF##@>!`L^+UFU5=1L=C2UD5?\9O":.,R&`^&!-WI3W;"ZDURO.-`<&`(2%W9AG'#A:.HB@_CQ M&N*"`^&!=Y%5?&667*\XT!P8`A(7F=U(3=CH<>HCK]C2LPXB8@2(&(E+XBIC M027'PT,6*"`:B*$D=>,B%DLK\\E+U]FZ9*6Q#B+JQC>+1(P:YZ98LKM,CH>C M&]Z%!HVA)'7C1(6]7RU9/>L#(+H60'10`PEJ1\7OQ-^?"I3 M/[#GS$AR!SNWOPVX>D>?##B<@XD4`4$`W$4)(8 MR*=W#CW^:!L=1+'4&R`"B`2B@&@@AI+40+I9Z!,I7;ESW#?DL'('$?7"0U^` M1@)1@?@"_+2J^?J@@X`O[JPX#.TY]6N+:J+BTH-30PEJ9]T1S$LV#GN)&"!"YHX^`:(`"*!J$"\G?R&/VYH:&$H M2=VXZ,;U(/>)3M<#7-^"B-J!S0-H)!`52)B=55W#;VYXMX9VDOI)MPGC[$QL M#W!ZO(CZX42XWX?:LHT:"40!T4`,):D!E]<3$^)CW!99W&`5_'=-.4__!H@` M(H$H(!J(H20UX`)XPH#/Y:2BX$$[Y^'=`!%`)!`%1`,Q(W'/(1G9]*=NIO,_ MG\A_7*)YVC>A6:P>`40"44`T$!-(6,;S(HM[Q=2/R^>)V?&QGN+&/@!,N>EQFBUPLP=-G(H&B``B@2@@&H@)Q$]. M5:WBGC5UD^X,AK6KF-@.P%XSB*@=V`Z`1@)10#00$XBWL[+?4(W[Q-2.B^I8 M:OS1NW"'TTFJ84$((FK+-XM$@$8"44`T$$-):F0Z\0N?^.\OR4$4A]L`$4`D M$`5$`S&4I`:F0[Z8"/D5R]YU$%$#/(T%:"00%8@OFGQ9KMC3DH8FAI+4CPOA M=RK+9S1=S.HJWG/]H\NZX$'>`!%`)!`%1`,QE*1&IL.^^)6P#R(Z,3S^!6@D M$`5$`S&4I`:FP[Z8"'NL+`C[T"Q:$H'XJLE6\*M/:*&`:""&DM1.FO:P9&'J MUQ7<,)#Z!2<"B`2B@&@@AI+4R'3,%SZO/UBR>*@WH1F=%ZZ1H%%`-!!#26*@ MG$[V'J>AD4-A!5$<;@-$`)%`%!`-Q(RDWT7F<5%+W:3)SNNJQ(2OX6N/(**N M(.%!(X$H(!J(H20UDF;ZL$4I?2B_7U=!1`U`EH-&`E%`-!!#26K`A7:,CM&` MPQ_6E1=1`YR(DA,)1(VD_P8DEDP?3'H\.GP!8BA)S:2Y#F6%^5Y7<2?M<[#D M:=X`$4`D$`5$`S&4I$;20!]GQ6>TO:3O//26$.1`!!`)1`'10`PEJ8'I("]] M(M.=R,1RQ6.["@,<(T$C0*B@9A`PJ:^_%G\5=-AWN-TT:TK_OUX$,7!-T`$$`E$`=%` M#"7)?%1I?@\%U>./OG0((FH`2^-X\AR1^NFZ@:=A4"D42D$&E$)D&IYS39ARW* MSSW[-*<565?LNZ:U?6';[=:8Y_AKJ/[*-%$5/8\-!R11I1!I1.ZM\3`(VY?W M[-\"]V\-']K3<]NT^_UYMNV^'>WR?V67<97= MVC=\[1D9%_FMS">XRF_MBZ^H_UP5]LS%Q)%U5=HC_;V]&$]BWU1_W3RW_]R< MGG?'\VS?/EE#RROW\O7)O]3N?[ATK_T[PE^ZBWU'O?_OB_WC@]:^NKR\LN*G MKKL,/[C+-OXYP\/_````__\#`%!+`P04``8`"````"$`Q$Z,U>,"``!M!P`` M&0```'AL+W=O+!RN;U^[%KU0 M(1GO,^P['D:T+WC)^CK#OWX^W"PPDHKT)6EY3S/\1B6^S3]_6A^X>)8-I0H! M0R\SW"@UK%Q7%@WMB'3X0'NP5%QT1,%2U*X!5Q0IZSXM]1WME201MB0+]LF&#/+%UQ4?H.B*>]\--P;L!*':L9>K-D&+4 M%:O'NN>"[%J(^]6/2''B-HLK^HX5@DM>*0?H7"OT.N:ENW2!*5^7#"+0:4>" M5AF^\U?;!7;SM*M[]L2#_2&5)@B-)"#*/]L`)%K$?)_]G<:TB$\D] M421?"WY`T!W@4PY$]YJ_`N9C"$<=8U"0VD*C[S3<'`*Y$G9?\C0)UNX+9*DX M8C86L\1HQ,P0VQ-")Q=TC&(@Q+F8T!M]:^O4=["8N;Z&A%/$]AH1+$?(1`QD MXQTQV@IEO`@R36:^-A83F2KJ[&TO-B:NHG==:6N&0?B8SS2)1LVF+AN+69B* M^)&?IE/[]M*>AO$Y;Q,=T(SOA*RM4QU!>LZ=U6$QB=7AAYXWTW%I3U+O',9$ M1S+1<>H]O3OSOYCQ;RPF,OYO?'_F?6*-1^/$=SKQ;2Y$%(\]J*US#;/NWEB, MS0%H".]F57Y>MRUTW8#T]:,+'&PO=V]R:W-H965T M\PQX`MJ^](TYWP^_GPN'\'[+S_JF_?*VZX2S<$GZ]#W>%.* M4]5<#OX_?S^NMK[7]45S*FZBX0?_)^_\+\=??]F_B?:YNW+>>Q"AZ0[^M>_O M#T'0E5=>%]U:W'D#GK-HZZ*'K^TEZ.XM+T[#HOH6T#!,@KJH&A\C/+2?B2'. MYZKD3)0O-6]Z#-+R6]$#_^Y:W;LQ6EU^)EQ=M,\O]U4IZCN$>*IN5?]S".I[ M=?GP[=*(MGBZP;E_D$U1CK&'+T[XNBI;T8ESOX9P`1)US[P+=@%$.NY/%9Q` MIMUK^?G@?R4/C.[\X+@?$O1OQ=\Z[7^ONXJWW]KJ]$?5<,@VU$E6X$F(9PG] M=I(F6!PXJQ^'"OS9>B=^+EYN_5_B[7=>7:X]E#N62TIQ@YW@KU=7L@?@Z,6/ MX?.M.O77@Q\EZS@-(T)CWWOB7?]8R;6^5[YTO:C_0Q!1H3`(54$BH*G\\7H; MQYMDFWX^RD9%@<\Q"EW3;4SBY&,N`9YKR`(5Q.&FHA\1,A\R[!, M,P1`;&('F;/91>%$1GI-,G1K[I2YD,A$Y"Z"[DP(M8F&XQ M-Y8:Z.:;H#0:`YS:S:E`,(?SE*=6G^03:%9=C.V6GDC%6^""0FARL<0@&]8> M?-6/V]`J3:[\5M@06JGLG"G@2"()6,E#@U0;^>#,UBTI":-M.P=1Y^O=AC$84.'4T7 M51YL"U.!%II"RMA,8!0$@NH&V9M[S];C3('F<^:.A>D6\^12H18V1N$R"N!. MQJAN&KMT,RFP2L(2R'H(,C*"G/Z0\K5`#U7-I.<,"X*P/^*86IOF1/='";76 M,^5?*);4MP52*'L&*7=T$(2D5B3:./D:Q1-G*['\C(Q^.U5T65P'LR7I]E,C M4R!DM2%;2P-SPT_3V.I]IOQNJNBR\`YFDQ1-K?QG"J3UM6-ANL7H:PIE6*C1 M8/[H4:-`^L8RVL&?+4S'F!M+J7.;@Z("&LWA#)0"@4K-XQXYM1BU]!T0FR(Y M72(E<($>*J-)SRD(@K!+Z(;:3Q_ZOI\I_T*7F/([JI]\\[)_C3@#I4#XXW'E MSI/IIZ'UE&"3W\G4LB13E&0C4^X\(4AE*G1^8JL@RD^)]01ERK^0*2F4"^5# M_31(V9MF5!-9U&;'PG2+V=;+0DQ10]]_0"G0/#VY8V&ZQ=Q8ZMW"B5$&S1-; MO[XSN.60#80O7W03)T['?@"0]R33X",MO/;`U_R:MQ>>\]NM\TKQTL#0$GB' MF:QXW9+!=3=^AJ7A6MY7M'A?@E]Z<1]>P9]$ M#]&PO=V]R:W-H965T;A88246Z@C2\HQE^ MHQ+?;CY_6A^X>)8UI0H!H9,9KI7J5ZXK\YJV1#J\IQUX2BY:HN!15*[L!26% M.=0V;N!YB=L2UF%+6(F/,'A9LIS>\WS?TDY9B*`-49"_K%DO!UJ;?P37$O&\ M[V]RWO:`V+&&J3<#Q:C-5X]5QP79-5#WJQ^1?&";APM\RW+!)2^5`SC7)GI9 M\])=ND#:K`L&%>BV(T'+#-_YJZWO87>S-@WZP^A!GOU&LN:'KX(5WUE'H=MP M3_H&=IP_:^ECH4UPV+TX_6!NX(=`!2W)OE$_^>$;956MX+IC?23G#42"3]0R M/0-0.GDUWP=6J#K#8>+$J1?Z08S1CDKUP/19C/*]5+S]:T7^$64AP1$"WT>( M'SC!(O;CY/\4UV9D*KDGBFS6@A\0C`?$E#W1P^:O@*Q+B&)H9:Z==]IK-&"6 M8'W9I.EB[;Y`4_*C9FLU2XQ&33@J7(@RA@+\/%3HC:&T=QHJF$>RDJ6YDW-P M>`D^JT%[H>%G^:7IT-<.0S5AQNO!F1*M9F)[Y<12/ M[DE+X/;/6C+PM77.]T>`S=AJDH%_E5OK;. M^2>`S=]J(I/_(D[&Z)/T]:(\#>?0'FV=XZ,18/%6,^!/Q4WP,+-7\-HZQ8?! MZ?HLWFIL=\(T?H1DB3^40>17:`ELLSORW!+B7[*K=45/0+;1J) M$Y("XY5\.#WI?C_]CF'P```/__`P!02P,$%``&``@` M```A``F=!>7J"0``BBX``!D```!X;"]W;W)K&UL MC)K;;N,X$H;O%]AW,'R?6&?)C22#D0:].\`.L%CLSER['24QVK8"V]WI>?LE M626Q_B(MS\U,I_B3=6#Q$Z/HX:W\Z[X;CXS*]3Y:+_K@=GG?'U\?E M__[[^:Y9+LZ7S?%YLQ^._>/RS_Z\_.GI[W][^!A.7\]O?7]9F!6.Y\?EV^7R M_FFU.F_?^L/F?#^\]T'ER!?M_U'V?Q[\7Y M;?CXQVGW_*_=L3?5-OMD=^#+,'RUTE^?K\"DOOGA_O^Q>[Z\/2[SZKZLDSS-RN7B M2W^^?-[9N$T?"Q,>QB?Y_>-;;;TDUF94^`XIJ1,;;=6_;.5NTDFW+.Q?G^JF_)A]=U4 M:%VSU:M$P9P441=6*OI$'!1*Q>D$2Z$ M`5R8_HID8:V819ZK36I)T[A-3HNJJ%0,'0J:=9E,04((530$:]4AJ,UJ25-0 M"-J]',Q](X#K.NK:6K7K8HJ=]I`TY/JN4"W>P6CF]Q^<6\S[HS4VD+5JYVKY MEC355/K,+274@C6@T80!7J<&G M\#6FZ\RWNIE%PHNTH!L$UN2&D"+/9=C1*8FHKEE3-6K3.Q#4=5Y<*6MJ*1)N MK3-C0?-<]S2+J+/\^K2O,)CZCL<26)Q$O!-EL`0JPS8=4631?:=BZW`T]6V) M_N/82@E!Z-\O0>W$(K\%00BT"@GL%O@,,`@$FVYM\Q@.>UN=HI9%LNUHFK.@ MNSC$4H+0/*M9)-V,[-(/P!2!%605DJM>>^IRB44>,9QH\V+,'<$61!4 M2+1ZG2J=&J06=.%%A`3=9G%?.K,^P.J8MB[A)\Z3R M3P#R"H*\+#-_#C"(.,VR&,W426E91"#QJ.``:`5^=%[S'L=89LVZ!/X8.@0RCRR+BS#W>;QE,;P%;3^2R_Z:Y6[7/,U5!=TAN*92$WENE%K@B=T( M"[J)`RLC\L@2AU<2%E&3%D55J70[$.15TG@!!&&N=;&CY,SZ+/LE7&8MB^@L MJPM@!X.><^@\CK$\AC$-$A:1<_4LZZX,HG.+JQ`BN37KS#T(.7,23>6O-41X M%8:(*?\5B.06-CX(?=S<,`93KX-*$+#$Z>9I86?GR*RQLYWY%D18)-T0XB)N MD%5!5@0?V>$A1/*14'$^T-FZ(<+]GB=;'B-;L.\CM":(\+1(#9!94ZD)0_,0 MR0-620MF%6=53M"1)0XAPB(Z0J5JJVX:U9?-/,XM9\9>#7^+8=&54WOMSE7$ M(>7,VJ-*HV51W.,TJ',LXF1R9NU1-PF+KI1U&@U<6J9<1T%!R)$[6J\]5XE+ M+!)G5%J@<0HDS]B?SGP+!2R2;@2#T`T21Z.@((1@5HKF+8N,=.8^,8F"NB*, MID1C$%+7X;88(606)>)("R:*>)G<$#'FSWL18$5:T$T<*P410]8Q/.\LHH=2 M71:9NHYV(,BK0KS5P2#BT"EBT-&7!A;1Z5#U[F#PVEN4(LX?9]9G,Z#!B!CW M'J,)"@##?A2R+^,T,6Y(6N``CRJA2OJC$(!)0^5V5XA:K7ZHK6 MLD@<8VE!=Y8^'DYC=Y?6?(L6+))N:)JSH)LXE$JBRWQWLXA*FU5)HFK?@2#- M\L0W!P:!R)IR#5$5/M]*$E%WJ];O8##UH^@]CJLRQ%6>^P0(_RPB[W>Y>CIT M..ROK.@_SK&2$(5;H"K@.N34>KHIX-5]J%DDW-"TL=64)XWD59&6',:NPU&X- M?(W1)/[44$??$&'N2+<@J)!R3:).4%N12-9`6-!=G&,5(I1CV&6A9) M-R/9]/VJB@/+F;'$X8V$102,=%V)/UUP>0E[+*A+\6<1S#5.K2I&+0]>`@6+ MXLR&P1N),&5#(;]N4/W<7Q5Q"')DSS7R&;1N`.E MOB1T**C+ZEH0\W"K0K@U2;`3(]RFZS9/"P]XC=@:2^[,MRXD+!+-+2U0VAIQ MI8^L&\8F#SG"(G-^_($+7H?>$&%0\W"K0[@UXJY#3<\B60.:%BFU!8QGZ51J MXLX\1VH223?"@EDAKH)2$W]D-T=*/4+*ESI$=CTOPJ`0;D%0X:VLT??.MB:1 MK(&PH+LXQFK"V(U2DTBZ$19T$^=5'>.5?@"QB.]XY@[GKW"$;!!45>F?F!A# M'%IU#%J:$RPB8OOUV3^M0(,^>G2.L)I:.H14".QZA!3]"HE_L.QPU,<&[ILX MO)P9:1("FT53_0.2@,#4_TH)FGFRN6&,I4G45K$/0F>]L M%DDWUUC56+IX5NGSZH8QJQ`B+#*4F.'U#1'F;H$S$Q3Q2)*M2?Q-@WC=C-": M'HW2@NZ065.I"3HW2BW(1,>I$19T@ZP*2DWPD5E%2CT2RI'6$,(NE'JD5-^1X4%W<1QU<1PY8\[-PZ) MB!=-6:EW!ATOXK(%I^LXI)P9CU#X&H1%Q&!_8:2.F@;U;Q)K1-*X:VA/[WV7;_?GQ?;X=O1L"8U?3I9Z5/DUGR*[#[G74T#Y@/A]\UK_]OF M]+H[GA?[_L5,3>[M+>-$WQ+3#Y?AW7WU^F6XF$^#W3_?S#??O?FP-+DWXI=A MN(P_V)V8OB)_^C\```#__P,`4$L#!!0`!@`(````(0#W'<%8;P@``)\I```9 M````>&PO=V]R:W-H965TE=$2RZOKP>RG-SK3;!]ZH+ MWC_]^,/C:]-^[DY5U2]D#]=N$YSZ_O:P6G7[4W4INV5SJZZRY=BTE[*7O[8O MJ^[65N5!7W0YKT089JM+65\#Z.&A?4L?S?%8[ZN/S?[+I;KVT$E;GCK\[ MU;=NZ.VR?TMWE[+]_.7V;M]<;K*+Y_I<]]]UI\'BLG_X]>7:M.7S6=;]+4K* M_="W_L7J_E+OVZ9KCOU2=K>"@=HUKU?KE>SIZ?%0RPJ4[8NV.FZ"#]'#KDB" MU=.C-NB?NGKMR/\7W:EY_;FM#[_5UTJZ+>=)S[.%3'\LNY_[-Y_:6J7TZ]G.Y47;)OSC*3_%Q<:K4&9.GE-_WSM3[TITT0 M9\LT#^-(I,'BN>KZ3[6Z-ECLOW1]<_D71!%V!9T([$3^Q$ZB;)F(-"_^3R\Q M]B)_#KV(I2C2*,WFQ[*"NK0?'\N^?'ILF]>%7&1RY-VM5$LV>I`]*R/B4$[( M7C5^4*U:(\.=C'Y]*L+UX^JKM':/FJVM$5RQ&Q1J1F3:>V[IAR>W:N6Y1<$[ MWMJ2F"MVMD*,XV>#D<63P0P&J.@FD+V,!D0AS[$%C5ZMVK4=";`4"4MA>JU: MI?DL562D`@U)10(LE5R3)YF1`C11GNKICI?13^_,^02)'@5+FCF3 MJBA/*I>]D10TI"X28"EREL*T4+7.60@:DHH$6"K%^G%G#`M"17DUMH6@&2P, MEU&DX;@93(R`$W69QGAAK!$697I?K(C36T`[;"]TNPC@;3>%C4$RP)S8"5-`Q MB&1DA=[96Q3!&$02QRD?Y(X)HB3*\[N`#T(Q8AR$Y3L@A`ZFB"Q#"&<`/!&) M\'1^]$1O80^*Z#1/T4?>2FEU]VFV^5-$AH-;?>TF`(O3)$L-P8X)BG66C3SF M-7,<61:[N&3","(<0HM)A*?SHREZ"YM01"V>HE/DQI,.FW0P'-RB"'>2R,@M M$8L$(N$,R>49;$+5>.&P"U%T(39282E$WY8Z>8Y6*&(6$PC/)T; M5L*&E;V*400.)DF6F\QG@CB;M%AP6ID6ZV9SOJUC$J"-UDPBO&8_EP0`1GZ2 M\Y!1VA9%--T4EP3GT@`*'3:K,EA>/JBSM76_'?<#+&(4T9+A,AWAZ?Q8$L"7&8<)A+!6$N'I.);N50%7^`W& M*Y(H8-FWL0)$8J0;[!D6TUBD4Q7X4Z>:Y^RF* M:+HI%,5N%.DPWS?V_11%$]8.'/)9ZT=2[$*2<4/9HHC6.H6DV(\DW3QK+0$0 M;D\280LG<2-)A^>L19';VHE&GIS3R*1]8E.I$.:S#(J(M33"T_GYDP!__$!` M$4T'E^D(3Z=(,?)GV(L)`,0/!!1-6#L@R+-J$TXC\VRBFXWY%>9='$6TU@%% MY@LY>>RAM5HS"2"9L9;0!E:M[G43.*SE_+E;"P"9L7:@#' MCG-IN`]D`!;Y25[>F*<%%(&#KK7.1SF6+H[#*29<1A$X+#CK4I&<,6GEJ9>$Z#$XT\EK= M4,J`-S2Y?6I!$>X8Q]^$F,#S-Z'<#R7=;&X9\Q$51<1P&F$UYWXHZ>:Y+8,B MFFX*2KETT7%ZT6&C*HO[*'+/[T0CK]5!(W)JR0$K=)Z+V'Q$11&M=8I&N9]& MNGG66HM&>)D>`*_.32/Y)WS[S;7)>Q1-6#N@B.\KGMQ/I=Q%)6L0A$%`7KS, M4:N?2OE;J(0B.I-35,K=5-+AV54['(&X>UB@NY%;RZED`C^WZ53$YM,JBFBM M<)EM;>'GCVZ>6[4H(NEHA%571>3PI5+,QB-A\ M4D01K14NQ6OE2_E^U+?>T6Y^HH:PF7BB\M?,$.?NF;F_Y6UW/3R^_+Z?^>Y!&PO=V]R:W-H965T&J8RP*6IMI](.&]T$@5X+U M>9>$T<9]ABYE5\S>8!*,1DQ@(PX#0G=*TZ83@PO"1G50\US=PAO%:*\M)EC9 MF?:WD(6-.-PB@L2&I+>0Y5L>2^_"TCLT35MAY).&A,O8SK$WF+"?N&[)86Y( M)P8K)TQMTJ,AI[9N,2@?AY"$\YP&L^K'Z"^6<3COC07P_#`(;=6I!?!#?U*6 MI1%N^3L:M76N<6EGV!M,:*Y:,IO,8>J-EK/8=.H-)UY+6ORN-&V=29LU9V\@ M0_=6<3B_Y1;`@]7LV[7!:M))K@Q^&$=O*8Q$LWG,^]I04=(#K6N),GYN^W6Q MVXQ6L_#VL/#ZK>&.#MA#'2GI=R)*UDI4TP)"/6<)S1%F99F#XEW_+AVY@@W4 M/U;P9:%P%ST'P`7G:CCHI3A^JW;_````__\#`%!+`P04``8`"````"$`Q&X> M7<`#``!2"P``&0```'AL+W=OVT3L)V9[;[,A'N/ MC\_]X'(WG][ZSGLEC+=TV/IH%?H>&1IZ;(?SUO_ZS_-3X7MCJU#:EI<^W)(#0)(QT6H)]?VI'?V?KF9^AZ MS%ZNXU-#^Q$H#FW7BN^*U/?Z9OWE/%"&#QW$_882W-RYU<,#?=\VC')Z$BN@ M"[30QYC+H`R`:;D9SPM1-_T]OOI#U?!)0[E4<: MVL%-\-?K6]D#$#I^4_]O[5%O.@/>!./F+9;&@-S%,(DXXY M*,AM(]&?)5P=`KD6TSD:GF$Q(Z61T14VI#Z$9(O]UAZ8TOO/6G2"B4W$E(FSAV5 MQB2JXC(E>]=0&P;K3JB:D:/[G=*Z]4'Y7(0R#>VX*HTI5!F3.,V0[=];?I0G MCK^V_&$$CEG:],;)^D:M+K2G*:N-$8G+@U1 M[F;.]"=%GCN)KRU_CL)%OB50?LBWU!E M=C5F3GXFD&ZRISAU"SGYIR!09&C0+X%+\$$ED9S`'Y=2N5VMCI9J`MVU.CVY MM]V%TPFU[4Z,M]E.IAS&/Q"J9[4]]YRZ54B#IJ0E8;043K^[-@"E<;&D;4JK M19%%Q4)ARY53>Y$[UUX/BR^"8AA_CH,"GK`SV9.NXUY#KX/:1W:;V:I7JDJN5&HIFAVPZ(SX3/[$[-P. MW.O("8Z&JQS&+],[D7X0=%0?ZP,5L.*HGQ?870E\[,(5@$^4BON#W+KF;7CW M'P```/__`P!02P,$%``&``@````A`++T0^)V`P``=PH``!D```!X;"]W;W)K M&ULC%9=;]HP%'V?M/\0^9U\$@((J$K2;I,V:9KV M\6R"(5:3.+)-:?_]KF,28@>US4-+KL\]/N=>Q_;J[J4JG6?"!67U&@6NCQQ2 MYVQ/Z^,:_?G].)DC1TA<[W'):K)&KT2@N\WG3ZLSXT^B($0ZP%"+-2JD;):> M)_*"5%BXK"$UC!P8K["$5W[T1,,)WK=)5>F%OC_S*DQKI!F6_",<['"@.U8,XYW M)?A^":8X[[C;EQ%]17/.!#M(%^@\+73L>>$M/&#:K/84'*BR.YP!YH*X3H:)*1)>^U0$@Z55%UHQC1+@P(=D8 MDLQ[B*$JNJE*1:%X`Q'39-83M#ZW&C/ME:=V(!L$C#FA-S.A:HZ*V]L1<)5N-Z;4';C@2DHXPR5"Y;]96?_EVRL/D M6C1#N3HTKQM5IUQ%+>5!8"G7F$YYXIJ:E*CKE*VHU,P(W/=MV!G387$,'[!W MWO"AHJ:/J7_=??3FH3&=CPE<+,R/8S&<4QL9I3D(<3WG#K?>6:\B[)*93$V^8"9AB@2>4B+ MT]C\Y^_EM]`TJCHN#G$F"S$V?XG*_#[Y_;?159:OU5F(V@"%HAJ;Y[J^#"VK M2LXBCZN!O(@"D*,L\[B&C^7)JBZEB`_-HCRS;,9\*X_3PM0*P_(9#7D\IHF8 MR^0M%T6M14J1Q37X7YW32W57RY-GY/*X?'V[?$MD?@&)ES1+ZU^-J&GDR7!S M*F09OV00]T_NQLE=N_G0D\_3I)25/-8#D+.TH_V8(RNR0&DR.J00@4J[48KC MV/S!A_O0M":C)C__IN):=?XVJK.\KLKTL$\+`MD4X,_2.(AC_);5?\GK6J2GFL>U_%D5,JK`?,*75!=8C7]?,A!^M95M]9H^PRZ/5'T M'XK?K((.JL#Z/N&,VR/K'3HWN9&FF@3QMJ0H"#!G=N>H_E7*ZAS69DK!.%,T!],^Q2%9ZC,X M8PR3YGV2AQF+/B,*0LQ9]CEVA"FK/@6\X9BT_I!$DKSYD$2"W_9)A+'K,ZC/ M^SZE$SFJ)VQUG]53P;"5=IK:YR3/4\UQFYU4-?6,&N;4L*"&)36LJ&%-#1MJ MV%+#CAKV'0-*`NS4W23(R3.=IV"6[@.@$9 MD!TB.*[KD5?LNP0G]*+(;4<,U0J^&#^JE3+C6L$635(YU22_J584>#9)U`SA M#`1:%_1NW<5#/XI()18(#\.(9&F)<9?^2X"7"'"([+N8\SL$<$SH+HD4)4)3B!?%0E9<95Z@@T+DPU14^4'?@. MB7&&<(?YM$8(9[Y+YFV!<,X=TH=+A+,H?`38^+?"N$.G<=W%`]4B;-)PG9,7)0G,1-95AF) M?"O@Y&##I+16?6F>\B$Q;N$PW=JL%X(Y[B4_BC[@\I45E9.((DFP0 MP$9&PO=V]R:W-H965T M6L#1/.&6HC? MU*(S9YID]^`DU;M]]\"4[`"Q%8VP;QZ*D62+EZI5FFX;R/N8C"D[L_WB!B\% MT\JHTD:`(R'0VYSG9$Z`M%H6`C)P94>:ESE^2A;K#)/5TM?GK^"]N7A'IE;] M-RV*'Z+E4&QHDVO`5JF=D[X4;@LNDYO;&]^`5XT*7M)]8W^I_CL756VAV]Z/ MJ0:L)X@21:-TVPZNX-"0D0^DV=JZ6JI58]@.L#3=-3-6K(`LDMA%$,EF3M\ M`]L&=@^K)$ZR)3E`5=A)M/Y0-!E$!)P&.[#XQ,Z=7MNELX'C(UK?2B"B MZ2"Z,AM=F9US>+OU469M"_UO!MX3`(<03B4BE[7KB_Q?"U6OT'``#__P,`4$L#!!0` M!@`(````(0!9W:)4KP,``&\+```9````>&PO=V]R:W-H965T'.(FU@!%V-MO_ M_L8>$FR3;ONR&^;[F/G&,QYF]>&MKH)7UDDNFG5()G$8L*84!]Z>:MO'FKR]]Q5]/NY=(^E:)NP<6>5US],$[#H"Z7GTZ-Z.B^@KS?R)26 M-]_F8>2^YF4GI#BJ";B+4.@XYT6TB,#39G7@D($^]J!CQW7XD2P+,@VCS M*O6ON/[-^.FLH-R9?J44%42"OT'-=0]`ZO3-_+_R@SJOPS2?9+,X)4D6!GLF MU3/7[X9!>9%*U-^11'I7Z"3IG4Q!9H\GDV2>D2S_M9<(%9E,"JKH9M6):P#M M`3%E2W6SD25X[E/H==R3@K,M-?NCIIN70*X$Z^N&Q&2^BE[AF,J>M$72(@SN MI,1E[&X,?53:;V$9(E!VEP=)^_+2^*Y&HZZ:Q-EC$C6;B48DR9#7$< MO:FC]W9JVKH.P8++Z_"1M-\0!UILX?2M-67EGG2D(/2GI)L M2!V[QH%G0W2\90XZ).U(TQ^G82#<*JJMOK3^,TVY)4A"@5[5=N^!Q4]`5YD>FP^4X31UE?EWC=Q&KO[./25S_[)Y>.Q= MB,+%')!RC4R^!'2P_^F8@FOJUU[O1`-NU1WFX M]^"V4+/NQ':LJF10BDMCEI7-ZF[%?6NK]RVS,=T!V():>F*?:7?BC0PJ=H17 MX\D,!GB'"Q,^*-&:#_E>*-A_S,\S++8,=H-X`N2C$.KVH%>R^ZJ\^1\``/__ M`P!02P,$%``&``@````A`/MBI6V4!@``IQL``!,```!X;"]T:&5M92]T:&5M M93$N>&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3HD#2 M27T;VN.``<.Z89 MUC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4*WDP7,;5B;6%=W_S2 M=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[66 M\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH]ATPXVRV%;P!\HYK" M%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;L MR8NO/OW]N\*1R5D1SBB!4-?A.KL$S(P5SX15Q/*O!T0!A' MO3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N\&DWQ%%2AAW0."QB M/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$6@2(GIF)$E]>)]R) MW\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G]T2Q7H7[#Y;H'3R+ M]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO..UK9>$\H8P,U9^2F M-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1%0Y"G$#?7O,TD4"F MI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[.CALY&2-58,ZT&:-U M3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL+B8GB]%1VVLUUAH> M\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU,,3<):G#[8>V^I+!3 M!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'!\*])`79T74LF$^*K MHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A*H)^@>LY;6TSY1;G M-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04\\VI9/G>:W/@G^Y\ M;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL_CZGL?/F MS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%]6QE=U1Z07H/<%2W0%`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`(>W&0C-#M."N&YJC3%8/!Z31AKV"= M/%#)8B]6ZV3]4*`3-]9,/E83^W%CQ5I4ZZ5M+#$N!!LV&2OS%1HG?%C=])=+ MH(O1<,C,BAW6TF#SQ1#&ZVRPBUEGFDV6D^6E5LVX6!3]Q@:<+'6:4C+@\NWE MN\[,J7^P,NU2&NXJ`UC"Z;6B`ZE;D=^72_;319QT7-#:\5@LE2/]./5R;OSD M>/:^]\'^J?==X%D^,RPN:O&[N9K,!5YHR489Q:1%T2QJ.L%(/3W+9,RD&;)*S8""5R1?Z4.9U3K[DH MC`R%A^91A'`3B4%4P"2PK16]=Y\)-9X?ZP@S6& M=>CLXH*1#8*ZQ6(]56>9<4G:0\5S7#>;L$]F;)X+K]Q>P]I!9(?^$I[TTL>? MGGI'#EKV&YY?S^?QJ='%U=36?3D936#Z"A%FE$>WX&_O)9BMAVLPD(I@! M@OGD:GXQ!B##Z54\5*<()@#@IU6+^_MEO*0L=F;: M^N-\K$7]L>)9(\Q35T&X@1GR<6MY=`%SQ.2UVVO7WD;08(?.PR/['04[UFX' M401[UK?7&\=Z"'S+A8>#XQ7'WQ57PJX^;.#?]*-'9_T9!N,6T1+;)$.T-4+& M>E,VFYA>3H>7T]GX(IFP:1K:LS?.P1.UR\8NC$LP([.M7'%D0S\;)`V'?#=C MP+R0NH]X1>SJV-/$"R`FCB%!O$*'COG.'E5'=`5-1W0!44=T!55'2)VBY#I: MTDL*+"J]IJZNP"]";MR- MV4^\/E&@J>0*44_)!05:2JZ@ZLC'S=&[G/!LZ8+1#`0,E%Q[Q MG)!@RD_YQA*9[HK5E8J7:VT2$BC5L(*>N%"W,E+QR+ZUE2''"!J$?$U5_*:M M"G0^:]MU/[)>Y._;K/V)#Z0];=$1.#B7R`Z.L1-V["$LVZ0+JEUTT M+KVH9^UV[O.'@[>RPV5\6#$>(GZ5;0_DS^[B'BU_'N]O>':\)MI/Q'P;!I&] MCN+#E/&N8AF>20F>42J(@J?)^-.2\<%.9'LT&1_6W`J="'8Q.CX$%WE\G?'` MCHVF00TNP$%=A41F1'?0J#G9H8G%0`: M#5E&L:8H!KD=,BTW`3RI,,$2JJZ>DC@H&!49!H"P#$"`3D"SMZ8QV"H`N-H,%2",02N!G>8$S@:N`II M"`/@,9(5>9\PXBI&AV9`$$PQ)(H&.#!LQA,8@RF.S%TQ-D61"((IAL2>,$61 M&(,ICD2N,$61"`)8Q`A#8D^8HDB,P11'YJZ8F*)(!,$40R)/3%JFR`%>-DT6 M4='ZZ>CR$K:KRM8>P4/'^?^ILYZVTI54V)J67IY,GY*I(S@CGDRAN?0(P%GL M<#A;/.T]!J'S,\PRV<>.U_""'?;9)](C9XU?^2FT=I_L)YB+)GMN3]M&"DHP MY>/#PG>_5V=P[?9I@(7@:8DAI)K'LWKIRGSO&%C)XS8[`87<0>T7H.3F M`WSY(:9R+5N@P2>G<].JT9?Q:G+;M-(R.E5+:7%3->/VV.>1&',GYXVJVL8Q MLE('R."TPH`*I_N04K1;VT#CTU\U2T:;;M6)AVW`5%'%7;KO4XLL7CS`^D1O MMNCICB95[FPCTU2Q=,"6BGS4`;)"'D$K22".TT7[4?*''('8ZPWS MGH9$>P'5Z4*3S0=@P/OTK%U0(*\ MZ?2CHR8K)>HEZ$C6THE'5FW)H:61W7A_JK&R8H*H:%'B=ID6/+\HXJW%-KKW M)QHL-H]U8\&.RW8#F@!$+2`X>!6OEZ2?$ZHB/U("-^NI.@DL;$\B7%*+)?#? MZ^A5!-A\]I)9LE:^HE[EI?JEW8\T\-D0QZ,^[=NB#IRQ[C#!=2MK56LA>G$'5]@155J$\%E> M&B_81L>#G'5,5`I(&Y4W18A7<7EZ%R>\O-$4*S<&K%`<7X%%7]89HE*#":S) MN]=`3K2Q;Z"2M:P(%-49,6D[GG!)7,9G9&L.Q)0!B/2N2:CXJQ20Z#`^QLGN MPZ1%7(9@052P4W;"L<(U0)K@+'8GN>X*T5@;\(O,W"@ MH"1<6P6(/Y916M3$C*=,2I5P-V4J/K/:3ZQF@=HU6A7::G.&)%HO.^"3?(%] MY;E7WUP!XR.!5S7LFR%-^`D(L57E(@-R3(G>6`)?1K M"J_N'A@;,&E,*K:6,HHVT*QCH-E&2P566:A.4`T!7Z^R,T'BY)?O\3J+S5*$ MDM`DE3659"D%9-9D76VSD^Q:,./.LJ;D"TI(^,55K?K3.J7(55`(KS%A@N72 M3`ABBCXD%XCSJT(N*#%[1R`5S`K(LBZDE+PD958I!,A<03&I.$^E.%X)=X&- MZT0"WQ:KX=;0)E"U0.&!DX[USZNLN`E9Q]M\5"K&)#A2L,!MX?E6Y"PL,$O8%`RC@P2SR;)[0U*LAJX>3;N#"%7 MSH#D5ED/P.S/FY:'R).M$N"F8_3+M*YHP:^""Q:X/5.DWAJT1F+8(7^\JVJ/B5VCXM)'71ES7U M?%T1XI[28FC(AC:5$MC\9>N$*Q2X8UMT8%A0B<^1]DM2J]\%F^UE2/MF9*M) MFQ]HIB/B.GE4MP%I5;M)"4DEIE;JY.FX^;A[`0@EF=$(85W*1=%97JP[J'=B M"Z>Z'LD5"XFI-52%^L!?197#M";S!$DAP1,4.M'@GX(YK:(^H$%.CTKJD&J> M/L#\/$P),>^`MO`#M&W!`=EJ@_.TWC$TB6EY;)T;47OG@]E`MN4Q9=Y,&T+> M3$;*B#I<(6&JO*I4M,7:H8ZV`^,6,),ZWO:M:PXNB8QT.K^6,4GH&AH/`%74 M2CZ17B4>HO=0:X1YL=H\E,Y(J]%*4/+L+<08!::>TE?(,B30(BO61ZU$[=3\ M(6FAP?2M*@'XMEU\<8C*0D&K7QU"9`%D'^UW!)*V9NR4Y]$[["%IK:XX2TI) M1PH"89CJ/@M=-'A\/SVX@UYR*[V/T;-K[WOKX,#N'#(=P_WJLOOM]7S+L^%V M(L/?]LYZ;]0 MZ5@6G.^J*PLD)!NJ;*4&RX)EQ;JRLN^V9=_`A&2!<6K+RC;X)O`(RX(/7=3% M!9*N(R7*!-\^(Z+$C&K@Z0W/HC1F#3P%^%\.$3(CNPH)8=,@BI!/3N3F M0#@1#!9)1`#W?LYT.6$4HHR_6:'/LH5+W9,8+=$HOY4V=/^;IVW6]\=VCZR5 M:_/S`3#4QMY:!S?ZE/WQII\__K.]<0X>!%/ZKF^='X,H%G'3SQ]_XSP\1I#% MX%N@FV_V4?R[=PB=F_Y_[N\NY^_NE^.SJ^'=U=ET8L_.YK.[=V>SZ>+NW;OE M?#@>+OX+)O-[-8+!?/]J>M3_WG'48[(-M=+X.O$&PW3IK M>[#?A4`J^T?;CCQW,!X.YX/YP+,`S M]`.`G_P;*S'8L\G31S;([?\$````__\#`%!+`P04``8`"````"$`+3KM%5"! M```LTP$`%````'AL+W-H87)E9%-T&UL[)WK;AS)E>>_+[#OD!"Z M=TB`I$11K>ZVNSDH49268]U&I-QK#/9#L2I)5G>QBJZLDD1_\D/LEP%F@'Z6 M?A0_R?[^YT1$1EZ*HM27]>YZ8(^IK,BXG#C7_SD1^G57?WKE8+J]^=_=N-;HH+X?5SORJG/'+V7QQ.5SRS\7YW>IJ40['U459 M+B^G=^_?N_?P[N5P,KM3C.:KV?+;.WN[7^[>*5:SR9]7Y8$_VKUW?_?._C?5 M9/^;Y?[C^6AU65(P^[O[\N!SM%'N[6\7]>[L/VN_^RW"6?ORB\^-*/][K M?_/QX5'Q;X/3:KD8CI;_L_UJH,/K\GRB%E#GQ?"R;+=Z^NSEHS?'Q?/#QT<' M@V?%T8N#=HO0SP'T70RGT'5#Q< M=D8-?3Z93,M%<4"#\_FBT^&SX>*\+`:C44DKVHSIFK_:XZ;-/[F^Z@RT>V_[ M#VM?>%4N)G,Q3/\D4\?YBI[`:M7:'D/+T'%OVR=_:K\]@'7'QKY/IL/S]J^1 M_//+2SCY>#D?_;#E7%H5+U=+$SZD<7JU.IY-1 M\60Z'R[;')3M\-I.5MV5OJZ1!0G(RU"3=O]'%]`NNUE MN;@L+H>+'\KE\'2*UBE'J\5D.>D2#MF0-JR*13DJ&9/66\6L7!;SLV(XG<[? MB4PHL+/BL]VMAP^^M#GRYQ=?H8L6I=39(;%9 M^+U8SME`(]WVU1`2][RP6+&%D4?:OS=88W*Y02_IMJ\ MG;WY6>[D05"D`U.DW7DYF%+O)1VFN'A]YB%>`OR8!,PKF;[_Q/ M)G^731[A=W1VV-6.7(3F(MH#UW>O6IW]N1^Y"G9;0J+S1H0HM<#2L)J-VCX\GTQ6^R3Z;FBOF5"-;A^`%V=7NL4>NFLDK!71<(,%V-&?EL,;\LWK7G@?X? MR66DZ_:<&P%*DDCSO5%#F?T,E%ZC/M*;DLO>%]<'_,X),'LVFN_7W0U9[`%TM0;=R2G&?[H+/P"OU;,)?N3C($8KLO&3KI"8X4IM7L+ M4FDR=<-*VJ\U*=7/I#?LD#M-ZPR[S:D]HA"EC2ZDQ"#P[-+\_%>+&,I8U-[N M(7/)7@67[.##+IEOO6R_ M=#2C_>S[U]-?B^P18"._V1QV_)ZJS@%Q9K)M91< MH+.%VPR7>!DUL+;;GDZ`"1):\J'VD!%Q`.;;H%O[:U-L;9N7)A18Y=]>SZ?3 M`F7];K@8=Z`W>V7[E+Z(\Y%'7.=>I7'XOER,!"RR*%MWU%O%QAJ_9.T;[<6? MH,E/L:88[B+$:@K;9O/9GU>(O$#,UI#R56PV'7WL3&W&-DZ4Z,LYG6[6S;7W MM>&E$(OZ[?:\>U]R9_63!NKWM@@B8'3W_0^O)DT7O1MU@[^\5VU MEWP3WX,,KN?XCD/X`8[OM/_DD??::_C`R)WVGSSR@X\!JN1Q&1NW5`+ MO0-^?+<64S2@[\Q:&*?4[J,\M+<&3'2L[&#\_:H*T;TA)XC.""3;D#JW52:: MN%>&'YH#)B?D]!I]$/W3>H`V!?+`RSWG+-IJ-\XC,>.L17DY65VN-?WM]YM^ MMW2&(!IQZ2ED+0$J)NNQPX/D*XRC:8SK%RK8'FLC:N3-8APT,KUWZ1OAJ_6@ M(@9K'6C9#YS%D8N-.+)LP?JAN\@8.,LMD#$GG;D[-^!#S*:&3L-0=]>O5H[Z M)W%2F[VUE96%>#7W=6CP:D6$AZDS$>IU']O[^IR\@`/:XL!;O6+QZZU;-Z:$ M."%$;1RX/:=!AC(RJ=.`/G:9,A%W)>N.?]!'I';O;<*>36:8'[DS-Q%V>&U9 MH6PZ-"=:Z8*A[?$T2=8]*DL">]-4A-++B=`_3[+,ST#9&?\6+ZXQE>TW#UT5 M*(+\*+^CW4^B;Z8&[VX$8F\6?91K=W'(XD:&;,0P!#WEJD=Y1.DZB4?[-8V, M.C+/[VY#[EV:I.5,K+*(L=V';71?PUX7]B/>;C@"[?>.5U>@;6(6=GA,_I5P M;R643^Z-C)I,%FN#'.3GKU^^(<.@+,/Q MF^?/!Z__5+Q\4AP?/7UQ](34\HN38G!P0).3HQ=/BU6Y-3.CJ=H\** MY^58H/660,L=6_Z$%$.U.JTFX\E0Z3V`X&(8NJ4[_><5_Z_ZBU!6*C[NW[F[ M_\UH/@5D6YR??GOGR9/[>[M/[M_3X\43\A3>[FA&@FJRU-.[UL%R_]+'QG2_ MG9"L51RD%9PI@8[F1"2G*%EE'R60F$!:5NS(EMZ(2*'-61ZZ0A-!%<:^9@A6 M%5C,O/J!Z@"Q_>3R2F!RM5-\1XJ-`#5D;>@^#LDPL17C$0ZB8BZ56[D0"L+. MH\VO&,#R,!:]5E>D-211\X7BT1TG_P?HQ%(NX9'=#Y*H?^M^EC4(6RPS0V/2041M/BY[A/LHZ<,)%[=(TM3/!$L5KO@;TFRS21GBB>LZH M^,[EV_GTK48,G>!"R\))KH?C,4)9\>0=F"E=N>UT'/"WV;ACK`?69;5@:2HF M$F3+(JEGVML"3"PNP#.+Z1!\Y`):S0&*BMV]>S_]V*":669$,CPLE'0\0R/- MXPJ-X,7I8CYDT8O%T#9*C"KK/B2Y,9V?(]@[-1_5)4_]'!>8`RD8`PXL!%*; M9S-8C5>G%*GIIT%;H)U`:X]Z(8G%$OP;\&A%!D!K(?4`G\ M8G-09\\GXS$QU>&P6NZ8RLP').(2[YE!'$_PG&%#FP]Q@50YAE.(L',2XDZ1 MQND*(5C3JD37S*^9.A%:O<()E5%`/6-ZD\J(?:2=2(5G_;MPPB(@_65EM/G; M7__CP,5RZV]__<^"?[I*C_]Z5\:_5I4:2`1H!//I7X8\2F#6V0'X$86-HL1Q M@(I6."+&%:%2G4UN)R([I47L;YQN4HD#6:4H"+`"%3O0^/K5*F%I1D$LW1@Y M>'EP=%7GWDQ\3DL4%GM&=.5,RGMR:U3R9_KKS<[Q3LPCH;D8`TFDJ09;65J= MUY'/"1X3<3XTLS>>#@:OH!P.)KO>.[PH;".(VR8S]A=-IR2#Z/R$*10J-K.- M&(``CV#&W7NB#15X(6E0'&__CRXA#XA.A+[#ED)=S2/QCNL57P['<,=<4V=^ M`0#-:,-/@1!JI1D&\Q?;0K*T04$;IJWLWZ&-T2;;FBC%0@X2./MCFZ888)JRZMMM0F@8U![OH->9P!BX$2D#$NI2XW MU^Y0=*/JI9[[3&P9P7<%0F!'6U MA%?AL+*$-*9("NWZO5PFB+R85#^X6L.+=;NEPM1B3$$./SO*8JZ]=E9QU?)B M9$IO]G:RF,]$$'GT9A$MR,`+)NJ[X*FT)R5#,GT^F:E*UT/../#_-7@&2\.F M-'B9H7-&CBP\CLS>X8?]C7)31MN2U`>QUN)$M19]^7TBOAL,W%G(>")<;G4Q M-9!<_A0*TX;(#91";JA#C#.=2\KC.TAHO^(*RJJW+]'6+`S3EO2YC@N2(M`H M]BY'-,\8*(^?4<92?`XFQX.4&=._B3PSF?W=OYNN`W'9>Y%0SR M<7!1OZ.S]9NO\:O_`VN4+/YLDG[D7M[_S==ID96LPG4Y7&!-<5-^XV53UE%> MGI:+GWYLGL7Z`)[W?R$C<\XLI-Q_D[7]Y@S,^D(QPR^ZOOWFJ9@:-:P1M/V- MLTU.K)%3T:+M#Y4$A0+"5@RVGQI:%B;+&T4+Y^D9>?WJSOY+,'F!0X02GG+> MD9,VGF"4YT34JYJJ(9ZI95#-S0!N*\N"$A8=/\0.VYE%T!U"BI"9';<#_OV- M\\WB-5Y2.(ND:3:G#EG7.#Q',U5=F1S9<49#-CGO@ZF>$+5_=G]OYT'4+3)? MMO+D']0I31!.U82S].#>'%^KR-Y-]J,),R&BU(A'FP@!MI-CCYZ6$>M4M,3<,TE!57JH:W M@`D<=S9?*MJH5F!+524WV[9%_AYX&CXOL[V5/F>]/R=3<,R^=\8YQ8CW96]N M/=8^D-@+/W&R8_5_^*$$&7M89_F<-W>\$0&NE+\5#%+98V#><3+7K MYQ3?R:43WX"L$SIX$7B6J,DE]V(SIODJN#^>F#.I`\+QTW(VS.-XI&*PYDC% M"6;L$;V_IN&8H\?44UA-7@_?BN`=A0M&1N*`&W'<()[`V<3W=B MHYZ^<.U'JIPT^1[BDC>FW#D%LE.\I(V(!/BX*$`=)C`QW%NBJU:&@:P;"$T4 M(RB(\Z&!3.24ARG')+FMYA&A?DMVD<.7Q1F1VAQSC["@N%!0#$H"<$F4N8"! M_CU$%*P-/)=:11QI/ZG$9#E">8ZZDUSBJ"*GK![2>7#(GD>8M\"GGLTO`044 M+0@8+'>R#>8A7/..O5JB%,FO%$-5(-.9^JC):#J31Q%<0#;'G!LE^2F\0B6] M73TZP1A0S85N#DZ^9GO@2WE-K.SRD9#6_2=>^$'4YPBR:76!\1/(PU9_Z[= MT+$Z+JK9]'(G4Q"NJ2`T@`&B+JQ'U#A;R>T2:;0^`PPD%DQ>TINSA#&0!4J$ M34B\"M/.YVH5)A2XU]`D^LO?==,1CI!`A['*76LT1_L(VY-$:FWC>EMW8CD2 MV9`9>Q"X%JX1;NED#"9D]][G,KVFGIB5YY:BT?N'O_M))04?$]#\P]_]M!J- MV_B[WV\6S^O#Z,=K#J.O%Z*7:'S/%QL\79]F1P4ZC'K)S1[DXU"*9)MU6'\T M7^`'0@A!!T>_<`4ZJFZ2909R%QD6<.W>$HB^S;*:%MJ MR6SP;PP=Q7CA5XV[]X%/NZNM261&4N@;E3SLWA+/!`16OI#5(YR"[\G%C_6OF*F?C)6%!I@IXN0_7$[*F)"B"YPY/# MYCAK8&/GX`/T*QA-.4L2L5_#>(?/J"!:Q1E1^9]%H>8@=X9U-A`N#='%#^X, M&7R,CRP5IGR)FFE*./CIG/-=7(2%'X%FDE>!J'>;!$T(!F*"ZTKD'?17A*][/6[#0TDIUN%7 M?VP'(JZ;GJS^P1$!KW6"8C&"T-$K6(4-6'+!CW-EP#^(0971LFJCRW"8V3@C M&0Q%_2*9L`;OV=.>I_)6A:[$K(G.&E\.2<:H&_EWE"HJZC!?U!$8]96)IV>D MD'+QIK)QTLAV%=9BS"S)B7'X2KG),(4:Q@GE"$1H-C,K30`T$-Z!`]W`+Z!# M='S?$T923&<..),C(<*.:'`P4DMF*\A=2#DK-&AFRZ4O_&(MM MLY`9-YD0IBY4&$N)))K1,I?0H1P2F'AF7O(:$SQ'!%$' M]_B7TBLRTA`"V8?N?8-Z7M+ZT/4G:I:IFD!`@J"L-BG6!6FY00III]WW.=J? M4?A=Q!$`U=%$<*:.RC9^V$1BUEQY(\]F_RAQ-/_\)'>VIT*V'M&,DTFRF2:M M`CQ">ZKS:7`DF^4J3K&:]([8*V6_3;&=31;5KD9&(0'TTN*3Y0_XU4QCEC0N4"CUQUQ%)+)7*M:BSG$KAA8 M)T&QW]\)2*4J,L:M3,:@VB#P=46`$60%39N7.MV"-:1Y*(N!K;5:LR08]QN/K-E[ M&I4]^Y"?X%6TVM+H>K0+'_2;&ZY6V+_._`QLI%VPP#*A,Z08?*[=%D3"GFICMH MN7YM:$Z`IA92SJZV,DUWN5G$2Z9LOW`48@F+5Q\TWU@?UJ5>V'T\#72)&Z[` MV3'W(%Q*FH$(RA9:>\`V5:T].F(6'L;MT#DGV0Q#.]4JJZ+1?JX`YTCRA_NR MI`^I@1/X)+O6-&&D2V3<_9"C\,S93'50P>&[51>:0&T$"5<%PW)(007`@65`P?Q*_Z%U""$/_ M[.`/20FJQ4<7.ZIXL8$$2?U_EX%%(2,8\(=PW:&4.AD#Y(2B?/%.AW/('*F\ M#-18,##V@PL0[=@>S#-P>=6N'R>?[]&V)4/A8:990I&P?RXX//%U#;*;QOM9MZ4S%#?=5,F MDD>O7O^WX>75[Q]++LGF!O=5A_#?S1S=< MG[$M?:]S[L-S\NZ6O[%P.UK1,%?+",NGIF7#)9']#S`!I$EV$56C.TTP!+6" MC^=H;X9*C-_JEQJ#4<_(::]0\Z:(4;ZZJI:7.D9AFJ=O\IKC&G-JMI.0`$.B M?!E]84C4H7F+H[SBF*V1ZP\!/&-2^_QN"+58F6.A"L6&_X\.:EYMXD5>QRR[ M?&@5'RK]5A!V9K8=HQ^'D"\J[&CH(;)\/K]H)%C6["USJ/!&97!#(ZQX"!IX MUC+7(;3W]K4QCB;;IHUAS<#$*N8EE8.J@[1@KG,3?;:BC$,C4D[BEII#7-M7Q833Q.3B$%%#H$.8CH+;.020"6):LUS*V(9`1T<8DKPE(B!&%G* MD:@_4$-95_U2CW/*;JAF4/L6L"XVQO?0ML?=&)?[V&&801@1KL>%'1JZ`H6( MV;CSS;>/7;[[?L6-./`GP"AC7'F".GXQ<".?@:&=/BLM8R8HG`@H$DNH1%(BAC9.0/O/Y&EMB3[&S.0 MG)IU()[=T_L,)X];*`V_]->B9-VXS:Z4^^"+I)5T&ZV5@(@UVZJ#X2V'H"I\ ML:C@4PN:P=1PVNV8$T+",.WK*0SB?Z>CE3!VGZ*U4F[IO^(FG;MF4I)>T[JF M;G-M2S$3,IE6)YT[:`@CLJQ7^0^GX82-:`B\XY`FX&E;J2%D,#MITT_5^1\9L?P:1F:_WR;,5>R*CTJF]S6$ MY_B%,GY-.[#5`_B<]K)L2?E> M1\SMG)8N0<"N2>^349%S-@<7U+7V^IEB!T2'<+--*!SO4T95+JY.G1:Z+2/>7W)5%]-JF\/1'KWK!5$&C4D/6Q!U[GDISP#( M!Y-[8LDJG+]4E&A.O@J.'=M.0)]A)E5"DQ!=C)C=^Z!Z$B=TDXKT*CL!>N\. M96BOZ6$3C`2PJN[OT,J$4E$$%X[<9*=B(&Y`U6UWTF!NB"9+/-&`K2G>E)?* M(2V1T*OLC80A/3<@X;&:B=U02S)OG* M2EAEQUACO^9WXHPCUV2".83NKSO2)XHV\G]00G/R`^!DT`@YKS2TEJ"$@QU" MENQC-Q@0FN5+D)[P35)[D3HZS>E8*BVZJB/(2W2&EOL;!%^ORRR,?LQ^KKFU MN=$NO[/%IRDJ]J/_'W@Q>D8LR*ZH`6/W^Q9*\H)VHR5;%N)W_A)#AX-F2K*` M-NLA])+?1K3KCXR0Z2G5XOQF\W1QHTPU?%?`GWJ:K4Y9R-&:GTI&M"EFY]R. MD[RM/X,1(`0SRJ[`2-NY!P&3L+S(5K9(>:,N--68\:*\&L?14R6'Y-J+`)NH[$@(W;TO M;LCIA;I"8FK/P"A$B5)&"R88+07O*XH&AEX8I.QU*?UPL[.X>F\$-*AJ53^E MV#ELDQ%&FQFG$RSAQU"GPUXG$"-.W=W)L'79ZG@"\#9"6U_)/CO#Z-X+3S^; MX-'-HRG5;]O'(Y5Y8U>M+1"@&]7+.58WP!=LKJMEE@C"([/H_9O7:S(RS$J3 M95C#U00XWQ:=:=VOV-'%8'6EI#>MLLL`LG90BF(9O\E/4(3PURON=/*X MHW:LK28&C@*>BVQ+UU/&\SK\XM['FK> M:A9K3*O>:-?/$')!1N`Z*5T/U(9K<9R!:*8A"1`U9G>53^=KS4*CLP%5SA%)V? MV,^I:W;"`;@/+F(#\%;Q=4^D"L)]E3/D!>=436[8)A/^NJ14+7W>36,69ACL MD1M#AYP"]LKXA*C)*N+8'U:!C/GL@#5(.Y7\0* M[P$)VW02K719FT69L'W6D62J'@)>4^2B"P]U#,Q#HU/5AFC5IB1 MCS=?/&)`\>I=B_6DH\QPYU=6NG!I""2%_F.EZ!EGT#C>0W`@11,<^W#WA!83 MO2.['8\M"V?C8$!I1,JQ--%T"(MQ[9J4J-\)<[-UN?J4%`3]V/@MZDZ+^67# MJ$"UF[L\V=]B.@V+GP/B[Q>'V#0B]WE9@FL=%F$U:2U'+IN]"=3D@NC7_9N4 M!*N751=CAS58<;:MO6;-FFF][BDN1&2,-@,_2-N3RR8PZI1ANMCFU_%)A7ZSL"+.,W!,EVOYH5?OHAB?)MAS9A6P2 M[]:]K>L!_H'M;/=P0EAQHT#1FEJ>3DNV/^3;HS(U(AQ7GQQ035^X[AT"A;HN M^?6A#CM[&&\-5Y^T;'PS3T>)%_/W%KJ(HDV[5[O-T65TAY%6V5000;`B4T\) M69`TU29YC2M@>R0Q2\:2/:O'9)-E"<@G!_WL9]"5Z^5#KKH/*'-C)[,K/!;' M>>0FQ&Q/UM].\2L?9?XB9&B=<9Y[%&K,\G=SACF0R=BK>0U@D`,8.4]T\2&Z MP1A_8NF'*`_]0UFL9OXQ._K81Z*W8B#BSW>:@5HMB@P4ST;C617XH.GWVYLQO5Y:T&_B4HP*#WXZ"]RK1E1-X* M[1<\A`^L#QG!H8.ZLA5M-./L'Y>]R,GQ1=3:&/_].04[$/V!*S$5O9K:DDXZ M$L+B(0":..OTF#S(V/!@+Y=%/6..&9BC>>$G/`O3BOA,,5DGS1E32U9.("VN MS]X30BE#%9,NP;TD6B&F(CU&O^A]CE#AFH".Z7\D-ZK8CG&/1+)VB"QTT'KE ML.A,`S?&V$&-,2&.N3;BM._)N%84MQE.N<-%U@0>-F7=/AZ7(;L6E89%AV$] M'*2)2S%_Z(I^[.64G4HR+6T1$QA:!W,@.&9:^-41.C%?+5RJ:=W$>R=YH?:] M@_*2.)@3;F&;/50NB>[0ZE93$A2/;@)UO9+-P>&*N#X"=,ZLA959.,UJZ6-$ MAZH'P=J:>A3!<&45_WL,*?K7'Q2.1=$^L&Y@9%L-_XUWA@02)*JIP[C_]`CP MI#)#O=*:H,U-!X$BQ**];N"F\E7U,)1PU37^CIO@R*8/SPW/Q#M1O16[7VR) M]Q^Z]T).1V'DV.%H1LD+.R19200M867&X-0H M3!<@+KK5_.!$MM\^6(XOL1T@HSJ6"]Z%NA.>(WF)LW&S@OL0@CAZS)$,WE"9 M`#S(.WH_YV&)8C-BB*B'J1>[2);7ZA,GI@"RW>\$<8.#?WUS='QR]/+%<5NC MI`]R'\PO3P-^4-WT90\A>(K;LX_WM-54OTGW2?!==&81G):DV/K?>#DK7HZ6 MI@81,L-N$9'DW3,^"6!.YV!2N;`KK!,QNF6\BY.8ZA,S0LP3 MH(1JJWBVQ)S+P3HY>6D.END307-DS<[0&';L4WP&&EO!([I-5&E^A/F8F0R( MT6:3^5;LCYGHHW>\&/4"T[?O"P-FB&WD2(2QV* M;U1W*I@W+1G(8P0,PS"JYSV%*?T^+8;C%;L=FJ(C@F5%DD%K&0565VKPV>X7 M._>B-:N3&C/R`HRG;(M'%QYK,A@%5+K_!I;U7'A"M+(2-,AEQ1DZ:ZZBPD2! MV]=_:C^LP(8AWT)QAM0]X,;Y0<]Q,_@*%S';(RN/@$0J^A,0QDT7C!TWD^T^ MG7`%)[P$!?F75%PU;^RR]V`.Y!63YS0X9:(('F:(%SBG)O_3_$[[E503GT7Q MGM[9UV\`W;43*C)SY"<5=$BY_,"]1]6RO!+[@#*>462@>1KXAF$BLKYKL+?4*/#:RU&D9] M22VQ"YB=586K5%H9B_V=D[6D.MD0MT""9"1V9R;_T)9DTO9%V-(5J6H M-1>^C#J'$15C.MLEONIA0!-5QRS[@(5^[?>=Y,3N@4!VQ8*:3;X(*D`AO)XF MZ0]Y/>897H6=G!W-F!$X83UD14(I7#PBHI5]MO=@)]W$ZD;=VYMZR*Q-W)KZ M2PDN8JX&1.A3#%=1('%G_R^0O,8D)3J.*[P[.U#!X`= MB2G,))C>"QZ;306-G0+G=.$3PW!M0`D( M<86NC$PWL]=O0=7\4`4^1.K?.G1!$%>UC6R#HJ90L+9RL_5%3GHUUQ5=:>_J M)+\D(S_-+[!Y.,%L2B#M-`($KHN*Y5/R$1XM,_9J7?#U#;0/5LNJW"R)8K&B M:3R/-63)&^]\*S8CX/LL3@*9B,>BJ:M>@X8M[67)DZL+UW;_=V1K`7A>FY M0:(CP[>KJH4:MP/$]E/!I54KBXK>KAP&6WWI#>4+S*LMH]?-9^ M0)>.'_-*WGNSG;AA?V,W3*AOU^T3>L"O;DUON1\__>C#-&E@23&E[\T;N6%6 M7&22ZZ];ZK\.W8["W2'7S36O8?_CUE'+=L"U?Q!@#81XZG&\#ERV^MX_)+*Z MDG9I_T`H!;(P`Q3OO!-P)Z+QX;5I;&DPW)%&IJW=W\876_?V@B!%X5[N=UC+ M/V'=8&O.DDI5X%^W^_3&P6BAD9ORTFPMUNEWPTZ0/W:WE_V<>!CCX!M0(JH[ M)@S*0GZB??7(*(5=V%;73E&3%/%J].`&GP.:<:DNX08N7GW()^A%=;QN/H9+ MR3^W:Y/9@#!#"_ZD23+W!OVM,OH0I_VE7!!1M@/`C8J(SRF5B9.N.Y[D5QY_ MDEC%*X\_+D_XL\?MWV4B933L9I]WO@\,D78JX!![IJ.1BP8.86Q8LUD+?AB6E#^,5\2HH&6IC)O-LPJ"CFI<"-BH$^:X*"$^VK5&]R@0UI!J\BF?K;[ M,/?C4=71?$)3$AB*%A[E>)7.3IV%;!.KM&$CH@MX7!C9($HA,!J:#BN@YCNLJ4&@;3K MT`.<_.Q;I6%/M!+J5(5ZQ.A:"`=?T;2R[["%J>+'%HX:53QBQM>^80J^@'_G M646FR'<]2PHR1Q$.\&DN(Q!EQ].T7,LR(HD4B^F8KP:U3W?RB-7;$%9*Q.[S MSNRMGY&1DA655[!'J4N@TV2A&NBPH<(&VT=$'I5,1>J(BI)J>%:J8IHN!$\H M)(]%[2@4.PQ#TP4;R(BINBS/G+$/8KU.G/V+AZ@U.!7(9S0RX;6Y4^FO8_'B M"-GFAB]Z2\N++!F$X9$,[($?O)>DNFN7<^/>"1^ZS7NN3K`[$G)UT+1-R_T7 MO5<@M%MM/-SZ\E[+ALJN[6_<_VU<(GW,NT7DYAQ_52N+S=0G'_6!JZ2J4(QB MZODUR7J"YG6&%W4NCAG^IH87D='9L-KP/MC92\CK/PPO?(OA_9<5*F?W*P/_ M*55!\7^LT3WGJ]S8CF9QP"]J;Q_F2ND7,K<_VZRZ&D<5YK;2&&ZR_`4UM\D7 M"E/EA#=ABU_L/(R\_4'%W5(A-D0>F?*[(U]=/7U_O9ZFW$>FH:F0I!NW]G9W MFT]O5%/D:',G&IZT[PAD$'4@?7$UN0*-4]8@7MWC%VW@`.`W*FM3%Z$;_$QD MF[X#G/E(7(Z'9<>4X92`M*I2VXUM3,:XR^!KR-STOL^"?-REV!QA^*2O-Z%, M;QE;FV#O*=N*E;WOK/$1^Q_9SFUU$%S1CWR(K(%Y MKA),D">D5<4PS7'DA0S8=)D%B M,'PDETQ#?8_5C;Z;0>L!',;!)0!0N4Q^;S:$QS^,YQ:;U<+U+N3@LS-2N#&G MQ4^QG[#`P%52!!_#+=J*E-_A[QHZ%0O'?Z7[05KJ3)F2,=$"U2`*/DS/Z$C" MBH\#4*[?%Q_W!]0:+&.JL)CZ4J,6Q_AN2ISM)(89*G?;B#BNT*C&+R[,'IS! M#=NJC(^ME"XU1$,_Q[-0#SXWZ_&U_\_02F1TL[J=WNFTWMW;^<);[G[].>GV M>'N9U]N<>ID\\5">,#!E5=@)C("XJY`T+)=YZW:G*G*ZDL%U).58/9R%3FBD M#N+L48D/;?[W[]V_%S@GI56\G)A7P[#*Q]N6^[6F"HNTH#*)N14;N`:!5D6]*7#WDV'8KE_4"-V<9'M)AM?M)\<6'&8%9XU16G=J/$N@PET M`WBHW0:Q&O7H'>_GAI7OM6>S<7LWZ9>?>!>$C-[-EZIF_EA(/T\2Y`7^NUN[ M>RUG<+E_`Y%ZH^V>!,3/1BWW^Y,0KUU5HW'8[HQ'@HB@0![8EZ%J@XS"`#63 M?H==I7ETU4U"MZ,R-;A>B."Z`_51:=>K2C%R>#%T^/'CT[+`;'QX.ZK3L`/#]HO'J;CQAN*T MFUYK#S$`(>,6(-`"=%#7Z<(.8F'D;R!+AB]UU$979;;'^([O4%_0P7;[AP'' M0@2&#K)O5[3;O")&F(_;3SIC6Y.[W;IFW]]"/>2_NWHRX"]M./'X3`_O;7_]7NJ)WC:O^^ M\=57[4?]6:_"1W=6KEFA0\N-W:V]!RV1)X+L>1;R5#47FYO0U^&77SYL3[+# M5WOM%AM?/>Q.`R>ATVYWZ][#3O^-70V6P>(5O$7/-%<=7H?M,+CK,KZ=&7=F M4K.*G'3AA!GGJ[Y+YJD]_4,KG$;^0CA0;TU?)\P>2>Y,Y8%#U[_X?!D((5W?'CPYC55L(?'G49] M7_RZ4=NE0X_2Q(_UV2Y%051O4&YHP+CRMR#[Q_6W63;4XB"8@/^[5? MV$"XY8!KDIFIB./G5;/[/-'[I/.P[5^.TY'4#G,\ M;WYPK?WF,S\+3731\3\V.O)_L.Y;;>U>-QYT)/%`EY$L[&X(^YA;^Q7C!9)P MK:^=M9NYALOVWXMC8Z2C[C M=MCTME^3JRW@QFYG7%^M7:>HJ884WH<6^U5WLKN=]6_<[XRVT66!3D]/!D>O MBS\.GKTY+)X?#H[?O#Y\?OBBZTC5K)H)]TWU_=D+^9'=UD;VQ_QKYM2N/>E_ M^4VJ9L5ME&\BQ23\(7-KP\EH*WK7NF[[H7==4ZFB+#>\Y M[81HA'[,(==PRG;B_JN;C#H&[9'M2A=B3'5Q0$XA"E7X\M3H@F0Z%`*L@IG# M?2.Z*X"UZ4/+E"TZ^<)):6A2IU67Z>;1=-`\3"$;R&&+>C1=0N!=ZH/KC!N' M8KESZEV\OI`]"3>O&I'][!4Q"]763@"O*G=X<@3-C9Z>[8O4M")9C)U1F`\[ M=8;RFXE,B'UY/E?_R(A@A["S&5_5Z\"4Y;`K!T%L!'\9M:-;*JQ7QH>>-!>J M&F^.%&^Q8UG/V>9U@)=^@7F)_5VS[-`9S+_,QS`$$Z8GE^\@C-!+PZ3"X7>) M"Q0+4L6_H$!VXT!=AMB^>^!WMY/Q9ZIX^>G'79SYYO9NU!MO`B6F_\B]_OU' M3>$^4^CL?[S\4C4/S?E)+C]E2J+FK51GH,P>TUK-NA-C_'2L4$F-"IVARXRD M:[BJ*B@%%0S7]1D1=+3;]'A)#%>?M2.PM8/5R!P0<,Z;?>,S3)_..)?;''1]M8"%PNVNK?M59 M+\C)%G0\4'NK^ZW9=C?/J(4/=V>V?NK7%1G\"-I3PY1B"$0;?(NF4\<-`%=]P,)KM%3X-6G7G#>#&9IQ MEJ,A),;<+@4UVZ>5#;G!`L534%Y1WT)BP/(-&MZ-0S^[G<`$O$>)4" M4L1A4Z;!D#&E9AZ/_*3PF7I/PTD7)'_'#D^$,[9:W/]F[UQWXTBN//\JA4%[ MP09(FA>Q)8T7`HID22Z;(FD6U>V&,1@4R2)%BRK2+)9D&?MA/^R#&/,`^Q!^ ME'F2_?W/B8B,BLPL%G5S:V%@UZ-F949&G#AQ+O]S":TCWR#8SVFC?G`97*WG M,JT\;],S#I_>J*1)MF;%`F+C:L+2LHK*A0X)P;K0T6ML3*N7)R0^,O7E>+.) M[CH>2E5>;$MH*AA32RD%$9YCSOI/K%&;'`GF#M<8I54/H+ MCI@C8=3^0/0.@5SMK+>6S^.M/\4NJJ,D?X+\"F(GAJAGLA1CY&_'&^PY9L510H+E/%M(+U?O<*`U>DH M#G[^G/%QL4BFHKL%&9B9:&RD+G"=^JQSR-%I513MXZ[M*,F*_&Z^*>FX)CRD M^N+^V%Z48W%RO30QB@KDK.6@.)6Q[7SZDK[9DF:N?'('H[KW"3$0^ZB!LDY! M^2&;[=.FPLNTD=EN,:7RKC$MM/%4-\1^?@2H.#AJ`$!3B4N&5(S*MTO!\Q/WBXEH,+^T9?GSOAT<%A[^CXYQ`8Z/WA M5?]0\$KMN72R#M5'WW98D*L?K#]U2=87H/D?;>]17$?GJ/A"\52S)9>FUMW? M[:2)U2S?5U[PN,=-N\6PS_:0">7?MD.%N>L!MEHUT:8ZRB=;>_[=/7M)XKC: M0TOFD+E3CS8?(#+5E#%D\>NY)(;*[P@/_7=%$+W_!LHUOS"W?)K8])/EK8;8 MS-.GRT_7U\K'LT68_XN$.%NQ?@+>;BMTSB/6.Z_DCS2;J=$!'OF MENZ:-0+8X!B'EN)!RP4.M19MN,X-O0-,AVC86Q(:-:)^C!`XMVCOGQ-HC4$.! MG89TA&:.+R=1XW40;0WG6E04]$!>[(F_$DED&3/E$KVW7?46JA6_NMJ-:&&5 M[\6EJ)M\R&NS3J'E<\;SY1\=3H:YY];$[?:V:Q+'@CP+Q<+U9/'=9OKJ,R5- MFY_<`U"5+MDA@P#\OK\S;"F_3S\[[!)H2E]@% MTW1P\^3Z]M:*?I%&UIO%Z7W/0N>U4FLH9OYN:ZW*7E_H`Y](24!I[!&L!<%2 M&#UNC2:#.OJF8C.^!,8ZYII0_:LR93+"I&*D<%FP'@2=:*&Q.D&=8+V&_!63 MR@NM^:%$?9PUT5GH`Y],U..Y"V?%NO2C.R^ULXC=?W`&X'#]16@49%8(`MYSE#^9*0QL MM"@4)C"<3Q8#_@<.'*$0O'N=PM`[+31!XX\$B:[(#E/E'+"))=7B/&*8C+G+ MG2-+K`7:Z)R=<4_>A\Y>?_O@R+P3;ZAOH30%#5;>$LZGTM_!HYNKZ>2+4'1M M]?'6K[[&&0,M4QS0KP\SNE1+U4\6$IE=="*7$^G;IX%CHC7%=Z',=;^D::X8 MLH9+'%K+B2;N($Z*?>3%E&34&JJERX_&*]3X![G- M\.<,_'4E'(#H:YAT'!-DB0Z*02(21N&R>;,<#534D8@]*OD`Z'BH%2#3!9R$ M"?%7E=5;9<)9O%W&]E\5NQPN'3%E50I.S2.XL?9P(5Y]H,*)24FIK="CA;[R MB0+&C*)09`/I=;F,7;=FRER.4MK'3#N7S&,"&;\H7#6+4+I3A;MGB6<64,H. M:)?=,N(K@R"S$FSLA2CR0+I_0>OIF:%@0IK@*3!?=)=)W9)^$N2*-=/P"-N< M1`#Z9)T-/TRX"4\MKY2CKOV`K#C>H[>7G!*$%?X2%;$?FLHYG@E4./[9R54E MQ?1`*<@D:\#FWM\#TZ7/6-C+^@$O*#W[K M_<;C:M+WC+C=-N(V26UQ1*/CNA%AD5GNM(VYDXU98@W-7I",3%U6$JRLV<4: MUH$$U(V09EDK<>`=K=7-.+,Z.5N]B%^\*>3%I71M]+CPVNCK:S:XNTI-HZ#20PDOJDTFLV];OKBQ%2$AZ6>@!8M8UG!?G.^]3]]4A4AW7'#(+N6E4+ M>RZC-$KXGSJWR@R7/H&FL^18#O^=9J)S4XQN\*Q>G7"XPEBV"`(H[^C305N7 M6J2G>4]QSKO3B^GD[A]_5P6FR706%YJ821_V#P],%A%8HMWW\MJ3S>7-S=038GBIC!M,$/5W^86MK^='Z^MSQ.TN>U!(::;-16H4"X=6L M9F?D35_!9=%H!(3?OU;EG*XG53ZK(D#OE?('"*V0,=[^^MJO1!VC7&SND"D! M?2\W.*K/:E/S,_Z]R';/LJ(T^4VQFT:UQ3>N..I\]_'F\M;6HXPH]1/W&S'Y M0[Z[2;^MI\N;3[:R80M:\^7VI^)BO?01`NL6')F\MCD()H]>NRH.8KW4,L\. MH+)U5';C(-^*2'PSNS6H3\Y,.81Q:YW"P%ZHU<:$I944^L??=TROEG\?'!_L M_'YENSL`_-XY>"GTNZO&U>5S&1(+FS%6!40?!6!>V>C(>9L7B3T*!@";.\#< M;DT-%KL6MEE0M,T^..#1J`-^:.EY%@.`GN;G8D,Q#R(R8KUN9M`=18-N8VUM MTV^S[2@8AKO,D_SQR["SIM/Z;E)']][]Q MA^LQ?TE_D&K5(]=C#GQU7W3(SZLFN_J/O\>J?=4N!SG`/ZI'K$S?$4B-F'_" M/3VW0^4MAAER)F)<@4V-M^WR3RU,[B?]=3TG][SS@LXCTTFCE0E]N+%5.&:C"U&5Q\^"3+WZ%%01 M8MXR3H-_+289W/&&AF7\N2IUS MEA?ZX">2:D6E/0$RC,88S)`J="6Q+*6H.JF6`GHCA]$935+'#Q/\_#+VL<6N MU0%%C>AW$P#1U>"QWTTQ[35D?JM(^H3;Z*DW5&8^5.:"JY>D$RV8(]_]1+DR M=L5+@+UD1L238[(0BK&=\8[J68259#))K:7+[V.9YEQ;K-O-M'LVXN7W['P: MT5Z]^B`)&6B>VQSW#$SB>AA9QB61*V0=\W*OP[;<(PR2\4SX'%!]1`)DPF_X MMPM)O!%NCAC>(+H-0V9^*JB^EM)D/%[W*+07IAC4&#$<5`.*\A8^3A"&V&CI M\AVD`UH!5&%MX;XS)NS]=<3]_#^E24F7Z6,*@QD-:Y!(1?6<'D$;5PSZY6*2 M7^N&,?<+:NN'LA(2P0`5=4L/*N<9X#X?A%._Y1@PM=+;G:9"& M<#*PU.,?GBYO;*XM-/HGJHL@)YR.K<)8*'1F:26Y[K98A0W*+J%&,XCK"/?K MK-CMY.Z(L!/5AZ*/8C>UQT@!?.`'BRRG,9$)U>(&QZ=49]=$V4+T>^#N M_+/"!#F_ZH2D+3#5BKC[8@#]4^"JK>4GFZ%HXQ[U^7G844>YL`?\:()]]#PPSB.-X@ MPUXP6[D"#;,$_>281+%G6AT2YWZ:L]<B\RG? M/X;;JT3NJ"'B9$/EI5U5D<2&^4Y!E?CJ8V^L[2N*LE<&IUBN`'L^B/E^4OE< MR4:%2\JCJ8#'K":A5F%]=#EYLW*N6YU27H`BV^4J0GR](DNMGTDO57^H.GJI MN4(_/41^#A`F%6P?RB^E1V)HM?/ADN!`^1A5A#T"MQO^>*=:*]&CSN?XXN#,5'R\]JI?ZWS-R M?8SUY8T?ZG_=J'=HN6?D1^6Z`_VL0+EA&QJ>KTJP##*X_R541#L$2.*R&;0F M=SI1[@ALJ@0.ML;&\>&7NL;']/1*]XFL+Y*VN7I&P)) M6,"F:0=5FZ=!5H)-`F_L,G!(R=0IP1(CXZ(<,:Y\\DE$15!7`$5#/(/]>S%I*2`:L:.BG%FC:J[X\9 MKX)+I8=,O;H2`CJQ*C=MO<;)U(I1F416D$LAH.J!Q\<$)V;W-ZX1"ZJ**;T. MV6,''@,BOY8\;:&%6JRN#_4\&M\E\\CX@L0=9I2NP%P.MK6^21ZNBDZ7Y;3= MZ)99XA#V3_.LP^.BEV9.IH06$=P\BV[ZRP%A+1F2X941#YL<8V`RP;?K%(*_7TB/KW./]8('0A5J MO\Q5](N5*%7/UZMACN%%+9J\`JM4BR6:@(98S.)_^Y95%;BOVA[V,@MVU&3! M[C)?0@*GY8:A;;%M`P!>+;X^*1T9R\=1[/K72QYNO?O>D*N'3''';Y"HV:#/ M1\B+X54YO\%=@R&Z&R+9M4&6-I=_B)A#M9@E;LE>JS>!XZZAK7I-T-+FUN-R M$A@J&XU/UNV+S;H)\*2FH;$W:I;,$G/<"'!)/O4M@K/US_RPO/&D]G`7N804 MK+5>5:H5^0(H#&N"=.Z41KK2-1?J&A8-TN5=R!5_L[]B^)IF]@)6.K^BDM]5)8MW[G!'&]%+BA[\Q/7?8)$C MPJ+**[][/P+JDJ#P2GQV4C8']H`T8-Z/)Y/WA@JDFN:J,0E@D;6:MG6# M/Z8+<.MI;;8;RS\\JC&^A/9&[=F&5633J(U,]&AKK2ZKP;>?UA7*/MEH]])?KM:S M/D:Q6>/1C,8ZIQ]A3#GGX#2,(TLW=J^7M6L6-JD+KSTUD1HT1+;%T*\NW^AF M;$RAL=UW:S;11!8+YU8FLL67E/3DH8J&CP$A\?L83CV1N>O=$AUAQ^HVJ"K\ MV;+F-5+3*,R(>EU9))1%6W=TB8?L+BW>"Y@@#!MZ<)F]DR$V;K!9 MR5V+&/+74_-Z.8+R>M+751!@2^15?%RG%N6B`@4Y%&;D-$_3C$RS MC:S`96:22A<.H9KJ-)HDJD[_S*:>>*\8!KEG+_&2;'_"QKC,M00XA*UOJERW M1(,909W!`96![EM;%==I2?79)[:#GI%EKRBF>DW7,Y!:.5ZARPVNW_24IV)T M40%]1;_4UD"&J`KV;:K-9,UV/Q=Z(2?`:!B^4*5WA_N3;R1\+17%/&@_TE\6 M`U^N@&Q]Z)#_:4(Q0IBF\9;UAR2L?+>V^BC>HO,UEO?IJVL($<*E51_-.J=9 M0PPTN.H5#7=5?_+@)(G#7:<&\T("S4*U6=>;D]#,G^X.B&4L65ZJ^Z5?A7R2 M)D`UFPWAO[MG;49[XWT)U?F<\9DE78*M;'2;8[>K]6WRM6?>0RR8Z9;N:7`Y M8N%K)U/EEL2&DFK7DI"08.#8"V9LQB[!-7NV\77/JU;(8/[+1]&\G_GXHF\O M;:S5;(*E]::_U;3^GF5J0!7WIRP'+ZL;*VFTM+Y9&V)0=16H/?YTJV;"W+M9 M*-8@[ANWZ1@AKGXMF/$Z,AR1=K8)V&+E!%;F\R+^X&$T++`HK$QGSIM MI=XY+PG:J`$:KAE]4>!S3=]:]#O"[,;7JN*ZLL_HO%F,K&.838-\*L)1*#O; MQ-/0N'OF`+ON9=O0S&C_I'FYO!3/[`H/T'(';;D8$%B0)`D1`3+1Z7DT3"&ZQMVN"ZO3PE#,K"#0H>O(4"0U=V(G1Y*[UQ`== MFSJQZX5.J]9,SJ2-ZVM=$%?TC"5@'QG0'7.F1-S^T8#B!&!A$_\\LF[K,-Q< M4S?BF[LFHQ8TF&_0:RF[W#[L?GQ6-O4=?*624_12ELTW^NO0RO-D70.2J[O? MGY6OPYM_GMY>3LY4U,IO;9K(H]-DLCVU*9Z,/@`-&)<,B.9R.R1YPV>_T3*I M>>.7[($^P/=PN;,]NKJ@KF^Y\P([BV0W=SX):L07??'9B[NCL1)3R$I_#R8D MH/Z,*B`U*\(GLF]ME-\:7),IT^F>RVRVW_J3V^'HRA[>+!_6%KP:*_V-:(H, M/L^A#'_Z/00_NV:^^$UD/VJ:P6%^#K>,/SR0D/'?VD2#)I$03>J. M7K77]#.XJ1H!50+%_YAU\A.<0R,[YN(^4G58/`DXI.=U/#OO$;Q%M.KB=1(# M,=#Z*-8,U^T7^"PH?IM7)5&#?,'_RKZJ_>4OR:P*)\K(H\?2B@O2F\\*]>.$ M2:GDG4W?3:H`Q`QC;0(ET:/;SI'JW*^C4( MF8[J4$Y`:JGXL(W8:-V(S=7.;Z.G,WN.XU9M2'S$'ZRZY&S;3E# M"`?U>X-%JPMA@NUE:V:71&V8P%7?Y_)EGGG]1-,GKW4G=(C>53NM0V5:-3`^ ME0X\@Z_JBW)=5JBRBC#7YPM-?YZ35'9;)-+8PRWC:ZW4;FFKM28LC$`\2!MA>)N3/ MEI;1,5)J!Z=)B<]7-EHG*E9:4L2VCYP>BB)5F$GL-C031H<3C2%8G^!'>[U= M#@%CT$E/O1>"/P\HK&)M!(*7.#4/:)R3WYUI5ZV?"ZUVN\CJ9-KC74=\):+F M;$IR1:R@KYA\OFEL8>%//JC+ZCVQUWQ6Y9X04WS9/[8[&CIJW;=SL'_CGDU'GS9CR4>-,9BN,@F5(D5^?N2&`1C>+2SKR]/O'!Y"O/K>O#1^&)X$2S4 M>(BKF!>&KVX?9L#S6(@5L;C8]CUOGVUQ)@3W%"VIU?\:I<0_L8$EQ@@UR,3% MAJ(Q5ZK,O@6%23$^$X%4UIM58RFB@37BY&8& M$=(6N6_5^1HG0ENC[P3@(W3NRGR(Z&+0.*#O8';ZD7A:]#]0I\/J0VGT.(7@ MGC@;R?[W=JF!5?1]=U^8K>PM<64UMJ'L8DG;6K>)HC"L\)K90;SCGTVY(D1R MAY2!+EY,E(D3]@G.(8)_/2Z;F)MHK,V-WE=<<;K:P3C9KBFQ5ITT(,^":W^> MGEU(^FB;`A^Q'9E?EVV-[51*J0FKXED.5'2/X:77-"4(Z+96F);,@S>R);#7 M-68XQG8(;7+!'HJ'6=.?*I?)/+X3A\W#N-68E2LJIG>Z7Q#78*$59=W M<=,G"YE3X29)5%1\CF&I+D<<[(KC^:HE'XG:5JES3FBM=N-ALX3=7QGSNL28T[)K1YH:#M\`SF7V1W[/ZFSA?;#2O#U?T/YO=0=_M/^@!OG8OEZP_2? M?$S*Y3_^[UZ;BL6& M8ZR(JCHYR&H8/>AM4WU"_*2#E-]ZKG^)DMZTI?/N\N(:CWUR1<_?8X*)P=9P M8.$.5YBG554*U"5L"D=J70"EK!^30HLJ;[(NHB-&)F#'K2)H*NER,]N1^_M8T1\,:2& M5QA*R@TVF^YV%$*]\925$]:LD"NT)244SL0U:U_GZ)866XIR4X*/)6AS23B) M89*V0DV^Z220?=YQ$.-M)X'*2<-OOB MI/A6R#*Y<@/Z6%(U6E%1G=I(\"DE%U&;8$R,W>Q-^=LHU;%I,2X;RFRH#,.] MH9T3?BTTE#UA$"GI0F02RJ*MN\%>6R<0C`,8/>%8'C>JLD:8GMDGCDP'-\LUM"JOBC?OV)&*+LTKX MT(5-T)/BR9G?C3>_DO:<^7#0?H)S"O6G7E7-:J1D\'_IDUE],DM@:1'90.ZC M?5$U\J]C.VXXMBTV[HR5B/%*)",8S#)J9\]K857F)N_'6=>FV*749[YJ1O3, M7Q:?QU<2'CF-C&A21T$S!Q,\?V2&C#/&.%818,Q4-1]`"=$82^&262,=L=FX M!7(ZRE%EMBXP7(O1WRSU%K)^'N@*6`'!0@-#XL7PY19GP+>'+-N'V_T[!]V] M;\#L?[;_O]NBQM0L:VFNEZB_91Q&#]_>/>T<.Z_;VC[M[W^1",!WE5V'; M=85Y!7`P6*+9;5TR3H.L8/N$+,"@O[M^32+6.-R:$_Y+1_PM;3#YN^!S%W4( M$(_]FT%]@^V*67FN"AC^4#E4/+8[.LS@$'[//8!-Q6V]?4]PM#;=`R#R'J!* M!A/`Q4H0578?<`><1X"3H3C!)\-\P>T2!79Q3>AO0?.G77$ M/+LDMAIA!Q8Y,V%UX8TG6#QBY>DRWLG(X(IV)AE\3E]YPCNA;BO[Y/61#Q1; MJL!:B_&QA3ZPL/BB7[%<#R.\==B>WMB%.E(Q6/J7H,[6M*:-/,&9,!X!B05@ MLZV!$$IXY;+#1&0#)N&VT%XM+2,+K/U$#NNU0:E"O`.V&+9=+GW,C<*ECZG7 MXD@2+^!]\_337598T?SD8"%8+TX#$8$ALPGI50X3IN!7!,\Y/>Z3#-\;HI;B M(M:UKN`J,]\%FK%PBSOH!FK\/18OU"%PG^5P4]=_>2T>AZ_C@OCG&%?.E^K^ MD&9'0T:]G2W0M*LAUCYPF'7D[F!^S<1T(L2J;92ZM["!'5IPODCDR?3F)MYF M)`8PQSCLH)VD>#YLZW0.@M&1&,/.!@20O6TH"5VR6)Z.K'TL+C5F2F@Z[I.' M;K%XH\X(];QB&H#!2+&$)*BT:,R.L/%_0D%A-R=D^2;^/M M-0]*\EU_NKKU9J(4TCXXGE`YT[/W)R7WF5-A7"CIBA/-.54DBB+/ M5:Y9YRX^H2[_TO"[#62;LRC_0+]AFFQZ#D2PXXZ^@H& MAG5IOQSRX#A6`!*J/)!#]?(+&,IF2]FUHA2*13M@.L44T?#'RJG0O_] MDCCR!<%@V(]GQKIA\W`T'D\^7+T;CB])DPMA%(EA4#(>1$B3V3X1'H:"2P4R MA+4(K!#^0S0QY0&7SJDZQ>,R8EA=P0GF)B>!(^\H@+> MSD0*XZ'9.#%V0T<\.5AV]?LV4&]GEI+$)-"P^JH""@H"8O:HNL*PO,FJ9GEB M26N*M+%T.I$:`)G63.C(8C,NS55\9,$D'CPGDY;I$+\86[,(XO8WHSL/HFD% M3'9"*]'AJ:'K(E2,D'=N7LN4$W,;A![R#`:T5A]97W^<\C7W-G,KTO3C>\8Q ML:\0HG0+::@V&ON8"2*H*(X''R8QT?H$1M'HZWM@;.!?H$X$=:)>;CFH^],? MN3Z88]%Z7-L5>G_<.3B]N];%#LX`<;#@F60G.I[(+Q+8#$MP#V065O$P90-0 MNY`V>*"5_\^+4WZ)U7P34,O+[M&@=?$?!5S\]__YK]8!&(UD-`(\>)&F&]>P!W)*K"O<9J\(0'%#RH0/C-@ISQ4T$2(:DR\#C^F)L<=0&5 MLBN2&4*4%"LZF1S'Q"-S9:M8D"P.9BSEBWX3+CKFHA`K*S`K)"Y<^M;M_>FX M\0EOZ8-VGJIL$QZI*W*+LIJM@.8V3H(J?D&ZJG43J5PQVR]PD>+O%A=,GK;9 M>\)>7E_>3'BXRIT;@AZP$DUVJ"PLLRG0TB>D?.%RL,+S2SSW2\-3IEQK5&-- MLS%T1:QMS6S5K7\Y7CLX/4\-H+"S@R@^$)%ANP0AA@KBI\'OJ# M%!RGM!+91+TAD3+\\?0S='?>,]/(-\7CD&\O)W:1)R:K16A%*3@#VW(R(G7< M(]EP"]L&]0U.&4:NL_"CA^Y4R6UBB)[&$W2FM!,O]U,+I(YM35*XUQ,\IRH&I3D,\ATTF M-JCG+951=IC8U7/?"X]S4C1'RE[,2XF^M*KH>!4U5*.-4;\ADYA]'"`&4;C/U]#`FPVRX@MTI]2`CTE<\*>K_%V;AF._CP)C#PT4^4HO06"<43PQ'E2.E-FI.=(/B`OPN M4C23VW8MVM`N/#;3MJ$X#"33(98<-;#>4%2OTN;3G/KRB#M0V'K&_1X7W<2( MO3%SW.M'_*@_^':C0M^P?%K9B]`SVBX)V`2SMSMD<&C,J%E_'%-JQ*"+A&4D M[!=1]5N.A" M'V;.GP0!8C^QQHAO5IZQ8&FRPE9D)[5 MJR^AS,X!C'QXET0QVT_6:":#$BPELS5:4(R@B()T/Y8]6RRQD,FP`"])AM5Q MHZ#4W,*LZ23_!M'X#(/84_GF\E2;\**QC)EC)EO#O)C^/.TY17N">X[& M5$R^5A3$YU0W0*L4(Y.08^(Z9%-0#)02W?P4F<3V[I\S)ZQ-!?A"1;WV:1KQ M/561\X*TU]=EG\4;'4^B&V$;=WJ]$DT$V;PAKB3>21%/##:UT_?%6E0P*"?3 M)7:>?4,+ZF2KFQ4@]R]O#DEM5/>_\\PWJ_J#:8]9;D:7)U6XI>2!7N'F M5S334S^$V$V/D@J5?/G=AM4(.B*Z>/S\3FWV+&SI96DZ=LZ$Y,@'TS=3O2&; M-9?(G&:P"G``2X1.@CC(?%//44_R-\]@#_)EM7-(>&Z%H,'P*DAS>>@@'^%, M\T(T(3?".R91=%R"FRP+,G7#XWD/X38A-\)=SOZY(7QF\'FBW_?9*T8EJW7\ M;-%OV@M=W>$P'<(6E-;`AJKPJ6`NMT`2Z"#H(,NK,>F(`]`TQEP$85Z54!-\ M,!,M$YL'U#S/%]#]>4S/?+ M^P?]^E3G$K79E2*0,0C&*S?"BKU'C-D&!#UG<`M/RXE9.TBWN)G8HXU9Z9-+ M&E``$ZD),D''PKUO<.2KZB:)EF]#H7U+BO?;R1O]9K(M,;R>'QR]^(7#&#[+ MX_[SGUL]U%\$G,H\OYV,89OLMY09S(1?'NR_4JN*7SP;[/=_?_"+G^0OWXEA MRP?]%_O=XU='OWP1-7@U..[V]W_QVRXHRTJOOQDMU9(?&CU1<*_")K0HC9!^ M,+DY!=5F?\?@3D*XW"]E<._X\:]:U82L>Z%JR*/T_$KE1D]/5#"LR(LWT(%T MIZ&G#JURR*L%K`(\EU%,]TL/J0G<(@B/6Q/C[#67YJAWW#_J2=QWMGO[O>?] MX\[A'AT#_(!5/N+N"-0`[&!'47XE*RH,B0=G>2%B]@.^?&LH`2%>TB4LV_OP M2M>>$S-6L@9Y(YWV9E9'U5O;WM/:[QLO)M+,I7CKDQN2!PPK>;2VOO3F>WL; MF`5$0Z3!2^D0:[RPSI/FJ:;4A/S>Y^Q=(SW^B!+S+=]$ZZ*'):%*`(U3V@E1 MA9U1@Y/`]D!^NT<#FJ^OK1EB&#_DB/',&WZ-KF#POUH;K7!+;SZL=N\[[G9< M6U/&0K6&."H-E8B@!H!X,T&4\>?PT>QV'7G:FJ:C2#&V$W>Z/:X3V_="2;P^ M7/`T2TL:?0<3*LN3X76UC/**(A>`@WI)8RN'M7UZ=XT8+^F=3IM3.N MUF)^_(4V;VR,%':77WP03_BVW85X:L/C10V69#PVCYR!(Q'R"-:\<`]D^92H MRS%4#6M5^.7F\(WH?)2V8"0_2E&]$D+0[2JJ1V/`I9-L2*"D0#TC?[XR.I:,E;1>Q8I-%HS6PCXPXA]N7M MV&^]?9;G M7P_9%O7/49X&@PO@G0"EZ&42U<_"#[%/43H(:6$IQ8V+5BC*4]P-1@G<8((S M--AGGM$4L-$GW&9+>YZ0EJ%W5`A$@[/;&@L=AJ'#LY;JQ:8Y=>);Q88]ZS9' M,!_9Q^N!39-(HL9W6U6;?'L61.]Q1/1TV$)_1E+JAQ^LVUC6B#-.IJ8F![T7 MIB/5O.]%[^#%4??PM_T='%$<^Y?=JKM.1=?!R)MH'8UN0F)*N^Z+SW;9M1>C M:R*G-_`(Z"+"U-.B"NHTL_/]DRS9^EG59G+B\X5UD`=TO3%MCUQ0T@?07;BD M#&./?XYNR>U"GDF5.#=/1NPF1]%B"Q0J('Q!_N+L%4ZL;@06;X;^'W#;[>AB M2@X14"'Z0&R$9J6-;%640DV#5PU)%]]:2"7^:<7A0NOI8EE*3/S4TP6YFT)" M#V6%BF%>*AF`#>%7?9Y3J%88-*)&B:,(;::(54L>N+C"*$7)A<-HDXKVDRDF MWA:8Z;<6&0L%XM'!,.QZL7@$Q(0J#TCGFDVSRXZZBDI'[Y4@C@)18R=FIBM" MWIC\U[5V=A*9>%Q&7)BLL$@-7YJOBQ8[GI$:=&VBY5LJ')$"$E[N\2HV^J+B5Q,J?FH^7,AZPNAPS#G&!BD-21@B M=%&N[ZD@A5@D1:"C_ST%!M#OSU/NM-56N_RZG-Q.N3>8GX]'IZ_'!`,O*$E) MY=GU"Y4-_>(46[QWM_=QYWM_OTKNTN]?9 M[1YW.TLT?U>_]='9][5WINA`RXQ^CD_BDB&3:XOY!G]H&&1W>#><\^'F35QD M!34>F[.ZI;X8-ESXO*SZ+JJ1S$Z?Z#KHD&XTJ5'%DU^^FXQ$_K"V7 M/Z0ZI\9?=0E5;%!HWT=LJUK-I[%B5[.=ED/>]]+9)7W*ZM>B#UYM#WI_>"67 ML?SF3B3\CAD?9%=:A"\Q M5*33^)+6LY8FC>>'X$#V?K>UL?HT62HH&>LHF3G^T624,VT*X4R9,R*0N5T= MUE?*:IEW615\?#/.330-'2PAL?7_EF[TU*)0<:';XO0U\NZ_,5NIT=W8.7NT?#ZP9,H=RCZ@#_9#3WTN6^;&Z MO`XEB#C@UG.KS^MZL^UY/D+U;GI8)D##(.57N_&B/#-TSJZG)W=J11`-R)J= MNYU?HN/N=6W(@.M,RA]^4H'S"DYC[9<>DV6_FL?[F4//N3GCU.R.3CTM>#,4 M`)2?6*K=2#KG[\7OO4TL96[;I,,*41.>=X'-Q"0#>`::@`B&2O M$7CIA_J-[5SM4[\1>IV=^?W+X[@NEUCNL&KEY1M_=PY>&[@=_]Y?Z>+ M0`N,*5X\/-CKJSUW9RG>$%X3XX=>E*L:679H1P`4O2YL%07YFM71G/=K6NB5 M`WD];$')BY)-FC]0OE0;]7E`:W8L,>,,%8!;]=;/+HO%X.U??3KG8-TJIQ M+&E92B'&$P,"(@3GAT4'HYH1RMDNG'%\3B(@=KLVDRS4OKO_,SNB5!%(E&YH M2.N;'8VIF:'JWW5L&U,]7"\3)YY>CL-+DEK^K9]II3[@Q@70Q-BI`7O8&4Y>VQ3M M'SV4$5)`ZJQ@O6=)_&87=$<["-'-'U<'#/0>5B6CA`1=JA])_5-]U)14 M7D!]JF3SJ5-\Y(3M*[?/%Z#Z@4UC'<;7JL.Y, M%P<,,PA?9`8P"885H[OK;$V=L>K48S]TT+&^.30PA40/8<`.2R9YB+YJE*C:5'W09HBPV@ADV5^Q&S<.EE\E!K<"NLS2;S9O, M\VV[!_'*OFTKPN/W#0J'7^Y@Q5OIZ@ZLUZHVDEM@QRI*90K0%`J!HE>W:IU> MWB(K.(UPO8!D&<[PD%7LM$Q*'"!".*1B>SJI:;572%BNK!F14YA M/+S*_P.^9UY&#=!O=5R`.?EKZ#AD9JTU2H\9K[1<0+N)K6T=:N_*:Q&TU+X7 M\Y)P0NN*._A%G2H2@7W;Q;2S01RY*WM+`EG4SAX" MN@BGJ&%3Q::C,W^^8L$X<$97'FE0VK'L^DQTR/:N_0HG`-Z%^P'S2J;`!^U[A_IR_XM M/34AO`1`YWQA+.:J0#,W0B1&+2JD M]$B;SO%%ME]?J/JV9GH\.V*L=*_3+L]3`]HD:'<)]BD?$\BL.,G/GHO:/[J< M.._D8`2M4*;F1)6O=$WD1+LZ%='0]&;F]-@6VJ/&V6)C^X>.++_I8%+1^!I! MO2+/$!H)T;,OLB71@>%D!S&;+Z'/M$I#`>)Z9&_7C&TN?"6 M\>DRVWN>50A98'&[G?ER?#/E!","\`34<5U4`@/-QJN)\:[N:\`?%:?U\*FY M):#TC>W93C;U0#NX_[9`37V.TB#[` MI@(H>G\%OK:[ZF;':`^T]H@\=K:VK3H<,$\LX`\;^6_J9D"3?I;C`+*]/]B1!+-C MY\VD8+0.?;IHP&KS0Q^`JAP>=G?\=C=$I[=D@"MF0!H$HV@@-T\XS,O=WK&U MS69Q3A0%9;]"=[6-U[.BG=P@0NQ)/2'RVIY7L1NQD=RQ>H^UP/10 M/XLA(XF9.MO;5P$77.5"2H<-?ANCSH$:)-=F69JZ@YT_O.H/++[;63H6&]:Q MS\'I:WJ(L"#FU#6CB_$1E5JL>'$O\_SX'=%\5GX&.UX1$?&_G&[Z"+A)WSF" M-R$8=Y!HTIPAR%^^3*?6[OZ+_O9>K],=#'K'./@M,ZU9ZME$O;I":]@.`1NF M\O8$N=FDO_(U(QJC_>\F032Y[8@%D55..A\`W26LR,W6VAS)-9Y*J'>ZP9*W M85MD)!#([WO'7=%BT-MY=43#X%X[/9YW^T<=@7B]SDLNKR-=T&\T:Z-?I7*I M)O&=?NEV%Z[K6,(%N2NFVJ;[4XV7^OL"EP^.YLTH)TL_=@,L:7=X='#84_J! M>54=H.O^H05SV^:=1CU0"2V&#/%,HR+_#?^[4=Z5V&QS^("1CE[U=CN]/]+8 MF%O^6EE,DV%F]\X$/@MG44?D`'T)$YF=-5"@P6HG=A2>*A<_.#[8^?W*=G?` M;+C33=-Q"+;MDR\`4Q!+2)M#C*EKS.6?0'!>RPSMHD4%@M@C'0(P!+>2555^ MN/I%A^3@1@3$#K(3[?_1B70N7QU,WV+QFN\T4-)#>+OU1,\\Q"F4.>`;%MC> MY`HG!6:;$%=W*[#MZ_U]Z-3K''?_R+[U#>_0):?0N(UD<20M-+RP)-_A>_PF M82OQCXRRW-F5ITT)C"]KH)E/K1S`$MQB1Q<^VSG2 M9AU?=RK;PO["$002B?J]'"5?5S8-5IF0VWF3&&1WBIU6J^!UJ2(@#0=_+YW$ M&`>0&%Z6ZFI+1IJ=KTG?A+GK8("52YX@^J;H!K[T*K_X7H0(N86U<]+'D<6Z MF?>*C-.*?M7*C;@E[?QVSX58YF6X0S/([2/4&@[P8;Q#\Y6Z$6;W@3;?^MGN MJV!*?_TK.G/6T8*BD6Y&R@$2E//)1C6OI2TGM96:8D[96[(+8G+J1.Q^5"4A MAHUO3"J=DZ;6^LW9%3J6=5C+72O98H$4G46D3'29#;!MDIPX)?NN18((7L.0EB_J3C$F51.+0!95Z0R#D`M6C-.,GAUC MHOKY%@?2*2KO1$)',TB/*SV=*LAJFPL/_9#9MAQ9==YUMXBQO_J,E5X/=SG>UN%@VMUP)Y&X$P0)=9UM.*O?K6TSA5O]:!HO\%DR4E,T`OF>8FHZ,!D>JAPQ6'`WB?C!05-F2>D8!.9)T[ ML%O:^K7UKEM%?SFOEYX.7OYY_;$]71M$,(0TE\(,DV7D'OJC?'?6,X,K`%FU M@?=M)47]JYV-36^940X*-)9^W"Q_I'_`:F?=VQ#40K_):3+7SU,0R@'Z8T'@ MAOP+2TSX7^@!)P=4U]VR=A2S#`P"'[6=S\97KZQ:7#JI6<8(;FCRZ(2UDD-2 M-ZJ/XL6JPPM25"YD6\T`W1A5T3_EGYE_:O)Z6&5=\(&0^E\NOIAWC;K%[S4" M1Z/B?R'VJ=IV,BX*HQYBA6&/=6+S$[1UC;"[`=>W<&HY^\#`G8_Z^@RK!K\Q M;$T-(5B`@X^M]>`^"%CMX/QIO2X5&[QYRK=G=I$1QQ.W7LN%_VFC-N("](=. MQ7[6]COJ=DP:;`WY4FJ467^QQN"+OECCH'W*_76J.%2=;LS$:OAB;:J+OEC[ M(I@F9[KA$[4G!R'5O$,*V_MK;HRL$;!&!YD=K>?2@Y%$;CP825_12X(,DC"2 MJQ&B\^Q5HB$X<+AD$[LFA]]CA*`3,F]"@"`)!W5BS,)@5;RI=3Z&&!*F(G+& M9<5*%2O"I<-,AG`"P<)"LX9J;&+:J1A:=)1HJ=D[^\Z]K:^L[_[D/ M8MS96LU\=S+F+!QFF)X_MON?ZG]R_?[[&BK^&0CI.=_6CK6BIEFD+G$P#-IH MBR82QOEU:0L*J]8\%6VS=FZ?E;8SH@^A$[7(K/P).BM'.Q>0@_<.]R>AIQT@ M"<&G-3&6-#;.5H0Y33`VSI&6,P'&701_O<\(2=*_AG:6\K?V0-#@"G5XJH!C M`^5[F*8IJR8'3LOG`O;:8MUQA>KHKGREE%7E[PE>BSE&R`?E=+AC@*L,"%>^ ML[[6;`F:M5+%PEW2E"\'*[+#32UPV.N:5GSJ8W>XO:/Q]P446OG)?LI@6=0P MKJ/TPO*LQ*H)WT8*MS/)_5;N?9!ZSA(1RJ!1@J*G"O`D+*"]Q"?F2LKG+?7% M5DFN>0_7DAWG/?QXL9&Y-@/;^,EB#WMVZ=/RX990PGU'>U#%Q1=*N$JD9L<7 M>^&>#V`ZO)R.<49OAEAN2L74::)98S<[U+;%%>26[HY.[[`.?Q[L8.]_SN+XSGYL?/("&=`BY MW*6/&JKY7&PTZ[/[O[`PKW_"4)]"@=;Y?31'\&(+DSU\?UH&^I0%SQFR>>OO MWYA7`Z`M8H_6"F"E:@702Y6H])B8E72=/[VT8HB:&=L:P[Y/456`RI[RSSHU MM[<*>"[':+=0W6@'*_']`='O"D%9X'.Y^[8,0A#BZB4_Y#-L>44[/U]^-"I= MD@X6"`0O1P*8GYE-E*^VGI./6P1.REP%4TUWWJ1:>/GCIO19N3A1>][TG7/6 M/VZZX>7[&6(Q4E;#?>:=S@?^''M>C?=9=[\:]I_%!S40[2$;M_%Y^4##?1$^ M\($_'Q]HO"_`!QKVG\4'B6)J3EY=+,%U$I9 M=N*]9D]DJ]E]F'FSV?IL":EN-@]X`/9LK1_P64/15UI^^^SN>ZMY9O4W?9QC7:1Q7%^]$^EWO,SM^5"Y7KJIMCEN3\3UI5_>3&!R.K8*&ROV>*_T M[=3CKS0HS/;NCUOK*/X?<5?7$]<-1/_*/O)`2B`HRE.EA2Y5)!)60/*^D$V* M2DC$LC1(^?$]9V;LZSO^N$[5IF^KO?[V>&S/S#FVVH$=M]HEWAZ^E2L\.:7@ M\NL5PJ\*P;I95G.7=F0=>G^MO1_J_VPA4;QV6\0NG[M@N'[5WOIA]919ADYN MMS36T`*N$79+2,?\[F[[V0]1U@\`;8"YV2"XE`Q.=X#)@%J?6,.2KS7+W4R- M)]'.SB<;H!VE>ZM9V+X:@7UQ)S??8"DY+_B%AR_U!3%.4Q;_FG7Z%,3O&&6T M6T?%MRQ&U/;'..S/^);S'QN&#^;!YO/MIU^"9R\[0\G'YW!*\1TNWQ0)R&5+ M)4#5?U5;O;CF"1I36"[BW8G60_@M<%"P`G[=7B%0!F7`W0PI\V4LE01R,SNA M?XH1PI+[M>5>:NXSR[U+=RG;(R&%?%*=@GN"]PQ%-X=DP<"=B7M,(.`PH1E1 M?I$=1`MO-W!48F+DGRPBB/X8$$_U9([7MEDA)U9]' MOLIQ>NN8EDT_,\I"<%`[DY4\5#)OI[=*C$#1+M%!(0XL^H6:`;*)XY2W\Y&J'R_+AEMH02$@@](I!,/CSZ`YZI_5Y5TK@'""8$TH[P<$2/$,2W!.NIKQ>` M%]#*QE$WM6$X,3#A80.@+N=Y`*$CU)."@R!CIR^J7BGWW_+>.LRWU1PQPA*? M+2^W^7IXK.&&%)4+(A[!.RL9$"JIA+](4.E+K@N;#5==,Z'N&15X3^R^CA'C M0NJ%^OZQ=$M7K$OOJS%-SJS,*5^8Y21S+M> MUS1%:(V@0&WAS60%H<_8F18(>?SRA.T[46K5D-PJ#FC<_Q)0)RG>]YS$&<\^ M@J8+6R[6.Y:<'&`1UEB^J-73ER4U.OUQD\$Y6R\OE;++:2?*+2FIEV6M8Y?, M&#$]%AY\*J9[C"DVW]93%>7EE0E1W14,EM58:CL!,`) M]&TMNP.@*\6BM2.(,JT#TO<(8[N*.!YP;_(0ZR4MRUU96UDZO`@IBS/;#[.4 M.#E^7"-X>SIEVO*U8HXJS4YWYW^TBY>'NH#*BTIH29J(67LNLHTOC%*FPM*N M3DY2?[&5V>LO(#0XFZS^(JKSW5]$.CIM0G_]/U((MN@5M#+. M7>DI37$+PTKT;0G18F8(0%182>=E+6Y4UFAS4+%1)1X<%JN;Q[A[;#N&ZGQ4 M;H]Z3^J9&BWZ-]?O>SV1T@X:]RILX_P;JWQH>#B0^ZGX:6U9J,JD:$XJFO^M MD:,!B_(7,,KG4=AQI8Q7DLO"E>25[O8S4&_J=KU?WJY_VNB/.C8(+4);4_QR M-N[5`]YHVZ'@@2Q%801ZC$Q/$6H)0H@WV&1H<5&W09%RH#S.Z< M"C+ZR".CNTZQ5H;!J@4RO(N70A51[4=$$^^-H=B6!ZJ?O(19EA3[[=H/6UL% M?=UQXCH6?L6',`A$(MM,^":$E+A3H5\"PZ'+1"C0\=+U&K?!'-W5SB1\?#]8 M3WE\6O7X"@H8\=#GO1U#XV9VPIBIU/V]G2M]2004OI6!*.5/(^, M36RRR6Z//LRGJEK:+A9'X$Y#N/F60"C810&TE2,;I_#;"C=?Z&PV`LCV[3T( M/MO'_%%M#\AF"RCPI.+(2J,'+2.;>`L$!$\!C*KRU"^X@GS9J M`J;PW;.)E";?P_-#TA,8D%Z(30O[`SR:6"L?U*C$WL+*!;907XRZ=U60_3<& M-X(?#]&]'P+?!0N"+R,'B@3*B#=J.@D\/N>P(\),%8&J[XI\$,F*K@U*"RB0 MQ?Z'QK#VH+;30X/G<.BH'[0J;UY?*F40WU'1E_%^7^`A@048[OEW=9'9J@3U;CN>^.)Y@Z*F@#7L-^I0<6'KQ!'\B M7%SO+N9`0IT>PU$R_!/!YO:):B?]?+&"XUV^(7CTX0;PX@+^_+?59^#<<5RC MI3^W6"B4DB]6W("*?NSK*_]&T#'4U^UEG.)E:!0#7$DK*1[CT+;KPQIE>ZL/+?*`FP$,( M):4:/#6EI^8DUZXX9D.QV6"J/14.8W$'B"5A5*EDI^^C64SCY:U)1=##H3*P MGX#C5ZD-.S04WMB`$E$T5*9$TH]9#!V>[8@YLX^I;LH^AG>7_$`;!XL%!BPR MCA>??K`OY>\2;7SBGB'$4A>&EXYQ,W*6@B)L,\GX9I&MA+P4C1??AF[BT,SV M!6:80N5]S#!3*T[C-#`:'_.MO^L%%2@[WU'_A$JZ^_GG4VK!6L^;^^')^@K4 M'/:ZBJ_^1ZAKIH;GC87S\?!4(*)1@P*))^"IFSJNQIL!STBTY\G6)V]=_37V M">QM-@^__@T``/__`P!02P,$%``&``@````A`$A^?,WF`P``*PT``!@```!X M;"]W;W)KJ5 M36:N;=$Z9[NB/JSL7S\?'V+;XB*K=UG):KJR_U)NOUN_?;,\L_:)'RD5%GBH M^.Y;NA465';Z&'1 M_H\/MM\7.?W`\E-%:X%.6EIF`OCS8]'PB[S,"=@T3'.2=.XH"G]7)7 M0`:R[%9+]RO[/5FDGFL[ZV57H-\%/7/EN\6/[/RI+79?BYI"M>& MNL]SL1/'E3T/9T'DSHD7V-:6%3KQ>B=SH-FO>S,O M#D@0WO?B(*,NDP^9R-;+EITM:`^(R9M,-AM9@&>9PMR%4N9R\;U<[3!@YF!] M7H?1TGF&FN0]9(.0Q+8&R%Q'I&.$EPP0!W@,9"#%&V3DJD$F'OQT?#<(2;JZ MR012Q:!%@E252)=TI17R5W()KTPQ`D+\:P3%H$7P)R-(Z\H&5D.U(M?(`2%Q M5VT2^D:]4VTYB,FP6XL.;361G[3J^05F!1&BY*<8M`CA9`1I-?*[,L0*(B3L M\DO\R`TBW^P8#3+W?2\*KA"-133)0EH-%MY0)V2!D)LL-,A-%E+0C4OD!\,E MDJL&FVLVR`8A_9F3./!]G6ZJ`I(D(=>FTHP11+7J4.[*$DJ)=(S,C@I@([]''!Z/DZ>OK.A.I(,;9 MJ@*)`J,Q"?2SVQ#$8*\%;O_20>D=D,Y):LZ5T^68"4J1QL6\?#T&N41N[,4D M-A5&PX2A&P8DN6)T)M,J1R9DSKR`/>8V$_2#F#M,IA4/?HY'O1_JI=_T&+4O M7Q,],JUZG?E>]Z.HJ5$4BUY57=5&/\H3\C;J?L2\WOVOKNM,)I1-[?X):1MU M/V+P#$'(L?WU(TC);9#.:5KDR%CEHE'W(Z;G,H^C*`B,;DA[/Q>^=F9=;R.S^WO,328Z)IID@K,I3G05;0\TI67)K9R=:I@P/!"_P8HS\88L M8$J"$=6PIW)6EG9G6(`)MLD.]%O6'HJ:6R7=@TMW%L'E:''8Q0?!FFXLVS(! MLVOW]0A_2BC,7^X,P'O&Q.5!!AC^YJS_`0``__\#`%!+`P04``8`"````"$` M#M]+!&P&```H&```&````'AL+W=O6[SILEAO$"E(&Z`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`41FJ;S\Q7/%5/I M_T=9`R,[DX_U6#\]]MUKI-M#YQRNM6DV]B!T";?&^,%8K4^S&K3UZQ//'M=? M=2VV#E("I(BC"2(PHIHC>#%!UCK_1$)/+2`1F3J*9")CO(1,/L6Q?$N`%+9> M9@)58$"9=/&"3+?I&JM.&_'0PT!DL)J"Y&1"E3@E];O?2AWNIC;6$EN MTBHE0"`WDZD4OE$LN0H#\KNSSQ`#VDG&2YC(J8I0!8``DTQ)X6<*1$)_RB7S MXU$EC,3/MY6QDOQDE4N`0/XB*23Q5Z%?"XCR_%!^O2^#_+0.QDMXI*0.``$> M*I.D62KD3O([+)B6U(#&;;M9,\D_DQ$PP"8M9#8C`T$<0+)[WX,V?^DPP$%(%1QKC@/2TD() M3Q*OR;)@LKEB2M_?;BU"152"%60#5RX(D&2Y"'80YH`E<]JC(J[$LA7PNAQF!& MRYHI0._TAO=9:&LX3'`ZA!:<95D7Q5P7J?*6#N.*GRD>;#AH08Q0HLA]/3`+ MHU_DGAA6'^0M;(64-%LI0@E\Q])YZ3$@N7DPP1Q# M"\ZRK%SR!Y3+8<(L,&J^7OJ1-=2,:2YSY9I5T@[=Q/#LQ4G/F-=;[GH!N'ZVW:RPH-PR1Y*^QY,[)5^*+;V]>30S[?7 M^M#\7O>']C)$IV:O0R:K3&M!#R^]\&/LKO9M\KD;]<.M_?.H7^0;_0B9K#1X MWW7C[8=Y2Y[>^)_^`P``__\#`%!+`P04``8`"````"$`K0A);:D%``!(%P`` M&0```'AL+W=OM:LQT52EN>7TL;^>M^L_?_I>5JK1==CMFU_I6;-6?1:M^W?W^ MV^:];E[;2U%T"D2XM5OUTG5W1]/:_%)463NK[\4-?CG5395U\+4Y:^V]*;)C M/ZBZ:J:N+[4J*V\JC^`T'XE1GTYE7KAU_E85MXX':8IKUL'\VTMY;X=H5?Z1 M<%76O+[=O^1U=8<0+^6U['[V056ERIWH?*N;[.4*>?\P%ED^Q.Z_D/!5F3=U M6Y^Z&833^$1ISFMMK4&DW>980@;,=J4I3EOUF^&DAJ5JNTUOT+]E\=X*_ROM MI7X/FO*8EK<"W(9U8BOP4M>O3!H=&8+!&AGM]ROP9Z,G[45!!+=#O.T/7 M[8WV'2HW?XCV7`3YCJ*UC32'0<.*CD5V,?`P\#$(,`@QB#"(!_"3(I1\S$5@_UA&2)'0,'C.*94(F4OK";8K>-0#WL.UB,X8.!BX&'@8Q!@$&(081!S(-H#J[&05R/!HU(!2-G# M+7HJ>X:E[#D0LL?`Q<##P,<@P"#$(,(@Y@!ECVHZP:-2`4C9PS-F*GN&X?$I M5"!8C';%GHL6SWK`P,7`P\#'(,`@Q"#"(,8@P2`5@)0]/"2GLF=XJ\(&&O?? MTD#WGCW7K/B3P%RM\.W@(`D,VUZA!X$K"^:6C3:Y)PL6)IZ#+PLL/[>RM%C0 MR4PM%L.X5+%3>RX22A4#%P,/`Q^#`(,0@PB#&(,$@U0`4O;L;4;H5X:;-,-R MJ<)&7!C$&`08A!A$`^@[Y[D.2;#;\/3)A6`9`1T#5-& M,(R-,%`M[KE(,`(#%P,/`Q^#`(,0@PB#>`#,"-0A),-OHQ$"D(Q@G?&4$SV7 MK5@:Z"K[ATBP@A"7$(\0GY"`D)"0B)"8D(205"2R$ZQ3G=@8P^5 M:`4?]R0NT7B$^(0$A(2$1(3$A"2$I"*1K6!MWY05O!W\_V<:>P\"OYYY'PAQ M"?$(\0D)"`D)B0B)'V39/V1-6U]9J(P366$M]#EZB*:R8KZRS:="=HXUB%/. M\<91=NX9HW^'VQM<)#J'B4LT'B$^(0$A(2$1(3$A"2&I2&0G6+,XY01O(B&Q ML2^:Z`H-KA*MP,0E&H\0GY"`D)"0B)"8D(205"2R%:QSG+*"=Y1R4>`6$0ZI M\';"Q"4:CQ"?D("0D)"(D/A!>,]JZG/+0*U8(BF,E;XP42O!#OI83H^^=V&; M0K_'G>/G>/RLI2J:NW&Y0-;,?=9L3\`#$Q'7AA@><=XJGIP'L+ MY7O#@?,-RF-V$#G!]Z:SGXIS,)W#%'=-!][E:'S/=."5CG+?=.#-CO+`=.`% MC_+0=.`]C_+(=.!U#[@V&@''F_?L7/R1->?RUBK7X@0>ZC,;5J'A)Z'\2U?? M^R.7E[J#@\W^WPN<6!=POJ3/0'RJZV[XPBXPGH'O?@$``/__`P!02P,$%``& M``@````A`(Z]/`8I!0``&!0``!D```!X;"]W;W)K&ULE)C;CJ,X$(;O5]IW0-Q/.(>`DHPFX1Q66JWV<$T3DJ`.$`'=Z7G[+6,@ M=CG2=-\TS9??A>M@NV#]_:.Z2N]%VY5-O9&UA2I+19TWQ[(^;^1__@Z^K62I MZ[/ZF%V;NMC(/XM._K[]_;?UO6E?NTM1]!)8J+N-?.G[FZLH77XIJJQ;-+>B MAE].35ME/=RV9Z6[M45V'`955T57U:52964M4PMN^QD;S>E4YH77Y&]54??4 M2%M"FO9?]S,"I+5>[&Y[IILY2`9>FN:52.,C03!8$48'0P;^ M;*5C<KOU?S3TJRO.EAW1;9$C>7.%)\%>J2E(#X'KV,5SOY;&_;&1CN;!L MU=!T2Y9>BJX/2C)6EO*WKF^J_ZA(&TU1(_IHQ(!ICK_K"WUE:=;R"U;,T0I< M9RN?G@),=O`#KO/@+_NQ'(W8K)$O^P%K:)@*7.>I?-H/9QP,UWGPE_W0H%YH M5B$S#S.?]42A-3+4EI?UV7;=-G<)%BQ407?+R/+77*A>::RJL33F.H-RSXG\ M!]$/HZ"".J#O6\=QULH[%&X^:G94`^X^-+;-:_:3AI0O,>QAX&,08!!B$&$0 M8Y!,X#$UG9_885),$TL9H$#0YLA!L(3(&>H<*/(S'RA]Q3]J1R5LG`Q>L1<5 MFJJJO,@311:O\$6%8Z/)!*)&1WD-10G,1N.?%3T5H2#'3T7(^82*(/QS&2'% M032#YYR*$L9S+I^PT['YG`J>8)+'J1YV%#@SV&/@8>!C$&`08A!A$&.04,"& M![)A\MDXX%$I`SCO88=^YCW!<'XP.8"'H/+:49'YB`@&'@8^!@$&(081!C$& M"08'#%(&<-[#$?/,>X(W,I307('@_9(/\8Z*&.\Q\##P,0@P"#&(,(@Q2"9` M]F2T*`_3;U,1IPS@`@''Y;-`$,P'8JFA;6A'-:OA3-#TU0KO#'M.H-GV"IT) M'B\P+!NM=Y\7F#J>0\`++-U$I1IR`M76\!PB)%!5M`G&O,!2-;21)JS`M$W# MQLG@!(9I6N@1*2LP5I;C/%8UERSH:9XEBV"4+!5-:UA&I=INR;XEQL6%3'>8^!AX&,08!!B$&$08Y!@<,`@ M90#G/30-S[PG&*4>KY$=U3#.8^!AX&,08!!B$&$08Y!0L!SV"U.W50>O$U9@ M.,NEAA9SR@DL:\FL52Y8I'=^%JV!HW`Q-H:^=#>*F'@)Q!.(+Y!`(*%`(H'$ M`DD$^>-:1-R58:`^_]P+Q!.(+)!!(*)!((+%`DI'0P]>T M]14ZG`^\)WN0C,NZO>Z M"SVYR#W=A=9:B[T*^+/-)=:-M%'NLN=._`E3D0\+GF MEIV+/[+V7-:=="U.$$-U84-;UM(O._2F;V[#.^1+T\.'FN'?"WR!*^"%65V` M^-0T_71#'C!_T]O^#P``__\#`%!+`P04``8`"````"$`IMI0JI\"```^!@`` M&0```'AL+W=O[F& M-$1`U01UM])66JWV\NR``:N`D>TT[=_OV$XHD)6V+PF>.7/FS(S'R=UKUZ(7 M*B3C?8I]Q\.(]@4O65^G^-?/AYL-1E*1OB0M[VF*WZC$=]GG3\F)BV?94*H0 M,/0RQ8U2P]9U9='0CDB'#[0'3\5%1Q0<1>W*05!2FJ"N=0//6[L=83VV#%OQ M$0Y>5:R@.2^.'>V5)1&T)0KTRX8-\L+6%1^AZXAX/@XW!>\&H#BPEJDW0XI1 M5VP?ZYX+L$%SR2CE`YUJAUS7';NP"4Y:4#"K0;4>" M5BF^][=YA-TL,?WYS>A)3KZ1;/CIBV#E-]93:#:,20_@P/FSACZ6V@3![E7T M@QG`=X%*6I%CJW[PTU?*ZD;!M$V^@K>0"7Y1Q_05@,K)J_D_L5(U*0[73G3K MA7X0872@4CTP'8M1<92*=W\LR-?91Y+@3+("F6=_X`2;R(_6_V=QK2)324X4 MR1+!3PAN!^24`]%WS=\"\[F$LXZQ*&AMH='W&FZ"0*X$ZTL6QYO$?8$N%6?, MSF)BC$9,,$?L+PA=GJ;-)P87A(WJH.:ENM`;Q6CO7$RPU'(-"1=:KA%!/(?D MUY#;]SPSO>%,[Z5IV@HCGS0DBJ-YCIW%K,S$=4OV2T,^,C]U!^MH/1><6[<1/),#%_H?7/& MG<58/8$?+_7N9W[/"Q>"8=-UCG.\YT\*L@+M'MO;WU%1TSUM6XD*?NS-\F7) M:+7/QPZ>#[.#[NB`K1Y(39^(J%DO44LK"/6<6\@M[`-@#XH/YF8>N()]-I\- MO-,4)NLY`*XX5Y>#?F+&ES_["P``__\#`%!+`P04``8`"````"$`QNO%';0# M``#G"@``&0```'AL+W=O MO"&'7#^^M4WP2H5DO-N$:!&'`>UJ?F#=:1-^^_K\L`P#J4AW(`WOZ";\067X MN/WPQ_K*Q8L\4ZH"B-#)37A6JE]%D:S/M"5RP7O:@>?(14L4?(I3)'M!R<$L M:IL(QW$>M81UH8VP$K\3@Q^/K*8?>7UI::=L$$$;HH"_/+->WJ*U]>^$:XEX MN?0/-6]["+%G#5,_3-`P:.O5YU/'!=DW4/<;2DE]BVT^[L*WK!9<\J-:0+C( M$KVON8S*"")MUP<&%6C9`T&/F_`)K2J4A=%V;03ZSNA5SGX'\LROGP0[_,4Z M"FI#GW0']IR_:.CG@S;!XNAN];/IP-\B.-`CN33J'W[]D[+364&[3;Z:-Y`) M_@8MTWL`2B=OYO^5'=1Y$R;Y(BOB!.$L#/94JF>FUX9!?9&*M_]:$-+9QR!X M")(`S<&/%WB9H2S__RB1960J^4@4V:X%OP:P/2"G[(G>;&@%D74):092UMKY MI+T&`V8)UM=MF:-U]`JBU`-F9S%E&(R8Q$54]PA&WTB4WNLK!:3&R*H MC%._PXZ_0,GD=XCD#I&;$MKJ$D`X'2NQ!"S&$LBRU!?"<:-L:I63OG#2F[T^ MVUW:Z]+(<.S1L)C4Z)#Z[:KFWF)6@D-"#__IP-TTT%8_N7_0+,9JD!9+5+CD M*L>/\W32T"$`)_4=`MKJ$YADM$VP&%O]0SIM-N.M'&^")W9.=@13=I;>;X)Q M^SRF0BR/`713HB@\HI4+P,E,*I?,.]-OMB.0'5SN&)BV]D#&@F9S8%AF+&XZ M/8SN>X_LC)J/`N2?L-T`LC4_E,ODR]0\).KSF)U)\W.V1! M`PG88IX8E0M`^&=S'KT_$XW9ZW[BG\$!-)"`&]2G67F(N%Q.\\+5PIV,M\,( M=_C=89B-M*'O%F2'/8*WCG&'HT.>'WTY$2_$'%BG0P:>H20\:(`TL(^5.R' MXKVY4?=&ULC)9=;YLP%(;O)^T_(.X;/@(D1$FJ!M2MTB9-TSZN'6*"5<#(=IKVW^_8 M3@";*NM-&_R^/GY\CK_6]Z]-[;Q@Q@EM-VXP\UT'MP4]D/:X<7__>KQ;N@X7 MJ#V@FK9XX[YA[MYO/W]:GRE[YA7&PH$(+=^XE1#=RO-X4>$&\1GM<`M*25F# M!'RRH\<[AM%!=6IJ+_3]Q&L0:5T=8<4^$H.6)2EP3HM3@UNA@S!<(P'\O"(= MOT9KBH^$:Q![/G5W!6TZ"+$G-1%O*JCK-,7JZ=A2AO8US/LUB%!QC:T^)N$; M4C#*:2EF$,[3H-,YIU[J0:3M^D!@!C+M#L/EQGT(5GD0N-YVK1+TA^`S'_UV M>$7/7Q@Y?",MAFQ#G60%]I0^2^O3039!9V_2^U%5X`=S#KA$IUK\I.>OF!PK M`>6.99>"UC`2_'4:(M<`3!V]JO]GSL)E',3)_Z-XFDC-)$<";=>,GAU8'C`F[Y!<;,$* M(E^F<.'H)P6Y+:3[0=I5)\#ET/JR39-H[;U`EHJ+9Z<]J>OTGM!T9%>'S)0, MFX\:/`#KZ6#.-MW<[V&D:L*$2W.DW=0R-QW9U!&FIB6?6A;#.`;O?,J;#+Q2 MA=*/$I,FL3G63GLBM8AD:C*[(1\U&&-#]6[D2JH;%V;2%R6>)];8VK-499VG MHSFJ(F6&'/N^V3L?R^$B'9)H4,)ZOT$I59MR88ZSTYY(45H,V5A+DL#LF1OJ M8E@(!F!R$U"J-N"P%E2>=MJC`9/`VAV9H5IB/A:CH3P&X.(FH%1MP*$4&E![ M-.!=Z%MR9LB!+>>F/$S>@)17W'"L7$\/V6K!14,9-)SV]'#VT6'(P7P87O7. MQ_*P.`PT.)C>09.M-IJ]-[7G@I;&%GDVEH>Q-=?[FL$5P/TS`E-'\>BP4[)) MF";#$M')NY@2O85#^SC,3'VRQ7-3'^]Q$U6>UT-Y%6H4]^`@`` M&ULC%5=;YLP%'V?M/]@ M^;T8R"=12-6FZC9IDZ9I'\^.,<$JQLAVFO;?[]I.*)!([4N"CX_/N??Z+#$REC8%K57#<_S*#;[=?/ZT/BK] M9"K.+0*%QN2XLK9=$6)8Q24UD6IY`SNETI):6.H],:WFM/"'9$W2.)X3246# M@\)*?T1#E:5@_$&Q@^2-#2*:U]1"_*82K3FK2?81.4GUTZ&]84JV(+$3M;"O M7A0CR5;?]HW2=%=#WB_)E+*SME]OS5_"CZ3TC4ZGC%RV*[Z+A4&RX)G'/5;X2`X M3"Y./_H+^*E1P4MZJ.TO=?S*Q;ZR<-LS=X2I&IS@%TGA6@`RIR_^_R@*6^5X M,H]FBWB2I#.,=MS81^'.8L0.QBKY+Y"2DU0024\B$PCSM)]&Z7*6S.;OJY`0 MD<_D@5JZ66MU1-`=X&E:ZGHM68&R2V$20R69V[QSNYX#L`'T>9/-EVOR#$5A M)\Y]X&08=9S)D+&]9*191R$02!<-Y-B+YAR%0X=1+&=I)^`CO0^F6+>)1-X/2L M`K#P5Q!';Y$-?*&7KJ3FT+%?,O(+G)Y?#QA8S*]:./2]Z@5.SZ('#"P65RT< M.LYBW`.!;WE=&\34H8%[2J'P'1IFRWVR M@J:#=WV$;V'F>)QT&S`*6KKG/ZC>B\:@FI<@&4<+*+(.4R,LK&I]F^^4A2'@ M'RL8[AS:.8Z`7"IESPLWE[K/Q>8_````__\#`%!+`P04``8`"````"$`DHM: MS+\"``#\!@``&0```'AL+W=O&?/QYN%A@I3;N"-J)C&7YC"M^N M/WY8[85\5C5C&@&A4QFNM>Z7OJ_RFK54>:)G'7A*(5NJ82DK7_62T<)N:AL_ M#(*YWU+>84=8ROR3CN(9`W5D+^J>:^.M#9_#ZZE\GG7W^2B M[0&QY0W7;Q:*49LO'ZM.2+IMX-RO9$;S(]LN+O`MSZ50HM0>X'R7Z.694S_U M@;1>%1Q.8,J.)"LS?$>6&Q)@?[VR!?K%V5Z=_4>J%OO/DA=?><>@VG!/Y@:V M0CP;Z6-A3+#9O]C]8&_@FT0%*^FNT=_%_@OC5:WANF.S)1<-1()?U'+3`W!T M^FJ?>U[H.L/1W(N3(")AC-&6*?W`S5Z,\IW2HOWM1.2`P3M`3%53TVSD260S1%F,90R-\X[X[4:,"NPOJS3 M)%KY+U"4_*#9.$V*T:`Y*7R(,H0"_#14%`RAC'<<*EQ,(CE):N_D'!R-P,?< MC14*?997',\F1*>971!G5XG&FF'(8CAIL@@F1*=9V%HEPBV.L8WRRF.*=QN'_4GEHTRMP8QW#H_"4G2N-T_P3#K/F M&MV:QWA"3ODY_$'D&H?,HY/?U=X-(??JMDQ6[!-K&H5RL>N@&PDTQ&!UPV\# MPR^TC3TX8"3UM&)/5%:\4ZAA)6P-O`2:2KKIY19:]/9-W`H-P\C^K>$KPV`B M!!Z(2R'T<6'FX_#=6O\!``#__P,`4$L#!!0`!@`(````(0`*NW4J?`(``*D% M```9````>&PO=V]R:W-H965T^8*D57Y_CWK\>[)4;&TJZDK>IXCM^XP??%YT_94>EGTW!N M$3!T)L>-M?V:$,,:+JF9J)YW<%,I+:F%HZZ)Z36GI7>2+4FB:$XD%1T.#&O] M$0Y558+QG6('R3L;2#1OJ07]IA&].;-)]A$Z2?7SH;]C2O9`L1>ML&^>%"/) MUD]UIS3=MY#W:SRC[,SM#S?T4C"MC*KL!.A($'J;\XJL"#`562D@`U=VI'F5 MXX=XO9MA4F2^/G\$/YJK;V0:=?RB1?E-=!R*#6UR#=@K]>R@3Z4S@3.Y\7[T M#?BA4FCM3W7\RD7=6.AVZER8:B$2/)$4;@0@<_KJWT=1VB;'T_DD7433 M.$DQVG-C'X7SQ8@=C%7R;P#%)ZI`DIQ(9B#S=)],DF4:I_/_LY"@R&>RHY86 MF59'!-,!,4U/W:S%:V`^I7#2,20%I64._>#@W@GD&K"^%*M%FI$7J!([838! ML\)HP"1CQ/:,<)5RM+LK`P%A@SK(^;VZ:32(<;=C,*MM>WL^2=7E@KQQ]\9_&E8D%:6)DP:)+K MFF]YVQK$U*'S/7ZN;\UHT;5G?#ZZ_6+I.<<_K4WF_'-Q__N8? M0M=IN^Q^RF[UO3BXWXK6_7C\]9>GM[KYTEZ+HG,@PKT]N->N>^P]K\VO196U MB_I1W.'*N6ZJK(.OS<5K'TV1G?I&U]UDSS?(^ZN_SO(A=O^%A*_*O*G;^MPM()RGC-*<(R_R(-+QZ51"!K+;G:8X M']Q/_EX$H>L=G_H.^K]UF^B*4^_E_<">AO&28[`O:U_WPK M3]WUX*ZVB\UNN?*#C>L\%VW'2]G6=?*7MJNK_Y3(UZ%4D$`'68--?3U8!.'& MWVQ_(@K!SR$*)/E^=WBJ:_LA M2;,N.SXU]9L#\QPZKWUDPBHQT)WZ#@Z,$ERJ?XDY0Z[L.R94$42V)*6276A+&)5$6,.5QLX?W4K,:$)_O)?5`ZO9 M'I#4Z@$,$@Q2#!@&7`'+>;@<7?7#+=[76,YAVZ62]1I MB:D(5LO-ADA24_)A%VZ)@BG%U"D<`V$`*T/8LW"&Z\V8H;QJ9QB%:/7$2C/= M.\$@Q8!AP#$0!K#LPEYFV!W6O*3?FS=*8]C$(,6`8<`Q$`:P;,IGFFG['6Q* MBGMS;:^A6&D,FPIL^QGDRZ$GHY_B-@P#CH$P@&4<2L",<4FQ\0TRKC2&<0Q2 M#!@&?`"R`*%I)H9KL*];CGUX4)FQW&/L&:].+3),:Z*[.Y*+$:_8E+1BA'!" MA$GL!&1]FR8+WF1\5?[,728*4RK:F?F$X7HF2#6HNDV"2$I(8P03H@PB6U7UK(9NZK$O5];?:,.]B4](20E MA!'""1$FL>W*PC1C5]4KNW?QE@-O%W)?,GL7DY1H&"&<$#$2>R>RG-< ME2[;.7K&BWVCONF.QB0E&D8()T28Q+8K:]6,757"OC,OC#JG[6*2^I@P0C@A MPB2V75FA9NRJPF7W+MG6C>JF[2JB-I;U_&Z(&S$?$TZ(,(GM7]:K&?^JC%G^ M(_1(&/M*Y._D@]CK<;E8HIF?:,4T\U-"&"&<$&$2RWXP7U5[C*IJ-+V<])T= M:]%D+B$D)801P@D1)K'MVC5TV*,#5>'>G]Q:9-K%A3$E&D8()T28Q+8+XV], M#ESR`WG9[F52*K7&=*U:320E&J:)>A]1Q1--/DX:"9/8:<@2.,WQ/@WCY2&0 ME^TTH@B_SFG1Y#HA)"6$$<()$2:Q;<]7R.!'*J06F79QS4R)AA'""1$FL>W. M5TAYRH5[-T3[1*Q%:_7V@)ZEQHO#44E*"".$$R),8CN?KY#!3(6,T.-^K$5F M1Y,*232,$$Z(,(EM5U:P:3J/FX@J;-_91'#U2P),4D(8(9P081+;KBQ/,W95 MU;(J#)T7N+0E<#)L/TNEA#!"."'RA%G%D95KJ@S*N3H[5@>55=%SCTHOHTV,/9%^4LV,,1 M&'!OO#&<8#^R2_%'UES*>^O&PO=V]R:W-H965T8LMPUI^A$,4!<_87F3'AK7:DDA64PWZ5<4[=65KLH_0-50^'[N[3#0= M4!QXS?5K3XI1DZV?RE9(>JBA[Y=@3K,K=_\RH6]X)H42A?:`CEBATYYC$A-@ M2CRL1L](5>+\1?+\&V\9F`W79"[@(,2S M@3[E)@2'R>3T8W\!/R3*64&/M?XISE\9+RL-MQV9(YFHH1+\HH:;$8#.Z4O_ M?^:YKA(\6WC1TI\%8831@2G]R,U9C+*CTJ+Y:T'!A2._[M M^%C`2,LHX&A9OJO%9%TM47Q3:FLQUI4P6$538UR$/[4.=IZI8SD"/W(XK%R[ MT^PF:)@LV8[5M4*9.+8P.B'&PO=V]R:W-H M965TZ56JJI^ M/!/B)&@!(^QL]O[[SC!\V&9U][YD-\>'F3,S]L'9?WFO2N>-M[(0]<%E"]]U M>)V+\5A2DY66F0+^\%8TJU%FYU*J/N=+;-\B-U]F86OBKP54ES4`L)Y)'1>\];;>A#IN#\74`&V MW6GYY>`^LUW*(M<[[KL&_5OPA]3^=^1-/'YMB_/O1D?CTC M!`][LZ=?N@G\V3IG?LGNI?I+/'[CQ?6F8-PK?"07)62"3Z]2B>H_(K$^%`4)^B!+D-FO!XM@LV*K M]>=1/%+459)F*CON6_%P8'M`3MEDN-G8#B)C"2$T@G2,14%O!+0MV,4!'OO#;J4]YQXSK$8R<#`3F'85`,\$#:J@YHU=8,(1%'$\'A,``09 M586FIF3."+8F)9U3HLU(,52%AJJA9X,Z7(4F:F*BP)(3$VQ*-FX76P)-Q>?"K5$=,-6B$4_OM5C#R2?V<1\%D4G30 M>Q*7-"1M(TS0T MQ-2$]C9I&J=!KF=HF1D7W$WP*.G3L)%4YYB)T;>FQ+-ID*U],@W-^_IIV$C* M-,04@)8U"1@K)R?3*U]'EMO%<`O$RNGM%S'SK=`K,2C=N\TZR'B7'/M'TNAJ M2!>JBK=7GO"RE$XN[C5LR@#L=T3'*^ES@*]]"X_QJHJX-R[`!;+)KOR/K+T6 MM71*?H&0_@),W6GIKDE?E&BZ:]Q)*+@Z=O_>X#&PO=V]R M:W-H965TWZN*\%&U7-O76 M90O?=8HZ;PYE?=JZ__PMOJQ=I^NS^I!=FKK8NC^*SOVZ^_67^]>F?>K.1=$[ M$*'NMNZY[Z]WGM?EYZ+*ND5S+6KXYMBT5=;#Q_;D==>VR`[#H.KB!;Z_\JJL MK%T5X:[]2(SF>"SS(FWRYZJH>Q6D+2Y9#_J[KY^R9OJ M"B$>RTO9_QB"NDZ5WWT[U4V;/5Y@WF\LRO);[.&#%;XJ\[;IFF._@'">$FK/ M>>-M/(BTNS^4,`.9=JZ<_/Z6UL>OI=U M`=F&.LD*/#;-DZ1^.T@(!GO6:#%4X,_6.13'[/G2_]6\_EZ4IW,/Y5[*(7ES M@5^"OTY5RAZ`J6=OP_.U//3GK1NN%LO8#UFP=)W'HNM%*<>Z3O[<]4WUGR(Q M'4H%"700>.H@;+6(@F6\_DR44$>!YRU*L`C62[9^P.(NN*ZK*, M-896RR7[0=*W[L9UH'H=H"^[.`SOO1=HFEQS]HH#?T=.8#*2&T,VC@R;4H!3 M0"#``^FC?F@.I/\F4Z)2YNT']@J`(*,FHCJQ&<'&E)W:E#B,3`Z?XRQ-CICC MK$:.,3WHVIGI2126%)I-',9C@"&E>\6)QA0D%$@IP"D@$&"H@E4PHTJB6Q*\IZ:)QER#8KW_=-W0FFL'48PQ9/**FB3%/C%!`(,(3#"D3"AVX/ M_;&YY;?F!.)P;2E%.`4$`@P],**1'IOW2U1JI/T MZEYQ)A$)!5(*<`H(!!BJXEE5$GVO*14'J:)`2@%.`8$`0Y4\9$P[V2U7$B6Y MBD@_[15'U31H?=&4Q9RD_W*\W!:M6H"4DU1[=/M`XBJWVX%4=@Q%0KW6%& MK3(-K!820QJ#*=(D+K&0U$*XA0B,F.*D(\R(4T8!?\>MWS8DAMQDL*C$0E(+ MX18B,&**D[O^)(ZN+*9,PUQ-RA.PW)G5A(Q#YY0B*1S0Y98R38EK1,M=Q;'<0ZA<-,J4*UUA1JXR M"RS74!O,.](`FXYDE5ESIN616$AJ(=Q"A$;TV7:Y,ES` M%&OZ$3V%!K8OQ1%YS=AK$E9M&9/%X18B,&**A!+/U#^0\'NG/$W"XM2P"4DM M#K<0@1%3G+02NSD#Y3"X.>.(O'SM-8G%\LSULO,7/LEMHAE8++4N;G$$1DRQ MIBW=]O=@SHZFM\!AW>PU:1++0GW>&RS&]XE_)7H`UFZYE<41&#&U2Q>8$FVU MJC(),^'T153>LAC^DUA(:B'<0@1&3)%R]Y]$C@E6IO#S?31`SJ&V*@M)+81; MB,"(*4XZQ(PX91QFYJQ65:2I^CYYRTL"ZC^IA7`+$1@QQ4K'F!&KC,04:[6J M(DUBF266^E$*=Y5F:W`+D?>9(T>)5=>3ZA:K*MI3D1272^?DS7,-QT\&RWI$ MQVO1AT!>A'CC%W!9>RKKSKD41QCJ+V!3<%IUKZD^],UUN"-[;'JX MIAS^/FZ6\?Y`^,-]J[_P$``/__`P!02P,$%``&``@````A M`"\_]T54$```'$P``!D```!X;"]W;W)K&ULE)Q9 M<]LX%H7?IVK^@\OO8XNR5E:2J6@A*>YBS?*L=I18U;;EDI1.S[^?`Q(0`9R; MI?NA[7SWW@,2%R16^MT__WQYOOEC?SH?CJ_O;X.[P>W-_O7Q^.GP^N7][;__ M%?UC=GMSONQ>/^V>CZ_[][?_VY]O__GA[W][]^UX^OW\M-]?;J#P>GY_^W2Y MO(7W]^?'I_W+[GQW?-N_PO+Y>'K97?#/TY?[\]MIO_O4!KT\WP\'@\G]R^[P M>MLIA*=?T3A^_GQXW*^.CU]?]J^73N2T?]Y=(/';X?EP^5\K>GOS\AANOKP>3[O?GG'??P:CW:/1;O]!\B^'Q]/Q M?/Q\N8/A?,_S^_D]E#Z\^W3`':AJOSGM/[^__1B$S>P M_W:V?K\Y/QV_Q:?#I_SPND=M(T\J`[\=C[\KU\TGA1!\3]%1FX'Z=/-I_WGW M]?G2'+\E^\.7IPO2/58AC\=GE(3_W[P<5!O`K>_^?'\[1`F'3Y>G][W-[_MSY?HH&)O;QZ_GB_'E_]V3H&6ZD1&6@0_MCR:SZ:^+ MP+.]$OS4(D%P-QJ.I[._2#V`>)#S8^2'V0^2#W0>&#T@>5#VH?;'W0 M6.`>>;@F`PWM+R5#^:MDF&I<&-!GY\&K>>-A0E8^6/L@\D'L@\0'&Q^D/LA\ MD/N@\$'I@\H'M0^V/F@LX-0\GE2J^8?!M=4K,UZ;5JN?!&.W9A>=SV1ZS<:2 MR(K(FDA$)":2$-D028ED1'(B!9&22$6D)K(ETMC$J7MT*7;=FS>-PG@KX8?U MJIEYE=XY#:U*)[(BLB82$8F))$0V1%(B&9&<2$&D)%(1J8ELB30V<2H=?:54 MZ0JWE6[>#PM-NH&%>E/Q]<6P'7::Y*W>WYC6QVC:1E29JR'%]2B:!]Y2L M>R^3UHA1S"AAM&&4,LH8Y8P*1B6CBE'-:,NH<9"3&XR6[-R8'"CLYD"3`4;G M5OW.W;?0LO,:SJZO_I6.4R.J/FXX<./6O=T.XHO]*4 MNYME39!E4]JR0W9*M1,>-37J'0Z"D5O?Z][!J$2,8A).>B=9>-,[&.&444;" M>>\D"Q>]@Q$N&54D7/=.LO"V=S#"C8.<]&$R8:?//(P*NVG29(#A\_6AFGG/ MU+)S&O:#XI4.&]MAPY'_CC1>77J#8#0,/.FH9M2PJ"A_'4&Z:G5%1&1>6_4E3A%36=SKS96DE%5514_2M%;=VBAK/9P'LC M-7913A,(\'Z5VD#+W49@$%J!:5M+S>RD&[=Q_]I<7]GH&AII-NE1S&J)1K/^ M#;\Q@>T*3SN)30WJM3+6REFK,(&]5FE0KU6Q5LU:6Q/8:S4&M5INO:N9J#7] M-\]>T,U0,?@V=;PP:(`IU+5IS[Q>8:F][/>F"1R/V^8^F\WF_K-GN9CR(E:* M&256I'H5S2;SN??4;BP7(YZR4L8HMR*5^'P0^"VZL%R,>,E*%:/:BFS%I^.A M-Z/<6BY&O'&4W%RJN:V4RV[.Z^12(^32""_5*A?>MT[FM!LR9]S6VBVP6,2A M,:-$B-P(+.70C%$N1!8"*SFT8E0+D5N!-4ZH6_MJ>BO5?C?M=6I?(ZMH_2X,X/6NN@ M`!XF91$+Q8P2C497::^3W/0.1CEEF8Q1W@>JAHZ+]J8@1>]@E$N6J1C5?:!6 MGLV=_^B!ZNH/]V@*:AQ5-Z-J(BYE5$_0[8QJY/1,'7-Z)NUF)6<=,(LTLT)C M1HE&ULUL&*4M,[&.6493)&>1_X MO2>INU,4;91+EJD8U:3\LR>)"FH<53>C:A8M953/KNV,:N3T3!USTJ?=D#YS MHVNU:J6FWA:+-+-"8T:)1E:M;1BE')@QRCFP8%1R8,6HYL`MH\8)=.M=S5RE M>N]FM.C,3.4M@@[96Q*,5HS6C")&,:.$T891RBACE#,J&)6,*D8UHRVCQD%. MI0^_LRC0P%L7EIMYQ"*!Q0)+!+816"JP3&"Y MP`J!E0*K!%8+;"NPQF5NNM0477@Q#?74W7HQ&?23O0SM9@V95B92O1_[5-%N MAN76ITI?!T(-B[6?O:%AA=HE>'/$C>5FU%*!95Q";KG9)7@#BL)R,R64`JNX MA-IRZTO@G0W+S930N,Q-L%H&L!+\T^=1+R[8B=?(WMX8=LS)LG;#`]E.HP>! M-X]:ZR`L.UR3&0DL9O'$8&=.(V=43CL>.M`:FJV,UD_V/*YN>M-C,![X M>\>1]K%W/;C`Q'AA,'M]0_"^A_8R&Q^#Z6#@+6"E1JC?9,FXN-QX_;"X@HH+ M://#"/7%55Q<;;Q^6-S6*RX8#T?>HEYCA-KBW%:A)M12J]`+%7:KT,@>V:NS MC]YJH4:XC.O3NKZR7B[2S-X!8;5$(WL'Q`3V;X/4H%X^8ZVAW^UG(Q5]XX2FXNU51:RJ7BWH1!(WN="5,V?YE0(WNW8RVPB$-C1HD0N1%8 MRJ$9HUR(+`16C7!?I(T M_-,%A>5BQ$M6JAC55F0G/I]Y[Y>MY6+$&T?)3>5WECLPQ*`'22.G,])+(-8& MB(FTLK(66*09?IC+C!DE0N1&8"F'9HQR(;(06,FA%:-:B-P*K'%"G=K'N6/Q M06JY^QHSR.F2>`-$NR'AIE97)K+?`/%>[&O+PT1%+!0S2C2Z;H`,O-V#3>]@ ME%.6R1CE?:!JZ+P@7/0.1KEDF8I1W0?*RMO>P2@WCHR;0F\5Q8SQ'WBUQ""[ M)]+,R9>.M'<\3*C%(@Z-&24:V3L>C%(.S!CE'%@P*CFP8E1SX)91XP2Z]?Z= MY9`'7@XQR.F#>,=#N^%I-6E?FBZX\&/3GG.H219TZFA,D@5= M-QJ39$$/CL8D63#2#M7HC:\:@^E0C>'8@C%UJ(9R;,'0.E2C-[9@](P6)5D6 MN+:%>&U+6):B!<,Q9%NZ'PRYD&W)@I$7LBU9,+/&5;?;+]YC@,DSKEJR+'`_ M"_%^EK`L1(:?L,.(FI'LB2PJ!U!CL$.%"Q2#,[UA.H8"$^H3I.P!:=\0G6"A"TX MO(,1B&3!R1!8I'<5]L)1H]*;'(?J$-.N9'EOB@7*68CEX)!6N!0M.*L5JL,] M?-4XCQ6J(SYLP;&L4)WT80M.9X7J=`];<`8K5(=\V(*C6*$ZZ\,6G,@*U?D> MMN!L)-2D.L`12:A)%IR4A)IDP7E(9%NRX%@DLBU9<#H2V98L.*$,M79ET\L/ M#BI#3;+@O#+4)`N.)"/;DF6!*UB(5X##KEV7+5TIRM8U-%HZ:KQ/A`M.,Z.JY9B M<*H=5RU9<'`=K4JRX/PZ6I5DP3%VM"K)@@]*H";5`;XK@9IDP>H]/.4<-2(9JC@J0#/4\5)]#\15OYZ@8R="H][%DB.>X M$[D`S9',U",N3S4'TBQF7DZ*:DD52.:8WTWJS0 M>4F\1@H,>3=!+,7"3_#/U@R^^O M#1]_LNEM]V5?[$Y?#J_GF^?]9RR_#-J_%W#J_KI3]X_+\0W+,OC#3<<+_EA3 M^^L3_@K7'G^:87"'8P"?C\>+^0=:T?WU[WI]^+\`````__\#`%!+`P04``8` M"````"$`4'8T[KP&```F&0``&0```'AL+W=O49!3N2+O2:C6[^TPPCE%L8P%)9OY^3]/= MT#=E,B_#^%35Z;IU=T'NOGX_GZRWIA_:[G)O.S=KVVHN=;=O+\_W]C_?LB^W MMC6,U65?G;I+KH3XVYVJX MZ:[-!9)#UY^K$3_[Y]5P[9MJ/QF=3RMWO?97YZJ]V)0A[#_#T1T.;=TD7?UZ M;BXC)>F;4S7"_^'87@?.=JX_0W>N^I?7ZY>Z.U]!\=2>VO''1&I;YSHLGR]= M7SV=$/=WQZMJSCW]T.C/;=UW0W<8;T"WHH[J,0>K8`6FA[M]BPA(VJV^.=S; MCTY8.H&]>KB;$O1OV[P/PO^MX=B]YWV[_Z.]-,@VZD0J\-1U+T2UW!,(QBO- M.ILJ\%=O[9M#]7H:_^[>BZ9]/HXH]Y:8U-T)*^%?Z]R2'D#HU??I^=[NQ^.] MO5G?.-[:=[>V]=0,8]824]NJ7X>Q._]'=1S&1#E.$@6VQ@K`(YQ*A4VJB_4C4[VTH(OL#T+<';^W0 M0D-*$9'<]XWN$U1VGR'T0B`'0ZPAB8:D&I)I2*XAA8:4(B*YCS/9D'V"RNY3 MA+3EW$^NMU7ZB2EAL5EIXROG1S(K\*&>)--X>[=I3-ELQR;I%J2$81 M,>Y9A]Q'8%7V>3'+.6LI(E+(N-F$D/E&(Z@<&D4V.+'F*GIKM=14:8O\SDJN M=ROW0T*5O&!*B1,$&\7[E+%,@]5T6V84<9.G`P+ALCI#"%%3B%$SFECAT'N#"4ZE#)(BHL:"E"N M&Q8Z5$I<2BO`>5+,9YE&CDN,E\L<0M3K&FZ]1AXXB8#PI).Y-"V^6. M39BA`*4<\N?<9@P2,I!SK86KT*&20Q.7'"`9))8`Y\.5SA=282FD[$QE"(H= MJO63^Y-IL0O4=[Q`X4DYSW*@90R2VOHSJQ7R:EL'GQ+DXZ*45I/S0Z:.)3\_ M;0`ZI$AYHY"TLRFT%6]7!BWS0>I0R!=30"$I!1I7P0RW"UF?F[@YG0:K[EXON&V]':[3&:9?II#YD'@#8T6"C..C ME4F"KUF/TZ97+"+RE*'4>R7#=C'A.4X6$T]^&^(5$CRK>0%\O+Y6S\V? M5?_<7@;KU!QPD*VGE^6>?N>F/T9Z!EI/W8COUN0XM([X>T2#CQWK&PPJAZX; M^0^RP/P7CH?_`0``__\#`%!+`P04``8`"````"$`^JZ*CG("``"9!0``&0`` M`'AL+W=OO"+&LY9+:1/=\T.DBL7((9WU$'\MA6]?:5)=@E.4K,_]%=,RQX0.]$)]S)`,9)L]=@H;>BN M@[R?LX*R5_9P.<%+P8RVNG8)X$@(]#3G)5D2(&W6E8`,?-F1X76)M]GJ;H') M9CW4Y[?@1SMY1[;5Q\]&5%^%XE!L:)-OP$[KO5=]K+P(C,F)]#2 M]M3/6K;*H8+,"[=>6N(E1A"4!>G3ILC2-7F"8K!1YR[HP#/JY%&#`#VZ@'C/ MN/!2[\)7R_N\"X(I;W:>-SO+\](2PS.&4V19!`070:<8FCJ-L'A#1*&/R?4\ MUL,K0(7@F-#_I1OHHQ*,T43I/SE`UR/1*PP>8WU&R;1`15;$#-^4?'&* M+])ELH@)>86W^%$"79A$/W^'#ZL0!DART_!/O.LL8OJ@P,K/3Y3&#=SFOM[O MY<5J.VPFB1]@87K:\&_4-$)9U/$:D*GO`C)AM\+%Z1XBAZW1#C9E>&WA%\AA MAM($E&NMW>L%')/X4]W\!0``__\#`%!+`P04``8`"````"$`/9,DPR@'``"6 M'```&0```'AL+W=O(;)W8!1:+/9X56;:%V)8A*4W[[3L4#Y$ZZYOVMK6]F6M;]:UJ#\WMM+7__2?YM+*M?BAOA_+2WNJM_:WN M[<^/O__V\-9V+_VYK@<+(MSZK7T>AOO&ZQNT'-ON6@[PM3LY M_;VKR\/H=+TXONN&SK5L;C:-L.D^$J,]'INJWK?5Z[6^#31(5U_*`<;?GYM[ MSZ-=JX^$NY;=R^O]4]5>[Q#BN;DTP[>VL'8CT^'!H0`&9=JNKCUO[R=L4?F`[CP_C!/W7 MU&^]]+_5G]NWM&L.?S2W&F8;UHFLP'/;OA#3_$`0.#O(.QE7X*_..M3'\O4R M_-V^975S.@^PW&-_57N!GN"O=6U(#H#T\NOX^=8\W`6+-VY M1QP_V/V"!0&/2<2'N@^9)WQRS_7,6[CO#7O)_&"_<+_@8X+7S!,^N>>'>O0@ M!^A*D6002_4SE0Y=ZS%']N50/CYT[9L%&P\6L[^79!M[&Q*790=;)Y$OD+85 M,7\B]EL;1@R)T`/]\KCPP@?G"R1@Q6PB;..K%CMN01*'A-WK(-9!HH-4!YD. MT1B1!)$4D0R1')$"IDH MZJ&T_Y)Z8J^JIT15[[N:>F$DU",2(Y(@DB*2(9(C4LA$40\'%5(_AY+_H\U` M[%7UE&CJ/4V],!+J$8D121!)$,@94@?!SQ-R4.AE4H9BBA>\A[0KA\[3UCQ)-]C M%&.48)1BE&&48U0H2)5.*I(D72PMK52*7HI\Z2KI(;3'*,8HP2C%*,,HQZA0 MD"J.E$:3.%8RY<(C5]'Q(6?G(;3'*,8HP2C%*,,HQZA0D"+.UZH[7[F1JU6= M(4AG.5/U6R!W]*#VB:(>3C6=/OI)5CRA8\;\E2CDB60V!5O,M;M7*IGQ:!F. MEDMF4S3/TZ(5DAE$4V=+.X/863$^7@SGIGJ)6M#LB;/1QV<30S"+?*@[;N7- M!=L;6,R8,D&L`W"=)"WFVO4L-43+<+3<8%:H3)T-5)&7#$MWY:^\U51N6>[0\,'X!FQ$,7/TIZ?S1(OESU?+91!, M1]/HF#(K*5:&8^5:K/5BZ0;+A7:=*918ZD21L]DT4>S,EB>*(IBH*3V8E51% M]SYEDN`8HX0A3_),L5F&46[P+!0S59]VPQ!%!-\L?'YE",NJ3"J2OH>DKQFO=G>I=?;GT5M6^WF"WS\G<"TS??T?+#3RUP6ATOMK`TXV! M>^!`QZ]YP+)LR#BQ3P$M["6[Y@-OWY]\@T<$;^4]$_#'HGMY MJO\LNU-SZZU+?80M[8XWGH[^KD2_#.V=W'RLYW:`7XG&?\_P^U\-[Q;<&92, M8]L._`M(=,0OBH_?`0``__\#`%!+`P04``8`"````"$`\!VIF\T;``!FB``` M&0```'AL+W=OW\\/YD=']U_NWOZ^/#M\_OC__E7\8_SXZ.7U]MO M'V^_/GV[?W_\[_N7XW]^^.__>O?GT_-O+U_N[U^/D,.WE_?'7UY?OR>GIR]W M7^X?;U].GK[??X/DT]/SX^TK_OG\^?3E^_/][<=]HL>OIXO9;'/Z>/OP[7C, M(7G^F3R>/GUZN+O/GNY^?[S_]CIF\GS_]?85]7_Y\O#]Q>7V>//O_V M^_=_W#T]?D<6OSY\?7C]]S[3XZ/'NZ3^_.WI^?;7K[CNO^:KVSN7]_X?E/WC MP]WST\O3I]<39'+TXA0Y?7CW\0%78,Q^]'S_Z?WQ+_-D=S8_/OWP M;F^@_WVX__,E^/OHY/KU_>'R\W)^NSV7*^6!\?_7K_\EH\F+3'1W>_O[P^/?[?J+2O^I3)TF:" M7YO)8N$S.9!P91/BUR:>N_Y@_W(6O3N:K MV5M-,W<=R/SA+GOY4UT/H\%6V/>E^>KGDKJ^-`\ZT^%^.W>=R/SQ]PSK>M/< M=Z>?K:?K3W/?H?3Q=3IZA;TWR6Y?;S^\>W[Z\P@N&MW@Y?NM/#:KEX=_H'7-6=U=FR3J21.@WCKDRV60SR M&!0Q*&-0Q:".01.#-@9=#/H8##&XC,%5#*YC2&R"XDHC5P-Z#6F.-&-MW#V'.9)/!R^`E:2;%O-&?J[4@V\@ZTB5IH4G+),B(YD8)(2:0B4A-IB+1$ M.B(]D8'()9$K(M=$;HCL0B):"/,=:J'-[."X,DED$XTD:J*SJ(DFI:F)B.1$ M"B(ED8I(3:0ATA+IB/1$!B*71*Z(7!.Y(;(+B6@BS"^IB4;7Y^9H1D.VR$BB M%CF/6F12FEJ$2$ZD(%(2J8C41!HB+9&.2$]D('))Y(K(-9$;(KN0B!;!W>*- M%C$:LD5&$K7(1=0BD]+4(D1R(@61DDA%I";2$&F)=$1Z(@.12R)71*Z)W!#9 MA42T".X.88NX@6&P;(:1+((I&9&,2$ZD(%(2J8C41!HB+9&.2$]D"(FPC`D/ M-=/LN;2-0^.JD@G34D89HYQ1P:AD5#&J&36,6D8=HY[1()`TE(G).#+>WPI? MOSS<_;9]VB^;N;YE%E2BSN50T+L890Z9M1$_Z5S-I"_(`S7G#0J%E0JK%%8K MK%%8J[!.8;W"!LFD>4V<%9AW,N,8?V&:[JYR:U:>8-G%^8121IE%<[.*,IEQ MN8E<:AZHN0(*A966K193H56@=J"$.E!S)30*:[F$+E`[4$(?J+D2!LFDJ4T4 M%9C:KO'\N">/49=H@A&))B"4F1YLA@!^S<+08C:/PJL\T'`U+Q166A:45P5J M-O,HO*X##9=YH["6,^\"-9MYM&+5!QHN\T$R:7,3`P4VG[KW&!L)VUHT@P.9 M.NYJ-9?C/T62_2CPBSN916M,3*:$BU4TKFQ,YF&:.<4<&H9%0QJADUC%I&':.>T<#HDM$5HVM&-XQV`LE6 M,I%*T$I3TQ@>S?%&%$Z`S0,,<[OULY:,4H9S0PNF1TQ>B:T0VCG4"R'4PT%+1#X+6.U*G\&#V)]K'(#XK4/"TS[6-F M`=/M=Q7/V[-`S?FU7&&%PDJ%50JK%=8HK%58I[!>88/"+A5VI;!KA=TH;">9 M:,/%#^+6/9<^S:)@\I@Z+=-'IK:BX"`+U*:V4EBAL%)AE65!$%$':@=JT@1J MKB:MPCJ%]0H;+`MJ@22N7R@X2XG5UBAL%)AE65!)>I`38]4FD##5:)56*>P7F^$E+@,U/:*Y M"C1<):X5=J.PG62R87\0V"\XL+?H(AR4JU44UJ56ZVQLTOG).HJ,,JNP1H`T MC>W5*@HU^+"QZM%?$A5U$"N5/%5:YPOQ[G+>+`HJ-ZEU]KG$G>JL5%@6Y?'M4_@T`VCG4"R_'\VU<"EFY MJ#NVNE9DCBXJ*LJDUS.)M`:GY2_A\G"^5R[%P4NXUK6B2[B)BHKZPT[/Q%^" M[(T_6($R&U>CB-VBR!M%-Y/4:F'$A*XEH9S18%%3BTFL=J,25UW*5N&9TPV@GD&S3M]?*%KQ69I%\,+R. M'@:E7LM5-V.4,RH8E8PJ1C6CAE'+J&/4,QH873*Z8G3-Z(;13B#92C]8*\/R M%XT\6AA+K5:X5L8H9U0P*AE5C&I&#:.64<>H9S0()`T%GZG>,`V/`G"+_,I5 MBM!DK^51QBAG5#`J&56,:D8-HY91QZAG-`@D#676A8*9Q7ZUR=P-M*4F/#0@ MZUGD)V^ITY)+31P(V90BMJ7D:#0-+69@DFZ/XNL%K:I9E@8NU0^##-LHU?GLD<\BESBX0IQ_R# M1UNEU3KW!J\XKYKS:ABUC#I&/:-!(&FI'ZR4+'FEQ")C]:F?K-9Q".JT%OM. M.5\LHEEA9A7@NUP/S!D5%JW.QFR6)U&L6'H%ETW%V=2,&D8MHXY1SV@02-I5 MA/8K7,7XZLJ20WN+8%=W):E#?N-'9I$PVYA7@`JK!;.YO$I&%>=5,VH8M8PZ M1CVC02!I*!-M3D,U,)2-0OV`VRY'9/(*.F`4\Z16"\^X0RWJA6->>#CNM1:; M:(J;V[S$$+<)-V/'Q&N!T@^6OGS7!!5G4S-J&+6,.D8]HT$@:6\1Y07VYBAO M.2+8VUU):E&P@2!SR,^J*NUSF\@IG+4K''$L40W]$UF->G*S78J4R M&B:EKXUKW,JB(-.:4<.H9=0QZAD-`DGKFS@G<`MO/2Y=CG%1^+C4(N%71ZV5 MO_=D5NO<[Z7)+0KL4%@D_*K-R[O:BA/6C!I&+:..4<]H$$@:4(1*0??E4&EI MD9QN;J([;FK5W'1S$4^E,ZL@IIMCUL(3C`B>8%RKO8C&2>G*"?T"95-;K2#G MAE'+J&/4,QH$DH8UP4S0,Z<[NPURPAN616)N.3(X:#?NLN6(@DO)&146"0\Z M)@Q0Q0EK1@VCEE''J&RXC'HLB#QK/+9W6-+>,[KV950A& M;LZHL,AZ2KSF?!;-#DJOX1JIXGQJ1@VCEE''J&F-R:?,*AGWAL]\_OSF)]]&67L%WS+&P()N:BP*)Y<6!>XL+*.O25\#WS#%1D$_-63>,6D8=HY[1()`T>!3VO#6?-&,W6E&V M2+A2&]4$\TFK%W>XSJQ#.)RT2@]]F8P/RV1'^%X7G MKE3O*RK.M&;4,&H9=8QZ1H-`TLPFJM#,/$8;PLP6A;-+,_[-72R875H4F"QG M5%B$BKGA6S*J.&'-J&'4,NH8]8P&@:2E3$R@66J,%82E1A2YT*B[I8@*][:S ML\M5O.TJLPK!.,X9%1:AXN8>OEB>K*)U^])K.%M7G$_-J&'4,NH8]8P&@:1A M350Q&=8\7!B7+C%0R26.2+A$B\+9Y8B$W0@5-GO8S5FE9%19%.15,VH8M8PZ M1CVC02!A*#@FU5![+N,;B]Z875HMXQVFV_-J$W6?S&GA?C%I\4W<:@7#OG`) M1T]YAA.W(M_H%5P35)Q-S:AAU#+J&/6,!H&DO4U(HG3,]1BJA"/>HG!V:5'@ MX3*'@MFE1<)L8_9!PM(E]-ZRXH0UHX91RZACU#,:!)*&,B&!9J@Q5!"&&E'D M&N/9Y7K4,LYXZG*K3>1`,ZME'C9-6DK''/,*1G#ALSH9#0))@XNX![YM/,'LAV^WKCD>LBATI1;!4[N+SBP*9Y<6 M!1==N(2!*V54<<*:4<.H9=0QZAD-`DD#BGC(WW/,?NIH&NY0-+N,UK=3JP;O M;?K4ZIP>CEL%N!MGW=PB,?AMX&-GESBZ+_:9DX++IN)L:D:-16=C!<_B!YPM M)^DL,I-T/\#B-8+>:F$.N+_R]=DR\O.#R%JV@PE"`L_Q9D<>@Q;A42P*IZ7K MD:W]0_#,HDUH_E%+F']$PO<2JFQ>0<*:46,1#.Y:JF6MSB+8V&GU%@63ZD$D ME!8TX<@A"_[KZ3OF!M.L:CV&+\*"%LW@X:9V7FVB1/(L"6DW06X<&ZN:;E M&F>"R@'7>PW70(/(1[:&B8<.M49T@(9YC3WV-Q:A-5R!J57#PJ-#F4/^86EN MD;#UF%E@RM(E],ZZXH0UH\:B8$-ZRUJ=13"HJVK/:!`)I05%F*7)'4UD7/Y]MEM&8'436 MLD%-Z/5WAL08J@D'99%P\2,3+GY$PL6/2#37B`*'6R(3,PH#KU]9%"2L&346 M"1=/)78N^]#%CUK"Q8<)A05Q06S!I7Y`W;CA,AHC^PQD@&B1W')]%CGTU&NY M`9`QRAD5C$I&%:.:4<.H9=0QZAD-C"X973&Z9G3#:">0;,,HE@PF.FZ]`UL= MXWN!15$K1=.KU&OY5AKS"LZ5R%FK8%0RJAC5C!I&+:..4<]H8'3)Z(K1-:,; M1CN!9"N9&"_P55/3C+%?Z),V-ASTM]&44<8H9U0P*AE5C&I&#:.64<>H9S0( M)`T5!:"3H3C0Q*[6?;?VWB]EE#'*&16,2D85HYI1PZAEU#'J&0T"24-%@68P M[M6]\3A_AIR`16%/(Y2YA'(3>7PR0QZH.6=1**Q46*6P6F&-PEJ%=0KK%39( M)LUK@C-MP(Y!FQBP%LW"_<2+>+$\W8QJP20ZL^BM4]8"-6]:6RA>@72LM'IX MJNU0%23U!FLT\ MFNOW@8;+?)!,&CV*,2??R[$DCEW?>Q/Y.O-95(%T4O-=,IL87,V/PYI\4K.+ M_/-Y-#LI)@WOO\J)^0*KB1TLL)[4Q@+7\[,HRFDF#5]@.S%?8#>Q@P7VD]I8 MX&H3O^8\3!K[`F5;FD$_/5SB861/X3\S?9 M8F(^;:FP:F(^OWIB/K]F8CZ_5F'=Q+S+ZR?FU\(&Q\85:&DU$PII5AM#).'5 M+9)K5V?1^$W-#!K&%1YE1';E9S%;S*/G"[E-%"QE%)Q/R:CR"?1C[#T611:.E^RYS)B="AT<#HDM$5HVM&-XS,-\:,H6%5V&MLI?&; M8>-7?A[OGS_?I_=?O[X39\KBR7K9+?W?#'? M)+O]VG;,S_#=,U.7F)\GN[T7C/D<&>$H0R7%`A*\N,T2^(?$='66P$TDIL>S M!-XB,;V<)7`)B>GL+,$WW'[9>WBJ,ZJLZ&\7J+#&E\EN?T>)\OEEE?R"]N." MMZMDM[\=1@EP[T[,C893X`Z>F-L-2W#33LQ-AR6X62?FUL.2+4RR54V"NT>2 MJI(,$N/>.#?<*1+CY5B"&T9BG!U+<-](C(-C"2:1J+76+;:X'C-UX#28U25F M`L$2S.T2,XU@":9S2:Y*,(U+S)2"TV`REYB)!4LPI4O,]((EF,4E9I+!$LS> M$C/58`DB7-A`ZR';S1HVT*R#:`XVT"0(ZG`]VB#/8&L3.'`-$+GA2C4)`CC4 M6LL-L04D6AI$:>C7F@3!&JY4RPT+_HE9=.:Z86T_:54)EO@3LP3-:7I(>E6" MY?QD4"7;S0)U4P?\9@;OJ/7>[0:.%HMN7`,\?D,--->)9VRH@2;9HFY;M6XI M)*DJP9.<)%,E>*"3Y*H$SW620I64D)AG!GP]>&R3F$<'+,'3F\0\06`)GH[C M2K76WL(&6]4&>!:+*]6L@V>PN%)-@D>QN%)-4D!B'@MRW?#<%=>C2?#X%=>C M2?`4%GU4D^#Y*_JH)L$6!I2CV0`[&5".)L&&!I2C2;"5`>5H$NQHP%C0)-C% M@)ZH2:KU`G73;F78_X.Z:1)L`T+=-`EV`Z%NF@2;@M`/-,D6==NJ=<.N$_0# MK=89)&;/`[["!)MG".EO5.BDDJ2K!!C'80+-H#DFN2K`W##;0TF#/;&*V@[)%L74V,;M" M68(=M(G9',H2;*1-S!Y1EF`_;6(V@;)D"^ML5>NDD*2J!+LW80/-HCDDN2K! MQDW80$N#K>NP@3:"L8,=-M`DV,@.&V@2[&>'#30)MK7#!IID"^ML5>M@/W62 MJA)LI$XR58+]U$FN2K"M.C'[@;D5JA5\U?CT.)JIXFT3V$`;67CI!#;0)'CW M!#;0)'@%!3;0)%M89ZM:!^\XP`::W?!R`VR@27)(S`Y]OM("$K,KGR75"CX1 M;QNQ!.^"P0::!*^$P0::!&^&P0::!"^(P0::9`OK;%7KX-4DV$"S&UY'@@TT M20Y)KDH*2$I5@C2&8 M)7A[.C'O!;,$+U$GYL5?EFQAG:UJG1225)7@M5W80+,HWMZ%#30)7N*%#30) MCC&`#;11@M,,8`--@D,-8`--@K,-8`--@B,.8`--LH5UMJIU\`Y]DJH2O#R? MF!?!V:(Y).9]<)84D)2J!">.P`;:R,+!(["!)L'Y(["!)L$Q)+"!)L%I)+"! M)MG".EO5.C@'`S;0[(:S+V`#39)#8HYET&P`GZA*J\)7B,!K80),4D)C3 M5#@-#N6"#;11@K.Y8`--@B.Z8`--@I.Z8`--@@.[8`--LH5UMJIU4DC,04=< M:QP1!1MH$IP4!1MH$AP8!1MHDNT"*TPX4I#+P9%V23;N*(MF#CB>+C'GS'$: M'`Z'W#3)%C;8JC;`06VX4LTZ.*$-5ZI)<%`;KE23X+RVI%`E.*,--M#2I(LE MKE2S#DYV3LSIS7RE.*TY,2MN!Q\=BPQ'[AB";X^EF2J!%\<2\SGKC@-/BZ6F*]>L03?&$O,QZ]8 M@D^-)>8;6"S!Y\42\RDLEFSA*+0>BF\MP@):B^(C@["`9AM\:Q`6T"3XY""N M1K,TOH0'B98&WQ7$=6H2?%X0?4K+#9^^@T1+@V\(HK?M):=3-WCY\.[[[>?[ M_O;Y\\.WEZ.O]Y_PU&?<(?O\\-F\'37^XW5\&>+HUZ?7UZ='\U[$T9?[VX_W M^,[GS'R2^]/3TZO[!TQ\^N?3\V\O7^[O7S_\1P````#__P,`4$L#!!0`!@`( M````(0"GBAZJL"(``*:H```9````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`_Y:#_AV49+QWA'IR?4PDZB*)R)C3%00L1S[*T%T MZCJ(GJ#_+A>VWJ:W`*\4(EUXLG'M@X4@TN&M#D89-"0:%:.:/#>BA'7#4J/- M*O'>!BWQWC'JR?L0E"+OZTM=]U/0$N^C0JH)7+H1MX%,?A/7P?9HBXETN;;M M55)Z[K768858>+3#8%H,U]ODAE.*^^NI45:;PWZ;+"0K<31EVU/7KKFX1K1> M+*Y-BKM<;==),W7B*!37[-;KT;2\].9Y':\"-2/,`:%3;J]6>BSE+AO& MG+,.@2H\VAZF?GI]G\ M-W%\"G)Q/"HO.L1NG1^%.%[.6W<^MRF0S-H>(?127NZ1BO-LN`VA+[U6A"J/ MHAM0S;X:-FP9=>RK9U\#&YX8C"H?7F.. MXAF7BAM$Z\7B3DEQJ^U^E]Q/1G%DS+@N6X@:Z6POE^QBZ=)';/"ZT*F9>$:J MI6:TBWNY1^$.6GE?^Q"7VJ/(5^-1Y*L5%'QU[*MG7X,8AGJ=!`5?H_*E>[G+ M*2B`V(;&=.O6Q_^X_QFOCU=S"H(&D2GAN"!GLFS:724]-(_4Q+0P6&FPRF"U MP1J#M0;K#-8;;##8R6"C9CJ^Z/QQ?)=9Q/%DW3:C.&U=$2H8E8PJ1C6CAE'+ MJ&/4,QH8G1B-"NE`N>PCZHA+H.:L1/4XC^*U$Z%B1:AD5#&J&36,6D8=HY[1 MP.C$:%1(!\HE"5&@SDYY/JF(AZQ'(=7*5X0*CZ);=LFH8E1[%&>V'IU);8.6 M3!$=HY[=#QY%53TQ&A52,5TGV=6YF$[Z>O0*>CG'%:T0^4+0"UENI"*!J0Q6 M"PO>&T$;+)"7V9DSW4A-2N@,U@L+)0R"=`F4[49J4L*HF6Z19U*I-:=2'KD_ MRQ5NKY(U1"Z&H>:%1]NP`U,RJAC5[*MAK991QZAG7P-KG1B-"NG8N60HFB%D M*EW/25(\E7JTP1H^BEV28.=>*UK#%!ZI)2_O%8C[[;R!L]GMDY5DQ:YK1LVK M2FN3TE:';5):QZY[1L.K2CLEI5UN-LE.R:AL%2UB2S$,\W[%AC6CQJ/(5\N^.C;L&0WLZ\2^1F6H`^6R"JLKS]F&ZLHS MVF`JC[IRNLFX]FE*6"\7'F'^#;?[J3ONTI8MO0GD$MN*O=2,FF#H^LSU*LG0VB`7QQU[Z1D-P=`YWJ0; M^Z<@%\>C\J)#G"1,9Y=BG$@A@W(=4DV9/I$*.7'AM:["Q%HRJL17B';M4=1F M#1NVC#KVU;.O@0U/C$;E2P?0Y3W68/;Y4+@?'#%DDY&;,RH\VE[.'?)RE>YX MED%#&K@2%&:`FETWHC6[WEX=#LD`:8.&N.X$!=<]NQY$R[O&N;:DOY^"AK@> M!4VN=53_8M:%WI'F]QZA#"DO9U1XM`O);?0VL=6(T*J1C]TPRY!Z*))M('KG,*HI=NJ`7PR@9\@B/2V+# M="D4M*0/5U)BG'ZM]\GF=\TE-L%77&*Z1`I:4F+WJA)[+G$(ON(2TZ53T)(2 MQW,EZM9Z)OUR"7+:6C-RB4+46NF:50SCGCX;8A$0&5XG02^]8;Q4$%_QV#): MRUM*3$47P]=XVZM9)4[-QZ MPRWHTE:<43+FDM#D8AB/.9^UQ17=7B<[%Z4WC)^F>>1644N_,5K15S64V`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`B5K%4QJCV* M#!O6:AEU;-@K+7V]SRS]W3/EY+XM2(^\)%'.12L>>;,O]X!QF1YV]"L",8S= M4V96B59P7WN4N$_&=R.&+[IO12NX[VSW2>_NQ?`Y]SKHR6I^F>YXU>XVE]`. M[IQ!%+LD*G3[KPBZ:],0NU6ZE^2UL-LN([L0 MP_FQX>7;I)U*-JD8U=K+*O72L$G+J$N])/M+O3+1D4(G-N=`QY,UW8P0*8E! MCBVRJ%&R5H5H]HCM+.X;UBK9=2Q8:^T]/4F:_FS"SA>X^.<-@W3 M[64RVG*O%77T0@QU5TLV!DK1PCA<.J0Q3'V]XF'JZZ7=)W-V\RKW+=>^$T/M MGGJ:K\1SM5>-@>=&JO.=:XQ)7W=*0>AU2[3P*H[DURJB%?530=@\FQZB;]ZN M\9.5\+]T."_ZZOIIT2AJH:1:D)2T?GNXC/^7MM"B_V))K:B%DCI!4M(N79CU MB\9SOG7[8+*-)X>Y?9[=2-DY]:1Y9G2(GX[M5LD--?>&T)*A7S`J&56,:D8- MHY91QZAG-#`Z,1H5TB%])OO9J*3V8&AWH`U:XKY32$<*DTL<*5E]X8@% M161&>LF[2N;>7`SCB,R&R(RE0J77BE#%J&9?#6NUC#J%]/6Z)7/4,Y;K=3SI M`3-2#WEVZ2G%',?JG6&\VO1(+5/YD8K7\O/_>GV5+DLJ=ETS:EY56JM+6UWO MTXV63KG6,7MFA>Y^F9?&;$:(F31U[K54@)9UO&B57@O1$%2Q8MU1U&B]4N26^5>*]YK$,/Y$.WJ^C+]47@9 M-,+ESZ5%?FIVW01#MS):'5:;9(G2!@UQW2D_.AIN26A%PR]A0_,<=S-"-,1O M[E%4Y4*TXK'O#0.JV+!FU+"OEE&G#-7%X9>'YL5-7(]]C]387Z6_K<^]5MRU MQ7!>J>+E:DFN408%"5O%;FI&33!T+8UU7#/ZT*/ MXC'MD;KPV3`:P*48ADY3L6'-J&'#EE&G#/7%/;-PPX^NT@G+(SVFTRWRW&O% M'=LC9.O3GG]Z7RB#7%JC8B\UHR88.L>'M-.U02Z..^5%1R)9Y9U;".'-"12A M&<7CW&NI<,Q:2.:E5J77BE#E$6XUHE6SKX8-6T:=\J4O.EG]+7V;5WE[C]P# MQ3"GK],M):^F^OMLB4Q[:G^\W#)9"97>"!IRL95'R.P$U>RZ"8:3Z_5^FV3N M;=`0/YURKWB_AU'T]/022>ZUXJ>^1V\%:.@^=\"^#EL2TDA)1\&)(^T8UE]@$ M7\%PMTYO^4%+2NS.E:AC^LR"#^_[H]G!HV0`)1TV]Y:J$_E%H`R@PR&YH97> M2`V@V4@-H!E%KIM@.`^@33HVVZ`1(A2[UN%P*[%H472VB\TKMWCIZ%[PYY;* M:F#-+*IXX=5PWDBJ53*J!,6S*/EJ1"OX:AEU@B9?^JJ?60KN>2GHDRK8:V64:>0NEZW[Q6WLMPU)JY7AQZID\FK=$V?BV&8 M_PN/W/.19=SOULD66QFTI!=4X@O-O!CRA"%:H<0F^`J&NW5RJVJ#EI38B:_G M2M2Q2U:3YT;(@5>9'NESPFE*G(MAU(<\4I/P;ITNNX.67&$E)<:-8<345S64 MV`1?<4R3/+`-6E)B=ZY$'=-D$7LVIKRX/7CDCM\MW6:W20]EB%KH-H4@E0#M M-LFZJ(S4Y"*KA6$^70HUXNKK%@IM%DNL)1?+W2:Y+;21FA3:+>RY0G5HW6(U MFM"7H3XO8N.)&\=2W,2MCUVD.7;NM>(%L1BJ\4/9H-?"(29WI]I@+DCNG)5H MA&RYYM*:5Y76BB]?VFJS3CIM)QI3:3IFR:+Z;'?DQ;;;MYQC*>V6>Z0"Y[5" MQRB]%@XJB6$E*&PTU>RK\0C'Y\2P%LH9%1Y%VT(EHXI1[1'VOV1X-QZY.7V97K>'Y#[7!BTQ[!CU['[P**KJ MB=&HD(KI59)EG(OII*\[I2#,8\L5\@N#12M$OA#TPCGE2$4"4QFL%A:\-X+T M:6-Z;7"D)B5T!NN%A1(&0;J$=+/V%*E)":-FND62W$7N.5>*UZ;>^2.*"[]>'.9#(`R:(5PSI6(?-7LO@F&+AO:I^_#:H-< M''?LI6E1<=:)>@&.N'JSEQB1=:'L5'T3V*(E%XA*A* MZ26CB@UK1@T;MHPZ-NP9#6QX8C0J0QVH)'M:ANZ<`:E`S2B969/Y+[^:M=1H M]H;SR=Y]>KLIO4ET4K5B+S6C)AA.72;)S]H@EC;KV$G/:`B&SN\V&3NG(!:_ MHW*B`^Q2&:LGSBF."O",U-PX(Q5-KQ5VELLK0I5'D6'-J&'#EE''ACVC@0U/ MC$9EJ`.%"2L.U+3J6N_?XF562Z=T*LE":T9Z6WN3+"5S'/2:#,/H+3Q2T^1N MFVR[E4%+FKKR2)7(6V=<8A-\A8EYE[[AKPU:4F+WJA)[+G$(ON(2D[VZ4]"2 M$L=S)>J&>R97PQV76FM&>@JA37EO&/7=PB.U*;])S[V604NNI!*$*6BY&QJM M-=T1`,7W!_"EKB?E2^=#LDB=ZYU/N:$T"/XO6<1ZHQ9L/H MX$OIM2)4>83,1^I>LZ^M&G4?1KD3/O@8V/#$:E2\=P&=2L6M.Q3Q*)N,T MP_!:T<`M/#J3*8M[GRGC\*S^$4DE;D+R6G-AC6CA#K[,PW10MTT*H[2\$S>A ML)X+&T3KQ<).26&4EH_BAC/EZR0!/-N_.3&<7.C//7BDVF@VQ"E2Z;FEU\+9 M2T&51SB"**AF7XT8!E^MH."K8U\]^QK$,/@Z"0J^1N5+]^\DL9L#^.Q/:*XY MW_-(/Y1('_KE04LB4S`J&56,:D8-HY91QZAG-#`Z,1H5TB%UZ9F1H5S/:5N< MH7@4/Y1@5#`J&56,:D8-HY91QZAG-#`Z,1H5TH%R:985J#G]4H'R**Q:\FM" M!:.24<6H9M0P:AEUC'I&`Z,3HU$A'2B7;D6!.CO+^?0L;+X=KSU"T*)I/WUT M*%I17N<1,I@I=[<^N3>[AH8,[2H8":K9=>.1>FS!/^T)6N*K8]1[%#T5&8)6 MN&1Z$\@I:(G[42'=$$EJ-C7$&C_-Q-!.GXTO2UY.VZYGI`^:;-,DVVNINY#W MY=Z-$S5CLA(HO26^53LB>*EYLG'4 M<7$]HT'\O%S<2=3\Q1VVR0IK5*YU\[G4*AI'2Q/-*9>:<&84_P#@>D:J/<0P MW/!+KX;/$D;C8=;#>67I9#5[:Q;+X*U=6##M/(N\]8R&Q3)X.RTLU&U4IBI< MJ\LDBYNZN_M]Q7-]?;;0^9TPO4#8)3M#^/RD*^S#17SZPV#XVB3IX?.2Q/!] M26+XP"0Q?$Z2&+X?20P?D"2&+T@2P_$#D3%+8FQE:.ZG&<_'F'.TU>7, MDA@G1]<0XT5-^B&^\4D,,2:&&!-#C(DAQL008V*(,3'$F!AB3`PQ)H88QRR) M<9+$3?W8Y6G/QYC3.[PO7#IHF'MWZ2^2$.-%+8HQ,<28&&),##$FAA@30XR) M(<;$$&-BB#$QQ)@88ARS.<;O'K_>WCX5-T\W']]_OWWX[3:__?;M\C6;<9;@V4;F-N19@H<7F=N79\D1T3F:T-Z+6ENS"YXK9NZIH>$-$O=TCR5X M3H?H6)(CHG,THY-#DIL2/"M##:R(XF%8YI[-<`UJ2-PC&I;@.1AJ;4EP^@(Q M,.=D1.=H1@>G`U!K.VX[U-J2X"P`:FU)<"0`M;8D.!F`6EL2G`!`[[4D.`B` MWFM)*7,_-K+JAONV*3DB!D<+>"D@* M4U)"XGZ'PC;XA0[B9DGP0YW,_2J%;?![G2%'NT#WZ^R#;X MZ6/F?MC($OS@$+6V(HH?!J(<2U(X/V1$_3&4;_(XXRTU)`8G[K2S;5)"XG\RRI(:D-B7X!3'J9MET MD+@?S;*W(V)P-&.00^)^1L\V!22E*<&K`E!KRP9O#$"M+0E>'(!:6Q*\"`2U MMEKNN,=J<#[XFN1P>.D%:FVMT@I(W-L=^'KPB@O4VI+@31>HM27!"R]0:TN" M]UJ@UI;DB.LYFM>#=[*@UM:5%I"X5Y)8M<9<94KP'A;4VK+!ZUA0:U.RVV?N MK41<#E["E+F7$[$$+U_*W#N*6'+<767N53LLP8N&,O?&'984D)2FI(+$O6R' M;?!NH,40:FU)\!XAU-J2X"5H*,>:Q?`.,]A8DF*'M1A>W&75`.LJ M4W)$W(YFW/!>+D3'BF@!26%*2DC;N=>FL@2OC`T_O%F2(Z)S-*.#][@C!E;<"D@*4U)"XEYASE>*][DC!I8$7]K)W+=? MV`9?V,G<)V!8@@_M(&Z6!-_;R=P'8=@&W]C)W'=A6()OZV"[SI+@:U*9^U04 MV^";3ZBU)<&7F5".)3FBG*-93@Y);DKP;:2L,"4E).[[.UPW?`5A2;'"GQ<^=6()/SB$&E@2?AD,,+$FQ00^9G^(EO1>? M/H,WZTZ+3Y3!FR7!]T"Q`6O._AO<3^?W15$Y6(>8$GP&$OW`'',;C+GYQ!UY MPWK4E.!CAJBU->;P<5W4VIJO\<'7[&A>#[[[FKFOD7(KX/.OF?L"*4OPC=?, M?8B4)?C4:U:;$GSQ-7/?(&4;?-8U?7D8,+`F^P(P86!)\B!DQL"3XWC)B M8$GPV67$P)+@Z\N(@27!]^<1`ZM?'Q&=HQF='!+W06^^4GPF'3&P)/@8.F)@ M2?!-=,3`DN#3Z(B!)<$'T!$#2X+OH",&E@2?0T<,+$F#&+@/VO/UM)"X[]JS MI(/$?=Z>)3TD[BOW+!D@<1^[9\D)$O?->Y8<(3F:DAR2W)04D!2FI(2D-"45 M))4IJ2&I34FQQOR&%]5PK1M(.E,R0#*:DF*-_1W\XL/RAITL4S+`9C0E_0K] M8&6U]@#)8$I.D)Q,R0C):$J.*^PCS>]"2V;E8H5]BI4U[S20=*9D@&0T)>/* M/0(U>PCJ=C3KED.2FY("DL*4E)"4IJ2"I#(E-22U*6D@:4Q)"TEK2CI(.E." MAZR(@=5#CHC.T8Q.#DEN2@I(2E-205*9DAJ2VI0TD+2FI(.D,R4])+TI&2`Y MF1(\YT=$K1C@:3]J8$GPS!\UL"1X\H\:6!(\_\X!G,$' M]RC-X`4&NSG6,=0M/F"@3_S=,FT\?GS_\^:WV]/-PV]W/Q[??+O]@L,2\SMV M'NY^^[K\Q]/]3YRFNGCSZ_W3T_WWZ9]?;V\^WSXX;1Q@^7)__R3_@^U%F0)``"6)@``&0`` M`'AL+W=O* M"]@BON2>VCJUYYSG$`RD)HFI.`RSWW[_;4FV6JUAX(7`KR]JMUIJ6>'FSQ_' M0^M[?B[WQ>FV'5QUVZW\M"L>]Z?GV_9__\[^&+=;Y65[>MP>BE-^V_XG+]M_ MWOW^V\U[:@8>B^$:J\T=",.X(ZZR: M@;_.K)_E^^>7"Z9[0":[XH"1\+-UW%,-X-&W/ZK/]_WCY>6V M'0ZO^N%@-`["0;OUD)>7;$_&[=;NK;P4Q_\KK4#[4EY"[06?VDMO>#48=7N5 MDP\,>]H0GV;X[E70[PYI\`_L^MH.G]JN?Q6.!\'@5X9P6STO/K5A$'[.'X:A1TKWNCCW,3H%K4G&+2M.7G0@W,/-(O M7PLV,#-)OWPM7#.703.9'X;;425PO["1ZW?-W2[A1$Y$P7 MO:ZC>AE@->Y(_9[T;]M(+^J[!/U^-QCT;CK?L:YV6F2?I5EDYF)(B/86!D=\KS'M9(Q2P1)!G"(A.F$=7"]TMN=8FUG!:3,K.$$RF[#@Z(#FBZ[B/#R->KWJ M>!)V`S=O6B%LFF^B41_57#]3V!_S%9L:K6'E>=3MP M0YM-8*(1PC_P!:1[BCV;"C7%..(U$U-SIO#L8E0($UDE?'3-35)M MPB;:]L)CI0W:%ZO:N%GR%&*5IQ"+3B%K]!1OR?0,%LHT4H8\(-JG?0&I_9L% MI%!3>^&QTD[NBU7O\/9$*\0J3R$6G4+6 MZ&D@4*:1,N0!T>[M"TCMZBQY"C65YY11'.A.8%>>0IC(9AOL=<7BK;7,\LF8 M+QXQ;>F^B-56SR)6B-6?;@AVC`I9Q98&`F4:>>HO_$DGJ3CO)!IA3JUTA$Y% MQ5K+GF:-,,V6H:1V:^?1/OY?7O:[;Y,"G2O`EJ%>U"M]YW%4 MS[!+5&NQV'5GL?JTUNHW*--H4#4;'NA/.DLH.XM&K.L&@=-58ZUE[T$:#>S\ MRG9MW%]7^V@P[#F>,^-&W0NRMWGJ$%;5_C+;JJ/8U1SJ)M-TZ%@C]B1*:]"D M-M5:@Z;F,XV&GD!IXQ>!XB(1E4=5\7?QRJI"]0D6IT+.RXK;IL):R]1J(E$J M42;15**91'.)%A(M)5I)M)9HPQ`O8.IF5DKK%:6Z',N=0O:["UW"4C]OSA:) M1*E$F413B682S25:2+24:"716J(-0SQ1U#=]B5+]E"5*(WLQ")2$`J4291)- M)9I)-)=H(=%2HI5$:XDV#/%$48NW$O7+W40="5@"-6K**D:)4:7AL-`L2874 MKESU@51K62B3:*K1,*Q]S30:8>'7KT1]]RPZ;[1,$`N)EM+]2B,KKK5$&X9X M3ND0\I65;-GJC2+-&/6JWW^_Z^*+.>?U-C1543&(R#YL: MUDSBS*`>&F8=5R]P1IA;:F:$A8M]4IS.6>7U@PUY9/^%@X)[NT2>KK;1IA(E&OVK\RG"HIFU,'B49CZ]QB4*.5:31LWI.FTM?,&#:^Y@8UOA;2 MUU+Z6AG#QM?:H,87?8U,E:7B4D6LOA96WXT=\_-S'N>'0]G:%6\GS'XUO356 MWT8+:4>";ZKOJYW4X1-\@UWM!RX/(WQ#@MRZO(J4$K3:BKBDEZ)+PYI,DX1C>JBIWB@;]`]Y\$NS[\.:33,)N-,$K MG8P`;[=1[)4DD*1>208)O2!*;Y,PQ#B^DL9;'L;Q21)($J\DA83>EN0X>+-# M!#[))!A&$W5D<+^"<7R228",XJ92VL20T.6GE.!V%N/X)+B$Q3@^R23H8QQ?7>,&$^/X M)`DD=#K/"RH:U]]RA#A`17LE^!8@ M2KP2W/SC27S><.>/)ZDDG3ID_+/0Z_8Y7V_/S_M3V3KD3V@AW>J;VK/ZOR+U MQT6]G+<>B@O^2XC>TULO^/^O'-\\=>D-_JDH+N8//$BG_H^RNW\!``#__P,` M4$L#!!0`!@`(````(0`A_]`%[P,``,P-```9````>&PO=V]R:W-H965T2Z0M6S9L%\D6V2W0`HM%VSTS,FT+ MD42!I./TW^^0^K"&IM!;S^]525Y%4H7LMY%=)9$1-2Y/!3U M:1?]^/[T,8N(-KP^\%+68A?]$CKZM/_CP_8JU8L^"V$(,-1Z%YV-:39QK/.S MJ+B>R4;4\.8H5<4-/*I3K!LE^,$MJLJ8)^AJ[AZN30?A]SNMX'0/3?GLH(`-;=J+$<1<]T,TC MRZ)XOW4%^EF(JQ[]3_197O]2Q>%K40NH-O3)=N!9RA<+_7*P(5@YILC/F+K-4^&K=NW$!AM*UTF`U$KU6(6KC#CG2X"S'26#MSV/10* M_@PYITOJD?>@)4)-U`8:-ZJ-RV61K&?+0=("G.10IRX"Y1IM8J)4L`>??I[, M5K>,+`#3]Y$5XE\,2:+6`LCGQ]NW`,S?1?#VTS"]O>)NA[/M]"(=[]\B,'\7 MP?S+,#\<<)\?TUL`IN\CN#RK,#^%R^!.`+77(;!"'\(99!,*UH5>B>@DP!Y4NLT2%R""\)NPA"2&%U\R%6"#B:+>:#!VCK5_#= M8((^A/EO5L3\`5]37*/>M".%/H0ZO9KP,5S8=T7"3G`(KT@A*Z\FK$P#7O:2 MZ*T[2J(/X20FW$RM-[W#Q!@NE(5X670AW(H)1].`I;TL[BWM%EE1G,6$J6G` MU2S#6?0N'E6J"^$L)GS-`K[&63@$KM,0PEE,&)L%C(T/E$-X$IW5<1(3OF:` M\KOM*5B$I]"%D$(VX6L6\#5-T=7A()Y$YW8L,6%M]EMK.X2G$+1V-F%M.USY M=?*N6`?Q-$+>SB:\S0+>QM_3#N$I!+V=37B;69=ZWO:ZW?EX=,NZ1:"*6S%A M;9B1[Q60[1S"2R+T=9WYSFYGYW9NK80ZB3]%66J2RTL-,Y`=6X?H,+,_,&MN M/[[8/+2S?#R\@1&[X2?QC:M346M2BB-PND-*5#N-MP]&-K!W&+2E@>':_7N& M7TT"9M<$9D1RE-+T#Z`<#[_#]O\#``#__P,`4$L#!!0`!@`(````(0!L+*:! MW`L``,PT```9````>&PO=V]R:W-H965TZ5D$]W_^/+RU?NQ.YWUU?&@'-]UV:W?<5D_[X\M#^S__CO^X;;?.E\WQ M:?-6'7^.D#Q7I\/F@O^>7CKG]]-N\U0;'=XZO6XW[!PV^V.[\1"=/N.C>G[>;W?3 M:OO]L#M>&B>GW=OF@OZ?7_?O9^7ML/V,N\/F].W[^Q_;ZO`.%U_W;_O+7[73 M=NNPC9*78W7:?'W#<_\,!INM\EW_A[@_[+>GZEP]7V[@KM-TE#[S7>>N`T^/ M]T][/($(>^NT>WYH?PFBLM=O=Q[OZP#]=[_[.%M_M\ZOU=L^;[V^7?U4?B]W^Y?6"=`^%R;9Z0TOX MMW78BS&`1]_\K#\_]D^7UX=V/[P9CKK]H#=LM[[NSI=X+VS;K>WW\Z4Z_*]1 M"J2KQDE/.L&G=-(;W8R"[EU_]'DG?>D$G\K)3>]V&`Q#T9,KK0^D(3ZE8?@Y M0[BMGQV?TC#HW@QZP]%M_?!7FAQ)2WRJOGXZ6)AB=:OXE+;H^"<#'>ATX0_5 M\N<>-E!)$G](T^$G355J`I.;P.3W2IPPY.3P,C%&\Y]]VE!9XP_=Y4\.SDXS MT.L),MU<-H_WI^JCA:J#R)W?-Z*&!5&`!,JI(4>8GBR8LUNA_D7H/[3OVBU, M@S/HC\=1<'??^8'9MY4Z8ZK3[2E5E*ND M9W90<^7C:DL+I=6TU`^]D9.0EE+24J9\7&UIJ;2PD]%/'O:])\^5EN,K]+8L M*]*'@K7SX[I66LW3WH7>XEPV\B:NSB#`J8`;!`*[@Z`A&`1J8$VD3MB6@LK13++> MK0D_17/+4IP.PSMOLBPL!>4ZH7Y2BC++TGJX@3?NEY:::B#7#!5,QZ5'I@QM MM-"6MW6H@N&M-Q_6EH9JKW0$L_R&NM M)H,<#KQ=1"DU&M_NP!#G5VY@-.=:9V`TR%ZKQ+V?F*G6.C35S.PM9I)9SQ93 M-->69C0N-#.+0T)-4XHR;6F\+34SWG+-C-Z*NBL8M;5FYE%+Q]0--?)OA]K: MX*M-HK@+\"M?@T*LB+I:AP-O)9E(0VBI>3RE:$913-&QXBAI)5:O"/((:D^=!KD;-')Q$$C#W]P<*+61>`?PXS$( M!MX!:28U[,L#B:SE?*[\7&]NH=6PV='+6;_KA2ZA;::TS4P[9XH]NT)J[6LQ>\I=^/M59K;A.&_JU;*168ZX1`G(>YT2&/SO;H M:)"S2Y-:]I5"[1&+WLB?*TO*VT,S6FIJ09RS:Y?,]!&"VW9 MW,CT>]YI9FTIJ.9*QX^;T%_<,O3H+8-$]BV#TK)O&1@VD\Q)&+UE8"P7#$NH MMY2BC+%<,BS7S"S`*^JNT&KF0F7-L-(Q=4,MCK!,F>HU1UMLS56^QA*YBQBY M95"&O[EET&KRV.^/F)E4L,I83-%EX=L?&+RX:\&4W?XME-=F]OY]:V^G[$0`VZ(FF:-]\W M7/5ZD>@%)J8GP9"(1&>H!*,@$EVB$N1??7W1\X;O-7[I,19C?-^Q7M(]_;%P MQ.GWHY)K^!"5=<"]!C"-(Y%T^A`))"+U5(()'(D10"68QY$8"%2" MJ1N)X4`EF*V1&!14@NH8C5G)!)()*YE"(J8$]8;J%XF)024H@E',2E`+(S%- MJ`VV"8@!ES+L%O"DG`2;`3PI)UE!(M8BV@ZV`1ADG`1K/<8&)UD%MY'8%3+> M(!&;0RK!MCP26T0JP7X<8Y.3C-&#,=N#"2135H(M';+`]1H[.V2!DV"#AS'* M2;!_PQCE)#AB16(_3I\'IZI([,JI!(>K2&S.J01GK$CLT:D$QZI([-2I!">I M2.S7J60,R9B53""9L)(I)%-6@I-I),XLM)T8$G%TH1*<4R-Q@J$2W)$CV]R( M'P=#2.K*Z]6023!"#^I=E2?!!0=BS4EP-X'HO(C!_.`G>/F#^(6$+'`2O$G"..`D>*&$<3X.413X'4N;+@8X*TN;#@)7NXB0RASK*2G),4VXF MK%!$.5Z@A')\C0+*\1+ED^-C]'7,]@@OXY%C[BGPQATYYB0Q)#$KP?MW9)*S MF:,(<#U;H'1R/$'AY'B*LLGQ#$63XTN43(Z/46#8^H+RPM6#.8H+QS.4%HX7 M*"P<'Z,<<_V9H!AS?(I2S/$9"C''8Y3AFG=TV<)/3-XW+[M\BYJB[J/QCT M'?T[I,>_`0``__\#`%!+`P04``8`"````"$`WE=E,80,```+-@``&0```'AL M+W=ONXR1&DSBPW6GGW^]+D10/+Z=-;^KV^0X47Y'41TJ]_OW[Z\O@ MS_WI?#B^W0RCJ_%PL'_;'1\.;T\WP__\D?^V'`[.E^W;P_;E^+:_&?ZU/P]_ MO_WG/ZZ_'4]?SL_[_66`#&_GF^'SY?*>C$;GW?/^=7N^.K[OWV!Y/)Y>MQ?\ M\_0T.K^?]MN'+NCU912/Q_/1Z_;P-I09DM-'UU]Y%TK]O3EZ_OO^V.K^](\?GP#X^7JZ0;B0OE/N\&JU&R'1[_7!`#X3L@]/^ M\6;X*4KN)]%P='O="?3?P_[;V?K[X/Q\_%:<#@_MX6T/M7&?Q!WX?#Q^$:[5 M@T`('E%TWMV!?YT&#_O'[=>7R[^/W\K]X>GY@ML]$R&[XPM:PI^#UX,8`^CZ M]GOW^^WP<'F^&4[F5[/%>!+%L^'@\_Y\R0\B=CC8?3U?CJ__DT[=I?=)8I4$ MOX$D/PBHQ? M'1E]+'*N(O&KN_FQP(4*Q.\O-HGYV%TL?G^MR94*Q.\O-AEAL,DA(4:=&A,? MZV?4CR;\Y5>;U8,HLD;1!YO5PRBRQM$'[VFD!Y+XB[[D'X_!D9Q"W=1+MY?M M[?7I^&V`]0R=/K]OQ>H8)2*=FG1J&/?3$*O!3KA_$OXW0]PA3+`SZ)^WD^7L M>O0GYO5.^:S9)W8]-MI#S&V1-O5!YH/0>?CPK!4AF.'XL:;MPA-2.8WQJ+"\EJ[7QGCUPY!1QBAG M5#`J&56,:D8-HY;1':-[!SE"XVEK"ZV70($[,;4`:TEB:P@228ED1'(B!9&2 M2$6D)M(0:6WB]!JW/]1K@=U>*R(K-+&*;XBD1#(B.9&"2$FD(E(3:8BT-G%Z MC3+'[K5Z#G:3ZO)\V'U9'[N*4H\!X>ZJH0@:Z"=///6>C!OE9`9**LD"ZV,? M-EFNW#F745BNPC!V^[!X-77#BMY)#]222$6IZ]['I)Y$7NJF=]*I6YLXRHKM MF55A:`4%=A649(J!V?=ILAJ[?=I(I]@\-U.5:(P+,'%C[RF145PNR M:E=(I^FJJW2F4>2E+562;F/353(5-51_I*'&:6BRF'M#H+4;-D[9>242[(T/H4D\TD?52HR[4E%>6K*TU">UL[C=%M4 M_*%^=]SMN$+8NEH#9!5Y`TMYQ:9;J4)+48^@SO6&8L81N6XJ[B*B\<2_CX7Q MT+>AY#P5H]H$BHM9S:9>!QKCH#.W3AI7/E'&!F:EV`UYXT8AN?/OQOA&(4^4Z5]Q[%8Q*#JP8U1S8,&J=0%<"49.&))"U*HHEW9.UV-Y!%6=I MBF?>6K!17O9\4F@UD>M''$V\NY9Q4*[09"H'T6*QG+ACM3`>^A)+SE,QJDV@ M&$31=+;T%KS&>.C4K9/'E5#4J"$)9>WJ2"B1O?R(G2]4=?22"'KIUC/VRA6" M0-JK8%1R8,6HYL"&4>L$NA*(\C$D@2HKS36N1?F-_GKK$&V-I9O&-62I&M0D40RB.)[&7NC$>.G7KY''E$Z5G2#Y9DCHC2")G%9+(T4HB M:*5;SR+RRA5R5B'I9:&2`RM&->=J&+5.H"N!*`]#$LBRT9%`(F\5\I:'322] MK!F3*K22CZ5I/)Y[SXZ,@W*%)G(EFB\FWG)7&`>M=.59 M8QQTYM9)XPHH"DU+P)_M_R)9F#K"2N3421(Y*DH$%?5592J7Y94K-#/%>L&H MU&C>YZHX5ZV]3*Z&4:M1E\N1)OZ;2KOC;J6MD#67-HQ21AFC7"&U]8J6RW'D M[8D*XZ*U+!6:F3*TXMRU">R>8?/I>.Z/'N.B<[=.;E>BOZFF8ZZF%7(DDEX6 M2MDK8Y0K9"TW!:.2`RM&-0S1L=*!U MAL(H8Y0K-,7*9J7WBOC">.G[7BH4XPG:!\;^@*FXQ=KD,H&3E5\M&2_=8ONS M%EWE1^&9:VZ+?X#3>*U-HYG7W5;GZ5ISE15UMZ7L3\>TK-,= MQ26R"XY8(D=>0AE[Y0K-S`E%H9&I5$J%YK9XE+[6@297HY')U3JY7&E$K>Q+ M@Q_G%\QY,"^UGY$E&\IO=.&11:($5_-R0J+`IV7V'YFJ>74=;TSGB3:.6NH=Z#0*Z,HR2T9>^UDJ>YH)Y']&@=_%T)9 M*&64,0:Y0HN(/"25W`HY0"IF*$)T MFMJ5CD3+A3I/'(^]C5NF@N"AIW;.J.#4I4(+/"OZ:Z+W/I7QTNEK1@VG;XV7 ME3[VGL5WQDNGOW>0\U0NN+52>V'5Z>\!O9.JW-:P,_)?,M0ZCVFMX=9:[?7# MUNZ\UA;8++D'D/(?DCL>>$IUK=\2NM=\HY-P.&6B]>\J4E_7R M*=?([+$+SE4J9.6J=*`Y?JXU,KD:SM5RKCL=:'*)CR?%A)YWN>10EA]#RB^R M7O>GI_UF__)R'NR.7]\P`B)\BW%[W?/^,\Q/W1&EQ]?X/+-[H/L\3O#Y#53U M^02?`Y+=Z3@63"($R$W9\/@383J M;,$83H3X;,%03L0]8`N&;R)N!5LP;/7GK-ZUI?$J$8LFQV"13,1ZQQ:L;^AI MR+)&.^O@%6"]2<0@YVQ8=I(T:,%2DX@ASS%88A(Q\MF"E281$X`M6'`2,0\" MEGB2B*T$6RI8JJ`%.S*H$XK!+BP1^PO.AMU7(K89;%G'"RC:/<:\^X/C&V0+ M736.:)`M9,'N/Q%[>VX'NW1D"UG6N+9U\-JP14XV04L*2QJT8,.NA/R(*#.XRWD`7G=QAO()^(HEM7!(78BCE_9@J/J1)S"L@4OO*!U<$V,YKCJT+C&:QM<=`%#JXZ9,%;&EQUR(*7-1A5(0O>V6!4A2QX,8.>ABQXVXR8T",& MKY01$[+@)2G4">FV@46\[F.M4UC$6S^VX-THU`E9\(H4ZH0L>`T*=4(6O`V% M.B$+7HJBIR$+ON1`3&CTXH,.Q(0L^&P#ZH0L^!`!ZH1TP\<'4"=D26%)@Q9\ M>P!U0C'X!`'JA"SXS@#JA"SXW``]#5JP5(7F2+U,\`T0W[4&"UB(MUB^0GP- MO=9!O3:PB(]5N`U\VP-50A9\U@-50A9\W0-50A9\P@-50I;U+,&7EMQ^ODCP M,1[S>I'@2SKF:RQUH;YOL-"%>(IE+L0S+'(AGB\3?-?%[198^D*\Q,+7\5'_ M<,;_T'G?/NWOMJ>GP]MY\+)_1`4[[KZ@/,G_S"/_<9%G@8//QPO^;XXX%AP\ MXS]=[?$!Z?@*!X./Q^-%_P,7-.K_&]?M_P$``/__`P!02P,$%``&``@````A M`*;CZF\6!@``]14``!D```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`-/#VWSIF&#(6G=/2?;U?2@C!4!#NZ MC`K\C,M$G+C,C?4YF,5`\H]+\"FA#"(9Q#)(9)#*()L!P3]LCIE_/'.$'G3\ MG67.%.WVJB*'!MT)ZIE2F:@ MHO&8O-U(SC(98SL7DHLYF*3&9*HH4E&LHD1%J8HR`0EQ@,.S./#$$CKXR@WT M*;%F:51(J)!((;%"$H6D"LGF1#`?@5XPGU#1?$;H542.AT`AH4(BA<0*2122 M*B2;$\%\'.DS\^=5V%^JXL5OABN09X5(BVXQ8B`^8U%:CE25`97:H0@FH;TC MEFXX"O&41PJ)V7)3$22CS*3:-B75Z2C$56=S(@2$-(+3U<$=)U1TG!)G[K?M MRE<"%=I@LDDP#5G@AK1;](KJ+5LTA8"]PC7X3,$OSD*.+)&%*HH8DAP MBZJ?H42=F*HH$W2)CI"F8,$1VBL(CE`D;4OI.`A,*H7B(6'>[;>&O"D[:A\GS7YW/)NTVA(A0--LZ`9.R MIWT:JBCB:'A9H^<.0[,0)%QJTI6J*.-HT"4Z2!J#R4%^WI(F1SI<&!+VIFE* M&R3@4CC+QAUL*4D&I[ MAUR.F'YL0.0]8@TF2R.(.+Y#+(W@`\73D`9IAD\^7"QH\BT/[RSJ"K[MH?=7 M^9/C/2TN[,.B(6W*PHY'DJBJ0K%[P>)(B!&24G4."MLCF55'4-\>2;`ZDF`D M61SQ30NV+;F),Q86+(W@((4%2R,X3V'!T@B.521R:01G)_*R..)Z:`E4;WS3 M@,U+J<3%#IN71G!]P^:E$=SBL'EI!);+ST,FJW'<]?\GWP/70DJGRH>NA,5-YY'IHSU0>NQZ:-)4GKIGJM;IUW+$S:Q,;S_MO2S'?W1T_VO/3<]/L*1HT"[X/-J MB3[_>/'\]G[R[/SW:/=_O/]X]?/Y[_SW]G_[@Y M/WM^N7W\?/M]_[C[>/[OW?/Y/S_]YW]\^+E_^N/YVV[W<@8+C\\?S[^]O/Q( M+BZ>[[[M'FZ?W^U_[!XA^;)_>KA]P7^?OEX\_WC:W7X^%'KX?C&_O+RZ>+B] M?SR?+"1/;[&Q__+E_FZWW=_]^;![?)F,/.V^W[Z@_L_?[G\\6VL/=V\Q]W#[ M],>?/_YQMW_X`1._WW^_?_GWP>CYV<-=4GY]W#_=_OX=]_VOV?+VSMH^_(?, M/]S?/>V?]U]>WL'/Y[_-DG&U.K_X M].'@H/^]W_U\]GX_>_ZV_YD_W7]N[A]W\#;B9"+P^W[_AU$M/QN$PA=4.CM$ M8'@Z^[S[V_XTKX]^SAWCP#N/7;?QU^_KS_ M_/+MX_GB\MUL>7DU7YV?_;Y[?LGN3='SL[L_GU_V#_\WZKZ\O%[&\868@1_!0C5^]N5JOEU[CWJV/) MQ>QM):^E)'[^O2L[,LR"1>F-M9\<@ MXY>_5]^9C:WY18J^U;TS&]*9"\U;'8QG59Y+_/(WJXQP3H^TB^O[MX5U9N-J M?GF;DR^F]^GP'FYO7VX_?7C:_SQ#XP97/_^X-4WE+#'FY`V4)_GX3J)IN#/J MOQG]C^>(,EZW9]"_/BU6-Q\N_L)+?B3V-V&X,T!ED,\A@4 M,2AC4,6@CD$3@S8&70SZ&`PQ&#UP`;ABT,=@B,'H@<#1>,-]1]MGV6!T),&S M_#YTX'K2N;H^.GU#9$LD)9(1R8D41$HB%9&:2$.D)=(1Z8D,1$:?!!Y&T^E[ M6)J1=ZY/Y);$%$&K@Q^N*;FZC-P_*5VA'_*49J'2YJAT?,J)I$0R(CF1@DA) MI")2$VF(M$0Z(CV1@_F]*/2T=M$4B(9D9Q(0:0D4A&IB31$6B(=D9[(0&3T2>!MC%I^X6VC M$7I[(I&WEY&WCTI';Q-)B61$B(#D=$G@;=-ZLT# M1O_9-AJAMR<2>7L5>?NH=/0VD91(1B0G4A`IB51$:B(-D99(1Z0G,A`9?1)X M&XWO+[QM-$)O3R3R]E7D[:/2T=M$4B(9D9Q(0:0D4A&IB31$6B(=D9[(0&3T M2>!MD[3^PMT'E=#?@B*'7T<.=UI'CS-*&66,D8# MHS%`H?]-IN0U+K:W-#,#T4,N:.X-S!EM&:6,,D8YHX)1R:AB5#-J&+6,.D8] MHX'1&*#0PR9%TCP\I4X8C=NGGC#)!GM=SI^69OXZRW\)I6?,E MHXK-UT[+-Q_ES8W3LN9;1AV;[YV6;SY*#0>G9[_KV83>(U;=$MS^I2&!4X7=(DQD>?UZ+G>F+E\O!]FQN>H-5]21S)I+:;7X_W-9?0. MIV)F[B:=,T;YFRY6B)9<;+:(+U:RY8I1_::+->'%;E:74=O:LN6.4?^FBPU6 M"T_GT=F+RRCE&@/S8?A-_J>%?\H+@_`+0OCM>[B930RQMF@K"+ZV*!44A'(J MZ*&<;15LJV1;%:.:;35LJ^6"':.>;0T6N5'0&!0,76R2/LW%4S(8N%C0)0;` M+IP+2N@FM<7\T+7@"_`J&D-L9T<-%X0)>1U))EH>R@4M\7:Z"L3/4^&TK/F2 M;56,:D&G:]XX#6NZ93L=HU[0ZS4?G)8U/P:V@LC-HZ3<=D@''F;B%B%RUO!& M&&[6HBVC5)`7A(Q1+@AW9VT5C$HN6#&J!7GU:ABU7+!CU`ORZC4P&H."H8M/ MY-USSKLM"KN?9=2Z;D3-=BSSJWD\='8:UI>I(*\YRACE@I:O-K:%T[+F2[95 M,:H%G:YYXS2LZ9;M=(QZ0:_7?'!:UOP8V`HC=R*?GW,^;Y'?L&-6"O$HTC%HNV#'J!7GU&AB-0<'0Q28+UEX. MR<7]ET-0V'-<1X.FC5F+A\1%VM_Y;'X3)91;IV&?@520UQQEC')!K[>_A=.R MYDNV53&J!9VN>>,TK.F6[72,>D&OUWQP6M;\&-@*(V=2:2UR4XKM#XCG@H*> M8V)>"[T5-0^E@H*X3`4]E(N6UT(7C$JV53&J!7F5:!BU7+!CU`ORZC4P&H." MH8M-=JVY>,JZ`Q<+"GN.%0VK)C5I?V]6E-#C>\CA[7&CW510T$!-6A[*1>OU MYK=P6O8)*]E\Q:@6=++BC5.PEELVTS'J!;U>\<%I6?-C8"N,FTF+M;A)[NTW M:H*"?F-B7ON\A:#4%N"FJ#QL.XTVM#MHQ21ID@))OV,V>M8:&(T!"CR\.)$V'WB8-@N*YG&CZ:N-:"&FUG=;1BFC3!"F MOVS!G+4*1B6CBFW5K-4P:AEU;*MGK8'1&*#0Z2<2Z04GTA8%PZ'Y,DJ3-Z)F M!Q7+Q2(:,&V=AG5O*@@/AT49HUS0ZX.*PFE96R7;JAC5KN`KDUB-T[+F6[;5 M,>H%G7;,X#2LZ3&P$T;N1"*-UM(T-7Z#9)$_'!+F#3NVC%)!05PXD18M;]A1 M,"K95L6HYH(-HY8+=HQZ0=X]#HS&H&#HXA.)]((3:4'HHFWH-HRVC%)&&:.< M4<&H9%0QJADUC%I&':.>TD8#HS%`H8=/Y+L+SGL7JSNDH+^Z@U'&YG-! M7@]=,"H956RK9JV&4ZHW'+?K%Z@Y1BP(1 M];U;IV5;H911)LCS>NZTO*Z/5G:C.<3&:5GS+:..S?=. MRSZ"DUV+@JQ@<1VO[A"U7ZSN$"WT9F:?YOQR<15%+Q6-8$!*N77^IJL55NOJ M<+6;>,%%R=>J&-76"GK*XZ=O6K?2B);S]*KZSEDUWC/HW76VP6NANCG7B MY1V!^2#^RQ.I^(&'N85%?FXAS%_>(0CW?VS7!/FA9)2SK<(B]]VNY((5H]H6 M=./%1I!7KY8+=HQZMC58Y.HU!@5#%Y](O)><>%L43K72\@Y10SIC7IZ;]U?Q MWL2MTW!!F"[G]229:'DH%_3ZE&7AM*SYDFU5C&I!IVO>.`UKNF4[':->T.LU M'YR6-3\&ML+(G4B\T:/$.8M%_F2K,-RLO=:642K("T+&*!?D36H6C$HN6#&J M!7GU:ABU7+!CU`ORZC4P&H."H8M/)-Y+3KPM"OL?6MXA:M+^KA:7-_'8V6G8 MN*2"@A9JJH&';W\+IV4?L9+-5XQJ0:=KWC@-:[IE.QVC7M#K-1^$C%$NR&NA"T8E%ZP8U8*\2C2,6B[8,>H% M>?4:&(U!P=#%4=YNTT43QMC%-C_'$,B-DFEYAY24]O?J:A7-*VR=@GT$4D%! M`S5=S4.Y:)F;<=>G1;-.RYHOV7S%J!9TLN*-4["66S;3,>H%O5[QP6E9\V-@ M*XS;B31_R6F^14&_,:EY[?-6U#R4"O)BD#'*!>'N;+T+1B47K!C5@KQ*-(Q: M+M@QZ@5Y]1H8C4'!T,4GDOHE)_46N:F.C2"O6=DR2AEE;"MGK8)1R:AB6S5K M-8Q:1AW;ZEEK8#0&*/#PZD3:?.!AVFS1)<:3[N6_CC]ABYKWQ&X9I8PR:]]] M4,U9JV!4,JK85LU:#:.64<>V>M8:&(T!"KU^(I-><29M43`>XD_8HB:CBMER M=AUMI=@Z#=M&I(*\%R1CE`LR#:$+.[7Y3LN:+]E6Q:AV!5\QWS@M:[YE6QVC M7M!IQPQ.PYH>`SMAY$YDTBO.I"WRQT/"O'''EE$J*(C+9-]#N6@A+K;>!:.2 M;56,:B[8,&JY8,>H%^3=X\!H#`J&+HXRZ<-W##-"/7FJ$J?8JPF%QT7$K\3& M:5D/;AFEC#)&.:."4MH:^3&4W,1$&LH:EFJZ&4*RQ56**Q46*6P6F&-PEJ%=0KK%38H;`Q9 M&`^3L'H?EW[]=DP9KO_5":?-FLPB>CNBV:6-T[)QV#)*&66,D8#(W,ZK_@+GIBB,9VV.YWR^;![^KK;[+Y_?SZ[V__YB.=]CC50 MGSX<^73.[_I],A[&-C&?72;FO!;8CB6K!8X&7JB2)22'-X3*K.QQPI$$YPS_ M=IC!C?@:YP\?-KK&?)Z,JCXJI=7IMV7R&SREW`;JJE<5-=7TKY+QD,G$%;I. MQD-G%_.;9#PLF(PX1AN)Z>RX1AAT)*:#8PE&%8GIYUB"P45BNCN68(R1F"Z. M)1A(X!8UR1J2M2K90&(&!6P-X[7$C`U8@F%;DJD2C-X2,RS@,AB>)69TP!(D M3HE)BUB"-"@Q20Y+D-0D)F5A"5(4A%^3;%:7N!_MP#^&B2#!(S/\!E,'.3F#D!EF!J!C'5))B]A-^T-Q&3F/"; M)L%,)?RF23!A";]I$LQ;PF^:!!.3\)LF64.R5B4;2,PD(]\IYG_A-TV206*F M'+D,9H/A-TV"Z5[X39/@DPC\IK5X^#("OVD2?/Z`WS0)OH+`;YH$'T/@-TV" MKQWPFR990[)6)1M(S)<+]@$^*L%OFB2#Q'S'X#+XQ`2_:1)\0X+?-`F^L\)O M6HN$SZWPFR;!-U7X39/@TRK\IDGPA15^TR3XA`J_:1(L;(`UK77!^H;$?%IG M'V!-`ZZC249(S(=V+K-&#=9J#3:0F,^N7":%Q'Q]90D^C",^F@3?QQ$?38(/ MX(B/)L'J$Y31:HUU)RBC2;#\!#'5)%B%DICE#5QKK#Q!M#4)5IP@VIID#6%BUJRQ!*L,$[,HC258 M,YB8M6DLP=)!C+\T"=:))685&)?!JJ_$K.EB"=9PH0::!"NR3K.&#]0D?7*$&6JN\6:#75,M@ M=6EBUB=JM;Y"K34)-F,@IMI;@CT9B5G_S]:PZ0)WJDFP]P+1UB38@I&8'0!L M#?LLX!U-LH9DK4JPTR4Q>R;8&K:SP#N:!+M:X!U-@LTMB=DUP=:P>P5^TR38 M5I:836-R\3L!.0RV(*9F-U_+,$> M2_A`DZPA6:N2#21FOR1;PTY6Q$>39)"8W9-M#';' MPV^:!)ODX3=-@KWR\)LFP69X^$V3X,`(^$T;/>'<"/A-D^!P"/A-D^","/A- MD^"H"/A-D^`L"/A-D^!H#OA-D^`T#OA-D^#(#?A-DV20F%,>^*G"`1SPFR;! M"1OPFR;!*33PF]8BX3`:^$V3X,09^$V3X.`9^$V3X/P9^$V3X(`9^$V3K"%9 MJQ(<\0._:65PC@_\IDEPG`_\IDEPJ@_\IDEP;`_\IDEPM!7\IK5\..$*?M,D M.,8*?M,D.,T*?M,D.-0*?M,D.+4*?M,D.$LN,<>8\1."(^428@^58@D/^$G.^ M'$O6D*Q5"4Y.3,R)>EQF"XDY6(\E."8Q,>?KL02G)2:9*L&AB8DY;8_+X$!7 M^$`;6^)<5]R/)L$IK7C>-`D.:\6SHTDV,XQ'<28EUR"'Q)RBR1*U/D@NCA.^^#-V/VZ_[MK;IZ_WC\]GWW=? M,`M_>?C3.$_37[R;_O.R_X%%#?AK=OL7_`6[PZ_?\)<)=SAX^_(=9OF_[/"^&" MLFZ-PEF`/-+5;$>[PQI]__9XER-/2-SM<,,ZLD9O1*#[S?MWJS/CS^)(B/1` MH1-K=)2R7_J^J(^DQ6+&>M(!LF>\Q1(>^<$7/2=XIQ>UC1\%0>:WF';(*"SY M_VBP_9[6I&+UJ26=-"*<-%B"?W&DO;BHM?7_R+68/Y_ZNYJU/4AL:4/EFQ9% M7ELOGPX=XWC;0-ZO88+KB[9^N)%O:>$O?%#:K'84,E!E M]SC9K]%#N*P6R-^L='U^4'(6UF]/'-GY`Z>[3[0C4&QHDVK`EK%G17W:J1`L M]F]6/^H&?.'>CNSQJ9%?V?DCH8>CA&ZG:DG-&M@)/KV6JA&`S/&K_C[3G3RN M49S-TGD0AU&*O"T1\I&JM$DNO.J-*4;J*S`9&_HGE6K2\-4 M=(T@@[$9BW2:7F$HN>[F(DIR!R]M/,NST.EF9>/S.(_#47_B#R;]-_Y4U*U) M,@KHZ2@,QZJ)&ZBLP&3/;+*GGFYK?A0ZK4T8.,D7AI/HXMPMLJFSTD9CMRXV M&(P+)_[F?_6G4->?XZ`PG,%?FCH>R@D4<$581%>J: MG(_9F@8:SF`R2ZY_'@V7$SA*G!PJ&_ZC23AN+).7Z5=1UYRS>V$XP_B'>>R8 M+VT\`_C:2G-VV?@\B;)KATP5S?5A#MV6\`,I2=,(KV:G3I_YF]48-;=6`;>6 M/OK]$8#+I,<'\AGS`^V$UY`]+`UFB?1W@]('"0 M!#,@[QF3EP=ULXTO')M?````__\#`%!+`P04``8`"````"$`H?1(I2X.``"S M4```&````'AL+W=O<9YJ0AME)R`!M]_[V1[)L(:V_D[A]:=*?EH3QDH2] M('S^X^_GI]&/W?&T/[S[D[W.]?OMV._U.[5\OQZ'3>OMQOGPXO MN]OQ/[O3^(\O__[7YY^'XU^GQ]WN/&(CO)QNQX_G\^NGFYO3W>/N>7NZ/KSN M7EC+P^'XO#VS_QZ_W9Q>C[OM?=/I^>G&G$SF-\_;_7O\Z_OKU=WA^94-\77_M#__ MTPPZ'CW??0J^O1R.VZ]/['G_;4RW=]W8S7]@^.?]W?%P.CRP_?YT+@\__=W^V^.9 MI7O&N]P=GM@CL7]'SWL^!]A3W_[=_/RYOS\_WHZM^?5L,;$,?=V=SNZ> M]QV/[KZ?SH?G_XD@HQU*#&*U@["?[2#F_-J83N:_,,:T'8/][,9@OPX\`':H MS;-@/W__6OI,.3$8+_\_C,RS.Y@+G/#F/WR!#.ZV<%_Z9Z3>6TN9\;L M5R896P+MN;G,E-\X-]U,,2Y3Q1P^6?FL$@FZY-G\C2=C=HGFO_QRBF[$1M!L M()OM>?OE\_'P<\1V99;OT^N6[_'&)SXRWSJL"=O"[GCKG[RY"6)\8OKC"YOD MGV]^L,WHKHVQ>V*,B1ZS[HLQ]9A-7XREQSA],5,]QNV+F>DQ'L;,R3!^3\A< M'R7`$,-8Z#%A7\Q2CXD&Q,0#8I(!,6E?#,EH-B`F'Q!3#(@I!\14`V+JGACS M,@MOV'27=ZLS_DY29B-(89AZ$E=#XC9#(AQ!L2X`V*\OA@RH?T! M,<&`F+`OABSW"&/H$HQ[0L@1)Q@"2S#MBR'9ROIBR!'G?3%D@RHPACZKLB>$ M/*L*0^!9U1BC/)(VW]F+L3K?N[V=,Y_G_#*1;_8VA36%#06'@DO!ZV!T>06A M2\4?$!,,B`D'Q$1],>3TQP-BD@$Q:1?3G>&L@W=.1CX@INB+(4^B'!!3#8BI MWX_1)AJ[*NJ;:)RUB49A36%#P:'@4O`H^!0""B&%J(-W\A,/B$FZF"[Q*86, M0DZAZ."=8RD'Q%0#8NHNAAVOEE!VW:PFE%X=\N;;,=N(+FO;)!NK+6*6S;6C MN32G"S)/UVK`C/3>J(W&9+Z8D%=B1PVX,LP)V;-=M=U8S)=3\O">&D`&]]6V M.;F$#-3&RX5&LY.&HFTJM]:(0DPAH9!2R"CD%`H*)86*0JV`EGEVKZ-FOGO- MX$PS3DZY+6(N3WXM8-Y,@=EDOC(F$W+"-K2/0\&EX*FC+J8S"P;UU8CY;&(L M(2100V;8'M)'C2C$%!(**86,0DZAH%!2J"C4"FB)9+>?:B+I$N;-[(Y/6\+D MFL86,4I"*6PH.!1<"AX%GT)`(:0048@I)!12"AF%G$)!H:104:@5T)+!"Z[* MW7:WJCC3545N1VT1(Q;1=&Z1W6@MFB\YVKP?[]!XEX)'P:<04`@I1!1B"@F% ME$)&(:=04"@I5!1J!;0$L1I-7X(XTP21#-@B1B2(O53A)K<6$=-F'Z0;8-?6 M73$X%%P*G@#Q@,L5;EZ^&F!,%[C[:0%S:`_I0T848@H)A91"1B&G4%`H*504 M:@6T?/+R:%]"&Z<9)9<&=AO4IG0V(4MRW;;W)Y1V)INJ(SMW&7=!/"E-X4VO M+_A:(YE.P7N-H6SL'CH"B4$2D!0D`\E!"I`2I`*I5=$SS`L_RIY*7^!X:1O6 M+BG2V6V0R+0YGY/+T'7;KFRO'_1PH(<+XH'X(`%("!*!Q"`)2`J2@>0@!4@) M4H'4JNC9XU6,][(GJASZ+0:Y3+?YVPXLQ9?LK$$V(`Z("^*!^"`!2"B%+UNR M,B/9V"V^N!4Q^:[F*[8/DTZ)[-0S8BH;NQ$S?<3^2^X85Q;Z$BPJ#EJ"+3*JS=_^(^N:R@9B'!`7Q`/Q00*0$"1J12S= MOI4;0Y\$)`7)0'*0HA7QV#.3U39@X970JP*I5=%SQVL#?;D3-0,]=V32VOR] M5Y([*AN(<4!<$`_$!PE`0I!("I_OY/!CV=@MF`0DE<('(',WDXW=`+D4'FZ1 M:\U":YV1DDHI6[O1*I!:%3V/O#2@Y!&ND$3I0,\G.0*;O_E-\DEE`S$.B`OB MM=)>>TV6/84,EY`>"]EHL"@IXS< M8=C\DPK+)>DR(Y=:#G1Q03PI?**3>>3+QFXF!R`A2`02 M@R0@*4@&DH,4("5(!5*KHJ>2EQJ45,I+'%&"T%)(J]NV(8)$"A=3=F>BWP2N MVP`UA4IIHRE&.S*&YV-**T>N_AC6TB)[H2?[=RGS00*0$"0"B4$2D!0D`\E! M"I`2I`*I5=&3R.L+2A)A"Q7U!RV9%BD7V(8($LFTEJPB31;'NHUXHZ"@=CPXME(W=H44@,4@"DH)D M(#E(`5*"5""U*GI./R@CF:*,]/X;)6V0FEO1[2(;B'%`7!`/Q`<)0$*0""0& M24!2D`PD!RE`2I`*I%9%SQ#;77M7'7>RZDRZ]YHB2"R(F4$WOG7;KN;I_1X. M]'!!/!`?)``)02*0&"0!24$RD!RD`"E!*I!:%3UK;U1XS+X*#WU+I0T263.- M!=X:K-L0-7&T".1`C`OB??Q0/G0*0$*0""0&24!2D`PD!RE`2I`*I%9%S]T; MQ1O^Z6=8<>3*U&Z#1.X6LQG)[;IM5Q,GAI4]R/V,`SU<$$]*W[V';.Q>L`*0 M$"0"B4$2D!0D`\E!"I`2I`*I5=$32"HX]+*5_\$&)))># M!"`A2`02@R0@*4@&DH,4("5(!5*KHF?Q@U*.V5?*(6O,;H.Z%65:4,MI(_IO M';7NQLQ:+&[2-;.Q. MG`/B@GBMM#O'?,(*#7COJ-:EWKIW[`I1/8<6PL-&(#%(`I*"9"`Y2`%2@E0@ MM2IZ3C^H#IFB.7NY8(DCD;K6PR+M0Z[9=31SI049TH(<+XDGINW>4C=UK:0`2 M@D0@,4@"DH)D(#E(`5*"5""U*GH"2>&&WCM:?04<0@!4@)4H'4JNC9(Z4;R%Y?"8A&H:>*E%[D@NHKN9`WTVU+!*FIHK*! M&`?$!?&D\.5#5H\O&[O5$X"$(!%(#)*`I"`92`Y2@)0@%4BMBIZD-PHB5D]! MA%X_V&V0F`LK@Y4Y296S#;AD<0/B2&FVL_F4O`RZ^H.8TR6YU?#D`%W.?)`` M)`2)0&*0!"0%R4!RD`*D!*E`:E7T+'Y0`K%$+4.[[*>7]78;)/Y6>+:<36?D M;=RU%D'JA!NMT5C,H%[M:!%7QGQ&IHNK!4S9=RXLR!%X6L2";!J^UDK?A`ZT M5G+T8=MXF:D12`R2@*0@&4@.4H"4(!5(K8HV'=B7G?7>_35.ZBT6O91I@RYG M8BV%KU!RXC:RL5M]#H@+XK4B=@[V9^4F?OK%UV),:]GW"1DYMH] ML/K+Y)I_Y=E1?.F<^,_Y\-I\?\[7PYE]AUSSZR/[99WM;:0W=5"DN/T[SO44"O.2$Z3AR3+.1H>S@SG4.+]AZ^G MX^9+W?5->WZ(Q&T<;>KSKMTWY^>'Z*\_/]UDT:8?JO.^.K;G^B'ZM^ZC#X\_ M_G#_UG:?^Y>Z'C;@X=P_1"_#<+G;;OO=2WVJ^MOV4I_!?7R\VN/5W`Q5-S;(9_1Z?1YK2[^^7YW';5TQ'6_57H:C?Y'G\L MW)^:7=?V[6&X!7=;)+I<<[[-M^#I\7[?P`I]&X*'MXNG/XT9^+W;[.M# M]7H<_FC??JZ;YYGQM4`++WZ.O[[UNR'EX=(F=LDC960 M2;1YJOOA4^.>C3:[UWYH3_\@2'A7Z$1Z)QIH>KN\E5DB$O/_7K;(:%R)K8;J M\;YKWS90'C!G?ZE10ZOM]^@2CM M/*9`3!YMKAA)$>6$<)%R;FTPL`5B5W:P9LY.Q5A_!5A.\4-#<**0\"(K2@,!OK#"=7'/HK#PV M;*(",4%L^(`-!LC2LC"TQ M*S.;*3W7?^<<3]$3V);#)B*TH85>>!#&[T:K=$X0!I`"!/09M@9+$28.7%": MKA&OT,3^3/LKRU,A$!0TD<6(#4?HQ*[WKDR,+3F,CV+%70C$^/!(I7B"2X_@ M>Q#WYSM&RLXUXA5VV)]#=A!\GCT$>7I"&L,"5PJ"R)^GM4S7DR=PO?+Z)`R'F;%".KF^O<,1V3G9"LF@H4\^?3E^E MX",V'*$3NVZ\,C$VZ3`X>J;NDQ@VN42N*\(XS#FR*0H/\D6N0=)9&`E`2\D6:8G]1B3O MI5I"-H-4\]/3:.9DN?I[$))-LB,@ZS$S!O M"X4'!>JU&+'A"*VW=7V0*_J0S+T;-ZT'30TK$9`NGDTB$%+'6[7E1[B$MQ8/0I;0.I*%BA&$CA/#]ZX'?)OBNC+(%67@9YS"@Y"B3%/% MUE`2@("C&@-8#_@VPW5=D-C@:?/CVN5!4ZKU\IV'(=3B;<,RA#;9O-]HMM=U M1"YU1/!4%1[DB2HXD3"M+RE"F#3E.DL1!K[$7*N:\EQ7$[FB)F9VX?=.J"8W M(!?PYSK+""F]GRGF,A5$*KR4A=UP.L2/PZR_\%>PPH."_K(8 ML>$(G9AJ!6_#:N4M@LM2X4$^$`(^9%X7B9%B`,4!E@%"=:9LORT:RIF9:)BY MB#&S'L2WHF>*'E:-UC^)ZY1Q'A0W94G%8A%3?*L@&]K,=>%9(@CGRN$+#0]I M:$\3+CI6A78HS#D*E"J5EP75%9DQ7&94J"$:)(13)?:4RY0ES\-+S+P5*56J M,0NJ*UK#E:10",*H"IGS%^*2`D3,ORA8`@"]E'/B*-MUN5$K048/[A9L]J!U%IR'D"7><>'-T*GNGNNR/A[[S:Y]/8\7 M4X_WUU&\6RO@;FV\G]I>#7#C=:F>Z]^J[KDY]YMC?8!'X]L4&F:'EV/X8V@O MXZW-4SO`7=?XWQ>XQ*SAUB.^!?"A;8?IA[M^NUZ+/OX'``#__P,`4$L#!!0` M!@`(````(0`QUHK^#P8``.T:```8````>&PO=V]R:W-H965T&ULC)G;;J-($(;O5]IW0-R/H;O!#E&<469'LSO2CK1:[>&:8&RC&+"`'.;M MM[IH8ZJHWLQ-$A=_UT]5]]=TS-W'M_H4O)1=7[7--E2K.`S*IFAW57/8AG__ M]>7#31CT0][L\E/;E-OP>]F''^]__NGNM>V>^F-9#@%D:/IM>!R&\VT4]<6Q MK/-^U9[+!J[LVZ[.!_C8':+^W)7Y#@?5ITC'\3JJ\ZH)QPRWW8_D:/?[JB@_ MM\5S73;#F*0K3_D`]]\?JW-_R587/Y*NSKNGY_.'HJW/D.*Q.E7#=TP:!G5Q M^_70M%W^>(*ZWU22%Y?<^&&1OJZ*KNW;_;""=-%XH\N:LRB+(-/]W:Z""FS; M@Z[<;\,'=?MIK&S;)RO] MNK,A&!PM1G_!&?BC"W;E/G\^#7^VK[^5U>$XP'2G=DC1GL`)?@9U9=<`E)Z_ M;4,-#M5N.&Y#LUZEF]@HG8;!8]D/7RH[-@R*YWYHZW]'D4+W,1?>P^=\R._O MNO8U@(D%=7_.[3)1MY#8F;L,T^U`5PJK?K#R;9B%`1CU$'VY5YOT+GJ!^@JG M^31JX.>DT9,B`MO)&_QFWA<+&[46M@'6\],8F.O0:6T""MA%BY$B[BR2"T$LNE,6Z:Y@PO1(CP@PU:^*,*PF5BR MC*.@+EJ$!V8ET*P3VJGI4`--TO4,%FPA%-^I1YB%8"TF9MIAT6 MK[/\$M*9!VGU+M.H8`X2U9F':BU032<:%=3A$B(3G7F@UI9/MNW1U8H*YF`' M08C.@@=J+4&=D4<=2IB%HYH6X:%:@XH7D9#-%17,P0Y:%.&!6@M0,QY0PBP< MU;0(#]7VQ,6+H#R@@CE(3^C,`[46H%89[=,2:AP%KO,BX#PO/R.T`/4&CI03 MRXT7Z\Z]E"M!:J3.%NMKS4XA.<.+D2; MY*':"%3K&S(/**%MNH2HA0=K\R[6J&`.`M8Z]F!M!*QU2HMP#,_ZA*/`%:Y, M)SX=>[`V4"HG@LXU*E@1=A"$Z%Q[L#8"UNPX@!)F(6"M8P_61L!:T8,92IB% MXYI.MH=K(W!-=PY4,`='.NF3\F!M!*Q-0O9PE#`+"6SE`=L(8!MZ`$<)LW!D MDSXI#]E&()O/]A)M'`6NU,*#=B*@G:G9_H<"6L,E1`T\8"<"V'2N4<$<)+"5 M!^Q$`-ON?]<]'!7,P:%.:_!PG8#J_[E&!7.P@R!$UZN'ZT3@FIV04<(L)*Z5 MAVOX&N"](AS#L^T/!RV*\&"="%AK3798E+`B'-=D)K2'ZT3@FNZPJ&`.#FLR M$]J#=2)@S1X3*&$6$M;:@W4B8&TR\K\*2IB%],36'JQ3`6O:)U10ATN(]LG# M=6H19>=P0\^P*&$6=A2$Z&1[P$X]8%\/-JA@#A+8V@-V*H!--R=4,`<);.T! M.Q7`UHF>?V^&$F;AP(9:KJ<.[0$[?1=L5#`'QSJ=:P_8J0`V7:^H8`Z.:U*# M\7"=OLLU*IB#Q+7Q<)T*7+.I=@S/MC\P>)WVZ!*B%7B87DM,DWT)%3GU0M,\-,*2A25-T>JGQ@.\T>#RY?1A?=D33 M%7@'<\.U1-'YS*/>3$S@3=^+IB_#"T9[A1>!/1#O#V`?\\PFNE$K[# MC^%`$NS;=KA\L"]$IA=5]_\!``#__P,`4$L#!!0`!@`(````(0#L&PO=V]R:W-H965T&ULE%Q=;QR[D7T/L/]! MT/N5IGOZ8V9@.W`WV;L!=H$@2++/LCRVA2MI#,WX^N;?YY!5;+)892OWQ6.= M*I*'9+$.V5]O_OS[T^/5;\>7\\/I^>UU<[.YOCH^WY\^/CQ_?GO]C[\OO^RN MK\Z7N^>/=X^GY^/;ZW\=S]=_?O=??WKS_?3RZ_G+\7BY0@W/Y[?77RZ7KX?; MV_/]E^/3W?GF]/7X#,NGT\O3W05_OGR^/7]].=Y]C(6>'F_;S6:X?;I[>+ZF M&@XO_TD=IT^?'NZ/[G3_[>GX?*%*7HZ/=Q?P/W]Y^'I.M3W=_R?5/=V]_/KM MZR_WIZ>OJ.+#P^/#Y5^QTNNKI_O#7SX_GU[N/CRBW[\WW=U]JCO^H:I_>KA_ M.9U/GRXWJ.Z6B.H^[V_WMZCIW9N/#^A!&/:KE^.GM]?OF\/2;/KKVW=OX@C] M\^'X_5S\_^K\Y?3]OU\>/O[OP_,1PXV)"E/PX73Z-;C^Y6.`4/A6E5[B%/SU MY>KC\=/=M\?+WT[?_^?X\/G+!?,=V[L_/:(E_'OU]!""`'V_^SW^?G_X>/GR M]GK;W+2[ONF'MK^^^G`\7Y:'4/CZZO[;^7)Z^G_R:D+S:RTMU[(%3ZYEN.G' MS;;Y`Y5T7`E^N9)F<[/K^V[8C:#RD^9AC9W`+Y<$H9_X#^R/7_;O;L9FL]_: M[=S2F,6Q=G>7NW=O7D[?KQ#!&)3SU[NP'IH#ZN)!YI;780;ZV[MV.[ZY_0WS>,\^D^$C/>;D$<8_5.MJP-?`4@"WH+[RQRC]$?[! M/?!/+4\)R!W:5F231RKB:L#7P%(`@BQBJR";QC2@B%DQICM)8B*?85R)SPIQ M"O$*64I$4$/$%M0X#FYR,.E0""40-?@I8F%?\2:G`4DY.W4;Z32O3NL0*\0K M9"D1T14LH;HK>V0?6DRZ'\$]]B.U/A$RB"COFHKTZI2*.85XA2PE(DAC[=6D M0W;](>O@+UD34K%N*]:KT\I:(5XA2XD(UJ-FW89T^:.Q#OZ2-2$5ZWH)KDXK M:X5XA2PE(EB'+4*5\[8_"9#@+DD34I'NJJ%>G5;2"O$*64I$D$8T%J13[@BH MY$9(6V0*A3B%>(4L)2*(-!@J@TF$)94$D6B'1#]KR&G(:PA;#>IIK$OR"=*0 MIS.-3$.*@?R4QG]*$,*YR$9]-6_LU>[6@DY#7D-+JCX.O:08!,&@2#HA*#*$ M,"@H#C5%\FJSCKE&05Y#"T--+"@I!F4P*))@"(H$A1534*PV`7/#7IB%PJN2 M-9>\VKB5V`Y-6WEX]BAF8Q&0[$30!*,3)!6B$P2A$RDZ9IC#6MK2MI"V)0RU MJY=G+\&'O`B2?$*Z-_B0"@@^!&TQ:L5P56HZ8_L;*79QN)IFNZFDU&6/U"_/ M4!$L2_)"ALRM];DNV8F0_7,GRJW!Y8=(8B$Z1Q`ZETC-#4,Y M-3@-^00-:\$E0<8B"_D^\USS`,F`X$,09KKL?BWP#7O)I5C%IV.O;A.GI!L[ M'<%43Y>#:.%"5L2$_)\[\>I@DUR(SA%4A/'<,%2F"X*Z'.R>O;H\2PM#%L\@ M#S_A^??35Q$4I":")T.9U(RT%,*[RRG;:M\4>A`& M%&DCK_.N#F'VVE)6V??[*NUX=B@SB(#DB`5/\@E"9/`A?2HCLF7)$L+6U]NZY,62M5,I.#ND/GB&2M$0D"0< MY,0@3"HC"+,\%2+6,I23C=.09TCPH8+&4@_[>8L/:9'@P_(D1*RO]U>Q/N@L MB]B@!Y"K*6><(#'C)20'4`K6NHJT,+5:F!*4&W<:\@P)/E0709)/$`!C0DD7 MQ`"RY)01V-3K=<;>/NX"*`*;OJW6J\L..0*IC)CQ$I*$@S@8A$DS!&%6EC(" M&2HC4$$>1$(?!)\2DGRDV*P3JD4%HQ^'1D9@O7UFKVZ(FMTW*B&R#N5MA^Q_*EEA*%25 M!:.O]_;LU8UQ_/0F--M3%SQ#Y7P+2/*U)62K)80A\$TMS0R!7(*;FDEF:&1/B15P%Y]A)\R,OB$S)UYD-[,"0?Z_2PI:PN2'*BES%9 MK=F9"W9((D7DUIDQ>Z4.>X9"1L\%AWP6HL6>>.D]VS;D_=R[E)PB7"UV4@BY M&QOJ8P<7[/9Q<37ML*GBQV6/W`FJNL_K8&$O:SY"XC<8DQZ(H2>HV([-6X(0 M`*EQIR'/D(@/*FCQ"8G?X$-Z(/@PE-?VO"6H6,A.0UY#"T/&+GQKRTV$JQEE MH4"$KK'3U9MP+H<1"[=+MMVN51/*JI7'U',A,8#D90P@#I_E`+YV:(SNLB,, ME1/-$`)_G6@-^01EM5H8LGC:.H1#:)U'&0H2L0YL.U2)"('L56^7''N! M5AA_ZX2>//*696&(PDID5YSC_]!@:]&*-8@+37."\F'8,00B:?Q]@HH3.D,6 M3RE:*BBJ$SJ._6H2&,H1,">O",EA">D_+V)J;A.VJ'3C$(=Z53]!?;AV]-N[ M7^I$R"5Z#&">W2&O+MF\H3'-#NOB1W5E_J!;KG+W2O#@->0TM M`I+D;0F!X"J*!)57]]FK@)R&O(86`4D^(57GN5RGD#)XF9"QRXH4RQ!1D--> M7D.+@"2?D.,-/JP&.6U.0?[#K&*8/8K96`0D0@')PNR$EI#HB2R;MT1S@G)*=0G*J=\S)/A0 M]4:6#=G)",T(5X-*0B".!NU0'ZVX(-9F?+:BVH:Z;$[)QS-4A,4B(#E\4A32 MRNYU\F<(=%-+,T/@EB"G(<^0X$/5&SN"WE*-/CYV8)T.HGLUK"0BX7IDL>*K M??_,!+7HZ`.7E%2`Z+%"IJKL$S@_E.V$`*56Y6 M&((DQBUZ?0!+9A3,$SSF!"492.TA!C]]Q$FKTD"0W**/BM;JE>;!Y8()\AI: M!"3)2Z%*27L@]1%#QH)47*-@KW*+KB&OH45`DD_(WSFEK'PHK0L^#)51HB`W M*,AK:!&0Y&-+Q*`E(D&PY)A16W3V*O*KTY#7T)*JUUMT/#QI#AFE;3%D!,GL MIFZNQOI>O;F:O&A#U_35GL.SO10^` M(<&'"EHYS!:,L#RKLS5#(/>M)7FN6Q?$PU#Y9`*2$SQ*&5AY.!JUC8ZH##7CCL!T79J>&C>F'.PT=0D0H6KL38 MPHQ29%:Z6DJBISP?,E0T[C3D&1)\J'J+CZT;H]8-AF3XC?ER5[P(,"IXX*"#WD)/B4DUX,4 M%K5-JO;.HQ86"LH3XEA=_'-<%[QR>%+!5TZ(B9>1H&Q9&K4L M,21E2=T_8B_L!,,"Z^H%Z+(]=X':*@^#[&4EA*`&>N!1FR>$K5(IY[ MY,3Z[@7=,Z^.ACLM;@R%;5'>9-?GZCE[I5!V&O(:6@0DTO5.ZEWLR<]>OHG^ M57B3-H4M4L&]NJ8UYKP01Y[;4(2'(/(I0S6^0>@KJ>A+2IV)%HE2F/ MH8I[?9$W>R6B3D->0XN`)'[%5L[YR&O(`D'UN/=J01(E@(JO)F=4"< MN:#T4A?1V(L?,ABWZIS)#D;R""8[I#YXA@P-W$O]6(=&ZT3TE*>)!.5;2TY# MGB&K<2D*:^,ZV^\)"H]%Y\"NCU8S>^%P6'I5^NJR5QX?;A$K*E=?W,83X;\W M!*!M;WZ21F.)*M`HD\NYWM67^;@@'R7U43S;H8FNTC>3?_/A.5!#GZA(' M0^4-1X:*XX+3D&<(MT#`4PYFR-59D=80H!1>YI(]03)+[.K38_+B2^U=,U;2 MY+)''C.JFDX'DEZ9]_-UY+W.^PR)S$%>N.2:6G+L54`^0?%$*1LO\W[1N,[[ M>X)D-.G,P5Z4.:QWJU(]>4%[AJQX*F6@H*=E8$^0B!N&67(,V0TWFS* MG)Y;)URNM82]DCV26Y4^Z@-RX9:F%6]S!C9H%2/\>@)I-J4D8)F%3Q)L]S^\ M)TS^=9](/\*;-KG%775?"2^CDIL\].^JK29>4%W=BCYQ"_C)+?PH*39X$"HO MY'(^M)*0;WU=>5*:JLJ$O!-L9L^Q&@]3B'O=E[#F M#_C'LJ&Z-M1IV<(*/^`?RS;MA\,$D35:@R4HLK9X6((P:\NTWZ&VN(#K/L,2 M-$R7@8:B-LLR[1O49L7!#$O83%NU-:C-LF#_BS+V&'1HQXJ&>=^AC&7QL(2- MFV8P[3`Z."MKR[Q#3W%PU)9IMP<#,U9@"8R3`-F`8]$Z#+S@#6'.__:,@V8!=S3UI89EMFT M.%C"K7%=!G?KT8YE66!93,O4@P%M=.J<"$MX9LMH!Y;PZ):V++"$)[BT9>JQ MMFFCI-I!#C$M#F6<:<$S5^BIM;876,)C318#Q`&>@=26N4<6F7P M%"MZ:EGP-"=JL^)@ZGLPL.)@AL69%@]+>/Q0L\83D6!@6:8.VP2ZRUZ/=8<< M3^=]9<&(8ANNVYEZK%,\8J4M,RSAJ65M<;"$AY>U!<]3HS^6!8]5HS^69=HB M=O""C*YMAL69%KRBA/Y89198PEM`NK:I@R[@E15MP;L\A_`6C+;@_1TPL"P> MEO!.C"Z#UW?`P++@/<&#HW>:JOF9MM@)X;TU7=L,2WC)35L\+.%=-VW!ZW?8 MJEH6O+&&,N8*WF)T<.-1US;#$MYBU1:\6(O:+,L"RV):INT6[5CK9X;%F1:\ M@8IVK#(++(MIF5ID/KHZ48TU7F$_.-/B80DOA^N>+K`LIF5J$;UT^42U@^@U M+7BA&_VQ8A3O=:,_M@4CBLLDFMO48D3Q405MF6$)7V#0%GP4`CVU+`LLBVF9 M6N0W/&F@:YMA"1\JT!8/2_A>@;8LL"RF!5]BP8'!RE5SB^R"RRJZMJE%])JC M,\,RFQ8'2_C`AZX-WQQ!.Y9E:C`&>,%'E\'GD7`$LBSX!A+Z8UGP*20<02W+ MU"!Z<`P,"R3`A$%CK5_O/A__ M[^[E\\/S^>KQ^`F7*C;QBMX+?=>5_KC01X.N/IPN^$HKKF;@XA\^P'O$A^,V MX0["I]/IDOY`YV_73_J^^[<`````__\#`%!+`P04``8`"````"$`G\UCID<6 M```R9@``&0```'AL+W=O]Y^?A:#209_2O;>=+6_ M"`:#P3,SDWK_][\>OEW\\_CT?']Z_'`Y?S>[O#@^WIT^W3]^^7#Y/_^H_G9S M>?'\?F> M75T]WWT]/MP^OSM]/SY"\OGT]'#[@G\^?;EZ_OYTO/UT3O3P[6HQFVVN'F[O M'R^MA>SI5VR/-QE[9?'T]/M[]]0[K_FJ]L[9_O\#S+_ M<'_W='H^?7YY!W-7UE$N\_9J>P5+']]_ND<)3-@OGHZ?/US^-L\.F_7EU6_3S^:X_V7KR^H[G-^=Z=OR`G_O7BX-VT`1;_]Z_S[X_[3 MR]_'Y\?JGN3=K+B[L_GU].#_]GE>8F]\G(0HS@UQG9 MO%M?SY;SQ:\;68H1_(J1!7+]10]6DAB_+K$OQ1N>P[US\?$KZ:Y_*=U&TN%7 MTFW?S5>SC2GO&]FA>YVSPZ]S\TW]K>CCUV7SIOX<#<56IVDQ4E6(R1LNS:<6 M@/^1),MWJ\7Z^N9<>V\E=?4^]Q6_>'>S7J\V-Z;UO)74U?;<5W?0[MY*Z:IZ M[NMZ^Z:_5[;)G[M*89.L>%=!+Q>^HVZ+UW M1OTWH__A$G6!#O$,^L^/B^WL_=4_T0_O1&>7T-$:N=,P'3G0,^U,LHC$[#)2EB M4,:@BD$=@R8&;0SV,>ABT,=@B,$8@T,`5!C1-\(PNG9H,,9IU0[G.CP[J[.Y MGD*:$RF(E$0J(C61ADA+9$^D(](3&8B,1`XA4='#^!!&3[KW.S\R<0\W23`: MX"?HXHLHM%9I@S$\4(K&@7Q2FMHGD9)(1:0FTA!IB>R)=$1Z(@.1D<@A)"K: M&#]?B;9KMD;C'%P7DITE6\Q5023CCCXIN60%D9)(1:0FTA!IB>R)=$1Z(@.1 MD<@A)"J26%.$D73A,UB'SY)%T,>)%$1*(A61FDA#I"6R)](1Z8D,1$8BAY"H M6%VG8V6PCI40NP0VTVY.I"!2$JF(U$0:(BV1/9&.2$]D(#(2.81$QW_VQ.Z$7SJ?5CE'7,102M#OB31$ M6B)[(AV1GLA`9"1R"(D**]:#85A==S58A\\2,_WX0*S6.A"Y*&%AY96VD5)A ME18WT^1>2C+4?9!LJVU7D](49"*-):O%9+J==+SIY2R:$_>3DC/=$>G)]##I MA*:C\7^+8,KE^-FJN::42,H,-^RUIY1QZAG6X.@ M8#$^,CHHI"-L]@=!A,.5;&KD-MOQ./(6J<@+PL_4:A?;FSCR5BL(32GFK_WP M4S&J&36"`ENMTUI-];-GU#'JV=;@M+Q?(Z.#0CK,9B<1A'EJR':'@5V!ZPT[ MH9#8Q&1@>%=.S,OB`5.[M?4+&S M:!7.@\M9-,7E9@^&"%]CK)]:YW)&@['56OB3@U(2*O.+5=2L*]%:KNPQSFJ] MB8;K6C0"TPVC]I=RVSLM/59%A>G8?,]H<+;"\%'Y1M%ZO7P'95K7I=F9I.K2 M\&@6M0C!=ETC-P=IMN(<*@0%H2P%!0DK07#9):PY8<.H95M[A_RPWW'"GM'@ M$OH"C8("OPXJH8Z=V:FD8F=X%#N+EN',MYQ%,U\^MUHWLW-#G4>MM!!Q,.J4 M@I:+XGG,<7$(I MR_4\6G>.7L%E=E!F=.68K5&J#B.[J2]X[.SF@E`3#A6"5/0EH0]N MY6QY5'/"AE$K"/%V.>X9=8("5WNV-3@M[\3(Z*`2ZMB9_4\J=G9?A-'$^;B; M6Z1&X.4LVHSDHH4!WARD7[^+EOV%R-6@80W+H+9>+Z))HY(T05>MV4S#J!6T M0L_PLTWRY6UV]EC/?"=)%I2&;P65V M4&9TY9A=7M"P?[;U,8^,HWE64#`^YH+"H5R0JA5K:^V;7R5:`:H=\DVY85NM MH)7?F^P9=8)N_*S3LZU!4.#$R.C@T-DO'5.SI0MBZO8Y"[O5"P<+07HHCR?A M7+2"P:)@5`I:8X+T0R4MS%V.=EI8;FAG4#L[?AYN.+?6:;V9VUZT-FH--H\Z M=)>TQ7U!=LI^%!V2">,BCZ*UDB*OUHMHKCPX._:=#_6@-=JS_K1_\%YV85$X M(0A2%6JU`E2*UMJWZUE[0C5^Q=*S5"PK\&EAK=,C[ M=1!D_=+]PVPJ@_Y!,?W'Z3OF!:Q;[&L!"[L)5?U&]J5^Y9:+5O"TIF!4,JH8 MU8P:1BVC/:..4<]H8#0R.BBD8VIVA4%,I]C9W:**G2`_[.;FK1HSJGM4,"H9 M58QJ1@VCEM&>4<>H9S0P&AD=%-*Q,_NU(';4'J,'-PN[OU,Q%12V1T*%2^BU M2D'JZDUHX91RVC/J&/4,QH8C8P."NDPFYU;$.:IB=H=G0JG M13]YE(.N;EIM=+0=[5D*T5(+#TF('S]3;J-)H7+F?6W5C!I!X0,=K^7-\Q,= MK^7JM&/4L_G!:X7FHSEU]%K._$$A735F_Y2J&KNO4E5C47C0C=`FZB%:EA:B MI>I!$J*G3/7`SW6<>;\`K!DU;+YEK3VCCE'/M@:O%;H:]=/1:_F@3V4$TD%_ M94^)J9:6V+*!].-S+EI1XZ>]D$T(OYQ#I4NH@Q[M6"JOY1+6C!I!@?F6M?:, M.D8]VQH$A<]U&!T44A%>1CO/GPWL9WV](Q44-G>'L!R=6BT_UQ&M(#2E2^@K MHV)4,VK85NNT_+'0GE''J&=;@]/R?HV,#@KI,$=[2#>PF[UMM%=TR(^IN:`@ M4`6CDE'%J&;4,&H9[1EUC'I&`Z.1T4$A';M7]HHX7:;86:3WBO1<1Q+^Y+F. M:*'KN.Y="E+FZ;E')5IRK+9(/-=ATPVC]I=RVSLM/59%,TO'YGM&@[.%I:[O MMK17%*W7RW=0IG5=FFU78A9=VNU8.(L*"O>$@L)#0D&JEJRM(&$E6L'Y7,T) M&T:MH,#6WB$_UW:#0=,U3)^:*I*/ MOT5+#@FW[^)EH M+38LTD,P'7\OK98\V)G'2SX1JT'#ID#]GK^IX.-O20,%5VDUFVD8M8*BYSK1 M`+WW6LY\YQ`J?>K$B89M'0_*,DA"5Y;%/'H\.GH%E]E!D#6C*\?L!(/*^>D* MT>XT1_UI_^"]Z]*B8)3-!05% M*1B5+J%?HU:"5GYRJ1WR+;]A6RW;V@NZ\1VK8ZV>;0VL-0H*_#HX=/9+Q105 MH?J'C2F^YT13,J^)1Z??9W4]3PC:JA50/!#F7LN-+P6CDE'%J&;4,&H9[1EU MC'I&`Z.1T4$A'>57-J6HHWC:%83C,1>HG%'!J&14,:H9-8Q:1GM&':.>T;0TSYV6;X^%H)OK\PH."[A9=/18>@W7B"M&-9MN!+W] M!*+U6L[\GE''YGNO%10Y?O]B\%K._*B0KHA7]HHKWBL*4BOJY2(Z[,Q%*UA0 M%8+>?IA>BA8>;Y_?L8I?:*J<%?]LMN:\&J>%)>+4*NCDI=5YK1?1NG?OK/B\ M.LZK=UIOYC7HO/"UN5Z1CLF6!@(VOB5;E/!J&14,:H9-8Q:1GM&':.>TQE>_5`1+\Y0.Q043F0X#-;#1.X2AA.93:AG MF_B@K92$T'(-N%)(E68=KJX2!EX+PMK`^5,R MJA32+H:+TD'+9:<-AIE2YA4.,JH?8G7(D%_O"":VT1GEU) M.*.CJ5P4PJVH2V./3A&H:+E0>@7G?J7,:%_#Q4K@*Z]5UA;!5VRF=A>MH')1 M4#5KTV`>,6WU9ATUU5*20.[:1Z6LZ-"%+U07'5FO>6H1Y)M=O#T2!56QU@S6!#9TT8*HE"20NS)6RHIR%6\L M^NG:A^Z,]7PB*&QU@D+G!`69EXPJE5#[DYX\S#NUT>I0D'E2/TT$R_@CCERT MPMIU">7)U_4Z#J!7F`*HS&B']73QL^7%AJ<10>%0*$AY;1,&[VF7HA6@RB$^ MJ-ZDIY$SCBK:3B-JAIW'N[U<$JJZMPE-/YUJA*=F28@ECFF^V^TF:O*5*&"! M@?#K6)NQWZTM,;S]9"F'#1(U&HN"R3@7+540JX4.[AI`*5KH2`Y5@M"6R4\, M\K%O+N].?CPC;8F;:Y<2G"_Y^.\^!$=_AXK_S M\7#,%QFN@4)>,5]FN.&(^6^K[#<4AP6[589+>A)\G>'*F01?S9#@')$XZ]4& MDG.[C"6;>;9#PV5KZ+U9GI04D)CVSVDJ2$PW8,ENLT0^J=*@,2.?E*2`I$A* M2DA,J^!\T(#A04JR6U]G.]NJHAA@BLS,3,36"DC,[,,23(B9F818LEMO4=)4 M+>20Y$E)`8D9JMD:9@^4)R79K1%1K+XX#9::*$]*4D!2)B585Z(\J32[]1KY MI-H.EF7()R4I(#$+'O:M@L2L>UB"HY[,G&*P9+="K.WD']5L03';IDY1&+)#I)=4H*SRRQ/2G"$F15) M"8XM,W.(QOG@P!(UEY+@W#(S1VJ`X`X=OJ:$:1]BHA90$I\^PEI+@,6]FGAVR;WC:FYE'B"S!0]_,/$ED M"1[T9N:!(DOP<#9C/UO#& M!&HA)<%[$:B%E&0'WW9)W_`P/C//;SD?/)//S&-YK($C^,S\U"7 M)3OXMDOZED-BWK#@-`4D15)20F)>KN`T>,\%[2`EP>LN:`=I"48*^WI$5#]X MT0LUE^HE>),+-9>2])"8]X[8-[S$A9I+2?"J%FHN)<'+D,@GU>+Q3B3R24GP M:B1Z<$HR0F+>XV/?\!HD/$A)=O#-O`7&:7)(S,M@+"D@*9(2O)2'FDNEP:MW MJ+F4!*\4P[?4&+*#U[NDUSDD>5)20%(D)7AE%NTZ%0.\)@NO4Y(:$O-Z)L<` M;\FB5:4D>%D6XTY*@A=DT=Y2$KQLCGQ2,RV^6$$^*4D+B7EEG'W#9RAH.RD) MOD;!NCK52_#)!"2IM1C>ZXOQ*CIJ+IT/VB@^*63?\'EG9KX_9`D^ZT0^ M*X-O=IB3XE!WUDY+LX-LNZ1N^G\[RI`2?46=% M4H*OJ3/S`2[[5D%BOL-E"2ZKR,R="BSI(3%7*[`$]U1DYCH%EN`V"NQD4Y(= M8K!+Q@!7(Z"DJ>C@5@24-"4I(3'?W;,'N`(![2TEP4T(:&\I"2Z904E3+1YW MS:"D*0ENE$%)4Q)<=9+MDC'`]2:9N5>#O<;%)IFY7H,E)23F2@V6X!:3S-RL MP1)<9I*9"S98@CM-,G.I!DMP.11*FIJ9<"D42IJ2[!`##I@S4XT--TZB2:4F'UR+ M"$FJD^(F/TA2N>1S'(?A%CHNS`Y]-#4MEABE4I/\#NPLN)I6]?A#'M]OOQR'VZOIK_V\O'?`@```/__`P!02P,$%``&``@````A`)FF0]HX'0`` MRXL``!D```!X;"]W;W)K&ULE%W9/G^Z_?_EP^C__RO]Q=7KR M_'+S_=/-M\?O=Q]._W/W?/K/C__]7^__?'SZ[?GKW=W+"2Q\?_YP^O7EY4=V M=O9\^_7NX>;YW>./N^]@/C\^/=R\X+]/7\Z>?SS=W7PZ*#U\.YN>GU^W=^O'V]X>[[R_6R-/=MYL7//_SU_L?S\[:P^W/F'NX M>?KM]Q__N'U\^`$3O]Y_NW_YS\'HZ4=S)W9!^5WOCZ[/H.EC^\_W>,-3+:?/-U]_G#ZRR0;%U>G M9Q_?'S+H?^_O_GP._CYY_OKX9_%T_ZF^_WZ'W(:?C`=^?7S\S8A6GPP$Y3/2 MS@\>Z)]./MU]OOG]V\O^\<_R[O[+UQ>X>V%4;A^_(27\>_)P;\H`7OWFWQ]. MITCA_M/+UP^GLXMWB\OSV62Z.#WY]>[Y);\WNJ3^?F%>=]7 MU";PP>'YS!^B.']W.3F_GEV^H>GR>((_1',R?S>?+BZO#KG\6JHN:R<^;R]^ M4G7N'AA_N&0G/_?$SA\=(GA#TGL=?=-T-38_,0?HO&J`\]LR3V4 M^/7-R\W']T^/?YZ@&4&N/O^X,8W2))O`JU+6Q9G'TH]*>&O$?S'R'TXAB'+] M#/2/C[/IQ?NS/U"=;D5FR3+36&+E)$R5,F;7*;!)@3P%BA0H4Z!*@6T*[%*@ M3H$F!=H4Z%*@3X$A!?8I,`;`&1QS]`Y*P=_RCI$WWG'YNG1`X*[$%4["J:Q3 M8),">0H4*5"F0)4"VQ38I4"=`DT*M"G0I4"?`D,*[%-@#(#(%6A"0E>X^F!@ M-/M1?;B,LWAI92XNCVY9$;(F9$-(3DA!2$E(1T+&$(F\@-8X]((T5^]\)\(MEE%!ZX:?H,FZ2EQDA2[0F@9"2;NV.@H=ZPHA M&T)R0@I"2D(J0K:$[`BI"6D(:0GI".D)&0C9$S*&2.0U=']_X357C8S$P4DN M:Y<6N4;+&'CD.G;;ZBCDU-:$;`C)"2D(*0FI"-D2LB.D)J0AI"6D(Z0G9"!D M3\@8(I%',.X+/>+<8.#8#1:9!FT7(6M"-H3DA!2$E(14A&P)V1%2$](0TA+2 M$=(3,A"R)V0,D2C/,;C3\MS`<9X+8F<<9GBT(F1-R(:0G)""D)*0BI`M(3M" M:D(:0EI".D)Z0@9"]H2,(1+EN9F2\_#VT%^\?+V__6WYB-9E"ZVMT/00.CC, M.S:BAO)SM#V;);.5_"AT=!8AI47FT^,8KSK*A*9G\1-MCT+.](Z0FDPW1YG0 M=%+$VJ.0,]T1TI/IX2@3FDXR>W\436TK4G/;[2:M^([-U@PU/Y52ZU,*,S>9G72JK8ND4^KY(095,KD5JZEODC4"S^:&J7L[. M+Y)F//<2+L,+ME,R5`DTO["FXUYZZUEG=LRIGO'!2- M*+E>VIP,\F@019]'LR2UO9=PJ8T"63NQ\\WT7'.^G;9#T1E9FK4$N!7.=]!* M('C:06N!@D?>.$5O*V>H8,62H4H@^-&EN&5HQXHU0PTKM@QU#O)#OYYM#0+! M+>ZY]@R-D6+L!S-EU_Q@I_*1'RP4]ZKSI*M93:S46[VJE8J:3#%OF_3Y_.(B M:=)S,1VUH&2G%*G`="60=(Y)@[#UK,O"'=NH&6J\8E`)SY.FH_52SGS'MGJ& M!H'PNF:I"1ER237NF&7.]!C9B3UM`@6:IR6`X$O0AJ/>S4."8C5G1-@-5WVWF#!4"S7R_5@H4V*I8<']G\ROT`/$(\?"R?BV]N2DZM^*KFM2%TM;'))4CM. MJN:DFI]*JO5)^?>?I6'-3K5%0U5^B$%5I"FD2`79.TLFL:,3.61O7'!,/.AO M5.RID4\*E(50H%Q#LA*IJ/18J0#:B-3,#WYS@>;>5N$@7_U+-E^QK:U`5[Y% MV+&MFFTU;*ME6QU+]6QK8*F]0,$[C@XZO&/LGR181`WOOQY_P!THZG9KSY2# M2`[RV;QB:,W01J"Y'U#E#!4,E6RK8JDM0SN&:K;5L%3+4,=0S[8&EMHS-$90 M[!\3'PGJS]$/-FX2=H!3"QE?'QO+V3P99:]$"L,N5YO6#&V<+;\*DC-4,%2R MK8JEM@SM&*K95L-2+4,=0SW;&EAJS]`80;%KS-Q?8S;TQMW86B2"$<=&H'D4ITC;\%RD)"@QO3@_3Y9K"C9=,E3]5&I; M)V5C.9.ZB*:>;N1%R,1LM$)D\*0?M%`XP#4[:B&%$N,KLX6"M]B(%(J(D\H% M"J(AA4"!8LE0Q;:V#@K[07J(FFTU3M$_5^L@;ZMSD)?JV=;`4GN!@G<<(\78 M#R9"H/G!1@ZBRBS!A&@YA&*L4RMU;4.E9GF?*K.5B$8L8MI&,B;7%Y.D*.=B M-IA4%P(%=DJ&*H$DM)/4R:UG71'9L8V:H<8KAA4PB1RU7LJ9[P2*I@EHE^(& MK^<4!Z?H\FAQG:2V]Q(NM3&R$SO>!&1X"X71'NQY.E1`/X19"Q2X M8R-0X+2@4'2-MXB`IJ%=!*!"W>1I1<4SZ9SI):FWL)5[@* M@0([)4.50!)$2B*46\\ZLSNV43/4>,6P`B83M-9+.?.=@]!4'[M.I0)2'@VB MZ/-HFJ2V]Q(NM5$@FT>QXTWX17.\#`=]PR-`N$'KHG\8)8K M-#\<\'@D(M!U6'1FBZ3M7CFIO^X!10)EPY63C4`2R[]:7"2!H]P+.)V"S90, M50*AX?3E'0N8<8>S]5+._(YMU0PU7C$POTBJ>>NEG/E.H#H$NO(QI9YM#0(%+[1G:'30X1UC M_R2!&A<(0$TA/U@HFA+.%LF<9"6*MB6P'U@QM!%H$=8:CL"*U/SZ,'.]7,RG M26J%L^-W@Y2<6N6D7DUM*U(7)BKUQ\=DA+QS-GQ*-:?4.*E74VI]2F&E3D8: MG6J+AK+\$(.JR-58W.DR=S9/7GET=@ZO')>:)'ST9JWFL)(99J&B![/'E4!1 MT9'@DP\";D3*?H1K]^HYR$L5`EUX=Y5LOG**8:VV*5[Y`>>.;=5LJV%;K4"! MK8ZE>K8UL-3>0?X=1X'L.\;^,3&'UUK=)/R*WIUJNX0M?$!O)5(8;+N&>,W0 MAJ&G M,X%\)[9B:,W0AJ&PM6W@J&2H8JA+4,[ MAFJ&&H9:ACJ&>H8&AO8,C1$4NPO=:NBN8[4Q>#*7L-`;7V[,1"I:VZ!/-T0J M&EJ*(GZ.LUS^>,.9]P6A8*@4*/Q^PTN%YI,!PM9+N?*Q8ZAF\XV7"LTG4Z+6 M2SGS'4,]FQ^\5&@^61G8>REG?HR@V/,F7O!W*JJ-+T05U4+AIQPS@3`2"KR8 M3*[6(A6Y7Q3]_"-WMCQ4,%2RK8JEM@SM&*K95L-2+4,=0SW;&EAJS]`80;'+ M3"PA<-FQLMH80^0:@9"K@1^2.?0*"^Z'6NY'0&N&-@*%GW(P5#!4LJV*I;8, M[1BJV5;#4BU#'4,]VQI8:L_0&$&1:[#G0G7-`8_;48',!#]P33)36(G4&YM. M12JL2,Y\V`#S/-!)V9#$Y>4LW?5:L.F2H36UK4C)DD:Z5+)CNS5#S4\E MU?JD@MQ-M[QUJBV:"/)##*HB302=E,_=I"<8(]-Q23(A%J628Y=(VB,+A)+D MVON50.&F5H&B,F)M(8;A%'-GRT_2"E8L&:JU%2A8^=BQ8LU0P[9:MM6Q M5,^V!I;:.\B_XQ@IQGXPDWG-#W:2'S:V&&<8UYC)HZ_1M,XH4F]\RR%2P8Q] MX\S;\.QLL9@F'7_N)9P_"[93,E0)Y)8Z$KM;3SN[.S92,]1X19\CT_1KL=9+ M.?.=@\*`-:]U<(J#0)@@FE"3R:1TK<-+N-3&R$[L?1.ST+QO8QF1]RT$[SN[ MJ[F%PNVL`D5^%44_OLE%"F_A;!6L6#)4"12N=3"T8\6:H8856X8Z!_E9=,^V M!H&"%]HS-$:*L1^2L(L;\F`K&K6&%HK[U;1;6XGB6_VJA&I\%&LCBHC@'0K8 MQ?E5,GG(O81W'MDI12IHCBN!I'M,!FE;SSJS.[91,]1X15\):1VE]5+.?,>V M>H8&@8(,H1HG'@G;VS!#8D\G`9RW`@3:GU205XNDHZZ4VWQ>-:Z*LCQ057D M\:Q5E%4CD[T7R;+1Z`P=WCFNV":P$W2E;U9L(Y],F2R$PNG:J)59'894\"YK MAC8"A2L;#O)SWD*@<&6#;55.T?<)6X&"U8@=VZK95L.V6K;5L53/M@:6VCO( MO^,HD+*R@9;J=?\D*QL'^<0_-G@3;%5>.2D?J%LSM!'HVC>I.4,%0R7;JEAJ MR]".H9IM-2S5,M0QU+.M@:7V#(T1%->?OXCZH#92/=&B/K2QW"GZTK%F:"-0 M4,%RA@J&2K95L=26H1U#-=MJ6*IEJ&.H9UL#2^T9&B,H<@U"8E'5<:/3`QY7 M$8'BT2EM+!>I5_:BBD0PXM@XTZ_&8'(G9<>OV"^7GF)5L.F2H36UK4BA MU3&CY4DR5-ZQW9JAYJ>2:GU280^9C*([U1;UD/P0@ZI(/:23.N;N)'F`,3(= MER(3C0DZR&,ILE&:<*ZYL%`XPA4(1<;UC6N!HC(BBCY*DSM;?G1>L&+)4.44 MO:VM0'"W>X@=*]8,-6RK95L=2_5L:V"IO8/\.XZ18NR'OXCX+#CB(]`;$1^1 M>N4S$9$(&MF-,VT#&9/+Q2RI/+F7<)E=L)V2H4H@#-5,I9PF(>>MIYW='1NI M&6J\8E`#TPU[K9=RYCNVU3,T""2A'>1(6FWW7L*9'B,[L9M-V$6K;C8<$U4W MB=`$H9V%A<)MK`)%3A1%7RESD0HB(04KE@Q5`L%K[N6V#.U8L6:H8<66H8X5 M>X8&@8(7VC,T1HJQ'TPH0/.##1%$?I!`0K1D0OO(%U;JM<[32D0-HYBV#??% M1;H1-!>K"'.X["\$"LR4#%4"21>8S)>VGG5F=VRC9JCQBD%E6R2]3>NEG/E. M(+-Q\1BEYM`JIS@XQ6,6)>^R]P(NL3$R$[O];\9Y$)1)A[D"1;V@E8IZ08[S MB&(8YV&H<)"O<*5`@<> MH=%!'.=9_$6D,"*W0=CY5?)) M4>'L^-A+R:E53@I!A..31!;!3FF5TLIDGNCLX.1WF,X\+6_*THST$^*4XVI!-&>40J M*CM6*H`V(A5&>1SDY[B%0&&4A\U73C&LUC;%,,K#MFJVU;"M5J#`5L=2/=L: M6&KO(/^.HT!*E`>9\[I_),J#1L/>I&/O%7FX>_IRM[K[]NWYY/;Q]^^H+#-L M*?KX_H@?[_#YY=!!)O@2=_L^&ATN(Y3P; M#X.L%%_@4B%%'A4M,TY@2ZA-`;#5Y0WC<&\$SK:FV)^"1V-P303/M48S#;A4XW!=!(^U1C, M*N%3C5F"6:K,"LQ*9=9@UBJ#R3OR6DL',W3DM<9@HHZ\UAA$MO"F6O.):!;> M5&-Z,"8VPK4$@2RT51JS!V,B):R#H!7*J,8@,HBGUA@$"-%6:0R"@B@'&H-X M(,J!QB`LB'*@,8@.HJW2F"68I15NE,0BIPML:@U`J MO*TQ6/'(S'H&IX/UB\RL3C"#U8C,K#4P@[4%='\:@_`]TCF,#)*>$<%XI*,Q M"*TC'8U!H!SI:`S6)S.S=,7/AC5)6-.8'HQ9R&(=+$=F9CV+F3T8LZS%#%8> M\6P:@_7=K%09+/-F9CV/K6%I-S/+>LQ@51?YIC%8W,W,(A_K8(TW,VM]S"S! M+%5F!<:L;K(.EL%MCL(,$/M68$8S9BL#O@WU>T-%:2VSF@H[&+&%MJ5K#;B#D MM9;.&LQ:9;`1"#FJZ11@S"81?FIL^D%)U!CL_4%YTQAL\D%YTQCLVH..]J;8 MG0<=C<$F/?A48[!7#S[5&&S&@T\UI@=C=GOQFR[!+%5F!<9LC&.=-9BURF#K M(_):T\'^1N2UQF";(_):8[`W&&^JMC-E=RD^-K(*E^@1K,.;S M&$YG`\9\_\(,/G?*S&T MK+,'8SZG909?/",/-&8Y0QMO%P^2=/`='YA#9#)A\$%YME6MX6-RO*F6#KXI MQYMJ##XMS\PWQOS4^)P\,Y\:,X-/R.%MC<$I#\@#K8SB+`>\C\8L86VI6L-' M_YGY>IN?8`UFK3(X`B`SWW*S3@XF5QE\[H]2I>G@JW^4*HW!Q_]9]1<,6B3U M37$V!_RCY0&.Z(!_-`8G=<`+&H.C..`%C>G!F$,=.`^68)8J@_-/D->:SAK, M6F5P_`ER5-/!(2?(48W!62?(48W!<4&9.76&GQJG!F7FI!EF<"Q09@Z<8:8' MTZL,3@3*S%DSK(-C?Q"1TQ@>,8/3ZY#7&H-#[)#7&H-3'_&FVA@6)SWB336F!V/.#>0GP"&/F3D^D!D< M[(@RJC$XT!%E5&-P:":>6F,J,)7*X+Q,E`--!V=EHAQH#([,1#G0&)R\&8$UA9!R>N(DG(@\T9HDG6*I/@"-.47:T9\/1IB@[ M&H,33C-SA"4_&TXU1:G2&)QFBC?5&)QY#6]KK>4>C#D[F=/!\=9X4XW!$<9( M1UMRJ,"8XX;9&HX71HYJ#`X+1CH:@T/%84U[`IPMCG*@,3AB'.5`8W"L..J/ MQN`H<3R;QO1@S/G3_#XXU1^K,5K[MH3.4M7!\>\H!YHUG`*/Y4!C MQ]<>0,=C<'=-O"IQN"*&_A48W#3#7RJ,;C*!C[5&%Q1!1VM MK<(=5-#1F!Z,N>2(WQ373\&G&H,[IN!3C5GBV#3=GHHAJ#&[+1!'5F`V8C0WW:QH5(ELJ45_#D9I&@XB72O37*,H'C;-CY.;Y MX_L?-U_NFING+_??GT^^W7W&)I+SPYW=3_=?OA[_\V*OKSCY]?'EY?$!.X-. M3[[>W7RZPT63Y^^PP^SSX^.+^P^*T-F?CT^_/7^]NWOY^/\"````__\#`%!+ M`P04``8`"````"$`*>O@QE\&``!2&0``&0```'AL+W=O#_A$D@;U'35A/M%6JWV\DP)25`#1$!/ MS_GV.P8,MH?-MB]-\O-X;/X>#V/WZ;Z*=,.?C9GI;TU>7KL.Y5715?5C5*F124/'JSF,S[JTZG( MREN+?569I]Q5Z;-V_OM6U:7-W#Q6ER+[F?O5);* MS`K.5=VDKU=X[A^:D6;4=_\#N2^+K*G;^M2MP)TR3!0_\U;9*N#I^>E8P!,0 MV:4F/^WD%\U*-$-6GI]Z@?XN\H^6^2ZUE_K#:XIC7%0YJ`WK1%;@M:[?B&EP M)`@Z*ZBWVZ_`[XUTS$_I^[7[H_[P\^)\Z6"Y3=(EJZ\P$OR5RH+$`#QZ^J/_ M_"B.W64GKXV5_FAJYD8W9>DU;SNW()UE*7MON[K\9[#21E^#%WWT`I_4RV9E M/JAK[0M.UJ,3^*1.F)G<&=T8.\+GV%'35IJA]D]PIQ\\7__LF[F?.<_Z3L>' ML2-\?FVFL+WZ$>'S2S/=COTT$@CC`GQNJMJTP/#E:Y/5Z*J2+W343PFKT:4D M7VC/N_-5AK#LP]E.N_3YJ:D_),@1,.OVEI*,HUG$VQC(8S!.H0T[+"/F+\1^ M)X->$+,MT._/YM9X4K[#7LE&FSVVT7F+`[4@^X6XM47@B,`5@2<"7P2!"$(1 M1"*(19`P0`'))MU@R;ZD&[$GNM$GWE,P"[D61*(6M(LM`D<$K@@\$?@B"$00 MBB`202R"A`&<2!!/K$@TA@B&/,C%D,D__'ZPV3Q,@AT0L1%Q$'$1\1#Q$0D0 M"1&)$(D125C"*0.IE%5FW':K!TB90U[$.X]T@5T*'\S6VPBR#48;R'^,T0-O M=)B,ILA"Q$'$1<1#Q$*H/,>?U&0D3)R,Q M(5]-^=HP5'Y7V;,5W58.1BY&'D8^1@%&(4811C%&"8HYKQ-% M*BN+;@@EPH&::;!BDWJZ6(W:C-DDWP)S1V;H4\GA,6;S".N-D/5\QHR.$"RP M$(\0,69W1H@9,SI"PC->:U*U,EOV_T*5'&*$6*4(UH".>*`,S@F4V0O,66#N MR/3'J:O'F)%SA*YJ0@7L,Q9TP&"!A=AYQ)B-SH4S2,Q84.<)SWA-29'+:#K% M[U#\#I<-_6%F3\YS1$X59)T""M"5/O3==_+C'(_VB#9S=#L4]3=)_>*Z(^*D'?PS MOGS:/?0P=R]H"XAAJ0RFACY&#D8N1AY&,48!1B%&$48T2N`^?9#YH-UWO# M?4B9-^?\D%^OK935[Q7(L-9@RTUXNE=\Z5\0`M^3^T8BB\AU"T['"WQMP>$0 M\Q?#>H&)XH:]8<$9:(&;%M3Y"WQC066[P#5PM#@"['V+Q"WN`WO>(N&+6V#K M6R2*<0MD`(L$,VZ!76^1F,8ML-MA;DLMD%*M_6(+9%&+;&;L#3*G1?8T;H&, M:9&MC5L@<5IDA^,6R)^6M]BR?["@=L8]#EL+RB',]YH*S[(4+%#1P+R66J`X M@7DMM4"-`FO3ITS-W)AL&``"G&``` M&0```'AL+W=O+\E M9`]*2?^]]_VWX4 MY6MU39):@@AYM9.O=7W7%*6*KTD654_%/>2%V7T@-M2)5."E*%Z)J7,B")P5Y&TV%?BCE$[).7J[U7\6'W:27JXUE'M! M7.+B!IG@KY2E9`S`HT>?.WD*&=)3?=W)L^738C69J=.%++TD56VFQ%>6XK>J M+K)_J9':AJ)!9FT0^&R#3!=/*W6RF:T@R!>.\]81/EO'19_\"S^(VO0:/EL_ M];&$R]9QU3D^V%.8&$U&^/Q63S>M'WQ^KZN#?56AF-2UK^IC MNL*0;#W[4CZHK,IJ2;X\U%^%#L5F"!^C.MIOR^)#@G4!'KBZ1V254342K1V\ M[4#JAC/,JIB8/Q/[G0P*PT"M@+[O%^O55GF'^1&W-CJVF?(6!V9!Y@@)>Q2! M(0)3!)8(;!$X(G!%X(G`%T$@@G``%-"P$Q+*_RTAB3T1DDF@,]`K.Q-48Q;, MY2@"0P2F""P1V")P1."*P!.!+X)`!.$`<*K!T$>JS1?=:"/-L$IRHVW-JZ)3 MF^6J4_*`R!$1`Q$3$0L1&Q$'$1<1#Q$?D0"1<$@XS6"6(LW(PM$M_WC6$A>8 MX?`QF+8;0(CX MB`2(A$/"J0B;**0BG?3LS4PL>-TH$7037\6=4:<;(@8B)B(6(C8B#B(N(AXB M/B(!(N&0<+J10]9@?\/$(I@7BY+IX#6"R!$1`Q$3$0L1&Q$'$1<1#Q$?D0"1 M<$@X96`/-Z8,P;PR+:$G&K);.R!R1,1`Q$3$0L1&Q$'$1<1#Q$]@.5<[78IC3VO&4.#X831D2%R%.A>$/.5\&(V!F9L MDIHCS!IA]@AS1I@[PKP1YH^P8(2%/./E)5OHP9S\7WGIEAMV+^SI=7).(Z,4 MELM.M^E\(;P2F%5?A"-#\W5S=IG#5ZDF<.DTK`6U6J\[*Z.U6C;W9(VN)D/]O+-P++M%@U@.<^QCN0SU ML3PQ`N;8QR)W>614+IM8=!S3NSEZL9$EY24Y)+=;)<7%6PZ##5[J^VV' MZ:6@OM)@TP`B"1SJI)&DN`4*Q.X1!1^X8'R>CGCHY.)QC$.@4?N9!J<^G/EY MKCV/=DF?:W!\P0[Z0H/]^`A?:K##Q!RFD$9JBUM@)FFDQ+@%9H]&*HU;8-IH MI."X!6:/1NJ.6V`2::3\N$5?:["'P1Q>GJ!N,UF$!Q4X[CK;``J>1N89]8&6#7C8*E^EP4 M-?L!J97N7PS[_P```/__`P!02P,$%``&``@````A`('&MU^R$```Z4T``!D` M``!X;"]W;W)K&ULE)Q;<]LX$H7?MVK_@\OO:XNR M),NL)%/1A?>;6'MYUCA*K!K;KWW?'T_[P^OXZN!E=7^U>'P^?]J]?WE__Y]_1O^;75Z?S]O73]OGP MNGM__>?N=/W+AW_^X]VWP_&WT]-N=[Z"PNOI_?73^?P6WMZ>'I]V+]O3S>%M M]PK+Y\/Q97O&/X]?;D]OQ]WV4Q?T\GP['HUFMR_;_>MUKQ`>_XK&X?/G_>-N M=7C\^K)[/?7QK\B];(^_?7W[U^/AY0T2O^Z?]^<_ M.]'KJY?',/WR>CAN?WW&??\13+:/1KO[!\F_[!^/A]/A\_D&]R!JO:KX^[S^^N/0=C>3:YO/[SK*NB_^]VWD_7[U>GI\"T^[C\5 M^]<=:AMY4AGX]7#X3;FFGQ1"\"U%1UT&FN/5I]WG[=?GGE$2_G_ULE=M`+>^_>/]]1@E[#^=G]Y?W\UNIO>CNV`\O;[Z=7WWU^/5T/KS\KW<*M%0O,M$B^*E%IC?SZ70RF]__=1%X=E>"GUHD"&XFX^G] M_.]<"AIPIX*?6F5\$TQ&,W4W/[B#!QV&GSH,`C_P#U!?73GJE[]34'!G`O'+ M7RMJ9B+PR]\JZMX$XIQ#Q(?I#[(?)#[H/!!Z8/*![4/&A]L?-!:X!9YN"0##>UO)4/Y MJV28:EP8,&3GSJMYXV%"5CY8^R#R0>R#Q`>I#S(?Y#XH?%#ZH/)![8/&!QL? MM!9P:AY/*M7\W>C2ZI49W:;3ZJ=NS2YZG]G])1M+(BLB:R(1D9A(0B0EDA') MB11$2B(5D9I(0V1#I+6)4_<84JCN@^F-&E?Z[IE[(16"'@L_K&YHYB6D=YJA M4[.<[EVGY<7I\D`061.)B,1$$B(ID8Q(3J0@4A*IB-1$&B(;(JU-G!PA%W:. MS&B@<)<'4WN+GHRMIX#(BLB:2$0D)I(028ED1'(B!9&22$6D)M(0V1!I;>+4 M,$9^J885=FM8D_Y-3PV>2R(K(FLB$9&82$(D)9(1R8D41$HB%9&:2$-D0Z2U MB5/#>$6R:UB_ZG3]S/EI__C;XM"]!9NVK=S=FM?$:MM$5IJH=T"KUYF[O3D!IVTG1N3`X7='&@RPG3) MJM\'MWZ7O==X?AF+5SI.O>(.<>.1&[<>O"YY813W:#*^J">#DZT>N.KIX&74 M,T8YJ1>#DZWNO5.7@Y=1KQC5I-X,3H/ZW'(Q*Q"@FX61PDH73P<$(9XQR$BX& M)UFX'!R,<,6H)N%F<)*%-X.#$6X=Y*0OP,-EY\\\C1UW$V70"%.:RW,U]QZK MI?8:#S.5E0F8"$^.%/NARH51>JKTF M#UV;"H*[Z;TW@\J,T%!G: MA$X'N4BSV8!B5DLTF@^=?FH"[RZ7D1DT:.6L5;!6:0('KE=S5JG>^[FL4^\:C?#STLCGWD"Q5.M9Z&_MKE2C8#KMVOU\/G^@ M)U%KP\7D-&*EF%'BB\\>'KQ'.+5CG+%,SJ@8`E5#QT5[NR/EX&"4 M*Y:I&35#H%:>/SC_T0/5UQ_NT134.JIN1M7<7,JHXMX[OT;.R-0S)WW:S4K. M.F`6:6:%QHP2C:R;21EE')@S*CBP9%1Q8,VHX<`-H]8)=.M=S:*E>M>S:_M) MTL@9DV9^^UJJ)0[UDF!W;3IR.C=/DM?(?V[DFG M@X-1SE@F9U0,@=][DOK;0M%&N6*9FE%#RC][DJB@UE%U,ZHFUE)&]83;SJA& MSLC4,R=]VLU*SCI@%FEFA<:,$HVL6DL991R8,RHXL&14<6#-J.'`#:/6"73J M??R=58N.NSV81O8N!:,5HS6CB%',*&&4,LH8Y8P*1B6CBE'-J&&T8=0ZR*WT M[RP*C'E1P*!A4K)DM&*T9A0QBADEC%)&&:.<4<&H9%0QJADUC#:,6@>YE:ZF MXE8/\[/UU;&>NEL]CT'#N\&2T4"*P16"JP26"VP1F`;@;4N<].EINA6NLS"V5A/W>VT:/23[0T=:;TRK8R8 M&I>&5-$&A^4VI$H7BE##8NUG[W%8H78)WAPQM=R,6B:PG$LH+#>[!.^%HK3< M3`F5P&HNH;'#-H]:6A[GT2&`QBR>66S=')_'4\C#BF"6P MFL4;RTT6WU@>1KQUF9M1M19@9?3RR.HU`CMS&CEOY;0#HLXF>B_E&@4_V0&Y MN.D=D-%TY'?`D?:Q=T"XP,1X80YVZ2%X!T1[F1V0T?UHY"U@949HV)+(N;C" M>/VPN)**"V@'Q`@-Q=5<7&.\?EC:X1X!V2L)M12J]`+%7:K MT,A^L^_"W8F91KB,2]>[OK!!+M+,W@%AM40C>P?$!`X[#9E!@WS.6@5KE29P MT*H,&K1JUFI8:V,"!ZW6H$[+?1K5JH%4[XI[;_8:.:M-M`."%__N:;1[5AUH M=D"0$J]AK'64LZS.2C&CQ(I4_=-\+#QV0_FF@\I8*6=4^.)X@&C$9/&*E6I& MC2\^G]Q[`_[&9]+,>?/1;M9NQ]J$ M6BSBT)A1(D2F`LLX-&=4")&EP"H.K1DU0N1&8*T3ZM:^6C60:E^O)@S/\0*K M"'WM8R9W&2YH!T1[64L.*Q.H=T""A_F#UV36EHMI,A$KQ8P2*U(]2?>3L7?J M,[4\C';&0CFCPHKLWR+N_*,&I>5BQ"M6JADU5F0O_C#W^I>-Y6+$6T?)225. M)XNI[+C;*1ID#T::0=^4M3)NUF;'6F`1A\:,$B$R%5C&H3FC0H@L!59Q:,VH M$2(W`FN=4+?VO[/N<QKHVVML4\>#4<:!.:."`TM&%0?6 MC!H.W#!JG4"WWK^S''+'RR$&.7,KWO'0;DY?IL6&'0]_##+:UJ)ZQ$(QHT2C MRXX'/SI]X=8*>\8R.:/"5_;W4LK!P33PBF5J1LT0^+U'AZZY=63<%'H+'I=' MAQ8TPE[S4S,F7=K.RL3:A%HLX-&:4:&0E(&64<6#.J.#`DE'%@36C MA@,WC-1'H]WLI!N:^WKO/P+M/]Q[V1V_[):[Y^?3U>/AZRO>S8+["9:#+KS_ M_'0Q"=ON=<[C:&2AN@-DP[.@*87J1MB"%A6J^V$+&E:H[H$M:#[F^U>O''P8 M^[&;[WI\@0]FNP.#/A^'K>BO"A!*_C@)/XJ7A`$$%RM)89B`EF19X#86HMH2 M%M64^=97L*C6RQ;T,*%JPVQ!1Q.JILP6]#>A:KYL0:\2JE;,%G0NH6K,;,'` M#S7I3C&\0TVR8)2'FF3!8(_&)%DPI*,Q21:,[&A,D@5OX%#KUEV\)H"7;*A) M%KQK0TVRX)4;V98L>*M&MB7+`M>V$*]M"Q9!MR8(W,F1; MLF#&':I)':MA4HWG0+)@KH:KENYG"R4P"+% M+!"S$"U+6):B!9N.J`.I'&Q4P2*5@YU%U(YD26!1.X5O`&(ED6XQ'J3>JKL$<.B]23X[`=U+H-=J^G M6*"9$&* M6<&B/@'ANL;W.LB"9,%G.\B"9,'7.\B"9,'':Z@#:<*&;]90!Y(%GZZA#B0+ MOF`+U:=2?-7X:@VU(UE:6-2'4QR##P!Q/Y(%WP&&ZE,QCL&W?[A3R8)/_M!" M)`N^_$,+D2SX`#!4GY%Q.06&+.FMJL`41^I#:PQD$F\P6$DZ#28WDO\"5Z2^ MS.,KPO>9:$N2!9]IABO1LH9%?:S':O@>$ZU,LBSP2BL]@2M,;*3>:8%A4KJ3 M)09)B:\P$$HULL*$1O*/,3Q*/,$0*.DDF,I(_CD&QH[?7@82_/VMM^V77;D] M?MF_GJZ>=Y^Q3C/J_M;`L?]37?T_SH&ULI)A);ZM($,?O M(\UW0-R?,8N-0;:?@MDU(XU&LYP)QC:*H2T@<=ZWGVJ:K;OZ\**YA/C757^Z MEE[L_??/ZJY\%$U;DOJ@ZJNUJA1U3LYE?3VH?_\5?MNI2MME]3F[D[HXJ#^* M5OU^_/67_9,T;^VM*#H%%.KVH-ZZ[N%J6IO?BBIK5^11U#!R(4V5=?"QN6KM MHRFR<^]4W35CO=YJ55;6*E-PFY_1()=+F1<^R=^KHNZ82%/CG(M+]G[O_B3/N"BO MMP[*O:$N.;G#F^"O4I6T!R#T[+-_/LMS=SNHYG:UL=>F;FQ4Y;5HN["DOJJ2 MO[<=J?YE1OH@Q42,002>@XANKRQC8^^^HF(.*O`<5?2OJVP'%7C^#Q5G4('G MUU4TEN.^-G[69<=]0YX*-#QDL7UD=/GHK@XU':HRI':J$[1+3LU?J/U!A3E` M!5J@'\>ML]YK'U#X?+#QL(W!6YQ&"UI\*NN+(!!!*()(!+$($A&D"Z!!_%,2 MH$F^E`1J3Y,P3M\;P9P54XAXM!A=?!$$(@A%$(D@%D$B@G0!N(BAH9<1C]6E M&);;HKJ6;O.1>,QF:T_1GQ#Q$0D0"1&)$(D121!)EX2+T>)C'%I[96^F9J86 MT/CP6'2S+L3+C+;+EK>,'6]TFHRF^B(2(!(B$B$2(Y(@DBX)EP+8+V5EIKB/ M>YRMQXBQ*"HB/B(!(B$B$2(Q(@DBZ9)P$<$>*HN(8CZB@;`#ANXQ)T1\1`)$ M0D0B1&)$$D32)>$BLN414C6/ M]/>!<1>CYGSJ&`'[<9*GP48W)^1C%#"TS,IL-(=BF<*>$9T:;_E;7G](! M(\9\\(6\D&'N;'NSV?+M%B&A&`DEO)!CV>N-;0F':+H4XK)#;RZR]/2$;8+,8HD7BFG!D?'[VY+%;`6'Z=W6@6$_=& MI&_[VEKZUA3WB,G$9A>X[7J[T1VQ_(/5HOD#C$)!R[!-60=@QQBC1-!R3,LR M[(W8!)PCGR5ZVY%EB=V"N"P-"+(TEOQ$]TRZF/3Y%/0'QB6!F2U0*/&,L&>, M42+QI%_"Z#S8"UB`[$L5N[A717,M3L7]WBHY>:]AYS,-J..$V;&+GC`"WP!?9!X>=9`H>88+%TS\!L]TX5:&^8OEODBGY%DNW&&P0^RX M=.W@@<2!X&0#J0-3E0W`NG`]Z6B[<*^0\)T+)ROFL>W"\8IY8KMP MH@+7I@G![PR/[%K\GC77LFZ5>W&!];/N;Q(-^TF"?>C(`W8"^+6!=/`+0__O M#7XZ*N`>N5[!V7HAI!L_T!=,/T8=_P,``/__`P!02P,$%``&``@````A`)0] MFK!:&@``37X``!D```!X;"]W;W)K&ULG)W94B4Y MDH;OQVS>`>.^#V<'PC*S+4_L*UO/S#5%DIE8)9`&U-)OW[].2"&Y?B^@IB^: MK,]=K@C7$NX*A;QR]W#MX^'__.O MXA\GAP?/+]G7Y^^WMR\'L/#P_/'P M^\O+S^3HZ/GF^^W]]?/L\>?M`R1?'Y_NKU_PGT_?CIY_/MU>?]D7NO]QM)S/ MMT?WUW;WZ[OWUX&8T\W?ZX?L'U/W^_^_GLK-W? MO,?<_?73K[_]_,?-X_U/F/CE[L?=R[_W1@\/[F^2^MO#X]/U+S]PWW\NUM7&?/NP=]+]WMW\\!_\^>/[^^$?Y=/>ENWNXA;?13J8%?GE\_-6HUE\, M0N$C*EWL6^#\Z>#+[=?KWWZ\7#[^4=W>??O^@N;>UW?S^`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`'6:'-;KN1SW MN==R';5@5#*J&-6,&D8MHXY1SV@02/@3L67H3^L5Y[+6>]8=22] M&Z%OW^JK1EWZ?"2ASXEDMA3ZJ@FVE_/%.NJF7L%==CUXSZ4['9HCG)[ZYWJ]D`Y+K=K2 MA\F911N,HZG@S5=0+&F?&5]9R99W3>K6R7E:VF44#?'!6QO6K,%\Q"PUJ8XT)#J(QU^*[ MO2K:#XWE6&J9:)FQ)")MIY5;K?5V0@47+!E5KJ"W53OD;35 M(=^O!HNV^_N6W=KD&9QXAQ&L68,9)PS?*;>G4B2T95` MLAU,DA.TPUM1D%F>C<(@AX*8W2'3_M,3F4+T+%!S\UJNL$)AI<(JA=4*:Q36 M*JQ36*^P06%G"CM7V(7"+A5V)9EL0Y..!6TXS6DV30L?VR,*8U:S:FY:]/6T M(`O4?%OYHHX5BEZIL,JR((.H`S7?:RA!:0(U5VNKL$YAO<(&RX(K.0O47KF2 M\T#-7:8-/I1+#TBTP7F <%%G`5J>HIS'FBXB[A0V*7" MKB23#6N2T:!AIX%JD]1PH([H%'^""33*\5(S9M%BQV.3+F:;*%G*K,(&S\O` M3!2$YE9+S`#K]4;F3T5STZC7*QYE^76698^BZZR MDY4M9L>1-_IW53:XROQMG$G+N`WIP/-W&;YPAE^]BTM9UV*V"%/9^3SJ!U=O M52V[J4GGM6YJT_RPFX[H%'^"_K65-YZ:-Y/HIB?S_[HJT%KU^>9TOJ%Y>[^7. M\&!1<'EG7FMO1?KVW$N=C0M&EXRN!!+MO_R+-9L]E\\9BZ)IZEA>8VJUEN,T MM8I:,7-V98^/VC+7M2);A:PJ7CPJ=2-15973\F.[?MUNXTJ\>@NMKA7=0A=5 M%5U/ENJRV=11]M9+;E\MHE>!:5> MR]U!QBAG5#`J&56,:D8-HY91QZAG-#`Z8W3.Z(+1):,K@63#F04P)33`U$Z# MD=;*4JL5+I\QRAD5C$I&%:.:4<.H9=0QZAD-`DE'F14JS5%VY2J(H9:TF)4R MRACEC`I&):.*4C: M_)-T_]ZJ#]31%>8 M686-?_^56Q2\32J<%M8I)C_1>[[2:MGW?!OL])7A:.7,^,IJKJQAK9:U.M;J M&0T"25^;-1?-UW8M)O2U1>$K-TRE9D!L_8I-YI`OF5LD7#D6#%Z`E5;KQ(>, M%=NJV5;#J&74,>H9#0))3R$P53UE>)25C&@E(KQ-G)5B2<@47"WWG7*Q7$:! M8F85@J6CG%%AT?IX-+.:1>ECZ17 M&2TR3I\ZTWH3Y;ZIU<+8#+3B+IG57>-6;+1FU#!J&76,>D:#0-+[(B5"X#I^@_&7>Q[-I!`]KRQ"J[@[3"U: M^TDTL^C$[[C)+1+.'GJ M">>%L4Q@IF;+#:.64<>H9S0()!TK4JO`L9Q%K2P*8TO+8-_URLRBX.YR1H5% M8@8=[0>HXH(UHX91RZACU#,:!)*>,OF)U@5M>N-=L%N-*)I!X]C2:4VQ9?3L MS:Q",')S1H5%+K9$YQ0/*,WS4"H9]82_"SHVK6;S;MO0*OF.2 MF=IJ!98;1BVCCE'/:!!(^EMD/8&_.>M9V:PG#"Y'%$QGF=4*=[I:%-QH9#0()1ZU%UN,=M>CVXM%KAT/?FS4-[L9PM(].EUYAZ)MNI&36,6D8=HY[1()!TN,D_@BGS MK7AR/>8KX51J43B56A3&DQ:%\:1%PI^C^6#>+)VM()[D@C6CAE'+J&/4,QH$ MD@X4Z5#08SD=PIZO?2P>Q9/1@F%JU6P\N3XYB1[WF54(XTF+PL'OS-B$?#Z; MKT[#_T7IN5?W_72\WL!HS?4TC%I&':.>T2"0='.4][BP?"=69A6"<9PS*BS"T#93Y1(/\6C=OO0:O@O:!,"['2Y<.!=&E1<)O8\$`%59+3(FC5H`JME4S:ABUC#I& M/:-!(.FHO\AO3'08K4589-+U*2)PG,U&RY8=0RZACUC`:!I+]-LJ%US#$)$<_J$<'? M[DY2]"+3*C#O4.90L'1I47"_A=/R!4M&%1>L&36,6D8=HY[1()!TE$D)-$>- MJ8)PU(BBJ9&BRU'+U#AUN?4VFD`SA$'[V>"-Z'+4$D-_,K^/+K&5D:++2<,U M7F5K"^S4C!I&+:..4<]H$$@Z7.0]^(\W5BL1\]`,,2(178X(U;J;SFQ!$5V. M6H$?"JN%YG(%2T:514'!FE'#J&74,>H9#0()!R+&"WJL>:$]KE;NN^.5Y%\_P@3,MV$&D2>M8;'7G#:9)# M85AJV<:_1\LLVH;N'XT)]X\HF+1+6S!`E45!P9I18Q$<[EJJ9:W.(OC8:?46 M!4'U(`I*#XH\2?'@OQY_HD/['L[YT\;E3_@[M3..CI.93.K4L.5XC#1/H]>7 MF=4X]4^NW*)@T!<68;8P9DYG\ZBBTBLXEU1LIF;46#3M4(\RP):+=!;AQ9"Y MF-4&)]_)V^Z]AKN:0=B1K2'2*:4UHJ,S-IQF.33W$6UJ&;)E=PV90S[BR"T2 MOA[MAS.S*^@GZXH+UHP:B^!==Q$M:W46P:%.JVCF;L.,AP:MC'O._/ZVW47S*K@=3%W4MN43#T"Z?UZBQ9.BT[L9_.CK?A M^])H2;?B>FI&C45V3C^9G80FY_/H&=6RA+8KHVQ_'$(V)*!_ULOCV-@N?=9M22 M>Z[C#"WU6FX$9(QR1@6CDE'%J&;4,&H9=8QZ1@.C,T;GC"X873*Z$D@VHDD' M@V$P19QCFACF2.8$%(P`;*)S3D\998QR1@6CDE'%J&;4,&H9=8QZ1H-`TE$F M]=(<-:9DPE$6^8&5;@AEC')&!:.24<6H9M0P:AEUC'I&@T#249@)0D>]&3L; M_6ABM2CL:80RS+'[@G)_,AW5%:BY?ELHK%18I;!:88W"6H5U"NL5-D@FW(O' MB'"O&[![+MWHT#SJ:$.U%S11F$MU]`%:J_4T`=JKH9!,NG^OYD98J-XW+L=0K.X&E/+1!O8 MDNC>^SB03_=RAJ#A#!4**]EX%:A9XU%^40<:SGBCL):-=X&:-1Z%D7V@X8P/ MDDFG1\GDU.(X"J";2<-7V$[,5]A-[-4*^TEMK!#OSZ/5 MGF'2V%VXI02'Q;LQP;:RO6"=&+^LK.)^7Z>3\P_9(N)^;*EPJJ) M>7OUQ+R]9F+>7JNP;F)^A;*?F%]F&1P;%S>EUTPFHT07.!V,I@^+D(C[;KH^ MCL9O:DN*&64L:1<5EO/E(HJ^#%,OD\CN-(@D/H$G-D&IHFDGQ>H@R24);@R]O$?"?*DL^; M;?(9E\P29(Z)R7-8@GZ6&)>Q!-TM,9YC"7I=8KS%$G2MQ#B-)?C1C\_:->_P M8R#[&2ZZ_YVY2<7.;I5<[6>F2/_S.OF,K_BXXMTZN=JO!44%\`S`[6FF\"1( MS+3%MC#YX\8U"29]W+@FV<$E.]4EF(625)5DD)AAPE>`&2C21`.X'XT"8(" MW(\F06B0F,<4UX-H`'>J21`%H)MK$F1*B4DIV-IN.X&Y<>D5258A4S,*AF7Z2'I50E6'.%KK9*L'Z<9*K$BPC)X4JP=)Q8I8HV3M8)4[,2B5+L%B< MF`5+EN!E'.Y4:],=?+!3?8!7/[A3S3MXY8,[U21X\X,[U21X`83[T21XS8/[ MT21XVX/[T21XZ8/^IDGPN@?]39/@C2GJT7R`%Z>H1Y/@_2GJT21X MH*)?:Q*\-$5/U"389Y"85^7<@L?:",8FX'@ M`TV"/4'P@2;!UB#X0)-@AQ!\H$EV\,Y.]4X*2:I*L!\E,1LF^'YR2')54D!B M]DIPF6J-L3V^I(AF,>S4@P^TL8T->_"!)L&^/?A`DV#['GR@27;PSD[U3@J) MV=_$5XW-8O"!)LDAR54)]HG!!UJ9:HWY`#LRN1YLF(4/-`GVS<('F@3;9^$# M38)=M/"!)MG!.SO5.]B^"1]H?L.^3?A`DV#[)GR@2;"+$S[0)-4:<]7XXI?Z M`>8J58(][O"!-K*PU1T^T"38\0X?:)(=O+-3O8,MU?"!YC?LI88/-$D.B=D0 MS&U:0&(V`;.D6F%.Q,<-+,&G)XGYJH(E^`(E,1]7L`0?HB3F&PN6X'N4Q'Q$ MP9(=O+-3O8,O(>`#S6_X^@$^T"0Y)+DJ*2`Q._/Y"O!!&'R@C1)\%P8?:!)\ M'@8?:!)\)08?:!)\+`8?:)(=O+-3O9-"DJJ2#!+S40W?3PY)KDKP55)BOJ?A M,M4*8W?&H/'V@2?%X/'V@2?&4/ M'V@2G#Z2F(,UV&\XA"0QYVNP!&>1).:8#9;@2)+$G+;!$IQ,DICC-%BR@W=V MJG=P)@9\H/DM@\2I16V&!5A@/ M?XRBP102=["G=1+SHS`LP<_IX*HU"7Y(!U>M M278+K`^/KWPC7W>8$O>OH&*.Y3^M=^Q0A_FM';XN_`Y28GYQAR7X.23T:4V" MGT!*S._O;?[#0I-/T2DZ/&*SSN-#L5AKZFW^(AN.='4\/B M-[Y_7G^[[:^?OMT]/!_\N/V*-S/S_;$P3^//@8__\3+NLC[XY?$%O^Z-[2'8 MRHZ?;;_%KP7.S4:]KX^/+^X_X-"CZ8?@/_U'`````/__`P!02P,$%``&``@` M```A`!K-L]:<(0``L*$``!D```!X;"]W;W)K&UL ME%W9;ATYDGT?8/Y!T'O;NKN4L-WPS7VYB<&@9^999ZLHG-F9PBV`RR7=__]>/[V?_O+E_N+W[^?Y\]>;B_.SFYZ>[S[<_ MO[X__Y]_5'^[/#][>+S^^?GZ^]W/F_?G_[YY./_[A__\CW=_WMW__O#MYN;Q M#!I^/KP___;X^"M[^_;AT[>;']? M)Z$?W]^N+R[V;W]E)Z?_?B4M5]_WMU? M__8=S_VOU?;ZD^B>_D'J?]Q^NK][N/OR^`;JWLX%Y6>^>GOU%IH^O/M\BR=P M;C^[O_GR_OSC*ANO#N=O/[R;'/2_MS=_/D1_GSU\N_NSOK_]/-S^O(&W44^N M!GZ[N_O=L;:?'03AMR1=337P7_=GGV^^7/_Q_?&_[_YL;FZ_?GM$=>^[ M[["$_Y_]N'5M`(]^_:_WYVM8N/W\^.W]^6;_9G>XV*S6N_.SWVX>'JM;)WM^ M]NF/A\>['_\W,ZV\JEG)UBO!KU<"V6?X09V,XM?S'X+-9^3V7@Z_7F[U*KF# ME\.OR%V\65_N5KN]>\IG+*(_3"7%[U+2P^KB:G-X7N[*R^'7RUV^JJ0KU/1D MT/TA95V]V:YWA\NI1IXIZTKJTOWA9:.Z?$X2M3];C9K!F]7VXB7WK#8BB#^D MN.M7%E=:S2HTF^=%W\YM=VKSQ?7C]8=W]W=_GF$@P?,^_+IVP](J<]I\:_<5 MN[1_=,-/COVCXW]_CKI!RWX`^L\/^ZO#N[?_1(?ZY'F.S+/6'+EPN$[EU!8I M4*9`E0)U"C0IT*9`EP)]"@PI<$J!,0+>PH>+(U']?\F1CM\Y4EQP%"!X=I-X M33A$I$B!,@6J%*A3H$F!-@6Z%.A38$B!4PJ,$:"\AK8?>TU:F8,QG$:M;'O8 M:V\<9Y[]-!-,C2@GI""D)*0BI":D(:0EI".D)V0@Y$3(&"/*5^B=L:]\5WV# MX53$JX\<"VMC:&2H8JAFJ&&H9:ACJ&>H8&A M$T.C@I1?X8C8K^),!T_.%`<<9V0=M3A""D)*0BI":D(:0EI".D)Z0@9"3H2, M,:(\@V#!\HR#M6<\,D=);D#/"2D(*0FI"*D):0AI">D(Z0D9"#D1,L:(\@S" MH=@S45\\>_QV^^GWX]T4^4E;J!BJ27,C3)CNEA)M5HGV-G") M]HZAGK0/@2G2OK[093\%+M$^*DA5`0*YN`JDO3I8NWI&MJYJ)/#;7B:F\YEI M'8*:8D9V:`*+V'J;S#6EUWTU5<=J<]AOD\BG\FJFQ&V:ZVLRU;S&5*M-7:RV MZZ1R.C+5DZGA-:9.VM1JNTHCF#$VI6K%93!6M4RXKA/1$"+M MUZ5Q20/V$#I]:(K;RY7N/+GG6@='%1[:'J;F>765#)QEH$L-5*RE9J@)@BZ- MVAV2-*H-=%'H2$(.L7;5/$IT$7QJ+1H%[O0/7+Q2U/=:@[U$82*\J.' MX'J!<@\I/\^"V^#ZTG-%4.6A:,:I65?#@BU#'>OJ6=?`@B>&1J5+.]`%])$# MES8Z!_K*43.D1MG5*AUEW96V_TNF49&430O`,;9N\N9XDIZ ML95+.K$TZ>.DXOVY&HEG+E53,[2+6[F'PK19>5W[X)?:0Y&NQD.1KE:@H*MC M73WK&D0PE.LD4-`U*EVZE;LD(FKELP.QAH;AU@7$_[C[A8EKR52QH.H'Z#`: M[].A];APZ;`C:;1YQ"8#3&%@I8%5!E8;6&-@K8%U!M8;V&!@)P,;-:9=[K*3 MR.7+P.*SEG@$GJ$X=5T15#!4,E0Q5#/4,-0RU#'4,S0P=&)H5)!VE,M`+$BF;QDJ&*H=I#<7;KH1?2V\`E0T3'4,_J!P]%13TQ-"I(^]1% M^7_%IW-6@)%6"GI<>0@]-LJBTCQ7N(+G"X&>R70C%K%7&5@M6-#>"+1Y/MN- MV,1"9V"]8,'"()"V0!EOQ"861HVI&ED_D5U-N!X./+3624,25N0B&$I>>&@; M5F%*ABJ&:M;5,%?+4,=0S[H&YCHQ-"I(^^Z)A,MY*!E*/;1!:+JTVNUEDF[G MGBL*:PH/J2B8%PU$_79>Q-GL]DEP6;'JFJ'F5=;:Q-KJL$VL=:RZ9VAXE;53 M8NUBLTF63$:E6M=0DJ])5+#FO,Q#J"'I-KF'5'7XO"Q,B:4(AC&J8L&:H<9# M48S51JM)==4YZE)=G"%X6O?EZAI1+/5<\LA)4L6#-4.,A3"]BL66H M8\&>H8$%3PR-2E`[*DF@EN:X9$I2QJ/;>('!-AE9DP$I]URJ*\^"V_W4''=I MS99>!'2Q5;&6FJ$F"+HV<[5*,K0VT$5QQUIZAH8@Z!1OTL7]4Z"+XE%IT2YV M*4_4%E\*;]=SBJ3:Z`RI(7.&E)]GZ#(,K*77%4&5AS;!V[6'(ET-"[8,=:RK M9UT#"YX8&I4N[4"7]T0.7-JHSX?"?'!$JNG::-1SD@[2!0U1W`@75/:L>A,NKQJ:FI+V?`H>H'@6: M5&NO_L6L"SZE6&N&E+<)*KS@+I[)9ZX(JH0K;I:DJQ&NH*MEJ!,HZ.H]A!]Q MS2!<0=>)H5&@29=V8))B+*!H)D^VEN3"%5:^"@]%"Z,E0Q5# M->MJF*MEJ&.H9UT#+0]`56TQ#I\`E M%L>7+.K:>B+])4XO`Y<\226ZXKYE MU)8O:K#8!%VQQ72X#EQBL7N5Q5ZX@L4AZ(HMIJ-XX!*+H^AZZAEU;26IV$OQ MAEOF2&MQAI(^E[@F%\&XS\V">'46/V&R141FSR0)7'=DB$%DFCTJ@83:0L2&[3-+6-V,1F M]RJ;O4B&1Q\$A\BMC$YNBQ)Y]35YQ+"XUH=3.GBW%8[R'7NY<2 M\8M7SQ6%+H4(QMV,UZH\EP]SM_O5+IG\*N$(@6?-UII766M%UQR>;K!XE$Q# MG7`$:SU;&UYE[22Z?#!\<;E.AM%1.#CRW20Y[XM=BW/A205RX6AO@8=4-?F, M.;3"TG-M@V`E4$C;:M;5>&@3=+4B&'1U`@5=/>L:6-=)!(.N4:!)EV[B+M&, MFOCLP"??NB+5]!-,:.:'BV1J/RY<<-K2&[;IR]D\8I/^61A8:6"5@=4&UAA8 M:V"=@?4&-AC8R0?IYDV3RQ3&) MDTP,#9-KXGHGJ/!,9;0CMXG81%LK6-#6":2UI>\C M^X@-VK0+GTC@,`VEO4F@.+38I8-U+EQA-BH\=-A,SMLD\7#IR2J&VJ4[LRK6 M6S^OMWF5WI;U=L_K[5_2J_WK\I)H0I31"B]BR;\SI&*^7;J2EWO!.)CPD-\0 MNGZ3!N@L4C%4IUJ2\+=AD9:A+M621'J]$M&>K,N] M#5L&FQU]7"""L7I*UBKA"NIK#R7JD_[=B."SZEOA"NH[6WW2NGL1?$J]=GH2 MX"_=D0-Y][H?\81[L1WY+LF3HDMO40/"4^R#VDW#(+PJ)PE"O>+2SXM.&X_Y+P9P MCC\)X&9(==/M1=+;JZH])T(:O74TKQSGE*O*^,O)AK8MD^5X2&87;R%DQF2;UI$,.Z^ M7A!+,]-[]NCQ4+RF'<_%^E$"\ M-)GLYOP@7G872(V7Z1Z?7+BBR<1#E_,W>=;Z0."0+E0Q5+/JQD-J6886#-K` M)>H[!6E/N;0@\M32QAV>M/$94M/K;I4,Q[G+W9/IU4/(]Z1`)4,50S7K:IBK M9:A3D'Y>C*_F\SH\>=X94J^"=NE>QAS;4YQ@'&EY2$6N_.+%<_DI8;V^3".5 MBE77##6OLM9J:ZNK?;KVTBG5VF?H`Z;/')[X;(;@,ZGJ'%\GD(-F*`I82\\% M;XA@Q8(U0XV'(ETMZ^J4H'ZX)^)L][UB^G`SY'9%1"%-DF[E7C!>?O`0EN9< M1+.ZND@_(B\#1WC\V5JDIV;531"<5!]6FR1J:0.'J.Z4'NT-%R5:PX&/:D/U M'/%IGW,0O"%Z>*&[:'D-"ZZMBF\T(9Z%(;%6NI&6J"H%-\2!M=&^BBN%-:M">2*.^E M0`@?KZ6CGH?B?NXAY8Y9$+FHE*KT7!%4>0BCL7#5K*MAP9:A3NG2#YU$?Q+3 MX#P)>C@/N7=N84Q?IZM,7E*U]UD2>=M4_SC'+XF$2B\$#GG8RD-(.02J6743 M!"?5Z_TV2>;;P"%Z.J5:N^.)$&_/(9Y`<(E3'\@%>&!\*SX9--5*LDJ%*H'@4)5V-<`5=+4.=0),N_=0N3+,: MP1R^J48P0SHS7*=K?7LO&.7*'HHS0X8JAFK6U3!7RU"G(/V\+@JSGG>.SM3S M^H`-<][2?5=I3)_OO6!8U5>L%HI;X277#A(F@,&&2Q";J" MX&Z=3%5MX))VU[UD4?G.K1G&OGNIATS\.LKTD-Y-G*;$N0A&;K9-5 M_S)PR1-68C&N#/8I6VR"KMBG21[8!BZQV+UD4?LT"6)?]"D'MP,JI=FT3%$B`>./KUD-Z)D>;8N>>*`V(15#V6LD'/A5TY;J;:8"Q( M9LY*.$*V7+.UYE766M'EK:TVZZ31=L(Q6=,^<_%N-#R^V!Q]9!WRP2-V_4PK M!F'[:.XAY3C/%1I&Z;FPVT8JO!(H+#35K*OQ$+:-B6`K@D%7)Q#O874KK?S0 M3[YGF=BG82VT7YRYKM]Y'3V7&PRB5I[.EH%+BEXP5#)4,50SU##4,M0QU#,T M,'1B:%20;EI)"+]T1P[5W?F;;K4UC/\Y0P5#)4,50S5##4,M0QU#/4,#0R>& M1@5I1[D0->J#BZ,*UK0*!FJ&*H]A$4,Z=Z-AUP_6<:%[2$9 MH=O`)8(=0SVK'SP4%?7$T*@@[5,7OO\5G_IP/YX`/(2&N#PA'XI[\%S!\X5` MSVRZC5C$,96!U8(%[8U`>NLL'8T;L8F%SL!ZP8*%02!M(5UF/$5L8F'4F*X1 M%^Y'-;(,!SX-B#WO$P\,GXOG=YLD\<@/,U>42A<>@E?%>LE0Q8(U0PT+M@QU+-@S-+#@B:%1"6I')*L4 MP0!5'HH$:X8:%FP9ZEBP9VA@P1-#HQ+4CDIRHRF27>_?8*_JXC-.DRY]FH2Q M:QGM=ILDE,P]5_Q&PT-JF-QMDP6C,G!)55>615[T88M-T!45-3W!K@U<8K%[ ME<6>+0Y!5VPQ664Z!2ZQ.+YD45>(^!2ZQ."I=NFH0!)A5X_`D,)LA-?C,4%3&`GO]ICD@C#0E0Y5`(26O/13I M:H0KZ&H9Z@0*NGK6-0A7T'5B:%2"VE%)RK>,.)S:(2AU+M"!&6V7]%PJA)@% MDQ&'VO#")?5;61:--CP+1A8;+Z@L4HMJ`Y=8[+CT/4-#$`S#"ZD_!2Y1/RI= MNAZ21.^EY8Q+3@`]I.(YG^V%=_V%YXJV;)0,51Y"G"EEKSVDW#RKCW2UK*OS M4+0JT;.N@05/#(U*EW+@U1.IV(3K'N^A9#!.,PS/%77M;8*3%&:?DH:CA3 MOG(Y5C17OM2^)_ZDVN8T+1ZH/9>JHYD+6P2EY9:>"SOE!*H\A/UE`M6LJQ'! MH*L5*.CJ6%?/N@81#+I.`@5=H]*EVW>2V,T.?/(]Q=62[X76 M(GV#E0H8*AD MJ&*H9JAAJ&6H8ZAG:&#HQ-"H(.THEZ=%CGIQX)OS.N5`#\7Q,:^I7WFNL%!3 M>`C1WY3.&S?-!0[IVA5#-:MN/*3>9/!W*H%+U'<,]1Z*7I0,@2L,7QM:3`]< MHGY4D*X(E^JD%;'&IX?PVWS#,E\W?.5DDEEHAO2NB6V:=WM!-3%Y7>Z`DZ(=X?Q]8:4?.\M5;8<'"!:R(XQSM92^K87,_0('J>-W<2 M-KSF=^8.VR3H&I5J77TN`8NJ;QEPYL1,]9<9BG>SX\9V5Y&J/D0PQ`"E9\.] M?$M<4'D,VU.ED=6LK5DD@[9VP8)HQ]IZAH9%,F@[+5@HF[N(WCW67+;97?/% M\O,EVS]N[K_>Y#??OS^:3/EXV*)L4QJ2 MV@'%[3A@&32SS+F+*6A?>!Z+\G&5?;2>\[C*<.*YQ,@7C0>;:*%,P!&2NI3(%73]S M[94I&`$RUVR9@H$@A%BP*TCG4@D5!"H>N85&P])&Y5)V?!RL@FP@<6!.F'4EL4O/M#J2T*WO&A]5H4O.I#Z[4H>..'^K$HV/4`'UA3\A'>.9K>P5MY M^,#R6P&*>V_,M5"!XEX?,P4OX>$#BX)W\?"!1<$K=_C`HN#-.WQ@4?`"'CZP M*-BMDKEM%%PV[%!!"2P*MJ:@!!8%.U10`HN"C2J9VV+!=K`Y!66S*$=0CB8% M>WQ0"Y8,MOIDA4DI02E-"O;UH'XL;34H;M\)EQI[C#.WY98IQP-F9^Q^9`KV MV65N%QU3L&L.VBP*-KQ!FT7!=C)HF];:DN@)6\&@S:)@"Q>T693B@-:+_>=6 MV=`23

-X'HM2[.%1?%K#,O@L)W,?W3"EV*-5X2L3IN"CE(^YV)*#4IM4O!U&\IFR72@N`^Z6-L1/CB:/LA!<9]XLDP!BONL MDRGXC!6EMBCXFA6EMBCXJ!6EMBCX2!VEMFKNN,=<,B_\)/T4'V2CU-:H7(#B MOCRV2HVYQ*3@*VR4VI+!Q]@HM47!-][0?W`Z%5-P^BS*9M8/*.[X59;!\;,HFT7!*;0HFT7!^;,HFT7!T9/9 MT2QU#HH[6Y%+@%,GL\*DX+S)S)VTR#(X=C)S!RXRY;@Y9.[<.9K>P;'#\('EMP*4PJ24H+@3=[EL.'X8 M/K`HN"LB<[<7L`SNB,C<)09,P541\(Y%P8T1F;O2@&5P2T3F;C9@"FZ'P'J= M1<%]*)F[[(1E<&L)2FU1<+<([%B4(^P<33LY*+E)P>T>66%22E#<#1)<-MSD MD;F+))B""STR=Y\$4W"O1^:NE6!*L<%,.^\G2<<04%J3@LN-X`.KUQ<;M!!\ M'L%V<'D/M%D47+(#;18%-]IA!=8<_=>83^>5_K34H+B+S;@$N,@,VBQ*L4&? MFT]&2;6!TIH47,>%4EM]#M=#PHXU7N/*PNQH/@]N+LQRDX(+#+/2I."60OC` M\@XN*\QJDX(["S-WBQY[!Q<3PF\6!?<39NY./9;!-869NT>/*;BN%3XPYU-X MYVAZ!]>)P@>6WPI0W/66;`>7A\('%@5WB,('%@57B<('%@4WAL('%@47A\(' M%@7WA\('%@4W*,,'5KL^PCM'TSLY*.Y*6G[2`I32I.`Z7_C`DL&MOO"!1<'E MOO"!1<$5OO"!1<%-OO"!1<&%OO"!1<'=UYF[DIF?!_==HP06!?=9^ZZ9K:#FZY1-HMR!.5H4G!E.&K!DL'-X5EA4DI0W*W57`+<$H[Z ML2BX+!SU8U&*%<:W^3*O=$0"Q5UNSW9PESW>&5D4W!6/$EAC%6Y^AZ\M"NYQ M1^NU*/T*[J[".<E`Z4Q*#TIO M4@903B:EP3JPZ8(6:;A)Z%Q/M)S6([@W"0/6@$W""4O`)N&(50B3D&,1PB04 M6/\U"246)TQ"Y<8:ZSEJ+$V8A",B'#.8=.N[QM#4N-5=`Q_/=C^O/;S?7GFWO'#>8O=W>/\@]GX,^[^]\?OMW&A-9&0D``!HE```9````>&PO=V]R M:W-H965T[/>/"!`"(``2O;=[]_/I]ZW_%H5 MY>6^[]T,^[W\ M7K]6QSRO>[!PJ>[[Q[I^#0>#ZG#,S_OJIGS-+Y`\E]?SOL:?UY=!]7K-]T^- MTODT\(?#R>"\+RY]LA!>?\1&^?Q<'/*D/+R=\TM-1J[Y:5_#_^I8O%;*VOGP M(^;.^^O7M]??#N7Y%28>BU-1_],8[??.AW#Y#G62/=8J!S*$W;"O[US(6H`E[[_WGR^%T_U\;X?3&[&TV'@^>-^ M[S&OZJP0NOW>X:VJR_/_:9$G39$17QK!IS(2W/BW8V\\$58^T`RD)CZEIH?_ M?J`PD@KXE`K^S=0;SH+IQQM!VEPG/J7>](?T)E)OVNI]XB#NH&8C?/Z4@S.I MAT^I-^[R\$%`/-0&91`YDIJ?N.BI?(G__)23PC!MUB7L!]U4B?.ZS+G='%"% M-I6=[.O]P]VU?.^A7>#ZJM>]:#Y>**S(FI;5TE8Y;K:#6/Y%K+_O(YZHWPKT MV\-T.+X;?,-MBA5_`1NXJ>N.B+B M:T7&2,)(RDBF$\,3C$*7)P*;GDA"QPW1,V-&$D921C*=&)Y@&+L\$=CT1!(8 M:@O('UDS():+NL`E1/S;]GY-&$0X'IKB3+=J^"U..2['&VYZ+A%<5[=&+)'NK41P5ZU*%9JT*#,438?$ M<'6DV:.AB\:F[$82!4,52ZO-Q7*!5F^)1*-IHS,>62II)U?;9(85TU$9.5Y]HDYE2I&HG4KIJ^B MA;M\E:U=OTL(&95'R*@\0MKNJ<=0)A$IF@Z)MNURB-JY$3Q"7>59911[<@3H ME4<(B>R:8#!D-V^[2E5`9M@R/1:]W.4Q]7C#8T)&_HA*-NLM).1-`LMRILS0NRCC$5-,"*U(/HTV M312]>'PY9+H)'4MD7`FM&NO1EJBK^4PJ3AR.6J.(',4K,%2>J(J_RE>C*MH) MU17F=&BUUDG9#^'.,SE'"41G8DKG&".F$B&.[17R)V[7F&P_W>7N%X;$VF&`>5YL#? MS<9$HL_.`J0XH?1,IM:9-E-6N@?'.=]KH58A_ZV3[-RQE*OD7B/[GGV M6O.]-FK5AWMMK;T\ZY"_4U8<)P=Q^G3EADZE1F[D0;5KPC'.,"P1A&[UHXQ$ M7;HRJ3CI'IWFW-9"(LW64J'.UHK;6G-;&Z78^;55J+,EOLT4%T1^41'3MY/T M'BE@1?F'YI.JG%(WR1VGP9:7,? MAD3GM7D0XK4UYU]&L.]4&(5X.>M0\`-H-`&PMX!$G(6X#NH_%*GA$M1\*#+$ M):CV4"2*2U#TH<@7EZ#V0Y$V+D&]AR)[7!)!$CDE:!JAJ%>N@]X1)DY)"DGJ ME*!3A**(N34TC%#4,I=$/I*`0Q.78#S#6O,0964!PQ9Q#1%KZY))'O81]7[>+1 M#_NX)`DDB5.20I(Z)7C<@P1-L4_3AUA$I]C')4F@(UYP<&MXZ8)]7!*\LL4^KBO%NUKLXY+@E2WV<4GP M9A;[N"21%V`?5UW'D,1."=YN8A^7#EYB8A^7)$)`F]EC12U!`%R5F^`6=<8% M!8U7XCR4,>K9*4AF8>(4I*ASIR!#F9-@T'J+'ZR\[E_R[?[Z4ERJWBE_QOP8 MBJ\3>U?Z;0O]4=/#>N^QK/%3%?'!0``@!,``!D```!X;"]W;W)K M&ULG)A;DZ(X%,??MVJ_`\7[B*"HI-2I5N2B8&UM MS>X^TQB5:B$6T)?Y]G,"A$N.4]6]+UY^.?DG_,\))"R_?Z0WY8WF1<*RE:J/ MQJI"LYB=DNRR4O_YX7Q;J$I11MDINK&,KM2?M%"_K__\8_G.\I?B2FFI@$)6 MK-1K6=Z)IA7QE:91,6)WFD'+F>5I5,+?_*(5]YQ&IZI3>M.,\7BFI5&2J;4" MR3^CP<[G)*8VBU]3FI6U2$YO40GS+Z[)O1!J:?P9N33*7U[OWV*6WD'B.;DE MY<]*5%72F/B7C.71\PVN^T.?1K'0KOX@^32)*+YF2[,T4%HO M3PE<`;==R>EYI3[IY*B/56V]K`SZ-Z'O1>^W4ES9NYLGIR#)*+@->>(9>&;L MA8?Z)XZ@LX9Z.U4&_LJ5$SU'K[?R;_;NT>1R+2'=)N\2LQN,!)]*FO`:@$N/ M/E:J`2,DI_*Z4B>SD3D?3W3#5)5G6I1.PONJ2OQ:E"S]KP[2&ZE:9-J(P'7QH6HK#?C^\OA6TQ>^__?X.EQN-0'^X\LST">B-_SX MZART.I]5'=A1&:V7.7M78'%!QHI[Q)>J3G1(3%,!31K;FH#2C'GX$X]?J>`" M9+L`^K:>CZVE]@9%%CU9;"3@2,#5P:>#'P9[&5PD$$@ M@U`&QQ[0P,/62$CIEXSD\=Q(8<%&@,[9B>2:B!!=;!GL9.#(P)6!)P-?!GL9 M'&00R""4P;$'!JY!*2/7IF9;;;P9;C6]:C,7BZ$KFSIF-F^=W")B([)#Q$'$ M1<1#Q$=DC\@!D0"1$)%CGPP\@U6*/-/-T;RSC4?`@H:O;I7J8\FW.F@.SXPV MR+3DA=H&M36'R`X1!Q$7$0\1'Y$](@=$`D1"1(Y],K`2GB9]*\5-CN/*/W'5 MFYH8O2)#Q$9DAXB#B(N(AXB/R!Z1`R(!(B$BQSX9.#-[[`S'0V<:4F\:^+U\ MBXB-R`X1!Q$7$0\1'Y$](@=$`D1"1(Y],G!F/G2F>6+RY:>4UR1^V;!J(R1J MB8I@Y&+D8>1CM,?H@%&`48C1<8`& M?O*S!-Z!_-9/'C[TLR&0L-8J8VH.[W;;)J@SW19"BVH7,X63QW389]=%M/9B MY")E3P3U=TD375+WNRBAOL?H@-2#+JB[WHDAW=W#+DJH'P=HD`*8:#\%HG0Y M'EI=$WA`=T.;EKQ-J8.,;FMCU\2$&NAE2'J.[QIMJTJ'H2^D##J-2'6@J3:- M+AK(^\Q`OC30>#9,^QX-=$`#!9\9*!P,I(]-Z8J._8$&^8`CW\.$5'R8D09! M2D2>MPWJ)Z!!BT4;M6O0;-(B1Z!IBURLY6$M7W3LM/8"=5H'K!5@K5!T[+3X M"9@7XJS2JHVJ3[3U22:E^85NZ>U6*#%[S:#$C"D448OKHW1H$:X-+DD-1TN< ML:4&.'P_&0\Z;/BA_!$W".QS\0";"8'-'.9/4_+T<$:;*8$M"^[@6H0G!#=X M%N%IP0V^17AR<,/>(CQ%N.%@$9XHW!!8A*<+-VQ,`ML(S.TY@;O^`[X@3E6' MDMW>@L`-$,<'"P*W+LPW%MD\G-#6(GP-X!ZV1>R'#3N+\/6`>S@6X:L"&K1V MMO!:Y!Y=:!CEER0KE!L]0\6-J^=57K]!J?^4[`Y+%5YPL!)>B%0_K_"FB\(6 M:3R".^B9L5+\X0.T[\[6OP```/__`P!02P,$%``&``@````A`(\,DS]J!0`` M=A0``!D```!X;"]W;W)K&ULG)C;CJ,X$(;O5]IW M0-Q/..1L)1DU23@CK59[N*8)25`''`'=/?/V4P8,QA7U=N]-")_+9?C]ES%L MOO_(;\I;6E89+;:J,=%5)2T2>LJ*RU;]^R_[VTI5JCHN3O&-%NE6_9E6ZO?= M[[]MWFGY4EW3M%8@0U%MU6M=WXFF5-J0N]I`2UG6N9Q#:?E1:ON91J? MFD[Y33-U?:'E<5:H;092?B8'/9^S)#W0Y#5/B[I-4J:WN(;KKZ[9O>+9\N0S MZ?*X?'F]?TMH?H<4S]DMJW\V254E3XAW*6@9/]_@OG\8LSCAN9L3E#[/DI)6 M]%Q/()W67BB^Y[6VUB#3;G/*X`Z8[$J9GK?JDT$BPU"UW:81Z)\L?:^$_TIU MI>].F9W"K$A!;9@G-@//E+ZP4._$$'364&^[F8$_2N64GN/76_TG?7?3['*M M8;KGK$M";S`2_"IYQCP`MQ[_V*HFC)"=ZNM6G2XF\Z4^- M'V:R3<+^?/D*#!"KN03VYZO7H+7SV?C@$-?Q;E/2=P6*"ZZDNL>L5`UBP,1T M#NBFL?<$6#-AX4\L?JNN505FNP+ZMEL:QD9[`Y,E78R%8\QQQ)Y',*.QM`<9 M'&5@R\"1@2L#3P:^#`(9A#*(!*"!9+UN,`=?THW%,]WX'5L<#$).)9%X!.]R MD,%1!K8,'!FX,O!DX,L@D$$H@T@`(Y'`3Z)(W$,,PP(B>&B^GH]OWFIC%LM> ML#TB!T2.B-B(.(BXB'B(^(@$B(2(1"(9*0/+F*A,5W:3Y;PO-!8!10D'H=*D M.K+:H(58CO/U>BSEO@_JC83($1$;$0<1%Q$/$1^1`)$0D4@D(^'@:2,*QRW% M<*,6OT>K):9@($0.B!P1L1%Q$'$1\1#Q$0D0"1&)1#+28?%8!X;'.G2D?:BS MM7:/R`&1(R(V(@XB+B(>(CXB`2(A(I%(1CK`LUST@U!(2GW-DA>+-ML2[A,6 M/M:G(X)/.C*'W51?>K.9/JZJPQ#%+7?$R,;(PFP? M+SS]N4H,CU7JB"YJ8LZD17O?11EP[)4SUS-)N2&J5PXCNT4SLW\`.$/0D'VZ MD%8[=XCBV3V,?)0]&((^R!X.43Q[-$(C=6%9%M7]+V^R\+'J'0'5^6C[#L%6 MC:,#1D>,[!:9J[Z?,P2Q;9RI&](&Q!T"^%@>1CY*'`Q!76+IL14.`3QQ-$(C M%0WPG"@C-VG#QWIQI,.NK3?@0I=*=]^%S:$N^BASMI)LVD7-ULTNUS36SS/,)J/1PMXU(>CA?)HQEP:+>)YVO=' M<>?+7EX>SD>[588="Y]4JPF%*8+YX&S?L=5@Q$.'%H.GCQP-R>P.C:1MAQ1R MN;SCD,OC:,CEXUQ!AX1<(>\XY&(OXZQ(%TVNUJ;MRW7[4I6GY27=I[=;I23T MM0!W0<'M-CWNW^J?FG5-XA9[VV=*R=PDL,5^P*<$=IB8/\W($UPH;K!F!'96 MF(/["%,.MX#K"!,0MX#Y"-,1MX`'"9,3MX#O"%,5MX#?^)<.^>:AA1D)]X$Z M)LQ.N.4`+@YN\5ON^E ML/'4)Q!\IK3F)VR`_HOA[A<```#__P,`4$L#!!0`!@`(````(0"];7#RNPL` M`#0S```9````>&PO=V]R:W-H965T9B.1\UIU[[L3V]/X__\$?^V'H\NU^WI97MH M3\W3^*_F,O[]^9__>/QLS]\N[TUS'4'A='D:OU^O']YD/<[-]Z0H=#Q-W.EU.CMO]:=PK>.>?T6A?7_>[)FQWWX_- MZ=J+G)O#]HKGO[SO/RY"[;C[&;GC]OSM^\=ON_;X`8FO^\/^^E7[L`O3???-Y4?Y_='EO/Y/S_J7N!KVWYC MKMD+0R@\(:7CK@?^=1Z]-*_;[X?KO]O/M-F_O5_1W0M69-<>4!/^.SKN60Z@ MZ=L?W>_G_N7Z_C2>+1\6J^G,<1?CT=?FW/7"62Q_067.5?`K5&[6BN?K'AV_W'\EG_S&TR+'NW+X_:EZ-MP? MO[]4CR/"PO[GIVIR9KPJ]C\_4]>D[\TN"\+M=?O\>&X_1QA:Z*_+QY8-5,=S M$%#>_[P3AXQ`8NZ8^Q?F_S1&"]'7%]`_GU?.[''R)U)LQWU\ZN/J'H'P8&G& M9$,31":(39"8(#5!9H+F0XZ9<*;`X/"`D)B0B)"4D(20G)",D)*0@I":D(J56B16:E1T89 M?J/K^W[WS6^[Y8_()>:N1XP3)9<("3E98!TW#.'Y?*J/SDAZB42-*4HH2BG* M*,HI*B@J*:HHJC6DQ9/M()25AX@;PWK<>H)I3H;$G2_TD`2]4[]2[I<47,C! M[Q#*V7*CEXNDUQ!*BI(>S=WA79-*IQOJF?02ZCE%!5$OI=,-]4IZ"?5:0UJX M,=^KX;Z7OLQ=[X:>H!M$94%/U)CS4EB5LI6A.W6,ET\D'81*3%%"A%/IQ(6- MU4`F'81P3E%!A$OIQ(6-I6HE'81PK2$MR`[&K1IED=0=U\,IT!0+RB$_E].U MGI\!=W/E0C'D:(&A-11TYT;!B'O--UU7S-W5=./HVK$0ZG:(W:!):'6I\+I9 M7:97-]LLEXXQ1',A)*LK:'6E\+I97654MU@LI\;(KH50O_]5E^H.6\-;IIZ. M&[W4+_<=])+H_H"[:5W2N\WEX(BXUVP^%(QIP82BE"-%*Z-:.2U84%1RM.X. M$+H>KCA:SH;GJ@7J'E7/9[9NMT6J7\]CI2FBXK.]*YLQIO@=TI+T2L#=U$F# MHYG;9^K*79OO.^DAJHNI3D)1*@NRT3U;K>?&A)1)#R&=4YV"HE(6[*2GL[61 M[Y7T$-*UIJ-'FBW[E4C?FY_9QM^8H`5"#X@*`\ZTP MC11BK`WT'MV;>WLO,?>NYK,5F7NYD)P,$UI=RM'MZC+N):J;S><+8S+,A9"L MKJ#5E<+KSMRKM0YYO]D8HZH60I:YE^T\E%ZZF^?]3@6"(J=]'$_V,XTZ)_=, MZZH>+>3<%_&2"_DRC3E:RL`D'"E:J2@HM3*!I%9.M0JJ58J"4JL22&K5FI:> MYVR'0B*(LUC,NVP?\D?[@6EX.!-P^(8&G39,RROSW>QS+^U48.4L]05#(+U$ M9X04113%%"44I11E%.44%125%%44U1K2HXPQH$9YF$T8-]8(/5(/"1R"0HHB MBF**$HI2BC**F!8EL.)1V'0/&MB#IP.9(S?,!V9RR<$H44 M113%%"44I11E%.44%125%%44U1K2`\6V#4J@[LY\?)NA!I`CY0C!(2@4Z,XA M@N(F1G-L88F%I1:665AN886%E19665BM,RV\[M]LO3JN#UB.[IPH<"]UZ22T M6"JR@N-VH(5/<1`VYA16TAE)QNU%#I;B)&FJ=Z=$W MME3WDMOE^RHEN3E2#Q@XTKJ`%\0ZD&_8C;5')*3A(9X\MK"$BJ>*&Q6UA!Q4O%C8N;1PV*AQ"O=:;'_&\V9R[=G`ED+'B-!PBXF[+R"3FZO0*- MN!=?@>*L8;TPM&,AI"RT:'6I\,+[-M"" M"44I1XI61K5R6K"@J.1(/6S@2#UL$*@;^7H^LWV%\H(<(M7O-]0M@,N1?MA@ M7D0'W$V;/_J2_+#!GF7_.\@;MI8[T7NS?]]E[B`,!VWL"UL2843Y70ZE+A=7,^S+B7 MJ,YVWB"$9'4%K:X47C>KJ_3JK.<-0L@R_4+[E_*<^1O3,D?:M-PSK:MZI)XW M8$O(Q-3S!H[4\P:.%*U4%)3#*!-(GA'D5*N@6J4H*+4J@:16K6GI,P7;HMV: M*?B!`_*J_\JL_[[HV)S?FJ`Y'"ZC7?O]A+>Y,YUCS39P\7W;TON"RE':L.!, MPF,;=&I!*GFLI=2"C/)8@ZD%6>2Q=E-+#0MK/K7@V[LOW4N`/!D>S.+ONQ"R M\9F'KSHL^G/O2[_S-2N8>_AV@1;`?(X:N@G++(%&^-9&!+`$5DL(2VBU1+!$ M5DL,2VRU8#KQ$JL%LXK',IJV!S.)QQ*;6G)86'Y3"Y9:B($MG#ZBXUNC@X4` M8F"+6PA+9+7@G8^6VLK@U8^6VBQ8`:`]-@O>\FB/S8*7/9+99L$['REKLV"9 MC(C:8H"E,9[`9L&*&$]@LV!AC">P6;`^QG"R6;`FQK/9+-A$H1[;\,!N%/78 M+-B4HD^[R=O(:^R:8+&5\?$$OO4)L(U!;]N>#;L99+S-@AT,\L!FP<8%>6"S M)+"P-37-T`ZPV.G[=2">T'48^LY7/ZA'IL%=X"HQV;!52!ZVV;! M?1]ZSF;Q\6SL(H,^&VZ=O,!J"6$)K98(%G:Y0=5B6-@=![7@.AXMM?4I;N71 M4IL%E_.(J,V""WG$P&;!/3QB8+/@RA@QL$4'M\2(@$-;?&M;\)T&GMC62GRN@5ZS6?")!MIBL^#+#+3% M9L$'&FB+S8+O-#"J;!9\FX%LMUG\A8O?"@OUAX^]0&?#!,F_I3A8_O6 M5-OSV_YT&1V:5ZQ(I^SCV=&Y_ZN'_A_7_O9L]+6]XH\8L&C%)_'XZY0&'SA. MV17;:]M>Q3]8!OE=;>[#N#A>'D$ MY/ET/FRN^/7\,KJ\GW>;I\;H\#;RQ^/YZ+#9'X>MA^#\,SY.S\_[[2X\;;\= M=L=KZ^2\>]M<4?_+Z_[]HKP=MC_C[K`Y?_WV_MOV='B'BR_[M_WUK\;I<'#8 M!MG+\73>?'E#NW]XT\U6^6Y^(?>'_?9\NIR>KW=P-VHKRFV^']V/X.G3P],> M+1!A'YQWSX_#SUY03[SAZ--#$Z#_[G??+]K_!Y?7T_?DO'\J]\<=HHU^$CWP MY73Z*E2S)X%@/"+KN.F!?YT'3[OGS;>WZ[]/W]/=_N7UBNZ>"9/MZ0TEX=_! M82_&`)J^^='\_+Y_NKX^#B?SN]EB//'\V7#P97>YQGMA.QQLOUVNI\/_6J6F MZIT37SK!3X>3&X83:8B?RM"[F_JSQ;(I_H;E5%KBI[2P"B8[_I4`*?1%(%8*5 M`GUD)V9-37*!,8J M:HPR*QJK5F>^Z"*X)A(2B8C$1!(B*9&,2$ZD(%(2J8C4.C%BA=FIQTI.U;M^ MK>;9*DPPL_%#FZY33`"OTFL"HVBXD_M+Z;4 M\I==@A(J7QYZM;.&IJ74`=+)%LZGP@IV7FIIT;NVJ*DU#.:]-9L9<).5: MS+L1WR;K1FPE&B-ZW<"=CY?FP%V+W2]6&;_?U802S;#"=X;^U#*,I-;TONF4 MJ;\8WWNF[U@Y:LYLFDUCPL6E2NMF<9E9W.1^/O>LV9LK1WUQ!1=7*JV;Q556 M<;/9?&Q-^5HY:D^D]'VE.!9P]E*[3S!Z22+TDNK_=6-N=4FK-NTG2B2U)OUT MBMDP891*I/G*V%?.A@6C4J)EOV!6$LW[J5@KU%35',\BNW>-YS;K-R(ET1@# MMAN6U"MKF#3CN:]1*-'$;T?JPE_:7\->0W5"S'X21FEO*.;W9+&<6DM3UFLH MUSG[*1B5O6'C>CQ96N.]ZC64Z]KP8T9:[`"T2'^X6K<[!CA4SE5\6H5JCQ9490 M[`6T"'9K;[M',"(ED;GV>M:P6WNMFK'VMNBCM;?54FOO8CI9T-HK'?6+8<+% MI1+=+BZ36JJXR70ZLQ;#7#GJBRNXN%)I?;#V&JW#N+^_MV95K1PYUE[XUGOI MPW$N]*U<42)C36Z9T54MFO4K3>1)U'],8XGF?6`2B31?J3+L?64*];YR]E6P MKU(9]KXJA7I?M>'+'.=B_Z*-\S:"N!W!NBMV*7^L1/H9"Z.0 M4<0H9I0P2AEEC')&!:.24<6H-I`9*&L?IKY+/N^W%.H_@6M&(:.(4F.W*9IV_^'('I['I]W/1)]#3 M&$VMCZRL!DP52Z2>?AJCF=XH(=/4E+?8_/.RR)]-,8B8PND(;8U,DS#2LYBY1K:*B:QPZ6L/-44Y/.[=,834,YSQVL M8.>EIB:=VZ.^N(* M+JY46C>+JZSB)LN%;Q57*T>\(Q#O7)R]U&XSC%Z22,_\&W/S-$8B[00EDD@_ MC6'#A%'*OC+VE;-AP:B42#^-D4@_C5&(3V.00+DCU6YKC$A)9)[&>%:OK!N/ M"%Z_YH82R=,8?SR9>=9F,NI5U"R,V5'"*.T-Q03WEN.I;UWG9KV*\IVSHX)1 MV1LVOJ<+W]YS5[V*\ET;CLS%0^R(M,7CPP6[W4$9G2"1?B"#4(N%QHAXB_0# M&:FEH5BA_A`E85^ITNHSR(Q1KE#OJV!?I=+J?56,:H7X0`:KI!'!;OGEW56C MRLNO?2`CU8SEMW7VT?+;:JD3$M>!C/2-G%`-CH2+2Y76S?4PDUJJ.->!C'+4 M%U=P<:72NEE<91;G/)!1CGCY%4\R?F6<-_KF_DXA?5F6#.6J<(82Z0S`*]#8&OS>8#7#P[N+0-Q M^N&2W$/2-,GRA:$7B,BP#49@(`+$$HRZ0,2))34D(EPLP?/BS\WAM%7^"L^. MF\,HF_L!GKFQG]4$!3CXYVGPV5GP:AK@H1([POJ/$IS!0B-63E]K2-9.20B) M&.5<3@1)Y)3$D(@QSS98?H+$*<$J%(@9P#98>0(Q$5B20R+F`TN0FB$&SJ&$ MZ*R24($<(Q%>,:X!4(1`?,Y8@8PC$!XPER`H"\1UC"9*# M0'S.6((<(1"?,)8@K0Y$JL<2I-*H@4N"#!HU<$F02*,&+@GRZ4"D@5P.)N@B6X)@K$%05+ M<#44B)L*EN!&*!`7%BS!Q5`@[BU8@ONA0%Q?L`07K2C']9G";2K*<4EPJ8IR M7!+,':*0DA"9V2"!)Q6\0MC2$1ET8LP?L& MM-357JM3':[Y+@V1O:XHISB#B+MU7L#6_;T$J7!$_<,')=WO#\"A*7#=ZQ84PW MDE&7M>$ON-XW+[MJ&PO=V]R:W-H965TSN,R4D04U"!'0Z\^_W&-N`/]1V M7DIS[O6QS[W7]H6'KS^N%^-[U79U<]N;UF)E&M6M;`[U[;0W__F6?/%,H^N+ MVZ&X-+=J;_ZL.O/KX^^_/;PU[4MWKJK>`,.MVYOGOK_[RV57GJMKT2V:>W6# MY=BTUZ+'S_:T[.YM51R&0=?+TEZMW.6UJ&\F9?#;SW`TQV-=5E%3OEZK6T]) MVNI2]%A_=Z[O'6>[EI^ANQ;MR^O]2]E<[Z!XKB]U_W,@-8UKZ>>G6],6SQ?H M_F$Y1LJD_G'NG>D"%E<\%,^&M<:U(#D%[\&)YO]:$_[\WU:F$Y M*]?>F,9SU?5)38::1OG:]S'\VYSOCMFPGYEG2>,[Y"4J^N+QH6W>#!0[0MC= M"[)U+']G&BPA3.&8(E1*2;R?B/O>A".BWP']_NAZNX?E=^2\9#Z!ZF.+'B'W M('DGM)$,Q#*0R$`J`YD,Y#-@";6C9"3P5R03=R*9+S;@P!0#6PI!R%WXF$@& M8AE(9""5@4P&\AD@"$2MS@3RU!$4VVB6.FR9(@6)%"16D$1!4@7)%"2?(X(B MG&(:100=%/&Z"1A"CTBR54(%B10D5I!$05(%R10DGR/"\EWM\@DJ+I\B6_", M*;*=C9BBD#GA,3JM76E'1:,3#TVL(`E%[.'^&LZ5=/1YASH;G3AU/D<$W3B= M9VECI^5BT'>NRY>@@0)K/"R)MQ@/BL"?3Q4RQ!G.4GME.6)PHM'.1\0*DE!D MKGOT(23SF82HX`;4 M1(6@8E0H@JCP0(<4\:8BC2CB3CXQ0YQQ5$*1N4"%)U-X\CF/L'P+G9MF_0,L M"F#0&@/&E*$-$U,6!0R^NM*Q55-GEP MZES@$963KD"M9XLV"[A,.$?`("CG4,@A>X0B%8H9).BB]#,H50=F*I0+7*(0 MR4Z1-;HP.,1,VA6EHD*I=/`(8.[M;3+ MLLF!,^<"C:B;=`D:W;1Y$'13:+[Y+`9-:8Y4*&:0((L.G$&I.C!3H5S@$H60 MYD`CA/8,@A`*27M0BF*($>3T6=,]N+-<)8&C`P]SS,;,ZC)1H51D=G<[Z9+* M)@?.G`LTHF[254RZ/[I$\7HH'ZH,$G8F]=I,-VO$O&90S"%WW+\)@V812+G7 MQ)6I4,ZA@4L42-J'22"_,BW:52`P/$@!@Z2=*;4^(?/ZX-9D7NS:="UG)_'$ MG&?#`J"MB1`W"@D[FT*; MV;UJ,6CJ"F(&N?,04"\A!`I7IG+E`I)ZO!8,F"B./CC+=49PC6/M[15/S)\9^T$Z/`_4!K05'[H=82P1)I+2A@GV1070#JV$^T MEA265&L)+`=K&_:X%!:DLN)JQ-IT%%S#6IK-DGH].4YT_]WSTFRH> M6"MHT949ND9HT5G0&D*+SH(.$5IT%C2*T**SH!N$%ITE\/Q`M^;0\]&GJUHB MST>WKN*QYZ-G5_'$\]&YJWCJ^:D.#U`0P_4@562`;:2K^Q`;8KA_)/]PZ^,U M49TWP3;1X2E.#AU/NO7Q8@B>Y3@!/M+>BU/U9]&>ZEMG7*HC#JK5\`KGQ?98<=\89W]TK?,)8+7!9'YNFYS_(!..7_,?_`0``__\#`%!+ M`P04``8`"````"$`EOMEH^4%``#8%```&0```'AL+W=O)\0CG"ITZ/F1IJ55JO9W6>:D`1UP!'0 MTS/_?LL78)OMZ7EI.I_+Y:IRN5SP\/E[=].^-&YO[?2#*-6UK@[+ M2X^&ZOD&?G\WG:KFNLD/17W7U@,:T7G:@3J#&JKZ'!B!`9H>'TXM>(##K@W- M^:@_F6%I'G3C\8$$Z)^V>1M7_VOC%;WE0WOZTO8-1!OV">_`,T(O6+0\8023 M#65V1G;@ST$[->?J]3;]A=Z*IKU<)]ANLEZ-;K`2_-6Z%N<`N%Y])\^W]C1= MC[KE[_S#P7%][Z!KS\TX92V>K&OUZSBA[E\J9>+E9RT6TP)/IL5T=IZY#^Q? M4&(S)?#DIKR[J,/DX'`;UI<,!@T\9[A8^K&8(RE@3,Q3DM M(#MK+/V$Q8\Z",)^CT"_/;K^X<'X!GE6,YE(E;%$B9A+X/S`:A,9I#+(9)#+ MH)!!N0(&>#N[#!GX*RYC<>PR-S;B8(F!+?G')?B41`:I##(9Y#(H9%"N@.`? M'(Z5?WSG,#WJ\'?>.=LW1;LC*N-ZLZ^Q0A*%I`K)%)(KI%!(N2:"0W!Z-QS" M%+(6'K-'KN]*'E$A:^610A*%I`K)%)(KI%!(N2:"1U!$-CS"E'C$\R9BA%9E M?%)BA20*2162*2172*&0V?HD0N0UXYF%IT2U&]G@" MKR.6(]61F$IY$,1%*'#$#4YF(1ZS5"$96VY)@GR6653;IJ2ZF(6XZG)-A(!` MN=_83TQ%QREQUG[;OEP=J=`!'HO?CB_YS30%I`;[ON.)XRE30EH`4F,S2JRE MD.5,!A[_OU!!A1RZD&F[@;A0R9307F-=9G&?N-PL/!DP%6-""<2$ASFFQ/=G MDE#BVC-)&7%FDE&R]H^2E>:"$GN95:YG"5L*=]R&^9B*YE-BPV4S!]'VY0N! M"5EDMRPGV(M!3.9Q'H.4$FN)0::0?)Z%[V'+MR2MQ3S.M99K'8*W)K2/&^X2 M+/K+$#C,M<8<63-*5)0RM'9)1;DZL5!1*4P4'<&WOIIV)FT&X+;@5D<,28=1 M*@(QDX*4P4'V`GFE+SI=,UR: MN+G=1JU&KSULM>W"7LZ8OFU#Y$-L#4R61B#B\"*^-0)OZ$]D&Z09$7YSW]`4 M62$T[>H*$2Q`O)7T/#GAT^;"$9@4;8Y`4H?QYD@"(WCKU.4A@4.\@^H(Y'&( M-U(=@70.\\T1J*M@VY:;4$O!@JT1*)A@P=8(U$VP8&L$RB=LV-8(U$B(_^:( M%\*%KWH3!6`RZ6"D'8@#L'AK(`W`X*V!+`![MP;R`,S=&B@#L'9K(')">(-0 MK8W=$)I=N"!VJRB,OC+:\CKT06BU5/O%":+A4GGHAM%TJS[P0FB^5YUZ8 M;_'""Z$1`WECCC9\;KI7E^:/:KBT_:C=FC,C/8[J`YGA";^`R\P?Y-\_`\``/__`P!02P,$%``&``@````A M`!?^42=M`@``FP4``!D```!X;"]W;W)K&ULC)3; MCML@$(;O*_4=$/=K$B=V#HJS2KK:=J6N5%4]7!.,;10#%I!-]NT[&,=R-FF[ M-QS&PS?#/XQ7]R=9HQ=NK-`JP^-HA!%73.="E1G^^>/Q;HZ1=53EM-:*9_B5 M6WR__OAA==1F;RO.'0*"LAFNG&N6A%A6<4EMI!NNX$NAC:0.MJ8DMC&4P?YVTHT]DR3[#TX2"F:TU86+`$="HM=W7I`% M`=)ZE0NX@9<=&5YD>#->;E-,UJM6GU^"'^U@C6RECY^-R+\*Q4%L*),OP$[K MO7=]RKT)#I.KTX]M`;X9E/."'FKW71^_<%%6#JJ=^"-,UQ`)1B2%?P)PA\"\KT1PEM]"*^6C[D-AB%O3QFD/ M""&"S[0MZC##Z041A3I&LZ37PSN`0C#]@]XY)7^3[4(4*/M`E!`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`_J90H5]))2SG!IW+2ZM_TD^9=N_]Q)VWE!)_:R4WKMIMT>^))WFF] MHPSQJ0Q['S.$V^K=\:D,D^9-I]7MWU8O_TZ3?66)3_VL'PX6AEC5*CZ5+1[\ M@X%.3+KPAV[Y8R^;Z"2)/Y1I]X.F.C6)S4UB\_M.G-#E5/>R,4;S'WW;GK;& M'^:1/]@Y&[*C5P-DM+EN'CZ=3S]JJ#J(W.5M(VI8DB9(H!H:JH>9P8(QNQ7J MGX7^??VN7L,PN(!^?^BU[CXUOF/T;97.@'5:OL90:X@1*-R.0C`.P20$TQ#, M0I"%8!Z"10B6(R(E(061,I7>)% M&L6;(IUT;\3$)PLC5Q1A@NJ##UM2VDD0?J741X:M5EAXAE;+]'=&8T831E-& M,T89HSFC!:,EHYS1BE'!:,VH])"7(63B%QG2)5YH5`G101PHTD?:;?3;85&W M6MIPQ&C,:,)HRFC&*&,T9[1@M&24,UHQ*ABM&94>\J*/J=N-O@ZYP'[()6DY M]8;(B,B8R(3(E,B,2$9D3F1!9$DD)[(B4A!9$RE=XL43*Y98/`7VXZF(7/2+ M)<>0R(C(F,B$R)3(C$A&9$YD061))">R(E(061,I7>+%4^QX>3E8U>_KRW[[ M=7!"`4C,S"G4_3@K@H292M'J=/UJ/I1*?10IH]1K!TN7D5'2U61,9*):LZ-D M:G1-NLP([*=+D@X*EI.)OM_P4)GUL.\V6JW.K:\UTEHMN2MH!M/#6,J[ MU4Z]6O1/)&G9!>U4^WBWI9G6DBVU>T'/R:BE.;6TT#[>;6FIM;QE1SMX\UQK M>;YZP0IR1<]01.W"N*ZUEGS;NUZP-"JE7,;5ZP0)GB?6"RKN=P.%T`]TWQIJ MK9X\W)"[-.$1EKVVT1LKO5YU?"/SJI";V(BWF6'66\;>YNQM82SMLRT-L]YR MPZS>BMT51LV^P]HP&Y+2,_5#+;9X3MW4`TZ<4`0C3J$V)&8P]=K!%GJH#7N] M:C11UD>.@D[96+'6K'#2-6,XB+&-O% M4;/];1UAI6?JAUKL(V.AEOM++]02^3-5)\CT4!S)507*75KP5&74[G[19<9* MPREA$T93X^?=YF9&K5LUUTZ""21CUW-&"^/FW=:61LV;U#O!=)P;-<\;#S@9 M42<01=R2YBVCIH+?=)HRFQM(._)EA=G;(V'3.:&$LK;>E8=9;;IC56[&[(J*V-LR^:NF9 M^J$6FU5G#*H38+'D-[.8VL_:1QF(HVR$LX?%AZG6O4XPDPRMEJV%QE"C,6M- M&$T9S1AEC.:,%HR6C')&*T8%HS6CTD-^_,7>UHF_";K<\R)Q.E"#Q-T&5TNM M(:,1HS&C":,IHQFCC-&W%7K_X$`9_N;DP&KIH3-F--$/81'I@M;3[C-&< MW2^LENL^/$&P6MI]SFC%[@NKY;H/3Q&LEG9?>LA/K-A<.HDUQ4EM2MVA(Y&_ M0&L'4_XP48:_.4O0:GUQ2?/](4DZP09IK#3$RZ.E47/;['6"SI8;-<\;+]-D7)UW+^*6X7.LC9H\ M7^B&YW"E4H@<,+1^<*L6+.#G7":.I8OC.:9HZ:;B!C;W-&"\?2-M`+ M3YF7CIIN(#<,4[@9Z7S,P(T6QE*>R+1;06E;.PJZN=+SXR=4;/8CE;4E#P'< MJ5$A]Y1!:[FG#!$V5LQ+F&S`0=.(Y2S",O8V9[2(6"XC+#?,3L`K=E<8-7N@ MLHZPTC/U0RVVL+%0J\,".R@'+8G\28Q.&916@I+D=**PLHZ,FMKVASUFK!2< M,C9A-#5NWFUM9M2PP3(]F^,O\E0 MRZ]ERF^='7;GY]UP]_IZJ6U/WX[HJ$E3%%3#Y1="!]VTK)R&/(%`[KL"R:K5 M3L5SH_0&$G2B5#P^2]!O4O$2+$&/T=](#;SAJZJ?6Q&+`;["6BT"`OU!"XYB M^FB@6D@$^I\[\!][I$$G+6,<`S\5W81?(H-$=!:68,BGHL^P!",_%5V')1CL MJ>A`+,'X3D4W8@GJ:3J(2H:0#*,2E,U4#"+VAGJ9BJ'$$I3-=!*5H'JF8F"Q M#186B$$L-5A?X$UC$BP?\*8QR0H2,7MQ.U@XH)/%)%@=H&_$)*OD#MZJF]*@ M>V!5C\XEPZAD!(FX M<^!V<+6$6,+S,4D*TC$C2(_`6YSD9^8),=@Q`4\FZQ0*Z." M`J4R*EBC4D8%)0IE5##`8XG;7FX=-_5(=$R"ZW@D.B;!K3P2'9/@V5@H8IE_BMT-OF>9=OSL_[XZ7V MNGO""K99?3WN+']6)/]S/;UA98N?=IRN^)50]><+?OZUP_<.FS?8+#V=3E?] M'_2IAOE!VTO&IIE?SZ:0[[OJ'_?'I9OJ?O_(_UM/)^;(]/FQ?^F-W,_V[.T__ MO/WG/Z[?^M.W\W/772;P<#S?3)\OE]=H-COOGKO#]GS5OW9'2![[TV%[P9^G MI]GY]=1M'P:CP\O,G\^7L\-V?YQR#]'I,S[ZQ\?]KDO[W?=#=[QP)Z?N97M! M^\_/^]>S]';8?<;=87OZ]OWUCUU_>(6+K_N7_>7OP>ET/E"NYFO*&TSYO99@9/M]_2`T3XY=8\WTR]> M=.]OIK/;ZX&@_^Z[M[/V_\GYN7\K3ON'=G_LP#;&B8W`U[[_QE2K!P;!>$:L M\V$$_G6:/'2/V^\OEW_W;V6W?WJ^8+@7S&37O^!-^'=RV+,80->W/X?GV_[A M\GPS#997B]4\\/S%=/*U.U_R/;.=3G;?SY?^\#^NY`E7W(DOG.`IG/BKJ_5B M$2[7J\]["847/(47;_[;3<'KAO[@*9S\?G>6P@>>PD=P%?J+U7K@Y!T>5L(0 M3]D#[\H+YTO&Y3MVF'5#H_$4=J'J^#MV&V&'I[!;:[2_8^@AH/BPL\CB0_JY M5WICP.`_O]5)3T8)^X^P_"2O7B";B_\(TT\/ZXQ'_#!3TNUE>WM]ZM\F2#_H MP/EURY*9%WD(.C%'Q$"-LP:3=\?4OS#]FRFXQGPX`_UQB_"^GOW`--P)G9CJ M^*9&(C785&1N4QO(;""W@<(&2ANH;*"V@<8&6ANXLX%[#9B!PY%(C.=O$ M:Y&QKUB-<7G>[[[%_5"JR+!@ZB8;`L%C#!0_7)BS*A%**E!2CJPPDT>S8+TQ MS3)BE@LS#.)HYF]"TZP8E>20E02IB.MZU%&N`\]RW8Q*TG6K(P:SJ%AT9B6# M##89Y$C(&)>K8+"9FWU*N!*O;_DB)QS-\51V['B"K42JYN,]CL-D<"%!@C^\'&,X5AA M(R`C&_D+:_HG0DN?0@+:!#QE^%Y@C5E&C7(!!2$/G]5J;56IA=*09)?43T6A M6AFR$/+"Q=K*<8W2D*Y;PX])(:LY713R6A2%DG02L\T86-4SCH`,OK@6^)*& M&=7*!02"I%9!H9(:5A2JJ6%#H=8P-"E@-:2+`EY;&A1PR,H^9-_&M8RYQ2&9 M?\QTE;%-*YC5#'(!!2(!^:CHK36[4"J2PY(ZJBA4*\,AA.:K]=+:G#9*1?IN M#4$H]K:8&?"FC#EZ70GR^MM2.C1KF`1"9:K@(KW15*07)=4C<5A6IE MR()HL5E995FC%*3GUG!C$LAJ2XW`C[9\'J]%#6(Y9&0G#ADL<@@LRE9EPI>F ME0MHH>KS@D*EA):CKXKZJJ66\M50J)70X,NDAA61&C5R4^'QXM*@0-2;:N(D M0DN;."F%,@KE`A*;(&^]GGO6-JA0*I++4D`+5896U'>M#(@;:^5+&08;NUI26O*-[4=O-)G_11'NTR)<0,8^QO.LT$^$EA:B*84R M"N4"^N`416B)B;W%WL+J;BO]T-,4 MGU766N;[,*9Y):YGQ,&%N>T1D$&O*.%5LLFH5BZ@A3J8*"2D#$L!+77RB/M: M&BI?C824K];P908=JZ@)-;@KPV"P$]*_^E?D/6Q@^966SPMP,*/&:FGO/6.A MM3$3@)7U$Z4EYTM*H8Q".84*"I44JBA44ZBA4$NA.PK=&Y#),BO:-99'.GDQ M;P0:A_1K!W89S#:&>J8D4$:U<@H5%"HI5%&HIE!#H99"=Q2Z-R"3*%9XNXCB M!;E!E(!4.92PS`ZBL,-0$46@C&KE%"HH5%*HHE!-H89"+87N*'1O0"91K*[7 MB/HPI?%]@$&@@,"0EG>M')X@Z@9.]>#CT'HE#L/FE M@%9Z?B'W%)72DNYK"C74?:NT5)<#WUI([I26=']O0.9`L'V`-A#CU.;[`X-P M#AFK=CBWWIY@^S#,=I6^4P&]OQYG0DNLQ[XW#ZUAR:4?M:04]&VEU,(H:W%A M[1$K\VTHZ^VS\5KZ46]KZ-M:J?7NV^ZLMZU0Z9NG9_?2CV/U_\6^!POW$-EJ M!Q<+2#]6$)"QRG-#[:XD$UK:94DN(>6^H+Y*`6F^*FFHSDYK"2E?#?754E]W MTE#Y8E^1L6XO!U\\E/E78?Q;ET-W>NJ2[N7E/-GUWX^(`&^^P$0?\?%[M"_# MD9N%Q_A.;;A@L'$?WZ^Q;&#C083;>XI_":,OJ%H<`I])ALEANX*$K<'4!L$: M,5JI!$$:,7:I!+$:,9*I!"$;,:ZI!&$:,'-)8K0M=K8-^SB,G*O5V,YAY%P2[.HPD@(1M1.CXX-@N8B=25(+3NXB=0E$)SN@B=AA%)3%XBYV\X9`)/74Q MBK,F]-0EP9$3>NJ2X.0)_7%)<+J$>'-)<,B$>'-)8O0G=O8'9ZQ1XI3@J#5* MG1((G>Y\!B9RTE7@L3E M%*3(6TY!AK3E%.3(6DY!B:3E%,1AA`__Z$CERPC?AE&\7D;XL(OB,3*EI?SQ/7KI' M%*CSX8.^$__1`O_CPH^M)E_["WZ#P$ZP)L_X<4F'[QGQ$X'IY+'O+_(/$#$; M?ZYR^W\```#__P,`4$L#!!0`!@`(````(0`RBH+#;@8``&X:```9````>&PO M=V]R:W-H965TN_YE MN%;5&(&'=MC'UW&\;Y-D**]54PRK[EZUT'+N^J88X6]_289[7Q4GV:FY)62] MYDE3U&T\>=CV/^*C.Y_KLOK2E:]-U8Z3D[ZZ%2.,?[C6]V'VUI0_XJXI^I?7 M^Z>R:^[@XKF^U>-WZ32.FG+[]=)V??%\`][?4E:4LV_YQW/?U&7?#=UY7(&[ M9!JHSWF3;!+P=-B=:F`@TA[UU7D?']/M8T;BY+"3"?JWKMX'ZW3G($_^^A4G8O7V_A7]_Y;55^N(TQW M)KJ4W0TBP6?4U*(&@'KQ;1\3B%"?QNL^IGR5Y6N:DBR.GJMA?*I%WS@J7X>Q M:_Z;0*F,/OF28_A2C,5AUW?O$4PLH(=[()PQ\:@S1B`3"ZM@0SXH]AQ!6$4(D0,1\G`RV M/QKV1Y$_R85E>NBB%`%Q&V5H/ M=LJ7`B%&6:I!*&+N1Z0<,1((S$A9,*.%C`D]="J9,.1?(+!_94'^-X8D&C\4 MO>L?UX``>!DSI3]E3(%PQ@P(14QA(;HAR0.J.PG!G&:338IG"TLFA8&X(3`K MB?!H,3W'$ZT9A7D9%.:%%[XL;EP)J5KS`EZMS,PKS,B@<-*05 M&YQ-K19:C%)ELGG!R4(G&(<(B$,.FYL6[]37AMF$`RR(3QI0!Z?.M3I8$IX9 M]515J%`X<0:%604D@ZTW*VYH:5,F3&MA^9*/%4)"L$+,)AQB82D1H.HN M)9PYB7"6$C5K9$K<#+(39X%0WDA`'TB&"DY"'%9*(.!+[\%DO5#3!+A_P$H@ M'%8\,^M2T5(HFY:-PKP"`N%LZL07B-F$9\L,!(<("01!NZ`X+#H:-)MPB(5] MEH3D`$^.5@,S$SPS[E3J%`JGSJ`PKX!`4):O8.3ZW.A+!%$FQ"M=D`@2D`B: M8V):(_1RE;V@3'"(A0V=!`3!+0!?$60O)P3G"THJ#N]N85,T_Q+A%C8W29EF M9T:AV;%0:'8HH+R@&QQ50&14G3K9R^.UD#H:T`0L0Q+A\3+"J7@IE<"\#`KS M@EGU>.&3"A40AY$C4*I8R'=P$=F"<&E/ILP+[/WXQ!" M`IPG-'P<8@+A1%`F'&%A5V'$A30"'\"9?VZ83?9YB'-3)#A$0!&PO,)-2H"7437% M2Z$P+X/"00,:X213:X3>-9@R85H+QP86$`2'EM8#LY1X;D1-T5(H1"LW>R:F M%9((M!DR7R%FDTV+T`418A\JA$2X59@;=XI60"&XA4*TLH!"I!O[(4TB\/*= M338MGB\(7R;6NB,0N!XDPJ/E[ADS"L^606%:,#0W*%8EN/QU56DVV;0(=9?O M=.4[7;>B`X[;59WS2S?'J$4H-J]ELWV"-D,M&0I MM,@+:KZI-" M"SS"![RE#]LC/*(&6@@PA2>_4`N,`)X%0BW`!T[0@1:Z!J9!/B),J`&PO=V]R:W-H965T M\*L,ZN*W-B8W;U6 MR[2M:$ET2.KIGK>?'T2B@,0/2]Z;=OO+1"*10.%,^,/?_WI\N/CG\?GE_O3T M\7)Z-;F\.#[=G;[/D__ZC^MKF\>'F]??IR^W!Z.GZ\_-?QY?+OG_[S M/S[\>7K^_>7[\?AZ`0M/+Q\OO[^^_LBNKU_NOA\?;U^N3C^.3Y!\/3T_WK[B MK\_?KE]^/!]OOYP3/3YG5 M&GD^/MR^PO^7[_<_7IRUQ[M?,?=X^_S['S_^=G=Z_`$3O]T_W+_^ZVST\N+Q M+FN_/9V>;W][0+G_FBYN[YSM\U_(_./]W?/IY?3U]0KFKJVC7.:;ZYMK6/KT MX?/IP#]+_WQS]?@O^_>/E^^K-^OO_2WS\= M$6W4DZF!WTZGWXUJ^\4@)+ZFU-6Y!O[K^>++\>OM'P^O_WWZLSG>?_O^BNI> MFB1WIP?DA/]>/-Z;-H"BW_[U\7*&'.Z_O'[_>#E?72W7D_ETMKR\^.WX\EK= MF[27%W=_O+R>'O_/*DW%E#4R%R/X4XS,D.`7$R\D,?YTB:_6T\G-?`T'WL@4 MTK/G^%/2K7\IW4K2X4])=W,U74Q6IKQO9(G.NO;>2HKYM;K[B9U>;Y7*QVKP3 M]ZFK;?,_DNORER)OBF,S]75]\Z:_U[:UGEMYABT,=@B,$^!H<`7".H8V31'OY?D37Z M)K(N)EL'?*CG41B=ADM2Q*",016#.@9-#-H8[&+0Q:"/P1"#?0P.`5!AQ+<1 MAM&U0X/1Q0;M<'8SU>'96IW5>@QI3J0@4A*IB-1$&B(MD1V1CDA/9""R)W(( MB8H>^H

O)Y7Z%GO]_?_;X]G2>2KKT9=1U#(4%[(U(0*2U9 MH[D''_E"]P35J.0:=TVD(=(2V1'IB/1$!B)[(H>0J+":)5DPU7'A,UB'SQ(S M>_.!6"QU(')1PNCOE6XBI<(JS3;C"%1*,C@9)(NZVVI4&H-,I+%D,1M-MZ.. M-SV?1#.OW:CD3'=$>C(]C#JAZ:C_WX]*SO0A)*HJ,'],587!NBHL054XF[D0 M'?>5KIS"*H5QEV3XYL:XSR<3G:P:E5QN-9&&3+>DLR/2$>G)SC#JA"Y&W]]^ M5'(N'D*B@FS6/ZDHG[D.LZ`PS@[I0*]UQ`K1"B/M$NI01W.SRFNY@M2,&C;? MLM:.4<>H9UN#H&"&N&=T4$A'V,S]@R[EO9[:+"^C!BY(1=YJK3$C'MOJ["9: M9!624$5>$OKNIG+F/:H9-6RK=5KGK97S&FW'J&/4LZW!:7DG]HP."NDPF[5! M$&;7&M@X%0Y^@(%`%HY)1Q:AFU#!J&>T8=8QZ1@.C/:.#0CIV M9FF0BIU=,JC86;0(Q[WY)!K2G8?,]H<+;"\%'Y]J+U\_(= ME&E=EV8EDJI+NT)1=6D1@NT^C=PL\6S%.50(4K5$"2O1@LLN8M.@A48;VCZX15\H&TN@9F&+;>"%N&L>3Z+%1RY:Z.#-[N[Z*IKF%R)7G88U+)W:V\UJNK)U#^'[&A(F6;1T/RC)(0BG+8KJ)9JY[ MK^`R.PBR9G3MF"50JG;LTDC5CD5!;YE/90'E1]%"4.!Q*2@(;L6HYH0-HU80 MXNT*MV/4.>0[XYYM#8("O_:,#BJACIU9V:1B9U<\*G86J2Y[MHY:;CZU6J[+ MCGKT0L2JTQ"[MIN;+691-U])FJ!7J=E,PZ@5I+OL:=36=E[+545NVSK M>%"6P264LDS6T31G[Q5<9@=!UHRJG%FTN'QOZ7/6UUVYH*!_S`6%7;F@H"2E MH*5O?A6CVB'?E!NVU0I:^+7)CE$G:.-'G9YM#8("O_:,#@Z=_=(Q->NW1(,W M9\#1,"A(=^7Q()R+5M!9%(Q*04OTA;ZKI(FYR]$."_,5K0QJ9\>/PPWGUCJM M-W/;B=8JG)C,I]$'W25MT;?`3@S)A'&1]Z*UD"(OEK-HK#PX._8.@3K]B]:L M[WX?O):=610."()4A5JM`)6BM?1MNG+(CR2UH%58762K=0F]K9V@C9^Q=*S5 M"PK\&EAK[Y#WZR#(^J6_CV@M2S']Q^D'NAC,6^Q9]8S7N(+"HQA&!:.24<6H M9M0P:AGM&'6,>D8#HSVC@T(ZIF:]E^IS[#HP'&1G@GRWFS,J&)6,*D8UHX91 MRVC'J&/4,QH8[1D=%-*Q,XNS(';4'J.#&G,Q)N['!?F51.ZT/"H8E8+4:DUHX91RVC'J&/4,QH8[1D=%-)A-NN[(,SCYVW7?:J)6O3.TS?8L"C>ZT0L;K;6NAVA:6HB6J@=)B.H8 M9RQ\FN/,^PE@S:AA\RUK[1AUC'JV-7BMT-7H.]U[+1_TL8Q`.N@_65,B0A1T M64"&7;8@'?1X+22V5-`EH0YZM&*I).$Z#/J8T!6N8?,M)]PQZACU;&L0%)[K M,#HHI"-L5D]!LWZW8[>K+=436:2:NR!,LL96R^H8]8P&1GM&!X5T[/#]ADUTC)WA4>PLTFM%.M057136;:1BU@J)=PLBE MG==RYCM!JJR\_.SLYJ(5 M[@8*4M&7A'X[HA(MM!IGJ^:$#:-64'BPPZ@3%+C:LZW!:7DG]HP.*J&.7;2Z M'%LVKR+G%NDNF+:_14L.=J;QE$_$JM.P=N&C.0I*;']+&BCX0-LT@9F&+;>" MHG.=J(/>>2UGOG,(N8P?<:)ADQ.#)'1EF4VCX]&]5W"9'039LNC*,2O!H,M^ M;X8X-_K1L&Q1T(OFHJ6Z?[%=TA9M M?[,30S)A7.2]:$F1L4$RC[J,@],X%UG7I5GS!77Y[O=AUXBJCBT*>MG7VB'?\ALVW[*MG:"-_[`ZUNK9UL!:>T&!7P>'SG[I MF)J5(<44/S)$PS77PJ/=;Y1?NAS?KE>;Z`!S*UHW:E(4]XVYUW)=3L&H9%0Q MJADUC%I&.T8=HY[1P&C/Z*"0"CR^`!5XUS&=N>[4!6$_QP4J9U0P*AE5C&I& M#:.6T8Y1QZAG-##:*Z0#9=:000L=`V77EN'7C29_;IU^$,L9%8Q*1A6CFE'# MJ&6T8]0QZAD-C/8*Z4!%*[[WND?L$L?3!X

MU.%*PR3:C2R]AFO$%:.:33>"WCZ4:+V6,[]CU+'YWFL%18ZO9`Q>RYG?*Z0K MXB?+QP4O'P6I2?9\%NU_YJ(5S+$*06^?KY>BA1/O\[6K^(Y3Y:SXX]J:\VJ< M%F8^8ZN@S9A6Y[6<15/AG;/B\^HXK]YIO9G7H//"KZ+U)&WOK/`1^N(GB\UHYM=6RK M=PF]K<$A;VNO;.E&;%8[0;<;]"9C#VP71.B!?;M8Q5?;MJ9M8WYU@]YF;#WS M63RM]EKN`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`[+U,@Z@5Q@#J,RHNC:7@H.V]][TXJP>%42&D:!-BI;RVFH%U[E+ MT0I0Y1#O9Z_2P\@91_[8842-L--X!9A+PK!A"GIG:2E:F#^8YGMSLXJ:?.7, M\!ILI8>7=V/-P\[9@CZQ%J0*8A,&5Y9+T4+#]6W":J%I`.DV83IYWQ^1G[(W M:I(%;V`]'I^_'?/CP\/+Q=WICR?,;F83,S,:N;PQ-[_)/F/YA=21!-NGF=DX M9,GGQ3+[C"*P!*NLS*PO6(*W[#Z?!]DX%[QQ=]ZYCODLP[-);&<[AU,)_GF1 M?<;V`7?1[%`M'!NH[3 M%(L;2-)Q0XO'RH#3Y$NT^*2D@*1(2K`H0DE3UK`:0DE3$FSA969WB3W`MEUF M-IE8@@V[S.PUL03[=IG9,B79 M+B9H;^=QAEH5O@6[+(\DV/Y&+:0Z9.QUT0EQ2T,6$M)>DC,W0"V MA@L8J(64!-[;HKVE)+B[GIF;Z8E\9JO,7%!G20N)N8'.$ORJ)3,7T5F" M'[=@+ISZ2O`+#$A2/F^V0I/-!&\4O%-D#_%HT,S]G9`E^)0IK M*25'GP>U_4:4J"G_UFYK>D[`%^ZIN9GY2R!#_O13M(27I(S`],.0U^5P]K MJ6\./YR'M92DA\3\G)NMX3?SJ-.4!+^,1_VD)%OXMDWZAI]C9WE2@E]EH^92 MY<&/LS/S>U[VK8+$_*R7)7C[(C-/-+"DA\2\U,`2/'N1F=<96(+'+;#Z3$FV MB,$V&0.\M("2IJ*#1Q90TI2DA,3\C)\]P(L*:&\I"1Y60'M+2?!F#4J::O%X MN@8E34GP0`U*FI+@Y91LFXP!7DO)S#,=[#7>2F4-*49(L8;),QP(-'*&DJ.GCK M""5-2?#D$4J:DM20F,=VV&N\;X22IB1XY@@E34GPCA%:?$J"I\%@+552O!"6 MF1>JV`.\"H9\4A*\!(9\4A(\"(;VEI+@7;#,O%[%^6PAV28E>&0-L4ZE*2`Q MSW:Q-;ROEI5)"=Y40RVDTN`M-=1"2M)O4)S4\G3`F)EJ;`/ZP^2`.<4D""\H MLL-X%A"25![Y%!M;>-*.TVSQA:8&Q1)]5&J(WV*W)9E%L4$84WF7&/52Y2O1 M!Z7*5Z)\YN5*]K5$^;5O'US\=GK%ORZ!_66\Y8]_-N2(%Y0GYHKH MU]/IU?T%+EV/_Q#)IW\+````__\#`%!+`P04``8`"````"$``_AIF>83``!= M80``&0```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`,=^U9L-FRS\"VVUL)T;N,V#D$2@C0$60CR$!0A*$-0A:`.01."-@1= M"/H0#`ZX0-B/L4??^:78&WL3>QNUC0538P1-L;46MD@<@B0$:0BR$.0A*$)0 MAJ`*01V")@1M"+H0]"$8'.`%&H.<&VC;EPW&X.GTY>7E6[^G;D:;]=4QZ%LB M,9&$2$HD(Y(3*8B41"HB-9&&2$ND(](3&5SB11B/`C?",HR\P6!D@VTL,,C@ M#V?D6`71'HW6[O"R7%_Y1MNCT;%3$TF(I$0R(CF1@DA)I")2$VF(M$0Z(CV1 MP25>`V#4=QO`1MW@0]1MK#8C63@=FDA,)"&2$LF(Y$0*(B61BDA-I"'2$NF( M]$0&EWCQQ'-5BZ?!?CR%C"]JYEFV)1(328BD1#(B.9&"2$FD(E(3:8BT1#HB M/9'!)5X\\6JAQ=-@/YY"G/XYDBNX/HXK2S^B MV]$J"'OP>(R/1L>P$TE'X@0Y.]I,UU]>S?SKYTT<5T';[;]T>O=[>_;_9HG?GQ`6K, M_784@G:T%]N.Z&IU>#-?S.;!`S8^ZK9$0B0=B=M>9),3*8B4Y*7L^"WVLB!HLIJTH993]UL=R_V'P97JQ@SR6C MZJ-GPYY;1MU/7:RW5MXS>+;VA]7!<^\WO\G,M.8?,S9D!?87 ML#$S*J9'H/DMVPI#6UL4"T+#6I0(\IIR=.:@C'WE[*M@7R6CBGW5[*OA@BVC MCGWU%ATF'0_S)(-7T`^QR?ID8J5@S)!*V]@#?M3/EE9]P7[*AE5@D[7O)XLK.N&_;2, M.D&OU[R?K*S[P?/EMYQ)ZK26&Y,]K^4$H>6LXRUT\X/!S5H4,TH$.8V0,LH$ MX>ZLKYQ1P05+1I4@IUXUHX8+MHPZ04Z]>D:#5]`/L<-^6D:=H-=KWD]6UOW@^?);SF246LL9'KRM"?*>'"-S M'A.QF3LWOY>IS1-!7KN,5@[*Q,J)>,ZH8%\EHTJ04XF:4<,%6T:=(*=>/:/! M*^B'V&246HC'3-/[<0CRGQRKX*5J:SXDC$.2^4"P6JVO@@PLGBQL'T@$>2/4 MZ,=!F5B]/O[FDY5U7[#[DE$E2)X<2LWKR<*Z;MA/RZ@3]'K-^\G*NA\\7W[+ MF=Q2:[DQY_1:3I#WY!B9,T+'$SAD57+!D5`ERZE4S:KA@ MRZ@3Y-2K9S1X!?T0FSQ2"_&87WHA%A0D+L%+TW8^FLGXNY@OPN]G\61A^T`B MR!F.4D:9H-?'WWRRLNX+]E4RJ@2=KGD]65C7#?MI&76"7J]Y/UE9]X/GRVNY MQ8D\_\#])X=%[I-#F#-"QXP206Z[,,H$.2-TSJC@@B6C2I!3KYI1PP5;1IT@ MIUX]H\$KZ(?X1%:_X*S>(O_)<1F^5HF9C+_7EY303P:V"R2"W`&*42;H]>$W MGZRL^X)]E8PJ02WHU MVECD/C>$.>-SS"@1Y#6+I./3?'LF5L[XG#,JV%?)J!+DU*MFU'#!EE$GR*E7 MSVCP"OHA-GFP%F+)O=T0"YJFH+8+R:(G%#-*&*6","K:;I"Q5U(V=4<,&24<4%:T8-%VP9=8*<&^H9#5Y!/\0F7=5"+%FS.^9+9CL-&5LL MR3`_(6=E1LPH890RRACEC`I&):.*4J!^ZFJ17^Q>$/,@H8(GKWQ9&7CF3!*!3E1SR8KY]%'*S@F M*^N^8%2R^VJR98 MQ!/!K:2":-4D->"8P7@V1;,N6#!J&1?%5O5C!I&+?OJ MV*IG-'C(;X@3J2V2PG#\$A1D!4&$MV+EKNY@E#!*!;E9`5OEC`I&)?NJV*IF MU#!JV5?'5CVCP4-^T$\DNTM.=BWRLH+E5;BZ0\S^8G6'6-E7Y-ER';1>(A88 M>FTW3QEE/W6UW%JM#]_#K\,%%P4[+AE5U@O2E>.W=UJW4HN5W-G\[65X9PV[ M;AEU/W6UWEKA'?]8IV7XQ7'PW/OM?R(51_7I1R?(S2W$S%W>(0A_V'9+!'E- M*5GVU+H9^\HMFEXW"O95,JILP>E]L1:$/VR]&B[8,NH$.??86S35:_`*^B$^ MD7@O.?&VR)]JI>4=8H9?M?E(=_UVO0XF8^/)PMYL(LAYDJ2,,D&O3UGFDY5U M7["ODE$EZ'3-Z\G"NF[83\NH$_1ZS?O)RKH?/%]^RYG,6?0-"]LNB13R1BA)ZMT1:D1_ M,2LEOIPYDH+=EXPJ0:=K7D\6MN8-^VD9=8)>KWD_65GW@^?+;[D3"?V2$WJ+ MO"?':.8T0BQF#DH$>>TR%G10)E9.Q'-&!?LJ&56"G$K4C!HNV#+J!#GUZAD- M7D$_Q"?K&P7 M*]A7R:@2=+KF]61A73?LIV74"7J]YOUD9=T/GB^OY58GI@4.W)\6L,A]<@AS M&B%FE`ARVX51)L@9H7-&!1;C<# MK#@_M\A_KWB_61EW0^>+[_=3J3Y2-/#C,,B][DAS!F?8T:) M(*]91O\.RL3*&9]S1@7[*AE5@IQZU8P:+M@RZ@0Y]>H9#5Y!/\0GDOH5)_46 M35.U6T'.L!(S2ABE["MCJYQ1P:AD7Q5;U8P:1BW[ZMBJ9S1XR(_PB;1YQ6FS M13,$?TK1K\)/V&+F=,^84<(HM?Z=]U2VRAD5C$KV5;%5S:AAU+*OCJUZ1H.' M_*B?R*3-7%/P"=LB[WV(/V&+F;Q5S%?SJV`K13Q9V+$M$>3\0%)&F:#7WRKR MR'[\ECN129L'2]AR M@KSWH9$Y[QVQE'10(LAKE[&@@S*QQV__T1X\T""YT^O#ORXX%('P^S M$@'?X*"DP^:MD"^B0;5?1L/29-&!_<=5]!$U96&SPDE,"DF2" MR@IZ:@C=7U$U3-E`VJH+,`?U`*X/\`''3%*0)Z`>:@FP!_4!3D`X@UIJ"C!EQ M.^PF#WHO$F?$35.0'2-NFH(D&7'3%.3*B)NF(!E&W#1E`V6C*ELH)K'EOH,Y M!\1-4S#U@+AI"F8@$#=-P10#XJ8IF(:+S"P0UP"S<9&9^6$%4VZ1F0!B!3-O MD9D'8@43<)&9^V$%,VP80S5E`V6C*ELH9K:,O6$B,S*39JRD4%)5R:"8^3(N M@WG+R$R;L8*Y?<1-&Y$PQ8^X:0KF\1$W3<%T/N*F*9C51]PT!=/VB)NFX&,: MO&FC"[ZI1>9S#M\/OJ/A.IJ";V>XCJ9L4`,S[\_>ME#,5#\K^`J#]M$4?(Q! M^V@*OLF@?30%'UW0/IJ"+YXHH]4:WSI11E/PR1-MJBGX\AF93VI\/_C:B=;6 M%'SE1&MKR@;*1E6V4+:J$D.)507?B1%1[3KX7(R(:@J^&D?F>]LN,,*.V6;PQ,!:KW18P>XIQ$U34BBIJF`O%?J!5@:;I1!K3<%^0L1- M^YUB6R'BIBG8.XBX:0JV$")NFH*=A(B;IF"K(.*F*1LH&U7!9DW$32N#'9F( MFZ9@8R;BIBG8GXFX:0HV8")NFH)-RI'9(\LMA[W*D=D7RPHV)$=F>RPKV)<< MF5VRK&![J(&Z:@J-3$#=-P0DJB)NFX"`5Q$U3<%(*XJ8I.+\(WK31!<<81>8$'>X' M.+H(U]$4'%>$ZVC*!C78J#780C&GJ_!U$BCFD!56P- MIW5%YA0G5F(HYC`G5G`T%R*J*3BA"Q'5%!S4%9D3GMA;>1WA0#KFU76$(^>8 MM]<1#IYCWEU'@\:W<[R'XOPS+H$SW=`NFH(3VA!)3<%Y:^B;FK+!H')8CQB\ M;V\QK&IOZ!D&2(U7>$1HO,-@K_'-=;11[_LZ2K3Q=XO'HV:?7D?,1,],V<*GSV-Q^./_WC9?\-B")Q> MOW_!:?>'OW[%_\9@A[-89V]@_'F_?['_,!&ULE%W;G9^> MW'V[??QX_^WS+Z?_\Z_B'U>G)\\O-]\^WGQ]_';WR^E_[IY/__GAO__K_8_' MI]^?O]S=O9S`PK?G7TZ_O+Q\S\[.GF^_W#W'FQ?\]^GS MV?/WI[N;CP>EAZ]GT_/SB[.'F_MOI]9"]O0S-AX_?;J_O<'S/W^Y__[LK#W<_HRYAYNGW__X_H_;QX?O,/';_=?[E_\/-QF MU>=OCT\WOWW%>_][,K^Y=;8/_R'S#_>W3X_/CY]>WL'3CW:>;/[Z^[!]_E'?WG[^\P-T+ MHW+[^!4IX=^3AWM3!O#J-_\^_/ZX__CRY9?3V>3=]&HQ65Q,%ZZ94GOQ!Y_(K\I4_S%;UKT<.O>^-WD_GY(=->49O`DS:_C4MM5L[? M74[.KV>7>.37-(^>PA^B.9F_FT\7EU>'7'Y-UV7MQ.?MQ4^JSMT#XP^7[.3G MGMCY`@7/J;[QCIH4:%*@38$N!?H4&%)@GP)C`$2N0!,2NL+5!P.C\PCJPVQZ&6?Q MTLI<'/J]0W%?$9(3LB:D(&1#2$E(1T+&$(F\ M@-8X]((T5^_0B3B'&`DT9OCQ+=0B]8@5ND:U.PK-IM>QVU9'H6/5(&1-2$'( MAI"2D(J0+2$[0FI"&D):0CI">D(&0O:$C"$2.0F]7>@DYQD#'SSC\G-ID6E0 M,0C)"5D34A"R(:0DI")D2\B.D)J0AI"6D(Z0GI"!D#TA8XA$>8Z!G);G!H[S M7!`[*#9][XJ0G)`U(04A&T)*0BI"MH3L"*D):0AI">D(Z0D9"-D3,H9(E.<8 MK85Y'C1&)R]?[F]_7SX>9A"N_!OQV!>"!.6?D)R0M46N+@^CKSEFF/.XX2J. M`JZB;0@I":D(V1*R(Z0FI"&D):0CI"=D(&1/R!@BD6O,A#X8UCH7&#AV@47, M).38$TSGBSA#5R(4=1>S\U@HMT+3J^/@:RUJ>,BC[=DL&0H71Z&CLP@I+3*? M'DU71YG0=#*TVQZ%G.D=(369;HXRH>FDB+5'(6>Z(Z0GT\-1)C2=9/;^*.1, MCR$2>1G3D-#+;U5`(QY[WR+PODMK)0A&@8'/)HFKK5#H:E&;'PT5A&P(*X;& M"(I=8V:<2@,YL3-1#)]=C5@*-(,S`]Q`W.1"FN.,Q\VKM-Y MHE@XJ>FATYM>75PE+=*&39<,5<[.JZEM16INN]BDQ=ZQV9JAYJ=2:GU*8>8F M,Y%.M761=$`]/\2@*J:9NW=2/G.3GF2,3,<%R>`F7X1NV4S)4"32_L*;CQF7K66=VQS9J MAAJO&+SJ/.GT6R_ES'<.BD:/7"]M3@9Y-(BBSZ-9DMK>2[C41H&LG=CY9BJN M.=].T2/G6PC.=W97H,73#LH%"AYY+1`>V4D5#&U8L62H$@A^=+:V#.U8L6:H M8<66HN$>P+9,CY&=V-,F**!Y6H(% MH:;^>B*+W4,'01J!`L62H$BCHX[8,[5BQ9JAAQ9:ACA5[ MA@:!@GY\S]`8*<9^,!$`S0\V,A#5.`LEW5Y2+583*_56MV>EHO;10M(W+9+A M:2%V@R9O(U!@I&2H\HJOU(NMEW*%=\>V:H8:K_B*^=9+.?,=V^H9&KRBJ79I MKNP][>R.D9'8UR8.$/CZK>F^621-YOL"1;V?1!?\""87J<`Q:X&N?+=9,+1Q MYGV_5K*MBA6W#.W85LVV&E9L&>K85L^V!E;<,S1&MF+_F$!`X)_C=-\&"**Z M:*%9.`V;S9,ZLS+KT7!@T+3E#*T%FH6A`V4":6W-SP_M_V1^@1X@'C]NQ%`0 M9BLYN>JGDMN*U)59E_KSPR1):L=)U9Q4\U-)M3ZIH`:G(;> MUL9!OOJ7;*MB6UN!KGR+L&-;-=MJV%;+MCJ6ZMG6P%)[@8)W'!UT>,?8/R8H M%%1L\L^_'K_#'2CJ=H_(U,@G_A'(9_/*27DH9V@MT-P/J`J&-@R5;*MBJ2U# M.X9JMM6P5,M0QU#/M@:6VC,T1E#L'Q,?"?QS](.-FX0-[]1"QI:?U<^34?9* MI-`5N]J4,[1VMOR*1\'0AJ&2;54LM65HQU#-MAJ6:AGJ&.K9UL!2>X;&"(I= M8^;^FFML3"!RC87B\>DLZ3E64RMU/;/S&+._-.[&D(EO40?)##*HB=9`BY3)W<7V9S/7'R'1POER(U!@IV2H$DA".TF=W'K6F=VQC9JAQBN&%3")'+5> MRIGO!(JF"6B7X@:OYQ0'IVBC/9/KQ762VMY+N-3&R$[L>!.)T1QO(S11*RY! M&[^BL9I:"%YV2>4"!>Y8"Q1$0@J&-JQ8,E0)%$9[&-JQ8LU0PXHM0YU`P?B[ M9UN#D_(1K3U#8Z08^\'$6#0_V-A+Y`<+Q;WI/"G2*VP].U3`5WI3*Q&T>&M1 M>=69W;*-FJ/&*805,)FBMEW+F M.P>A%3IVG4H%I#P:1-'G4;J[T4.".M5/TU;1@:"-0H%@R5`D41/NV#.U8L6:H8<66HSMGPZ=4 MP[QOY)8DCDGR3\:L:\:6VW$`98 MKAZO1"J`IQ9V!A#U(8*A)_`#\D<>F6V:QB?^A%0SM!:H/!3#H8V#)5LJV*I M+4,[AFJVU;!4RU#'4,^V!I;:,S1&4.P:,X/77&-G]I%K9+(??Z213(Y6,ROU MQJ93D8HJDI@/&V!E'BA2-B1Q>3E+=[UNV'3)4"60F=<+E#.%HMITO$77L(5A`W;*1FJ!')+'8G=K:>=W1T;J1EJO*+/ MD6GZM5CKI9SYSD$8[Q^SDM]]$233O MV^A)V)YCE&D*!+SO[*X$@JL=E`L4^544_?BF<+8\M&'%DJ%*H'"M@Z$=*]8, M-:S8,M0YR$^9>[8U"`2WN)S8,S1&BK$?DK"+&_+,.;PBD`G,'HL.=6LKD7JC M7Q6IJ,VT*2)"="A@%^=7R>2A<`_@FY<-VRD9J@22[C$9I&T]Z[)PQS9JAAJO M&&1(NH[2>BEGOF-;/4.#0$&&4(T[9IDS/49V8D\G`9RW`@?8C$CML(6B_M!" M47]HHBC;Q/ MYE?7Z2+GQAGR@Z62DZN<%&:CQT:$Q[,B)>L:Z?>8.V?$)U5S4HV3>C6IUB?E M'PB]6[P8VJFV:#S+#S&HBC2>%2E9V##9>Y$L&XW.T.&=XXJ=A)C>K-@<>D*W M9NHZTG`-R4J@J/18J0!:BU2XLN$@WS=O!`I7-MA\Y12#E0V!PI4-ME6SK89M MM6RK8ZF>;0TLM7>0?\=1(&5EPZRSAQ6;_).L;!SDDXF(#=X$6Y573LH'ZG*& MU@)=^R:U8&C#4,FV*I;:,K1CJ&9;#4NU#'4,]6QK8*D]0V,$Q?7'!&FTH:@$ M;\*&5R#\'%NO&6TL1]=TZ#E]Z<@96@L4U*:"H0U#)=NJ6&K+T(ZAFFTU+-4R MU#'4LZV!I?8,C1$4N\;,\S77V/E_-$N0D$`T.J6-Y6AAC6M>V8LJ$L&(8RW0 MZS&8PDG);LSI+#VQ:L.F2X8J9^?UB(](H50?/KU*ALH[MELSU/Q44JU/*BCT MBV04W:FVN(>T^1_D[J`J<@\I[CWF[B1Y@%'L6--1*4)@52U%!SQN:`4*1[@" MA1M;!0K>8NT4?92F<%`P76'%DJ'**7I;6X'@;M=![UBQ9JAA6RW;ZEBJ9UL# M2^T=Y-]QC!1C/_Q%Q&?!$1^!WHCXB-0KGXF(1-#(KIUI&\B87"[21:K"2[C, MWK"=DJ%*(`P%3*5,3TC=>MK9W;&1FJ'&*P8UD"::7LJ9[]A6S]`@D(1VD"-I MM=U["6=ZC.S$;OZ+T,Z"0SL"A:$=@<)MK`)%3N30CK/EN^L-*Y8,50+!:^[E MM@SM6+%FJ&'%EJ&.%7N&!H'"T`Y#8Z08^^$O0CL+#NT(E(1VDDYE)5*O=)XB M$36,QQB%J1,7%^E&T,*E[9N0#9LI&:H$DBXPF2]M/>N\NF,;-4.-5PPJ6]K= MM5[*F>\$BH<):57J.<7!*=J^#5F4O,O>"[C$QLA,['83:PG&3#3=2#:(+&QL M)AQ+"13U@E8JZ@4M%#G;0D%0IQ!;`;1QD*]PI4"!K4H@#`[=2V\9VK&MFFTU MK-@RU`D4;E]E6X-`P0OM&1H=Q'$>*$;^<1'7`YZ,1FSHQTS]_70C+1TK40R: MQYRAM4!OQ'E$"F,I&X2=7R6?%&V<'1][*3FURDF]&GO9BI2$>=(5TITSXI.J M.:G&2;V:5.N3"K,R613N5%M'HSR+OQGE M.<@GQ8FC/"(5O$K.T%J@,,KC(#_'W0@41GG85N44PVIMGRN,\K"MFFTU;*L5 M*+#5L53/M@:6VCO(O^,HD!+E,17KU697HCQHS.S%+O:"BH>[I\]WJ[NO7Y]/ M;A__^(9J/L.6H@_OC_CQ2IE?#QUD@B]QU%A'2^1_G6>_ MXMWP<`FQG&?C8425X*A0F,].#,5G/#.I/9CS`S!Z,<00SJ"NX M9D=CT"!EIQJ`(WM88C'K@;8W! M2`?>UA@,>.!3C<&P!C[5&$Q2H*,5::^GD8'*568,Q MHQG.-XQ7D:,:@V$K2J+&8/2*\J8Q&*:BO&D,YI?0T=X4\TCH:`RFD_"IQF!6 M"9]J#*:-\*G&8/8(GVK,$LQ2959@5BJ3@\E5!I-TY+66#F;BR&N-P80<>:TQ MB&#A30]=:M**(6J%-]68'HR)@;"W$;!"6Z4Q>S`F(L(Z"$ZAC&H,(H!X:HU! M(!!ME<9LP9B($*>#N!_*@<8@_(=RH#&(`J*MTI@EF*7*K,"L5"8'DZL,PJAH MJ[1T$#J%MS4&(5-X6V.PLI&9=0O.`ZQ39&85@AFL.F1F38$9K"&@F],8A.F1 MSF&PDI0=!-V1CL8@A(YT-`8!<:2C,5B'S,P2%3\;UAYA36-Z,&;!BG6P[)B9 M=2MF]F#,\A4S6&'$LVD,UG&S4F6PG)N9=3NVM@6S51FLWB+?-!TLXF9F,8^M M82TW,VMZS&`M/%NJS`J,6<5D'2R#9[G*8#4\,VN:K%.`*50&"]\H(9H.]HS@ M?;26'%M'X&V-P=X0>%MCL$4$WM88[!2!3S4&VT'@4XW!?B[H:*TE-FU!1V.6 ML+94K6'7#_):2R<'DZO,&HS9!<)YC5T]R%&-P>8>E$2-P1X?E#>-P68>E#>- MP>X\Z&AOBEUXT-$8;,:#3S4&>_+@4XW!ICOX5&-Z,&97%^?!$LQ2959@S`8X MULG!F'UPS&"+(_):8["/$7FM,=C.B+S6&.P!QIMJK3+V_>)--:8'8W:1\K-A MRR_:*HW9@S%[2ED'VWM11C4&>ZCQU!J#K=1HJS0&VZ=1#C0&.Z=1#C0&&ZA1 M#C0&^ZC15FG,$LQ29;`;'3[5='(PN"C<;RIQN#;<;RIQN`3\LQ\2\S6\-EX9CXI9@:?BL/;&H/3')`'6AG%F0UX M'XU9PMI2M8:/^S/SE38_`;[Q1PG1&'SJGYEOMEFG`&,^W68&G_6C5&D,ONY' MJ=(8?.2?F>^YV1J.Z(!_M#?%&1SPC\;@*`[X1V-P(@>\H#$X<@->T)@>C#F\ M@9]M"6:I,CCG!'FMZ>1@S'$7;`W'G"!'-0:'F2!'-09GFB!'-0;'`F7F=!E. M!Z<#9>9$&69P_$]F#I9AI@?3JPQ._LG,F3*L@^-]$'G3&!S7!1UMG(@SN:"C M,4M86ZK6<*A3ME*9'$RN,CC3*3.G_?!3X^"FS!SZPPS.;\K,V3_,X!BGS)SW MPPS.:\K,L3_,5'C3K?JF.&0-.EH>X*PU^%1C<.0:?*HQ.%,-/M48G*,&GVK, M$LQ2959@S/EF_#XY&'/,&3,XP`YYK3$XI0YYK3$XK`YYK3$XW1%OJHUA<:(C MWE1C>C#F?$!^-ASFF)EC`IG9@S&G!3*#@QM11C4&AV/BJ34&9V1FEBOR6F]AITA'8W"R*G)48W!.*O)` M8Y9X@J7Z!#C*%&5'>S8<88JRHS%K,&N5*<"8$ROY37%J*=Y48W"V-;RMM99[ M,.:,9+:&8ZSQIAJ#HXJ1CK;D@(.'D:,:@V.$D:,:@T.!D8[&X/!P6-.>`&>( MHQQH#(X21SG0&!P?COJC,3@R',^F,3T8<\ZTECMHXW%"/#-+Z"Q5'1SSCG*@ M6<-I[R@'&H-#WU$.-*8`8T[PYB?`^>[PC\;@F'?44XW!:>^HIQJ#$]Y13S4& M%R]DYO1^?@+!3 M[=EP&1%\JC$YF%QEUF#,I37\;+AL"#[5&%PVAV=3^Q(\]5)]:MQ6AF?3W@'9-`:WD>'9-`:7DJ'L:`SN)D/9T1A<0H:RHS&XBPQE1V-P>V!F MKI?C?,.-@2@A&H-;`E%"-`8W`Z*$:`PN",S,U7.<#BX%1-G1&-RTB-S1&%RX MB-S1&-R[F)FK]S@=W+6(?-,8W+.(?-,87+>(?-.8`>&0PYZ$9%:/.T'QS%IK MC1L^D8K&X+Y.Y*?&X/9-E%"-P669**':D^&"3)10C<&EF"BA&K,&LU89W(>) MLJOI+-%8:W&--3IF+1:SO,J66H[E5UFNX6N$KS2\O,IPG2W[MT)02\/KJPS7 MUK)\@U"7AO=7&:ZGA?S9T;7/']Y_O_E\U]P\?;[_]GSR]>X3]HB&PO=V]R:W-H965T_'5Y.#\?G=]>K-[?75X?G^^.GA^E\]_SI M[O'X?'AW_:_#Z?HO[__]W][^.+[\>OIZ.)ROT,/SZ=WUU_/YV_[FYG3_]?!T M=WIS_'9XAN3S\>7I[HQ_OGRY.7U[.=Q]RHV>'F^&V]OIYNGNX?F:>MB__)D^ MCI\_/]P?_/'^^]/A^4R=O!P>[\ZP__3UX=NI]/9T_V>Z>[I[^?7[MU_NCT_? MT,7'A\>'\[]RI]=73_?[OWYY/K[_\#]7]T\/]R_%T_'Q^ M@^YNR%`]Y]W-[@8]O7_[Z0$S2&Z_>CE\?G?]8;6/N]WUS?NWV4'_>#C\.#7_ M?W7Z>OSQ'R\/G_[V\'R`M[%.:04^'H^_)M6_?DH0&M^HUC&OP'^_7'TZ?+[[ M_GC^G^./_SP\?/EZQG)O4I/[XR-&PG^OGAY2#&#J=[^_NUYCA(=/YZ_XO^G- M9KY=KX;-]=7'P^D<'U+;ZZO[[Z?S\>F?I+3BKJB3D3O!7^YD]V9>W>[6,_KX M23M(\^#XR^V&G^I/K(^_K#^^&8?-O,W&ZH%N:++92?[N?/?^[6[3YI?TCJ[ZYWUU?PQ`GH;^^G>?/VYC;_C_V)_5D?QEY*4"=T+HSMFB4)KX'0@_$ M!A#&(K0:8XM/$YK#[N+38;V51BRD,\T7PYU"O$*"0F*+"-,0L(UI.0[6V&L4 M23H.DCI"!G\N1D_SU!E-2E,;+<,X2B5W4;KX5R%!(;%%Q#RP@9IY%!`4XA42%!);1!@RFX8D5!K" M"/JY+.DP=GO;D=*PO<2A5TA02.2NL[.%;8ED:_8IJY50:1LC^-/8UH6;(Z6A M;FZOD*"02,@JMQ*V(6P-VQ(J;2,D;9;&MKF+74]K89. M(9!"X_W8(L+Z%>PQS,^PM)\A3*!L#E<@XC;*T*D_9*GAHA58JS5'0-*>E,#U M4J\HKR.1E,$7AM9(58VO=IU#B]:8G;5:K6]OI8:O&J7KP%`3(K%H(43K:)O: MEYQ$2NQU$LR6;Q*WG[\^W/^Z'-''JI(E\8"8'$&87#'*K1BJ&=1Q6_1 MJ$$4&:(@DLY..;Y.XE5G$R4(9Q.$R55G,]0DB41BB.RQ:H4"U56*#%EV)@KX MB9U_/WX304&,(>QDJ!KE4*%FH^J^\!H*&HH,&?ELE1BBLW.8WJ"XO<0'T<"!)I@:"Q30NL51N& M%4'"GA:2]B2V,.PA$A$129`DM4U?NB'(F!/206"]U2GXHE`V8.`V3:A$`0F# M!YO$,BSS&$,MB16H)ANOH_4<=BP5O M(6FO))U+`&JF&0@2`4@0C"N#>]9JH,"0L(<:6@&8DK7A/\KA8CV9"MH`Q`5+ M5QGA`)EI9<[^TT5HE9E,OUGJG9&[82SE>V$N0B#^"QGK(]1B"[:WV M$"3L:2&YGBFC&_90HA?V<.YOXT\=_K%"V1P*OV'7%1:^RJNYU$0L=PL)9F6.8;AMKP8ZB)-:^AP%!KCX"D/9)`DZS44 M&!+Q07U9]J3$;]A#?-!N+XR:3:Q[VS'4;&2OH:"A*/J2_DF)W;"'\KVPAR"Q MHF-?A*])">/E@G'<#FI!+QIU00D2#FPA:7#*_-7@UPZ-:R(*,1&"Q$(3!.N+ M49X;-E`H4&6KR)"UT"GC5SL++ZZ)"(0]!*5=UVR5+E$Z;OC*"9VU?G)"+QJU M9(D,&>241FLF\:JSB57$Y`C"Y(IG7>X4=4L]#'N&VA-Z@9H3.D.6G8D?JK.5 MG=T)'4.KW<]0C0!7M#(D8A#NULK9[>[/FM@(HE"9^D,R:S7YWVLH:"B6[O75 M/DHZTT3*\\)$3OVBXIKZ4U3N#SE+Y.C^L.J+%AU6A]NQ+ZT":S2K$04D0\&F M$%3[??9B"&5IW2H75BF0+UHU]0>&A#W4T,BRJ=ZTUEUG_:S9'TVG_FC%6G!` MRHE#5X;Z*BXS"`PUD1(%)-TG2>$2ICKYCP2AD"LC.89@6X&\A@)#PA[JRZ@( M4+"V[E,DU3U;R.J21!A*MT'-CN_J?L=:R3%5:^K.$+YJE0F&TKU(*'T(1];: M($$VW5Y[DAO![O@Y:S_TC:5\UZKRH:QA> MH,A:UBK9_+31_,00+"[=.H90_A;(:R@PU$:-@*0';7Y*[N\.,`R)'*4*]*+$ M*6K7WW_[JE"F$!AJDX2`I+V2OUZ-'\"*&(F@+O!<$Y2T0'(/67"+=?RC$AVN55,F M2);HLS+KHE7VJ^>^T+!`04-10,)XK&F[6L5E&99)FZ&V1->0UU#04!20M,EO,%:B)$@UY#04-10%)>VR*F#1%%`@;H\:,*M%9J\FO7D-!0[%TKTOT MR6:-#'=+2$0B>5<]7.6&4DMEMZ)%!=UJT]4<@>4M\0E(>ED2R24*-6%,!+4Y M3$.^0)4=`D/"'NK+R&&331@9[ES*^1KQ65==G7JXH5AU;E@S;]!:L8QHK'I* MP#7-7EQ&>5EL%(+2U64U<=,?S";2X@)]I2KT*K\D&H:$2ZD7RZ62%B[VZO2/ M]R)3>FPK=(;:"EU#@2%A#_5EV2-YXV*/YHJ)H/0LQ"C;KF3P M55S=1_TV01%9RRAA$C-8RZVI)&O"?96L'4.PK0SN-108$O90]X8]L\T;&98[ MA"$9?G.][LK7:*YHT67R,*KXJPIE#H&A=KT%)%+,;!-+ACN#B6O:^&.MMM;7 M4&!(V$-]&?$W2V)YK9S+ZIV=Q$&OG!"YH3PASMWEGZ]:U;OXF8M'25*LMCA#2`E6G#3;V&]!SQY#7*5"3]C#(6M:"V!PT:PYB MJ.6@`E7"\1H*#(D`^4,.2N\A&CL^PYW_B$I^?ACD=GAZEMRWV?3WO[XJ5/\I MCHJL966$E/HK(;T:T,04+5'-!+6'089P4"I&>0V%`E7O1X8L.VTBFC41,20+ M(7489*U7#H.E+SH,3O@.1;Y[$$HW-6U'AJQ8E>3UJJ\UJF3>/;F9+]Q6$Q`.T=)O"VNEQ%_35*_E MJE:QVFLH:"@*2!!*>@C3Q'LI(#(L]R=#[/O>:U.0*Q@;(MM2S6-P9IJLF:^CRIQZS3D&6K*D\"0 M-7C+*\W@E.N%MPB2A>]<;W^)E[>L1<0RS>JUCJI0YA`8,K+SMF61QCK-%EE3 MUKD%J@\]O(8"0];@+34T@VMJV!*47I>L6:MZA\>$1FY M=M_V>[7YP^\OMA@V! M#,NLSI#,)=O^7%.T^!)X7/74Y*M&L3@P1'6K-,_.^SN=]QEJ"9XA7,.4D;R& M0H'R,K3-=!*-.TXR=<'(0M#,II4YBA:E#FLKWZJ1K$X,&3$T\ZF@0QW M2T<)OHT;UD)Y7$;R&@H,68/;*7VG4SI#KZ0.UNI21W]LJUK%ZE!&Q+9[/77L M4NZN*YI3QQK?.`.V7F+,ZITK4P_(-Z+\VO:72]Q0'D*WW8-W7[7J;+A[Q/>? MF(W-'3O-'0QU>[MW-/I1^MMHYGK;:.9XCJ>&E4RMA=4+1YN2O3=Y3@6S(I4%-S"D@.9]#`M&Z?W^`' M!?KG)0REZ]$:%]N^D"M:DG]K`4-VT(\-T'?T3X>7+P=W>'P\7=T?OS^C;]QL MX\1\P?EG#N;=_@/]SD$GP7EDGPX-B.!.@I]&^)"S2XC-DH## MT)OE:`=)(@>KMP&]69)EN]DO*#QU&P=)JE*U!%7R/A6K6H+"$FTLCR[;+<:Q MPL]!DDHAW5N`)%5$6K)LX1T<0K7$;3%3G,BT9-FN88$9(9"DTXMNXR%)AQ@M M"9"DLXR6+#,\BEL>+7&0I%LB+0F0I,LB+<&]%K:M)5GF&>-8^\I!XDR)A\2; M$ESSP`*K-]SVP`)+LLR(:]PM:ZMQ:XYQ+`GNQC&.)8F01%/B9L0U[G/U.,N, M-<7EI98X2-)-IY8$2-*%IY9$2*(I<1/6!SE=MUDFY!`\W]$2!XDW)0&2]$Q( MMXF01%.R3-@_>!"BVSA(TE,3+0F0I( MW=LR817P&%-+'"3.E'A(TM-0W08/:#&.)8F01%.R;&`!7K/1O3E(TFLZ6H(W MBO;I;1TMB9"DEW:T9-E@;]/AK/<.),Z4>$C2NRNZ-[QF`PLL280DFI)E1!S@ MS3/=FX,DO1ZH)7AC<9_>$M02O+@(IK4D>($/5EL9=MFLX`,K#APDZ54S/4Z` M)+UQIB5X"0XSM23+B#H#KTSK-FX<,1]K?=P(CU+)V:W/,D[PF[7G'"3.E.!5 M6GC4:H-7:#&.)<&;M+#:DBQKQ`X^U3#F`TGZU$-+`B3IBP\MB9"D#S^T9%F# M%_"5@I;@\XU]^O!!2SPDZ?L'+0F0!%."+S9@@=4&GX:A-RO'+VO4+O3\LEL? M!TGZKLFR`'G'E."+*UA@M<%'2FAC1<@RP#MT3.XM@"1]N&A8`$DP)1&2:$J6 M88>96OO'09*^\+/&V<%J2Q+1)IJ294#FP[>]NC=\M8SY6)(`2?H>6+>)D$13 M@@]],8X5;PZ2],&L[BU`DKZ;U9((2;0E*W@4K^KK-LL*'L5Q7DL<).FC>RW! M[P#``DN"GP.`!99D&9#?<`FB>W.0I&_3M21`DCY1UY((230E^/&-??II#=W& MK9!=\)L56K+`.XOI'0>),R4>$F]*\#,3&,?V-7R`'W[1%K@5?&!*\+,WZ,UJ M@U^_P9I:DF6%Z*4#>K\;(7&F!#\``PNLZ`V0I!]5T5;C]U]@@259$M$:+5PJ MART\'4D,?$%PXF>)]-!NAWE8`H^@-04!,6L*(D*6!#<7;^&G!;_=?3G\U]W+ MEX?GT]7CX3.N!F[S1=D+_0HA_>-,/P]S]?%XQH\*XO8`U_'XM<@#?@GL-MW( M?SX>S^4?F,3-Y?3>INE8D=!FH+*3`\&) MLEM,OFW!)@U)M.N_-^NZ.M&3Q_"^>?)\7ZK%03?))SBO6E,CDN4H`2-:JXR/,2:PA<\L#Q$9C:B8A&I!03TGZX9@!( M@:$!#29X3#*"O[L!G/9_7AB2BZ96H;=QIE'WDBW%*9S:!Z^F8M=U63<;-*(_ MP:^KAZ=AU%29XZX$(';<3\-]6,55;A7(VYX=WER3>+^O\.^LDF*PH\(!#R"3 M^!X]V9V3E]G=_7J)6)&3>9H7:5&N"T))2?/YIL+GUGB?34`]"OR;>`:PP?OG MG[,O````__\#`%!+`P04``8`"````"$`'(0:_I4```"I````$````'AL+V-A M;&-#:&%I;BYX;6P\CD$*`C$0!.^"?PAS=V?UL(@D65#P!?J`D!U-()DLF2#Z M>^/%2T/14-UZ?N>D7E0E%C:P'T90Q+XLD9\&[K?K[@A*FN/%I<)DX$,"L]UN MM'?)7X*+K+J!Q4!H;3TAB@^4G0QE)>[-H]3L6L?Z1%DKN44"4X" ML-JK:N`\@8K]`ZCT2[0:_R/V"P``__\#`%!+`P04``8`"````"$`YN$1QX0$ M``!%$0``$``(`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````"<6%USFSH0?;\S]S]X_-[823NWMQGBCHQE MAXD-%$':/&E4D!M-,+A(>)+[Z^\*\H%CH<1]\`Q&9W>/=G6D%<[7^TT^V/%* MBK*X&)Z>C(<#7J1E)HI?%\,DGG_X=SB0BA49R\N"7PP?N!Q^G?S]EQ-6Y997 M2G`Y`!>%O!C>*K4]'XUD>LLW3)[`<`$CZ[+:,`5_JU^C]XJLIJ(,5_D+:SX>`GDUS3N1CN6"58H8"6AK5_FN=\*U4U^5Y6 M=_*6:I.4:R*7'FKCEYE@3_+L^UL1E>X5^GOX4N5>+*$C\&47P M(\EJA:(;&LPI\1:^,0IROR4>B;W`)\9QSX^1O_"F2TP1(3@VHR#,%8Z11A'L M)I$7>]B,G",OHM=HF6"ZPH@D$5YAO\>KYU_#6!#U^0JC(,11?$,QS"'4?HQ3 M0*X;)7A&\8\0^Z2'UPQ/S=;:=WQC=$SBP+V:(@*^W6"EG2.=2"/6\P&":8Q^ M]!!80C9ZAL!RY<5-GIJZNH$?>_X"^VY?9B(<>VUFZ13[>.[%-%RBGA)'>(EB M/`N13F4<`0RY_0N"X(5FTA!9X&`1H?#2J&P.1 M03_U?/;ISJCM,PZ%:.-TB,;W6VC$@-*\5L8`9O':@O2IM[4Q!NFJU^;:(%\; M_$"_-K`^%*T%?5+X>XK_B"70[&=USIL&2\JZ*7U&C3GHW1Z:>$>9+"KHGX^+ M,H?&G%X?%86H,KT[+@ITC'#M,4;9V^HT#NY3;[2F%A.XWKP=)>)I6:0B%\W% M!VKTMLD^L1E_A\E!%/.>M#<9GU45D-IQZX)\W.I7HA";>J,57%><1I`VEM/0 M.)E'$XVA6OJ%U`9Y<^50YI19&S)S^7M/F$9_1F+])XRV,9K83QCS+FZW^6B, M8S^5>N*\:NFL=;0?87L!]NZKKVZH2U'6P&PO7W)E M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$`WXBYO2D&``#3 M%@``#P`````````````````>#```>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``& M``@````A`-9ADG"G!0``X!,``!@`````````````````=!(``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`&H5^EF.`@``QP4``!D`````````````````UBH``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``I.JN:E`@``908` M`!D`````````````````RS8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(D5>[#``@``MP8``!D````````````` M````]T(``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`):-L)?]"0``$S$``!D````` M````````````$DH``'AL+W=O,"``!M!P``&0````````````````!&5```>&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`/.!R_;(`@``#`<``!D`````````````````\5P` M`'AL+W=OH)``"*+@``&0````````````````#P7P``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`,CA8&;'`@``\`8``!D`````````````````MW(``'AL+W=O&UL4$L!`BT`%``&``@````A`-AHR]NT!``` M3!$``!D`````````````````67T``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/MBI6V4!@``IQL``!,````````` M````````EX@``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$` M(#=#_N(0``!?N@``#0````````````````!&PO&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*T(26VI M!0``2!<``!D`````````````````J2P!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,;KQ1VT`P``YPH``!D````` M````````````OSH!`'AL+W=O&PO=V]R M:W-H965T/G@(``',& M```9`````````````````$Q"`0!X;"]W;W)K&UL M4$L!`BT`%``&``@````A`)*+6LR_`@``_`8``!D`````````````````(44! M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`*+**C;>`@``8@<``!D`````````````````%%$!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#V3),,H!P``EAP``!D````````` M````````G'@!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`-WOM19D"0``EB8``!D`````````````````YKX!`'AL M+W=O\# M``#,#0``&0````````````````"!R`$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`-Y793&$#```"S8``!D`````````````````NM@!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!J,-XDD`P``M0@` M`!@`````````````````/`("`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#'6BOX/!@``[1H``!@````````````````` MH!L"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"GKX,9?!@``4AD``!D` M````````````````W6D"`'AL+W=OS-W)AL&``"G&```&0````````````````!S<`(`>&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)/\#S8_!0``T1(``!D````````````````` MKH<"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`)X:$UD9"0``&B4``!D`````````````````B,D"`'AL+W=O&UL4$L!`BT`%``&``@````A`+UM&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`);[9:/E!0``V!0``!D````` M````````````*_T"`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A``CK[S(3#```\S(``!D`````````````````51(# M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A``/X:9GF$P``76$``!D`````````````````JCL#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`'#T//,R`0`` M0`(``!$`````````````````#(`#`&1O8U!R;W!S+V-O&UL4$L!`BT` M%``&``@````A`!R$&OZ5````J0```!``````````````````=8(#`'AL+V-A M;&-#:&%I;BYX;6Q02P$"+0`4``8`"````"$`YN$1QX0$``!%$0``$``````` M```````````X@P,`9&]C4')O<',O87!P+GAM;%!+!08`````60!9`%@8``#R %B`,````` ` end XML 18 R70.htm IDEA: XBRL DOCUMENT v2.4.1.9
LEASES (Minimum Future Rental Payments Under Operating Leases) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Leases, Operating [Abstract]  
Year ending December 31, 2015 $ 700us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent
Year ending December 31, 2016 546us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears
Year ending December 31, 2017 279us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears
Year ending December 31, 2018 105us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears
Year ending December 31, 2019 0us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears
Thereafter 0us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter
Total $ 1,630us-gaap_OperatingLeasesFutureMinimumPaymentsDue

XML 19 R55.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCRUED EXPENSES (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Payables and Accruals [Abstract]    
Compensation and other employee-related costs $ 19,933us-gaap_EmployeeRelatedLiabilitiesCurrent $ 17,428us-gaap_EmployeeRelatedLiabilitiesCurrent
Legal and other settlements and expenses 27,686gmed_AccruedLiabilitiesLegalAndOtherSettlementsAndExpenses 23,765gmed_AccruedLiabilitiesLegalAndOtherSettlementsAndExpenses
Accrued non-income taxes 4,720us-gaap_SalesAndExciseTaxPayableCurrent 2,938us-gaap_SalesAndExciseTaxPayableCurrent
Other 9,160us-gaap_OtherAccruedLiabilitiesCurrent 6,994us-gaap_OtherAccruedLiabilitiesCurrent
Total accrued expenses $ 61,499us-gaap_AccruedLiabilitiesCurrent $ 51,125us-gaap_AccruedLiabilitiesCurrent
XML 20 R78.htm IDEA: XBRL DOCUMENT v2.4.1.9
SUBSEQUENT EVENT (Details) (Subsequent Event, USD $)
In Thousands, unless otherwise specified
 0 Months Ended
Feb. 25, 2015
Subsequent Event
  
Subsequent Event  
Payments to Acquire Businesses, Gross $ 52,900us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
XML 21 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACQUISTIONS (Textuals) (Details) (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Oct. 23, 2014
Dec. 23, 2013
Jul. 18, 2012
Business Acquisition          
Goodwill $ 53,196,000us-gaap_Goodwill $ 18,372,000us-gaap_Goodwill      
In process research and development, cost to complete 14,100,000gmed_InProcessResearchAndDevelopmentCostToComplete        
Acquisition 2014          
Business Acquisition          
Payments to Acquire Businesses, Gross 36,128,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		        
Range of aggregate undiscounted contingent consideration from acquisitions, maximum 15,000,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		   15,000,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Net assets acquired     47,428,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Goodwill     34,824,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Acquisition 2013          
Business Acquisition          
Range of aggregate undiscounted contingent consideration from acquisitions, maximum       14,300,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member		  
Net assets acquired       16,775,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member		  
Goodwill       2,999,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member		  
Acquisition 2012          
Business Acquisition          
Net assets acquired         6,031,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
Goodwill         $ 5,564,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
Minimum | In-process Research and Development          
Business Acquisition          
Pre tax royalty rate 4.00%gmed_FairValueInputsPreTaxRoyaltyRate
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		        
Discount rate 13.50%us-gaap_FairValueInputsDiscountRate
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		        
Maximum | In-process Research and Development          
Business Acquisition          
Pre tax royalty rate 9.00%gmed_FairValueInputsPreTaxRoyaltyRate
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		        
Discount rate 19.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		        
XML 22 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2014
Inventory Disclosure [Abstract]  
Schedule of Inventory
(In thousands)
December 31, 2014
 
December 31, 2013
Raw materials
$
8,847

 
$
1,369

Work in process
2,490

 
2,820

Finished goods
79,608

 
66,161

Total
$
90,945

 
$
70,350
XML 23 R79.htm IDEA: XBRL DOCUMENT v2.4.1.9
VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Allowance for doubtful accounts      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Beginning of period $ 1,581us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 $ 961us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 $ 602us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember
Additions 318us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 693us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 363us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember
Write-offs (252)us-gaap_ValuationAllowancesAndReservesDeductions
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 (73)us-gaap_ValuationAllowancesAndReservesDeductions
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 (4)us-gaap_ValuationAllowancesAndReservesDeductions
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember
End of period 1,647us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 1,581us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 961us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember
Deferred tax valuation allowance      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Beginning of period 327us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember		 533us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember		 1,149us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember
Additions 0us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember		 0us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember		 0us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember
Write-offs (282)us-gaap_ValuationAllowancesAndReservesDeductions
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember		 (206)us-gaap_ValuationAllowancesAndReservesDeductions
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember		 (616)us-gaap_ValuationAllowancesAndReservesDeductions
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember
End of period $ 45us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember		 $ 327us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember		 $ 533us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember
XML 24 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 25 R73.htm IDEA: XBRL DOCUMENT v2.4.1.9
RETIREMENT BENEFIT PLANS (Details) (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Defined Contribution Pension and Other Postretirement Plans Disclosure [Abstract]      
Nondiscretionary employee contribution match rate 100.00%us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent    
Maximum annual contribution match, per employee $ 6,000us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount    
Maximum annual contribution match, percent per employee 3.00%us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent    
401(k) and other retirement plan contributions $ 2,185,000us-gaap_DefinedContributionPlanCostRecognized $ 2,106,000us-gaap_DefinedContributionPlanCostRecognized $ 1,055,000us-gaap_DefinedContributionPlanCostRecognized
XML 26 R57.htm IDEA: XBRL DOCUMENT v2.4.1.9
EQUITY (Textuals) (Details) (USD $)
 12 Months Ended 1 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Aug. 31, 2012
Aug. 03, 2012
Class of Stock          
Common stock, shares outstanding 94,705,743us-gaap_CommonStockSharesOutstanding 93,442,753us-gaap_CommonStockSharesOutstanding      
Gross proceeds from issuance initial public offering     $ 25,000,000us-gaap_ProceedsFromIssuanceInitialPublicOffering    
Proceeds From Issuance Initial Public Offering, Net of Underwriting Fees and Offering Expenses 0gmed_ProceedsFromIssuanceInitialPublicOfferingNetOfUnderwritingFeesAndOfferingExpenses 0gmed_ProceedsFromIssuanceInitialPublicOfferingNetOfUnderwritingFeesAndOfferingExpenses 20,960,000gmed_ProceedsFromIssuanceInitialPublicOfferingNetOfUnderwritingFeesAndOfferingExpenses    
Net proceeds from issuance of common stock $ 9,738,000us-gaap_ProceedsFromIssuanceOfCommonStock $ 7,555,000us-gaap_ProceedsFromIssuanceOfCommonStock $ 1,504,000us-gaap_ProceedsFromIssuanceOfCommonStock    
Class A Common          
Class of Stock          
Common stock, shares outstanding 70,828,187us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 66,065,197us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		      
Offering price per share (in usd per share)         $ 12.00us-gaap_SharePrice
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
Common stock, shares authorized (in shares) 500,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 500,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		      
Common stock, votes per share 1        
Class B Common          
Class of Stock          
Common stock, shares outstanding 23,877,556us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 27,377,556us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		      
Common stock, shares authorized (in shares) 275,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 275,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		      
Common stock, votes per share 10        
Class C Common          
Class of Stock          
Common stock, shares authorized (in shares) 10,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember		        
Issued by Company | Class A Common          
Class of Stock          
Shares sold for initial public offering (in shares)       2,083,333us-gaap_StockIssuedDuringPeriodSharesIssuedForCash
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ gmed_StockOfferingInitialPublicOfferingTransactionAxis
= gmed_NewSharesIssuedByCompanyMember		  
Conversion of Class E to Class B          
Class of Stock          
Conversion of stock, shares converted       15,597,300us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_ConversionOfSeriesEPreferredStockToClassBCommonStockMember		  
Conversion of Class B to Class A          
Class of Stock          
Conversion of stock, requirements, maximum ownership percentage       10.00%gmed_ConversionOfStockRequirementsMaximumOwnershipPercentage
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_ConversionOfClassBCommonStockToClassCommonStockMember		  
Conversion of Class C to Class A          
Class of Stock          
Conversion of stock, shares converted       73,554us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_ConversionOfClassCCommonStockToClassCommonStockMember		  
Conversion of Class B to Class A, Selling Stockholders          
Class of Stock          
Conversion of stock, shares converted       3,039,385us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_ConversionOfClassBCommonStockToClassCommonStockSellingStockholdersMember		  
Equity Ownership of Less Than Ten Percent | Conversion of Class B to Class A          
Class of Stock          
Conversion of stock, shares converted       49,655,411us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_ConversionOfClassBCommonStockToClassCommonStockMember
/ gmed_EquityOwnershipByAmountAxis
= gmed_EquityOwnershipOfLessThanTenPercentMember		  
XML 27 R76.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT AND GEOGRAPHIC INFORMATION (Products) (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
segments
categories
Dec. 31, 2013
Dec. 31, 2012
Revenue from External Customer                      
Total sales $ 128,801us-gaap_SalesRevenueNet $ 117,787us-gaap_SalesRevenueNet $ 113,573us-gaap_SalesRevenueNet $ 114,210us-gaap_SalesRevenueNet $ 115,245us-gaap_SalesRevenueNet $ 107,187us-gaap_SalesRevenueNet $ 107,009us-gaap_SalesRevenueNet $ 105,018us-gaap_SalesRevenueNet $ 474,371us-gaap_SalesRevenueNet $ 434,459us-gaap_SalesRevenueNet $ 385,994us-gaap_SalesRevenueNet
Textuals [Abstract]                      
Number of reportable segments                 1us-gaap_NumberOfReportableSegments    
Number of product categories                 2gmed_NumberOfProductCategories    
Innovative Fusion                      
Revenue from External Customer                      
Total sales                 270,852us-gaap_SalesRevenueNet
/ us-gaap_ProductOrServiceAxis
= gmed_InnovativeFusionMember		 254,033us-gaap_SalesRevenueNet
/ us-gaap_ProductOrServiceAxis
= gmed_InnovativeFusionMember		 238,723us-gaap_SalesRevenueNet
/ us-gaap_ProductOrServiceAxis
= gmed_InnovativeFusionMember
Disruptive Technology                      
Revenue from External Customer                      
Total sales                 $ 203,519us-gaap_SalesRevenueNet
/ us-gaap_ProductOrServiceAxis
= gmed_DisruptiveTechnologyMember		 $ 180,426us-gaap_SalesRevenueNet
/ us-gaap_ProductOrServiceAxis
= gmed_DisruptiveTechnologyMember		 $ 147,271us-gaap_SalesRevenueNet
/ us-gaap_ProductOrServiceAxis
= gmed_DisruptiveTechnologyMember
XML 28 R77.htm IDEA: XBRL DOCUMENT v2.4.1.9
QUARTERLY FINANCIAL DATA (unaudited) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]                      
Sales $ 128,801us-gaap_SalesRevenueNet $ 117,787us-gaap_SalesRevenueNet $ 113,573us-gaap_SalesRevenueNet $ 114,210us-gaap_SalesRevenueNet $ 115,245us-gaap_SalesRevenueNet $ 107,187us-gaap_SalesRevenueNet $ 107,009us-gaap_SalesRevenueNet $ 105,018us-gaap_SalesRevenueNet $ 474,371us-gaap_SalesRevenueNet $ 434,459us-gaap_SalesRevenueNet $ 385,994us-gaap_SalesRevenueNet
Gross Profit 97,525us-gaap_GrossProfit 90,101us-gaap_GrossProfit 86,990us-gaap_GrossProfit 88,898us-gaap_GrossProfit 88,471us-gaap_GrossProfit 81,872us-gaap_GrossProfit 82,248us-gaap_GrossProfit 81,525us-gaap_GrossProfit 363,514us-gaap_GrossProfit 334,116us-gaap_GrossProfit 310,795us-gaap_GrossProfit
Net income $ 27,638us-gaap_NetIncomeLoss $ 23,061us-gaap_NetIncomeLoss $ 20,647us-gaap_NetIncomeLoss $ 21,139us-gaap_NetIncomeLoss $ 20,985us-gaap_NetIncomeLoss $ 20,310us-gaap_NetIncomeLoss $ 7,426us-gaap_NetIncomeLoss $ 19,891us-gaap_NetIncomeLoss $ 92,485us-gaap_NetIncomeLoss $ 68,612us-gaap_NetIncomeLoss $ 73,831us-gaap_NetIncomeLoss
Net earnings per common share - basic $ 0.29us-gaap_EarningsPerShareBasic $ 0.24us-gaap_EarningsPerShareBasic $ 0.22us-gaap_EarningsPerShareBasic $ 0.23us-gaap_EarningsPerShareBasic $ 0.22us-gaap_EarningsPerShareBasic $ 0.22us-gaap_EarningsPerShareBasic $ 0.08us-gaap_EarningsPerShareBasic $ 0.22us-gaap_EarningsPerShareBasic $ 0.98us-gaap_EarningsPerShareBasic $ 0.74us-gaap_EarningsPerShareBasic $ 0.82us-gaap_EarningsPerShareBasic
Net earnings per common share - dilutive $ 0.29us-gaap_EarningsPerShareDiluted $ 0.24us-gaap_EarningsPerShareDiluted $ 0.22us-gaap_EarningsPerShareDiluted $ 0.22us-gaap_EarningsPerShareDiluted $ 0.22us-gaap_EarningsPerShareDiluted $ 0.22us-gaap_EarningsPerShareDiluted $ 0.08us-gaap_EarningsPerShareDiluted $ 0.21us-gaap_EarningsPerShareDiluted $ 0.97us-gaap_EarningsPerShareDiluted $ 0.73us-gaap_EarningsPerShareDiluted $ 0.80us-gaap_EarningsPerShareDiluted
XML 29 R71.htm IDEA: XBRL DOCUMENT v2.4.1.9
LEASES (Rent Expense Related to Operating Leases) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Leases, Operating [Abstract]      
Rent expense $ 676us-gaap_OperatingLeasesRentExpenseNet $ 424us-gaap_OperatingLeasesRentExpenseNet $ 419us-gaap_OperatingLeasesRentExpenseNet
XML 30 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
QUARTERLY FINANCIAL DATA (unaudited)
 12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data (unaudited)
QUARTERLY FINANCIAL DATA (unaudited)
 
 
(unaudited)
(In thousands, except per share amounts)
 
March 31,
2014
 
June 30,
2014
 
September 30,
2014
 
December 31,
2014
Sales
 
$
114,210

 
$
113,573

 
$
117,787

 
$
128,801

Gross profit
 
88,898

 
86,990

 
90,101

 
97,525

Net income
 
21,139

 
20,647

 
23,061

 
27,638

Net earnings per common share - basic
 
0.23

 
0.22

 
0.24

 
0.29

Net earnings per common share - diluted
 
0.22

 
0.22

 
0.24

 
0.29

 
 
(unaudited)
(In thousands, except per share amounts)
 
March 31,
2013
 
June 30,
2013
 
September 30,
2013
 
December 31,
2013
Sales
 
$
105,018

 
$
107,009

 
$
107,187

 
$
115,245

Gross profit
 
81,525

 
82,248

 
81,872

 
88,471

Net income
 
19,891

 
7,426

 
20,310

 
20,985

Net earnings per common share - basic
 
0.22

 
0.08

 
0.22

 
0.22

Net earnings per common share - diluted
 
0.21

 
0.08

 
0.22

 
0.22
XML 31 R50.htm IDEA: XBRL DOCUMENT v2.4.1.9
INTANGIBLE ASSETS Expected Future Amortization of Acquired Intangible Assets (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]  
Year ending December 31, 2015 $ 1,545us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
Year ending December 31, 2016 1,541us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
Year ending December 31, 2017 1,423us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
Year ending December 30, 2018 856us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
Year ending December 31, 2019 852us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
Thereafter 3,752us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
Finite-lived intangible assets, net $ 9,969us-gaap_FiniteLivedIntangibleAssetsNet
XML 32 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Schedule of Revenue from External Customers By Geographical Area International and Domestic
The following table represents total sales by geographic area, based on the location of the customer:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
United States
 
$
427,091

 
$
396,615

 
$
355,609

International
 
47,280

 
37,844

 
30,385

Total sales
 
$
474,371

 
$
434,459

 
$
385,994
Revenue from External Customers by Products and Services
The following table represents total sales by product category:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Innovative Fusion
 
$
270,852

 
$
254,033

 
$
238,723

Disruptive Technology
 
203,519

 
180,426

 
147,271

Total sales
 
$
474,371

 
$
434,459

 
$
385,994
XML 33 R75.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT AND GEOGRAPHIC INFORMATION (Geographic Location) (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
segments
Dec. 31, 2013
Dec. 31, 2012
Revenues from External Customers                      
Number of reportable segments                 1us-gaap_NumberOfReportableSegments    
Total sales $ 128,801us-gaap_SalesRevenueNet $ 117,787us-gaap_SalesRevenueNet $ 113,573us-gaap_SalesRevenueNet $ 114,210us-gaap_SalesRevenueNet $ 115,245us-gaap_SalesRevenueNet $ 107,187us-gaap_SalesRevenueNet $ 107,009us-gaap_SalesRevenueNet $ 105,018us-gaap_SalesRevenueNet $ 474,371us-gaap_SalesRevenueNet $ 434,459us-gaap_SalesRevenueNet $ 385,994us-gaap_SalesRevenueNet
United States                      
Revenues from External Customers                      
Total sales                 427,091us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_US		 396,615us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_US		 355,609us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_US
International                      
Revenues from External Customers                      
Total sales                 $ 47,280us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= gmed_InternationalMember		 $ 37,844us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= gmed_InternationalMember		 $ 30,385us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= gmed_InternationalMember
XML 34 R37.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Grants in Period, Weighted Average Grant Date Fair Value
The weighted average grant date per share fair values of the options awarded to employees were as follows:
 
 
Year Ended
 
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Weighted average grant date per share fair value
 
$
9.63

 
$
6.34

 
$
5.90
Fair Value of Options, Assumptions Schedule
The fair value of the options was estimated on the date of the grant using a Black-Scholes option pricing model with the following assumptions:
 
Year Ended
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Risk-free interest rate
1.51
%
-
1.95
%
 
0.98
%
-
1.74
%
 
0.90
%
-
1.10
%
Expected term (years)
5.3
-
6.4
 
6.1
-
6.4
 
6
Expected volatility
35.0
%
-
41.0
%
 
41.0
%
-
44.0
%
 
44.0
%
-
47.0
%
Expected dividend yield
—%
 
—%
 
—%
Summary of Stock Option Activity
Stock option activity during the years ended December 31, 2014, 2013 and 2012 is summarized as follows:  
 
Option Shares (thousands)
 
Weighted average exercise price
 
Weighted average remaining contractual life (years)
 
Aggregate intrinsic value (thousands)
Outstanding at December 31, 2011
6,454

 
$
5.14

 
 
 
 
Granted
1,228

 
13.10

 
 
 
 
Exercised
(1,061
)
 
1.42

 
 
 
 
Forfeited
(368
)
 
9.55

 
 
 
 
Outstanding at December 31, 2012
6,253

 
6.99

 
 
 
 
Granted
1,222

 
14.78

 
 
 
 
Exercised
(2,173
)
 
3.48

 
 
 
 
Forfeited
(416
)
 
12.23

 
 
 
 
Outstanding at December 31, 2013
4,886

 
10.04

 
 
 
 
Granted
1,495

 
23.45

 
 
 
 
Exercised
(1,263
)
 
7.71

 
 
 
 
Forfeited
(264
)
 
15.33

 
 
 
 
Outstanding at December 31, 2014
4,854

 
14.50

 
7.1
 
$
45,731

Exercisable at December 31, 2014
2,390

 
9.08

 
5.4
 
35,093

Expected to vest at December 31, 2014
2,464

 
$
19.76

 
8.8
 
$
10,638
Stock Option Compensation Expense and Intrinsic Value Schedule
Compensation expense related to stock options granted to employees and non-employees under the Plans and the intrinsic value of stock options exercised was as follows:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Compensation expense related to stock options
 
$
7,111

 
$
5,177

 
$
4,635

Intrinsic value of stock options exercised
 
20,216

 
25,034

 
12,507
XML 35 R52.htm IDEA: XBRL DOCUMENT v2.4.1.9
FAIR VALUE MEASUREMENTS (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Minimum | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Discount rate 3.10%us-gaap_FairValueInputsDiscountRate
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		  
Maximum | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Discount rate 13.50%us-gaap_FairValueInputsDiscountRate
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		  
Fair Value, Measurements, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Cash equivalents 9,802gmed_CashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 $ 20,363gmed_CashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Contingent consideration 24,335us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 14,177us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Fair Value, Measurements, Recurring | Municipal Bonds    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 54,655us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 89,660us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Fair Value, Measurements, Recurring | Corporate Debt Securities    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 92,629us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 53,089us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Fair Value, Measurements, Recurring | Commercial Paper    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 44,671us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember		 36,089us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember
Fair Value, Measurements, Recurring | Asset-backed Securities    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 21,283us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		 6,652us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember
Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 8,548us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember		  
Fair Value, Measurements, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Cash equivalents 1,302gmed_CashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 800gmed_CashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Contingent consideration 0us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 0us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Fair Value, Measurements, Recurring | Level 1 | Municipal Bonds    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Fair Value, Measurements, Recurring | Level 1 | Corporate Debt Securities    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Fair Value, Measurements, Recurring | Level 1 | Commercial Paper    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember		 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember
Fair Value, Measurements, Recurring | Level 1 | Asset-backed Securities    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember
Fair Value, Measurements, Recurring | Level 1 | US Government-sponsored Enterprises Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember		  
Fair Value, Measurements, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Cash equivalents 8,500gmed_CashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 19,563gmed_CashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Contingent consideration 0us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 0us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Fair Value, Measurements, Recurring | Level 2 | Municipal Bonds    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 54,655us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 89,660us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Fair Value, Measurements, Recurring | Level 2 | Corporate Debt Securities    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 92,629us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 53,089us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Fair Value, Measurements, Recurring | Level 2 | Commercial Paper    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 44,671us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember		 36,089us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember
Fair Value, Measurements, Recurring | Level 2 | Asset-backed Securities    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 21,283us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		 6,652us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember
Fair Value, Measurements, Recurring | Level 2 | US Government-sponsored Enterprises Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 8,548us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember		  
Fair Value, Measurements, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Cash equivalents 0gmed_CashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 0gmed_CashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Contingent consideration 24,335us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 14,177us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Fair Value, Measurements, Recurring | Level 3 | Municipal Bonds    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Fair Value, Measurements, Recurring | Level 3 | Corporate Debt Securities    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Fair Value, Measurements, Recurring | Level 3 | Commercial Paper    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember		 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember
Fair Value, Measurements, Recurring | Level 3 | Asset-backed Securities    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember
Fair Value, Measurements, Recurring | Level 3 | US Government-sponsored Enterprises Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring Basis    
Marketable Securities, Fair Value 0us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember		  
XML 36 R67.htm IDEA: XBRL DOCUMENT v2.4.1.9
INCOME TAXES (Components of Deferred Income Taxes) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Components of Deferred Tax Assets [Abstract]    
Inventory reserve $ 22,808us-gaap_DeferredTaxAssetsInventory $ 19,635us-gaap_DeferredTaxAssetsInventory
Accruals, reserves, and other currently not deductible 19,043us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals 17,133us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
Stock-based compensation 5,548us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost 5,152us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
Foreign net operating loss carryforwards 418us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign 724us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign
Total deferred tax assets 47,817us-gaap_DeferredTaxAssetsGross 42,644us-gaap_DeferredTaxAssetsGross
Valuation allowance (45)us-gaap_DeferredTaxAssetsValuationAllowance (327)us-gaap_DeferredTaxAssetsValuationAllowance
Total deferred tax assets, net of valuation allowance 47,772us-gaap_DeferredTaxAssetsNet 42,317us-gaap_DeferredTaxAssetsNet
Components of Deferred Tax Liabilities [Abstract]    
Depreciation and amortization (9,865)gmed_DeferredTaxLiabilitiesDepreciationAndAmortization (9,759)gmed_DeferredTaxLiabilitiesDepreciationAndAmortization
Other (2,643)us-gaap_DeferredTaxLiabilitiesOther (1,229)us-gaap_DeferredTaxLiabilitiesOther
Total deferred tax liabilities (12,508)us-gaap_DeferredIncomeTaxLiabilities (10,988)us-gaap_DeferredIncomeTaxLiabilities
Net deferred tax assets $ 35,264us-gaap_DeferredTaxAssetsLiabilitiesNet $ 31,329us-gaap_DeferredTaxAssetsLiabilitiesNet
XML 37 R61.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION (Fair Value of Options, Assumptions) (Details)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Risk-free interest rate, minimum 1.51%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum 0.98%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum 0.90%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
Risk-free interest rate, maximum 1.95%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum 1.74%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum 1.10%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
Expected volatility, minimum 35.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum 41.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum 44.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
Expected volatility, maximum 41.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum 44.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum 47.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
Expected term     6 years
Expected dividend yield 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Minimum      
Expected term 5 years 3 months 22 days 6 years 0 months 28 days  
Maximum      
Expected term 6 years 4 months 16 days 6 years 4 months 16 days  
XML 38 R47.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACQUISTIONS (Assets Acquired and Liabilities) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Oct. 23, 2014
Dec. 23, 2013
Jul. 18, 2012
Business Acquisition          
Goodwill $ 53,196us-gaap_Goodwill $ 18,372us-gaap_Goodwill      
Acquisition 2014          
Business Acquisition          
Payments to Acquire Businesses, Gross 36,128us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		        
Inventory     9,599us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Accounts receivable     1,529us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Equipment     518us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Trade Names     300us-gaap_FiniteLivedTradeNamesGross
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Other assets     292us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Accounts payable and accrued expenses     (5,034)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Contingent consideration     (11,300)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		 [1]    
Business Combination, Consideration Transferred 47,428us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		        
Total identifiable net assets     12,604us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Goodwill     34,824us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Net assets acquired     47,428us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member		    
Acquisition 2013          
Business Acquisition          
Contingent consideration       (6,704)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member		 [2]  
Total identifiable net assets       13,776us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member		  
Goodwill       2,999us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member		  
Net assets acquired       16,775us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member		  
Acquisition 2012          
Business Acquisition          
Inventory         158us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
Contingent consideration         (2,311)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
Total identifiable net assets         467us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
Goodwill         5,564us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
Net assets acquired         6,031us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
In-process Research and Development | Acquisition 2013          
Business Acquisition          
Identifiable intangible assets:       20,460us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember		  
Customer Relationships | Acquisition 2014          
Business Acquisition          
Identifiable intangible assets:     1,600us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		    
Customer Relationships | Acquisition 2012          
Business Acquisition          
Identifiable intangible assets:         120us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember
Non-compete Agreements | Acquisition 2013          
Business Acquisition          
Identifiable intangible assets:       20us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2013Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		  
Non-compete Agreements | Acquisition 2012          
Business Acquisition          
Identifiable intangible assets:         80us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember
Patents | Acquisition 2012          
Business Acquisition          
Identifiable intangible assets:         2,420us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisitions2012Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember
Supplier Network | Acquisition 2014          
Business Acquisition          
Identifiable intangible assets:     $ 3,800us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= gmed_Acquisition2014Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= gmed_SupplierNetworkMember		    
[1] The contingent consideration relates to the achievement of certain sales milestones. As of December 31, 2014, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranges from zero to $15.0 million (see “Note 5. Fair Value Measurements” below).
[2] The contingent consideration relates to the achievement of certain regulatory milestones and royalties. As of December 31, 2013, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranged from zero to $14.3 million (see “Note 5. Fair Value Measurements” below).
XML 39 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACQUISTIONS
 12 Months Ended
Dec. 31, 2014
Business Combinations [Abstract]  
Business Acquisitions
ACQUISITIONS
On October 23, 2014, we entered into an equity interest purchase agreement with Transplant Technologies of Texas, Ltd. (“TTOT”), an allograft tissue processor located in San Antonio, Texas, pursuant to which we acquired 100% of the equity interests for $36.1 million. In addition to the initial purchase price, we may be obligated to make milestone payments of up to $15.0 million over the next three years based primarily on sales thresholds from the product lines we acquired.
TTOT was privately held and provides human tissue products including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets and represents a key step in fulfilling our strategy of building a broad business in regenerative biologics. While we currently partner with third party suppliers for our existing allograft products, the acquisition of TTOT will expand our suite of regenerative biologics products. We believe this acquisition will also improve our capabilities for the development of new and innovative human allograft tissue products in the future.
We accounted for the acquisition under the purchase method of accounting, and as a result, recorded goodwill of $34.8 million. The results of operations of TTOT have been included in our results of operations from the date of acquisition. Prior-period results have not been restated and pro forma supplemental financial information is not provided as the impact of the TTOT acquisition is immaterial to the operating results for the years ended December 31, 2014 and December 31, 2013. Amounts recognized for assets acquired and liabilities assumed are based on preliminary purchase price allocations and on certain management judgments. These preliminary allocations are based on an analysis of the estimated fair values of assets acquired and liabilities assumed, including identifiable tangible and intangible assets, and estimates of the useful lives of tangible and amortizable intangible assets. The final purchase price allocations will be completed after we finalize our third-party appraisal, review all available data, and complete our own internal assessments. We expect to complete our final purchase price allocations by the end of March 2015. Any additional adjustments resulting from finalization of the purchase price allocations for TTOT will affect the amount assigned to goodwill.
As of December 31, 2014, we recorded the following preliminary purchase price allocation for the identifiable tangible and intangible assets and liabilities of TTOT:
(In thousands)
 
 
Consideration:
 
 
Cash paid at closing
$
36,128

 
Contingent consideration
11,300

(1) 
Fair value of consideration
$
47,428

 
 
 
 
Identifiable assets acquired and liabilities assumed:
 
 
Inventory
$
9,599

 
Supplier network
3,800

 
Customer relationships
1,600

 
Accounts receivable
1,529

 
Equipment
518

 
Trade names
300

 
Other assets
292

 
Accounts payable and accrued expenses
(5,034
)
 
Total identifiable net assets
12,604

 
 
 
 
Goodwill
34,824

 
Total allocated purchase price
$
47,428

 
(1)
The contingent consideration relates to the achievement of certain sales milestones. As of December 31, 2014, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranges from zero to $15.0 million (see “Note 5. Fair Value Measurements” below).
On December 23, 2013, we entered into an asset purchase agreement with a small robotics development company, pursuant to which we acquired substantially all of its assets for $16.8 million. In addition to the initial purchase price, we may be obligated to make a milestone payment and revenue sharing payments based upon a percentage of net sales of certain products based on the intellectual property we acquired in the transaction. The acquired company was privately held and is focused on developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets. The technology is intended to enable surgeons to perform minimally invasive and percutaneous surgical procedures with greater accuracy, safety and reproducibility than is currently available. We accounted for this acquisition under the purchase method of accounting, and as a result, recorded goodwill of $3.0 million. The table below represents the valuation of the assets acquired and liabilities assumed as part of this 2013 purchase:
(In thousands)
 
 
Identifiable intangible assets:
 
 
In-process research & development
$
20,460

 
Non-compete agreements
20

 
Contingent consideration
(6,704
)
(2) 
Total identifiable net assets
13,776

 
Goodwill
2,999

 
Net assets acquired
$
16,775

 
(2)
The contingent consideration relates to the achievement of certain regulatory milestones and royalties. As of December 31, 2013, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranged from zero to $14.3 million (see “Note 5. Fair Value Measurements” below).
On July 18, 2012, we entered into an asset purchase agreement with a global medical device company, pursuant to which we acquired substantially all of its assets for $6.0 million. In addition to the initial purchase price, we may be obligated to make revenue sharing payments based upon a percentage of net sales of products we acquired from it. We accounted for this acquisition under the purchase method of accounting and as a result, recorded goodwill of $5.6 million. The table below represents the assets acquired and liabilities assumed as part of this 2012 purchase:
(In thousands)
 
 
Inventory
$
158

 
Identifiable intangible assets:
 
 
Customer relationships
120

 
Non-compete agreements
80

 
Patents
2,420

 
Contingent consideration
(2,311
)
 
Total identifiable net assets
467

 
Goodwill
5,564

 
Net assets acquired
$
6,031

 

These acquisitions, which expand our product pipeline, did not have a material effect on our consolidated net sales or operating income for the years ended December 31, 2014, 2013 or 2012. The assets acquired and liabilities assumed as a result of the acquisitions were included in our consolidated balance sheet as of the acquisition dates. The purchase price for each of the acquisitions was primarily allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates. The fair value assigned to identifiable intangible assets acquired was determined primarily by using the income approach, which discounts expected future cash flows to present value using estimates and assumptions determined by management. Purchased identifiable intangible assets are amortized on a straight-line basis over their respective estimated useful lives. The excess purchase price over the value of the net tangible and identifiable intangible assets was recorded as goodwill. The goodwill from these acquisitions is deductible for tax purposes.
The fair value of the IPR&D was determined using a relief from royalty approach, including a pre-tax royalty rate ranging between 4% and 9% and a discount rate ranging between 13.5% and 19%. IPR&D will become an amortizable asset upon completion of the projects, which are currently expected to be completed between 2016 and 2020. The estimated costs to complete the IPR&D projects are approximately $14.1 million as of December 31, 2014.
The following table provides a reconciliation of the beginning and ending balances of contingent payments associated with acquisitions during the years ended December 31, 2014 and December 31, 2013:
(In thousands)
 
Balance at December 31, 2012
$
7,358

Purchase price contingent consideration
6,704

Contingent payments
(5
)
Changes in fair value of contingent consideration classified in operating expenses
120

Balance at December 31, 2013
14,177

Purchase price contingent consideration
11,300

Contingent payments
(11
)
Changes in fair value of contingent consideration classified in operating expenses (1)
(1,131
)
Balance at December 31, 2014
$
24,335


(1) 
Reduction in fair value during 2014 due primarily to reductions to a contingent royalty accrual, offset partially by increases in other royalty and milestone accruals.
XML 40 R62.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION (Stock Option Activity) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Number of shares outstanding beginning balance 4,886us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 6,253us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 6,454us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Number of shares granted 1,495us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross 1,222us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross 1,228us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Number of shares exercised (1,263)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised (2,173)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised (1,061)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Number of shares forfeited (264)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod (416)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod (368)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
Number of shares outstanding ending balance 4,854us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 4,886us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 6,253us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Weighted average exercise price per share outstanding beginning balance $ 10.04us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 6.99us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 5.14us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Weighted average exercise price per share granted $ 23.45us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice $ 14.78us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice $ 13.10us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
Weighted average exercise price per share exercised $ 7.71us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice $ 3.48us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice $ 1.42us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
Weighted average exercise price per share forfeited $ 15.33us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice $ 12.23us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice $ 9.55us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
Weighted average exercise price per share outstanding ending balance $ 14.50us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 10.04us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 6.99us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Number of shares exercisable 2,390us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber    
Weighted average exercise price per share exercisable $ 9.08us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice    
Weighted average remaining contractual life outstanding 7 years 1 month 6 days    
Weighted average remaining contractual life exercisable 5 years 4 months 24 days    
Aggregate intrinsic value outstanding $ 45,731us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue    
Aggregate intrinsic value exercisable 35,093us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 2,464us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $ 19.76us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 8 years 9 months 18 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $ 10,638us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue    
EXCEL 41 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W M.&5B-68U8C@B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D9!25)?5D%,545?345!4U5214U%3E13/"]X.DYA;64^#0H@("`@/'@Z M5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I7;W)K#I%>&-E M;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D5154E463PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-43T-+0D%3141?0T]-4$5.4T%424]./"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7 M;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E9!3%5!5$E/3E]!0T-/54Y44U]!3D1?455!3$E&63PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D)!0TM'4D]53D1?04Y$ M7U-534U!4EE?3T9?4TE'3C$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D%#0U)5141?15A014Y315-? M5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-43T-+0D%3141?0T]-4$5.4T%424].7U1A8FQE#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.0T]-15]405A%4U]) M;F-O;65?5&%X97-?5&%B;#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQ%05-%4U]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K M#I7;W)K#I7 M;W)K#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E9!3%5!5$E/3E]!0T-/54Y44U]! M3D1?455!3$E&63$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%#455)4U1)3TY37T%S#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%#455)4U1)3TY37T-O M;G1I;F=E;G1?0V]N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.5$%.1TE"3$5?05-315137T1E=&%I;',\+W@Z3F%M93X- M"B`@("`\>#I7;W)K'!E8W1E9%]&=70\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9!25)?5D%,545?345! M4U5214U%3E137T1E=&%I;#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.5D5.5$]224537T1E=&%I;',\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%# M0U)5141?15A014Y315-?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1%0E1?1&5T86EL#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D5154E465]497AT=6%L#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQ%05-%4U]-:6YI;75M7T9U='5R95]296YT86Q?4#PO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/34U)5$U%3E137T%.1%]#3TY424Y'14Y#2453 M7SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)%3$%4141005)465]44D%.4T%#5$E/3E-? M1&5T83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-% M1TU%3E1?04Y$7T=%3T=205!(24-?24Y&3U)-03(\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-50E-%455%3E1?159%3E1? M1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E9!3%5!5$E/3E]!0T-/54Y44U]!3D1?455!3$E&63(\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H M965T&-E;"!84"!O M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T M,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!);F9O&-E<'0@4VAA'0^1TQ/0E53($U%1$E#04P@24Y#/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA M2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^3&%R9V4@06-C96QE'0^1&5C(#,Q+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q-#QS<&%N M/CPO'0^1ED\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^3F\\2!#=7)R96YT(%)E<&]R=&EN9R!3=&%T=7,\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S&5S(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA2!A;F0@97%U M:7!M96YT+"!N970@;V8@86-C=6UU;&%T960@9&5P'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6%B;&4@=&\@3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E'0^)FYB'0^)FYB3H\+W-T3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T,6)C M7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F5D("AI;B!S:&%R97,I/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P+#`P,#QS<&%N M/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F5D("AI M;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S4L M,#`P+#`P,#QS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"!P'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&-L M=61E9"!F7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F5D(&=A:6X@;VX@;6%R:V5T86)L92!S96-U3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T M-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES M92!O9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ+#4P-#QS<&%N/CPO&-E'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!S=&]C:R!O<'1I;VYS("AS:&%R97,I M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#$W,RPP,#`\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@96YD(&]F('!E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!S=&]C:R!O<'1I;VYS("AS:&%R97,I M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#(V,RPP,#`\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O<&5R871I M;F<@86-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'!E;G-E'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@=&\@3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E6UE;G0@;V8@8G5S:6YE"!B96YE9FET(')E;&%T960@=&\@;F]N<75A;&EF:65D M('-T;V-K(&]P=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA&-H86YG92!R871E(&]N(&-A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`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`@5V4@87)E M(&-U2!F;V-U6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3)P=#MC;VQO2!D979E;&]P:6YG(&%N9"!C;VUM97)C:6%L:7II;F<@861V86YC M960@<')O9'5C=',@86YD('!R;V-E9'5R97,@=&AA="!A6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^("!3:6YC92!O=7(@ M:6YC97!T:6]N(&EN(#(P,#,L('=E(&AA=F4@;&%U;F-H960@;W9E3II;FAE3II M;FAE6QV86YI82!A;F0@;6%R:V5T(&%N9"!S96QL M(&]U&-L=7-I=F4@65D(&)Y(&5X8VQU2PF(S@R,C$[("8C.#(R,#M';&]B=7,L)B,X,C(Q.R`F(S@R,C`[=V4L)B,X M,C(Q.R`F(S@R,C`[=7,F(S@R,C$[(&%N9"`F(S@R,C`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`\+V9O;G0^/&9O;G0@'0M9&5C;W)A M=&EO;CIN;VYE.R<^)#`N.2!M:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MC;VQO3I4:6UE M6QE.FYO3II;FAE3I4 M:6UE6QE.FYO3II;FAE3I4:6UE6QE.FYO6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3)P=#MC;VQO3I4:6UE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.R<^,C`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`Q-#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$R<'0[8V]L;W(Z M(S(S,68R,#L^+"`\+V9O;G0^/&9O;G0@'0M9&5C M;W)A=&EO;CIN;VYE.R<^,C`Q,SPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$R<'0[8V]L;W(Z(S(S,68R,#L^ M+"!A;F0@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3)P=#MC;VQO3II;FAE6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE M#MT97AT+6%L:6=N.FIU#MF M;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE M'0M9&5C;W)A=&EO;CIN;VYE.R<^1&5C96UB97(F(S$V,#LS,2P@ M,C`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$R<'0[8V]L;W(Z(S(S,68R,#L^+B`@079A:6QA8FQE+69O MF5D(&]V97(@ M=&AE(&QI9F4@;V8@=&AE(')E;&%T960@'!E;G-E#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE2!T:6UE+B`@5V4@:6YV97-T(&EN('-E8W5R M:71I97,@=&AA="!M965T(&]R(&5X8V5E9"!S=&%N9&%R9',@87,@9&5F:6YE M9"!I;B!O=7(@:6YV97-T;65N="!P;VQI8WDN("!/=7(@<&]L:6-Y(&%L2!O M;F4@:7-S=64L(&ES7!E(&]F('-E8W5R:71Y+B`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`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`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.C$R<'0[8V]L;W(Z(S(S,68R,#L^(&%N9"`R M,#$S(&%N9"!R96-O'0M9&5C;W)A=&EO;CIN;VYE.R<^,C`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`N-"!M:6QL:6]N/"]F;VYT/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^ M+"!F;W(@=&AE('EE87)S(&5N9&5D(#PO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$R<'0[/D1E8V5M8F5R)B,Q M-C`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`F(S@R,C`[ M4%!!0T$F(S@R,C$[*2!I;7!O"`H)B,X,C(P.TU$150F(S@R,C$[*2!O9B`\+V9O;G0^/&9O;G0@'0M9&5C;W)A=&EO;CIN;VYE.R<^,BXS)3PO9F]N=#X\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$R M<'0[/B!O;B!A;GD@96YT:71Y('1H870@;6%N=69A8W1U3I4:6UE6QE.FYO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^ M+"!W92!R96-O9VYI>F5D(&5X<&5N3I4:6UE6QE.FYO3II;FAE6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE2!)6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M2`R,#$T+"!T:&4@1D%30B!A;F0@=&AE($EN=&5R;F%T M:6]N86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A2!A9&]P=&EO;B!I'1087)T7V$X,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3)P=#L^+B`@26X@861D:71I;VX@=&\@=&AE(&EN:71I86P@ M<'5R8VAA2!B92!O8FQI9V%T960@=&\@;6%K92!M M:6QE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^)#$U+C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`P,#`P,#MP861D:6YG+6QE9G0Z,G!X M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-#6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^261E;G1I9FEA8FQE(&%S#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$ M;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`\+V9O;G0^/"]D:78^/"]T9#X\=&0@8V]L#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PV,#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^5&]T86P@:61E;G1I9FEA8FQE(&YE="!A M#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3(L-C`T/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#L^/&9O;G0@3II;FAE M'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE2!R96QA=&5D('1O M('1H92!A8W%U:7-I=&EO;G,@F5R;R!T;R`\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7-T>6QE.FET86QI8SL^("AS964@/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T M>6QE.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SXF(S@R,C`[3F]T92`U+B!& M86ER(%9A;'5E($UE87-U3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG M+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT M.'!X.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#L^+B`@26X@861D:71I;VX@=&\@=&AE(&EN:71I86P@<'5R M8VAA2!B92!O8FQI9V%T960@=&\@;6%K92!A(&UI M;&5S=&]N92!P87EM96YT(&%N9"!R979E;G5E('-H87)I;F<@<&%Y;65N=',@ M8F%S960@=7!O;B!A('!E2!W92!A8W%U:7)E9"!I;B!T:&4@=')A;G-A8W1I;VXN("!4:&4@86-Q=6ER M960@8V]M<&%N>2!W87,@<')I=F%T96QY(&AE;&0@86YD(&ES(&9O8W5S960@ M;VX@9&5V96QO<&EN9R!A(&YE>'0@9V5N97)A=&EO;B!S=7)G:6-A;"!R;V)O M=&EC('!O2!I2P@3II;FAE3II;FAE'0M:6YD96YT.C!P>#ML M:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E M;&QP861D:6YG/3-$,"!C96QL6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T M>6QE.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SXH26X@=&AO=7-A;F1S*3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!C;VQS<&%N/3-$,R!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^0V]N=&EN9V5N="!C;VYS:61E6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE M/3-$;W9E#L^/&9O;G0@3II;FAE M'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE2!M:6QE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^)#$T M+C,@;6EL;&EO;CPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$P<'0[9F]N="US='EL93II=&%L:6,[/B`H6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^(&)E;&]W*2X\+V9O M;G0^/"]D:78^/"]T9#X\+W1R/CPO=&%B;&4^/&1I=B!S='EL93TS1&QI;F4M M:&5I9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ,39P>#MT97AT+6%L:6=N.FIU M#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@ M3II;FAE2P@<'5R2!A;&P@;V8@:71S(&%S6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^)#8N M,"!M:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3)P=#L^+B`@26X@861D:71I;VX@=&\@=&AE(&EN M:71I86P@<'5R8VAA2!B92!O8FQI9V%T960@=&\@ M;6%K92!R979E;G5E('-H87)I;F<@<&%Y;65N=',@8F%S960@=7!O;B!A('!E M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^ M)#4N-B!M:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^+B`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`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`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^0V]N=&EN9V5N M="!C;VYS:61E6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M:6YD96YT.C0X<'@[9F]N="US:7IE.C$R<'0[/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^5&AE'!A;F0@;W5R('!R;V1U8W0@<&EP96QI M;F4L(&1I9"!N;W0@:&%V92!A(&UA=&5R:6%L(&5F9F5C="!O;B!O=7(@8V]N M65A6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MC;VQO6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^+"`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`C,#`P,#`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`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`@("`\+W1R/@T*("`@("`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD M.SY!8V-U;75L871E9"!!;6]R=&EZ871I;VX@)B,Q-C`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`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`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,S8L,S`U/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE65A6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9EF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^*#$L,#8V/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q/CQD:78@F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q/CQD:78@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE'!E M;G-E/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MP861D M:6YG+6QE9G0Z,C1P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#L@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PU-#4\+V9O;G0^/"]D M:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@F4Z,3!P=#L^,C`Q-CPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,2PU-#$\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^ M,C`Q-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z M,C1P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^ M,C`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`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`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/"]T7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA#MT97AT+6%L M:6=N.FQE9G0[9F]N="US:7IE.C$R<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MF;VYT+7=E:6=H=#IB;VQD M.SY-05)+151!0DQ%(%-%0U52251)15,\+V9O;G0^/"]D:78^/&1I=B!S='EL M93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ,3)P>#MT97AT M+6EN9&5N=#HT.'!X.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#MF;VYT+7-T>6QE.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SXH26X@ M=&AO=7-A;F1S*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N M="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY#;VYT3PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD M.SXH:6X@>65A6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY'F5D($=A:6YS/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY&86ER(%9A M;'5E/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^4VAO#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^)B,Q-C`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`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`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`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`C,#`P,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#LG M(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P M86X],T0Q/CQD:78@6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)A8VMG"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-S4L,S0W/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H M=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG M/3-$,"!C96QL#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.'!T.V9O;G0M6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&]T86P@#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O M=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U M8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#(\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P M,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z M,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D M,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T-S%?,6(R-SAE M8C5F-6(X+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE2`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`Z,3!P>#L^/'1A M8FQE(&-E;&QP861D:6YG/3-$,"!C96QL'0M86QI9VXZ M;&5F=#LG/CQT#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI M9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HQ<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY,979E;"`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+7)I9VAT M.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-30L-C4U/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C%P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z M,S-P>#MT97AT+6EN9&5N=#HM,S)P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-#0L-C6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C%P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,S-P>#MT97AT+6EN9&5N=#HM M,S)P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M:6YD96YT.C!P M>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE M(&-E;&QP861D:6YG/3-$,"!C96QL'0M86QI9VXZ;&5F M=#LG/CQT#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ M8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HQ<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP M861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7=E:6=H=#IB;VQD.SY,979E;"`R/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.W1E>'0M9&5C;W)A=&EO;CIU;F1E M6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`@5V4@87-S97-S('1H97-E M(&5S=&EM871E6QE M.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SY!#MT97AT+6%L:6=N.FIU M#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@ M3II;FAE2!A;&QO8V%T960@=&\@=&AE('1A;F=I8FQE(&%N9"!I9&5N M=&EF:6%B;&4@:6YT86YG:6)L92!A2P@<&QA;G0L M(&%N9"!E<75I<&UE;G0@87)E('-U8G-E<75E;G1L>2!M96%S=7)E9"!A="!F M86ER('9A;'5E('=H96X@=&AE2!W:&5N(&%N M(&EM<&%I2!N;W0@8F4@2!N;W0@8F4@'1087)T7V$X,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^."PX-#<\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-S`L,S4P/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W M.&5B-68U8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q M9#-?834U-E\T,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2P@4&QA;G0@ M86YD($5Q=6EP;65N="!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@ M("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N M=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD M:78@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X M,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-"PQ,38\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ8V5N=&5R.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^26YS=')U;65N=',\+V9O;G0^/"]D M:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,3`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-C0L,34P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C$L M,#0T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M'10 M87)T7V$X,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I M>F4Z,3!P=#LG/CQD:78@#MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL93TS1'!A M9&1I;F#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HQ<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.W!A9&1I;F'0M:6YD96YT.BTR,'!X.V9O;G0M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q M/CQD:78@6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-C$L-#DY/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`Q,3PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$R<'0[/BP@=V4@96YT97)E9"!I;G1O(&$@8W)E9&ET(&%G M3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3)P=#MC;VQO'0M9&5C;W)A=&EO M;CIN;VYE.SXD-S4N,"!M:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^+B`@5&AE(')E=F]L M=FEN9R!C3II;FAE3II;FAE M2`R,#$U/"]F;VYT/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P M=#L^+B`@0V%S:"!A9'9A;F-E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^ M(&EN(&5F9F5C="!F;W(@82`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`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T M,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$#MT97AT+6%L:6=N.FQE9G0[ M9F]N="US:7IE.C$R<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3)P=#MF;VYT+7=E:6=H=#IB;VQD.SY%455)5%D\ M+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D M9&EN9RUB;W1T;VTZ,3)P>#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAEF5D('-H87)E M6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^-3`P+#`P M,"PP,#`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3)P=#L^,C3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^ M,3`L,#`P+#`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`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.CEP>#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7=E:6=H=#IB;VQD M.SY#;&%S#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZ#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M'1087)T7V$X M,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3)P=#L^=&AR964\+V9O;G0^/&9O;G0@3II;FAE2!T:&4@0F]A6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I M>F4Z,3)P=#MC;VQO65E'0M9&5C;W)A M=&EO;CIN;VYE.R<^9F]U6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D M:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N M=#HT.'!X.V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3)P=#MC;VQO'!I6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXS)3PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$R<'0[/B!O9B!T:&4@;G5M8F5R(&]F('-H87)E65A2!O=7(@0F]A2!B M92!I2!S:&%R97,@;W(@6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI M9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^('-H M87)E6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S M=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M#MF;VYT+7-I>F4Z,3!P M=#L^/&1I=B!S='EL93TS1'!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7=E:6=H=#IB M;VQD.SY$96-E;6)E6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[ M/D1E8V5M8F5R)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE#MT97AT+6%L:6=N.FIU M#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@ M3II;FAE6QE/3-$;&EN92UH96EG:'0Z M,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.V9O;G0M6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN M92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HY.2XX M,#4P-C@R,C8Q,C`X-24[8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.W1E>'0M M86QI9VXZ;&5F=#LG/CQT#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0Q M-R!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O M;G0@3II;FAE#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0U('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O M;&0[/D1E8V5M8F5R)B,Q-C`[,S$L(#QB#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7=E M:6=H=#IB;VQD.SY$96-E;6)E6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.W!A M9&1I;F'0M:6YD96YT.BTS,G!X.V9O;G0M6QE/3-$)W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^+3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,2XY-3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3,N,3`\+V9O;G0^/"]D M:78^/"]T9#X\=&0@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9EF4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@#LG(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`C M,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C%P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,S-P>#MT97AT+6EN M9&5N=#HM,S)P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^-"PX-30\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,30N-3`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-#4L-S,Q/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.W!A9&1I;F'0M:6YD96YT.BTS,G!X.V9O M;G0M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE(",P,#`P,#`[)R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`R,#$T/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[<&%D9&EN9RUL969T.C)P>#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)O'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BPT-C0\+V9O M;G0^/"]D:78^/"]T9#X\=&0@"!D;W5B;&4@(S`P,#`P M,#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P M86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#MF;VYT+7=E:6=H=#IB;VQD.SY996%R($5N9&5D/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C%P>#L@'0M86QI9VXZ;&5F=#MP M861D:6YG+6QE9G0Z,S-P>#MT97AT+6EN9&5N=#HM,S)P>#MF;VYT+7-I>F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#MF;VYT+7-T>6QE.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SXH M26X@=&AO=7-A;F1S*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT M+7=E:6=H=#IB;VQD.SY$96-E;6)E6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I M9VAT.F)O;&0[/D1E8V5M8F5R)B,Q-C`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`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`@("`\+W1R/@T*("`@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#MF;VYT+7-T>6QE.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SXH26X@=&AO M=7-A;F1S*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP M861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP M861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,3,W+#8T,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,3`Q+#0R-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#LG M(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-36QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE.FET86QI8SMF M;VYT+7=E:6=H=#IB;VQD.SXH26X@=&AO=7-A;F1S*3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.V)A8VMG6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*#$U+#,X,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#8L,C@P M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#8L M,34W/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E M>'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z-#AP>#MF;VYT+7-I>F4Z,3)P M=#L^/&9O;G0@3II;FAE2!5+E,N(&9E9&5R86P@=&%X(')A=&4@=&\@;W5R(&5F9F5C M=&EV92!R871E(&ES(&%S(&9O;&QO=W,Z/"]F;VYT/CPO9&EV/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN M;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^,BXV/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,BXX/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`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`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D M/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.W!A9&1I;F"!A6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE2!O9B!D969E69O6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P M=#L^+"`\+V9O;G0^/&9O;G0@'0M9&5C;W)A=&EO M;CIN;VYE.R<^)#`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`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#MF;VYT+7-T>6QE.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SXH26X@ M=&AO=7-A;F1S*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BPW.3D\+V9O M;G0^/"]D:78^/"]T9#X\=&0@"!S M;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^-C8Q/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,RPY M-S@\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3)P=#MC;VQO"!R871E(&ES(&%S(&9O;&QO=W,Z/"]F;VYT/CPO9&EV/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN M;W)M86P[<&%D9&EN9RUT;W`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,C1P>#MT M97AT+6EN9&5N=#HM,C1P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!R871E/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIT;W`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`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`Q,B`H=&AE("8C.#(R,#M!5%)! M)B,X,C(Q.RD@=V%S('-I9VYE9"!I;G1O(&QA=RX@($]N92!O9B!T:&4@<')O M=FES:6]N'1E;G-I;VX@;V8@=&AE(')E'!EF5D(&9O"!C6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3)P=#L^65A6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3)P=#L^=V%S(')E8V]G;FEZ960@:6X@,C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,C1P>#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K9W)O M=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-S`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`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)A8VMG"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PV,S`\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE3II;FAE#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-#$Y/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/"]T7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MF;VYT+7=E M:6=H=#IB;VQD.SY#3TU-251-14Y44R!!3D0@0T].5$E.1T5.0TE%4R`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`R,#$Q+B`@26X@1&5C96UB97(@,C`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`R,#$S+"!T:&4@ M:G5R>2!I;B!T:&ES(&-A2!O9B!$95!U M>2!3>6YT:&5S)B,X,C$W.R!P871E;G1S+B`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`Q-#PO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$R<'0[/BP@=V4@86-C'0M:6YD96YT.C0X<'@[9F]N="US:7IE.C$R<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^ M26X@1&5C96UB97(@,C`P.2P@=V4@9FEL960@2!J M=61G;65N="!C;VYC97)N:6YG(&-E6EN9R!D86UA9V5S(&-L86EM#MT97AT+6%L M:6=N.FIU6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MF;VYT+7-T>6QE.FET M86QI8SL^3G5687-I=F4@3&ET:6=A=&EO;B`\+V9O;G0^/"]D:78^/&1I=B!S M='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ,39P>#MT M97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z M,3)P=#L^/&9O;G0@3II;FAE3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^('!A=&5N=',@8GD@;6%K M:6YG+"!UF4Z.'!T/B8C.#0X,CL\+W-U M<#X\+V9O;G0^/&9O;G0@3II;FAE'0M:6YD96YT.C0X<'@[9F]N="US:7IE.C$R<'0[/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^5V4@:&%V M92!H:7)E9"!S979E65E2!E M;7!L;WEE9"!B>2!.=59A2`R,#$Q+"!.=59A M&%S(&%L;&5G:6YG('1H870@;W5R M(&AI65E(&%N9"!O=&AE M65E7,F(S@R,3<[(&9E97,N("!4 M:&ES(&UA='1E2`Q,BP@,C`Q-2!F M;W(@86X@=6YD:7-C;&]S960@86UO=6YT+CPO9F]N=#X\+V1I=CX\9&EV('-T M>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E M>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE#MT97AT+6%L:6=N.FIU#MF;VYT+7-I M>F4Z,3)P=#L^/&9O;G0@3II;FAEF5D(&ET(&EN(&1E=F5L;W!I;F<@;W5R($-!3$E"15(\+V9O M;G0^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M M:&5I9VAT.C$R,"4[9F]N="US:7IE.CAP=#XF(S$W-#L\+W-U<#X\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^/'-U<"!S='EL M93TS1'9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^('!R;V1U8W0N("!/ M;B!.;W9E;6)E2!I;B!D979E;&]P:6YG(&]U6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^/'-U<"!S='EL M93TS1'9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^(&%N9"!#04Q)0D52 M/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3)P=#L^+4P@<')O9'5C=',N("`\+V9O;G0^/"]D:78^/&1I=B!S='EL M93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ,39P>#MT97AT M+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P M=#L^/&9O;G0@3II;FAE2!I;B!T:&ES M(&-A3II;FAE2!D86UA9V5S+"!A;F0@0FEA;F-O(&%B86YD;VYE9"!T:&4@ M8VQA:6T@;V8@;6ES87!P2X@($]N($UA2!O9B`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`R,"P@,C`Q,RP@06QT M=7,@4&%R=&YE6QV86YI82!F;W(@<&%T96YT(&EN9G)I;F=E;65N="XF(S$V M,#L@3VX@07!R:6P@-RP@,C`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`@F4Z.'!T/B8C,3F4Z.'!T/B8C,36QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3)P=#L^+"!)3E1%4D-/3E1)3D5.5$%,/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^/'-U<"!S M='EL93TS1'9E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^+"!-3TY5345. M5#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$R<'0[/CQS=7`@F4Z.'!T/B8C,3F4Z.'!T M/B8C,3F4Z.'!T/B8C,36QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3)P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3)P=#L^+"!355-404E./"]F;VYT/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^/'-U<"!S='EL M93TS1'9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^+"!A;F0@5%)!3E-# M3TY424Y%3E1!3#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$R<'0[/CQS=7`@F4Z.'!T/B8C,3#MT97AT+6%L:6=N.FIU M#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@ M3II;FAE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`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`R,#$T/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[/D1E8V5M8F5R)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,2PP-34\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A M.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T-S%? M,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA2!4#MT97AT+6%L:6=N M.FQE9G0[9F]N="US:7IE.C$R<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MF;VYT+7=E:6=H=#IB;VQD.SY2 M14Q!5$5$+5!!4E19(%1204Y304-424].4R`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O M;G0M=V5I9VAT.F)O;&0[/D1E8V5M8F5R)B,Q-C`[,S$L(#QB#MP861D:6YG+7)I9VAT.C%P>#L@'0M86QI9VXZ;&5F=#MP861D M:6YG+6QE9G0Z,S-P>#MT97AT+6EN9&5N=#HM,S)P>#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`L,34Y/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@ M'0M:6YD96YT.C0X<'@[9F]N="US:7IE M.C$R<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#L^07,@;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^1&5C96UB97(F(S$V,#LS M,2P@,C`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.C$R<'0[/B!A;F0@/"]F;VYT/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^1&5C96UB97(F M(S$V,#LS,2P@,C`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`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@#MT97AT+6%L:6=N.FIU#MF;VYT+7-I M>F4Z,3)P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^;VYE/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^(')E<&]R M=&%B;&4@2!I;B!T:&4@56YI=&5D(%-T M871E#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&1I=B!S='EL M93TS1'!A9&1I;F#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0Q,2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIT;W`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I M9VAT.F)O;&0[/D1E8V5M8F5R)B,Q-C`[,S$L(#QB#MP861D:6YG+7)I9VAT.C%P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE M9G0Z,S-P>#MT97AT+6EN9&5N=#HM,S)P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-#(W+#`Y,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE3II M;FAE#MT97AT+6%L:6=N.FIU#MF;VYT+7-I M>F4Z,3)P=#L^/&9O;G0@3II;FAE2!O=7(@<')O9'5C=',@:6YT;R`\ M+V9O;G0^/&9O;G0@3II;FAE3II;FAE2!P2!P#MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I;F#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0Q,2!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIT;W`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ8V5N M=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[/D1E8V5M M8F5R)B,Q-C`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`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C,X+#6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HQ<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^1&ES6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M86QI9VXZF4Z,3!P=#L^,C`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-? M.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$#MT97AT+6%L:6=N.FQE9G0[9F]N="US:7IE.C$R<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MF M;VYT+7=E:6=H=#IB;VQD.SY154%25$523%D@1DE.04Y#24%,($1!5$$@*'5N M875D:71E9"D@/"]F;VYT/CPO9&EV/CQD:78@'0M:6YD96YT.C!P>#ML M:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E M;&QP861D:6YG/3-$,"!C96QL#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O M=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.W!A9&1I;F'0M:6YD96YT M.BTS,G!X.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^.#@L.#DX/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.#8L.3DP M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZF4Z,3!P=#L^.3`L,3`Q/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG M/3-$,"!C96QL#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O M=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.W!A9&1I;F'0M:6YD96YT.BTS,G!X.V9O M;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M.#$L-3(U/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^.#(L,C0X/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^.#$L.#6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`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`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`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`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`@ M("`\+W1R/@T*("`@("`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`@("`\+W1R/@T*("`@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q/CQD:78@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE M/3-$;W9E"!S;VQI9"`C,#`P,#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE#MT97AT+6%L:6=N.FIU#MF;VYT M+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE2!O=VYE9"!S M=6)S:61I87)I97,N("!/=7(@8V]N6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z,3!P=#LG/CQD:78@#MT97AT+6%L M:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^ M/&9O;G0@3II;FAE'!E;G-E2!R979I97=E M9"!A;F0@=&AE(&5F9F5C=',@;V8@#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE&5S+B`@5V4@87)E('-U8FIE8W0@=&\@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M,3!P=#LG/CQD:78@2!46QE M/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M2!T2!F;W)E:6=N('1R86YS86-T:6]N M'!E;G-E*2!O;B!T M:&4@8V]N6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD M:78@6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF M>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M2!L:7%U:60@:6YV97-T;65N=',@ M=VET:"!A(&UA='5R:71Y(&]F('1H#MT97AT+6%L:6=N.FQE9G0[9F]N="US:7IE.C$R<'0[/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MF;VYT+7-T M>6QE.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SY!8V-O=6YT'0M:6YD96YT.C0X M<'@[9F]N="US:7IE.C$R<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MC;VQO2!O=7(@ M86-C;W5N=',@#MT97AT+6%L:6=N.FQE9G0[9F]N="US:7IE M.C$R<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#MF;VYT+7-T>6QE.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD M.SY#;VYC96YT6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ M-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M M2!S=6)J96-T('5S('1O(&-O;F-E M;G1R871I;VYS(&]F(&-R961I="!R:7-K+"!A#MT97AT+6%L:6=N M.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O M;G0@3II;FAE'0M9&5C;W)A M=&EO;CIN;VYE.R<^1&5C96UB97(F(S$V,#LS,2P@,C`Q-#PO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$R<'0[ M8V]L;W(Z(S(S,68R,#L^+"`\+V9O;G0^/&9O;G0@'0M9&5C;W)A=&EO;CIN;VYE.R<^,C`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`Q-#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$R<'0[8V]L;W(Z M(S(S,68R,#L^+"`\+V9O;G0^/&9O;G0@'0M9&5C M;W)A=&EO;CIN;VYE.R<^,C`Q,SPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$R<'0[8V]L;W(Z(S(S,68R,#L^ M(&%N9"`\+V9O;G0^/&9O;G0@'0M9&5C;W)A=&EO M;CIN;VYE.R<^,C`Q,CPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.C$R<'0[8V]L;W(Z(S(S,68R,#L^+"!W92!D M:60@;F]T(')E8V]R9"!A;GD@:6UP86ER;65N="!C:&%R9V5S(')E;&%T960@ M=&\@9V]O9'=I;&PN("`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`@;W9E'!E8W1E9"!T97)M(&]F('1H92!S M=&]C:R!O<'1I;VYS(&ES(&1E=&5R;6EN960@=71I;&EZ:6YG('1H92!S:6UP M;&EF:65D(&UE=&AO9"!G:79E;B!T:&4@;&EM:71E9"!E>'1E;G0@;V8@;W5R M(&AI6]U M=',N/"]F;VYT/CPO9&EV/CPO9&EV/CQS<&%N/CPO&5S/"]T9#X-"B`@ M("`@("`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE3II;FAE3II;FAE'0M:6YD96YT.C!P>#ML:6YE M+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP M861D:6YG/3-$,"!C96QL6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE M.FET86QI8SMF;VYT+7=E:6=H=#IB;VQD.SXH26X@=&AO=7-A;F1S*3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!C;VQS<&%N/3-$,R!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@F4Z,3!P=#L^0V%S:"!P86ED(&%T(&-L;W-I;F<\+V9O M;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#L@'0M86QI9VXZF4Z,3!P=#L^,S8L,3(X/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^0V]N M=&EN9V5N="!C;VYS:61E6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9EF4Z,3!P=#L^)B,Q-C`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`@;6EL;&EO;CPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[9F]N="US='EL93II=&%L:6,[ M/B`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`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`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`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`Q."P@,C`Q,BP@=V4@ M96YT97)E9"!I;G1O(&%N(&%S6UE;G1S(&)A6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE.FET86QI8SMF;VYT+7=E M:6=H=#IB;VQD.SXH26X@=&AO=7-A;F1S*3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!C;VQS<&%N/3-$,R!S='EL93TS1'9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,C1P>#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.#`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`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`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X M.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M6UE;G1S(&%S M3II;FAE3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3)P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3)P=#MC;VQO'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN M;W)M86P[<&%D9&EN9RUT;W`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`P,#`[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=VED=&@Z,3)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6%L='D@86-C2!B>2!I;F-R96%S97,@:6X@;W1H97(@2!A;F0@ M;6EL97-T;VYE(&%C8W)U86QS+CPO9F]N=#X\+V1I=CX\+W1D/CPO='(^/"]T M86)L93X\+V1I=CX\'0O:F%V87-C3X-"B`@("`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+7=E:6=H=#IB;VQD.SY!8V-U;75L871E9"!!;6]R=&EZ871I;VX@)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,RPW,3(\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^0W5S=&]M97(@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-RXS/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,S8L,S`U/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H M=#IB;VQD.SY);G1A;F=I8FQE(#QB#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#$L,#8V/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-S$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M'!E;G-E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3)P=#MC;VQO'!E8W1E9"!F=71U6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#MC;VQO M'0M86QI9VXZ;&5F=#LG/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O M;G0M6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F'0M M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MP861D M:6YG+6QE9G0Z,C1P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#L@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PU-#4\+V9O;G0^/"]D M:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@F4Z,3!P=#L^,C`Q-CPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,2PU-#$\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^ M,C`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`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`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`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/"]T7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ M#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`C M,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,30V+#0V-SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,30V+#0S.3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3DL-3DX/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C$L,C,V/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-S4L-#(R/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^*#$Q/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,S4L-3(Y/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.W!A9&1I;F#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M3&5S#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q M/CQD:78@6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S8L,#@Y/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#(V/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ M#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`T/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE M9G0Z,C1P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,36QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@ M'0M86QI9VXZF4Z,3!P=#L^,C<\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@ M'0M86QI9VXZF4Z,3!P=#L^,36QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D M9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,S8L-3(X/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.V9O;G0M6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP M<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T M:#HQ,#`E.V)O#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F'0M:6YD M96YT.BTS,G!X.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E M:6=H=#IB;VQD.SY,979E;"`Q/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.W!A M9&1I;F'0M:6YD96YT.BTS,G!X.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#L@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^."PU,#`\+V9O;G0^/"]D M:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HQ<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^375N:6-I<&%L(&)O;F1S M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-30L-C4U/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`Q/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q/CQD:78@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.W!A9&1I M;F'0M:6YD96YT.BTS,G!X.V9O;G0M#MP861D:6YG M+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT.C%P M>#L@'0M M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,S-P>#MT97AT+6EN9&5N=#HM,S)P M>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`L,S8S/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^.#DL-C8P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^,S8L,#@Y/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT M.C%P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,S-P>#MT97AT+6EN9&5N=#HM M,S)P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT.C%P M>#L@'0M M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,S-P>#MT97AT+6EN9&5N=#HM,S)P M>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.W!A9&1I;F'0M:6YD96YT.BTS M,G!X.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,30L,36QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M'10 M87)T7V$X,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M#MT97AT+6%L:6=N.F-E;G1EF4Z,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I;F'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#MC;VQO6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M."PX-#<\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q M/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0MF4Z,3!P=#L^5&]T86P\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-S`L,S4P/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W M,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M83@R,6$Q9#-?834U-E\T,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA M2P@4&QA;G0@86YD($5Q=6EP;65N="!;06)S=')A8W1=/"]S=')O M;F<^/"]T9#X-"B`@("`@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP M861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,RPW M-CD\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,3@X+#`Q.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-CDL-#6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO M#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M'1087)T7V$X M,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z,3!P=#LG/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H M=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG M/3-$,"!C96QL#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.'!T.V9O;G0M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`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`P,#`[ M8F%C:V=R;W5N9"UC;VQO#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3$L,3(U/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE#MT97AT+6%L:6=N M.FQE9G0[9F]N="US:7IE.C$P<'0[/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D M9&EN9RUT;W`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`L.#(X+#$X-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^.30L-S`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0Q,2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP M=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.'!T.V9O;G0M=V5I9VAT.F)O;&0[/D1E8V5M8F5R)B,Q-C`[,S$L(#QB#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O M;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M.2XV,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T'0^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN M;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0U M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI M9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[ M/D1E8V5M8F5R)B,Q-C`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`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^+3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,2XW-#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,"XY,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIL969T.W!A9&1I;F'0M:6YD96YT.BTS,G!X M.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE M.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-BXT/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE M.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-BXQ/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`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`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P=#L^+"`\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3)P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3)P=#L^(&ES('-U;6UA'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN M;W)M86P[<&%D9&EN9RUT;W`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-BPT-30\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^.2XU-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.W!A9&1I;F#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HQ<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^3W5T#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C%P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C%P>#L@ M'0M86QI M9VXZ;&5F=#MP861D:6YG+6QE9G0Z,S-P>#MT97AT+6EN9&5N=#HM,S)P>#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M&5R8VES86)L92!A="!$96-E;6)E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BPS.3`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`P M,#`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`@("`@("`\=&0@8VQA#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.V9O;G0M6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP M<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T M:#HY.2XX,#4P-C@R,C8Q,C`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`[,S$L(#QB#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.CAP=#L^/&9O;G0@3II;FAE M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O M;G0M=V5I9VAT.F)O;&0[/D1E8V5M8F5R)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5C9F8[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#L@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-2PQ-S<\+V9O;G0^/"]D M:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-"PV,S4\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F'0M:6YD M96YT.BTS,G!X.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,C`L,C$V/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,C4L,#,T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3(L-3`W M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M'1087)T7V$X,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S("A486)L97,I/&)R/CPO6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@ M'0M:6YD96YT.C!P M>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE M(&-E;&QP861D:6YG/3-$,"!C96QL#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-#6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,3,X+#8T,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,3`R+#`P,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,3$T+#8U,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MT97AT+6%L M:6=N.FQE9G0[<&%D9&EN9RUL969T.C0X<'@[9F]N="US:7IE.C$R<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3)P M=#MC;VQO&5S(&%R92!A6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP M861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN M9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#MM87)G:6XM;&5F=#IA=71O.VUA#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,C1P>#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3`L,36QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-#@L-S6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#$T+#`X.#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q/CQD:78@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P M>#L@'0M M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,C1P>#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*#$L,C$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZF4Z,3!P=#L^*#,U,CPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@'0M M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,C1P>#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R<@'0M86QI9VXZF4Z,3!P=#L^*#,S/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D M/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*#0L,#(P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9EF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,S,L,S@Y/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/"]T"!2871E(%1O($5F9F5C=&EV92!2871E M(%)E8V]N8VEL:6%T:6]N/"]T9#X-"B`@("`@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`C M,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S4N,#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S4N,#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,S4N,#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^*#`N,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#LG(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#LG(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CPO M='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,S,N,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P M,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,S(N-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S4N-CPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO M#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)3PO9F]N M=#X\+V1I=CX\+W1D/CPO='(^/"]T86)L93X\+V1I=CX\+V1I=CX\+V1I=CX\ M&5S/"]T9#X-"B`@("`@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I M=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E6QE M/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F"!A6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,RPU,#`\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M"!S;VQI9"`C,#`P,#`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O M=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,RPR,C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,2PQ.#0\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M"!S;VQI9"`C,#`P,#`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`Q-CPO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M MF4Z,3!P=#L^5&AE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE.FET M86QI8SMF;VYT+7=E:6=H=#IB;VQD.SXH26X@=&AO=7-A;F1S*3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#(T/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7=E M:6=H=#IB;VQD.SY$96-E;6)E6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#`Q*&LI M(&%N9"!O=&AE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,BPQ.#4\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M'1087)T7V$X,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!4 M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE'0M86QI9VXZ;&5F=#LG/CQTF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0Q,2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIT;W`[8F]R M9&5R+6)O='1O;3HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE M.CAP=#L^/&9O;G0@3II;FAE3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O M;G0@3II;FAE#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[/D1E8V5M8F5R)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C$L.30X M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M'1087)T M7V$X,C%A,60S7V$U-39?-#%B8U\X-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'1E#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3)P=#L^/&9O;G0@3II;FAE#MF;VYT+7-I>F4Z,3)P=#L^/&1I=B!S='EL93TS M1'!A9&1I;F#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0Q,2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIT;W`[8F]R9&5R M+6)O='1O;3HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP M=#L^/&9O;G0@3II;FAE3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7=E:6=H=#IB;VQD M.SY$96-E;6)E6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE M.CAP=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT M.F)O;&0[/D1E8V5M8F5R)B,Q-C`[,S$L(#QB#MP861D:6YG+7)I9VAT.C%P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z M,S-P>#MT97AT+6EN9&5N=#HM,S)P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-#(W+#`Y,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE'0^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X M.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M2!P#MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I;F#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0Q,2!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIT;W`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ8V5N M=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[/D1E8V5M M8F5R)B,Q-C`[,S$L(#QB#MP861D:6YG M+7)I9VAT.C%P>#L@'0M86QI9VXZ;&5F=#MP861D:6YG+6QE9G0Z,S-P>#MT97AT+6EN M9&5N=#HM,S)P>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C,X+#6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HQ<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^1&ES6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M86QI9VXZF4Z,3!P=#L^,C`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-? M.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@'0M:6YD96YT.C!P>#ML:6YE M+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP M861D:6YG/3-$,"!C96QL#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`\8G(@8VQE87(],T1N;VYE+SXR,#$T/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.CAP=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M8F]R9&5R+71O<#HQ<'@@F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#MF;VYT+7=E:6=H=#IB;VQD.SY$96-E;6)E6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HQ<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^4V%L97,\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO M#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@'0M:6YD96YT.BTS,G!X.V9O;G0M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.W!A9&1I;F'0M:6YD96YT.BTS M,G!X.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^.#@L.#DX/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.#8L.3DP/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI M9VXZF4Z,3!P=#L^.3`L,3`Q/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`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`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`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO M#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.W!A9&1I;F'0M:6YD96YT.BTS,G!X.V9O;G0M M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.#$L M-3(U/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^.#(L,C0X/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^.#$L.#6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`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`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`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD M:78@'0M:6YD96YT.C0X<'@[9F]N="US:7IE M.C$R<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3)P=#L^06QL;W=A;F-E(&9O#MT97AT+6%L:6=N.F-E;G1EF4Z M,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I;F3I4:6UE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M M6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MC;VQO"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MC;VQO6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#MC;VQO"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#MC;VQO6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#MC;VQO6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M65A'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$#PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S('1O($%C<75I'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6%L='D@"!R;WEA;'1Y(')A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@86YD(&%C8W)U960@97AP96YS97,\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!M:6QE2!R96QA=&5D('1O('1H92!A8W%U M:7-I=&EO;G,@F5R;R!T;R`D,30N,R!M:6QL:6]N("AS M964@XH"<3F]T92`U+B!&86ER(%9A;'5E($UE87-U'1087)T7V$X,C%A,60S7V$U-39? M-#%B8U\X-#'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA6UE;G0@4F]L;&9O3PO=&0^#0H@("`@("`@(#QT9"!C;&%S6UE;G1S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@Q,2D\'!E;G-E'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6EN9R!!;6]U;G0\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,3`\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M/B@X."D\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N('!E'0^-R!Y96%R65AF%T:6]N/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#,T-"D\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N('!E'0^,3<@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V M7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T-S%?,6(R-SAE8C5F-6(X M+U=O'0O M:'1M;#L@8VAA2!38VAE9'5L92!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAAF5D($-O'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^,2!Y96%R/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,2!Y96%R/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ MF5D($-OF5D($QO&EM=6T\+W1D/@T*("`@("`@ M("`\=&0@8VQA65A65AF5D($QO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F5D($-OF5D($QO65A65A&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA65A'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ MF5D($=A:6YS/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&EM=6T\ M+W1D/@T*("`@("`@("`\=&0@8VQA65AF5D($-OF5D($=A:6YS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M&EM=6T\+W1D/@T*("`@("`@("`\=&0@ M8VQA65A7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!A;F0@17%U:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\2!A;F0@97%U:7!M96YT+"!G'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@17%U:7!M96YT/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@17%U:7!M M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M2!A;F0@17%U:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^-R!Y96%R2!A M;F0@17%U:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT+"!G'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,R!Y96%R'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT M('P@36EN:6UU;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$65A'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^-2!Y M96%R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$65E M+7)E;&%T960@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,3`@9&%Y2P@8F%S:7,@'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5D(%)A=&4@?"!- M87AI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!#;VUP86YY M('P@0VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'1U86QS M*2`H1&5T86EL'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&EM=6T@8V]N=')A8W1U M86P@=&5R;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,3`@>65A M65A'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,R!Y M96%R'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!);F-E;G1I=F4@4&QA;B!\($UA M>&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!3:&%R92UB87-E9"!087EM96YT($%W87)D/"]S=')O M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!3:&%R92UB M87-E9"!087EM96YT($%W87)D/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D M,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T-S%?,6(R-SAE M8C5F-6(X+U=O'0O:'1M;#L@8VAA'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2P@;6%X:6UU;3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'!E8W1E9"!T97)M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S65A65A'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E8W1E9"!T97)M M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XV('EE87)S(#0@;6]N M=&AS(#$V(&1A>7,\7,\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2D@*$1E=&%I;',I("A54T0@)"D\8G(^26X@ M5&AO=7-A;F1S+"!E>&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!/<'1I M;VYS+"!/=71S=&%N9&EN9R!;4F]L;"!&;W)W87)D73PO'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@07=A&5R8VES92!P&5R8VES92!P'0^-R!Y96%R'0^-2!Y96%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E8W1E9"!T;R!697-T+"!/=71S=&%N9&EN9RP@3G5M8F5R M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#0V-#QS<&%N/CPO M6UE;G0@07=A2!3 M:&%R92UB87-E9"!087EM96YT($%W87)D+"!/<'1I;VYS+"!697-T960@86YD M($5X<&5C=&5D('1O(%9E7,\2!3:&%R92UB M87-E9"!087EM96YT($%W87)D+"!/<'1I;VYS+"!697-T960@86YD($5X<&5C M=&5D('1O(%9E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T M,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$&5S+"!D;VUE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!P"!P"!P"`H8F5N969I="DL('-T871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M/B@S-3"!P"!P M"!P'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!5 M+E,N($9E9&5R86P@5&%X(%)A=&4@=&\@169F96-T:79E(%)A=&4I("A$971A M:6QS*3QB"!$:7-C;&]S=7)E(%M!8G-T7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2!N;W0@9&5D=6-T:6)L93PO=&0^#0H@("`@("`@(#QT9"!C M;&%S"!A"!A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B M-68U8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-? M834U-E\T,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R MF5D(%1A>"!"96YE9FET&%M:6YE9"!487@@4F5T=7)N'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M"!P;W-I=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQAF5D('1A>"!B96YE9FET(&%T('1H92!E;F0@;V8@=&AE('EE M87(\+W1D/@T*("`@("`@("`\=&0@8VQA"!R871E/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XD(#@S.#QS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA"!%>&%M:6YA=&EO;CPO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T M-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6YT:&5S(%5302!386QE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$65E(&-O;G1R:6)U=&EO M;B!M871C:"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ M,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA2!4'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'1E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'1E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'1U86QS(%M!8G-T3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'1E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W M,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M83@R,6$Q9#-?834U-E\T,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U M8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U M-E\T,6)C7S@T-S%?,6(R-SAE8C5F-6(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A M.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W.&5B-68U8C@-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83@R,6$Q9#-?834U-E\T,6)C7S@T-S%? M,6(R-SAE8C5F-6(X+U=O&UL#0I#;VYT96YT M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT M+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U&UL/@T* M+2TM+2TM/5].97AT4&%R=%]A.#(Q83%D,U]A-34V7S0Q8F-?.#0W,5\Q8C(W ,.&5B-68U8C@M+0T* ` end XML 42 R43.htm IDEA: XBRL DOCUMENT v2.4.1.9
QUARTERLY FINANCIAL DATA (unaudited) (Tables)
 12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information
 
 
(unaudited)
(In thousands, except per share amounts)
 
March 31,
2014
 
June 30,
2014
 
September 30,
2014
 
December 31,
2014
Sales
 
$
114,210

 
$
113,573

 
$
117,787

 
$
128,801

Gross profit
 
88,898

 
86,990

 
90,101

 
97,525

Net income
 
21,139

 
20,647

 
23,061

 
27,638

Net earnings per common share - basic
 
0.23

 
0.22

 
0.24

 
0.29

Net earnings per common share - diluted
 
0.22

 
0.22

 
0.24

 
0.29

 
 
(unaudited)
(In thousands, except per share amounts)
 
March 31,
2013
 
June 30,
2013
 
September 30,
2013
 
December 31,
2013
Sales
 
$
105,018

 
$
107,009

 
$
107,187

 
$
115,245

Gross profit
 
81,525

 
82,248

 
81,872

 
88,471

Net income
 
19,891

 
7,426

 
20,310

 
20,985

Net earnings per common share - basic
 
0.22

 
0.08

 
0.22

 
0.22

Net earnings per common share - diluted
 
0.21

 
0.08

 
0.22

 
0.22
XML 43 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACQUISTIONS (Tables)
 12 Months Ended
Dec. 31, 2014
Business Combinations [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed
As of December 31, 2014, we recorded the following preliminary purchase price allocation for the identifiable tangible and intangible assets and liabilities of TTOT:
(In thousands)
 
 
Consideration:
 
 
Cash paid at closing
$
36,128

 
Contingent consideration
11,300

(1) 
Fair value of consideration
$
47,428

 
 
 
 
Identifiable assets acquired and liabilities assumed:
 
 
Inventory
$
9,599

 
Supplier network
3,800

 
Customer relationships
1,600

 
Accounts receivable
1,529

 
Equipment
518

 
Trade names
300

 
Other assets
292

 
Accounts payable and accrued expenses
(5,034
)
 
Total identifiable net assets
12,604

 
 
 
 
Goodwill
34,824

 
Total allocated purchase price
$
47,428

 
(1)
The contingent consideration relates to the achievement of certain sales milestones. As of December 31, 2014, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranges from zero to $15.0 million (see “Note 5. Fair Value Measurements” below).
On December 23, 2013, we entered into an asset purchase agreement with a small robotics development company, pursuant to which we acquired substantially all of its assets for $16.8 million. In addition to the initial purchase price, we may be obligated to make a milestone payment and revenue sharing payments based upon a percentage of net sales of certain products based on the intellectual property we acquired in the transaction. The acquired company was privately held and is focused on developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets. The technology is intended to enable surgeons to perform minimally invasive and percutaneous surgical procedures with greater accuracy, safety and reproducibility than is currently available. We accounted for this acquisition under the purchase method of accounting, and as a result, recorded goodwill of $3.0 million. The table below represents the valuation of the assets acquired and liabilities assumed as part of this 2013 purchase:
(In thousands)
 
 
Identifiable intangible assets:
 
 
In-process research & development
$
20,460

 
Non-compete agreements
20

 
Contingent consideration
(6,704
)
(2) 
Total identifiable net assets
13,776

 
Goodwill
2,999

 
Net assets acquired
$
16,775

 
(2)
The contingent consideration relates to the achievement of certain regulatory milestones and royalties. As of December 31, 2013, the aggregate, undiscounted amount of contingent consideration that we could pay related to the acquisitions ranged from zero to $14.3 million (see “Note 5. Fair Value Measurements” below).
On July 18, 2012, we entered into an asset purchase agreement with a global medical device company, pursuant to which we acquired substantially all of its assets for $6.0 million. In addition to the initial purchase price, we may be obligated to make revenue sharing payments based upon a percentage of net sales of products we acquired from it. We accounted for this acquisition under the purchase method of accounting and as a result, recorded goodwill of $5.6 million. The table below represents the assets acquired and liabilities assumed as part of this 2012 purchase:
(In thousands)
 
 
Inventory
$
158

 
Identifiable intangible assets:
 
 
Customer relationships
120

 
Non-compete agreements
80

 
Patents
2,420

 
Contingent consideration
(2,311
)
 
Total identifiable net assets
467

 
Goodwill
5,564

 
Net assets acquired
$
6,031

 
Contingent Consideration Rollforward Activity
The following table provides a reconciliation of the beginning and ending balances of contingent payments associated with acquisitions during the years ended December 31, 2014 and December 31, 2013:
(In thousands)
 
Balance at December 31, 2012
$
7,358

Purchase price contingent consideration
6,704

Contingent payments
(5
)
Changes in fair value of contingent consideration classified in operating expenses
120

Balance at December 31, 2013
14,177

Purchase price contingent consideration
11,300

Contingent payments
(11
)
Changes in fair value of contingent consideration classified in operating expenses (1)
(1,131
)
Balance at December 31, 2014
$
24,335


(1) 
Reduction in fair value during 2014 due primarily to reductions to a contingent royalty accrual, offset partially by increases in other royalty and milestone accruals.
XML 44 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2014
BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Principles of Consolidation
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of Globus and its wholly owned subsidiaries. Our consolidation policy requires the consolidation of entities where a controlling financial interest is held. All intercompany balances and transactions are eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates, in part, on historical experience that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary.
Significant areas that require management’s estimates include intangible assets, contingent payment liabilities, allowance for doubtful accounts, stock-based compensation, provision for excess and obsolete inventory, useful lives of assets, the outcome of litigation, and income taxes. We are subject to risks and uncertainties due to changes in the healthcare environment, regulatory oversight, competition, and legislation that may cause actual results to differ from estimated results.
Foreign Currency Translation
Foreign Currency Translation
The functional currency of our foreign subsidiaries is their local currency. Assets and liabilities of the foreign subsidiaries are translated at the period end currency exchange rate and revenues and expenses are translated at an average currency exchange rate for the period. The resulting foreign currency translation gains and losses are included as a component of accumulated other comprehensive income. Gains and losses arising from intercompany foreign transactions are included in other income/(expense) on the consolidated statement of operations.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash and cash equivalents include cash on hand and all highly liquid investments with a maturity of three months or less when purchased.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts Receivable and Allowance for Doubtful Accounts
The majority of our accounts receivable is composed of amounts due from hospitals. We carry our accounts receivable at cost less an allowance for doubtful accounts. On a regular basis, we evaluate our accounts receivable and estimate an allowance for doubtful accounts, as needed, based on various factors such as our customers’ current credit conditions, length of time past due, and the general economy as a whole. Receivables are written off against the allowance when they are deemed uncollectible.
Concentrations of Credit Risk
Concentrations of Credit Risk
Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents and accounts receivable. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of entities comprising our customer base. We perform ongoing credit evaluations of our customers and generally do not require collateral.
There was no customer that accounted for 10% or more of sales for the years ended December 31, 2014, 2013, and 2012, respectively.
Marketable Securities
Marketable Securities
Our marketable securities include municipal bonds, corporate debt securities, commercial paper, securities of U.S. government-sponsored agencies and asset-backed securities, and are classified as available-for-sale as of December 31, 2014. Available-for-sale securities are recorded at fair value in both short-term and long-term marketable securities on our consolidated balance sheets. The change in fair value for available-for-sale securities is recorded, net of taxes, as a component of accumulated other comprehensive income on our consolidated balance sheets. Premiums and discounts are recognized over the life of the related security as an adjustment to yield using the straight-line method. Realized gains or losses from the sale of our marketable securities are determined on a specific identification basis. Realized gains and losses, along with interest income and the amortization/accretion of premiums/discounts are included as a component of other income, net, on our consolidated statements of income. Interest receivable is recorded as a component of prepaid expenses and other current assets on our consolidated balance sheets.
We maintain a portfolio of various holdings, types and maturities, though most of the securities in our portfolio could be liquidated at minimal cost at any time. We invest in securities that meet or exceed standards as defined in our investment policy. Our policy also limits the amount of credit exposure to any one issue, issuer or type of security. We review our securities for other-than-temporary impairment at each reporting period. If an unrealized loss for any security is considered to be other-than-temporary, the loss will be recognized in our consolidated statement of income in the period the determination is made.
Inventories
Inventories
Inventories are stated at the lower of cost or market. Cost is determined on a first-in, first-out basis. The majority of our inventories are finished goods as we mainly utilize third-party suppliers to source our products. We periodically evaluate the carrying value of our inventories in relation to our estimated forecast of product demand, which takes into consideration the estimated life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we record a reserve for such excess inventories.
Property and Equipment
Property and Equipment
Property and equipment are recorded at cost less accumulated depreciation. Additions or improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation and amortization are provided using the straight-line method over the related useful lives of the assets.
When assets are sold or otherwise disposed of, the related property, equipment, and accumulated depreciation amounts are relieved from the accounts, and any gain or loss is recorded in the consolidated statements of operations.
Goodwill and Intangible Assets
Goodwill and Intangible Assets
Goodwill represents the excess purchase price over the fair values of the identifiable assets acquired less the liabilities assumed. Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by comparing the reporting unit’s carrying amount, to the fair value of the reporting unit. The fair values are estimated using an income and discounted cash flow approach. For the year ended December 31, 2014, we performed a qualitative test for impairment as permitted under Financial Accounting Standards Board (“FASB”) authoritative guidance. During the years ended December 31, 2014, 2013 and 2012, we did not record any impairment charges related to goodwill.
Intangible assets consist of purchased in-process research and development (“IPR&D”), supplier network, patents, customer relationships and non-compete agreements. Intangible assets with finite useful lives are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to seventeen years. Intangible assets are tested for impairment annually or whenever events or circumstances indicate that a carrying amount of an asset (asset group) may not be recoverable. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset. Fair value is generally determined using a discounted future cash flow analysis.
IPR&D has an indefinite life and is not amortized until completion of the project at which time the IPR&D becomes an amortizable asset. If the related project is not completed in a timely manner, we may have an impairment related to the IPR&D, calculated as the excess of the asset’s carrying value over its fair value.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
We periodically evaluate the recoverability of the carrying amount of long-lived assets, which include property and equipment, as well as whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be fully recoverable. An impairment is assessed when the undiscounted future cash flows from the use and eventual disposition of an asset group are less than its carrying value. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset group. Our fair value methodology is based on quoted market prices, if available. If quoted market prices are not available, an estimate of fair value is made based on prices of similar assets or other valuation techniques including present value techniques.
Revenue Recognition
Revenue Recognition
Revenue is recognized when persuasive evidence of an arrangement exists, product delivery has occurred, pricing is fixed or determinable, and collection is reasonably assured. A significant portion of our revenue is generated from consigned inventory maintained at hospitals or with sales representatives. For these products, revenue is recognized at the time the product is used or implanted. For all other transactions, we recognize revenue when title to the goods and risk of loss transfer to customers, provided there are no remaining performance obligations that will affect the customer’s final acceptance of the sale. Our policy is to classify shipping and handling costs billed to customers as sales and the related expenses as cost of goods sold.
Research and Development
Research and Development
Research and development costs are expensed as incurred. Research and development costs include salaries, employee benefits, supplies, consulting services, clinical services and clinical trial costs, and facilities costs. Costs incurred in obtaining technology licenses and patents are charged immediately to research and development expense if the technology licensed has not reached technological feasibility and has no alternative future use.
Stock-Based Compensation
Stock-Based Compensation
The cost for employee and non-employee director awards is measured at the grant date based on the fair value of the award. The fair value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service period (generally the vesting period of the equity award). Awards issued to non-employees are recorded at their fair value as determined in accordance with authoritative guidance, and are periodically revalued as the awards vest and are recognized as expense over the requisite service period.
The determination of the fair value of stock options is made utilizing the Black-Scholes option-pricing model which is affected by our stock price and a number of assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends. The expected volatility is based upon the historical volatility of a public company peer group over the most recent period commensurate with the estimated expected term of the stock options. The expected term of the stock options is determined utilizing the simplified method given the limited extent of our historical data. The risk-free interest rate assumption is based on observed interest rates of U.S. Treasury securities appropriate for the expected terms of the stock options. The dividend yield assumption is based on the history and expectation of no dividend payouts.
Income Taxes
Income Taxes
Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which such items are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established to offset any deferred tax assets if, based upon available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.
Significant judgment is required in determining income tax provisions and in evaluating tax positions. We will establish additional provisions for income taxes when, despite the belief that tax positions are fully supportable, there remain certain positions that do not meet the minimum probability threshold that a tax position is more likely than not to be sustained upon examination by the taxing authority. In the normal course of business, we and our subsidiaries are examined by various federal, state, and foreign tax authorities. We regularly assess the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the provision for income taxes. We periodically assess the likelihood and amount of potential adjustments and adjust the income tax provision, the current tax liability, and deferred taxes in the period in which the facts that give rise to a revision become known.
Derivatives
Fair Value of Financial Instruments
Fair Value of Financial Instruments
As of December 31, 2014, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued expenses approximate their respective fair values based on their short-term nature. We classify our financial assets and liabilities that are measured at fair value into one of the three categories based upon inputs used to determine fair value.
Advertising Expense
Advertising Expense
We expense advertising costs as they are incurred.
Legal costs
Legal Costs
We expense legal costs related to loss contingencies as incurred.
Medical Device Excise Tax
Medical Device Excise Tax
Effective as of January 1, 2013, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively “PPACA”) imposed a medical device excise tax (“MDET”) of 2.3% on any entity that manufactures or imports certain medical devices offered for sale in the United States. We account for the MDET as a component of our cost of goods sold.
Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements
In May 2014, the FASB and the International Accounting Standards Board released a standard on the recognition of revenue from contracts with customers that is designed to create greater comparability for financial statement users across industries and jurisdictions. Under the new standard, an entity will recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the payment to which the entity expects to be entitled in exchange for those goods or services. The standard also will require enhanced disclosures and provide more comprehensive guidance for transactions such as service revenue and contract modifications. The standard will take effect for public companies for annual reporting periods beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. We are currently evaluating the impact of the new standard on our financial position, results of operations and disclosures.
XML 45 R56.htm IDEA: XBRL DOCUMENT v2.4.1.9
DEBT (Details) (Revolving Credit Facility, USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Debt Instruments  
Credit facility, current borrowing capacity $ 50.0us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity
Credit facility, maximum borrowing capacity 75.0us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Revolving credit facility, minimum termination notice period 10 days
Fluctuating Rate Per Annum
  
Debt Instruments  
Credit facility, basis spread on variable rate 0.75%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ gmed_LineOfCreditFacilityInterestRateOptionsAxis
= gmed_LineOfCreditVariableRatePerAnnumMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_RevolvingCreditFacilityMember
Credit facility, variable rate LIBOR
Credit facility, period of variable rate 1 month
Fixed Rate
  
Debt Instruments  
Credit facility, basis spread on variable rate 0.75%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ gmed_LineOfCreditFacilityInterestRateOptionsAxis
= gmed_LineOfCreditFixedRateMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_RevolvingCreditFacilityMember
Credit facility, variable rate LIBOR
Fixed Rate | Minimum
  
Debt Instruments  
Credit facility, period of variable rate 1 month
Fixed Rate | Maximum
  
Debt Instruments  
Credit facility, period of variable rate 3 months
Letter of Credit
  
Debt Instruments  
Credit facility, maximum borrowing capacity $ 25.0us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_LetterOfCreditMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_RevolvingCreditFacilityMember
XML 46 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS (Tables)
 12 Months Ended
Dec. 31, 2014
Valuation and Qualifying Accounts Disclosure  
Summary of Valuation Allowance [Table Text Block]
Allowance for doubtful accounts:
(In thousands)
Beginning of period
 
Additions
 
Write-offs
 
End of period
Year ended December 31, 2012
$
602

 
$
363

 
$
(4
)
 
$
961

Year ended December 31, 2013
961

 
693

 
(73
)
 
1,581

Year ended December 31, 2014
$
1,581

 
$
318

 
$
(252
)
 
$
1,647

Deferred tax valuation allowance:
(In thousands)
Beginning of period
 
Additions
 
Write-offs
 
End of period
Year ended December 31, 2012
$
1,149

 
$
—

 
$
(616
)
 
$
533

Year ended December 31, 2013
533

 
—

 
(206
)
 
327

Year ended December 31, 2014
$
327

 
$
—

 
$
(282
)
 
$
45
XML 47 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2014
Intangible Assets Disclosure [Abstract]  
Intangible Assets Acquired as Part of Business Combination
A summary of intangible assets is presented below:
 
 
 
December 31, 2014
(In thousands)
Weighted-
Average Amortization
Period
(in years)
 
Gross
Carrying
Amount  
 
Accumulated Amortization  
 
Intangible
Assets, net
 
 
In-process research & development
—
 
$
24,560

 
$
—

 
$
24,560

Supplier network
10.0
 
3,800

 
(88
)
 
3,712

Customer relationships & other intangibles
7.3
 
5,525

 
(1,344
)
 
4,181

Patents
17.0
 
2,420

 
(344
)
 
2,076

Total intangible assets
 
 
$
36,305

 
$
(1,776
)
 
$
34,529

 
 
 
December 31, 2013
(In thousands)
Weighted-
Average Amortization
Period
(in years)
 
Gross
Carrying
Amount  
 
Accumulated Amortization  
 
Intangible
Assets, net
 
 
In-process research & development
—
 
$
24,560

 
$
—

 
$
24,560

Customer relationships & other intangibles
9.5
 
3,623

 
(864
)
 
2,759

Patents
17.0
 
2,420

 
(202
)
 
2,218

Total intangible assets
 
 
$
30,603

 
$
(1,066
)
 
$
29,537
Schedule of intangible asset amortization expense
Amortization expense was as follows:
(in thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Intangible asset amortization expense
 
$
710

 
$
528

 
$
468
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Expected future intangible asset amortization as of December 31, 2014 is as follows:
(In thousands)
 
Annual Amortization
Year ending December 31:
 
 
2015
 
$
1,545

2016
 
1,541

2017
 
1,423

2018
 
856

2019
 
852

Thereafter
 
3,752

Total
 
$
9,969
XML 48 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
MARKETABLE SECURITIES (Tables)
 12 Months Ended
Dec. 31, 2014
Marketable Securities [Abstract]  
Marketable Securities
The composition of our short-term and long-term marketable securities is as follows:
 
 
 
December 31, 2014
(In thousands)
Contractual Maturity
(in years)
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Short-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
Less than 1
 
$
28,684

 
$
2

 
$
(3
)
 
$
28,683

Corporate debt securities
Less than 1
 
73,066

 
7

 
(42
)
 
73,031

Commercial paper
Less than 1
 
44,663

 
8

 
—

 
44,671

Asset backed securities
Less than 1
 
54

 
—

 
—

 
54

Total short-term marketable securities
 
 
$
146,467

 
$
17

 
$
(45
)
 
$
146,439

 
 
 
 
 
 
 
 
 
 
Long-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
1-2
 
$
26,005

 
$
3

 
$
(36
)
 
$
25,972

Corporate debt securities
1-2
 
19,617

 
3

 
(22
)
 
19,598

Asset backed securities
1-2
 
21,236

 
1

 
(8
)
 
21,229

Securities of U.S. government-sponsored agencies
1-2
 
8,564

 
—

 
(16
)
 
8,548

Total long-term marketable securities
 
 
$
75,422

 
$
7

 
$
(82
)
 
$
75,347

 
 
 
December 31, 2013
(In thousands)
Contractual Maturity
(in years)
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Short-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
Less than 1
 
$
77,342

 
$
17

 
$
(15
)
 
$
77,344

Corporate debt securities
Less than 1
 
35,525

 
15

 
(11
)
 
35,529

Commercial paper
Less than 1
 
36,083

 
6

 
—

 
36,089

Total short-term marketable securities
 
 
$
148,950

 
$
38

 
$
(26
)
 
$
148,962

 
 
 
 
 
 
 
 
 
 
Long-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
1-2
 
$
12,304

 
$
13

 
$
(1
)
 
$
12,316

Corporate debt securities
1-2
 
17,533

 
27

 
—

 
17,560

Asset backed securities
1-2
 
6,651

 
2

 
(1
)
 
6,652

Total long-term marketable securities
 
 
$
36,488

 
$
42

 
$
(2
)
 
$
36,528
XML 49 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9
BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2014
BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Background and Summary of Significant Accounting Policies
BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(a) The Company
Globus Medical, Inc. and its subsidiaries is a medical device company focused exclusively on the design, development and commercialization of musculoskeletal implants. We are currently focused on implants that promote healing in patients with spine disorders. We are an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures that assist surgeons in effectively treating their patients, respond to evolving surgeon needs and address new treatment options. Since our inception in 2003, we have launched over 130 products and offer a product portfolio addressing a broad array of spinal pathologies.
We are headquartered in Audubon, Pennsylvania and market and sell our products through our exclusive sales force in the United States, Europe, India, South Africa, Australia, South America and the Middle East. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.
The terms the “Company,” “Globus,” “we,” “us” and “our” refer to Globus Medical, Inc. and, where applicable, our consolidated subsidiaries.
(b) Basis of Presentation
The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) for financial statements and with the instructions to Form 10-K and Article 10 of Regulation S-X.
Certain reclassifications have been made to prior period statements to conform to the current period presentation.
(c) Principles of Consolidation
The accompanying consolidated financial statements include the accounts of Globus and its wholly owned subsidiaries. Our consolidation policy requires the consolidation of entities where a controlling financial interest is held. All intercompany balances and transactions are eliminated in consolidation.
(d) Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates, in part, on historical experience that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary.
Significant areas that require management’s estimates include intangible assets, contingent payment liabilities, allowance for doubtful accounts, stock-based compensation, provision for excess and obsolete inventory, useful lives of assets, the outcome of litigation, and income taxes. We are subject to risks and uncertainties due to changes in the healthcare environment, regulatory oversight, competition, and legislation that may cause actual results to differ from estimated results.
(e) Foreign Currency Translation
The functional currency of our foreign subsidiaries is their local currency. Assets and liabilities of the foreign subsidiaries are translated at the period end currency exchange rate and revenues and expenses are translated at an average currency exchange rate for the period. The resulting foreign currency translation gains and losses are included as a component of accumulated other comprehensive income. Gains and losses arising from intercompany foreign transactions are included in other income/(expense) on the consolidated statement of operations. We recognized foreign exchange transaction losses in other income/(expense) of $0.9 million, $0.8 million, and $0.2 million for the years ended December 31, 2014, 2013, and 2012, respectively.
(f) Cash and Cash Equivalents
Cash and cash equivalents include cash on hand and all highly liquid investments with a maturity of three months or less when purchased.
(g) Restricted Cash
In December 2014, we set aside $23.4 million in cash for the payment of a portion of the Synthes and Bianco litigations. We classified this cash as restricted, as the amount was placed in escrow to be used for payment of the litigation obligations, should we not be successful with our appeals. See “Note 14. Commitments and Contingencies” below for more details regarding these litigations.
(h) Accounts Receivable and Allowance for Doubtful Accounts
The majority of our accounts receivable is composed of amounts due from hospitals. We carry our accounts receivable at cost less an allowance for doubtful accounts. On a regular basis, we evaluate our accounts receivable and estimate an allowance for doubtful accounts, as needed, based on various factors such as our customers’ current credit conditions, length of time past due, and the general economy as a whole. Receivables are written off against the allowance when they are deemed uncollectible.
(i) Concentrations of Credit Risk
Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents and accounts receivable. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of entities comprising our customer base. We perform ongoing credit evaluations of our customers and generally do not require collateral.
There was no customer that accounted for 10% or more of sales for the years ended December 31, 2014, 2013, and 2012, respectively.
(j) Marketable Securities
Our marketable securities include municipal bonds, corporate debt securities, commercial paper, securities of U.S. government-sponsored agencies and asset-backed securities, and are classified as available-for-sale as of December 31, 2014. Available-for-sale securities are recorded at fair value in both short-term and long-term marketable securities on our consolidated balance sheets. The change in fair value for available-for-sale securities is recorded, net of taxes, as a component of accumulated other comprehensive income on our consolidated balance sheets. Premiums and discounts are recognized over the life of the related security as an adjustment to yield using the straight-line method. Realized gains or losses from the sale of our marketable securities are determined on a specific identification basis. Realized gains and losses, along with interest income and the amortization/accretion of premiums/discounts are included as a component of other income, net, on our consolidated statements of income. Interest receivable is recorded as a component of prepaid expenses and other current assets on our consolidated balance sheets.
We maintain a portfolio of various holdings, types and maturities, though most of the securities in our portfolio could be liquidated at minimal cost at any time. We invest in securities that meet or exceed standards as defined in our investment policy. Our policy also limits the amount of credit exposure to any one issue, issuer or type of security. We review our securities for other-than-temporary impairment at each reporting period. If an unrealized loss for any security is considered to be other-than-temporary, the loss will be recognized in our consolidated statement of income in the period the determination is made.
(k) Inventories
Inventories are stated at the lower of cost or market. Cost is determined on a first-in, first-out basis. The majority of our inventories are finished goods as we mainly utilize third-party suppliers to source our products. We periodically evaluate the carrying value of our inventories in relation to our estimated forecast of product demand, which takes into consideration the estimated life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we record a reserve for such excess inventories.
(l) Property and Equipment
Property and equipment are recorded at cost less accumulated depreciation. Additions or improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation and amortization are provided using the straight-line method over the related useful lives of the assets.
When assets are sold or otherwise disposed of, the related property, equipment, and accumulated depreciation amounts are relieved from the accounts, and any gain or loss is recorded in the consolidated statements of operations.
(m) Goodwill and Intangible Assets
Goodwill represents the excess purchase price over the fair values of the identifiable assets acquired less the liabilities assumed. Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by comparing the reporting unit’s carrying amount, to the fair value of the reporting unit. The fair values are estimated using an income and discounted cash flow approach. For the year ended December 31, 2014, we performed a qualitative test for impairment as permitted under Financial Accounting Standards Board (“FASB”) authoritative guidance. During the years ended December 31, 2014, 2013 and 2012, we did not record any impairment charges related to goodwill.
Intangible assets consist of purchased in-process research and development (“IPR&D”), supplier network, patents, customer relationships and non-compete agreements. Intangible assets with finite useful lives are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to seventeen years. Intangible assets are tested for impairment annually or whenever events or circumstances indicate that a carrying amount of an asset (asset group) may not be recoverable. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset. Fair value is generally determined using a discounted future cash flow analysis.
IPR&D has an indefinite life and is not amortized until completion of the project at which time the IPR&D becomes an amortizable asset. If the related project is not completed in a timely manner, we may have an impairment related to the IPR&D, calculated as the excess of the asset’s carrying value over its fair value.
We completed our annual qualitative indefinite lived intangible asset impairment review in the fourth quarter of 2014 and determined that our intangible assets were not impaired.
(n) Impairment of Long-Lived Assets
We periodically evaluate the recoverability of the carrying amount of long-lived assets, which include property and equipment, as well as whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be fully recoverable. An impairment is assessed when the undiscounted future cash flows from the use and eventual disposition of an asset group are less than its carrying value. If impairment is indicated, we measure the amount of the impairment loss as the amount by which the carrying amount exceeds the fair value of the asset group. Our fair value methodology is based on quoted market prices, if available. If quoted market prices are not available, an estimate of fair value is made based on prices of similar assets or other valuation techniques including present value techniques. We reviewed our long-lived assets over the course of 2014 and 2013 and recorded an immaterial impairment charge as a component of cost of goods sold during 2013; there was no impairment of our long-lived assets during 2014.
(o) Revenue Recognition
Revenue is recognized when persuasive evidence of an arrangement exists, product delivery has occurred, pricing is fixed or determinable, and collection is reasonably assured. A significant portion of our revenue is generated from consigned inventory maintained at hospitals or with sales representatives. For these products, revenue is recognized at the time the product is used or implanted. For all other transactions, we recognize revenue when title to the goods and risk of loss transfer to customers, provided there are no remaining performance obligations that will affect the customer’s final acceptance of the sale. Our policy is to classify shipping and handling costs billed to customers as sales and the related expenses as cost of goods sold.
(p) Research and Development
Research and development costs are expensed as incurred. Research and development costs include salaries, employee benefits, supplies, consulting services, clinical services and clinical trial costs, and facilities costs. Costs incurred in obtaining technology licenses and patents are charged immediately to research and development expense if the technology licensed has not reached technological feasibility and has no alternative future use.
(q) Stock-Based Compensation
The cost for employee and non-employee director awards is measured at the grant date based on the fair value of the award. The fair value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service period (generally the vesting period of the equity award). Awards issued to non-employees are recorded at their fair value as determined in accordance with authoritative guidance, and are periodically revalued as the awards vest and are recognized as expense over the requisite service period.
The determination of the fair value of stock options is made utilizing the Black-Scholes option-pricing model which is affected by our stock price and a number of assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends. The expected volatility is based upon the historical volatility of a public company peer group over the most recent period commensurate with the estimated expected term of the stock options. The expected term of the stock options is determined utilizing the simplified method given the limited extent of our historical data. The risk-free interest rate assumption is based on observed interest rates of U.S. Treasury securities appropriate for the expected terms of the stock options. The dividend yield assumption is based on the history and expectation of no dividend payouts.
(r) Income Taxes
Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which such items are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established to offset any deferred tax assets if, based upon available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.
Significant judgment is required in determining income tax provisions and in evaluating tax positions. We will establish additional provisions for income taxes when, despite the belief that tax positions are fully supportable, there remain certain positions that do not meet the minimum probability threshold that a tax position is more likely than not to be sustained upon examination by the taxing authority. In the normal course of business, we and our subsidiaries are examined by various federal, state, and foreign tax authorities. We regularly assess the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of the provision for income taxes. We periodically assess the likelihood and amount of potential adjustments and adjust the income tax provision, the current tax liability, and deferred taxes in the period in which the facts that give rise to a revision become known.
(r) Fair Value of Financial Instruments
As of December 31, 2014, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued expenses approximate their respective fair values based on their short-term nature. We classify our financial assets and liabilities that are measured at fair value into one of the three categories based upon inputs used to determine fair value. See “Note 5. Fair Value Measurements” below for more details regarding inputs and classifications.
(s) Advertising Expense
We expense advertising costs as they are incurred. Advertising expense was $0.5 million, $0.5 million and $0.4 million, for the years ended December 31, 2014, 2013, and 2012, respectively.
(t) Legal Costs
We expense legal costs related to loss contingencies as incurred.
(u) Medical Device Excise Tax
Effective as of January 1, 2013, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively “PPACA”) imposed a medical device excise tax (“MDET”) of 2.3% on any entity that manufactures or imports certain medical devices offered for sale in the United States. We account for the MDET as a component of our cost of goods sold. For the years ended December 31, 2014 and 2013, we recognized expenses of $7.1 million and $7.2 million, respectively.
(v) Recently Issued Accounting Pronouncements
In May 2014, the FASB and the International Accounting Standards Board released a standard on the recognition of revenue from contracts with customers that is designed to create greater comparability for financial statement users across industries and jurisdictions. Under the new standard, an entity will recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the payment to which the entity expects to be entitled in exchange for those goods or services. The standard also will require enhanced disclosures and provide more comprehensive guidance for transactions such as service revenue and contract modifications. The standard will take effect for public companies for annual reporting periods beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. We are currently evaluating the impact of the new standard on our financial position, results of operations and disclosures.
XML 50 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2014
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis
The fair value of our assets and liabilities measured at fair value on a recurring basis was as follows:
 
Balance at
 
 
 
 
 
 
(In thousands)
December 31,
2014
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Cash equivalents
$
9,802

 
$
1,302

 
$
8,500

 
$
—

Municipal bonds
54,655

 
—

 
54,655

 
—

Corporate debt securities
92,629

 
—

 
92,629

 
—

Commercial paper
44,671

 
—

 
44,671

 
—

Asset-backed securities
21,283

 
—

 
21,283

 
—

Securities of U.S. government-sponsored agencies
8,548

 
—

 
8,548

 
—

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration
24,335

 
—

 
—

 
24,335


 
Balance at
 
 
 
 
 
 
(In thousands)
December 31,
2013
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Cash equivalents
$
20,363

 
$
800

 
$
19,563

 
$
—

Municipal bonds
89,660

 
—

 
89,660

 
—

Corporate debt securities
53,089

 
—

 
53,089

 
—

Commercial paper
36,089

 
—

 
36,089

 
—

Asset-backed securities
6,652

 
—

 
6,652

 
—

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration
14,177

 
—

 
—

 
14,177
XML 51 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
RETIREMENT BENEFIT PLANS (Tables)
 12 Months Ended
Dec. 31, 2014
Defined Contribution Pension and Other Postretirement Plans Disclosure [Abstract]  
Company Contributions To Retirement Benefit Plans
Company contributions to these retirement plans were as follows:
 
 
Year ended
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
401(k) and other retirement plan contributions
 
$
2,185

 
$
2,106

 
$
1,055
XML 52 R53.htm IDEA: XBRL DOCUMENT v2.4.1.9
INVENTORIES (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Inventory Disclosure [Abstract]    
Raw materials $ 8,847us-gaap_InventoryRawMaterials $ 1,369us-gaap_InventoryRawMaterials
Work in process 2,490us-gaap_InventoryWorkInProcess 2,820us-gaap_InventoryWorkInProcess
Finished goods 79,608us-gaap_InventoryFinishedGoodsNetOfReserves 66,161us-gaap_InventoryFinishedGoodsNetOfReserves
Total $ 90,945us-gaap_InventoryNet $ 70,350us-gaap_InventoryNet
XML 53 R72.htm IDEA: XBRL DOCUMENT v2.4.1.9
COMMITMENTS AND CONTINGENCIES (Details) (USD $)
 12 Months Ended 3 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2014
Jul. 31, 2011
claim
Oct. 31, 2010
claim
Loss Contingencies            
Provision for litigation litigation loss/(income) $ 5,667,000us-gaap_LossContingencyAccrualProvision $ 23,055,000us-gaap_LossContingencyAccrualProvision $ (786,000)us-gaap_LossContingencyAccrualProvision      
Synthes USA, LLC, Synthes USA Products, LLC, and Synthes USA Sales, LLC Litigation            
Loss Contingencies            
Damages awarded   16,000,000us-gaap_LossContingencyDamagesAwardedValue
/ us-gaap_LitigationCaseAxis
= gmed_SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember		        
Patent claims (number of claims)         3us-gaap_LossContingencyPendingClaimsNumber
/ us-gaap_LitigationCaseAxis
= gmed_SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember		  
Combined litigation loss   19,500,000gmed_Combinedlitigationloss
/ us-gaap_LitigationCaseAxis
= gmed_SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember		        
Provision for litigation loss - cost of goods sold   1,300,000gmed_Provisionforlitigationlosscostofgoodssold
/ us-gaap_LitigationCaseAxis
= gmed_SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember		        
Provision for litigation litigation loss/(income) 600,000us-gaap_LossContingencyAccrualProvision
/ us-gaap_LitigationCaseAxis
= gmed_SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember		 18,200,000us-gaap_LossContingencyAccrualProvision
/ us-gaap_LitigationCaseAxis
= gmed_SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember		        
NuVasive, Inc            
Loss Contingencies            
Patent claims (number of claims)           3us-gaap_LossContingencyPendingClaimsNumber
/ us-gaap_LitigationCaseAxis
= gmed_NuvasiveIncMember
Bianco            
Loss Contingencies            
Combined litigation loss   4,300,000gmed_Combinedlitigationloss
/ us-gaap_LitigationCaseAxis
= gmed_BiancoMember		        
Royalty Rate 5.00%gmed_RoyaltyRate
/ us-gaap_LitigationCaseAxis
= gmed_BiancoMember		          
Altus Partners, LLC            
Loss Contingencies            
Provision for litigation litigation loss/(income)       $ 2,000,000us-gaap_LossContingencyAccrualProvision
/ us-gaap_LitigationCaseAxis
= gmed_AltusPartnersLlcMember		    
Minimum | Synthes USA, LLC, Synthes USA Products, LLC, and Synthes USA Sales, LLC Litigation            
Loss Contingencies            
Patent claims (number of claims) 1us-gaap_LossContingencyPendingClaimsNumber
/ us-gaap_LitigationCaseAxis
= gmed_SynthesUsaLlcSynthesUsaProductsLlcAndSynthesUsaSalesLlcLitigationMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		          
Minimum | NuVasive, Inc            
Loss Contingencies            
Patent claims (number of claims)           1us-gaap_LossContingencyPendingClaimsNumber
/ us-gaap_LitigationCaseAxis
= gmed_NuvasiveIncMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
XML 54 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
ASSETS    
Cash and cash equivalents $ 82,265us-gaap_CashAndCashEquivalentsAtCarryingValue $ 89,962us-gaap_CashAndCashEquivalentsAtCarryingValue
Restricted cash 23,370us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue 0us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue
Short-term marketable securities 146,439us-gaap_AvailableForSaleSecuritiesCurrent 148,962us-gaap_AvailableForSaleSecuritiesCurrent
Accounts receivable, net of allowances of $1,647 and $1,581, respectively 75,430us-gaap_AccountsReceivableNetCurrent 62,414us-gaap_AccountsReceivableNetCurrent
Inventories 90,945us-gaap_InventoryNet 70,350us-gaap_InventoryNet
Prepaid expenses and other current assets 5,742us-gaap_PrepaidExpenseAndOtherAssetsCurrent 5,080us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Income taxes receivable 5,772us-gaap_IncomeTaxesReceivable 2,723us-gaap_IncomeTaxesReceivable
Deferred income taxes 40,062us-gaap_DeferredTaxAssetsNetCurrent 37,317us-gaap_DeferredTaxAssetsNetCurrent
Total current assets 470,025us-gaap_AssetsCurrent 416,808us-gaap_AssetsCurrent
Property and equipment, net of accumulated depreciation of $118,544 and $99,910 69,475us-gaap_PropertyPlantAndEquipmentNet 64,150us-gaap_PropertyPlantAndEquipmentNet
Long-term marketable securities 75,347us-gaap_AvailableForSaleSecuritiesNoncurrent 36,528us-gaap_AvailableForSaleSecuritiesNoncurrent
Intangible assets, net 34,529us-gaap_IntangibleAssetsNetExcludingGoodwill 29,537us-gaap_IntangibleAssetsNetExcludingGoodwill
Goodwill 53,196us-gaap_Goodwill 18,372us-gaap_Goodwill
Other assets 975us-gaap_OtherAssetsNoncurrent 909us-gaap_OtherAssetsNoncurrent
Total assets 703,547us-gaap_Assets 566,304us-gaap_Assets
LIABILITIES AND EQUITY    
Accounts payable 15,904us-gaap_AccountsPayableCurrent 10,073us-gaap_AccountsPayableCurrent
Accounts payable to related-party 5,359us-gaap_AccountsPayableRelatedPartiesCurrent 2,656us-gaap_AccountsPayableRelatedPartiesCurrent
Accrued expenses 61,499us-gaap_AccruedLiabilitiesCurrent 51,125us-gaap_AccruedLiabilitiesCurrent
Income taxes payable 569us-gaap_AccruedIncomeTaxesCurrent 2,358us-gaap_AccruedIncomeTaxesCurrent
Business acquisition liabilities, current 6,081gmed_BusinessAcquisitionLiabilitiesCurrent 1,730gmed_BusinessAcquisitionLiabilitiesCurrent
Total current liabilities 89,412us-gaap_LiabilitiesCurrent 67,942us-gaap_LiabilitiesCurrent
Business acquisition liabilities, net of current portion 20,195gmed_BusinessAcquisitionLiabilitiesNoncurrent 15,528gmed_BusinessAcquisitionLiabilitiesNoncurrent
Deferred income taxes 5,166us-gaap_DeferredTaxLiabilitiesNoncurrent 6,385us-gaap_DeferredTaxLiabilitiesNoncurrent
Other liabilities 3,320us-gaap_OtherLiabilitiesNoncurrent 4,089us-gaap_OtherLiabilitiesNoncurrent
Total liabilities 118,093us-gaap_Liabilities 93,944us-gaap_Liabilities
Commitments and contingencies (Note 14)      
Equity:    
Additional paid-in capital 175,242us-gaap_AdditionalPaidInCapital 153,987us-gaap_AdditionalPaidInCapital
Accumulated other comprehensive loss (1,657)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax (1,009)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Retained earnings 411,774us-gaap_RetainedEarningsAccumulatedDeficit 319,289us-gaap_RetainedEarningsAccumulatedDeficit
Total equity 585,454us-gaap_StockholdersEquity 472,360us-gaap_StockholdersEquity
Total liabilities and equity 703,547us-gaap_LiabilitiesAndStockholdersEquity 566,304us-gaap_LiabilitiesAndStockholdersEquity
Class A Common    
Equity:    
Common stock 71us-gaap_CommonStockValue
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 66us-gaap_CommonStockValue
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
Class B Common    
Equity:    
Common stock $ 24us-gaap_CommonStockValue
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 $ 27us-gaap_CommonStockValue
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
XML 55 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Summary of Significant Accounting Policies      
Foreign currency transaction loss $ (899,000)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax $ (804,000)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax $ (220,000)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax
Advertising expense 500,000us-gaap_AdvertisingExpense 500,000us-gaap_AdvertisingExpense 400,000us-gaap_AdvertisingExpense
Restricted cash 23,370,000us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue 0us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue  
Medical Device Excise Tax Percentage   2.30%gmed_MedicalDeviceExciseTaxPercentage  
Minimum      
Summary of Significant Accounting Policies      
Number of Products Launched Since Inception 130gmed_NumberOfProductsLaunchedSinceInception
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		    
Estimated useful life of finite-lived intangible assets 1 year    
Maximum      
Summary of Significant Accounting Policies      
Estimated useful life of finite-lived intangible assets 17 years    
Cost of Goods, Total      
Summary of Significant Accounting Policies      
Medical Device Excise Tax $ 7,100,000gmed_MedicalDeviceExciseTax
/ us-gaap_NatureOfExpenseAxis
= us-gaap_CostOfGoodsTotalMember		 $ 7,200,000gmed_MedicalDeviceExciseTax
/ us-gaap_NatureOfExpenseAxis
= us-gaap_CostOfGoodsTotalMember		  
XML 56 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Equity (USD $)
In Thousands, except Share data, unless otherwise specified
Total
USD ($)
Convertible Preferred Stock
USD ($)
Additional Paid-in Capital
USD ($)
Accumulated Other Comprehensive Income
USD ($)
Retained Earnings
USD ($)
Class A Common
Common Stock
USD ($)
Class B Common
Common Stock
USD ($)
Class C Common
Common Stock
USD ($)
Pre IPO
Convertible Preferred Stock
USD ($)
Pre IPO
Class A Common
Common Stock
USD ($)
Pre IPO
Class B Common
Common Stock
USD ($)
Pre IPO
Class C Common
Common Stock
In Conjunction with IPO
USD ($)
In Conjunction with IPO
Convertible Preferred Stock
USD ($)
In Conjunction with IPO
Additional Paid-in Capital
USD ($)
In Conjunction with IPO
Class A Common
Common Stock
USD ($)
In Conjunction with IPO
Class B Common
Common Stock
USD ($)
In Conjunction with IPO
Class C Common
Common Stock
USD ($)
Post IPO
Class A Common
Common Stock
Total stockholders' equity, beginning of period at Dec. 31, 2011 $ 282,476us-gaap_StockholdersEquity $ 51us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		 $ 106,708us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 $ (1,202)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 $ 176,846us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 $ 8us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ 65us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ 0us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Balance, Shares at Dec. 31, 2011   50,691,000us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		       7,453,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 65,018,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 58,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Stock-based compensation 4,635us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue   4,635us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		                                
Exercise of stock options (shares) 1,061,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised 0us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		       898,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 147,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 16,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Exercise of stock options 1,504us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised 0us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		 1,503us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		     1us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Tax benefit related to nonqualified stock options excercised 2,661us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation   2,661us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		                                
Conversion of stock, converted (shares)                 0us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_PreIPOMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		   (690,000)us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_PreIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_PreIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   (50,691,000)us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		     (37,097,000)us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 (74,000)us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		  
Conversion of stock, amount converted               0us-gaap_ConversionOfStockAmountConverted1
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_ConversionOfStockAmountConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_PreIPOMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		   (1)us-gaap_ConversionOfStockAmountConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_PreIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		     (51)us-gaap_ConversionOfStockAmountConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		     (37)us-gaap_ConversionOfStockAmountConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_ConversionOfStockAmountConverted1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		  
Conversion of stock, issued (shares)                   690,000us-gaap_ConversionOfStockSharesIssued1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_PreIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		           52,768,000us-gaap_ConversionOfStockSharesIssued1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		      
Conversion of stock, amount issued                   1us-gaap_ConversionOfStockAmountIssued1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_PreIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		     0us-gaap_ConversionOfStockAmountIssued1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember		   36us-gaap_ConversionOfStockAmountIssued1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 52us-gaap_ConversionOfStockAmountIssued1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_InConjunctionwithIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		      
Issuance of common stock from IPO, net of expenses (shares)           2,083,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                          
Issuance of common stock from IPO, net of expenses 20,960us-gaap_StockIssuedDuringPeriodValueNewIssues   20,958us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		     2us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                          
Comprehensive income 74,266us-gaap_ComprehensiveIncomeNetOfTax     435us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 73,831us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		                            
Total stockholders' equity, end of period at Dec. 31, 2012 386,502us-gaap_StockholdersEquity 0us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		 136,501us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 (767)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 250,677us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 64us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 27us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Balance, Shares at Dec. 31, 2012   0us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		       63,892,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 27,378,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Stock-based compensation 5,177us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue   5,177us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		                                
Exercise of stock options (shares) 2,173,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised         2,173,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                          
Exercise of stock options 7,555us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised   7,553us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		     2us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                          
Tax benefit related to nonqualified stock options excercised 4,756us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation   4,756us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		                                
Comprehensive income 68,370us-gaap_ComprehensiveIncomeNetOfTax     (242)us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 68,612us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		                            
Total stockholders' equity, end of period at Dec. 31, 2013 472,360us-gaap_StockholdersEquity 0us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		 153,987us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 (1,009)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 319,289us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 66us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 27us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Balance, Shares at Dec. 31, 2013   0us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		       66,065,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 27,378,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Stock-based compensation 7,111us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue   7,111us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		                                
Exercise of stock options (shares) 1,263,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised         1,263,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                          
Exercise of stock options 9,738us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised   9,736us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		     2us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                          
Tax benefit related to nonqualified stock options excercised 4,408us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation   4,408us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		                                
Conversion of stock, converted (shares)             (3,500,000)us-gaap_ConversionOfStockSharesConverted1
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                        
Conversion of stock, amount converted             (3)us-gaap_ConversionOfStockAmountConverted1
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                        
Conversion of stock, issued (shares)                                     3,500,000us-gaap_ConversionOfStockSharesIssued1
/ us-gaap_ConversionOfStockByUniqueDescriptionAxis
= gmed_PostIPOMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
Conversion of stock, amount issued           3us-gaap_ConversionOfStockAmountIssued1
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                          
Comprehensive income 91,837us-gaap_ComprehensiveIncomeNetOfTax     (648)us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 92,485us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		                            
Total stockholders' equity, end of period at Dec. 31, 2014 $ 585,454us-gaap_StockholdersEquity $ 0us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		 $ 175,242us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 $ (1,657)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 $ 411,774us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 $ 71us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ 24us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ 0us-gaap_StockholdersEquity
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
Balance, Shares at Dec. 31, 2014   0us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_PreferredStockMember		       70,828,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 23,878,000us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 0us-gaap_SharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassCMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                      
XML 57 R59.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION (Textuals) (Details) (USD $)
In Millions, except Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award    
Share-based Compensation, Number of Stock Plans 3gmed_ShareBasedCompensationNumberOfStockPlans  
Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award    
Maximum contractual term 10 years  
Award vesting period (in years) 4 years  
Unrecognized compensation expense, unvested stock options $ 16.1us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember		  
Weighted average period of recognition, unvested stock options 3 years  
2012 Equity Incentive Plan    
Share-based Compensation Arrangement by Share-based Payment Award    
Base number of shares that may be issuable under stock plan 3,076,923gmed_ShareBasedCompensationArrangementByShareBasedPaymentAwardBaseNumberOfSharesIssuable
/ us-gaap_PlanNameAxis
= gmed_A2012EquityIncentivePlanMember		  
2012 Equity Incentive Plan | Maximum    
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares available for grant 10,769,230us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
/ us-gaap_PlanNameAxis
= gmed_A2012EquityIncentivePlanMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		  
Annual percentage limit for incremental shares that may be issued 3.00%gmed_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentageIncreaseInSharesAvailableForIssuance
/ us-gaap_PlanNameAxis
= gmed_A2012EquityIncentivePlanMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		  
2012 Equity Incentive Plan | Class A Common    
Share-based Compensation Arrangement by Share-based Payment Award    
Shares reserved under the 2012 Equity Incentive Plan 9,085,832us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
/ us-gaap_PlanNameAxis
= gmed_A2012EquityIncentivePlanMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		  
Number of shares available for grant 6,019,966us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
/ us-gaap_PlanNameAxis
= gmed_A2012EquityIncentivePlanMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		  
Original Fair Value of Common Stock | February 2, 2012 Grant    
Share-based Compensation Arrangement by Share-based Payment Award    
Exercise price per share granted   $ 10.34gmed_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsExercisePrice
/ gmed_CommonStockValuationAxis
= gmed_OriginalFairValueOfCommonStockMember
/ us-gaap_PlanNameAxis
= gmed_February22012GrantMember
XML 58 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCRUED EXPENSES (Tables)
 12 Months Ended
Dec. 31, 2013
Payables and Accruals [Abstract]  
Accrued Expenses
(In thousands)
December 31,
2014
 
December 31,
2013
Compensation and other employee-related costs
$
19,933

 
$
17,428

Legal and other settlements and expenses
27,686

 
23,765

Accrued non-income taxes
4,720

 
2,938

Other
9,160

 
6,994

Total accrued expenses
$
61,499

 
$
51,125
XML 59 R65.htm IDEA: XBRL DOCUMENT v2.4.1.9
INCOME TAXES (Components of Provision for Income Taxes) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Current Income Tax Expense      
Current income tax provision, federal $ 43,561us-gaap_CurrentFederalTaxExpenseBenefit $ 41,741us-gaap_CurrentFederalTaxExpenseBenefit $ 40,338us-gaap_CurrentFederalTaxExpenseBenefit
Current income tax provision, state 6,097us-gaap_CurrentStateAndLocalTaxExpenseBenefit 6,118us-gaap_CurrentStateAndLocalTaxExpenseBenefit 6,419us-gaap_CurrentStateAndLocalTaxExpenseBenefit
Current income tax provision, foreign 519us-gaap_CurrentForeignTaxExpenseBenefit 912us-gaap_CurrentForeignTaxExpenseBenefit 345us-gaap_CurrentForeignTaxExpenseBenefit
Current income tax provision 50,177us-gaap_CurrentIncomeTaxExpenseBenefit 48,771us-gaap_CurrentIncomeTaxExpenseBenefit 47,102us-gaap_CurrentIncomeTaxExpenseBenefit
Deferred Income Tax Expense/(Benefit)      
Deferred income tax provision/(benefit), federal (3,630)us-gaap_DeferredFederalIncomeTaxExpenseBenefit (14,088)us-gaap_DeferredFederalIncomeTaxExpenseBenefit (5,510)us-gaap_DeferredFederalIncomeTaxExpenseBenefit
Deferred income tax (benefit), state (357)us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit (1,210)us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit (352)us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit
Deferred income tax provision/(benefit), foreign (33)us-gaap_DeferredForeignIncomeTaxExpenseBenefit (84)us-gaap_DeferredForeignIncomeTaxExpenseBenefit (418)us-gaap_DeferredForeignIncomeTaxExpenseBenefit
Deferred income tax provision/(benefit) (4,020)us-gaap_DeferredIncomeTaxExpenseBenefit (15,382)us-gaap_DeferredIncomeTaxExpenseBenefit (6,280)us-gaap_DeferredIncomeTaxExpenseBenefit
Income tax provision, total $ 46,157us-gaap_IncomeTaxExpenseBenefit $ 33,389us-gaap_IncomeTaxExpenseBenefit $ 40,822us-gaap_IncomeTaxExpenseBenefit
XML 60 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
RETIREMENT BENEFIT PLANS
 12 Months Ended
Dec. 31, 2014
Defined Contribution Pension and Other Postretirement Plans Disclosure [Abstract]  
Retirement Benefit Plans
RETIREMENT BENEFIT PLANS
We sponsor a 401(k) Plan covering all eligible U.S. employees. Under the 401(k) Plan, we make nondiscretionary matching contributions at the rate of 100% of employee’s contributions up to a maximum annual contribution of $6,000 per eligible employee, limited to 3% of the employee’s compensation for the period.
Additionally, we contribute to various foreign retirement benefit plans required by local law or coordinated with government sponsored plans which cover many of our international employees. The benefits offered under these plans are reflective of local customs and practices in the countries concerned.
Company contributions to these retirement plans were as follows:
 
 
Year ended
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
401(k) and other retirement plan contributions
 
$
2,185

 
$
2,106

 
$
1,055
XML 61 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9
EQUITY (Tables)
 12 Months Ended
Dec. 31, 2014
Equity [Abstract]  
Schedule of Issued and Outstanding Shares by Class
Our issued and outstanding common shares by Class were as follows:
(Shares)
Class A Common
 
Class B
 Common
 
Total
December 31, 2014
70,828,187

 
23,877,556

 
94,705,743

December 31, 2013
66,065,197

 
27,377,556

 
93,442,753
XML 62 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT AND GEOGRAPHIC INFORMATION
 12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment And Geographic Information
SEGMENT AND GEOGRAPHIC INFORMATION
Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. We globally manage the business within one reportable segment. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. Products are sold principally in the United States.
The following table represents total sales by geographic area, based on the location of the customer:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
United States
 
$
427,091

 
$
396,615

 
$
355,609

International
 
47,280

 
37,844

 
30,385

Total sales
 
$
474,371

 
$
434,459

 
$
385,994

 
We classify our products into two categories: Innovative Fusion products and Disruptive Technology products. The following table represents total sales by product category:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Innovative Fusion
 
$
270,852

 
$
254,033

 
$
238,723

Disruptive Technology
 
203,519

 
180,426

 
147,271

Total sales
 
$
474,371

 
$
434,459

 
$
385,994
XML 63 R68.htm IDEA: XBRL DOCUMENT v2.4.1.9
INCOME TAXES (Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Unrecognized tax benefits at the beginning of the year $ 3,978us-gaap_UnrecognizedTaxBenefits $ 3,500us-gaap_UnrecognizedTaxBenefits $ 2,799us-gaap_UnrecognizedTaxBenefits
Additions related to current year tax positions 0us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions 661us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions 673us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
Additions related to prior year tax positions 614us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions 64us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions 46us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
Reductions related to prior year tax positions (209)us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions (109)us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions (18)us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
Lapse of statute of limitations (202)us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations (138)us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations 0us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
Settlements (953)us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities 0us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities 0us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
Unrecognized tax benefit at the end of the year 3,228us-gaap_UnrecognizedTaxBenefits 3,978us-gaap_UnrecognizedTaxBenefits 3,500us-gaap_UnrecognizedTaxBenefits
Portion of total unrecognized tax benefits that, if recognized, that would affect the effective income tax rate $ 838us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate $ 1,184us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate $ 747us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
XML 64 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 65 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:      
Net income $ 92,485us-gaap_NetIncomeLoss $ 68,612us-gaap_NetIncomeLoss $ 73,831us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation and amortization 21,754us-gaap_DepreciationDepletionAndAmortization 19,397us-gaap_DepreciationDepletionAndAmortization 18,108us-gaap_DepreciationDepletionAndAmortization
Amortization of premium on marketable securities 2,680us-gaap_InvestmentIncomeAmortizationOfPremium 2,358us-gaap_InvestmentIncomeAmortizationOfPremium 0us-gaap_InvestmentIncomeAmortizationOfPremium
Provision for excess and obsolete inventories 6,962us-gaap_InventoryWriteDown 8,212us-gaap_InventoryWriteDown 6,119us-gaap_InventoryWriteDown
Stock-based compensation 7,111us-gaap_ShareBasedCompensation 5,177us-gaap_ShareBasedCompensation 4,635us-gaap_ShareBasedCompensation
Allowance for doubtful accounts 318us-gaap_ProvisionForDoubtfulAccounts 693us-gaap_ProvisionForDoubtfulAccounts 363us-gaap_ProvisionForDoubtfulAccounts
Change in deferred income taxes (4,379)us-gaap_DeferredIncomeTaxesAndTaxCredits (14,858)us-gaap_DeferredIncomeTaxesAndTaxCredits (6,079)us-gaap_DeferredIncomeTaxesAndTaxCredits
(Increase) decrease in:      
Restricted cash (23,370)us-gaap_IncreaseDecreaseInRestrictedCash 0us-gaap_IncreaseDecreaseInRestrictedCash 0us-gaap_IncreaseDecreaseInRestrictedCash
Accounts receivable (12,667)us-gaap_IncreaseDecreaseInAccountsReceivable (9,612)us-gaap_IncreaseDecreaseInAccountsReceivable (6,886)us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (18,001)us-gaap_IncreaseDecreaseInInventories (16,678)us-gaap_IncreaseDecreaseInInventories (20,541)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other assets (249)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (2,955)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (117)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Increase (decrease) in:      
Accounts payable 4,628us-gaap_IncreaseDecreaseInAccountsPayable 1,840us-gaap_IncreaseDecreaseInAccountsPayable 3,048us-gaap_IncreaseDecreaseInAccountsPayable
Accounts payable to related party 2,703us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties 100us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties 1,378us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties
Accrued expenses and other liabilities 4,018us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities 26,963us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities 4,208us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
Income taxes payable/receivable (4,821)us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable 4,222us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable (1,548)us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable
Net cash provided by operating activities 79,172us-gaap_NetCashProvidedByUsedInOperatingActivities 93,471us-gaap_NetCashProvidedByUsedInOperatingActivities 76,519us-gaap_NetCashProvidedByUsedInOperatingActivities
Cash flows from investing activities:      
Purchases of marketable securities (251,422)us-gaap_PaymentsToAcquireInvestments (240,892)us-gaap_PaymentsToAcquireInvestments 0us-gaap_PaymentsToAcquireInvestments
Maturities of marketable securities 184,567us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities 40,560us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities 0us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
Sales of marketable securities 27,737us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities 13,637us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities 0us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities
Purchases of property and equipment (24,754)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (23,680)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (24,684)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Acquisition of businesses (36,128)us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired (16,775)us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired (6,031)us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Net cash used in investing activities (100,000)us-gaap_NetCashProvidedByUsedInInvestingActivities (227,150)us-gaap_NetCashProvidedByUsedInInvestingActivities (30,715)us-gaap_NetCashProvidedByUsedInInvestingActivities
Cash flows from financing activities:      
Payment of business acquisition liabilities (1,200)gmed_PaymentOfBusinessAcquisitionLiabilities (1,300)gmed_PaymentOfBusinessAcquisitionLiabilities (1,100)gmed_PaymentOfBusinessAcquisitionLiabilities
Net proceeds from initial public offering 0gmed_ProceedsFromIssuanceInitialPublicOfferingNetOfUnderwritingFeesAndOfferingExpenses 0gmed_ProceedsFromIssuanceInitialPublicOfferingNetOfUnderwritingFeesAndOfferingExpenses 20,960gmed_ProceedsFromIssuanceInitialPublicOfferingNetOfUnderwritingFeesAndOfferingExpenses
Net proceeds from issuance of common stock 9,738us-gaap_ProceedsFromIssuanceOfCommonStock 7,555us-gaap_ProceedsFromIssuanceOfCommonStock 1,504us-gaap_ProceedsFromIssuanceOfCommonStock
Excess tax benefit related to nonqualified stock options 4,408us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities 4,756us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities 2,661us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
Net cash provided by/(used in) financing activities 12,946us-gaap_NetCashProvidedByUsedInFinancingActivities 11,011us-gaap_NetCashProvidedByUsedInFinancingActivities 24,025us-gaap_NetCashProvidedByUsedInFinancingActivities
Effect of foreign exchange rate on cash 185us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents 230us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents (97)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Net increase/(decrease) in cash and cash equivalents (7,697)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (122,438)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 69,732us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of period 89,962us-gaap_CashAndCashEquivalentsAtCarryingValue 212,400us-gaap_CashAndCashEquivalentsAtCarryingValue 142,668us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents, end of period 82,265us-gaap_CashAndCashEquivalentsAtCarryingValue 89,962us-gaap_CashAndCashEquivalentsAtCarryingValue 212,400us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosures of cash flow information:      
Interest paid 32us-gaap_InterestPaid 96us-gaap_InterestPaid 63us-gaap_InterestPaid
Income taxes paid $ 51,096us-gaap_IncomeTaxesPaid $ 38,719us-gaap_IncomeTaxesPaid $ 44,875us-gaap_IncomeTaxesPaid
XML 66 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Balance Sheets (Parentheticals) (USD $)
In Thousands, except Share data, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current Assets:    
Allowance for doubtful accounts $ 1,647us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent $ 1,581us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent
Equity:    
Common stock, shares issued 94,705,743us-gaap_CommonStockSharesIssued 93,442,753us-gaap_CommonStockSharesIssued
Common stock, shares outstanding 94,705,743us-gaap_CommonStockSharesOutstanding 93,442,753us-gaap_CommonStockSharesOutstanding
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $ 118,544us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment $ 99,910us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
Class A Common    
Equity:    
Common stock, par value (in usd per share) $ 0.001us-gaap_CommonStockParOrStatedValuePerShare
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 $ 0.001us-gaap_CommonStockParOrStatedValuePerShare
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
Common stock, shares authorized (in shares) 500,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 500,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
Common stock, shares issued 70,828,187us-gaap_CommonStockSharesIssued
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 66,065,197us-gaap_CommonStockSharesIssued
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
Common stock, shares outstanding 70,828,187us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 66,065,197us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
Class B Common    
Equity:    
Common stock, par value (in usd per share) $ 0.001us-gaap_CommonStockParOrStatedValuePerShare
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 $ 0.001us-gaap_CommonStockParOrStatedValuePerShare
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
Common stock, shares authorized (in shares) 275,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 275,000,000us-gaap_CommonStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
Common stock, shares issued 23,877,556us-gaap_CommonStockSharesIssued
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 27,377,556us-gaap_CommonStockSharesIssued
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
Common stock, shares outstanding 23,877,556us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 27,377,556us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
XML 67 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
EQUITY
 12 Months Ended
Dec. 31, 2014
Equity [Abstract]  
Equity
EQUITY
Our amended and restated Certificate of Incorporation provides for a total of 785,000,000 authorized shares of common stock. Of the authorized number of shares of common stock, 500,000,000 shares are designated as Class A common stock (“Class A Common”), 275,000,000 shares are designated as Class B common stock (“Class B Common”) and 10,000,000 shares are designated as Class C common stock (“Class C Common”).
The holders of Class A Common are entitled to one vote for each share of Class A Common held. The holders of Class B Common are entitled to 10 votes for each share of Class B Common held. The holders of Class A Common and Class B Common vote together as one class of common stock. The Class C Common is nonvoting. Except for voting rights, the Class A Common, Class B Common and Class C Common have the same rights and privileges.
In August 2012, we completed our IPO. We sold 2,083,333 shares of our Class A Common at an offering price of $12.00 per share. We recognized gross proceeds of $25.0 million and our net proceeds received after underwriting fees and offering expenses were $21.0 million.
Immediately prior to the closing of our IPO, we effectuated the following conversion:
•
the automatic conversion of all shares of our Series E preferred stock to 15,597,300 shares of our Class B Common;
•
the subsequent automatic conversion of 49,655,411 shares of our Class B Common (which reflects all such shares of Class B Common held by those who beneficially owned less than 10% of the aggregate number of all outstanding shares of our common stock) to 49,655,411 shares of our Class A Common;
•
the automatic conversion of all shares of our Class C Common to 73,554 shares of our Class A Common; and
•
the automatic conversion of 3,039,385 shares of Class B Common to 3,039,385 shares of Class A Common upon their sale by the selling stockholders.
Our issued and outstanding common shares by Class were as follows:
(Shares)
Class A Common
 
Class B
 Common
 
Total
December 31, 2014
70,828,187

 
23,877,556

 
94,705,743

December 31, 2013
66,065,197

 
27,377,556

 
93,442,753
XML 68 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9
Document and Entity Information (USD $)
In Billions, except Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Jan. 31, 2015
Jun. 30, 2014
DEI [Abstract]      
Entity Registrant Name GLOBUS MEDICAL INC    
Entity Central Index Key 0001237831    
Current Fiscal Year End Date --12-31    
Entity Filer Category Large Accelerated Filer    
Document Type 10-K    
Document Period End Date Dec. 31, 2014    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Common Stock, Shares Outstanding   94,761,428dei_EntityCommonStockSharesOutstanding  
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Public Float     $ 1.6dei_EntityPublicFloat
XML 69 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
STOCK-BASED COMPENSATION
We have three stock plans: our Amended and Restated 2003 Stock Plan, our 2008 Stock Plan, and our 2012 Equity Incentive Plan (the "2012 Plan"). The 2012 Plan is the only remaining active stock plan.  The purpose of these stock plans was, and the 2012 Plan is, to provide incentive to employees, directors, and consultants of Globus.  The Plans are administered by the Board or its delegates. The number, type of option, exercise price, and vesting terms are determined by the Board or its delegates in accordance with the terms of the Plans. The options granted expire on a date specified by the Board, but generally not more than ten years from the grant date. Option grants to employees generally vest monthly over a four-year period.
The 2012 Plan was approved by our Board in March 2012, and by our stockholders in June 2012. Under the 2012 Plan, the aggregate number of shares of Class A Common that may be issued subject to options and other awards is equal to the sum of (i) 3,076,923 shares, (ii) any shares available for issuance under the 2008 Plan as of March 13, 2012, (iii) any shares underlying awards outstanding under the 2008 Plan as of March 13, 2012 that, on or after that date, are forfeited, terminated, expired or lapse for any reason, or are settled for cash without delivery of shares and (iv) starting January 1, 2013, an annual increase in the number of shares available under the 2012 Plan equal to up to 3% of the number of shares of our common and preferred stock outstanding at the end of the previous year, as determined by our Board. The number of shares that may be issued or transferred pursuant to incentive stock options under the 2012 Plan is limited to 10,769,230 shares. The shares of Class A Common covered by the 2012 Plan are authorized but unissued shares, treasury shares or shares of common stock purchased on the open market.
As of December 31, 2014, pursuant to the 2012 Plan, there were 9,085,832 shares of Class A Common stock reserved and 6,019,966 shares of Class A Common stock available for future grants.
The weighted average grant date per share fair values of the options awarded to employees were as follows:
 
 
Year Ended
 
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Weighted average grant date per share fair value
 
$
9.63

 
$
6.34

 
$
5.90


The fair value of the options was estimated on the date of the grant using a Black-Scholes option pricing model with the following assumptions:
 
Year Ended
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Risk-free interest rate
1.51
%
-
1.95
%
 
0.98
%
-
1.74
%
 
0.90
%
-
1.10
%
Expected term (years)
5.3
-
6.4
 
6.1
-
6.4
 
6
Expected volatility
35.0
%
-
41.0
%
 
41.0
%
-
44.0
%
 
44.0
%
-
47.0
%
Expected dividend yield
—%
 
—%
 
—%

Stock option activity during the years ended December 31, 2014, 2013 and 2012 is summarized as follows:  
 
Option Shares (thousands)
 
Weighted average exercise price
 
Weighted average remaining contractual life (years)
 
Aggregate intrinsic value (thousands)
Outstanding at December 31, 2011
6,454

 
$
5.14

 
 
 
 
Granted
1,228

 
13.10

 
 
 
 
Exercised
(1,061
)
 
1.42

 
 
 
 
Forfeited
(368
)
 
9.55

 
 
 
 
Outstanding at December 31, 2012
6,253

 
6.99

 
 
 
 
Granted
1,222

 
14.78

 
 
 
 
Exercised
(2,173
)
 
3.48

 
 
 
 
Forfeited
(416
)
 
12.23

 
 
 
 
Outstanding at December 31, 2013
4,886

 
10.04

 
 
 
 
Granted
1,495

 
23.45

 
 
 
 
Exercised
(1,263
)
 
7.71

 
 
 
 
Forfeited
(264
)
 
15.33

 
 
 
 
Outstanding at December 31, 2014
4,854

 
14.50

 
7.1
 
$
45,731

Exercisable at December 31, 2014
2,390

 
9.08

 
5.4
 
35,093

Expected to vest at December 31, 2014
2,464

 
$
19.76

 
8.8
 
$
10,638


We use the Black Scholes pricing model to determine the fair value of our stock options (see “Note 1. Background and Summary of Significant Accounting Policies, (q) Stock-Based Compensation” above). Subsequent to the February 2012 and March 2012 stock option grants, we reassessed the fair value of our stock options on those dates of grant by updating the assumptions and facts considered in an October 2011 valuation report upon which we relied to take into account our actual results, market conditions, comparable company results, and the timing of our IPO.
Compensation expense related to stock options granted to employees and non-employees under the Plans and the intrinsic value of stock options exercised was as follows:
 
 
Year Ended
(In thousands)
 
December 31,
2014
 
December 31,
2013
 
December 31,
2012
Compensation expense related to stock options
 
$
7,111

 
$
5,177

 
$
4,635

Intrinsic value of stock options exercised
 
20,216

 
25,034

 
12,507


As of December 31, 2014, there was $16.1 million of unrecognized compensation expense related to unvested employee stock options that vest over a weighted average period of three years.
XML 70 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income Statement [Abstract]      
Sales $ 474,371us-gaap_SalesRevenueNet $ 434,459us-gaap_SalesRevenueNet $ 385,994us-gaap_SalesRevenueNet
Cost of goods sold 110,857us-gaap_CostOfGoodsSold 100,343us-gaap_CostOfGoodsSold 75,199us-gaap_CostOfGoodsSold
Gross profit 363,514us-gaap_GrossProfit 334,116us-gaap_GrossProfit 310,795us-gaap_GrossProfit
Operating expenses:      
Research and development 31,687us-gaap_ResearchAndDevelopmentExpense 26,870us-gaap_ResearchAndDevelopmentExpense 27,926us-gaap_ResearchAndDevelopmentExpense
Selling, general and administrative 187,798us-gaap_SellingGeneralAndAdministrativeExpense 182,518us-gaap_SellingGeneralAndAdministrativeExpense 168,862us-gaap_SellingGeneralAndAdministrativeExpense
Provision for litigation litigation loss/(income) 5,667us-gaap_LossContingencyAccrualProvision 23,055us-gaap_LossContingencyAccrualProvision (786)us-gaap_LossContingencyAccrualProvision
Total operating expenses 225,152us-gaap_OperatingExpenses 232,443us-gaap_OperatingExpenses 196,002us-gaap_OperatingExpenses
Operating income 138,362us-gaap_OperatingIncomeLoss 101,673us-gaap_OperatingIncomeLoss 114,793us-gaap_OperatingIncomeLoss
Other income/(expense), net 280us-gaap_OtherNonoperatingIncomeExpense 328us-gaap_OtherNonoperatingIncomeExpense (140)us-gaap_OtherNonoperatingIncomeExpense
Interest income, net 805us-gaap_InterestIncomeExpenseNet 467us-gaap_InterestIncomeExpenseNet 80us-gaap_InterestIncomeExpenseNet
Foreign currency transaction loss (899)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax (804)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax (220)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax
Other income 374us-gaap_OtherNonoperatingIncome 665us-gaap_OtherNonoperatingIncome 0us-gaap_OtherNonoperatingIncome
Income before income taxes 138,642us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 102,001us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 114,653us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax provision 46,157us-gaap_IncomeTaxExpenseBenefit 33,389us-gaap_IncomeTaxExpenseBenefit 40,822us-gaap_IncomeTaxExpenseBenefit
Net income $ 92,485us-gaap_NetIncomeLoss $ 68,612us-gaap_NetIncomeLoss $ 73,831us-gaap_NetIncomeLoss
Earnings per share:      
Basic $ 0.98us-gaap_EarningsPerShareBasic $ 0.74us-gaap_EarningsPerShareBasic $ 0.82us-gaap_EarningsPerShareBasic
Diluted $ 0.97us-gaap_EarningsPerShareDiluted $ 0.73us-gaap_EarningsPerShareDiluted $ 0.80us-gaap_EarningsPerShareDiluted
Weighted average shares outstanding:      
Basic 94,227us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 92,647us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 89,608us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Dilutive stock options 1,230us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements 1,545us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements 2,600us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
Diluted 95,457us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 94,192us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 92,208us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Anti-dilutive stock equivalents excluded from weighted average calculation 1,666us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 1,975us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 2,383us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
XML 71 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2014
Fair Value Disclosures [Abstract]  
Fair Value Measurements
FAIR VALUE MEASUREMENTS
Under the accounting for fair value measurements and disclosures, fair value is defined as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or the liability in an orderly transaction between market participants on the measurement date. Additionally, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable inputs. The level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
Our assets and liabilities measured at fair value on a recurring basis are classified and disclosed in one of the following three categories:
Level 1—quoted prices (unadjusted) in active markets for identical assets and liabilities;
Level 2—observable inputs other than quoted prices in active markets for identical assets and liabilities; and
Level 3—unobservable inputs in which there is little or no market data available, which require the reporting entity to use significant unobservable inputs or valuation techniques.
The fair value of our assets and liabilities measured at fair value on a recurring basis was as follows:
 
Balance at
 
 
 
 
 
 
(In thousands)
December 31,
2014
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Cash equivalents
$
9,802

 
$
1,302

 
$
8,500

 
$
—

Municipal bonds
54,655

 
—

 
54,655

 
—

Corporate debt securities
92,629

 
—

 
92,629

 
—

Commercial paper
44,671

 
—

 
44,671

 
—

Asset-backed securities
21,283

 
—

 
21,283

 
—

Securities of U.S. government-sponsored agencies
8,548

 
—

 
8,548

 
—

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration
24,335

 
—

 
—

 
24,335


 
Balance at
 
 
 
 
 
 
(In thousands)
December 31,
2013
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Cash equivalents
$
20,363

 
$
800

 
$
19,563

 
$
—

Municipal bonds
89,660

 
—

 
89,660

 
—

Corporate debt securities
53,089

 
—

 
53,089

 
—

Commercial paper
36,089

 
—

 
36,089

 
—

Asset-backed securities
6,652

 
—

 
6,652

 
—

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration
14,177

 
—

 
—

 
14,177


Contingent consideration represents our contingent milestone, performance and revenue-sharing payment obligations related to our acquisitions and is measured at fair value and is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The valuation of contingent consideration uses assumptions we believe would be made by a market participant, such as the probabilities associated with successfully completing clinical trials and obtaining regulatory approval, of achieving sales milestones and the period in which these milestones are expected to be achieved, as well as discount rates, which range from 3.1% to 13.5%. We assess these estimates on an ongoing basis as additional data impacting the assumptions is obtained. Changes in the fair value of contingent consideration related to updated assumptions and estimates are recognized within research and development and selling, general and administrative expenses in the consolidated statements of income.
Assets and Liabilities That Are Measured at Fair Value on a Nonrecurring Basis
The purchase price of business acquisitions is primarily allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the excess recorded as goodwill. We utilize Level 3 inputs in the determination of the initial fair value. Non-financial assets such as goodwill, intangible assets, and property, plant, and equipment are subsequently measured at fair value when there is an indicator of impairment and recorded at fair value only when an impairment is recognized. We assess the impairment of intangible assets annually or whenever events or changes in circumstances indicate that the carrying amount of an intangible asset may not be recoverable. The fair value of our goodwill and intangible assets is not estimated if there is no change in events or circumstances that indicate the carrying amount of an intangible asset may not be recoverable. We have not recorded impairment charges related to our business acquisitions.
XML 72 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
MARKETABLE SECURITIES
 12 Months Ended
Dec. 31, 2014
Marketable Securities [Abstract]  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure
MARKETABLE SECURITIES
The composition of our short-term and long-term marketable securities is as follows:
 
 
 
December 31, 2014
(In thousands)
Contractual Maturity
(in years)
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Short-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
Less than 1
 
$
28,684

 
$
2

 
$
(3
)
 
$
28,683

Corporate debt securities
Less than 1
 
73,066

 
7

 
(42
)
 
73,031

Commercial paper
Less than 1
 
44,663

 
8

 
—

 
44,671

Asset backed securities
Less than 1
 
54

 
—

 
—

 
54

Total short-term marketable securities
 
 
$
146,467

 
$
17

 
$
(45
)
 
$
146,439

 
 
 
 
 
 
 
 
 
 
Long-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
1-2
 
$
26,005

 
$
3

 
$
(36
)
 
$
25,972

Corporate debt securities
1-2
 
19,617

 
3

 
(22
)
 
19,598

Asset backed securities
1-2
 
21,236

 
1

 
(8
)
 
21,229

Securities of U.S. government-sponsored agencies
1-2
 
8,564

 
—

 
(16
)
 
8,548

Total long-term marketable securities
 
 
$
75,422

 
$
7

 
$
(82
)
 
$
75,347

 
 
 
December 31, 2013
(In thousands)
Contractual Maturity
(in years)
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Short-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
Less than 1
 
$
77,342

 
$
17

 
$
(15
)
 
$
77,344

Corporate debt securities
Less than 1
 
35,525

 
15

 
(11
)
 
35,529

Commercial paper
Less than 1
 
36,083

 
6

 
—

 
36,089

Total short-term marketable securities
 
 
$
148,950

 
$
38

 
$
(26
)
 
$
148,962

 
 
 
 
 
 
 
 
 
 
Long-term:
 
 
 
 
 
 
 
 
 
Municipal bonds
1-2
 
$
12,304

 
$
13

 
$
(1
)
 
$
12,316

Corporate debt securities
1-2
 
17,533

 
27

 
—

 
17,560

Asset backed securities
1-2
 
6,651

 
2

 
(1
)
 
6,652

Total long-term marketable securities
 
 
$
36,488

 
$
42

 
$
(2
)
 
$
36,528
XML 73 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
RELATED-PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2014
Related Party Transactions [Abstract]  
Related-Party Transactions
RELATED-PARTY TRANSACTIONS
We have contracted with a third-party manufacturer in which certain of our senior management and significant stockholders have or had ownership interests and leadership positions.
We have purchased the following amounts of products and services from the supplier:
 
Year Ended
(In thousands)
December 31, 2014
 
December 31,
2013
 
December 31,
2012
Purchases from related-party supplier
$
21,948

 
$
20,039

 
$
20,159


As of December 31, 2014 and December 31, 2013, we had $5.4 million and $2.7 million of accounts payable due to the supplier.
XML 74 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
INCOME TAXES
 12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Income Taxes
INCOME TAXES
The components of income before income taxes are as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Domestic
 
$
137,643

 
$
101,424

 
$
114,176

Foreign
 
999

 
577

 
477

Total
 
$
138,642

 
$
102,001

 
$
114,653


The components of the provision/(benefit) for income taxes are as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Current:
 
 
 
 
 
 
Federal
 
$
43,561

 
$
41,741

 
$
40,338

State
 
6,097

 
6,118

 
6,419

Foreign
 
519

 
912

 
345

 
 
50,177

 
48,771

 
47,102

Deferred:
 
 
 
 
 
 
Federal
 
(3,630
)
 
(14,088
)
 
(5,510
)
State
 
(357
)
 
(1,210
)
 
(352
)
Foreign
 
(33
)
 
(84
)
 
(418
)
 
 
(4,020
)
 
(15,382
)
 
(6,280
)
Total
 
$
46,157

 
$
33,389

 
$
40,822


A reconciliation of the statutory U.S. federal tax rate to our effective rate is as follows:
 
 
Year ended
 
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Statutory U.S. federal tax rate
 
35.0
 %
 
35.0
 %
 
35.0
 %
State income taxes, net of federal benefit
 
2.6

 
2.8

 
2.9

Domestic production activities deduction
 
(2.7
)
 
(3.5
)
 
(2.3
)
Tax credits
 
(1.2
)
 
(1.7
)
 
(0.1
)
Nondeductible expenses
 
0.7

 
1.7

 
1.4

Other
 
(1.1
)
 
(1.6
)
 
(1.3
)
Effective tax rate
 
33.3
 %
 
32.7
 %
 
35.6
 %

Deferred income taxes reflect the tax effects of temporary differences between the basis of assets and liabilities recognized for financial reporting purposes and tax purposes. Significant components of our deferred income taxes are as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
Deferred tax assets:
 
 
 
 
Inventory reserve
 
$
22,808

 
$
19,635

Accruals, reserves, and other currently not deductible
 
19,043

 
17,133

Stock-based compensation
 
5,548

 
5,152

Foreign net operating loss carryforwards
 
418

 
724

Total deferred tax assets
 
47,817

 
42,644

Valuation allowance
 
(45
)
 
(327
)
Total deferred tax assets, net of valuation allowance
 
47,772

 
42,317

Deferred tax liabilities:
 
 
 
 
Depreciation and amortization
 
(9,865
)
 
(9,759
)
Other
 
(2,643
)
 
(1,229
)
Total deferred tax liabilities
 
(12,508
)
 
(10,988
)
Net deferred tax assets
 
$
35,264

 
$
31,329


In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that we will realize the benefits of these deductible differences at December 31, 2014. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced. Of the amounts presented above, $0.4 million of long-term deferred tax assets is included as a component of other assets on our consolidated balance sheet as of December 31, 2014 and 2013.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Unrecognized tax benefits at the beginning of the year
 
$
3,978

 
$
3,500

 
$
2,799

Additions related to current year tax positions
 
—

 
661

 
673

Additions related to prior year tax positions
 
614

 
64

 
46

Reductions related to prior year tax positions
 
(209
)
 
(109
)
 
(18
)
Lapse of statute of limitations
 
(202
)
 
(138
)
 
—

Settlements
 
(953
)
 
—

 
—

Unrecognized tax benefits at the end of the year
 
$
3,228

 
$
3,978

 
$
3,500


The impact of our unrecognized tax benefits to the effective income tax rate is as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Portion of total unrecognized tax benefits that, if recognized, would affect the effective income tax rate
 
$
838

 
$
1,184

 
$
747


Interest and penalties are recorded in the statement of operations as provision for income taxes. The total interest and penalties recorded in the statement of operations was nominal for the years ended December 31, 2014, 2013 and 2012. Our uncertain tax benefits could increase in the next twelve months as we continue our current transfer pricing policies and deduct additional tax credits. We are unable to estimate a range of reasonably possible changes in our uncertain tax benefits in the next twelve months. In 2014, we settled the IRS audits of 2011 and 2012 tax years, resulting in no adjustments. The tax years that remained subject to examination by a major tax jurisdiction as of December 31, 2014 were 2009 and beyond for Switzerland; 2010 and beyond for India, Belgium, Germany, and Poland; 2011 and beyond for Denmark, Sweden and Australia; 2012 and beyond for South Africa and Israel; 2013 and beyond for the United States, the United Kingdom, Netherlands, and France.
On December 19, 2014, the Tax Increase Prevention Act of 2014 (the “TIPA”) was signed into law. One of the provisions of the TIPA was the reinstatement of the research and experimentation tax credit from January 1, 2014 through December 31, 2014. As of December 31, 2014 a benefit was recognized for this tax credit and is included in the 2014 tax provision.
On January 2, 2013, the American Taxpayer Relief Act of 2012 (the “ATRA”) was signed into law. One of the provisions of the ATRA was a reinstatement and extension of the research and experimentation tax credit from January 1, 2012 through December 31, 2013. However, as of December 31, 2012 no benefit could be recognized for this tax credit due to the passage of the ATRA in 2013. As the passage of the ATRA occurred in 2013, the entire reinstated credit for the year ended December 31, 2012 of $0.9 million was recognized in 2013 in accordance with accounting guidance.
XML 75 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCRUED EXPENSES
 12 Months Ended
Dec. 31, 2013
Payables and Accruals [Abstract]  
Accrued Expenses
ACCRUED EXPENSES
(In thousands)
December 31,
2014
 
December 31,
2013
Compensation and other employee-related costs
$
19,933

 
$
17,428

Legal and other settlements and expenses
27,686

 
23,765

Accrued non-income taxes
4,720

 
2,938

Other
9,160

 
6,994

Total accrued expenses
$
61,499

 
$
51,125
XML 76 R60.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION (Grant Date Fair Values of Options Awarded to Employees) (Details) (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]      
Weighted average grant date per share fair value $ 9.63us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue $ 6.34us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue $ 5.90us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
XML 77 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
INVENTORIES
 12 Months Ended
Dec. 31, 2014
Inventory Disclosure [Abstract]  
Inventories
INVENTORIES
(In thousands)
December 31, 2014
 
December 31, 2013
Raw materials
$
8,847

 
$
1,369

Work in process
2,490

 
2,820

Finished goods
79,608

 
66,161

Total
$
90,945

 
$
70,350
XML 78 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
PROPERTY & EQUIPMENT
 12 Months Ended
Dec. 31, 2014
Property, Plant and Equipment [Abstract]  
Property And Equipment
PROPERTY AND EQUIPMENT
(In thousands)
 
Useful Life
 
December 31, 2014
 
December 31, 2013
Land
 
—
 
$
4,116

 
$
3,769

Buildings and improvements
 
30
 
10,369

 
9,541

Equipment
 
5-7
 
17,783

 
14,588

Instruments
 
3
 
123,864

 
107,867

Modules and cases
 
3
 
25,155

 
22,325

Other property and equipment
 
3-5
 
6,732

 
5,970

 
 
 
 
188,019

 
164,060

Less: accumulated depreciation
 
 
 
(118,544
)
 
(99,910
)
Total
 
 
 
$
69,475

 
$
64,150


Instruments are hand-held devices used by surgeons to install implants during surgery. Modules and cases are used to store and transport the instruments and implants.
Depreciation expense related to property and equipment was as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Depreciation
 
$
21,044

 
$
18,869

 
$
17,640
XML 79 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9
DEBT
 12 Months Ended
Dec. 31, 2014
Debt Disclosure [Abstract]  
Debt
DEBT
Line of Credit
In May 2011, we entered into a credit agreement with Wells Fargo Bank related to a revolving credit facility that provides for borrowings up to $50.0 million. At our request, and with the approval of the bank, the amount of borrowings available under the revolving credit facility can be increased to $75.0 million. The revolving credit facility includes up to a $25.0 million sub-limit for letters of credit. As amended to date, the revolving credit facility extends to May 2015. Cash advances bear interest at our option either at a fluctuating rate per annum equal to the daily LIBOR in effect for a one-month period plus 0.75%, or a fixed rate for a one- or three-month period equal to LIBOR plus 0.75%. The credit agreement governing the revolving credit facility also subjects us to various restrictive covenants, including the requirement to maintain maximum consolidated leverage. The covenants also include limitations on our ability to repurchase shares, to pay cash dividends or to enter into a sale transaction. As of December 31, 2014, we were in compliance with all covenants under the credit agreement, there were no outstanding borrowings under the revolving credit facility and available borrowings were $50.0 million. We may terminate the credit agreement at any time on ten days’ notice without premium or penalty.
XML 80 R64.htm IDEA: XBRL DOCUMENT v2.4.1.9
INCOME TAXES (Components of Income (Loss) Before Income Taxes) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income Tax Disclosure [Abstract]      
Income before taxes, domestic $ 137,643us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic $ 101,424us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic $ 114,176us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
Income/(loss) before taxes, foreign 999us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign 577us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign 477us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
Income before income taxes $ 138,642us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments $ 102,001us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments $ 114,653us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
XML 81 R66.htm IDEA: XBRL DOCUMENT v2.4.1.9
INCOME TAXES (Reconciliation of Statutory U.S. Federal Tax Rate to Effective Rate) (Details)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income Tax Disclosure [Abstract]      
Statutory U.S. federal tax rate 35.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate 35.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate 35.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
State income taxes, net of federal benefit 2.60%us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes 2.80%us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes 2.90%us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
Domestic production activities deduction (2.70%)us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities (3.50%)us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities (2.30%)us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
Tax credits (1.20%)us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits (1.70%)us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits (0.10%)us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits
Nondeductible expenses 0.70%us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense 1.70%us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense 1.40%us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense
Other (1.10%)us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments (1.60%)us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments (1.30%)us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments
Effective tax rate 33.30%us-gaap_EffectiveIncomeTaxRateContinuingOperations 32.70%us-gaap_EffectiveIncomeTaxRateContinuingOperations 35.60%us-gaap_EffectiveIncomeTaxRateContinuingOperations
XML 82 R63.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION (Compensation Expense Related to Stock Options and Their Intrinsic Values) (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]      
Compensation expense related to stock options $ 7,111us-gaap_AllocatedShareBasedCompensationExpense $ 5,177us-gaap_AllocatedShareBasedCompensationExpense $ 4,635us-gaap_AllocatedShareBasedCompensationExpense
Intrinsic value of stock options exercised $ 20,216us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue $ 25,034us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue $ 12,507us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
XML 83 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
PROPERTY & EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2014
Property, Plant and Equipment [Abstract]  
Property And Equipment
(In thousands)
 
Useful Life
 
December 31, 2014
 
December 31, 2013
Land
 
—
 
$
4,116

 
$
3,769

Buildings and improvements
 
30
 
10,369

 
9,541

Equipment
 
5-7
 
17,783

 
14,588

Instruments
 
3
 
123,864

 
107,867

Modules and cases
 
3
 
25,155

 
22,325

Other property and equipment
 
3-5
 
6,732

 
5,970

 
 
 
 
188,019

 
164,060

Less: accumulated depreciation
 
 
 
(118,544
)
 
(99,910
)
Total
 
 
 
$
69,475

 
$
64,150
Schedule Of Depreciation Of Property And Equipment
Depreciation expense related to property and equipment was as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Depreciation
 
$
21,044

 
$
18,869

 
$
17,640
XML 84 R51.htm IDEA: XBRL DOCUMENT v2.4.1.9
MARKETABLE SECURITIES (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Short-term Marketable Securities    
Schedule of Marketable Securities    
Amortized Cost $ 146,467us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember		 $ 148,950us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
Gross Unrealized Gains 17us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember		 38us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
Gross Unrealized Losses (45)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember		 (26)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
Fair Value 146,439us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember		 148,962us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
Short-term Marketable Securities | Municipal Bonds    
Schedule of Marketable Securities    
Amortized Cost 28,684us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 77,342us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Gross Unrealized Gains 2us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 17us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Gross Unrealized Losses (3)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 (15)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Fair Value 28,683us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 77,344us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Short-term Marketable Securities | Municipal Bonds | Maximum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 1 year 1 year
Short-term Marketable Securities | Corporate Debt Securities    
Schedule of Marketable Securities    
Amortized Cost 73,066us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 35,525us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Gross Unrealized Gains 7us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 15us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Gross Unrealized Losses (42)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 (11)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Fair Value 73,031us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 35,529us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Short-term Marketable Securities | Corporate Debt Securities | Maximum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 1 year 1 year
Short-term Marketable Securities | Commercial Paper    
Schedule of Marketable Securities    
Amortized Cost 44,663us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember		 36,083us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember
Gross Unrealized Gains 8us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember		 6us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember
Gross Unrealized Losses 0us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember		 0us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember
Fair Value 44,671us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember		 36,089us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CommercialPaperMember
Short-term Marketable Securities | Commercial Paper | Maximum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 1 year 1 year
Short-term Marketable Securities | Asset-backed Securities    
Schedule of Marketable Securities    
Amortized Cost 54us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		  
Gross Unrealized Gains 0us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		  
Gross Unrealized Losses 0us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		  
Fair Value 54us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_ShortTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		  
Short-term Marketable Securities | Asset-backed Securities | Maximum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 1 year  
Long-term Marketable Securities    
Schedule of Marketable Securities    
Amortized Cost 75,422us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember		 36,488us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
Gross Unrealized Gains 7us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember		 42us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
Gross Unrealized Losses (82)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember		 (2)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
Fair Value 75,347us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember		 36,528us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
Long-term Marketable Securities | Municipal Bonds    
Schedule of Marketable Securities    
Amortized Cost 26,005us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 12,304us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Gross Unrealized Gains 3us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 13us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Gross Unrealized Losses (36)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 (1)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Fair Value 25,972us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember		 12,316us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_MunicipalBondsMember
Long-term Marketable Securities | Municipal Bonds | Minimum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 1 year 1 year
Long-term Marketable Securities | Municipal Bonds | Maximum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 2 years 2 years
Long-term Marketable Securities | Corporate Debt Securities    
Schedule of Marketable Securities    
Amortized Cost 19,617us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 17,533us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Gross Unrealized Gains 3us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 27us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Gross Unrealized Losses (22)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 0us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Fair Value 19,598us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember		 17,560us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Long-term Marketable Securities | Corporate Debt Securities | Minimum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 1 year 1 year
Long-term Marketable Securities | Corporate Debt Securities | Maximum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 2 years 2 years
Long-term Marketable Securities | Asset-backed Securities    
Schedule of Marketable Securities    
Amortized Cost 21,236us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		 6,651us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember
Gross Unrealized Gains 1us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		 2us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember
Gross Unrealized Losses (8)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		 (1)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember
Fair Value 21,229us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember		 6,652us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_AssetBackedSecuritiesMember
Long-term Marketable Securities | Asset-backed Securities | Minimum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 1 year 1 year
Long-term Marketable Securities | Asset-backed Securities | Maximum    
Schedule of Marketable Securities    
Available For Sale Securities Contractual Maturity 2 years 2 years
Long-term Marketable Securities | US Government-sponsored Enterprises Debt Securities [Member]    
Schedule of Marketable Securities    
Amortized Cost 8,564us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember		  
Gross Unrealized Gains 0us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember		  
Gross Unrealized Losses (16)us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember		  
Fair Value $ 8,548us-gaap_AvailableForSaleSecurities
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherLongTermInvestmentsMember
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember		  
XML 85 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
COMMITMENTS AND CONTINGENCIES
We are involved in a number of proceedings, legal actions, and claims. Such matters are subject to many uncertainties, and the outcomes of these matters are not within our control and may not be known for prolonged periods of time. In some actions, the claimants seek damages, as well as other relief, including injunctions prohibiting us from engaging in certain activities, which, if granted, could require significant expenditures and/or result in lost revenues. We record a liability in the consolidated financial statements for these actions when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded. While it is not possible to predict the outcome for most of the matters discussed, we believe it is possible that costs associated with them could have a material adverse impact on our consolidated earnings, financial position or cash flows.
N-Spine, Synthes and Depuy Synthes Litigation
In April 2010, N-Spine, Inc. and Synthes USA Sales, LLC filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. N-Spine, the patent owner, and Synthes USA, a licensee of the subject patent, allege that we infringe one or more claims of the patent by making, using, offering for sale or selling our TRANSITION® stabilization system product. N-Spine and Synthes USA seek injunctive relief and an unspecified amount in damages. We intend to defend our rights vigorously. This matter was stayed on July 14, 2011 pending the resolution of an inter partes reexamination on the asserted patent granted by the U.S. Patent and Trademark Office (“USPTO”) in February 2011. In December 2011, the examiner withdrew the original grounds of rejection of the asserted patent and we appealed the examiner’s decision. In January 2014, the USPTO ruled on the appeal, rejecting certain claims in view of the prior art and affirming certain other claims. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
In a related matter, on January 8, 2014, Depuy Synthes Products, LLC (“Depuy Synthes”) filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. Depuy Synthes alleges that we infringe one or more claims of the asserted patent by making, using, offering for sale or selling our TRANSITION® stabilization system product. Depuy Synthes seeks injunctive relief and an unspecified amount in damages. We intend to defend our rights vigorously. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
Synthes USA, LLC, Synthes USA Products, LLC and Synthes USA Sales, LLC Litigation
In July 2011, Synthes USA, LLC, Synthes USA Products, LLC and Synthes USA Sales, LLC filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. Synthes USA LLC, the patent owner, Synthes USA Products, LLC, a licensee to manufacture products of the subject patents, and Synthes USA Sales LLC, a licensee to sell products of the subject patents, allege that we infringe one or more claims of three patents by making, using, offering for sale or selling our COALITION®, INDEPENDENCE® and INTERCONTINENTAL® products. As a result of the acquisition of Synthes, Inc. by Johnson & Johnson, a motion was filed to change the plaintiff in this matter to DePuy Synthes in February 2013. On June 14, 2013, the jury in this case returned a verdict, finding that prior versions of the three products we previously sold did infringe on DePuy Synthes’ patents and awarding monetary damages in the amount of $16.0 million. The jury also upheld the validity of DePuy Synthes’ patents. There was no finding of willful infringement by Globus.
We do not expect the verdict to impact our ability to conduct our business or to have any material impact on our future revenues. As this lawsuit involved only three products that are no longer part of our product portfolio, this verdict is not expected to impair our ability to sell any of our future products.
We believe the facts and the law do not support the jury’s findings of infringement and patent validity and are seeking to overturn the verdict through the appeals process.
For the year ended December 31, 2013, we accrued $19.5 million in damages and other litigation-related costs related to this case, of which $1.3 million was included in provision for litigation loss (cost of goods sold, due to a write off of certain inventory which will not be sold due to the verdict) and $18.2 million was included in provision for litigation loss (operating expense). During the year ended December 31, 2014, we accrued an additional $0.6 million in interest included in provision for litigation related to this litigation.
L5 Litigation
In December 2009, we filed suit in the Court of Common Pleas of Montgomery County, Pennsylvania against our former exclusive independent distributor L5 Surgical, LLC and its principals, seeking an injunction and declaratory judgment concerning certain restrictive covenants made to L5 by its sales representatives. L5 brought counterclaims against us alleging tortious interference, unfair competition and conspiracy. The injunction phase was resolved in September 2010, and this matter is now in the discovery phase of litigation on the underlying damages claims. We intend to defend our rights vigorously. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
NuVasive Litigation
In October 2010, NuVasive, Inc. filed suit against us in the U.S. District Court for the District of Delaware for patent infringement. NuVasive, the patent owner, alleges that we infringe one or more claims of three patents by making, using, offering for sale or selling our MARS™ 3V retractor for use in certain lateral fusion procedures. NuVasive sought injunctive relief and an unspecified amount in damages. This matter was settled on Feburary 12, 2015 for an undisclosed amount.
NuVasive Employee Litigation
We have hired several employees who were formerly employed by NuVasive, Inc. In July 2011, NuVasive filed suit against us in the District Court of Travis County, Texas alleging that our hiring of one named former employee and other unnamed former employees constitutes tortious interference with its contracts with those employees, and with prospective business relationships, as well as aiding and abetting the breach of fiduciary duty. NuVasive sought compensatory damages, permanent injunction, punitive damages and attorneys’ fees. This matter was settled on Feburary 12, 2015 for an undisclosed amount.
Bianco Litigation
On March 21, 2012, Sabatino Bianco filed suit against us in the Federal District Court for the Eastern District of Texas claiming that we misappropriated his trade secret and confidential information and improperly utilized it in developing our CALIBER® product. Bianco alleges that we engaged in misappropriation of trade secrets, breach of contract, unfair competition, fraud and theft and seeks correction of inventorship, injunctive relief and exemplary damages. On April 20, 2012, Bianco filed a motion for a preliminary injunction, seeking to enjoin us from making, using, selling, importing or offering for sale our CALIBER® product. On November 15, 2012, the court denied Bianco’s motion for preliminary injunction. On October 1, 2013, Bianco amended his complaint to include that his trade secrets and confidential information were also used improperly in developing our RISE® and CALIBER®-L products.
On January 17, 2014, the jury in this case returned a verdict in favor of Bianco on a claim of misappropriation of trade secret. We have accrued the verdict amount of $4.3 million as of December 31, 2013. The jury found against Bianco on the claims of breach of contract and disgorgement of profits. The court granted our motion for judgment as a matter of law and dismissed Bianco’s claims for unfair competition, fraud, and exemplary damages, and Bianco abandoned the claim of misappropriation of confidential information. Bianco’s claims of correction of inventorship, unjust enrichment, and permanent injunctive relief were not submitted to the jury. On March 7, 2014, the court denied Bianco’s claim for correction of inventorship and ruled he is not entitled to be named as a co-inventor on any of the patents at issue, and also denied his claim for unjust enrichment. On March 17, 2014, the court denied Bianco’s claim for permanent injunctive relief. On July 2, 2014, the court awarded Bianco an ongoing royalty of 5% of the net sales of the CALIBER®, CALIBER®-L, and RISE® products, or products that are not colorably different from those products, for a fifteen year period on sales starting on January 18, 2014. The court entered final judgment on the jury verdict on July 17, 2014. Post-trial motions were denied on October 27, 2014 and the matter is currently on appeal.
We do not expect the verdict to impact our ability to conduct our business or to have any material impact on our future revenues. We believe the facts and the law do not support the jury’s findings of misappropriation of trade secret and are seeking to overturn the verdict through the appeals process.
Altus Partners, LLC Litigation
On February 20, 2013, Altus Partners, LLC filed suit against us in the U.S. District Court for the Eastern District of Pennsylvania for patent infringement.  On April 7, 2014, we settled the litigation with Altus Partners and recognized a provision for litigation of $2.0 million.
Bonutti Skeletal Innovations, LLC Litigation
On November 19, 2014, Bonutti Skeletal Innovations, LLC filed suit against us in the U.S. District Court for the Eastern District of Pennsylvania for patent infringement. Bonutti Skeletal, a non-practicing entity, alleges that Globus willfully infringes one or more claims of six patents by making, using, offering for sale or selling the CALIBER®, CALIBER®-L, COALITION®, CONTINENTAL®, FORGE®, FORTIFY®, INDEPENDENCE®, INTERCONTINENTAL®, MONUMENT®, NIKO®, RISE®, SIGNATURE®, SUSTAIN®, and TRANSCONTINENTAL® products. Bonutti Skeletal seeks an unspecified amount in damages and injunctive relief. The probable outcome of this litigation cannot be determined, nor can we estimate a range of potential loss. Therefore, in accordance with authoritative guidance on the evaluation of loss contingencies, we have not recorded an accrual related to this litigation.
In addition, we are subject to legal proceedings arising in the ordinary course of business.
XML 86 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
SUBSEQUENT EVENT
 12 Months Ended
Dec. 31, 2014
Subsequent Event  
Subsequent Event
SUBSEQUENT EVENT
On February 25, 2015, we entered into an agreement to acquire medical device manufacturer Branch Medical Group, Inc. (“BMG”), a third party manufacturer of high precision medical devices located in Audubon, PA. Under the terms of the agreement, we expect to pay approximately $52.9 million in cash subject to certain closing adjustments for BMG.
We expect the closing of the acquisition to occur in March 2015 following satisfaction of the applicable closing conditions.
XML 87 R49.htm IDEA: XBRL DOCUMENT v2.4.1.9
INTANGIBLE ASSETS (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Acquired Intangible Assets      
Intangible Assets, Gross Carrying Amount $ 36,305gmed_IntangibleAssetsGross $ 30,603gmed_IntangibleAssetsGross  
Accumulated Amortization (1,776)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization (1,066)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization  
Intangible asset amortization expense 710us-gaap_AmortizationOfIntangibleAssets 528us-gaap_AmortizationOfIntangibleAssets 468us-gaap_AmortizationOfIntangibleAssets
Intangible assets, net 34,529us-gaap_IntangibleAssetsNetExcludingGoodwill 29,537us-gaap_IntangibleAssetsNetExcludingGoodwill  
Finite-lived intangible assets, net 9,969us-gaap_FiniteLivedIntangibleAssetsNet    
Supplier Network      
Acquired Intangible Assets      
Weighted average amortization period 10 years    
Gross carrying amount 3,800us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= gmed_SupplierNetworkMember		    
Accumulated Amortization (88)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= gmed_SupplierNetworkMember		    
Finite-lived intangible assets, net 3,712us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= gmed_SupplierNetworkMember		    
Customer relationships & other intangibles      
Acquired Intangible Assets      
Weighted average amortization period 7 years 3 months 9 years 6 months  
Gross carrying amount 5,525us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		 3,623us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		  
Accumulated Amortization (1,344)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		 (864)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		  
Finite-lived intangible assets, net 4,181us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		 2,759us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		  
Patents      
Acquired Intangible Assets      
Weighted average amortization period 17 years 17 years  
Gross carrying amount 2,420us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		 2,420us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		  
Accumulated Amortization (344)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		 (202)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		  
Finite-lived intangible assets, net 2,076us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		 2,218us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		  
In-process Research and Development      
Acquired Intangible Assets      
Indefinite-lived intangible assets $ 24,560us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember		 $ 24,560us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember		  
XML 88 R41.htm IDEA: XBRL DOCUMENT v2.4.1.9
RELATED-PARTY TRANSACTIONS (Tables)
 12 Months Ended
Dec. 31, 2014
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions
We have purchased the following amounts of products and services from the supplier:
 
Year Ended
(In thousands)
December 31, 2014
 
December 31,
2013
 
December 31,
2012
Purchases from related-party supplier
$
21,948

 
$
20,039

 
$
20,159
XML 89 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Comprehensive Income (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Statement of Comprehensive Income [Abstract]      
Net income $ 92,485us-gaap_NetIncomeLoss $ 68,612us-gaap_NetIncomeLoss $ 73,831us-gaap_NetIncomeLoss
Other comprehensive income/(loss):      
Unrealized gain on marketable securities, net of tax (96)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax 32us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax 0us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
Change in accumulated foreign currency translation gain/(loss) (552)us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent (274)us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent 435us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
Total other comprehensive income/(loss) (648)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent (242)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent 435us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
Comprehensive income $ 91,837us-gaap_ComprehensiveIncomeNetOfTax $ 68,370us-gaap_ComprehensiveIncomeNetOfTax $ 74,266us-gaap_ComprehensiveIncomeNetOfTax
XML 90 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2014
Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure
INTANGIBLE ASSETS
A summary of intangible assets is presented below:
 
 
 
December 31, 2014
(In thousands)
Weighted-
Average Amortization
Period
(in years)
 
Gross
Carrying
Amount  
 
Accumulated Amortization  
 
Intangible
Assets, net
 
 
In-process research & development
—
 
$
24,560

 
$
—

 
$
24,560

Supplier network
10.0
 
3,800

 
(88
)
 
3,712

Customer relationships & other intangibles
7.3
 
5,525

 
(1,344
)
 
4,181

Patents
17.0
 
2,420

 
(344
)
 
2,076

Total intangible assets
 
 
$
36,305

 
$
(1,776
)
 
$
34,529

 
 
 
December 31, 2013
(In thousands)
Weighted-
Average Amortization
Period
(in years)
 
Gross
Carrying
Amount  
 
Accumulated Amortization  
 
Intangible
Assets, net
 
 
In-process research & development
—
 
$
24,560

 
$
—

 
$
24,560

Customer relationships & other intangibles
9.5
 
3,623

 
(864
)
 
2,759

Patents
17.0
 
2,420

 
(202
)
 
2,218

Total intangible assets
 
 
$
30,603

 
$
(1,066
)
 
$
29,537


Amortization expense was as follows:
(in thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Intangible asset amortization expense
 
$
710

 
$
528

 
$
468


Expected future intangible asset amortization as of December 31, 2014 is as follows:
(In thousands)
 
Annual Amortization
Year ending December 31:
 
 
2015
 
$
1,545

2016
 
1,541

2017
 
1,423

2018
 
856

2019
 
852

Thereafter
 
3,752

Total
 
$
9,969
XML 91 R58.htm IDEA: XBRL DOCUMENT v2.4.1.9
EQUITY (Schedule of Issued and Outstanding Shares) (Details)
Dec. 31, 2014
Dec. 31, 2013
Class of Stock    
Common stock, shares outstanding 94,705,743us-gaap_CommonStockSharesOutstanding 93,442,753us-gaap_CommonStockSharesOutstanding
Common stock, shares issued 94,705,743us-gaap_CommonStockSharesIssued 93,442,753us-gaap_CommonStockSharesIssued
Class A Common    
Class of Stock    
Common stock, shares outstanding 70,828,187us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 66,065,197us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
Common stock, shares issued 70,828,187us-gaap_CommonStockSharesIssued
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember		 66,065,197us-gaap_CommonStockSharesIssued
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassAMember
Class B Common    
Class of Stock    
Common stock, shares outstanding 23,877,556us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 27,377,556us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
Common stock, shares issued 23,877,556us-gaap_CommonStockSharesIssued
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember		 27,377,556us-gaap_CommonStockSharesIssued
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonClassBMember
XML 92 R69.htm IDEA: XBRL DOCUMENT v2.4.1.9
INCOME TAXES (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Income Tax Examination    
Benefit recorded in 2013 for reinstated 2012 tax credit   $ 0.9gmed_IncomeTaxBenefitEnactedLegislationEstimatedBenefitExpectedToBeRecordedInNextFiscalYear
Other Assets    
Income Tax Examination    
Long term deferred tax asset $ 0.4us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherAssetsMember		 $ 0.4us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent
/ us-gaap_BalanceSheetLocationAxis
= us-gaap_OtherAssetsMember
XML 93 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS
 12 Months Ended
Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]  
Valuation Accounts and Qualifying Accounts
VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS
Allowance for doubtful accounts:
(In thousands)
Beginning of period
 
Additions
 
Write-offs
 
End of period
Year ended December 31, 2012
$
602

 
$
363

 
$
(4
)
 
$
961

Year ended December 31, 2013
961

 
693

 
(73
)
 
1,581

Year ended December 31, 2014
$
1,581

 
$
318

 
$
(252
)
 
$
1,647

Deferred tax valuation allowance:
(In thousands)
Beginning of period
 
Additions
 
Write-offs
 
End of period
Year ended December 31, 2012
$
1,149

 
$
—

 
$
(616
)
 
$
533

Year ended December 31, 2013
533

 
—

 
(206
)
 
327

Year ended December 31, 2014
$
327

 
$
—

 
$
(282
)
 
$
45
XML 94 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 290 350 1 true 67 0 false 8 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.globusmedical.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.globusmedical.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 1001001 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.globusmedical.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) false false R4.htm 1003000 - Statement - Consolidated Statements of Income Sheet http://www.globusmedical.com/role/ConsolidatedStatementsOfIncome Consolidated Statements of Income false false R5.htm 1004000 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.globusmedical.com/role/ConsolidatedStatementsOfComprehensiveIncome Consolidated Statements of Comprehensive Income false false R6.htm 1005000 - Statement - Consolidated Statements of Equity Sheet http://www.globusmedical.com/role/ConsolidatedStatementsOfEquity Consolidated Statements of Equity false false R7.htm 1006000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.globusmedical.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R8.htm 2101100 - Disclosure - BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.globusmedical.com/role/BackgroundAndSummaryOfSignificantAccountingPolicies BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 2107100 - Disclosure - ACQUISTIONS Sheet http://www.globusmedical.com/role/Acquistions ACQUISTIONS false false R10.htm 2110100 - Disclosure - INTANGIBLE ASSETS Sheet http://www.globusmedical.com/role/IntangibleAssets INTANGIBLE ASSETS false false R11.htm 2113100 - Disclosure - MARKETABLE SECURITIES Sheet http://www.globusmedical.com/role/MarketableSecurities MARKETABLE SECURITIES false false R12.htm 2116100 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.globusmedical.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS false false R13.htm 2122100 - Disclosure - INVENTORIES Sheet http://www.globusmedical.com/role/Inventories INVENTORIES false false R14.htm 2125100 - Disclosure - PROPERTY & EQUIPMENT Sheet http://www.globusmedical.com/role/PropertyEquipment PROPERTY & EQUIPMENT false false R15.htm 2128100 - Disclosure - ACCRUED EXPENSES Sheet http://www.globusmedical.com/role/AccruedExpenses ACCRUED EXPENSES false false R16.htm 2134100 - Disclosure - DEBT Sheet http://www.globusmedical.com/role/Debt DEBT false false R17.htm 2140100 - Disclosure - EQUITY Sheet http://www.globusmedical.com/role/Equity EQUITY false false R18.htm 2141100 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.globusmedical.com/role/StockBasedCompensation STOCK-BASED COMPENSATION false false R19.htm 2142100 - Disclosure - INCOME TAXES Sheet http://www.globusmedical.com/role/IncomeTaxes INCOME TAXES false false R20.htm 2143100 - Disclosure - LEASES Sheet http://www.globusmedical.com/role/Leases LEASES false false R21.htm 2144100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.globusmedical.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R22.htm 2145100 - Disclosure - RETIREMENT BENEFIT PLANS Sheet http://www.globusmedical.com/role/RetirementBenefitPlans RETIREMENT BENEFIT PLANS false false R23.htm 2146100 - Disclosure - RELATED-PARTY TRANSACTIONS Sheet http://www.globusmedical.com/role/RelatedPartyTransactions RELATED-PARTY TRANSACTIONS false false R24.htm 2147100 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION Sheet http://www.globusmedical.com/role/SegmentAndGeographicInformation SEGMENT AND GEOGRAPHIC INFORMATION false false R25.htm 2148100 - Disclosure - QUARTERLY FINANCIAL DATA (unaudited) Sheet http://www.globusmedical.com/role/QuarterlyFinancialDataUnaudited QUARTERLY FINANCIAL DATA (unaudited) false false R26.htm 2149100 - Disclosure - SUBSEQUENT EVENT Sheet http://www.globusmedical.com/role/SubsequentEvent SUBSEQUENT EVENT false false R27.htm 2150100 - Disclosure - VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS Sheet http://www.globusmedical.com/role/ValuationAccountsAndQualifyingAccounts VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS false false R28.htm 2201201 - Disclosure - BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.globusmedical.com/role/BackgroundAndSummaryOfSignificantAccountingPoliciesPolicies BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R29.htm 2307301 - Disclosure - ACQUISTIONS (Tables) Sheet http://www.globusmedical.com/role/AcquistionsTables ACQUISTIONS (Tables) false false R30.htm 2310301 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://www.globusmedical.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) false false R31.htm 2313301 - Disclosure - MARKETABLE SECURITIES (Tables) Sheet http://www.globusmedical.com/role/MarketableSecuritiesTables MARKETABLE SECURITIES (Tables) false false R32.htm 2316301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.globusmedical.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) false false R33.htm 2322301 - Disclosure - INVENTORIES (Tables) Sheet http://www.globusmedical.com/role/InventoriesTables INVENTORIES (Tables) false false R34.htm 2325301 - Disclosure - PROPERTY & EQUIPMENT (Tables) Sheet http://www.globusmedical.com/role/PropertyEquipmentTables PROPERTY & EQUIPMENT (Tables) false false R35.htm 2328301 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://www.globusmedical.com/role/AccruedExpensesTables ACCRUED EXPENSES (Tables) false false R36.htm 2340301 - Disclosure - EQUITY (Tables) Sheet http://www.globusmedical.com/role/EquityTables EQUITY (Tables) false false R37.htm 2341301 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.globusmedical.com/role/StockBasedCompensationTables STOCK-BASED COMPENSATION (Tables) false false R38.htm 2342301 - Disclosure - INCOME TAXES Income Taxes (Tables) Sheet http://www.globusmedical.com/role/IncomeTaxesIncomeTaxesTables INCOME TAXES Income Taxes (Tables) false false R39.htm 2343301 - Disclosure - LEASES (Tables) Sheet http://www.globusmedical.com/role/LeasesTables LEASES (Tables) false false R40.htm 2345301 - Disclosure - RETIREMENT BENEFIT PLANS (Tables) Sheet http://www.globusmedical.com/role/RetirementBenefitPlansTables RETIREMENT BENEFIT PLANS (Tables) false false R41.htm 2346301 - Disclosure - RELATED-PARTY TRANSACTIONS (Tables) Sheet http://www.globusmedical.com/role/RelatedPartyTransactionsTables RELATED-PARTY TRANSACTIONS (Tables) false false R42.htm 2347301 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables) Sheet http://www.globusmedical.com/role/SegmentAndGeographicInformationTables SEGMENT AND GEOGRAPHIC INFORMATION (Tables) false false R43.htm 2348301 - Disclosure - QUARTERLY FINANCIAL DATA (unaudited) (Tables) Sheet http://www.globusmedical.com/role/QuarterlyFinancialDataUnauditedTables QUARTERLY FINANCIAL DATA (unaudited) (Tables) false false R44.htm 2350301 - Disclosure - VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS (Tables) Sheet http://www.globusmedical.com/role/ValuationAccountsAndQualifyingAccountsTables VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS (Tables) false false R45.htm 2401402 - Disclosure - BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.globusmedical.com/role/BackgroundAndSummaryOfSignificantAccountingPoliciesDetails BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false R46.htm 2407402 - Disclosure - ACQUISTIONS (Textuals) (Details) Sheet http://www.globusmedical.com/role/AcquistionsTextualsDetails ACQUISTIONS (Textuals) (Details) false false R47.htm 2407403 - Disclosure - ACQUISTIONS (Assets Acquired and Liabilities) (Details) Sheet http://www.globusmedical.com/role/AcquistionsAssetsAcquiredAndLiabilitiesDetails ACQUISTIONS (Assets Acquired and Liabilities) (Details) false false R48.htm 2407404 - Disclosure - ACQUISTIONS (Contingent Consideration Payment Rollforward) (Details) Sheet http://www.globusmedical.com/role/AcquistionsContingentConsiderationPaymentRollforwardDetails ACQUISTIONS (Contingent Consideration Payment Rollforward) (Details) false false R49.htm 2410402 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://www.globusmedical.com/role/IntangibleAssetsDetails INTANGIBLE ASSETS (Details) false false R50.htm 2410403 - Disclosure - INTANGIBLE ASSETS Expected Future Amortization of Acquired Intangible Assets (Details) Sheet http://www.globusmedical.com/role/IntangibleAssetsExpectedFutureAmortizationOfAcquiredIntangibleAssetsDetails INTANGIBLE ASSETS Expected Future Amortization of Acquired Intangible Assets (Details) false false R51.htm 2413402 - Disclosure - MARKETABLE SECURITIES (Details) Sheet http://www.globusmedical.com/role/MarketableSecuritiesDetails MARKETABLE SECURITIES (Details) false false R52.htm 2416402 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://www.globusmedical.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) false false R53.htm 2422402 - Disclosure - INVENTORIES (Details) Sheet http://www.globusmedical.com/role/InventoriesDetails INVENTORIES (Details) false false R54.htm 2425402 - Disclosure - PROPERTY & EQUIPMENT (Details) Sheet http://www.globusmedical.com/role/PropertyEquipmentDetails PROPERTY & EQUIPMENT (Details) false false R55.htm 2428402 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://www.globusmedical.com/role/AccruedExpensesDetails ACCRUED EXPENSES (Details) false false R56.htm 2434401 - Disclosure - DEBT (Details) Sheet http://www.globusmedical.com/role/DebtDetails DEBT (Details) false false R57.htm 2440402 - Disclosure - EQUITY (Textuals) (Details) Sheet http://www.globusmedical.com/role/EquityTextualsDetails EQUITY (Textuals) (Details) false false R58.htm 2440403 - Disclosure - EQUITY (Schedule of Issued and Outstanding Shares) (Details) Sheet http://www.globusmedical.com/role/EquityScheduleOfIssuedAndOutstandingSharesDetails EQUITY (Schedule of Issued and Outstanding Shares) (Details) false false R59.htm 2441402 - Disclosure - STOCK-BASED COMPENSATION (Textuals) (Details) Sheet http://www.globusmedical.com/role/StockBasedCompensationTextualsDetails STOCK-BASED COMPENSATION (Textuals) (Details) false false R60.htm 2441403 - Disclosure - STOCK-BASED COMPENSATION (Grant Date Fair Values of Options Awarded to Employees) (Details) Sheet http://www.globusmedical.com/role/StockBasedCompensationGrantDateFairValuesOfOptionsAwardedToEmployeesDetails STOCK-BASED COMPENSATION (Grant Date Fair Values of Options Awarded to Employees) (Details) false false R61.htm 2441404 - Disclosure - STOCK-BASED COMPENSATION (Fair Value of Options, Assumptions) (Details) Sheet http://www.globusmedical.com/role/StockBasedCompensationFairValueOfOptionsAssumptionsDetails STOCK-BASED COMPENSATION (Fair Value of Options, Assumptions) (Details) false false R62.htm 2441405 - Disclosure - STOCK-BASED COMPENSATION (Stock Option Activity) (Details) Sheet http://www.globusmedical.com/role/StockBasedCompensationStockOptionActivityDetails STOCK-BASED COMPENSATION (Stock Option Activity) (Details) false false R63.htm 2441406 - Disclosure - STOCK-BASED COMPENSATION (Compensation Expense Related to Stock Options and Their Intrinsic Values) (Details) Sheet http://www.globusmedical.com/role/StockBasedCompensationCompensationExpenseRelatedToStockOptionsAndTheirIntrinsicValuesDetails STOCK-BASED COMPENSATION (Compensation Expense Related to Stock Options and Their Intrinsic Values) (Details) false false R64.htm 2442402 - Disclosure - INCOME TAXES (Components of Income (Loss) Before Income Taxes) (Details) Sheet http://www.globusmedical.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails INCOME TAXES (Components of Income (Loss) Before Income Taxes) (Details) false false R65.htm 2442403 - Disclosure - INCOME TAXES (Components of Provision for Income Taxes) (Details) Sheet http://www.globusmedical.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails INCOME TAXES (Components of Provision for Income Taxes) (Details) false false R66.htm 2442404 - Disclosure - INCOME TAXES (Reconciliation of Statutory U.S. Federal Tax Rate to Effective Rate) (Details) Sheet http://www.globusmedical.com/role/IncomeTaxesReconciliationOfStatutoryUSFederalTaxRateToEffectiveRateDetails INCOME TAXES (Reconciliation of Statutory U.S. Federal Tax Rate to Effective Rate) (Details) false false R67.htm 2442405 - Disclosure - INCOME TAXES (Components of Deferred Income Taxes) (Details) Sheet http://www.globusmedical.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesDetails INCOME TAXES (Components of Deferred Income Taxes) (Details) false false R68.htm 2442406 - Disclosure - INCOME TAXES (Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits) (Details) Sheet http://www.globusmedical.com/role/IncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetails INCOME TAXES (Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits) (Details) false false R69.htm 2442407 - Disclosure - INCOME TAXES (Narrative) (Details) Sheet http://www.globusmedical.com/role/IncomeTaxesNarrativeDetails INCOME TAXES (Narrative) (Details) false false R70.htm 2443402 - Disclosure - LEASES (Minimum Future Rental Payments Under Operating Leases) (Details) Sheet http://www.globusmedical.com/role/LeasesMinimumFutureRentalPaymentsUnderOperatingLeasesDetails LEASES (Minimum Future Rental Payments Under Operating Leases) (Details) false false R71.htm 2443403 - Disclosure - LEASES (Rent Expense Related to Operating Leases) (Details) Sheet http://www.globusmedical.com/role/LeasesRentExpenseRelatedToOperatingLeasesDetails LEASES (Rent Expense Related to Operating Leases) (Details) false false R72.htm 2444401 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.globusmedical.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) false false R73.htm 2445402 - Disclosure - RETIREMENT BENEFIT PLANS (Details) Sheet http://www.globusmedical.com/role/RetirementBenefitPlansDetails RETIREMENT BENEFIT PLANS (Details) false false R74.htm 2446402 - Disclosure - RELATED-PARTY TRANSACTIONS (Details) Sheet http://www.globusmedical.com/role/RelatedPartyTransactionsDetails RELATED-PARTY TRANSACTIONS (Details) false false R75.htm 2447402 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Geographic Location) (Details) Sheet http://www.globusmedical.com/role/SegmentAndGeographicInformationGeographicLocationDetails SEGMENT AND GEOGRAPHIC INFORMATION (Geographic Location) (Details) false false R76.htm 2447403 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Products) (Details) Sheet http://www.globusmedical.com/role/SegmentAndGeographicInformationProductsDetails SEGMENT AND GEOGRAPHIC INFORMATION (Products) (Details) false false R77.htm 2448402 - Disclosure - QUARTERLY FINANCIAL DATA (unaudited) (Details) Sheet http://www.globusmedical.com/role/QuarterlyFinancialDataUnauditedDetails QUARTERLY FINANCIAL DATA (unaudited) (Details) false false R78.htm 2449402 - Disclosure - SUBSEQUENT EVENT (Details) Sheet http://www.globusmedical.com/role/SubsequentEventDetails SUBSEQUENT EVENT (Details) false false R79.htm 2450402 - Disclosure - VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS (Details) Sheet http://www.globusmedical.com/role/ValuationAccountsAndQualifyingAccountsDetails VALUATION ACCOUNTS AND QUALIFYING ACCOUNTS (Details) false false All Reports Book All Reports Element us-gaap_ConversionOfStockSharesConverted1 had a mix of decimals attribute values: -3 0. Element us-gaap_LossContingencyAccrualProvision had a mix of decimals attribute values: -5 -3. 'Shares' elements on report '1005000 - Statement - Consolidated Statements of Equity' had a mix of different decimal attribute values. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 33 values. Shorter duration columns must have at least one fourth (8) as many values. Column '1/1/2013 - 3/31/2013' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 33 values. Shorter duration columns must have at least one fourth (8) as many values. Column '4/1/2013 - 6/30/2013' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 33 values. Shorter duration columns must have at least one fourth (8) as many values. Column '7/1/2013 - 9/30/2013' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 33 values. Shorter duration columns must have at least one fourth (8) as many values. Column '10/1/2013 - 12/31/2013' is shorter (91 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 33 values. Shorter duration columns must have at least one fourth (8) as many values. Column '1/1/2014 - 3/31/2014' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 33 values. Shorter duration columns must have at least one fourth (8) as many values. Column '4/1/2014 - 6/30/2014' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 33 values. Shorter duration columns must have at least one fourth (8) as many values. Column '7/1/2014 - 9/30/2014' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 33 values. Shorter duration columns must have at least one fourth (8) as many values. Column '10/1/2014 - 12/31/2014' is shorter (91 days) and has only 2 values, so it is being removed. 'Monetary' elements on report '2401402 - Disclosure - BACKGROUND AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2407402 - Disclosure - ACQUISTIONS (Textuals) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2440402 - Disclosure - EQUITY (Textuals) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2444401 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)' had a mix of different decimal attribute values. Process Flow-Through: 1001000 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 1001001 - Statement - Consolidated Balance Sheets (Parentheticals) Process Flow-Through: 1003000 - Statement - Consolidated Statements of Income Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: 1004000 - Statement - Consolidated Statements of Comprehensive Income Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: 1006000 - Statement - Consolidated Statements of Cash Flows gmed-20141231.xml gmed-20141231.xsd gmed-20141231_cal.xml gmed-20141231_def.xml gmed-20141231_lab.xml gmed-20141231_pre.xml true true XML 95 R74.htm IDEA: XBRL DOCUMENT v2.4.1.9
RELATED-PARTY TRANSACTIONS (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Related Party Transactions [Abstract]      
Accounts payable to related-party $ 5,359us-gaap_AccountsPayableRelatedPartiesCurrent $ 2,656us-gaap_AccountsPayableRelatedPartiesCurrent  
Purchases from related-party supplier $ 21,948us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty $ 20,039us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty $ 20,159us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty
ZIP 96 0001237831-15-000009-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001237831-15-000009-xbrl.zip M4$L#!!0````(`)J!6D:JCD#E<;X!``T8(0`1`!P`9VUE9"TR,#$T,3(S,2YX M;6Q55`D``U.,[U13C.]4=7@+``$$)0X```0Y`0``[%U9<^)(MGZ>&W'_@R_/ M0QDM;(YN3X"`&J9=99=Q=4\_5;?WTRQ"@1FDY3+F9B8<:&4 M,O.<[^RY_/*O][%[]8IPX/C>KR7E4Z5TA3S+MQUO]&OI^Z#<&AC]?NE?M__[ M/[_\7[G\W_;CW57'MZ(Q\L(K`R,S1/;5FQ.^7/UAH^#GU1#[XZL_?/S3>37_ M>37T\1AA=WKU!WKN.2[Y9E`NSS\UN6G4E4:U/FR0_Q_JMJ8VA_4A0HWZ4%%5 M-$36/]]OFK96T]#S4'FN(EVQ5+..]&H5-8:UNE*MZOBS`FD]_U MWOPI?5%-OF@C)_T=\B"E'_1NO:2WIT]27AB-D;U\X>WM[=/(]9^C@/SJ6*;[ MR?+']"5=45>O.-XK"L+T7F;/4OIQ`E]7E7JBJ_A-'X](\XIV/6^Q>(&P].>> MUO3QLQF@17//=*P@?4SQ(SHD)3DDS_>\:)S>AQWBZW`Z0=>D49FT0MBQEN]] M_%+R!8R&.V=2NR9/%PT#QTJ?`GF0,H$@G.`=[BH#PRS=FM?D^:(I?6!OR,62GK.' MB:9A:M/JK&FXWM39!U`O"$W/6D+N?0NB;UK<6FDVF]?QTV73P$YK2#ZK7/_W MR]W`>D%C<]78^;AQ>3D:HJ;^\0OM[":(GSRBX57<^6%#'\B(RG- M'U-&_%H*G/'$)7.ZCK\STW>6[X7H/;QRR*A['?KN-_W/IT[39J_9$YZ[&L7BR/HA5EXM?YA3:1S.- M(YII1]),RX!F_1AG*K,$FPE<.(=8K:Q5EE^=/SEG^K/9ZX9/'*;!BXE1P`,A MJC,5?DE"Q#@@LO-C;I-^#$("+>H4&JX9!/?#0>A;/UOO3K!L8?CCL>_%C]M? MT/@9X3QIMQ0H-**CG/TV^]$FG;]/7,=RPMFXKFR'M)DYQ//1W^R<7^EVT61[ M@K]0"XGM'T-3ZFGR'W0;Z9D.^L`'XRAUNB M<[@E"(=/MM'`80YL-(U@5(XB&/7("$;-*.J;T6Q;,+I_1V1&!"03WR/_#!+" M\4`"=80QLF-<<2P>:;-9CR@T'0_971-[M(;#,3SW(R1]HI+!Y*S`P`#5MU_U&3*H MOAP"&_7,P`80*K5Q7D.HFB="]X*L9=M.2(AGN@^F8_<]PYPXH>ER#+C]/-\[ M7^[YGVI#(<(L(L+,P1XIP&T&N:WDR6WP/L#[8`:AYQ;O`*'G%/]$0FBN%A-R M#)!C8$*'II2)#-^;+Y2?,Z`]_>XY?T>H@P(+.Q,:RL20HXLYJ7O7?[C?!57` M>2K4#B5QZ9;2^&:=QA='.X@:TP6ZDVJXD&')+!*+W@*#W;I3&9 MV&^A,<.2%68-MDRJM>.3CU#2YSC)!7I`*"`T\P+MV>XA MB:5\[Z_(L^C/]`"$,Y,]$J+^2#=S-\6+2?U((8;,N;O,"2YD:7D37,C9\A.G M0L*VB"5Q61743MI]`!`H)F?/REX$A8]=^%G)C`XRPX_,L'*LT:[B*#BTX#]R MZC^>"VL)$RR0SV`?UJ?M%.*]PLQL>3>'M/-I09!E1>/()4WM^_`%8=H,HQ=* MUU?4]RQ_C(1%P<%SES`X.OE\'_#RP,MC?Q'6[M0Q3\#+)U\NGF]T,\P1F$7!@59!R+SCB*M`9:CN4*O`90K*R?8"&2.K?0#%X`>`&,POJTM63@"!3M M"##G4C)P.HZ$:I:E??F@Z9G5]*<=/@LULWPB.59O>I))D8(68V`E"*BEPM42 MLH=9W($*;* MDT.ZQ!7R,LD5[.8JXA+TXT^,!0>B"`>"(?Y#*%)T*))#,N.<=6)@O,!X,>B0 M,5#4DU`RN"OJR2><+"2SF#OW$#(;#*WN@S0'LX)[VNIK*'OE$QYD>/DS#X?6 ML7/W,43-+$7-[-R2#+A@"1=9719Q?)8-#"3?^;.-4["^FF&$T?VP^SXA=$(; M,4,0W@\_^[X=//E<9M)39K?N(*=-+T>U'^B9__-\QNWE^-W5ZB.!+AVWR/Z:>0\NZ@5!"@,VM,OYE\^GN6R$PY"%(0D%L:/B,3*Y+/!BS/A M,""\--J.Z/H(JJ\Y+KO)GJ=-JY15[9(V[6*8EAE[LO#X)+T5?VX030C9$/Z* MPC/J(`F=AZ:7EV![TBUY_0J6]`7Z#J MWI$$6V'J((I="O50@V06^+R61_@%OKQ%G,W55L>X+QI_$#W*S]"*6%MUV;30 M5B$=TM8%IJTO76Z_@/">%7L%Q,^AZB'K,.1\R\FX`BL:XA*&URS@FH'P M.BMKO([F4Q`9+_W?;,T?)$^"Q9ZYYXN+[%?`2U698;TZPMSZ^$U%DFFN@BQ3@>S!I?'3P8OE#4@X[ND_%A1AK(#EZ`GA<=][14&X5MA:6_A("/XTG:#@?MA! MSR%1TK,C@0;(BK`3.BBIK+Y$'B'VQ'3;OF=SJ+-VT6W#)]I)N$L5*@^D^]JR ML13".)CXF`TL:K-@#MW*"]EP.`\0M@/#:O;=/ZB6Q`>`$(WT-_ MN?`]>/%Q"/K[1'3OIA[H[CRB^V+@/1XC;#GTAB,R!X!U3K!.H;ID(>3(%ZGCG!N*#7(Q9V3U3D(GH"^\58++:?H;)`.63A,TH3[C/H.4*H#[&0 M6(@N(!9B##E<"H&X'@XK7CS4RR6METN";_%]%T:! M7>@B)R80#;NXA/%"BMS%Q4=^12P0,K,MFX4P[+)9"+&`PL1B=A9`PH)U%-_7 M8]`X@I\'AE&(NBI#-2=(RDB:E&'.K#-2@8*X5Y*X%P0`RE`L"@(L-V303=K+ MEF6K1],;H62BTX7>01Q!'&$;-HM5 M,DC^,"2=IU;3(/4C@)`>:S=!.@6WG2"61;NRJ65=\&49D<6<:E4Q)G%A)!4,OD4CZAG@GV$XHH[,HG%%)R MM9^,B"783U[D4S;[R:N@0M86LK8@D`P))&1MI;:; M!17VHTCKYD+\R8.`LN7N@AV5P]T%*UJT%85XE'T;"K%HT5<(]TP'_VZZ$6I/ MOR`SB#"B$^UA]'>$/&N:D(UEV[66P2/E&W:\T9GB*OJ]W`<0>H700RA=F-"R M=U%WQMIG?H%;GI@M#W)E$8Q`VT M#?PS(UB\GYY\&&]21&J;.9>2)'%$O-!3GCF1;(55R>;^]-1+B+8"HLW,*:\@ MVQ!"@N@7+_H0U5Y8C#F5K!Q@S#$RA(OTP&9`)`@V`S0#1(H@^A`I,EGE$.0& M*'&PS\(]W9Q8-Y55ZP85CB5SP+A!A4,@R1;/7(*`@P47MMHAFTQR78"0$/]9 MVSG9\,^U3>(8_Y!,A.R%?)D[5KT>R%O(ZD)!WD)L?PY,I+3>(5AMJ*5#3A(J MZI"3E-4[!SD')QWDG#&A%"ADYASZ$)]R')_"2G$(7T^6?%@I+G!T*^(Q'!#? MPLD@X`6`K(.Y!UF7-9L%L@[Y+)!UKGQXV:22:V^;=?RG'&2<@0@(=$@X@XB& ML[G9@+3)Z;':G$#:E/M$:XTO+P5*>>Q(DSB!2*'512VC^./"DLULK@%6SD"F M@8>5,SG+>=$)0'&6I'.._6+7?W-BW:!JQH-]@ZH9TYET3F2=V1@59!V"59!U MKJ)6V:22ZPB38_S+#%9`AF01CSBI`XAT()M1M-:'DAGWH(?Z5/&>/D3UTL`,_%JI3`IM+J$V!!0<+#G(.AASD7#Y[ M#G46L.109V%"$,5+$'./?@FSL:Q:.$Y%0$Z;)"'^F:T\0BX6"HZ0BV4X1R.; M,'*=3Y$0_\Q:-LA=@&F3.7?Q@'WRC7#ZX))/S^DQH2-O3RFA$K)R9WHV?P)R MP`Q7#%]-D7LNZ\!EAKBQ^^H)DG)"@8/FR\20'N,7*L)0#-(((].-7^ M@V9@3S.P@I%8,_1)[SB*HW%!@1!KA:UI`:^:(.7"@4Q"A7UW#_!Z MG48!(<41HX.;-9@#NLGI)1O\`=V4][Z-,X&^$0))#^=C0D(`;4&@A9BDX)A$ M%$!!(`,0N;RAE"+`R=%00AASDEZ#@JZL4(G9?^=XZ'YH8&0[8<^T')?,J4_: M8Q2$CZ2W^TE(J!VL\))XP7E'-FVUH>WN?&]$/C&F2V:W5.0C>O7=5^*.)#OE M!W@QEHZ@VQQ]>PAW*;681O>5AMQ+>,G$8#.?+39BF<='?OGL\Y7>[R9VS&<7 MT88/"+<\;^%U2(*F"^B_W30$50@>08(;(N4:Y?,<(/EY*0\E2?KD!AP4$MXM M$"*5+5KNN]NBSMKFG13RL"XW4GE4^1H-WO)N8#0@$7A&(E`._<^L'F8-(A0A MZC>E%8VB(%P[U,![19B2]'XX"'WK9WOZW7/^CE`'!19V8N6RTMWKK0W7#`*# M;GOWO?C-)W_VT^H7_M!T*#GFJO8D>N0(.[5<:1P#N[C]96'7CV&GS6"G+7$W M",F'Z0QC&LV)O77N#)/&PWNAW3.\)>0\(6]N+?\[TKMN">->Q M'=M#WKFE.YB^E\HAG.OM'\(?R8SP9O+Z*%5K\`/ITU2MP7\".),T@BB*#A1+ M5HJE`-@-D.LZWBC^^\5W;?(J(/%`$LD,SAAK,4GNAR1,I]LO/">D!X-&SX06 MBQ^?L.D%II6$Z%?T-G@Q,0KZ01`ANSTEQ)Z8WF9Q2]2X-L;@T:2;8W<_[2[E M,[(>1$D.F>%]X(+5RP,^K@Y8[+U9F)[>X_O>.+Z4X1F$4H<._.'JL34UO;K[IH; MUWQ-*?X!:W-B+6LEO]YL*9*^2`8NLUCT3ADSF8>YQ\[(\4QW>>7,_7`K`;O' M@/70,XY,/%5ICY^QR=-)J?,\8#IUYF;H$/)-;N5UMJ:'M>&:/.(5>!N4=S-XI#4E!S8 MG1,ZHWCB],B)E6D83#TR]>![8-ZYUNH?#]BW(RL,R(\MSU[]/C!=1'])M\GN0\QLS3[+]&U^=:0UE%7*Y+_9!]Z[X-5VB*_@ M"X28]0E)%F+/V*XY)E*Q``$B?&M-0J&AY[$@%%T4,%X5) MO7-@``;F1JA0Z%Q?5@@('.>CLNX[;AW1EZW9D"J:R<.\\!@#Y51\7%;6/R-_ MA,W)BV.9[OI1XR'"7DQGT^4/=3MGMSQB?&MZ$OHIZJ&0L.C^.#S]\7T@"`CF M$[KY/LB1[>J1;%>+9CMH`ED@H8$FR%,3,!"Q',=VT`2R0.)@-Q$T@4BNX/;5 M'30*N\<#A%\=*W$'D>>_FG2U;R\*N$QXILUMJ0+2)B MD/7B^:X_XO#HQCV0V#U!,`X`BV)AP9VV`.,A@Y9004NPI"58R3$<#`O0$C+` M0?NF?'OJY,G5/#5K-JM8M&\:3S2K'TFS9EFK9$`SE2>:Z4?2K)8-S72.:*94 M6/!Z=(YPIA^),STCG.DVKF\\Y\]OWS'!U9*@U!GFZ+Q7RQ6UK%8/!L=& M^XMM7E?6%L6MMF6[KO]&=UO2ZZT?44!B'Q1L@62[^?VP,[]%X,E\YW6CZ6%4 M6"'I"#)DBZ_$)J_LMQL#6D1!2T[;EP$P7`.&R0RU#A`3%6(LU,06Q_L`OH3` M5\['[0!:1$%+5ELY5#!?`@&&R>K<>1[2LE7/QQT_>@Z'D=NRX@66$B#KX]E+ MZ`^=D0,`-!6)IHPC_C-]9<`&(]C(PC,^/QL$\&#&$+&0^SDSU`(T,:)LLCH7 M]8RR%F"#$6QD4<0Z/^@&>#!CB`H*L2//F:')B[;8/49F$&%T._\:^7/QG<63 MM4_3#Z5]-PKLU(\Z@:^K2OWF^Z!SPE>#^"*[/:.=-3AMO`\(QQ?E)3YO.Z\$ MK@ENT'>^1F.$S=!/'.URZ"S_D1C-QJ?6.ND@SQ\[WNYN/IASLI_-KRV>K6;X M$8TFLX7D/RR"N)&/IZE\B->5SULX)[$BH(?E_YBXIK>[@_A`_?B&@5-ZF)#A M>60>KNF,]TR"/CYE_#/%L/O#\P8'C=Q&SDV+M+;I&SW7'%W-A?D1#1/9L=+, M.)A66&ZT.W6EIBM=O:(9:J71:[65;J>C*T:WV6W4NJ7;H>D&1*JW/K[LTH@P MIK\Y@66Z?R(3=V>*YH#>ZZUJ5]>K]4:]V>UV6UJWVJPL>N_U]&;IMKS08?MZ M6@ZEXUO1>-GB(59N/?);<,!8>LVNTC;43E-OMAO-5J7>4]K+L71:2NFV]^=L M&#M[V3$..M)#1]%N=C6]KE>J;:6B:[U67>UT%Z,PNEJO%'N1:>-8]K(UBMD( M#^=*I]&K]515Z6EMI6ZTF\T&`<)\#*IBU$H)3W9G3UOCH.;U$!)TC5[':"M& M7>N2&3>,6DM?=-^I:-72K5(I_Y;LF'YZV5\WMJP&^1F;;M^ST?MO:'I`QUJS MV6DTZTJSIW-L>Q=M=OK'WOHY!Z=K;C)05T'N,9 M_NO\9V>8D9I+WB"8^#N/KBLWP(#SKFMXBR&T;-<50:_1/PE4R M5+72))1LZJ7;/ZGB_ZBGC>'T'!=A8VY:#D%TI:-TE9;6TSJU9I.,J5O5%Z/0 MZCVC='MGXA&Z(JX=^^NO=;_2P MT?\?R'5_\_PW;T#,J.\A.[[G&!\PCFZCH]84I5%K$2H86J-6K?<6XZAU:YW- M<>SH*1[/[(!CR\(1LN\<\]EQG9"X/W=H9+HD&HGO]1B@,'3C\SYH@-)]GY!( M!@7;V-*^Z0EL:6MC-AH58D!:3<(U8M":K9K>:,:L[#2JM8;6VL06T6RU:HRL MTT=X\0GJ>R985:O$1A(M:-2)@:[5&M5V=S%!G;@O6Q.LUQJURTWPU71<\]FE ML2$]Y'&`K`C'GS%\:A"L,#+=+T1[D1]3E-1&?OBPVVSN?&_TA/"X[Y%P-8S' MMG$"YQ?S+Q]37W:X&EXROJ?EXK9I_43VJL7'IWHF;II=<^C: M+:/>:'2(EF\UC);15'H*,4W-1IV@K]4DKL/_LW=MRVWC3/J)]B\TSM@['&=3 ME8E3F9G=^B\5B4ZTI4@N2?;$^_3;H$B)%BC1EN73Q%-34[*&(KL_-+J_!AK- MS_3?+?P/P>\=]K*9Z@YVZ@7RQ$0(UY%)E9)+J8:=)^121"'L\`Y[_3;3)?(* MC.'YXC/8N^">4F2E2&VHL=PIT#P#GP32,"7)N[T_%O@#%D^@_L'=XMOK,02.IU>CF5O,)Z<;.N9$*3@?'0DDT81N784:;PK:.ZO? M#?U$O`_8-SH3&P7F>8%$#D@U18@9[YB4)XR1MV???WS'A.[<3N7'CVHYGHYF MGT=7U?)DXY9<:<\PN<``7L4GH0UHJEK8<1*8 M=VM_(I=.HR51^4!$,D$!,/3Q+?`APG8"N$D2@@L$@89D*;5:V3'JLYK6+V[#ZZ"GIJ<`6=(0HC62.8B,.6=YTG2UD4P MST1ACXKP$H2G5.FE`1SPL6""##)1[XCS5`CE.&\!3%!.:`!&>CS2FT#0?\_? M?9AOOV@M_N#R^T'8$GH%I7-LTD8`"RI3:"9-E$P+5E8W`3T?:(?5>!&DA@P, MDE*YJE9;P.D9@[<.Z8JTE*O(H/!3^`/6$S*>$"L_6GW/-/0&Z5[WMV&Z&L\6 MN>"]-\!L:>?V!^YV^_&_IBC5,XP=6:47\Q_QBB]]A`!\ZA(E0].;%%.*16IP`OC^[1@ M**],RL6=TGE!.<-PHC;^DR,BKC`YHT^>V#6SK28Y\_Y6,UF\XF`FO-7NX_9R M?%CG-5!N.IJ/%SW:B>[*FG'*2\*HQ`1:$Q\%;5:?/;?!%D/-[R1]_1(_F49_ MW,[7WZO57ZO1Q]EX]T?SMJ@5?FGGD]WW>=4V?[F[W0`8BJ+_EMHC:R")1TU$ M<^H1P4"^6RX(&?$P-.8WU3)W`KBXK(^[?4%CG3;FV"Q97_P]QTN^3Z\P^QWC M]Z-O=^?!II,"V.MOUZO=BP6*.[O;O^93G`FA6HV7TZOM$GT-8_=J/QNM5JYS M!._/1?U5YYL2--K-?YD!$X+5VN6LSB>[65*G(#W2W2[7:@_NDW_!#K*3(-EA MVNDXV%FU"M75$J7=9(/SB?V1#_']7_WG0U=I>7`$AU\I2AQCD30G]L!:,*H@ M[$8)LS.(!PMW5KV.K1DRYJ6D3C'BN+$`W`MMJ',B+QY26NJENT>R'J'77IS[ MO*SP)E\6MZ/9^O;+D7/!6U//QULOIR@<)O`WU>0#VL/\V_3KK-HTG,1HD+>6 M:AN^$P,^S-%-C*O5*G?9R$$810PYRBZNLK$]=$NI?S)8[Y64^;0T$)>LME8W MQ_-2,D39WLE`3`/K$#;_!!3O5E;TH\@EEY%:"@[GG')<$:Y:%!TU_2Z%\`>C M.*",7ZS6Z`T7/ZYFU3ZD??.K&TETWIG+"X$A(44PW'&G6Q4TJ/(\+8=N)'F0 M9%V%QHL?65U7S7%XUW&.LE23C_DL[*R>B'&U1G'QN_:*GU=5ON3/A:N0$"V6 MDVP,GU#/W6G^88_9U1Q3;091R:@PZPPIF*B8H8%EFD&3+30W=_5^"@6Z`-VU M\]^6!1T9/LW*@F`$<[VD&4YP&IEME\E=(GQ?/T:0774U[)'@P0(><^W(T$ST MC%(JI'5@M8FB%5!C4"X$Q&Q?W%O`CTAPD#6@\Y\V"_07E_\]6D[S1OE1SU,S MC^ZO4=AZ^14?6"VKU3K_^J)F*JL=5;GS@^G/:I*OVO,RN5P,;_$CUQ$4?:.^ M5#>+V0VR_+L//;VV5(M@O;12@*9!QZ2B:>F.$/D(_V?V>P/E$%:_(*H'"NN0 M?S@I122*!!ZY#H;:%E5$NSXX^J90[3X&'VWG\U;K,P#<)1Q*:ZF3,,CG*(5@ M"9/U^]`$GU@7_=.%!5& M6!VY#"HHD\"GZ%MI99*\GX-2=E3XXYHF4>R,:R`F:,JI@'<&<>W%.J,Z@Q5/>@!#IC36B, M5@D2;#YT4YL;Z/K<9+G?\2)J#%46"DL4%\IJYC%-TX&U&PJ@<70*.@_T<6KD MM*Z:K-)R\2.WXAG5MH<7C6:;YDD7EY=57I3^5.%=_\(L??EW+CJ=?TM5W2.T M_?_]G6KN87XQ!6<5SX=<.6%1$T>VYJ<8+_(SG&BRJ_&Y%7A6;`9KR'!.LI@8 MY59HY9SSIL7&)5TT\OEG@#(P0W@(`9-T%W!2.XYI/3=;4*ABA<$\#R@WT[QH M?+E8WEUL'R,G65Q^RYQDM9A-7N].`\;G"$1A/",!9Z,R0AK,)[7D$5(J"T'N M>L_[ZK^#["&+@P_=4.JNW5%G:03@)@AM(RH%-K4L)!\IZ>=-HE&L=YFN;@KH M4)))7O%"4]@O\G*WNTL:CVS_'BTG.>NJ&V,VI`N#_++"BS[,-WT&NQ7^K84> MYRVY>VON)[?#Q&:/NSFZD#G$?#V]J?)5YUE/EBIQY)LX[8PBQN53"V*#)GZE M/>E'LR6ASPK<&<8K?]&RM,V#ZIOC<\X[*@?II:)`==X:83XY(0-:;HMVC@P] M_2P943AO'PWX80&_Y0 MPIHM>..29'LD;=<4&\B_&'_LV!R&;VAL>N[8S/K.":*\0C'HD6M!BM63^.-J MMKBMJAKTC9AE$X(H'-*:8"GWA'+,#95N;9IYA"ZOG/S[*$;W5F,(CZV%9WGK M1MB#*]L?/J7N:I>S1LF@1:`B$$HQU/!6&06\FSIU.W(?GYZE5+4>#?1,INL M-*W80'F1BU(IY#&I>T4Z@PY'SU,1JM"5<6\U8FI<("QLSU-15=B(8$VEP:-U M^%*-J^E-_@TR\9/P5R:"`>^94H$R$FC4._R=+/(F23GTFTV?+(\0^AC@D`R: MNP$PUO"$:1_:3"NT0!I;K$<*WIS`.T7HW.%UN[MYHIE;Z^L8R+R64CF)'L]N M3<3TI.Y,Z'V!^^4X5=JC!DW!4I=`>1\(N,!UW$J+UET:M"SL^?["/O8T)EJM M5@BI=]KBIR1"TS(&A<6,+!;"`E#1)^Z!4XPGB'L,6T6$Y0`Q%V1B'F`.I%O=@Y]G54^9#^:E5]5R?9NC:'ND^ZH\\#L8 M+@-/43"IK42'HH6F'%KM<&[*HH3`&"AFYEGD?B8PCI[N]#PA=;"&>*X\IB&> MLA8,8GI",FC!"^?ZI&C435LRI5I6W_.;CFZJS:3]N%BMZL6=8J=I,*!@U&!2 M"O#&,O0;@?KM=(10$J;_P/$O[/LAXIU7M6/CZ7'0'+(2&3U.5"\,(V[+!1VX M4C4IU/E4:XY9YDXA4_2M?G0U78]F#QL=B1,T0,BK_R)H!LRY[;EI160Q/T$P MH_=TZ)?C-%F/P2WS6UVTI`Q=I([1D=RANH6[[U2K$I33$V3]W^NFT\6?BP,_ MJ-./K_OI1UWPNIJNJS^J9=XLW&Q3YU*F;_/Z+G5^_>!E?I$,.E#4'?4VDE&T M,]NLVA(G35G7+=E>/'MBC5X%?+N6)6N<3OGYFT6C_(3%/(MSM[51OV0#!PB0 M`!,CJ6!!.^Q9+!@D^*.H-UV`%TOHH=3L4@&GKKSX4`SMIU#A.`"$3425FHDR2 M>$8,19[+A2M8NX*FC\TO!=^S6+*EWEE!1$Q`00/C%,DUC2XD9Z4L6=CK'PID M>O'RLAJO\WYK_TKG@TD$LX3JD!0FF@)]<.X*%]KYCCRI["R#T#T8I7L(_IQ@ M/(OY!2%S*\/Z54C>\_S?+3OC217F][:!':HDPBP":1&Q($*(RD>UXT?6Q*+P MD:O]U=NW!\:S6)F'Y#T#97AR-(&0DL4=L+Z8OF\;V('@2XCWEH,@UDM(!@.` M9SGX2AM\=*Q8X>.28C7@F8"] MJ99K#+/;\J%[!;\[]=A66Q:\50)2=!HI6W1M!;!EK-A4XF1O#;(0X<$2]CC. MKH1>Q>`4U0H<(S82ZIAH)=0^%7Q2G%_"GDG7E=`0KE-,07D+A/H8E=EBF,`^ M6L+9+/*,BZ`TW;'W%IVC^3Y^509<.`1\K:<=R0H96A$FI[(MA8*:<,P M93]-E;]S=5-:+,/B^NOZ\GI6[OJ=M.-$M(L)S0L82&=28(S1=F%2,E4$9Q"Z M5.?>LIU3JV/+K582154DFN6Z:OQ#^^URJY*R(+8@>6EO)VK5V<*XN-P_QOA@ M)V"0G],@A3)H.<<@M&IKR_!)UWU]C`>,BEIP@!=JXW*_ MA<"DW!S7(PX"CUT?UE884J;W2H'.(?ES8#%@IL"4B0RH!.%T0F!,6VU)M-4D M]6`!1HFWB<6`X2OB.!&>NGQ\TZ"WM#ZU6#B@H0\+-)VGQJ)G%@\V3"'18YA6 M)$J/>O``MEDBM@",ESW),2G=+R'KF:T')#D:BA1F==X$DS@@00Z*Q:TD2(X+ M_JX($_O!Z)`D)T5\)TP"))7HCZ/6.FC'?"N0L5#22L"0HGL$ZHU^Q^4ZND6J M+#(/*3BQ1-CHK6[.$*-*7PW(=[*)_O#WB(]\4BF("]*A0/OS[EB`LW(K)\1H^! M9Q13,)LGHG!$U2(?Y`D)(7!3:>QV1:"8G238<'HPW M)!3.#,.%-O]\"$_Q9$$AA<>):%-`)F&(^7_VKK2YS2,Y_Y4M?T\RT\<BZ74ZZU8V4_I[02+*-6(E6DY(W_?7I`XI7$@4D`PD4('R0*I`"^\W1/WT<) M<0%E)@RYCE`RP]E#N9$42Z4Q!TNF.%-R,-[:H`ABEAJ@Q3'8Y?%AT>=^$7P& MHYH/:@I1E)#[/!J;@N_32X@54C$^\,JIY"=A"*6L/EH>FZS3KM=0AWBZH?V MT\^97INIJ)3[UM7@2P^&6U\M?-K"8YP_OA-RWJ3:1E,EDF"=<)8``J4UD;0D M&88T1KSQ0K+C**S06HB8&XJK-4+K=N"24B0PA(9"=(<-L#V#G2$'U5O![)!BGO&KTU(52!]98B'W`=Q;;.U0E)71MLBW8CCG["XV.IZHP M$`97G6_2B\\#F1J6M"HD0ZGFA58'UU&`GJC6WMP?32/PMGT2>6[,GQ^%1,]/ MDV0#'@RB0\O-B`-E_M`WD'(?\5B'W-H1/:!C"Y:-(FH4(V02&PO&&(.4VA:P MDG'H8>#68[HKQ\9U&X%MD^_K&T(H'(D!P8>ZP!=84/)8RG=$W^(9"=F<0\K@ M4'Q2+`V'%O("5A-+U=='<03H$-4O:DJ'D(*7`BD@%X&[CB`+)30S-/!ZQH?:ZP<:Z1TUCN]5-7G7<,C1*`IC;R3I7@X1072H% M,%9IKLD2SF)H"'W9R''OE5FG`.=&HJUFQ]5+LIQ%(HCIC5CW*+9@QI9=CG[O MELXIH/BW%]]?_SZ[N>J?]>+]]=7M]W[7-[?S&_[]KH->+5%H:Q05V_[ M#!S@E&B)LG%A<*0"TVFQZA8U1M0@M%S1!R*LN0(3TO>[:&J M8QO%(:$X;"F2]SVP10$+++DG$P[F!^^]LN/8*&[F=633G'!A5[@ABGH=B)/B MA3PH7B+G[?E#N)6#X=A518TQ,0;LC%@G=>'&PD&/!L\>RHT4KG>5718'9-CT M3!#4.%UF,^X[A.`>-O3L%\%SKE?81OK&Q,Y6'YKC'J1@C\M>&^\LYD'Z7BAU MA+A2+,4YD=*JB5*5-O=3^_2[N=BA2^-"HR/&J(A;3&!\14N&5!E#7=ZG1)?[ M=`+Q+J"*J4+"Z(MC8->(EB1JC$/T^T*B79!HMQYG(!&7;*T&.1=JS9LE"856 M;F%Z/B0\V?*2;>P+!I-R3Z?FW&UE+G"_0Z'T53%EB`TL=LX\,X/P9`FVF9G! M`CZAK4W]'E;-I:HL369&'H<#']R1/&]2;6-M^$;%YRBVAA)T^Y^*A;2P0;#Y(X)JH66S"+E->T@O2N#_C0JG# MFQXQ@J\)6RK5"*L^2V6RY\&,&:0+C8YG<\0J:KI3LB$YB2486]*25NI8#U43 M%UH=W-@H$"M7E7FME['4R,%-0:C29"CMOY#HY*R,>M=$:!M[!,D0A.)TRYH= M4E%'(>'S,P9J;#&U!&BS\86+]_9^CB$5P#".&C]B..+8RF$3!1XDEP*D"L%$ M4->F9%.7N!KPX]3R(\8.CHWK-DI7?`!4*Y::;\!,0N43OB:=E*/_C!0E.EM, M0XC0FOB4@KM?Z:"P$H[CD8[IE9^10K7BR4?FFJWTC0\A8;#.MD9CQ?'. M7>C[V:A]YO'MZL&%Z]=<;%E]#(V@1$9VU*I)DJ-*/92PV04=A712^ M.-[)07)0C9_)%5'AV>?06!>$,=\;4N@-T."N]#V+WS;*6X:B@^W5G\'$J%Y\ M0P%ZC/^>-VNE=/%XU"I0"_61E=LY1"] M9(1E32EZ$K-"-YFUW:2S!'>K41D2K'>BCGX"TVQ3G9^6(#=E[55S`=R'$"''HH9QUU[?+CG]I#8'J+;S62O'F17S0ZI%.,Q MX;)C(84PL)MG@O.`Y*#V9G$<6PO,+9@4(+8^2?6^`IIY106T*NIU)^Z>*30+KV,JMN^P*T9X_'0557\J5P\\T87VPR0B%,G60MUW$_W?/G MMP/Y4\J+!DBDVB+&]9ZQY7!0\@KLJM)*=T1_ZOC@;M5Z`55E9LP^N<5\SPHM M+$'V^F)%]][#I4'?$LB;)4J8$D=52.H5&.ZS"?PTW4&-@R%BW_OZ]BD=\C8K MAZI5LUP@Q1;[%HP8)+GE.C[3QOD\&^V%R!NM^_G3YW]L-=$B[*<.K#7%MRX_ MN(3E\\<5V:J->LXW>_[O;ZYO;_]V=3-[^;93[ON7\ZL_7_JK3GG"`!W46*#@&)3OHN'4K`>(F::\2DZ#M+U@ MO@L=UY(RNBM63(E0((G*Y4]9EG%D$:QK`G\KL&^D]6(R-:-JBLR>&2G:"%/. MI4FZN2%YD8(JQ7,P@=7'=Y/4S`N=0[@,8 ME-QL;*E53(6JG?A0-=V8P[X@_95R%CB+2SE91V+18E0N7R)>$8:"=+MNY.M; M@'RS,>1LT6=N):N_8(N*7)HR-2V/>S/6CN'N'6DZC'6+5-2Q38Q5].^*(HZG M*84T[E(Z4WP.:MQZD2S6J(:+135<*G'9,T0^E3)ZBA?,=R!TJ[.40@*;@TT> M@5TN4\3;CP/N3\;:.A'4-Y*[HD9;Z/5PP3!']+TQ;@KV%C^:;Q>P]Y?K,<8) MHG@!*ZFH@5&=F7)M>=RV^3PIL863$91'3S./SE>][RX;#-B'"%:&.B77K4D# MS"?C.Y\$TEN5BQ07U6_V)DJRI0E`GE)P$MLX[/N"^):E=Z;U"?V6U6FI2.!C MF%A;5F19#A\8_E%?'2U90;;O,N[ULK5E56/>F9[%T5MOL(7+$*)+%AV?9F"I$5ZHH92 M,PYQ1=@R:'ZZT!S,E,VJO/J\[*K.`ZK+X*:K#L[OQ&,X2Y"WD:LYH>0@Y`3T MLD,$K%->(JW84_C%Q5PZR9H$9:%`E(?5CEE)4P+HU9B2WS/[O&^4`Y M"?:@U^J6\#],WR$9*[X2"` M%`L;#FK+?@J!CQ-DUFZ:^C:PWFDZ@ETVBK]OV7M2+Z*23$%@$!Q&7-IG2HLM MW(H4JP'@%+T)M:7@#/BEYJO(@QBF9VH8G$@ZHL3HN>608T2,F(GKE!).L6RW M^N+\H=YP:7E!#D%].!"@WF2.>W+58_0\`W\^#8.0(1XM1RC932IT1F$C/@O&5]PP8P__7ZZM4V;2N9 M2[1JB'KT?9-TU5=3VTIJ*T[BU`-;\S2?GFD'AWBL=R7C(BKD4U!B1`8(69:' M$!F7"VRR:_=/#I$^WLZO9K>W*@S_/K]:<&A6PVC^>G:S>/$_-R^O;G^=Z1M? MVZ?Y_?[#Y)5RZ.U\8OS;_9W/A4P,S5;;Z"%E`FJA2@A(D=V:%A! M&B2`IP?TW.1D:T#R87[U1L'[XB/D1C_CS?T,N?ZOGW[]Z>.'5]?O9K?W0UO? M_/9$3]O7(<:?VZ/6`)%)I7EJ1!Q]=A&-KU%_TL9:I44T9@W$MCWXH3`=QJZL M">EM?]\3F&)L:,259C&8IA>RQ854`=.G5\2QMX'P;#"E_\:4I*CJW@>W9LN6 M6JQ]O;BJ&_440.^W"<[&[`P--NN)$1_5U@#6IJR&DN0(("U$#C6[W*IMM@X!`"!$WO<1?YF]NGYSU8VN'U[K MA\Q_G7=K8.%5WEU;57=J0BX_KUN/M["IM$ZEZ!2A$8DR>>H'=4MA:Z\9`(CY(W.P9CJ-"OTL-]R7H/DM!UR!GR`;8 MU`ET<3S8612B-$%A^1,M25[#MU@JSD:9\6,*M"N85P\ M#^SO')&[_[F(]1X8>JP1DH\YD4VU3Q*V5B+V#8G"5E\-HB;"_H`?P#@,[OHI ML_GO_9VWAT:_,4LKJ1>M.Y=]-42*?LHI.@AIK,?A!V/:#X')OHGPV0\.#'_U M.;G6"J:JYAF'@*ZH:VV;+^IHCW-+V>`>1?Z`QMZ`[V&S]^\>!F7VCW>"5&LR MO?^;C+*WRIFJ[%Y"=9YQW%+"]DE;_^LQV!O*/UQ]4!=KOE*L[,1^G-[;Y@K; M[,?Y[Y__TKLG3'\LPJ;Y[LSMI> M"^\+VSX;)T\F4G)C$`#VIZ4_0_<;I6"/8UZ_>S_[,),W-[/96F.PJ?2PC=ZV M5E%(Q=E=RV0G(%=>V4=RH=^>Z/>S2MDU&@"X^6A!;-](T"*+DFM)LFX%C[[U M&5^ZK_3]OHI2J*KSX]UN!+A59% M=5VZZ^!:D!'].!'-D+O0<1]TW$)L5DO=-VHE4BD00-1(G\0FCBTA9WP#=V(@ M;D6_Q<>]^/C^_=OY[.:OLP__O+[YQU/M#NK_8D_%W___7-H6/. M-F<#T24;2O48<[9Y4E!6:-R0\G0>YNLQ.`+*^_6`G>**6!P[R-'TMF[C(W8U MHFSM[6`&1([["_CL'V85TP=F8[#@H(+)426^56D0[D9C=#9N@89.C(=3OW=\ M^H,BNZ_,"'FJCAQGL(6RX]I@M_SM^^/1&9X&LA21(6:WV,A))<6/*OHW&6 M@S.XDW3J4S`I]"8FD-QY<;@')H\H*-GP_(`J"*WY(GUKG_9,U`,\6Y3WG M+23E4/OH0]_4G.AC9E-$YZ+A:E,=BX+7*0G<.=;YY6V/D?0O/=C^^\NWW=66 M#_GES?*U MGFH7YWBLZLD'-4XJ0#'6M>)3[`N:%Y?%!O%Q:(A4JX8>^#4'.\=CM4U`-D&Q M?;1OBH5K*B%-(_)-'"HM>YH?CG.,Q^J7HJ`+(6%SO6C41KU5<:HV]FTP&H.J M9M[+,7Z>W3LKL[NO8[DQ+,J-'^F#J289TW+Q)J.:$CWX>']/ M^IJ[0>-%C^O09?7C[?!<^/BY@FO.0^)(4?TE5>JIR/) M3T:/GZQ/]2K$:EO;+-![Z6I8GJQ/O!U.YI5F.SK7];MW\[N.B_[^9?7+JX?Y M^$_2X)/23Z12+/AJ.(J#UM;C[+N_ M_-OVST%?/(>JP(AB0F%OU=W+XKU?/H?D84K2T\]Q??7BP_6K?_S\\N:GFQ/I,1\0@/8X!%95GM:I8;FS4 M+&( MGE%/MV??-19MMMG5\F<@;B+YN`-;PRP+NAZ2I6T>1YR%Y"FU?)?DE!6KN??" M:U1LX*!`V5I[4/H53WE*I7Y,LG"U$P5T8-..=8&"KDK-69ZS2?OO\93C,,F& M!(NOCX8P&*=EYJAVG?TQ([SI(QFF.^3WG*T?4.-=P.__479OATHP2$JP_>5_ M,VE%FZT")F:!U`/9*T0^*34`>0WEV7`G4\''M`9+Q0;OHP-I0S8>:!M,9MM+ MJS'":,X;WQJM/;KWF%85`&U0WI/4!!Q:UO;OHF+15I7T:(;^@_8I:[4V9Z(5 MA\106U$C/@>!`B6PRA31B2$8D'UBB%9HB^<2PRD]P6-:HXY6&V$MVP;`6%N5 MJV$D5:(5^&B"4T>K%4XZ<.<2PRE=P&-:3=3%1I`J%RIU![I0?DUKQCJ%N4\, M.16:0`PO[N]N[RX75YQJ'FD241=M,B./(0F=O,\JKV71D@JZSU<_P23NX#D- M^)FDLF23D"52*B]<'8RKLNY\%SB?GV<<7YGJ?S3.4Y<]'5L\!/K[5B\&P*R%0 M'.00FU.A2G#>R6*D"NTU]=ZRSA/)FE(;]Y:9HP^D;2'6P^*BM771MC)*8J+0 MKB&V\";(&CLM4!%\-?_*EWHM$5CK5J>5HH+HVS?:^#RR;FH5_)?YYR]WXU.6 MGG=N#[7FX$+VD=U[B0&BLKJ4+KIV#C*GH?T$[&!\>3JHH0,HV%%*L M5SM6.]W=S7$"IMO)K+;>8>_+SB$TIZ)NCV`]8JM^JYO%ZFKFT8R^CQ_OO]Y? MU_KIZKUNST\X,CW@XO?IG=7J.6[;`,9^`%2!^Y9-<8C1)HC#:% M;0WG[-WS1Y;>9!N=\[`6WQ=!_>+2Z[`4652=H\S&R-N@A8JJ7J*#SQZ:P(PC M.?=&F7&D].92)]&;VA7*Q!O+.5.JE'-P0(%,0[F7+.O/)'WQVVQY.[]9=%', MUYO[U40C_N.[WDF">\ZG^0[TY[\6\_^YGZ79[;$&S$KH2G($H%SPVR,0KGD7H/=3W.__&(9ST*NKU9.ENC=B?L7?]O+;_.[R M>OQ"0%3K:'*HO?F:K:+HN)J3:I5\O_KY-KEZ>D1T=G&./F,`A=G4I6"`%"U[ MI9@4)BAMLO6DB&@*OD]PC7$VIH$SK/B^U"?E)8;ZRFSEDJBDP`G3R&*(4YBV MOG\]X,K7X@KA_O/][=U:`-<$7_R^X._R9?Z-_ES_K`<)W?N$BT\_S6YO/WRY M7'R8+7Z>+3]NIQ@]4P-V/WL=+NRP^!&._3J[OIXO/J\^_G)S?<5?.LQ$R6PSZ(`S M'U?8UO*'RF5.1I4HP::^'C(EE%=.?\<\C*=(79"16:039OX577UBNY6Z*'H[ M1Q0+W??)KE]GR_GL-C]."3HQ`:V_5 MH*&B0H+&5RIL^R[+>,_"CG,5V!2J/4R5`J)"-2(6LQ;S,T MTJ&'JVRN_$AD^Z88^_8KKX?*D*J/LD*R M'.]5'OK:A@GETW^H)Q!#K_>8;S].IMU6B>K M0ZX7ZKF$!+6]H40*F8GO?7[P1'\X!?/Q).;?W-Z]<>YSYJZLE5'YI(M,VGJO MU@4[;;*%4VQ1/_MO[RX^U<%8M[_>7%\=$O:!O"`9:5DZ;#"H.(<.W>`7`N%] M4U^T&O9&@NXA.`[=2+^G+J&^/*\CGNKX9`'@T&4=L.[ADZ+I<.3`6N%^"?0$ M>&-3A M'Y$%,"EG@RZA@E+'V4LE._2A4+O+'BS"RZ$?$17A2N+PV`=-DB,2G7P47A)I MEA.IVB&FJ+0Y'?W-0^F-.@5ZE[L!_"< MAGU$;HHWD:3VZ,@YH2RYS=88H*!1-;W"?K]3^)S81Z3&HHQ)AA+!%ZSCY#65 MC=2`PO82GHWSJ=C7W:2GBXP*8+5GEYV:@);$1=^P";;9R]49Q:VHXV6BP.[O_;.Q\V$=$)B*FD%6--2A$8/!VRW?O ML1%W+?;WO1Z/?15#U:&<-Q^G\%.&XQ#.&+(PS/YDT0!M+;UT/0\LL5_LAV%- M02'M9W,9[ MU8TDK5"9IIA_-"%I]F\6P=N[Y7T-SNGR=G[[Z[?E[/+J8O'?E\O5<-A?^)L= MSC!6"<-/\\7LXE-_Y\CJ;OZI=?K!*,G0T?C[Y@_L?LJG[6 M7LKPT\WB,W^+KQ7BAS^_S?;>`OQV<_W;?/'Y\0]MLX;=`8+%&(J>A9Q3A4S! MIMKSN'H[[74*M'O;O+A??:/55#&[01V]W3'68W93,G9= MMM[D&E.%A.0YBTC.9&U7HX60@NODB?,>2[]QK$3/BWI$XIP;.*2`0?[)B9P1K]UZ?+,KF M6>T[9=1T![-.3J82LA0YL@K"NA0C8/!UEMA6R#CQ;FA!.'`L@[@F(64L#:G/ M5M$;8YVKC1.`FW'S3(KHZ?U[Y_"U*!E+2G16VA1!22B&7T9 M2FVK'RK(MJK-OF\JT+,Z>YU_7X="/5';F)9*Q6&%!T/6L1]F\T^XG=#O2\/P M=QR&^&'L>Y!.Q#]:Y):2^5R%)LA44T)MNLT<(HO6Y`,Z/<+\:0D8T53/W=Q)Y/%G[5>6/2WY>8(W>Q.>#B-Y-N`A[C+:NEF&K652 M3@D?.;%?";%,G,B4=MG^EV#B;M;.H.:2!0J"@A()@ZXB/;6@I_$B7UY>+C[-?O\QF=]5*;;MDND]8S>19_X2>?A6]FV06[X*.KB1(6E-V M&&17R/!LC=JF@'Y?,$K15'S`\_!!4R(.O)*C0$YQSJW#9L2\KXN>F\CQ3'PX M6O4219.=S"(:Q;%*Y-AQZ\VEH4;UD$WWB#D>%=JCE4RHQ-$X9J,-^I2`+.B' ME$*T(*VU_:'442#C@"X=OG,O)0O$)-F=E:1\; MY>^7RZO;3:WF..8[$Y-+8)(7JR%`I;AMHJ^,;PI%5H[8XE%\DY,W&#OY(C*1 MD[883O`"JZS>>/<4++:-!0=JDU.1QQ]T?[8);VO_(_^^MJ2+JTVT>[MJ0*3+ MV]G5[B?4YK7CSM,YE'^K5@_.I M)\"^2AN.3(%=UE2B8VLL.51)I:AMY%+89+55\\,9\#Z2YR,>8G0@HN@-I")$ M73&ED-1&PI'#WD9(..\]:'?&$-?IJ)'!+>?_OJ]*\#/G;=6M/&S]/KHZ"]EQ M>F.UY2#"N*BTZ:XIHJ_+-]J[%=W(^#BL*0@9ZQ($ER%&\K%2X9UR:V6MA,2> M25N2[>KK$#)2@)4(DM.EQ#XLQ]4N"44=(4*XQF1*:*W.-(3DK]^N;_Z<+?]^ M>??Q2^VLV?W[]:B9IU`G=^L#TG*JFNI5/**+SH4NA8T^U>Z;MF4,_O($XIX` M]2D4__WRC_G7^Z^U^>CR>O$X175[ M&9ARJ]HNUJ>/'(Y%9XWEL--Z$T(RJJ/?1!E[3E[\1:AI6-`O M`M^6C'0531QM-H7PL>[-QF@3<1S-R<:&&DQ94GN[:U?ESD16I0"T'LCLI0-WCVR)*&_J!@^8" M81S6!'2,R(-BQDMO,;%$+.N>%0Z3`[MHAZP^K#\/(F.;@Q]MTZZ-GA^?(H@[5J]D'RL8WS0B$A& M:DK=9A0"CAL'-K\[^8"]%\ISP*I_PC\/@ZW:Z2:Z4)^N`H>R&1)Q,&[, M`%AY'K!R"*Q4M9`C.$.POJYJC$8P6(DJ:4O>'08KW%G`J@&PB!!$21A6Y8E8 M>^9-!6M"YM1R/X]_`<[B`%A9(@HMC`')_R6+1)OF$^'8')J7!SN@8)#9$)3( MR2VY3-DY2KX#RQH'A\%:/`-8'%0P""X6`^P)/0,6,@F;JQB`2BP5.,19=1:P M0PHFJJ?VJ02TH'0P2=;2#0T=D(O?+1.3:[8EGM^>UY^"CGD0_LT-VM`2*T.W8W>36'>2G4W3^Z?'_0H:F^1JQ0@D M,X>"R;-R/!JF&X<;!<\##I?M)G=-S'$$#SM=&Y35Q1`^M:?U-;I$NW*Z3I7" MAS277XS@(;N`V05?0K2Y8C')H$!2+AVO!$.02\=L08&*2DN)6*9NE*A.3-VA%'%;LOR%>1 M\(@S9D)*X\%%$8OE&)EYOW;&DJJ$+T+PT*4+6H#G6I:@C,?,&,G6*X>L2_!^ M("X;,C302J6,-NRS0(C M"#1MMB'8L2&5V-SBOA?!GSY-;A___BG_N/U\,_MS.>[X]UF\>?B,^3/]0:!/ MWV[N">_I\$H++]PE;M!N$`<89T!;:0G>516KOW3J$X<0=T:NQB80/"25";J1 M,E0CE66YJ5?0&IFJ7M&9!'PAKD:J,#G2>&9!?VHPP,:[+*&M)M&JU[HJIL[) M5;NE[\/-#_HH57NGLR=4WW4#SWRVE_YM%4P)9`<3\A#`II@52%Z:AD6S_>#X M7)86F\O6]Z?M;"S5RK=U2M3VI;T`I@!/*J`#S@U+#.UO/TM@7I2E6O.V9C@+ M&`%%^@`&0WH5HC<-2W%[W?(&2T)ERBU0XXQS2R0I&VO MI4Q][X2_HA"&M3Y"`!$E9]8:32V=ALEE:P'&5-3&]CJ%D"9W3TN,U8?_?+JY MGWZ:3N[>+^;KKWGZ=,\TY?BU$-&Q8!QZ&0Y<6X6V@#<:X6,,O<)@,&H"CB+^ M>D(9OB92.$QB<@F8+A+"HX\V-4))<0M1:/-15?WB0AF^-CD[[@HF^X&%@N+Q MH:CUM?'&EAU"&?=_UQ'*N_GL;O6C_[B?K/L.#[TKQMG(E/E0#S57P;010 M=,G]$N#R,`GT47HA=D>PNL3CMPG_B!!WY%=H?UVTLI MG;+">I4Q6>7:TRO"4K^EL6:'?K.78''QR_[9H=;K&(\+@GD4P>O M??$\>.FM`XU&CS!,>UC]"QWM@5:_2^8%^!RQXUH4P$"6JJAX4MXH(8A/-&&J M%-7GZ9=\CJ8A5^=S6'6E!`$IJ.*L%4;+Z)1#/KDH0A2W^SSYE?GLGUT^/&A1 ML=A,10T\6\6`0Y:L#6/%%N+KIBMRA[&[B]H+LCVLSE:6@%&KB"H[/%F-SC6V M!EF4';U>8%\]V\/:7;2WD=K;K/):&,Z*L6O#;+F"_L2;P8&7^&QL'P80LJ76 MF=NB`7C.H(!;[Z5NSU?&7^C:A= MW*&ZA\82%V)M6#W!\.PCU\R)2#UAT:NR5D^,%W?4A5`5SL/:NA/S]\D]?N1N MH]/]J/%2-*Q29#PID6-6.2CN^*H2:3%D8'6?HY&PW9\W2M"IY`].9T@D6F#" M5GR4EAG`U*TAWSE6+W%UKC.6=1SY_Y@LODUITKMO0.T=[4MXP!_FEZ./'^:/ MU%"[/<#V;O[X<;*SN[T[6+[\01528TL,[61884*.3)6GS#47$4\5[6^0_;FG_[(#AKO[_2"M_6I]2A&;1T[BH2I;G_U@F^6 M+`?D\(O):SH;EU>F>0.55>)1L&""]]$T\M)%EATE7GY=>;V9W=%XSO1Q\AN& MAW=O9H_(+56.5F.[X>?;FW_.%ZO549LB>#-[OYC3!:'1:A(N)C:)I#?_^J7> M9'Z`RFUV2B2:H7,R*HG!E=262@XKJUT*QO7]]4'N_D4DN(\28MBE#&8,&L.M M#$$+=`2-!%W@ZHR7=J<(_NMA\NGI_K?IIYWUX>?K>(0SR*60_+`#9I81//Z/"8]%%[ MW;!L'%ADF9N/5^>X:[`/X'B)/?^/IZ]?[]&BOYL\?I\O_KL^:8SHHN3&2[2R M&40PEF/B;'T0S-)@`;+-?BFV#]-TI3EFI0ZO>O2H\"[[IDF=L/*R1/[-1W%] M33^#`'9INE:!0-M]BBR'B"F/YNWE!A["Z]#T42?X[/<<*JK.#F-64`&4M':= MK>12_$J%7R4_VR[IN0O(:@JN,U/"*9.8-.L6`-K/Z74D?B[#SH._O7WZ\K0L MM>R>8QPK6G&/"A:=LA$-IX4$F$6M0CF61:G17#CK8'(<3N`E^+N<\=DE-Z9I M*[F)W+NB(5DE2^N!,`_KRLUVH"7_#XBM8[)V+^GSDLMDLBX1+5@J-C2"XD97 M:$_0V17W"@0U5#6U7F;FHLTF\ZC0@H6F*8QE*5A5?>'&O+K[(X]4A*&89=?B MBY0P9$=)>6.C8RE!E([:J/#.9(@5EDX',_\7%M8IQB9%@&@81*$!?4K"","W M<8_L0780\M59FU/EMI^UX=8#7C$76!2T*QN=%6\D)4'UK#.]FJ`V/K-N7?&? M'B>+CY@@%_S`@=C&.D/QW-,2GRBR"JZL`7EX%OBO&LI4[6]61R@]@>-WR."' M[Y/[;Y.WR.WG`_'T,$#A+BBT%C:9%(OVZZ7,:&M1'I7/Y:H#W78:L2?P?=PA MQRQDB,7BI4>OB!X&(C3\&MD=$D1C>=(9G^%XES]B_G0@6EG2)N`UQ?,T&IS4 MS-N6S;YE2%;M[T%WTW@BFQ\^+R:'X@YZJ\1R(VN43"\'E7US9TUT-7Z+!'$B MHTLJ3^7T^_PP/JEK*H?$?;`A69&4:':CXGGF&K,8KRD_E<_O\WVYW+W`X?IN M7:N<-)Z^+H;`OC&7;$-C9TL%#X?>?V^%J!^2!#`JJ>BU16.1I5&FI$8* M^,4:2?)2EV37%H.KZX55&<.=XF..L9`NZ*);+Q-2E1.A`-V^$NEN(+BV//:L MK'C-([=H)KQ"SX$,FK;TP*.K<@``OG..Z>O=G)7-/9&I"B*B5Q1.J^#\ZE0*010EZ.J*T?"\+W#^Y<2PTD7VIL$ MM*>[J&!<1%T0L5$+7[K8`RA M'M!G^]<2!R3P87%S-WEW\V72X^)6S!/D>T(6GK?S/#U,9Q-D\O9_GJ8/RQ:X MYVNP\47Z]`C34;N81`I:>`IN;4(''@7D()B4.M5;FG:'/!U&MOE=+ M_L1OG3W<+.?B_GHSG=&.C3#YA-_SX>;'X=L$75*\H(,V4FF7.,9JR:)UPUR6 M>Y;JU8[0=<[[$W<^IL96%!>1D"6=:;&L5BQ(0E72QJ?LD;=Z1:)E\N69&H/L M!,VH98XYP;53B14%Q)23P=(FXYHIY\["U%_G\[OOT_O[PQ[G2@X8XF*:J!RW M,4/1.C>`^877&[RX%9WE2LWOW9.8P6T6/CFTSL"<4U*4$-,*`V!)#&I)%8@+ M[O21Q+Q97CKQ'T_W/[D]V.H\T*='S([.+A)043(.XPN,C+@7;?]5KL-'I3H/ M>(PFPN8$,,E88):6&?0R%G\'XQ/V91K"TF)49]CEH'Y=#0*[D! MW5>3Q)EQV_GGQJ_?GZP:GZ^S(8&+*)SC$F5F0L(((2P!^GQ(6NH*](9&OVU05XX(`#'4C^M@L2_3KO@OJ;^IB M0M)#J#3\+%0-1C*,&VM[3J1I4]XAV4]*VWI@\QL]<4UJY`KG+S/1DUYALG$&Q:B"[3LZ/,2,8 M'[,WQ1M:0\,;=5>I5.KNS%D,UNA:DV2"5:)X8:5-!H_0-NH.:.OK`KQ07.Y% MUFH:D0)"&J[HPW1:!8H;P[()__+PN!^>>V>U(G4_.YE\]#9[IZ5IYT-1&^L% M15SR3N9X`KF78WMLCX`RZ&L%<(.GA]81X](6CPG`UJTWJ`^=>.%5LCVBM"9Q ME4(DQ"EK&,=_\=4R="6"RKRG&<1TUSN](-N]RS7WT'%5!`LTH4.WM="B2=&. M[P=I>H:]S*DL]^W9/"?'8VM3DBPJ^1(S@:EDIR)O\>4P$:L:Y]3KYWALKBU[ ME6PDL%`5M2D@C5YKMJ(.C[HP[%X)QV^GL_EB^OCS#3*\P'OB9W?;/X5`)!]_ MOIT\?I[?O5G.G.Z-/=-9H6>8)CBA4H0VUHJF1(@>"QUKW4/`,1LX^?(?R][K M$>O(74.[B;;%&6=MP>R@T/ZK1JS*BQY7@AD"_W^QCEQH);6..5N,\#@AY&DK M19M.,%%O^A%62WA%8L6?M^XR64_*'GQA#:I3EL$DNJ"<,@`-K6:%4)51);/0 M)X&*DN.H'5M8Z!DF?82CPF01QF/NH-K-)5`JGR.$L'TV^$S4COD+T!C1,9=- M6JX*]3A_R9 MUK9&]5.YHN`PZD9.G&7)`[T+TR"9XS$+W<(G%\/JAEF+@?;YJ!N+=8'>0PWF MLJ#(E&`PX!KJ$I2J7J\X-OZ81T7'@.`!XC MM=(4Q5GA=5^&@3YOW*'A&"H'NX4MYDBQI&+Q=`7WU#_2ENX-JXO=QNRP04-4 M+B8W#Y,T6?WY9N9OE].T*/:?-<7[9+6"^0PZ<2.M]C)%6VQS;SB46C-9IY@X M2M*I#(P%%=(JVOD2@J:>':L-$ZWRAGK;.[>==8P79V"T/*+!>&`%8V]D0Z$* M\88!RWSMNS1<]`36N$+O;Q9'`:5XB_>@J)`Q4D["%1$$;Q0J9]83C9@#V=DF M\+S,C2@;J!AU9HIPNM$".N%8>U;"^\H0=<&(7I2W$3VD+B^;2HK>:73M/*X; MG98+(]%QU4:654;V`LSMLL9[J")(ZZT3G"ME<_8F&"Y:5>2U0=;65FYME*HS ML#&B='@8F28R7-(.,\TH2H8V>`BF,A!.\\JO7(.-L2@#,[[";;1!*1:U]S:V M,5`H=81&.PBK./(,?"R>)G=;\&\7&V@]F'BO&SD6^?:LS\W_N_P)JF,D03&/>B9 MDLHQJ.S:-,@F535)X7_LJ91[4GQA]D?4UU-!T]#SD0H`TN,_GC,9WET&22AM M3N_AQ%X/_R.:+HW.@$&)]$H$C0X<`Y76QD)?'81?]?BI#C1[G"^.4NW(M(B< MG*'0X%*!Q%J#&V*5I0+K3CP-TG,*Y2-:Z3@-F:CHJ1IGP3H76ZV,K.Z-X.CX MQH[E3)2/Z5-4X+-DQ6J9):986;;QKC/U0,2RQ'$VRM\O)E]OIG=I\FFR6$SN MFBG9M?JM.FX/?^(*VH!-8FD>5$(O5URC1H6'2HTX'PM"]B'S(IR.O=P:9W,Q M&'!)[IC6L;@6P!"YJC>G.U55Q%X+JV,U2A6X3N`U3?EATDP[8\=""L\.SE\(36@MA(A2&?P_9H.VSPDJ/R4RINH0&V=FF MY43"Q_(54&@U,/R@QE\!U@1:RXNGXJDQH%0=.]0PHBV:V]``:'#,(P377+4]]&L]R[* M]$FANZSR[%(81,+,/V[OG^XPX!SL\[\.KN;N9)/@O;CV9+0Q99;!R7:&-)9Z MW!SD$FAA2ZB'2>',(I0O+D*EA9&,6>U=-!S36`TM&E^(I@:S.K<(JZ&N_31O MX($-2HQ,,@D.@+:1,=6\#"G>LQ/6*=&-.L=I.@,30\];,J![T5;*`$D6R,8) MWS"10XT+(R19EU.96/86K*HL+6#,X?T!TBEI:8&V8R)ZZQ,F_C9C*I`@<,$K MC;)==>JGXTABQS8(6Q0<8$@;4Y`0.:1@EC-A,=F4Z@8M695)STKM:#O9_Y)W M9[LJW7%O-76?IM2VDGC&L7(EVYG,KQ]0RY%] M*.EH\Y([7=6)8\D6@`-B(_!!AN*9+K9VI7:$`M%RV,L6#!M$VW>D!U![5&M` M8@*+2.22<5$%-'XQWS7/^+)I%+>I"*T_^P"BA@JMG&I*H%AC30[!C-6^6Q-= M\[2VJ'\.HH9"`A-=#H5_[W4K4(N7_7L=(9Y_'5_6T MU^/_X6-U$-.'?FEBR*"B(E&CV+IFR87L+)LCEU,VF;].[1(81(G]NL0@2:>S ML,NB5,+/))PK:(GYS:HGY/B#B*SIV8&U9&C*X8P8X:I),F=;NI,$"+EJ+]"71. M.;Q-DV^'=_GG:*3FK(\M#V3M;]X4`VG#D&-SYWTRB4/WV2BT]C$I)K!DL8C25E5]M4&*'@\F<=$S MNPB-'H.R??AXP7GW]?V7PUO;:PLG%.])@%0Q1,ZPEE5%5H.V$[%'[R!!YV!A M*'0R5#,+]$%XK[6PSG6ZH4UNZHL*3.LX7X21`0WR!'7LN5YK%16,4`1=@9XM M6#,8Q]E7:RX.8V3KY>*0"082WA2C=+&6.#L)V2P[K$FR,K7Q*O@>Z.NV6\*= M).VRML296V`[FY-@(U;1C=&O2"*;VG$"Z82'0VFBVZOYOK3/DYNK\72VZ&H_ M$/T]2SYU"%E`#MJJ4%W8DE"T;3W#\'O%5N%M).A$ZG?F_4Q,8(.FG.>D3H00 MJ:RHUP#-G7(-_GI1PK'4'[4@,DE@975"1^G(%LEQ6.K4(K5)3$U5U39R-ZU4 M/'4%I*\U9L[_O`\<>:%G&<**P,(10>/;O);'$M@MWZEK=VXFL_OIYM;KN*3';\M;]U(5U$+_(&2&L` M\\H&XGDE4K=O."N)I4&NHBZY1:.SDCIYD5J0;TQM'7_F5+1E'Q_/[R>VGN_'T2QK_==:B_Z\DG#>P- M+WS4*'F/B7.5$K!86A8VOH+,L7G@!,H=B4HG"KN09@=KA(+.//+>)Y9GD^0QRL2)%!'+2 MY*(B.I2TEDM*367:GE$ND]EL,:G_:6Y%:I_VZ.9B.GFXGC6[@?;I#>,(P,AL M/$G,=2Y=.MN!7AC=W*>\L[UIJ0&"3B-^:`J4BH<2*EH-)R,&^-S#JIF)WURN_\&_^.K^DMWM MS64MGW3?_WUT,Z[?7/^Z`6V-2801$MW%K9'V#:%8X'E#-.>J%=F%=;$XHB003`#6W0S0E]7IYW M-P&CB3Z6'"@%&54)_#/K)CUH2L2F/S/W`L2_NEHG'H` M+893OZ/U!!FET9?1I_&,OHVF5^.K>;CT9D^_<,ES6,B1#IZ/[7.3;]?UY6YEFT6V6Z04BGR+2*5/RJ/US>3?BE^H]! MZ?YR_S":73]4K)\A_@VR*745U3DB8ET6GL.*?^V>C/0^Y1]^)/Y/UY,2`CO; M;%6J@#\(<\#>I9R"?S*>\HIZ(A=0X/6KU[!53T46M576%_`F1193+$5WJL5A M=GX&U?IE?%=G-.9VG^U9^/[GK+8.E^O;T>TE_R!=WET_'#>6ZXW#E$C&E)5E M>PLIQ%7'A0?9F%ZE10^8=7_BSL;3$(H5!U663WDHP0C."6-:Y0NI\.EOW8ED MQ7IMGH8FQ3DBS'Q6D2SG!QQ0R-RUBJKBVE4`\TV*S\?3XH+_--VK,,Z%!+B@ M@U0I>@74Z9YOT<;>@;!R+^7;0-W9F!H"8@E:D9=64O8`9"RM(+13R=3B%+Q3 M:L'4ZW(U!,%"WI2J?B+6[L8ZF=H]*LYHVQ4G4C1UJ_-RU!(8F4;9\_M29>%I#1QZL7B)C5%"7\LH0 M.,7/1>9NIC&V*#\6'#2/8OWYAU`VL#]"H769E,^FH@PCEF#]8G]$[:PO;;G% M.W\VRG:"Z@M/0!0,BE(*YRJ*G_%BAX13D&5S,66U:MSRW:LD`EA9*DR;<$[7K0@J=T.CE-MF/>%= MXT6/IFRG@P]!<%P<8V%?R&Y#^=AM3P'`=K[%]0&BCJ9L8*.$M3XC"ZOJ6+8H MH_%QN5$"ZS1X(S,IH;'\QU*V>XF*09 MMA,HVWD"@M24@8/KQ#98LE,1`(O-$E:@;[=1*1!X)J,QL%W".B&+M*Y$5C!G M@\VV@ZVME;<6(&[>P7TFRG9Z8V3_1#IZ4AR^&TF*NH4J5K>[S;W2^Y_->:)8 M1VJ^3J;SB>;?QY_VGK@6CVU;J)XIBSKJD5TPEAW"JOYFHWXR?+_XB"<%@.V$ M/*&W<[;+4;HC'"I[5.GK9BA"G>=H:321S024Z[O$H>/4?Q/G%,B['3R2!R.\2L MC#1'2?&$V"EQKA0(4U-LZR6RW` M'@S$GE0=P\E1'=:1$Y=25UE!YF?`.:>,9<40_]>F!.(H?C;U7N_YH[4B]##^ MQW@T/7#HH2+J0A0YH>;HSA$?6M/5176[T>QPKAZ1=B1GD_OI$9SIVJT=-#M& MZ8CC"\TAQ8HSX4QC,&5OD/QP^HYC[X_/T_$Q3RZ(NL_"$Y6DK:H[I+!32G:P M[=B2]5PK*@B(G_4!PH*NKN@D"W-]6]PNG!Y!W#W!^? MQ]/QZ./=EIO'[75ARWFR2]93JJ"".3*GW44?A5UML@=3MHNOW_C=)\!@L+_1 M(5;B=;*9(H3UI8J69L/R[YTJ^)2:4^@>\O_U]HPDLH5@ZQ#Y686U/;?0')W^ M`K)GHWMH,TNFE$%5A"4RVJ&+II.W1],"4-N=9V(7W7-4N@:J\Z@!*B91<@R` M;'\DR:RC"K&;8G9M;1.][XE[)S$GT;WSD*8ZIJ:%HY@PL86%%WE,6*6)GNI"I+5G%?K+%R"%7Y!A=K9@%^P@=H>"<<0N7-6 M37$6GS63)J0TG$V+):`N$QF%:S/KWE*5/8F,DR]?I^//K-F+BW<.?;?O`*?; MJ_F_;N87R73U7_>+&=@Y\L4?H_^YJ$.P_,(3$+*+4P&&_/_ M4;!#I3`^HNQ>@E;%^41@Y'K'&NHV]7EG^D6'-R?8F@0_Q]G6(J)"2P1^?IG' M)[VKT&C1>N=]S_:>]#XO[T-W!CJ!LB4224^<'S/3IK-KU%Z:O5-Z/S5Y$\P/ MH5IC8>7P@>,R(,/IBHRPKM.T>]W?86]SPTLP_^Z MOJT?\.'V]SH.M)BFGU[/^*5T7X>#+L;3Z\G5ZO,//@[6.I&\#0C)B^(II/+R2H(9Z3V+(%=<3JJ9YF]A==3W9FYJY8+^3\X,*:ZBIH,1L M.`>B7!$C11THZ&[G8RCM6>L!W;V']$5178AB=$C$['*2U^&D<:#? M>A3A-L3T&PDYFMZ=T;T+*DN(!2AJ$!S0FHY>XZ!)00#4AHQI3WKYMO'5S M`,^4V>>41JSLDT@?V@,:O(W1V&P* M`*!W"L52,YS6L3UP:D/@\3R4#Y6RG*]H/R!<**S#)8!;Z8F7);40QNYHF:^J MHG],Z/*?]]?3<;AG*SZ>S<:SOTW[]W*5=/.K_/W^KUS1U+K&=?[&;#Y??3?_ M?C/NV7M]"/NDVD23ZG8A+SEHY"^6H^8)++6U^P7R\6/^AY@Z7@*;)K%6[Y__ M^.QZ'HBNY^?6WZP_.<`Z(#/LC?8B8:D.PF+R(%!866+<@`F+LJ>TYV)][KIK M?^'RE<.1@&U1%3#`4WUN?`25S5W+>O3M*F,4O4[!0Z@[(UM#_D9;YQ$R:LA6 MY1S)/5JY&5OL&+2],MTK\354RU`.55B`-[%Q-$:EKAN?@ZMV3_8AJG<@7SL7 MM`_A;2(_A2@Y5<@!=?%*A6YS5<&VRV(7`]LVJ1]&\(!"Y>1479!-#C52#AQS M=0B+BJW@AG$5Y]5NR9^'\"$`Z\1)K+8=1J=W<[&5 MN+/Q-*!3)3AC.?@%;8AM4K5!8?5HC&R7,"KHHUV^`D]#"X,XT&=?2-[Q`R@< M#L&:)\4*V#XG:\[SG!;;J39NI3KJSB]7Y/<<5"FAN0T6R;8>5$?V' M,TS1Z1SLQ%[V.0NVK$4ZR?$T\!^RNTZCV')@>Q7-PSF87(['5[,RG7SY:3:[ M']U>LJW@L&IT/'\>U\+#7\7\\J$U2NN"BQ%RA=P64_%D99 M-EFQ_A#0WK0-GAG@Z2 M="H#0U:+\WAV(]8+@QE`:X@=R+,H;>.'-3U8D6=G8*C6#38KTJ2BL"!,#C9W M'C%KWPXJV5[/]O$,_#RZ6];AYD=K8>CX7,71S5Q3U M;6=5?[9(IL:+P;.-JF@4-JX']V);5=K"Z1!=9V1HR.I:)9SE*%%(Q$@031:K M1^ACBTHIV;5L?X(OR->0,194LDRAI"A"@8+>=7Q%@VU>9>T9^=H<5VXH*`VN M@Y%:ZBB!#$I;5]?HY<2EU"E3:D\8:M$:FQWDG$IY5P?;^K/A>U<1G-?$?KJ= MW4WOYV=[H![&664@$QQQ_A(=1!6L[3`62VB;_(5UK7EY4\S_/+FZOQDOC-IL M/"0`1:IF.B4(=B$).54MU#U];/?`*06JB8G>"O_K@NGU_!:1W[;Z\J3 MA_$^.E$28"8RPJ=`CO4BZDXGE+(-^ISO;R9_@Q+I7AO@/;I@YXF*BTY1D!:7 M#4?,NQ-M7B^U<4V$^=:8?S^ZO1K@.[!74B$6DRUH1!3%=\^\A-S6Q6UOP=,; M9'OK>^>I<'W[T$D(GDI13F8*Z$AX&6V'0$NYC<0YMWHQQ[#[)EPJYU.1HB2O M=(%LRXINN6&Z6[(.RQ=[GOIY79J@K*)W&&4VS+,FSG$[B^Y:V&"IP&&3I[\I MY@]S:76I09W(%:RW*HB(TIO.?CO=UB:-;-/\M\+_>5R:M8((R:.4D$O1J@C9 MA3FF[9&3HK_`[@V*9%^?9IS1%IU129-TRIOB.^8AMM>]TEH';YWY/7P:AW6! MPY<,C@UW"AJ,51W?&YJ'M93XUMD^W:)T\R!0X023KL@!1 MEV[(9S"XIOOU^-SB=M=A%C)["H+FY-EG*JZ$CE<*0?X@ MO![H8M?J':CBHM9UJRGQN12RI!7[#@56]L4/Q'_/G^X"2ET@VC<201>25-IQ MN`%:D%89S$HB013#$K'_F@)YBAR[=C;1504!Z0PY<"45A2N!:"FJ-3`_D$#V M]KY'Z$XB3_K_R+NVY49N)/M'"B`!))"/N&[T0X\=MG.K)`)X"`TJ]*1C.E2!-2VX>U\]=0ECBS? M$-LRZ[Y#G8EW1HP8=+WO\"A?3J%'/J$N2KXAYF6.`;(-CG>/PF2S!M_.7`]+UGY4!N!CFCJK)&"''IPUJ@*M7-T1'">;>6#%\U0QMJH MPU"&P%E&T7*]ZLVTX)7;V^2N_7\RN69.:!N(FV_E:G>3WR6W3'G`?)XO% M#TX'>B:"#"7NE'A[*UU98B5YH9V1[``51X68.47O7"_3V7QZDR>+.;]AR1[JX=M#8PG2 M]*_9]>S4"=,>6+&B3M8E2%)BI+99DGJ:)15'+6[7&`\MZ<42''H>17J35)VO MD+5A8\4!@%Y+P%K6I;5@>[9S\>M$"9H)$#64_,_U;#FM]Z,G/VK7PO,8:I(Q M5&\V)&.#K-U>'M=,+UET1P\`[32U#:SF92L_!+Q$\$3D>#,DK$EOQ?MQY>"[ MW#K:[MRX/'GEO[$IFS\\CR[*Z]JZ0 M9H)4AXO\LOA]NO@^N]XH.Z79^P7U;YQO`*:-7 MRI&/A)P$@;3K>"K:[I&/K/-(Y!O(]FD^O_L^J;*5AV7_D*>M.%%G3J"09`HL M6%9!2;&6"SUV*9=5[9`[FUR_W[-!:$K=T[LOB\G?7V?7D]5(V29)6/SXW__^ M?;^=M;56S=F]8\U#CNS9':YE*=`EI%?&X`Y)TNO(\OB@[J>+><.!,KD=>$K: M*.4$!&-B9R/-[SU M_!SZ^$`%^Y`>`_O\Y1WD[HXYFUQ)@HP7(;"R1[,BKZ];.KG.+3XI.)8842T& M*.S!&0[G+1@=@DNJN,3J6RGLJ1@%JMOS+NJDS3&7=Y#%.W%&XOGQHE51I>04 M4ALGRX1=PR<-Z%%U[[#/B0$CIESX=UFI.,N3+;D&YM!#N*6U&?7AGL_G$.=^ M$2HC;9$0**82]3K'5>@[]HSWU.[1[42?HS,94PS52ZA.*9-)E/7M:*F[ M5:1*TJ=&]#EJ1)_#1D]KZ3DV)J]X7P81_/H9H>FRX"A"E*-OCW/XG,":Q,:; M(FN=0QL*!_\M_;RQ/0UK3H\8S`V,BG"5"P&!`B]*%EMT4TYM1D6`-]TI55*R ML^P)C9^_O,,#4Y*)EKT-RD(U][/)^L=Y$8(??]>H2V7LB"H^,#0BVE)R%L@; ML.9#J&4S:0:RPQO*9S8_J<@39/R;6$3AQM=),RK<;,!;J'1N/Y'!U+308,YW$Q MN4JCFV3+7-$[_5CM3M]Z'=E.]#D<)LO<7/'AL$44%_-Z'$]2GKK6#"RK&IQ- MKA?YG"A$#K5;VO`69A.3):8V+N!4H4MO;`6=3_]&]#E8,[9L752ALFU08.?3 M^ASJ-M)QDNU.,.K3V]O*_#6=3Q>\POF-O_DVF\^6]XM&CY[-+X0RZ*)%$+DR M9%NAL)U_DE67)42B*1M"R]("T&7"T[C#-]J_CFCL`,/AQ+F6.L1+I>IEBVQ\'W." M\L:Q!&>55I3H.+_G),9*>-SJE0TXU5XJ_:\AP9\GU3APE^.7RX5LC MY+)NR'KJDV9UI.3\YC?V3<=LO M#-G:.E0[NSAO#5[7&&R"5UVAC_5F3.,7ZOR2O`;/4I(?'+S#(]]XUX$ITCN, M2B0MH)VLQ.XK;]5YWR=X_[RKK."WL_L?]?<>._F.V;];Z:/R#J+5H*()I(6, MVK3TGC8YC05(QN,@`MR:1T\(]D.J/ M#6EWKV]%V@:3J)5KPT%>0,V8VC6D0*3Z(94?`])57^JI&[\H%Z0I)G,T9X55 M#DJKI2)!N`PM7WOA!>\H2ZP1288!#Y=K[\0AI]EM39]Y02R\,TL,; MOQ30V2<,9(&MJ,$,+:1*EMX(Z8ISN_<%Z6^SY?^5Q73:E(38E/2#:A>#9W?.;>&)EG!&^UOP)O0U%4NN9 MJ@78@Z?5'Q;/[H;?Q#/X7"1H#N4UL*M/`66KGZRL^_23S+O'\W@WOXDGOX.@ M]AVF1-ZPF\=5#:=Q\U&+?CP%O>I^?Q/[>;R/W\132@I*6)E4,L$H<`[,&D_D MJ'\?GN[#XGEXOV+ M.FIEX%;^[63^C\FWC3,]7[=^;=*^__%I?LW?/OL^K>_:N.6U67#0)B[%@P:@J:3W6@\&U+7&XF3(L&^GJ8$57AYV, M\+#VX7:6I[+!^_9?_-G^1N27/YS!^YA[*E\YU^DGB9+!8.LQYKI%.^AB;-]S MD/SD"-085GT`JI_Y>8RY6+>OWKW[VM*[]2,"Y3+]/'5Z:_+F;7P[=^8.M*9@JJ&)&)$V+$[&/):]1( ME9TVXE^GBV:%;(^OQ!B1R&F2G0/-Z?+3?'5`]L?=_>26W?5B-E_.KGLN4!UQ M?IPH%TN2_\/"FN6<7S,RV5#+CMTF*B...94=5ZP+P'&HPYA#X,R!L#`E*@D) M)+5&#WJ&B#&,2G]$'(>ZYD*QD?,)6SD\A(A11K_&4=C<9:D7L,,6]=/AR+[I MK^GL_F'Q]).GWPVFVC&J)"GC6:U`BC450R7>@M+C2U:3,,;#K4>,UX=I8)?: M.E6#O02*G`-9[T-IX_@$J@\F/;)Z701,0[>>+7&,[0-#E40AC23T>A/6ZE1? M9(+C6K-SP]1$@^U7[YE_-N0[P0ME).5X? MIX%=1U`2&5?I3%Q)MK6IX[9DYO9@=-H`+,-R@:9,*B6O4)>%L#=S;P),.I0#,CB.+Y@MU"CLT<=]=KXW=MF3P#CE1KC MX.<]`-RU`IL`!XD*R&E.S$CY[!$RK`%VVT9@)[]%]3X`_N7A?GD_F3>\AP>2 MB:'RB@N*BDJ(',6039R1F=::*O+=V37&JF.:>$<0Y%QP[:M"R4,PN>@A%`2G M-"4)JE96'BVF+\'U5>NT&3?8ZXCPV@#!(989*:Q6SOLZ/B;;C,5AZU*,L'T` M@5'O"Z"#Q#4&C.:4`:T%$ZR6BEH-,M*FOJ3*N7&SJC<'Z)`E2E98FW.FXJS@ M\*04XUL-(D^]`/VL6^RT0J_<7^@5(42RE=JLQAC.1`?RZ7Q4E_VAG!PQTCA2 MLLM`$_:CB:X4##Y@Y0B0(6J5RAI-74#OC]N(/BB::C^:.D9$3U`]857-&'U; M(*EWD?>A*<65^*C*>>!,1WD;9-H=A2) M7P/\#3WP7[XLIE\XU7E))D(AF9!#(I\\QT@`Q5L&7G-"!R%UF?VDP%UFN;<2 M])7A?DYT%5PJCB"I+*Q1NO:?$Z,+B-:3I+X$!O3(U>IC)3L-SN6I)U7'FXKA M2AJ_#IGM,HELK8C26GQJ[Z42]EJ+*WU*T].H,EX4O(?K:%`/,PF\RD6PR\NV MTA,_Y@0V!+\/7G6E3VEC>+_P'JZB.9D85FTC9N?K$%1:-5,W72)LB_?!:Z_L M*?V5%PQOSP':F.8!-;+5I:"S%(9TI;BAM7GP+NVM`].5.:5A?60I+PSB`1-1 M21(I@7-6DBB<:?BV-<<4CWLM,%S!*:7@]XWQ83NAV/36J=XF631>LPY+:A,Y M:>)>C,V5>C<8'RSVO\Q*5/ZD:$L4PG-DYE16Y:FXO,M.L@&ONCKIWM5X$EX. ML@/&`5A'(1O/(2]R&.$DMD77X*,ZD#+;,0.(GQ'9PR9!&@W*>N.5UCH4+X.Q M:Y,0C-\;.@"'9F.ZMI<@VQ5\51Y4_N'+P_)>C=;WO15SB>`Y46"H##KV5;&8 MQS8/C#$1'?!7G5QLCUQ_#J=H?^[">>@VZQ_3Q;<>\IRU4=OL2BPLB\/BE3`B M`_HVVHE95!()Z8/CMV?(5C'D3:G$MB%$%*5R<;9-9K*D!C_Q&=S[QD\_5__8*)E@ M(%HGE%"!'644[;5:VPR'_`CZ-XS?OB%OI@BD2MMNJ&Y4L]12M<<7LF!G<(@R@GKZ`\XBR;D`VXE' M?IM^F\SJQ);(P"T8E(?)[4%-W(H;7/3"F@#&I11++FNR/788CGRC8?HSZ#$T M[/F2C(KD_J.F?;\/1R"9V3U$A)A,<4&"UWKC'"T1-G-/Y>=13-WS!1D5R.'* M^XB:*D6*%A-H+2(EEZ2TOA[D&)VL@EPUU?V+/LM1?/'H`G9QWWQZO;T9+\H3 MNA]>W4.M.-S-:P;4\P7-%P_P_TJT7I)!*U+F;!=LR1@ADU#.U5"SY\3'ZKZ. MK$WY7PV=<&9T4`82K)<*I1*7-X(EGAL=3;0/- M`)J,LG4488D5'H,<)LK4=SO9O`8V!\7[=3']:[I83&^.D1",%!Y2%"G9F(3( MG"8\;H_BV6;U2<@A7D_OZTN$A$NU'MZ5##[6Z7E)>A%`YM_EP#(T%S7[-"$-822Q"A)*E%"9!B'W'Z5;9D;?(L^$YM_FP"63P MQ5I5QYLH042J@2^6+8V_;1LIS!9CP;GG/;C"AE51+-.F-LO?9/KL:KGF)(R;N^^X]GQV4\ MFY$,IT.6`T@+&)*A[(U8[PU;>J^>CRF=OE2;P9["\O-&47R$*(L*0E=/$511 MOI2^,,P*UW<]^$W@.;?-8$P*:XT&XZTQ@JPUC%.IT\%]=KGO6DV=*GHI\)S; M9B1=)XY[%Z,)3J$VUKH*#YC@P>2^,.SLN(QG,XRH=%TB:0-U(J.)GIH@LS)& MH4Q]-YV/EZ[^_J?E\F%ZDQX6[32)U8=6?R]WBSKH>TOLU;F?7!V0KKBS5F,Q M_F*QFAM\L_O9Y/;7AS]O9]?K/_ZQF,R7+%"MZ+246_^8_GOSQT*#V&3^XYS\ M=&QT.9>-60>;JW]+7V;23BEMGI8CL;M>+@9BN:EO=P*%VJZO4I! MU5$O'.<';<$'6KNTF'U?C:#"N6V:CL+E>"@W9K2T;86G\\0`NI(\4;"<`$NE M.3!I3\.,L*9',MZ2\GC)>I=Y)BDO4WDPUK,,`P'0,'8Z:FR51Y=>B-WN.*F? M&^%SAPXF.0FH3*%$-D4%$6L\C4!%B.#[*CA2V_>$\+FC#R-*PE)=2JCG&%,9+]`6$55&J5*R68FJB(*$%XKZMOIE031` MW).$LT4Z8Q2G]<;Q=GL:/A)E[+NX#')W0.VE2'F9WL(&ZR7'OZF@,"D8COGM MVELXB+V1VP5"/,!L5(DULA`Z:"J6DQEPOATBERGU\O:RA;],*2]3D;#(:)TJ M'A)GT$4`&<.V*`B+,D#L*S>\$L1-(\I@)K#?R.JD'0JE8O(Y%47@VMJK]KHS M)!L$H3A&K.UUC2?)9>I'3)9-N#`R!J>E\`5,:VA8/5(7QHN"\"`*_N9F5O62 MT_/)[.;3/$[^GMT/CA$F%MUG1H&(`&7R\>D@D,U3GV+MG@2/BLHX&5ZT`2SG M_9@LZ5)U?:V[C1WU^W0+^#X#3!%I"S80+(UIMZ MG0PX`^=.:TEEHAP(#6^D%C#!=B&,M"O/G#\?:&O/6Z%$(0*EA(1PE!!M14A; MH-@!A8TKL>.YX%JW+T>$I%!8BZVV6H@D"(>`J_:.,\*\U`?M%'"M01O8Q!NB M8;RQX`AIYG$"3V)^ST;8S>7F5L93P\':+;-(:"V"[1[.)!RVWLL--B:%#&E+ M40FC)J&SP=4ET#D%E41>M..$))K#A=JD!-/EK7EC*FG6ZV^RETN]LK3>^^-8 M,H>]E<7`(J\$>'SW-SZ/"FT-8@AQAC!07OHPKP4IL#)9>#N<6[""#ALFAC;U M%M?6NL02;$QB`>!4$JB]84HLILBXD@P1;+D73C,VV$Q&PPG7AC*BC<;:498X M%`*WBH)0:_<:+^^HT-;A_26&&J6\#:2X4,Q[QVX2+^'2.L)=B=$\'6X5X=X% MK+N\WTN'Q71WN[5M#3W2`#)$4,81-M3[(6HA48TI676((\)6;.#9$O9983/Y MP$K(M80*"J(H(2XD/T]SH%D8]EI2."M$S)&0J=O-@@)KH:3A.A@\G$`%;$"& M0>S5#2D9.LM)C$>$IO;2`&@T8X`'`H'`VX(<3RHGF/% M,"F7=WP)$5BA,@Z^\?T\/*2,A$"'(B'FQ:?E:%87X?E!KO#P`/7$HUF*R(4!UZ@Q_242<;I#W;&8:ZM6*3C<.] M2'*8(8F]UJ/$X:D$\[(]#"),5[Q`&G$(K+L MWPM>7J%_8TGU?-78"AQ%L(-6*Q(\`2]S%6*+C&%)RA&IY6:-1X2F;NVLL``* M<26590)"!H2#(3$2*\.A@Z525(T-2MG3$.4BV!WE'P]KD4@L))SBB1 MRO,/+[DV!X"E9NULN9L$3#B'V@GI?U&/1W:*ENR12T8/0PYUQ#TH"/HI^(#* MF^TZ-,F?[Q6N\&<@#D6KQ]_M3LH9.(&TL.&=0A;.88U9Q)@%`R7E?.S-[:B8 MM4.),)2%&`0TSC*4T`6].ED^4$V\A54YQ:X;50%TF%7A77W.`PM90C2?KE!" MZ01;7B%A"*]*)GCU"INIF#5VDB!!F!,FL8HE2&K/K@*4F5Z(0857(>JE?,C2UOL_X_+\VLIQP.A+?+'5(!&HT8 M!@Z4;)8#P%*S8DX,UY!93;AEF'B:<'@1?/,F24G077I%)0Y"#S5H9N;UK'?[ M*?1>%#?>+`6/^5=.T-)D8YA@P0]#_=5I9HJA-[`)ET'L`>@=2>46YH>U-8=^ M=M_UMD:ZXAW#LMGR\VAFKHU,_5*V!A(0U\ZP;RZ M`G("C2,)M$"78OT'@*7N@#:TRC+GW0_O?V#O)#JB0]DLY3PD()1V?`EI4KFN MVF/C>VEFAR2@5%#"E`4FF%W$ALT2"#'W_\J!T`21RL.,-9<*@X0IHI`WME!H ML4B4A!,:%AIIO^'&T?".FCED&A$:RB"0@P!2JED(^'D_C`G)<MB[U)@ZS"EG!JHI%]PF/,T(H! M;0$68=`#ULYY9IZO%'%5,GFP6.I^4.E*UPZP(H)JS+Q%QKV8L39,9IROU`I7 M.G'!RU/N7[%2DW:'::=(BP]I,>Z//$NY87[_?ICEPVG"A;_V?5Y,Q.?NQ24, M*TDY0BQAEF!@E)Y%/`*U6%4..VZUKYW6?``0-N0^:B(=,LIAQ[Q1:31'=`%" MHMF*@]&M>+MI*&Q*3&,&(P@4E]X-3(`.'0$%4BH!2FL'DY*(:Q0*?Z2C47\Z M5^`?V>C.7Q^&NHU'=_G0/WJ/LBM-`=)$>/7+*%*`*H:00`8):K`PKI0:L"\2 MFQ9^2$@V\`D`PONF.%1+44&`UX;"!4@XDE`:=):0;&`:RQ)O>4(B!4PT%-2[ MHA-(B/_5R;+;+I:R50^.B_$LJT`V7'9!T%B$[J%;M2B$+NM1FY(20V,`DVD#H M.0(J!22<#,%0=JI9--"2E#1+@T"HRL[R!JU7HB%V;(%7+)1!:N;$P&RY*G$I M7Z>*-1\`A`T),0BX--)`BZN8@>(U:Y@ARBB!L8`;B$IQX@YLK"\,, M8F@=F9E97CZ"DL-+X7%0^)#VQI/&7L^?^&OGH4A_OY4/#_VL&\8'A*C`>.0_ M^C6[ST:=_=A#8Q6LR=`*(;$.8JDE?V0/6W*P-N/QFN4?'IX-C".,#'U6/25X MW\0!DU"[4*IX1>H/Q%NY::>%T28E(SD7C`N'64(Y8R;8ZA.^\K)&ZA75[*@) M&%W?=4;_R,?]WB_W#WX;]O8V]5_W*?67?.B,5@S:7A?[8=Q@2J!WZCG"F`D. MY2SV([S[4D[O8$M=H?9;8RW;7!EU\NW8?I=MAFJ>Z<".?C__ MW!ETTT(.>IX5TN&GM%"=?OAH?0[T^D=9C M[_5L+&D"EBG)O1X!`B=:*CX3DZ&47I>T"%T2`5MM]LCPE"___=;,CA/\"Y1% MD6[$*4R%5IZJ$H2YM\`QI7,[S`I)5\2[(!''`0H=A8ZLM\BQ8Y-(*!7>J3?S M08Y60()+_HI8\MQ.`9Y*Z`@C3#2@2DEE`)6"N1D=&<&`*,6#$HR/@Q,^"AG! M8-)SJA.G#4)&>%U%YF1D`"KW2DGXD>CH%?A404>AUXGB0%G"C+8B-,^7GA4P4=86$T(89) M11/(&)4.J@7#L>7)Q1=_(TFM,.F[SO!CF%>F\V(T&V`V*%Z<(7X$RM)"<)HD M*+$>,8:(9?.HE!5T16HCIKL(\!?VWSP$*]&%CB>4`L@3;(BD0LU&#TYEF%W7 M&J8Q*.)CT2'"E%.G:;`SO1-#%4'H45/*DL%%14/I\'4(5D&'4!%".-:>M9UW M&`F00^L8/AS67*X\5(ZQ)D@6`D= M,IIH*!/O+BFO>QET9"$/`4K6G?G4C:)9A/0:I(H=<@8;:SF1PH26%,HN?')C M>`DOL@/A/6ZX$2A505XANPUQB!RUVAEG`$R2.7E)BLN56DOMV0\,V/$TJ_<5 MB*!&8R,EU$PXK.=DI0$ON59L%\7:,)BJH"M-L"-(.&&\C!*)H\8M?*W0]Z]\ MBG!4NCJ:IJ3>7&.A59N44LD$>Z9;B"MA>:E[%$IV";4V#*:L\%-@PFXY0A"_[;"""V-)$G$?(.0&+)J@PE9*AFI88.EFU2GR+H[ M$VC0^EQ;[XM+;J3R/KH&\^TQSY(K9Q'1[0AT]1*KW-P&XDR09M0Z1;5W5YB# MGC3M=*B$5^QJY23O8`UL]>[JW]PFPO3N@J/<&&6].8>Q,6BQ.93@5>,1A1>L MK]U<&&!WY77@<)SV?LTZ-UE_DEEILJ+;SXOQ,+WVFU#]O/OGRZ_K,2:$1`*D MTDH1%OYG*)B=(WG7R')[\;Q3JQA][:<_7]SZ1U[>=NZS_M>KZ^P^ M+5J_I9];'_+[SN#=Y&]%]E=Z!<'#Z-W%#Q]'[Y9N[V>#]/)NLNWHZ7/1T^>&SU>M*QO@7FV\\&O70P_?WI%PWRH:?$Q5>-\H?PX"^/#QZ%3(]6-^WW9]=,IA"&WXN' M3G?^^^XO\W/6&]U="?$C!PD(Y1C4[YDGW[^[R8>]='C9S?O]D'!R-?^A]!8? MESA<_!3ZBX:%#7Z^X!>M8?YY^C-<7/MVU'O\<;CR"9.5_7S!T/?/GO#XY)5/ M>[P1[GO?P;_PT/<=Y@M?>J\S&O5R<91U._T9*4V9Z]TSID&>`9YRQ-/?9\SX M]*/AE&4#UVQ:YA,V?5DH\?UD$I^+I,G55Z&8-.N^(*3>_#)HC>[R<>&50?$? M:R74\S>RV!.^6`_HC(WGLNOA2ZO(^UFO]=VD]`Y4`#A:!GP]R%TO_M+ABP)T M!]D/7I3])NU.7*(?.ORAJ#P=%)-(1\O+XU8>^B"T MTON'?OXU32^'Z:0[@M]%,2J.*2]>?&R#]@[^2?7\B5B;(_.]=K>>3]EX1NBJU1YTL]6JA2V(_*BZ3- M$*C=>CP7'HTN[@'TV?DP%VH+7+]K=B[,%;VOK6">]`ZNA>]J."PZ*ON)MA=1 ME;'?!G3.A0NC9Q8YZD6X:%N(R@[ROQ6.BH[=Z_"_SD-_0$.@K)*"1K%)() M;$-4V8%`%)+;FJ-O)R4/*Z]?\?-/;[>OGWDLMYFV(?S]]J5VA?FB0^%T!-*L M3^%U6-F:HDE!!#CJ#1\[:1,+0K.W(YSO^-BU%V^_69K4SX M\,/V:#Z2([XU$^ M_V!J-$P^F98'00"J*P@*P[%>51&4\%AHTY#[3F:AS=[@D0X7=G4+3K-4JF$@ M-LZWBO4ZV]3KM$*93JP4BY1WY$JQ72K"7GO&$4DTDNA^)(KV\/<;T&Y]#L,86IV)8[W> MQXYA[F.%N?W^8PA[3]S./SS-#Y#$=Q($\]K0^]^."12[[Z/\8TMIBI<2!*_\]A7A0O4J;N#(=?_?I?9H/[ M,)FK%GO!F'7.,5>N2AL?,._1G3I M;TQ2`B+MI,)VC^:FLS\?RX>JZ\C?2(!K,/[9C_5/'H]"_5L'J#8OS38.4<6TC4$=S$*;O<$3R68Y+6,QXA/QV8#/XW)C M,_8*1H:?B!B+S=A/.;EO-:RQ&?L92N781S@V8X^$>RZ$&YNQ1UIL"BW&9NRK MB+8Y_<5C,_;8C+T2-&,S]MH+K6(S]M..Z36^5C1V+'U6;1`[EB[V&45-%#51 MU-0F:F(S]BAOHKR)\B::-HT4-2<293K/5H[GYL6+'RLKL(J:[(R+W7&;HLIZ M>S9%C-1M]$6..&..>,-I[)82[HLY,)%=MNF6PI+*:FR:0OI',>4;%$HXH3Z' MS42MX0T0&P3:Z8KJ39DVY]/+MM*6BGO#UA0!%D/*D3D;Q)QO$*AL7,ZK4?NV M'9W(N;$%_#.UB6!ED]_.7BW&XX^Z&TE&*13QJR#.?_[I[KGW3__]F__^B\_31[U7VDOO"63?LJZJ?W2 MS8KTNO/EO8>]^W5QN8=Z$/#\D-[^?.$,`I#\-_G?:W/1RGK^@TYW=,D!-DY" M8!63&!HB78+M_[-W;J?)&S.9699,>> MG=I'F(0LSE"DEB#M:'[]:8"D+-FR+5F@!%#]E%#F!6A\_0'H;G1?7/BN/;P< M#(;VNY\>C<^BK%])>[AJ>#=-!?D8`^X;,>!ND/.GDBTIA4M*Z1(0[XLXV:*3 M?Q0\CT:SI>25_J.#RMMT7#XW'(U8D$=WPNI$TA'Y/YH4-)N1*FF41?(Q(]\` M=/!U\BU+^_7;MA+0TWDL,T(C*00 M=SZF.8'&%R/0^"*#_J29E&*621+@9`1`VHB,&Z$4QCX*)%C_%L2 MB8P@5SG-&3\FY'<8ZB"026K$K>(6(7")#N`?^$HB``4R3PN@WI3+_]^F:OTR^RP2Z%NL]D.15,&9A$;.OHPLVS5A0XNTT"1?SF7P=`=BG((49_&$( MA"R/E2_S[AI$>N&>]_JN<^;X?>>LYSEG7M^11.KX%V?#\\[^B+0I0EF4*>C> ME"6@?#*P'_"1IV1:B552`:L%2^X%,CB`)8:%-S]IBE,QAW`#.82]+7,(=_J8 M2%:3YXQIJ-X=--ZK:6P.3;068=*P%Y.&U0ER29475_FI#T0>(N]%Y+T]-3-" M$"'8#`37CB7%,R[/`W9QZZO,Q*Z/Z+33=>5<:'8M)RW2D!CB!G,LVU>V\C,; M-N(Y/-B"#*8!%)'!UC\7VK?Z7755#HV(8,I@F4$0&V^!DN]7UFS_;;@1L MMF6P;4.0E+G$5WG9'\4W+;YR6/J'-W:K.Y[;/;/[GGO1Z7?./?NTZ_BE6]T9 MN@/GM'UN]:5:*[5;'9WFZ#1'E^O>GS.FH7IW$)WF:SC-(W2:H]\(G>:(O`-# M'CK-$8*Z01"=Y@H`^_E1WA-"5^QTT9*+EERTY.IJR>TY:,9%1Q32ETY01/I: M6U0=M_ET?49@!ND+Z4L3*")]K2TJOXOTI9D3?5./]RJO^:_LCB4%N\S2R?![ MSK*$QG6=-'XV^\32VXQ.QV(,3S-&/R?R%O$%^"$)+^`^#B.\L6?][&)P=C:T M7;\[/#OSSOPSSSTM/>OG`\_K#_>=^6,G23&NQZQRJD-+2.F&SD1@!!V3J.?+<98/1UGJPE/VS<6,TU M<`CIX_-Q>Y8]QZVWO4M`-6LC46\A>+1J^7S=B`_NZGN7VU1VF M>$4\;:$K5"E4J><7!CVKKS#5)ZH4JM3!JY1M>7UU!H$#42ET,FTG_^N'J< MQ>S9%--,S6&C]]R[*T;49^B;.OR^3L21_,73^?`">&$6)3P*_D7C@M7-VO@XO7_IGSG^N3,XL[T+U_>=3K=3 M'J?OGYWUO3W6?]_A9/G^-L5J:US0_ MCX^9\,TYVXT=-+V#>#I?D_#!ELEGC=/Y>O@L\8#^GMQT>(B_!=JMQ\%2K=0= MS^DC,-L!3#R*WUI@XE%\E5%2P4%&26UD:U-F%&]._L9SS&Z.M`4:':!L]M1: M8-CQV9[E.,T>U-=I[)^;`I!ID&F0:1JN8V$YO1XR#3)-BYC&B*`)+6C(C&@< MW^IZS:82,08UVQ+80?@CE!S27S,>!`UKZ@UKKYV--.[LHVM;KM-5!96VR/67^,E0)5`GC5<)QK8ZM;"_>%I78.CA<1="VC`$O^-$MI=.3TU!* MG`-VSE.>\V^P4PAFFP1XGP]]W>T.O9?N^R-[1E@+<]O/3\OK/O`._' M(-@FF+N\?#W"9T&J9+A&`7?=X]=_9W-/&EWH6B`0(P+(\S&;B=)O)$J"(LM8 M>/RR1LQ1O28,ER%[1Z-8(/HRS:YHS*X8?#/*(\8W@6V_?W[NVZ?.\-+IGOL= M[_QL."S/)3C#[L79ZF&L%<+2TGN(8!]?2'O`K/G\&L&&\R"QN1GFHMMTVS=7=*.F_HA2LB, MT0S/(+4WHEXS1C^=I""+OUA(A)D'88>PVPGL/F4IY^2W)&/P38&^3S12%_R/ M\$/X;0:_+W"M+HDOX@_Q]R+^+FF4$>D1;'0#I5$"P":=P%=SA\G+[@],G;B# MU(DH.`6(0<8@X?02'B'N+X`QUR"RWP)^J/9CSXU$4// ML^RNLG0]S\JE+1,!:A=JUR;:A8J%BH6*U8`=PU=FRWQ5*(=MX4#%0\5[M%[T MFM^,Z*)&>S$+MEM4"52) M^KD^:@-J`VK#DCCZKN,JPPOJ!>J%\7HA%DX]96OLMJ@$.KTWD?8IYRPGHOLL M1)>W5IM>C61G+JF_EAFC/2;.CK*#$F^665NF$-1,U$R]]R^HHJBBJ**HHJBB MJ*('HJ*XOCUT][Y*$5ZG.8T7JP2MK`N$9EAEC(;R4<98'C!6F!8"JMLD^#2B MFK:Z&NSKBM#X6NR.W[7\KKH8[M<$9P2.FE[,(H,A@R&#J6(P)"\D+R0O#9"' MY/6&,SZ=G0MMH[,^1@`/4YT@MR&WZ<9M,.,I9SGM#ZRH<[6_!BLCBI5T+=M6%R2D^^"+Y_`<(5(-4LWNJ4996DWM MQQU9!ED&669/(<]>\Z5XWA3JK`M)JQD-!;E@3H*4=/ MN6;T_DJQ%^-8OF]UNCLKA=,6KD>-0HW2J?@;ZA7J5>OUZH.CSG:]IFP.VQZ` MVG;`V@;K0E^=X>U`YJ^V10RHE&U9(C&N<]HU6R%1(YEJQVDHN$8$UTCAB^=& MPXA*!KNKB+'-@3,S2F7T.I:O+J3U[0(U`GA-;T.1))$DD20U),G]R]((S"$_ M(C^:@E7D1Y615!JL(-]D6S4"JAB(A?RI'2B1/Y5NPCT?%YD[MZ7_(,W$*^]? M^/]"O^(H84=5+1O'M=\_AIPSCW-;*SYKX0V#%M37*P1_'4T8)[^P>_)K.J%/:'E"L]LH*1M) MBSRM?RCG`/G+?13FXY/!X+AO=^QNWW6[(*A^YWT-+@!.3*>>\_Y5+"^K6_6@X[WUP5T_M_,/8@>Q@SIVT)#@ M:;-6PR@?E,\K\GEH;D?O`!>U$?3R\KY'GPC'`_?$Y(/DX+3I.0J[.4-(!*34]]K!;K M.?R:T2`O:$Q^IKD(HYF]*-S]-?5#E)`9;`;5C3X2^`:%9G>O*?N'W.DD!5G\ MQ4)RGO(<88>PVPGL/F4IY^2W)&/P38&^3S1*##[)B/`S&WY?X-KDD[2(/Z/P M=TFCC/R+Q@5K=`.ED9>T23_*U1C6,&K+P&LD.>U4&P77."?N4(@F"$X;82'B M$'&(.$0<(DX?P2'BWB(X0QTRRRTPI)Q]BUPL\KDOC'.2CVE"E&5T11Y3+Q]= MMN?*XFN;ZW,#@;`]R_.5G27092C%O,-6HY:+^!8#)A61#1F$SIE&7F6F.-V_XC:1]PE1"O:]G]M?,D8)D05"E4 MJ5?$M;,B5ZA-J$VMUR8LQHAZI8%>&:%I5HF]=>I6S+^FY\?EH= M"[QI&3^%@L/<\MK%LV%N^8^.W[<&'7O_$C4">4VO;9$ED261)?5C2:^ADM1( MD$B02)!(D,83Y`>W(?\!EG@3SV$,%/*G=J!$_E2\#>]J4";3".3MQ9Z^?X:L MRKNYMN(H-CU.RZ*L4%:;9)YK0&ZFR0IQA;A"7"&N3)$5X@IQI4?258WL($UN ME+ZDHN58PT$#>D/!8;9I1)PN@D/$(>(0<48(3AMA(>(.`7&&^`:PAH.&Q]R= M(V4>/.0O]?+195=^D/E8'=?R;,S'BC2`-'#0-*`L:XNQG-0F=T050Q5#%5M:&G;5 M9:5JNW9AT,J*YTXY9SD18\_"!@P`N,_72#0&$'ZXH&PQ-0V=93-N.422SVE$U/ND!_+[MQC0Q@S9=K MB.MSZ5BM0<7$3OG-;^@_23+SR_A7_ M__L/!3^ZI71ZIEF5S1F5W,[\S5T_"Q.@S]_^I___J^_U_>?%3Q* M&.?GZ>0F2F@>IN[?C_]/]]??&.1"'\ M0(/\Z+(SM#O.\,+K=+VN<^IUAWU[>''AN_;EI>>>7;S[Z=%`+`KU.IHP3GYA M]^37=$*?I]R%QV-H]E&5F-=Q[?>/5>^)N1K MD*$IH0]I\BRF?B$G[F.9D663"FG!%ZFS$V M@=O)?92/R75&$SZ-*5Q?LV"<@&;?`B)).H+K[Y1;Y$L>'I,/=:RY:W^\OOYZ M/;]T/O[-$M^C,3R8T5%.\HCS@I%IE@8`WC0C@%*:RZ:1*[CS%%J81*E5OQ]: MQ@OQ?6CX_3@*QJ([-(#VB_XXMOU>-"8?L\=]XF0$;W\RFF^1ZO]ZW6.'P&TQ M*)F2-QX3\AFD`H`1>BOZ)GH0)7!)XX?1F&91P.0`3NB,W#"2W@"6I+C@D0G] MDXE606>!L,B4SL3`R<$IIN(&-9UW.L>VTLX3L4Z3'4Y`%^`_`#DR`^;EY`9Z M'8IN3V@&KR$@&PYC;F8#N M31'%L@.4W&0I#>&'5>K5E_* MKY>X6T7H-0+EBT9%#NN08Z/U\'H4`)0AR+.+?@W$.OBD-RF:2C'!YY0-%GYQWW5D]4U=+%LNIQ>@!0R MN>+D<^B.J4`F8TE%0>6,+G"V^KDYBX>TA/B"7.&#W[(HS8[@]B@-YV^0WTC2 MO/R.F.3E5%C1HABA"2U542YA8"8=P.DG-!8(CYPP0(V@479@Q'!<\K5 MF6S\LW_V0!*G$X$B+A%SF\#(E%"DXM@(?U@)B??$T8-"P]^+B?@=*+F<5:$+ MP,9Q-`&99+-'BPRIT$$U-I)^$A+`3I#"((*^T]MR4?A'$=[*14:)"?GTPRN7 MWK'X74$8"8UG/.+SU1KH[T0.WXA&&;FC<5&N*]?LF+4PU45"_:-1).-SFH(SF)+@.W?5;XLOH1.8^:*_Y-N?O+!2#@&TQPNW M)7E('8<57)!.`)X2MJ-<3"75LS"P4EODK')4SBIT.LUHQ,4DF[&[2'"Q(/)Z MHRA4AY8=JM\J7Y'>)^4J6#1)M)+S>LR`T6!Z88%<3B\]]'H/;F;EP"62W7ZF M<*/`:$=@-)G-%[/BFZ&@YW(Q6JJ%&"6I\55?:3WM+7'GTV\*I#_,C'0TDDT7 M+"RU0O0.9H-R.5PSZ;'9B[]3KF(JJ-8SE9E%-C@44XZ4ZXDP<)1?>YZ9E$P= M%B+C.9TNH&./Z&,:HYZN;K,%KAXY9C;PIN73+IV_98* M2N)Z\=.)F+#B)8ND(^Z9O[@,2`Q8'%?W_/C.?B>O._W$=A/CX1V^_:P`>(B^F4LY/Z/T]L.`_M7@PWG1O].BM#A-<( M6)5M^?%=O_O^57/BLL6S>M!YXW.#'7_/V^@Y0P_;/D"Q_S8F[==F/GGW203+ MP"AXQO#WX;/8K*0%!\;@FWC$-"][IK?CZ]`=@QAX_U)"O(3#5%^M4YK02"PC M@L[]/>GP_E6UV506YY2/R91&L+?-B?!$PJ?V.6GH0FH'F1[7ZUJ.NO@#7892 M/(=GOC7C58UFJ5VG#Y;^!6&9#1873F]9-VU[PKY%6;TU;E4Y$)=S?Y,P#+^5-_<0 MVFM"(.7N(GA;$ZCK]RQ_EX&Z)L`(E]FXS-Y$FM6LZ=J*%]C;Y=$QS!2IE1"U M$9RQ2,2EWL?/BT$#:P86->)T0-^"#E#32SZFS\&[-75]3NY`E]-LMD_X:6^K M4;?]VN)\I#8[JX'5&0P:EX@N8W]`=KH6$'G;^?JJ.A%#$I;?I]F?+P?E'DHB M4L_JJ_,L'`KQ(+_@0G$#GVC!H=E,G#N*RU,$XVBZ2:[60ZQC9'45.CQQH:2- MZK6`R-K.5Z?E,5%YP(]%=S)Y""Z5!"=U7&6;MT.A'F087"JM+]_A?XI('O7' MU=%+8NHXZKSSN#;21M=:P%QM)ZCKC(:,)'2R4;&-]JZ)%(:E'@KA(*_@BFA] M^7[-X6]5I``NBEZL]CA0EYX9%T7:J%L+R*OM'#4W&$WIC,YS%`5!5K!09O=) M>#/+I?;5V.Q8MO-R[[5=W$)@4L( M'9FJ7814;G2J++>BX,52^MMF#!*8A:!)$6(6`LQ"8.#Z59N98+VJ:1LEO'XD M/)FT>[$OCY-@D^>$L6J6*O-?2]O^ALFI"R2)FW5YQ6Y_15IQ#.]%J4B1$6^:$72MO+`@JAUE5:% M9L:BG$]=BJ>NQE'6PYJ7_1)5'9DS4#+-$N9J(U_5L MJ@H*90JDU0W*QS27!9#2(A:5CF95$\/_9^]=F]LVDOWAU[M5^QVF?#95=A6D M$+S3N511HI2_SG%LQU(V3UZ.@*&(&`087"1K/_W3/0.`H$A*I#@@`;"W3HY% M$I>9GN[?=/?T93[$K#U*R`(.ST@:N_Q7!/ZN'(:.VGF3/O(.]#84H8`+R MFZ5*Y+D&>A_]2+#.*9-UJOXCZU3]*CAV=90=-7*]]8J:^:V`+>+=\[V;-H'Q MYT1O%3H?H%MB)C1)N\36RG:)\@1B;9-$SL(I-F8)?)@,MN7*-]'")BO<>WRI MD6$8WX81_.K`@V0C'11,)PK3JA7Z>AF:7?WMH33U,N3+W0R3-G+WP@,Q""<\ M<+!S2-KI4#48BF?88HC-1("-./B=4)W+H@0J<]B9-2G+.A.IH4:@00@KBG&\ M`;9TBAX75B?I:19A-TQN)2VJ;B:Y*Y)E7M>US\$5M.+DI0E_.++)G>R!F'9W MPWZ'<7"'>US*3FSF*X25,P?XQ3Y6^2Y]MP%.#=^"P4M\)F*\*VG#EXPS2IMW M/LHV5C!AV9<*""\\J5/A6P6B.'P%\Y?OF,(:3B4_.MX]#['YFVRU!72.@5>% M'X?STMF%[TN"NG'W8-+?-3)=2KI>$Z'Q_19P\%C5VVV`CO*^]$FE.A;)\J9*=525K\+^]=..364A;H.\KF.LV&T>Y2 M+B!I4$>M016+PA]][P3=>M@A._/X4ACZ"[A4N,9T+&!5(KFK`8H='JQT$JU, M?;\JAU%ONT9/8ZH,9?T=G?CA?;NW\FH>HI57B785RB0L)3R:+:/7ZY(:1VH< MJ7$5SDNJ'.XTC8&^9@UE66'R:)401$H$R47RWL=,XG1E%JU;EDKD MBNPOY6B7UCS5R$4RP4+O=0Y/T$HP'BFPA]][*'MIUZVY:ME+3>E7V4B#N M8KC.#QYS*4PJ)MQ_Y"Y&):]-:&H=(J')WE-"4_NT10E-1]8HGQY3%W]Z16:TIAV3E?*TI3RE)4PY$0Z M\V'VF@[3.>WN.1UFA^R7)F6_4/;+:F6.LE\.[X2D[)>CBZ`G;P-YNJDW?#D\ MU'7H#6]VJ*D7N8C+"-HUP^;]9R:2^E0&IBH7?>JF/A6;^D(]U%_3@8%R7TBA M*".,U1VM]I>H5SE0ZE..,"E*I"@5!CV?>41)P2]'=K=)-R+=J)3(=7B`TFJW M^907_&KBO6T:+=/4)J:4%UQ*\:L!9I5H!Z`]((H2 M>'/W=8Q.5UM9E;*L,+F;2@@B)8)D2N"E!%Y*X'UZ7]=HM`JRI"E_E_17[5O/ M^OS=O:UHV5/+;B8B7,R/-)+T+_%MAIDU?ARDB4MLYLR$*YL3V2!QGA^Q";^7 M_9VP)Q#F4P$#"K@06]7`?>BL1.&4:52Y5*B`83,F+G.5',_RIR+)=Q+L$8@; M,M7&:(FP6TXPD8MFRQPW&VJZ:>[IG*W2KGJ[ODP^WM"35(5)L5H>Q'2EY6'N ME)8'I0VV-L_A2K/8LN9'^5S>!Q%@^*'EQK;JY[7$=K?%(FMPIX-F'R9$OG69@Z, M";!A*E\VQO1;;!&%DN4].[?YI?A8P!@UUDV'AM.U!4CZU,$[YS._?61QB,*L M4BNE0/,9H`80+H63-*,[1&`!C,"1QU$,RV?Q<,)P_U!=RE2J7S),]=ATLF&2 MV0@4F:D5R`T'!C'E'K^382(PX<_)0KY,>A@#G_JPR?Y749@#4P<<V[+!G8#J\J$2?ODW'.K,#V$"5=W45F#^ M$\Y/Z'WU^4O6>V'TE+45VR'RN(X8*QJJ0@:/.<96N*.N!+8]00*F5\'N)F2E M`?SY5D0/0GA%;&CM[PIXJ.2_`IX[*&RP/,.7O5'>;)UVJD1\LQ#J8WK]HB0A MZ-P*M0=X*;#R#+E4GCS&];DBW],0A.HOP-1,_414GO>-S/8,V"%N17H[HGYQ M"PPZSW*]U/*N;[.Q(AI'RP++K2S;YRP_C.1.G2[""CA-%U/MK0B8W^3=L)(% M#!&KK)BZBA"L7+%01[V$O9HC*U>R;INZ#QKW@]0[);X`F]V#UJ1,!C`"+-"A M%_JFW@K8%&3#791!,#+E%J$,A/!)A:&LN@>@EF\YDO55)96\%F7'0:KW5M9R MW2-&K9W$SN;NBI=1B0_=)3X&@]-^H]/H]IO-+A"JW]%7\*.]:\&/WIX+<)BO MOI$J=VP@U%2YHT1^=#K"?7+?6>)4Y-%2-<-E-RD5JZ!B%:OOZQDM*E=1+"`= M'G<*SE1:]"VO*Y'ZFDVQ=I%L6AN$';54E7B;+[B"PK*#H`C1JD_(^EM]]?Y? MHDF]4VYH]ULECA.LY1WBP?_B"=_:4N&6BR??8R>)%LC"4/"`P0M%,=)24MMF#6-/+?N&R[:Z;!Z/N74K;AMDK/F'L**)Q:?R/BNP_U7-VMRY;5,VG]W[UIN+?>MITT::&*:^ MA#="BBINZ7LR=+6=2U`*,*4`%UGTKVVT6M3#=^_F40E26 MAL@RS2PKB+EK@(DQEKT]>9`TX+Q]Q.2S0/!0F2-^-,&J_NE]GCWOPIL^Y864 MOFU0Y\?OX_#DCO/9^S-,E!-A>.Y/;QU/VCPC)[1<'[O`WL`BG+F^]?7G?_WS M'S\^O64D0BMP9!KGT+.'6?/*SX#DEB/"[&Y)&?CP18Q_>G,Y0FK^UO[S9O2& M.39\P:WHI'71Z_?..NV+?J=]WFDW^ZUA_V(T:C<;%Y=#T^R\^?D)PSR'1.MX M98>`\:<\N$LNA/RX%`)[-CS_OU^^?/K]XX@-X;_KWW_]=?CE3_;IDEU?_?+Q MZO+J?/CQA@W/S^&2FZN/O[#/GSY6$Z)]SIL$`O-W,EGI7#6UK6R^ MB[SO%]>_C4/VJ^K7:[`KSSI5B<%1*/OQ.K8#:")D*B\O(EMC=:M@V*FM&-.J MQ3?+!6&^QZRN)/'<%IA5;N`=PO5GLOTP#AENG8K``O!R_IMEY$SCT(H!*KX* M5\B2D-,9F$=1F+3"7+DZ MX0Q3N&TGE`KC"A1\S=JP(LB=3)I[3&#RJA"X>YS8`5#8RXB?-'.>.*%LM@YD M#/C,L8%$"5W]CW:GO:\"S%>!1_@.P#KA)SHK@IA'G%P)V26N)>4 M]%#+',&6$R4)3[#-I90V9$:\[\GT3''ON_=X3?(0!C.QD\Q]VPXP(=X#L)6/ M4FWD52Z_KI6Y=M#$QCH0^,;C49+]G>6)4M<'GO6!!D*D_&UO-EL[9Q^ M^212?V&E0`>`D?)Y+18_B,:P5_HI554>^FW@`G@:,!:M)N+D?0"[A%SD&?-BOCFV#877!PRA)MLV_43J4,>,6 M5M-V`JRNHW[.NF)S%$[%)`!S4># MS"+;BHM@JKJ(*S'K-^'71%TPLJ_,'_(_JXUXW:\/8MTO<9C_0694SG\$%LO_ M&@B4;D#/=;L^IL4+E4P-^@]JY<9RK9N\5G"Z8H^JLFIW^XZ=J3HL8_8Y8^D7 MH@NJQZ!@K2EN1#A?6-PQ(+F'^SF\!+Y0RYMA4WOG+('V#,;N*)?Q%VL6M*QZY/_KT#> M/<"RGHL@XK`J@-W)<:"EFN_E5F_*;:&J'SE`VQD\V;?SA)7E%N2BIL6E$MTX MO7:6$XG"BO<<1/"M=R#O&7,"KYQG4H'L4B-&>87\)Z7/DJI?28$MH%&RC:3F MX@-H?VBE/7C+N\2GA5T$23I#%\PC\*NL^Z6VR\4KX`U8G$H6*$OV)>FF">`U M./#Y6!U,E1=@4@!R3X1KPPN';O)U:M-D%1BD1A1P+^0):J!R)UQGBKZE#-KF MXRA./3D(I]OOV.^A#"BXR`J>U8R]U2ZU4)1C$R9?O:/AOC3GTGGQ-X3(*?\J MGJD;IXQ=5:P2!P'#`GL*M\1I)D-I>;BG!?F4GITX.9^6#5EWDWH-3G+S>:<& MPJK!!6#M>W$RG"R<)%>.1-TDMW:Y0RBO"E815.9-2AI#N4R"R$#GBO(K2*\/ M/A0@`HUI2:T#L7`2:JXG>4$5CR%V:!DH]1;40Q/ M5;4<0YA]["(=I56;U*CSP]R2P2T7:YBY14 M3IC=!IJVJTI));;<1OPG*U2IG1;^?)1/RM6+4W3P!);[X\%CKHI1*&QHIR.WFA,61%S0<9,8$:)QX-1UAB M,=WH#)B8;WT]4:4Q9:M0V#J00PQ5"PA7757P5(48I1_E%E8;JU8Y'D@0.M&, MA=*-<\DWY*J#R2YKF<'7.*R[Y/ER9U65+B/^3>2!$WY5;XUA M$E(+E&B`AT&HT*&LWM&6GXA%!4$,`'36/2VM)9UM?#=R M/T3>ELII,O+L[FC.#.P.9#29LQ^F`\@*#,MRQ"AYOB<]UV/$HG@:J\&I4UC\ M.1`3&+[RK"%&P!A^67ZP(WVV4@87].%T@$NJ\$*A8_DR]?COWR;T>I<>Q"RZ MA=*M3#+"+`E.32`+*Z4!P&/IV_2]&35S`TA'_%SUW'^OE81R_8^=8@Q[75/YQ`:;- M/7=?3+"JEG:8S5$6W!?S.68FFOP!O0#2WL;_7)=-8$Y@8;L.W&!+JRF,IO/X M"MG\(P[0,R,UPT"`30ACF<@^'RZ:70\3/)](R_'7BW?NWK$O`@],I4L!25PC MCKGRYGD*N&_(^(E0MM%P@%T*@)E_-UNG[2)W;_0ERGX3J8V0^!U0E9T01L*?EPV9HA90J#<>5"5]X[U33$Y992 MXS$*TG]('$@RQ`E'EAL5WCE_*_-OW70`!@LGTHL&BX*]>&[1]V"AHP.=&5(X MT>KCLYG`\,_=8Y:4.TCLOO"K92EW[/@10[K,]BE&\DV=:.X.S5)@,40T=R:I M)W;H5KBP%K@`4U\Y^+CCXEK>\(]!#9\&4_^6G6YJ4H90JP9PJ*.SH"9!AB>/,-X^^/6G23_QP MAN1.@8('Z,!;\S`>R;KZ:K]$#\?SGD\\MO-DF7-T#0:J0XU$9X&AY_*48=V; MT+N2>/PV>)-$+XS@0R#+>A#=\\#QXY"-N85A0H@[$O5D1`HLF3\509CS!V>G MU58@;$=FR=IIMS%00>XBU5\)U&2`/B`#$-'(7/E)X`+#DN[^]%$Y8?!$$]TJ M>+WD6?H:AV^..'7&HGN9>[8&6-/IBHX5344F<&>XB7Y$ZF//DXC*YZ0)V%3 M]-\;ZK`I2]VPUFK14F%>ECA@TF7ZYUZ@=NK$NI*Y(*ND-L!M9RJC#I/3`ZD8 M\.`.-O]8:FCY0WGIA%3^Q;Q,2@E6>#03@0PG\;T[7\8:J!$E^)&.:-8]"5$$0].=D5,?':IT2EL=^E2'D$I:OA86N#^>%NI'5@CP,")O.YQAF<\S\1-/8NIC>BYO[BO7,R\N\1:#H/ M5E,*94K!Y+PW:T3J.N,L+"T0:@C)-)2Y!6:BC4B41M<].L*U?N7S`I#]^D3M71'ZQ.D=.FI%)-2O7,U6OT)-)*M6>%S05#DK(>J2J@6IG! MR^^='[IC2!'PA%*YYZ&I2OWBR1])CP@?U8N M6V M1I5*ECU9!3C>BN3@)(U>`2X&2])5WAX9S?(H_1[**%.G*_BPW*-5,!=VKTXB MV13#>#8/,*\2&]>.I6PD8Y@?T221W$F0=Q+6S=W05[;D@EMZ;I0"[\C05FF+ M>IC;BUP7HDM&_A/@.)!&TLY)8"(-)L$P3#F*W`00*"4/GL!4/`#D*2H+P2.F M\@*C5&`(J]()5JE&6%OC"Z#*>D/TX57\LB,E>]587UR6&)21YUFA^; M.8[F<=>9NUD&G:&+&T4W*XSX=%0R"RJ-4?47`M%5^)G%PV0?4UG.MI@FR8_H MPHOX5_D0Y;/+U5F,%CK42G7&>K24:I$^"EXLZZ7@+-`%_'?,4V]9>N2=@.O\ M29D71PY,>=C5[BN=[Z$([I4>*!W@291Q;L+ULGU=S,3"^,&DQ@R&2<@:#U4% M@A4BO#!!D4YPR?;('=;DU'8;DZTM)\E-8D,[.>1`:8>]+@"%.SG*1,.0R^,A MW'4D?[LR9P/VPU3U0/W44_4",21<:712Z8,]")4YW!Q'N57!"67MD/24SU@@T"SA M%6/.*$9Z"K"2)[)#0L5.,HG&GAM#N3,W&7_S*.V7U&Q:T/Q7Y:XL&A&Y.-]: M@=#T'?L%MC.INB&9KN9I)2I@O4:\F4TTJ^*@5/9DHYDMUM_/!'CNH\CD-C64 M^3S]1C6R1EU9XICR`^0RUC#=2D),-@I,%8"],3GP6%3>N;)LXJE47?#_/$PY M2=65C9ZQF+86>PY"[+UPL5:%C(U?D=R&5RTD'F5*B)(U(STJ6ZS8O/R01*?* MTT[";J8+*/CD7MY=D/H!1'(Y\Q\Z_LF.!QZRXT?7P^FRAA@&/ M8=<+TM?>H8D.6RWNJ#NV=*_QNI62!@4=VQWAJ=T#ZCIVRX>IJKFI9AD@9E&LD,.\&)+*`6RGA/``M+A8;DR]_E M0>CJ\Q?Y"?\;Y='(R&QO]!$_^,%7`VMVJ?"5+.H@-9W#B3-31@(PQ8E*!(6! MW@5"J7_*<_QD`M+EC1Z!2"QJ]K+FG#(:\F<"B6<+@TJR+?!6>&+L1"]9$OD0 MLR=F1("C2I/>"F!B$)(BL``8O8#'AICQ&`E12*"SW+M66X49'+G36&^1BHN,E:PHU19+PGDH='@X,^?&>K'+'R)'>AFFK&S%O!FPP#WW2I4^(3&<,C8:M+ZD&6-K:B("4]T3_FE4D0G)4;?DDCP,A&%`1%RKIE M9GGOV-6<1X`-/F`TR`?)3;7S%#U[+I-MLNC;>1LE;6@)%P6\: M^#5;Z1TWU-$2.N3"E7K#O,[)D]4"+PW M1&4]C?M'#\+Z+3H7FR(KI^`\<2((4,H1[*0;U9.!R1!MY4G#_2)Z"NSEU6_4 M!)(H@=PU2IW'NL'R=#W+_O@[]I%T22E=Z7S$,E+C>324FNNJZR29I!*07FO( MBM=I1@J,:[R@:\G*B-FKDX=@X($#(L*#+)PE\=BS+'X==%QKXCE_QUG@HJIS M*?VHR?/GE^3C%Y)M:4D:YL81<$^@*K4=W=Z"[I:D7DMZ'(8BAXL7.*J*^Z*[ M8$64DI7$T*AS:7GB,N^5T?H!23P/NG<60'SUPB1W']-BU&NS]C&-6M;_P8PN M#,:I66FF=';)(5X2;:0RXT40QES&>`H\J97EZ]7V$J"_1(4>B6^.C$"81T:@ M!`2/TM[R+74@;$B`E'T08"-SO@EYE)E%)B5H*ULVRF0W%:B4U>][E*<^ZF!Y MR,)*0#'R;\[1,=$>,BLQ)1)"$]'RB2Q;G@: M(@_[2B]21YWS6I7I,R+&L\Z\J._.$@](`V\7X/T?EO*FP]$>&SL2L M:01&P;BJ\BR6G`>%T56&;BX'+$S6:UZ=4EF[\Y#3<`7`UPNN9K+JP]SA.YH[ M?&N%66M\VHH[GHE*>>'.U)P`1I)UXXRT+8%(72QU MXI57$3Q2O[%1^Q&V`S^DG;W63#XA%FK*$JV67F%+,%?G+URV)\FND9,:`U`[ MB16GQ%5J2-P%?/>4XR2Q9P#UZB5Q?[]CU[+8YYDT!K(O5!\0W,0>Y'$WFDG*=LRVPKL`MVU9;S@SGM:8@/B,I>B'S!.[6!)% M7JRV)=Q;766UHE(\&84`QS0.]174E*$L1I%GF++R4.JYF5NOGPA_A8]PA9>K4H& MR$)'*P,&YHE>3^L1XU,S'W"R4)(RZ0VO)$^=@N]NEN+FT^JB"XPHR_RF?:(R MIX`*84Y/(L]<#NAP;6%=B#"Y]B35AJ<^J,NI+RM,E"DAF^#(7`7Y?!5%)5+!<^=+/$O$.%>G.W>=*F(4@P)I90W#9@+FH3Q4&6O)'!;,*?*R_A$R31.V M63G`K(7'_!1W86J9EGM=1_ML.1=<6OZMC.6V%Z^>YY;>!!)?'QUN=5X*AT/+P156/8)X1JGQ&IQEWR##0K\JU^NQ71 M@TCD:$61^Z=N8\FZTN4@OUO?"4'MH_-\?SFJVR3/8M,Y9LJ+.D,7'E$%RMI2<14A29NN,71Z=I*Y[[DDR@"?7AD!ZJK#_*OK8 ME"],-NL8)T=L^=>H'+%8U4.:H:*O'(3*1Z6<4RQI6Y"[2SXHJ?TCLU*E1I$$ M?\/0;M-S1JP%&F)6;1HAE'_[>F[S52'#,/$82HX5WWBF(=XJJP`>)J$ITEM7,<[(URO)%58V5I6`RWT)FGY6RA'K4\0+WG>T2KZIP_0EY2R?W9*W,>#; MW%`\K'H@%NK;*CMYKCBNT8,4T.E.-X, MS!EU?H/*;&HQ+L;%[:\<;>%X:FK4AY0K*=*D4>=-?3\A@=25ROJ;;XPIAVSK.J?3W$ MZ!W[`-N2JPY3ZX+,KIR2PN1HQOP9.3B MFX7&U0W_5NEEOI">/=2&5>7%_^5>C,6H%"JVE!K_&;0IM$T_!Z#Z65EQC>%X MC&>"J'R?XQX]M%3P,Y\JQ$Y\$_]/=G)4E\A"*7:<5*A+'Z`\)!CJYF%80O*C M%;&W:6@60@7+Z:"?/P_/APL9S$Y2?)ZS:;)0MEHHH18*[>I\]N&OHXN;A0?H M#U]MR/_M'#%YVOI.SXXOE^U1E<5^9&D;VQB=!JIWKXP+`\,GS!Q=B[1$#AE+ M#[&L\L/=S,_\NR?/HJZCI%GM'UG]CFPO1X*OJ@DHZXLM!4@M5@LH*.UP/7D^]A:NOJ/ORF._\L>DS12B(%;LR(),9254Y0I_ON9'4N4-=\6T1F9Z MCA[,`\MS'=2SL.4HD*YD&?LP#W=-0YULD80U8S!L(-"[=B?_"9+2-.F>CN"_ MZH`U#F7TK!7(4DZ>'6-_J.00]:\X<$+8=M+3G]^S+NH>@$4Z#Y4HH[:RI"K0 MTSAEZ2>;.4F@LDNZS6E8^X20N>)DFM3^N9XDG\G>/)0QH^1O;).JR9';F'=I4)*]0IDNUG02$P MY8ESZZ@0]HNLTP=/&@4[:57%*#]@X<@8]T!$P'@91LJ37*F8J#IE\.5),J%< MH6>>!;#826I6.IQYM_/D$&>>/F':CI4EL.7Y."T]/)>2]%#0R%J4+Q0P MRTHM)0SP/,*G?__X?1R>W'$^>W^6G/^-L-F:(RC?V](/+\9]<7TAYSV-VAV0?^/!%C']Z?-Z`US M;/@"*''2Z_79Q6C4;C8N+ON#X>#-ST]@>D/5H9%' MWHIM;]1VLR1M-Y>%9B.V7Q24>:\^O#'O)AEEPKN-Q%P,AF;C?-!O7YQWFJ-! M\WPT:DF),<^&@Y[9/[3$I,RD4VB61>33K[]>W?QZ\?'FF@T_CMCYIX\W5Q]_ MN?AX?G5Q7=FR$*G#31UTW/ON?5J&8QYY*TLKB:0FN_+(95E:R\%F^$4[7_4D*5U/V_-@9O2U[*4>)U.V M99X`)@ZJ>O6IWI7/_9.VKNU$J>[UO1\D^S0^WE6QQ%*1RH)@D@K)653'RGJE M*[3D+,PES&BE8(QG)5`5P?T@7^Q=11VY"RT<8AG4Z"6!:&E^8Q;0G*\.D_PJ M%K+0^?Q-V>/3,7!9QRJ)!\($G*2SJ^(6^5`5"HB7W@KDJ?FS9:23K*N/BVLL MA$\M9OW/'Z(.^9-:^-DP0&T*94&/VSB2_+@TXD10UI/!>!+F+1^-ZRM?G68U MHOVC$%P-PE,1Y!:7+37"EV+B0`QSL\]61RZ6,Y4]ZK)IS0,S,5-#UNK&RLA. M5K4GFS1<.<.&!8F5D@ASS;C2VQ>(P7`6."X:;0V#93._\JQ3.>UT MPK]?#]DUYLP:[,.'<^``-)'#&'@O[5`:9S%N,ML`U"79/)J=8RVCS)^I:LN7N+U7._0U%#9+SD32*)JE/J0!4[9/;:2JC@>9F`[4P_C$C&C!TEP>%C"%MWFG`_Y[HE`9`Z M3JJWW"?ES\=)R"MH:$E/)Y$%F&)$JU*)TMXX$::Y2!?76"11O`%2(63WSIT? M^''H/DJ'CYRCY:8LJ6 MX5&F%S%LM[%[2SJU'&#XY8*C$U2I*5)2J029'PN_2O0*%5*MRCS8 M`=AB&19/5"C`KS5-ZKH[]RO+^;`@=N<95NJA1CH*#,=*E.8$).`OU=@HC:3&P&M81,6^0+-@ MFK\K:;B5VBEIB5 MA(WZDWI;(#!(W=@\BS4EQ+S[;Z;[+80[2-U)JC_S(L&J`I!44:6_,U<<<6%Z ME4T#23=[GDU.@8MLY9;R5]](6&Q1U_F<%2[!G3\O5@O7+8C7OO2#Q9&J_3U< MWN!EN.[*/?.IC-+FN>OFN;@DN&6&^]HS":+V`%'%VEX+&CW@C;&@@"U"T3/V M28WL,ZGP*7U$$W'V!<[YU\O1+AMQ:\>_8,XI'V@:\I15TEIMYH5+IJ&:^ZJG M(HQO\+@U9N/J765?QJ0\+]&#Z&E!H%=L?N>?AA^.9^\SV-7'T<7G"_A_'\\O MCF+*JD'5QYN++^K4YN+CS?##<KTQGB(.9$%#!K1')[3T[";^!!XE M)B+ZA54#P'R^6P::V`<)TU2E%I;4096'O1E(+HXX9^?."Y&A,OB0Y(5-`>$B MG$ZB!:8;T_Q<85\(^V^S>]K0&N67:*ER+62@4#R;"%[!727XO1G;\Q?5OX^IV/4P/6Y.D?16SI>BF>!=%(SV\P'K\ M:0*_;+,J"VGBUVD:O6S_[*>=$1[90NG?^?E'DL2>.QH M^_A4-K)44L^7!7\3MUD:0)U6^,P:;AOJV>F,DM.B?,$/54CXZ0RE&B./X\;Y M86?X5?5%3T^ZYLGRZ2$I+$/*$DG]APSLGI86E8?PJOMU3C+F]1#G`I@6-T/; M58*A+\M.(5HN3F0'<: MYMQ)H8IQ2&?IW`@_2>WSI?2K;/LU)%C+6%0]$>GF:4OO'!]X%MXEXUH6:V_D M'"K2@?%V.1W$8':<%+)X"!P9DC"6Q002%_.\NK*B0[[P3E)0/:M5G,C/4B/Q#1.N]I1(:N]M]&Z MU=:-]Z%3)Q=<[EBP,9!LF7.A)>:)\I0!NF$(*<5-RPG6R`>0=N'*8]I/",5]93D]ZWVQB+Y@)]K^-` M5E2>N_NP7PO8;)[ES$`5,3+]178R2X/MDMI$ELL!*Q![LW`GS.,4,L0G0VCD M9'3XX5"PS)PG0_UDY5)@61@$&!;XUG75[_$*J2/AT[%939#XR7)^1^E=4VH6 MENF5GDBX,*GZ9[#8D\525(M()YL"AB;-G(!;J>L_-\69["B-Z"G/Q).XS&LQ MB[+3W48:0CFWK:6ZG;7@DOUU9',"]31TU,\YVL_:\(C`E;5R4G4@.S&EHXLC M.[KX&/]'=<"H$?)]LB)_+C'I#!,GU]Z"P++7KH@"6W?D6X.8KN,Z2?AU^.6Z M;'[E?KO?+,"QW/J/3&;CLOX]T@/;M.7"W!$@`^R5$$NE4?H4;)DU-A<&L)#D MOOKJH_6E$#-5.Q:!_E+GZK2%5(SSO>34%Z7V%MYA6IW#@IC M',E$X16ZI=)W'-49/9\ZK5)]LRR-(AL%.G9L.?*X(Y8%8)_*MY5V"?'G1R(&IN=,N:?VRE3MA6]C3`V_ M%PN^*9!P/_#$X\(YPE@0!J08<.:`@NO71O`_81$";-W35,X86+YK?HM^(9\E M4WU6;"]5O>!UNML%#[&,P8(.IP19*BZ9(&,O4"?,]1>PL0D`IGECTR1A!2)* M[;@Q%O"6!@IH;^AFRXP\9ZJZM0+RJ!8+:,FI?4SU),K"$(8?KLXNOI1-?RCT M7!KD-UG/ITJP3)U31N_"&J2QR;DU`"R9@U$*@ZN,;H.-`Q[;Z"N\# MG3*8ASZG;EV$0V.-?B*^(;KF3GG5N76:BY(R[@*_9J?F$HCPU!F;:7AJF5:.'#++=7JA5)/3^W+["PIY>BD&)D\+<%&ZQ@/(0]`DWQSR>I/`25\ M'E&DNJ..W4.Q`"[+@/+EZOJ(XGN.B;U//N0#>ZJ^U6>5_WI&+C]DDV`?_'W, M[R7DI6*'VZ[:Q_'+E_8.Y>14,13),4W^>/P5`3M;G=>I0YRV[F-/Y;5??]Z= MC^$98_)/ID/-B9BEQLMG+6^P:368.S](XA!4K0#L&ID\7P%LFO2$D)2#U,QG M+PO@)`H\^F/Y0_IH6+QP-30G`Y-^AW7;O+%ZEU9?IQA]"Q]\+UGU9[EF'21G M*LRJ`O8*RVBN><@-0,6*W$Z=*/-"J]54.Y+2 MG1>DZ:6]3DU]+//YUXU7M=F5"5L3D47VI+6F5,:XLF.38HLGZ=UI`-1`>>MR?U@9?0B MNJ%@ZY5U-]*.;)$RJI2O;/X$99R-G7&$K=IDR$G:]-1+)"B,>&)NY?27)/EP M8?<3,IC"3AJ#9YM>LL'*'3A5-K+,Z%[VG,]^&)VH'LIJZPS5!I``G)\[W4IN MRL(*YR?"\]IP",,RR*_:L7TEB*'5'M'YDJ):B8C.8IV<0S>*0_89!,\3P5*2 M7*4Y^M-""D3J2%@UX5BX$\:P[O)Z;#W/W5J9S/8C,X2XY?^Z`EF<- MBS-0"F2NW?+ZJ#)=*M2_F[K3'ZHM0V>^%T>1PZZ_"E=$LD&9Y]_SI!Q:O21J M[O8;I.SZ\O3W+U]L:5287>7)MME8?,U2O5@CU94O[R97^3!INHST`:KGAFOR M.D/GVVO#&\A>J/-LT5XXMC388\L%-=CEIR^_'(B M6,E2AEA0[-C0.7\HOV1IJC"CEX*:5+2@\KE21_;6;26V:A+QI+^$AXVP5`K&%R?\>H[E MOR/\:X-F$JV+MMD\;[2ZYK`]:EV>-X:=\[3]2K,Y:AZZF<1!VJ_D*2H=-8JD M#&E:58Y?T8+E,JNYCGZU()ZJVF0JW!/P"8`IHMTS_W`L4Y"6=[60E@.5GR#%@ M@""B5B[CW^4!`.R\E8;(ND5AIRPEV[)&?=(`C-WR4*C3I9D(,,0DBRU(1C0' MUS#K89EU#\,9@A!CZ#,>M4](S MU&Q\ESE$T1,J3W%WZO:]6:!7,M@<%)2KT^<*FF[12WR?--#11'3E;`LHQZ%M MQCMW/E\YX\W[=*[2'-9N_T_5A*3O!ERW?9NV\_Y9HS_JF,U>I]/NG%^>=WL7 MJ9[0-H>M8]03/JO""$D$UP*!*QL$O!K3)7AC&T=9E^#E=D7SD'HQWY^!1LD) M65I9XF'BX\Z(>==XQG<;.K;#L?TG1OPM](J1.:N2:=,--$Q"`/-7Y+?T![D3 M\;1!E3PT&^<4GK2F2LBP7!Z687.3KY.9PN;OHAV5Q)'D&V:B>I$D($0J)V9A M'*?/K_Y*&5XKFPM"/!*WT>N:Q@W/>V9K=&9V+EK-LW[[HMTZ,U73N.[YZ/+\ MO';RNR2MHXNSF\+$\A#P\P'[B_YXXK#<`X:Q6]GK))_S?8JP+5&WN?I.QUBJD#NWZZR9Z< M,@W?WUR;NN>*NL*)M.]5G)I0O>PR1T%273E)^,-:22!IQ@OL`.,7V'9GCUR0 M0%%'%P.HGKKVO5);;C%0.E-TDD((2=_LI/\UFN5L[,96E+2H#M`3/1.J3_<4 M_34@?(GWQ.;HT-$RU@]79Y_T1/+(GNKSGN.[<[5\JJX*/">R]W`:K3YS0??= M%V\U3GN:\E5D"#_&WW\#89(,4D9*XR"U/$E?Z:+%U<]DJ6P25%&V3-,ZGFI; M=QB&[\T[V*W#>YG?EGBVP\2U?0_6)Y9T65FD,-]I6#U:&J+RI;*="&`MEEJ: M\F^R:^V"F>S*:CEW(DM&22L?RF&D]K+NDSL@!=-^ M3O&Y;OB4=Z2*$(@TJ1//=<.(JSKX>:U[`^52GFYDZFCN9OGL2FOL?PC9Z5N= M9J?-BY?$$%4+[U%V^F:K_&&O@F:A27^T^6+M(L^/G(198,VQO,34`0F6::D> MYI!NZY5=XZAYXLP)G'M5UW1[?VSWO-5IGEWV+ON-!CIR&MW+7NJ/[32;YJ'] M.0?P4];)M[,UNZUCI46.RSCRT_@\+0*&QP;*%7&.E>6O<6=3K]]V>HU^NWSLU'O4AT3F/TSLWW6.S1;%N]FO+[Y=/Y_)V?#ZXL1 M.__TZ^>+C]=#C.*OMG\N+^G+F@U[R7ZM(P,?IEMK601Q(VUMAN ML6MYZ6>XU)!7PI?]A2]Y4DT9C_G8!>AVL(U?R<,U5`/Q&O86M[HW\@+\_.9= MHLYEW^!Y@@P-PM8ML(N`/BBK]2E53J,S!;=CD MG5`Y.),^R6<^#VS<'/$,QQ88)Q6)M,B(BJZ`D3W.Y'24P\'`PA^!Y926,83_ONQ5;>@WW2;@SRK\?TSU4IJ'I)J$6`P]@> MY997HH*(J634R:I$RI)N*.#)[Q+,)K!%HI?627K)X55`FM\S8RI[1^+AOP-; M`H4]%["ES%YYZ.7R,&3#M#6"/"5!JP0=^EC#QLY'.P$FVT<2=\-;)SQSMMX3B5#)*TJ%#%@%II@3]XLO..Y9Z8ZW.0+$;>VG[AP?,QIF^0'"!;CZ-O MFA[LWEYT594O[>5J]K,F$ M[I;46(0]R9%-'>;\B7SVUKG/D3*K3Y(4)\E-(*TN@#/TO%@&)Z@3J33.>(G_ M5YUSS24TX^C]G@ZV-%='6B'T,KQ2";RLRQ6(L0AD+6JI+>49B*L:'[)#1E+E M*FDI*:,+94GE164C`[(%128W@!48@XXV]*DEPP`M#@4CK2J9J&/)X!(,6K5B M,J9>1:ON<<',AM'K#HQFJZ$31!+JK45JV0%EKF7-B2"U397)@,4H4.^*O13+ M4WE'!&HCDGGE([38/PP=J%U0N^BN*+2Q>Z'=?,;9N7F64M M('7&[FNZ`Z/1[QC]ULYQGGF16"$%BDFQM5%PGUBK^YIBUVB8`V/0[>YEBHN* M0U*X25D++X3)E5T.$>64NH8+J$YW^)_!D^^-O\P9%< M?4NX;G+-3V\:;^3G<,:M]//V[L`'QXXF[P>#TWZCT^CVF\TNS+G?^>Z'6TQ@ M"TYD@@4H=._3/Y;\@/,A!ME?Z"#!@7D_O3%;;U@`]%\6GI![]*JGS6\T]WW?WE]($ZSD!-9M`?N-9;?8\VO77GA_]B8[# M"SS#V)1^))0DE(4*9>L`,OD"+0\MI:O-8GSZ;<`L%V3XIS=H:2X3 M8Q)CEH`QET\0B#&),4O`F,LN.)WZSRVWOMX%V&OE)'&<6980X[$&TIM;LO%3 MM\3""%JM)_Z7DU;S&2_.:UC]CRV=6+H`H\`EJ#R2:$?:M<3>A5-UDNG?>V.K M32W!S8DAF4XK-0:G76T;<^F7?MTF0$!#0$-`4RS0=$];VDS3TB\]`I]&;F`<=%J[-PLRDS9SA'Q3ZL6>FZQR`YS8W-0[-D!3E0#Q:.QZE@`?BT;+S*,4^["GV`:%,K'"8>'NQF+Y_9#>6O.TLUQ:N2CRS6'T0/33[N)=3J(N`^OMMFT52:^3 M4M*K*J(Z6"X]3*)ZS*):.@V39';QOL;IH$\R2S)+VVOI1=4\[14?6D6B6B51 MI>VUY#+;V$>L$3ZB(Z2WPJ=P9=D0CHICNJ<46U#`N>UQL(ZV`RD" MFR/A&`*;`P2)[#N`4P.C%*I$4YS&LG9][[L\DBW62FDZE\8Z;G5.2VH=EV7W M(U]5'7Q5I1&XMDD"=WP"5SIEBR2/).\H)(^VNL,)7)L$[O@$CK8ZDCR2/-KJ MCDO@>B1P%$=P$$\GC,FQL7_AHR/;R`JO>[-P"4[ZQ\(ZE6AZS MLA#%:QZDI7=H.B1-;4^=$#NI3[GJY)OK9,DV!!LJ9UC:II;M5Y=3:U:D7ES) M>S!JN*]5E8%25\M**($OQ01N6OVG*H7Z/BEUYEJUOGX;3?PXA&UXJWA_8JX- MF8MZ:2WQWU+')O%-!)83"EE16EOU(N+"TG'>YL[+`W!A(*;<\="PL^"&`*R] MF+O,=<;B%?E0Q)F$CZ_ES.'=72#NL!:_`WSH>*%C)47\7[%74^CV;MS]*8[" M""B.N,`CEKIG6.*5V5^QN/JE0'>-=J?X$B.52&=^E:.TFN$`I=N*M&_5U69% M:NVT11ZXOI+AU68:PJ^2XA<1C@AW0.-MCT0L/>'J$$'6;&LVKW[!-G.;=XPI M@ERE42=,H]G45AWU6#0#@N-BBUMLX1DK0"):&JNDD40U%P28\] MO#E5;@7W(CG;UJ;BUC-3Z:UI-+K[[KQC%DHD[8J#MO-G\FWHB`HK3`[WKF6? MMC?NV/9JUBJ+$)&GNJ1J)Q&."$>>ZE(0CCS5*^Z[](.Q<#3ZJ@MO"']0?;[5 MU=?H:T-"';=23VA?8T?XX+2CK==E63B?_.#DYR7ZE)H^Y`<_5C_XX2/KBW=) M55K![AK-CK8N1.2U(Q\*><1SPG4Z&)!LD6R18Y<(5S/"D4>\7[ MHBG,@WP;Y*E^TK[,CO'G:U&8=EX7UR1%.CEZB3ZGI0X[P8W6$'SYX>W_>X$IJV&VCW]>G M8I/;CIPHY!*?Z]N-TT;Q9;E)N$BXB'!$N)+J].03)Y\X16]OK#(8[0'55R`7 M"SFMT_N:K=,V201)!#EEB3ZE5'!)CSV\.55N!9>BMS>MO-WL4O0V16^7!OJ/ MQU7=.^T57_.^+$)$GNJ2JIU$."(<>:I+03CR5*^XCZ*WM]+GFUU]I]\4O4UN MF^-VA)N=TQ9%;Y-$D*.7Z%-*_9G4Y,-;:S6+WBY(?X1Y,=N/;UV1*9!:UR1Y M&UZQK*J61C]O&_U."0A0`X?<\7E=OWW:T=9NGOSQ)%RE(]P.BHH% MJH@(-!]_[:_C,S&;/O.A]-#V[[VQ514\PNV.T6O1.7.AQN7QV9!)>!5':^.@ M-N2.IN**)Y9&!.+@&G29 MK;+.J;:]FUBGQEC:ZAB-`1V-Z[`>RNGQ.9!9,1-6)&P6^>Q>A%$]SZ?*;72T MBXH@>^4!U1%;(^37)+\F^377'-<-3GM418V0AH[K]F,8]D^+;S5"S$;;VK%O M:PVCVZ*F/J\PN+^/\#1JU?5[&UB.:*[CB9.)4$#>;'SWE.G,;FI,*\K^%8>1 M,WYQM*`1;HLR6(Y0?'Q3% M;GW7SH-HO]EL_/#1CP0S3]E9QM2,PW_7\73*@T<_OV.7>/03\YX*&QV[D]GP@LY3B-[D[F\R*\A-N.WL+N\.V4P MPMM0_!W#DB)ID:"7XC:(<=#-AMF4L_B5!]9$?!A*$(< M]R:+`C='$Q^6V^81+#%<(Y_%;A]9/(/OD#+X''AH/$WNP9&,N16%``E>Z(`) M#B]S//B>?;(B'[TP,$13OE82#08U\X,(G@A_/TPLH)T[$OPIX`/S% MU7K(@<(;8N["96'LXN1@_;Z*"-]I.W(@!OP]G?%`GB_+/[W'^>4X2AQYY$QQ M$LGLKSY_.EUFPBJ)9YX;F?B&?TM:\L0CMKB^=ZJ$'_X@IC/7?Q1"+2"`U7)TN,GV!1`@?6V)KST.+S15I!A3UPN"UD8]\%32E\KY7&Z[`W M]YP%K:?QQ`>)G_,O\OQ@RMV%+=_$:[('1XJGA.LFU_STIO%&?H8MT$H_KUBY M&V<*Y/PH'M@7?\J75,4'QXXF[P>#TWZCT^@"C'1ASOW.=ZDK"_98E\]"\3[] MXX>G^^I\B'G7\7QO;JUT^&_@?99#^^E-I__=B]O^HFZ1W&CN^[Z]OY`F6,D) M'BA8BXS,FM-G/ESSI?2'HHL);.GGZ;^.7OVU^O>?8/^P"]AK-ZZ_1I/C$F,J9,QM<4F$6.6C3$WSUZN'-SU"&D*:&B%-)0HZE0*&JE(GK-O2UH&KVERS*X`=Q7G$[F2^VC@>A!QK^AUK MMMC')XS>,-#+P.A(RGUO+`?YO=4Y/!92[F+^AX(I(R M]@)A^7<>_&++X/OGSLEB#^LTP-]IQ/D3JR&:\$B5PM/GQ3?Y^\?OX_#DCO/9^Y$36JX?QH'X-,Z? M-GY1Q#OWPRB\GO!`R%24S_QQ"N(1WH"HG+E`P9__]<]__)@^ZY([P7_0+)L_ M='XEYDV@A'T1XY_>7(Z077]K_WDS>L,<&[[@5G32'@Y[H^Z%>=:_/+OHCR[. M.^>#B]&HW31;H\'YL/WFYR>2GJ?1"X'OJ]!U6Z!X"L&[@(+\N'02?SF\^L+^ M,_SP^P7[]6)X_?N7BU\O/MY<5SMAY/E M@C4*DQ2;60ROPEHV6;Y4)*R)Y_P=8V9.J"`T&4/N13"*FTG^=7=`%P=Q&?H/'_1W[^(\DYE$H^:7#-85]\)E#TXT219W)=V`R6YEYEU"_^05ZF;8`C#/ M2SY6410N#W,Y?4GVW&KNKGCRUR?,BUN]'LDD;:R&E,_Z@]5%>8R#`.4>Z`KD M@OT$]#MX$-!,V'F!5YE\H/,AG24993Z72@.$/9-9P/]WL-(B?%]M4GY`;IKO MWF::V6DV?UB4C[=SR7GW2F'YH7!2+1AU1=.JF:/5DJ0S'_57E$Q/"]#\(+^H M%?U:.?JMP$HDE,J2598`""R0(H+?@5R>G^Y4L!-QT(^YX^*]1G)+(/Z.G4!E M9*NT6Y1=)'&"S:"9Y]%RU?O]8.5>5''LO%F9#JT!39]DONJET@9Z=)527\U& M0V.R:W?'9-=V:]\ICWM_83US.FF"59\@9>76HNEC8>7$5CMHSKC+/0N[2=#) M45U9JG3T(?XA_B'^(?XY"'V.(C"QS(422I;66C*%C$H!5`$XCY(UI=.5:E[J5`CG?Q]`Z/?T&:QEW[MU[EE]\821[P]$M(<-]*81HN0AI"&D(:0 MIF"DZ1N=1H.0AI"&D(:0IE"DR:4Q$=X4Z>PY/I_.K['GJ*3O6]^S7W7(5KLZ M.)VVT>UHJ_=8%X$BU_P1BT0!.Q#)!6"M@H2"1()VBKH`'H_;:*"&<8( M"F:+6[@;ZT/(,A)%")Y6NA]4(@=-H]L`/)7EV=;J(UWDG",1(Q&C#8RD MBZ2KDM)%&QB=+A77UW>*?8JXRV9\)@)RD,!][;;1[6E+EZZ+1)'/\(A%@GR& M)!^ M.?+-D8B1B)5%Q&@#(^DBZ:(-K#PB1H=+&Y'Y.K/0L,?4[Z?7I^P.1=[#_H,G MX>P;G7:?'"?D4"2'(CD422Y(+FBG((D@B:"=HEY' M3[M*4=+$M=G0;+,47)Y_CP2M&A%+0SCB1.+$?P';P/'@X# M]4(']"VI>A7A&:]/^$^S;;1:VNKCU3[RI\(V>7G0_WBDBX+K2,1(Q$C$2,1( MQ*HK8J0COC;4XON(W[IBU?5[&UB.:.A^/DE.%:G-XTW\C.LOY5^7D&J&VM%O?O8]=%WRN&SS2&V!=N- M"`H[P94/.N,N]RS!>*1+_2&6*AM+E8X^Q#_$/\0_Q#_5.8:LVFEC_W5T[:=Z M@KSZO1/!`*PUFL/;*X]%$S\.N6>'[XK@SL2J38WWV3<6^JYCL_]IR/_54R$; M"4M,;T4P9^R6:;!UGI%FP]16.(2`DUCS6=;\(.Z%R[05`R5^(W[;@-^:Q&_$ M;WODMXWWTZ-0)/>:-"#+GY8X7R"1"GG$LR02U;*"""R)N8BYB+F(N8BYB+DH M1T%7C@(/)TS\'3OWW(4W;*/+:6?4TL=A_5L7=5YDP$T#[S8G1@%!>`VCU:4J MR'OCB2/>'PEJCAMJ^HT&X0SA#.$,X4RA.&,.C`ZI-`0U!#4$-90E6#J\H0.\ MC5SG\N,6=:`_./S6<5_M67^QN/D>+=`J6)VE M(59ES77B..(XXK@R$ZXTQ"*..P:.H^#O#8._O0C>!P^'@7JA`UJ@5`B+<)E7 MSC-NM@VSU].%<77Q?9??O"\/9-=.)"BRC^2"Y(+D@N2"Y()4*`WA`]]'_-85 MJZ[?V\!R1$,/\$GB\3>;C>^>\I/932T21=F_XC!RQH\+1DJ[OVBC-%])[>9+ M-@H+Q"P0(7:Y87X`!7 MLQE_G.(M_BW,2#XWA&M<'@F;1;Y\,+?^CIW04;_A,YR0304/XP"NX1$;5AV]9-!%LRH.O(C+8 MP\2Q)OF9<99TQ4Q?*4?[X$23Y,[)`4C8._"E; M$K+7,'OKU/Q.RX-P*EH>9+9..WJ&!%SYAT".``9(U@$6P9DB/5%8./"I=^?C M:Z%ZQ7#"!M>=#[!A0G9LI`\)PHY MP8]GMOPS_PKDJ?F(D7$"8?D@X?]-V-O!1X0"95!>;*/H^C,ILO@Y!%Z"%QL, MW@WO=.67W)X"EX<1CN%>\:(7SH>.(\2&;G(T803_3!7DC>$*D"!QNKS.FN#] MZ<:Y"Y0G+LEFRQPW&\F/>/-[)X*76N5OA:&&+2C:C^6\)Y?&QDL!PK>LL`'L\ MA>^SK0Z>#/1/Q0`TK6'%%UR(J)!K.(VZB,I2NDF'=I^(Y2L.9LZ(SG M=/;\9/PX_-R<%B8BQY^;S>X3@068<$!V_#%;R]PZP)@"I.D3M7.E:)\^;V,D M?__X?1R>W'$^>X^@*#%Q!.J+ZR,OAC<`4V>`"5]__M<___'CTI6?QI>I>%QY ML"W%P-9\T^F:WVQFU MFH.S5K\W&IU?7)H7HU&[V;BX;)ZWNF]^?H*V>0"\<:9`B(_B@7WQ06=?:^24 M9%/;=!O+;TUCEI&7Y>A;Z;UI*-41+4KB2%AB>BN"N2.E91H,&4W+XXU%B4[W M)]`)L7$J8HKUI(,J6#<3/XA.<'\!H;\':)FJ[[DE#0()M\*1YESN2S`L>;K) MPI=!#)*=Z7;2BODF(2K9.$$NT09!#3"_;MT2X7"G6K,Y`;(!`GDBW4:C22"09I&X\P,G&U0\\[UT%XY#A5OI-IR? MQ*LAZSD@6H0N/P"!\,Y!UQ.>]7@#1EF(5@+@Y="SY4=7F?;JY@P`-X"SRT:S MU^P#A/4;K;-.WQPT+KHIG)F]R^.$,T5OEA*U9B?UKI M;!--9)Q0`?4]QW:X%`TG3"05=>[Y/2"FP]7"F,C8RH>AC$8):964YCP:`K$J M'1)HSTJQD96W-DORP\&%0F'@ZX80#`1X)W<>\P&&.5@87$[U'!9;8-+ M1I@EOH/P!3-\!C3JO9''9:%Z/F ML#W*=+?6H#$Z1K#[)6]PS$FT"Y<=*UE8+;@4WCJ M2'!32W2%-P$%.QT%(BGH6NA)``#*F\01>J'!MI_&T\1MJ(Q6Y37<]!F11+$9 MZ%,(&['G1#`T="W<*L>T.AY8OBH[ZNW]$#XU#8W4Q;)HMRX_9,F\3?S0F=D: M2S"39B9"DO(F)AYHD2BI>(:I-$EN3>")EPE0/PH>X/8`UVVL,S\CO,]Z[SP\ M6W$71"?YZFF*`9Y&%:WBK^!J`X\SDD,@W'+8W\`I(/!2TT;F6&*-$"^?.I%< M!LR+R!EL0Z7=X]I<`Q+8/+!#=N;#/^QMRACPYLOA]5GVT?SA'>-Q!)I[^MJ[ M&+82S\)];!1G;(;+%M*Z9>M62AK`;)?[">\^6RG?99WP+9;S"-=HX[U:\F+*4ZE0*ICIMHM:Z@E`?>(E7W/(E`>AJ\]?Y"?\;Y1' M(SROG\"?0/CV(7M_C[9Y6"OA)T0S\PR)2*Q:6"^\RWP5GAB M#+NRV@KQ*CPCPX4\P45E4P&8:B\UMB$I\=G(H$;UQEG<3BX M[G.T0<7-S8).YL>$@*I_"4L:!H MU19+PGDH=`Y(W.O]M9M[(!8<%U?9'#\%(R><^2%W/XT_^-[=!P!O^[4NC.%E MYV+4N.A=C"[.^JW+LU[_HIFZ,`;]?N,871A7"V>^2.(32>/Z^3#^2%4)C"4# M^1(J!$XDDIG`/WH='E,16;&3N$@A5U(H/?M7P)!X#+,H@,73_X5PL2+.SG/[ M6GY;4\%TBYO;\&E(@`H!P#BE)/0`;=OUFT>HE"9Y7:CP5$X$W2RVE%8GA=`G M`\,-/_'Q())%3R&GO#NOF@",[Q-Z]^?7*$43F.WN<2&X\^_81]*E`9'H%@-. M<8`B]]QQYUK&JNLDF>3VE%Z+H229(HOC&B]H`2H`,WUU\A"X*G1`1'B0JEL8 M0")=V?/8STA8$\_Y.Y:,AOPKPUZ5AR]Y_OR2K;W8KX'QQ7U`.KAN^+=YA,(V M>'\Q!)NF=]%J`]HWFNWSB[.V.I\S!V?M<[-7.[Q?1O>/YY]^O6`WP__OXKK0 M2,"%[(,]G+UE)T.Y8$?`.SS/23]%_%MJ5`)B^2XBU_NBB&"A_11LPB0+E&H\ MR>+%S_E7)RZ8?"J'B==D#Y8I`LR"C26YYJ_8&0`+S6`V2 MQY&??J&R:N0W#XX=3=X/!J?]1J?1[3>;72!4O_/=#[<8Q11@HKG+9Z%XG_ZQ MQ#3S6>33L.>Y&ZV5^2D;9'++H?WTIM/_[L6TD,44D^1&<]_W[?V%-,%*3K"B MQ477P>(6>T&MB\X=G#Z;%Q)1V)[N@K-O3`8_L/]IR/\=93V1%RO8[)]FQ'^% M\M_FBM^6%%RMQ?^9'=H32Q)+5H%^%=%3UMOB_=?1K+^%Y_7M%?K:_#CDGAV^ M(V7F6"5WSYM)&JG#U@;H$.<1YQ7)>4LQ8LM14\2"Q()[9<&-6TB5K=*X/I5G M=X8=80@$3%^;E5(>LI5.SK7CX%IB)T`ASQZ64*(LK/?OO?'<6VV^P?NHH1Y!6`E8D2!L#`;:<.D%VI1%?(I6 MHDB>CEB>.OK*G),\D3P=O3RU29[VHB&7R/(ODK8W?L1=\I:4*DJV!9)H^S$F MM^P"4]4VB_6Y4UZB[1'X6UI]H]O>^)B_.(I6@O/(ITPH615>)934>;#6-!H- M\_`4K03G$4H22E:%5PDE]9[==3OZ(J@()3=T752[(V()"F4D)_? M)F44WZGR>U0V@\IF4-F,4MU7F8&6>X(5B0^IEI)-]*E:LE7IZ%UJPL+%! MG#8':'GH6"ZNW&LMB+)HM*4H]U":J+!VR^AT]87.EGWQ\3X*?B6H(:@Y`-28 M1J]-4$-00U!#4%,PU#2,5JM/4%-O/W>Q1NAUQ"-!SB/]SJ.7*G^\AE8'K>S1 M-1H#;;4]ZH(I)!%'+1&FJ6W[)8D@B:B!1+1-;?4)ZR(1="JRU:F(WF*I):)C M=7'HI<`JK40^;#E(??#U:J+5!?=(-$DT-=)QL'E$(XDFB2:)YOY$L]7ND&@> MEY>Z=&))]-D3;+WJ8'&7&,=B%?Z&8>ZO9/51%(4B821A?.6!=M_H]0JJ<$G" M2,)(PKB-,/8,L[$_D_L8A+%N)P$Z:3L28Q$$PM:6@UDBNI47\EY,J=XC$:M` MN-(0BSB..(XXCCBN%"F7H*!= MI:<*<"0P&PB,V38:?6UQM"0Q)#%UEYB.T3%IB]E*8.KF>BM6X=6:%58B*E87 MI.H3+/2VU=%WWOX25>H-:B1Y)'E;:=I&4Y_>0+)'LD>RM\6NI^\L_;@ECUS4 MJUS4>M/F"*0.&Q9T8*PJJ'_J>MK4&[%(VDC:UDM;7UN_$I(VDC:2MN>EK:VO M9`N)6QT\ZZ433B)]/SD"2V@-XZ3M&JU]29R&) M+8DMB>U*L>T:S3YMMF4U.`[O_]=)JQL_HG#TO9E<"V9^"P3(]N-;5^PI[[<6 MY?8W)>&>*59`UG37,#7&-[U$MTJP$=Y'-0P(P`C`*@!@K198GP45024`(P`C M`",`*[HK4K]94-V:8P6PG,G]?<1A^JNNW]O`.3X'O/'+)H(>"B/ MXL@/'MGOI]>G;*PRS%G$O[&`1X)%/O/C@(GQ6%B1,C&O@O0'3Y? M*6<'(EG"BT2P=KUR3UZ@9"-]BN/!EJ(^YU_M^<&4NPM`8^(UV8,E9S%+N&YR MS4]O&F_D9Q`;*_V\8CENG*D(V4?QP+[X4[ZTFTUY<.=X:I`3]X/!:;_1:70!/[I`J'[GNU2\865=/@O%^_2/):::SR+ODYJ+?&.E=W(# MMY8U]SWR^D@6IY847\H]5208D^\^'VRQTT]L+V MM26]Y,<'M8/=^JZM'O0GZ"M,P#YGOT*%(JDDJ3S`.6P!4OD"+0\OIR-AB>FM M"%C+-%BS86H+M2;.(\[;B//FI$U84%MN#;$@L>#K6'!C[UC58[N+]*E=/^_! MT>:`+`\U2R?^98P[.^C97>>4(M!T\.!WI61"DEZ27I)>DEZ27I)>DMZJ>%2+ MMD$$,B!^% M[I$\O%(>M-6*('D@>:B!/&@+#*^+/)"'_)F6?J"5AC!]-@M\.[9D^"/':$8G M2=X!]CQ] MM7N/6_+(O?S##?_&K$#83A22?X#\`QN4+CO5EGAY'"!#XG+RY/>$ M.$776#FP8TR;I4]-NDC<2-Q>$C=M)%5D*7* M)*5$MU4UI8\P?;I5%"B^AKZ47TWR3_*_5_G7F:Q!\D_R3_)?+?GO%.6#(/E_ MI?S7ING'7W$8.>/'A>84!;?]&(FQ"`)A+]1F88$8NV",R08@:(VI[AZA[`DB MIC,_X,$CLQWX-A">!3?<,M#1U[*PU#`3=RSF>OP6\=5Z;389^3. M@T'9;.P';.QXW+,<[L(/\.0(Z,-F<3#S0Z'NQ0&D7YPR=@V4>?>PG6.SD4"$(KBG0_PJ@E_IH^#UM1M_B:VJ$*C5;!K]AK8*L*5?_%>Y MY0EJ"&H(:G9/M1H8W5;Q-?/*LOB[0DU%O0;%ZHA#RPIB[H9&JB/"7WC0YV-> M%K/B(``5TGUDGA^Q>>D#,@;U&X,O=:/<.7S]`/#4:&N+SZP+"I%('+-(]`RS M12)!7IT=J'T=^=;7DUL>"EO&W`@OY%00OV3(5%QMAWU#5L?HM,F=0<)%PE6( M<)D=;<5O:R]<9,"ON._2#P2\2G5PG(F`RZ!=UP]#9O$@>!S[P0,/;*K%?0B@ M*CHC?=]XU3;UJ0(OT*8NH$7R1/*TEER]IKYB:4R1[V\E>KS,@V3N#VU9K1:#;U*0Q+X'85]0+HY-6'T549&HDX>,VTKNBX^+. MEF`M*M5N2J4J5*QM=8QFMZ"4]Q6D*0LSX'U40X*0AI!F?TAC&JVBG'(U1AIJ MW[O!I-:T[[WRI`(9AC`LV7PW$#"6_RH_W"/FQ*S,EYERC]^)J9`M=+W0`48+ MV<-$R`+<3L2B$?NY$SY5$V:O7$E6/&(=EB)B1563SS5:_A.^') M\F/JOG$^N)H/0JU0LC2J@S-0=>PD_9XG(LR_98%$IC"'))_X#D#DPX/?8M16/`ZED`VKY*`_` M!Q@LF#)GS$2H&#[*N[ M*OCQ-?,L@I%AD5T?E1=<_C6@!LONQC8N&8C3O*&Y[&1141XA4LN35O;S?,V#3FND(@P!+X!K+-`(LHU2 M@?R=XWF(-4A_V%CEGQD,QA[>=N?A=BU9-ML4@&DY[F.88OM"LLD.E'JA*VSN MR0N&5"-]2D)<_)Q_=0(L>;/"Q&NR!TL-E%G"=9-K?GK3>",_@WIMI9^W0S\< M^90'0&\U2!Y'?OJ%LH7E-[+=.5P-Q$F4?UA.E\]"\3[]XX>GBOQ\W'F'ZMP8 M:*WTO6_@DTUZKW?ZU%V^)/=59J#EGF!%#B&JY>TB^E2M`7OIZ%^JZM'O0GFN'H/;*))8DEJT"_BN@IZT\6^J^C63^58>4<H9/-CT,P84.*K#]:R=WS9I(ZQ-A:/QAQ'G%>D9RWY(K5EGQ%+$@L M^#H6W+BB7=T2;70R[.]KW>X\>N*V3_SXCV#9:+-IRD/DTJ&"=M2L=@$W?2%@ M+_'H/A26I7@FET!K/+'$KN3<`@#4\'<@7!E(&;D,RL.`HS;?)3QOF"X MS_Q0746>.?V>N9=RWW=.KMHW0BER])MF4]N.6!9Q*5IE(KFHL5QTNR;)`\D# MR4,J#SUM)WUUD0]ZJ=E?5'F,/>O9A$PU-O3?-AO:3JR6%WW;V5>A MNBB)RS&+BTGB0N)"XK*QN&@+2#T.:2$G\WHB?L#*-)B.$$8\BB/YI^M,G8B3 M6[EL2%4?"QT4Y(TSCJ@[(DD>29X^Y:%5?#H+21Y)'DE>\5&"Y)XNA_%;)`FO M112YLBXT^9X/@3^UZSXZZ%"S7W+&D;A5=]=_@49E$:!=-W^2*Y(KDJN2*-4E M,F8/6L)'>#85[]DOR&TAM)I:M54[2WA_#=[JGWS>,IK-@MH/;T//2O!=T?H> M821A)&%D&3%29XDTPDC"2,+(,O`J8:1.C-19A8TPD?$8^^/>9UU0\:(`.P-3LT%J-KCN:;5O54<3K/H$*Q]\ M0DU\JFNL9,.E/A;4Q(;9.?Q1&TGUA^)_(;G4S] MV0\P>TX&"OB@/CUG1$]X9#!GS.87&.S!CUV;<6E8/V]CD]_X4'YCF#_YA%]) MM_K[>_M[R+*J!,/LZLPEX"+@(N#:'W"9AMDOOC!A)5BFXM"EC<:$:R5F4L*U MS>C4:_<(U72@&IVNO_YT_0J=/R*,&/=L-A,>=R-'A(P'0IK_P#TV&/C2XL=R M/#+K5Y[#ST2@ZO'@@?HL\.^=$/T+8S_(.01$>,H8'N`KGX.S^F6;ON@!WN3Y M4P?ND^]),QY"3(&`VY>697?RK'5<+2LDN[_,*&(&*_W`NS]6+F$QPUWV">[^ M6&##3S)RQ`+\Y,AG>8^7)9U;P+:!X*%(V=`#*631@W#O!9O"&R:2U1\$7.Y% MCA<+&8R2-NJ*`NZ%8Q%@F58,M6`SP%I+RA)0RI8571F*/_(R,#`.`-X'GU%& M_A!2Y&)/1G!$/@,I<:88L<(9//A.%L'"T?EXQ2,6?PT=&>PQP5]#'+._?H)K M9P2OOO(D/QLXLU!F]MORXJLOUXS'.#Y\-UQBRIG@`LF'2\DS8%!A#&(,$X:7 M>#Y,$5%,%@=(93^]6'H6X88IC`]>$L:W?TEO(LSV&T>QEA[*VT>8\Y3_Y:LR MMW_%@1/:CBR'B_2'L51=SH'2L-;-1F,@*7HK'GWX!Q'M^L&)_BL"%[[^`=_> M>'K!E6<[W&!GPKUSXJG!?A'!E'N/AKSNLY_=:#Z]<22\*0^^&O`*`?N*_'D( M"Q7`SL-_4*OZ=#!^'$W8<`S\S.5O5V'`A2LO;CV]&#GF=\_!4L77"-_`&;FO M_@_XP_9AO!\%?"OG%ZHQ7P)W6^*T1COJ)X]E9\'FP$B$"XEQ`^Q\E8+,YT#< MPVB0JX_##X%PO(4-5GT9@H!:$[DDXAMLN0[^K`1RCE1L'/A3]K_`YGDW84LGX#"N83T$EJ=0*LF8.SA1K.^$>2(A#1W$7,N-GI)$[?,E+>4&G(K7F(P M.Q9II.N,AR&_$PN3=KSTY<-=94$N;;CV3;XEM1\[?:61Y"-'3I`#&CLC7DYG M3U3V97KXXR($N(!G_KMQ.F!PCPLL4L8ARZ<\@:MDG?!?;J'1A9LO`Z5C(C_' MGE3D[F+'?GE73O_^\?LX/+GC?/;^2MI](.@C)[1?__7/ M?_RX=.%GU)$?LXND9@T?OHCQ3V\N1XB8O[7_O!F]88X-7W`K.NFU1_V^>=F[ M..\/NBVS;0X[YQ>C4;O9N+@<-GNC-S\_PI\Z1W:!6?7Q MY8A'INB)$"N>K\A5K3UE),">"I+P!(`?$2EC"C366\=U%AP5"W`IV#B.@/L4 M:,*F(/Z.!3`TEDR(`N'J>,IMD(4/Y;0XJ41[0'VUN'#=0L\;Y3*1I,S6.>]=R3WIJ4<2V%YX M!@PAG`'7RV6Z52JI7,6%UTB)&,@2JW?(JR(,)1>(*0].I/"^#9T;(<'*0BI M=\`;X07W\+4?`WF%+0+N&@HHE5$/)`<654*>OMT1R:(%XBYV>0`30H$($^W2 MCU!MA#'Y<81KE>KQH"?NN3\(-X_01.*/<^-(R2V=X*.8*OGO_P@E7ZC-;W M1)E[HO%%@/SHL1Q*%%RA(6Z@_%T,+P;M;K][UNST1ZU>^ZP_ZDCESS0O>L.A M63OE;TG5N_IX,_SXR]79APLVO+Z^N+DN:N-8#E+5N6W(^X8`,-,I&M(@*$[& M(-F.C,=*(/\>*B.`T/X#Y6OJSM<<#$[[C4ZCVV\VNT"H?D=C]F9[Q^S-=N>U M*74M2AHLR7V5&6BY)UB1M,^*1&41?8@^F]%G/ERSW,5L#YK#M7%L;D5@K(;9 MZ^5+X-PS\_XAOQ#VB3Q66173-P3*X?G6<(J9BFBG"3YDV]:@^<00?VC9[B8/WPZ'E)5;= M2F?HI.:5=S(+?`O/\=(0P!R!\2_\C]GB7KC^#$_OM)EDI22P7G#-,>Q^FDP> M'B,/CHO:H;#T'3WU%87>(>6T-%FES;;1Z>JKZUSVQ5^GGA'4$-00U%2OX5W9 M.8#PAO"&\(94FPI`346\3(5VJH]G,]<1`?-$].`'7ZOK0"[61C<;I]KDBC:J MS7L@%QP64D33H+Z^ID%E08FB=3J2B!I+Q-N^MK*JRVM>G':F78@HPH6D99/] MH[=YS?=CV3_H@&X];<_C$`8I,'_:56E^$V<6LOG1G(^YF+GTH><3X*OIB2E6 M^>^=ZFL44AZ:51?4M1+QH&C?,3K-#OEK2+A(N`HP/$RCU2Z^+CH9)21[)'M/ M[FL;9M^DC:U(^Z9>9LQGCG5`M-DF=3-!S!Z=/Y#_:),C8*/=I/,'D@B2B,P, MT&@$D*Y/XE)S<6D:C5Z7-A`-"GJ)3.(B:7N3=JY9+$]&CH4#QWL2X;34`FG- MOC';CY&Q=\GHK78#,GUAMB_1MOY=[5I=H]70=^CS:H)6@O&*MOP()`DD"23+ M!Y)O3:.GSPS9G:!;&?R5X%8Z^2,(+1U3$H1JU#/;1J^N)4C)V* ML6NA)A5C+SS1BHJQ5]NG5_I<4:I8NI!M0!5+LWD2U!#4$-04!C54C)WPAO"& M\(94FU)"346\3/4LY5@W*WYPJBW!BG:R&B>[MXQN4UMMS[+`2-%*'TE$C27B M;;]+U5+P/HJ!(7'9I%I*KZ,MQZ8LK'\05;Y$KH0*U3DL)]5*7@"Q1$2K+E2_ M%&E3GUJV6DLJOIIL90$PQ,M>,V=$ARJ03\PK;9-+5U M?JO]MDC''T47DB04(OKHTPYTE>NI0G&4_57E.1#%"CA8:AC=AKZN<2\6WZD" M&Q5M.1*`$8`1@.FRJTVCT=U?`<976="5X#TZ1R1X(W@K&[PU!T:GU2/];.\U M$/%K/^`I+5YN;I3PT+1T( M:`?):O?S*$4J>C5(;@B^"K M)*Q(\+4QJ=I=@B\Z?5XZ?RSJ-#IAC&;+'#<;ZBD78*1;6,9^'$=Q()8"\!=- M>AXR?\R6YK[[,-;Z:9:]U;N_C#ET]%[1H_?.CB?O_2Z=V]*Y;1G:7)'>3$<7 MR7W+JMM8_F\-/PX]+^;N0M^95ZA)U13WW3GU3U#DF/!P="QW-/Z\%D!R78A< M[T=NRT6?NITG+HZ@/=/;008L`&VU/$M$Q'*Q))6K/I27JC2.*-/HM(L7M+*L MO49O4Y74J,*A6EO&("%RC:MF(M:8NCCEJ"&E1!K-WK%&7_I>>8A871"J3^$J MTVCK*PI/FE`Y=O>]HY.V8UT"H1IK0OV.-HWYJ`&E1%OXWI%&6_WY$A&QNA!4 M'SVHW]%769>TH%+L[/O%IAOX2?!Q)`+2A4@7VJ`95T\?XAPUL)1H(R^\8#`I M/P<^&RRF[EJE8YGW5Y"M_@'R`V/0U6?AO)J>E>`[C9O-^ACZ57__^'TT7#^,`W$#$S]S?>OKS__ZYS]^G%]_+[S(#QY77`B4])!< M7\3XIS>7(XP%_ZW]Y\WH#7-L^();TZ8VZK8O&J`4?!IW+_L5HU&Z: M[=%9IV.^^?D)^?.D?"':>=7JO2J8/_=ER,"KC_^Y^'CSZ:]4S.)VB[\MA!1<2?;\"SXJ,Q:=8\U>5R:%B893N4)5B M8>0L6<^P7_@#FW)81(>[!^VI5&T3JQ1!P]6PW/M&OUU\C%8EN&97P[Q"&%:Z M39<2&PZ"4:6!(=-H:70@EGWM-;H`JVF0[D["/_S@*W,\-@M\2X3;Z$KU/9MM M&NV!MC*!95GHHG=EVGQK+1'])DD$&>`;T_;2\9QP(FQVY_MV(;O*SOWK*R-\ MO8'1;>@KG/9:NI6%MT:9E=;?N?12R>99)HC_:A1*#4*W91D M@X8QT%@7@QJ%EA*[2J=5$(`1@&DRE1I&JZ.OPP'G1OAQV>Y?]P:5Y)H-C&Q>7Y[W^H$[!L>KCR^%C*3D= M\;P+9H=I_16'D3-^++:C]-72Z+=\RHJJV'/2,!X(>!;'LN`\8M%$,-@=18"U MORT_C)@?L"D/OHKHE+%S_,()F2TB$4R!6#;#0N%L[`0A$L!(_O+CB-WRT`GA MGAMXXI3_!2^+'O&A?APPY\G[QPL.,ZS7_8`W.9[[R.+(<6$J,#(GL$]F/(#' MA/%LYCHB"%GD`_#$@27D!;\=6A*_]0[`9$,.W$=G@,>*>NS',4L[0XD'P M".O*\$NQ:E2.QP+AJD+H\`[\6O!)*`Z-@&>Y@XUH1% M_*M\"-P*PALZ`)3)L^#M\P>YSA@&\PCHE'\4O%CP4,A93(3'_HZY%SD1#@N> M,('7,/$-#%\[]Z20NR+,!A8:2$#X&R`:EB<0H0CN!?X,I(/AX>UAF)_PZ?.` MN![4GF#5$J"%T10N#*^\D;B-AI[]J^0E1-*+OV-@B6MAQ8&<'/QX#CL1K/I- MP%'JUJ85;`"(K7/SO&NV!F>];K?1&77.S[J7*EO`O!@-FZ/:`>(2_/TZ_/)_ M%S?#LP\7[/KB_/PH;E3V=^Z$C!260TG/A!=(+HPU`. M7!\5-_PTS?B*A1E+4?'_RN9)F+LF2K1>'=:_]PR+QAXS MO_((S:;'3:VD/0_UK>.Q1\$#ZLI$:8I[8KFDZY*PI>.3V([8;B]L]TO@AR'[ MW0L$=R7W_<(=[Z")G,1^Q\Q^'^#S"V=HQ'_$?[KX[Y([`?L/'LP5:D"5*-*Y MR`"(Z^S`1%O7PQ)1KG2B380K'!/W2,0J$*XTQ"*.(XXCCB..(XXK#^&(XUY# MN(H>R"R.0'>+AU]CS[&<&7?9K>]ME=5<7K+I-6?E?1\PL#*:<(]I2XLD'--/ MG[*8Y]K27(J;()@((`HBUEH(VD"C+4NZJ)]3MO+M8Q]6Y'\S\`%-_;7$;Y;(# M=;%5.2E;#=]6B6A7NJUL\WISM:DGUVL9C6ZW<.:JRT9`TD72M8UTD6"18)%@ M%>#':&OS9;Y(E./V<)#@D>`]T1=;Q1LC91&C@S@.ZN\?F$Y%8#G<93,^$T%U MG;&5L_X)M&O<-J7=-KI=\MV22)!(I/=IZV-"TD#24'EI4.3H-\VF-GXAN2"Y MJ+QG(NT1&;XEH5UU0/YX6:QUMB1)' MWUZ-)),DL]SV"XDHB2B)*(DHB2B)Z)&(*.FWQWZ\KY.$LGUPODO0RKY`Y(;5 MAFA$'VV(1>U=BR1AY=N[FNVNT>[JB^&F_JZ$8(1@A&![1#`"+P(O`J\2G#))/IH0J[#`-3!Z4/\0_Q#_$/\0_Q33OH0_]3X;*`6K0?+2<\"DMC- MD_V5)SUBQ-..4(90AE#E0R'.K^%8\KPIU+@N[4%L#0B%"H:+-JHXQZ!7OP"C+XN^J M\%3TO+Y8#V+A/2#)95@BTI1N"ZMOK6)S8'3UI?76!8-))(Y8)*CE"4D#24/F M0VAJ5R2.VU5`TE)C:0%UJC.@+D$Z3-H2N=2H]<.1F\`EHEEUP;P^)6^;IM'< MP]%*7>"?I(ND:QO<)L$BP2+!*L"4UV:84#0`R1W)W3;J8E-?<:ZZ[VIU.`!O M=>%I\@K'`[&+WI^83U.!%\]\+_0#83-^)SR+ M3LKII+QD\/Y"LY?*H7S?Z'3WU@JG+EA/$D425:;F;R17)%>UEZNWIC[?]8:T M.6Y_`$G;$4L;Z(5M?8ZW(]F_ZA8QH).VJD6BF]:T*[9#8HEH6CI,(\(50KA" M&E^L6XU*=#+87T>,71+.JM$JH]*M-2N;>?>G? M2S?QRNMS?^?FY3J>.$EZV9C-QG=/6<[,XMPVBL_*/7D!0!I/HN7P<_[5GA], MN;O`_R9>DSU8N;\MX;K)-3^]:;R1GV'1K/3S"L+?.%,1LH_B@7WQIWP)EJ<\ MN',\-4@>1W[ZA=H#Y#%+?D1K/UVAOW?=_>7T@3 MI`F6<8(5"9ZNEC9,]"'ZO$"?^7`[Y0YPT1M!+S\^*"7MUG=M]:"1L,3T5@2L M91JLV3`WKJA4$?1:K^WW7T?+?DI*>?5[)X*'6VN(^_;*8]'$CT/NV:$^3TD! M7%G2K(_59#V';P-N13%WV:\\PC":QV>)>[BAOG4\]@C&H+[5)P#?HM'L_B7E M\"PWG/I`B_\*FYW[841L1VRW%[;[)?##D/WN!0+>B=SW"W>\"F-O`EHESI1)L(5S@F M[I&(52!<:8A%'$<<1QQ''$<<5Q["$<>]AG`5/9!9'$%%VMG7Z(A%WO=!A"&+ M)MQCVBJZ$H[IIT]9S'-M\;7%S;F`0-B>T6IKRR4HRU+B?52]B&"`8&##25,' M/H(`@H"CAH"W9D?WM*GH&B$$(41M$$+:"MHJ#)=E*7=5%.IVXEVLZZKP/NKE MI&PUO%LEHEWIMK+-ZX?6IFU(JV-TFMJ4PMJW#2'I(NG:QN5"DD6219)5B"=C M?QK1<;LX2/!(\)XJC-1GKE#/0?T=!-.I""R'NVS&9R*HKC>V&HMGSIXMFHMOP/9KMO##J-PU.T$IQ7M&Y+ M*$DH22A9/I1L%=22F@"2`)(`D@"R\@#YMEG0^0&U>,/[*`:*\+-T3$GXJ=D, M[Y:@368E..\@_O3#(V32WJW9T!S%5HYL6:(5T6J;RG,%T*UJM"*^(KXBOB*^ MJ@JMB*^(K\I1=+5$?I`B#:4//HZ<>CB4`-Z(<%1MFCBN+(0CCB..(XZK!.%* M0RSBN&/@N(J<#5`/AQ*FN9LGVD[P"+_TTZ,V>T6GIJ^)8]PJ\)%TD75O0J:FM2R9)%DD6 M2=93.NDM[D@B1B)&(K:@&G;U5:6JNW11T,J*^X9A*"*&:R_L`AP`9.>7B#05 MQNRZE;[N&MV.OI965/2:).K8):J@LB`D321-1RA-^L(/-B4-A2>0L&TF;)43 M)E3VM&U/96']@UCC)7*`%=^NP4WSTJE;0RE#IHAP5":R="%L5"82VR.U^U2+ MO!Q6)($D@22!9/E`LDUE=`D@"2`)(`D@UWA`2P"0K_*-5H)3J5<#P6?IF)+@ M4ZL1WFF2$;YW7_KWTDV\\OH5?__X?1R>W'$^>W_EW8LPF@HO"J^\D;B-AI[] M:^9VOO@[=J+'Z\SW##^>PT)QQ[L).#*H#",+1TYHN7X8!^(&J'7F^M;7G__U MSW_\F+[D@[CC[KD?1N%G6`?K,;L*:.\A@;^(\4]O+D?-AMG^K?WGS>@-]KH7;WY^LF!YXM\X4Q&R MC^*!??&G?#TTYVYW'4^<)`5\S6;CNZ>B:'9!%I]ABN8KF0+O4Q_Q\O=.!(^W MU#1,WY47SD>[&O1^W9_,0AQEZG*^_X0 M3'R;"2\4S)53LG!*+!`NCX3-(I\!5X6226"HPK.`!1D/F>,!0P;"/GU>4):8 M?2T?+G#KG/WGC*^NWX!=>^W19;LY,L\ZS;/>>;_5;IN]E%V'Y^WS8V37.4'9 M]6;'6"5FW&2;:;;,<;.AGO(I#E8?U2&CNK$MV'2Q1)P!C+0F`Q=_FDY%8#EP M\8S/1&"P)5*]1M9RH_+'[/?3ZU-VAYJKA]A_$LY\+_1!I!A/Y&S7EZZ@$^,> M/!]WC).EP&-#_1@(V`WA$F?LX%A`VN^YXR)93\9^-6,QP)2TQO13!7VUNFP1`G"B#G*6/# M9>KDUAFI&>`P;:1EQ,;<"=@]=V,!C`F<&$U8./!TV(_U?.'IFOL=\8'8+ MF044*HG2M]SEG@67302H`C"HFPDLXH0#8.-K:)"!\!\4#:`48%A\0=N6?$T5EL%S$4$\N=`3&!#<>[QY?!9;#;FSX&8.O$T ME%2P09T!E3*:4_#.@X6`MX"\,'@3%?DG.!#J$3+K]7L0*^&.B. M/,$>'&`6!\/J05M,*8N7X9CX%)C(^:]\Y/>P*H&0#X=1SA*R?K](T@06[16+ MJA92O4"R@+%R`<,(_I%:*]ZD+H=Y7*4CA$43SKTD38ZG5KP/1CCC8!HD>HB: M>\)-J&/`51*Q-N+]&NUIH)I-@1=0U0>2P5X5C6'6/I+LG@>.'X=L`AL\#!IX M)'J<)92;\B@#=.#I^&["IJ!OI;*RL#5*,!%"37^0-P[L#/A*'(30*"4/'@"4_$`D*>H+`2/S)D"LP9R MI#!%P:T)/`%)B+@"NH(C4>1JC``4>T$JU5*+EN@+H\MPRI&:=0B0$"AE&VB_ MZJV&@CQ\QH/CNGA9#A.=YZ1S+IQX'3Y+^F8*4@B(8S93;L*Q;ZO3KM?4% MI1[V_Z$E(0A(]3GP/?C34@BBKM[>,FTU^IUN=SCJGIO#P:#9/[_H9I9IY[Q] M=HRJ_A>!R5?N([M"QK?9G.9LD>A5A4IYWY7'?N6/4J]3PG$YO#[+MD.Y"2FN M!MS*4>`ZPZ`S'_Y!S4'P$&$N@R?<9912(04LW4]PIT,-0KX9:<`595D8P^AA MKTK>GY$-'YAR`#S1SI2YI1'*P47\*XQL/$8"X3MF\2U(K^(#+]UKN.?%W%W: M2D*@TYWC>?@-'R/[I/8-,SO2K.DJLTWP`$2>V_XLA7*8\L2Y=6`S@%%=(*GQ M718PA9RD8FQ8B"@_8.%(O0O41V`\7"N@$#P7!RCU-J7MPY"1R9T()%1Y]QE"VDP)%MI#XS%"T)A;N&^@),<2]?V4WY+;T2.QG7-F M\\'NU;5B*+,CGK)Q',72">!%TB'WJ(S.U?.78"JU\@Q*O@'L(M`_`D8JXY?C M9:[K/X3/]YW;@9=>2(#//7GAL+>1/B5A/_RP#ZE!\CCRTR_4>;W\YL&QH\G[P>"TW^@TNOUF MLPN$ZG>^2P\"89%=/@O%^_2/)2B9SR*?EI(=#G96IA)MD-@B1_;3FW[WNQ>/ M'1=/1I,;S7W?MY\75K0JQYPS^Z\#X_X6UM3;*T]Z44(`X9!R#@O(.2QG_]C# MTJ?RDKD[T?Z$W1KL.1S=W.9IF=H:Q9((D@AJ%\$2A43NMY85&`$=79)9(B*6 MBR6+@+32EY[3%QFZ0^!G:6([>PTJ.EAS):IPH-;6N8+PN,:54SIMZG!"*N%N M2%-\A7>"H&.LOMSL#4@+(BUH)VS2EB!%$%1C+$C!Z]4,7C=;.T:O M=_H4O5Z2^RHST')/L"+.F&HIZ$2?S>.:BW"]5#WN65=3,>*_JO!?86U[Y<>E MC*HTL4/8Q)+$DE6@7T7T%,J3),D]N.3N>3/)90:NJ41`G$><5R3G+17#:!$+ M$@L>E@4W[I]"Y\WK&3;OXM=FJ92'=*63=>U86.W3O5+DO5;CT+C;TY:J5FV> MP?NH81[!5PE8D>!KBWZ@VJS6:O,,P1?!5TE8D>!K<_C:0X)3)7AF5_C2T$IN M\^K#"T6+/V,I;-\;>O8G+/_\V0\C;"`2R*+'9\(38V=EA[E-FG&=#C?I(3QEXN;JR\7OUY\O&%G%Q\O+J]NV.`Z&^\D^6&(Z<_U' M(1;+V>=N-M@#MD/Y*A@(%A;W5AUNL"/'E$?6!!\K:[([MW%2!5R5HP^26N1+ M!-Y]HF:C\5T!C\71IO3(PV>TC@XT'V-SE M#]B5P/)!,\#^-<)6K3CF#?78O*&>>HCJ1B%!"(0&FP2-D]Y#^68A>23:E2]4 MWA*L;3(;+,P^EJU^XA3C0I&,3O4YDVTT,.0;QJ8FJIINI%TLL#6%I5HW(<_( M+@6R+P@0UH)98+.'&O%/6AI_$?E4TPH9>)_Q2[+$@JJ[4X`\A5XWSWL59J]MK-EK#9O?RHCU4 M$:/MT>AL<'EL$:.?OWSZ?/'EYD\V_#AB%[_]?O591H\^RR44VE*NT!:SRR#\Y86QT*XKDZ'2CNL[0,!540 M"U:EP!:=:J]GV`^@PY"G]-"J3;&$*\(+IE?R/=/A(`%8F5B0`VYA4+:/7I6(UN@\?J^DOWIV$9['CXM!4;KXSG04`E7CN MJ2T(F,"^;/0IUA+2U_J2.&<^W)<:<+^&5@=ML&TVC):^?:PL<%JT2DTB46.1 M&!B=MDD20?[O36F;!:F1Q5YO)WAYM+O.2:^&-"L=LVV\R6DEXF$5PI[1ZVO+ M-E]+E[)@-SE?2;KV*5UMH]/ODW219W!3$EYY813$Y`HD5^#K78'5)4SI&*>^ M;@^SV3+Z76TQF67!3W(%DDSLX!WO@4QH,[7K(A/D#%Q/VU]].W:%.L>UL'$* M69+D%*R8GE"BV4!<'))4C2M4_I:AJM)DD7N00W)J&L MK\)F2:D4J6D*W4?0A$5EHT_!NN.)-@@BUMEB&SML3PS]NUG7Z+4V+A6]:[F& ML@`R^1A)H@J3J(XQZ&F+Y3X6B:JZA[)T\D>$(\(1X2I!N"/TH9C]OM$PBT_' MK,OV2.)%XK6->'7;1J.K3PFMNWB1C_*'#R(,WS-N6?$T=F5+=5O,`F$YLC-R40'/&V99"!\1S*E%,(J=!Y`8#8V#N MS9MY'!)7=5]GD42\\2/NDE5,WCHBW'$1;F%G:,'.8/LQ-H799>NL=I4V?;7] M7J)M_8O_=0=&NZ!Y8BV;<_`O^(P ML43(XE#8[/:1A7%P)WPO9)'/'+B+NRX6:\5FE2&SXP#FI:X)'D\96TH%E$^7 MSX+[P\B'3_A;%'`OG/E!Q**)D,_-1J.*P`'DE?>-RC2!*L^P-\]OYS-_MEP-&KWNJ-AU^R>-7IG%_"QV;BX-"_[HS<_ M/UF3+4Y*5RWIMJ?'3]=]E\/R38])/N?/RS?K-E:M"(S/JP,",%PB$!9*K\UX M!-P31LP58;@VL?24L2%,#O\,F1\L=-*5C[/X3)+ZO\(VV,/$W0=Q6NVV:HXNST;!UUKRX;`_.VP.)N&9[ MU&JVVX=&7(K7*2!>QZQYWI:-^ M<,:">(["%@X;MD#!6\2"50G>HLB99RJ&@0Y#IS6'5FV*)5P1CO@"FB$HNO:; M9K,JA*TO1]+Y(9T?KB55VS#-;N'DJ@37X'T4`$$`5@)6)`#;O.V2T:,(+NWQ M#]7T%^].PK/8<7%H6>&`[.R;?"3E!?N2NGX5/FD+SB+.V;SNZVMH==@&`0VC MI6\?*PN<%JU2DTC46"0&1J=MDD20_WM3VFX6UTD6>^6=X.71[CHGO1K2K'3, MMO$F5Z..43VCU]=6TZ+V#:-(NDBZMI&NMM'I]TFZR#.X*0ES)4[)>B57X*M< M@=4E3.D8I[YN#[/9,OI=;3&99<%/<@623.S@'>^!3&@SM>LB$^0,7$_;I=+Q M9$F24[!B>EZ)*%8Z5CM"IT6S8Y@=?3VSZNZT(.DBZ=I&NII&JTG212[!C4GX M"4NMK&G%0V8M^0A?I3N>:(,@8ITC[A/?-7JMC*LKT15W4-9.ODCPA'AB'"5(-P1^E#,?M]HF,6G8]9E>R3Q(O':1KRZ M;:/1+;[:>UW$BWR4/WP08?A^;6%G,HSKZJ4D^E2,/L?K6'EKFGVCH[&1W(8$ MFC/.MA0Z()Y3B6(2.0TB-Q@8`W-OWLSCD+BJ^SJ+).*-'W&7K&+RUA'ACHMP M"SM#"W8&VX^Q*UJ[3IJ^WW$FWK7_RO.S#:/7TQ>Z\F:"48CYS5!))5 MX54"28T@V3;,3D&V'H'D>B-0>P_9U1T,?XMY$(G`?;QTL.NFP]TK;XR=^=#! MOU7?V/;EY6@T')UU1Q?MH=EJM2X:JHOA:-!JFA>'[F*HO6_L4GN2WWX??KFY M^/+A3W9Y]7'X\?QJ^(&-AC=#]C;V>&P[D;#?L6*U$FKN:".[;OUK,'$-TO,(@:J/PLGV&@]:;I. M)[X%"'XYNC-N;A$?&B9^Y8$UF9,JFSCJXMFP15?LU07:7@VON4MV[2CI<]G^(MF_> MK'F+RWV3TS3;1E-C1.]1'^(2%!XU%!+,'2:[U6P9G5[QQ5,KP3<$801A)6%% M@K`M(`R[=A7?$JX2?$,01A!6$E8D"-NB_4S?Z#>T]=VM-M_L"F%'$2JQ.YE_ M"?PPQ$+*8X<*)Q=PHE&*?D#[9JH^X-A`6XO'NB`2B0V)S?-BTS4&`VU^9!(; M$INC$)M!PS#U:PFD`]N-#6R@L`?O#&7&.MC:4]]+$M=/V"T/'8NFMO9.*A*L\PD6R1;)%LG7, MLJ6O;RG)%LD6R58A9F[M96OKOC.Y>5&G$NI40IU*J)%'J0=:[@E2IY*2U"FI M&7WFPZ5.)=2IA#J5')_@4S7R(CN5:`L](Y8EEGTMRV[5J80XECCVX!R[?:<2 M8EMBVX.S[=:=2C;F6@H_VDT.J%-)51TNU*FDXL5C]TU.L]$Q&F;Q*8E'46"6 MH/"HH9!@[B"1"6:C9S0:Q0H4TGI$.RX:D2; M`Z,_H"KM)($D@0>2P)[1;G9)`$D`20`/UBJH96KK>DL22!)($KBU!`[ZQ1_F MUD4"Z;R6&I54&=P6:75L)6KK@D(D$45)1"4$HD&GKR00)!"T0Y!`D$"00-") M:0DL.FI44C[@JE>C$CHI)>&JGG!50K;T&90D6R1;)%O%J.(D6R1;)%LD6_MI M5)+^_>/W<7ARQ_GL_6\Q#R(1N(^7CL<]R^'NE3?&=B*1XWLW,/^_ORO M?_[CQ_26+\+E8!5^AAL?;P+NA=S"B\.1$UJN'\:!R.X#VGI(P"]B_-.;RU&S M8;9_:_]Y,WK#'!N^@!M/VLU^YZS7NVP,F\UNK]\R^ZWAQ6C4;IKG@\'EH/?F MYR<+DB?N"^U)5JWG1@U:GEGTYBL7'>^3'YGM]A=VF:B\[P_!)OQ>2!X(8*D% M]H.()HRS:.($]LD,&8C!LL5C^!78)F".QQXFCC5A%@@TAT_^F/EQP$+A.7Z` MU_([,871,NZ!\,-4G#'(O1P;L-L$:"J"4+T6KI]PF_D/'GPU<6;P<&!T$4:A MO!EDSDY^F/FA(SGXE-6#XK,XL"8\!()'$\'&O@N;&HPMK2V/5)T%OAU;"2U" M$=P[%DC2./"G\IXPGLU<1P3OM=)C`_%Q<0S ME/H@#@DAU2YD2`4P-T^9,HV!O@)8U6:;=$(P0[-5)GXT6]5$@ M!",$*Q,K$H)M@V!FAQ!L?Z$A>QM8V0_.A_),?&D*KWG4%@[GM<7.]!E MG]UK'F^P!R$#,+0\[=^=TS:#JUS']TI&QW\W3WMZAP:LR"U+A6K,^*.,8;!C MP2)_(3;C]'DL6`KUVB)NZTF\5RBP$?S0LT?B7KC^#"-P+K[-A!>*SX">UN,& M<5Z=T=G@R?3D6X3@0/5-_"*,_3P038C%G++%@^14V@&[(/#^"9W!K M@C%@Z35R4F/!0^<6I_$H'ZZN9MR-1.#QR+D7;!QC-!Z+0[$]Q+P(%4^@Y5YX ML?@B+/_.DS%XZJ)M`DC/3;-]?G%YUNQWSQJCLWYC>-9)@>6RT>H<)[!(NK(< M86N%*6IV3@@\+B?X7XPMG0@/DUC#&!@0' M&"[K>(@O")<1F_CA#!DAQ*')X-H0FW_#,V>(('`E"C3BU"5<`(`!R)%&?AKY M-^?H"(^5R`*2(?](B017Q:$B@@-("S.1<\,'<]=E/EP+K\CI%5(#S!ZP`]C?'Q&!9,OCI]KE*"^TVS]P,NM@=` M"2J8F$4\X2"I>`%M8<:?8-%F2NT!FN#@7%AJD`&&T<0S&6@K@=6S7?R@]BN` M7!<'G9L+;GAJO?!Z?$-R`):BO+P";\<1*"J!M6IOC\HOH.P")E_CIA&[XM-X M:%E!+.P/#K]-MKT;9/MGP+GU%)R[S7.S=3[J=2X;EP.S;UZTFA4Z4PY,'@M-_H-+K]9K,+<^YW]`4E]W>,2>XU]QW1NO<74LANB0(H MY_)!P9&O.VUXGLA+L3H[.3I7DW7K:!V*C*QMC%G567/C\,=:!Y(UGRI0)_(; MGSI?:MQ'\0=>EXS_2T44>1*G[WRD:9^T==8 M-+6K"-OL&=V^MDY7=9$T,O*/621:1J^KK?%-742"G`N[T3\Y!V-`^1/58)9% M_%LQNU!]*KFUC5Z3NL"1B5NB_:P^PM4T!BVJ[TO6EU8R?T*;JQ"Y.VR%(OWB M-S``HK2)WPO4J8L4DF5&$K667%UC,-!VD'\L$D6&W6[TO_$C%>@IS;M7.!>W MX,(6<*'MQQ@(N(N05MN-KN_TY27:UO]XIFL:[8&^;-E7$[02C$?F>4E/H`DD M"20+!,F.:9A-;0<"!)*;JJ.O;4>Q>?+)FIR5LSAT/!&&0^OOV$G*^I\]YCZ= MPSR`E4&A/,?T*AL3KO*M+C;(.&R=70Z:9KMWV>N,R"\S#W%F>9KYAMM.MN',\+\V7$A[.B=UR%W.N M9$$&*ULKS(-/P@#"T+<!?#\\_!&8.,2'BMWS_%=,N+@R#RM> MIJ58P3:3V+D$Q(J7Z6TEL7GD=^6RNJ8\`+E0@^1QY*=?*'50?E-XXE=[Q\2O M?H_RH@[HV*QY7M1^DDO*94B5S=>GCR5WI^:9TADP=3W=TEBRDVEK)J?5#BT+ MX4H1#5T:8[%GM#ITJ%XH(!T>=Q9'T-9\HI`6-)>U0T3>@+'RUN9K-L7:!6MV MC5Y#VY'?44M5B;?Y8L5M[LS)'`1%B%9]XL;>ZO.%OD23.?\4IP-H%]^-S17: M_5:)XP1+;&$Y/#;F3L#NN1N+)XZ\A7TP+9WD)*7S9O)[[Z[01)_:QQO85N&'JT(H\Z-[&I+(U@USU2:BHA'-C:!]D1N+"KP#/MR&Z9[1Q^3L ME^)&7\N&ZF,^A*XXC5%?J@X.8"=R%B34:ZCY16"_$MF/9<$R2(+#<7>7[=1F M@3/E@9,V7$INDAT]>-Z&"/Q'[F*W),Q(X*X!)L8X%&CT`Y6X"_??/F('*&S] MHLP15;PNN\^SL3^<"",0[/0IX0M-/+9`G579$SNG0:Q)K\`ZRS`++PH_C:]D M*:0;_BWI[W2FVFZ]U"-D*9VBW^WV1]UN^_)L.&H,FIUF-TFG,`=GK;-AX]#I M%,NNI#TD4U@9H=-L"9E.$<(:??\V:7#V#E`Z8/F*5+(;#@^35(R00NXK%')O MMG:,N>_TJ8=)2>ZKS$#+/<&*N#G+E2A`]-G<15J-+B>EHU_9:$;\5ZDHULT)+1L1R<5[U)/=`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``C`"L`@#6:H'U65`15`(P`C`",`*PHKLB M]9L%U:TY5@#+F=S?1QRFO_+Z%7__^'T98_%3?\V\6WF?!"<28\,7:B&WS'#1#DS/6MKS__ZY__^''5#\S#Q_\_.3A.)D(B1LF\W&=T\ES>R"J.68X:\XC)SQH_K*\0"MH_?M_F+X8/.5#(+W M)?ZE9LL<-QOJ*;A"W'N4Q`NLK'O MPIX2/E_"9P=26/!*$6Q"Y(4-H9$^):$>?LZ_VO.#*7<7$-#$:[('2Y9GEG#= MY)J?WC3>R,\@SU;Z>7OVF/+@SO'4('D<^>D7:D^7WSPX=C1Y/QB<]AN=1A>` MK0N$ZG>^2W$'5L_ELU"\3__XX2F.S&>1=Y;-L:BUTFVZ@;]-#NVG-YW^=R_" MW"+@)C>:^[YO[R^D"59R@A5Q,%=+AR?ZY(9KECOL;FF?[;^.7GB;_/2@-MI; MW[75<_X$190)V([M5ZB@91;*]5K\KC245[]W(GBXM8:J;Z\\4-'\..2>'5*\ M;`&2^V(ML0($]P5:'EJ41\(2TUL1L)9I,#2PB.^([_;(=W/")@RH+7F)&)`8 M\#4,N+'SL>JA\T6Z+-L-\^W7=PPT&>9'<-E3K].B3F&94WX2]HPZ89_&X:AB,*A9W]P^*WC.I$CMH^# M:?7.SAMFX[QW`:QRUC`O^^:9BH,9G'6&%Q='&`=S#>]UQB``\"`KBUIB_ICY M<<#L9`&8(X.86,2_`0TXA<)4-11FL&,D3*])<10EN8\"1>A,NN;&0(V.9G:B M()U*$^>5D?->?RY=^6UE=[Y,C1M4JD&=1O-&6V-8DN#-)5@/K7:JVE$ZXA%S M$7.5J/EFB1SF^RUY?N7=PW;N!X\L$*$([JEA417!;RVQRZ**E.*4H30'"`&>&FUMN29U02$2 MB6,6B9YAZNL=51>1(*_.-M2^CGSKZ\DM#X4M8VZ$%W),\2&+JT3(5)^^G!VC MTR9W!@D7"5MM782+#/@5]R5];9DG(N;/1`"Z@'?'7#\,F<6#X''L M!P\\L+4E`!-0'7%SP#WV!JP+:)$\D3RM)5>ON;?6MG61IUH["YZFZ^Q,;=D' M9YZ(,P\6)(.F3+A6&X.FW3/ZIK[N+G6W:$BZ2+JVD:ZFT6WKTQCJ+EWD+UAQ MWW^X&\OS`L8Q`9=[%IWFDRFS.[G>MO5%(FU(FZU:?)8%U"C#DZ1-@[2UF@7U M4#Q6<2._@A:_@J$.(L;LOC@]HT14KR\D'DE7\G;/Z/4*:H:V!5&/HC`4R37) M]1Y=)2V-CDB2Z_KY6722<*$<@SLO,DR1[V\E>KS,@ MV3N1WA:(E.W'V#Q-FR58BTJUFU*I"A5K6QVCV2TH MY7T%:K1KPKFGB>S$>"RMR[L65 M["$+C_K"(_%%6+YGP7-DP,W6G7Q[E^99;]2\'([:[4&WT6B.!A=I)]]>][)W MZ$Z^+[L,-??Q';)@@:*8P!--!#R41['L(//[Z?4I&PN0`NY*73F`96"1+QO] MBG21U+=.2`U^MV><,C3X-1L[=OCM]/?=R+8R+85IH%7T/U1+T27ZS(?;+_4?%>7/2;MN+FUB0 M6+`8%MRX*D/=@L5T,NSU\QX<;0[2\E"S=.*_/\(5$:%0Q"'@:6-OY*M?A,>< M![\K)1.2])+TDO22])+TDO22]%;%HUJT#2*8(P_PT?(0\RJ1J3UR*SPQ=B)R M.I37(UT:#&N>=G71H2P2@O=1@"#)PROE05M"!>1>_N&&?V-6(&R'4O?)/[!1 M$9)3;0U_C@-D2%R.6URT&:@D+B0N=1>7QJE)XE*X"ELBB[+0$E6^ESB@,>E< M?)L)+Z2*G@='J'J:Y8T]>*++(EAX'_6R)-':DVAIU*%)M$BT2D"X$HF6OH*" M=1TG7V,Z=.MHD#Q-?2E_&J2?Y+_O2[;N-K&M;XD5.]/B'8\.3QMA1`N_\(NZ%%XO+P)]> M?(M$X''W/`YA@400GCU^5NFGV"3E6@3WCB7"K7J:=-K=X5FST[ZX;`\'%^=] ML]%6/4W.!V?#L]&A>YK\!3-UQH\+O3=T=C51J0`3D?0=@9$PU:DC$+-`A/"Z MD$6R3W+(79CL[6.:\,LL6.,[/WA\SYYENFTGOP$1%Y"RM)U)5-L1L]'0V&BD M5;E&(Z^];^\OI`E6/!8AMJQ1-`W3UE"]> MSE?W$\"GKXJ8S#J/7 MR,&5Y_GW7$947,8AE:^KIBE:^H0$?X9S=[>BE/41:;HS&DW^M_, MPZO)*U/V[!URVQ1'V_K[==J]MM$J:H?9AJ*5X#SR71-*5H57"24UHF2K;;0[ M!?F+""4))0DE"24KCY*M?L<8#/05\264W-#)H2%?7F^:^YID^DON!/_A;BR& M82CDG1\*PX"$($S'CKA8IK^!@GTHT;SO#MLG7]8;_7,R\Z*H&^->J<7S2.)X$>R,WND=[,'S,_#AB7=&?EBL%M<#?;`X?XP2=;[_V%]4PHIPE6 M?8)4$J#@?*X":/6\.KB4DK43A>3'I:2L,^YRSQ*P*^M2J8FERL92I:,/\0_Q M#_$/\<]!Z',4@=%E+N92L@3ZDBED5)&D"L!YE*SY0=P+EVEO6$W\1OSV#+]I MRY`G?B-^VX#?-LX_/`I%4B^9Y9ML8?F!//Q['\-+`SQ,4:]01W9DZ)"A7#8\ M)/XA_CD\_^Q4ZZUTQ"/F(N8JD8N/^UE`I M"KR4)CYS8/0;5--N;RQQQ-LC(_9KSID>ZDTUFN( M>M#25YVVT>UT=$E:702*7/-'+!(%[$`D%R07E9<+VBI()$@D:*N@`^B]'$#[ MP0QC!`6SQ2WZR#E' M(D8B1AL821=)5R6EBS8P.ETJS&";3D5@.=QE,SX3`3E(X+YVV^CJ*WM?%XDB MG^$1BP3Y#$DN2"YHJR"1()&@K8*.EPYCK<@Z$R=($&'3X=*&1&N:1K-??'/V MNL@H^>;(-T>^.1(Q$K&RB!AM8"1=)%VT@95'Q.AP:2,R7V<6&O:8^OWT^I3= MH.^^KH)6I[0I9_^3M3$/\0_Q#_$/\0_U310U=P[? MP?O@X3!0+W1`WY*J5Q&>\?J$_S3;1JNEK3Y>[2-_*FR3EP?]CT>Z*+B.1(Q$ MC$2,1(Q$K+HB1CKB:T,MOH_XK2M67;^W@>6(AN[GD^14P6PVOGO*:&;W&9,L M]YP%!FX\,>SP<_Y%GA],N;O`XR9>DSU8DHA9PG63:WYZTW@C/\/Z6^GG%:2Z M<:8B9!_%`_OB3_D2-#PX=C2!/V&>28M<8"F7ST+Q/OWCAZ=L-!]4L$KDS>Y* M.=S`B)>#^>E-N_7=BUR^*$K)C>9K[]O["_=]7V4&2A,\Z`0/=(99'WVG'#[; M'&);L-V(H+`37/F@,^YRSQ*,1[K4'V*ILK%4Z>A#_$/\0_Q#_%.=8\BJG3;V M7T?7?JHGR*O?.Q$,P%JC.;R]\E@T\>.0>W;XK@CN3*S:U'B??6.A[SHV^Y^& M_%\]%;*1L,3T5@1SQFZ9!EOG&6DV3&V%0P@XB36?9>..+]D:#FN*&FWV@0SA#.$,X0SA2*,^;`Z)!*0U!#4$-00UF" MI<,;.L#;B,R_QIYC.3/NLEO?LZF)A;0@!D:WJ\V(J(M`D6O^B$6":I.37)!< MT%9!(D$B05M%7=I85,U8.?>#&487"F:+VXAZJ&](MD[+:/0'Y#D@3V5YMK7Z M2!]1>+F^_1 M`JV"U5D:8E767">.(XXCCBLSX4I#+.*X8^`X"O[>,/C;B^!]\'`8J!W'$^>W]M380=N^+3^)([P7^X&PO5O&_HV3GO[:^" MAW$@[$_>%XR5#H`WSGCHA#?XUAL@T9GK6U]__M<___'CBB?'$=S[J^,YTWCZ M!6P$[G[FCU-L*W/I!Y]FTE;P[C[`.\23)Z(U@2OP18Q_>G,Y:C;,]F_M/V]& M;YACPQ?-:][+WY^]+;/1FRQPW&VEP._/';(F+=G_PZI[6N"H%O,Q@4\4R;"P9B`62 M==@LX1TF#QN8G_(/'9V+D7[!'D+&0<'L7Q,A>P M.WS_K+#ML.XO-#K-/7D!C1M/;'7\G'^UYP=3[BX`MHG79`^60,`LX;K)-3^] M:;R1GP'EK/3S]K(PY<&=XZE!\CCRTR_4WBF_>7#L:/)^,#CM-SJ-;K_9[`*A M^IWOTL9BL,@NGX7B??K'#T_1=3Z+8-6^UEFY"6W@KI$C^^E-O_O=B]B_N(\D M-YK[OF\_+ZQ(_-GZ/;C_.N#LIV>9\NKW#L"*8RV?;LHGO[WR`$;\..2>';XC M;77_#FGR.Y>6J8K4CO^$W9H)#T?'4L6#MDT79D4R(B5A>"ZI-LW.Q1B6C2@G;#ICYI0:0%O1QYT-#FUCAJ0"G1 M!KYWI"E^KR((.D8MB$JND#:DA:@W\)/@XVBKJOTEHUB%`4E%QZ1Q1+-O+/1= MQV;_TY#_(US:@$9'#4\E4@N*I.V-'W&75*D#GS$N2F(+)-'V8PPYW`6NUJY& M\C89YEA:H==W0OD2;7^$\]7TK`3?:=QL-.0/O#[*?TW> MP)5G^5-Q)L9^(-3?-_S;"/X)8:F'G@V/%4#7K3,&1MU!K]WK]]N=9GO4-(?M M1C/)&!B;.U8_Q\IT_Q\R6YKS(#+?<$*^(.JI:)0/39HMI.`[^H,(OZK M&O]MKOAM24'Y<2FG*TTM$3:Q)+%D%>A7$3V%,C5)<@\NN7O>3'*YB6MJ(1#G M$><5R7E+Y3A:Q(+$@H=EP8W[K-&)]WJ&30\[M%DIY2%;Z>1<.PY6^VRQ%%FW M%3FR;O6,;EO;GEMMOL'[J.LD05@)6)$@;(LL%]-H-[59KM7F&X(P@K"2L")! MV.80)FL$:RM94&V^V17"*G_ MUINK5-[KMC8_Y*563 M?,J$DI7@54))G0=K3:/1,`]/T4IP'J$DH615>)504N_97;>C+X**4')#U\7N M93]>5:1C;<&/>^%%?O!X'@?8[''[RA[FR.QWNY>#BU:CVQOTVI?G3579HSVZ M&)XW#UW9@XI:Z"]JT=^QID6O5<_*!E2ZH1S''(6D1"X6\5&_X;T%)4A2#LRK ML9]@M_8%,.B^AP-SRD3%?;;J%@UHU)U3?Z[>)[)U6" M:\@G6%*?H%8`*PNWE0*C2@-#IM'J4J.M0E6H>FE*?_C!5^9X;!;XE@BWT94V M#KZK7'!=TV@/M%6T+LM"%[TKT^9;:XGH-TDBR`#?/!?+\9QP(FQVY_MV(;O* M2UZC^C0-ZPV,;D-;[\M7TZTLK$7F905VN..1SF[7,+L%A8L=H7222:8Y&:.0 M.+`JN"'W%^Y5&R?VH&$,VMJZ)[\.A[W+(>[5]X8(R@CQ]^^F5SOK-GO M-_HC<]#O7@XZYF6CD323&PVZP_/104).-WA.-0),BV^)UMLQ?+3=HZC,DMS7 MJ,I`:8('G6!%G`+54JR)/KGA=LI=0&8I(G77YCS+D>:QQV/;B82]<9CY@:32 MW-%5MS""5NN)(G72:BZH8_ON@F0P\S=._5C+Z+^2/6-3=_< MCCPT3/S*`VNR&+.^SKZD=`IBV3*P[/_&GLAQ;(,XECBVW!Q[#?O_T^0@8EMB MVY*S[>J4-AU<6[9(N_V:(+O+P35WA;8T.(J/*D/Z36%'3_OFS5+D[Q1WNKEO M2@(;1G^EZ2N'[";GGH6.0D/+23L%\0B.FD1^.TJ2WDMRXH M1!)1E$140R":)!`D$"00!T':N4!>!H"/38BTZVW'C2-CD MR2H1<&U(Q(I8@=J4WMH[J4BXRB-<)%LD6R1;QRQ;VFQ3DBV2+9*M8LSD8L2RS[6I;=JE,)<2QQ[,$Y=OM.)<2VQ+8'9]NM.Y5LS+44?K2; M'%"GDJHZ7*A32<6+Q^Z;G&:C8S3,XE,2CZ+`+$'A44,AP=Q!(A/,1L]H-(H/ M3J@$WQ"$$825A!4)PK:",),ZE1"$$825BA4)PK9HMM0QFFUMQ6.KS3>[0MA1 MA$KL3F;J5'($N=K[9JJ^246P26Q(;+85FR9L_]3@A\2&Q&;+W:;?HPI3)#8D M-EN)3=]H]ZC!CPZSD>)>%LKN4*>2TB'8<=6(-@=&?T!5VDD"20(/)($]H]WL MD@"2`)(`'JQ54,O4UO66))`DD"1P:PD<](L_S*V+!-)Y+34JJ3*X+=+JV$K4 MU@6%2"**DHA*"$2#3E])($@@:(<@@2"!((&@$],26'34J*1\P%6O1B5T4DK" M53WAJH1LZ3,H2;9(MDBVBE'%2;9(MDBV2+;VTZ@D_?O'[^/PY([SV?MK:R+L MV!6?QK_%/(A$X#Y>.A[W+(>[5]X8&XM$CN_=X--O@!1GKF]]_?E?__S'C\M/ M^"(L_\Z#*=I7:+`Z8T?8PS`443BT_HZ=`#YY]@>'WSJN$SDBA-_BJ;`7GPW+ MX2'-OXCQ3V\N1\V&V?ZM_>?-Z`US;/B"6]%)^Z+7'IV?GU\VSEJ-YD6_/V@/ M+T:C=K-Q>=D<]/MO?GZRAOGU>*&CR2H6V*BG2XY/_HI#F/SC@O'>[B_:[LU7 M\DYVWS!D_I@M<COD2/5VU97>\3%V74$\O$&>Q`L MP!?;PF;11+"Q[P(2`Y'9+!"N,P6>#![9+`ZL"0\%?.E8@G&XQI)#A>L#>9^3 M<)YL>!-Q[\[!/[AG,\>;?Y1,*;]UY^R(]+RY^73S_EGQVX$OEHIRKN6X!=@N M;?>?*0_N'$\-DL>1GWZA=E_YC6H09#8:^EH"=7;L"-3O[KEMRF#/[VO5L=O* M^FUXWST;MNG,L'%UX0((6@4%MV1,5B[ZE.UT0Y_([D[-<]\+8:M/])0B)'*? MA"P]*U:(Z\I%N(KNKHLC:&L^=CSGX83-N&,S'H'QZX?PJD-N&F4!-6WURHJ; MLWZ'3ZMKF$V*?2/=Z*AUHX(!%[Z#IPNXT\HK3H6XHE_HDU(?5[5I&JV&OCRW MU]+M6""OQ-*KFXQA/%M#"YC2#TMNQ_EC>K-(.2Q,Y:6`!QV5WJIS(2ZY$[![ M[L8"'<.OQB,4AK+:F!T M!L4WH"O+VA^1GZX&0%YWO+Z.9S/7$0'S1/3@!U^7(UJ/,=F[9?3UG2P<"_`0 MOI"BN,69:!S"L`%X`N%*IWXX<69A$>A3HQ-/HZOQP),4I=*(7@V`K.YX-;0L M8)4HQ#09X=S+;"]2E1"3.DUMQMNQ0`\A#*E*F]/WXN_8F4V%MTV7SB/4CCHF M5=P@W:B,R%5W@+H)N"V8QZ>B$`.N6/&B\5K8BO2*_8F9J_^+[]X+@NJ1#/ M.I?;1K])*@2I$&5$JGH!DC)TDBJWPGY2_K88AP15(2B2A%2%@*H05%!_+S[$ MOV,G=&26!0LX/"-DX\"?LO^*P,>+EI98#QG_;79.&T@#=U71)CWO8&]#(0J8 M@/QFJ1*Y`L]^L]GXX:,?"=8Y9;).U7]DG:I?!0_C0+)"F%UI+N.LIIG?"M@B MWIWN#.//B=XJ=-YWJXU/WEQHFBTI-"W9L4+V)4G+Y MX$03QEDX!5T>@`@FXU@ALT%L75]&UF+G30"D1P/O#F,.W\`C'R:.-<$79<4H MPO@VC.!7!Q[TB)8!"J83A6G5"FR#LL0G>R)`$!70")83@4: M"AHLX$:ZJ,^+@ M"EIQ\M*$/W`J'`;Z+6(`OBGH@J#?X1Z7LA.;^0IAYXC,1XUU3'GP%QDG&&0EKXOFN?_>(0\$)>[8BO/"D3H5O%8CB\!7, M7[YC"FLXE?SH>/<\=.Y5J`'2.09>%7XV$$8>Q&QKPWS5WB(]31?$<)6DO/ M%I67,[F4BQHJ)H))R/UYLY(W2)(9#R)U&]`6@3`C);7- MH;8YU#:G9(8\M79E%ZY:E$KDB^TLYVJ4U3S5R MD4RPT'N=PQ.T$HQ'"NSA]Q[*7MIU:ZY:]E*3LI=>E;T4B+L8KO.#QUP*DXH) M]Q^YBU'):Q.:6H=(:++WE-#4/FU10E-1,S^BA*;_C=U'9O:EP#1?E@BZ,G;0)YNZ@U?#@]U'7K#FQUJZD4N MXC*"=LVP>?^9B:0^E8&IRD6?NJE/Q::^4`_UUW1@H-P74BC*"&-U1ZO])>I5 M#I3ZE"-,BA(I2H5!SV<>45+PRY'=;=*-2#4%EU+\:H!9)=H!*(>WE%#6[O9(WR)]JX3852^(H@3>W'T=H]/55E:E M+"M,[J82@DB)()D2>"F!EQ)XG][7-1JM@BQIRM\E_57[UK,^?W=O*UKVU++G MJ9K\_>/W<7ARQ_GL_;4U$7;LBD_C+\+R[SQXF)V&@@E[*'>U8;*I#3W[PSPM M9ZBRN;WW]^5___,>/JYXMLS<_\R!ZO)DW9PH7;Y;YH/#ABQC_ M].9RA*WQ?FO_>3-ZPQP;OH![3L[,?NN\US1[P^9Y>S@:=2XNFA>C4;MIG@]& ME]WFFY^?K%&>;"\DQJR2A%(N\1^"3?C]/&=,-I1B8]\%D74P6TPFV"YFJ&%. M52@"3!%,6O_A/6$\F[F."/0F3VU`UVJD2A60!V4V=TR$ZNP[,8Z5Q.6H#CP.=Y2&NRN&7Q+^7I_@AK&+K#?8EDR9`T;:#)HN M,Y>QX@]Q+7%MY;BV6:B>4:`_;[\*B(;HV\11D7@>DEI>)UC,Y3'S01P20JKM MF2Y%PG@U#CR:IC%H%Y]07@FV>97[FPXTRID#7&U6)`3;IJ-DHZ6M_GZUV880 MC!"L)*Q("+8-@ID=0C`M"+9U;?/G(P`V.:5?>\3O11??9L(+Q=:G^NU^]WPX M'/4'K6Y_-&KW.I=F3YWJGPU'9^?MNI_J)XS;;)GC9D,]!=K;C.+SB//VRWE+(:(4;$&`6K&SD7)G*!N1=_-HLE?*0KG2R3B?6=&+]RC()O6[AQ*H$S^!]%'!#\%4" M5B3XVKS*8%.;U5IMGB'X(O@J"2L2?&T.7R8%"Y8Q6'!-O-^:^,#K"0_$&5:K M.<<6,%XH"YY?1W#'IYD,,QQ:D7/O1(];AP^:0RS]<]D?7(PN&]WVF7DY&JGP MP?[9V46G57CXX+X+`$FJ,5^2C?&$;,R.91=[K.OS"!P2JC-0/5WAM\A7?\WC M#3VC7.D-20G9&$\G?(@C?-,@S39AOOQD9=Q*G/H9;OS MVGBX9E4B_LH=*:CAOE95!DJQEV6VD[+AZNKK4I7R3TH+9%)/#-E;BO6@X\Z] M\M\?\@M4K8`D_`Z38D1@.:%@L\"QM)W0$1>6CO,V-^D/P(6!F'+'0\,.#>$` MK+V8N\QUQH*]E68>X2/AXSXXQJEJ*^FOTZ25\/=W#7:'3HOH_.R,BM)=%Y&YV7K^WN= MZHM2KS;3$'Z5%+^(<$2X`QIO>R1BZ0E7AQKZS;9F\^J7@(,YK2U_^#7D*HTZ M81K-IK:*J<>B&1`%*JM*31YP\XA2[O2DM,'9;F\5R M+)H!P7&-7=9F^[1'V0PD$>23)?J44L$E/?;PYE2Y%5R*W=XLUJ-IF+WB?=$4 MYD&^#?)4/[FO==K6%V=%GFJ2+2(<$:X-?K_X1N?' MHBN0$X5?.+D$Z?H[8U5!J,]H/H*Y&(A MIW5Z7[-UVB:)((D@IRS1IY0*+NFQAS>GRJW@4O3VII6WFUV*WJ;H[=)`__&X MJGNGO>)KWI=%B,A375*UDPA'A"-/=2D(1Y[J%?=1]/96^GRSJ^_TFZ*WR6US MW(YPLW/:HNAMD@AR]!)]2JD_DYI\>&NM9M';!>F/,"]F^_&M*S(%4NN:)&_# M*Y95U=+HYVVCWRD!@8L@5N7T%'+@D#L^K^NW3SO:VLV3/YZ$JW2$VT%1L4`5 M$8'FXZ_]=7PF9M-G/I0>VOZ]-[:J@D>XW3%Z+3IG+M2X/#X;,@FOXFAM'-2& MW-%47/'$TDANTV@-]"FD+]J*11"E=.)-OD=]IE_E++S!:8-JTI-`'%R#+K-5 MUCG5MG<3Z]082UL=HS&@HW$=UD,Y/3X',BMFPHJ$S2*?W8LPJN?Y5+F-CG91 M$62O/*`Z8FN$_)KDUR2_YIKCNL%ICZJH$=+0<=U^#,/^:?&M1HC9:%L[]FVM M871;U-3G%0;W]Q&>1JV\?L7?/WX?AR=WG,_>7UL38<>N^#2^GO!`G/%0V.?^ M=":\D$>.[UU'OO7UTPS_#(=6Y-P[T>,-ONH&Z'+FPH\__^N?__CQN<=]YH]3 M0.3A`P_L_./^P]U8OF,8AO%4?;?X:%@:#^G_18Q_>G,Y0O/WM_:?-Z,WS+'A M"VY%)ZU1XZS3N!P,VOWSBP%<,!R,+D:C=M/LGS4OS>&;GY^L9WYM;IRI"-E' M\<"^^%.^'O]RM[N.)TXF0FU1S<9W3\7)[*9N`L4S?\5AY(P?%SP'[?ZBXZ#Y M2C[*[KN9"#;F3L#N@:2"^6,6P3>^(BE[X"$3,(HI1]^"[\D?;?B07GB'Y=!8 M',J06';F@MB^+5SVX$03>>?_S]Z5]C:.(]'/N\#^ M!Z*Q`V0`)2M+UM5S`#Y[`\QTNCOI:J= MF86)F%V]3[UQCAI43JK4;J_Q3(Q&J58(J3J^28Q:FU_+K]2!F MJX19G%[EA&KMIH90/0)4L7K)@6F&-!Z1JPEUX^20@N"EIO6^PH`'[H^(R`BO M\"Z<+!/"16F,B34$JE)#0#[5$;8AA61S(1J#9'."()%C!W`*4)12C6B,T]BT MKI^BP$W]P$\G4BZ=I5D=Z\:-I*MC668_]%6=@Z]*&L#5:PBXRP.<=,86(@^1 M=Q'(PZGN=("K(^`N#W`XU2'R$'DXU5T6X"P$',81G,33"6WRX1T],O%I<,A) M]6?L;\_M!%NK:>*('BTIU!C4&-28(AI34LG`M]?XVU4^D#VD.6D%;I(<4@_0 MM,R:JNIFL]F&O_2VH78:>3U`L]5V+/4BZ@'>93'Q0>`P-[LP+4=+1UY[T6@4 MA21A(Y>0QPGA$B;/-*;$3:8%_027\-O7J%MZ[@H8+[>DGU.PHI^IO;6BV+%+ MG[WY/FRHN+5+Z8NXHO5*^-7O_10>[N7?;%0PN>*34CD!S674AEDUMYR"1H7P M@C#Y]-`@+3YOH%TJWBZMAM*MZLJF"JZTPEFQ9T3JY.:+E[2TN:_5\EIGCMKV MA?8@QLX78_NL%M=M9WW5=BZ?[!\BF%E+]9)>R%[%]C)J0H]O$R7(`E[G?!/C M!>8O+DA+56S-5FJV5;K@9-$==A\>=G3.&_5R0T[3%=NR%,/`\\6DTQR$W*FV MZDN%G%-7+-50K+JP7..SAUQ%ZLD?P\B<'0U\LD1UN>]P?3X\Q$^.$7+R2N!5Y8).1FX,\LX;Z69I-/LB MGTGX-WE<2DU5!1XNJ1<]7-+&0`U)[JM,0^7N8$5<$.=O*YZ9?.;-U2NQ:RV= M_&23&>I?-0NL;8^1X$>?TD../D65O#25E$M^%;%33ALU?!O"6C;*$EC"'A0[ M+)D0Y=*\ZB'WR)/)^A8>%O-$S3NNYFU$*%:XW#FJX'FH8&7/%)8I.N3K3K>[ MFZZY[:=^?'80A+`UC3Q"EHX5A+/F3F%7XGB7?QY-YRI_D)"N.%;Y9VI60FO8 M?1BRBP0F@2HB@1U`8(9:?I6R2F@-$A@2F"2JB`2V?Y"L8CD.$I@(`JO\MD1Q M$3:@8;PD%HEIX/(C&2/B97%,X5EL.%$Z8LL<"G;9$)Q'<8F& MJD2RK2XSE5=#X>B4=83R2;+@#=V#"*UC0@N1AT>UL9*8S7NA?::JP':O-03^T]R?$%J9U(%SV@$L-X8)P0;CL#1=A`:F7 M@19T,N\6XF^L,@U+1TA2-\U2_F?@C_S41;>R;$QU/BMT,)#WSCBZS)-SA9D" MB#Q$WHKQH)>?SH+(0^0A\LJ/$D3WM!R+WS)%>$_3-*#LI%_T/9^"?THH$W!: M`\`15T5Y7^%P4@"+,5NTL87&YY:_)]OR3SW5%T\3Y2]\LSTKH7=GV M'G(D$&49/%!YR6V'+/9K>EUV[3;5J-3 M;]3UZ7F);:>MU=NG/B]QLZ!UD=,1^<>-@M9_-'[[VGBXO?M(&JW6W=>/#_>D M\;%-/G]M_';;_?/VXX?Y]R]J3X%> M@$1J0VI[D^!T4UP^3U7U":D-J4T2541J$R>XJ_)+Y+XI1;&".HA5#54 M,BF(3E(N<\0=AB.S5HB.X*KFOFNIWK1#S/VSK()8+KIDT8"RES,X7U\,.DP' M#YY"="`Z=JPRQ1W+]J;5I`20*G/!B$BZ&"35%,-&.TS$8D8B+\N)5CG"7'_H M=[EHOXM03I)9+W`/#+V_R$*2LI`N[LP.F;4".0@Y"#E(4@ZZT@P\=`.WS)&P M9%(R)*R7EFYFW4*SZ7`_TWYE3PJ4AOA/EJ1^?U)NW8LV[=,XGM9A?9H54"'N MK!P&%K[`PA=5K"IP]F43L(-5[V#E`["P\$55\W*Q\,51=J)1][#P!6K33981$,Y,$*\:"<2B8%U4G*9H9>?JTR";1" M=#Q/-?=@L0A&==$EBP:4O:#!^?IBT%&"LP!1@B@Y,Y1<::JP]2;F@B"4+AA* MNB8L>4$"4)QN32.1LP5K8N.[X M_;TWI+TLH'?]/V;5)QIA[W,&/>Y/0&$:G@<"3).VGWA!E&0Q?0"!-(/(^^O7 M?_S];S^O/R?J=_W03^EO_A/MW8:I&PY\:%@C26B:=+,4'M`813!:_^/OZGP? MTS"A#ZSQ\P?#B(1,[%]H_Y=WW39S#GVN__G0?D?\'GSA>NEULUZS&K;3Z6BF MW6XT-4/OMCKM=EVKU3J=FM%]]^O:,"X/R2NE)+9IP:'E-;BJE%4Y9`MHF!R] ME/9(GXN8^'/)$Y>)GKA+0H>O6';4AI85;\;,J;>8%'9Z]XJ_C/@)ZTD_8L52 M$JR4(KI2BN/ZS'#L!3/R M60:"SKD&#T)#L[`8UY0?K(+EI"Q=A)V(%62$)G;`G9 MAC"+^:()1:(I_.A,4W[]0J2@2[2#[".+,]*Z)W`R:9H4H"(8/[5+`$Z&-$P_4+'[*YPL"6K M8(_@?]/N=HVV43?59E-MVO5.4]?SX/^6XW3;<@3_+SVW2*P__[@1.WC?^?![ MY^,#:7QLDP^=NP]?&I_^?=LBMQ^[=U]^;SS[4-K>RSJWXM&8X`&^R7J$SKX;$#_LL\A[G@?!$@B>7#_@D?9NV",T/X(57A'301:X<3`ACQ.2#BGQ MAC[MDVC>L![U_(0]9.3^16.%P#MG7UW#5^P2QD%C!=[(?^&ABL/HF:01/]_5 M8^V*:1)EL0<:R5[OASQ;(TG8I?`FWM+0HS>$?*-D$$2/<.,$WABZ`\I;]9C! MM7`#>?;3(=R^,>IOD3[(5%"7$FTIF0V?-G(Y.+.95AANL\:=I-$P6^8#!V($D M.DX'5;8KU2?:'&-JPES?6+*XAG`5HZ4Q?W]4J?&^?8$_UTN MJU.7]42M1:U]D]8*BQQ%K46M/9K6[KWO+MM^=%&C;*4%NK[FZKG6-<$Q,2NN M/U%4@7O7F->*>:W;[ZMKEJ(ZPK+-I!_]722/7(-<@UQ3<@2C8RKF$("]G& M6>"`M+33;B.6L*ZS%,U6A9'8*^(Y%[I"2"&D=AL&EF+7A>VZ(:004@@I5=%M M<0Z!"X$4;C()2(S,HZ[1%8/ID;+1`Z9'BEP&U17=$K>]A0F2R)+(DC+H*K*D M0);4ZTK=P#1R9$ED261)9,D=S@K;4!RG)`<@LN1N)\?N8AL'-$P[D'=DSRS_ M1D&V;I+`BTB4Q60\RZSWPS024ZT@?8Z$/(>P@@R#*/9I\I[<51!H^TFD$*(JI&6(RFVXIUA!.A*Z$W12FLHOL1QU[Z M;HT206^9>&_9Q64D:JJN&`+/#+Z0E$3$%&)JI[AJMJK4-6$GN2.F$%.(*5;@ MI:S$QO/%%.XY8>I\A?@-TYTPW0E3YZN@>>B[1I:LBJXB2PID24R=1Y9$ED26 M1);$U'E)6'*OU/EM?__\KRRY'KCN^/WT*/DO_)AY4+FVGWA!E&0Q?8".-X/( M^^O7?_S];S_/KQ^Z,6VRT\I;T6A,PX37LF[$L1OFQ\PW)XM+/KD3]E7CV8U[ M=V-V8?(!+DR3V_`3""7J?>-!R+37@.%W!Y3_V'93VG7]^`\WR.@#Z]6\)>R$ M>S8>7VC_EW?=-LOW^%S_\Z']CO@]^,+UTNN&8>J:W6EU[4ZWZ]@U0^_8G7:[ MKM7L9LW4]7>_KHWO\EB]DCN]33VD+!G`4N>?IZ(E;BY;,F#")3V0+AG3F"1L ME$@?!$V>F*23V6GS43Y0Q&6C!O>G$:&C<1!-*%SS3.$F-YDFYB?O7]34"T^R M=YP;6S54T]8T$_IL&YAR+VW"-G:PZAW$E'M)X@'/3#Y[I-S+L?6(6??GHW0H MGSU!*4>2IU0HQ9QY5,SS4$Q,BT?%E%(Q,?/]2%%(WPYT8@GS.^/VD@0)9+*X MZ:7($9-FB\>Y,3%3%8D&B0:)IERB,6]T<1O)L@\]$LTE$$TEHA*D8*%JA+L8 M-XZXHY[BMEM'5M*;:JM<-'MJB=KHM0VV?.K1E7:>*A+'D']GE+Y0".Y&M`0@!C`8]EU['$P3+-?IRUA-Z>3O$$_0O,;,U$D M6=Z*98DEA/F.6'MXF%,N(^CJ4G^AA3V:TG@$6M(C?DAXWIH=TSY4WG'YW)+&[.3-]G4G>7 M]6Q5$1.&_'FP&M-VMT=)EOJ!_S^F&>R.9@!SZO6]-XS8*3'YM=?CV&>A7604 M]6A`GH>^-V2WN_U^KJR/^3$[^?/9Q3G87!)FS$G,WNV"0HWR-RN@%EZ0,1DN M]/TI"ES6D'2B+($`>J20V$_^NN['`%B?N;79V,<,D.P5\TMAP'P0=6]V#,Z6 M![,FYR#.QE,8#WUH<\R4;?DZUEPRSAZ!0X%&1F`=3$!IH!_,UA@O5&O$*`;4 M#T9XABJX'.9(H!#60*[O'&1)#O#>:M=FH[0R+NOMWWDAZ\X2U%:',?$!LG[? MAQ]&%`#7(P.`6][IP!_Y>5M2UG)X-AN\)5$`W;G39NR4_7PX%U)E:O?(0,:! MOW0UCY/\>G-_0QYBSJ\3P**7@6[[C%+&XS@"I6&/97R=KO<^>4E.LW$G$Y\& MO5WM6HSU9$EMYE`)H\5SQNXDRM+D97K8UY)ZT7Y9M7]8WP!T8+8F'<[)'Z.4 M;@DMWB>@MZW9AF9V&U;'[+2Z1KO6G0;TFJVN9K;.SNK9L'$ZG[_>/OPIC.&U M$P0DWP$F7>`2/M&"7C(T<0IIL:50WV>G=C'=!;/6,DL!Y`+#QX4(ED*+G1!'&BN=(%>Y-\368&J=7=#B%\Q_J/WTHZ"^ M:I9QU+XV7^MKJVWK2V]K:Q5.+<#IW,(@^>J`G-!L4DH M#7++7L@H1.'F#O*;1O,IFL[_U`7K,M^EWNS#$";YZ;^W1T,:(`S;7[N!C3:`!&'[`U@`$&*#\,O8H%93;#B@Z>`+L,5 MG>\>'>?KZ/P[PCV"8,.G\WMGS5$VQF'>O/GCARXL^K@M!W/;]%G\.C``G_R` M#B@8=I7&X&U(&MD`WK3PJ[/P%X4\4[Z8""AC*69QWWZZ`PE_H\P]*8AB-46U M=47?4A>Y",-.5PCKRL>6X/!;'^YG;@6^[(-+A;SZGS7M1M0\,8]ZR:6]Y"^` M]1ST"&PFC])>(J[QFG&C$K@LV.96>U,?&$38&(0T7;27+3U]MMIR^[!.(AEH M=/S,5E4P''WNK6%WS09HZAF9)J0)ZFA-<$=AB*J-?EC^]_S(8,O9B/,= M6\:Q49AB";#/&8%R%TK&+9=TY?1>6.8]`>N#8%_.&#PH(6]G"N&.Q1_9M?K; M%IJ7I_!9>^UMKF[RE)6RE$;C0S9[-C1J;817]C6YZA32E;G=:6YN^1SPO)5Q M*;2KQL[!+"2O+6@3":[IBA0T,^6>N1E`N,,N"-:FJWO*#M4F'<`A!0ID3OU\ M)2#,(C04P[$47?!Z9F6VG=E2/[U,B_OL"B)1(%%<$%$DV6-"_YLQ#_"$LP"YRO=>@-`",!N2G/6RV3)RVUJ8K2/9_DPZC!)*GH<1 M>:0A[?N>SS?8HF>V=Q#0A.VO@3DO:*G\@QA9S'9+!X.8#IB_"]:&V"/D/,K'AV7_'B` MJ7'2TVM6D[4H-JR,IBN>(LU($G(N[M621 MR&)NP@19H.90GK#[`O,7%Z2E*K9F*S7;*EUPLN@.NP]+#4A8:N!"(*?IBFU9 MBF&(.R@6(8>0.[W@Y(6<4U8(,R%E48"RIRV/8#=MJMNK=9L-J=9J6 M=9("%DO/$5^PXOYK\[[S^6OGXP/I_`'_?W%XI0]U"4F7/L:9&T^(9G`[V,BS MW7A5&%X=)F+)H^X@IKS,'`MM7/;),YT__;^_:>AO7C?!S"_0_$.E!D0*.(U^D6'NV M"\BWHD!/[*DDM*<=Q?WQE2BIV[G;43V9F7Q5KA;6:^^3BD MR%%09^P+7K@T1YINI:FYD7&/D4<()9327F8'E>]W[H2O2U/=OJYI3!K:)&+2 MGL)+PQ!/O7>+>WXR#]`XEHD=))[' M+1_8<-L\L8?W&HZSQ>]^>C]X7J_M'N:IM(,_=D<"[KN`>[^A_!IG*_^&9^S3 M7/,D>MD)R_W_O-4/+;,?5FM7P-24%"&@3>Y)6U-;VYHB[#V%O2`J%@:$.$+< MJR#N*Y04)^EH1)`CR+T.Y`8F-]F&4RN=;WT[X]:[&+?WPC72Y8PQNLC-/+%AY%JPFR"I!=!7E,M^[G[63+O+019[- M=],V"??7SG;PP^>Q#\:[JH*`72]G:+Y^-][A^70O@;R#O..15>;9UF_);K2: MK(!+[7+!2)[T;CRI47,[%(=M8S%3H5V6-UKE;&WKC_9=WO6^RU8YJ$N#=''"6^(,A1XHN#/<1"B2\.:9MT'Z]0-FJ- MMK]SY54=4?1>^MV\YJDZ%(GX,LE^H[E[)ZXZKHCBB.(J`D6BN.TI[MAK M[/Z;JR\ZM+.'**03/0?%@]4$626HKJ)LYK;H:[8[W7)[-SMKE`1CI]Y5%03L M>D%#\_6[\8X=;!:0EY"7')B7'#>=K:TWZ2X(N=([=J569 M?"(H<#Y+R:"3?FW%$HO\`97FBO&2ZVH MI5:D!HA-9ZD6YJ(7G]H240XJ4NF435(]0U7K.F-?!0NY4HM'&^,9-*8S%@NM M0=_+["M&W5&I[K(J-'D.A:"%<1YSQ2ZYEKK&YH()F\%%/-X3&%.`4J=8Z/F> M:HQKE@@1B:B&W:"P";OB2J:Y9B-PHU1IIO-P@@6QTQ!,EDZ%TC=+T+.?X:%2 M8#L6*A%)E#4IK@#70.1DG$U0A3`HP68SL4B$XC$34"N=+K`? MSN:3-!:@AB5,X:D2;`YFRT0"S8%)QEPFT!HVLA1S/A&844`L3/E(B"G(E">8 M?T6$F826ZD^3WST"6XN/;C'8%RW.1X/""GH-JNJU.QVOV^QTN]U&O]4ZJ`B4B:I9J/#`2FBDQX\IF8T+O@$<`%',`&,2-V$@F`&@)GJ$S M>#`5Z.DRP4+@RE.DK[D$S_I2_UQG?PV"7X$&_IM+!9H"%/"QJ<&R%'Y]%S>< MH(W?<:WSZH13*#LW)+!Y+)B M,J@R>-1\R')6+!QJO$!U2#%'%14Z$\:VI:JDOJFFQ`@Y$8K*9'W\84';X2K- M9@(@F6":,:.'!.A1:PC[ZH?DMI^A7SD"/2.ZT=06#H7?KIIGT++Q6AS6N&@? MFP+)\"\9OQ9%0(2PT/GE-T,K*5-2?[>]PEP,:RF8N@T;8#P%?PXGH!!Q@Z^) MX'$V";$-D5Q)E2:HD5H1$.%(&>XX:`1+S8J;R>5H8C&6.K;46C@L+!@XR`8* MN^5[T/6JXY6FBLH"S\#W?K!P>^HW40$`^_N'49IF29J)O\,/=FT>J121.,FR MV8?3T_E\7K^^5'$]5>/3IN.T3O'/IUCPJ"B?+690'M!N7F\?8=M%X["$*LI, M%`89?[1!A7_6"_HM;]CL]9H]I^DZ@V+],QP&GMLOVXTYD%@9B#Q3YS_Q97Q[ M/-`W&N2(G3X[H'Z[X_M>QVNU/6?0Z/?.W([GMYQ!SW>\1N`,'QK0MR6XVK\!E3%"5.,1X^*9LJJR-P7J*]%"H539WX`\,/.H(S_7+\3W)<2AO06$FYDCEL2]CH=%\JXSK#5"II#OQGT2@E;_;/! M!A+>0EC']>YJP8X*>`%BAA"?3F,8`Z:3%,G)E\]'GR[L#%K2.$ZF$NQ@ M:4B)V$P!0#AFO1).,&PP/(]1DV5$ICDN=&!6`B)*$Z32P+#PO:,LEI#Y>`R, M".W6,-J`0`SG@IO@Z$XX=GL\AA;GH@@^8,HI1A@M1PB3FK:K.*8L.QN._)]0 M*1;ZJ>'6'1QKC.T=:R'8GV#*@[GR'V@DM\Z&7"J&NSZ"_0*3)82()H@PI1H_ M8^B4SO]<_WAZR[H;&'P#IZFJP5`@/170RTZZW= M8.#.(YPWX?''4S2<_(#_PL__`U!+`P04````"`":@5I&LG!.YRX;``!KA0$` M%0`<`&=M960M,C`Q-#$R,S%?8V%L+GAM;%54"0`#4XSO5%.,[U1U>`L``00E M#@``!#D!``#L75MSW+:2?M^J_0]:G]>=B)?A+17O*=FR]/B_CH@69Y ME";OWZD_*>^.:.*G093KST6GJ MEPN:%$O#N"3B[FF2TQR:9UK\?)?1 M\/V[6R@.G5;GJE9W^6\[BA?/]_3]NSQ:W,?0V6-1VIS2@D1Q5Z5>22'I=D.\ MN#->FT+B-/N]C'+&=0Y]WA1%T.(DSVF15[_(:'"2!)\CXL&'6T0=;-JG-H2^ M?$R3`D8<&*C@ISP*:%:-*I?DF0U>5VD\?Z5HW02UXV[Q#`T(@^ M%26)>_!EAZ0H'3\0__MMEI8)H^)UN5B0[/DBO(YNDRB$DDD!WSS\*[/L91I' M?K0?UP%5CM@K3LL,KWG$/B):$,N2']/%(BK8")*#+JLQAJ<7'*(2M.3D%7\- MXG1.P31-;PD&0!U1PM6OK^^VZO!T/ZZ@/]7 MQKT(/Y+\[BQ.'SOIW5H!NL;IXCZC=^#S10_T'!9""]I;]]U58??B$TRIQ7-? MQ3>EL74=!C(.KJ?4*_9IM%Y&9+N<@^B6HN*TR&#U7@!KSZ($AI"(Q.>P7,VJ M13^'8CS28N8OG\X2%>:H%T%Y].61% MZGNM0IME]\7]NVLH+UZ+9T;A42I=D9B;)_D;BD7RC) MRXQR30*M0JB:<4+'(XNJ)Q_E.$1%:5E[4C?D:;]66XHB:,'\YS2IW;Q3&M(L MH\':/W,:NG>%R#VJ?_TYS?,/%.9`*JQG_!4C]_`R2Q\BMJUTEF;">L=7*4+/ MUG[D^W1Y9!'T_$JRK/((N^.\2Q1!RROJI^"NQE'E^EV$'^AME"3@Q%2>(?-F M3A8LZ@86_Y9D4/@VB?X`GX`\?:`)#2/N<1ZS30FXL*5N6:39\[?K,\JV&6(H M=@7+WYOT4QA2GUF+_74X&CU;$H+&W$7P<]:;1_IYL+X^E#S?`K6)8VK%= M2K^@P5E9@),`-,Z*Z(_&L,OM-T$]$M`4%@J\XW*;E#C='F#"2C..V/V6H@A: M<)M[EP2"3KP&VR$@2J//X%OO5V.SE-BVOT1)M"@7]3=U!;TE<;.7G'^#U7!V M<5_M,">W=7%.6XJH6VP_6?/-B8HK&K-8[DTZI&_=ZQ/;'SX";RLK2H\O)/L. M/82JKZE?9M71BGWZM,E@ZL5I6@Y13"WY;+I?4I2.L.(!1A?/+-ASSS[;?:KM M%$#3B-.P^^30].,SZ1XQ4=K]LR19P0Y%KD+VIZ0@WQ)2!A$,8/NTY!27I"VG MY;O5(DEW/E9TJD24YLUD=@E-/]]D),F)SW5(<)\B7U#_R#H/2Y`R?]:I/4%[Y/H5,EPC0O4O_[!U@Q M!2SN#TL[OD^A50I7M_6?7Z]&*XEF8QMPO+FC47:>%%F4Y)%?[>QQ\TE"V[@X MK38S5UO])WE>+NZ[N`[#:\;MXZ_@(13@(=*52OF+3NQ&`#/,)V@[?:8#33^H M*5P4UIAWPG8.^,^$]*T/MS^W^"(9NPH MCJ0-+W"M4DBZ<9*P34B49FRT(?776%V.8-,++)3C*'QFVZC-+_>IVJT6N;IS M$J%797)[PD>;/G5M[0=HZ)=Q5=5G*-049?H.N-1:MP3C$DT"%N/":&NKD59- M5@U"DW'J;R#9-%/='@Y)[E5W?XA_ZWY MM=NHLG8]\F.996O#74P\&K]_!ZV[>V5%'9 M^W?JNZ-'&MW>%=6/=0TD\]\P;?,2>5/B.&>WREB-LZB@BZ4\NRF/8M$4'S?H M60M7WHXN[#=;NO>9WI*8'6(N[FAV38LBILM;8:]'@#5"]*_,57W34;50FRF6 MY\]LS;%G*@V-F>_I6J#,51K,23^&:`?($*E`ME-&S/!R36!VJM3THYP=<[HD MSVS&VC^X[)%TB36G@6T.&E*W$T<_0.+@H2:#)16O^\RX[8*N;8;4TDPJGB/S M`^:(<-#6*/++\2L/$,$MW.;R"G=$=Z3VP&NGE%0= MO5J=Q#T/@#%1&)'5V;UE!WY-T^`QBN/-CE0Q0!I\I6T?-5*+KJI[)M4]>WI. M^%+U%E"615S#-U3'4>D,G[]%J,HNB.Y2`X:7*\^RF2 M=7P;X<_W@M(ZX::T@1\A[O9RK!)IJ$N=@?=,^9DG%`B+#GV0I MG-A'"G^PD]4/)*X^V^(CR3*VMU2=7&@Q.I>\J]JZIFCSPXW]][=D*@QZX5#6=*S)):I/%-M""-Y)VAD0QA]\Y&0PZ>0!O`#F-I^E&0M3O]S2 MX9AF]LD"OJ%)-!^!+9*V`X2Q!0,K*?QH3C3`8I8"LZ$#L#KEVG3?*>8JQER9 MJR;"'"1I`T`<*\3")(,0RUO&S^TQJ_5BKND86JC1N7B#&P=F\(&PR##P94;O M2;3&[92V\W4%H$W.=N>+I<^W`5YF#0E:"\1EW+?DU3?P!R\D7<5>A^MP) M581@ILP5Y;!@)@Y.,1=TU+4T%81%ALR5Y># M&(*$DPR&3./0CM74K,%5GT(;<^.O%0786!8P, MHZ\?:$F"ZN[D71H'JPSE+?;?)^J:5*6!&DQP;[93/[?TC`2^K@4APK0E9V-. MK.E>'Z`7@9=D[O/1'&`Q'.HK"$M?.4L=5+L/`TJRP?>'0+:'1N:&&/>5J>T"KF*8.EO$_P"&[V6P'3MA@U$:@0-KF<]X;R3O M%8>>&Y9J&PB+&^GS`@(_1&$FB2T3N[0^9@!,/"^$`261#.NO=O"2X:T,$!YP M4S%N&000A0O:[N+V^!U+<$HOK8-,=GSR_L!H;JF,2B,UU7M9GF&,J, M*(Y=W2CWJ4YUZ5]G%,-%5<9DQ$Z?@:+5:Y+P;7]X_I:S]57SQ@-+>%AEF6W? M[N"OQ+5\HGD&!K?D^+;2N(6*::_U3W/[_R)L=\UW+7\XQ5U#T3PU<.C,LRU[ M%MB..J.&,:_]>=/40OC7P://#)$B6)9+I8#9CQI9ZE,:Y&<`!GNLG+DSYPFH M0.++THLC_P)&R@SZ#MBP1T7!'(_L1%MR>T:K;<7EO^_+=BB\(9=X5@BK!&5& M8+$XLSQ+G?GJG-0(*:'A60&=\H`DA6T30%W22>=VV5= M1Z,DL#V$J4_.LAV9:9A`RB`/.($P#K\\DLSTO[Z#U=S;1QHZ.5>#ZG7G.@V( MXAWL54Q)I),-\HBN/;NAF!<#7?LME0#^-E6M86E5QAS?QG;MQ6`J99YLGLV] M29LT9[7JBSU!B#8QUR:^I6H8]S[&=?L'6_7U]"@61-ENU1=2-'=9JJNQSZO4 M522.\XMP]]473M>K=_W,J]`U?7ZP21-E\6\DL&43E2DL@(_[JG$=MDM)AQUX MG^"J`)-V")B.,FONO`':90[=68EK>YKJS4W<>W(_XHPJ$M)1B+4,"M*\"LA4 MCFV3C[8+M5JJ89Z&[U@8MUF,'YM<8D$=<1UY<5]E!1ZVCMQ2"<#M&=0(#O;, MX]CK2#&82F)6?93SB+K_FZ<;`7*[#,]I8=@T"3T,D@2G"S2K(C^J'[?>E)NO[BK:W9@*M[!IAJ11!$A)#4;=:$FFD=88,HB4I6\[S=82-+3]+%M\'E; MV#6=P#9I<+`G,2529#!R,OBP?0>HA1/;!=ANMQV:*L(4).=*AR1>"$-/4JSP M(A MT=*!;P_YMLK!)V,:<]O`N&2B_.#,&0;C.)1I$J$O)^&M"=$[<8FG0D#'4U4- M8W-='?=4$3[)D/`==]YKDLOTFO0:61BD0U\),19IZ@\54,9`A1J;D6.^DYE6ZOI5KY4`WC?1#UAPJ1XV(J,^G%1L*)='&?T3MP,*,'6O=D M4S%9J2?>ZE$=T@)86WC>(N5"0ZI#AZUR_SI[(_!LEBA;'>!AFVH6V@(`4WD) MPB7;K`>[%$46>67!QI&;M$Y)T\*1@36[MJV&Q#$/]NH%%JODXSHF#[\E,*7% MT1\T^$<:5R^9D"AA7;U(7L[VGV11#O]T6K+KY/692HXA&JM)UYY[9F!A7*^5 M,QY*91@GNTP#(PQ/5-;RGMVHIF!Z&%<*A4#ILFRX'7 ML[`0[&5PZM<,=+O,TC!J\__62KF&;_N>&F+L9MGE]RGPP+C+L_#'-P65GKW_FU[`*;@T_ M;Y1T-2TPJ&/CWG?#//(BRM##@9'J"+2DOMQ9%@8[)?!"C'TS2<86/8*+@$B& MV:]H3J$==E'\%,:B.*T23#1*MU"@5OETR\*! MU8$`$J\N2;5P98^D:YF.900!PG`BYSR:6)*(1TO:ML/7-$DW)]K]`TF[H&L; M6D@5C*6CG`'D8,(/HLT@YP!9C="&KNW+U5TBKFE1XID'OL4JR(!OPJC",)/! MBMW[5LL=WOJ3:]_+[U"+:UCL[&]XL&_L(G('%\819[;N4QK#<>[,PX/-P8E( M$W&023JX7$_63=>;;.Y[]__>2+BFJOC$0D(2=MZOR M\$@Q]6MM+NZKE=I1M>.<6H^\H>>' M&(]NR:4#YLPR$+!1J%`=H>I"ADH`>N=[0>`<[%;+<)/MXT!?G$9AP2K/HLPWCX^#$%K%$[`#Z]2>K%34ME#E:>D.=+0:>3@JI"A8]!` M.=C3`C*XA(7D1'BVGM,;.M3L(N3;DWZSL[O#6-BY.4`VL(CE((QWBL-_=;)//`/]QX`ONLN!#7L'>P=D?V7G?PWAQ+' MC/#_=85[.CL//5`XA1_R(O+%8KNL%;#R0UWW<5]T_^N$L&0;R3O&U:E'^WVR M_I4"2HYI^ACI4/\ZZSZ:B4::RM"T:,BD7[FNESVC`K@#V8,@N2=9?T_'T@Z6(2'-N9XI`Z"12 MIG6P3Y0 M+&&<$0>=S+!A=Z=ECZ2K$=6QJ7:PYSXPO!;QF,GD2#.%]J=*>P7L<4PU)-K! M9H\2:MT=S!$.H4P";4RF_6G$4PT[EF7ZQ@]T"A&!3$A`2AV3ZNEVP)C46@&# M6=,]C-S2)'<7U&_2+\ M0&^C)&&O![&;B.QJWLFB>N?L(F1)\OWT-F%I\D%V>>QB9(79H%6RXW#?KE_6 M]%0*/OKF-'.E2*K?C"-M@6;6T8H_DI;&!N0J04B/%4V`B__`A^5]1Z9*5;10R-4"4^;F0/\W37A"@W"-:I MD.QKRARE$HJ!6[P_E5_?*@&A4*,*1;AZ+.=0ZH1X)PC?J3#PM.X+(/?/DL11 M&-'@,DN;W[T\=CJ0E)RM,.-IQ)LC;+$:?[H!$@_SJ7"WNM7[\CC64)*^KHY] MU883F@AL-/]LHZ8`;/$#5@5);MFH7I\S1XZ];#8F)]ZSV2:;O/R"!F=E469T M/8W"17CB_UY&54BSBY[(:4>C!/C^&8CV1JWV*_/M@JXQIXZOZX.\`ZEQ. MD;QVQKWUUZ2NVOZ_I9FW\^3RRSU:6OVP^T"@%>HJE9PL*>2Q1M_ M*#Y2K<_FO_R.!M6#OP#!1;A,G\9#A=W2T&_;M#S[8)?SXGDA%"Q\3V(UW4IP M(CY3DDMIX@O88%$NZDV8*^@AB2_)<[5)]@T:RUYR957%Q_0T7JE2J]SHO]3Y MM&Q]N(NO!M=6Y]Y<5R>8?X"S!\U%Q>%0-!6QM[05BYH(DYKD%Z%%6G[7F^%8 MD,J8!SD[<9[C/<4#'\?SF[*Y-BVQ!8IT6VZ$'< MV+:JC'V"BF;^?W57U)L@#(1_TMRFQB5[6;+-^+#H(GLVI58E(K!"E_#O=T=1 M4!%A2_@ M8#1R#9PJH=E+Z5"HM;*JZ0*(IHXE@H.L`#P+Y37_5".X9?&"H!#SP>06Q@,X M<\&5/#J-0`9(8=$J7`+[SB1*@B$^J?B>M M[K;%4[_G/O8?6FUL$X^V262J_D8<\9"Y_U=>Z';N#`W;C6(I\\*YVJDLKY1U M%N':%YE[C@47+XZQ)IYN!;'H#>]Y?V2BJP"16(*QT+-H8M.KH+,,0I`C/Q63 ML";TTX.0_2M+V%?`U!(MZ,"&<%&Y`T=JY")K#R7*P1%2;;L0C7DD4;CT^"52AUXK")77R) M[3QTWC#OB092^=%EDJ!HH$(1'4G(MV>J:Q8@R]>G58?LCFF4S4M@*VIL&F^DF_S5@&I/3+67C@'4%"LDV3HRHW%M\+JWH_I*LP)EH7A$;BT MT(GC/&NV"'.4[H218@/&_,L.4*`P_W5,FKWR?(<_N?"BP(=?4$L#!!0````( M`)J!6D8RTWKI[E8``/HV!``5`!P`9VUE9"TR,#$T,3(S,5]D968N>&UL550) M``-3C.]44XSO5'5X"P`!!"4.```$.0$``.Q=;7/;.)+^?E7W'WS9K^W_]@92HV(E>2(JDJ)E-51);0@/= M3S>!!KK1_.VO+]/)R;-)TBB>??P`?P$?3LQL%(^CVG;V[=NW7U[NDLDO_F MZ=2,HU$X^6443\_R5F=L-$KF9JQ>GLPL-:D=/N?BU\?$W'_\\&";6WP@@LX" MG;]L:)Z]/IF/'])H^C2QN)RUQ8TT61A-ZC+U`U5'O-V&=Y/:>+TG:H^S?\RC M-'\L*O#S4],.N&!I:K*T^"`Q8S8;7T3AG7W&LZB&3IOTUH$L(IYE=G*R>3CZ^I#$\UENBC?SZ31,7B_O;Z*'671O6\XR^\S;;W/-7L63:!3MQG6/ M+@\H547-[-_S`67L4(-=:5+$TVF4Y3-(:GE9S3%5I*A`V@.7%>VJ>@_M\3Q+ MK=+&N6/+PTGN>-T\&KLV[69U!V'G'%Z%B07JT61Y^^;\KN^F"^YO,OMOH=S+ M>Q&FCWH2?ZO%]]8..NN:D_;NK8M\U%OZ[R5J"W.=!@E_QM. MYN:3"=-Y8BHM`EN).N6L(G15:#OELYK)52!MB\N%)W4;ONSF:DW3#KC(_>=X MMG#SI+DW26+&;[ZNJ.C&'78LT>+CBSA-N;%KH&E-LNH==RSA51(_1WD$2L=) M:])5Z[0#R=[\6.W1K4+;`9^?PR0I/,+Z.&\B[8#+:S.*K;LZB0K7[_*>FX=H M-K-.3.$9YMX,F^:G;E;C7V:);?PPB_YI?8+PA9N9N8\JS_-=CMD#+OE6=Y[% MR>N7&VWR,,/$-KNVV]_;6-W?FU&NK?S7_=%H.%)[&%@O]B&R#\Q^3=,.N*BL[DT4'?!456$;"-KBZ,+ZUKO9>-^JW;$_1;-H.I\N MGJEK*VTX6<:2TR]V-YQU;8N/3V'RU4IHN[XQHWE2I%;LXF<;39=\551M!=(NN:RFT]V4 M;?%H=SS6HK/7_+#G*7]L=[&VD:`SCBHJ=A==9_Q54^D.LK:X^Y]YF&1Y_N3J MR%Z&6?AE%L['D9W`=G%9D;PG;BMJOEXO/?%>S2IJ==(6Y\O%[,H._7J;A+,T M'%5*$MQ%US5_%O9D_5[S54MRB\L3R61PZJYX0T[:]; M>2I.EQ5H.^:S7OY(K4Y:XWQ^EYI_S/.3N^<*IQD;FG?$357@ME)UQ%M%(]Q& MU!9G^6P3+I[&XG)$OKS8C?(DNG_-PZC+#W>Q6J^7?GFO:`B-.NM7DFIFTZ2O MM7*$R:@49?GC6VE6=VRC678VCJ9GRS9GX63RGL4-MWC+B[GYY5^OX/P-99L, MV9_SS/UX=CHV]^%\DC5D;V,_'3$;3\-HMC^O[[IIE=6BY].IF=Z9I"F?Z_IH MD\E'VUA^F=X6ASM/3 MAS!\L@8+W3,SR=+RDWQ)<$\!7%94^,ORXX#/TVAFT@5G:2FH.<_,=,70)+PS MDX\?+`-!%;+`EQYA!"F*N>\BY2`!H'`=(C@!'$/V7M!)?O(3)R7BG4GZ/1E] M#?,I?WWS6V&`6Z2OVU7@4$=P09F2B/M,0:WK M*9!4*0FUP-HGOJN%Y%B56&`'.,%:Q[L M=Q+^,0RK?X,ZSX-@(SNA7YO4V`$?K<7F7+A]&<^Z/6LMR]E/JW'WV/5A,V*>9O'4)$60*W<`'J.G M=*>E;*$*.$24^,@#$A(@-*08E,^?I(C"1O;A'+M]M(=8'U;Q.XTBLU$`7`\ABGUK'P^="QB1(M20NYXS;9B[K';1&N`]6$25V%6R0K> MM0N4E';+H#6S\`!JI6`2EG)`YC?;(*%C5_P^&&W7]<^!B/R3X&;^]#2)3/+9 M9-_BY.M&)6YN'#B$2XY)+X0C;2I'>LFFP-J#X>W37[_!UG M(!LH`BRY`*[O,L4U%];+AI0O95.`"]K3VC[,\XYV0#N402P.R7?O-7?2!L)# M4"C(/"Z1@X'#""V=7,V18,,]O]A;@Q4LH@VL_O@V,K@3B.&91@MNP9O!\R^W MNP5K&P<*>IXC)6"`$P2PCQ36)9>>`+TILII;T"+J<L@ M[Q1IB!AA6"J&7`Y7?'+K#0UKP]Z]"IMCTX8.G5HZ7+8.7,&`(Q`"TKHMPL?8 M(>4>0D-"FNFPLPUV/SILADT_>^G%??';>"EV"8A)?T_B=)MGOHO4+DB00)]I M.]<@!:3C4`5606/7&_Z$O'_\NV6,^O2V1#R]BV;%">'UJF+.^=A*$]U'X6H/ MNSZEI\B_H.KQ4\M%;'"[!%3RK*E>L)!P*H.'!+7!EW_<&O)/O;WA"` M/3Z#+4]HJIQ)M#QB0!5EVN,(^TIQ!R&AR$K3E('A+YU#,]JFT!Z;V8IYDM>` M7[2TO9CH.>S1AC<-'T@F`,60,$$\[%9 M]T_53CHVY]5X@77,',=!'$G'Q9((N_CI$E=(73VL2,/@[;\J@3!H%I_`1V4ZK:%S;!/6NWGZ M,GO<&J7N=N"`:8)\0BC"'%&,/0V05SYIB@O0R`[]H[+#02%\I+;\YHM^;?G- M%P'((^'0\SS73A.:`PYA:0".UHYJ9,ODSV[+S1$^.EM>O=NQ_*ZO@ZDU(P=2 M2DT\X6%/YH`SP$CI`SD$JV;.)?WS6O/>$!_(G-^]9[0H0[9X?P&L9YL;NPDX M%@PH1PNN)?,=@#5>H8"9W^PL%()CM[2V`#NV6?"SZ6LC;4<*--2^0^T?B%U- MF0,D6>:@$5<#UVMF?,<5!3HLIGW8Y^]Q//X6?;]>NL:PRB8!\ATFF8L$9XQ" MPC1"I.0>"-'PRL]QQ68:@C'@J::4J+\I9]>(`5/(SMRNY]MI'$NK*WM[9]4?>JUHL;7(UQ&7E9`"N`YP M?41U[=^JE_L:AR@I5)+1##FH*%O M57M^:UY6HK)*]RTK40^IP9:5N`[MW+;CPL2J3<`(!IZ0%E9?29\2X'.^%-IN M:E1?54>ZO2)16;-Q.S#UX8(5O.V\WO:F52`H@`I0Z7I`>(@A`!8'';D,BN`! M7W1HH(=UFMP+A^/4Z>`N)O2KROY5N'S=TDXEOFL78$RAQ+YR-5&4N':=4ZR4 M@WJXMPH7U38AC300MR=_+WH,7ZKI\6V[0`&N"7%\)(%/%0<"BY4\C?3Y&1):9[%]JJV5/@(R@(UIY2A$C,E*:>5V*!7=C,\1[:Y=.FGE6W M8`[`L&J61&K06P"4@X5`F``(.>-4^D2L)DTNT7#]NT0!M9'02[I4<010HY#-(,2 MV&/$X1Y5#")/6+Q67BCQ1#/;J!^,&:;/U`YHQU^,07D08-_U%(;8X;Y#"')+ M>;FOO.'Z/7MKL'95AF98_?%M9'">RO!,HXY)=%>P0U-(.%2RM>E0;$DR<,"A8!%@.#R_G*> MC>*I28N73/YW]/!8+T]OCX$"[7/7Q8Y]M!S""0!,X.](*MA7!<=#6MM!$?U7 M,FF=A$??Q\11$%,BD&A]FZ M_,I*=($FOL:.)EQX"C&I7$>5\0'E:J]9\9W#U'JHJ\*&5:4/4[6AZF(V/^RU.@F4DH1*BY:$B$.I*`$KJ7P.FX4^#U,BH=&3WR5:W=[\X.'H MZT-BS3._*WGIK=!(Z'&=7$8T!)#9C/82P]CA'S/;F0HYHHA70(!>,-W#'5T\:([+?_XBJ&]@>HG3R8S232] MLO_$XWSE2S_'&9OD.K+"5\B\VDT>0)( MG3^I:[?QVO-9*1%U@1BNG]""EGZ<`]J"YX^@^,&M^X/0]R'6^NDTGA4\5ECF M?V@;^`ZVZ`CF:;M<:>@HPE"Y']<>)<-:X?=1R$_K^7Y0]'9=NW*E!4Z!%9Y: MZ27$BF,7.:6/*Q!H^.JQCG+;>UNJF\(ST-OX2ON^BZ5P/$VYD@*"E8FZB@UX M,6Z@AVW7\AOA<)PZ'=PZVZ\J^U=ALPH+/F8.5)CZFF$,/*5=M_0QA,+NP+;* MC32PM<)"/?E[T6.C"@MVX1?0L4:M%)0>DM957*$AI6IVW-5/A86F>MQ#_D;1 M]<_S?*3+^ZLD'L]'67H1SF?Y';>;:#8RY_;O4_;&:?@Q?%:-.E!8,ZF)\H2G M[5_'`2XHY>`4]7:5>+L>^XNA=0);+_DU<6(L+HLZ\:/7HD9R.,J9_=TB>Q&G M*3?W<9$HM"W?IGHO@6;(E];]]Q6R7B:ABGLK?+GK#B0GN!?3Z1Z^7DQHX_WJ M+ZFYGT\NHONMN5H5R`.+*F"2(`[M)E+Y&F--5KX09>FMNOT;2/6Q_6 MPL;/)LFBU&*Q#"%ML8V?&P>4*(<3;`703AYF@E32E2>$O&9'*JWGXO9J"7NC MU,O6S:19$HTR,Q9AFJ>?Y?_E;PM[#B?YC0>6B3!)7JT,16;BMNU=O9X""ESN M:)$((&]/*H$%*+-7BG3>M9OKQ;3+82-W-9/BTP[:9ZCD5$OHRC- ME[LKDXPL0^'#QGRO772!,L[%KD3A*K2!M2K*.!*$8^HBEU$"W86)04$IV5DW MI@,,QI$/-?!R/&8 MCUV4OU2)^ZB406$-CR'"5UD/6\)"S7`X3IT..,+7ARJ/)<(G('$]YF#L,D:I M@STD0"F'"]"`(WR5-;`UPE=/_C[T>&'1?%@4K`AWWI'YN7&@I:8>0BX1$A"8 M%TQD?(4+]YK=FN\RN;6S171OXR:20#)?(E]CJ0G`+M"(NJ24 MSF%@P+6M]U'55JWOCC[+ZO(]&24 MG[VL/K\))R;_\#O+VRO,M=1]H#5UA6_Q4%*Y5`/MN[)$`O:8F%5MO=]?H?'! M,6R83?(L5:F:.7$EY][[B-*1F1--R5*&DK+,K[^@9-*;%@HD(#KS M%%=,T.SO:Z`;Z$9W$E=Z,5O-U^=I>OY,8``I+Q&2W$.&A"%J7R__<&)$$QL" M9"MX-2Y#`X!((DKJJZF?3H@R)S#E'//D6,0-;EH[7<: M)282_,Y#V"B0%'&BUING)K7S7W;V,/N[VJBF)6UU?RFX?7EPH!+%-808JB1W ME#F)(>]6?41*G5;WB7ME.;?.!M4-E..N6MW''\URMGC8')((^RO'D<%!$4.N@6SZTHJQW"HDA;]0QG%ZG[9K83+X_5[SSP=!&X. MF"3#5"D+A4:"H?8[F3)I)7OSY+YEC5,-QR:)PQZ%!Y^7T".,:.`%(MIKIZAS M%G9:I>*N<1HF.C-;Z8`D410W3M\7S1[_R[I^J2#S]6:[_O)W4U=@LU[>GR*P M]PL"IY0`"(E@D$OO89/]U$HCM$ASF?,DD^6C-Q=<-S#`:CZO=[-E)U%_Z_MZ M9)#<.`UA=&Z18H:8N"JU)_B64)B6CY0GT:RDZ1V(4]Z$I*8`]WJYN(\+U;V> M+>.6L/K\M:JVUV;>C%Q-@J"#B-FUA@N99>&*0UU\12"HB4MU;WBN@9SB;SVKHIS'2@E;.S0XB@Z;LP8 M%!8#(2'6+**DVBE$`,#3#1^.P-+E*BEI\/P.Q$\N9C@)OF_`\[Z\RZ'Q;L^R M.,\?#M1RY1$3TF$-L31(>OUD(_7TZ^+TIN1H79P!6!1F5U_#KFZ[HE%#)76> M(Z"(,]XCU8'C/)[8)?\\[*9A4>0"YJ%SRU^;;3V;GVNS\_+!@`DQ3%FDJ2`< M2HTA:!J.QW!]!(1*,)LY#"N$RY.#N(Z>#3 MQ8JE]^0_E;37,SH#-+_W;5MML5!`><6((DPQ&;V@%@L)^<3:A8ZD)GE!*F(5 MOL\6RV:#ZM=UDV_TN9KOZGT7KT-5BK.&XM+8P(WRG%$2S:<"PBJ,G&_E!5*F MV8YLB28C*<78L!11@\/]R\VG:EY%Y8T?_T>U[:$!9X8%9Y5U`')J@#:`6T]0 MYP(AG1B_S):T,A;YXR%2@OY) M5%R-"/&6\E9F1>1$RBF,S/KXP)29U$WSV#]G/ZMGR]#9V7WD^:"LYYASCHWG MT;T%43S0RJ4532,\6^NTT:;Y<"A*4&RK+U54O_OXI0?)>YGK,Z."1E)S00B2 M%",?Y3)&/R&6&,46$Z=[/$#*G>#T\,I>K$\*0>\Q]092IKQ61("G=&Q::RBY2*XBU80@HXPE[ MDE*0Q)LU8.),CPC);??;?ZQ7\P%;[J?A`5"EB:?6*Z:HM%@Y1QZE=ARD1EFF M?F27`9HRSMJ+&HZ-!7(_Y\M=D[;D]PD^RL#"^SD+!-I M)@!._7`N`S0E%.*:!O40$`8!D\@AIBW0#L%.G9OV66G$3OV`+5'\$N0]VQ_V M6L^//A^(M8@)"SQE""&#HN?9R06!3)RO4S\Z&P.+"+V5^+Y=XA:&Y9-V'_K^ME!'73N(S;7STB MXWU?$3!$VAHKJ1-"*17WCK@],'`BM>U\-GL[8LP\$T(E0R!WLU^-%]D_^/%R M0)`XNI?68A+%BN;("`#:0WZG!4A-PO M&-IC>`!-M2@%/4(,:N$)`EV"D?-:E"J--%'=&`.S0II2[ZK[9_#T4H_C8P(6 M&B&G-<-"BGVK6]_)QR.8TXJ1E]")48`JJ`C/@@:]%>'MF*`](#S*Z"E6OHDA M8F3&8L\E%&$P4`EW2S5NTWTA38;-8_";!YOF?68[OT'!Z$-%9!Q MW^Q0C>YLB!7>4UR>^4,P\$AZTL3"=6E\X64;_EC$\& MK7#LO:^>]!T:!/54>4P$^%J].#TH M1`\'>T2Y1R=7*4Q;&97G MB9>MWN_IX7A8E="'I*#"&=08$(IPPZTUSB*`-`?M1M=;8*<6M\^N#:-!5>XV M[?Z3+U[$>_5HL(+8N+F1('ZZ@(`VF8>M-`R5ZVW1-WXTG):C-VJ3$2ER^'=_ MOT=XMKR;+>X_K,SLVV([.Y>V<6)$$%9)!XUQW!-EO><*=H:-PZG=F\[`]CC` M%#KQW3WL]F&*O2<:]?1;77UMJD;LBSZO'ZJF#-8?U?;CE_.MLZ]\4]`41^%Q MW`M#[JRT6IL."QO=GVF%"7(H25;`RES.WJ4?)2I1WL^94ZVNU;9Y_GW4I<9S`2J(X=^,:BR)IGO*X M[#KGC2?\`:U(T9AVX+BN)E4O]BAO/:N2WD=*$6.8@:6)Z31/`BJ M!28.:6H]Q<*W$ADKW'NL2]F;I6Q7W^E'5 M-46\\VZEQL6:T5YS!2^9R]>:D1&I]QA-YY11JCU47EO"C?'8BS^F.]Q^'0UN^NJC]_G=4](^FG1@>BXXR"CBKJA!,4660Z M$\B$GUQ!X^'DG0ZNCP128<78?^)&[;9?U_7B/]6Q]EX]1@6J1'2`G(>$QJ6O M$4X_>KH64&W3N@[<(NX^@B(,!. MRH8P3]ONW2*6/AKQ2<#V^E97\\6^[V#\>5GM65C=JX=UO5W\9___)RN" M])13\R+BWC[4-O@V"YX&R'U>;CEZ;, MNX^[JU-AV?:+\OSQMXE/M_B,EWD+[RHN;;1A&#!.C3$8">11U+A])TI+F>'O M+"X-I?1>4,&II3Q.62L%>Y2&*"U+G7%<&Y?N3<+YN/1UTD\V+AUGV?=HX",) MCT>_^M?_K!;_WE6VVLSKQ;<]/>?#U'U?$115$1S*+838QX4>@+C;>X0LVOI2 M'5V&1*U[L_[&\\F"41E/^-6G_S%[J"X'-4^/"IY&+P]31#7'UFM#)>Q`U-Z` MZ8:UQZ?QDIX,ANWW5)')!<`GK1G7:,3)EO?5A[N/)Z.@;YX)W`!$#9-(.:@4 M!=APUWZ3!;94UEK?X.<8Z*['P2*)GP^K*,*_=JMY@]B/Q?;K1;9.CPC>:(R) M:3H2&M=T2P>B=9$(T2ZMD'.^P/78W(V&3-I,6V^VEZ?:\X>"H$PJ2#WD`%,# MF>!*M5^%.$YSK+)M_L>?:P/`*!-0'#/W4SMK5%0]1*&23:*Z0J);3+1*.T6\ M?G+>PHL>"Y3WD`*HHBA>68TDBU!Y2+B"K404&S%=)WD$EB[G`J;!\SL0/SG7 M=Q)\WS0[,"GWTW%E+75(*B4=Y5H+W"V"TKF)I0,,H>1R[N=U6+R'W$\DA:26 M.,8QUDA)+F0'CH1T8G?K\[";AD5A=LTU[#X^'*)^(NRXM(XC*XG8%YKO-G1^ M:@YW%G;3L"CJ;Q]"14W<:KW:E_+IZ7,?&Q>H@])B1RD'T79%8^:5:>4T2J6E M\5W/^4W][A&`*:$`KS[SHA=V]/G@@%4$1AE8W.T+*A'T[:D-=4K1=^"!#^-K MG0^EWT<+INN.3X#\\J3?U8^E._?6[J)M/_9X$(`BJPV@F)-HV!#GM#VBIQ&T MM/S,;)[Y0&;>=AX>"DCA]+R>_MMS>8@B&#H//(?(11L(./>M/$CAB;7#&)?@ MH6@42;P[7I?K(M-GQP5@,8Q24F$1,1$W2@GLY!2ZE`-W$];'1*9PZN6IHEN7 MM:'O.P*CT0S*N!L"&#/8=!UCG?S>D+0%/UMB[LB:D0FE$EKRNN[6194X/B`P M8Q#AS`B*/38:.Z'H1WPVMEZ?!@W$Z39W>,^>^[VI MU(8EPI(P3A"F+#I!H.DFVLX8!=,.>+/M$(HQ/Q2H,IN'?^TVA]+M?ZY/^+U[ M%?XK(G7?F-'HZ^SOAGRJ#CUAJL]5_7TQ;RZE+M;WGZKY^N\#EY?J:>?^TR%N MS)01&GH,@5?>6P0ZXN+JGF:)LFUA2JGEQ&`OMKX=+D_:71W7X,.7'Y;F_2\_ M[E-.-^YG5<\7F[/75:]_62#"8Z*P4RZZ$MQ1C)[V`D*(M.MFV79,1=?'G$#> M4+7V,V$DS3K]K@"$5X`@0:TP6F@CF.L.H[C#9EI;L1LKUF@X3L4N_SG[Z;Y\ MJ>9;'Z'>3QO]>LD>:'Y[_(5@D&=Q\CEG%284:RTA;;&3CJ=E8&7KCC@E*SL^ MNC>YOG)8L`__O:WNX1F=NS@V$!\AQL1!X+AG5A)J2.I06:L[5@O)F>#,3MANO) MP7XG+":/`P-C''`N+`=.0,40A18]2AI_A=)\HVPM&6^\DJ2!=L-E)$$]7@P, MAE(OE3,(`JHTA929UK`RB65B4?!L/1QOO(*DH7;SO?T?U8_]K\[G,?9Y04!8 M1CO:;`=@W(5R0(EO#6R<&#BQR]_[/][.@=ZM-^X#U.;E^*`]P!0J2##E"#"C ME>.MW-"+-".4KS?D%';HJ>`52J1Z'>[OT43NS*C`":#0(T@<;B:(0N'ZS;''`]1("0,] MX%YX9KF$W+10>(E*%1F[ZM;-($I?]Y0;#DH)-^+U9UZ\;'%\0-".$F<1M=P" MPYJ&ZIH]26;]=._<#"/J`NN#T/F=^"_/^X7;-E.@_1:)M]_7R^]QEV/JZ&5M M_6S>]+W\U2/_]LRX8"C4"F.EK2/8&LPI]MT:*1/+8V<[CQA*UIL\W/&@*;)Q M?/&9ETI$OGDX&$XEM1#2Z"\9#@3%6K02<0S3,D@RE[$9T[`/AJ0\R9>KF1QY M/`)$**58:FZ`D-%!]IZW4F&@\71-^A"*SK(]")G?A??)F?);TWT#KZW:1@OV M\DP&.V&3KWU%,$Y@X:1%T@IBJ?&,=KZ''J+!<0E,$KW3$!.,H<@U,`QX[7V3+;'D(QRD59A M\OI+.C<[8DE%HAB3E\]+GYX*5"))I1%-?6SIG8/(NE8&P@V:GE\V@(=C3`[" MX7UR.AG_ZC94EJ?PGQ'.AS/^T]'G`K18"DZ)IT(UW0N]P;:+_<>?I^$I#6)@ M/9[\17B<_>S'X_/GHJ%!4$IB"/0"2"`Q(K25PYAB,8F2/`Z0OP2/+]T!/=LL M-I^_U=7L_N/JN3-^+FN^[RL"P8@9C&T473:WO#4@'898FXE5^\B;AS0:3$6. ML8_L^\VNKALYUG6]_M%$56??XF_.E@&YYC6!`$H!EH92#2ER7#CP MO_52,;:R9(3J5@KSN!(.59A3KPE.*XF:6]@R8@X)!1#`;H6&B9>WLF5%EU"8 MD:`J;X:>M73[^.7YXKA?-7N;HO.O"9A+0P2$Q,(H.7:4J6[:")=8ZR5;B8V\ MYFA4J`8?OAVN=KS\D#XG<,?&!:^(2_$V/B!W^.G?J]\_.35?#%;/F&2M1'[^;]\VZLL[9=U M2G'6[+UY.K#H"WK,_I^]:VMN&T?6?PGWRR.NLU/E35))9JO.$THCTXG..I)7 MEUSVUQ]0$F4[CD0*`DG(.0^3<1P"1'_=!+H;?0$>&P"CU$1[@CEK":QYK=J[ MV/5-5WOZRK,G@W$&1+/90,>AQH9(*61 MK,YAV5B&Q8O5;) M*.[VISR!*$<1W.Z3_:J#B^GV56I^Z^;K;6S3W6+YY5E5O#[>^[Q^"<4R%ETACJ+5%',D&%&MA8@&B?A7C+$SNW-;\/(0& MR0RZL+NUX5@1+C2!C!FOD*>"-!^7BZ=[N=IP!BZUM[E.@^LM M\H)YZJUJ*`+$IQ7W&K*M>0;NIF$Q,'>3VII[#:A"3AAIL$'`>8(.X'#BTK[= M(=N:9^!N&A;#W7[<;%='^L03+GD[<^B,2][ST.A!(3T2X[[[NMY^F\?MYO/L0?_8 M=<`Y51_LQ)!`E;**0^&YA=!!0[4C#9F6H"+C&;.P;=$+0$EI"S^]?O?RTQ6? M3@P)6M"Z[ZR#$0>LF1`*F?V*/5>^U)I?69AP@JL9,+H&[A:CB)7'U/S,?'MW M4\6=Y_-D_K&JDU^F<4L_7<2I\P0!24GBJ88XAP@I(K$#J*%&6394LX0N)9VR M,.4$E[.A-(QK_Z<6=?K'7_/9?S;5D[S'M@K;':<(D#OL@2%"6N!!M&5TA+JA MGJDT-U#/=;=SGMX]`S:*N+R9?&FWVD^,"@`J+(S6$'"GN.#`\L,7)PQ1Y9W_ M_;&Q34XNANUUBD@Q2L152$8&O>+9ZZOEK%JY=_'Y:KFL&[?%Y7Q<[,)5GEQY MGE8TTF<,%&C@#$16,<[B_BN(<0V]B)&TRDG]Q1'DX-QB#.0NEI07R]BO+$E( M.D\6H%51TQ)8(0XY!$Q0P1HJ,5"%5=;J53[Z`BV/:)BV_)A6.23&W?^O8N'HQQ"7_6H$_NWVW^OI]- MFU]^7$[FJ\GTA,6;-E$0=?'F^,T@0!"CA%I-&CO1&Y98:K7G+A;9O=9]P]:_ M4)SV@B9,%:!CV@IG,$&<($RC'L8;"K4PL#S;MV]6)DO,18B^1MDIQBB^=I') M("IOJF]/(W[C9KKX\C"9'V]:V6%4@,HC:DV-"N.8$0G\(T#4%%+YN7^V+/J" M;`AG6=ZL9N8M`L`BJ#E`!ENBU,%J,]`.I8Z.[F#/A=`U)+76 M,@'$@2)4XOUY1BZU9[FFP?,:&%^,`E`4O\>X#[DLJ]E(9@W$RDBD*8$L[HB' M.V.CY&"QK,F9D9U9TI[5?!X6UY#5K`%R,,J\Y'7K`V:Q?U1S",8%)\3EXVX: M%M>0U:RP=7I;'!I(YS7GU![D%5N;EDLU9%9S!NZF87&M6HWOEK/IR1#TPT-!,J4TH5@XQ($!D1KK M&PH`U(7UW<@<>YX*PRC?L=JL/R^6L_^>EZ+^."IX4H=TFFAQ\KCIU;VEL#T( M*Z!IT8R#[-L]?,7)N`S,^W\MUG&C>3_[]'E].ESQER."`U&.`4,20>>-QTAA MT]"&>7NN]\!W>7WQ_`),AG&8Q37NO'MV4WL.=T7\GWK]_&)I)JO/)SUH72<) MEC,/-+3*"&$TY]/N":0A!>;=<3*OJ=N4C2/5:)_-I M]4O7\PDYZ3Q'L%);Q9R@-<9>.B+L@7XM$V]C>FNND5=,^D(IZ:JE\V+>5.NW M=W_-(]#?EK-ZR_-5/.KFM\V_N^\/U7Q5'0T#R/ZB8*)"#)@03L:BK:.#+VKO`&B'-HQ`R0%!= MRN&`(=:)(2*@;$$8$+%^"V#XR6SYK\G]IOIG-5EM]FM_OH"\E3!^^<(Q"V(< M%J16JVI='_0WL\G?=0//6;7:+_+V[?Q]-=TLZ^,_/O!F,5\V?]TV:+SI4$@C MZWL"19(SAK0@QELN4!W($@6*(,P]@;JU3FVY6+:5Z\CVCE#[B"GR%E(B`=92 M:RCV&`I+81'%/4:2FD49F/=00B2SH.L?3_8QOXP'0#6?MA6TZS`Z0`*D$LQS MXSBQW`@JP!XHJ1$IL@C)"&)R3%"S(3N$HOZK,_&PYM:HG0ZC0WT?"I4C)AHE M@M>)$(8V-`NF:+GQ6UDY>DQ:LB/W>TA-<<%?I0M+&4*R.FS`K=$F788'((4! MF"L5086`,@X-;*@&/C'SJ+=HA*Q\["`C%\(UA)"\G\P_52TZR^&98)F+AC)6 M0,`Z+Q-Z+/%^_?5E_5#!9%>FF:3B-QC_6_>")T\%"J@V&`O&K-:$8>^E:6@` MS+MR]8D$/OR*DQ?A<)T\+>ZT'Y:5P[/PGQ'.+YLOK4Q\]ES`2$`G(<1$2J5Y MI`$W^HUC2@S6=+?;:9S$@44^^@?AX\X5W,['I\\%[C5C#!"M-?>8,U+'O>WI MH#SQ<^PM$#`+'R^@?U!=6O\X_/B/6;6,[_[\XZ;Z6MUW]_N8F#8`3]JAXH+O#(%JQ=P1S/17I*09-$?G2=PH#&.IC#!GA`2#1(B2(.# MI_PZ/$)9&-W%ALL,X^\K5L4ID5>,@-,I*NAT;G!JJM?X"W*P+]C4G(Q7F/)!$J2B?VH(#4UT!B'D9148BL$ M.^"&N4S3>'K3=<>3B32\QI()G"03N+'CK*/88R\)`LP*HJCVS5VUYXP-I`47 M+Q-I>`UC]_[O8EDW_EF]O;/5W^NH\^\[/]9J_]8R:#&8.LX0F.,DV@N&`PD5 M\U@(Y!K:`0%I6D?/)4G&MYCZ0;<0R6K5:SO/$1"WPAKMM/".4(F`%;RA'Q)$ MRC65LG/X?`FZ",/?3Y:*LX^N1X1&$)W-?#:=/4SN]6)^>[P:[*G'`Z&">&YT MW336<@H0M(V;TSO+!BNPTTW-Z8%;/\O#Y2`-DUNQ?%@L)^NJ1N&1^`[E.TZ, M"X0)9K"FDL;OAY+X08G&<^YMQ*`L.ZA_83V9_KNZ/6-'.#$J$`^- M\H`Q$FVX2*JT]!"OK:+9.)!=4XPDY,-J"'GXZ\,?BZ_52^D$D0TJAKNT:(#>*@OT+T$#@)B6 MS#=9?:Y)_3JY?^8YLK-5G?BP61[/VVL=&;`!CA'(2-UG3@@B@&A>D'TT&.GZ^3V7WM$/*+Y8>X\$`<0F">`-1MO^DV,"!E(*CO)BS&%E``&&F\VQ[+Q*;9_7ON M1Q6C@K*`::](-HJ*Z%FPNG]CAJ/6Y]8!*DW M9;<,LDW\^G>C> MYV)VO[Y9K%:ZNHM*;Q&+>K=3A*[-*T>^A?/!J(48)P:HA@#2F-N#3GLEZJTV_T>(9KGAL`[=Y1(@[)'C`!WH]Z7U;NA'@^P+ MK:2KEP.)NII';-=N/IFNJ]N;ZM-L=;\EV*W6LR^3^+OFB>\/5?W(QX6NWE?3 MF@?1R'\3554_6T5S[W^JR=%^B_V\+>`Z!L)PQP3B@AHO%>4-3@:YM*R*WISU M>:6J'%S[=:(]\1W4ZYU/XQ>SI>SMG8YDSN<[-Z/;MD)17VI'X*JN9+R,#W^: MUZT5'N$9V,?R\WKK+FV;*($__OK@JRAKD_OX6.VU_+AP=W>1+;.OU?MMW,\` MJUQ/YI]FT;K9;45#OBO-\W-D'U/3;?71VY]?TU8CM2,%CE\Z?EW+,3=-E6(BK94A#SS0S&HNHRF"P6STQ3OJT M3)),GIK<#%CTADNQWIH_YWL&53=QUW@!HOZQC2K9=?@[[<0YB7CA$>P3N"%L@!8*'M?_9O*E:C7_$V8+!C$@ M))6(\@B)`EXQU&""!-?E^HEZX_YY4I81U?^7N!J;XCQ1URQH8PC8MFG%*BK? MJZK./HVV@:TS1A2`.&%M%"TOG[Y6S+Z0H M/WZ#1/9DT:7.F"5HS8BF&AJC!28"*O>(@0%L*.?%^'I4?Z"-+#AGGF9GSA2, M89I0IB'6##B*I!*'3U2)HLM;]\'Q[E*5$[F?5 M\DVU_K98_ONHDG/\X2"MH'7U0H48519!IJ1N5NF@*"U;HB\>+#(#-=AE[0L8 M.EW;_GI40%Q;*:-ZQI4!3MDZK[2A$7.1]MWWEP31LS#D1VP(J7@W66\[D"O"ZN>_3^TU]??K'8G'[ M;?9X8W.^R^W%5(%QYA"3GD2S4%H%L6VL0HJL)JJ,LZ1GN>D9M9&MD#^6BU6B M5V0[-,0#DAK.O222QTU5>J2;+P;QN%F7<>J,MKT-;G#70.7$;^HM5TNOFRN:_CAM27Q7(]^^\V MA"7M&S\R6?!.$:2%M$`!"4PTI41C22%E09I&D;U*PWA??1[F```"LD&6"84`*(DG5?XCVETKNT4`-V91*2%:-AM,WG2WQ3K<_3,-N' M1QM,(40`E8P(*X7V44-JJ';.IITR_,HDHP>D1CYW(@5I9TP<&&2TN:PUSFLN M.0!2+*OGV]XQP,;,(F[6=`+R MFPY)Q>=,$VJM$6#GO*?>>".@!$1&XY`J0K3'K7E4(VB2.^K4ZMUDN7Y[IS>K M2,RJ3HC_NV,VJFTC,>C\\`AH,P>M_BE#9:0>C)ON1]!.$??[`7, M8D-H&_JV=*]F7?*=?STBZF`6UK5:,<=$PCIES,,&$,?X4+U@SZO$/J0@_)P+ MF07'0?)@?['2'3KMM^VM8P,7&B#'XRGLN)72`1"Q;.A5WI<;P7$Q!SM(1`ZL M7K^,%!>#49YH%&7B]!5-Z*"#+.ZZ!"M-M(8(H`8#RFA:ND_?_:E'/(+ZP_9U MAX0A130$"&KK$8*@3@VU![V36%7ND=4+QR^,#4M#\_>6L.(.O&L4K*($ZJ7# MIW8%S5>5V=5#4/-H$W^M/FRFTZJJG9N/J>HK]?=JO9Q,$]V&.=X@L?OU7W7ZM_+N;KSXE*8(>) M`^?""8Y@A,9I5K>&QZI!BG%6F'`6(S=G>,VR,Z$\<:U!_/AMD4U*]_,%8J4W MF/!ZDT'<(BN-:'!Q@J8)YQAQQE>$X;!Q= M5!"4%C'57['X5R.7">`7*I;QV;QB&9\-PDNBA<&6(2*\@Y+`1KVAD/&TR]7> MVBV](K$\'_SRQ%+=K:ME=ME\-FM05AD#J3(""T`)L]`W+&%$@4+B"%^7@%[" M@6N.0N,">L=`_!JY5EI!(HQK*-6"I-HQMB'8:7R/^B^5L ML-<,4I'R\+;^$;RI_H^]:WUNVU;V_]&]>#\^XMG)3-KD)$[/W$\<168<3671 MI22?^OSU%Y1%R;$ED8)(D$H[T\FD"D%@?[L$=A?[F"Q3S/!K>,']^O[Y4_H4 MZ*NZN3YM^@!]"7.5'Q[RJAO*XN[Y\00P/T]4+67[-7_*-QD&-\50:^F?V[]. MRC\"-5\/=0=,-=^0@:K[PCW'._6];Q&I>M9[,@>AP8KIJGHUIUP24ZFIR$NI M*+5BH%#5-C0T!:2V?D?&*)0>*B3#.0B4(TKX&@/B462:0L=AISUQM4B#V7BC M2SMLIQ/4)^^DU)(A8*0A3E)<0Z*<3U5N[JS@GAX8WK:]SGEP)0D1[+B=BN40 M8>$AMY);9P`63-<42L'=>*-P+F=:^[XJ<2C]C/(PNIB9,8E!>O9__AZ,ZIN\ MO*^,GN7JOE6AGN.#,LH1$A`))J2G@'H@`*PI9$+@5.R_N.%.:U:]UBZZPB99 MO:[WQ>+N7`DX/3##%`3X*./`*X^E=9+X6C7C2HZDTDJ/4M`I/BDD81.Z=Q.F MV_3-_5JYU-R?Z]GJ::\B-:B,+=^0$401\8)18!"E3D).2$T[MB:N;V?/X>'] M:Y#]H#<2R6G4)UJ_(^,&$^&L(!03)!EG#-0?)"5"D/&JFYUS^'P)N@C#OY\L MC4Y5O1X1&D!TUHO9=/8PF>MB<=NLP!QZ/*,6((R@Y4;QJN2\YZY6T"CP*%F\ M?SNUI0=NO9:'RT%*P7I3E`]%N>E6]G6U)[Y1!DZ.RRR5"`$")`_3`HN%T&JG MHPDPLLJS_0M#EVBED8K[^Z#AS:I[KJ#JM9"&`\]GPG!MA=<***\IT-(IL-M* MG1U9_&4**;@((LDH36-BLLX M2>@MXK%_2>@.JQ3R\.7S+\5C7BXJ*_SS0[%8%F5^ZQ:KO'PH9YL[YK..CIC7 M98*&KT$K+R#%WE$%O-V?G!;'6;Z]!2?V+T$)0$PA6I\FB[N\P3FR>R;SVE'G M%%9`<&*E(R#LC]OU>R/C_./G'R@C_X6J]PY?$##^Z_FTT?WYKBN6I'(>6;\A$ M.-^"22"(=-8#"C3$>Y/3RI&YZ])$.O:#W;!RLVEA\&51YI-YM?Y?`MHG2]J> M]:),``Z%%8!*:2BEVD)8?T',0!=W`]";NV]H*>H`PE$)T_O3S6/.>D\6SG;- MM7:6,PFTIQZ@VBM2]3,>68;TR$0I`L%A)2E*;#((I460,LB5-H$B3WBM"S(? M]N1Q>02'EI$SX>HWU^Y09DW_^4,?R^(A+U=/E2?VX3EY(.%D0V8.U8OY.)\L M:E_T9E'O6Z0+-0_.K.-&$$(,P$IH(H`SREE+$.#(:ME8.:"G\-S=)W>4A/8I M0J=?D4'A#+':,(P%M`@([TV-`($N5>CNR0RA+AEY-"VH4YQ&FQ5TE$K]5-WZ M-%QHM!B=2:2MYEPY8S!02EN!2`T4DB)5.$WD54=74O"Z@6OGP*50?(Z#$9;0 M&)+78G2&.0DG.9<>5D4>L4/*ZCW-"HWWSJ13CK:5EHN1^WM(S>AN9<8N+.F% MY/UD<=OH_-\_E&FN>-6[&%"KM1`0*2UK"C0U<7$XO?F(.^5)T1$H2?(*U[-Y M58HET%S_]=W]0UD\YNTRC%J-SZ12TA$JO?)$&0\#B*BFFP,65^^K-Z]OG\+0 M!UXIY&2'0:-$O'HR4\)R#X'!AC.Y`#[Q;+ M8,6<_I0//YBYJM>CT8I5WCS*B91L1Z4",.[,[LTQV@??.@$FBFV_%I5QLPQT MF$U1H).L._APAI"%CF%*-:?8H'#::+S;0BR*8U]O/LO>V-<%.(/JX)L4U4U\ M9^/.V_H=&4-<,:=5U?'70.V#-K)SOCAL1U;>L,\]N2_,QA?1RIB40>*-]IP9 M*8+5`O>Z)]!QEQC)$GI["8F\,0)PY[U02NTT1VN3G:(I^7@!_2GX:/.',I_.-N5@3K#Q MY6,9`Y1Z1C02!G`M"05NYU\Q"*4JCW>I_GOY;>H%J`QJ%7U9YM_6\_>S;Z>N MU%N,#HJCA!0RIJ257"IC`\D[8Q[Z.#,YO6?RJ=ECV(1@U.2V+_I='V_WE2H?KFYA;_/\PT_ M%K]4I&!'4V20$!RPIT MSXA3PRH/M`AJG&3&,`65\8[RG2N*Z#CU);UOM\?=Z7R4^@U#?1.CV7\,ZK_6 MDW*5E_,G/UM,%E4I$#M93;XL)NO;V:J:9+"I$S0*:%A!_^AOFR14O>B?;LK) M8CF95F\:9,X$>!^;.@70JUFYN3S7^2*\:%7M!0/,F`3D0Q/W#_'GYU#7L+_^ MDA=WY>3A^VSZ;O&M*.]_,+H'F'K_X_NZ(&Q4[/N1:]C]]4.5X;#43_OY5)E/ MWI\(:3]K?$8(\#J<@$B3H#^[*K-OXRF%#K2*C^N&GF,AZJW'9H`12A#AA"#K MF=':$E73(51DZ9R.8M-[XDC1+T:CC4O_O`H;_L80W-$XF3=<1AX=DQGM&:9. M6H(QLP9+"GD-BH7)RM&WNISL@=6OR>1L@YZ3>NU*N#C8D#[*QAR M.>;%A1!$!GL&DW>Q48,G\Z9PSS>/9E7Y:6"\X;;RQ5"DB/7U"JF(O*+NKS1' M9TSJ")`4V^MOZVIA'[Y]RA^*! M+(G;BCO_RM.P_#)L^O48-W@^/I;%[7JZ&K1+J%NL9JNG?\]N\Q<+V\+I`RO= M7YL]=6[6RU5QGY>G_"47OS/34&HG'/720,8XQ+0VMI@W4`W>/?1/-XV-JRLTH)+J"P@%.$=-MB.K![T`(;"17@-ZF=($%VR*J9_Z,FR M*G)\_Q`.ROZ#2@[.^/+O[J_JK_DVJNFFV(SX\+`):0I(W7S/9^6[Q:J?S,K-$CY\JU>X7*[O'UJ$?B6*$&CC]WG[<.8<5]@;[+11 MU0&EE=QV7Z9<8SU4J<=ZH8V>F!\>S)"@FCA&PI\\4.6!AKJF!F*7ZB[SI`OE M$B8<"V&(H7ZT3HWS,NXQ0P!`X956VD.H.1.\)IHRFTI]/<]]$A\`VE9F9Z%<7GU MGE@@&=/204.T%%@&Y7Q+!R?-]:"'RZMOS8&3>?7GT3_>O'K`G6+*4$2J?I$! M#^UW!XV0/JYO6Y*\^F@^7D!_$G?`]TF9O[$V5%E6M#^70MT_\G'RM+$B_S,I M;W<&R0L[Y--L^87[>0D9(3X<$\0CSAP4KFKZ[6KTI6,C M:\-W5?(=A?#5R7?E$)NN\MO?BWEXS7RV>AI@!S^YB,Q310'S`FA`/!0:$[8[ M0:70/DK&^^L)-E(9[Q+CGT7*T^[C)Q>1$4>AMH(!9S4"`FM"X-DEU+Y-F5A""0+"/G`"6."L4ISNKE49> M[/?74*UC*1X#IE>[-]O9X^PV7]Q6'VSJ+?GEW!G2D%,;N$XQ4+BJ)0UV&A]3 M)&XG[JV&\MAWX@N@[?E^_."EZR^!V)4-:]W1M-Q?OU:T5K?&[OYA7CSE`]X- MO[BW5M-5@'CU--A:AHHDN`F3K"?S8:_"8S^95E?G%[\\(\(+[!4S'%3_`8H% M4((;JZ6!4C?ZO_K.G6@D<7F,QO;Y$A?.D7F`./)`>EA5M/55#J+:8J@4]ZDJ M_)Z^X$\H*D>3)=("W4,LP9&PR4#-_7;+K4Z$9ZH.QPJ#UAM&9$J#L&*'L96(:!@P4&A' MO<9^?*$&'>'?Q,V+\!D_7T<3;C`N=G;`Q@_E[&ZVF,Q?Q$F^6-#IN/8V8S,6 M[!1/'*UN?9FFPD*-MS1HK]%(+@\[XT31+SY)LHSFD\5OD_O&G,07CV4&:644 M-D'=D<9SIC$S-140@E0!"E=R*'<`84I!:,XQ^^'!C$$J!0>8,<$DI%9S)FM* M#!%D?*?T90PYPM6+T+AF_H[FM!Z2K1V]`5(%"-]_K5<3\HG5*UDXQP] MS<)CSV>0&T6!`U69'60()PK6"J;67(RD/$V7S.L(BA3;Z;-"\/30I#C]\%PF M(=3.::(XAPHQZ2`D._&SD:&=YP=F7)GF=`F&H[C<.XK+GK+%;>L#NH_I,FLM M801Y8ZF63E)N]QLCI(J.5XV+E(YS;_+2@?J/R':#[N@TTRN6U/026M\8O[BW M;GX'QH],]1L'O`?B\ MN8+9+%4UJ@]O'\ZH=U9>PY#5W+\4B6:I[ZQH4 M`%IB@<,02,PP0A7%E#YAG@1('@1&>`:.H5[4_Q'#( M1V:B1W'@9-F#\^B/NIHZ?(;4W1XV:L,/+2/?-+YK.3Z304<(APW"FCOOJ,': MN9H6)9*%;7;E;ND^%+A/.$?A/SX&V8ZZZE^7:KWZ7I2S_^Y[\'89U']LKHP" M#I!''GICA'!(<(1VGQIG<3$-_=4`&#!2?6#HKTF4'R>S>:5I^Z+<7%TGD.C7 M4V8"Z"H]UWF%@78^[!<,[M`UD9%Y_27^7[]@7\B!#D_Q`PO>ZA>F6*S*R;3* M_*K28\\[W%N_-K,B'$:88JLPP99;K53M'C""B;BP[O[2\4=UYO>%\JCWS\T? MO^?+U6QQ]S$O9\5M8PI^1]-DC@KC">4<X-[98;_7#CWO[N^5R?;(+>/=39<8RCAW7S"H@I23<*[-C$P4X2B[[2Z0? MU1Z:$OFTLJD6B[#]AZ^HBF>=W.7O%M,R#P^]6[S50C8$+:;=2VW,(C(@N*C\ M&<%@E;SJ]DMV=TO&81;7=8;_(\_I>))6TK=E(S:J]-+]%0B;+?./Y:P'>3X^ M559E]#DL)48<2^61TW*G8Q'`XR[]Q#]2VS7R28_]M-8KGXK5O^7KS[ET^)NT>#PZFW.#!F#K*16.^XD8E4YI)T&QIF, MZTXC?R+)'AL+KEK$G_7^.V7BI5U()E`5M6"L!8(*RP&R:N=5QS2V M)P7XYVM(RYB>:UZMOR[S/]8+U[=AZ$!(`A3RHPABIB:/J>,&6^XU\4<:Y:`BS#Z M^61A=&%BXQ&!P5G?&$IV\/E,$(JH5Y9R1XVREEM$*KHD=J#J&SRR,*3+^7.: MXU&H#,#M956G5(>I_FC/\?V8#&@D'.&&<`$X5)!*Q[9H*47!R(I>]*T21@.3 MU*X:M")MA^:5!%9"0!D)=JM"##(HPK?%,!?4&J2NV+R"4FI*@)?0,P68=9S4 ME!D((I,A4YE7K=G2QKPZ#XF_@7G%N?(<46VM0@`+[@GR-2`"Z;A;OB',J]:< M;6E>G0?,]:G4F&LL(+5*,N4#;E4#G)H^A2"^/O.J-<=:Z]9Q&/U\LG`UYE5Z M$1B<]9'F%44&$BV8,MP&0X(!H7A-%U8\KNW'`.95:_ZT,J_.0R4%M[>703HMU@$DM;O^UGLQGWYYFB[OZQ^%7,*3U^?_E M7^?NGA/WOV]1!%P[&KI\C2V;$J[^)50IIASRCRB#'VO.%&.68LVDBO M3GV.,2$[*TXE(.1Q&<1I`J3`0$CNGK&@2+.U7**S"C=CAMOUL"M6$[\\=-.T MW^-VR?C"N*T/=?=4'R9(Y&D!*H2@!/%B+V=#9C1!!I`^*8#`(J\UR42(5VFW M((!K3++.=WQ46$UI7A'HG/,(,6V,=EY)A8>Q+`&2Y>KMI=,ZBS5O0N]:N%.< M/K\$RJQ/E:&WONUL>[S[MC\V_3MX5,:/-ZX\YY`@X16`7@.%*$:J?V+!:6$% MKY9-XI]EIY=&:YM7RUONZZ^K[C[L?*BC3"429$:72P`!$/)26.V0<"=+6 M]!B$X9BV"I2MF$)6QN2#;96R/>W3:;K]X?$\2+=MTX0A$7?YGJ%00K0*&Z(I MMK%@G0:<5<6Y5,JMQ?)CN?TL1^^:5\XMSFI?206R M24"H7G@PI4AAI8>R9G;6C"<-O^UY8[[LNL_QBNEXOB#\'F_1?CRD\^B5>!64 M2&D)-8'V=*40E-X/WP25Z&]E^\R5PZME\-R>9[:^/WXZ'5Q,5V)#B(HHZ0#3 MG!&!!/;>,CI@S9A)6VO,5JBG'#8E0YC769EF,YPU7,I84<_C,G"#`3T-=N4` M=EYS$N2Z#4/?8:O1Z-ZQ_\EE"(/"&`.,-=(CZYS0GO58:";6VBRUL,LP.<-O M`L``00E#@``!#D!``#4G5MOVTB: MAN\7V/]0F[G86@21;YJLTN_OY MW6\?S]%'?'GY[J]_^?=_^^D_SL__$5Y?`9(OMYLDJP`NDKA*5N!K6GT&OZ^2 M\@NX+?(-^#TOOJ0/\1FXS8M-4JR?P._)392NZVN6Y^?]I4#W4_WAEQ^;_]S$ M90(>R_3'-'^=OQJ MF;[VQ?JRYL4_?KGZV.9YGF9E%6?+Y%WM!@"='T6^3JZ36]#\_[?KRS?EP8OF M&Q=94PX>D2//5QRHNJJOX)EG7.MJK?2Z2V]NGNZ3G]^5Z>9^7?MS(9.`@.+J6[7:Y+4V_"JB\I"O+R^H6O"GNEHG:B5_ M>TG5HKN;C68K'??PR\NJ%J]6L]Z;(Z_BM>*;XYM+OBUZW7SMJOZI_V9S^0,8 M;J/W<-V[ MI[=/]0,)+9?Y-JM*=%-61;RL%M!&!D81]6W7B8CI1MB!*/`Q0=0UB&\OVJLO MDNS\MX^#F/8C+='>\=CSK?-%4N;;8MD]O6J9S4.]4_Z742"(LQ78202#1O#' MH/)_?[K8I?G?G!MF_T3^$Y]W M+\W/E[K,[[Q<-RV2O!ANXV?P_`3U?6"D,4=$B^2Y8*IP<%U+E+!0@ZWJ=?VVZFF4MYSHID^(A*3_5%T./ M:;FP+!,:IN\22D+/#AT+&TX?W3,=D?HMB4\IJS;P\9!X3*)6X/SM"JLGJ330J-$T1$TF^B=-LX9B4TLBR MO!#CD$8((IL,L:%A075$9`QX*IB2X2^?V:%6>8*"4S.B5C)C]Y?\(6E64UYFAX<$KO/UNFY(?XV+ MU<+&3NC:)""N&1J^ZT/+&)O-U/<\'O#JB*\9O8-DD&:`84"M40YZZ;Q#EUI* MAPW&IRX8/ASK*1,M1!8P]@"3=1;33*BL-<5\NKM>Z211&*^;CQ80&92X/@D1 M(K[I&T:`AEE[#R''7]R_6#TM.87!&I>GJK^4R%SKP^0NS;*FU57W:;NK*)T; M8C99Q>20#F<5SPZ=@5[DR<<(7C%.>'J(U_B98%%Q4EP31&*6*4(?_AP7=\UR M;YR75?TY?;Q/LC)9F-!"(31#QZSU8&2;,(K&Z2ID"HX'J%2@>QYIM4H;S;PS M1IKL5@'%*9Q6#LE>-*ART,AN?]L+GQ4XWS!7&*2RA?5=@%4Z22[0JK%4U<*D M9+5=MH!9.`A2PPM]SPFLP(XBXKECF]?S<+CX9L.6[-(9]MA,=?_85K6C'/B] M2*OD/+^]54M;'H^5+$E2[*LNINYTS@JA.UGBJY/X2^"[`*5(7GRKE$2-4]P% MCQP*,:0H=!WJ!QXU+6J-JPAG'JBV]1^P=+R_ MXRXAJ\G?187D3DJH2\AG&7-5#+=EFB5EB?/-39JU,G:;`@UBND;=#Z61X6"$ M31=[%K:M@!BN9SN0M2LB%4/?TW&0!?9UG6Y[["&7#E0X)>;.I)ZIR277P?6I%?A#5X2TC(I0..KS0 M<'G&6)0'USR\,NAMGGECG=R7?`9NGO8_$-P!J[Y0V/!WTO+@0Z*&HM#"2EY+ M#_!36^G,A*GZ\LLGNLTYV7M=W]#=+C,4>(:+B04#GQ(?!H8?AGT`WS*HPP-5 M]JMJIF4K1&SW*H.&W:";<$!">R]X=(C6]7SV+ MH6%2`Q+;-;#K(,3^THH#"P0V10-`2!KF=Q MK9WDNK+N59&=&-X%CGSFL%5^?;[P5?]>QZEVUCRSX=`20B&[9@(!0?$OE_U) M6,`.@OAQ+P@UPB@(+-\AA@]I:&`/CT&(;1E<(."ZLFX0=&)X0+;)->BJ.K9FF.SD MGJ\;O6`G>-RW*C+$H+P(V(!T2O?YD*7`>"TLXW3P`.UTE<5,>*@MO7R:6UHM M4W+14CQ*F*N]9%1S5ZA03L'BUYP5Y[%4.7T?3)9+D8_+"NSD8/.'(E\F9=FL M%:K_ZC/*5B1Y2-;Y?;/7KF]L$Q,X5G,@CQEZKN>90_`(0ZY=Q6HB:N?O M^7VG$@PRVT6O>T*Y*:O$:%:N3NTQ+TG!AR/VGJI#SF3=052JM'XV<%2:U#;'(AE:?-0U#<^W M7>J9GA7Z5A`X]A`X]"G7T*)\M!.PZ`P,&D6[M@I,%B>4/G_E6<5E[63<>N88 M)\'$W)XQRP038J":C%5'^7:W25:+O6AU\3O#D:[0A"%L!A<#&(1F5'=C21^) MF,1E>C63Q.4U$VR_)="H8D25C%^'V32157PP>ND20S=/F5VK_NVT[?Z-4]OV M3(R&F^P%M)NL&A0[IM6#^.T\7R&O`E-.C%H5&>3*[A!!F);-P[0/95`/!P1! M`P>>04PCQ.."6!)$-!*A*<_UI\6I+<@'+L?X>*K++&&@EJU1LD3E>16XX;J7J8,5!7Q9698%4KA#:Z*VR$$5JL/!1V'$A10Z)B^C0,4D7!H M$!,:.4S+@&6N/RU8+0E,,#O&#U8=9LF!U5(!5F;'Q,&JPSDU8&5Q4(BP%A=A M>0V:(6&Y4SA`6#$[9,8YK\:#LPDV;,NP_0BA$!D6#%`P;)TGD4^X=EQ(!3K! MZ*;\4":'C\*CF'HL5#'9?5Y$ M?FC;GE6W"ZT@#`P#86^GDII<+SN>6)IF7G9[R/-;$-_=%>UII6";K=*R?5-, ML@++,;7FQUUNH+D)0?SL3)R-T-:\J8N:KQTYPU(6;'GN97(&=KF`9\F`_6S. MP'AW#!F=M:\_2L8@-R1L`[BGUJCYR55+`'&W53#N):8I/.%'T.S* M3<6S:)<4V,]JV`L!%584A-BE#B+4MNBP09[:D26A`F8-S6'Z@+IE7U_SO1/$TKQ87` MT'0]G?]\R&,XJ..L>Y%J^T+5DUO/T<0]71&(M7<5%P5;ZY?+I+>:PGJE,321\117C.S/PH$@\+3O?N-Q;<#[4*EML^D@:@VIY?O M*E)O&']][-^"9#F0VF'H(63[!@E,Z`Q1(A2Z7)U6SDMK;OKM:IO@^]HXC>)$ ME'J/1&%THG>H/3."A2Y\CLV-(YSJWR*&B`G\;&A/D'Q_^['*EU_:DXP,VS0" MTT)6$'EF2!V,;#($I#YFVC$N'T4S,;JC5^MG")O`4?2&F;V[,?ICQ=R+1,';AC8#K5"ET2N'41#)$P" MR@,=@; M/.M>3#"NAL;44D7#QD!0W.3-)^`/PU(M]+9S5`X%. M&R]"!!QC1(A>JS@1THH!@U4G.B/Z6TL.(43$,GU'2B,$-8`$R$DE$8(LV/<"-%AE01"PAD@).1!"*]_ M\T,(=P9O(T3,#/Z1E*OQ%`+;\#&"ED%\#UN60X/Z^D,DA_/`$H'+3S?:>L5R MNH8RUSA'3?08)CSTRN25WO&2T1&6@1)^^V9"$9D,WAH:$36#F2+=CA6\+8HZ MVC@QA$T_2X=UA@V4GFT)^U9@#1)$S=&DUG1&9)W,;TZ4/;-Z4`H&J6"G=<3=U(SCYEZS4:"%')R]??OF_!"E8,/\6F; M<6\[=[!W*&WW3."E(I-O>HN*S.$Y3=P&W9:#P#]W$!'MJ]6'].,[`M M5^`^*4#9"/TOH8%O2:]Y1L*GLUEH:/QCYW`ML*ZLH)/8[WNK18)6Y4F&RP_Z M=G3\7(WK,X&'6%7:9<(]MHX)=I6G_.B.05FX:(`&0:-3,>M&X)-K+"? M*"2&&Q*FPQ=4Q)D4*IO,TL27O$6759EMLZ7.CZU/=M/S(]VX>V36H^#N$LVV=ZS:%L MC%,P*FVER3*)U41!'FGP3YY%9^#RB'?3@*A3P0,A3COG"B#>-([!1\@6K-+M;V"@BCNU"UT(8F0&A+L1#3-\(D!1]>`*=`D'Y3I\LA[@\%821 M+CM5$.D]BY738&E/"@^;1-R=*Z"$ M>E#_O$[:C;+9"FWRHDK_U7[^H<>"=#)RM?QGG2.18MYQ3JI*6J9XY542D0$+K&([1H.MG%DN8@2XIB$V@%Q6'N6 MTG'T$:27!EIM8%_8DC]EUH*HKDS4H.Z`:PUH,=QQTD^!;?NE>5<34WU7JIY]]62UC?^/H6RVB$=/0\0S/ M\!T$'61:U/$<*V@#4R\B?L1:;^4#Z:NM+[HKSWLKIVNE'+7L0,U49_=,ZJ/" MA%Z^&%.Q5?)U[[7Z[^(@,"+2GD"./&*&(8T:B/M>;?U4&UMQ6&;0")#$P MI-9I2>#I-EDE^^;16.&Q4H2),B4R=SQ*Y<9*2GD#F:%)DB)]B*OT(;G,:CRW M1Q>7M9:_)ZN[-+M#=0OJH7WOUD[3CN-V!+W0MLP@JGN\6+3/4V"6/P-*?4 MOK""B51\ILV./ISRWR2*B`U2#8OKM.Q.J(P\Q_!-QW%"C)R`&"9$P1`3F81K M%:54H.GXL1,'&G5B9]?*F2K>'-/BIX+VUFD.LCWD$&=+B=O8V<%()A>&MHZ@ M00*8PGG6-IL^U1?H#\`TB>W4U\;$\0T*ZXA>9`TQ<>@%8I@2"#0=I@9QH%$G M>N2MG*F\F-+LIS"F1BM/=!;N(8>8,"5A[.PP)9/+FYB2-D@`4U?CD59>:+J1 M[1F1C0T3>]`F@3[P*M?!GN?8CN,&8>A!TW1A=_VZN>5&QY;F M[F]4L&%TY_#>_^$=.>2Y7TZT`(H_Y^[:VV.%$>V?X5/-W8CW',! M`1)Q/TD()CIV^A$SO;,QT1\JL(UM=LI%7Z#<[?WU*_&H*MM593T!3\3NCK?; M0YX\*8XR)9$JKGZZK1[^EWG93_[LA^=S_BD&CNB!-EDSZX(^_LK0J)'6B:3@ M-:Z^/&/XG'E9DF2I!%P_815*LQ,FB:CH1#%B9Q0R#Y]&J484#D=+(?A MDM8*:=9$Q<(F84IJ(<&5,;UX1L)9P5`E;#&*H>S`"\G0HT)(,X9^C%G97.7K M/XJ\3C?7-&^+%4@#&D0$IA[$48RS,(O3T1;P@E!4-I0-6%:.L3US#\SAR)R4 M7\"="U]YKL??ZP(R"75R&J+&F@$=.<7%"2G1IFX!:J+O0V5P+$GG(5FY+NJ$ MF;BMZL>5%R1>Z&:QFWI!D&0^120;S<29)_2ED.JSI\E!.DS."$HZ`9&D2S3] ML,>44O(A2I*QS..)_V?S#C6F%J`36O!?Y!PZ-`BI`QT6L_@>RBJ,PH@FL1M3 M2'`<1(`WV1F>CS`57L60>JCM?8P!2[>C*J$#_[@4=IAL+42S&*08QW)0DB0*@UL,[SI]*-PR*Z0Z:@'-+FD@Q**LGMLC34Q0QWHQKR@$90JJB0M[B=$7) MB9/*HDZ)D+9@9NFZL[;.;U=9F"#7Q6Y&$0A#'.*([`S$@2NL)W)/M:PA.S`. M1R.A&I+.\5@5>Z(T+^S,2Y9KH1"-V0 M@`R#S(^0'Z"4!#M5"9#DUH66J8E.4QR[8$.H@[05>D6W.B9C5FGG0YU4H2$W!I)(^ MJ9!H3)E.L')6E'297(P>:3OR0HK,4".A0K]7Z^VFS>M^][A9!;[OIFX2@I1$ M/HU([-'=!E.<(J$.(>I/GT9U=JCZ0PTRRRV*I(EJC$V^E+1%G"ICBO*,@[-* MHLK78A1$V8$7RJ%'A4S%U9]'^[7XQKO+;V[YK93;9D40"@B`;NB'`0T]$,>9 M.]IS0[$/\+6-3%1E#49($9">3YO+]?E5;:N\G:5N`!X*':!FZ44PHA&=/^Q7HR$FL*J M/7D:C>D1.1TD:5V1(DI43&QQI*0@8O084XT#W\]*A0I'B]$')?`O1$&=`O$. M&[O^B9]NDNK^6[%INN^KAZ;R2=6T3;>0] M-/2IBVB($4PHB3%VA2^>L8S"X@[JOL%I=>,<0G?&RQLZ\,-:Y[L.OS,Z,&-3 M5"W"C[RW$T=R*6TP)O+V><>,*4D6EI+?KNZ*Z^V:8>IL$V[[$!VN:_;J%!T6 M\KC_G0$?_I[7UWUOQLSUH9_QH_701VZ&(ASB'4`H=F!V>E26DYG1$2XTAV+R M1'0.O7$N'X^ICM.YI-C8=<(8B\T>%>CKVY$1W`<1)]-2:A$"U!EOO-S=5?=^SQ^8E_OM\(GO8 M49IOG*)?:=@V1>.PW^YON'?ZR>OJ0$5^TNW/=8JG(Y.*&5Z7T+E+WXG*Y%#3 M%>ZAI2CO"P1@"@"-_8!X;+;`_FZ>(&+W*^C:F$F\Y=H/:Q.I*.`6.#0CX1/3 MIRGC%FA4$_*#>WO:NV+4[&)SF]^R/RHW3EMUJEXX)2M!)I7PD]V;3;&Z5!F7 M=>,U(5>B14S*/]7E;;G)UUE>UMQ>OS8U(OA0W%\6]2I*0)@%:9@DP(](B*A' MP&"89,07ZJ=DSIIE>1\Q.AQD)U#C*O%.MF0TR@S!`F(_.;=RLB]`J_.U1RDU M!YCA5V(VF)QGM7FAH_EAI/FJI[F7_[QU;KN.F]=Y6V@KOP@?I^8`HUPN838P MZU!E:]C)7E;+1A9O_-D5%(E/<()!`I`;)QF,"(B2T8;GN9'49;0R#[:L^QQ+ MUX-6[;8C.8[$ELFMT2,GW>+,V+D!]H"%,\O,2F0M9*58#?OS&UK5"9!6@B$C MC;PP1M`%482BV`LI@5$\6DD")-0"2_'1TZF!VK5"LDS)*8(%DI0U89X+@YXR M(:`+DI0M3!EDT9_0!B42Q"I)S`+E\UNAV\?WS+4-OQJ$FQU2$Q("B&E&`0U] MEIYD(89H-!G&<2Q<0VK:L:P;')S3HW-V\+KKU66*&ETN!IE:["CSO^ZGZSQ!C2ZC\3+E2F1]0,BJ>%9?U-J\??6[Z M9[Y*,!CS8()#-W6]&#)K`0RP-^XC$0*1N'XK6["LW",NQ[]PNA>EPR8C->K< M">CU)+3)*?5QQI146ITZ"7V>A$+%U;JC5&JK\BF/3^FQ-D-+4&)])RJ3@T:R MPN[/7+%_IROC8\\C:4H"#*&'_2A./2_823S-I!;;Y)YL66W[0X_]O;TJRVV2 M-(E5U_88DA-6"7*LU-9/>#A36JOQM9#*6A%\96+(R)[15SZ\N8>WN7ZV!D`I M#:+`SQ(:DCB-0TCWV:,78J%-W5D!3JA0:DN`\X1-3.H6'S$YQ1R*VN$H_3PK MDC8H/2.^LT9P(1H^+P?/#]O/'Q#A&26]_[:N'HNBVSS^](T#'=):1#,`(AQ' M%'NQ&WB9'Y'=TG`DUB94WXIE;>^/F_2(1)M6&*!.3)JG84U27P=,SB%S`I6^ M%:$]2=`9M=0G=2&29\"1RO1X,YW.GM+)7W8WS0 MR[6-)J_Z<&S+F<#GAV>_/C2=V!H(H*$T=MK8R8FJ=MBY6D=7)E]&'.D"VQIS<*W&8E>%-426V"S M4*ZV)6:,>K&M,E%F3FV=&6=V"5MIYIVJ;`[&J>J0'<2N5SK>MG=57?Z'>12Z MT/4S/_.R)$$H]1'TQR^T$@@CJ?.PTZ.;8MIJ'/;?HGY@+_5VPX9N]]&B]J&Y M&2-JN4Z9))@3ERU/%+P?%'O'WDH9R">KZNX0RPJYQ$N`GV88N"3-V-0:>3N\B=QG7+.!M#QC[66JZ64J'Q%V M_5!N)0X(SD[5Q!.5U5`N8+YZ,A!>.2FZZ(GK>:`FF+^4Q\9?;!I3Y\'2;*89 M&)UUO2,(/^0_ROOM?5)MN@:HVWS]I:CO5Q2QH@^$@&(0``HIP9B.F%"$LM5# M45]6&@M^YJ#(:-HA:F%I&W`Y5WM@#IOG[O77H0S&0WDE<)Y`*$PN#GDYN9!A M0AG^;IQ0QH@=>.!\65K$M!<4YXFF6/5G0PX6*;[Q+]#^ M]ECD=?-W[8/YFK3)+4*:C\9RUR8M^/KZDJ4M@NU7B=W__%XT_/*2_C9J;Y6& M*,F"$$(`20)=`!&$(\8@\(7VTV8!-LF!X(<>D_.MOW7];^7&Z35AJD)0*626 MBS_;T9J\X.MC/7CD]"Z]E0+O2#!L%'4Z,7_KA9R6[Z:*-_T`Z!1L`@#Y'SRM M,/E=GET[\81&$*201!2[<1P',,-C>YK$"UV@>6;#+CC+\PQ'YFR>+SVV=WGK MW.>/SF7AE`/2(3OM,]9ODCTF9@FKK;Y\]CKGM[=U<9NWQ:D7FPV`9GOY[^*JY:U[QSHTWUP[ M%2M#:R?G'C>6*E`MLN6JTFGBNMQ*=2+_7Z]>IPR$Y8P#;S:LTF;)$#]#DM\6 M[S=7=<%^Z?WFY0IWYP$+WLI%$+D)R@!)8PA`1`-OO%@K24&4VL]%K,"V70UW MF'D9/(!VUN5]V7;[827'WRGE^K3*33)SV1D0-K.8V5BN+:`C:UN.;XN'LIJVW2K;T[!TZ-M MV[0L3^(K-KWJ7/"$B_]RWC^R'`=6N7FKV9=*3(WG958'UIO.V.PR8R27FR!X MEK.\X;OM[HA"D_Y@GI1-\;DN&4Y^RU$*XACX$,0X\U,2[_97`A=ZVH<#[,*S M?F!@A,/DD^'A&ML+87^6;:*D3"=^-E.OB0(W^6;&X-=%?TZ-_7,W"CKG%A_S M*7*EB6*OEA&=?&OWM_+=&ND7:($^X\F'@4B]Z13#A/]&$@EC@9#O6E/4#\S, M<>0?JPW?HR_Z_;'F2]7FZ\._Y_>L?ZS:/XKVU^*JNMUTI_?])/%I'%*2PC3V MHSB$^WTS&,54J>O-Y"@M+_G\=Z<,L M=D[B;418+L_8=_CIG3IYI_F%L_.L3S!80O$D,>&.L=]I667>.GO?YFH29#I& M9\Y2S#\N%G*P8@%$G&IR-'-HYI_K^J,BK+@?_HC_GK="/H2^EU#JHA!1Z/H4 M[SZQ!LRY14R`:M`MSXK_*LK;.RZ&.:O(^6KE<#*PNG'J/V+7(^++ MBP,FY^N(:NIF="?(.2,CP/58G0'LN+O2.`PNR^.*'ZWSY7NQ M?F"_46W:._%.9&:T3X[8,Y)H*4(+44I;WE63#',[NOI^\^5[Q:6E6:4)]0#) M@$L9FBB+V3^3$0C[/YD%:96P/J.Z1G;4589ZHP)KB75+&GO!198?UV*@G0[U M,M5USZJ^P"I$Z&UIK(J#:C*K3*4%I66CLNBAT`"E01A`XHDT MK[T9>RMZ)&[@81\"C"G!0!$=D5"/"MUB;-'\C,J+;"FO!/F&A=<.[[9U MEZ->MNSN>#6ANO)!>FNBJ^"AJN:JDFE!'X"(A#CG?@G MKIV5!7'S,TIN;$URQ+#8J MKI8HMJJM(L&84UCW^/1U52$^;TM651Q44U5E*DV+ZBH+J`^I2WW"\F=",H#W MYL,D]58M/X=D5$I?M2DEH#MXX@+*_Q4[VODZG485TRB3%@\1+%,;]151F/^W MI8/B;JFIGR1MPII'BYMRPP]5;MJZO-SRPY"?BTW#/_;;7'_BW2T^5TU;%VW9 M-^_I[EZC97.UKAH&='<6+$II0FD6TR0,/1?&!.,XI33P4M^+O$BTV>Q4<.R] MY(,'SJ$+SN!#US*D\\)YZD9_6Z&S=V2^4Y.&(G!&**:.\4*$9'*WJWE?+=EN MY5=WQ?5V77RZX8>VFT\WOSY%\H5W'_E2_&@)(_7/%0:N&Y(TC+,`IQ'$&/IP M1($\L?YLEDQ;KF7Y^?9\\_A$8!KG2^7L43NDV+!HMU+WS]H*A)CPSQ@#.7T? M@?)/N3JH_(=?GROYUPZOPP$['>+);V*7XO.,6EL*S$)$V99WS]MYVR11K+'2 M^TW+AG')[."F*=ICRAXG./0!#GEAS3++-"8>X-_`0!(0!)+7/NPS9<;>N[L' MY_3H9#,N.[1*M+*9F%ZUSC3G:-9M1O,Z`4>TS#1U2V@58]*=RLX(D^K[ME/( MYP`Z;5Q%012QTC>+2)00@((,`'>PF:1Q)G0SJ1%#EK.[P_3BY7O4IQ52`J5- MK(#H3\FI>K:V##IE^I9-2*N:TFO2*]A_[#P-I_3>%'M+$'MCOE06AI=DH9^5 MF[(M?BD?BNOG=LGCA_S?59VL\Z;!/\IF14@4D)!X2<(FE@!Y.$59#R'T$C>2 M:D!BTJ[E2:"'^J[#>N2]NGQT.KQ.!Y@EK@RRJ(A9B8)8B3]7`.1F#+/<6ZGM M)8@\4]C;",="JGHKKE7V1[,Y)=T#^)C?%[2ZS\O-*DDB$H01R]9)Y*:A'V/D MCS`PPE)?RINV/:NB7CQYISEJYVN/VZ"LJH5$6UJM1\.DO"H%8FJ-/<:HFLYJ MQ6;Y6JOGGKC>&J!1<)%B^^W;NBSJCT7[O:K__-`=W%[%%(4`H`C[48BI[T4X M)J.EU$-"5^-J/-[V@L0`RAE0217+:GR)K#A8ITIRG>$92\[7'I+]-^I#0.(8H M@3AQ4TQIB(+1)(!(KJV3AAW;N_G;IJWNV@T@"U"TD2C;CR_."D M,7J$]>ISWO+CF(,1BA!QL>=Y`7()L^@G-!J-^#@)9!1*[LF6-6D`(RDVDN2( MR8L]7N0$9<`QEX`\H>&,9*C1M1"14`1?F1@Q,E4@OOK_;5F_+$-_*3?%^[:X M;U;`=6&81+Z7(I=Z-(N":+?>E[FA>$6H;\JR5(P`7\ZU,H6/`48%:L9IR933 ME],\.E\Y/J<#*%5-&B!5HK*B9V6*1,&A9_U_<_KZ"_],+8%HH,S[K[)I8H-KA9E+9$%&A?2/9J MUB?AS0]EPH1U[_WFFG\Y=&KS)?UQM=[R3C8_5]7U]W*]7D4P2OTHSH*(1#'% M'J#CN:'0IR3`,AIHW+AE/=SC?;?NWMK]XIV3R^3%]M@74\99B9=3R0/.3YW: M^=L.KS,"_OO$DBE+Z!GYM!:;A4BI/?^JB0:YN8,\/]=5P[L(A6$"818',0R0 M&V<^&:7=AQXP=0Y2S)AE">U`.%=Y73_R]Y4EE-M-:^X8CB"ANOFC!2X-YH[= MM=\,WV+2QIXNM5,T9,T-7A=/<%47K M7.=M\9/I3S9/2;T!QI>P[JGIP;EO,57(,)&$XBLV2+?KG%^T>+"^M\I2'/@$ MQ=3%;NPFOA>A\5B0CZGKK3;%+?^7OAC)3E51"+V.Q6/AI3)[PG.%5+@74#M/RD6-M#\339#)G"NGMHX^6GF"M& M(_;CR(U`$`9N@-F/X6@USE*I1D>:IJ9+J+ME>4O&#W^I[9J/#"KEBTCDA MKY+'"@X9//:-]L1Z>)ZH,]IGB.&%Z)PI;RHKPU!Z?^BIG8]%^W+AE"+L^X$; MQA'OSXM(Y@$ZVDY3*G6[F1&#$VL92TDVA>PJIAEF1?=[)B95>[F`(5S&OL[K MQ)W=RS'(^T+DS:Q/+_9LC!-FHD1F,%8Q\#)*DS0C,(:LI(QAA'!"VDB^(II MV;#W@NUA.7M<\W79/L?2F7?+"+D+>;/,^%)9&'W*G:OQ0UZNN?&LJG_+#S$, M';5"+\X\5H2%-'%Q&F"4H1%`YLM50>:L6LX5#GO$G7@+I=KP6:!=3-GF85Q. MY@[)WJ%\=U/5[YI#QG)NT!28``'D$2Z&0F M;3*U<^[UR-@TRD<7`CCI5PBPNTP$"';-CY?<.)["=VDW!HIFT#Z7.B8Z_13WJEZ=%_7MQ^5] MT:QN#XXQP"0,:1#2F#*)(9:0PJ!K,:8T,BH5K#V2+'[)BV3]7RV\NM M1A@J0<0Q@9++B&6"(;EM%1/.C-[W'-F48X'2P.SITUA:^VG4A(R:Z=3FC+8] MI1Z(U7&NC@B6)9(]$2U;T;QT8)LMD@S6O/ZOJL_5[S2?K[/B8L675^*O=;EZ M.%@@T,4F"G&()(TQ3$.,!0L(0EWS499F)BIFJTW'>+-=+VAMH- MUL?K9`.FJ*PQWW?A<7K23=<@;?'M:$VR%X%'ER?MIL`3/;0>UK-%2Q>TV53( M;>%+T@A1D5&$(Q2RF,0Q[`I?C"@U.O'27JO^J.2P"32+_%M32@?4.]/*>6;< M>I,X3B\-$W$ZBFD:F+EF#J*NOVJNE^5E>9??)-7R:E>`9S",PB`C*2>0,BR) MZ`IP#&5H5`H/:L"U%G:80`O*5.@&4=93TURS92A?CXF:JZ!]B95C>C2&1%^D M9U0,3U5F/"&]!26MZKNJSE>%EK.]BG4'&6,6AA!!1E2J8191FO!==4RAT74( MXUIR+#$[%O5EF=]\R>^*>ML834F249EPR&6"8<($A[L"562IF4@-:<&Y.'6@0(O* M6),&L=97BUP39JI!C[F:3WI>X.6HY(SAT1NI&17$,XD93TG_\Q#T6S!)?OEG M7K6@35Z>@O3U[-?JONB7NI%R[.[:ME4 M=7$EENKYOJO+IFA>'']1K,0PX9(&.)("<,,XHL_TV9O^67>^S?>N-3`=O8AK0WD]QYV/< M3&H-WLC\-.`.JNE>R_QTY/HJMTGQ1%8=!3?@%.".C/YAJ7]*?%N!8#EGWX1!R1Y%5SKNLZ63QJR"VAV$65VG5K!:4 M1US5&A0QD4F(81)$^RFAC!DMG]MJT[5%=6"`1F,Z=VR+UY[SR#-0.M!X7AJZ M?P"/R09)WI23GZW;C\-C4\Z6L^#)N-UZ6$^GHIW09D$"V^LBOB[K(K_1('[) MRV6SH)`$-*,0,Y9BC),L"#HACM-`&&U1M-RT8T']4<%UUO\;1`HGT-_:0OX$$L2$B2B(S$#"82 M2QAV.\IC2-F0:V_L`NCU?(^^\>;9PZRQF>]2L$N]93VU1_O5GU7JKZ1]); MEPS)&7PG358VES=5LZZ+\^+'*E'Q_KF(*29Q!BGFC(L,HE02]?\,!2*6D'`Z MYDJ:(>TYKGZ?72H`]B!'WDLSB-U^:C4UL6:R=8Q3\(=&"%J(4R_G]V#MB);9 MY-P34;,:TAL7THRGR^#$P+PNDKS1$XRW^GJ\S=FI=:T`%7I1+WG8?^1+_J!_ MQ/_.ZZO/=_J#S>?UJE'@]=4YOU]3\N.$WBB"-(!8ID2B#"*68(B21. M,TCBP.RTP5D@NMY!I2'_=*$Q@\.XP$%@X.(!''YN&QQHH_L`MO&I/^PC!'_H M&,$V2.,#\6?J#?V4_`0Z@IGXS]T''!W7Z")+QW:,S=LM//&GN5EX=L2D!TF9 MPP5_6[?;DR&/:0!CQJ!@&8N$4&[=`<6"!(N[HBZKJ[-57J\FM\&>&$V$[VDX MO35P@T7O]FDT^@94!T)V47PKE\OV3YNSE.?SL[YYG=S*'"33"Q?[`#:1G:Y] M;?!/XUR&O>#]F98I`>[\:E`J)K.J7]0'5\W'Y9=6L-M9_874=P5RR9(`!1*B M4*`X[*!*'B*S6?4Y$#J?CG]F4]\TRN)J8D,:E+UI+,EUVN8SI4UDH%R"36S; M5=,3,Z87\N/0FL;TAG=B3J,HL&Q/X]/1WZ!6U>6?'YMF75QEZUKYX:;-%E[3 M_N,6D_BA#P11>!>0I23D840%D?J>;9)%.ZL,XR`>L!O&`8IIML0\,YJB`VAJ M-0[RT--)9N)^=J/HXCGPBJE-PICZ8Q[@+H^^2+S#")\JN&LR)ZL@9%5?%^5J MK7!WAK((`T&9H!'BD?(4&.$DI!U4@L)TB(+/`',FB;_>0)V\FAB4R6FJ"6?9 MF]TD#B*;SR;L9\=A+3&F+_AB-'-28+F6&)^.&==E2,JXE)!123#"04P4[IVG MRC#F"L;,F4VR79MY:D/%2N.:=G>^;VG;R-1$1Q9O0VIH?P3W,;U@?0Q0^V!.PF!T!+@3?[M*QUL\D7ON?H89ZLC+_9 MN?A%TYZ?<<*;OWJF=QH#M]W7WI_#6V?(W1#`33)]&R,LB(Q"S*BJR$@,:8Q% M$'5#'!$3&LZZ!6T4\DDVINTT-M]J;+<0`^Y:C=7W$;3ED:\[UL9U#J_LW&J/ M.`T/?Y_&/;];]^Y*_UT6W9^6>7S9,&WVS+@QVEEQ-(10X!2%24`S0@($>132 MH`LAB$1HM5*?$+?C$KV_$3O:DS=E%[!DNYYFW[[U-L,W\9V8`=M+Z1@3GJ%C MG8H1ST&-J1G/EK[I#'FW":M7%'%``Q3%,,0$JC]P@N0NBC2#1I?K>`;=&UL> MO(/1+SZG\N;Y>L&,]OS"ULEWY]!&B75ITFYZV'OQ:4?LV+9JETFVP7OCV,XVI$[>'2;R[#E[PHRN_>)> MUG?GVX;)=>G_%N9_S8=F^WB?1N+9I*?689CF@21$+R+*4TVRVE8TIF MW'8["O<$FW&'K4._EUVZGB\F]NT?IZ*O4],RTV*B6=HF4],M2'W.;;=-66D] M@QCRE#+.>$!4TG=EFXC$E)M[S=$YKF=>>U5:(YQXV\V`S$VSP<9MTN;;2G,0 MUXD>%/4L,P[M;'@O>"?&-8(`RQ8U-A5SF-%1+^6J'HDED@(&F20T57&PO9=R MNRMH$V'V9B+."T<;E_[)?6ZRS'OB?BH9_:ANN.Z3@\N!R\IOR^M'MA?W+@C!-(9!%@:,A"S,8`!Y!YAAR68ZFLD0I6.CYM^^ MU>U1JJ#L<(%[#6QLS3U/2J>9[IXFFY[4S[L(W[H/V\L)[5=3-!@01-$8XQ0AC'C^D70!)(.,0_9I///(V#.9G!>U)W& M29V\O'293T^J2`\LSDFNIBD(AW80GTQN9B;V/#>\/];P?35-)SM*%YG-=>[W'RV*S;S8=UI[6.Y1/+NT5+Y8K M4T>)F]O!^^X+$QSC%&4Q"G&<,E5[0P%55%%,$$YH8/=D@7E#>2]N;V<;[$EV MQED'!W/T0T^'#.]X)_:XY$\_PK#=*]_WN,,Z6].,1MPD>;+)]+?'6+U7PUD, M,0U#%H8B#FA$HR0+5(0(HY0+,>#>G],(Z[V,7>SO$#[Y#CO-PH*G?=73\YW"X8K'##W7IS'0B3%G>45EMN3//7]S$.%N)?WIS@DF4BA0S*3`2,I$ M)ASK@#@B,&"!^59Y+Z-XER.?_>:(WDO@I];Y?%G'F:+?G<(H9D"7.Z7YF;Z-.(Q&^B)E\>LI/:WN.-C\M[U;Z&V7Q<9L7%2F'[-:__+%9Z=DC\ MM2Y7#V?%Y;HN5V71J'],BWJEAD3G==ZB;9IBU61ENZ."]^K!*5XC\7 M/*4"$+1P$)<^^5='UFKO/C:P"0[L MHP/_T)_8!@BV$8)-B/\$^R`-K7^^?M#/V4^B"Y@9M\OL@S]TA*`-<>KKBUVE MZHCCSMX[/#'4^7FH/'ML3Z\F@[9.E9`W\4E3?ZOSNNRJ3 M/RZOJ_JV+1Q,YV=L<#Q,J%S3.U:S_!CZ]&#-0,O&<.ZIK(T*Z0V%&T_7FV*G M&KQ:G%U^+Z[6-\7GZ[/\IFB2A_VSS>LB/]CPU MY"-/IBO&CPO?/&0;RMX!SRU`D#P<.HO&.!^_5]7E6C^0K;-YQO,C;+WY5CC6 M-WD-KO;FHI@O]_X-6AFLV\7[U?<"Y+?56MF2^E"]>0PV3T'1/067NZ<@7ZWJ M\F*]G6!??<]7X-L^D77Q37][^\M_JQ]\WWU?V0#5=%&7^ MMJFSJ'6"GOG]P4CM-\W9K9!!P%5KAXCT_&^>I;:&>]]F_D-_U$VBS21 M<80%RU`4Q5D:,1R0KL%,_=%HE#^X%<>6=XA'%)'DT2@>+'YN0@[3Z6N%C(W-ZHZ,V M#644Y1+DH-T%]C,X_ZX^O_],7A=@W6Q61K9++_KF";W,V^Z*?+2&T325:D%; MS]_EZCNX:NL^<-N*6P.N"H5ATUJE`%8UN,V7#R#_H7I'N^Y2;#$X7O'8I6K@ MJH=YJGTP+OM!&:Q^#*6L]TSDYB"GS]>_[WKF=AZB6<2JC(M:2.2RGJ7,UT=T4JX'63^5JP6*,0\P!E+(2>,"BY%N)O_ M##/$%O=%?5'U7A4Q_':3Y^802/\-&GJ+`V@T+-.E#U.B>BYX.&3(3%FV(#X` M!6/JU8W')!Q;TQA(ER>2,1C^T_6+433T%@?]_L5^D^1N0[C`H0Q(&'%!".0) M9>I_NK40DA!'F/3L^@._W=T3T+Y0=;@O>*[7&EYFYLAC,9)*3YZ.L5%45OO7 MJ&=EOZ$XB60B,*-9F*8BH^H_0=PU%PID]`K#T#8<#^LU+$,W'JDO`\(X*C!#:>DW0]Z]_B_7*RUFM_H-AO^T,UK5-;_\ M:UW6Q=7'Y4IUN5)5#9O7('>2%X6)S&B`41ARA&2BRH6815F$>20S2-XR;/<` MW#UWNU-)-KC!(7!=17?0P1[[]NWH7O8_=:(,YH*]2=BP^6''B>LW23N&P]W(3P4QO#"X__3AGR M!NA`M%ITH8"#6`Q??)HTH?V&N;[ETLR:)TNCDU&T!>Z/C+BGS*PGH_-)0Z[F M>Y`,_:-K_PC$_<)E$!$"(R&DQ#*5*0T81%L,*)&1T=775AMV[`@[K7A#4P9L MYG"3AW[Z/EL*S(3<+OM.U-J$R2.R["0AGNBOF]BJ"7JTO1'Y\\)!EQ3+IDC7 M=:U/9EPJY/?%V?KRLBCT3E99-I?YS?\6>;TO)'"6!SWBJQA=^QP_TO>L&-HL`NSU@ MZCK`1FJ&U0B3=@I/_,L;.OK7%C.DRH8J)V7W-CJ$X]CB=+5"T1S6#K+AL]QF#*/@`E*!@BW-/ M-I(R?MIIXGQ,838Z`+")`&Q"\,=B>O`]<);)8B+]-PBKT1K,+5DGV9&\:PT[ M_[M:H(S)-$)$UV4AR<*,I;0#(RAVJ.I]$^=`A<:[H+]*:2[39<" M[K5@;\FUIM.FR3I)>38.27"FRK;YGTZ5U>_XK\KJLW95V21?IZO*1E&.5V5S M4AVI,K]6^K6#Q#.>I@'F*8THQ"C.`MFM9,:(0Z-SX%WB<*S/Y]^+NL@U(J=B M;,B]"T5V1_L4LMRFZ$3$^1'3UA1Z6/Y.4J8'ACI*J\?0:T.P]"F%8%R+P+Y5@26DQ^+^?6XS:NY/&OHH<#[`S0V15UH[1OI$0" M`6:3;))S#A;[8*AM=>(=M]7'E\ST?OHE)4M6=SLRBQ=9!]BG7-M5_-/ZJ5@L M%KOYV,^DQX6NQ"-0=3YK,\&M^W'6$S\.T!-WK\Z%1U&>D"*@<1IAE-$0^2P/ M*,4T*A")E2[FU/QHQS@E7[ZPKR,W5UA11PV)#H6!@4Z_A82E@VK7>D@8*C83 MR.AZ__HXF8D(RD#(R_UW02?Y"_O'&8]I`&KT9<>B8WQ([YJ`8"E_4YW]!!+%DKQJH)E>61A_ M>E&;WPQE&B&57^IF`S/*@:I??5B#V/E<"JVO93T?- M#5J$*?$))TDDUL@DR=(P[-S($.80`-JV[7QAVKG;P!`(0.M"JZ'PEAK#H#B0 M=X2/IT-S$U,1J.(('UW-QTQ(Z6QX]31?:^@J\D>YWLC&,+S>R7;-7ZJE/+*\ MKO:G[^D"YX3C)(ZB(B)^6I`P8+PS[&<9;&%I;,TQ(;]\KW>'=^(''[W'R>;VGMG]V[%PZN"C:UIK8D]$^99 M'-#KE:]EJ0#]J)H+_?:?JV4ED"H\^%`=.INL(`7S$8YSG^8^+G@4D,YF0/,8 MUG_*P)#KS-G)-V_7.]=L$,H>=>5F4_]1BJ_'7O[I+^@NB7`3L8C?QBFZ$S^S MEVTJUS^JS3.X"96)^(K$FTIW(.PZR3\/)!>>W8QS(S*-(<)33M;/`\!>7Q0!_LF%F=+_!@ M"R:/&F6<*0.C2N_&+:Z]&6HP@@PMJ6:""#W?:PO?%6A=QJYZ*M>KKO+JM!?9 M[B]T].$I]5F`>2300X,HXD6,.],DRD!DL&'/,3!.+GI5ZV-[1W/=;/XO6P]/ MM5'0\@L;4JM19FJ58?#I!#ZY-RBNZ`I/;Q/:**@V5B=A4?.94,SJD%Y7/UB7 M"Q#V+.O'ZJN\V_8<;2U(P7&(,0YSCA$*?6'3[XQ1$@/C'QT+S@,AZ91W:.[T M/2_@P$&1EGBJT9%KW:!A4B-9X]"+!=AM`'51GM$(RD3.F4#(PXAD[GFKS/O*$!(CS,.8YBA/"*8E2OS<2$WE@7/T$#.R304B"'WAI[T(V M6LH!E5),0#L3"9AQONDB3'6YI:?63("AZ?S%*E`]"0`)HOJIVAV>Y8$3V9A9 M5A0\R0IUF93B648S2E!(\T3>^\*CY&PSC6"'B6(Q(KQT]3J`L.J\:JELX^S M*5PZNZ15NZ2A^DP(9W=,RA5,VH(I$V^08Q\8BXHB2-+"YW$2!$$>B-5D;PSY M&:@UF)X%QTQK-Y>T5GJ:BJD1R[U8,$2]W(2[&9$NRC*"(#,99\(,+KZD9-DB@PR1-^5!X M[#__^O[K?P')8$]A-7;<1%P8708N]AF>P_/MFA&H2C:")NNJSP1>]L=5._ZZ M:I[S^%0^RT5:EUW/0K$8*XHP$J90E.>I[W<5V(RF/FB-I&G",=SZ@P9/K5N: M1S2@NBD&0.XE`P9$G5HGCVY]'..E,&,QDYF2,\&0Z2A^(S-#V*"">)!D"":\BCP<6^;TS0Q`(Z>P8GQXQUJ;]*I[9,Q, M9"TZN=?7E%4G#[V3BS.!UT7=U%%F)OL\P68XIG',V1`,`KW=L5H-PKO.8)C2 M(&"4)F&:I0%F/.:]02P".R#I-*VXQYMTK#]4`J>9KGK*")M`.#"W<&3MV0 M5)?E&<>3H:3S89+I0-Z"R(HT4/H,JK_[6DKN1U@8Y7%(N#Q>$A;=&1.6$Y]J MT$?#BF/ZO#CZH;V^TU401"#'XND1:'@.Y,8(>JO/=009:#HO!)D,Y#*"C*6Y MBJ!OC]5J08_[];;:[\GR'\?U?BV+`R_`+Z5YG*($?G0D]CJP;:0QC5R_OP$%@*.5,WE6]/,KBOJ9* M=FXROW!.6>Z3)]Z3O,ZDWMYY9=,'Y_"]\N[+C3R>X^V_5]7!6XDUUYW\IV77 MU/2'[,?6_>?Z?K/^UIC>RS-3Q^;\C]P4Z?(BLDRR7&_E#QYJ[_["0R2F5OSD MYMC<='=_/'C;^B`>K,>U7/*+GQ',;5+HQW+C/:XWU?Y0;ROY^7+4[0Z,_"_B MIYL!5;N'>O?8C*#[/_^J_.Z330-ID!#_?J=43PT;H/*AN8XA05)"8!"'E..%^BE%G M/*%4J0^S78LW#Z!/YY.6+V,3>P$?1'WCD-J1\+:C:I6R69FM%UZ? MG?G_"-M"A#U:5^WFNS'_.%MG4.JAMK9D.NU&+MM-8QX3SJ(B3`/DAT2^I3N[ M01B`:@J,C3E^.5IN/*(IJ%I,/JF6L/?=BQ8D+]]SL@?MS8H\`Q]5TS/CF%WM.2S] M[(&)@&K$FD@[&*M:V<#!N+LS;%`R65!U)DRR,9)+1]ILB*.3O5SD-(IB0ED2 M^R1'B$=YUH5L'&4QZ#YPR.=.DJ^TDJ>\+A$X06E5'>W,Y.T2DFJ92&659L(& M+==_GGL$#E_]]LOZ4:SGF\6XO$RI6ZXOI4G*2!@F>4+]C%.?(D+"N#-).`:5 M+)K8<1R'#%Q[F;.0SGF_?*@/E8>B7Z'W7IH(J\:0J32%,>6UG"_\FOI2RY\K M-$(=&[K.A$)6AO+ZVDIK\H`H56^;8W+MM6Y%&A4D"3*_\(L4^;'L#-G920*. M%C^JW7T-@1/HXR%/S]`3T$-4;[V]=$D#/#"MU&GC3"0X8H0ZC2]W[6VY=][[ M_?Y8K6X`F*$H5ZBBI=^,4*+G_P5^&`BA7@V]6C79Z7+SJ5ROWF_S\FDMU@&+ MM"`90WG.,(](P3DFJ(^D,`IAM=":-AR'-&>W/'G]P+OUUENVGD'KH74U5&/* M%/+!T#)03KKD">7R:\JY*82^+,T(8$S%G`EGC(?QN@3:BBR0,QA=E]0FER-H M][2KOE?;_?I'U=9A_U;O99_KCP]?RS\7-`Z%W9"B`F%69`6E>>]&(19VP),9 M5FV[IM2@H>SIYJ&AP]Y&^`H_OV%7?46.W5!X(-\&FK>9Y!>^=F=`?I'N_MJW MX1<^3W\.!*+H&!8=S&]/DCB441FOGRM9M%*M6+F3I2O[@5M%];!> MK@^+",613])0&$MXCI,,BQ7IR7*B$@M:6"X(RG^"(906B M6>9CA(,^-(MHZ&ON\NL9FWKKO[_@(S M:6?")WOC`?:G!`JE7A3Y5.U*N9_X6U7NJ_W'A]^J_;ZJBO5^N:GWQUWUM?KS M0(4$OR\0Q2FG248%/).<,MGLFQ5%A%C&<-.(&U`D:<^LX^"I=1!:*6E1536& MW4A0&,UZ)[W62YGI:OWTSHYZ__VUB;BDPU[C\=1]>M6U'"NZM#\A,V&@BY&] M+LIT)9XR%[M#-WG]>+_>-L>Z+EE/<)JS,,ICW\_B+(L8*K+&>E&$XM<0PD1+ M)AWS\-))12@>;8FKAL8;Z`K#8B_IP,.70+P9"M6T&\&@9?%G@D#;HZJ=?F.! MZ'O5$#T@F`4%#D(4\R*A:<3\N`5LB#!EJK63P$]U][3=^A8`Y5[_FHK-Y!'1 M];ZV\K4Q3@G+(N1+SUR,>1J&1>PS'&5AD48^3SL'\I0$9IEB7:N.W_G7L@ZN M-=7-*$\AIX5$_C2/"8L#2(_2DB0TX13DI,4YT7N!PP'JNE6(QLN'\V36S(K(1WS M&L]N%RB,Z33Z^%F0=S9/G(VQO'G(K`FD_%Q]J`[2UJ==_6.]JE;T^:][V22V MSW.0Y6']H\W^=IXD14H0B8L`X0(S\4O(6.=)&`2@JX$!4)8@-O)W[GKWS]XOTF-OO?W5.R=QSU[? M#I)P94?0Z7":9@)4ER.L)_O.P^%[KI=<4):G499%*0X0`0QCFD1:%(6AWZ"8. M.B;68$SMO6RG434-1KL&:W7SIZ4,2)X&`\KMH(?JV*/A.."4W.IY:MSSQI\=R]WO5KHKWU?*XTPFI+:FN!L'I!8=1\.S?*<2] M\U[+?W)R8@XJ"3<"0KO"SX2$E@=5N_RN:K!P*\1]_KMXJ*NB_F.[*%@6Y'Z4 MAU'(,\:3A)(^C>(C#FHUJ/'QCBG7A-M[^8P]U#NO^G/97+0@@H_Z?B\^\E") MM63KLQ[BH&*J\\RACG!X-@N$K3A&/$-*4Z M[^ZE6TT7GCANR7-;'[6&_2+!8.Q9%S.(B"_R"4)3VBT@: M!RF$-T:&7"_?-IOZC^9&)QG8K$[>>>7)/2!\S"150]!D:L)`]#)"[!SSR%4A MG?!H3*01*EG1=B9LLC.6VL&73_.ZK,$5\&0K+[O)Q5^NA=TB"!.&XRBC*8[S MK$@(H?TB+T&YSG59VL99/6R;\;79KU,[E&4^J6E)X)Q>R-YR>79ED2"I`Z6N[D&>RB:G\=;EWN M]]7AO&V9H1!%<8S\E(;RLHRH(%&/4Y2">FC9L^J8;[]TGOXJ`-?^3@`.6IAL M46353-,M](4FH$YZ_M)Y^:M\CPP*0!I/;U?\H2SB:-;*]D3,!(0.!O8FQ^5& M.@,T?JZ$Q?7R(!;$Y?[[(F81"EA$0AS'F9\)-Z+^+`D/.%MLJV^RW^%7$S`" M;2H]KUG[O+YQ3_G9/3O5%.X9XQ`JK"X%78AI$WX#7?-172<"WDN]0)S3E'JV M>-,=SU6J&0EE`+-NG?RY6E;K'[(L0/8@H[C`E/"0XCQ+TL+O]A!"G%)L!6@: M=J>!6N>8K%,^>68,-AV1=>'F2EB;@.LU_JR@\420>ZL;"'0&LL\6=B9CN@H\ M8\$,H/?^7!:P8"C,[`5V;;W MA;2+X$7.DC!'!2LHY;$('$-:\,Z;B.;4"L6L>#(-WDZN>E7KXZDLK+F8IVS\ M-(:>G6G1I>%T4V$3D]VLG-QM)J6]+8ER9: M9LM5.Z-3WU$Q%]%")O)3^=QD`^*" M\XQ'6<0I3RGG08"[%&B(H@QTG["Y-=<5?UU&[*GUQUK*45E-TWRC"R'M)AL_ M79-VXDSCR1^M-"-4[=DB3GM`R@E&/:GL@>QSU5QW]ZG<2:XNXI@QEOE!CL,` M,?&=P0R=X](0>!;5KNV)(==V@VEO@GP2+D)[#UN7WA(#':KNA(AWWLEC[^3R MW!#Y4E`38&I.S3\+/G6'!X6ID8QF:-T=J]7+:[2:5?^E&';!*$E8Q@I6D#A) M\C#"M.NQ$L8L!MUEY=P9]_"5WE[*B`ZN\;-!8*LS9(#D6TV.+48WT_7Z:L`V M77IQ@3\':@,TAV+M.QJL">G="FY-_4!C?Q?6,X0(3\<[)0X12'B>< MI'UM3(,0O,.2&:HMF0:2$WU7] MP5%C69O"JR'S1IK#B*EQL#N9@)-UV,3/O6`*!XIM1L&WA=[MC* MX@S["&'J"W"GPGJ2]Q5?'&/0B6X'YAW'FZ^O:EEWKMJ_JL5H$HQ(.I7^5HG: M.SV+9MEP9>&0M3%-\X:ME1&J0=>>F.I-?LKG4S?MYGKI777NF[A?)-P/HYBD M?A1RGV4\#\.N.V)8Y`71*&4ULC=1P:KX^^^ES,O6#U9ZM)IIK$91][KJ=?TY MN27W%T^.>0//IN[Z,R+2"/JL:#L3R-D9R^NN/_8$@G0G6U;5:L_%$/^C/)R> MS*8>M76&;%=YN=GL/SZ0'^5Z(Q]A7N^^E)OJ2_\@+_(\)&%`,4IYGI$(M+IG0O2IQWTVXYODTNN]9*0%D=]\/VD MX.*+B]-"1-8L3UG2E]( M@J6G=XWN[+KNTR09?JHB).5@/A5S`:B#D5U+1]@23Q^>]+A?;ZN]X,.'ZO#Q M029_3_^R6O@)#P2\,T1C/Q8A,">\CWUQDOLV\&EB?QJ`-N[LU]T]3?>]PZ;8 M-))>$YS.Y;:&SK.G=\W5L$+Z9G^K<_?6\!Q1$H)/&Q,R5X!:&=LUA-H3T$%= MP(*2PF<(96D4A$%$<1BBI//`+TALH9I*Q^Q4U53'=O_Y8B&`LSJ`ZZ+;WO^W MJK?S??_9;O9;V>17GHN94-/%R+0W]8'BF1*3K[?E=OF3NZ]%!!SG/D>,I=C/ M`UZ$9T]\%EFHI#(Q/W$EU4/GJOU**J-),"+I5/I;)6KO])PKJ4:4A4/6QC3- M&[961J@&77MB7H7OMT<1`I_BY8\/79P\6,X.#VG%"8VRA%`4AEF:($:RH+,= M81Y#F@-:M3M1DK3U=KB^%Z`]K_OAIU_MBC^.V>D%-UGE2Y$['[UA\%;'G7QY'<3?[ZHG>?6T^--3 MM5O7J^8"O/I^L_[6V!"/P$Z,2?QS$X+(GRA?YL+*_FFYDY=Y;8[_Q]VU+3>. M(]E?P=MV1[BGB1LO^P:"9(L?>JIK9AWU0R!+MXJQ,ND6JNFJ_?@%>=+,M M`R!`L7=>QM66E2_[MI'U`A$O@9!',67(R["?<#9TKR!Q1I2Z1%P)FN.=B@R7 M7TX*"(K.'?#2^B-TH@.LI>G3#Z#*$COKL3.L^9#.@,$;T+L#.G_``'B?@C]V M"DBONH83_<>&IKUZZ_?T8ZVSTL]ZS,UB@GN5Z7H#EH]"#H#8N^Q6[7#OCL?^ MT!EF^`/P.#P.0_N8\6NV;?+?7=VO-LJSB`.NYWTUBZDVHGAS`'KWR*OGYZK\ MW%2K_UG@)(XYH8F/<1)RSM-D?_!$8A(;5VR:69L^`AB6$[%BK%J@H)9(1Y1L M&O*L>$P^*<6&"_7CR4(MC\,[9C]?9M9Y/>:;A"D688XC>R9)18L.72BWM$&5 MLL*EWU=BQ_9E^3W.R_RQ:-IZSZ_+;1XOZWPM`$B!;8..-_*9"Y;R#&8D#F$6 MXMAG0<#0`(H$4*NEGELDCI6Q`R_[+X&'#OZ^EVE3@;(J_]@M-\5C(?[=ZB.H M7MK$BZ9..AXM-0V=ST#IZ6L_1O+.]!YY7P8OL?_R(,_0W;YX`3:R_H\B^ MH,W3#.),='LB9ZMKS!-GY_.++(UI%C+J!9!EB*7"Z-"ABO@!]BQ4-)F8G:JB MZ:@_U*\_[89#X;>.YYV=SG\\!+9/Y:VR[_PT?K9'\%:.WI7'8B8JZ\(SXZ-V M3?+4X^7'QWS5W#T*IE[H#_U0"4)QJA4>VS3L.AINLL58]UJL:X:V>\('H.!33W0KJ=W;^.*'([A3![(:3%Z*6UT,R$P$U(UOYU&I M.P*51?1M:_=M:<)Y#]4%3;#G4TQCQ!".PIA&=+@'FG@HUFI3:M7P!(%HT6/Z M]>3:O"X^;4LIY`^YRIR>8!S4%/5J0Z"GJ._*Y@WHL((W>D%/+*DZ5%Z05"-;-<$C;452F0B7M]L?(C+^YW*SRQ=>&D$61Q!R/\XRDN!DWW2:<)RA M15<>]KE9;ILQBJIK5V<>GT/4G]+GJGD#'O*GHBSEYE*^.M\:F,5Q*; MCL.L9Z^Q4TK3=AQEMN=K%.`D"U(O]9!'4AQ!A`?C:4S\?KZFY=KJ;/W`JOYL M'0#:F*NYK$?Y_SU+%?G_:\U25:?,9JD69^FD,O81F:13#?;*>!9CI)'ILV72^TB3E-D[X(TVN9_ M)N)HW:W*[6.K?367D(Z\;NZ7Q7I!,,S\F)",(>XG/,KB<.@/3I(`([V[MS2^ MV+'4#5C`BP"C?966#D%J4N6,&ST]VM-R?Y$61]=='2BX("I&3,U$.OY#I=;"3.A)P2%)H&7$NJE'%(OV;_G@RA,-*_@T_INYTIP@1IH M4J4J".Y8TM6$DYOPKJ`+)TQHE_'#[2OU#(_EQNUW==G>1OXH--?5MV2=7_RHNGKTV^9M_R[?(I;W^9+)L\ M6Q;;?C]((`\901&GB&20!3Q":9(0F`99&%"\$'_Y4"EOR6:&7F?^'CNJ/(T' MB♉/$B18RS/EEWP+:NDM>!2`P3>)6'=K-S,^5;>(,X/M<*OY3DDL.')6 MEF<=?VYXZ;_U^`;T/M^`SFMY;-GY?0/V3U?O>O<1()T'TGOPS\O/E)L=[+2# M>VDG/-/';"8KWVSI.=^9SQ6G;G3_30"KMC^2?8YOGU1@@4^\V*,H1M2'*&,9 MY:W)),41QIER^&INPF4HVZ,"!UC72[!=X.ABD#N>V9E,>RNNO`I^;=&C'@BO MON;KG>RGOS?.=]NM^.F+[*W_)?_>Q!OYOA?!'"8P1A'S&64PR3P6[^V33.O% M4FM&79\I]#CE&<(>J6YL:8U@Q:#P&MQJ1G-OT7H#>IC@OUN@0"(%+=3)#P\4 M*;P4,]D>A9FHGGV_SJ,4-\1IG+`^U/D?.V$O_=8>[`[ZF\$@Y&%&DH1%7DQC MR!(>\Q`CPH.4*=^V9OS]+L_Q!DB@PW3-8[NWV;EX3C>2T+G,K-%^O#J)LT*, MZI%V:>1Q"FU.><,#($45'*.!^I/8I6 MKJ,^'3@+^J/*I;$".:#1B@9]R.!4*M0!T=,A35+GJT2ZCGRL14;4F*K1?^3/ M#_EV$1**:,82&J24LR0)$D2DL0BG'H34&Z%$BA8F5J%QNJ/*FI'F."!L[.ZJ M@W1EJ>E`J,N,)H_SE!A=)R[+BQ$EIM+R>U'FMTW^7"^XQWTOHY'OQ7[FI1%B M/!ZDS(\3/$)=U(W\I01&@SLCC7%#VUB9D:A`"^O*4K.G1UUM]!F=I^`8^'%9 M#$*4Q)P$H2R8Q*D4>KW!AFCGMYQL[&5OY3PZ+!G=ECEAKC1 MIU57/"E^CR"-`RM]4N>I/B:.?'!D94J-0?6+K%GK"N+*]7^VO7%_M/W;5M5. M`#G4XQP@(2^@.$H\%!`"HX1Z"21=?9M4REAOW^40AV,-VP,&`\CV/?D#]OU_ M-RZ<<3`VBOHWDV'15,BC\IK#Z+PS*"?%A',HN=%F6JD*Q]WXS46,IW#UW5H= MU_0:"/JG?%4]E<7_YNO;M5A+VE[GK*[SIAXN:1=8CZX#$[_;/>?KLRHCFG`( M0YC@)`Z9B'V].$H[F!AZ<6!8]3@-M@F+(SOP8$#?BLT1?M`[8+P"3#28NJO" M_,;1?*4X^`(.SJ@.[)QJ-JT,BM*B,NWPSVZAF=C]=Q>?:PR#P8+TQFV4=?SC MZ%]\?P^I^*DNQ#BV2^H!HE@N0TXYY"A*H\C/XL"+!XAQQ#.SQ<@]+L<+T0$? M.`$(/E6;S6.UE>\P#4W:S:OW)Q@^W>5G7B-GOO2\=2=S+5_G//KW#7AWF&>T M]HP>$:5U9[IQG]V:,Z'K[ZXW4].OOM8TRR;OKCYN[^CZ6FV$[5JVJ6M^',J_ M4XI"Y/$DAI'/(NJE+.`895&4$$0SY5,I*\8<"LR`3RK,,<)_`QW&*[[EH$+= M)26P2OUO5;14C MHTQ8HD$"(WFA)>A6E= M,1Q!LIO.M8JD79!!Z[S/1`GM^W7>PM8-<>9Z^/?E\U`ZF5$:44P1C64#W9C3 M"/J#R3CC6J=J8^RXW[,.4W$(3VZ`A&=:73V*4T.=HMR/$$NAK#;`/$@'`XF7*!T" MZ7^K8P426(``HR@S!J1<%A6W?.A)2$^%0JWT6$[6U6K7]D:62^R5N#G!8"*S M+]NBVLIKI(NR:(KE!KSL'C:%$);'QWQ;E$_*>BO]E"I*(.HU])7G;RBF.3M7 MUL<1P*NQ#X:.]MW*!-:_=N5*/B!_%LW7@[F,QQ@3#L,$\]3''O?"9#!'XC14 M5L(1-ASKXFT)CJ`!B4U7)\<0J*":$W&GIZ'OT&:DJ6/XTU#8B7@%ZN M\_::O7."FZ_Y>R+\M[$J_#X[[VFR!3[GH-`VW*CL/F9:D6M5-P<+(?4C!FD& M`P]3#OTP8&R?T52\`L'@:UW'K@*,=O"JQXM*].J,$LWPM6?#+'[5HT4G@'5& MSWA%73Z*I\ZI?)YX_VX4:T31'$32$'DU^OG03C4^/U6XA`CG`91 MD@8HB4C(.<2'D#E#>JW8#0SH/.I&W=);-("##IMV(E&?,=7\H5.J=-.&$@P8 MJ+K2:]*O*;F8(C3F;S:907,/7B4$1Y*A7U71'1;+YME5*=].:H](:`JC!*>4 M!EX2LSCA&>.#4;F@/>-XG(GFC'2BLOEH:6K,O1C[ M?+O-U^WIZ[!I\RA*8NY1'!`1>*$@H$-]"!4"I]4DS4M;96;[%R05]&D3@3>1GG0V7QJ3+*TAP;(HQ@F&9> M%D"41J'O!4$V&$(,^WIE8+K?[EQ6VMR#B8X8,*63G'%%DE%NYJKR\8J/#Q,S M)MS-1#A&./!F6L:<"F7)8.MU^Z[-"WYNS#`$:QOP>0<:*UI[)GU;6,'8""%BDX@0HZK+J29H]S17F["MV: M4J?$-/CI]ZJN?[Z:^JD2>4D)K0_&7%31OF/G"NF(.F6U_)0WRZ+,U^ER6Q;E M4SU8XQR1P.F+V MBJYK"=;;S%Q0IY%4SD2*QGI167V^3,_U?S]T.8ZYCST_H%P>RX4H0W"HQZ0^ M#S1+@PP,."\-.G1%N&;'[E?$J!PZZ[,XDUDRQH/WCI=-R="X9GVUS9=UGN3= M_]^6K_LFR/Y*6==?:4&"*&9A+`8\HE%,?!)'0_T>]0AD.FNS;=N.%^T!+OAI M`/RSK-9_N^>(Q`UZX+H'U=;'1&W9O^9PZ,4#+D;"B0)J4GI!'ET-SDRTTYE[ MU33/N&Y,\G4I'N^[75,WRW(M8J`%S3*$4A3+-_LB'L7(Q]'>4!BDBY=\6U1K ML3!L&\6P1-N&SH0]AZ,\=^.E^.2GV]O$A@\A` M0/2-3*(@7RIY8%.?+/9YB^\&/.1/12DWE;))2&=A\DW/.6L7-SW&%,]E\HSP MX-6F9R09&H?*_]K5S7-[]4CUSCE1.Y%5Q,!=@!M'D;5WO\G6RDV]%=^:[ M:+;]Y5W;*[!.O^?;52&P+TB88<)PRE($DR"E&!T.!,,PA'JOPUDW[S@3.`"1 M068;AX*J0PA^JEO4/U\CZ-2B\*.@U,UXS$1!7'KX5E#KDLRQL[Q5EK>!>&'& M/()"FH0\#F,>^NF^I#-(,=<])K-MWWE8^NX\UWX9UCKUBEFMJW*NF?5J">[` M@@YM'_;=M-?;R91A^Y$>,]B#GH?8OD^JOM9:&*!Y2ZT-!]64UAJ55K,+7Y;? MT\?'?-5D@K%V,8C/8\(%1YDO!#]-$X8)Q7$<03K`B](@M)]$L('*N2@+D.`A M+_/'H@';O*MP%#O-LBK_:&\DE->9G09E^??5ATIQW9&TES:8>@B=90?Z`E4Y MVG$_VE)=WLT:S#`?H#`6([?]-D=[)@O&Y&X;;.+MTV[>4[_;2?1O,.=KN""9 M3V),4NBE0>8G$:&<['/F'O479?XD1?/+B`;[VD:5)"7J).45/F5Y.>T17W<] MXE<#2H7-N2O*U?1](IKMM=_O\($]P&MWX#_GZX*ZVN-Z)KIIT:&/>O*/I,I< MZ]BSO&?ZR'",2,JSS$.,HP`BG\B?AB88&:(VM$[;Z!6U;MEB/4C>6*73)]Q0 MZ=R0;$_I.GSS4;ISOG24SICKN2J=N4,?*=U(JL9&=5TV`RY\/_""($P"+PTA M\Q&%">JMBE\A/NJR)#U3CD]6WE2UHLL)V@W?E+D=%;NYH-5>X-:AN[:6G3"E M'[+I4CQ7%3/T1BU8,R-I;*0V6.649A%+.8(>93&%U.?#7MB/<*1UH?E(4]?0 MKSXJ*SZ8;4Z8'16/N2#57C`V#_4Z84H_#-.E>*[J9>B-6@!F1I*=^I>_YW^V MOZH7"$=B,RN/AB`)L\"C)!MVN4(Z<6"MYD7=I&,UDRCDRQIR[JVZ9EW=R4J; MB;^]O[L!9=Y>O)U_EYG/7*4`QND0C#H6=\F^O;/PX>T0@;/[Q(5JA.F+C?;L MF188Z=,_$TFT[95.(9$I:5:*AP[&X\S#%#)(,`V0Y_.8I<.]ZC[,0JU]JAV+ MLQ-(BY5#&KR/KQ9R0[GU"J&YB>(I=X:%0/KUYKZ2_ MY\W=XY?E]T5`/`HS!$F*I19SY"?AP234ZL@_QH[SO>YQ0['"I'7;*!95M[;3 M$*B[KWVW&9L4L7;)$`C%7K=IML7#KEG*WN1-!>[%\D:T'2!^&*,H0"DFB8=0FH3><(N`'V8I[M\:3LNU8M2F;4%G MCIV"49YLRBT'9O@NO2I],YDH(QSX\%UZ/2K&O$OOA3##&?5BG%!&&.$9&7HM M^1BED?:LT#TDF6:W^UX9]C"F7K5.*7@TI)A2-9,IH$Q_//%8A0-&HF26FQJ M?JNJ=?U9K$P+Q+T`(X9\#T;0]S#&`1S,!"C2>NQUO]MY0J1N-^Y/$A"H!2+M M=(@F5ZHI$'M!QC7^*=&<^77@O-6&`="(%[=]87F,:!3SV2!;XP@?TDPWO9\W'JZ5U&,\:28R4:P(%EN0;K M`SSMJVE&L:DF2=,1J2=+)QP>(1M4:O+K:B[0=$&=[-`[$X6RY,RK.VSL4:2> M0LPWXK=/O^6ED,B-,,W6ST592'ELBF_Y8%T83Y/,RQ+.HR0AF>>'WF"=K9]NH\>>R"-&4=E'52O"IED)B7JQ]LM=KNEANQ3_U6R'='%CX3 M)AE+,(MPEO@L3=`^4(001CH".-:68^7;`P&/U19LBJ9X:OO/G/PH7/CUIZY` M3_?%C-%4JPG@E"SK*9]$!HZ@@1[;#=BCFUCQ/N#J@M398GDF&F?-GED]M2)FXFNC+"@8]R69I4Z&M'5]0B%>S_J+NZYK9Q+/M7\+;= M5>X9@B0(^X!>7!Q`=PK@J_0AY1%*:9AQH(TA:@/OB(?X<1(/30^W[%^[-\)HZL' M1HQI*H(AN$J`,WN18=I>J8+-GA>"X*9RE%S`W/R4_UO\W-$C493.A,=&N_'JX/]5HA1UIZLVA3EPYKN-AN9 M+[K9Y.LZ7\C4ZX>\7,MH+2WNQ<_(FYU1@H.8HAA2WX](EB08!0("34(492$F M.G)DTZYCA>J@@D6'%6SW8)O\M*9<6:5<3<'.Q;:>J/5$]S#!`4X@@0ZWS.\: MM/*6^<12IT'D$?5S,1PS$40GKE7NGV8[2\W;-,Z\)(@Q1JGGDW"8ZTKJ[,";?C7%NW`.LB MDE86P59ZI+V*G0]G6E?=YP'9Y5K[8.NAK8ZW=Q7L?>V?@=8#T+H`#GPX;`PF MJV#R'V(E(22P7.>;)W"Y+1YE:4PA;.+3!.BUFESV=Z<H>LE'&$ M&V^JV%A:E!7GNM@>[)1#$J0QI"&D*$$PP9#1_C)&%$,8Z03E>I_L.&R6=2)/ MY1".!T7S>>;Y9BYB@_EQLFK)YPXU)EGD1AMA' MF'LH2;PP8'VUAL@CB5;+`F,CCN?8'I:[@.Z-ZC-Z5.;8R=A3F^2'4@3 MF-JRF.>[/_T>/4>$932C,]&8\7Y4EA^UD&4Y2=TDVM*AT%`7739GJB_:;IQ0&#-:E#7F?XORX:OX?/*]V.0/ MQ?7N\:[8?+I_57!\B)U@B&/JQ9@2CI''XU!F1SL<,/*TCI!:-^Y8E7J\(&\! MMRNL&E1[J+K++?O\JVG96:G7$[F!]0XK:,$V/3!;_@_P#OIWOB6<+K5'--+9 M*,U$/-WY5TWTN#N2VS:N))1GG'D)#3T<2Y''I*]"'`7B>RZT5LWR#)>4EJFU M*Z/V676JH>=8G6I1:4$S]8;D)Q-,3><,U=*$0IV=\DW3BR!?T::;9&O^L`?8 M3=4OPHOEY_RI:5RPV8CGOFCW\/TTS6*2>#B)PS3SXAC%??."*.&15JOU">!, ML::6M:G:KIS5M^;$A/X.O/-14=ZLG].`:._K]^!!B[[7X9<][H91X_?WQ6([ M*/9O=](KT+D%#OV:_F#`R($X?H9@JE&>B<1/Z?'KDPG3DCTV;N[6>J_;HY'( M"R,>)XE/?)Y23%-*AQV>,$XM1,[&MF>9.K5.\*CX>1)NI\A"S".&?H]._2AZ M],#,1&2=N:<625NB45D^R7I;+KM`XDNQV&W*;5G4_,=BM5L6R_8P[>,WH?`R M)/QT_VKC_+':K;>W&44T@I"E:>31*(M"+QVJ%21QJI7ZG0:18ZF53ORV?!Y6 MRZ:1W_.5G`Q!T;G3GO'_ZV7V>)&O%KM5XZ&F6D\TGFH:/K^AU%/V0_Q@[P#@ MST;OP`>I^6_MO+6>3"SY5M@_,A%,.[HSF1XF=KHZYPNE6W9]\;58[E;%I_NF MP6KZ1%=Y7=_(M<$MAQ[D/(Z].(A@$D8()CR1G;M##"%.M4H-C['C6/9[:$WL MUXC^W1-HX($_&H!'=ISL]8YAT4T#]?9J.:*0-B?%9<>5D? MW1H]ZHTVI87.WE6Y+IJ[D+>8AEZ2D9BQB)`@HQZ+>V,^#KA6+P@S"XZ5J7UU M^I=)M^&F&6=J^N.>+CWE>CAVV1&I:W7Z_>$!AASSE+?SV*/,DZSH+<9DLR[%4N_NTJ]I>\(4SKOSB$J M]5>HW;=HEKT7;QR%FKR;[?MD'7N=;'`\E[?*BB^OFMY:(\A@D?%Y(RNC;)\^ MBT=/7MZ6U[6;[E)M^`!C3D.6TB@(8LA\3W;BY(R%OB?L0QZ8K3A&&IUP^=$C M;5H0#3!'+T/&LJZ[)IF0<+TPH0=V`1IHNC0[7J,KJH!62U21P:GXMJI\BPTXD4(&V(^IGD_29")]5ERIWSZ@MN9.& M6?68E^O;`(>!G^$D@P'G63MB3.1/`/:YRYY)BZI2IXQ7>KM/,4S][&0QT1N4TPPS!#T$$O3.(8^ M29/>0HKT*@=H?*QC`9-(=/MN:G"B)D..Z-!3&PD"_-'"F%I.]@0<40T#EF8B M#B;(7S:^-'5>^55/=^6JN72V7O9_O7R4I?':L[2=\820A()JJ88E>-4&9GED]K7E&ZO#%(<1S*9$211@%"*44!]L2I-@R$X8[ZZ,II] MO&-U[$`UBY6%A*6C`(:$*>BD>Z[TM/*0I@:1D6(:\J6AFNYY,U/.5_R-U<\W M'7U/0\>Q,@<='>E!9>T1L;6MV'3CDCG^'D#D8Q+QE*3(3RA,,Y:FI`?``\:M M;"YJ6W6LOFV3N6^'&XV%X4K6(M,C]Q>=DFQUE[&EOX%ZKN6Q,HLF6X[&(S&3 M);4#QU2W'T=2-UX@KX;3]8QC&H=A2+V`Q&D8>YP.EEFJUTW!@KFSG+JP)88: MK(Y403>$6I2_<][$.0ED4 MIGY,/9PF(?+XL,-!?5^K2I#6!SM6JT,LFAJEQX^:&CFC1D]WU%AQHBR'IH]H MB!%1,U$+,^R5A2?%5FSS>UW<[U97Y;T\O9]`!*.()"S!":%,6![R>#"SR@(HR3QF)^DG"1IC"`;[B-![&GUEQUI:LJE6K%_!1\D.%ORIDCJ M2&6SSZ=54?MPG-%IY:P!8Z)D>B3/7<0TO5'5+Q.2U*L3+A:[1UD(KU@>!H#B M[ZM"_D4`(8_59EO^N_G^NR!O81@&`@U'?D@(ICA!=-@N\),@O%T7#]+*C4:= MPJFP*;W%2?L6OW)#^8V^*NKZ'R#?.P66YUL5V>+VR%L_^?#-1!^F]_ME#;OS M$#\^7+HNMO(81\Q$@!91&A%(:,81'K+J89KJ-,D>94@K5-+OF7TC?V4N$[C@ MPV3ZUJ%Q)B^G'5]4IVY]@L;6@BQ^;%/A[Y^W`:))"/V,(A9E/(U#/^[,)C!. MB=8>T5A;CE<=AT59+NMZ)\O\BFCYH%9.7R:\KW!HIT:D.M=J:Y$I:=9;C)RL M%0DD2M#`G$G9R)ZU([IFB^^92)LU=]1*2!K2I';P,LT7?SYLJIV(5-;++[O' MQWSS).R7#^OROEQ(E5TL9*5=\6Y_KE;EHBSJH7T<"3S(PP@G@1_'C$8124,: M^%F2I&GFGSS-XMR^N]7U!_#YT]4EO>1?E!HV3CQ*&F<E->BK3V7DT^W_'3G,4;I!S) M4XRA<":YB5$N5/:>*$U%N5R+=[)\_"S^4RUI56_KZVI+5I).H6-=,3(8$(]Q MSC@5I@GR(4-I;SLBH=9)5BL&'6M.AQ&T("]``Q,(G&``:EH,T0[?:L(T.=5Z M2F6'94=-AT\S=T3.K!(_$WVSZ].KUL#6"=/HN%%O/]U_J*IEW>Q8=G>?,`I1 M1KF(VF*$N8]YAH8(+LL(U.KF8V;"L#5>4?!21)(L1\3C+/(+3B,$. M`_409Y83B>J&9Y-,M)_0TF#?6B+1#?'NDHE7*C5,O=8EM?Y;NU/"?QI10D739$ MR1>/1QEA6X/6FTR142C_:M.\;B@O>[1_&SO'J)'RWM1B MF=(YS"BV7:KED+L'[I=I]LD MYGX:1^*#,U]N-L&$);TE'B*M?N8&'^\XD#M`!(H6DF;RTX0RM<2G8[;TPK%# MHO@IHMS%8_-I"Z$Q>KL%C]^O+YM?KT:O%4QR^MTZTQOT<5HCV MG*EB%4WY&@Z\FX,K_S%6]U%TY+MB8=RCF!3TUR\'*]+'X4RYNJN7B^ MJ>75_^U3>\P]#F$:9;$/@PS&`<>$I)3$F+*4^,0/M%($XZTY%O$68`TZB#(. M:D'^5PU:F)HW;2SRK)97F)9B/<5OL8TBUTGRX21G1W(1]OB>26K"HD.5JT?3 MHLBU_VV.WZ,$A9`2%'J419AE/"9A;SWF4*N/I"63D\C=T1?2Y"*.+;['*YXC MJJW+WCFN[ZCQ9BA]!L3_!/IGXI6&"!J39B?<$Q_5'<.G"89>2!#T/(P#)OX0 MWEL7H;Y6]6I+)L^MA!=-/QW3*T&V>+<0`[JAW+(B*K,]?3PX\&<:%.H/P$^@ MC"9>Z82'IJ194<:KX1`F]2"%B/D0,A3%2AO9)?\GT$,#IS3DT)0R];J575] M70AP[L:/\_(`NYGR$&PY"'+(M1B%/(>V2!^+Y6^.,>CNO8 MJ&FSNGCV\K<[:'__926\^/4?NO'0!".D&"S-:W`T(ZEF7-X4Y5^D`[]>`.&# M%&ZY)7HVG1[/\;&`:[H!G(F:3^GQRU!M:K)':_[O:V%^)<\!_'>UDK7%/XBE MM83[:?VE6.PVY5;6V]PTITJ9^'+]T.+OO;GU@S1(1.PIUMXTBXD?(-_K\48T MT"K,?C:0CN>'/7[P(,_-B=7=8[[YL]@V96_JP84+L&[E:*M\]N7LU(V<1V8U MM-9GEX.![]P#TK_NW^5SL'<2=%Z"ULVA4M)^AIK)M#1VR`PFJ\F>DIE/8=/Q MH#BQ33PPHZ>[K-H4Y<.:[C:;8KUXNMGDZUK,NFT7H>:K57/TCBS_M:NW7<^3 M=MJ6'8;$/VRWF_)NURCW3?4YWS2-A>*,(<;"-&Y6:0B'T;!."U*FEPR>%7+' M$R/]*KZ2:Z5G?<3N6U?!HO,5;/?N-1-HMZJR-$6>Z9D8-V_._W&P/IEV+H/> M9W#@=-,AY\!ML/?[<`:]`)WWX-!]F6)O"9C)#.MD<`VFW?,^9#.?B\],CN($ M/8*C&"4X(![/&"8H37M8B".HTVS/-1:MF=6P'Q^H3B4F7>0E MQPR0Q:3D1&/C,"/YD\Q6BJR/S5%:&,^9SRC6W37)3EJC6:,F[RM$P_(0>UF` M6.;++C^4!"'Q$SSL@"4ATU'T,785Y#:'B/.;_;R4O,R[)>B.5) MU]I&7DY^S/]5B86,[-3:EJ#(^S%^53<-U%^KO^0&BOR]]CKT!DA".<&'VU>_3S]D94,?&#/(<+XQ-Z6YU%+;2JY@^MF5_@(P=O M8U?;Z@4)IF#*8!!G&&0I"QBGL,3*?()U##)," MFW!:;;WYK7$'O%IX7H#6)7#HT^DRJC,86K5ME]F.JOFT/&)`M29K-_=[+([' MLP"SQ$QYX/D91YOM9 M0*/$9T'$:>1'L:K\C#'A,OW8[-[*"R1[7.>[2W*$I".ON`UJ9_+&6G'E5<=2 M6_3HOT_\1_YXF(&YC7TOSG`FVP(0B!F#\H)(9Y#[:JT"QUMQOODRO%4'T`Q+ M[HW@4E.9G-)HK$M:#+I5I9<$J6B2,:ES4R1S1][3HY'4Z!W,:^.,KFEJ2(@7 M841#$D4>20/,:#@8(A'5/O*N]>F.U:<]I45.M.&QQ93&F3=G))F<8NMV6\_4 M$OD5'Z?.EQEQ-Q,)&>'`6V?`1E`Q*H"Y&JJ58!)@(@8V0'Z0L"`)(!NB)NA# M+?D89^DL@8R%`$:#2_,@YC_D7=MRW+:6_15\@)P"08($YXTW9%SEV#Z63U)3 M>>BBNBF+DU93(=F*-5\_`&]-R5*+(`$0\CD/IYQ62UA[;7"M#1`7-33**60^ MK'8&TEFF!"L:<88-D21)P4RH;.92-%FJXNPZ*\MLQYIME?%#GE[E^V;OXL>L M_L@(:;9/U)L@B3PK2FSD^1#9%"4>1(-6T@"*75\HKUV1IV_6'88?"KZ@)BMO MP:X#S?>HMZ_%!,5,(MO3A&T=FL5$KL?8R%P_^@=W[P\?L>TWS:ION_R=+RXV-;4(B+W$)\@B.J!]@KX<:H2046%V\"C[% MQ6('M;F/CJ_CXT\EW1+,/\T-S1\N.?X8:_=VR#I)/%>!5$SMAC<\;R.GL MRK4#?`&ZH,`H*O;A<$-PWP/ZR/AFKZL,?!EU"!X>:.,#/,"WD'VA=ODT+W_GB_5/[^"JX24< M@1$.H>_XOA<0$OJ>8Y'0@PZR/>+3:.H4R*(VU/D(AP4:7*-7S-5Z[YC/T71F M,""%74/J?SFQ/+T27AY!XH]5MP_@L!N-,W[+4@YB]^GPA1_FQ(]O8E]@0X^R M_\\PK?*J??5DLV$'1C2VL.-#._3#\`0PQI;052'Z4"FNZ$>/;@>;%PYL;#]` M;_82C<'/?,FM,9&"8FI4#FW$?" MA]&30LOL[R,_=ZBYRLIRH!\0EWI1XCFQ%Q%,8->T'R)GTNR/S/84:_\(%QB` MS;M'3PJ[@K*MB5@Q09['J5K%?9FH*5HJ@6;35%)&2"_IGS2ZQ)7MN8:[JZB< MV()6D#A11`CQ7!IYK%COFB:NV-X9&>UIJVHOP`M/Y+S;\:1P+:ASFFB>6WC. M9UBMZKU,VQ35DT"Z::HG(Z275$\:78M4KQK*RV[I&/1)!&TO")CH6A"[GA59 M?=N01O.&_$L:7$?WQN-!"8(G3O-\Q5/*L!3)>S387FFMZ13F!%5O-O$&R][\ MF";HWD+"Y@QDAW_^=YZ5[`_$HP>7WDC MX`7)6%`9:LG#[-X*>6B)`K%5?3]X>Y85XUJ M6UVIBF*(L&,%@016*$NB;]$$=6Q/<+^#[V[9@0 M=]`_-G2>-W*=T8X6,4(2Q&@R%KPEAAZ;-`3@65U;ATSM=BH4S^ ML#"Z"6G->FX*INVPC]+J)OG[F-^G^T?3E:>] M/QL[@HGK6*X3(+ZZQR&0]),#U(U];_)N>0EM*?8+CA!D)X@BFYIE,'E>T]<@ M44RE&_Y&Z!Z]E#HAU$VKP+YOS?3.V\/=D'K?D%I<@^V33LOO&^MN6;I*V>]M M,U#=9%D-=FF]_)Z(UPEZQI)D4VO"'FJ9X11J>J#@H"2X3_,]WYU#B_*2M7[) M?:BQJ@VA-/)AC/BQW<2/(F0%\3`,(D1HB>6"9A3+_V]I^5?6WFY\`C76,,V5 MXLM,G2G[)-!K2`TG(Y)">M\3?*A&!=]SCS(*(@ORJ<[8MF.((72=?K*3VGXH M]&`M;$IU;54<:E;3\NT#+/]5ONNN!!0<92_E<]JP62.5@N/@_,`OA@A%FX[E(B7^=)/"-ADM@W1,9D15,HZ:*"7H&MA3`*"/0%`5%:1EFE"NFQ$Q[1PN7QZ! M;=+R#/_@S_4N5!+F](R4JLN/(>JJ,,!"5U<7U.`OV9Z?AL6OR'WX6J:'*MUR M,)]9M[])*V8'C*3Q=S:4Q$&`4>R[=N#&!,+`==K+EC`,`ENHR)3>N&(%'H`! MWG=`V4)[=\>Q@>IX=[?/LZF'%ZI+P#2Q795[,:WM8#07WS^`$=@+\"0CC[ZI M66E%"3TCM,IR8XC.JHNOT-3)!54V.E9U<9N535O\ZOJ;_*Z_K"*T')]X#H:Q M16!$+=^%,+(1B4(O]AU?J*9=TH[J(7L'#3S")BB6BWBVNM M'#K#T1E5D\&L(0(F)91"?L<3E"5^XGIQ>Y?56?"MS-I-)OU69(0#U_YF=.!47%[U=V3PT]D_G;(_R_;O=\Q`/EUG@ZW`P?; MOX]YF>T>+X1A/SO>\B.<[]GWB_)AX\+0CA,_3&P<(0M:20CM%BQIK@:;,V6H M%Z%B#1R`S)PFU)PNL:E$!Q'T M78L$B#J^@QQ"/:_#;MF^%:]E;K,!*W:Z[NUOQ>_*ZS"MZ&[STZK?ZK1DU`C? MZR(=[E,=!?N&K>^E_&GRP<7=YR6<*'1(20E;Q2[Y=HP[/INZ\0**$')" M)T:V&Y.(C5UI#];R;;J6/TY'J-@0!R`KVJ!`NO3[GII,&6%T$W)OO*T-,6CR M,?'N\!,:UPP2%#K5W)1,/_RCF0AIYD&^ENDN^YC>9M6O95%5&\P,T`Y0["`; M4>18./9]UB+U["1R7.@+G>0QOQG%)M'``0T>T3,V%E`W3>LUL28FV(^FSD;L M78`&F>X#+%ZDZ(QH2N#5$.63$([[BAX[LN MIM#!O7(F802-F$>:!E6Q%C8@NC);`MC;#-CIB$,+:M_ZX,H1Q:^KFI\(H@G*:??*NK5C%%Z>DTTQM$/W[XMCGZ@UQ;G=)6?UQ9GL:'>%N[TJ\SYM`[:Q.Z40`31*.0QH&' MH$O=`8,;>$OW*LUO6/&\Y?.R]@@N&.%=[EH+4C#;@O2P+\-/9A"ORQ->)%%, MX)?GPERUEA#;Z](KB\!5AA8?LWI#+>HAG_W/D1%/!+Y)\(K. M#!OB'UI#+M9[H!3X`D>4<<-B.=P/W^.7FB34)2CV`N0FF%AQ$(9.CRDD'I%M M"+.!:'`"?A1)HQPU1W313)`4UX,K7&6'[#H7W;>F-CORW$!+8E390)N]9N*# MPQ]]G^?17/E_B?2%NK\XEV](\)?'.D/I)1$L5>+C;'=L#L*N_G5,]VSDDNT^ MET7W6GK4U,0NCJO,MN!LP M@G0`"79],`K,0%H>Y7F#UMPIMHHAE@LP!`-.T8`NG`>3;6-B/A:ZB.RLOR%3 MD1[Z#(]10[]4RV$?1F6VR^MJ@VE,L9MXB/E<%"<81Q3U*`)JJW(5`01ZC(/K MSK9%I,`;1`B7)_^R25:L\/P'+5Z3-?Q$ZD*9GI&=-Z3$8'[Y]NNO6I%>;(*0A MPA'Q7=]&'@D00L%I?AUCD05V$IM5O&;N]/Q+79DRC^$E"JN<7%6Z:I*(/D>B ML'0NRH31@KDLLDDR*8&\R>(X-!SGU79?5,@FK@#W+M<($ MMC?;VA;R:2A2=RYJ2'%].7Z?+RA]R_B;)G;:J!.3MY&HG8"!/SDTT?:'C M.9[.*)@4>@W1+#FQ%`KZGZ`N_>N8ENQ)WC_0_)`RJ^3K(*Z+\K9]=S7@"*ZJ MNDRW]29"&`61%Y*(.!9.K!C[#0P$/11XX=0;)F0WJ^[I&Y""`2H887WT2/9P M=3^0@FR>>495Y<60QU99>(6>[BWX<%]N;[+=<9]]NCX+Z"O?''%2FLAE54\4 MQ7:(78I#2E#H]V"090N=3:T&@>I%I!UHOFKTE<=?L(I1E)!IFKM^+L245R`- MK!IJ]M"N5Q/-(O>,$*M-EB%RK#C(0F?_%Y3FS^TIF%5PV`7\$,QT7PUN`!// M@Q:-($+4@;8369`VI5X-"U\$PP0ZR^I9A$EA3 MZAJ)S2DN8CJ0_3O\J?,M,OD\+U,K42FF5CV+XX,XA"=AE!&\*[9'_DJG\2W3 MB'X$;OK"RYL,\!W;C-S=B6=FSL-9T?M1*M(:U,TO['B1R/]99G=%R0^0`W=9 MF1>[7R;[":>)NX1CH$W.BT_,=+&-FYU^F MZ>SLO`1V#:EIY<3RP^R\-(*F3^#=I&46IA4_%O66UW'M!O6R9!TPX^8:/IR^ MPJIN_E'P3UKN:)J7OZ?[8]:<9W+7O-K\DE=_T3++WA^8-&15S5^!_I8?\MOC M[<9W?((<.\)LF`L#XKM6$//;IWP?>]0A0BO?C`&M6"TYM'?7#!O(.W#-FHX+ M<-OB$YT;-(6VJ=.)IN!5.`/)\;^[X@&`<9!@%"6X>@#C[W61@B;4"\"#!4VT M8!3N!>`!`QXQZ$/N#CGY[;7.HV;Z4E,RS\UXFM:?##$S\WAY.J]J'$#33#;] MWN!W'!I#WZ'(U^+_;LS_`K0L9E`L4! MABXED(V[J45"VW'#(0(2TM5L=AELQ4;;@P/W`SHC1K(+<[V"S>I+LS%&.W2> M4\P_SW#V;#YU>:V<3O4SNJTD9E3ZK6X?="'L5QUU_6+LPU^8XKH(TOP7'??MCV[/Y7-EQ!3O5?Y#CBC*S@N/. M2IZ8XUZ]'L&52`1?L_+6VL3$<1#$'DP(C)TD)H&'>\0>1D([1%>$J_. MLM"5DB=@F>;GS3R+_'JV-ZBS0R6Y>LW^UNT@)MG=RDP\9V\F)&?=`62GVHS:CP9Q@,CG.G>PPXJ]^8Y(5F$*)CQ+<@59.=\;0"^-/U&/J7 M;,_/&X^*JJY^0%Z=5@M;7I20&$,86-1V?)^$<;<'+K'#@`C=UJ0:BV)7NZP9 MB'?A#U(H:&O*,S+-M$Q*AI@EC?8N%->/3:D##QKT%\^94K7F?H>%G)^Q$EW9 M-,0HM(5;K//0B`Y_CK>W:?GPZ9H[3>M,^WWQ3\JX')T.8!-"$QRYMN='"1N` MV7[D31QBZ^18<),BC6DV1/X&^ MWJ;'YJO?\GJ8WFHOA3[/2U*7M!O?!QBSXN10UP4 MA"P*!+VV4$<1CD@LHJ.K@U6])/Y1?%P?QA$VYT3V,?+Y@"Y*T(4)3G&"N@!] MI.V9N6VLX$\>+>C"%97PU>F?*/^KXU1G'>;T$"7.HSIS9US+F$YCB..9PT=A MZ-,MZ+0OX-P$+HQ0&%`<.S"*:8Q)_XX'179@)YOVN)/+.BWK:38YMR41V7H* M:K*"/=(K?EI^=VOW<.3+5?8M/S02U1W\\I"EHE>7S.9ZFL'H(%C,%UYT`&R.7B,`JY74R..+T_;,LLK;+J2U8=]_SP)+%M>X3&'K'=)'0BZ*"H1Q=37V@QDR9(BDOZ8+=K@8"RFVQE MA=>V1=LH6Z.!=SU<.3HG/6V+9''-C$E2T0O0!P&&(``7`="%`=HXFE_Z_'HR M=6JO(/WB4JTJOV8KN[*HIQF!6M+5^,9GAJI\!EL0)%[L!A9%GN]8V/4\2'ML M8>2H:\X@7J93G%TLR^19]8'/,2 MEY!#^%*/B#,1;+[K!S"(K=B-"2%1Y#I>,DS*V`[>'+)O:;MN=J%5R,4U27[\ M5GY^"$%@6KBY?%>K94C.WR++6"%GLBVC#^&M6880]>*6H2:S9EN&HIBG689* MPI=:QDGF'H'[D-Y5V:?KX.YNGV_YVHG+.JV/-?OH0WZ;U_WUCR[TW2@*?-^Q MK0#AF(3#S%E"/4N>@RB%J<=0&JQ\`KYJ,?)_[D\HY3B(VG0N,I3U4RC;7X:( MGAK,D.I35.#RE/4/4[*NTW"6I$;-UL@ MJC_R^H9]G[^B/M8W1=EIE*M=D/\?0P)JYZ$:-EZ8/U]2:M_RB.^]W[V[MT6R?7UQFK.>_Y M_>WMWE.,21C'=DB):R=A8KFVW:-Q(TMHDZ:UD6EG,Z, M2JK9VC0UH$&+&@RPVS7C^@\@F,>NN!++2I?90BTMRFDZ+I=4]QD<#>'[--,..2]T4(8(=3),0>>W&K21,2.0O)X;NM6P M&ZMWP.H\L)JO6,*'T3$J2YVCLTQKD4M"9CNA+YKDGQ5"+-^!V/[(=Z=]_O'V,O;FJ)O.@?,>[O,)1L]0 M)G:`O8BZ=DKC&/$!;>A%/4K7)J!+AQ>&ICG%CT24#RT')1[AM7J'H5E]X1!* MIFESHP?,NYTC(FQ7/WTJC611AV.U9^N%H3C6C0WC& MJF3U:!7D%]7QF9Y35@R-FCPR=N!%&NF],#-SP+@'9@M-@34X0^CR6"(K:"7[ MS4SP_2[?;49FQVC$$:F'.J>'W;O#L2H.=;%M>M&]%\^0$>3&+&2A[SN^[3(_ M"I@S(`O#6"83+`A'=R88R_^32:/.#RL[[*S!DVY\`AR'+!F]ZWG"T,`!\\2L MF$T_S7#),.[*[4GT0IL?_]G"^02\=%@%H%-66;LG9]:*M>'M.,9Y%^/17J>Z M:1!E-X04P1?_JQ@:P$,_J?#TB_D_>;4MN+;_MW1/01`N\C]&3I?]U87@0O9? M(;XK9_\U/"Y7>YB`X\"8M]IR7^P:2)_XJ^WCJ,<1!8Y-'!\GKN^[-F-1$+[W>=T>:3U""ARVS:-3;D"V&).P%/H$UHW5`K.^ M=G^O-X:Z1M>5T9$2E@T9]ZCQI=30#*$%=F)71E(?BSN>I^M-$A,OB!P[=ES, MD!<'=A+T5I";@,[4!OZT9D7ZL]U"->"!5JP!>9*L1--'$;#"[!D[!JG-4XZN MU8E-(],019F*_GE=UQP2I%4C+:N\^'YH#S/B*E5EO`O6[OKBO:_FG_MV2]=S M&8LI2K"#/83M,,01L9W8Z0$EG@LZ24@?"MV+J"UPJT=NC;`"=4EC).0DS(P@ MP-3N,O\=ZF9H.L9MCA1.YOJ*:NJ/GR$"NX"CY=*/!G1HFM4_N&7Q5_+O4_&0 M[<5.J>?&P\0+W21TB(_L.(PH]GPZ]#0#GX#&J$HL:I9C@:YYZIL7(YS0H:H: M>B7'K(LS"QR\OD:J05U+*0ZOC6B5QL`0G53LU/,QK@;*I/6/2^Y.3`]^//[( M*[K=-L?.?\ZW.#9!#8JZ^:9Q2FO3&`^R#QL!J+&K6OQZ7 M=0;6/+GG"X]NR\IBY>G;\?:TM_JO`]51$?ERZK@\[S!U;/`U)#<(K0LA,$@G MI=B\HI-JHV&(3BIVJM39@.%+&%LNRU5[%6!1_Q57^:XXBE<;WXY)P$T&*/0\ M)XD9)O;0-<48M+5VCAW=?<(QM'81H\%F"7#P)8SI=$JO8"S")'@!XXRJ8>YF M3*-!"G>%O^LK&K-9-T3-E+CR@PI#)1C1K4X\+KDC3:9/3HT48@ZG1`,D@!7J-IBOZ,YM90]1GOA^EXB8' M5)Y/57F?5\?'3[R5'?G`4LR^W8OZSQ>%)A@A)_6#@"5)ZG@.2?VAT"3Q`]`F M)&5&M9>KM3B;&9D!)%"DU#$L)UJKD`L3L1XBUS`!\BF]!@F;+)57A$YY-`P1 M/O5^E9J;,5`8?RO+W=_%?M^6#?/66_#^(*WK_.6R!/9'[^^(AWUW&8B,^;@Z) M'Q+D>@@1)XR&I0H2QJ`C5;0`T#WX'3`W=S9PK+\V8*?)J)X02`Z6UV8?.)`> M$5]9/>"+03!(9Z>0?&T8KC-FAFBO7A^?#]_U$RJMQY_SA_QPRC^W!WI>VCR" M`A>E=NS%41#&,8UM+XT&PSAA$/&=;TVSTG8`K1%"H+HJ(%1.2I?E$J:;%V@T M2!_?9.Z*&*ICW1#E4^A0J:N!@C6MSOF71:T@XQCV93,ET.WP[=9H/-ZK]6TG MI4GDX!`[-$!#E2!!L%/>5=C3KFLMQ&:,.`()%C<%S,K*V[*D0@7N,I_]`15& MJ=V;1%[5.W5A,$;Q%+KT0O-4TS7S'/3VI(-FO"_J:7C_4LR5]BO5!#D125P; MV]0)4AK9,3E/BR:POIT.^YI5L3D+XM?HQ1ED2LX4G\F\G$JN33I,-5\_\ZT[ MZZ>=P>PP-^L^!NV@F\#U%6'5&3E#A%:KBU(G4ZND$U"G(ZZW:2Y2?MK=C0(: M>'$9,MU%F`,FBA3L^6 M01W&UWBZ6JDSDUI#%&N^'R\J=900(ZT]+*^*ATP(W8L)1"=UN*C9)&5Q2F(G M\&GB]19]1`*(^LPPHUE_1LB`\C.'.CD!6H@UF`2-0!FD0:]3=46%%/!KB`ZI M\*14WOB@![WTUWA\O$V+0W;8%MG^W:$^5LW1D7TGC+*$^!%R6>PF#F.>0RD9 MC-L,)$MJ+&I6J*>W8`PXK1%0Z#DN:HB6$['E.8;IF02]!NF<%)M7)$]M-`Q1 M/\5./3]910-ETII(=P]Y=2SJXO`]+NL+53=QC`*71KQ+&/+!J!.[3MB;Q3$% M72J&![DDY?=\5VRS/ M_"/.][\PO^;C,'1MY`3(I;87.=CUAD56/W:D.E(*S6E6I0ZDU:*T6IAB6AER M\84B8J^+U4JUND.Z8(M&3O6\IKKBJ5#OQAKCK MHSI7D?67AKP:I=FW?4B1=B%7:&#P*[LA_SO<[/[5)4'_G*; MCV8!7N`@D9@52+S(QPGU<$"2H4O-2.I!>KC*C6NO(!0KZ/M'ZUU=G\2NA_,# M^Q0]L%NL/@ARO>55^8>E(P[U=;H-ZE9#*;W2V]86'4,ZX?K\*Q=JYN"%Z=OB M((ISQ.U*WTY--3AOY,G=_;Y\S*O?L^/V1S.3,?H\KX3D;#P2<>VG46C;*0OB M@W4,0I#&'!%NXU@9#L_Y^*`_BWK0J%YC$U;9YBUE/X#DMB#H3$29RZ:>#X/;+4\T`G+2X`1_>\3@O5RAJL%Y3^QKKG M`M.G`C62KS1(>+OXZ@FIT$ MM'@LEPSTD;U(4NCS51`F*0K"R$5^Z&.6!"S`/30O#D%E$4O@,2(M-)W+E=*# M=.#TYP<=,5LC071^_$098O+X0$M<_Q_D"+#+"I/$-+KG9@FQJMP=(/"??+?! M*4Y$6F(8L\A'L1.'*QB=`"TJ%GIL8U^^>M?S;[(LKGL1KZ/ M?5'IEQ*"HI1)'V*NUJB^IW2$L[T@<(S4.D.UOO9@E[\-!L#DE<=63T0,>7PU M.??B#AE]%,K5JEU!\(>X.F+#/(=$)&&IBVUQ5P2)4=0;#:-`ZNH&-98T=V2N M/[A?&XR@4JKYU$H4JBW*JDHE7(500%G:HL1.JTB;2;!,F1TB)PU"VEN*D\@#G?T^ MX>=O=]OS__X5)6[T_98\S=YA^K\_I=LGXLWSQA_S^^^Y=4F38D;!QQA MPA*7I'8:B.WT+3:4T%AZ<+L4(,VRUB&T_OQ";ZSW[^,;:_2.U7O3?22&'../ M&Z>:SZRS7Y#QW6)1E1A7FQA0F,:JCZ7UM74*-&A?+*B`L;V)P9TV!;!*D.4F M#A21_-K\PM(Q-&$:8G&?RQ4?&DA_X,/I(:N+A_S=8=M9P5X:I0))$HM3+#RSE/:%F4K::P!$@ M[^CE:EH&@7(F)_XO/'U-QJ=38H(@ST!?*FD7$)&,BNRP+3L#ONW0E#@."5+D M.V&,J>?U!HC'I"9IX+^J61I;+)#G'<:)A!QJHP.FA"V,21((HP2@?MJHF29\ M;S46.:$;._6:QDURW`1YFP:\G!MSB*C1_?%4?\JJXX'+!>]N=J8)ZP5! M&CB)CQS'2TEO*J:AU.5)5C.$@SSB4TF3T+\%^((IX5.JFL'N M%%6<2AE`'Q>@;N+)-R];F[*.XF6G7U/2F129H*ES72C5M1A%=6+OBT/^[IC? MU9O8M@F-EK54C$FQ/;ML;"!D0ND8G$P3-%^M0Y(E9%.I MDB\`X0)XMOC(LKOL>U[3OS/.Y:XYOWSC$8>Z/HX]2H+$\Q/BHF"8ZW6P5/&P M0G.:,T('R].6+I4Y$W.KA6- MJ"/F:TTQ"=PP3B,6D=`/G,B- MDMYR$#'0]DX%YC0+VJ?L*+9Q;AM(UB^'!I0X#:I]YU_S%&X2OY,43C>UU`&^L%N*Z"G>!,WF%FT.XF0HWRZ/K"C>?+.DA_#>Q:70_K,CO.9!-Z'JN MXQ/?]2AE*(R<<-A5%OLTECHR=L[O:]:P'I5UAF4)7,#AY"3FY(;GNDD##\A7 MXPLVX-;-V^0A]D7^9A_Y?=GC*V/H.?P8,FJ>Y4*IKKE`9/9S^9CMCX^?>=]I M@WTA?RH9D'MH%B?Y4]PA?,BH9RZ*(')Y2)L M`'11%RO3Q+!G1YSV:]V657,KPJEN+CX\YML?AW)??G_D.F(5AV.^W^?;HSAD MZKXJ[_.*_[_BL#U5%1=3,5FY*RK^^5[SCJ6UY5_+BH/UO2QWM567 M>_ZU4W6^DN&^K-H;&_*J*'>S-7C$[FO".R4`)JCM)-SES)8'T=5/5?E0U+SU M\7;T5,;%75?E;=,$1`O8!)Z';81PZ*.`I"E*,!FLAU$H7]NDSJ3N@7H/M'G( MGO4\K%^;V\#$,W=^3"!:I9!Y"5U?AW28ZO\T?`,RQSJ\3\LK?Y3'_HX[07-Q M>.`_45:/UM]5<3SFX@*>VW&:R%[$:)0E%.4&:?Y>RQSJ`V!"7M'@5:FUU0(G MC?_GE%5/HZMZ.9:[!L?HKDN/D#1,0HI2S-N.1YSS79=1XC+(Q+$BDYIS MTH!R=,4URXZ9]@698%KK$\`BB]76]BW;DN+LR MH:R8?$,FE55[56IML?`#4G,Q6/LC^X?6=7ZLWQ?9MT*(K808KLWCBEMM0A"6HMZE\RZD"*P<6%YU;J[$Z=C,MU8)8G&[S4I(!G76>D MODW=%5542[TABJC8J9=GH2JG;'K?Y5T_I;`)71LCUW$\%OLQHS:V(V_07D*C M69T5>3.:-6\`8O$OY=7#A*LX)A,HIV8+<0>3L(N=N@'8VMVY`0BD_P:GU1!Y M4N')6SVTJ>1,%R+^HG\O^><^/]3YY_8!%07?=+NM3MF^WD0ABR@B49RX-`G= M$/OV((L>]J'73NB`H%G`>APWO8#5-Z-+*;J.]/[1.I1':Y>+(TN*;_O9*J3(6C_,7Q`T>&^383A!XE%"?,I0F".-V MN,_#PY@MM8]R58":M?[+L=S^]>LW`N&35LF&*-NLD'O MV(W5N-;%_=)-!HY@*[!MX'4A M,E6_%7KXECJK)G.Z]OY6B9T'GL><($U3+XAPF@0Q1BGIK"$G9'_+NH MF_UC1@=O@EFI)XJT3]0+A-)/UP#,RGID<^5H"L43M4D7K>J$ZLPO?9O?963K M)6D0#9M!N:F"-L>EM]1M-EW3I>Y#?MPPE$2!XP:AX_FAYZ$`I5YO*W!9.*M7 M)6-@K3[533M4O;4>U`N<%+$3%4TUIPHD[$-+I(%*QI%!I`O"K:E:!?+A+7&" M$S*WDG)4T#E4,"5N8&/>^7-P'!+F1!&SDT$/DP`TLZ;0['HUE2.TR@LK)P5` M3LM6XAZF<`II7[+.\@*)\&++.9$P1`]U>"97=CF?/+E=W9=-LOR^RK=%OW)" M[\0V_O^TFUA)B%TD-I%3+Z*):[N>W<_3(3_V',#X51."98:R8X3-.FDVP@C9 M;JPA!-<5=$W:Y_<31VAOK!=!H.8$`;#W>]U@3-L#KCPH:624\- MENE3#W`2P3,0>HA3G&#>H%'WQ,-SCN3F'R8S:TBW6XDKK\]&S*0'K$GO#MOR M+G]J>$-8Z#-D!SB(_,2/?!8G\6`3AW@0)?B,Z21[4U1)R03J_@QRHEQ-XQ>F M5_HX52Q8:RY57R))0K%F<6N89,WSY17-4D"0JE,D-LCS$>^Y83O$@>]3/^CW M77&SB-AXUA(/T);FU1ZQ$J&A?@9*Z,2E'8U5;G]>?\<.SJOX51'_F>X_F!GZ#4]5&,HP@W9^VPQ*4N M!9W[-<^2Y@4>@<;*6SA`A9K)H)P^+4<>3)U&=Z<;KC)$AG7NM+I;+-7G(0$`>!ZTJ_A3DS:7":594S9V;=+"_5YNRV=?;LA]N+^*(8!][ ME!9!YN$DH8EW'&/#@DIO4[<(99H-@6&7*&^M(` M]@A]F!=T)4`*M<+,@=*>IQW>$=[.]K!I%PBYWH.[(:;+DX-@SU2S6:Y:(=2^ MR$R=P9^E:HLQ<2D!VW3SL[1JG=9)9AC((__L>GO\X#0?@N(8YXE'`IP5'LS\ MD&`XH"VBT)]J6D$#HNVES!99`ZHMN.<#`=X&H+UE=VQ6`:PVRZ:I[JMRS?^G M4Y.[?@O'E`-*G82)GH:9IY`4'XJ M)IDV&(^!I;D"`T%WJ3Z9D06#LP+&@F)U?1LG44'R%"49@JCP`IB%QUF)W$>H M7]\NMFM[J]L_PR"_NCW`_>]2JO&E5-%@_<)+J<(N&EA*E:-36`J.HI-7S6I3 M-P?V[)\N6/7\!/MI@9.`XB2-V<@JS[H+5@/?RX)"9M.WGB7+PXY3=0!^+Y<< MF\R\GB$RQ;:>3,>C7"5_1N$9LCGO;K[(U`6U,\.P([IFR)G:QD,HJ56W.SZZ MW[_>LN=NC[;KXJ]#]`3,66=YL2S*=E/^?N@J`9 M)-X153/I46WM*969=/ZZ>BS7ATW)FY>--GVYN1_0O0'&G\T3NH(F:81\Q,:, ME'HI]OGL>(_.S\1N/)D8DF6='!P!-_=O>RJQ_];2T*DC)S!)[&;0Y+1X-%[H M70^L\0!**?:L,968\G4SMFI3O,<8U_=@?:D#(/_"\Q#C\AA?_K4-/WSX6&_6 MH'IB7WGI!FW:Z\;&:!Z;Q9T^CB[,VL[@=3WKRR,YO#E>R?QE^?WW)4MS%;_N MLXA"&`9IP@RA*(M#FJ!X&$L5"$F-:-0L6$[.#`MX&L!(CET4*1,;KMAG2RXK M'O%<`<[9$=(\K8H^9>?"&$2/34>&'9I.U"8?,%5U^4^]^[_K+9.Y5=DT"U20 M-$4%]$E&PH`D,$J.UBB2NZ%7T81E?>%@^`+P4.0B,RH,>J:SBAZ,28T.J3(*PVMME7#BJY_UO6:-RZZN1_N,U\@'*8D M#BC-HR"(4N+%)!U,9Q%,E&1'PY[MY:4>&7C@T%0E2(=/23V:B$IE<3H2V@(\ MWG4S@)Q+I<9I$Y$L`Z2[IE\F7!H3,V-TR2L;;W($0XJS!/'IWS1!-`UPX`TV M"/4RF?Z-4C\LI56*G67G>H$N-^92HLFU5T(*^]BS+T^`S`U03]6^G4E#V_5Q M7\J*MZ,_+O:>)D,@BG">9R@(V#O&_DEPE'8^&'@=^T4W\TWAR$E01H7<9:SP@:C((FZ M=HI\3W`,I2[:FP;15.NYK.3O'0"=.Z!S9#CVV8`_MNQY!N][DTJJ\T1A%!-M M]R*HN+C+@M<';8CA^^#QI@_O0S?_5APC`;B@_],&V)&T,+'3]9SOE'(2.6NS M^\YTA$B4((02E.FK/NO.J:[_>NWLQX1[Q4XPW&* MO2Q,4192F""8=5,B.>5_"E1ET(CQ236Q10Q:R.`[>GU8M?,L7\O=2[7J"^,%SK`/"U)0G\%E M17$2144_J4*]W)>Z,F8>A+:WOG6HNWY(`VYP!`[N7L$`O9WV',#W8B*ZHWGF M*,LJOJL!EDL+]F)K.3L8I%\HA4)F%,[ MC*S"H-A9XL]=_D1T31#DPBE?71=J<\^+C,3F5;,[/'-3W\K5X[;>U`^OO;D8 M4C9H)3X)$(U]ZI,"DL$<3B@4EED-&Y:E]H0,G*#)B(<.?0*2.Q%S,X\8,H/$T,^"B3&:?;0S'K&I/D.-YB+,3&^6Z$P>1*$/B3 M8P0MR*DG!939O#!I8#]"CDPJ3.!H/?7#+U,Q\TT)A^6F07?-?K=<[1<4)33( M\H#X$2O(_2RD%`Y&,NHAD4)/^D?MO;8#%/#G`$:JII.G1Z*2LTJ36OTF19=8 MT?;>R[%239D-%PHT=?"UB0="YHW_UX'7>6V++#[Y29;[\J'>566S@#[,8I^0 M//("%/@^#HD_6`OB6&BGCZ8)RV54!ZSO1<>A@=41FXPL:'`H()_3T">GHPXP M)Z<S"H)K&7F-1N>CCJ^)CJZC/E@OP:\*(V^O@H[]Q$J]7N4*Z'&R.J#\>3 MTB*`.5Z$4N\X;9I!++5L;="L9>'N\0V'5]0WP.OS*S;$G8E:.5$_ MW_0^,'R&TZ7=[C]C46B3HK%0.#)XM>'9Z'9"P^0):R/:M#R7ZZ^/RUV)ETVY M)O43EX$V[_:*L(A@$N.8QGX10AR@+(SB7IE#CQ08+U[*W5TMJHR&C,J\NN?X MA-_@@V;/(@/I9Y=20*>+%!',&QN7$\@@0M`C_<<O]$??T??E;GW324'Q MH]RM*E9(76]OVROTVGYAU]O]KMHVU:J]%&B1(B;F-`L2@MB_?:^($1RPYQX5 MNN?8*<#6MSKU:$[W';_17R;0G1-KV?+5!?)$"U\7L%HLF<>T_\Q#?BKH_'N] MEZ!U\PKTCEZ!HZMM@][6V2MP>HA:5Z(WJ52W:6'QY$\YA8G[X<'3H&3 M[0.ZJI_*W^JFX];\L?[>[@LME7JT40[L"ZQZ<=(-DB^$0 MRUVN1$(N)?5!^!O'_?=N?\().CAA'\+4?_];%ZW\I]&RU"M6F>H+^6.*`#J2 M%B9Q]4/CVJGHM2GBE/UG];!=1'GA^31*`Q)2&&(2>T%V1)1[0CN")X`QB83_ M[]\VK7J\5?+[#J)](1<.B34=MQ&-*66<_BQ4KJAX#]2LB,M&[]?5<&E/]25< MC5RQS2C\#ZH)MC4E#@BW,J))>GWLO MJ-=*A#FHUVI^7-!K#6*4]/KF_K>R:;X]+K??2C[GOF(/6W_T#V99&/@^3!(? M0A1F0>'!P3K*XU!5O35,3JWE]3W@6`$'"QA:T,/5D"0=PN4E?B*N-05_C&:E M<]<&^59/"!/Q;B@]:/"OE##&V1%,'P;H=3"9F/#J0FHQ1IK$K7/;%V:;/9LW M]U_YUA?\^L>V^NM0YF6SVE7MFF\[,/&3(J`>"=,L]Z@791%F:6^P'Z-,;K>F M,;/6]VNVZ,`)+SA#.$\S0U'N+DS8&J??D>E9\WY]N-[,"G%B=>$;XR4_W5+< MLN>JW.W*=0OF6TTVRZ;!_!*V>MM^U*M'Y&&O(#[,49S$'H%I2(H!#HQ#H8V! MMC%8KAS/7F&63%N0H.`[KKL_8ID"QF8D!"I(1X(@5U*^Y;^#S0)P!`XZI3T% M!'3H^\]5ZDR;89(H/!T)EUHE:CUL8N6I.H=C]>H$47&A@)W"S7K:AUTU9WZP MVT/YB,3/$2NQTP#!Q$]\+TZC-!Z0!!Y22Y?FS,^0*?'I#4>J$FR0?\DD.0_U M.OGQ4S$]AL/"T0R==2E)BCR)D9<$#%5>D#@:P/D%%&ID.RVBF4>&5Z"'#LZQ6QR6 M:,3._!!RFK!--:K\/)93C#4U@FIO^#E-<*<>D2H'VEOMJ^7F]G"WJ5;#AV=W/+?KM*E'/,0J$.B% M,(["*,>A-Z`@;`PNMJW!DO&)-C<,\'@KBQ8UZ&"?_<494Y0?..9CJ%XRU6@F,ZVUF(RA3YSI5PV,IY M%L(R>=8S='Y)@3!]&^;UM4=9<-\VA7.-7WLEL MN1WN0_,1A5%.>)Z-DR`.,X^>4FY$)"[%T+-C>2ZV`\4/>O>PI"YUT*10("%- MR)Y<[F'`NF:/#?C`H=+TIBZ9,M=D3$>JXET9>N0*WIEQD86Q/&"(.Q\)T/\9RW+])`:P3-' M`Y[+'6@X./"W:@L.S?KTR=]5>@P+4G=9KRVS)CDT:-EI42?-8]5<5[B/.)QZ>#?]9Z]-U^JA\=]LR@\]O->##/H%Y30`**`#.:" M)!(JZG1M6%]<;]?EFFY=[J7>LQQZ%`=);5"F44PHIF!0=IW[?%&S`P4Z5),? MS_R4FPN2HLNF(_JB[<:'LY8F:!&O1+BAKO;)#SQC=^VMSVLB6N_(LGESGB*0IP5$2LT'N@""*(Z%-LA;,6M:GOJQOZLV:]QD%53\I]-Q-"M5#H<,+ MFU:S&NF*QF`(!"N>>=B7T[:\?"DW]7-[(\'7_?*A!.V-Q!7O(MK-U'5(K_J1 MU]4P].)1XMBGKJ.$2;U49YF/C",Z:<.S]W6:+?*$U?1V5Z_* M$U9),348`3$MG8=\.2F]?R,CE-"\QD/($DC^/T.$+W M:"ZQY#\]..L;`HY*0$64X`HPS_CFVG/?`'<.++?KX]<$;KL5F^$V3OC8I/A\ MD75A'GU&[VLG7B_=;F%=1=E]O"_7_L++@RR$D*(`QAG*(M\_,PSEKEG2MV9] MQNY\WWT_<=<-?<%J0#EW=[#WI%V<,ADB@2T7+D1'=MK^37>I+C!?W@2FQWW6 M"_76K<"H=@*;*4!J^SJNM^OJI5H?6&G'7?FPW)=@>^";"/CGR\T&U(=]LV=U,Z^8^W3)_F;U9OUK7X._F+7J_K6= MQER='I3NHJ4/9T__QVB+,?'@C%76MF/M0OULW78Q(15H++5+\JOV][!6CU6*X/F_;] M_JW>/OR#_<83X$#!"6D#_FS!BFZAT^)3;&;2-I62&UP,L6AE^/`)51<&##K$ M.C)$T'*A-O><2:H/?W#X<\--\HWW7=-AS,2-^-1+*!.W/,G\A`RV:`:%KH/0 M,F!9?]Z^+5=BY^P,TB>F-M:9DY,;)=*L:,MGQ%P0%RT>'5$7/1]J@P^6IKX, MU]T445CD,,J3W",Q#BG"\(GBJ-$BK#F?"E?ZLU+M7T@NW)=[>ER56VJ_7``@40^1D&` M<%Z$04Z")`KHL9#*$JF5!3U+EA7H"`YTZ,``3U)]-.D4$Z'IF)33HE$2Y0\A MF1&DBT1=T"4S!#LB3X:1P5/DZ)Y^<^ M@A`%H9<=!VYYB*2F;U0,V)Z\:3&U35!;5++S-4J<"<[6V*9+VRV7]9[LN;]N[+IBN6 MBC1(BRR'69Z&>41H'!V'7$51$.'M9B:-VI8>!O7L=1K0\MY9'5[``8,>L4+O M3J,!N*Q9LW(OJ6._%.T26\7FHE]U>]A]O7MJ_Q_>\(=_GT>E&H*PXT&H6\C: M^[0DF!G;FV6#7!?V8UGQJ[;\5*IFH4_L]B4URW<)\H,XR@F.80HC@KS!LI_F M:OE'W=RDF6=4^12:9QIB6S+93$.T3IIQD&/%S#(-UVHYY=N%)-)N.5Z7?&V2 M>=,VF>,;CH=&=?R]W%=_8QRW?ECNTW1Z>^F%7$`9>@&*O"-.(LG%6[D?! M8!IGL=#LBDE[EO,.W1Q6^\.RZ[3$7TT&#[3X5/5/AUO))#,1K7I99@#YCEZE M)J6F>%9,-!/QK99ISI_D-]EF),U,EU'&:1-)*09(=RVGF'!I+*D8HTMA1JWZ M4:ZYW<$>#?*\"%$0PC!EXZB`7R/1V8LI#(66`+6-V,X?'$XK;E\^-0M,8(&+,(QAGL9A$.*0H,%]6ETY'E5VTW+A[Z4Z5%46WPLJF:K\^[ MVJIG(QZ.Z*<=W]YO[;-'H):.]JUV/F(H,,I@&A[_D# MAM"'0MLNK!B>6D>'7G)6=%2=?G4=G81Y0SHZ](MS4D?'B)344>UX.*RC^KX) MZ*@A`A5'[7G9K'95NVWAYOZ\'FX+Y4609"1,?3_,?68W**(8';4\+8C4*0VC MAO^_NBM9CMO6HK^"I5,5.YR')0?@E:NUS\` M'+K5:K8($""136*W6[KGG@L<7%Q,:^NHO-GZ4L9%9NPKDKUPUGZ"E$KJRVT' M#.VF4_?K1,Z>ODN*AR;2J<:WJ]-XJ03RKY%W;]B\M'R#(@?",/90&'J!$\26 ME8[U`QB:L^;N5_ATS^B-[.G#EHQY) M77B_Q-^`D4\8\6W]D6#M98._M_YNU#=2!@RJP@B3X* M_<")7<\U@MB-(QA"8[2?^J[8#JNE1A6/(<=+D7:O2A9YR6;-[=$#4%9M_V0U M\414!!?'@7.(63,$RT:;$Z3#R--C!3W8S3@7'(/6Y%YL./J];^8OFO9PR*1L MZ77R0P_`H.@#1CO+R7XO\+./TF.-?^3TR8B:_"+FH=01Z0TVYPQ.L@*BVS@E MS:^I(4LN<;/+1.Q9R"]U=9>W-RB)$LNR+8->KVA$"`6)"=/4,:%+/C*X;@'B M^;V*QZ#NYS5)%H^ MV-V8T(.>FP96:/F>984!2MS!6(3@S.<*E]G@:?M"KP[25P1Q#XV./N.C)Q0C M>,_V*^U6[A87J;K20991JTE76>A$);.U+>P^:5X<6OH^2@*1X9DI)*.0Z4+D M&X$QF(M-9"SK0'.M;-Z%]A1H_K3V;K,)OCCZ$2_#FO8D;C?>Z$MBM,R_@;'; M4?&Q),T(?\_^Z9_0C'&)R1"85&6;EP>"YS-I:EEWN<5MT];9KKU)?=\S_"AQ MTMA+7`=!E*(.40#]D/.M2W4P5!>F^WU+'71`L`^OX/+>YZ@P$O/6[S0)`E]9 M89I_\*Y'_LNOX`@>'-&#OP;\J]\D*0;HAO]QP33N*DS#TTM#U$F0.9B&:=X96EJV5-#CO-*`E&O!85T]YPZY* MN>M0B\FQ.+U]5+`Y>YB\8=]P@C-(XL8,D@K%KIT;@#,91:'`=5)!C<5-=:UK^;6&2B.;2 MMA4Y%E,X!A!DY1XPB#HIW77NWM8[2=SKI7JRG+JL?5(IX\[FJAKG]^5KLV[L M093$IF=%9.KO!;[IAH-9,PU#D6Q.U-:VV5R'6C";$Z:7+YM;@UG!;*Z#II/& M3;$U(YM;RK->NK;M%6; M%3+JAF^:XE*R$944)9-:'7R;4QD50*ETRJ_R:57#$Z[3S299+^U:[`U7O8V3 M)(YS2G>8V-T+E?D"QXQ2RX(P3,C4V/&0;0V0HC@P^(XMJ<.A.'L;H%_HJK_- MZ*KKAV6>,NH2$3[9O!(,C5='%G!]17;7B*`FFKR*JZ_.2JU%+[>:]]7,J;'$ M@8$1>-`W;.A[J6V2OXPS^L3AO2E*BLFU-/I28OK;N]M1&,263F3QSJ?,*U(N M*,+#2HI&2>P\\F:HJB3V-1-065Y-:*54TKAE\46A><3Q]4I%Y3(\Z48#:5R#I4S!%-J1#23 M3;F^38BG`@+Y,\NNLCIEW4U:U":S%%K& MD<4[9V:Y'N6BF66_JJ.A7%XG;TYF*8=]S212EE=3F:5,TF253V^"&)G0<%#L MNHGI^5Y,>4H='Q41M*%:OCQ>W MWK!?M'+GXN]42RG5I#,M=J.2V])X3VG^>"RJ9XR_XH),T_:?\NR67K62XZ9? MV;TQS<`U?3\R'"N,R?S,Z3?2601'$J8FS^1HN375>]JJ'Y3U[K836MZHV@=< M`]SC?E]WP,&N:KB?D9%`];RT8%V6^1(#>,[D";KQSD$!]0L)Q*]?VH1&[GRO)ZOJ9;L-YRHH#IH\Q]H\N MWF;D>SL,F@>,6[!G]T3>@>JVR._[W3IYR9XOV9.OU]7AGEXRF?7?I'%\S)[9 M79/T+LEBNAM^`'_0I^/;"I!QL,"[MGORL=]]^5C5PR7)]./B2"]XMR=XZH0WI<*688@^KU3HDY]SD6U;@SLXN;^B4Z$O7.89T(4V-P#2,T+&184=. M:H:1,9@E,+@>\EAJ2_&(/(P)956^/U8J9\N]-$;G34#6))-O;&7(^@&38F.% MR1[=5M./-]BZ,OF0Q;,F4P]I[E1JFB.G?#'%?"VH@U7;CZ`9(S,Q[-0W0V+9 M'T73@Y!K.^-"4XK%BZ'C5*JEY,T3JA5YX].I+LF_.!/81J2N,W5%HR11K(E$ MR?*F4M(..05JVJ#AI=".7"_T[2!%KF^X5CP8M!P7\BR=B%M1O'CRG?X(R/H^ M]G9-0TF_$NE2RQG5I#=)<*22W=AXYRB[![P_%/CS7;=P$V.Z8VIPE^!8,S+)='0IO4E(=NYF1)HZAQ3J9>!VQF MI,!?S`E`O0#,C;7/KBUD_=JD;*5X:J+AJ[E[/JE;E6:!\8`N)570RUTWB%KD[JNVIZ!;0=WMWA M';V]?<1#'PO[BBF?9-[!EOK.,"6>E<113&;QEIN&@6N0>?R`R4]35TS<%0!1 MK.Y_?/CVX<5=I>SUUN\5&%WI/GGI@[#$JX@4K\9O'"1QD3^&Y$3@+T1')XGG M)WN6QBN,H78BK]+729573K"`S`\;V@F8J&DP6_0^*2V=P8F"P$>!&4#/0D'D MN$X4.N.,PC`$2SER,6R3NI._73@0LB!QEQP87D'?+B;B6CX&@&IXA[H[OWVR M.4@C&>>B>):"JPF:=N*MR,U)W59)JX!D_U'69,BX+_/_,4C]_*#Y6A4%JNJ? M6;T_0V1',?21Y]IA`KW8@[%OPQ%1Y#ABJBT=AF+A/LOGB%[$^#XOZ0M'W6Z9 M0'<.-81*Y M:1K9OHM<'\)^K=\VT]B@M%%$#^#4R4:7K1O#C/SA7]0.Q.>5DIO`PIQCZU;!D8S\BUJ'6)9"`!V*K`;[O-D5 M57.H67O)RSMZ0%4W578^S MQZ`YW+*MXFQ1XN0WGX+/;JL#,5M7AT?VM1T%7^>X67SP56W+F$JR-&F/.F1? MNE!1Z2<7XIMA6%?[D_2NC\=.=-V5+W6U/^S86L$W7#_E.]R<[-Z)3">T8\.% MD679@8F@:PR`XRCV!7?*K(Q2><'^^N!\^PP&^&P4'AP0WTBS=I2Y=]EH'&"^ M)$PTMCJ5^"5'8]X>G8U:@'8+!)L1,;V[9]/0S#\1^93E!>U#J*KIJ?%O>'>H MNW7L8_W#C:W0)49"(XJ2%*61F70'R4*3/CG+,SS)L*=XH/D]J__&+=.5(SK. M440*K?/&@[49Y5/V$=U[T@G>-]D+4K>7[QGD71%BF=1K(JE273H_JBJ=+H'< M'65Y_5]ZA]6EO3N_XXS.[?>?B5+3JZ7(;#[.FOQ\3P^*Z76^,$F=R/#]F+[P MZ/<%890$0226KZ^!3+%T4A<`\^'78#SVD#_T3^1#X`L``00E#@``!#D!``#L75MS MVSB6?M^J_0_>S.NZ#8`@"'1U=@K77E2"5(D+2O3#QU9PCD\EP\'Y^#&/_YZ/YTU+< M'OUM'.=?CZZS='KTMS3[FGR+_O/H.LVF<39Y./I;?&62B>69'Q^O6!TM/]DO MOUY%>7QTGR>_YZ/;>!J=I:.H6(AS6Q1WOY^Y0[\5RU_OR^_>-+^N[=H#1EC)XM? MUTWS9%-#RQ:>_/W#V<5"Q>-DEA?1;!2_LS8X.OHC2R?Q>7Q]5/[[Y?ST"8.; M27HUSZ?Q.!E%D]]&Z?2D;'7"1Z-L'H_U_5T\R^//-S%[]_ER?1N8I4]Z4H:%1=1,FDJU$]4/=:T!REXGL=%OO@BB\=\-CY+HBO;<8ND@4_;<.M!%YG."AMQ M;*"RG_)D'&>+J/(Y>BB#UWDZF=CP]#W*QLT5:\NZ!RU=T;R%H`^)XOMB'DU: MX&4+955*FTVE2E!$DM[*L8XR+%@ZD`TCIB"MW#MW) M/,NMT\9EMBJB29EX7=S&=FRJ%[6&L'<)/T>9-=1M7)3MV\N[F4T?TE\4]O\+ MYWZZEE%^:R;I]T9RO\B@=XG3Z5T6W]J<+_D6G]I":!JWEGT[J[ZUT'9(+1[: M"OZ4NF]9=S-R/W95\551)]'C-ET^US&(;FC:G129K=X+BUJ3S&P(2:+)J2U7 MLT71[R"8"_4PLCK;L@&3821W2^N;\.A,[M7LCQVZM1VYBX?363G-LRB`:N5U MH.U*3K<8V$^L6W(MIWK&\TELHU2>SQ<%\*=Y4<[[E+-K%[=V2'9%:&N&?6GT MZ6Y1L9W.QO%]/+Y,%P)E^;)92Z6:\.Q6+[?>MJEMQW(T*YU?).I*,A,EV?]& MDWG\(8[R>18[#0(O$O4JF:/I7&A[E=,-<@ZD74FYS*0NH_MZJ38T[4&*,G]. M9\LT3\77<9;%XT<_.SJZ-<.>-5I^?9;FN8CM&!AWIID[XYXU_)REWY)R6*; M9#:S2E=XJ_]S=&BV?U)T-;!9[D]C.L5PTJM=D M<_N^Y'$V\(MD?4E7KE*.BGALYH5-$BR,LR+YY\JQU?);1QIU\*B^K.`:EU^B MZDZV;W;`2C.'N?L-37N0PMG=VRAZD,G585L(NI+HS.;6]6(\;=7MLS\DLV0Z MGR[[U+G5-IJLUI+S+[8:SC[=+5:89S?+YHZ^[()WMWJ6CU_MJ#B/)^5<[F6Z MBV[-^76KCQN`-[7M2HX/4?;5:FA97\2C>;;86E$GSTLT?"@G>^[*;ELGVE:"WB1R=&P=76_RN;FTAJPKZ?YG'F5%N2ER M/66OHB+Z,HOFX\0&L#HI'E*\M5@]MD^^N$RBV9Y M-'+:)%A'U[=\CG!P).];6C<`N%%W)VN1+*=Y5Y,.GR>1B]]?HNI7-F>?.Q#W M*ZFKO^MINY+S(KY9+8?^&:]`^MG\ M8#P?.4^N\")5O[(]_OQS-;J@ M6"UL6SM>WL9)=CHKLF26)Z/%RIXSG@9X=K]V6B]FKI?Z>9[/IW=-4H?=.?>K MXY\V0RALAABO1""@=H^VSTX=X1]?O]*A^K?`(>;Q<.7#?$]*67[_Z M.(9+!]J>Y6RV?Z01D\XDGU_E\3_FYY+&U7`O4O4DFR,(7R+J M2K(RVD3+WK@X'%$.+[90GB37#^4RZNK+.E&;<1E6=D<@M&(VK"9NL&G#J[$> MC\_8LJ4.L_BF3%;.HJMX\E3&3723+'M"5I[K9>6Y7D@66FSBUJ&4'^.B6T%_ M9MBAK)_C+$G+?0W=2KR9;>=R7Q11UK&MMS'N4/;+.,OC;J5^SK)+>=,BFG0L M[S.6W;Y\4T4W5ES0.\DGA1Y]4T9P;UC`%>W&OQE]77X.7I8 MQ&D;PA?BV%R.7^5%%HW6Z=.DM,/[=_;YH0-5"'00`&@D0,A@X&$)@=%*8:B4 M1[743]6S\>?\IMP9;S'I\23?#1)RYVO958J+)^O&U1P)PX) M#BBE`&$""/:!]C&"E29`D]Y[T8/_DQ[-K!5:=WS3G[N>GUT MR(VIV)OME\BSSK)654H;XS'"#02EL1$(4(!$XW[9C9[5G,-J(NH18.0\RQX5 M<1NTK:4-(:0^#`(.,&)"2(8!Q97.DJE?I`<[>S[MU[Z/.O`NEYS&N)(G38*!K, MX"_#JILP=1$MK:+O1TE>;HI>6:H^2-50ADH!"FWNB3T#/(X59'QM5JN[;`DN M[[#!U8]UAT#2`O?/NT4]D%XF#+V`:R@,E,!3`616VV#=9XC6M)[-"+P%\'1EU\$+ MG$U3M&^VO@F,3Z0B'K=5JDT<%"8H6!23FAAH`O`Z]\N=CP-U:#'/DUF< MEP=PKY)9M-Q94-^C7R(+A<":2!LL->"(2>4Q1:KY(4D)>9TNO4%DMZG'9@Q" M$M@*R,/2M_FKSQC64+%*>_MOV[)S#[MR-R!(![#RH/VX\96H;[BK8^8+K@3W M`L0%%`&Q?I`>HE($`E*@7GOTKH1?NB=9""\>'OVU&!ZD$D17MB`(H,.!8B\(<4=A!]8?`HFGY2F( MD>VGY]:O]H&W-A]2\;=XDB[.7WZ(IU=Q]@+^G.A#'$!*D0@4@E("Z'L2>97> M0L@#RKE[0T3:O]V'P)NZL/02B/J;EC4IW<1'SFRQ>KGK6`FH[40B0SPEC MOM4O@,A:C!I9:2B0W[9`V,.5PZ'PU)FQAX#3YZAP0M"3=J%6RF:OQO!R1Q>S M6G`%*ST@#]IF^'NX3#@4:':Q;ZL=,1?SN[M)$F-HP*5V3A8'R*:=8,R("#VN$)5AI28$@L.W@L8?H>YFN M.E,E?YS_F:7Y2\BJ([6I&:0PX,:.G%@#A1#38*VMYQ]V:M+"Z<_F2CJU[Y`Q MZM'FA//U??^G8ZM-=4^V.VWUPRML#>S7=YC*6=_S$D&G&C2\P";06"&.IZ=K3 MC(/#3B+W#?!MW?+6(+\Z]K%L:;G$R;=H0/QO>WRHN`2,0,J1P0PC3$T0K*P. M/0;;3O?OX:+/WG>&CGSTUGK&L_OE>^X*Z^>%-IE$"&&!%?*(HM(.NJ:R*V2> M.9REKKW'?ENG#+S1\3*+QG&Y)%A;+FXG"GW;A3V.%$8>,@A#7S%F-32!IR4F MH.T"&?E%8->99=]:H'PR/BQ.);]&\K!X<,@-+2_H89@(S`CQ##1#\/V@T<_A*#<`@)]W_=LB#$""`@K`"!C4-LSM=2Y M']3='/BK=H?V3GISW2&=E:\I>Z3S4'.(&YX<*J4,]:5/?%4:G`-.J_0-4:+; MYM3L7QWB];ST2CW""IXGX\5;^-+9XI4Y2__#9O#>RB841'*@D9'"*!X@0`Q9 M6X'PH.W,-P2_;A;3E;'?6A#^&`\U?6&?%)8752!F_X/$,XPCH.AJ^R@M+[/R MVP+W5UEK?%U_#('M/]-T_#V93%X`9=4DQ`'BBGM8"LX9I-Q@3"OI@92MCU/^ M*BN`+0VYQR&NTFBX4%?WQ)!K;$<,SP_L\$&4]13CU1RXAR!KNTX!FZ_:]7X/ MV3Z%O([],N@=*3\2WR=9R6JCR7DZF5RG6?F"HX.[,,77T*>!),H.2Q0+H(CF M]N]RJSCPO:ZN6:^WKUG:=]LF3V<&H6%*0HB6Y3L7Q$#E51J9@/PR%YZX.C8= MP,JO5Q5N4J?EW$<=MQ`HQ;!G`QD%RF.""(_ZE4T"!@9#WMV6UXYTA;^^H.)4 M,G;I@E:;T]W%XIDM:F^6YW_7+\SCX_%R9ZTUSVK^[;K=%P2&>'5(9 M:(X"B#5@`?>Y]FV.NK(A0:+M5=)[E.+W#.!]==5.<'_TW"UZ?$@F<5ZDLWAE MPCH0-^<8$E\**(`QVF-`!($)P-H32)NVY:=[8C_4C/&0".W=#Z\19N5M^=WI MC]>TOC3H]_O`D!,B5`"D)Y@&B$%;]*/*6MK';6]LV:-]\;[W/J9`H!<@ MJ!3RB4VEK(6%4:M;OCUH/]9"O1]-?QS+>S[W%H\=%AM:7`O?R9-"O^PDU'8- M)2@'@@!17H:RM*=-%MKN67QK$S#.L-IZX^QKN&.(T:W!B=,M8;(9K'=^2L@4 MH-*74"*F&2-&!$!4-A1,MMVILD:4D6X-LSW*UL0#[9-3O<01X,E&_VZ8`_@V/`M+"VXA4`C(B4F%$`H MN&`JH'(=IH4ZH!RX-[0T0V4'7A@&F4.\D47Y#`N,,4+4<"B([>^PTMM(5OL. MR(-!WVZH:/56EF:V?Z4;(UO>8*X5\3E%PF>:0^Q+:Z]U^D)]V197>WA!U&"# M;3>F?BT8=7>#N?8A(('G:P()$@&B%'N5OB+0!SC)V-KCC6\P;V;;5AN8.KC! MW##(RM4Z2BFC`AH;FM5*2@65?T#O4>S08_4WF#9*`@\!+S"<"PX0HW8DK;0T@6J+GCW:=;H/F6E;>P^! MJCYO,`>:,QT(CACT#;'13^*JIE,!4H>=G+9P>M,;S)O9=[_V)#_>?[V8ZO]T M_6E>C-)IG"]V7O]W%)A">1Y`-]H@*"@"7Y(*7@\X7>T'Z*[AEWVY\H0`APST% M;,HM&/04PWK=88UJ.\&YAVED+Z!J:<=61>?Z:-/I[&Y>Y)^S^#*Z/T\?HDGQ M?A)9 M)?DHG<^*+1!RH`H]@#Q)C">1'?D))BS0M-(1DM;O>7UKUUBW#2+=F;957*E9 MY9-I7ERF=M2\F\3;@TPC)J'6BC)EK:4@%E!I1L%:JT#`MIL%WMJ=T:TB3I^6 M[O\\A8A&7V\R"^_R<-/%?#J-LH=/UQ>)3<.N;T"0\0H8QUD"G/N2`0()^KVK6??HLE%>>C++E; M="^KW3,U7`YH->850HHUD$`0&^6@LGVMO/)B91,!_+8'Z?=HTFDXV&PI?OIR MQEX&CG8'M=Y&_.`>@!J3@-E83I4DA`M3A]#C0-G\6DNK-/=1N;>DTIIP?$#;=W;R^;,]I9V;=@A`E9)^ MNBZG^_++\MK?VGW+FPG"P,>^D64-3_U`HT`;?]WMC.$'D./VX^BT!^L.ES6WCRO8O85\^8KV5JKS8EC>G9GMQ:@OV\3=J]OKU?)F.]VL/T^VBW01X]ML,:T^Q5^[0\1]1&HW.CCF ME?7"44-]_(40P*"60TORSXK+9ZAW.33D1?+1EJLJXO+0!F-ZOVL5.IFFR?XK M.FB?E^NUKFZ7N\2Z0_EI[=\2O"+<1O^,.Q*_3B&=I@V^&N,+N#-0A';#0U^$ M?GN+:?RYKFZW\\^SVX-YD2V&AX@J4%80#;E"CGO&O&B\":ERVPMW=JWOJM5? MRXN@7/^HE^":NHD:V,S6$8O'L[0#S'K]<)#"(2U8%,"C=-X&I96--T%H;J3N M?=I;I[/H9(2+Q&NJ]68UFVZJ&S-9IV3/])O[O^WL;C)/=['4QDQ6J_LHPRZ' M^%!,I]N;@@184Z^UPH)IKH@6AAA&T_$:<$0>S3$:_[V`HFP;%OXL(_]_'K+L M;'4WFU;N/]/9.FW2U]5JFO3V?6].U[%QP2$5_6,`O5?">T0=W64V/[J\/#>1 M:T0W`LH9]CV#W2-1NM$C<"LLAU%P2+4T$6IBFK55$)P;+1A1UO^Y2=$1XE%F M[5YTVK_04,N4N"UP_`\J:1E[:&_!@##L:,V?H8Z/%^LXTYN'QEAISO=M,OP/ M#0M`QA;:*4*&5T?/O>%>PH"-'MG5K5MO9C\G MF^K04?3O#P9G).4:`8,PL9`:#ARO)8'8Y1X[C2U*6."ZXC2[J_S MAVXE[9>K['<&HZ`CB%!(@!!$2X`,JO%Q%.<>?HTM,^(<3"REE")96&^Z=1WV MTS;C@TCEK9Q`DD%@A%8DFH_-`L]9;O!Z;#&@LVRL`RB@!/'B9W)3Q8E?;7Y4 MJT=/0AP@'BMQ@=`'(680Q0="R&\\4JY6FY.6.Y^/+9PT#F( M-X0"RN2=+E(0XJ%`U-?9^M\F*G&V27\Z[#?L&Q7291(>9>104(J10R7J_OV=MF^(<$C;YT$`I#XN6#!.9$- M8)#HW!B'^.!47YB78-3U:OFK6FWNK^<)BL5-,AUWI5C:,ZSM*Z()`"'RC'/K MG$<42<^:Z(YC/+=FN/Q@W%`Z*,'`9S4*7_:#:<_!]B\)A&(+%9`:"TR]XAT=&R#' MT`-#C4YMMI0!U.M&7I*=%`\_#B[Z1[]0`M<;=?H>$\Z.NK0M1@<:UW\&D%=. M(R((4APV$4D)8?8%WH\#BB'P+U)VXD=$4T_6U4VJ!!FGNM/M55WX[=,N$A27 M[&3L'@^K9+PM2(BT=!@0H!#W2@,CGZQDE[\*?IQ3E-!'F4A,:AZ04MDZ1&+> M'A(T5YP:(Z1S4&F/A5!-_-(BE5V+Z>-PHC?02U#*5JO9W211OX.7L7]00![% M;P-(;XV7!G&F'*TE9%#FWMN`'\<1/<)>)!^E+M%]=>MGB\EB.IO,/RTB`MN? M3T?$AW)/VHP/RKJ(),368(>LI4@IV<@-;#;=/@XIAM%`X2M#NR)J[=>U(R,# M,28Z2TK'I5M$6V!7>;R6E1B56^\%?AQ?](U]"9Y]KKY/YAT9MG=,D%KZ^'.\ MHCSA%"6,HC7GR1;D#_ZQ+1%Y[DO>\4AB")0,:6,(D$JE\/'N\ MJ`RUM\?SY5K:J`XI4R8Z8PPQ81[G;X#3%[`3]*S'O45TNR%9C`F=BN@*BA&+ M6Y_B#!.%@-6G2BJAVT]N!(KK=<"MR,R&KB*Z!(CK2B#&LE)2(46)` M+0<&Y-+TWU5[!XOH=L.N2+1TMIE]W^G"3(YVI'K]I7]\FO+> M_:7/UP?O)38\XN&LP](#S]/9YP,2\*)J^Y].AN79\<]BXI?MW60]NTLU@`]S MZM6#@:1>)A!#KS"S0A`'C:]G1Z"X@$*YP[#C5"2S]*QGD\5T>5C%SY\)#"#E M)4*2>\B0,$116L])4IN[IXPH:W@8[9X`8I9BU7RS75]/5IM%!"HN(H=5_/;3 M`4'F'*:<>XX<@RAU-*CG:92X@-*QPRB[%SBSU'[`>/Y\K)%#F['!`"!3]V"A MF<0$*RD@;J@K16Z2QHB^_V&V\G/R?=JK?Z>1-W='"L@ M?'QPH!+%'8X8JB1WE#F)(6_L&40N($0^@/9?NBU]PWP&8EU7BYN4_#:?S'ZN M'UI3M"?6&X.#(I+'Y=IKJZ5@'&FL72TQUS:W?L>(3-'BQ#H=YMQ][:\HRLV\ MV:?G<5X'=K(WG@X"I\BB9)@J9:'02#1'3H8IDYN7\X[VKGPZ](=KEOZ_+N\G M\\W]U\EF[TGLLT<"840#+Q#17CM%G;.P8:2")G='&9'A.K"F\\',4N_U:GDW M6T>P;Y>KW\DU7:XWR]OOJ6GW>OD$Q$OEMWY!X)02`"$1#'+I/4Q5\6MIA!:Y M#NS8+GT-1XVAH#Z#P:&FT]5V,F\D:F]MO!P9)#=.0QC=1:28(2:NAO5QDR44 MYEY='=NEKY*FQHD8E\C3JFMJ5S=Z,I\LIM6W'U6U.4]Z5M/&_-EEI>OE>E?P MH$565IOA`3/%*0#00HL$D)1!2PW2FD=M<\*/'D@/+/F^3*VW'PR$"L74[E(S MI9&QG&M32V,DS;X`/)YO=ACEOKQ9?@JJ10H;U!-\WLK]R/G[WC$!&RXPUH0H M;"EUT=@5KI9/2YKK18R9-1T5NX\?)T)9@BK/IWCTX/WUPT%'3YA!83%(E8LT MBRBI1XDLB1JX0'+D:_5EUO:IFPAE@: M)+VN):)$9Y?=&5-7QSX4^D9&_TE(%N:&[L*-QX<#H(9*ZCQ'0!%GO$>J`4@6M4$.')O5K;M0@U$M%HD%E(8=PV75QOB6G@T]E%[4?(G5R%M^KPZ; MG*T)L+98**"\8D01IIB,_D"-A839%<='N%GU1+%A`2ZRD]U-9O.T8?OE*B6N M/G5U>&C3=7!S.S8V<*,\9Y1$0U`!815&SM?R`BES][L1G=SV3*B^(2U"H5<] MC+Y4FQ;L.3`L.*NL`Y!3`[0!W'J"&D<`Z>PC_Q$=!/=-G/[0+,&9IN5'G.4! MCCQ_+$"AG-'"0>6F M(]I.]N/+1XO1P0L-'.*>1-)K1(BWE-8/)`R MY;4B`CR=:RB>6]"W>Q7,Y68R?P^D.`6^,O;)GB9AAVW60\."EU)+K2#6AB&@ MC"?L24I!LJ_@CJC>9>\F26]PGC>>\F6YF)X04GD:'@!5FGAJO6**2HN5<^11 M:L=!_EGTY8:"!X"UC&'[>U.X2'GWG^E\FVYRU+WC#MJYQX<'Z3W!Z?Z',IR@ MB*L$=4C262:RZ]!?;M!W`%A+D*D%89K90T`8!$PBAYBV0#L$FT_!.)&]35UN MX#83NA**?^;#M]J#WGP^$&L1$Q9XRA!"!D4KO9$+@OSV*)<;DNT#QW+NSE$_ M)UC'(>8,$.BB6V\@-J:9N8QV>RX#N@=@WY>'TQ&X(O=I9I._9O.=`91*UZ1D MKA_+>53'.IG7F_L6F2UM7Q$P1-H:*ZD30BD5_7M#UY#Y9W.T/`G\?$"2.IKBUF$2QXA9J!`#UH973`F1O../C3?_*WG,X M>!+"9^#.UVJ>[FBEBBSM$A):#`\@5:A4T"/$H!:>(-"DJSJOLQN:CW`]*LVK M/O`NQ++5-FKI"9Y6U'I[3,!"(^2T9EA(@;CSU#?R\0CFY>2XE.!3+R`7)-&S M0[#6)'H])F@/"(\R>HJ53^>IV/+&:U0@]PK!")VK4B0Z&>2L@@AZNXZVWWJM MIE&8AWN:K9:9]H.#T(8*R+A/T07HD`).UE(HB'-;9HTP#68PJ@R&=F'?[?B* M\X9$@,@H"H?."B&9%C.\`:H554 M(:P]9QX(#FM9F,YN:C'"C)ASKC39@!?.G6G+L;9#@Z">*N^(Q0)!@%7Z8FII M$4:YCM@(LV@&7XAZQKK8J4173NT?%*)%ASVB7#G/@'(IS5D\;=0FMWSUB)K0 M%F-3;R@7-H?:V4'!:$*HTHY1H`R$GAA9K[(>1K#*Y>!AT=`J5P76O'*\^S+_#^$Z/2_>%1L/+-S*.L]5[#9CCDL5Y6FQ+E[[TSI!]1"YQ#;G]O=P=O.;H\>](L?U:I/N>7:G-U&]W#PZ<37=X4-,51>*RAA=Q9:;4V#18V&GR7<_`U M!,$&!;M,F8K-)!45=Y/5(AINZV<2V>IV-IT=,HR.#PX$4@*4P%%(Y@UGJQ\3N9%H'Y)0P!DCE!.71DI3>UH?$7@J8&P(:XD*\8%)1`<>*DA5I*P"%'S0I+-,[MD)21\WY18:$^P'Y&K=(E MP:]W@/ZH-NGYRRT0;BE`4C`LI5$@&K:0&!FW!>>\<4SCH_5O!Y:\8X%PATBJ M+JJ94I@GSTZ26AJO-,W="$88I.M7N8<+A'=#M8S!T&>!<(!AZCBLD/`,:D>, MPK:6SW&3>]P]9M9T5&SK`N'=H"P2=3NQ0#B-^Y.@6F#BD*;64RQ\+9&QX@)Z MW?6HU>,%PKO!62XLFU\@W%O,H/$1&ZFTD#KZ4*KYB+PMUI3B3$6@6ROT>('P M;D@6YD96@7#(.6+81%/:&*45`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`8![!89#-N@O0E M%7P=$R>'$$XI4FX*"O[73#YHXQ!QE-.H0A;"F57P0SC[P M&:&/8G1T.TD210ZH:W^@G0`(]57(:KXZM.F^W2!17(>7U4?\L'0338/$OAD9 MEBQW21NA?W94'.M%&B5XM@%C!>_V1B#''K;M:Y:$!*W!>QZXKYV0QF*E'@TZ MDEN0:807#T?%N1YE4L;(V(KR269:T$/AIX,_3O>R[U#3Y`D507*FK9+<:2^, ML:VN('!NP9XQ5KH=$P-[EDL9'>YZ6<$Z[:OMSZ?`/*MZLE>U.[*/I#'%C'., MP,*J$X+5)8+;68A5;N3["%.(CHJ70PGH/`3]`L;2TG%>W=8G&LCAY6>6A\;9)AUP]*81[WE/B M'*:Q1L2!'H,#O)T,^'%[H!=TVCL6^ITD@+.1\44-OD;)>`O"KNSLT'4*UHB@ M`Z@SA@OA*).VV80H#_R"(MK/2=?A)')6_C[QR&?NW&_WDD*07AJ8NHYBK"(7 MH&&W&XH4N8;W",^7S\W*D\$O%&1]I'+=2X!_8@&@-=83##]TD"B$5I\Q^64C M1IBDM&QX]C#XGY&!VQBSGJZ:[.DL!:XEPEA:!)-1`0K"M8ZQ*&7NT?,(M(QSW!M7L:99$!*68&X48C2CHZ"AMPA^I=S[W MHNUXS^J&9,++R)G^@"\4LW5=53>K")C],5G?+SHH<1*4$R<-DQ&25K<6$2Y46`C7`A+ M,O4,HBE-Z?IE>V#NH6X20L)'>!^I/&`?G`JBU=!%D+G!.",TJ,]$T)XE<):= M.R>)P?&=)`&:N,'6>2:X840H@FVK/_N0NTB.][#PG+MZ7V(X"Q&;JMG5M@A2 M#>+NDWT9?[ITDY"(!*:BQI8C#KM#75JR#181+O>N\_%QV[\3&?L3Q+BLZEZL MZ62-1P%CK1BAA%E)*18-`LB;W`/K[@'OLZ2P) MV".X0Q&'H"1RI$[+WB*"0FZFV!%JBR7].OTAOI^#MW?53EV:)RXLT\)83*E6`@>C23,2,+[X\($.(]E8>Y'V8G`! MY%'IB>%39P"LDR-_FL/73V:?[[_-IM=7WT%2,/;-=O_O.4CPG]H,FM_&:GO. MN/M\%\OV/NGZ_J($L]EC[+3EAJ!(A7>F.8=G-K+;-MHG5)5\:]H-0KYUSPK0K,++.7[YSIDY-#P5Z"9N'G-:SK M7R<_;36OOD_7&\?2F[>KWT!L#P5/ZC>9X"*.S"H<%;7"2&E(@Q.3.'?)'&'8 M0T%ZEA3)N$R67DR5%(/E41F.)#:1F`"#;L)!F)#9)5N[W[L_E]$\!"D'P[_( MX@EJQ#5H&#"S_I[,;ZLOH/Y?S3>^IOGF.F+M`GV8S`X<3'?I)A$:M5*8(LT# M0S:XM9*,I+FAA&.\";H(`0;!N8R5T,`\FJU_CR9[@L8>/I8 MJA-R"\M8!(R$=SI:U1PT,B]I[J8WP@N:O(J<@^X0EI6NH+.Z@Y[^K^6KZ4&T' M\?S5RE=3V:41GM^\\6[="JP22B79YI-9?D&DRPEDT!I&.1GOJ=;(&@#V8(U2A/:V21)%R'PD.3#A#F2%:MFJJ9N7*W)0\GAU4 M@>\/[?.YC;8EM,_M*7J_J/=Q_J$]1<%CX$01Y+S%6AC-43#241*U]HSP>+`` MX\!C_WH@"=3S!Q/6.L+"J"3W7!+"O%:B&8T!7EV.2=*S=%\>()T":YGU?_X` MP]V47MN,W_[Z]WSZO_>P9ZZNE],?&P'^G.[S*![;13+57]R!<=V%2H^M4N15HG=T<.*=^\+[/9Z3)&Z-+I7>Z]H9HWPQ>K]>$I_O2AI+C0!O.():+<8:&D M,:V&E1]\,L(;8/W/\1.`+!+NUFA#;C99K7:#/J!4OMLFV>"=`=H2CHTF%OY! M5+N(69,;TC;"1:$G+;(O*(NHC4]>\;"V^.KA9&`HT7A+M`"H(F;2X&9$G+K< M'6.$FD(/4GVI%9X*9R%_Y=UBOGE5\^[V\O[#*4A3ET4EVA@=N+16T782Z1!R MO9.="0([P+?%T!O-"0)][8(\#?EQNY"%9 M5#_=.GWKXY;%?'.3Y$@=]:UVB0>L/0V<2P2[+FS#T;AFG,Z8W(NQ(S1H^M93 M>X"SR&WKYZ]Y4%U]\_D4D#<,PQ@$V..*:X)CXY/AP62GOANSQGJ:?%]>H.X! MU3+Y@MQY/"G'BK4.<2@8K*)&2-_Y>#J`=/&/\.%PY4:JO$N&< M#&8Y'>4X?KQZ-C'#*`X118E)@"4721F;\1!#<^^3CM`OTB\Y3D6R!#/,S#F[)(+)W/=,)T7 MEQ)NF+[-ZEP4"]U(?U$&\74PWI?%;!87RW\FRP,WUKOTE)C4UB@+KZ6YMDPP MJYOC4HX8'K[05GG[.X,(!ZM6]@ERD86H3C2YNKI?K]:3>7WM:]\Z]/+9Q.M2 MVH'8.H)&.VV)H+H=CY*YFG-GTI1*#S68O%^N52SGRO5O8RX<3U81J M)B0CE`LP"5"@J)US!N=N89WM](OCSJE0ES'DF_MO=6F8M^W(S23X]C('[I=J MF^J^^JM:/DROJ^T-IR_5]>)VONGE4%:RH;\ZR>B,4Q9'BE$T,7J"6L'!#I.[ MDX[RB*P4J4M]ZNS5L/KS:1$"OPL]J>3U=[2V(U;VSQ%2D MS-!@`BA#,G!*'JUKI=0%Y?HNNC(/*80STG(SBWIBY?M]):2B08PH[I6SRCHE M0NN2EH'FEIGN[!BYI+5U:"F,19_X.OFYS3+]?H+]$]6&([XA.1(%3-T0O*&, M4VLUY@UV.LCUEVV3)2RX&!$QCDA,!*M_ M:SSZD>2&]QR?@/>WH=J)T)]Q5=OJ(!E+VJYA$D(B*56=/%1A(^ITH60W4OB( MY&J'^O`296?!W&$9W&C<+WD(G]N M=\L)E'O>/MF(*,<&,\HE0<)9$YJT+@)'E;MQXA$&38[!JY(+?*'@V[X3H3'$ M<228!5I/+D>$5X]CQ-F1_2.,KRRW=?8%]_AC#)A0EFA)`F4>$1*\0DTLF%`Q M9`?[=SZ(*%,@Z'PA!MV`_@@A!DCA2"-'EGINF&$NLB:L1U`2LO/E=#XNN##J MG(KT$^X43K]XQD(=VZ]N7^:(A(OOM$A141)+/GTR$*Q*89)0:IP3&=3+09CQ@_5U0DL63)?IR M)IZ$9!EU<@5ZR;\6BYO57XO9OL/@%T\FXI"DQ!"!L,8"44HE;L8B27;JS7&: M)+VRXC0D2[#B7\O%:O5YN?@^W;=./'DJ>1+!)!=8:FQ`48G1&=.,@3.;ZW\; M83;EOMF0CV())ER!:@1"F=^&G_4Y[&/E\CV\>+=-4@Y38S5B@E/!O3=@7K=, M5^6N17R\-:,O3,O]]L\6-SFW[[XGMXL[==HMQ*`7IOE`)& M186/M)T;@H8+RJO:@ZQ?W;OJ#]DBAF4UF]4E;JHY(#&#MS8W=]/YM$9A/7VH M#E/IN`X2##SXB*)W3GO/(A(*-2-GCEU0XL[^.34(Q"7(51?!`/NS!J.N`6.N MKY?WDQGLP`_3U?X8LP,MDS`P3F,\-9I&+TSPI(428YSKSQBA([5_.O6+[5E4 MHRXJ47)2T3HYE7,6_E/,"Z]WXQ$P,7*3N'57A8:O@],[5TY%LR@[CJIV^L;3 ML'(R@IT75CH6/;46\V;E%(3+W-6D^R7S#V=2G8YF$8;4V1/^7,P7S]_VL'*S MOV&B,#J),;&!4X8=QHZ%9J02Z=SPA,X1S!^0-WT"6^8Z^K9^^[/WW._("U!F/?K'S;E1&WU'9[9 M'TW0H9WCA MG2:WF.^XOGT.&%^M_IC.%\OI^E>S^IKYS?->MD???U3KO^L*FP_5[@;2P0/= M(F^13)0T(!DY04*`0&SPLE$FM!0%`Y8_G)HV7C&5FRKU=;FMHF&K>;7_G.Z= M%@DSI2SWUFO&4&"&Q=B.C5&KZ74'NFR>3]X$$3%@$XGQ M%#L:G&K&%8G+OL,P/JJ<+MH#7,D!]!Q$\=/9_7IOAI%W6B0NL&2".^D#9UP: M!99LZ\_GJECRL0L@2QZD)>CR7]7T]F]X-?,`>OMM]>=]G0SVZONKR/$_,.[72=^DG&A1@\THXA MJ>HI)TT3_2LH_.UR=L#A*)+)Q1P!%#+FEYM9.9GMZCMLWMRLU\OIM_MUG5#Y MZ^(Q&\[GR:_-%%XN)_/;Z@AWUHF=)V)M5$8CJ16S$2G%%6_='R';2S7"?;@8 M98M+Y8P+ZD[WZ'+!L&-/R0C$1%!:$T."==)9YUHUB:G<.)H16J#G7E1[$D$) M.IKY>GI3O^[TH?JKNKY?3M?3:A5^7L_N;ZJ;K=?X[L?]5NI7WU_IX)M$%WM( MVDO_*3H.@L#>@OH%)IM@R+;Q!%K9;!UTA&4D^M9!SR&`X6]%^NK;^OEW%KK[ M6'^QGZZN9XO5_5$>P;<;I,!)!).5PH(CD8'%!GX$[QE!8,=2?E##+3&ZKX"I MA2_ZGZ.'U[9(ED8;N%:>.!>\@O]AT8R/!);KEABA!G^J@!=#`%IF!OJZ2,UL M]:$GHE'*4^>)#SA81)SEDAO0!+QUG`#FYYN(G^;PBO=MN9@#0WOQ=")$>N-X M8+!?6&&P(E@TXW)"Y%[8^#@3\&C!OC$!3P.SS-6,^2U`>U>_[5?XU@.%C=]Z M/&%+C'(X(AE5%%YJ#`KP;E11DPNZK7Z23%]=OS@9RG,0Y&`QX[<;)-AT6/"$ M>^E!\[,L&BL>1^:SHV_&1Y+3!'N`)5EHEKF"^K"8/8#*[T`2TW6<7$]GF_B> M@_7^]K1+M4UB*#76!T:]HY+3V$XN+7-]#1^`-5T%_>K^:7^P%LF*\>PU#^Q" MKQ].3G+-/<:<@$XKD>+4JF9$DN+,2YXQBW[;"[ M>V*>$.HJVJ5M6:R15#[VUR\HB:PJET12X"$6'R;&;0,4\LL/0&8"F9A@V+3/ M/:@SD.-3HW'_.=4\`D0HI5AJ;H"0A##O>2D5!GI&[Z-W46DM.Y*0',5"R7:[ M(EIZ&&[CAG.J>;",.JB%`=!"A9#"!,AJF;5D1F\]=E/JK]9)=RSK&?+E:W9; MZ)U`=-1Z\3?A[7*=E;]:BE)>-/ZXV&7']UG.;".7?B(8)[!PTB)I!;'4>$:K M[=(YEWJ1:H(G'GUL+@/#VYDP)X9Q=E-IWSD4Q]D*%EG51C,D$#4*E%)`86=P MVVXXQ9YC3E]H=^;,GXO-LI@,Q4`^9!NU7C]\/;O37-`[RH$!5@PX(JB/JZ.% M%)=R:,EFL/$,H=1S?.D-Z.Z[TO)'=EL,HSU+?ND2L,R3*@Q"@7J3F: M$[Q-V:?#FXK?:/IOCI<]M@I4(DFE$9)B*KUS$%E7RD"XF='A:(+>3FD^";.-`!NS$X\'RO*^R7-[OL:YU%<*9' MT`8Y[0AAR`I&,-&DJ&Q[Y+?0J>?V$[SIUJ=]T`^:XS.EN&V__10UL[A]OW[J M!=4]\-;V$X%@Q`S&-DX263P%KP&I9AO6QLUGG^FL_UH^]0;Q*&'U$X&>0V6< MG/"X?RMTV;; MF\WR_G!M_>FBO%^M6V^?]9\)F$M#!(3$PB@Y=I2I:LH)9U+CO),/U_2]A?8* M<^$64/<6SKQ>KD[G7I)X*77!!-&05"4ZV<=*"2R'*:>C)P M>;W9U\N4?B$>(TUBL_RV+_/OX[#7-\O%ZA&7[743*,J1/1F06M_^([O]4N1& MWL1_VN>*79AED?S5(+&73&,$A0?$$"X5M46*"XQ:%,@WACZ&QJDY#>-9RV"< M`01Z`QV'&ALBI32E/(#@&5V='D7K+^R++FB/8Z^^1.7CRSS*H,[;C,JC=.<2+UH%I2#UFP&,#8#3,<#36JJFF M5*K3.\EP7M^+3"J*(YBB^&.,8Q@@$W>!.'[G3"D!%3(U%#VA MA;)'[7<#KW_U'X]9?'1)%JM_9XN-6]_:TX'`NN8!.V()T]Q!KIA4GGKI2CDP M)/3UGT?T0H*>\!MJ&?#+5;8Q<3Q?\DW](O"L98#$0`J\!"Y:EL8C*[0O1R\] M3"U--*$#@AZ7@"[0]:_XTB`JK/DS&G_:)%!&F3422,NUDH1A37DY7J%LZEX_ MH4!_+ZKN@-EP.CX$B^M7^)-M@["0,F&LDYI(A32.;EVU3;EF*W7Z0?M>M=X% MO.'4_[CK^/@WI_SAFM;%?4,"K?6".NB4D%BJ:H<2&J>>VTSHP;=>*=`-OJ%) M<"!H>QH\:1\$5(Q$.#3F6"'B'>&5R:HQ2=WL)_1$VP!$2`>P?RJH.*S;_=!6 MBU.U55^T"9X:`4#QI++`E"JJF*Y&+$ER^?,)O:G6B\J[@#:89W\H&KS+;_YN M4U>W77/D4V;$;U#.11-_I6M5O]3F1R-?8*E!`FK*45>*&ZA,Y96(2V#DT]:YAD/[`?%H7CQ M9[YZB*K8'+S6<\;"R;:!(`0<,!0[S9!E6D);N3W2B>2C_WE&!KNA-]CV<0A8 M?/OT M*M?U#C_=Y@G"9PT#4MPARQ&&U,>E5!`'CGLIAER[QESC8:39&X1W^2H2>7L8 M\+M\EUU6>KSU-P+E7F!L*7"<%,?PI'A<_HB!$6I&^?:IRL_'@7:L&?KIYBZ[ M?5AE[S_O+)F$4ZF+.F]*$*H`EAY!0CB4$C02 M>:#)7*&]YXW^:5:+[;;IMFQ-K^`@@,X)`01F4!)&H72EG)&X[W<2$-R9&Z8 M2[AQ;!R\!E0A)XPTV"#@/$$5.)RXT9Y6?+W<2$-R;*/C;8N$BI/M`S?%G38E MK&5*86^`%=5ZR+%+#0%/Z#Q@2".U#TS'6T=:GSBWZ1;B1.#<.:M17"R!L<[X MTB5$1/GD\^:IKRT)>CZYO/0"ZU7(2R[O,RNRV]_SPS'Z,7+[&N.N=4*247#@XHP!ZCRRX@%_) M4%^;9*V*";3[0#"20T`4A0!PCFW\GW*EY!#A&1VK]DV%2U:R5+ROS;0VOG*K M_J%(GX?4(@@M9:)X`ENH"E9%4\NE3]"Y:U/?,V!J)('(&VJ9=UH0)'@EKU8S.H--572[ M`_M$0$>;B7%\#XO5Z[P[PZ+S[K0RV,6]$FE-@#)(&^&I$Z;Y3LEKN3LC-.*1 M+,@R":04BL?_+^743L_(*DM5\`5W9RX#L][D.E,TYR#%^^_KB-?=\E[_5%_S MA_6N[@W,FBZ!*F45A\)S"Z&#AFI'RA''Y6-&!>)ZT5L^"*Q]$.'PX_4O7-9T M"5I0Q*!Q,.*`X]P0"IGCB#U7?B[O6O:BM!H6=,"T#Q:\__PVBZ2^6ZQ_SXJ* MMS<1C_JG"5M_("`I"880<0X14D1B!U`IC;)L+K6K>E%H#4-Z0WB<0Z;UMSCL M?1GVX[+YQWKYGX?L28'VAA!DVT\$R!WVP!`A+?"`2JHCU*7T3*4&(2=Y8Z;/ MS6A@H*]"LZ+@6_.5S?.]`H`*1RM.0\"=XH(#RZN9*LRL7GKO7>U-O$J&.6F' M>_;SV6:9;=V'4@7[X?R>'ZZ+/3F.K=_RTK\8*-#`&8BL8IS%62F(<:6\B)'4 MZCZO@58I6L^O@7IGEKT8QG%D201K_;$`K8I[OL`*<<@AB.ZI8*64&*@9/?$X M*+>&`KP?6ID^:=7F8\$+[>+$@4`A%\T*ZHCSI904F=0LA@DEDX]'JP$`'V.U M^I2M5OO,^,DGE,H^E36M+QTD M\7'_J^\_1X7$(;Q9+W?+Q>J0F%_^Y>^;Q7J[N*GQ%],^%`0P0,7YA@!!C!)J M-2F])6]8\N/HD[Q+WWL(GEW9U47KL?K'^6;\QUO<*4'E$K2E081PS(J.C M70%$3>K5DPFYA\.K-!\*[M>7JLZ\C:JQ"&I>5+VW1*G*03'0SLAZ&B(>VA>N MKR%572E`)?*,(2HMMY8)("J)T!Q.[WK4:G.J^F5POH94=2.9-1`K(Y&F!+(X MHZJC):/D:-<\KI1RVEJAS:GJER'Y&E+5-4`.QADCN2'0,XO]X]9,,!XM_^OU M0JJZP=7K_T#:0SFO.J:W8CJU-33.:I'L]##?2D'P]J>J(&@PA5,HH M@BR&"M+CX0S;Y^8G,F1"SYP,>FC?`Z:O-55=86D\Q!KC:+`I88T%I)22QYDW M'Z.UHY8O252_#-11?.)BC!\VRYO:*\I5HR"94II0+!SBP(`HC?6E!`#JU`5E MBN>@O=(B&<*KK!_J87>7;Y;_=UG%@L=>P9/B3J:)2RV/&[.G(FZP%=$!3;V. M.,5SS6%7CV1,1^;-GWE1WOOC\LO=KOZ^XP8$X!P!#$D'GC<=(85/*AGER M6N`$@VF#\:4#GN,$7^,8#Y%B^U!$H0]/"3V-(/M\8Q;;N]IH;-N/!,N9!QI: M980PFG+FF*X0933U9L4$+=^>-ZJA(!Z#9!\V^4V6W6Y]!*D8ZV)]DYT\`JGA M6.MO!"NU5AV%`()QTUMA[,NVSW_O,?ZZBB M[YMEL=3Z+&[/Z]ORW]V/^VR]S<[>GNC]AX*)S@-@0C@=)QM'QC(F*D,2^-1- M\^*G#*]73>Q2!DY"$==:"-]_?F(M7+@`/NL;.%<$4(LI)T`)%S$7E;Q1`ZE' MGQ-Z.G&\A:\+LE?)_CA8`H>_WF6WL-;:;^@;@,62(.051DPJ22%\,G,03,UP MG="+C$/9_?TBVSWYHQC$Q^P_#\O-_@!X^]OBQ_+KP]20P`P0514XJ#+%.OA,VH4<UH\P8!USU)`]J+F(_GJ1M M*L_4]@L`<@VC#<6QUUPPK$3Y0!B&0.+4T/($3QSZ47D^'+A7FK;7+$4SR.P% MAFH@B91<":$E)U#$A9,@S(7TIO'BU\"2JNTVVQ4.S=OEXJ_E*KHXV?:HCMOW MZX_9S<.F<'-B@W?Y>E/^IUYLEXU%;7K[C5"@=(@%2">6X<)Y8;004X MRBPU(C,JP',%GIQC:F_Z&)6#I\;<>%FX1>]0W$F"RA%CA!"\R!>+*\%19L%4 MZELU4^9@'PPXQZ[>D+X6N[;5'&R\,MBF>P!2&("Y4A%4""CCT,!2:N"3<_2F MS*\^.-""7QVA'H-@'Q?K+UG#1EFU"98YJ!160,`BXN!815^U,[H)NGU;8Y!5'(U/^FE"$G^^-GO!`XT MQM$?)=@30J)E3P0I$-C>.W_9*R`; M9S")YB,'GC(#3)2KE-&Y.57^'DCWYQC6&>MK\0DE\>G8*TA-#33&820EE=@* MP2K<,)>IN^@$;:_K\2D-ZVOQ"2?Q"9<^B744>^PE08!90135_BBC]YRQ&5IE MH_,I#>MQ_+__S3?%8V;;]Y]M]M%=X1*!*S@I?R0 MH!D\M3`8(RYG7!+FHW#N8;V\6=XO5CI?WYZOV%K7/!`JB.=&%P_S64X!@K:, MZGAGV8P*0PV@Z5^YU!W@<:[3;^[SS6*7%2@\"M^B^DM-OT"88`9K*FF<>Y3$ MR2C*(*.W$8/YF/?#$ZE/I,=*PLXV-T7VTN(^V[2J(_2B?9#.,,L!MPP*R#26 MWE=+.!%X1H7(QV!0=X3'8,[>TM2+F[^SVPM6HII>@7AHE`>,D>B:1%&EI;J4 M445O:#[F^O`LZ@_G,;CTQZ?_R;]EFW7A'G^ZS]?;/.K*K:,B[C?+;03CLNTN MY7-!0ZLIEY98(SR7T@DB2U0,=ZF'S!-,^1^>?2,H8-3(5P>O^FV+ZFN]_DZ@ M2'+&D!;$>,L%*LHS5UL%U*E1CPD2^?I1CVMJ+BWK_YD/H8Q6C\MEBNBAGG\\VG M./#'3:#.9CS;*0COC006,:>)D,8@J&P5W18B]?KQ!%W7ZS*N=U6,0;8G`+5; MY]IU#$@9"(H#.HNQ!10`1LIC&H]E\KOJ$_1VIT&Z7M5QA1/38JS%2\,?%[M6 M68\O>P7E`-->$&V5E5`SX?1Q)8]&LD^N1S9!UW@:E.M/%U=*AMZ;M?/)A4:" M1H05]!@KR20O"MP<$M"9I]@UAH:&D?2Q:O2EK'UT/=I4/NCU=X(O;I@P9RPI M:@5H;JSC)9;12IS1^\G]4.K7$H=75,;PB\F;_V?O6IO;N)'M7\+[\1'/5*H< MV]=V*G4_H1AI9'.7YOB2E!SGUU^`Y%"2)9(SX+PX26W5+JT=8*9/'P"-1J-[ M&7\6GV9_#31Y'-[_J+(:<\>)5H$2ZZ)-X)D`#$),M<*DREVAH#A[<:`W.>O, M!*>:!6*9HU!Y[H#Q'#*H':@D1=)/*.RS%7V7G4';ZS!-==/*95KSDS=WIZ8G M__>065':'\QINI3846N!91(*#X20R$1%>XVX.1LYV(V<%>SQFW=+P9-UX&VQ MB?9I6@&BBDY(7;N/0*7U!$#NJ>($&@@!/6!`-)N0EZT5)I3]X-S38?V+H7Z0 MH\;(JM4^&.<%-W&/(Z"R'@'N(:CD5@KDQA6-T*?6!;^ZP+@/;KWXUE^7#U&* M+4Z[_O`Z#%E8K*+5Q6#F!!6'@`#8E;$+'`CV3KPOX M1T+,A&3\WYW.E[>Z6!9W\\UZFQHW[MR+VZZ=HV](.0\9=5 M_/@FA-LV")1:Q+WWE&OBW;84J]Q+!I&W_56D+#>SQ91(E0/O(,1)#O>=^A:+ M\GNJ@="$12];!\N]3(%?!EHAG(K_!5DEL[0R=UFM7X='[BBU+#[/-O%3IS9= M70SY(#1[6S2R[^+CP4*G>0H81)0)2B&'GE92<9Q=3[EQ09W)S4W-P1W0&??$ MG9COD7NED^!PBC'@'A$CI$5:6^`.@\;Q"5V:[]$M=SG065&XKW^!+:(F;N;5 MKD-]+5>;^=_;?QX+RFW<49""I',PXQ35RF&`*:AL0\@,[3YAZTB6NXLT7_:H M@IZ7OR:Q:D%>_S+)>OJ"7^6&_F-V=QR.HU,,8\QM0Q+["'ABG-Q1XGSDUVC2^[I`"_%9LOY6V*.EEOGI7';(?+N5\1;+K- MHZ0`%D'D@3?.P8,.I,X]"FKN#QO47.N1_#UI:C#3[_VJ?)BGDK9QE$_6[,/. M6!P9(K40%'&&XD*Z"V07#E!T-CE$1[[T7CGEVPO@B:G"V>"'->?X=:QFB M1"!.VTH;*9F5E!D/*UF=)[GIKD9(LCX(\3H'6P*_1Z)]C`HMTE7"J.\Z5E70YQRWV]WDS'%'6@:JF?-&0X:4 MYX`)#JFL9(56RND<6@\XQ[4#?H]$.P)2MBT7M"%.<>(E`DA%$$VZ1WU`4.>> M-H[0=3\?">AT$X@00+)JYV'%F,8S_.)@9AI@)%4WMA1]'.-FJ$OJDWS,C M-9^$=;H)GA,A(P)QLR6,H,3$Q:)"`<'L>F0CG/Z&I&('JNAU/MR9L1?,AR<[ M"-10BC6").4HE)H+X'$E.2,TEX0CW(H,.A^VJ801&(OY!F$0VD,'B-"XM^D8#7!$5;JKQ1ZW7#U6 M-1[TZ#-W.]$.JKT>4S[Y.6!BQ_9/(X$Q@!I%$%<`<\HY4?M!R@#2=/"TCKMO M_^DDO`I0BJ;6P?76.)%C5L\!8:J,$MYR8Z$D'@$B*[RLI[GNU!'NZ5IAS=', MC7V@W\>2\BC1RQC6%Q-MTR MM&OD^V6GN[LK;C;SA\?!EC(I?RANRN7-?+&[)95!S^;=!A/-!*UT-`X1M5)0 M`.5!,]S:W.(H(]P%=LO/SJ'OEZ`O;S$_2^:;PH]\O(WU-.^_+S]A):KB;D,[U:;G*BW*&0^,PXA(@[)'C`!U0]2HW9+CQ MA/10K/XL!^!6!A.R*[TTPSK/V5*)N-^`NV7<`D05%)_GZ\568+?>S+^FK%+5 M$W]]*VZV2:;TUJ\>]7?[Z_)MW-CZN)>8+?ZWF+VVQ'7XMH`I%L)PQP3B@AHO M%>453@:Y"<5QMLO(\>BD5P_-\].@=W5IW&T;ZRT5<3NTEPTKW-OUFV_%:EZFNP&K3:<$ M'`]9RBX4-"#YXM!>%;-U6D_7]XM4^&.;LF=GN[[?JC<^_;Y1U0J#$]'*T,0`@DR%G/5R0F;@M9&Z6TV.;@R\CP*MNAL!1[H/2CENF8(^ M[A<)I(QSX"O4M"$3NDDT#?ZWH\W]S?:;G\GU9O9M7;R[4]^^+>8WR1^= MKL'>;^*?WLR_SG$+5"'TQ+YSGL/&KNWR$R&NV. M;MGX6&PVBV*;F?./^>9+?#XIY'[S)27W/%V;H=7W!$N$=P9Q:@U"W'KGE3KH MU-O<43+>PFO7-DIZT>MU>76T(W&X.RV]B_QA'E$**MFBD+FG[,-U#+.X^"KHVJOPQVCS]M2`J`TM MN'"(2*LA0%P);JSF#@-U]HY,-W+6N:"GJORX!\4]>_@$'BWT'AC@,K*92H6\ MCSM-+#RL<*,HN_#NE1W.U69/.;0&^E@NZTCU>IZKDQN72[I-%ZN90)8KQ!P5 MT"JM2852TMMTCCN&XFE+T(^%H/;@7?B?^]EB?CMO]4"5D!![X!G(SE5S9;??NR3CA9`/1\374FHVIM]KG02EO4;4 M",DD1EPHA)!Z-+EI+ND:>[B'S2W9+NE:`+H/O]YFMOR<9N7=;9F&WKFC]UZ> M]UK+ZU:S97!1*9H9R;'&"CBDW"$AG_?.^6$\;\<_O$ZRGAJM`Q.4,PL$55(Y M"XCQ7%5R@\C3Z_>35E>)K?\_DW'4M54J=98(0QI*%GD6@:"^)Q7`%V7V^<].R?,]IJ MZ['L#-Y^KHK?%G?SY7Q3O(DK^>W/GZU__#;[3[DRB]EZ?2:72<.>@L0Z!:&* M.(MY`#VF6/D=%A1"AB90LZ5=2KR8U;N$>P34>_S^M[.OQ=FL*!F]!8,8$))* M1'F$1`&O&*HP07%#=/T4[)PMS5C9@A;Z8>;[57E3K%,P6!%?^$4M;VWQ4"S* M;VGK?#;E2JWV`4`&J>4B565-<6,>B`/&5F47:;D^]EW&BA<,;!_[/CCG6UF$ M&_02M&9$4PV-B08-$5"Y1PP,8!.XVM;I`MP=U`/3K>'"V["G8`S3A+)H3FL& M4NB%$H>!K43VL<,(I[U.&%*?A2V@GY7^Y>-]NE-0K-X6F^_EZK]'5\OC#P=I M!<58,(48519!IJ2NOM)!,:'TAYWIKVP9Y-[2VKV`H5:"N]=;!<2UE3*N\UP9 MX)2U5)!*1LS/9Y@=_QK7%Y':1[L/1KV?;=)9UUD./7LN6"$T4!!"(H".0B%C MV<'V5*:_FF.38PX`!X-0P!)T`%EH?#S.].Q>?4:1Z()I9@Z#W`)NYV"1;4 M'/PMGN;>#QR1P=.V^FO;P=DHC\`'>KBX\TM9WGZ?+Q8G>-:TJ\`X%WKI MD:Y&&^(P.^)U;.OD$'-:%L*9N5SKL>+XPP$12SF/.TQG$",XVHZ<5U\IA,B] M^S2B>E\=\:`U3`>>2=3-S?W7^T4*.U=?R]5F_O=6EWESRY'.@G>*("VD!0I( M8!!DHO)F(&7!=/*0##?IM`-]'V1\^GDO]R\GB'>Z88A:4D@RP#"A!!`5?])* M4NE=;LS"B**4.V97J_CV8Z`__\2WQ::947Z^>;`I()8`*AD15@KMHV%82>V< M[2W1QM6RJ@.4!UXRHP1YRV-L&&3TF?`2'LK("4(*4*\ M-IHP&7??5&%O`3\[(@8PF7<2J?7[V6KS[D[?KR.KUVM3?OVS9DG"%GH/FF'I MI=(R+L3.`X>`,CO<2!Q;4RA#UR.WFAC:G>BGCS6M^M2M"+N\F^=J(+[>(MJ" M%@KB.>:82)AJ=7E8R>881]?/O4&8\'/9NU;0'XI9.W3.QRB=;1NXT``Y'M=R MQZV4#H"(926O\F>O5UT/VR[6>`T&78+M1(,M'4S9S``@6&FB-40`51A01G,O MUHSHL&4,LUEW&IEV3&:T7-*U7ZBM1PB"5%C+[K%(9Z:Y1X$CG/TZ8BM_*Y>9+IIE;H^/`N7"" M(QBA<9HIS0U6%5*,LPD1>S2<:^!I:EV!XZ-Z`O'3][(UAN_["\1*;S#A:8)" MW"(KC:AP<8+F$ONZMG171.P\O8V4S_'UN<[_$ST&@94GG'@),*%"2"JBA;G' MAAMM_A%&^+5Q.D-SXV2U+^]/7=+)ZS`(+@@V@D/LL%)>.`XK]R,5!.5&AHTH M_G!ZG,Y0W$@I'9]ME]+QV2"\)%H8;!E*!8B@)+`RR2ADY\^SKR=UZX0HW5QQ MXZ.TNHLJ;YW7SWH-RBIC(%5&8`$H81;Z2B6,*#"!(,MID?L2[5USF!T7T#L& MXDCF6FD%B3"NDE0+ELO3$6:/O4*>-E=0_W%Z6T_^->2T1##^1PILI6:`II_. M[+*#$A`59\\Q/5.&NH']E=JO'N_P>`Z640P^)A=;$9_^/AI4QC[8*"L=ER3EL2:K'R[@AW.T0QI`H=];+V)N< M]1+S'V\6J!?"$"*<$U2DLA$6@DI2IT%N=J01V4*MZOO%7;76H.UUF`Y;Q[;U MT8H@(,[%R1AXIJ&7GOH*:,#]V*W8@D5*Y9WC7-C[K:OC8^+P`TWXN)N^_\X]R]=]#TN,Z9'G6("AG MA%`.02,-P88CR@^2>04F%,70*5LN`;57NB1C2ZZ0 MYTAPY076^&#C&`]RX[R;'\?W4'2M0YXTA[)7'+HU=/N>Z"'$1@Q9J)!535$'K@=('!(C/';37 M9E/6Y<$15T[+,'<_H-\4L_5`H_C_R;NVY39R)/M'.[A?'G'M<(0G-&Y+E78L5 M?*!%4$(R`6TTV!FE7"JE:V5,.L7Y2)Z9[3@WP_YQ%17'HCC-3].^DP`U%UXS MJ=-+?T8[AA"J4>#>7$"%V5\@#[5^/T>5\F'U\.HK_IJZN_\R>UD_ M`OP]KN3JW03']/1TM^H]%T02A0B*VA!QVDJL#49>2H2TP(T)UX.L^E>1;.13 MR\2NZN")]BN_H:.`+8L'"(O6J+8(."6Q(34:CND+>G3E;#X<7_W=`CV$C=9R M`I_*;_^W6(?EG,^Z75_!&0NQ]AC8"`KS,O[;U'C$_\BMJS%!]])(Q,O&>EK< M2SD,W;%OVUNP1#A""8\:.]#2,,KCP?R*"5:$Y[HW)^B5&H]_N6A/BH$IXZ`S M`FX["X!`A3A6RFI%:,0%,ELC8J$=SMMUN?S+!7M:])L_=[?_;3M+I9=T*EJ2 M<('(X*BT+T^_:SJ(I9"N,_GWV[O@*'(L5R,\0! M!HI!*@&H\4@U>"\GD6,D\F5C/2'NG<^XX(E%W`*+=-SO=52`U6[NU#2'7GV< M1(R1>'8BPD/YM9(K:Q/N^+58/TOP;7&1OBPDL)"$.<`UQPPI2XVJKP6PP8V9 M1H,L\#?2.'X;?+1=8)!11--+2=!C!@W1FM1S55@UYII\?$]5:VD?7\QGX3K4 M$A[QFKB[Y2DM(3!NC58YX+F+!RY[O;5S`"DO&I.#^KX>_F5;_]7_[Q?OO?\9 M=\=G]!\(\08+YM)[:)IHA3DE-7:2H=RZJ!]HN;=FS\%+Y>'P'S+;)04^;7>P M#%8>;!VH,I0KI;BRUE.+HUJ#ZCEC;R[H4>C^.-<5NOT?-)]GU;^C%AC'>%W< MK*KY"[:;C_K.;+ES>3*6]-444]O?Q6S5**^/M4JK89*WW\9%!&.,*51!1Q M20'2QHL:8>Y%;B+F!`^H;HBV)UYQ`G(99YL9T_KL8[=Q6%O*L8V`(\NL4=!O MW`"*`&X;,TOZ5AC4SMU-H>BRG=1^!42@]5$A2:X!R1`DO:@P\ MRGZL[:/M!ZVI<%"#Z!;H(313/;N?E3?%]<^B6%XEP;9XW.9`DV"%\$Y*'75L MD))$G*2XGIUR/O=QY`G2J`>)OW^!I!N0QZ)0\^LU!QL%RR'"PD-N);?.@&C* MZ7J&4O#<&D03I-'Y0F[!FBQ4!S&*?RZJY;>B>GBC3WTN'OX^>F-WN%&@'"$! MD6!">@JH!P+`>H9,"'S9O#E5S._/L*YP'>0:;OFSJ*X6Y=VI[#G>,&`*(GPT MF@->>2RMD\F3M)YI-/]E;D6D"3I1>F!0I]@.P:+UNS7?XL\]_?/'QHK[S78[ MK@FU["&0:-`1+Q@%!E'J).2$U'/'UN3>_TR05_TK1OU@/A&^-:I-K?L(W&`B MG!6$8H(DXXR!>AE3(L0%533IG!&G,RX+\T$XMRKG-_/'V;U>E+?-Y^.^SP.U M`&$$+3>*`R&IYZX^_RGPZ`+J!/8HZ?=<.A_@(6AC%M7CHIHMBX3";O*-_#G: M+E@J$0($2!Y_%E@LA%9;%4"`"[JCZI](72(]#*,>'HKJ9IZN<1^+J@63]GP? MA.':"J\54%ZG<'RGP'8+=\W.VH^3^3`$@\Y'>`CFK*]+].SFW\7M"3O1D58! M66P,AW$A&.D-LD@26L]1<9G+H@GF+_3/HNYP'H)+WZ__6CP759D,T^O'1?FT MB+)R913$8S5?AU:>=-SE=!<$C2M)*R\@Q=Y1!;S=G?86YQJ#$TQ?Z)]]`PA@ M"%I^G95W18.O8?M-\-I1YQ160'!BI2/`V7K\WLA<__@$#\'^O0FYJ`[&BL8] MZ,U707%K-(.*13X3&?^A(*_G8(FXH,###+GMDWP6;H/8[:^!C\T&^]OO0MPJ M$6:(.,DUDY1HAL16>4/H@F[.LJ3WWA8_`[MA_(7_;<>!M]\%#SV7SED8C[4X M"2,\9?4\J,F.Y9B@D=T)!\[`;MC`X<,GX%6+5^M/ZB#`3](/Z<@^/?//E0W)K%T[%XSI8]!!&UPFCC M"2*=]8`"#?'._V#E!?F;^Z5=O[B/R[F_JL73T_>R*F;W:?Q_S>;EL7/TM(Z" M`!P**P"5TE!*M86P7GW,0)=[=?9!3?4^&=@!_),BXM7B:.'[D_H)42/67&MG M.9-`>^I3:L$&!R!D_Z]%RU<:EL7=.J/]3V-CAA#&)6,6\P*$TB)(&>1*FS@C M3WAMA#$?CX2A/-O/1?7WXL(9=B+8X^0*C9@)WTNJD%&(*2<)!40IRAR0Z_KV M",@H##%2JM`1P[5%CF&+UD%3'K;0$2AGKK8*FGK>0EU2^HAOQMU[$N1#W MOYJ_5(O'HEJ^I/NZQW2[-LHBKD?QY7Y6UK>'Z]&T6,F-;8,D###`B9)$0>0( M(VB;;6FY;_24#CSGTW*'3^DF4",$\-8SY(5B%D8MQ==(8.5RG[F9X`+OD!6+ MP0`?8;F/F>7;[ZK7QJ]?6A9&`AFU<4P@>]UI.<(,-&8)]>WG/SB#]NF^Q[L( M4#A#K#8,8P$M`L)[4R.0GMGYDU9[:S8<].IW"O805M_!`>N7%*O3$(;2HG60 M2%O-N7+&X*C.:"L0J>>,9'/MJ(]#L.YIT/94R89[5(JE,3?FN+1H'3`GT=;E MTD/LG,<.*:MW@AV7@:;F@MZ.[52>BXX`':0$P2KBDDKKE+?U'S\]/%:+YZ)=7G"K]D$J M)1VATBM/E/$P@HCJ>7/`@F-;#!K9].[+H$0T'"$PV'`F MUV!YN#W\6?;KH!.\!>R3-^>AFA4J\ZF,9L+J^!:R_\/@G+/`:,72)0_E1$JV MG:4",%=!F6`(51\R[P34+)%_7B1]?EVT;?W,W%&Q[_TX(&2A8YA2S2DV*)Z0 M&F^W+HMR13_!!(_>1-\%L*,:.NMB&.O4E\;3HG4?@2&NF--*4R0-U#YJ7ZJ> MO\,V-[Q[@F]/]'F.](7W]!*%&),RKA:C/6=&BF@=PIV>#G3N??P$]=7>_3"Y MH$XS3\C&62,3%PQ3`#FCF7)TNW08O"`'78;C4)>"8F\,0)PY[U02FV5*6LOZ7#HA`-G M8#>J(GK5(CFHN7&PCAM!"#$`*Z&)`,YL52&K9:[K:X(NC/&N='+1'H)?MHAR MNIFOY7>$26\_"PQ0ZAG12!C`=0J;(CKKO?'\J?JSN MK^8_CH4LM&@=EYF$%#*FI)5<*F/CE+<^'^ASO2D3/*=Z9%'W0(]*KG5X?0ZO MU@T#Q20:`\`BJ9V26E!HMSLWY""W-.($#[,Q*)6#\2#9#C;M)8UO__<'Y'0NF[N@G`B0$1ZP<140I;KBD!N]\6SB7H=--V.F1 MJ",)9=0-\OACE<>:I3L6$:TCR8QA"BKC'>5;IR?1N5K;Z;<7O3\\.\;F>#K" M(P3_CIBVTW/$OZ6(62-T/!.>YH'%WT])Y#X2&P/L:#2B;'_&[`+,MFW2CBJ+_\^9?JUD5Q7+_XN?E MK$P%:.UL.?M>SE:W\ZBDC7+N_#ZF3^6/1?7PJBIN,WA:G$(G]A20880@:PU$ M@!I!B>5@DPH$,.>-;S&.@$>;(D12CA*2'*3[:VY>A40!UK;1#=!3KMHL6@=? MB^>B7!7'#.T]5JJ`6NX>PGH]EY(+>F>Q-TN_ST,Y">`@?Q=H= M&+64'_-C3'GS5?!&&80P`L0K#93WPFSG0'QSAN;'41V'8DD^ND,P)/+V4QD/ M@J*AYM$OWP5GG*3&&,P9A00SCP7>8H'I!075#\62<_`=)`%C5I7S\N[I2U%= M_XS(Z=G3_.8(7_9^'Z*"XQBU`DG$6L&A!&ZLAC18V$*">FX;-M4,^4JFKL5B4A_7HILJ( MWO/Q+!6#*%*&:V$$B3*"EDJP#1[@NG%7[:R_0+ET609RKJ5R`U=.:-0>K;_0GA_[WD:_%^E+Z2YS!R[=J5CY%2&)/ MXVP=AP;38J]H:AJ04D10BRR.)H;!QB.J:@>TL*3Q2GG8&9]69^N$7H(31#L+ M!9-4R`B*(836.'`D+\C]T1TEWF=C]`;W>.M]3-]FG\N>8"P-0#9J^\@P`[S0 M6T^#5FRD^GKJYF:Q*I=/7V8OZ7AX,XM407]558TA7HW-`\1$6B*-TI`!XSEC MVM4S1P;_20N]-0E^C]KJ&N=!&?,B$9IGT>,=1QAX&`J!V$`X9@(_7K$ M>\2B`,8V.X^*XS2+LUU7@4C-A`:2""6)1URA5Y,J(1+_=$'%';LCQT'KLA?, MA]@$EO-J74U)%V7Q8[Y,H4GC+'X;?[Y,S\*4RVK^]VJ]F1;ETVLDT[K@PI=% M%-=VP.N1GN2IZN@7@O4">`.3K<`5-\9236LA`DL:'POJ*3;TV%0VTCW18LWM M,C#@O')<>*^`Q9AYZVV-$/3L@N)(!^?4^VC3840TUDXTIL'[<38D1(@7R&&` M&2"$`T7`ID8X]P19/\Z&M&]V<0+NX?%^\5)4GV?+N+;*NU]G7]T<-ZKS.PU4 M:I`*4$;5V]N4E$,@KU$R5C:B].=M2JUY]5LF\D!"&B:??>]D-F4>5%FN9O=O M_V>ZE-S,M%`/R3-Q.IU/Z#P@Q)!U)@(DC3,>>XY8C9BG]()L^8G2NC]A39W> MV=OU*;T'+IR'7&@,F6`DFFJ6DQHS:K)KQ$\P?.LC$SQ/6B,R/+T_^K6X6=R5 MZ=V]TSG\:_M`/'%I-5M"K&;04(U4/6^(R`55<9TH2\^2QUCVS8C.UH]CWL03 MTECKI3640L"E3@6_UZ)$D,'F8NI]NVX3\YZ2"_"7B60X;MMT%!0&@&I'I2?* M,:X41[Q&0T"66]KU@LV8UOPYZ-WM03#][SC7Q=TZM[2\_:M8W%6SQY_SFS4V9J>==B%SG4)%@AB`>.6!@/$>&8@J]!6LF#I8!M#)8;9H:G M>5Q;M`Z$4$4H@QAH[HPP,IZ@VWFS[,O;"6X`YXO^_8KN'-[1E_'N+Z^2I%/T MY(@^TR[7-U%<>`,Y$5H['%5"@EXOY1Q(^_;)-[:-E1+6&7+Z98>HJHK9H;?T M6K<-@!$:!\]3CJYG1FM+5#T/H2XIXO:]`9N$.8F]=14FL=83?_)@BYB_J.C"#F2\7U'`*LN]DTA9!_WF7CF.50%_01DE'VHWSX-\5`EP'C#;2H_1Y$BUMVC'0.\CM-`FECC'-`0RWHN9[Q[.B%B]*R&N9^B,SBTR.Z%3I">) MOZ^;T!7$@ZBBV<5["*(*4BL-4%P*I[Q#V^6&+,E5.D[>>OI,>1^&,.YS?%TR&75Z^_%[34$4'C M/"1",6DYI:[&%ECX)[C)6M/KX$75>`(9J(AY&NH_J\U`&[QJ^SZ/.['D7AA` MG,$:68.X5_6L#)<7%)H^,BM^+XM\KC`&I-C;>3?ZWPZV"81S#9A'B``!(?!0 MUWYO%J?=7$7\XY#M//'NY\K9@&;Z8\K%6W.W\J5H]IE_^5MS\+!?WB[N7X[(_W"(P MY./&:*#!RD?+#AJ'3#U>S2_L*:HNY=\9IH,4B3OQ7#WFW#N[SZ"AU$XXZJ6! MC'&(*=GMME`-9G7_:9K-4!*;ML\'8^BQLDH++J&R@%"$MZL=V\',MR'*'`X@ M\08_T&EH9YV'*2)J-;L_5GQA[W?!*^ZQM-A`&D]I*(GWJ!Z;]"`W7P/UMIMT M98YW`<='O!U0P@.B!07>88X9T]#">H;8N-P'7":D[)XIV?:W`*=!F;6NZU_? MG(-FMBSN%M6\.'CC>+!!0!!)!E.R.L`*0ZB)V8V6L=P]?T(:1S>"[Q3&T9WZ M(^:L=.G+=Q0BX:24CIFH[WFN_<:DQ!`I=_*+&8WW_4N/;P6)1/XV5;[=);4@K;;C";8F7KK+;_;^_*>MS(D?1/6MX',"\\&P9F MQKU>HQ?S1,A5Z;(PLM2MPV/OKU]2JLPZ+"DE*F\7T.AVRYE),KZX24;LZ^=_ M2M/]??9C[X1>EGR_J$HUT MXY<#Y,:)Z!W&0-1C(J70MFK+J)6H;?PW'G/;%6.]OE+>*4!]Z:#G?W;?TQ_+ M8KD?5_LWWO]Y*(NXO/_XI9BOWZ5[M\O-_.Z/V6)7]%N+:Z":3`/FD#4Q5$_E M!73DM[)Q#0$P&L1^-)E:[$9\^V*45X7MVX#B4X\_Z/S5>OU;/EP*(/QXR>-JOXS6]\_*B'WO5C? MS3?%YEVJ#39?11VU32T[GJNDN[^90LPM3]R%IHYJSJ-4S`;-(6"B\TDI["#5G@I?SI\Q.Z&A8+G"O M.RUDDJXSZ$^>$COR5.#0<.N])P9`2PFBDIMR#8#P"<&?@=LQY+/HU@7V_Y@O M4UG$6O1?/!<\L4`RIJ6#AF@IL/2R7`'/%3\KT5OU1SM.N&!0VG,>AYX M_EP`W"FF#$6$8N\B/;2O-*&0/O?`Q`#CAD9XX`;:=5KPY>\7'._\^>'@'(]Q MA\%.&Y7VCK62OER1QMWM*G6116G();B9BH/.@%1>]+,([\-\\V^_+HK]3G"Q MV7Z(!'A4CFUD0:Z<0I!$"D1B5(^C>Z^$9%!5OKTGHK8ERGBLVBVLUU1VHUUT MIB$;!Z/1JVPF(/"@4AY5U)?NOKFEN.Q]J.2C2QT1B<;:8/@ M;EO<_[%:Q,\LYML?/5B.LY,(GBH*F!=``^*AT)BPR@F00N?V91E@??^ARD>3 M^$Q%0KJU'V@N,3$*R\.E,0C[5+_[3 M-8O_6*R_PCJ):&708`4A"%`.G`"6."L4IU7FAV;?IZ;3EX`AX#%:FV#GW^;W MQ?(^"7O7IN#YV`%IR*F-J%,,%,:4:E!YJ4R17`O`IL__`X*EKZ,#O\4%;VV< M;[6NS=,A@K3>=`"P[./T=LSOR/D5J9W"@@-I#<)<>HX<*IL)"8!KBP8-3.4] M8K_GB^IHS/\6\X/10_,TV+IZVNG$D`!!JA"))I'\!#Q8U\PH/3 MSEJ7C^#@X<6LV_#1JW8A[4N5/CLFK>ZVT11L?[SIRR-,1]*1.J*(,4XB[02B M1!+B-#-6@WKY'*:^?+_;;K:SY?U\^?!AM5CXU3K]98MJ\?B`00G-L")`.!+= M(@X(-;2D+N`L]]CI`#=;NF+#AG5?([@-.FCZ>:&'Z^W=",-AK``4$Q`P*8&3 M5N(4)KB2GM3QSN3@S[V)BX'+>MMN:-0S6[8G)5F`CD%`7GI!OZU7F[.'0YH? M+7@,O55>:DB@!P0YPE!)4Z]0;NGV89XNF9:`W`YG-\>?HDO\;K/9%?=VMXZD M.TQWO[+-\VN%Y66,LQ[3U1\+0!J.%,(BM5"'V'*+*Z6!&,P]3'?Y]J$\,/BR M>)@=\J._&)>W#=D8]'PDXN=BODWW'4IY;5'/'QDM(.B$=`*3Z/%:!3#52)0T MY03EUK6^?(_P5Q>#WC$=@YST&S!P(Y7W0`K/*:&0\4C>2N]XE%N5]^I=Q$/` MX);W;P+2'9PC$X]7&=/2>/Z^GM\5"8[/76:?+IQ,H$PSY#36F%*B(6=>L4=$ M'&;VAM*?;YFI<6`Z(2GK7[0"]QA1*2*K<`8$HP[B4L,YQD5GK=Y'F.%JG+W[ MD<0K66`0XK>Y96NP,1%L;A8!.6H(TE!8SB$!"J-4]/6``<1N0MTY?"7AA@#,+WN+Y4)*+U?8*?Q@I1AR$) M*%!&2"45Y)%+*P?#X=RVG0-T,D>:QKP5LI&)0$_VY\(9!!4M/O/$.P"MY\)$ M$.23^E&Y,=D`/<#QBTN#0`[Z'FNM!?U0I":E\7>S6N[1V0QW#7L*=NO;%(WGYFN?PC5H4,<@:*=5S"DJM'*3/'\V`3$9 MZ8^LA$H;03#2I#R4YK@EN0>H!GC%=J2"UCZH8W`+GZF;SHKAGQPS<$X%B]X" M@I(CB2R`0)7TE=3G-H+C;T(S,.A&9H->KK4C4_-JT"`T$8P28BF-$:FP7`-> M4E@AF>NZB3?A&!IV8S`\26\QEQU,/#>G]_L+/41O:<`I?.`$>8](X2[[77BB9\%.$`2IB; M+X0#/!4\+7O9.+9]%:/:]]!X*SSUL@$T$)9Y;P#RDGOB)62'*F+">>QKMZ*' MJ3BOK*6VYXM+^I+W.J]@+$$X==R,9@T1E;H#VA(KJ5FV-S,Y_7DQ4_=;PN\F M>#OQ7^Z^%/>[103A^+*?%ZM(*SJ0ZZD$[.5RU>A`P8$4H2D,O#(&`B`%U24E M,]7%0MIS;W M\2`A-E98P1AB`%NFN445%81HO\S.5#FU-XQZB][B?'>SQ5N]]2/,`Y6R6$@) MH(*.(AM9B2K!C=52*4!JVWWT8T4ON5Y5VSJ^J3&"!X@C#Z2''`G@!5-4533D M_JU*\-7,=J5-;0NJ+-,:)_;UT;#'6]:??3YXC'G4X`(!021'7''CR[E2 M:";4O[H'?%?-(]`8M]A5VJFXAE\.;P2E09RQP]A*1#2$J?1CM7J--P8AI*BS4^'$- MVFLT@7[!C:&X:I>V7:0??E_,EO^9,EBLQ1.3F30>D9&X# M\`079%$OR\RH^!-R?^WFVQ_OEG=QG?-O19K%>0-S_JV@*>;*>HLM15$%>JJX M*.=-I?UKO9^@=*,]GO*IV'_]3S`7*C*'`@U2!! MAG"B8.EG:K\1]>/!5+>\O]D/:&"Y8:PDCR!M+M722`^ZG]6^FF4.B"RYY/L=;>_OQPH)X)2Z'"7GAM(+8(E#32%K%<[V^( MBNQV5%<-D[,3!MGG/?=35;4&[^>'`[6..06``<);X(TSV)8KXAQUMCW:15^\ M6P!]S1NW4K(+WOB0%&F-2:J>"0!:8H'#$$C,,$'.L2=2F.PF"P.LL-2_"F=<4ZM*GCT5H%02*0*-@8*^8X2#]`R@6)=T-E#HW`33``F7]VZG.XG[04;?+I(18BK0^!7[4,Q:+U9K2[][4;M MME]6Z_G_G>\/W?18@0(.D$<>>F.$<$APA"H[Q-F$+E?UP-I#@6U,8O!M-E\D MV^57Z_VV;`?2\'K((("&!B/G%0;:^:AK&*RH:[(/7PUQ[W3\0G$C>@UZ'D4,XQUQ$[S`7G)14)09WU_'G3T.T@ MUJ!6OF"^Z8>75N7=9K,[<56MK:&"L8QCQS6S"D@I"??*5#!1D%N!<(@)CD'I M[BY1ZY:OU7(9S4Z4P'2R=?90O%O>K8OXT+OES[[3?D'+HQ4ZNY]$`(*+E!J- MX;WD&#-+JKW;U',LMP75``NKCTX6.L"S6REY4>ZGKEIM6T.%=#W.82DQXE@J MCYR6E5](`,_=D+^Z6OJOY[MWB5NG1R*+];H^>_E#@&[5X'"*=:/4>?TK/G0N(NYU($"B=1C+6`D&%Y0!95>VG,$2$<0)MYH!KK@5[G%ED@HYI3WM MF\%]G1>[G9Z=Y'5?3;/^!N&)-Z*/RZ47RAE&O=$.(X!@N38L?+;I&#RO7`EM M#9_DD;,G5JF_Y7?JG<"X`\(#0!"FE!F32I^7ZW/*9)>&'SZ[7(UP/<=DT;0' MGJD].WKT^2`(1=0K2[FC1EG++2)I71([`"&=T!G2!K`]SRU9%.V!4RXZ+WKB ME6"`8'&8`R`HQ*Y M=.L944E,"O(2>*<"LXX24*X,@^]KS\*4R`]Q+@L_KZ#FN MX)-SY3FB.D;I"&#!/4&^7)M`.G/B\1U-QQ-\4F0@T8(IPVT,E1@0BI?KPHI/J`53 M`]A>%'Q>1]&Q!9\26`D!9418KA"##(I2%UN#U-2#SX9,42X]N^"6LCK^QY6Z M^VLW7Q=ZMXG3W6R*S6_KU>9L^=Z:5P.*BX5020N$D=:`*&FT7*UC;+IIT0S` M7]=F;9:VG4>D9UM5EC.Y<<([OI;L;D@OW?9!P)"4`+( M4[-,GK(1I;YSQ"3!NCG5=2 M/=;NBZN6`$UH=[!I-KB*R[*HW06/5;/UJ[5=[3YM/^\6I0#6YA3K7PZ>VD&@D^*BJV_[2S?OEN?%]L-JL8@*/EV).<.3 M&5\+V!!-L4T5GS7@E,NRVG.DB>-3JH;>(K^\+F?:.@[]!QEZMCA1$N&J]X-4 MP%EZJ/63BKL"H4KI9TJ1SF+:/_=WR/YG.UMO6^7"5GGCJL@C#X'^.<]\F:T? MHKNQ2E[HZQC&GNA&'#D4P]<`1D3BFA/^'Z7VCJF2= M$]JSDA::B0F=1&^:.6[:"[V.[/W;I.;V0C76E%(.,+%`4JF]\Z9<.7(TM_;1 MZ!@NFR/R]D*O(WO_#-?,7JBE"'`OD;%6"PR5B?Y>1=1(@2DR6S-LD+,7>AVU MI[]QP`T&=!_]*@>P\YH36YD2C7)O!`XP$=&UJFL'@6ZN;GS].EO_>'ZXLI2H MRRZ%U[\>#!8B]9%AF$OC@!-85JLF#D]RA[YQCOCIOD?CA*^+^/[V7^GA3[-- M$?_G_P%02P,$%`````@`FH%:1BL)+J`%%@``=O,``!$`'`!G;65D+3(P,30Q M,C,Q+GAS9%54"0`#4XSO5%.,[U1U>`L``00E#@``!#D!``#M75MSV[B2?M^J M_0]QFJHYCRY?,)#N>4Y1,95DC2XHD9R9/IV`2DK"A0`U`VM;Y]0N`%Y$4 M2)"4'/,L-96IDD&@T=T?T.C&]=>_OZP=[0D2BEQ\V^F^O^AH$%NNC?#RMO,P M.]-G?=/L_/VW?_^W7__C[.S/WG2HW;F6OX;8T_H$`@_:VC/R5MH?-J3?M05Q MU]H?+OF.GL#?M(5+UI`X6^T/^#A`#J-)S\Y"4EKPZX7:GZBU@FN@`<\CZ-'W MX(`5NX,+X#O>;9M/ MY^?/S\_OEX[[Z-,UM)$%G/>6NSZ_O.A>=R^ONAV-Z0#33TOVL6(1)M+W5)&7 M1^*\=\F2Y;RX.N>?'P&%47;L8NROY05LCYQ[VPT\9YG.6"Y(D!674Q=*%^`9 M;"\ND^3JYCSXF,R*"F1`F'H`6[$,+WLR/U^)W-V/'S^>BZ]Q5FK+,C*RW?,_ M[XKLXON&4 M:,-)F:4%SZ'CT2CE;$?J/>.AHYU7Y(>X#J1'8DC0.I@CWB".Q9&@58NCHI:4 MP\]^$?[7653NC">==2\/9&/7*:NQ$94["AL?SP&Q.-P,.K]TG\XMU\<>V9:V;;)RT1^U MC%J:JD\(\Y4$V#V^[9#F;X=&`G_PZ6RX:*J5*P(PJC)0CG@L:I0K`ATFBK/AL"J\K`BE$76 M]=H>IS!G.33$`C[=LH@/;>:-0DPA[6C\Z\/45(36@HMLV;B>J*9=6_KMLGOY M2_?B0CO3[A"U')?Z!+(_]'Y_^F#<:<:?$V,T,V:_GF<+9FGZ%-IC_)OXG55# M6#K,4E0RTW?+%TQW#WFY,#726PS,&CNV$)=_"RU4%\> MS-G<'(]::)QBS>F40H^*!`)M'=M#!!Z1@_@@5\]H52)=;,PN?KZ^N"K`37L7 MU*%%E6@`VUJBFI_:;.EB(/HN]A!>,GG8+XIL2`1[$[#EL_A3UW$6+GD&Q#X0 M\,KUJ-&_+D1_5Z&6JE$+J]02=9Z:`H>HUH"7+5T\V%W\+!WL$K"=QKDY?/%\ MX!QJ8;-DU/U)XAHF@0GIM;BO](#U?4E<'_,!:^:OUX!LQXL96F*T8#A@C_E_ M?.:2F9V)ZR`+5>Q-=>@KG)NNQ+GIZ?W?/T_'#Z,[36?_SQ[N[_7I-VT\T&;F MYY$Y,/OZ:,Y=4)9E;HX^:Y/QT.R;[8O3:N!1I],>4(VB4WT!*B:EO7%/KN>HT\[C]2AE'L8U:&NHA.L4F_OI:8]/[X M_MZ4\M#-69;;+XQ MH0<-^:,16*76P8`L5[:Z9<"N(*7J")F;`P.,`**&K@/*Z&I3)"K2@AA.H@?*- MOWSD;8^"8TA*`=U-)>@"FB>P`@T?L=.5ZV=7E)4A$@>+PZTH6 M?MT9O7D;E5LGG$J6*XZ;KF1Q$U=U>\.C.TC0$V/C"0X09@XM`HZ)J4?$89^J M.!224O0"V:+YG3$UO^IS\ZNA#)5U"O9*JH:PI8NK49G(75L&]AC/JN)^:%'P5@U MY(H(%2%V$4\LQ>K0"I-TU>G;IBUOQ"LK\K`$Y[%U4C8AM1 MD>A&B:JTH*X6[U;(`C+>B'TA)K;A"[3GKM`;H4&V8R!>J@(UZ'O;NF2@AW5I M866:YP;M@/P7#6/#>PBX=JJ'RG(*Q7Y']X/$[QCHYE3[J@\?#.W>T&#9)S)Q:FE`T\PO3\' M+Q5A2993A%&7$G-FCOKC>T.;ZW^V;Y-10G5\$=/%P>+-'5Q`0J"=^%S'L%6G MKO`1+J\O;HK@X^"=`0($2LN!W;&/3KJ+O=S<9>+ M*9[Z%%?P%%HNMI"#!%?C10\N$<8(+\62"Y_6U=?\``0SA@^8L,Q+C/X);5:V M!S'CJEX4^2H,J)O&A^*FD6:%6^28F7#)2$QSA_SP[TF.>.?7(IY.C4N&+=\A MY?.;^!YF`\A/!SLLVQ1X<.X:BP6T>+?D?QZY256M5MV0]B;,50TI9D%[>#][ MKX5LB";#:^:3Z3$K(J75#<@#>(G8$!I<)U"Q&60**^8,96N5YFBNCSZ;O:&A MZ;.9T;[9PJP2Z_5'.0W%'*%L9GT/CU/?B+3*[[VQ/&@/?(_IBHU,Q$/_#,U> M=`O':Z!Y2+WJ%B")FK(M(&)`"SC0DBQP@QM?0;+C0@MO)SDUGA"06D&4E(1B M0EFV<"GIU*T-FYZ8`"ZI>J`U6:YXE+N43R5_-4;S\;2%QU43FJMG#/>*%]NT M2_ED8*S_-IND6)6UK%&V=+$ANI3/XR1P:*D)&D)0]5+*L(AB#>M*8GB&AM[" M&R@#?=TSDFM_'3@M4RZ1$UZ.11\PBPG'&W%G%EX&V>M8IX,J4H2^5Q([%L"I MO0MKC!RRH,[HZB^JB5JUN%HMJ+?%86Z@`*ZF\/+**73X.;*Y>[1&4(&X&O@] MISP"GM>BA=5H83U\0N.$=0;K&B-)*,KA%&+5T7+L'Y#MKO3WXVYSJ.=F=%GE<];Z';+E%G'N!7144PNR`8P*3;M MM54R[=:P7`5D%+,%,CN6@U%+S=HDN/A^R_:]C*38VA/C?NSB8Z'^SF4WTT MT_NM?-\C3ZMUS*2*EL(^RHY@Y0/57JN8I^8:YE!!2F$'96>QB@!KK?7S4'#& M+=R!.7%`9=LG):&P?++8>&K,S>!\G-8S1L;`G&N3H=Y&NR?3:#VK5T1)8?-D M47(>1&VV>#(5U[)W!804UDX6+^=#U5);-X/+\$ZDS]!=$K!9(:ON!4LJ6@KK M)[N3;F9\%F#Q*]8_&^//4WWR/V9?,T>#\?1>Y\/4";"4DG>)T;N_=4QD[4H4 MUE-V=YT:8NW=KD(MJK'%4;8"G0EQ;=^JMS6W(FDUW'L+_67@CJHY89P'1(VA MM!Q%Q9@JN[FP#*)M'5T]U_K>`ZP\/YP+6;A6?5"5DU",I;)WPV;SP1ABBQQ+TH]8_N:C"A, M9+NS!%_QI6[\>*-@38MYTP+FVFS0I6#'%^O$U^_IE/KK M3>TIO0.J4;>8O9.*^2V&UQB`GKCN[V]:HMI36\B`])D`[-VQ+A6C17=P\6=N MN04PUAO'W<)C&IQZ]:I;R[[KE]M:!`L:YT';-1R:O"@R9$2<;8U8.;6@#)*) MX4'GIW]K7@Q:F;BZ+>Q=7I3?%I)CB1;5=((Z@T:=`*"(D,+O[\K\_EP(3]Y^ M4L$'W"=:CJ*Z^^U/NN1C=[IQ=.8_4OB7S\\[/%7=#YDMJXC3/LKBM(?>S/CR MP$-JXVL+=T%F5%BKW\A)*#K*1UE'R8!QZA6A3NL,0%(*BI'GHVSDV0.EI2,. M]Y-!X)&)EZ7YI,`79KW18LOO.@H3*X%4DF2Q7;N1W83"+WP-!IGP3>K@Y=PO M#_K0''SC#U1'Z2<893JO8PBK42ZVCS>RZU3*@]I>RUD.A!H&M1+A8CM[([M6 MHPJX__\M\*_G+]3^!#8;A!>N2`M3,'8#$8)$G@:=X%5'\$@]`BSOMN,1'W9$ M(_*4C;`> M\OQ@6L?U-[>=ET?BH$_(@^N.YC%A;CO8Q=A??[+=-4#89!^XC!TMR+B!!+GV M7&2T?1*N5YSO2[:3Q+)8W?80@4?D!,?GXC;$@XF>PV*86*"2F0^0RXO(O(9H M0[@$#G\4QUM!,H.>%Q3A'2^<%J?YHI8K7$?T(&7M8F9AR38K^&/P>/9MQR+, M@G@R?2#,'][QI.K(;\,Y=S.QC@4Y#PE5J#/6%YOR-89E;;2+Q:/"5+!N>)WI MF3D?WZY#EI&#3_DN7@P)'3I61I*\KTTP]T_, MA^-,#%PR`\D#N7T7"V&9`W(//)ZXC06J6*B^,8B$.#YD/6!]7[+*,7\4;>:O MU\S2CA*MC&F'9^*/;R(8!G7O$7%B/C:+A13.Q3(=0>,7QW(:/\N&\ MMF(2WDK?)Z18!]+,C7-?2HH[)4_N8+W7?7CPB#@J:K$\*" M==L.!E1FN$.,)X*%Y&";5=@KU_4FRJ[6HVIJH+_B:>9NNT;4WK9'4G%A!0W6 M:Q_0%0^#GYCOD)1G%SQ&"BJ5\RU,&L`*;6YBED(OC.>X?^5^;=P0D^LQ M,!'6R(NBWKCIIQ7CEUC^HU#+CQ,S MW!:RFXA\02G\OH*W^(:VF9.&&ZV$&^6W(QH2$KPDFQ>F54D9E"@V8+TCQ MSYF;0C%]+0;J>_#"+Z8=/_.IN17:L`B%K\N`)92*7ZEX+=F9X)N`R.&2WX4H MS<%+.JEY8R`+=XB_XIQYQP=[UQX*Y/5BW4V%G4N,V% M[='`@!O5(5PB&FP9,QBG:WYX-Y\JRR:K=KQ:<:Y""Y( M@@8&G&P?E'UJH!7ARU'C15\8V0&PQ(*J8!Y2C_L]T6'J1%Q7K4B3X[R4).@% MVIS]-)#%61H.J`25]+1#VJ@.,_F%ON^HQ]S(-*F63J(DW+$0Y6YV)$GNU\;M?E`(M+]D4"+?FZ\-Y/#(MZEN][S+LIF;Z4'>N[;O M0+$G0[Q^F.I0>1\;.(J-X/-L!=AP9%+JLVATRX-W@#,+`0')U_.@0^ME;0GB%F9OC)KDUR-:UT[E>5 MK)8W/_*?``VF_3*M3/*A@5UF3-"2N01.XL*LW'7NDGD;T'W"C3N[J%Z^I3D2 MK'SVYFT9S45VXE)O;QXWF]C`%CDA<)_M=%H36AB?.88V'1!WS<<1("P5:R;` MF?B/;-@?+Q:0QY\C*)8-;$B>^0$@O!Q`,9A&W[.G*%^#<',=1B;M$^+A^\(E MZ5V^%FNI[F+INC:EKF,GU%.Z0'/%EBP0-F,M,.9PQL=?YO>-%P6;6L2(+5YV MXR=Z4X^[[7G(QR38C,/2.XDRJ-))#0K-#"5R14KO!%=G:\!&<(E0 M4_@$L0^Y<39>Q&2MT_>9W5E#0GO;W3W3P-$)!*GY7+ZXR/(Q*2Q5:WBE6IK> M8OA!V91\7+J]4Q(5\C=OFYJ"^9P^4IBW41V%Q]5[U_>K(*XKU](,K?<6QN=1J?VUY>4(4:N]F0%)- M[E5(']`-`U)OIK%P14/L;:+&"P,043@AZ`B-KY#T`4U,U/9*&I/($N[O3MQJ MP!<9BK53A4P35EWD4L3-G4]^A`^F%4DMS=^\":W@UN,PAI0&GHEG^)(+O'4* M-GF9MY(\Z072>D4;,*N1N/):\BH#\RW3;R]$'DJ./WLD8@UU6TO=9K+OO58N MUD`GMI0,:5^V4I$&N+0%PF\V#H)D!+UGEV1FR/,^-G":=;;%W@K2!PJ&CK7[ M(UZ"<2Q^94^<+D(0ECB,Y]PRDA^-7`-U%5T1GMU/)TG_<;TUN(N1,JNY!NS/ M_P-02P$"'@,4````"`":@5I&JHY`Y7&^`0`-&"$`$0`8```````!````I($` M````9VUE9"TR,#$T,3(S,2YX;6Q55`4``U.,[U1U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`":@5I&LG!.YRX;``!KA0$`%0`8```````!````I(&\O@$` M9VUE9"TR,#$T,3(S,5]C86PN>&UL550%``-3C.]4=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`FH%:1C+3>NGN5@``^C8$`!4`&````````0```*2!.=H! M`&=M960M,C`Q-#$R,S%?9&5F+GAM;%54!0`#4XSO5'5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`)J!6D;S+5I@4>D``$-!#``5`!@```````$```"D@78Q M`@!G;65D+3(P,30Q,C,Q7VQA8BYX;6Q55`4``U.,[U1U>`L``00E#@``!#D! M``!02P$"'@,4````"`":@5I&**$CD+20``#2,@<`%0`8```````!````I($6 M&P,`9VUE9"TR,#$T,3(S,5]P&UL550%``-3C.]4=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`FH%:1BL)+J`%%@``=O,``!$`&````````0```*2! M&:P#`&=M960M,C`Q-#$R,S$N>'-D550%``-3C.]4=7@+``$$)0X```0Y`0`` 64$L%!@`````&``8`&@(``&G"`P`````` ` end XML 97 R38.htm IDEA: XBRL DOCUMENT v2.4.1.9
INCOME TAXES Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Schedule of Income (loss) before Income Tax, Domestic and Foreign
The components of income before income taxes are as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Domestic
 
$
137,643

 
$
101,424

 
$
114,176

Foreign
 
999

 
577

 
477

Total
 
$
138,642

 
$
102,001

 
$
114,653
Schedule of Components Provision for Income Taxes
The components of the provision/(benefit) for income taxes are as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Current:
 
 
 
 
 
 
Federal
 
$
43,561

 
$
41,741

 
$
40,338

State
 
6,097

 
6,118

 
6,419

Foreign
 
519

 
912

 
345

 
 
50,177

 
48,771

 
47,102

Deferred:
 
 
 
 
 
 
Federal
 
(3,630
)
 
(14,088
)
 
(5,510
)
State
 
(357
)
 
(1,210
)
 
(352
)
Foreign
 
(33
)
 
(84
)
 
(418
)
 
 
(4,020
)
 
(15,382
)
 
(6,280
)
Total
 
$
46,157

 
$
33,389

 
$
40,822
U.S. Federal Tax Rate To Effective Rate Reconciliation
A reconciliation of the statutory U.S. federal tax rate to our effective rate is as follows:
 
 
Year ended
 
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Statutory U.S. federal tax rate
 
35.0
 %
 
35.0
 %
 
35.0
 %
State income taxes, net of federal benefit
 
2.6

 
2.8

 
2.9

Domestic production activities deduction
 
(2.7
)
 
(3.5
)
 
(2.3
)
Tax credits
 
(1.2
)
 
(1.7
)
 
(0.1
)
Nondeductible expenses
 
0.7

 
1.7

 
1.4

Other
 
(1.1
)
 
(1.6
)
 
(1.3
)
Effective tax rate
 
33.3
 %
 
32.7
 %
 
35.6
 %
Schedule of Components of Deferred Income Taxes
Significant components of our deferred income taxes are as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
Deferred tax assets:
 
 
 
 
Inventory reserve
 
$
22,808

 
$
19,635

Accruals, reserves, and other currently not deductible
 
19,043

 
17,133

Stock-based compensation
 
5,548

 
5,152

Foreign net operating loss carryforwards
 
418

 
724

Total deferred tax assets
 
47,817

 
42,644

Valuation allowance
 
(45
)
 
(327
)
Total deferred tax assets, net of valuation allowance
 
47,772

 
42,317

Deferred tax liabilities:
 
 
 
 
Depreciation and amortization
 
(9,865
)
 
(9,759
)
Other
 
(2,643
)
 
(1,229
)
Total deferred tax liabilities
 
(12,508
)
 
(10,988
)
Net deferred tax assets
 
$
35,264

 
$
31,329
Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Unrecognized tax benefits at the beginning of the year
 
$
3,978

 
$
3,500

 
$
2,799

Additions related to current year tax positions
 
—

 
661

 
673

Additions related to prior year tax positions
 
614

 
64

 
46

Reductions related to prior year tax positions
 
(209
)
 
(109
)
 
(18
)
Lapse of statute of limitations
 
(202
)
 
(138
)
 
—

Settlements
 
(953
)
 
—

 
—

Unrecognized tax benefits at the end of the year
 
$
3,228

 
$
3,978

 
$
3,500
Impact of Unrecognized Tax Benefits to Effective Income Tax Rate
The impact of our unrecognized tax benefits to the effective income tax rate is as follows:
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Portion of total unrecognized tax benefits that, if recognized, would affect the effective income tax rate
 
$
838

 
$
1,184

 
$
747
XML 98 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
LEASES
 12 Months Ended
Dec. 31, 2014
Leases, Operating [Abstract]  
Leases
LEASES
The Company leases certain equipment and office facilities under operating leases. As of December 31, 2014, minimum future rental payments under operating leases for each of the next five years are as follows:
(In thousands)
 
 
Year ending December 31:
 
 
2015
 
$
700

2016
 
546

2017
 
279

2018
 
105

2019
 
—

Thereafter
 
—

Total
 
$
1,630


Rent expense related to all operating leases recognized as a component of selling, general and administrative expenses was as follows:
 
 
 
 
Year ended
 
 
(In thousands)
 
December 31, 2014
 
December 31, 2013
 
December 31, 2012
Rent expense
 
$
676

 
$
424

 
$
419